Ligand source activities (1 row/activity)





Ligands (move mouse cursor over ligand name to see structure) Receptor Assay information Chemical information
Sel. page Common
name
GPCRdb
ID
#Vendors

Reference
ligand
Fold
selectivity
# Tested
GPCRs
Species

p-value
(-log)
Activity
Type
Activity
Relation
Activity
Value
AssayType

Assay
Description
Source

Mol
weight
Rot
Bonds
H don

H acc

LogP

Smiles

DOI

2583 212673 51 None 6 4 Human 9.0 pAC50 = 9 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 292 5 3 4 1.7 CC(C)(C)NCC(O)COc1cccc2c1CCC(=O)N2 10.1038/s41467-023-40064-9
CHEMBL839 212673 51 None 6 4 Human 9.0 pAC50 = 9 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 292 5 3 4 1.7 CC(C)(C)NCC(O)COc1cccc2c1CCC(=O)N2 10.1038/s41467-023-40064-9
1978 7038 60 None 28 2 Human 6.0 pAC50 = 6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 336 10 3 5 3.0 CCCC(=Nc1ccc(c(c1)C(=O)C)OCC(CNC(C)C)O)O 10.1038/s41467-023-40064-9
40 7038 60 None 28 2 Human 6.0 pAC50 = 6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 336 10 3 5 3.0 CCCC(=Nc1ccc(c(c1)C(=O)C)OCC(CNC(C)C)O)O 10.1038/s41467-023-40064-9
7107 7038 60 None 28 2 Human 6.0 pAC50 = 6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 336 10 3 5 3.0 CCCC(=Nc1ccc(c(c1)C(=O)C)OCC(CNC(C)C)O)O 10.1038/s41467-023-40064-9
CHEMBL642 7038 60 None 28 2 Human 6.0 pAC50 = 6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 336 10 3 5 3.0 CCCC(=Nc1ccc(c(c1)C(=O)C)OCC(CNC(C)C)O)O 10.1038/s41467-023-40064-9
DB01193 7038 60 None 28 2 Human 6.0 pAC50 = 6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 336 10 3 5 3.0 CCCC(=Nc1ccc(c(c1)C(=O)C)OCC(CNC(C)C)O)O 10.1038/s41467-023-40064-9
10184665 10763 51 None -173 10 Human 5.0 pAC50 = 5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 485 16 4 6 4.6 OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O 10.1038/s41467-023-40064-9
4799 10763 51 None -173 10 Human 5.0 pAC50 = 5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 485 16 4 6 4.6 OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O 10.1038/s41467-023-40064-9
7353 10763 51 None -173 10 Human 5.0 pAC50 = 5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 485 16 4 6 4.6 OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O 10.1038/s41467-023-40064-9
CHEMBL1198857 10763 51 None -173 10 Human 5.0 pAC50 = 5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 485 16 4 6 4.6 OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O 10.1038/s41467-023-40064-9
DB09082 10763 51 None -173 10 Human 5.0 pAC50 = 5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 485 16 4 6 4.6 OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O 10.1038/s41467-023-40064-9
216416 118358 48 None -117 23 Human 5.0 pAC50 = 5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 413 6 1 3 5.7 Oc1ccc2c(c1)CC[C@H](c1ccccc1)[C@@H]2c1ccc(OCCN2CCCC2)cc1 10.1038/s41467-023-40064-9
CHEMBL328190 118358 48 None -117 23 Human 5.0 pAC50 = 5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 413 6 1 3 5.7 Oc1ccc2c(c1)CC[C@H](c1ccccc1)[C@@H]2c1ccc(OCCN2CCCC2)cc1 10.1038/s41467-023-40064-9
11823027 199395 37 None -5 3 Human 7.0 pAC50 = 7.0 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 309 5 4 5 0.6 CC(C)(C)NCC(O)COc1cccc2c1CC(O)C(O)C2 10.1038/s41467-023-40064-9
4411 199395 37 None -5 3 Human 7.0 pAC50 = 7.0 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 309 5 4 5 0.6 CC(C)(C)NCC(O)COc1cccc2c1CC(O)C(O)C2 10.1038/s41467-023-40064-9
CHEMBL521606 199395 37 None -5 3 Human 7.0 pAC50 = 7.0 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 309 5 4 5 0.6 CC(C)(C)NCC(O)COc1cccc2c1CC(O)C(O)C2 10.1038/s41467-023-40064-9
72093 41835 9 None -10 28 Human 5.0 pAC50 = 5.0 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 483 16 1 4 6.3 CCCCCCCCOc1ccccc1C(=O)Nc1ccc(C(=O)OCC[N+](C)(CC)CC)cc1 10.1038/s41467-023-40064-9
CHEMBL1433361 41835 9 None -10 28 Human 5.0 pAC50 = 5.0 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 483 16 1 4 6.3 CCCCCCCCOc1ccccc1C(=O)Nc1ccc(C(=O)OCC[N+](C)(CC)CC)cc1 10.1038/s41467-023-40064-9
CHEMBL2103773 41835 9 None -10 28 Human 5.0 pAC50 = 5.0 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 483 16 1 4 6.3 CCCCCCCCOc1ccccc1C(=O)Nc1ccc(C(=O)OCC[N+](C)(CC)CC)cc1 10.1038/s41467-023-40064-9
4418 40996 85 None -19 18 Human 6.0 pAC50 = 6.0 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1038/s41467-023-40064-9
CHEMBL142635 40996 85 None -19 18 Human 6.0 pAC50 = 6.0 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1038/s41467-023-40064-9
12582 7737 45 None -1 7 Human 7.0 pAC50 = 7.0 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O 10.1038/s41467-023-40064-9
2783 7737 45 None -1 7 Human 7.0 pAC50 = 7.0 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O 10.1038/s41467-023-40064-9
CHEMBL49080 7737 45 None -1 7 Human 7.0 pAC50 = 7.0 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O 10.1038/s41467-023-40064-9
DB01407 7737 45 None -1 7 Human 7.0 pAC50 = 7.0 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O 10.1038/s41467-023-40064-9
3083544 33582 51 None -199 6 Human 6.0 pAC50 = 6.0 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1038/s41467-023-40064-9
CHEMBL1200811 33582 51 None -199 6 Human 6.0 pAC50 = 6.0 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1038/s41467-023-40064-9
CHEMBL1363 33582 51 None -199 6 Human 6.0 pAC50 = 6.0 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1038/s41467-023-40064-9
CHEMBL1951071 33582 51 None -199 6 Human 6.0 pAC50 = 6.0 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1038/s41467-023-40064-9
CHEMBL605993 33582 51 None -199 6 Human 6.0 pAC50 = 6.0 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1038/s41467-023-40064-9
100 10577 58 None -2754 38 Human 4.9 pAC50 = 4.9 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 10.1038/s41467-023-40064-9
2637 10577 58 None -2754 38 Human 4.9 pAC50 = 4.9 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 10.1038/s41467-023-40064-9
5452 10577 58 None -2754 38 Human 4.9 pAC50 = 4.9 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 10.1038/s41467-023-40064-9
CHEMBL479 10577 58 None -2754 38 Human 4.9 pAC50 = 4.9 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 10.1038/s41467-023-40064-9
DB00679 10577 58 None -2754 38 Human 4.9 pAC50 = 4.9 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 10.1038/s41467-023-40064-9
11980903 21264 19 None -354 25 Human 4.9 pAC50 = 4.9 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 382 4 0 2 5.3 Cc1cc(/C=C/c2ccc3cc(N(C)C)ccc3[n+]2C)c(C)n1-c1ccccc1 10.1038/s41467-023-40064-9
22526 21264 19 None -354 25 Human 4.9 pAC50 = 4.9 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 382 4 0 2 5.3 Cc1cc(/C=C/c2ccc3cc(N(C)C)ccc3[n+]2C)c(C)n1-c1ccccc1 10.1038/s41467-023-40064-9
5281035 21264 19 None -354 25 Human 4.9 pAC50 = 4.9 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 382 4 0 2 5.3 Cc1cc(/C=C/c2ccc3cc(N(C)C)ccc3[n+]2C)c(C)n1-c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL1201303 21264 19 None -354 25 Human 4.9 pAC50 = 4.9 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 382 4 0 2 5.3 Cc1cc(/C=C/c2ccc3cc(N(C)C)ccc3[n+]2C)c(C)n1-c1ccccc1 10.1038/s41467-023-40064-9
2713 212050 82 None -2 27 Human 5.9 pAC50 = 5.9 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 504 9 10 4 4.2 N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1 10.1038/s41467-023-40064-9
5353524 212050 82 None -2 27 Human 5.9 pAC50 = 5.9 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 504 9 10 4 4.2 N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1 10.1038/s41467-023-40064-9
5360566 212050 82 None -2 27 Human 5.9 pAC50 = 5.9 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 504 9 10 4 4.2 N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1 10.1038/s41467-023-40064-9
88536661 212050 82 None -2 27 Human 5.9 pAC50 = 5.9 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 504 9 10 4 4.2 N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1 10.1038/s41467-023-40064-9
9552079 212050 82 None -2 27 Human 5.9 pAC50 = 5.9 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 504 9 10 4 4.2 N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1 10.1038/s41467-023-40064-9
CHEMBL1330113 212050 82 None -2 27 Human 5.9 pAC50 = 5.9 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 504 9 10 4 4.2 N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1 10.1038/s41467-023-40064-9
CHEMBL790 212050 82 None -2 27 Human 5.9 pAC50 = 5.9 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 504 9 10 4 4.2 N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1 10.1038/s41467-023-40064-9
6436135 106348 43 None -1 2 Human 4.9 pAC50 = 4.9 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 412 9 2 4 5.8 CCC(CC)(CC(=O)Nc1cccc(/C=C/c2nc(C3CCC3)cs2)c1)C(=O)O 10.1038/s41467-023-40064-9
CHEMBL283754 106348 43 None -1 2 Human 4.9 pAC50 = 4.9 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 412 9 2 4 5.8 CCC(CC)(CC(=O)Nc1cccc(/C=C/c2nc(C3CCC3)cs2)c1)C(=O)O 10.1038/s41467-023-40064-9
5906 21267 23 None -1 4 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 167 2 3 3 0.8 C[C@H](N)[C@H](O)c1cccc(O)c1 10.1038/s41467-023-40064-9
CHEMBL1201319 21267 23 None -1 4 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 167 2 3 3 0.8 C[C@H](N)[C@H](O)c1cccc(O)c1 10.1038/s41467-023-40064-9
202 8290 77 None -10 17 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 297 6 1 3 4.6 CNCC[C@@H](c1cccs1)Oc1cccc2c1cccc2 10.1038/s41467-023-40064-9
60835 8290 77 None -10 17 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 297 6 1 3 4.6 CNCC[C@@H](c1cccs1)Oc1cccc2c1cccc2 10.1038/s41467-023-40064-9
972 8290 77 None -10 17 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 297 6 1 3 4.6 CNCC[C@@H](c1cccs1)Oc1cccc2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL1175 8290 77 None -10 17 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 297 6 1 3 4.6 CNCC[C@@H](c1cccs1)Oc1cccc2c1cccc2 10.1038/s41467-023-40064-9
DB00476 8290 77 None -10 17 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 297 6 1 3 4.6 CNCC[C@@H](c1cccs1)Oc1cccc2c1cccc2 10.1038/s41467-023-40064-9
3191 109635 97 None -831 33 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 469 9 0 3 7.2 CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1 10.1038/s41467-023-40064-9
CHEMBL305660 109635 97 None -831 33 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 469 9 0 3 7.2 CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1 10.1038/s41467-023-40064-9
1786 9298 85 None -10 7 Human 5.8 pAC50 = 5.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1038/s41467-023-40064-9
4171 9298 85 None -10 7 Human 5.8 pAC50 = 5.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1038/s41467-023-40064-9
553 9298 85 None -10 7 Human 5.8 pAC50 = 5.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1038/s41467-023-40064-9
CHEMBL13 9298 85 None -10 7 Human 5.8 pAC50 = 5.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1038/s41467-023-40064-9
DB00264 9298 85 None -10 7 Human 5.8 pAC50 = 5.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1038/s41467-023-40064-9
6436173 61890 45 None -4 22 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 785 2 5 13 6.2 CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c5c(nc6cc(C)ccn65)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C 10.1038/s41467-023-40064-9
CHEMBL1617 61890 45 None -4 22 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 785 2 5 13 6.2 CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c5c(nc6cc(C)ccn65)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C 10.1038/s41467-023-40064-9
2274 9947 58 None -1047 37 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
4917 9947 58 None -1047 37 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
7279 9947 58 None -1047 37 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
CHEMBL728 9947 58 None -1047 37 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
DB00433 9947 58 None -1047 37 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
3464 9946 28 None -616 2 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 290 5 4 4 2.0 CCC(C(c1ccc(c2c1ccc(=O)[nH]2)O)O)NC(C)C 10.1038/s41467-023-40064-9
4916 9946 28 None -616 2 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 290 5 4 4 2.0 CCC(C(c1ccc(c2c1ccc(=O)[nH]2)O)O)NC(C)C 10.1038/s41467-023-40064-9
CHEMBL160519 9946 28 None -616 2 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 290 5 4 4 2.0 CCC(C(c1ccc(c2c1ccc(=O)[nH]2)O)O)NC(C)C 10.1038/s41467-023-40064-9
DB01366 9946 28 None -616 2 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 290 5 4 4 2.0 CCC(C(c1ccc(c2c1ccc(=O)[nH]2)O)O)NC(C)C 10.1038/s41467-023-40064-9
31729 212563 10 None -707 7 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 287 6 4 4 2.4 CC(NCCc1ccc(O)cc1)C(O)c1ccc(O)cc1 10.1038/s41467-023-40064-9
CHEMBL83063 212563 10 None -707 7 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 287 6 4 4 2.4 CC(NCCc1ccc(O)cc1)C(O)c1ccc(O)cc1 10.1038/s41467-023-40064-9
3926 214020 40 None -27 18 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 491 9 1 3 5.8 Cc1cccc(C)c1NC(=O)CN1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1 10.1038/s41467-023-40064-9
CHEMBL92870 214020 40 None -27 18 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 491 9 1 3 5.8 Cc1cccc(C)c1NC(=O)CN1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1 10.1038/s41467-023-40064-9
1016 10519 78 None -2344 40 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 10.1038/s41467-023-40064-9
2561 10519 78 None -2344 40 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 10.1038/s41467-023-40064-9
2733526 10519 78 None -2344 40 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 10.1038/s41467-023-40064-9
5384 10519 78 None -2344 40 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL83 10519 78 None -2344 40 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 10.1038/s41467-023-40064-9
DB00675 10519 78 None -2344 40 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 10.1038/s41467-023-40064-9
2267 7347 71 None -741 14 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
271 7347 71 None -741 14 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
7121 7347 71 None -741 14 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
CHEMBL639 7347 71 None -741 14 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
DB00972 7347 71 None -741 14 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
2435 10362 83 None -4365 21 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1038/s41467-023-40064-9
60149 10362 83 None -4365 21 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1038/s41467-023-40064-9
98 10362 83 None -4365 21 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1038/s41467-023-40064-9
CHEMBL12713 10362 83 None -4365 21 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1038/s41467-023-40064-9
DB06144 10362 83 None -4365 21 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1038/s41467-023-40064-9
2540 11173 111 None -2570 28 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 610 10 1 11 6.3 CCOc1nc2cccc(C(=O)OC(C)OC(=O)OC3CCCCC3)c2n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1 10.1038/s41467-023-40064-9
CHEMBL1014 11173 111 None -2570 28 Human 4.8 pAC50 = 4.8 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 610 10 1 11 6.3 CCOc1nc2cccc(C(=O)OC(C)OC(=O)OC3CCCCC3)c2n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1 10.1038/s41467-023-40064-9
64139 91560 96 None -3 9 Human 4.7 pAC50 = 4.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 315 0 1 2 4.1 O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1 10.1038/s41467-023-40064-9
CHEMBL223228 91560 96 None -3 9 Human 4.7 pAC50 = 4.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 315 0 1 2 4.1 O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1 10.1038/s41467-023-40064-9
451668 21229 110 None - 1 Human 4.7 pAC50 = 4.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 228 2 3 8 -2.1 Nc1ncn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)n1 10.1038/s41467-023-40064-9
CHEMBL1201129 21229 110 None - 1 Human 4.7 pAC50 = 4.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 228 2 3 8 -2.1 Nc1ncn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)n1 10.1038/s41467-023-40064-9
33624 10593 34 None -3 6 Human 8.6 pAC50 = 8.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1038/s41467-023-40064-9
4061 10593 34 None -3 6 Human 8.6 pAC50 = 8.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1038/s41467-023-40064-9
565 10593 34 None -3 6 Human 8.6 pAC50 = 8.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1038/s41467-023-40064-9
CHEMBL499 10593 34 None -3 6 Human 8.6 pAC50 = 8.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1038/s41467-023-40064-9
DB00373 10593 34 None -3 6 Human 8.6 pAC50 = 8.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1038/s41467-023-40064-9
1222 8445 49 None -467 25 Human 4.7 pAC50 = 4.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
3396 8445 49 None -467 25 Human 4.7 pAC50 = 4.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
85 8445 49 None -467 25 Human 4.7 pAC50 = 4.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL46516 8445 49 None -467 25 Human 4.7 pAC50 = 4.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
DB04842 8445 49 None -467 25 Human 4.7 pAC50 = 4.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
1836 9370 59 None -39810 18 Human 4.7 pAC50 = 4.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 585 12 2 4 8.9 OC(=O)CC1(CS[C@@H](c2cccc(c2)/C=C/c2ccc3c(n2)cc(cc3)Cl)CCc2ccccc2C(O)(C)C)CC1 10.1038/s41467-023-40064-9
3340 9370 59 None -39810 18 Human 4.7 pAC50 = 4.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 585 12 2 4 8.9 OC(=O)CC1(CS[C@@H](c2cccc(c2)/C=C/c2ccc3c(n2)cc(cc3)Cl)CCc2ccccc2C(O)(C)C)CC1 10.1038/s41467-023-40064-9
5281040 9370 59 None -39810 18 Human 4.7 pAC50 = 4.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 585 12 2 4 8.9 OC(=O)CC1(CS[C@@H](c2cccc(c2)/C=C/c2ccc3c(n2)cc(cc3)Cl)CCc2ccccc2C(O)(C)C)CC1 10.1038/s41467-023-40064-9
CHEMBL787 9370 59 None -39810 18 Human 4.7 pAC50 = 4.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 585 12 2 4 8.9 OC(=O)CC1(CS[C@@H](c2cccc(c2)/C=C/c2ccc3c(n2)cc(cc3)Cl)CCc2ccccc2C(O)(C)C)CC1 10.1038/s41467-023-40064-9
DB00471 9370 59 None -39810 18 Human 4.7 pAC50 = 4.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 585 12 2 4 8.9 OC(=O)CC1(CS[C@@H](c2cccc(c2)/C=C/c2ccc3c(n2)cc(cc3)Cl)CCc2ccccc2C(O)(C)C)CC1 10.1038/s41467-023-40064-9
5591 164310 90 None -12 17 Human 4.7 pAC50 = 4.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 441 5 2 6 4.4 Cc1c(C)c2c(c(C)c1O)CCC(C)(COc1ccc(CC3SC(=O)NC3=O)cc1)O2 10.1038/s41467-023-40064-9
CHEMBL408 164310 90 None -12 17 Human 4.7 pAC50 = 4.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 441 5 2 6 4.4 Cc1c(C)c2c(c(C)c1O)CCC(C)(COc1ccc(CC3SC(=O)NC3=O)cc1)O2 10.1038/s41467-023-40064-9
3151 8244 97 None -5128 23 Human 4.7 pAC50 = 4.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
945 8244 97 None -5128 23 Human 4.7 pAC50 = 4.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
965 8244 97 None -5128 23 Human 4.7 pAC50 = 4.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL219916 8244 97 None -5128 23 Human 4.7 pAC50 = 4.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
DB01184 8244 97 None -5128 23 Human 4.7 pAC50 = 4.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
2303 9961 68 None -6 20 Human 7.7 pAC50 = 7.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1038/s41467-023-40064-9
4946 9961 68 None -6 20 Human 7.7 pAC50 = 7.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1038/s41467-023-40064-9
564 9961 68 None -6 20 Human 7.7 pAC50 = 7.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1038/s41467-023-40064-9
63 9961 68 None -6 20 Human 7.7 pAC50 = 7.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1038/s41467-023-40064-9
91536 9961 68 None -6 20 Human 7.7 pAC50 = 7.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1038/s41467-023-40064-9
CHEMBL27 9961 68 None -6 20 Human 7.7 pAC50 = 7.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1038/s41467-023-40064-9
CHEMBL452861 9961 68 None -6 20 Human 7.7 pAC50 = 7.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1038/s41467-023-40064-9
DB00571 9961 68 None -6 20 Human 7.7 pAC50 = 7.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1038/s41467-023-40064-9
5282219 42643 63 None -3 9 Human 4.7 pAC50 = 4.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 450 12 1 5 5.7 CC(C)=CCOc1ccc(/C=C/C(=O)c2ccc(OCC=C(C)C)cc2OCC(=O)O)cc1 10.1038/s41467-023-40064-9
CHEMBL1441961 42643 63 None -3 9 Human 4.7 pAC50 = 4.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 450 12 1 5 5.7 CC(C)=CCOc1ccc(/C=C/C(=O)c2ccc(OCC=C(C)C)cc2OCC(=O)O)cc1 10.1038/s41467-023-40064-9
105 10234 91 None -28 3 Human 4.7 pAC50 = 4.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 239 4 4 4 1.3 OCc1cc(ccc1O)C(CNC(C)(C)C)O 10.1038/s41467-023-40064-9
2083 10234 91 None -28 3 Human 4.7 pAC50 = 4.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 239 4 4 4 1.3 OCc1cc(ccc1O)C(CNC(C)(C)C)O 10.1038/s41467-023-40064-9
558 10234 91 None -28 3 Human 4.7 pAC50 = 4.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 239 4 4 4 1.3 OCc1cc(ccc1O)C(CNC(C)(C)C)O 10.1038/s41467-023-40064-9
CHEMBL714 10234 91 None -28 3 Human 4.7 pAC50 = 4.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 239 4 4 4 1.3 OCc1cc(ccc1O)C(CNC(C)(C)C)O 10.1038/s41467-023-40064-9
DB01001 10234 91 None -28 3 Human 4.7 pAC50 = 4.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 239 4 4 4 1.3 OCc1cc(ccc1O)C(CNC(C)(C)C)O 10.1038/s41467-023-40064-9
11976 7707 59 None -7244 16 Human 4.7 pAC50 = 4.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 315 3 0 2 5.2 CN(C)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)Cl 10.1038/s41467-023-40064-9
667467 7707 59 None -7244 16 Human 4.7 pAC50 = 4.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 315 3 0 2 5.2 CN(C)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)Cl 10.1038/s41467-023-40064-9
CHEMBL908 7707 59 None -7244 16 Human 4.7 pAC50 = 4.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 315 3 0 2 5.2 CN(C)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)Cl 10.1038/s41467-023-40064-9
DB01239 7707 59 None -7244 16 Human 4.7 pAC50 = 4.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 315 3 0 2 5.2 CN(C)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)Cl 10.1038/s41467-023-40064-9
155774 10868 40 None 42 3 Human 6.7 pAC50 = 6.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 339 8 4 6 -0.2 OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1 10.1038/s41467-023-40064-9
2848 10868 40 None 42 3 Human 6.7 pAC50 = 6.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 339 8 4 6 -0.2 OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1 10.1038/s41467-023-40064-9
538 10868 40 None 42 3 Human 6.7 pAC50 = 6.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 339 8 4 6 -0.2 OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1 10.1038/s41467-023-40064-9
CHEMBL75753 10868 40 None 42 3 Human 6.7 pAC50 = 6.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 339 8 4 6 -0.2 OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1 10.1038/s41467-023-40064-9
DB13781 10868 40 None 42 3 Human 6.7 pAC50 = 6.7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 339 8 4 6 -0.2 OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1 10.1038/s41467-023-40064-9
180 7189 56 None -48977 38 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
200 7189 56 None -48977 38 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
2160 7189 56 None -48977 38 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
CHEMBL629 7189 56 None -48977 38 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
DB00321 7189 56 None -48977 38 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
3689 109548 55 None -3311 16 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 325 5 2 3 3.8 CC(C(O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 10.1038/s41467-023-40064-9
CHEMBL1372983 109548 55 None -3311 16 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 325 5 2 3 3.8 CC(C(O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 10.1038/s41467-023-40064-9
CHEMBL305187 109548 55 None -3311 16 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 325 5 2 3 3.8 CC(C(O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 10.1038/s41467-023-40064-9
1971 9641 38 None -33113 32 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 10.1038/s41467-023-40064-9
2404 9641 38 None -33113 32 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 10.1038/s41467-023-40064-9
4543 9641 38 None -33113 32 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL445 9641 38 None -33113 32 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 10.1038/s41467-023-40064-9
DB00540 9641 38 None -33113 32 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 10.1038/s41467-023-40064-9
5482 21192 80 None -13 13 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 386 6 0 4 5.9 Clc1ccc(C(Cn2ccnc2)OCc2ccsc2Cl)c(Cl)c1 10.1038/s41467-023-40064-9
CHEMBL1200438 21192 80 None -13 13 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 386 6 0 4 5.9 Clc1ccc(C(Cn2ccnc2)OCc2ccsc2Cl)c(Cl)c1 10.1038/s41467-023-40064-9
2419 10236 84 None -1174 14 Human 5.6 pAC50 = 5.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1038/s41467-023-40064-9
5152 10236 84 None -1174 14 Human 5.6 pAC50 = 5.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1038/s41467-023-40064-9
559 10236 84 None -1174 14 Human 5.6 pAC50 = 5.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1038/s41467-023-40064-9
CHEMBL1263 10236 84 None -1174 14 Human 5.6 pAC50 = 5.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1038/s41467-023-40064-9
DB00938 10236 84 None -1174 14 Human 5.6 pAC50 = 5.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1038/s41467-023-40064-9
129211 10521 78 None -5495 14 Human 5.6 pAC50 = 5.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1038/s41467-023-40064-9
2562 10521 78 None -5495 14 Human 5.6 pAC50 = 5.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1038/s41467-023-40064-9
488 10521 78 None -5495 14 Human 5.6 pAC50 = 5.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1038/s41467-023-40064-9
CHEMBL836 10521 78 None -5495 14 Human 5.6 pAC50 = 5.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1038/s41467-023-40064-9
DB00706 10521 78 None -5495 14 Human 5.6 pAC50 = 5.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1038/s41467-023-40064-9
26987 7736 33 None -21877 34 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C 10.1038/s41467-023-40064-9
6063 7736 33 None -21877 34 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C 10.1038/s41467-023-40064-9
671 7736 33 None -21877 34 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C 10.1038/s41467-023-40064-9
CHEMBL1626 7736 33 None -21877 34 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C 10.1038/s41467-023-40064-9
DB00283 7736 33 None -21877 34 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C 10.1038/s41467-023-40064-9
4640 85041 30 None -218 11 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 379 6 1 4 3.9 COc1cc2[nH]c(C)c(CCN3CCN(c4ccccc4)CC3)c2cc1OC 10.1038/s41467-023-40064-9
CHEMBL2107011 85041 30 None -218 11 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 379 6 1 4 3.9 COc1cc2[nH]c(C)c(CCN3CCN(c4ccccc4)CC3)c2cc1OC 10.1038/s41467-023-40064-9
4486 129761 25 None - 1 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 405 11 2 9 0.3 Cn1c(NCCN(CCO)CCCc2ccc([N+](=O)[O-])cc2)cc(=O)n(C)c1=O 10.1038/s41467-023-40064-9
CHEMBL360861 129761 25 None - 1 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 405 11 2 9 0.3 Cn1c(NCCN(CCO)CCCc2ccc([N+](=O)[O-])cc2)cc(=O)n(C)c1=O 10.1038/s41467-023-40064-9
1549120 203265 85 None -17 19 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 319 4 1 4 2.9 CC(/C=C1\SC(=S)N(CC(=O)O)C1=O)=C\c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL56337 203265 85 None -17 19 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 319 4 1 4 2.9 CC(/C=C1\SC(=S)N(CC(=O)O)C1=O)=C\c1ccccc1 10.1038/s41467-023-40064-9
2372 113245 40 None 12 6 Human 7.6 pAC50 = 7.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 345 10 2 5 2.6 COc1ccc(CCNCC(O)COc2cccc(C)c2)cc1OC 10.1038/s41467-023-40064-9
CHEMBL314010 113245 40 None 12 6 Human 7.6 pAC50 = 7.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 345 10 2 5 2.6 COc1ccc(CCNCC(O)COc2cccc(C)c2)cc1OC 10.1038/s41467-023-40064-9
5606 16965 67 None -3 2 Human 5.6 pAC50 = 5.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 227 3 2 2 2.8 CC(C)(C)NCC(O)c1ccccc1Cl 10.1038/s41467-023-40064-9
CHEMBL1159717 16965 67 None -3 2 Human 5.6 pAC50 = 5.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 227 3 2 2 2.8 CC(C)(C)NCC(O)c1ccccc1Cl 10.1038/s41467-023-40064-9
65948 25328 109 None -12 6 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 582 9 2 9 4.7 CC1=C(C(=O)OC(C)C)C(c2cccc([N+](=O)[O-])c2)C(C(=O)OC2CN(C(c3ccccc3)c3ccccc3)C2)=C(N)N1 10.1038/s41467-023-40064-9
CHEMBL1275868 25328 109 None -12 6 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 582 9 2 9 4.7 CC1=C(C(=O)OC(C)C)C(c2cccc([N+](=O)[O-])c2)C(C(=O)OC2CN(C(c3ccccc3)c3ccccc3)C2)=C(N)N1 10.1038/s41467-023-40064-9
4908 195585 78 None -5 7 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 259 6 2 4 2.8 COc1cc(NC(C)CCCN)c2ncccc2c1 10.1038/s41467-023-40064-9
CHEMBL506 195585 78 None -5 7 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 259 6 2 4 2.8 COc1cc(NC(C)CCCN)c2ncccc2c1 10.1038/s41467-023-40064-9
4452 9538 19 None -8912 21 Human 5.6 pAC50 = 5.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 387 6 2 4 3.8 COc1cc(NC)c(cc1C(=O)NC1CCN(C1C)Cc1ccccc1)Cl 10.1038/s41467-023-40064-9
983 9538 19 None -8912 21 Human 5.6 pAC50 = 5.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 387 6 2 4 3.8 COc1cc(NC)c(cc1C(=O)NC1CCN(C1C)Cc1ccccc1)Cl 10.1038/s41467-023-40064-9
CHEMBL20734 9538 19 None -8912 21 Human 5.6 pAC50 = 5.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 387 6 2 4 3.8 COc1cc(NC)c(cc1C(=O)NC1CCN(C1C)Cc1ccccc1)Cl 10.1038/s41467-023-40064-9
2470 10425 50 None -46773 23 Human 5.6 pAC50 = 5.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
3300 10425 50 None -46773 23 Human 5.6 pAC50 = 5.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
5265 10425 50 None -46773 23 Human 5.6 pAC50 = 5.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
99 10425 50 None -46773 23 Human 5.6 pAC50 = 5.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL267930 10425 50 None -46773 23 Human 5.6 pAC50 = 5.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
216239 30567 118 None -15 11 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 464 5 3 4 5.6 CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1 10.1038/s41467-023-40064-9
CHEMBL1200485 30567 118 None -15 11 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 464 5 3 4 5.6 CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1 10.1038/s41467-023-40064-9
CHEMBL1336 30567 118 None -15 11 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 464 5 3 4 5.6 CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1 10.1038/s41467-023-40064-9
3760 57074 37 None -3 5 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 414 6 0 3 6.5 Clc1ccc(C(Cn2ccnc2)OCc2c(Cl)cccc2Cl)c(Cl)c1 10.1038/s41467-023-40064-9
CHEMBL1571863 57074 37 None -3 5 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 414 6 0 3 6.5 Clc1ccc(C(Cn2ccnc2)OCc2c(Cl)cccc2Cl)c(Cl)c1 10.1038/s41467-023-40064-9
30323 69259 57 None -14 21 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 527 4 5 11 1.0 COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 10.1038/s41467-023-40064-9
CHEMBL1563 69259 57 None -14 21 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 527 4 5 11 1.0 COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 10.1038/s41467-023-40064-9
CHEMBL178 69259 57 None -14 21 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 527 4 5 11 1.0 COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 10.1038/s41467-023-40064-9
135398735 143746 32 None -12 27 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 822 4 6 15 4.3 CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C 10.1038/s41467-023-40064-9
136262914 143746 32 None -12 27 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 822 4 6 15 4.3 CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C 10.1038/s41467-023-40064-9
CHEMBL374478 143746 32 None -12 27 Human 4.6 pAC50 = 4.6 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 822 4 6 15 4.3 CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C 10.1038/s41467-023-40064-9
176 7186 66 None -4 40 Human 5.5 pAC50 = 5.5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 10.1038/s41467-023-40064-9
2157 7186 66 None -4 40 Human 5.5 pAC50 = 5.5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 10.1038/s41467-023-40064-9
2566 7186 66 None -4 40 Human 5.5 pAC50 = 5.5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 10.1038/s41467-023-40064-9
CHEMBL633 7186 66 None -4 40 Human 5.5 pAC50 = 5.5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 10.1038/s41467-023-40064-9
DB01118 7186 66 None -4 40 Human 5.5 pAC50 = 5.5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 10.1038/s41467-023-40064-9
2333 149113 97 None -25 14 Human 4.5 pAC50 = 4.5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 422 3 1 3 5.5 CCc1oc2ccccc2c1C(=O)c1cc(Br)c(O)c(Br)c1 10.1038/s41467-023-40064-9
CHEMBL388590 149113 97 None -25 14 Human 4.5 pAC50 = 4.5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 422 3 1 3 5.5 CCc1oc2ccccc2c1C(=O)c1cc(Br)c(O)c(Br)c1 10.1038/s41467-023-40064-9
118422671 9533 65 None 22 23 Human 8.5 pAC50 = 8.5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 405 6 3 5 2.4 OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O 10.1038/s41467-023-40064-9
1887 9533 65 None 22 23 Human 8.5 pAC50 = 8.5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 405 6 3 5 2.4 OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O 10.1038/s41467-023-40064-9
71301 9533 65 None 22 23 Human 8.5 pAC50 = 8.5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 405 6 3 5 2.4 OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O 10.1038/s41467-023-40064-9
7246 9533 65 None 22 23 Human 8.5 pAC50 = 8.5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 405 6 3 5 2.4 OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O 10.1038/s41467-023-40064-9
CHEMBL434394 9533 65 None 22 23 Human 8.5 pAC50 = 8.5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 405 6 3 5 2.4 OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O 10.1038/s41467-023-40064-9
DB04861 9533 65 None 22 23 Human 8.5 pAC50 = 8.5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 405 6 3 5 2.4 OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O 10.1038/s41467-023-40064-9
2585 7590 103 None 1 34 Human 8.5 pAC50 = 8.5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10.1038/s41467-023-40064-9
522 7590 103 None 1 34 Human 8.5 pAC50 = 8.5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10.1038/s41467-023-40064-9
551 7590 103 None 1 34 Human 8.5 pAC50 = 8.5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10.1038/s41467-023-40064-9
CHEMBL723 7590 103 None 1 34 Human 8.5 pAC50 = 8.5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10.1038/s41467-023-40064-9
DB01136 7590 103 None 1 34 Human 8.5 pAC50 = 8.5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10.1038/s41467-023-40064-9
3149 19386 15 None -8 26 Human 5.5 pAC50 = 5.5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 334 15 0 1 6.1 CCCCCCCCCCCC[N+](C)(C)CCOc1ccccc1 10.1038/s41467-023-40064-9
CHEMBL1187011 19386 15 None -8 26 Human 5.5 pAC50 = 5.5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 334 15 0 1 6.1 CCCCCCCCCCCC[N+](C)(C)CCOc1ccccc1 10.1038/s41467-023-40064-9
2601 10552 33 None -1023 17 Human 5.5 pAC50 = 5.5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC 10.1038/s41467-023-40064-9
443951 10552 33 None -1023 17 Human 5.5 pAC50 = 5.5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC 10.1038/s41467-023-40064-9
56 10552 33 None -1023 17 Human 5.5 pAC50 = 5.5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC 10.1038/s41467-023-40064-9
CHEMBL73151 10552 33 None -1023 17 Human 5.5 pAC50 = 5.5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC 10.1038/s41467-023-40064-9
DB13399 10552 33 None -1023 17 Human 5.5 pAC50 = 5.5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC 10.1038/s41467-023-40064-9
5311064 8148 46 None 3 7 Human 5.5 pAC50 = 5.5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 317 8 3 5 2.3 COc1cc(CCNC[C@@H](c2ccc(cc2)O)O)ccc1OC 10.1038/s41467-023-40064-9
534 8148 46 None 3 7 Human 5.5 pAC50 = 5.5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 317 8 3 5 2.3 COc1cc(CCNC[C@@H](c2ccc(cc2)O)O)ccc1OC 10.1038/s41467-023-40064-9
806 8148 46 None 3 7 Human 5.5 pAC50 = 5.5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 317 8 3 5 2.3 COc1cc(CCNC[C@@H](c2ccc(cc2)O)O)ccc1OC 10.1038/s41467-023-40064-9
CHEMBL493682 8148 46 None 3 7 Human 5.5 pAC50 = 5.5 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 317 8 3 5 2.3 COc1cc(CCNC[C@@H](c2ccc(cc2)O)O)ccc1OC 10.1038/s41467-023-40064-9
150 9287 21 None -1445 17 Human 5.4 pAC50 = 5.4 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO 10.1038/s41467-023-40064-9
1764 9287 21 None -1445 17 Human 5.4 pAC50 = 5.4 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO 10.1038/s41467-023-40064-9
8226 9287 21 None -1445 17 Human 5.4 pAC50 = 5.4 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO 10.1038/s41467-023-40064-9
CHEMBL1201356 9287 21 None -1445 17 Human 5.4 pAC50 = 5.4 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO 10.1038/s41467-023-40064-9
DB00353 9287 21 None -1445 17 Human 5.4 pAC50 = 5.4 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO 10.1038/s41467-023-40064-9
2291 9958 58 None -6 13 Human 6.4 pAC50 = 6.4 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O 10.1038/s41467-023-40064-9
2561 9958 58 None -6 13 Human 6.4 pAC50 = 6.4 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O 10.1038/s41467-023-40064-9
4932 9958 58 None -6 13 Human 6.4 pAC50 = 6.4 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O 10.1038/s41467-023-40064-9
CHEMBL631 9958 58 None -6 13 Human 6.4 pAC50 = 6.4 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O 10.1038/s41467-023-40064-9
DB01182 9958 58 None -6 13 Human 6.4 pAC50 = 6.4 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O 10.1038/s41467-023-40064-9
2464 10412 58 None -7 3 Human 5.4 pAC50 = 5.4 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C 10.1038/s41467-023-40064-9
5253 10412 58 None -7 3 Human 5.4 pAC50 = 5.4 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C 10.1038/s41467-023-40064-9
7297 10412 58 None -7 3 Human 5.4 pAC50 = 5.4 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C 10.1038/s41467-023-40064-9
CHEMBL471 10412 58 None -7 3 Human 5.4 pAC50 = 5.4 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C 10.1038/s41467-023-40064-9
DB00489 10412 58 None -7 3 Human 5.4 pAC50 = 5.4 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C 10.1038/s41467-023-40064-9
4567 16720 34 None -72 12 Human 5.4 pAC50 = 5.4 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 299 7 3 3 3.4 CC(CCc1ccccc1)NC(C)C(O)c1ccc(O)cc1 10.1038/s41467-023-40064-9
CHEMBL114655 16720 34 None -72 12 Human 5.4 pAC50 = 5.4 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 299 7 3 3 3.4 CC(CCc1ccccc1)NC(C)C(O)c1ccc(O)cc1 10.1038/s41467-023-40064-9
2176 9901 68 None -1 8 Human 8.4 pAC50 = 8.4 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 10.1038/s41467-023-40064-9
4828 9901 68 None -1 8 Human 8.4 pAC50 = 8.4 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 10.1038/s41467-023-40064-9
91 9901 68 None -1 8 Human 8.4 pAC50 = 8.4 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 10.1038/s41467-023-40064-9
CHEMBL500 9901 68 None -1 8 Human 8.4 pAC50 = 8.4 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 10.1038/s41467-023-40064-9
DB00960 9901 68 None -1 8 Human 8.4 pAC50 = 8.4 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 10.1038/s41467-023-40064-9
44112 128068 48 None -1 12 Human 8.3 pAC50 = 8.3 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 380 7 2 4 4.5 Cc1cc2c(OCC(CNC(C)(C)C)OC(=O)c3ccccc3)cccc2[nH]1 10.1038/s41467-023-40064-9
CHEMBL357995 128068 48 None -1 12 Human 8.3 pAC50 = 8.3 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 380 7 2 4 4.5 Cc1cc2c(OCC(CNC(C)(C)C)OC(=O)c3ccccc3)cccc2[nH]1 10.1038/s41467-023-40064-9
9931954 17706 76 None -3 2 Human 4.4 pAC50 = 4.4 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 323 3 3 2 3.0 CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1 10.1038/s41467-023-40064-9
CHEMBL1173055 17706 76 None -3 2 Human 4.4 pAC50 = 4.4 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 323 3 3 2 3.0 CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1 10.1038/s41467-023-40064-9
3486 9931 56 None -1 2 Human 5.3 pAC50 = 5.3 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1038/s41467-023-40064-9
4883 9931 56 None -1 2 Human 5.3 pAC50 = 5.3 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1038/s41467-023-40064-9
555 9931 56 None -1 2 Human 5.3 pAC50 = 5.3 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1038/s41467-023-40064-9
CHEMBL6995 9931 56 None -1 2 Human 5.3 pAC50 = 5.3 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1038/s41467-023-40064-9
DB01297 9931 56 None -1 2 Human 5.3 pAC50 = 5.3 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1038/s41467-023-40064-9
25382 15929 37 None -141 21 Human 5.3 pAC50 = 5.3 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 291 3 0 1 4.7 CN(C)CCC=C1c2ccccc2C(C)(C)c2ccccc21 10.1038/s41467-023-40064-9
CHEMBL110094 15929 37 None -141 21 Human 5.3 pAC50 = 5.3 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 291 3 0 1 4.7 CN(C)CCC=C1c2ccccc2C(C)(C)c2ccccc21 10.1038/s41467-023-40064-9
36811 8236 37 None -11 17 Human 5.3 pAC50 = 5.3 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
535 8236 37 None -11 17 Human 5.3 pAC50 = 5.3 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
937 8236 37 None -11 17 Human 5.3 pAC50 = 5.3 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
CHEMBL926 8236 37 None -11 17 Human 5.3 pAC50 = 5.3 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
DB00841 8236 37 None -11 17 Human 5.3 pAC50 = 5.3 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
16362 9899 71 None -616 35 Human 5.3 pAC50 = 5.3 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
2172 9899 71 None -616 35 Human 5.3 pAC50 = 5.3 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
90 9899 71 None -616 35 Human 5.3 pAC50 = 5.3 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL1423 9899 71 None -616 35 Human 5.3 pAC50 = 5.3 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
DB01100 9899 71 None -616 35 Human 5.3 pAC50 = 5.3 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
2318 161635 29 None -8 15 Human 5.2 pAC50 = 5.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 351 7 1 3 4.1 CC(Cc1cccc(C(F)(F)F)c1)NCCOC(=O)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL400599 161635 29 None -8 15 Human 5.2 pAC50 = 5.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 351 7 1 3 4.1 CC(Cc1cccc(C(F)(F)F)c1)NCCOC(=O)c1ccccc1 10.1038/s41467-023-40064-9
11504295 9697 47 None -954 8 Human 6.2 pAC50 = 6.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 386 7 4 6 2.4 COc1ccc(cc1)CC(NC[C@@H](c1cc(O)cc2c1OCC(=O)N2)O)(C)C 10.1038/s41467-023-40064-9
4814 9697 47 None -954 8 Human 6.2 pAC50 = 6.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 386 7 4 6 2.4 COc1ccc(cc1)CC(NC[C@@H](c1cc(O)cc2c1OCC(=O)N2)O)(C)C 10.1038/s41467-023-40064-9
7543 9697 47 None -954 8 Human 6.2 pAC50 = 6.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 386 7 4 6 2.4 COc1ccc(cc1)CC(NC[C@@H](c1cc(O)cc2c1OCC(=O)N2)O)(C)C 10.1038/s41467-023-40064-9
CHEMBL605846 9697 47 None -954 8 Human 6.2 pAC50 = 6.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 386 7 4 6 2.4 COc1ccc(cc1)CC(NC[C@@H](c1cc(O)cc2c1OCC(=O)N2)O)(C)C 10.1038/s41467-023-40064-9
DB09080 9697 47 None -954 8 Human 6.2 pAC50 = 6.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 386 7 4 6 2.4 COc1ccc(cc1)CC(NC[C@@H](c1cc(O)cc2c1OCC(=O)N2)O)(C)C 10.1038/s41467-023-40064-9
2398 7741 62 None -4265 36 Human 5.2 pAC50 = 5.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
2801 7741 62 None -4265 36 Human 5.2 pAC50 = 5.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
701 7741 62 None -4265 36 Human 5.2 pAC50 = 5.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
CHEMBL415 7741 62 None -4265 36 Human 5.2 pAC50 = 5.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
DB01242 7741 62 None -4265 36 Human 5.2 pAC50 = 5.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
1499 8872 47 None -58 38 Human 6.2 pAC50 = 6.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1038/s41467-023-40064-9
3779 8872 47 None -58 38 Human 6.2 pAC50 = 6.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1038/s41467-023-40064-9
536 8872 47 None -58 38 Human 6.2 pAC50 = 6.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1038/s41467-023-40064-9
CHEMBL434 8872 47 None -58 38 Human 6.2 pAC50 = 6.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1038/s41467-023-40064-9
DB01064 8872 47 None -58 38 Human 6.2 pAC50 = 6.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1038/s41467-023-40064-9
137 7158 52 None -3 8 Human 8.2 pAC50 = 8.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1038/s41467-023-40064-9
2119 7158 52 None -3 8 Human 8.2 pAC50 = 8.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1038/s41467-023-40064-9
563 7158 52 None -3 8 Human 8.2 pAC50 = 8.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1038/s41467-023-40064-9
66368 7158 52 None -3 8 Human 8.2 pAC50 = 8.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1038/s41467-023-40064-9
CHEMBL266195 7158 52 None -3 8 Human 8.2 pAC50 = 8.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1038/s41467-023-40064-9
DB00866 7158 52 None -3 8 Human 8.2 pAC50 = 8.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1038/s41467-023-40064-9
4631 201751 29 None -1 5 Human 8.2 pAC50 = 8.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 265 9 2 4 2.0 C=CCOc1ccccc1OCC(O)CNC(C)C 10.1038/s41467-023-40064-9
CHEMBL546 201751 29 None -1 5 Human 8.2 pAC50 = 8.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 265 9 2 4 2.0 C=CCOc1ccccc1OCC(O)CNC(C)C 10.1038/s41467-023-40064-9
2169 51621 35 None 1 12 Human 7.2 pAC50 = 7.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 380 9 3 6 1.4 COc1ccccc1OCCNCC(O)c1ccc(C)c(S(N)(=O)=O)c1 10.1038/s41467-023-40064-9
CHEMBL152231 51621 35 None 1 12 Human 7.2 pAC50 = 7.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 380 9 3 6 1.4 COc1ccccc1OCCNCC(O)c1ccc(C)c(S(N)(=O)=O)c1 10.1038/s41467-023-40064-9
1155 8410 53 None -17 11 Human 5.2 pAC50 = 5.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1038/s41467-023-40064-9
3343 8410 53 None -17 11 Human 5.2 pAC50 = 5.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1038/s41467-023-40064-9
557 8410 53 None -17 11 Human 5.2 pAC50 = 5.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1038/s41467-023-40064-9
CHEMBL32800 8410 53 None -17 11 Human 5.2 pAC50 = 5.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1038/s41467-023-40064-9
DB01288 8410 53 None -17 11 Human 5.2 pAC50 = 5.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1038/s41467-023-40064-9
5329102 201505 86 None -54 37 Human 5.2 pAC50 = 5.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 398 7 3 3 3.3 CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C 10.1038/s41467-023-40064-9
CHEMBL535 201505 86 None -54 37 Human 5.2 pAC50 = 5.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 398 7 3 3 3.3 CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C 10.1038/s41467-023-40064-9
2249 7300 111 None -38 5 Human 6.2 pAC50 = 6.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1038/s41467-023-40064-9
255 7300 111 None -38 5 Human 6.2 pAC50 = 6.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1038/s41467-023-40064-9
548 7300 111 None -38 5 Human 6.2 pAC50 = 6.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1038/s41467-023-40064-9
CHEMBL24 7300 111 None -38 5 Human 6.2 pAC50 = 6.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1038/s41467-023-40064-9
DB00335 7300 111 None -38 5 Human 6.2 pAC50 = 6.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1038/s41467-023-40064-9
9801 98360 35 None -17 16 Human 5.2 pAC50 = 5.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 329 8 1 1 5.4 CC(Cc1ccccc1)NCCC(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL24072 98360 35 None -17 16 Human 5.2 pAC50 = 5.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 329 8 1 1 5.4 CC(Cc1ccccc1)NCCC(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
135409453 10545 41 None -2398 36 Human 5.2 pAC50 = 5.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 301 7 3 3 2.6 CCCCCN=C(N/N=C/c1c[nH]c2c1cc(OC)cc2)N 10.1038/s41467-023-40064-9
226 10545 41 None -2398 36 Human 5.2 pAC50 = 5.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 301 7 3 3 2.6 CCCCCN=C(N/N=C/c1c[nH]c2c1cc(OC)cc2)N 10.1038/s41467-023-40064-9
CHEMBL76370 10545 41 None -2398 36 Human 5.2 pAC50 = 5.2 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 301 7 3 3 2.6 CCCCCN=C(N/N=C/c1c[nH]c2c1cc(OC)cc2)N 10.1038/s41467-023-40064-9
242 7258 124 None -213 32 Human 6.1 pAC50 = 6.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
34 7258 124 None -213 32 Human 6.1 pAC50 = 6.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
60795 7258 124 None -213 32 Human 6.1 pAC50 = 6.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
CHEMBL1112 7258 124 None -213 32 Human 6.1 pAC50 = 6.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
DB01238 7258 124 None -213 32 Human 6.1 pAC50 = 6.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
2663 105538 34 None 60 2 Human 7.1 pAC50 = 7.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 379 9 3 5 2.9 CCN(CC)C(=O)Nc1ccc(OCC(O)CNC(C)(C)C)c(C(C)=O)c1 10.1038/s41467-023-40064-9
CHEMBL27810 105538 34 None 60 2 Human 7.1 pAC50 = 7.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 379 9 3 5 2.9 CCN(CC)C(=O)Nc1ccc(OCC(O)CNC(C)(C)C)c(C(C)=O)c1 10.1038/s41467-023-40064-9
2335 18620 22 None -57 34 Human 5.1 pAC50 = 5.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 10.1038/s41467-023-40064-9
8478 18620 22 None -57 34 Human 5.1 pAC50 = 5.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 10.1038/s41467-023-40064-9
CHEMBL1182210 18620 22 None -57 34 Human 5.1 pAC50 = 5.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 10.1038/s41467-023-40064-9
CHEMBL221753 18620 22 None -57 34 Human 5.1 pAC50 = 5.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 10.1038/s41467-023-40064-9
56959 38330 103 None -5 9 Human 5.1 pAC50 = 5.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 427 9 2 6 2.3 COc1ccccc1OCC(O)CN1CCN(CC(=O)Nc2c(C)cccc2C)CC1 10.1038/s41467-023-40064-9
CHEMBL1404 38330 103 None -5 9 Human 5.1 pAC50 = 5.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 427 9 2 6 2.3 COc1ccccc1OCC(O)CN1CCN(CC(=O)Nc2c(C)cccc2C)CC1 10.1038/s41467-023-40064-9
CHEMBL1526084 38330 103 None -5 9 Human 5.1 pAC50 = 5.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 427 9 2 6 2.3 COc1ccccc1OCC(O)CN1CCN(CC(=O)Nc2c(C)cccc2C)CC1 10.1038/s41467-023-40064-9
5639 105671 75 None -15 13 Human 6.1 pAC50 = 6.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 387 7 1 8 0.7 COc1ccccc1N1CCN(CCCNc2cc(=O)n(C)c(=O)n2C)CC1 10.1038/s41467-023-40064-9
CHEMBL279229 105671 75 None -15 13 Human 6.1 pAC50 = 6.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 387 7 1 8 0.7 COc1ccccc1N1CCN(CCCNc2cc(=O)n(C)c(=O)n2C)CC1 10.1038/s41467-023-40064-9
2351 11072 49 None -3 22 Human 5.1 pAC50 = 5.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 366 10 0 3 4.8 CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1 10.1038/s41467-023-40064-9
CHEMBL1008 11072 49 None -3 22 Human 5.1 pAC50 = 5.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 366 10 0 3 4.8 CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1 10.1038/s41467-023-40064-9
CHEMBL1257078 11072 49 None -3 22 Human 5.1 pAC50 = 5.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 366 10 0 3 4.8 CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1 10.1038/s41467-023-40064-9
11658860 9123 51 None -724 10 Human 5.1 pAC50 = 5.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 195 0 1 1 2.6 Clc1ccc2c(c1)[C@@H](C)CNCC2 10.1038/s41467-023-40064-9
2941 9123 51 None -724 10 Human 5.1 pAC50 = 5.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 195 0 1 1 2.6 Clc1ccc2c(c1)[C@@H](C)CNCC2 10.1038/s41467-023-40064-9
4374 9123 51 None -724 10 Human 5.1 pAC50 = 5.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 195 0 1 1 2.6 Clc1ccc2c(c1)[C@@H](C)CNCC2 10.1038/s41467-023-40064-9
CHEMBL360328 9123 51 None -724 10 Human 5.1 pAC50 = 5.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 195 0 1 1 2.6 Clc1ccc2c(c1)[C@@H](C)CNCC2 10.1038/s41467-023-40064-9
DB04871 9123 51 None -724 10 Human 5.1 pAC50 = 5.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 195 0 1 1 2.6 Clc1ccc2c(c1)[C@@H](C)CNCC2 10.1038/s41467-023-40064-9
119607 212982 113 None 1 6 Human 5.1 pAC50 = 5.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 314 3 1 4 3.0 Cc1onc(-c2ccccc2)c1-c1ccc(S(N)(=O)=O)cc1 10.1038/s41467-023-40064-9
CHEMBL865 212982 113 None 1 6 Human 5.1 pAC50 = 5.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 314 3 1 4 3.0 Cc1onc(-c2ccccc2)c1-c1ccc(S(N)(=O)=O)cc1 10.1038/s41467-023-40064-9
68617 212306 62 None -23 30 Human 5.1 pAC50 = 5.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 305 2 1 1 5.2 CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21 10.1038/s41467-023-40064-9
CHEMBL1709 212306 62 None -23 30 Human 5.1 pAC50 = 5.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 305 2 1 1 5.2 CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21 10.1038/s41467-023-40064-9
CHEMBL809 212306 62 None -23 30 Human 5.1 pAC50 = 5.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 305 2 1 1 5.2 CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21 10.1038/s41467-023-40064-9
16363 7383 53 None -1621 21 Human 5.1 pAC50 = 5.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 381 6 1 4 3.8 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
312 7383 53 None -1621 21 Human 5.1 pAC50 = 5.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 381 6 1 4 3.8 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
9215 7383 53 None -1621 21 Human 5.1 pAC50 = 5.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 381 6 1 4 3.8 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL297302 7383 53 None -1621 21 Human 5.1 pAC50 = 5.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 381 6 1 4 3.8 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
DB12867 7383 53 None -1621 21 Human 5.1 pAC50 = 5.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 381 6 1 4 3.8 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
1054 8367 54 None 66 2 Human 6.1 pAC50 = 6.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O 10.1038/s41467-023-40064-9
59768 8367 54 None 66 2 Human 6.1 pAC50 = 6.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O 10.1038/s41467-023-40064-9
7178 8367 54 None 66 2 Human 6.1 pAC50 = 6.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O 10.1038/s41467-023-40064-9
CHEMBL768 8367 54 None 66 2 Human 6.1 pAC50 = 6.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O 10.1038/s41467-023-40064-9
DB00187 8367 54 None 66 2 Human 6.1 pAC50 = 6.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O 10.1038/s41467-023-40064-9
275196 132451 52 None -26 5 Human 5.1 pAC50 = 5.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 413 4 0 8 2.9 COc1ccc2c(c1OC)C(=O)O[C@@H]2[C@H]1c2c(cc3c(c2OC)OCO3)CCN1C 10.1038/s41467-023-40064-9
CHEMBL364713 132451 52 None -26 5 Human 5.1 pAC50 = 5.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 413 4 0 8 2.9 COc1ccc2c(c1OC)C(=O)O[C@@H]2[C@H]1c2c(cc3c(c2OC)OCO3)CCN1C 10.1038/s41467-023-40064-9
156419 7725 74 None -138 15 Human 5.1 pAC50 = 5.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 357 6 1 1 6.1 C[C@H](c1cccc2c1cccc2)NCCCc1cccc(c1)C(F)(F)F 10.1038/s41467-023-40064-9
3308 7725 74 None -138 15 Human 5.1 pAC50 = 5.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 357 6 1 1 6.1 C[C@H](c1cccc2c1cccc2)NCCCc1cccc(c1)C(F)(F)F 10.1038/s41467-023-40064-9
647 7725 74 None -138 15 Human 5.1 pAC50 = 5.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 357 6 1 1 6.1 C[C@H](c1cccc2c1cccc2)NCCCc1cccc(c1)C(F)(F)F 10.1038/s41467-023-40064-9
CHEMBL1201284 7725 74 None -138 15 Human 5.1 pAC50 = 5.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 357 6 1 1 6.1 C[C@H](c1cccc2c1cccc2)NCCCc1cccc(c1)C(F)(F)F 10.1038/s41467-023-40064-9
DB01012 7725 74 None -138 15 Human 5.1 pAC50 = 5.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 357 6 1 1 6.1 C[C@H](c1cccc2c1cccc2)NCCCc1cccc(c1)C(F)(F)F 10.1038/s41467-023-40064-9
41684 37995 105 None -19 32 Human 5.1 pAC50 = 5.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 307 4 1 7 2.2 CC(=O)Oc1ccccc1C(=O)Nc1ncc([N+](=O)[O-])s1 10.1038/s41467-023-40064-9
CHEMBL1401 37995 105 None -19 32 Human 5.1 pAC50 = 5.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 307 4 1 7 2.2 CC(=O)Oc1ccccc1C(=O)Nc1ncc([N+](=O)[O-])s1 10.1038/s41467-023-40064-9
1673 7749 24 None -1 3 Human 6.1 pAC50 = 6.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 299 1 1 4 1.5 COc1ccc2c3c1O[C@@H]1[C@@]43CCN([C@H](C2)[C@@H]4C=C[C@@H]1O)C 10.1038/s41467-023-40064-9
5284371 7749 24 None -1 3 Human 6.1 pAC50 = 6.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 299 1 1 4 1.5 COc1ccc2c3c1O[C@@H]1[C@@]43CCN([C@H](C2)[C@@H]4C=C[C@@H]1O)C 10.1038/s41467-023-40064-9
725 7749 24 None -1 3 Human 6.1 pAC50 = 6.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 299 1 1 4 1.5 COc1ccc2c3c1O[C@@H]1[C@@]43CCN([C@H](C2)[C@@H]4C=C[C@@H]1O)C 10.1038/s41467-023-40064-9
CHEMBL485 7749 24 None -1 3 Human 6.1 pAC50 = 6.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 299 1 1 4 1.5 COc1ccc2c3c1O[C@@H]1[C@@]43CCN([C@H](C2)[C@@H]4C=C[C@@H]1O)C 10.1038/s41467-023-40064-9
DB00318 7749 24 None -1 3 Human 6.1 pAC50 = 6.1 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 299 1 1 4 1.5 COc1ccc2c3c1O[C@@H]1[C@@]43CCN([C@H](C2)[C@@H]4C=C[C@@H]1O)C 10.1038/s41467-023-40064-9
31101 7516 40 None -1659 29 Human 5.0 pAC50 = 5.0 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 10.1038/s41467-023-40064-9
35 7516 40 None -1659 29 Human 5.0 pAC50 = 5.0 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 10.1038/s41467-023-40064-9
403 7516 40 None -1659 29 Human 5.0 pAC50 = 5.0 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 10.1038/s41467-023-40064-9
CHEMBL493 7516 40 None -1659 29 Human 5.0 pAC50 = 5.0 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 10.1038/s41467-023-40064-9
DB01200 7516 40 None -1659 29 Human 5.0 pAC50 = 5.0 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 10.1038/s41467-023-40064-9
135564886 21265 5 None -3 25 Human 5.0 pAC50 = 5.0 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 752 14 1 6 8.7 CC1(C)C(/C=C/C=C/C=C/C=C2\N(CCCCS(=O)(=O)O)c3ccc4ccccc4c3C2(C)C)=[N+](CCCCS(=O)(=O)[O-])c2ccc3ccccc3c21 10.1038/s41467-023-40064-9
135673376 21265 5 None -3 25 Human 5.0 pAC50 = 5.0 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 752 14 1 6 8.7 CC1(C)C(/C=C/C=C/C=C/C=C2\N(CCCCS(=O)(=O)O)c3ccc4ccccc4c3C2(C)C)=[N+](CCCCS(=O)(=O)[O-])c2ccc3ccccc3c21 10.1038/s41467-023-40064-9
137157436 21265 5 None -3 25 Human 5.0 pAC50 = 5.0 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 752 14 1 6 8.7 CC1(C)C(/C=C/C=C/C=C/C=C2\N(CCCCS(=O)(=O)O)c3ccc4ccccc4c3C2(C)C)=[N+](CCCCS(=O)(=O)[O-])c2ccc3ccccc3c21 10.1038/s41467-023-40064-9
145948239 21265 5 None -3 25 Human 5.0 pAC50 = 5.0 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 752 14 1 6 8.7 CC1(C)C(/C=C/C=C/C=C/C=C2\N(CCCCS(=O)(=O)O)c3ccc4ccccc4c3C2(C)C)=[N+](CCCCS(=O)(=O)[O-])c2ccc3ccccc3c21 10.1038/s41467-023-40064-9
71587099 21265 5 None -3 25 Human 5.0 pAC50 = 5.0 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 752 14 1 6 8.7 CC1(C)C(/C=C/C=C/C=C/C=C2\N(CCCCS(=O)(=O)O)c3ccc4ccccc4c3C2(C)C)=[N+](CCCCS(=O)(=O)[O-])c2ccc3ccccc3c21 10.1038/s41467-023-40064-9
CHEMBL1201304 21265 5 None -3 25 Human 5.0 pAC50 = 5.0 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 752 14 1 6 8.7 CC1(C)C(/C=C/C=C/C=C/C=C2\N(CCCCS(=O)(=O)O)c3ccc4ccccc4c3C2(C)C)=[N+](CCCCS(=O)(=O)[O-])c2ccc3ccccc3c21 10.1038/s41467-023-40064-9
1028 7079 71 None -10 19 Human 6.0 pAC50 = 6.0 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
139148732 7079 71 None -10 19 Human 6.0 pAC50 = 6.0 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
479 7079 71 None -10 19 Human 6.0 pAC50 = 6.0 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
5816 7079 71 None -10 19 Human 6.0 pAC50 = 6.0 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
CHEMBL679 7079 71 None -10 19 Human 6.0 pAC50 = 6.0 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
DB00668 7079 71 None -10 19 Human 6.0 pAC50 = 6.0 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
2405 7452 76 None -6 4 Human 7.0 pAC50 = 7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 325 12 2 5 2.4 OC(COc1ccc(cc1)COCCOC(C)C)CNC(C)C 10.1038/s41467-023-40064-9
380 7452 76 None -6 4 Human 7.0 pAC50 = 7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 325 12 2 5 2.4 OC(COc1ccc(cc1)COCCOC(C)C)CNC(C)C 10.1038/s41467-023-40064-9
7129 7452 76 None -6 4 Human 7.0 pAC50 = 7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 325 12 2 5 2.4 OC(COc1ccc(cc1)COCCOC(C)C)CNC(C)C 10.1038/s41467-023-40064-9
CHEMBL645 7452 76 None -6 4 Human 7.0 pAC50 = 7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 325 12 2 5 2.4 OC(COc1ccc(cc1)COCCOC(C)C)CNC(C)C 10.1038/s41467-023-40064-9
DB00612 7452 76 None -6 4 Human 7.0 pAC50 = 7 Functional
Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity methodCompound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method
ChEMBL 325 12 2 5 2.4 OC(COc1ccc(cc1)COCCOC(C)C)CNC(C)C 10.1038/s41467-023-40064-9
9849126 19211 0 None 3 4 Guinea pig 10.4 pEC50 = 10.4 Functional
Agonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contractionAgonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contraction
ChEMBL 507 18 5 7 2.8 NS(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(NC=O)c2)c1 10.1021/jm801016j
CHEMBL1185969 19211 0 None 3 4 Guinea pig 10.4 pEC50 = 10.4 Functional
Agonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contractionAgonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contraction
ChEMBL 507 18 5 7 2.8 NS(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(NC=O)c2)c1 10.1021/jm801016j
CHEMBL443435 19211 0 None 3 4 Guinea pig 10.4 pEC50 = 10.4 Functional
Agonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contractionAgonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contraction
ChEMBL 507 18 5 7 2.8 NS(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(NC=O)c2)c1 10.1021/jm801016j
1499 8872 47 None -58 38 Human 10.1 pEC50 = 10.1 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm701324c
3779 8872 47 None -58 38 Human 10.1 pEC50 = 10.1 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm701324c
536 8872 47 None -58 38 Human 10.1 pEC50 = 10.1 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm701324c
CHEMBL434 8872 47 None -58 38 Human 10.1 pEC50 = 10.1 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm701324c
DB01064 8872 47 None -58 38 Human 10.1 pEC50 = 10.1 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm701324c
1499 8872 47 None -58 38 Human 10.1 pEC50 = 10.1 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmcl.2008.08.009
3779 8872 47 None -58 38 Human 10.1 pEC50 = 10.1 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmcl.2008.08.009
536 8872 47 None -58 38 Human 10.1 pEC50 = 10.1 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmcl.2008.08.009
CHEMBL434 8872 47 None -58 38 Human 10.1 pEC50 = 10.1 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmcl.2008.08.009
DB01064 8872 47 None -58 38 Human 10.1 pEC50 = 10.1 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmcl.2008.08.009
1499 8872 47 None -58 38 Human 10.1 pEC50 = 10.1 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm800222k
3779 8872 47 None -58 38 Human 10.1 pEC50 = 10.1 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm800222k
536 8872 47 None -58 38 Human 10.1 pEC50 = 10.1 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm800222k
CHEMBL434 8872 47 None -58 38 Human 10.1 pEC50 = 10.1 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm800222k
DB01064 8872 47 None -58 38 Human 10.1 pEC50 = 10.1 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm800222k
1499 8872 47 None -58 38 Human 10.1 pEC50 = 10.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm8000345
3779 8872 47 None -58 38 Human 10.1 pEC50 = 10.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm8000345
536 8872 47 None -58 38 Human 10.1 pEC50 = 10.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm8000345
CHEMBL434 8872 47 None -58 38 Human 10.1 pEC50 = 10.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm8000345
DB01064 8872 47 None -58 38 Human 10.1 pEC50 = 10.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm8000345
1499 8872 47 None -58 38 Human 10.1 pEC50 = 10.1 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptor
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmcl.2004.11.001
3779 8872 47 None -58 38 Human 10.1 pEC50 = 10.1 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptor
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmcl.2004.11.001
536 8872 47 None -58 38 Human 10.1 pEC50 = 10.1 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptor
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmcl.2004.11.001
CHEMBL434 8872 47 None -58 38 Human 10.1 pEC50 = 10.1 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptor
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmcl.2004.11.001
DB01064 8872 47 None -58 38 Human 10.1 pEC50 = 10.1 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptor
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmcl.2004.11.001
11268355 103171 0 None 1 3 Human 9.9 pEC50 = 9.9 Functional
Agonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-ARAgonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-AR
ChEMBL 358 7 3 3 4.1 COc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(Cl)c3)c[nH]c12 10.1016/s0960-894x(03)00073-8
CHEMBL26183 103171 0 None 1 3 Human 9.9 pEC50 = 9.9 Functional
Agonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-ARAgonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-AR
ChEMBL 358 7 3 3 4.1 COc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(Cl)c3)c[nH]c12 10.1016/s0960-894x(03)00073-8
1239 8458 55 None 1 5 Guinea pig 9.5 pEC50 = 9.5 Functional
Agonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contractionAgonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contraction
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1021/jm801016j
3410 8458 55 None 1 5 Guinea pig 9.5 pEC50 = 9.5 Functional
Agonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contractionAgonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contraction
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1021/jm801016j
3465 8458 55 None 1 5 Guinea pig 9.5 pEC50 = 9.5 Functional
Agonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contractionAgonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contraction
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1021/jm801016j
CHEMBL1256786 8458 55 None 1 5 Guinea pig 9.5 pEC50 = 9.5 Functional
Agonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contractionAgonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contraction
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1021/jm801016j
DB00983 8458 55 None 1 5 Guinea pig 9.5 pEC50 = 9.5 Functional
Agonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contractionAgonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contraction
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1021/jm801016j
24936881 24289 0 None 1 3 Human 9.2 pEC50 = 9.2 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assayAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assay
ChEMBL 476 8 3 8 4.1 Oc1cccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)c1 10.1016/j.bmcl.2010.08.039
CHEMBL1257913 24289 0 None 1 3 Human 9.2 pEC50 = 9.2 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assayAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assay
ChEMBL 476 8 3 8 4.1 Oc1cccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)c1 10.1016/j.bmcl.2010.08.039
12065 7415 26 None -6 2 Human 9.2 pEC50 = 9.2 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 370 6 4 5 2.7 Cc1ccccc1CC(C)(C)NCC(c1c2c(c(cc1)O)NC(=O)CO2)O 10.1016/j.bmcl.2009.10.013
45483813 7415 26 None -6 2 Human 9.2 pEC50 = 9.2 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 370 6 4 5 2.7 Cc1ccccc1CC(C)(C)NCC(c1c2c(c(cc1)O)NC(=O)CO2)O 10.1016/j.bmcl.2009.10.013
CHEMBL579394 7415 26 None -6 2 Human 9.2 pEC50 = 9.2 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 370 6 4 5 2.7 Cc1ccccc1CC(C)(C)NCC(c1c2c(c(cc1)O)NC(=O)CO2)O 10.1016/j.bmcl.2009.10.013
164622827 195343 0 None -26 2 Human 9.2 pEC50 = 9.2 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 400 7 4 4 3.9 CC(C)(CCc1cccc(Cl)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
CHEMBL4868585 195343 0 None -26 2 Human 9.2 pEC50 = 9.2 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 400 7 4 4 3.9 CC(C)(CCc1cccc(Cl)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
CHEMBL5028721 195343 0 None -26 2 Human 9.2 pEC50 = 9.2 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 400 7 4 4 3.9 CC(C)(CCc1cccc(Cl)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
9891927 190976 9 None -5 4 Guinea pig 9.1 pEC50 = 9.1 Functional
Agonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contractionAgonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contraction
ChEMBL 494 17 5 7 2.8 NS(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm801016j
CHEMBL446840 190976 9 None -5 4 Guinea pig 9.1 pEC50 = 9.1 Functional
Agonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contractionAgonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contraction
ChEMBL 494 17 5 7 2.8 NS(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm801016j
CHEMBL483200 190976 9 None -5 4 Guinea pig 9.1 pEC50 = 9.1 Functional
Agonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contractionAgonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contraction
ChEMBL 494 17 5 7 2.8 NS(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm801016j
CHEMBL483201 190976 9 None -5 4 Guinea pig 9.1 pEC50 = 9.1 Functional
Agonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contractionAgonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contraction
ChEMBL 494 17 5 7 2.8 NS(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm801016j
45483810 203923 0 None -3 2 Human 9.1 pEC50 = 9.1 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 356 6 4 5 2.4 CC(C)(Cc1ccccc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1016/j.bmcl.2009.10.013
CHEMBL567863 203923 0 None -3 2 Human 9.1 pEC50 = 9.1 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 356 6 4 5 2.4 CC(C)(Cc1ccccc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1016/j.bmcl.2009.10.013
123686 8762 51 None 74 3 Human 9.1 pEC50 = 9.1 Functional
Partial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrsPartial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrs
ChEMBL 354 9 4 5 1.7 C1=CC=C(C=C1)NC(=O)NCCNCC(COC2=CC=CC=C2C#N)O 10.1021/jm400348g
12581 8762 51 None 74 3 Human 9.1 pEC50 = 9.1 Functional
Partial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrsPartial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrs
ChEMBL 354 9 4 5 1.7 C1=CC=C(C=C1)NC(=O)NCCNCC(COC2=CC=CC=C2C#N)O 10.1021/jm400348g
CHEMBL11268 8762 51 None 74 3 Human 9.1 pEC50 = 9.1 Functional
Partial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrsPartial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrs
ChEMBL 354 9 4 5 1.7 C1=CC=C(C=C1)NC(=O)NCCNCC(COC2=CC=CC=C2C#N)O 10.1021/jm400348g
1499 8872 47 None -58 38 Human 9.1 pEC50 = 9.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm9000709
3779 8872 47 None -58 38 Human 9.1 pEC50 = 9.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm9000709
536 8872 47 None -58 38 Human 9.1 pEC50 = 9.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm9000709
CHEMBL434 8872 47 None -58 38 Human 9.1 pEC50 = 9.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm9000709
DB01064 8872 47 None -58 38 Human 9.1 pEC50 = 9.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm9000709
164623105 195347 0 None -47 2 Human 9.1 pEC50 = 9.1 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 400 7 4 4 3.9 CC(C)(CCc1ccc(Cl)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
CHEMBL4862449 195347 0 None -47 2 Human 9.1 pEC50 = 9.1 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 400 7 4 4 3.9 CC(C)(CCc1ccc(Cl)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
CHEMBL5028738 195347 0 None -47 2 Human 9.1 pEC50 = 9.1 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 400 7 4 4 3.9 CC(C)(CCc1ccc(Cl)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
13345218 204000 0 None -8 2 Human 9.1 pEC50 = 9.1 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 372 6 5 6 2.1 CC(C)(Cc1ccc(O)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1016/j.bmcl.2009.10.013
CHEMBL568272 204000 0 None -8 2 Human 9.1 pEC50 = 9.1 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 372 6 5 6 2.1 CC(C)(Cc1ccc(O)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1016/j.bmcl.2009.10.013
44392175 138572 0 None 1 2 Human 9.1 pEC50 = 9.1 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptor
ChEMBL 480 12 5 7 3.2 O=C(Nc1ccc(C[C@@H](CO)NC[C@H](O)COc2ccccc2)cc1)Nc1cccc([N+](=O)[O-])c1 10.1016/j.bmcl.2004.11.001
CHEMBL369346 138572 0 None 1 2 Human 9.1 pEC50 = 9.1 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptor
ChEMBL 480 12 5 7 3.2 O=C(Nc1ccc(C[C@@H](CO)NC[C@H](O)COc2ccccc2)cc1)Nc1cccc([N+](=O)[O-])c1 10.1016/j.bmcl.2004.11.001
1499 8872 47 None -58 38 Human 9.0 pEC50 = 9 Functional
Activity against human beta 1 adrenergic receptor (AR), expressed in CHO cells.Activity against human beta 1 adrenergic receptor (AR), expressed in CHO cells.
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm0101500
3779 8872 47 None -58 38 Human 9.0 pEC50 = 9 Functional
Activity against human beta 1 adrenergic receptor (AR), expressed in CHO cells.Activity against human beta 1 adrenergic receptor (AR), expressed in CHO cells.
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm0101500
536 8872 47 None -58 38 Human 9.0 pEC50 = 9 Functional
Activity against human beta 1 adrenergic receptor (AR), expressed in CHO cells.Activity against human beta 1 adrenergic receptor (AR), expressed in CHO cells.
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm0101500
CHEMBL434 8872 47 None -58 38 Human 9.0 pEC50 = 9 Functional
Activity against human beta 1 adrenergic receptor (AR), expressed in CHO cells.Activity against human beta 1 adrenergic receptor (AR), expressed in CHO cells.
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm0101500
DB01064 8872 47 None -58 38 Human 9.0 pEC50 = 9 Functional
Activity against human beta 1 adrenergic receptor (AR), expressed in CHO cells.Activity against human beta 1 adrenergic receptor (AR), expressed in CHO cells.
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm0101500
1499 8872 47 None -58 38 Human 9.0 pEC50 = 9 Functional
Activity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP productionActivity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP production
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm0509445
3779 8872 47 None -58 38 Human 9.0 pEC50 = 9 Functional
Activity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP productionActivity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP production
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm0509445
536 8872 47 None -58 38 Human 9.0 pEC50 = 9 Functional
Activity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP productionActivity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP production
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm0509445
CHEMBL434 8872 47 None -58 38 Human 9.0 pEC50 = 9 Functional
Activity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP productionActivity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP production
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm0509445
DB01064 8872 47 None -58 38 Human 9.0 pEC50 = 9 Functional
Activity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP productionActivity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP production
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm0509445
1499 8872 47 None -58 38 Human 8.9 pEC50 = 8.9 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.ejmech.2021.113697
3779 8872 47 None -58 38 Human 8.9 pEC50 = 8.9 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.ejmech.2021.113697
536 8872 47 None -58 38 Human 8.9 pEC50 = 8.9 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.ejmech.2021.113697
CHEMBL434 8872 47 None -58 38 Human 8.9 pEC50 = 8.9 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.ejmech.2021.113697
DB01064 8872 47 None -58 38 Human 8.9 pEC50 = 8.9 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.ejmech.2021.113697
44392230 72371 1 None 1 2 Human 8.9 pEC50 = 8.9 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptor
ChEMBL 479 12 6 6 3.0 O=C(Nc1ccc(C[C@@H](CO)NC[C@H](O)COc2ccccc2)cc1)Nc1cccc(C(=O)O)c1 10.1016/j.bmcl.2004.11.001
CHEMBL183283 72371 1 None 1 2 Human 8.9 pEC50 = 8.9 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptor
ChEMBL 479 12 6 6 3.0 O=C(Nc1ccc(C[C@@H](CO)NC[C@H](O)COc2ccccc2)cc1)Nc1cccc(C(=O)O)c1 10.1016/j.bmcl.2004.11.001
24822304 104640 0 None 6 2 Human 8.9 pEC50 = 8.9 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 412 9 3 5 4.1 O=C(O)c1ccc(Oc2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)nc1 10.1021/jm701324c
CHEMBL272234 104640 0 None 6 2 Human 8.9 pEC50 = 8.9 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 412 9 3 5 4.1 O=C(O)c1ccc(Oc2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)nc1 10.1021/jm701324c
105 10234 91 None -28 3 Human 8.8 pEC50 = 8.8 Functional
Agonist activity at beta1 adrenoceptor (unknown origin) expressed in HEK293 cells assessed as cAMP accumulation incubated for 60 mins by microplate reader analysisAgonist activity at beta1 adrenoceptor (unknown origin) expressed in HEK293 cells assessed as cAMP accumulation incubated for 60 mins by microplate reader analysis
ChEMBL 239 4 4 4 1.3 OCc1cc(ccc1O)C(CNC(C)(C)C)O 10.1021/acs.jmedchem.1c02006
2083 10234 91 None -28 3 Human 8.8 pEC50 = 8.8 Functional
Agonist activity at beta1 adrenoceptor (unknown origin) expressed in HEK293 cells assessed as cAMP accumulation incubated for 60 mins by microplate reader analysisAgonist activity at beta1 adrenoceptor (unknown origin) expressed in HEK293 cells assessed as cAMP accumulation incubated for 60 mins by microplate reader analysis
ChEMBL 239 4 4 4 1.3 OCc1cc(ccc1O)C(CNC(C)(C)C)O 10.1021/acs.jmedchem.1c02006
558 10234 91 None -28 3 Human 8.8 pEC50 = 8.8 Functional
Agonist activity at beta1 adrenoceptor (unknown origin) expressed in HEK293 cells assessed as cAMP accumulation incubated for 60 mins by microplate reader analysisAgonist activity at beta1 adrenoceptor (unknown origin) expressed in HEK293 cells assessed as cAMP accumulation incubated for 60 mins by microplate reader analysis
ChEMBL 239 4 4 4 1.3 OCc1cc(ccc1O)C(CNC(C)(C)C)O 10.1021/acs.jmedchem.1c02006
CHEMBL714 10234 91 None -28 3 Human 8.8 pEC50 = 8.8 Functional
Agonist activity at beta1 adrenoceptor (unknown origin) expressed in HEK293 cells assessed as cAMP accumulation incubated for 60 mins by microplate reader analysisAgonist activity at beta1 adrenoceptor (unknown origin) expressed in HEK293 cells assessed as cAMP accumulation incubated for 60 mins by microplate reader analysis
ChEMBL 239 4 4 4 1.3 OCc1cc(ccc1O)C(CNC(C)(C)C)O 10.1021/acs.jmedchem.1c02006
DB01001 10234 91 None -28 3 Human 8.8 pEC50 = 8.8 Functional
Agonist activity at beta1 adrenoceptor (unknown origin) expressed in HEK293 cells assessed as cAMP accumulation incubated for 60 mins by microplate reader analysisAgonist activity at beta1 adrenoceptor (unknown origin) expressed in HEK293 cells assessed as cAMP accumulation incubated for 60 mins by microplate reader analysis
ChEMBL 239 4 4 4 1.3 OCc1cc(ccc1O)C(CNC(C)(C)C)O 10.1021/acs.jmedchem.1c02006
164615126 195283 0 None -104 2 Human 8.8 pEC50 = 8.8 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 382 8 4 5 2.9 COc1ccccc1CCC(C)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
CHEMBL4854569 195283 0 None -104 2 Human 8.8 pEC50 = 8.8 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 382 8 4 5 2.9 COc1ccccc1CCC(C)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
CHEMBL5028293 195283 0 None -104 2 Human 8.8 pEC50 = 8.8 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 382 8 4 5 2.9 COc1ccccc1CCC(C)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
90645347 119290 0 None -7 3 Human 8.8 pEC50 = 8.8 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 578 12 6 7 5.6 CC(C)(N)COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1-c1ccccc1 10.1016/j.bmcl.2014.04.095
CHEMBL3298987 119290 0 None -7 3 Human 8.8 pEC50 = 8.8 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 578 12 6 7 5.6 CC(C)(N)COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1-c1ccccc1 10.1016/j.bmcl.2014.04.095
164618895 195314 0 None -95 2 Human 8.8 pEC50 = 8.8 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 400 7 4 4 3.9 CC(C)(CCc1ccccc1Cl)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
CHEMBL4868938 195314 0 None -95 2 Human 8.8 pEC50 = 8.8 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 400 7 4 4 3.9 CC(C)(CCc1ccccc1Cl)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
CHEMBL5028525 195314 0 None -95 2 Human 8.8 pEC50 = 8.8 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 400 7 4 4 3.9 CC(C)(CCc1ccccc1Cl)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
45101519 205302 0 None -1 2 Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelAgonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP level
ChEMBL 498 11 8 7 1.6 CC(C)(Cc1ccc(NC(=O)CCCNC(=N)N)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1016/j.bmcl.2009.06.104
CHEMBL577917 205302 0 None -1 2 Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelAgonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP level
ChEMBL 498 11 8 7 1.6 CC(C)(Cc1ccc(NC(=O)CCCNC(=N)N)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1016/j.bmcl.2009.06.104
24936492 24321 0 None -1 3 Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assayAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assay
ChEMBL 482 8 3 9 4.1 Oc1ccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5cccs5)c34)CC2)cc1 10.1016/j.bmcl.2010.08.039
CHEMBL1258026 24321 0 None -1 3 Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assayAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assay
ChEMBL 482 8 3 9 4.1 Oc1ccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5cccs5)c34)CC2)cc1 10.1016/j.bmcl.2010.08.039
164612078 195257 0 None -64 2 Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 382 8 4 5 2.9 COc1ccccc1CC[C@@H](C)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
CHEMBL4848617 195257 0 None -64 2 Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 382 8 4 5 2.9 COc1ccccc1CC[C@@H](C)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
CHEMBL5028119 195257 0 None -64 2 Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 382 8 4 5 2.9 COc1ccccc1CC[C@@H](C)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
9927453 103462 0 None -1 3 Human 8.7 pEC50 = 8.7 Functional
Agonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-ARAgonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-AR
ChEMBL 328 6 3 2 4.1 C[C@H](Cc1c[nH]c2ccccc12)NC[C@H](O)c1cccc(Cl)c1 10.1016/s0960-894x(03)00073-8
CHEMBL26393 103462 0 None -1 3 Human 8.7 pEC50 = 8.7 Functional
Agonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-ARAgonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-AR
ChEMBL 328 6 3 2 4.1 C[C@H](Cc1c[nH]c2ccccc12)NC[C@H](O)c1cccc(Cl)c1 10.1016/s0960-894x(03)00073-8
42625513 19331 0 None -3 4 Guinea pig 8.7 pEC50 = 8.7 Functional
Agonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contractionAgonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contraction
ChEMBL 494 17 5 7 2.8 NS(=O)(=O)c1ccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc1 10.1021/jm801016j
CHEMBL1186722 19331 0 None -3 4 Guinea pig 8.7 pEC50 = 8.7 Functional
Agonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contractionAgonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contraction
ChEMBL 494 17 5 7 2.8 NS(=O)(=O)c1ccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc1 10.1021/jm801016j
CHEMBL475389 19331 0 None -3 4 Guinea pig 8.7 pEC50 = 8.7 Functional
Agonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contractionAgonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contraction
ChEMBL 494 17 5 7 2.8 NS(=O)(=O)c1ccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc1 10.1021/jm801016j
90645346 119272 0 None -2 3 Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 578 13 6 7 4.7 O=C(NCCOc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1)c1ccccc1 10.1016/j.bmcl.2014.04.095
CHEMBL3298762 119272 0 None -2 3 Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 578 13 6 7 4.7 O=C(NCCOc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1)c1ccccc1 10.1016/j.bmcl.2014.04.095
42625517 19493 0 None -19 4 Guinea pig 8.0 pEC50 = 8 Functional
Agonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contractionAgonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contraction
ChEMBL 536 19 5 7 3.8 CC(C)NS(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm801016j
CHEMBL1187654 19493 0 None -19 4 Guinea pig 8.0 pEC50 = 8 Functional
Agonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contractionAgonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contraction
ChEMBL 536 19 5 7 3.8 CC(C)NS(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm801016j
CHEMBL514032 19493 0 None -19 4 Guinea pig 8.0 pEC50 = 8 Functional
Agonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contractionAgonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contraction
ChEMBL 536 19 5 7 3.8 CC(C)NS(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm801016j
11180293 119285 0 None -22 3 Human 8.0 pEC50 = 8 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 543 12 6 8 3.1 O=c1ccc2c([C@@H](O)CNCCc3ccc(Nc4ccc(OCCN5CCNCC5)cc4)cc3)ccc(O)c2[nH]1 10.1016/j.bmcl.2014.04.095
CHEMBL3298897 119285 0 None -22 3 Human 8.0 pEC50 = 8 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 543 12 6 8 3.1 O=c1ccc2c([C@@H](O)CNCCc3ccc(Nc4ccc(OCCN5CCNCC5)cc4)cc3)ccc(O)c2[nH]1 10.1016/j.bmcl.2014.04.095
56668796 73376 0 None -31 3 Human 8.0 pEC50 = 8 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 598 20 7 7 4.3 O=C(CNC(=O)Nc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1)NC1CCCC1 10.1016/j.bmc.2011.08.043
CHEMBL1835860 73376 0 None -31 3 Human 8.0 pEC50 = 8 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 598 20 7 7 4.3 O=C(CNC(=O)Nc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1)NC1CCCC1 10.1016/j.bmc.2011.08.043
CHEMBL1852632 73376 0 None -31 3 Human 8.0 pEC50 = 8 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 598 20 7 7 4.3 O=C(CNC(=O)Nc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1)NC1CCCC1 10.1016/j.bmc.2011.08.043
45273268 202408 0 None 194 2 Human 8.0 pEC50 = 8 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 362 10 3 4 4.0 O[C@@H](CNCCc1ccc(Nc2ccccc2)cc1)COc1ccccc1 10.1016/j.bmc.2009.06.031
CHEMBL1204004 202408 0 None 194 2 Human 8.0 pEC50 = 8 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 362 10 3 4 4.0 O[C@@H](CNCCc1ccc(Nc2ccccc2)cc1)COc1ccccc1 10.1016/j.bmc.2009.06.031
CHEMBL556274 202408 0 None 194 2 Human 8.0 pEC50 = 8 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 362 10 3 4 4.0 O[C@@H](CNCCc1ccc(Nc2ccccc2)cc1)COc1ccccc1 10.1016/j.bmc.2009.06.031
10217757 119047 0 None -31 4 Human 8.0 pEC50 = 8 Functional
Agonist activity at human recombinant beta1 receptor assessed as cAMP accumulation by radioimmunoassay and cell based assayAgonist activity at human recombinant beta1 receptor assessed as cAMP accumulation by radioimmunoassay and cell based assay
ChEMBL 497 12 5 6 5.2 COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c(NC=O)c3)cc2)cc1-c1ccccc1 10.1016/j.bmcl.2014.04.069
CHEMBL3290998 119047 0 None -31 4 Human 8.0 pEC50 = 8 Functional
Agonist activity at human recombinant beta1 receptor assessed as cAMP accumulation by radioimmunoassay and cell based assayAgonist activity at human recombinant beta1 receptor assessed as cAMP accumulation by radioimmunoassay and cell based assay
ChEMBL 497 12 5 6 5.2 COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c(NC=O)c3)cc2)cc1-c1ccccc1 10.1016/j.bmcl.2014.04.069
164614147 195271 0 None - 1 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 400 7 4 4 3.9 CC(C)(CCc1cccc(Cl)c1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
CHEMBL4856990 195271 0 None - 1 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 400 7 4 4 3.9 CC(C)(CCc1cccc(Cl)c1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
CHEMBL5028233 195271 0 None - 1 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 400 7 4 4 3.9 CC(C)(CCc1cccc(Cl)c1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
164618813 195313 0 None -275 2 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 366 7 4 4 3.2 Cc1ccc(CCC(C)NCC(O)c2ccc(O)c3[nH]c(=O)ccc23)cc1 10.1016/j.ejmech.2021.113697
CHEMBL4865833 195313 0 None -275 2 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 366 7 4 4 3.2 Cc1ccc(CCC(C)NCC(O)c2ccc(O)c3[nH]c(=O)ccc23)cc1 10.1016/j.ejmech.2021.113697
CHEMBL5028523 195313 0 None -275 2 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 366 7 4 4 3.2 Cc1ccc(CCC(C)NCC(O)c2ccc(O)c3[nH]c(=O)ccc23)cc1 10.1016/j.ejmech.2021.113697
164619360 195317 0 None -371 2 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 370 7 4 4 3.0 CC(CCc1ccc(F)cc1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
CHEMBL4868763 195317 0 None -371 2 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 370 7 4 4 3.0 CC(CCc1ccc(F)cc1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
CHEMBL5028547 195317 0 None -371 2 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 370 7 4 4 3.0 CC(CCc1ccc(F)cc1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
155774 10868 40 None 42 3 Human 8.0 pEC50 = 8.0 Functional
Partial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrsPartial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrs
ChEMBL 339 8 4 6 -0.2 OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1 10.1021/jm400348g
2848 10868 40 None 42 3 Human 8.0 pEC50 = 8.0 Functional
Partial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrsPartial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrs
ChEMBL 339 8 4 6 -0.2 OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1 10.1021/jm400348g
538 10868 40 None 42 3 Human 8.0 pEC50 = 8.0 Functional
Partial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrsPartial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrs
ChEMBL 339 8 4 6 -0.2 OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1 10.1021/jm400348g
CHEMBL75753 10868 40 None 42 3 Human 8.0 pEC50 = 8.0 Functional
Partial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrsPartial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrs
ChEMBL 339 8 4 6 -0.2 OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1 10.1021/jm400348g
DB13781 10868 40 None 42 3 Human 8.0 pEC50 = 8.0 Functional
Partial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrsPartial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrs
ChEMBL 339 8 4 6 -0.2 OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1 10.1021/jm400348g
10863093 57101 0 None -19 3 Human 7.0 pEC50 = 7 Functional
Ability to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentrationAbility to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentration
ChEMBL 439 10 4 6 2.1 C[C@H](CNc1ccc(CC(=O)NS(C)(=O)=O)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm0101500
CHEMBL157210 57101 0 None -19 3 Human 7.0 pEC50 = 7 Functional
Ability to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentrationAbility to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentration
ChEMBL 439 10 4 6 2.1 C[C@H](CNc1ccc(CC(=O)NS(C)(=O)=O)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm0101500
16049450 70867 0 None -125 2 Human 7.0 pEC50 = 7 Functional
Agonist activity at adrenergic beta1 receptorAgonist activity at adrenergic beta1 receptor
ChEMBL 481 13 5 7 3.5 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCSCCCNCCc3cccc(Cl)c3)c2s1 10.1016/j.bmcl.2011.05.097
CHEMBL1807827 70867 0 None -125 2 Human 7.0 pEC50 = 7 Functional
Agonist activity at adrenergic beta1 receptorAgonist activity at adrenergic beta1 receptor
ChEMBL 481 13 5 7 3.5 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCSCCCNCCc3cccc(Cl)c3)c2s1 10.1016/j.bmcl.2011.05.097
16049234 70868 0 None -177 3 Human 7.0 pEC50 = 7 Functional
Agonist activity at adrenergic beta1 receptorAgonist activity at adrenergic beta1 receptor
ChEMBL 481 13 5 7 3.5 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCSCCCNCCc3ccccc3Cl)c2s1 10.1016/j.bmcl.2011.05.097
CHEMBL1807828 70868 0 None -177 3 Human 7.0 pEC50 = 7 Functional
Agonist activity at adrenergic beta1 receptorAgonist activity at adrenergic beta1 receptor
ChEMBL 481 13 5 7 3.5 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCSCCCNCCc3ccccc3Cl)c2s1 10.1016/j.bmcl.2011.05.097
16049448 70869 0 None -56 3 Human 7.0 pEC50 = 7 Functional
Agonist activity at adrenergic beta1 receptorAgonist activity at adrenergic beta1 receptor
ChEMBL 515 13 5 7 4.2 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCSCCCNCCc3cccc(Cl)c3Cl)c2s1 10.1016/j.bmcl.2011.05.097
CHEMBL1807829 70869 0 None -56 3 Human 7.0 pEC50 = 7 Functional
Agonist activity at adrenergic beta1 receptorAgonist activity at adrenergic beta1 receptor
ChEMBL 515 13 5 7 4.2 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCSCCCNCCc3cccc(Cl)c3Cl)c2s1 10.1016/j.bmcl.2011.05.097
16049374 70873 0 None -89 3 Human 7.0 pEC50 = 7 Functional
Agonist activity at adrenergic beta1 receptorAgonist activity at adrenergic beta1 receptor
ChEMBL 481 13 5 7 3.5 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCSCCNCCc3cccc(Cl)c3)c2s1 10.1016/j.bmcl.2011.05.097
CHEMBL1807869 70873 0 None -89 3 Human 7.0 pEC50 = 7 Functional
Agonist activity at adrenergic beta1 receptorAgonist activity at adrenergic beta1 receptor
ChEMBL 481 13 5 7 3.5 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCSCCNCCc3cccc(Cl)c3)c2s1 10.1016/j.bmcl.2011.05.097
1499 8872 47 None -58 38 Human 7.0 pEC50 = 7 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmc.2009.03.044
3779 8872 47 None -58 38 Human 7.0 pEC50 = 7 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmc.2009.03.044
536 8872 47 None -58 38 Human 7.0 pEC50 = 7 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmc.2009.03.044
CHEMBL434 8872 47 None -58 38 Human 7.0 pEC50 = 7 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmc.2009.03.044
DB01064 8872 47 None -58 38 Human 7.0 pEC50 = 7 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmc.2009.03.044
9888047 100156 0 None -398 3 Human 7.0 pEC50 = 7 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 414 9 4 5 4.4 C[C@H](CNc1cccc(-c2occc2C(=O)O)c1)NC[C@H](O)c1cccc(Cl)c1 10.1016/j.bmcl.2007.05.069
CHEMBL245673 100156 0 None -398 3 Human 7.0 pEC50 = 7 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 414 9 4 5 4.4 C[C@H](CNc1cccc(-c2occc2C(=O)O)c1)NC[C@H](O)c1cccc(Cl)c1 10.1016/j.bmcl.2007.05.069
44441231 154833 0 None -50 3 Human 7.0 pEC50 = 7 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 431 9 4 6 4.3 C[C@H](CNc1cccc(-c2csc(C(=O)O)n2)c1)NC[C@H](O)c1cccc(Cl)c1 10.1016/j.bmcl.2007.05.069
CHEMBL393470 154833 0 None -50 3 Human 7.0 pEC50 = 7 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 431 9 4 6 4.3 C[C@H](CNc1cccc(-c2csc(C(=O)O)n2)c1)NC[C@H](O)c1cccc(Cl)c1 10.1016/j.bmcl.2007.05.069
44441235 157771 0 None -251 3 Human 7.0 pEC50 = 7 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 430 9 4 5 4.9 C[C@H](CNc1ccc(-c2sccc2C(=O)O)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1016/j.bmcl.2007.05.069
CHEMBL395834 157771 0 None -251 3 Human 7.0 pEC50 = 7 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 430 9 4 5 4.9 C[C@H](CNc1ccc(-c2sccc2C(=O)O)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1016/j.bmcl.2007.05.069
45271523 201907 0 None -10 3 Human 7.0 pEC50 = 7 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 435 10 4 4 4.4 Cc1ccc(NC(=S)Nc2ccc(CCNC[C@H](O)COc3ccccc3)cc2)cc1 10.1016/j.bmc.2009.06.031
CHEMBL1204000 201907 0 None -10 3 Human 7.0 pEC50 = 7 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 435 10 4 4 4.4 Cc1ccc(NC(=S)Nc2ccc(CCNC[C@H](O)COc3ccccc3)cc2)cc1 10.1016/j.bmc.2009.06.031
CHEMBL550096 201907 0 None -10 3 Human 7.0 pEC50 = 7 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 435 10 4 4 4.4 Cc1ccc(NC(=S)Nc2ccc(CCNC[C@H](O)COc3ccccc3)cc2)cc1 10.1016/j.bmc.2009.06.031
45272417 202220 0 None -1 3 Human 7.0 pEC50 = 7 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 455 10 4 4 4.7 O[C@@H](CNCCc1ccc(NC(=S)Nc2cccc(Cl)c2)cc1)COc1ccccc1 10.1016/j.bmc.2009.06.031
CHEMBL2448074 202220 0 None -1 3 Human 7.0 pEC50 = 7 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 455 10 4 4 4.7 O[C@@H](CNCCc1ccc(NC(=S)Nc2cccc(Cl)c2)cc1)COc1ccccc1 10.1016/j.bmc.2009.06.031
CHEMBL552368 202220 0 None -1 3 Human 7.0 pEC50 = 7 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 455 10 4 4 4.7 O[C@@H](CNCCc1ccc(NC(=S)Nc2cccc(Cl)c2)cc1)COc1ccccc1 10.1016/j.bmc.2009.06.031
42625823 19451 0 None -501 3 Human 7.0 pEC50 = 7 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 576 19 5 7 4.7 O=S(=O)(NC1CCCCC1)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm801016j
CHEMBL1187371 19451 0 None -501 3 Human 7.0 pEC50 = 7 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 576 19 5 7 4.7 O=S(=O)(NC1CCCCC1)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm801016j
CHEMBL500782 19451 0 None -501 3 Human 7.0 pEC50 = 7 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 576 19 5 7 4.7 O=S(=O)(NC1CCCCC1)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm801016j
46832804 13758 0 None -50 3 Human 7.0 pEC50 = 7 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 496 17 5 8 1.9 NS(=O)(=O)c1ccc(COCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc1 10.1021/jm100326d
CHEMBL1084655 13758 0 None -50 3 Human 7.0 pEC50 = 7 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 496 17 5 8 1.9 NS(=O)(=O)c1ccc(COCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc1 10.1021/jm100326d
10553603 106474 0 None 1 3 Human 7.0 pEC50 = 7 Functional
Increased cAMP levels of Chinese hamster ovary (CHO) cells expressing human beta 1 Adrenergic receptorIncreased cAMP levels of Chinese hamster ovary (CHO) cells expressing human beta 1 Adrenergic receptor
ChEMBL 506 10 6 8 1.5 CS(=O)(=O)Nc1cc([C@@H](O)CNC2CCN(c3ccc(NC(=O)CC(=O)O)cc3)CC2)ccc1O 10.1021/jm000544b
CHEMBL284612 106474 0 None 1 3 Human 7.0 pEC50 = 7 Functional
Increased cAMP levels of Chinese hamster ovary (CHO) cells expressing human beta 1 Adrenergic receptorIncreased cAMP levels of Chinese hamster ovary (CHO) cells expressing human beta 1 Adrenergic receptor
ChEMBL 506 10 6 8 1.5 CS(=O)(=O)Nc1cc([C@@H](O)CNC2CCN(c3ccc(NC(=O)CC(=O)O)cc3)CC2)ccc1O 10.1021/jm000544b
42625517 19493 0 None -1995 4 Human 6.0 pEC50 = 6 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 536 19 5 7 3.8 CC(C)NS(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm801016j
CHEMBL1187654 19493 0 None -1995 4 Human 6.0 pEC50 = 6 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 536 19 5 7 3.8 CC(C)NS(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm801016j
CHEMBL514032 19493 0 None -1995 4 Human 6.0 pEC50 = 6 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 536 19 5 7 3.8 CC(C)NS(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm801016j
42625588 187205 0 None -630 3 Human 6.0 pEC50 = 6 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 508 18 5 7 2.9 NS(=O)(=O)Cc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm801016j
CHEMBL475237 187205 0 None -630 3 Human 6.0 pEC50 = 6 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 508 18 5 7 2.9 NS(=O)(=O)Cc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm801016j
10121328 11210 0 None -100 3 Human 6.0 pEC50 = 6 Functional
Beta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptorBeta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptor
ChEMBL 593 11 5 10 1.4 CS(=O)(=O)Nc1cc([C@@H](O)CNCC2CCN(S(=O)(=O)c3ccc(-n4cc(C(=O)O)cn4)cc3)CC2)ccc1O 10.1016/s0960-894x(02)00608-x
CHEMBL101606 11210 0 None -100 3 Human 6.0 pEC50 = 6 Functional
Beta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptorBeta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptor
ChEMBL 593 11 5 10 1.4 CS(=O)(=O)Nc1cc([C@@H](O)CNCC2CCN(S(=O)(=O)c3ccc(-n4cc(C(=O)O)cn4)cc3)CC2)ccc1O 10.1016/s0960-894x(02)00608-x
11575154 83990 0 None -100000 2 Human 5.0 pEC50 = 5 Functional
Activity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP productionActivity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP production
ChEMBL 411 9 4 5 3.8 O=C(O)c1ccncc1-c1cccc(NCCNC[C@H](O)c2cccc(Cl)c2)c1 10.1021/jm0509445
CHEMBL207943 83990 0 None -100000 2 Human 5.0 pEC50 = 5 Functional
Activity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP productionActivity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP production
ChEMBL 411 9 4 5 3.8 O=C(O)c1ccncc1-c1cccc(NCCNC[C@H](O)c2cccc(Cl)c2)c1 10.1021/jm0509445
44237766 65013 0 None -10000 2 Rat 5.0 pEC50 = 5 Functional
Agonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effectAgonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effect
ChEMBL 550 10 6 6 5.5 O=C(Nc1cccc(CCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1)Nc1cccc(Oc2ccccc2)c1 10.1016/j.bmcl.2010.12.096
CHEMBL1682221 65013 0 None -10000 2 Rat 5.0 pEC50 = 5 Functional
Agonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effectAgonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effect
ChEMBL 550 10 6 6 5.5 O=C(Nc1cccc(CCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1)Nc1cccc(Oc2ccccc2)c1 10.1016/j.bmcl.2010.12.096
155517986 176986 0 None -478630 2 Human 5.0 pEC50 = 5 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 366 7 4 4 3.3 CC(C)(CCc1ccccc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.bmc.2018.10.043
CHEMBL4445289 176986 0 None -478630 2 Human 5.0 pEC50 = 5 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 366 7 4 4 3.3 CC(C)(CCc1ccccc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.bmc.2018.10.043
164622775 195342 0 None -120226 2 Human 5.0 pEC50 = 5 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 428 10 4 7 2.5 COc1cc(CCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)cc(OC)c1OC 10.1016/j.ejmech.2021.113697
CHEMBL4867311 195342 0 None -120226 2 Human 5.0 pEC50 = 5 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 428 10 4 7 2.5 COc1cc(CCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)cc(OC)c1OC 10.1016/j.ejmech.2021.113697
CHEMBL5028718 195342 0 None -120226 2 Human 5.0 pEC50 = 5 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 428 10 4 7 2.5 COc1cc(CCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)cc(OC)c1OC 10.1016/j.ejmech.2021.113697
44313150 110554 0 None -6 3 Human 5.0 pEC50 = 5 Functional
Compound was evaluated for its inhibitory activity against human beta-1 adrenergic receptor (AR)Compound was evaluated for its inhibitory activity against human beta-1 adrenergic receptor (AR)
ChEMBL 628 12 6 6 6.7 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2cccc(-c3cccc(CC4NCCc5cc(O)c(O)cc54)c3)c2)cc1 10.1016/s0960-894x(00)00459-5
CHEMBL308868 110554 0 None -6 3 Human 5.0 pEC50 = 5 Functional
Compound was evaluated for its inhibitory activity against human beta-1 adrenergic receptor (AR)Compound was evaluated for its inhibitory activity against human beta-1 adrenergic receptor (AR)
ChEMBL 628 12 6 6 6.7 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2cccc(-c3cccc(CC4NCCc5cc(O)c(O)cc54)c3)c2)cc1 10.1016/s0960-894x(00)00459-5
1960 9632 67 None -38 19 Guinea pig 5.0 pEC50 = 5 Functional
Effective dose required to stimulate contractions in isolated guinea pig atrium.Effective dose required to stimulate contractions in isolated guinea pig atrium.
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00019a001
439260 9632 67 None -38 19 Guinea pig 5.0 pEC50 = 5 Functional
Effective dose required to stimulate contractions in isolated guinea pig atrium.Effective dose required to stimulate contractions in isolated guinea pig atrium.
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00019a001
505 9632 67 None -38 19 Guinea pig 5.0 pEC50 = 5 Functional
Effective dose required to stimulate contractions in isolated guinea pig atrium.Effective dose required to stimulate contractions in isolated guinea pig atrium.
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00019a001
CHEMBL1437 9632 67 None -38 19 Guinea pig 5.0 pEC50 = 5 Functional
Effective dose required to stimulate contractions in isolated guinea pig atrium.Effective dose required to stimulate contractions in isolated guinea pig atrium.
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00019a001
DB00368 9632 67 None -38 19 Guinea pig 5.0 pEC50 = 5 Functional
Effective dose required to stimulate contractions in isolated guinea pig atrium.Effective dose required to stimulate contractions in isolated guinea pig atrium.
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00019a001
10301101 109737 0 None -1659 2 Human 4.0 pEC50 = 4 Functional
Agonistic activity against cloned human beta1-AR (beta-1-adrenergic receptor) in CHO cellsAgonistic activity against cloned human beta1-AR (beta-1-adrenergic receptor) in CHO cells
ChEMBL 509 9 3 6 3.5 COc1ccc(S(=O)(=O)N2CCC(NC[C@H](O)COc3cccc4[nH]c5ccccc5c34)CC2)cc1 10.1016/s0960-894x(03)00387-1
CHEMBL306423 109737 0 None -1659 2 Human 4.0 pEC50 = 4 Functional
Agonistic activity against cloned human beta1-AR (beta-1-adrenergic receptor) in CHO cellsAgonistic activity against cloned human beta1-AR (beta-1-adrenergic receptor) in CHO cells
ChEMBL 509 9 3 6 3.5 COc1ccc(S(=O)(=O)N2CCC(NC[C@H](O)COc3cccc4[nH]c5ccccc5c34)CC2)cc1 10.1016/s0960-894x(03)00387-1
145984792 172508 0 None -12882 3 Human 4.0 pEC50 = 4 Functional
Antagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assayAntagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assay
ChEMBL 461 12 4 5 3.1 CC(=O)NCc1cccc(OC[C@@H](O)CNCCc2ccc(NC(=O)c3ccccc3)cc2)c1 10.1016/j.ejmech.2018.03.032
CHEMBL4246134 172508 0 None -12882 3 Human 4.0 pEC50 = 4 Functional
Antagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assayAntagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assay
ChEMBL 461 12 4 5 3.1 CC(=O)NCc1cccc(OC[C@@H](O)CNCCc2ccc(NC(=O)c3ccccc3)cc2)c1 10.1016/j.ejmech.2018.03.032
45483848 203919 0 None - 1 Human 6.0 pEC50 = 6 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 394 7 3 3 5.3 CC(C)c1ccc(CC(C)(C)NCC(O)c2cc(Cl)c(N)c(Cl)c2)cc1 10.1016/j.bmcl.2009.10.013
CHEMBL567843 203919 0 None - 1 Human 6.0 pEC50 = 6 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 394 7 3 3 5.3 CC(C)c1ccc(CC(C)(C)NCC(O)c2cc(Cl)c(N)c(Cl)c2)cc1 10.1016/j.bmcl.2009.10.013
11567751 207538 0 None -29 2 Human 7.0 pEC50 = 7 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 374 6 4 5 2.5 CC(C)(Cc1ccc(F)cc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2 10.1016/j.bmcl.2009.12.087
CHEMBL600401 207538 0 None -29 2 Human 7.0 pEC50 = 7 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 374 6 4 5 2.5 CC(C)(Cc1ccc(F)cc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2 10.1016/j.bmcl.2009.12.087
10145482 10942 0 None -34 2 Human 6.0 pEC50 = 6 Functional
In vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptorIn vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptor
ChEMBL 604 12 5 7 3.4 O=C(NCc1cc(F)ccc1F)Nc1ccc(S(=O)(=O)N2CCC(CNC[C@H](O)COc3ccc(O)cc3)CC2)cc1 10.1016/s0960-894x(02)00607-8
CHEMBL100057 10942 0 None -34 2 Human 6.0 pEC50 = 6 Functional
In vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptorIn vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptor
ChEMBL 604 12 5 7 3.4 O=C(NCc1cc(F)ccc1F)Nc1ccc(S(=O)(=O)N2CCC(CNC[C@H](O)COc3ccc(O)cc3)CC2)cc1 10.1016/s0960-894x(02)00607-8
10281165 11185 0 None -16 2 Human 6.0 pEC50 = 6.0 Functional
In vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptorIn vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptor
ChEMBL 560 11 5 7 3.3 O=C(Nc1ccc(S(=O)(=O)N2CCC(CNC[C@H](O)COc3ccc(O)cc3)CC2)cc1)NC1CCCCC1 10.1016/s0960-894x(02)00607-8
CHEMBL101485 11185 0 None -16 2 Human 6.0 pEC50 = 6.0 Functional
In vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptorIn vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptor
ChEMBL 560 11 5 7 3.3 O=C(Nc1ccc(S(=O)(=O)N2CCC(CNC[C@H](O)COc3ccc(O)cc3)CC2)cc1)NC1CCCCC1 10.1016/s0960-894x(02)00607-8
11539348 207566 0 None -9 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 434 6 4 5 3.1 CC(C)(Cc1ccc(Br)cc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2 10.1016/j.bmcl.2009.12.087
CHEMBL600616 207566 0 None -9 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 434 6 4 5 3.1 CC(C)(Cc1ccc(Br)cc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2 10.1016/j.bmcl.2009.12.087
44309649 211071 0 None -186 2 Human 5.0 pEC50 = 5.0 Functional
Agonistic activity against cloned human beta1-AR (beta-1-adrenergic receptor) in CHO cellsAgonistic activity against cloned human beta1-AR (beta-1-adrenergic receptor) in CHO cells
ChEMBL 436 9 3 7 1.6 COc1ccc(S(=O)(=O)N2CCC(NC[C@H](O)COc3ccc(O)cc3)CC2)cc1 10.1016/s0960-894x(03)00387-1
CHEMBL71348 211071 0 None -186 2 Human 5.0 pEC50 = 5.0 Functional
Agonistic activity against cloned human beta1-AR (beta-1-adrenergic receptor) in CHO cellsAgonistic activity against cloned human beta1-AR (beta-1-adrenergic receptor) in CHO cells
ChEMBL 436 9 3 7 1.6 COc1ccc(S(=O)(=O)N2CCC(NC[C@H](O)COc3ccc(O)cc3)CC2)cc1 10.1016/s0960-894x(03)00387-1
3083544 33582 51 None -199 6 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human beta1 adrenoceptor expressed in CHO cells assessed as increase in intracellular cAMP level incubated for 1 hr by alphascreen technologyAgonist activity at human beta1 adrenoceptor expressed in CHO cells assessed as increase in intracellular cAMP level incubated for 1 hr by alphascreen technology
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1021/acs.jmedchem.0c01195
CHEMBL1200811 33582 51 None -199 6 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human beta1 adrenoceptor expressed in CHO cells assessed as increase in intracellular cAMP level incubated for 1 hr by alphascreen technologyAgonist activity at human beta1 adrenoceptor expressed in CHO cells assessed as increase in intracellular cAMP level incubated for 1 hr by alphascreen technology
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1021/acs.jmedchem.0c01195
CHEMBL1363 33582 51 None -199 6 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human beta1 adrenoceptor expressed in CHO cells assessed as increase in intracellular cAMP level incubated for 1 hr by alphascreen technologyAgonist activity at human beta1 adrenoceptor expressed in CHO cells assessed as increase in intracellular cAMP level incubated for 1 hr by alphascreen technology
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1021/acs.jmedchem.0c01195
CHEMBL1951071 33582 51 None -199 6 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human beta1 adrenoceptor expressed in CHO cells assessed as increase in intracellular cAMP level incubated for 1 hr by alphascreen technologyAgonist activity at human beta1 adrenoceptor expressed in CHO cells assessed as increase in intracellular cAMP level incubated for 1 hr by alphascreen technology
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1021/acs.jmedchem.0c01195
CHEMBL605993 33582 51 None -199 6 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human beta1 adrenoceptor expressed in CHO cells assessed as increase in intracellular cAMP level incubated for 1 hr by alphascreen technologyAgonist activity at human beta1 adrenoceptor expressed in CHO cells assessed as increase in intracellular cAMP level incubated for 1 hr by alphascreen technology
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1021/acs.jmedchem.0c01195
10280301 116514 0 None -2 2 Human 7.0 pEC50 = 7.0 Functional
In vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptorIn vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptor
ChEMBL 536 12 5 6 3.9 O=C(NCc1ccc(F)cc1)N1CCC(Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)CC1 10.1016/s0960-894x(01)00645-x
CHEMBL322973 116514 0 None -2 2 Human 7.0 pEC50 = 7.0 Functional
In vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptorIn vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptor
ChEMBL 536 12 5 6 3.9 O=C(NCc1ccc(F)cc1)N1CCC(Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)CC1 10.1016/s0960-894x(01)00645-x
10231394 174595 0 None -190 2 Human 5.0 pEC50 = 5.0 Functional
In vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptorIn vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptor
ChEMBL 562 15 5 7 3.5 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)N2CCC(CNC[C@H](O)COc3ccc(O)cc3)CC2)cc1 10.1016/s0960-894x(02)00607-8
CHEMBL430662 174595 0 None -190 2 Human 5.0 pEC50 = 5.0 Functional
In vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptorIn vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptor
ChEMBL 562 15 5 7 3.5 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)N2CCC(CNC[C@H](O)COc3ccc(O)cc3)CC2)cc1 10.1016/s0960-894x(02)00607-8
24823782 104821 0 None 3 2 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 396 8 3 4 4.0 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)nc1 10.1021/jm701324c
CHEMBL273097 104821 0 None 3 2 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 396 8 3 4 4.0 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)nc1 10.1021/jm701324c
45484646 204073 0 None -1 2 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelAgonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP level
ChEMBL 456 10 6 7 2.0 CC(C)(Cc1ccc(NC(=O)CCCN)cc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2 10.1016/j.bmcl.2009.06.104
CHEMBL568667 204073 0 None -1 2 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelAgonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP level
ChEMBL 456 10 6 7 2.0 CC(C)(Cc1ccc(NC(=O)CCCN)cc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2 10.1016/j.bmcl.2009.06.104
24894323 183237 0 None -52 2 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 468 12 4 5 5.2 CCCOc1cc(-c2ccc(NCCNC[C@H](O)c3cccc(Cl)c3)cc2)ccc1C(=O)O 10.1021/jm8000345
CHEMBL459645 183237 0 None -52 2 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 468 12 4 5 5.2 CCCOc1cc(-c2ccc(NCCNC[C@H](O)c3cccc(Cl)c3)cc2)ccc1C(=O)O 10.1021/jm8000345
155536813 178985 0 None -263 2 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 368 8 4 5 2.5 COc1ccccc1CCCNCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.bmc.2018.10.043
CHEMBL4473790 178985 0 None -263 2 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 368 8 4 5 2.5 COc1ccccc1CCCNCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.bmc.2018.10.043
45270680 201817 0 None 5 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 421 10 4 4 4.1 O[C@@H](CNCCc1ccc(NC(=S)Nc2ccccc2)cc1)COc1ccccc1 10.1016/j.bmc.2009.06.031
CHEMBL1203993 201817 0 None 5 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 421 10 4 4 4.1 O[C@@H](CNCCc1ccc(NC(=S)Nc2ccccc2)cc1)COc1ccccc1 10.1016/j.bmc.2009.06.031
CHEMBL549421 201817 0 None 5 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 421 10 4 4 4.1 O[C@@H](CNCCc1ccc(NC(=S)Nc2ccccc2)cc1)COc1ccccc1 10.1016/j.bmc.2009.06.031
45269853 203347 0 None -4 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 426 11 3 5 3.1 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1)c1ccccc1 10.1016/j.bmc.2009.06.031
CHEMBL563872 203347 0 None -4 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 426 11 3 5 3.1 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1)c1ccccc1 10.1016/j.bmc.2009.06.031
52943968 24566 0 None 1 3 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assayAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assay
ChEMBL 518 9 4 8 3.8 NC(=O)Nc1cccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)c1 10.1016/j.bmcl.2010.08.039
CHEMBL1258824 24566 0 None 1 3 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assayAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assay
ChEMBL 518 9 4 8 3.8 NC(=O)Nc1cccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)c1 10.1016/j.bmcl.2010.08.039
16222840 202510 0 None -316 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as stimulation of cAMP level after 1 hr by enzyme immunoassayAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as stimulation of cAMP level after 1 hr by enzyme immunoassay
ChEMBL 566 11 4 7 4.7 C[C@H](NCCc1ccc(-c2ccc(C(=O)NS(C)(=O)=O)c(OC3CCCCC3)c2)cc1)[C@H](O)c1ccc(O)cc1 10.1016/j.bmcl.2009.06.083
CHEMBL557253 202510 0 None -316 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as stimulation of cAMP level after 1 hr by enzyme immunoassayAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as stimulation of cAMP level after 1 hr by enzyme immunoassay
ChEMBL 566 11 4 7 4.7 C[C@H](NCCc1ccc(-c2ccc(C(=O)NS(C)(=O)=O)c(OC3CCCCC3)c2)cc1)[C@H](O)c1ccc(O)cc1 10.1016/j.bmcl.2009.06.083
24895559 179880 0 None -338 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 483 12 3 5 5.4 CC(C)COc1cc(-c2ccc(OCCNC[C@H](O)c3cccc(Cl)c3)cc2)ccc1C(=O)O 10.1021/jm8000345
CHEMBL452034 179880 0 None -338 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 483 12 3 5 5.4 CC(C)COc1cc(-c2ccc(OCCNC[C@H](O)c3cccc(Cl)c3)cc2)ccc1C(=O)O 10.1021/jm8000345
105 10234 91 None -28 3 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human beta1 adrenoceptor expressed in CHO cells assessed as increase in intracellular cAMP level incubated for 1 hr by alphascreen technologyAgonist activity at human beta1 adrenoceptor expressed in CHO cells assessed as increase in intracellular cAMP level incubated for 1 hr by alphascreen technology
ChEMBL 239 4 4 4 1.3 OCc1cc(ccc1O)C(CNC(C)(C)C)O 10.1021/acs.jmedchem.0c01195
2083 10234 91 None -28 3 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human beta1 adrenoceptor expressed in CHO cells assessed as increase in intracellular cAMP level incubated for 1 hr by alphascreen technologyAgonist activity at human beta1 adrenoceptor expressed in CHO cells assessed as increase in intracellular cAMP level incubated for 1 hr by alphascreen technology
ChEMBL 239 4 4 4 1.3 OCc1cc(ccc1O)C(CNC(C)(C)C)O 10.1021/acs.jmedchem.0c01195
558 10234 91 None -28 3 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human beta1 adrenoceptor expressed in CHO cells assessed as increase in intracellular cAMP level incubated for 1 hr by alphascreen technologyAgonist activity at human beta1 adrenoceptor expressed in CHO cells assessed as increase in intracellular cAMP level incubated for 1 hr by alphascreen technology
ChEMBL 239 4 4 4 1.3 OCc1cc(ccc1O)C(CNC(C)(C)C)O 10.1021/acs.jmedchem.0c01195
CHEMBL714 10234 91 None -28 3 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human beta1 adrenoceptor expressed in CHO cells assessed as increase in intracellular cAMP level incubated for 1 hr by alphascreen technologyAgonist activity at human beta1 adrenoceptor expressed in CHO cells assessed as increase in intracellular cAMP level incubated for 1 hr by alphascreen technology
ChEMBL 239 4 4 4 1.3 OCc1cc(ccc1O)C(CNC(C)(C)C)O 10.1021/acs.jmedchem.0c01195
DB01001 10234 91 None -28 3 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human beta1 adrenoceptor expressed in CHO cells assessed as increase in intracellular cAMP level incubated for 1 hr by alphascreen technologyAgonist activity at human beta1 adrenoceptor expressed in CHO cells assessed as increase in intracellular cAMP level incubated for 1 hr by alphascreen technology
ChEMBL 239 4 4 4 1.3 OCc1cc(ccc1O)C(CNC(C)(C)C)O 10.1021/acs.jmedchem.0c01195
44377726 63592 0 None -389 2 Human 5.9 pEC50 = 5.9 Functional
Agonistic activity as cAMP accumulation in CHO cells expressing human beta-1-adrenergic receptorAgonistic activity as cAMP accumulation in CHO cells expressing human beta-1-adrenergic receptor
ChEMBL 550 10 5 10 1.6 CS(=O)(=O)Nc1cc(O[C@@H](O)CNC2CCN(c3ccc(CC4SC(=O)NC4=O)cc3)CC2)ccc1O 10.1016/s0960-894x(01)00063-4
CHEMBL164378 63592 0 None -389 2 Human 5.9 pEC50 = 5.9 Functional
Agonistic activity as cAMP accumulation in CHO cells expressing human beta-1-adrenergic receptorAgonistic activity as cAMP accumulation in CHO cells expressing human beta-1-adrenergic receptor
ChEMBL 550 10 5 10 1.6 CS(=O)(=O)Nc1cc(O[C@@H](O)CNC2CCN(c3ccc(CC4SC(=O)NC4=O)cc3)CC2)ccc1O 10.1016/s0960-894x(01)00063-4
1499 8872 47 None -58 38 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmc.2009.06.031
3779 8872 47 None -58 38 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmc.2009.06.031
536 8872 47 None -58 38 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmc.2009.06.031
CHEMBL434 8872 47 None -58 38 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmc.2009.06.031
DB01064 8872 47 None -58 38 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmc.2009.06.031
1499 8872 47 None -58 38 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.ejmech.2009.01.022
3779 8872 47 None -58 38 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.ejmech.2009.01.022
536 8872 47 None -58 38 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.ejmech.2009.01.022
CHEMBL434 8872 47 None -58 38 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.ejmech.2009.01.022
DB01064 8872 47 None -58 38 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.ejmech.2009.01.022
16223251 183238 0 None -204 2 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 449 11 4 6 3.9 CC(C)Cc1cc(-c2ccc(OCCNC[C@H](O)c3ccc(N)nc3)cc2)ccc1C(=O)O 10.1021/jm8000345
CHEMBL459646 183238 0 None -204 2 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 449 11 4 6 3.9 CC(C)Cc1cc(-c2ccc(OCCNC[C@H](O)c3ccc(N)nc3)cc2)ccc1C(=O)O 10.1021/jm8000345
24895787 193473 0 None -1 2 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 409 8 3 3 5.0 C[C@@H](Cc1ccc(-c2ccc(C(=O)O)cc2)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm8000345
CHEMBL488431 193473 0 None -1 2 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 409 8 3 3 5.0 C[C@@H](Cc1ccc(-c2ccc(C(=O)O)cc2)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm8000345
44309272 210657 0 None -2 3 Human 7.9 pEC50 = 7.9 Functional
Agonistic activity against cloned human beta1-AR (beta-1-adrenergic receptor) in CHO cellsAgonistic activity against cloned human beta1-AR (beta-1-adrenergic receptor) in CHO cells
ChEMBL 611 14 6 8 2.9 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)N2CCC(NC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)CC2)cc1 10.1016/s0960-894x(03)00387-1
CHEMBL68766 210657 0 None -2 3 Human 7.9 pEC50 = 7.9 Functional
Agonistic activity against cloned human beta1-AR (beta-1-adrenergic receptor) in CHO cellsAgonistic activity against cloned human beta1-AR (beta-1-adrenergic receptor) in CHO cells
ChEMBL 611 14 6 8 2.9 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)N2CCC(NC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)CC2)cc1 10.1016/s0960-894x(03)00387-1
44392181 72845 0 None -10 2 Human 7.9 pEC50 = 7.9 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptor
ChEMBL 465 12 5 6 3.3 COc1ccccc1NC(=O)Nc1ccc(C[C@@H](CO)NC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmcl.2004.11.001
CHEMBL183744 72845 0 None -10 2 Human 7.9 pEC50 = 7.9 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptor
ChEMBL 465 12 5 6 3.3 COc1ccccc1NC(=O)Nc1ccc(C[C@@H](CO)NC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmcl.2004.11.001
44441230 100562 0 None -7 3 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 431 9 4 6 4.3 C[C@H](CNc1ccc(-c2csc(C(=O)O)n2)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1016/j.bmcl.2007.05.069
CHEMBL247518 100562 0 None -7 3 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 431 9 4 6 4.3 C[C@H](CNc1ccc(-c2csc(C(=O)O)n2)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1016/j.bmcl.2007.05.069
2687 7676 16 None 162 2 Human 7.9 pEC50 = 7.9 Functional
Partial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrsPartial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrs
ChEMBL 279 5 4 4 1.0 OC(COc1cccc2c1[nH]c(=O)[nH]2)CNC(C)(C)C 10.1021/jm400348g
532 7676 16 None 162 2 Human 7.9 pEC50 = 7.9 Functional
Partial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrsPartial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrs
ChEMBL 279 5 4 4 1.0 OC(COc1cccc2c1[nH]c(=O)[nH]2)CNC(C)(C)C 10.1021/jm400348g
5387 7676 16 None 162 2 Human 7.9 pEC50 = 7.9 Functional
Partial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrsPartial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrs
ChEMBL 279 5 4 4 1.0 OC(COc1cccc2c1[nH]c(=O)[nH]2)CNC(C)(C)C 10.1021/jm400348g
CHEMBL420746 7676 16 None 162 2 Human 7.9 pEC50 = 7.9 Functional
Partial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrsPartial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrs
ChEMBL 279 5 4 4 1.0 OC(COc1cccc2c1[nH]c(=O)[nH]2)CNC(C)(C)C 10.1021/jm400348g
44441226 100443 0 None 1 3 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 415 9 4 6 3.8 C[C@H](CNc1ccc(-c2nc(C(=O)O)co2)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1016/j.bmcl.2007.05.069
CHEMBL246908 100443 0 None 1 3 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 415 9 4 6 3.8 C[C@H](CNc1ccc(-c2nc(C(=O)O)co2)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1016/j.bmcl.2007.05.069
1239 8458 55 None -67 5 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2014.04.095
3410 8458 55 None -67 5 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2014.04.095
3465 8458 55 None -67 5 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2014.04.095
CHEMBL1256786 8458 55 None -67 5 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2014.04.095
DB00983 8458 55 None -67 5 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2014.04.095
90645345 119256 0 None -11 3 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 574 12 6 8 4.7 CC(C)(C)OC(=O)NCCOc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1 10.1016/j.bmcl.2014.04.095
CHEMBL3298692 119256 0 None -11 3 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 574 12 6 8 4.7 CC(C)(C)OC(=O)NCCOc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1 10.1016/j.bmcl.2014.04.095
56943485 119280 0 None -12 3 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 544 12 5 8 3.6 O=c1ccc2c([C@@H](O)CNCCc3ccc(Nc4ccc(OCCN5CCOCC5)cc4)cc3)ccc(O)c2[nH]1 10.1016/j.bmcl.2014.04.095
CHEMBL3298831 119280 0 None -12 3 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 544 12 5 8 3.6 O=c1ccc2c([C@@H](O)CNCCc3ccc(Nc4ccc(OCCN5CCOCC5)cc4)cc3)ccc(O)c2[nH]1 10.1016/j.bmcl.2014.04.095
46832798 20975 0 None -31 3 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 485 16 4 6 4.6 OCc1cc([C@@H](O)CNCCCCCCOCCOCc2cc(Cl)ccc2Cl)ccc1O 10.1021/jm100326d
CHEMBL1084648 20975 0 None -31 3 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 485 16 4 6 4.6 OCc1cc([C@@H](O)CNCCCCCCOCCOCc2cc(Cl)ccc2Cl)ccc1O 10.1021/jm100326d
CHEMBL1198879 20975 0 None -31 3 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 485 16 4 6 4.6 OCc1cc([C@@H](O)CNCCCCCCOCCOCc2cc(Cl)ccc2Cl)ccc1O 10.1021/jm100326d
46832509 20984 0 None -50 3 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 510 18 5 8 2.7 CS(=O)(=O)Nc1cccc(COCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm100326d
CHEMBL1085399 20984 0 None -50 3 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 510 18 5 8 2.7 CS(=O)(=O)Nc1cccc(COCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm100326d
CHEMBL1198908 20984 0 None -50 3 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 510 18 5 8 2.7 CS(=O)(=O)Nc1cccc(COCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm100326d
46832232 20987 0 None -100 3 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 467 16 4 6 4.5 OCc1cc([C@@H](O)CNCCCCCCOCCOCc2cccc3ccccc23)ccc1O 10.1021/jm100326d
CHEMBL1085837 20987 0 None -100 3 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 467 16 4 6 4.5 OCc1cc([C@@H](O)CNCCCCCCOCCOCc2cccc3ccccc23)ccc1O 10.1021/jm100326d
CHEMBL1198923 20987 0 None -100 3 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 467 16 4 6 4.5 OCc1cc([C@@H](O)CNCCCCCCOCCOCc2cccc3ccccc23)ccc1O 10.1021/jm100326d
1239 8458 55 None -67 5 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human recombinant beta1 receptor assessed as cAMP accumulation by radioimmunoassay and cell based assayAgonist activity at human recombinant beta1 receptor assessed as cAMP accumulation by radioimmunoassay and cell based assay
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2014.04.069
3410 8458 55 None -67 5 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human recombinant beta1 receptor assessed as cAMP accumulation by radioimmunoassay and cell based assayAgonist activity at human recombinant beta1 receptor assessed as cAMP accumulation by radioimmunoassay and cell based assay
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2014.04.069
3465 8458 55 None -67 5 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human recombinant beta1 receptor assessed as cAMP accumulation by radioimmunoassay and cell based assayAgonist activity at human recombinant beta1 receptor assessed as cAMP accumulation by radioimmunoassay and cell based assay
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2014.04.069
CHEMBL1256786 8458 55 None -67 5 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human recombinant beta1 receptor assessed as cAMP accumulation by radioimmunoassay and cell based assayAgonist activity at human recombinant beta1 receptor assessed as cAMP accumulation by radioimmunoassay and cell based assay
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2014.04.069
DB00983 8458 55 None -67 5 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human recombinant beta1 receptor assessed as cAMP accumulation by radioimmunoassay and cell based assayAgonist activity at human recombinant beta1 receptor assessed as cAMP accumulation by radioimmunoassay and cell based assay
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2014.04.069
24895557 179879 0 None -575 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 469 12 3 5 5.2 CCCOc1cc(-c2ccc(OCCNC[C@H](O)c3cccc(Cl)c3)cc2)ccc1C(=O)O 10.1021/jm8000345
CHEMBL452033 179879 0 None -575 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 469 12 3 5 5.2 CCCOc1cc(-c2ccc(OCCNC[C@H](O)c3cccc(Cl)c3)cc2)ccc1C(=O)O 10.1021/jm8000345
44392490 72017 0 None -1 3 Human 6.9 pEC50 = 6.9 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cells expressing human beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cells expressing human beta-1 adrenergic receptor
ChEMBL 507 10 4 6 4.0 C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1cccc(NC(=O)c2ccccc2)c1 10.1016/j.bmcl.2004.12.033
CHEMBL182708 72017 0 None -1 3 Human 6.9 pEC50 = 6.9 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cells expressing human beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cells expressing human beta-1 adrenergic receptor
ChEMBL 507 10 4 6 4.0 C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1cccc(NC(=O)c2ccccc2)c1 10.1016/j.bmcl.2004.12.033
44268327 105075 0 None -1 3 Human 5.9 pEC50 = 5.9 Functional
Compound was tested for agonist activity against cloned human beta-1 adrenergic receptorCompound was tested for agonist activity against cloned human beta-1 adrenergic receptor
ChEMBL 448 11 4 6 3.0 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)C1CCCCC1 10.1016/s0960-894x(98)00169-3
CHEMBL274807 105075 0 None -1 3 Human 5.9 pEC50 = 5.9 Functional
Compound was tested for agonist activity against cloned human beta-1 adrenergic receptorCompound was tested for agonist activity against cloned human beta-1 adrenergic receptor
ChEMBL 448 11 4 6 3.0 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)C1CCCCC1 10.1016/s0960-894x(98)00169-3
10575455 106754 1 None -60 3 Human 5.9 pEC50 = 5.9 Functional
Increased cAMP levels of Chinese hamster ovary (CHO) cells expressing human beta 1 Adrenergic receptorIncreased cAMP levels of Chinese hamster ovary (CHO) cells expressing human beta 1 Adrenergic receptor
ChEMBL 448 8 5 7 1.2 CS(=O)(=O)Nc1cc([C@@H](O)CNC2CCN(c3ccc(C(N)=O)cc3)CC2)ccc1O 10.1021/jm000544b
CHEMBL286574 106754 1 None -60 3 Human 5.9 pEC50 = 5.9 Functional
Increased cAMP levels of Chinese hamster ovary (CHO) cells expressing human beta 1 Adrenergic receptorIncreased cAMP levels of Chinese hamster ovary (CHO) cells expressing human beta 1 Adrenergic receptor
ChEMBL 448 8 5 7 1.2 CS(=O)(=O)Nc1cc([C@@H](O)CNC2CCN(c3ccc(C(N)=O)cc3)CC2)ccc1O 10.1021/jm000544b
11504295 9697 47 None -954 8 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 386 7 4 6 2.4 COc1ccc(cc1)CC(NC[C@@H](c1cc(O)cc2c1OCC(=O)N2)O)(C)C 10.1016/j.ejmech.2021.113697
4814 9697 47 None -954 8 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 386 7 4 6 2.4 COc1ccc(cc1)CC(NC[C@@H](c1cc(O)cc2c1OCC(=O)N2)O)(C)C 10.1016/j.ejmech.2021.113697
7543 9697 47 None -954 8 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 386 7 4 6 2.4 COc1ccc(cc1)CC(NC[C@@H](c1cc(O)cc2c1OCC(=O)N2)O)(C)C 10.1016/j.ejmech.2021.113697
CHEMBL605846 9697 47 None -954 8 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 386 7 4 6 2.4 COc1ccc(cc1)CC(NC[C@@H](c1cc(O)cc2c1OCC(=O)N2)O)(C)C 10.1016/j.ejmech.2021.113697
DB09080 9697 47 None -954 8 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 386 7 4 6 2.4 COc1ccc(cc1)CC(NC[C@@H](c1cc(O)cc2c1OCC(=O)N2)O)(C)C 10.1016/j.ejmech.2021.113697
145982668 172693 0 None -15 3 Human 6.9 pEC50 = 6.9 Functional
Antagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assayAntagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assay
ChEMBL 418 11 3 4 4.1 CCc1ccccc1OC[C@@H](O)CNCCc1ccc(NC(=O)c2ccccc2)cc1 10.1016/j.ejmech.2018.03.032
CHEMBL4250215 172693 0 None -15 3 Human 6.9 pEC50 = 6.9 Functional
Antagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assayAntagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assay
ChEMBL 418 11 3 4 4.1 CCc1ccccc1OC[C@@H](O)CNCCc1ccc(NC(=O)c2ccccc2)cc1 10.1016/j.ejmech.2018.03.032
2419 10236 84 None -1174 14 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmc.2018.10.043
5152 10236 84 None -1174 14 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmc.2018.10.043
559 10236 84 None -1174 14 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmc.2018.10.043
CHEMBL1263 10236 84 None -1174 14 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmc.2018.10.043
DB00938 10236 84 None -1174 14 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmc.2018.10.043
53357711 71272 0 None -125 4 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 531 19 7 7 3.3 O=C(O)CNC(=O)Nc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1016/j.bmc.2011.05.064
CHEMBL1814279 71272 0 None -125 4 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 531 19 7 7 3.3 O=C(O)CNC(=O)Nc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1016/j.bmc.2011.05.064
CHEMBL1814280 71272 0 None -125 4 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 531 19 7 7 3.3 O=C(O)CNC(=O)Nc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1016/j.bmc.2011.05.064
56675511 73183 0 None -100 3 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 527 18 5 7 3.2 O=C1CNC(=O)N1Cc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1016/j.bmc.2011.05.064
CHEMBL1814273 73183 0 None -100 3 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 527 18 5 7 3.2 O=C1CNC(=O)N1Cc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1016/j.bmc.2011.05.064
CHEMBL1851850 73183 0 None -100 3 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 527 18 5 7 3.2 O=C1CNC(=O)N1Cc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1016/j.bmc.2011.05.064
42625587 19472 0 None -125 3 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 562 18 4 7 4.3 O=S(=O)(c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1)N1CCCCC1 10.1021/jm801016j
CHEMBL1187520 19472 0 None -125 3 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 562 18 4 7 4.3 O=S(=O)(c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1)N1CCCCC1 10.1021/jm801016j
CHEMBL506518 19472 0 None -125 3 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 562 18 4 7 4.3 O=S(=O)(c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1)N1CCCCC1 10.1021/jm801016j
9845280 84102 0 None -7 3 Human 5.9 pEC50 = 5.9 Functional
Activity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP productionActivity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP production
ChEMBL 424 9 3 5 4.5 COC(=O)c1cccc(-c2cccc(NCCNC[C@H](O)c3cccc(Cl)c3)c2)c1 10.1021/jm0509445
CHEMBL208352 84102 0 None -7 3 Human 5.9 pEC50 = 5.9 Functional
Activity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP productionActivity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP production
ChEMBL 424 9 3 5 4.5 COC(=O)c1cccc(-c2cccc(NCCNC[C@H](O)c3cccc(Cl)c3)c2)c1 10.1021/jm0509445
23661589 100196 0 None -19952 3 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 430 9 4 5 4.9 C[C@H](CNc1cccc(-c2sccc2C(=O)O)c1)NC[C@H](O)c1cccc(Cl)c1 10.1016/j.bmcl.2007.05.069
CHEMBL245873 100196 0 None -19952 3 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 430 9 4 5 4.9 C[C@H](CNc1cccc(-c2sccc2C(=O)O)c1)NC[C@H](O)c1cccc(Cl)c1 10.1016/j.bmcl.2007.05.069
42625741 19371 0 None -158 3 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 494 17 5 7 2.8 NS(=O)(=O)c1cccc(CCCCCOCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm801016j
CHEMBL1186940 19371 0 None -158 3 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 494 17 5 7 2.8 NS(=O)(=O)c1cccc(CCCCCOCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm801016j
CHEMBL483202 19371 0 None -158 3 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 494 17 5 7 2.8 NS(=O)(=O)c1cccc(CCCCCOCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm801016j
42625898 192034 0 None -501 3 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 591 17 7 9 1.5 NS(=O)(=O)O.NS(=O)(=O)c1cccc(CCCOCCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm801016j
CHEMBL485847 192034 0 None -501 3 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 591 17 7 9 1.5 NS(=O)(=O)O.NS(=O)(=O)c1cccc(CCCOCCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm801016j
145983711 172162 0 None -2691 3 Human 4.9 pEC50 = 4.9 Functional
Antagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assayAntagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assay
ChEMBL 476 12 5 5 3.5 CC(=O)NCc1cccc(OC[C@@H](O)CNCCc2ccc(NC(=O)Nc3ccccc3)cc2)c1 10.1016/j.ejmech.2018.03.032
CHEMBL4237802 172162 0 None -2691 3 Human 4.9 pEC50 = 4.9 Functional
Antagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assayAntagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assay
ChEMBL 476 12 5 5 3.5 CC(=O)NCc1cccc(OC[C@@H](O)CNCCc2ccc(NC(=O)Nc3ccccc3)cc2)c1 10.1016/j.ejmech.2018.03.032
24895265 193472 0 None -70 2 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 409 8 3 3 5.0 C[C@H](Cc1ccc(-c2ccc(C(=O)O)cc2)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm8000345
CHEMBL488430 193472 0 None -70 2 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 409 8 3 3 5.0 C[C@H](Cc1ccc(-c2ccc(C(=O)O)cc2)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm8000345
44392552 71300 0 None -23 3 Human 7.9 pEC50 = 7.9 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cells expressing human beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cells expressing human beta-1 adrenergic receptor
ChEMBL 543 11 4 7 3.6 C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2ccccc2)c1 10.1016/j.bmcl.2004.12.033
CHEMBL181440 71300 0 None -23 3 Human 7.9 pEC50 = 7.9 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cells expressing human beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cells expressing human beta-1 adrenergic receptor
ChEMBL 543 11 4 7 3.6 C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2ccccc2)c1 10.1016/j.bmcl.2004.12.033
155564340 182203 0 None -263 2 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 493 11 5 5 4.9 CC(CC(=O)Nc1cccc(CCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1)CC(C)(C)C 10.1016/j.bmc.2018.10.043
CHEMBL4576089 182203 0 None -263 2 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 493 11 5 5 4.9 CC(CC(=O)Nc1cccc(CCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1)CC(C)(C)C 10.1016/j.bmc.2018.10.043
44574826 185379 0 None 2 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 484 13 3 6 3.7 O=C(Cc1cn(Cc2ccccc2)cn1)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.03.044
CHEMBL467301 185379 0 None 2 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 484 13 3 6 3.7 O=C(Cc1cn(Cc2ccccc2)cn1)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.03.044
45270697 201949 0 None -20 3 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 451 11 4 5 4.1 COc1ccccc1NC(=S)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.06.031
CHEMBL1203995 201949 0 None -20 3 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 451 11 4 5 4.1 COc1ccccc1NC(=S)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.06.031
CHEMBL550444 201949 0 None -20 3 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 451 11 4 5 4.1 COc1ccccc1NC(=S)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.06.031
44580039 193729 0 None -15 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 530 11 4 5 5.9 O=C(Nc1ccc(Oc2cccc(CCNC[C@H](O)c3cccc(Cl)c3)c2)cc1C(=O)O)c1ccccc1 10.1016/j.bmcl.2008.08.009
CHEMBL490222 193729 0 None -15 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 530 11 4 5 5.9 O=C(Nc1ccc(Oc2cccc(CCNC[C@H](O)c3cccc(Cl)c3)c2)cc1C(=O)O)c1ccccc1 10.1016/j.bmcl.2008.08.009
45271036 202007 0 None -2951 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as stimulation of cAMP level after 1 hr by enzyme immunoassayAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as stimulation of cAMP level after 1 hr by enzyme immunoassay
ChEMBL 526 11 4 7 3.8 CC(C)Oc1cc(-c2ccc(CCN[C@@H](C)[C@H](O)c3cccc(O)c3)cc2)ccc1C(=O)NS(C)(=O)=O 10.1016/j.bmcl.2009.06.083
CHEMBL550871 202007 0 None -2951 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as stimulation of cAMP level after 1 hr by enzyme immunoassayAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as stimulation of cAMP level after 1 hr by enzyme immunoassay
ChEMBL 526 11 4 7 3.8 CC(C)Oc1cc(-c2ccc(CCN[C@@H](C)[C@H](O)c3cccc(O)c3)cc2)ccc1C(=O)NS(C)(=O)=O 10.1016/j.bmcl.2009.06.083
24895363 180370 0 None -3162 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 447 11 3 4 5.3 CC(C)COc1cc(-c2ccc(C[C@@H](C)NC[C@H](O)c3ccccc3)cc2)ccc1C(=O)O 10.1021/jm8000345
CHEMBL453322 180370 0 None -3162 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 447 11 3 4 5.3 CC(C)COc1cc(-c2ccc(C[C@@H](C)NC[C@H](O)c3ccccc3)cc2)ccc1C(=O)O 10.1021/jm8000345
24895261 193443 0 None -676 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 435 10 4 6 3.7 CC(C)Oc1cc(-c2ccc(CCNC[C@H](O)c3ccc(N)nc3)cc2)ccc1C(=O)O 10.1021/jm8000345
CHEMBL488223 193443 0 None -676 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 435 10 4 6 3.7 CC(C)Oc1cc(-c2ccc(CCNC[C@H](O)c3ccc(N)nc3)cc2)ccc1C(=O)O 10.1021/jm8000345
42639967 19284 0 None -128 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 497 11 3 7 3.1 CC(C)Oc1cc(-c2ccc(CCNC[C@H](O)c3cccnc3)cc2)ccc1C(=O)NS(C)(=O)=O 10.1021/jm9000709
CHEMBL1186557 19284 0 None -128 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 497 11 3 7 3.1 CC(C)Oc1cc(-c2ccc(CCNC[C@H](O)c3cccnc3)cc2)ccc1C(=O)NS(C)(=O)=O 10.1021/jm9000709
CHEMBL469610 19284 0 None -128 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 497 11 3 7 3.1 CC(C)Oc1cc(-c2ccc(CCNC[C@H](O)c3cccnc3)cc2)ccc1C(=O)NS(C)(=O)=O 10.1021/jm9000709
44591506 186111 0 None -676 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 435 10 4 6 3.7 CC(C)Oc1cc(-c2ccc(CCNC[C@H](O)c3cnccc3N)cc2)ccc1C(=O)O 10.1021/jm9000709
CHEMBL473495 186111 0 None -676 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 435 10 4 6 3.7 CC(C)Oc1cc(-c2ccc(CCNC[C@H](O)c3cnccc3N)cc2)ccc1C(=O)O 10.1021/jm9000709
11152564 106791 0 None -4 2 Human 6.9 pEC50 = 6.9 Functional
Agonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-ARAgonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-AR
ChEMBL 358 7 3 3 4.1 COc1cccc2c(C[C@H](C)NC[C@H](O)c3cccc(Cl)c3)c[nH]c12 10.1016/s0960-894x(03)00073-8
CHEMBL286818 106791 0 None -4 2 Human 6.9 pEC50 = 6.9 Functional
Agonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-ARAgonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-AR
ChEMBL 358 7 3 3 4.1 COc1cccc2c(C[C@H](C)NC[C@H](O)c3cccc(Cl)c3)c[nH]c12 10.1016/s0960-894x(03)00073-8
44574651 185296 0 None - 1 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 444 11 4 5 3.3 O=C(Cc1ccccn1)Nc1ccc(CCNC[C@H](O)COc2cccc3[nH]ccc23)cc1 10.1016/j.bmc.2009.03.044
CHEMBL466704 185296 0 None - 1 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 444 11 4 5 3.3 O=C(Cc1ccccn1)Nc1ccc(CCNC[C@H](O)COc2cccc3[nH]ccc23)cc1 10.1016/j.bmc.2009.03.044
213051 99354 2 None -4 2 Human 7.9 pEC50 = 7.9 Functional
Agonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-ARAgonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-AR
ChEMBL 402 9 4 4 3.5 C[C@@H](Cc1c[nH]c2c(OCC(=O)O)cccc12)NC[C@H](O)c1cccc(Cl)c1 10.1016/s0960-894x(03)00073-8
CHEMBL24350 99354 2 None -4 2 Human 7.9 pEC50 = 7.9 Functional
Agonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-ARAgonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-AR
ChEMBL 402 9 4 4 3.5 C[C@@H](Cc1c[nH]c2c(OCC(=O)O)cccc12)NC[C@H](O)c1cccc(Cl)c1 10.1016/s0960-894x(03)00073-8
65772 67177 8 None -5 11 Human 7.9 pEC50 = 7.9 Functional
Compound was evaluated for its inhibitory activity against human Beta-1 adrenergic receptorCompound was evaluated for its inhibitory activity against human Beta-1 adrenergic receptor
ChEMBL 345 5 3 6 2.6 COc1cc(C[C@@H]2NCCc3cc(O)c(O)cc32)cc(OC)c1OC 10.1016/s0960-894x(00)00459-5
CHEMBL174984 67177 8 None -5 11 Human 7.9 pEC50 = 7.9 Functional
Compound was evaluated for its inhibitory activity against human Beta-1 adrenergic receptorCompound was evaluated for its inhibitory activity against human Beta-1 adrenergic receptor
ChEMBL 345 5 3 6 2.6 COc1cc(C[C@@H]2NCCc3cc(O)c(O)cc32)cc(OC)c1OC 10.1016/s0960-894x(00)00459-5
164623433 195351 0 None -380 2 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 352 7 4 4 2.8 Cc1cccc(CCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1 10.1016/j.ejmech.2021.113697
CHEMBL4870623 195351 0 None -380 2 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 352 7 4 4 2.8 Cc1cccc(CCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1 10.1016/j.ejmech.2021.113697
CHEMBL5028756 195351 0 None -380 2 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 352 7 4 4 2.8 Cc1cccc(CCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1 10.1016/j.ejmech.2021.113697
9804536 172476 0 None -7 3 Human 7.8 pEC50 = 7.8 Functional
Antagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assayAntagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assay
ChEMBL 465 11 4 5 3.5 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2cccc3[nH]ccc23)cc1)c1ccccc1 10.1016/j.ejmech.2018.03.032
CHEMBL4245391 172476 0 None -7 3 Human 7.8 pEC50 = 7.8 Functional
Antagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assayAntagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assay
ChEMBL 465 11 4 5 3.5 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2cccc3[nH]ccc23)cc1)c1ccccc1 10.1016/j.ejmech.2018.03.032
44574825 185377 0 None - 1 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 534 13 3 6 4.8 O=C(Cc1nc2ccccc2n1Cc1ccccc1)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.03.044
CHEMBL467298 185377 0 None - 1 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 534 13 3 6 4.8 O=C(Cc1nc2ccccc2n1Cc1ccccc1)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.03.044
45273276 202463 0 None -2 3 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 429 10 4 5 3.6 N#C/N=C(\Nc1ccccc1)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.06.031
CHEMBL1204005 202463 0 None -2 3 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 429 10 4 5 3.6 N#C/N=C(\Nc1ccccc1)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.06.031
CHEMBL556689 202463 0 None -2 3 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 429 10 4 5 3.6 N#C/N=C(\Nc1ccccc1)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.06.031
44579966 199397 0 None -15 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 429 9 3 4 4.8 O=C(O)c1cc(Oc2cccc(CCNC[C@H](O)c3cccc(Cl)c3)c2)ccc1F 10.1016/j.bmcl.2008.08.009
CHEMBL521611 199397 0 None -15 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 429 9 3 4 4.8 O=C(O)c1cc(Oc2cccc(CCNC[C@H](O)c3cccc(Cl)c3)c2)ccc1F 10.1016/j.bmcl.2008.08.009
24949572 183805 0 None -34 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 438 7 3 5 4.4 O=C(O)c1cccc(Oc2ccc3c(c2)C[C@@H](NC[C@H](O)c2ccc(Cl)nc2)CC3)c1 10.1021/jm800222k
CHEMBL463182 183805 0 None -34 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 438 7 3 5 4.4 O=C(O)c1cccc(Oc2ccc3c(c2)C[C@@H](NC[C@H](O)c2ccc(Cl)nc2)CC3)c1 10.1021/jm800222k
44565931 19217 0 None -4677 4 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 552 11 4 8 3.6 CS(=O)(=O)NC(=O)c1ccc(-c2ccc(CCNC[C@H](O)c3cnccc3N)cc2)cc1OC1CCCCC1 10.1021/jm9000709
CHEMBL1186040 19217 0 None -4677 4 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 552 11 4 8 3.6 CS(=O)(=O)NC(=O)c1ccc(-c2ccc(CCNC[C@H](O)c3cnccc3N)cc2)cc1OC1CCCCC1 10.1021/jm9000709
CHEMBL446806 19217 0 None -4677 4 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 552 11 4 8 3.6 CS(=O)(=O)NC(=O)c1ccc(-c2ccc(CCNC[C@H](O)c3cnccc3N)cc2)cc1OC1CCCCC1 10.1021/jm9000709
11381882 106078 0 None 2 2 Human 6.9 pEC50 = 6.9 Functional
Agonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-ARAgonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-AR
ChEMBL 328 6 3 2 4.1 C[C@@H](Cc1c[nH]c2ccccc12)NC[C@@H](O)c1cccc(Cl)c1 10.1016/s0960-894x(03)00073-8
CHEMBL282039 106078 0 None 2 2 Human 6.9 pEC50 = 6.9 Functional
Agonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-ARAgonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-AR
ChEMBL 328 6 3 2 4.1 C[C@@H](Cc1c[nH]c2ccccc12)NC[C@@H](O)c1cccc(Cl)c1 10.1016/s0960-894x(03)00073-8
155515718 176742 0 None -2884 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 423 9 5 5 3.1 CC(C)C(=O)Nc1ccc(CCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)cc1 10.1016/j.bmc.2018.10.043
CHEMBL4441752 176742 0 None -2884 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 423 9 5 5 3.1 CC(C)C(=O)Nc1ccc(CCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)cc1 10.1016/j.bmc.2018.10.043
24894317 180479 0 None -22 2 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 467 11 3 4 5.6 CC(C)Cc1cc(-c2ccc(OCCNC[C@H](O)c3cccc(Cl)c3)cc2)ccc1C(=O)O 10.1021/jm8000345
CHEMBL453575 180479 0 None -22 2 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 467 11 3 4 5.6 CC(C)Cc1cc(-c2ccc(OCCNC[C@H](O)c3cccc(Cl)c3)cc2)ccc1C(=O)O 10.1021/jm8000345
44392228 71636 0 None -7 2 Human 7.8 pEC50 = 7.8 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptor
ChEMBL 441 11 5 5 3.1 O=C(Nc1ccc(C[C@@H](CO)NC[C@H](O)COc2ccccc2)cc1)NC1CCCCC1 10.1016/j.bmcl.2004.11.001
CHEMBL182127 71636 0 None -7 2 Human 7.8 pEC50 = 7.8 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptor
ChEMBL 441 11 5 5 3.1 O=C(Nc1ccc(C[C@@H](CO)NC[C@H](O)COc2ccccc2)cc1)NC1CCCCC1 10.1016/j.bmcl.2004.11.001
1028 7079 71 None -6 19 Guinea pig 7.8 pEC50 = 7.8 Functional
Effective dose required to stimulate contractions in isolated guinea pig atrium.Effective dose required to stimulate contractions in isolated guinea pig atrium.
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00019a001
139148732 7079 71 None -6 19 Guinea pig 7.8 pEC50 = 7.8 Functional
Effective dose required to stimulate contractions in isolated guinea pig atrium.Effective dose required to stimulate contractions in isolated guinea pig atrium.
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00019a001
479 7079 71 None -6 19 Guinea pig 7.8 pEC50 = 7.8 Functional
Effective dose required to stimulate contractions in isolated guinea pig atrium.Effective dose required to stimulate contractions in isolated guinea pig atrium.
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00019a001
5816 7079 71 None -6 19 Guinea pig 7.8 pEC50 = 7.8 Functional
Effective dose required to stimulate contractions in isolated guinea pig atrium.Effective dose required to stimulate contractions in isolated guinea pig atrium.
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00019a001
CHEMBL679 7079 71 None -6 19 Guinea pig 7.8 pEC50 = 7.8 Functional
Effective dose required to stimulate contractions in isolated guinea pig atrium.Effective dose required to stimulate contractions in isolated guinea pig atrium.
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00019a001
DB00668 7079 71 None -6 19 Guinea pig 7.8 pEC50 = 7.8 Functional
Effective dose required to stimulate contractions in isolated guinea pig atrium.Effective dose required to stimulate contractions in isolated guinea pig atrium.
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00019a001
155524038 177670 0 None -120 2 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 414 8 4 4 4.2 O=c1ccc2c(C(O)CNCCCc3ccc(-c4ccccc4)cc3)ccc(O)c2[nH]1 10.1016/j.bmc.2018.10.043
CHEMBL4454489 177670 0 None -120 2 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 414 8 4 4 4.2 O=c1ccc2c(C(O)CNCCCc3ccc(-c4ccccc4)cc3)ccc(O)c2[nH]1 10.1016/j.bmc.2018.10.043
155550544 181088 0 None -1 2 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 388 7 4 4 3.6 O=c1ccc2c(C(O)CNCCCc3ccc4ccccc4c3)ccc(O)c2[nH]1 10.1016/j.bmc.2018.10.043
CHEMBL4550290 181088 0 None -1 2 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 388 7 4 4 3.6 O=c1ccc2c(C(O)CNCCCc3ccc4ccccc4c3)ccc(O)c2[nH]1 10.1016/j.bmc.2018.10.043
44126933 202944 0 None 1 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 470 11 4 5 4.3 O=C(Cc1ccc2ccccc2c1)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/j.ejmech.2009.01.022
CHEMBL561291 202944 0 None 1 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 470 11 4 5 4.3 O=C(Cc1ccc2ccccc2c1)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/j.ejmech.2009.01.022
45268516 203022 0 None -588 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as stimulation of cAMP level after 1 hr by enzyme immunoassayAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as stimulation of cAMP level after 1 hr by enzyme immunoassay
ChEMBL 605 13 5 9 2.8 CC(C)Oc1cc(-c2ccc(CCNC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)cc2)ccc1C(=O)NS(C)(=O)=O 10.1016/j.bmcl.2009.06.083
CHEMBL561743 203022 0 None -588 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as stimulation of cAMP level after 1 hr by enzyme immunoassayAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as stimulation of cAMP level after 1 hr by enzyme immunoassay
ChEMBL 605 13 5 9 2.8 CC(C)Oc1cc(-c2ccc(CCNC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)cc2)ccc1C(=O)NS(C)(=O)=O 10.1016/j.bmcl.2009.06.083
16222940 193253 0 None -2290 4 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 433 10 4 5 4.1 CC(C)Cc1cc(-c2ccc(CCNC[C@H](O)c3ccc(N)nc3)cc2)ccc1C(=O)O 10.1021/jm8000345
CHEMBL487682 193253 0 None -2290 4 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 433 10 4 5 4.1 CC(C)Cc1cc(-c2ccc(CCNC[C@H](O)c3ccc(N)nc3)cc2)ccc1C(=O)O 10.1021/jm8000345
24895259 196075 0 None -588 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 528 12 5 7 3.8 CC(C)Oc1cc(-c2ccc(CCNC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)cc2)ccc1C(=O)O 10.1021/jm8000345
CHEMBL512147 196075 0 None -588 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 528 12 5 7 3.8 CC(C)Oc1cc(-c2ccc(CCNC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)cc2)ccc1C(=O)O 10.1021/jm8000345
44591507 186138 0 None -2290 4 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 433 10 4 5 4.1 CC(C)Cc1cc(-c2ccc(CCNC[C@H](O)c3cnccc3N)cc2)ccc1C(=O)O 10.1021/jm9000709
CHEMBL473702 186138 0 None -2290 4 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 433 10 4 5 4.1 CC(C)Cc1cc(-c2ccc(CCNC[C@H](O)c3cnccc3N)cc2)ccc1C(=O)O 10.1021/jm9000709
9842600 194895 0 None -38 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 375 7 3 4 3.0 O=C(O)COc1ccc2c(c1)C[C@@H](NC[C@H](O)c1cccc(Cl)c1)CC2 10.1021/jm800222k
CHEMBL498305 194895 0 None -38 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 375 7 3 4 3.0 O=C(O)COc1ccc2c(c1)C[C@@H](NC[C@H](O)c1cccc(Cl)c1)CC2 10.1021/jm800222k
44377535 62191 0 None -117 2 Human 5.8 pEC50 = 5.8 Functional
Agonistic activity as cAMP accumulation in CHO cells expressing human beta-1-adrenergic receptorAgonistic activity as cAMP accumulation in CHO cells expressing human beta-1-adrenergic receptor
ChEMBL 508 8 4 9 2.8 O=C1NC(=O)C(Cc2ccc(N3CCC(NC[C@H](O)Oc4cccc5nc(O)ccc45)CC3)cc2)S1 10.1016/s0960-894x(01)00063-4
CHEMBL161949 62191 0 None -117 2 Human 5.8 pEC50 = 5.8 Functional
Agonistic activity as cAMP accumulation in CHO cells expressing human beta-1-adrenergic receptorAgonistic activity as cAMP accumulation in CHO cells expressing human beta-1-adrenergic receptor
ChEMBL 508 8 4 9 2.8 O=C1NC(=O)C(Cc2ccc(N3CCC(NC[C@H](O)Oc4cccc5nc(O)ccc45)CC3)cc2)S1 10.1016/s0960-894x(01)00063-4
56673609 70877 0 None -112 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at adrenergic beta1 receptorAgonist activity at adrenergic beta1 receptor
ChEMBL 499 13 5 7 3.5 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCOCCNCCc3cccc(Cl)c3Cl)c2s1 10.1016/j.bmcl.2011.05.097
CHEMBL1807873 70877 0 None -112 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at adrenergic beta1 receptorAgonist activity at adrenergic beta1 receptor
ChEMBL 499 13 5 7 3.5 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCOCCNCCc3cccc(Cl)c3Cl)c2s1 10.1016/j.bmcl.2011.05.097
56672116 73139 0 None -630 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 570 19 5 8 2.4 NC(=O)CN1C(=O)CN(c2cccc(CCCCOCCCCCCNC[C@H](O)c3ccc(O)c(CO)c3)c2)C1=O 10.1016/j.bmc.2011.05.064
CHEMBL1814276 73139 0 None -630 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 570 19 5 8 2.4 NC(=O)CN1C(=O)CN(c2cccc(CCCCOCCCCCCNC[C@H](O)c3ccc(O)c(CO)c3)c2)C1=O 10.1016/j.bmc.2011.05.064
CHEMBL1851624 73139 0 None -630 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 570 19 5 8 2.4 NC(=O)CN1C(=O)CN(c2cccc(CCCCOCCCCCCNC[C@H](O)c3ccc(O)c(CO)c3)c2)C1=O 10.1016/j.bmc.2011.05.064
44441227 154828 0 None -10 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 415 9 4 6 3.8 C[C@H](CNc1cccc(-c2nc(C(=O)O)co2)c1)NC[C@H](O)c1cccc(Cl)c1 10.1016/j.bmcl.2007.05.069
CHEMBL393469 154828 0 None -10 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 415 9 4 6 3.8 C[C@H](CNc1cccc(-c2nc(C(=O)O)co2)c1)NC[C@H](O)c1cccc(Cl)c1 10.1016/j.bmcl.2007.05.069
145981079 173461 0 None -39 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 358 6 4 4 2.8 O=c1ccc2c(C(CO)NCCc3ccc(Cl)cc3)ccc(O)c2[nH]1 10.1016/j.ejmech.2018.04.041
CHEMBL4282047 173461 0 None -39 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 358 6 4 4 2.8 O=c1ccc2c(C(CO)NCCc3ccc(Cl)cc3)ccc(O)c2[nH]1 10.1016/j.ejmech.2018.04.041
164626310 195374 0 None -346 2 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 356 7 4 4 2.6 O=c1ccc2c(C(O)CNCCCc3ccc(F)cc3)ccc(O)c2[nH]1 10.1016/j.ejmech.2021.113697
CHEMBL4874945 195374 0 None -346 2 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 356 7 4 4 2.6 O=c1ccc2c(C(O)CNCCCc3ccc(F)cc3)ccc(O)c2[nH]1 10.1016/j.ejmech.2021.113697
CHEMBL5028930 195374 0 None -346 2 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 356 7 4 4 2.6 O=c1ccc2c(C(O)CNCCCc3ccc(F)cc3)ccc(O)c2[nH]1 10.1016/j.ejmech.2021.113697
164614249 195273 0 None -295 2 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 352 7 4 4 2.8 Cc1ccccc1CCCNCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
CHEMBL4859591 195273 0 None -295 2 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 352 7 4 4 2.8 Cc1ccccc1CCCNCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
CHEMBL5028241 195273 0 None -295 2 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 352 7 4 4 2.8 Cc1ccccc1CCCNCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
24949889 194934 0 None -35 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 451 7 3 4 5.4 O=C(O)c1cccc(Oc2ccc3c(c2)C[C@@H](NC[C@H](O)c2cccc(Cl)c2)CCC3)c1 10.1021/jm800222k
CHEMBL498531 194934 0 None -35 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 451 7 3 4 5.4 O=C(O)c1cccc(Oc2ccc3c(c2)C[C@@H](NC[C@H](O)c2cccc(Cl)c2)CCC3)c1 10.1021/jm800222k
42639311 19296 0 None -56 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 524 14 3 6 4.5 CCCCCOc1cc(-c2ccc(CCNC[C@H](O)c3ccccc3)cc2)ccc1C(=O)NS(C)(=O)=O 10.1021/jm9000709
CHEMBL1186600 19296 0 None -56 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 524 14 3 6 4.5 CCCCCOc1cc(-c2ccc(CCNC[C@H](O)c3ccccc3)cc2)ccc1C(=O)NS(C)(=O)=O 10.1021/jm9000709
CHEMBL472089 19296 0 None -56 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 524 14 3 6 4.5 CCCCCOc1cc(-c2ccc(CCNC[C@H](O)c3ccccc3)cc2)ccc1C(=O)NS(C)(=O)=O 10.1021/jm9000709
44392558 72029 0 None -2 3 Human 6.8 pEC50 = 6.8 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cells expressing human beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cells expressing human beta-1 adrenergic receptor
ChEMBL 471 11 4 6 4.1 CC(C)=CCNc1cccc([C@@H](O)CN[C@H](C)Cc2c[nH]c3c(OS(C)(=O)=O)cccc23)c1 10.1016/j.bmcl.2004.12.033
CHEMBL182770 72029 0 None -2 3 Human 6.8 pEC50 = 6.8 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cells expressing human beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cells expressing human beta-1 adrenergic receptor
ChEMBL 471 11 4 6 4.1 CC(C)=CCNc1cccc([C@@H](O)CN[C@H](C)Cc2c[nH]c3c(OS(C)(=O)=O)cccc23)c1 10.1016/j.bmcl.2004.12.033
44237669 65009 0 None -7943 2 Rat 5.8 pEC50 = 5.8 Functional
Agonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effectAgonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effect
ChEMBL 540 9 6 5 4.7 O=C(NCc1c(Cl)cccc1Cl)Nc1cccc(CCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1 10.1016/j.bmcl.2010.12.096
CHEMBL1682217 65009 0 None -7943 2 Rat 5.8 pEC50 = 5.8 Functional
Agonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effectAgonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effect
ChEMBL 540 9 6 5 4.7 O=C(NCc1c(Cl)cccc1Cl)Nc1cccc(CCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1 10.1016/j.bmcl.2010.12.096
9933039 169824 0 None -6 3 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay
ChEMBL 442 11 4 6 2.8 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1ccccc1 10.1016/j.bmc.2009.06.031
CHEMBL417613 169824 0 None -6 3 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay
ChEMBL 442 11 4 6 2.8 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1ccccc1 10.1016/j.bmc.2009.06.031
9933039 169824 0 None -6 3 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 442 11 4 6 2.8 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1ccccc1 10.1016/j.ejmech.2009.01.022
CHEMBL417613 169824 0 None -6 3 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 442 11 4 6 2.8 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1ccccc1 10.1016/j.ejmech.2009.01.022
44309523 108966 0 None -52 3 Human 5.8 pEC50 = 5.8 Functional
Agonistic activity against cloned human beta1-AR (beta-1-adrenergic receptor) in CHO cellsAgonistic activity against cloned human beta1-AR (beta-1-adrenergic receptor) in CHO cells
ChEMBL 420 10 3 6 2.3 CCCCOc1ccc(S(=O)(=O)N2CC(NC[C@H](O)c3ccc(O)cc3)C2)cc1 10.1016/s0960-894x(03)00387-1
CHEMBL302803 108966 0 None -52 3 Human 5.8 pEC50 = 5.8 Functional
Agonistic activity against cloned human beta1-AR (beta-1-adrenergic receptor) in CHO cellsAgonistic activity against cloned human beta1-AR (beta-1-adrenergic receptor) in CHO cells
ChEMBL 420 10 3 6 2.3 CCCCOc1ccc(S(=O)(=O)N2CC(NC[C@H](O)c3ccc(O)cc3)C2)cc1 10.1016/s0960-894x(03)00387-1
10601234 118784 0 None -23 3 Human 5.8 pEC50 = 5.8 Functional
Increased cAMP levels of Chinese hamster ovary (CHO) cells expressing human beta 1 Adrenergic receptorIncreased cAMP levels of Chinese hamster ovary (CHO) cells expressing human beta 1 Adrenergic receptor
ChEMBL 493 11 5 8 1.7 CS(=O)(=O)Nc1cc([C@@H](O)CNC2CCN(c3ccc(COCC(=O)O)cc3)CC2)ccc1O 10.1021/jm000544b
CHEMBL32888 118784 0 None -23 3 Human 5.8 pEC50 = 5.8 Functional
Increased cAMP levels of Chinese hamster ovary (CHO) cells expressing human beta 1 Adrenergic receptorIncreased cAMP levels of Chinese hamster ovary (CHO) cells expressing human beta 1 Adrenergic receptor
ChEMBL 493 11 5 8 1.7 CS(=O)(=O)Nc1cc([C@@H](O)CNC2CCN(c3ccc(COCC(=O)O)cc3)CC2)ccc1O 10.1021/jm000544b
10140889 12838 0 None -4 2 Human 6.8 pEC50 = 6.8 Functional
In vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptorIn vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptor
ChEMBL 484 12 4 6 3.3 CCN(CC)C(=O)N1CCC(Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)CC1 10.1016/s0960-894x(01)00645-x
CHEMBL108061 12838 0 None -4 2 Human 6.8 pEC50 = 6.8 Functional
In vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptorIn vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptor
ChEMBL 484 12 4 6 3.3 CCN(CC)C(=O)N1CCC(Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)CC1 10.1016/s0960-894x(01)00645-x
44574978 196069 0 None -1 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 524 12 2 6 4.0 O=C(Cc1nccn1Cc1ccccc1)N1CCCc2cc(CCNC[C@H](O)COc3ccccc3)ccc21 10.1016/j.bmc.2009.03.044
CHEMBL512099 196069 0 None -1 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 524 12 2 6 4.0 O=C(Cc1nccn1Cc1ccccc1)N1CCCc2cc(CCNC[C@H](O)COc3ccccc3)ccc21 10.1016/j.bmc.2009.03.044
24823464 104394 0 None -588 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 418 10 4 4 4.7 CC(C)Nc1cc(-c2ccc(CCNC[C@H](O)c3ccccc3)cc2)ccc1C(=O)O 10.1021/jm701324c
CHEMBL270964 104394 0 None -588 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 418 10 4 4 4.7 CC(C)Nc1cc(-c2ccc(CCNC[C@H](O)c3ccccc3)cc2)ccc1C(=O)O 10.1021/jm701324c
24823464 104394 0 None -588 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 418 10 4 4 4.7 CC(C)Nc1cc(-c2ccc(CCNC[C@H](O)c3ccccc3)cc2)ccc1C(=O)O 10.1021/jm9000709
CHEMBL270964 104394 0 None -588 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 418 10 4 4 4.7 CC(C)Nc1cc(-c2ccc(CCNC[C@H](O)c3ccccc3)cc2)ccc1C(=O)O 10.1021/jm9000709
44392457 172736 0 None -34 3 Human 6.8 pEC50 = 6.8 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cells expressing human beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cells expressing human beta-1 adrenergic receptor
ChEMBL 457 11 4 6 3.7 C/C=C/CNc1cccc([C@@H](O)CN[C@H](C)Cc2c[nH]c3c(OS(C)(=O)=O)cccc23)c1 10.1016/j.bmcl.2004.12.033
CHEMBL425161 172736 0 None -34 3 Human 6.8 pEC50 = 6.8 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cells expressing human beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cells expressing human beta-1 adrenergic receptor
ChEMBL 457 11 4 6 3.7 C/C=C/CNc1cccc([C@@H](O)CN[C@H](C)Cc2c[nH]c3c(OS(C)(=O)=O)cccc23)c1 10.1016/j.bmcl.2004.12.033
44127677 202184 0 None -2 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 471 11 4 6 3.7 O=C(Cc1ccc2ccccc2n1)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/j.ejmech.2009.01.022
CHEMBL552089 202184 0 None -2 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 471 11 4 6 3.7 O=C(Cc1ccc2ccccc2n1)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/j.ejmech.2009.01.022
567 7512 16 None -323 7 Human 5.8 pEC50 = 5.8 Functional
Agonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-ARAgonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-AR
ChEMBL 363 9 3 4 3.1 C[C@H](Cc1ccc(cc1)OCC(=O)O)NC[C@@H](c1cccc(c1)Cl)O 10.1016/s0960-894x(03)00073-8
9841972 7512 16 None -323 7 Human 5.8 pEC50 = 5.8 Functional
Agonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-ARAgonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-AR
ChEMBL 363 9 3 4 3.1 C[C@H](Cc1ccc(cc1)OCC(=O)O)NC[C@@H](c1cccc(c1)Cl)O 10.1016/s0960-894x(03)00073-8
CHEMBL284782 7512 16 None -323 7 Human 5.8 pEC50 = 5.8 Functional
Agonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-ARAgonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-AR
ChEMBL 363 9 3 4 3.1 C[C@H](Cc1ccc(cc1)OCC(=O)O)NC[C@@H](c1cccc(c1)Cl)O 10.1016/s0960-894x(03)00073-8
11703823 207934 0 None -131 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 390 6 4 5 3.0 CC(C)(Cc1ccc(Cl)cc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2 10.1016/j.bmcl.2009.12.087
CHEMBL603274 207934 0 None -131 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 390 6 4 5 3.0 CC(C)(Cc1ccc(Cl)cc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2 10.1016/j.bmcl.2009.12.087
24950234 182776 0 None -223 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 494 10 4 5 5.8 CCCNc1cc(Oc2ccc3c(c2)C[C@@H](NC[C@H](O)c2cccc(Cl)c2)CC3)cc(C(=O)O)c1 10.1021/jm800222k
CHEMBL458923 182776 0 None -223 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 494 10 4 5 5.8 CCCNc1cc(Oc2ccc3c(c2)C[C@@H](NC[C@H](O)c2cccc(Cl)c2)CC3)cc(C(=O)O)c1 10.1021/jm800222k
131487 11753 13 None - 1 Guinea pig 6.8 pEC50 = 6.8 Functional
Agonistic activity (beta-1 adrenergic receptor) for the percent maximal increase in contraction rate of isolated guinea pig atriaAgonistic activity (beta-1 adrenergic receptor) for the percent maximal increase in contraction rate of isolated guinea pig atria
ChEMBL 273 5 4 5 1.4 CC(C)(C)NCC(O)COc1cc(O)c(O)cc1F 10.1021/jm00107a027
CHEMBL10494 11753 13 None - 1 Guinea pig 6.8 pEC50 = 6.8 Functional
Agonistic activity (beta-1 adrenergic receptor) for the percent maximal increase in contraction rate of isolated guinea pig atriaAgonistic activity (beta-1 adrenergic receptor) for the percent maximal increase in contraction rate of isolated guinea pig atria
ChEMBL 273 5 4 5 1.4 CC(C)(C)NCC(O)COc1cc(O)c(O)cc1F 10.1021/jm00107a027
24822648 104383 0 None -28 2 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 425 9 3 4 4.6 COc1cc(C(=O)O)ccc1-c1ccc(CCNC[C@H](O)c2cccc(Cl)c2)cc1 10.1021/jm701324c
CHEMBL270889 104383 0 None -28 2 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 425 9 3 4 4.6 COc1cc(C(=O)O)ccc1-c1ccc(CCNC[C@H](O)c2cccc(Cl)c2)cc1 10.1021/jm701324c
45484558 203613 0 None -4 2 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelAgonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP level
ChEMBL 498 11 8 7 1.6 CC(C)(Cc1ccc(NC(=O)CCCNC(=N)N)cc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2 10.1016/j.bmcl.2009.06.104
CHEMBL565770 203613 0 None -4 2 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelAgonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP level
ChEMBL 498 11 8 7 1.6 CC(C)(Cc1ccc(NC(=O)CCCNC(=N)N)cc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2 10.1016/j.bmcl.2009.06.104
44574687 185300 0 None - 1 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 406 11 3 6 2.2 O=C(Cc1ccccn1)Nc1ccc(CCNC[C@H](O)COc2cccnc2)cc1 10.1016/j.bmc.2009.03.044
CHEMBL466713 185300 0 None - 1 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 406 11 3 6 2.2 O=C(Cc1ccccn1)Nc1ccc(CCNC[C@H](O)COc2cccnc2)cc1 10.1016/j.bmc.2009.03.044
44219629 185348 0 None -1 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 484 13 3 6 3.7 O=C(Cc1nccn1Cc1ccccc1)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.03.044
CHEMBL467083 185348 0 None -1 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 484 13 3 6 3.7 O=C(Cc1nccn1Cc1ccccc1)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.03.044
44126931 202133 0 None -1 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 496 12 4 5 4.7 O=C(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)C(c1ccccc1)c1ccccc1 10.1016/j.ejmech.2009.01.022
CHEMBL551831 202133 0 None -1 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 496 12 4 5 4.7 O=C(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)C(c1ccccc1)c1ccccc1 10.1016/j.ejmech.2009.01.022
24895664 183475 0 None -251 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 467 12 3 4 5.8 CCCOc1cc(-c2ccc(CCCNC[C@H](O)c3cccc(Cl)c3)cc2)ccc1C(=O)O 10.1021/jm8000345
CHEMBL459863 183475 0 None -251 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 467 12 3 4 5.8 CCCOc1cc(-c2ccc(CCCNC[C@H](O)c3cccc(Cl)c3)cc2)ccc1C(=O)O 10.1021/jm8000345
44396568 74060 0 None -34 3 Human 6.8 pEC50 = 6.8 Functional
Agonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptorAgonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptor
ChEMBL 529 12 5 7 3.7 C[C@H](Cc1c[nH]c2c(OCC(=O)O)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1016/j.bmcl.2004.10.035
CHEMBL188196 74060 0 None -34 3 Human 6.8 pEC50 = 6.8 Functional
Agonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptorAgonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptor
ChEMBL 529 12 5 7 3.7 C[C@H](Cc1c[nH]c2c(OCC(=O)O)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1016/j.bmcl.2004.10.035
9853471 211633 0 None -389 3 Human 5.8 pEC50 = 5.8 Functional
Compound was evaluated for its inhibitory activity against human beta-1 adrenergic receptor (AR)Compound was evaluated for its inhibitory activity against human beta-1 adrenergic receptor (AR)
ChEMBL 628 12 6 6 6.7 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(-c3ccc(CC4NCCc5cc(O)c(O)cc54)cc3)cc2)cc1 10.1016/s0960-894x(00)00459-5
CHEMBL75604 211633 0 None -389 3 Human 5.8 pEC50 = 5.8 Functional
Compound was evaluated for its inhibitory activity against human beta-1 adrenergic receptor (AR)Compound was evaluated for its inhibitory activity against human beta-1 adrenergic receptor (AR)
ChEMBL 628 12 6 6 6.7 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(-c3ccc(CC4NCCc5cc(O)c(O)cc54)cc3)cc2)cc1 10.1016/s0960-894x(00)00459-5
44331425 11217 0 None -186 3 Human 5.7 pEC50 = 5.7 Functional
Beta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptorBeta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptor
ChEMBL 576 13 6 8 2.5 CC(C)C[C@H](NC(=O)c1ccc(N2CCC(CNC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)CC2)cc1)C(=O)O 10.1016/s0960-894x(02)00608-x
CHEMBL101630 11217 0 None -186 3 Human 5.7 pEC50 = 5.7 Functional
Beta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptorBeta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptor
ChEMBL 576 13 6 8 2.5 CC(C)C[C@H](NC(=O)c1ccc(N2CCC(CNC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)CC2)cc1)C(=O)O 10.1016/s0960-894x(02)00608-x
45483838 203711 0 None -14 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 383 7 4 4 3.5 CC(C)(Cc1cccc(C(F)(F)F)c1)NCC(O)c1ccc(O)c(CO)c1 10.1016/j.bmcl.2009.10.013
CHEMBL566352 203711 0 None -14 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 383 7 4 4 3.5 CC(C)(Cc1cccc(C(F)(F)F)c1)NCC(O)c1ccc(O)c(CO)c1 10.1016/j.bmcl.2009.10.013
10302342 116563 0 None -3 2 Human 6.7 pEC50 = 6.7 Functional
In vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptorIn vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptor
ChEMBL 538 14 5 6 4.5 O=C(NCCCC1CCCC1)N1CCC(Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)CC1 10.1016/s0960-894x(01)00645-x
CHEMBL323258 116563 0 None -3 2 Human 6.7 pEC50 = 6.7 Functional
In vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptorIn vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptor
ChEMBL 538 14 5 6 4.5 O=C(NCCCC1CCCC1)N1CCC(Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)CC1 10.1016/s0960-894x(01)00645-x
44396488 73505 0 None -14 3 Human 7.7 pEC50 = 7.7 Functional
Agonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptorAgonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptor
ChEMBL 556 12 4 7 3.8 C[C@H](Cc1c[nH]c2c(OCC(=O)N(C)C)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1016/j.bmcl.2004.10.035
CHEMBL185703 73505 0 None -14 3 Human 7.7 pEC50 = 7.7 Functional
Agonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptorAgonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptor
ChEMBL 556 12 4 7 3.8 C[C@H](Cc1c[nH]c2c(OCC(=O)N(C)C)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1016/j.bmcl.2004.10.035
9831168 211481 0 None -2 3 Human 7.7 pEC50 = 7.7 Functional
Percent adenylyl cyclase activation at 10000 nM of compound concentrationPercent adenylyl cyclase activation at 10000 nM of compound concentration
ChEMBL 552 11 6 6 5.0 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CC3NCCc4cc(O)c(O)cc43)cc2)cc1 10.1016/s0960-894x(00)00459-5
CHEMBL74085 211481 0 None -2 3 Human 7.7 pEC50 = 7.7 Functional
Percent adenylyl cyclase activation at 10000 nM of compound concentrationPercent adenylyl cyclase activation at 10000 nM of compound concentration
ChEMBL 552 11 6 6 5.0 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CC3NCCc4cc(O)c(O)cc43)cc2)cc1 10.1016/s0960-894x(00)00459-5
11005613 126577 0 None -1 3 Human 7.7 pEC50 = 7.7 Functional
Ability to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentrationAbility to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentration
ChEMBL 501 12 4 5 4.3 Cc1ccc(S(=O)(=O)NCCc2ccc(NC[C@@H](C)NC[C@H](O)c3cccc(Cl)c3)cc2)cc1 10.1021/jm0101500
CHEMBL348269 126577 0 None -1 3 Human 7.7 pEC50 = 7.7 Functional
Ability to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentrationAbility to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentration
ChEMBL 501 12 4 5 4.3 Cc1ccc(S(=O)(=O)NCCc2ccc(NC[C@@H](C)NC[C@H](O)c3cccc(Cl)c3)cc2)cc1 10.1021/jm0101500
44441234 100564 0 None -63 3 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 414 9 4 5 4.4 C[C@H](CNc1ccc(-c2occc2C(=O)O)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1016/j.bmcl.2007.05.069
CHEMBL247520 100564 0 None -63 3 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 414 9 4 5 4.4 C[C@H](CNc1ccc(-c2occc2C(=O)O)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1016/j.bmcl.2007.05.069
44441228 174551 0 None -3 3 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 431 9 4 6 4.3 C[C@H](CNc1ccc(-c2nc(C(=O)O)cs2)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1016/j.bmcl.2007.05.069
CHEMBL430390 174551 0 None -3 3 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 431 9 4 6 4.3 C[C@H](CNc1ccc(-c2nc(C(=O)O)cs2)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1016/j.bmcl.2007.05.069
46832507 20986 0 None -12 3 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 475 17 6 7 2.8 NC(=O)Nc1cccc(COCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm100326d
CHEMBL1085638 20986 0 None -12 3 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 475 17 6 7 2.8 NC(=O)Nc1cccc(COCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm100326d
CHEMBL1198915 20986 0 None -12 3 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 475 17 6 7 2.8 NC(=O)Nc1cccc(COCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm100326d
10203169 21011 0 None -25 3 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 433 16 5 7 3.0 OCc1cc([C@@H](O)CNCCCCCCOCCOCc2cccc(O)c2)ccc1O 10.1021/jm100326d
CHEMBL1086536 21011 0 None -25 3 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 433 16 5 7 3.0 OCc1cc([C@@H](O)CNCCCCCCOCCOCc2cccc(O)c2)ccc1O 10.1021/jm100326d
CHEMBL1199300 21011 0 None -25 3 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 433 16 5 7 3.0 OCc1cc([C@@H](O)CNCCCCCCOCCOCc2cccc(O)c2)ccc1O 10.1021/jm100326d
44574867 185352 0 None -2 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 562 13 3 6 4.4 O=C(Cc1nccn1Cc1ccc(Br)cc1)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.03.044
CHEMBL467102 185352 0 None -2 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 562 13 3 6 4.4 O=C(Cc1nccn1Cc1ccc(Br)cc1)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.03.044
44579650 193934 0 None -15 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 435 10 4 6 3.4 CC(=O)Nc1ccc(Oc2cccc(CCNC[C@H](O)c3cccnc3)c2)cc1C(=O)O 10.1016/j.bmcl.2008.08.009
CHEMBL492005 193934 0 None -15 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 435 10 4 6 3.4 CC(=O)Nc1ccc(Oc2cccc(CCNC[C@H](O)c3cccnc3)c2)cc1C(=O)O 10.1016/j.bmcl.2008.08.009
44580041 200087 0 None -9 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 530 11 4 5 5.9 O=C(O)c1cc(NC(=O)c2ccccc2)cc(Oc2cccc(CCNC[C@H](O)c3cccc(Cl)c3)c2)c1 10.1016/j.bmcl.2008.08.009
CHEMBL524145 200087 0 None -9 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 530 11 4 5 5.9 O=C(O)c1cc(NC(=O)c2ccccc2)cc(Oc2cccc(CCNC[C@H](O)c3cccc(Cl)c3)c2)c1 10.1016/j.bmcl.2008.08.009
44127480 203336 0 None 6 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 454 11 4 5 3.8 O=C(Cc1ccc(Cl)cc1)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/j.ejmech.2009.01.022
CHEMBL563810 203336 0 None 6 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 454 11 4 5 3.8 O=C(Cc1ccc(Cl)cc1)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/j.ejmech.2009.01.022
44560793 195676 0 None -2951 3 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 434 11 3 5 4.5 CCCOc1cc(-c2ccc(C[C@@H](C)NC[C@H](O)c3cccnc3)cc2)ccc1C(=O)O 10.1021/jm8000345
CHEMBL507506 195676 0 None -2951 3 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 434 11 3 5 4.5 CCCOc1cc(-c2ccc(C[C@@H](C)NC[C@H](O)c3cccnc3)cc2)ccc1C(=O)O 10.1021/jm8000345
9873257 91720 16 None -74 3 Human 5.7 pEC50 = 5.7 Functional
Agonistic activity against the cloned human Beta-1 adrenergic receptor was measured by its by its ability to stimulate adenylyl cyclaseAgonistic activity against the cloned human Beta-1 adrenergic receptor was measured by its by its ability to stimulate adenylyl cyclase
ChEMBL 591 14 3 10 3.5 O=c1n(CCCC2CCCC2)nnn1-c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(99)00182-1
CHEMBL22375 91720 16 None -74 3 Human 5.7 pEC50 = 5.7 Functional
Agonistic activity against the cloned human Beta-1 adrenergic receptor was measured by its by its ability to stimulate adenylyl cyclaseAgonistic activity against the cloned human Beta-1 adrenergic receptor was measured by its by its ability to stimulate adenylyl cyclase
ChEMBL 591 14 3 10 3.5 O=c1n(CCCC2CCCC2)nnn1-c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(99)00182-1
155527926 178032 0 None -8709 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 451 11 5 5 3.9 CC(C)CCC(=O)Nc1cccc(CCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1 10.1016/j.bmc.2018.10.043
CHEMBL4460095 178032 0 None -8709 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 451 11 5 5 3.9 CC(C)CCC(=O)Nc1cccc(CCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1 10.1016/j.bmc.2018.10.043
164612026 192148 0 None -776 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as increase in cAMP accumulation measured after 60 mins by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as increase in cAMP accumulation measured after 60 mins by HTRF assay
ChEMBL 237 4 3 4 1.3 CC(C)NC(CO)c1cc(F)c(N)c(C#N)c1 10.1021/acs.jmedchem.0c01195
CHEMBL4860455 192148 0 None -776 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as increase in cAMP accumulation measured after 60 mins by HTRF assayAgonist activity at human beta1 adrenoceptor expressed in HEK293 cells assessed as increase in cAMP accumulation measured after 60 mins by HTRF assay
ChEMBL 237 4 3 4 1.3 CC(C)NC(CO)c1cc(F)c(N)c(C#N)c1 10.1021/acs.jmedchem.0c01195
56670092 70878 0 None -112 3 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at adrenergic beta1 receptorAgonist activity at adrenergic beta1 receptor
ChEMBL 445 13 4 7 2.5 CN(CCOCCCNC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12)CCc1ccccc1 10.1016/j.bmcl.2011.05.097
CHEMBL1807874 70878 0 None -112 3 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at adrenergic beta1 receptorAgonist activity at adrenergic beta1 receptor
ChEMBL 445 13 4 7 2.5 CN(CCOCCCNC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12)CCc1ccccc1 10.1016/j.bmcl.2011.05.097
56675509 71270 0 None -79 3 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 513 17 5 7 3.2 O=C1CNC(=O)N1c1ccccc1CCCCOCCCCCCNC[C@H](O)c1ccc(O)c(CO)c1 10.1016/j.bmc.2011.05.064
CHEMBL1814270 71270 0 None -79 3 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 513 17 5 7 3.2 O=C1CNC(=O)N1c1ccccc1CCCCOCCCCCCNC[C@H](O)c1ccc(O)c(CO)c1 10.1016/j.bmc.2011.05.064
53357712 73181 0 None -251 3 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 541 17 5 7 3.9 CC1(C)NC(=O)N(c2cccc(CCCCOCCCCCCNC[C@H](O)c3ccc(O)c(CO)c3)c2)C1=O 10.1016/j.bmc.2011.05.064
CHEMBL1814271 73181 0 None -251 3 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 541 17 5 7 3.9 CC1(C)NC(=O)N(c2cccc(CCCCOCCCCCCNC[C@H](O)c3ccc(O)c(CO)c3)c2)C1=O 10.1016/j.bmc.2011.05.064
CHEMBL1851848 73181 0 None -251 3 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 541 17 5 7 3.9 CC1(C)NC(=O)N(c2cccc(CCCCOCCCCCCNC[C@H](O)c3ccc(O)c(CO)c3)c2)C1=O 10.1016/j.bmc.2011.05.064
56658244 73182 0 None -79 4 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 513 17 5 7 3.2 O=C1CN(c2cccc(CCCCOCCCCCCNC[C@H](O)c3ccc(O)c(CO)c3)c2)C(=O)N1 10.1016/j.bmc.2011.05.064
CHEMBL1814272 73182 0 None -79 4 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 513 17 5 7 3.2 O=C1CN(c2cccc(CCCCOCCCCCCNC[C@H](O)c3ccc(O)c(CO)c3)c2)C(=O)N1 10.1016/j.bmc.2011.05.064
CHEMBL1851849 73182 0 None -79 4 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 513 17 5 7 3.2 O=C1CN(c2cccc(CCCCOCCCCCCNC[C@H](O)c3ccc(O)c(CO)c3)c2)C(=O)N1 10.1016/j.bmc.2011.05.064
9958539 109882 0 None -5 3 Human 8.7 pEC50 = 8.7 Functional
Percent adenylyl cyclase activation at 10000 nM of compound concentrationPercent adenylyl cyclase activation at 10000 nM of compound concentration
ChEMBL 527 3 2 5 3.4 COc1c(I)cc(CC2NCCc3nc(N)sc32)cc1I 10.1016/s0960-894x(00)00459-5
CHEMBL307647 109882 0 None -5 3 Human 8.7 pEC50 = 8.7 Functional
Percent adenylyl cyclase activation at 10000 nM of compound concentrationPercent adenylyl cyclase activation at 10000 nM of compound concentration
ChEMBL 527 3 2 5 3.4 COc1c(I)cc(CC2NCCc3nc(N)sc32)cc1I 10.1016/s0960-894x(00)00459-5
164615222 195285 0 None -91 2 Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 396 8 4 5 3.3 COc1ccccc1CCC(C)(C)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
CHEMBL4857267 195285 0 None -91 2 Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 396 8 4 5 3.3 COc1ccccc1CCC(C)(C)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
CHEMBL5028301 195285 0 None -91 2 Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 396 8 4 5 3.3 COc1ccccc1CCC(C)(C)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
164615492 195288 0 None -120 2 Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 380 7 4 4 3.6 Cc1ccccc1CCC(C)(C)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
CHEMBL4848704 195288 0 None -120 2 Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 380 7 4 4 3.6 Cc1ccccc1CCC(C)(C)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
CHEMBL5028319 195288 0 None -120 2 Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 380 7 4 4 3.6 Cc1ccccc1CCC(C)(C)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
443372 17006 26 None -8 9 Guinea pig 8.7 pEC50 = 8.7 Functional
Activity for Beta-1 adrenergic receptor was assessed from ability to stimulate contractions in isolated guinea pig atrium.Activity for Beta-1 adrenergic receptor was assessed from ability to stimulate contractions in isolated guinea pig atrium.
ChEMBL 211 4 4 4 1.1 CC(C)NC[C@H](O)c1ccc(O)c(O)c1 10.1021/jm00019a001
CHEMBL1160723 17006 26 None -8 9 Guinea pig 8.7 pEC50 = 8.7 Functional
Activity for Beta-1 adrenergic receptor was assessed from ability to stimulate contractions in isolated guinea pig atrium.Activity for Beta-1 adrenergic receptor was assessed from ability to stimulate contractions in isolated guinea pig atrium.
ChEMBL 211 4 4 4 1.1 CC(C)NC[C@H](O)c1ccc(O)c(O)c1 10.1021/jm00019a001
CHEMBL2062275 17006 26 None -8 9 Guinea pig 8.7 pEC50 = 8.7 Functional
Activity for Beta-1 adrenergic receptor was assessed from ability to stimulate contractions in isolated guinea pig atrium.Activity for Beta-1 adrenergic receptor was assessed from ability to stimulate contractions in isolated guinea pig atrium.
ChEMBL 211 4 4 4 1.1 CC(C)NC[C@H](O)c1ccc(O)c(O)c1 10.1021/jm00019a001
44392215 72376 0 None 1 2 Human 8.7 pEC50 = 8.7 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptor
ChEMBL 465 12 5 6 3.3 COc1ccc(NC(=O)Nc2ccc(C[C@@H](CO)NC[C@H](O)COc3ccccc3)cc2)cc1 10.1016/j.bmcl.2004.11.001
CHEMBL183307 72376 0 None 1 2 Human 8.7 pEC50 = 8.7 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptor
ChEMBL 465 12 5 6 3.3 COc1ccc(NC(=O)Nc2ccc(C[C@@H](CO)NC[C@H](O)COc3ccccc3)cc2)cc1 10.1016/j.bmcl.2004.11.001
5311116 9114 9 None 4365 3 Human 8.6 pEC50 = 8.6 Functional
Partial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrsPartial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrs
ChEMBL 484 15 5 8 2.2 N#Cc1cc(OCCOCC2CC2)ccc1OCC(CNCCNC(=O)Nc1ccc(cc1)O)O 10.1021/jm400348g
544 9114 9 None 4365 3 Human 8.6 pEC50 = 8.6 Functional
Partial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrsPartial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrs
ChEMBL 484 15 5 8 2.2 N#Cc1cc(OCCOCC2CC2)ccc1OCC(CNCCNC(=O)Nc1ccc(cc1)O)O 10.1021/jm400348g
CHEMBL207802 9114 9 None 4365 3 Human 8.6 pEC50 = 8.6 Functional
Partial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrsPartial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrs
ChEMBL 484 15 5 8 2.2 N#Cc1cc(OCCOCC2CC2)ccc1OCC(CNCCNC(=O)Nc1ccc(cc1)O)O 10.1021/jm400348g
56598832 95043 0 None 4365 3 Human 8.6 pEC50 = 8.6 Functional
Partial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrsPartial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrs
ChEMBL 527 16 5 7 3.3 O=C(NCCNCC(O)COc1ccc(OCCOCCc2ccc(F)cc2)cc1)Nc1ccc(O)cc1 10.1021/jm400348g
CHEMBL2348218 95043 0 None 4365 3 Human 8.6 pEC50 = 8.6 Functional
Partial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrsPartial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrs
ChEMBL 527 16 5 7 3.3 O=C(NCCNCC(O)COc1ccc(OCCOCCc2ccc(F)cc2)cc1)Nc1ccc(O)cc1 10.1021/jm400348g
164617772 195303 0 None -173 2 Human 8.6 pEC50 = 8.6 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 368 7 5 5 2.6 CC(CCc1cccc(O)c1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
CHEMBL4848793 195303 0 None -173 2 Human 8.6 pEC50 = 8.6 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 368 7 5 5 2.6 CC(CCc1cccc(O)c1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
CHEMBL5028458 195303 0 None -173 2 Human 8.6 pEC50 = 8.6 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 368 7 5 5 2.6 CC(CCc1cccc(O)c1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
164611794 195254 0 None -131 2 Human 8.6 pEC50 = 8.6 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 382 7 5 5 3.0 CC(C)(CCc1cccc(O)c1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
CHEMBL4854261 195254 0 None -131 2 Human 8.6 pEC50 = 8.6 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 382 7 5 5 3.0 CC(C)(CCc1cccc(O)c1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
CHEMBL5028104 195254 0 None -131 2 Human 8.6 pEC50 = 8.6 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 382 7 5 5 3.0 CC(C)(CCc1cccc(O)c1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
10289065 19317 0 None - 1 Guinea pig 8.6 pEC50 = 8.6 Functional
Agonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contractionAgonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contraction
ChEMBL 494 17 5 7 2.8 NS(=O)(=O)c1cccc(CCCOCCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm801016j
CHEMBL1186683 19317 0 None - 1 Guinea pig 8.6 pEC50 = 8.6 Functional
Agonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contractionAgonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contraction
ChEMBL 494 17 5 7 2.8 NS(=O)(=O)c1cccc(CCCOCCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm801016j
CHEMBL474616 19317 0 None - 1 Guinea pig 8.6 pEC50 = 8.6 Functional
Agonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contractionAgonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contraction
ChEMBL 494 17 5 7 2.8 NS(=O)(=O)c1cccc(CCCOCCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm801016j
42625511 19509 0 None -3 4 Guinea pig 8.6 pEC50 = 8.6 Functional
Agonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contractionAgonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contraction
ChEMBL 494 17 5 7 2.8 NS(=O)(=O)c1ccccc1CCCCOCCCCCCNC[C@H](O)c1ccc(O)c(CO)c1 10.1021/jm801016j
CHEMBL1187778 19509 0 None -3 4 Guinea pig 8.6 pEC50 = 8.6 Functional
Agonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contractionAgonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contraction
ChEMBL 494 17 5 7 2.8 NS(=O)(=O)c1ccccc1CCCCOCCCCCCNC[C@H](O)c1ccc(O)c(CO)c1 10.1021/jm801016j
CHEMBL520313 19509 0 None -3 4 Guinea pig 8.6 pEC50 = 8.6 Functional
Agonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contractionAgonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contraction
ChEMBL 494 17 5 7 2.8 NS(=O)(=O)c1ccccc1CCCCOCCCCCCNC[C@H](O)c1ccc(O)c(CO)c1 10.1021/jm801016j
90645344 119233 0 None -7 3 Human 8.6 pEC50 = 8.6 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 550 11 6 7 5.0 COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1-c1ccccc1CN 10.1016/j.bmcl.2014.04.095
CHEMBL3298324 119233 0 None -7 3 Human 8.6 pEC50 = 8.6 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 550 11 6 7 5.0 COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1-c1ccccc1CN 10.1016/j.bmcl.2014.04.095
10239722 119235 0 None -11 3 Human 8.6 pEC50 = 8.6 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 550 11 6 7 5.0 COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1-c1ccc(CN)cc1 10.1016/j.bmcl.2014.04.095
CHEMBL3298326 119235 0 None -11 3 Human 8.6 pEC50 = 8.6 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 550 11 6 7 5.0 COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1-c1ccc(CN)cc1 10.1016/j.bmcl.2014.04.095
164621302 195330 0 None -120 2 Human 8.6 pEC50 = 8.6 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 382 8 4 5 2.9 COc1cccc(CCC(C)NCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1 10.1016/j.ejmech.2021.113697
CHEMBL4863282 195330 0 None -120 2 Human 8.6 pEC50 = 8.6 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 382 8 4 5 2.9 COc1cccc(CCC(C)NCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1 10.1016/j.ejmech.2021.113697
CHEMBL5028641 195330 0 None -120 2 Human 8.6 pEC50 = 8.6 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 382 8 4 5 2.9 COc1cccc(CCC(C)NCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1 10.1016/j.ejmech.2021.113697
164610792 195247 0 None -134 2 Human 8.6 pEC50 = 8.6 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 380 7 4 4 3.6 Cc1cccc(CCC(C)(C)NCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1 10.1016/j.ejmech.2021.113697
CHEMBL4855974 195247 0 None -134 2 Human 8.6 pEC50 = 8.6 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 380 7 4 4 3.6 Cc1cccc(CCC(C)(C)NCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1 10.1016/j.ejmech.2021.113697
CHEMBL5028040 195247 0 None -134 2 Human 8.6 pEC50 = 8.6 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 380 7 4 4 3.6 Cc1cccc(CCC(C)(C)NCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1 10.1016/j.ejmech.2021.113697
145984584 172666 0 None -5 3 Human 8.5 pEC50 = 8.5 Functional
Antagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assayAntagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assay
ChEMBL 444 10 5 4 4.4 O=C(Nc1ccccc1)Nc1ccc(CCNC[C@H](O)COc2cccc3[nH]ccc23)cc1 10.1016/j.ejmech.2018.03.032
CHEMBL4249564 172666 0 None -5 3 Human 8.5 pEC50 = 8.5 Functional
Antagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assayAntagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assay
ChEMBL 444 10 5 4 4.4 O=C(Nc1ccccc1)Nc1ccc(CCNC[C@H](O)COc2cccc3[nH]ccc23)cc1 10.1016/j.ejmech.2018.03.032
24822643 164433 0 None -4 2 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 413 8 3 3 4.7 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)c(F)c1 10.1021/jm701324c
CHEMBL408145 164433 0 None -4 2 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 413 8 3 3 4.7 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)c(F)c1 10.1021/jm701324c
44392212 175148 0 None 12 2 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 405 10 4 4 3.9 O=C(Nc1ccccc1)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.06.031
CHEMBL1204383 175148 0 None 12 2 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 405 10 4 4 3.9 O=C(Nc1ccccc1)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.06.031
CHEMBL434524 175148 0 None 12 2 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 405 10 4 4 3.9 O=C(Nc1ccccc1)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.06.031
45271492 202013 0 None 16 2 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 390 10 3 4 3.5 O=C(Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1)c1ccccc1 10.1016/j.bmc.2009.06.031
CHEMBL1203997 202013 0 None 16 2 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 390 10 3 4 3.5 O=C(Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1)c1ccccc1 10.1016/j.bmc.2009.06.031
CHEMBL550906 202013 0 None 16 2 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 390 10 3 4 3.5 O=C(Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1)c1ccccc1 10.1016/j.bmc.2009.06.031
10113837 72343 0 None -39 2 Human 7.7 pEC50 = 7.7 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptor
ChEMBL 435 11 5 5 3.3 O=C(Nc1ccccc1)Nc1ccc(C[C@@H](CO)NC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmcl.2004.11.001
CHEMBL183129 72343 0 None -39 2 Human 7.7 pEC50 = 7.7 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptor
ChEMBL 435 11 5 5 3.3 O=C(Nc1ccccc1)Nc1ccc(C[C@@H](CO)NC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmcl.2004.11.001
44396531 73609 0 None -38 3 Human 7.7 pEC50 = 7.7 Functional
Agonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptorAgonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptor
ChEMBL 647 18 4 8 6.4 CCCCCCCCS(=O)(=O)Oc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)c[nH]c12 10.1016/j.bmcl.2004.10.035
CHEMBL186135 73609 0 None -38 3 Human 7.7 pEC50 = 7.7 Functional
Agonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptorAgonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptor
ChEMBL 647 18 4 8 6.4 CCCCCCCCS(=O)(=O)Oc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)c[nH]c12 10.1016/j.bmcl.2004.10.035
24822469 104553 0 None -26 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 401 8 3 4 4.6 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)s1 10.1021/jm701324c
CHEMBL271765 104553 0 None -26 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 401 8 3 4 4.6 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)s1 10.1021/jm701324c
24950568 196544 0 None -234 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 422 6 3 4 4.3 O=C(O)c1ccc(-c2ccc3c(c2)C[C@@H](NC[C@H](O)c2ccc(Cl)nc2)CC3)cc1 10.1021/jm800222k
CHEMBL516002 196544 0 None -234 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 422 6 3 4 4.3 O=C(O)c1ccc(-c2ccc3c(c2)C[C@@H](NC[C@H](O)c2ccc(Cl)nc2)CC3)cc1 10.1021/jm800222k
11625493 207491 1 None -12 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 400 8 4 6 2.8 CCOc1ccc(CC(C)(C)NCC(O)c2cc(O)cc3c2OCC(=O)N3)cc1 10.1016/j.bmcl.2009.12.087
CHEMBL600007 207491 1 None -12 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 400 8 4 6 2.8 CCOc1ccc(CC(C)(C)NCC(O)c2cc(O)cc3c2OCC(=O)N3)cc1 10.1016/j.bmcl.2009.12.087
44565908 193903 0 None -1513 3 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 512 11 4 8 2.7 CC(C)Oc1cc(-c2ccc(CCNC[C@H](O)c3cnccc3N)cc2)ccc1C(=O)NS(C)(=O)=O 10.1021/jm9000709
CHEMBL491726 193903 0 None -1513 3 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 512 11 4 8 2.7 CC(C)Oc1cc(-c2ccc(CCNC[C@H](O)c3cnccc3N)cc2)ccc1C(=O)NS(C)(=O)=O 10.1021/jm9000709
10139127 64263 0 None -50 2 Human 5.7 pEC50 = 5.7 Functional
Agonistic activity as cAMP accumulation in CHO cells expressing human beta-1-adrenergic receptorAgonistic activity as cAMP accumulation in CHO cells expressing human beta-1-adrenergic receptor
ChEMBL 455 9 3 7 2.6 O=C1NC(=O)C(Cc2ccc(N3CCC(NC[C@H](O)COc4ccccc4)CC3)cc2)S1 10.1016/s0960-894x(01)00063-4
CHEMBL165893 64263 0 None -50 2 Human 5.7 pEC50 = 5.7 Functional
Agonistic activity as cAMP accumulation in CHO cells expressing human beta-1-adrenergic receptorAgonistic activity as cAMP accumulation in CHO cells expressing human beta-1-adrenergic receptor
ChEMBL 455 9 3 7 2.6 O=C1NC(=O)C(Cc2ccc(N3CCC(NC[C@H](O)COc4ccccc4)CC3)cc2)S1 10.1016/s0960-894x(01)00063-4
44589133 182623 0 None -2 3 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at adrenergic beta-1 receptorAgonist activity at adrenergic beta-1 receptor
ChEMBL 354 8 2 4 3.4 CC(C)NCC(O)COc1ccc2c(c1)CCCN2Cc1ccccc1 10.1016/j.bmc.2008.11.030
CHEMBL458541 182623 0 None -2 3 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at adrenergic beta-1 receptorAgonist activity at adrenergic beta-1 receptor
ChEMBL 354 8 2 4 3.4 CC(C)NCC(O)COc1ccc2c(c1)CCCN2Cc1ccccc1 10.1016/j.bmc.2008.11.030
10145446 10955 0 None -102 2 Human 5.7 pEC50 = 5.7 Functional
In vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptorIn vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptor
ChEMBL 602 14 5 8 3.6 O=C(NCCCc1cccs1)Nc1ccc(S(=O)(=O)N2CCC(CNC[C@H](O)COc3ccc(O)cc3)CC2)cc1 10.1016/s0960-894x(02)00607-8
CHEMBL100124 10955 0 None -102 2 Human 5.7 pEC50 = 5.7 Functional
In vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptorIn vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptor
ChEMBL 602 14 5 8 3.6 O=C(NCCCc1cccs1)Nc1ccc(S(=O)(=O)N2CCC(CNC[C@H](O)COc3ccc(O)cc3)CC2)cc1 10.1016/s0960-894x(02)00607-8
46232816 207733 0 None -3 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 432 7 4 5 4.0 CC(C)(Cc1ccc(-c2ccccc2)cc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2 10.1016/j.bmcl.2009.12.087
CHEMBL601858 207733 0 None -3 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 432 7 4 5 4.0 CC(C)(Cc1ccc(-c2ccccc2)cc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2 10.1016/j.bmcl.2009.12.087
11632691 208321 0 None -3 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 398 7 4 5 3.5 CC(C)c1ccc(CC(C)(C)NCC(O)c2cc(O)cc3c2OCC(=O)N3)cc1 10.1016/j.bmcl.2009.12.087
CHEMBL605372 208321 0 None -3 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 398 7 4 5 3.5 CC(C)c1ccc(CC(C)(C)NCC(O)c2cc(O)cc3c2OCC(=O)N3)cc1 10.1016/j.bmcl.2009.12.087
44377523 63005 0 None 1 2 Human 7.7 pEC50 = 7.7 Functional
Agonistic activity as cAMP accumulation in CHO cells expressing human beta-1-adrenergic receptorAgonistic activity as cAMP accumulation in CHO cells expressing human beta-1-adrenergic receptor
ChEMBL 509 9 3 8 1.0 O=C1N=c2cccc(OC[C@@H](O)CNC3CCN(c4ccc(CC5SC(=O)NC5=O)cc4)CC3)c2=N1 10.1016/s0960-894x(01)00063-4
CHEMBL162711 63005 0 None 1 2 Human 7.7 pEC50 = 7.7 Functional
Agonistic activity as cAMP accumulation in CHO cells expressing human beta-1-adrenergic receptorAgonistic activity as cAMP accumulation in CHO cells expressing human beta-1-adrenergic receptor
ChEMBL 509 9 3 8 1.0 O=C1N=c2cccc(OC[C@@H](O)CNC3CCN(c4ccc(CC5SC(=O)NC5=O)cc4)CC3)c2=N1 10.1016/s0960-894x(01)00063-4
9933039 169824 0 None -6 3 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 442 11 4 6 2.8 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1ccccc1 10.1016/j.bmc.2009.06.031
CHEMBL417613 169824 0 None -6 3 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 442 11 4 6 2.8 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1ccccc1 10.1016/j.bmc.2009.06.031
24895563 183517 0 None -173 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 435 12 3 5 4.5 CCCOc1cc(-c2ccc(OCCNC[C@H](O)c3ccccc3)cc2)ccc1C(=O)O 10.1021/jm8000345
CHEMBL460256 183517 0 None -173 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 435 12 3 5 4.5 CCCOc1cc(-c2ccc(OCCNC[C@H](O)c3ccccc3)cc2)ccc1C(=O)O 10.1021/jm8000345
11668125 207790 0 None -4 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 384 7 4 5 2.9 CCc1ccc(CC(C)(C)NCC(O)c2cc(O)cc3c2OCC(=O)N3)cc1 10.1016/j.bmcl.2009.12.087
CHEMBL602258 207790 0 None -4 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 384 7 4 5 2.9 CCc1ccc(CC(C)(C)NCC(O)c2cc(O)cc3c2OCC(=O)N3)cc1 10.1016/j.bmcl.2009.12.087
155536314 178954 0 None -6025 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 354 7 5 5 2.2 O=c1ccc2c(C(O)CNCCCc3cccc(O)c3)ccc(O)c2[nH]1 10.1016/j.bmc.2018.10.043
CHEMBL4473515 178954 0 None -6025 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 354 7 5 5 2.2 O=c1ccc2c(C(O)CNCCCc3cccc(O)c3)ccc(O)c2[nH]1 10.1016/j.bmc.2018.10.043
24895789 195646 0 None -72 2 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 375 8 3 3 4.3 C[C@H](Cc1ccc(-c2ccc(C(=O)O)cc2)cc1)NC[C@H](O)c1ccccc1 10.1021/jm8000345
CHEMBL507003 195646 0 None -72 2 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 375 8 3 3 4.3 C[C@H](Cc1ccc(-c2ccc(C(=O)O)cc2)cc1)NC[C@H](O)c1ccccc1 10.1021/jm8000345
44396715 74225 0 None -20 3 Human 7.7 pEC50 = 7.7 Functional
Agonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptorAgonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptor
ChEMBL 612 12 4 9 4.4 C[C@H](Cc1c[nH]c2c(OS(=O)(=O)c3cccnc3)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1016/j.bmcl.2004.10.035
CHEMBL189081 74225 0 None -20 3 Human 7.7 pEC50 = 7.7 Functional
Agonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptorAgonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptor
ChEMBL 612 12 4 9 4.4 C[C@H](Cc1c[nH]c2c(OS(=O)(=O)c3cccnc3)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1016/j.bmcl.2004.10.035
155551006 180724 0 None -44 2 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 423 9 5 5 3.1 CC(C)C(=O)Nc1cccc(CCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1 10.1016/j.bmc.2018.10.043
CHEMBL4541169 180724 0 None -44 2 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 423 9 5 5 3.1 CC(C)C(=O)Nc1cccc(CCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1 10.1016/j.bmc.2018.10.043
164620585 195324 0 None -616 2 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 382 7 5 5 3.0 CC(C)(CCc1ccc(O)cc1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
CHEMBL4866766 195324 0 None -616 2 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 382 7 5 5 3.0 CC(C)(CCc1ccc(O)cc1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
CHEMBL5028602 195324 0 None -616 2 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 382 7 5 5 3.0 CC(C)(CCc1ccc(O)cc1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
56598833 95042 0 None 436 3 Human 7.6 pEC50 = 7.6 Functional
Partial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrsPartial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrs
ChEMBL 433 14 5 7 2.0 CCOCCOc1ccc(OCC(O)CNCCNC(=O)Nc2ccc(O)cc2)cc1 10.1021/jm400348g
CHEMBL2348217 95042 0 None 436 3 Human 7.6 pEC50 = 7.6 Functional
Partial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrsPartial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrs
ChEMBL 433 14 5 7 2.0 CCOCCOc1ccc(OCC(O)CNCCNC(=O)Nc2ccc(O)cc2)cc1 10.1021/jm400348g
42639314 19342 0 None -575 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 550 11 3 6 5.0 CS(=O)(=O)NC(=O)c1ccc(-c2ccc(CCNC[C@H](O)c3ccccc3)cc2)cc1OC1CCCCCC1 10.1021/jm9000709
CHEMBL1186804 19342 0 None -575 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 550 11 3 6 5.0 CS(=O)(=O)NC(=O)c1ccc(-c2ccc(CCNC[C@H](O)c3ccccc3)cc2)cc1OC1CCCCCC1 10.1021/jm9000709
CHEMBL479341 19342 0 None -575 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 550 11 3 6 5.0 CS(=O)(=O)NC(=O)c1ccc(-c2ccc(CCNC[C@H](O)c3ccccc3)cc2)cc1OC1CCCCCC1 10.1021/jm9000709
443372 17006 26 None -8 9 Guinea pig 5.7 pEC50 = 5.7 Functional
Activity for Beta-1 adrenergic receptor was assessed from ability to stimulate contractions in isolated guinea pig atrium.Activity for Beta-1 adrenergic receptor was assessed from ability to stimulate contractions in isolated guinea pig atrium.
ChEMBL 211 4 4 4 1.1 CC(C)NC[C@H](O)c1ccc(O)c(O)c1 10.1021/jm00019a001
CHEMBL1160723 17006 26 None -8 9 Guinea pig 5.7 pEC50 = 5.7 Functional
Activity for Beta-1 adrenergic receptor was assessed from ability to stimulate contractions in isolated guinea pig atrium.Activity for Beta-1 adrenergic receptor was assessed from ability to stimulate contractions in isolated guinea pig atrium.
ChEMBL 211 4 4 4 1.1 CC(C)NC[C@H](O)c1ccc(O)c(O)c1 10.1021/jm00019a001
CHEMBL2062275 17006 26 None -8 9 Guinea pig 5.7 pEC50 = 5.7 Functional
Activity for Beta-1 adrenergic receptor was assessed from ability to stimulate contractions in isolated guinea pig atrium.Activity for Beta-1 adrenergic receptor was assessed from ability to stimulate contractions in isolated guinea pig atrium.
ChEMBL 211 4 4 4 1.1 CC(C)NC[C@H](O)c1ccc(O)c(O)c1 10.1021/jm00019a001
145983266 172307 0 None -66 3 Human 6.7 pEC50 = 6.7 Functional
Antagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assayAntagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assay
ChEMBL 512 14 5 6 2.7 CC(=O)NCc1cccc(OC[C@@H](O)CNCCc2ccc(NS(=O)(=O)Nc3ccccc3)cc2)c1 10.1016/j.ejmech.2018.03.032
CHEMBL4241176 172307 0 None -66 3 Human 6.7 pEC50 = 6.7 Functional
Antagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assayAntagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assay
ChEMBL 512 14 5 6 2.7 CC(=O)NCc1cccc(OC[C@@H](O)CNCCc2ccc(NS(=O)(=O)Nc3ccccc3)cc2)c1 10.1016/j.ejmech.2018.03.032
319 8106 44 None -2290 18 Rat 5.6 pEC50 = 5.6 Functional
Agonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effectAgonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effect
ChEMBL 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 10.1016/j.bmcl.2010.12.096
321 8106 44 None -2290 18 Rat 5.6 pEC50 = 5.6 Functional
Agonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effectAgonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effect
ChEMBL 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 10.1016/j.bmcl.2010.12.096
444031 8106 44 None -2290 18 Rat 5.6 pEC50 = 5.6 Functional
Agonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effectAgonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effect
ChEMBL 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 10.1016/j.bmcl.2010.12.096
784 8106 44 None -2290 18 Rat 5.6 pEC50 = 5.6 Functional
Agonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effectAgonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effect
ChEMBL 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 10.1016/j.bmcl.2010.12.096
CHEMBL1346 8106 44 None -2290 18 Rat 5.6 pEC50 = 5.6 Functional
Agonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effectAgonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effect
ChEMBL 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 10.1016/j.bmcl.2010.12.096
DB00496 8106 44 None -2290 18 Rat 5.6 pEC50 = 5.6 Functional
Agonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effectAgonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effect
ChEMBL 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 10.1016/j.bmcl.2010.12.096
155543518 181777 0 None -794 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 457 9 5 5 3.7 O=C(Nc1cccc(CCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1)c1ccccc1 10.1016/j.bmc.2018.10.043
CHEMBL4566727 181777 0 None -794 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 457 9 5 5 3.7 O=C(Nc1cccc(CCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1)c1ccccc1 10.1016/j.bmc.2018.10.043
45101521 203606 0 None -4 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelAgonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP level
ChEMBL 570 15 8 9 1.3 CC(C)(Cc1ccc(NC(=O)CCCNC(=O)C(N)CCCN)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1016/j.bmcl.2009.06.104
CHEMBL565747 203606 0 None -4 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelAgonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP level
ChEMBL 570 15 8 9 1.3 CC(C)(Cc1ccc(NC(=O)CCCNC(=O)C(N)CCCN)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1016/j.bmcl.2009.06.104
44560794 180280 0 None -346 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 474 10 3 5 5.4 C[C@H](Cc1ccc(-c2ccc(C(=O)O)c(OC3CCCCC3)c2)cc1)NC[C@H](O)c1cccnc1 10.1021/jm8000345
CHEMBL453056 180280 0 None -346 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 474 10 3 5 5.4 C[C@H](Cc1ccc(-c2ccc(C(=O)O)c(OC3CCCCC3)c2)cc1)NC[C@H](O)c1cccnc1 10.1021/jm8000345
164623230 195350 0 None -1479 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 380 7 4 4 3.6 Cc1ccc(CCC(C)(C)NCC(O)c2ccc(O)c3[nH]c(=O)ccc23)cc1 10.1016/j.ejmech.2021.113697
CHEMBL4865710 195350 0 None -1479 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 380 7 4 4 3.6 Cc1ccc(CCC(C)(C)NCC(O)c2ccc(O)c3[nH]c(=O)ccc23)cc1 10.1016/j.ejmech.2021.113697
CHEMBL5028744 195350 0 None -1479 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 380 7 4 4 3.6 Cc1ccc(CCC(C)(C)NCC(O)c2ccc(O)c3[nH]c(=O)ccc23)cc1 10.1016/j.ejmech.2021.113697
44579940 198671 0 None -37 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 468 10 4 5 4.7 CC(=O)Nc1cc(Oc2cccc(CCNC[C@H](O)c3cccc(Cl)c3)c2)cc(C(=O)O)c1 10.1016/j.bmcl.2008.08.009
CHEMBL519985 198671 0 None -37 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 468 10 4 5 4.7 CC(=O)Nc1cc(Oc2cccc(CCNC[C@H](O)c3cccc(Cl)c3)c2)cc(C(=O)O)c1 10.1016/j.bmcl.2008.08.009
46232857 207537 0 None -19 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 440 7 4 6 3.3 CC(C)(Cc1ccc(OC(F)(F)F)cc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2 10.1016/j.bmcl.2009.12.087
CHEMBL600400 207537 0 None -19 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 440 7 4 6 3.3 CC(C)(Cc1ccc(OC(F)(F)F)cc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2 10.1016/j.bmcl.2009.12.087
42639654 19412 0 None -1258 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 513 11 3 7 3.8 CC(C)Sc1cc(-c2ccc(CCNC[C@H](O)c3cccnc3)cc2)ccc1C(=O)NS(C)(=O)=O 10.1021/jm9000709
CHEMBL1187156 19412 0 None -1258 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 513 11 3 7 3.8 CC(C)Sc1cc(-c2ccc(CCNC[C@H](O)c3cccnc3)cc2)ccc1C(=O)NS(C)(=O)=O 10.1021/jm9000709
CHEMBL491891 19412 0 None -1258 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 513 11 3 7 3.8 CC(C)Sc1cc(-c2ccc(CCNC[C@H](O)c3cccnc3)cc2)ccc1C(=O)NS(C)(=O)=O 10.1021/jm9000709
164615990 192081 0 None -831 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human beta1 adrenoceptor expressed in CHO cells assessed as increase in cAMP level incubated for 30 mins by immunoassayAgonist activity at human beta1 adrenoceptor expressed in CHO cells assessed as increase in cAMP level incubated for 30 mins by immunoassay
ChEMBL 427 9 5 6 1.6 CN(C)C(=O)CNc1ccc2c(c1)C[C@@H](NC[C@H](O)c1ccc(O)c(CCO)c1)CC2 10.1021/acs.jmedchem.0c01195
CHEMBL4859326 192081 0 None -831 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human beta1 adrenoceptor expressed in CHO cells assessed as increase in cAMP level incubated for 30 mins by immunoassayAgonist activity at human beta1 adrenoceptor expressed in CHO cells assessed as increase in cAMP level incubated for 30 mins by immunoassay
ChEMBL 427 9 5 6 1.6 CN(C)C(=O)CNc1ccc2c(c1)C[C@@H](NC[C@H](O)c1ccc(O)c(CCO)c1)CC2 10.1021/acs.jmedchem.0c01195
9832011 112258 0 None -138 3 Human 5.6 pEC50 = 5.6 Functional
Compound was evaluated for its inhibitory activity against human beta-1 adrenergic receptor (AR)Compound was evaluated for its inhibitory activity against human beta-1 adrenergic receptor (AR)
ChEMBL 644 13 6 7 6.5 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(-c3ccc(OCC4NCCc5cc(O)c(O)cc54)cc3)cc2)cc1 10.1016/s0960-894x(00)00459-5
CHEMBL312074 112258 0 None -138 3 Human 5.6 pEC50 = 5.6 Functional
Compound was evaluated for its inhibitory activity against human beta-1 adrenergic receptor (AR)Compound was evaluated for its inhibitory activity against human beta-1 adrenergic receptor (AR)
ChEMBL 644 13 6 7 6.5 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(-c3ccc(OCC4NCCc5cc(O)c(O)cc54)cc3)cc2)cc1 10.1016/s0960-894x(00)00459-5
11091850 54005 0 None -25 3 Human 7.6 pEC50 = 7.6 Functional
Ability to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentrationAbility to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentration
ChEMBL 465 11 4 4 4.6 Cc1ccc(CNC(=O)Cc2ccc(NC[C@@H](C)NC[C@H](O)c3cccc(Cl)c3)cc2)cc1 10.1021/jm0101500
CHEMBL154370 54005 0 None -25 3 Human 7.6 pEC50 = 7.6 Functional
Ability to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentrationAbility to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentration
ChEMBL 465 11 4 4 4.6 Cc1ccc(CNC(=O)Cc2ccc(NC[C@@H](C)NC[C@H](O)c3cccc(Cl)c3)cc2)cc1 10.1021/jm0101500
44441232 100563 0 None -19 3 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 415 9 4 6 3.8 C[C@H](CNc1ccc(-c2ocnc2C(=O)O)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1016/j.bmcl.2007.05.069
CHEMBL247519 100563 0 None -19 3 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 415 9 4 6 3.8 C[C@H](CNc1ccc(-c2ocnc2C(=O)O)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1016/j.bmcl.2007.05.069
9892481 77008 14 None -501 4 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 435 12 6 6 3.0 O=CNc1cc([C@@H](O)CNCCc2ccc(NC[C@H](O)c3ccccc3)cc2)ccc1O 10.1016/j.bmcl.2014.04.095
CHEMBL1940832 77008 14 None -501 4 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 435 12 6 6 3.0 O=CNc1cc([C@@H](O)CNCCc2ccc(NC[C@H](O)c3ccccc3)cc2)ccc1O 10.1016/j.bmcl.2014.04.095
9849126 19211 0 None -630 4 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 507 18 5 7 2.8 NS(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(NC=O)c2)c1 10.1021/jm801016j
CHEMBL1185969 19211 0 None -630 4 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 507 18 5 7 2.8 NS(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(NC=O)c2)c1 10.1021/jm801016j
CHEMBL443435 19211 0 None -630 4 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 507 18 5 7 2.8 NS(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(NC=O)c2)c1 10.1021/jm801016j
9892481 77008 14 None -501 4 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at recombinant human beta1-adrenoceptor expressed in whole cells assessed as cAMP accumulation by homogeneous radioimmunoassayAgonist activity at recombinant human beta1-adrenoceptor expressed in whole cells assessed as cAMP accumulation by homogeneous radioimmunoassay
ChEMBL 435 12 6 6 3.0 O=CNc1cc([C@@H](O)CNCCc2ccc(NC[C@H](O)c3ccccc3)cc2)ccc1O 10.1016/j.bmcl.2011.11.072
CHEMBL1940832 77008 14 None -501 4 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at recombinant human beta1-adrenoceptor expressed in whole cells assessed as cAMP accumulation by homogeneous radioimmunoassayAgonist activity at recombinant human beta1-adrenoceptor expressed in whole cells assessed as cAMP accumulation by homogeneous radioimmunoassay
ChEMBL 435 12 6 6 3.0 O=CNc1cc([C@@H](O)CNCCc2ccc(NC[C@H](O)c3ccccc3)cc2)ccc1O 10.1016/j.bmcl.2011.11.072
44574720 185329 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 494 11 4 5 4.5 O=C(Cc1ccccn1)Nc1ccc(CCNC[C@H](O)COc2cccc3[nH]c4ccccc4c23)cc1 10.1016/j.bmc.2009.03.044
CHEMBL466923 185329 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 494 11 4 5 4.5 O=C(Cc1ccccn1)Nc1ccc(CCNC[C@H](O)COc2cccc3[nH]c4ccccc4c23)cc1 10.1016/j.bmc.2009.03.044
49861320 61740 0 None -6 3 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay
ChEMBL 426 11 3 5 3.1 O=S(=O)(Nc1ccccc1)c1ccc(CCNC[C@@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.06.031
CHEMBL1204003 61740 0 None -6 3 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay
ChEMBL 426 11 3 5 3.1 O=S(=O)(Nc1ccccc1)c1ccc(CCNC[C@@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.06.031
CHEMBL1615579 61740 0 None -6 3 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay
ChEMBL 426 11 3 5 3.1 O=S(=O)(Nc1ccccc1)c1ccc(CCNC[C@@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.06.031
10048077 104670 17 None -52 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 425 9 3 4 4.6 COc1cc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)ccc1C(=O)O 10.1021/jm9000709
CHEMBL272383 104670 17 None -52 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 425 9 3 4 4.6 COc1cc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)ccc1C(=O)O 10.1021/jm9000709
44574757 185264 0 None -12 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 511 14 3 6 4.4 O=C(Cc1cccc(OCc2ccccc2)n1)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.03.044
CHEMBL466467 185264 0 None -12 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 511 14 3 6 4.4 O=C(Cc1cccc(OCc2ccccc2)n1)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.03.044
10048077 104670 17 None -52 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 425 9 3 4 4.6 COc1cc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)ccc1C(=O)O 10.1021/jm701324c
CHEMBL272383 104670 17 None -52 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 425 9 3 4 4.6 COc1cc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)ccc1C(=O)O 10.1021/jm701324c
11003341 53071 0 None -10 3 Human 6.6 pEC50 = 6.6 Functional
Ability to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentrationAbility to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentration
ChEMBL 376 10 4 4 3.5 C[C@H](CNc1ccc(CCC(=O)O)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm0101500
CHEMBL153558 53071 0 None -10 3 Human 6.6 pEC50 = 6.6 Functional
Ability to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentrationAbility to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentration
ChEMBL 376 10 4 4 3.5 C[C@H](CNc1ccc(CCC(=O)O)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm0101500
56658246 71271 0 None -1258 4 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 525 17 5 8 2.9 O=c1cc[nH]c(=O)n1-c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1016/j.bmc.2011.05.064
CHEMBL1814277 71271 0 None -1258 4 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 525 17 5 8 2.9 O=c1cc[nH]c(=O)n1-c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1016/j.bmc.2011.05.064
CHEMBL1814278 71271 0 None -1258 4 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 525 17 5 8 2.9 O=c1cc[nH]c(=O)n1-c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1016/j.bmc.2011.05.064
11003341 53071 0 None -10 3 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 376 10 4 4 3.5 C[C@H](CNc1ccc(CCC(=O)O)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1016/j.bmcl.2007.05.069
CHEMBL153558 53071 0 None -10 3 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 376 10 4 4 3.5 C[C@H](CNc1ccc(CCC(=O)O)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1016/j.bmcl.2007.05.069
2419 10236 84 None -1174 14 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2014.04.095
5152 10236 84 None -1174 14 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2014.04.095
559 10236 84 None -1174 14 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2014.04.095
CHEMBL1263 10236 84 None -1174 14 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2014.04.095
DB00938 10236 84 None -1174 14 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2014.04.095
42625511 19509 0 None -316 4 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 494 17 5 7 2.8 NS(=O)(=O)c1ccccc1CCCCOCCCCCCNC[C@H](O)c1ccc(O)c(CO)c1 10.1021/jm801016j
CHEMBL1187778 19509 0 None -316 4 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 494 17 5 7 2.8 NS(=O)(=O)c1ccccc1CCCCOCCCCCCNC[C@H](O)c1ccc(O)c(CO)c1 10.1021/jm801016j
CHEMBL520313 19509 0 None -316 4 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 494 17 5 7 2.8 NS(=O)(=O)c1ccccc1CCCCOCCCCCCNC[C@H](O)c1ccc(O)c(CO)c1 10.1021/jm801016j
2419 10236 84 None -1174 14 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant beta1 receptor assessed as cAMP accumulation by radioimmunoassay and cell based assayAgonist activity at human recombinant beta1 receptor assessed as cAMP accumulation by radioimmunoassay and cell based assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2014.04.069
5152 10236 84 None -1174 14 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant beta1 receptor assessed as cAMP accumulation by radioimmunoassay and cell based assayAgonist activity at human recombinant beta1 receptor assessed as cAMP accumulation by radioimmunoassay and cell based assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2014.04.069
559 10236 84 None -1174 14 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant beta1 receptor assessed as cAMP accumulation by radioimmunoassay and cell based assayAgonist activity at human recombinant beta1 receptor assessed as cAMP accumulation by radioimmunoassay and cell based assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2014.04.069
CHEMBL1263 10236 84 None -1174 14 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant beta1 receptor assessed as cAMP accumulation by radioimmunoassay and cell based assayAgonist activity at human recombinant beta1 receptor assessed as cAMP accumulation by radioimmunoassay and cell based assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2014.04.069
DB00938 10236 84 None -1174 14 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant beta1 receptor assessed as cAMP accumulation by radioimmunoassay and cell based assayAgonist activity at human recombinant beta1 receptor assessed as cAMP accumulation by radioimmunoassay and cell based assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2014.04.069
2419 10236 84 None -1174 14 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at recombinant human beta1-adrenoceptor expressed in whole cells assessed as cAMP accumulation by homogeneous radioimmunoassayAgonist activity at recombinant human beta1-adrenoceptor expressed in whole cells assessed as cAMP accumulation by homogeneous radioimmunoassay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2011.11.072
5152 10236 84 None -1174 14 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at recombinant human beta1-adrenoceptor expressed in whole cells assessed as cAMP accumulation by homogeneous radioimmunoassayAgonist activity at recombinant human beta1-adrenoceptor expressed in whole cells assessed as cAMP accumulation by homogeneous radioimmunoassay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2011.11.072
559 10236 84 None -1174 14 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at recombinant human beta1-adrenoceptor expressed in whole cells assessed as cAMP accumulation by homogeneous radioimmunoassayAgonist activity at recombinant human beta1-adrenoceptor expressed in whole cells assessed as cAMP accumulation by homogeneous radioimmunoassay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2011.11.072
CHEMBL1263 10236 84 None -1174 14 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at recombinant human beta1-adrenoceptor expressed in whole cells assessed as cAMP accumulation by homogeneous radioimmunoassayAgonist activity at recombinant human beta1-adrenoceptor expressed in whole cells assessed as cAMP accumulation by homogeneous radioimmunoassay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2011.11.072
DB00938 10236 84 None -1174 14 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at recombinant human beta1-adrenoceptor expressed in whole cells assessed as cAMP accumulation by homogeneous radioimmunoassayAgonist activity at recombinant human beta1-adrenoceptor expressed in whole cells assessed as cAMP accumulation by homogeneous radioimmunoassay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2011.11.072
10180590 77006 0 None -707 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at recombinant human beta1-adrenoceptor expressed in whole cells assessed as cAMP accumulation by homogeneous radioimmunoassayAgonist activity at recombinant human beta1-adrenoceptor expressed in whole cells assessed as cAMP accumulation by homogeneous radioimmunoassay
ChEMBL 422 11 6 6 2.9 OCc1cc([C@@H](O)CNCCc2ccc(NC[C@H](O)c3ccccc3)cc2)ccc1O 10.1016/j.bmcl.2011.11.072
CHEMBL1940830 77006 0 None -707 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at recombinant human beta1-adrenoceptor expressed in whole cells assessed as cAMP accumulation by homogeneous radioimmunoassayAgonist activity at recombinant human beta1-adrenoceptor expressed in whole cells assessed as cAMP accumulation by homogeneous radioimmunoassay
ChEMBL 422 11 6 6 2.9 OCc1cc([C@@H](O)CNCCc2ccc(NC[C@H](O)c3ccccc3)cc2)ccc1O 10.1016/j.bmcl.2011.11.072
10202462 77007 0 None -223 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at recombinant human beta1-adrenoceptor expressed in whole cells assessed as cAMP accumulation by homogeneous radioimmunoassayAgonist activity at recombinant human beta1-adrenoceptor expressed in whole cells assessed as cAMP accumulation by homogeneous radioimmunoassay
ChEMBL 422 11 6 6 2.9 OCc1cc([C@@H](O)CNCCc2ccc(NC[C@@H](O)c3ccccc3)cc2)ccc1O 10.1016/j.bmcl.2011.11.072
CHEMBL1940831 77007 0 None -223 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at recombinant human beta1-adrenoceptor expressed in whole cells assessed as cAMP accumulation by homogeneous radioimmunoassayAgonist activity at recombinant human beta1-adrenoceptor expressed in whole cells assessed as cAMP accumulation by homogeneous radioimmunoassay
ChEMBL 422 11 6 6 2.9 OCc1cc([C@@H](O)CNCCc2ccc(NC[C@@H](O)c3ccccc3)cc2)ccc1O 10.1016/j.bmcl.2011.11.072
11669967 83295 0 None -12589 2 Human 5.6 pEC50 = 5.6 Functional
Activity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP productionActivity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP production
ChEMBL 468 10 5 5 4.5 C[C@H](CNc1cccc(-c2ccc(C(=O)O)cc2C(=O)O)c1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm0509445
CHEMBL206002 83295 0 None -12589 2 Human 5.6 pEC50 = 5.6 Functional
Activity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP productionActivity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP production
ChEMBL 468 10 5 5 4.5 C[C@H](CNc1cccc(-c2ccc(C(=O)O)cc2C(=O)O)c1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm0509445
45375919 203790 0 None -87 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 400 7 5 6 2.1 CC(C)(Cc1cccc(C(=O)O)c1)NCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1016/j.bmcl.2009.10.013
CHEMBL566973 203790 0 None -87 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 400 7 5 6 2.1 CC(C)(Cc1cccc(C(=O)O)c1)NCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1016/j.bmcl.2009.10.013
10232096 114442 0 None -1 2 Human 6.6 pEC50 = 6.6 Functional
In vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptorIn vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptor
ChEMBL 586 12 5 6 5.1 O=C(NCc1ccc(Cl)cc1Cl)N1CCC(Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)CC1 10.1016/s0960-894x(01)00645-x
CHEMBL319041 114442 0 None -1 2 Human 6.6 pEC50 = 6.6 Functional
In vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptorIn vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptor
ChEMBL 586 12 5 6 5.1 O=C(NCc1ccc(Cl)cc1Cl)N1CCC(Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)CC1 10.1016/s0960-894x(01)00645-x
44396530 73862 0 None -23 3 Human 7.6 pEC50 = 7.6 Functional
Agonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptorAgonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptor
ChEMBL 591 14 4 8 4.8 CCCCS(=O)(=O)Oc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)c[nH]c12 10.1016/j.bmcl.2004.10.035
CHEMBL187317 73862 0 None -23 3 Human 7.6 pEC50 = 7.6 Functional
Agonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptorAgonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptor
ChEMBL 591 14 4 8 4.8 CCCCS(=O)(=O)Oc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)c[nH]c12 10.1016/j.bmcl.2004.10.035
44396798 176171 0 None -56 3 Human 7.6 pEC50 = 7.6 Functional
Agonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptorAgonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptor
ChEMBL 542 10 5 7 3.2 C[C@H](Cc1c[nH]c2c(S(C)(=O)=O)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccc(N)c2)c1 10.1016/j.bmcl.2004.09.054
CHEMBL442225 176171 0 None -56 3 Human 7.6 pEC50 = 7.6 Functional
Agonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptorAgonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptor
ChEMBL 542 10 5 7 3.2 C[C@H](Cc1c[nH]c2c(S(C)(=O)=O)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccc(N)c2)c1 10.1016/j.bmcl.2004.09.054
45483846 203590 0 None -1 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 412 6 4 5 3.7 CC(C)(Cc1ccc(C(C)(C)C)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1016/j.bmcl.2009.10.013
CHEMBL565685 203590 0 None -1 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 412 6 4 5 3.7 CC(C)(Cc1ccc(C(C)(C)C)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1016/j.bmcl.2009.10.013
44574868 185353 0 None -3 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 534 13 3 6 4.8 O=C(Cc1nccn1Cc1ccc2ccccc2c1)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.03.044
CHEMBL467103 185353 0 None -3 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 534 13 3 6 4.8 O=C(Cc1nccn1Cc1ccc2ccccc2c1)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.03.044
24823131 104177 0 None -15 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 429 8 3 3 5.2 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)cc1Cl 10.1021/jm701324c
CHEMBL269823 104177 0 None -15 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 429 8 3 3 5.2 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)cc1Cl 10.1021/jm701324c
24823294 165847 0 None -870 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 459 10 3 4 5.6 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3ccccc3)cc2)cc1OC1CCCCC1 10.1021/jm701324c
CHEMBL409718 165847 0 None -870 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 459 10 3 4 5.6 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3ccccc3)cc2)cc1OC1CCCCC1 10.1021/jm701324c
44127374 203013 0 None 1 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 421 11 4 6 2.5 O=C(Cc1ccncc1)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/j.ejmech.2009.01.022
CHEMBL561693 203013 0 None 1 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 421 11 4 6 2.5 O=C(Cc1ccncc1)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/j.ejmech.2009.01.022
24823294 165847 0 None -870 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 459 10 3 4 5.6 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3ccccc3)cc2)cc1OC1CCCCC1 10.1021/jm8000345
CHEMBL409718 165847 0 None -870 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 459 10 3 4 5.6 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3ccccc3)cc2)cc1OC1CCCCC1 10.1021/jm8000345
11420551 19291 0 None -436 3 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 495 11 4 6 3.7 CC(C)Nc1cc(-c2ccc(CCNC[C@H](O)c3ccccc3)cc2)ccc1C(=O)NS(C)(=O)=O 10.1021/jm9000709
CHEMBL1186589 19291 0 None -436 3 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 495 11 4 6 3.7 CC(C)Nc1cc(-c2ccc(CCNC[C@H](O)c3ccccc3)cc2)ccc1C(=O)NS(C)(=O)=O 10.1021/jm9000709
CHEMBL471060 19291 0 None -436 3 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 495 11 4 6 3.7 CC(C)Nc1cc(-c2ccc(CCNC[C@H](O)c3ccccc3)cc2)ccc1C(=O)NS(C)(=O)=O 10.1021/jm9000709
24823294 165847 0 None -870 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 459 10 3 4 5.6 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3ccccc3)cc2)cc1OC1CCCCC1 10.1021/jm9000709
CHEMBL409718 165847 0 None -870 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 459 10 3 4 5.6 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3ccccc3)cc2)cc1OC1CCCCC1 10.1021/jm9000709
1028 7079 71 None -6 19 Guinea pig 6.6 pEC50 = 6.6 Functional
Agonistic potency at beta-1 adrenergic receptor for the percent maximal increase in contraction rate of isolated guinea pig atriaAgonistic potency at beta-1 adrenergic receptor for the percent maximal increase in contraction rate of isolated guinea pig atria
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
139148732 7079 71 None -6 19 Guinea pig 6.6 pEC50 = 6.6 Functional
Agonistic potency at beta-1 adrenergic receptor for the percent maximal increase in contraction rate of isolated guinea pig atriaAgonistic potency at beta-1 adrenergic receptor for the percent maximal increase in contraction rate of isolated guinea pig atria
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
479 7079 71 None -6 19 Guinea pig 6.6 pEC50 = 6.6 Functional
Agonistic potency at beta-1 adrenergic receptor for the percent maximal increase in contraction rate of isolated guinea pig atriaAgonistic potency at beta-1 adrenergic receptor for the percent maximal increase in contraction rate of isolated guinea pig atria
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
5816 7079 71 None -6 19 Guinea pig 6.6 pEC50 = 6.6 Functional
Agonistic potency at beta-1 adrenergic receptor for the percent maximal increase in contraction rate of isolated guinea pig atriaAgonistic potency at beta-1 adrenergic receptor for the percent maximal increase in contraction rate of isolated guinea pig atria
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
CHEMBL679 7079 71 None -6 19 Guinea pig 6.6 pEC50 = 6.6 Functional
Agonistic potency at beta-1 adrenergic receptor for the percent maximal increase in contraction rate of isolated guinea pig atriaAgonistic potency at beta-1 adrenergic receptor for the percent maximal increase in contraction rate of isolated guinea pig atria
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
DB00668 7079 71 None -6 19 Guinea pig 6.6 pEC50 = 6.6 Functional
Agonistic potency at beta-1 adrenergic receptor for the percent maximal increase in contraction rate of isolated guinea pig atriaAgonistic potency at beta-1 adrenergic receptor for the percent maximal increase in contraction rate of isolated guinea pig atria
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
10119515 115166 0 None -7 2 Human 6.6 pEC50 = 6.6 Functional
In vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptorIn vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptor
ChEMBL 536 12 5 6 3.9 O=C(NCc1ccccc1F)N1CCC(Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)CC1 10.1016/s0960-894x(01)00645-x
CHEMBL319840 115166 0 None -7 2 Human 6.6 pEC50 = 6.6 Functional
In vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptorIn vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptor
ChEMBL 536 12 5 6 3.9 O=C(NCc1ccccc1F)N1CCC(Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)CC1 10.1016/s0960-894x(01)00645-x
11758172 107711 0 None -181 3 Human 5.6 pEC50 = 5.6 Functional
In vitro functional efficacy in stimulating increase in cAMP in chinese hamster ovary (CHO) cells expressing the cloned human beta-1 receptor.In vitro functional efficacy in stimulating increase in cAMP in chinese hamster ovary (CHO) cells expressing the cloned human beta-1 receptor.
ChEMBL 592 11 3 7 5.8 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc(F)c(F)c3)cs2)cc1 10.1021/jm000286i
CHEMBL293994 107711 0 None -181 3 Human 5.6 pEC50 = 5.6 Functional
In vitro functional efficacy in stimulating increase in cAMP in chinese hamster ovary (CHO) cells expressing the cloned human beta-1 receptor.In vitro functional efficacy in stimulating increase in cAMP in chinese hamster ovary (CHO) cells expressing the cloned human beta-1 receptor.
ChEMBL 592 11 3 7 5.8 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc(F)c(F)c3)cs2)cc1 10.1021/jm000286i
44336319 13135 0 None -524 2 Human 5.6 pEC50 = 5.6 Functional
In vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptorIn vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptor
ChEMBL 617 12 6 7 3.7 CS(=O)(=O)Nc1cc([C@@H](O)CNCCc2ccc(NC3CCN(C(=O)NCc4cc(F)ccc4F)CC3)cc2)ccc1O 10.1016/s0960-894x(01)00645-x
CHEMBL108214 13135 0 None -524 2 Human 5.6 pEC50 = 5.6 Functional
In vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptorIn vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptor
ChEMBL 617 12 6 7 3.7 CS(=O)(=O)Nc1cc([C@@H](O)CNCCc2ccc(NC3CCN(C(=O)NCc4cc(F)ccc4F)CC3)cc2)ccc1O 10.1016/s0960-894x(01)00645-x
46232973 207567 0 None -19 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 424 6 4 5 3.4 CC(C)(Cc1ccccc1C(F)(F)F)NCC(O)c1cc(O)cc2c1OCC(=O)N2 10.1016/j.bmcl.2009.12.087
CHEMBL600617 207567 0 None -19 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 424 6 4 5 3.4 CC(C)(Cc1ccccc1C(F)(F)F)NCC(O)c1cc(O)cc2c1OCC(=O)N2 10.1016/j.bmcl.2009.12.087
44392255 172740 0 None -5 2 Human 7.6 pEC50 = 7.6 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptor
ChEMBL 401 11 5 5 2.1 CC(C)NC(=O)Nc1ccc(C[C@@H](CO)NC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmcl.2004.11.001
CHEMBL425173 172740 0 None -5 2 Human 7.6 pEC50 = 7.6 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptor
ChEMBL 401 11 5 5 2.1 CC(C)NC(=O)Nc1ccc(C[C@@H](CO)NC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmcl.2004.11.001
44574827 185411 0 None -3 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 518 13 3 6 4.3 O=C(Cc1nccn1Cc1ccc(Cl)cc1)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.03.044
CHEMBL467502 185411 0 None -3 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 518 13 3 6 4.3 O=C(Cc1nccn1Cc1ccc(Cl)cc1)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.03.044
24950401 183804 0 None -147 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 481 8 3 6 4.5 CN(C)c1cc(Oc2ccc3c(c2)C[C@@H](NC[C@H](O)c2ccc(Cl)nc2)CC3)cc(C(=O)O)c1 10.1021/jm800222k
CHEMBL463181 183804 0 None -147 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 481 8 3 6 4.5 CN(C)c1cc(Oc2ccc3c(c2)C[C@@H](NC[C@H](O)c2ccc(Cl)nc2)CC3)cc(C(=O)O)c1 10.1021/jm800222k
44127171 185297 0 None 1 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 421 11 4 6 2.5 O=C(Cc1ccccn1)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/j.ejmech.2009.01.022
CHEMBL466705 185297 0 None 1 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 421 11 4 6 2.5 O=C(Cc1ccccn1)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/j.ejmech.2009.01.022
10722793 120124 0 None -407 3 Human 5.6 pEC50 = 5.6 Functional
In vitro functional efficacy in stimulating increase in cAMP in chinese hamster ovary (CHO) cells expressing the cloned human beta-1 receptor.In vitro functional efficacy in stimulating increase in cAMP in chinese hamster ovary (CHO) cells expressing the cloned human beta-1 receptor.
ChEMBL 640 12 3 8 6.4 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc(OC(F)(F)F)cc3)cs2)cc1 10.1021/jm000286i
CHEMBL331744 120124 0 None -407 3 Human 5.6 pEC50 = 5.6 Functional
In vitro functional efficacy in stimulating increase in cAMP in chinese hamster ovary (CHO) cells expressing the cloned human beta-1 receptor.In vitro functional efficacy in stimulating increase in cAMP in chinese hamster ovary (CHO) cells expressing the cloned human beta-1 receptor.
ChEMBL 640 12 3 8 6.4 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc(OC(F)(F)F)cc3)cs2)cc1 10.1021/jm000286i
9871800 63262 0 None -269 3 Human 5.6 pEC50 = 5.6 Functional
Agonistic activity as cAMP accumulation in CHO cells expressing human beta-1-adrenergic receptorAgonistic activity as cAMP accumulation in CHO cells expressing human beta-1-adrenergic receptor
ChEMBL 534 9 5 9 2.0 CS(=O)(=O)Nc1cc([C@@H](O)CNC2CCN(c3ccc(CC4SC(=O)NC4=O)cc3)CC2)ccc1O 10.1016/s0960-894x(01)00063-4
CHEMBL163262 63262 0 None -269 3 Human 5.6 pEC50 = 5.6 Functional
Agonistic activity as cAMP accumulation in CHO cells expressing human beta-1-adrenergic receptorAgonistic activity as cAMP accumulation in CHO cells expressing human beta-1-adrenergic receptor
ChEMBL 534 9 5 9 2.0 CS(=O)(=O)Nc1cc([C@@H](O)CNC2CCN(c3ccc(CC4SC(=O)NC4=O)cc3)CC2)ccc1O 10.1016/s0960-894x(01)00063-4
46232974 207588 8 None -27 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 386 7 4 6 2.4 COc1ccc(CC(C)(C)NC[C@@H](O)c2cc(O)cc3c2OCC(=O)N3)cc1 10.1016/j.bmcl.2009.12.087
CHEMBL600817 207588 8 None -27 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 386 7 4 6 2.4 COc1ccc(CC(C)(C)NC[C@@H](O)c2cc(O)cc3c2OCC(=O)N3)cc1 10.1016/j.bmcl.2009.12.087
46233013 208083 0 None -19 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 386 7 4 6 2.4 COc1cccc(CC(C)(C)NCC(O)c2cc(O)cc3c2OCC(=O)N3)c1 10.1016/j.bmcl.2009.12.087
CHEMBL604125 208083 0 None -19 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 386 7 4 6 2.4 COc1cccc(CC(C)(C)NCC(O)c2cc(O)cc3c2OCC(=O)N3)c1 10.1016/j.bmcl.2009.12.087
45484538 20869 0 None -2 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelAgonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP level
ChEMBL 556 13 6 7 1.9 CC(C)(Cc1ccc(NC(=O)CCCNC(=O)C[N+](C)(C)C)cc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2 10.1016/j.bmcl.2009.06.104
CHEMBL1197779 20869 0 None -2 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelAgonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP level
ChEMBL 556 13 6 7 1.9 CC(C)(Cc1ccc(NC(=O)CCCNC(=O)C[N+](C)(C)C)cc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2 10.1016/j.bmcl.2009.06.104
CHEMBL585382 20869 0 None -2 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelAgonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP level
ChEMBL 556 13 6 7 1.9 CC(C)(Cc1ccc(NC(=O)CCCNC(=O)C[N+](C)(C)C)cc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2 10.1016/j.bmcl.2009.06.104
44579651 193935 0 None -14 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 425 9 3 4 5.1 C[C@H](Cc1cccc(Oc2cccc(C(=O)O)c2)c1)NC[C@H](O)c1cccc(Cl)c1 10.1016/j.bmcl.2008.08.009
CHEMBL492006 193935 0 None -14 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 425 9 3 4 5.1 C[C@H](Cc1cccc(Oc2cccc(C(=O)O)c2)c1)NC[C@H](O)c1cccc(Cl)c1 10.1016/j.bmcl.2008.08.009
24894202 195804 0 None -676 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 473 10 3 4 6.0 C[C@H](Cc1ccc(-c2ccc(C(=O)O)c(OC3CCCCC3)c2)cc1)NC[C@H](O)c1ccccc1 10.1021/jm8000345
CHEMBL509156 195804 0 None -676 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 473 10 3 4 6.0 C[C@H](Cc1ccc(-c2ccc(C(=O)O)c(OC3CCCCC3)c2)cc1)NC[C@H](O)c1ccccc1 10.1021/jm8000345
44574688 185267 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 461 11 5 6 2.0 O=C(Cc1ccccn1)Nc1ccc(CCNC[C@H](O)COc2cccc3[nH]c(=O)[nH]c23)cc1 10.1016/j.bmc.2009.03.044
CHEMBL466519 185267 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 461 11 5 6 2.0 O=C(Cc1ccccn1)Nc1ccc(CCNC[C@H](O)COc2cccc3[nH]c(=O)[nH]c23)cc1 10.1016/j.bmc.2009.03.044
44574722 185331 0 None 1 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 433 11 3 5 3.5 Cc1cc(C)nc(CC(=O)Nc2ccc(CCNC[C@H](O)COc3ccccc3)cc2)c1 10.1016/j.bmc.2009.03.044
CHEMBL466925 185331 0 None 1 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 433 11 3 5 3.5 Cc1cc(C)nc(CC(=O)Nc2ccc(CCNC[C@H](O)COc3ccccc3)cc2)c1 10.1016/j.bmc.2009.03.044
44219630 185354 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 498 13 2 6 3.7 CN(C(=O)Cc1nccn1Cc1ccccc1)c1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.03.044
CHEMBL467116 185354 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 498 13 2 6 3.7 CN(C(=O)Cc1nccn1Cc1ccccc1)c1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.03.044
24822310 104517 0 None -41 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 395 8 3 3 4.6 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)cc1 10.1021/jm701324c
CHEMBL271576 104517 0 None -41 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 395 8 3 3 4.6 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)cc1 10.1021/jm701324c
24822310 104517 0 None -41 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 395 8 3 3 4.6 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)cc1 10.1016/j.bmcl.2008.08.009
CHEMBL271576 104517 0 None -41 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 395 8 3 3 4.6 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)cc1 10.1016/j.bmcl.2008.08.009
44127054 202065 0 None 6 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 450 12 4 6 3.2 COc1ccc(CC(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/j.ejmech.2009.01.022
CHEMBL551350 202065 0 None 6 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 450 12 4 6 3.2 COc1ccc(CC(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/j.ejmech.2009.01.022
24822310 104517 0 None -41 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 395 8 3 3 4.6 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)cc1 10.1021/jm800222k
CHEMBL271576 104517 0 None -41 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 395 8 3 3 4.6 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)cc1 10.1021/jm800222k
24895365 180371 0 None -309 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 447 10 3 4 5.5 CC(C)Oc1cc(-c2ccc(CC(C)(C)NC[C@H](O)c3ccccc3)cc2)ccc1C(=O)O 10.1021/jm8000345
CHEMBL453323 180371 0 None -309 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 447 10 3 4 5.5 CC(C)Oc1cc(-c2ccc(CC(C)(C)NC[C@H](O)c3ccccc3)cc2)ccc1C(=O)O 10.1021/jm8000345
10298968 64280 0 None -239 2 Human 5.5 pEC50 = 5.5 Functional
Agonistic activity as cAMP accumulation in CHO cells expressing human beta-1-adrenergic receptorAgonistic activity as cAMP accumulation in CHO cells expressing human beta-1-adrenergic receptor
ChEMBL 471 9 4 8 2.3 O=C1NC(=O)C(Cc2ccc(N3CCC(NC[C@H](O)COc4ccc(O)cc4)CC3)cc2)S1 10.1016/s0960-894x(01)00063-4
CHEMBL166085 64280 0 None -239 2 Human 5.5 pEC50 = 5.5 Functional
Agonistic activity as cAMP accumulation in CHO cells expressing human beta-1-adrenergic receptorAgonistic activity as cAMP accumulation in CHO cells expressing human beta-1-adrenergic receptor
ChEMBL 471 9 4 8 2.3 O=C1NC(=O)C(Cc2ccc(N3CCC(NC[C@H](O)COc4ccc(O)cc4)CC3)cc2)S1 10.1016/s0960-894x(01)00063-4
44396596 130078 0 None -25 3 Human 7.5 pEC50 = 7.5 Functional
Agonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptorAgonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptor
ChEMBL 485 10 4 6 4.3 COc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)c[nH]c12 10.1016/j.bmcl.2004.10.035
CHEMBL361505 130078 0 None -25 3 Human 7.5 pEC50 = 7.5 Functional
Agonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptorAgonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptor
ChEMBL 485 10 4 6 4.3 COc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)c[nH]c12 10.1016/j.bmcl.2004.10.035
44396521 130458 0 None -6 2 Human 7.5 pEC50 = 7.5 Functional
Agonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptorAgonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptor
ChEMBL 514 12 5 7 3.6 C[C@H](Cc1c[nH]c2c(OCCN)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1016/j.bmcl.2004.10.035
CHEMBL362136 130458 0 None -6 2 Human 7.5 pEC50 = 7.5 Functional
Agonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptorAgonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptor
ChEMBL 514 12 5 7 3.6 C[C@H](Cc1c[nH]c2c(OCCN)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1016/j.bmcl.2004.10.035
44127171 185297 0 None 1 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 421 11 4 6 2.5 O=C(Cc1ccccn1)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/j.bmc.2009.03.044
CHEMBL466705 185297 0 None 1 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 421 11 4 6 2.5 O=C(Cc1ccccn1)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/j.bmc.2009.03.044
1028 7079 71 None -10 19 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human beta1 adrenergic receptor expressed in CHOK1 cells co-expressing Galpha15 assessed as increase in calcium influx by measuring fluorescence intensity by FLIPR assayAgonist activity at human beta1 adrenergic receptor expressed in CHOK1 cells co-expressing Galpha15 assessed as increase in calcium influx by measuring fluorescence intensity by FLIPR assay
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/acs.jnatprod.9b00418
139148732 7079 71 None -10 19 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human beta1 adrenergic receptor expressed in CHOK1 cells co-expressing Galpha15 assessed as increase in calcium influx by measuring fluorescence intensity by FLIPR assayAgonist activity at human beta1 adrenergic receptor expressed in CHOK1 cells co-expressing Galpha15 assessed as increase in calcium influx by measuring fluorescence intensity by FLIPR assay
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/acs.jnatprod.9b00418
479 7079 71 None -10 19 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human beta1 adrenergic receptor expressed in CHOK1 cells co-expressing Galpha15 assessed as increase in calcium influx by measuring fluorescence intensity by FLIPR assayAgonist activity at human beta1 adrenergic receptor expressed in CHOK1 cells co-expressing Galpha15 assessed as increase in calcium influx by measuring fluorescence intensity by FLIPR assay
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/acs.jnatprod.9b00418
5816 7079 71 None -10 19 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human beta1 adrenergic receptor expressed in CHOK1 cells co-expressing Galpha15 assessed as increase in calcium influx by measuring fluorescence intensity by FLIPR assayAgonist activity at human beta1 adrenergic receptor expressed in CHOK1 cells co-expressing Galpha15 assessed as increase in calcium influx by measuring fluorescence intensity by FLIPR assay
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/acs.jnatprod.9b00418
CHEMBL679 7079 71 None -10 19 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human beta1 adrenergic receptor expressed in CHOK1 cells co-expressing Galpha15 assessed as increase in calcium influx by measuring fluorescence intensity by FLIPR assayAgonist activity at human beta1 adrenergic receptor expressed in CHOK1 cells co-expressing Galpha15 assessed as increase in calcium influx by measuring fluorescence intensity by FLIPR assay
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/acs.jnatprod.9b00418
DB00668 7079 71 None -10 19 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human beta1 adrenergic receptor expressed in CHOK1 cells co-expressing Galpha15 assessed as increase in calcium influx by measuring fluorescence intensity by FLIPR assayAgonist activity at human beta1 adrenergic receptor expressed in CHOK1 cells co-expressing Galpha15 assessed as increase in calcium influx by measuring fluorescence intensity by FLIPR assay
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/acs.jnatprod.9b00418
45101537 202053 0 None -1819 3 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as stimulation of cAMP level after 1 hr by enzyme immunoassayAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as stimulation of cAMP level after 1 hr by enzyme immunoassay
ChEMBL 526 11 4 7 3.8 CC(C)Oc1cc(-c2ccc(CCN[C@@H](C)[C@H](O)c3ccc(O)cc3)cc2)ccc1C(=O)NS(C)(=O)=O 10.1016/j.bmcl.2009.06.083
CHEMBL551272 202053 0 None -1819 3 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as stimulation of cAMP level after 1 hr by enzyme immunoassayAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as stimulation of cAMP level after 1 hr by enzyme immunoassay
ChEMBL 526 11 4 7 3.8 CC(C)Oc1cc(-c2ccc(CCN[C@@H](C)[C@H](O)c3ccc(O)cc3)cc2)ccc1C(=O)NS(C)(=O)=O 10.1016/j.bmcl.2009.06.083
45483830 203774 0 None -14 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 329 7 4 4 2.8 Cc1ccccc1CC(C)(C)NCC(O)c1ccc(O)c(CO)c1 10.1016/j.bmcl.2009.10.013
CHEMBL566777 203774 0 None -14 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 329 7 4 4 2.8 Cc1ccccc1CC(C)(C)NCC(O)c1ccc(O)c(CO)c1 10.1016/j.bmcl.2009.10.013
44237720 65012 0 None -91 2 Rat 6.5 pEC50 = 6.5 Functional
Agonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effectAgonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effect
ChEMBL 530 9 6 5 4.4 O=C(NCC12CC3CC(CC(C3)C1)C2)Nc1cccc(CCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1 10.1016/j.bmcl.2010.12.096
CHEMBL1682220 65012 0 None -91 2 Rat 6.5 pEC50 = 6.5 Functional
Agonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effectAgonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effect
ChEMBL 530 9 6 5 4.4 O=C(NCC12CC3CC(CC(C3)C1)C2)Nc1cccc(CCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1 10.1016/j.bmcl.2010.12.096
145983355 172580 0 None -26 3 Human 6.5 pEC50 = 6.5 Functional
Antagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assayAntagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assay
ChEMBL 454 12 3 5 3.6 CCc1ccccc1OC[C@@H](O)CNCCc1ccc(NS(=O)(=O)c2ccccc2)cc1 10.1016/j.ejmech.2018.03.032
CHEMBL4248093 172580 0 None -26 3 Human 6.5 pEC50 = 6.5 Functional
Antagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assayAntagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assay
ChEMBL 454 12 3 5 3.6 CCc1ccccc1OC[C@@H](O)CNCCc1ccc(NS(=O)(=O)c2ccccc2)cc1 10.1016/j.ejmech.2018.03.032
44268273 103855 0 None 1 3 Human 8.5 pEC50 = 8.5 Functional
Agonist activity against cloned human beta-1 adrenergic receptor as percent activation of adenyl cyclase activity at a concentration of 1000 nMAgonist activity against cloned human beta-1 adrenergic receptor as percent activation of adenyl cyclase activity at a concentration of 1000 nM
ChEMBL 476 11 4 6 3.4 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1ccccc1Cl 10.1016/s0960-894x(98)00169-3
CHEMBL267306 103855 0 None 1 3 Human 8.5 pEC50 = 8.5 Functional
Agonist activity against cloned human beta-1 adrenergic receptor as percent activation of adenyl cyclase activity at a concentration of 1000 nMAgonist activity against cloned human beta-1 adrenergic receptor as percent activation of adenyl cyclase activity at a concentration of 1000 nM
ChEMBL 476 11 4 6 3.4 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1ccccc1Cl 10.1016/s0960-894x(98)00169-3
44392190 72357 0 None 4 2 Human 8.5 pEC50 = 8.5 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptor
ChEMBL 421 10 5 5 3.2 O=C(Nc1ccccc1)Nc1ccc(C[C@H](O)NC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmcl.2004.11.001
CHEMBL183211 72357 0 None 4 2 Human 8.5 pEC50 = 8.5 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptor
ChEMBL 421 10 5 5 3.2 O=C(Nc1ccccc1)Nc1ccc(C[C@H](O)NC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmcl.2004.11.001
9896742 211723 0 None -13 3 Human 8.5 pEC50 = 8.5 Functional
Compound was evaluated for its inhibitory activity against human beta-1 adrenergic receptor (AR) at a concentration of 10000 nmCompound was evaluated for its inhibitory activity against human beta-1 adrenergic receptor (AR) at a concentration of 10000 nm
ChEMBL 618 12 6 7 6.0 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc3cc(OCC4NCCc5cc(O)c(O)cc54)ccc3c2)cc1 10.1016/s0960-894x(00)00459-5
CHEMBL76403 211723 0 None -13 3 Human 8.5 pEC50 = 8.5 Functional
Compound was evaluated for its inhibitory activity against human beta-1 adrenergic receptor (AR) at a concentration of 10000 nmCompound was evaluated for its inhibitory activity against human beta-1 adrenergic receptor (AR) at a concentration of 10000 nm
ChEMBL 618 12 6 7 6.0 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc3cc(OCC4NCCc5cc(O)c(O)cc54)ccc3c2)cc1 10.1016/s0960-894x(00)00459-5
66653268 95026 0 None 3311 3 Human 8.5 pEC50 = 8.5 Functional
Partial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrsPartial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrs
ChEMBL 491 14 4 6 3.8 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1cccc(Cl)c1 10.1021/jm400348g
CHEMBL2348201 95026 0 None 3311 3 Human 8.5 pEC50 = 8.5 Functional
Partial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrsPartial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrs
ChEMBL 491 14 4 6 3.8 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1cccc(Cl)c1 10.1021/jm400348g
164622954 195345 0 None -245 2 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 400 7 4 4 3.9 CC(C)(CCc1ccc(Cl)cc1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
CHEMBL4871708 195345 0 None -245 2 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 400 7 4 4 3.9 CC(C)(CCc1ccc(Cl)cc1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
CHEMBL5028726 195345 0 None -245 2 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 400 7 4 4 3.9 CC(C)(CCc1ccc(Cl)cc1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
164624634 195364 0 None -131 2 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 370 7 4 4 3.0 CC(CCc1cccc(F)c1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
CHEMBL4868684 195364 0 None -131 2 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 370 7 4 4 3.0 CC(CCc1cccc(F)c1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
CHEMBL5028836 195364 0 None -131 2 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 370 7 4 4 3.0 CC(CCc1cccc(F)c1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
24822971 102223 0 None 3 2 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 429 8 3 3 5.2 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2Cl)cc1 10.1021/jm701324c
CHEMBL257106 102223 0 None 3 2 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 429 8 3 3 5.2 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2Cl)cc1 10.1021/jm701324c
11134054 53757 0 None -2 3 Human 8.5 pEC50 = 8.5 Functional
Ability to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentrationAbility to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentration
ChEMBL 444 10 4 6 4.1 C[C@H](CNc1ccc(CC(=O)Nc2nccs2)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm0101500
CHEMBL154150 53757 0 None -2 3 Human 8.5 pEC50 = 8.5 Functional
Ability to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentrationAbility to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentration
ChEMBL 444 10 4 6 4.1 C[C@H](CNc1ccc(CC(=O)Nc2nccs2)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm0101500
1499 8872 47 None -58 38 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmc.2018.10.043
1499 8872 47 None -58 38 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.ejmech.2018.04.041
3779 8872 47 None -58 38 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmc.2018.10.043
3779 8872 47 None -58 38 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.ejmech.2018.04.041
536 8872 47 None -58 38 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmc.2018.10.043
536 8872 47 None -58 38 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.ejmech.2018.04.041
CHEMBL434 8872 47 None -58 38 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmc.2018.10.043
CHEMBL434 8872 47 None -58 38 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.ejmech.2018.04.041
DB01064 8872 47 None -58 38 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmc.2018.10.043
DB01064 8872 47 None -58 38 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.ejmech.2018.04.041
45484583 205271 0 None -3 2 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelAgonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP level
ChEMBL 456 10 6 7 2.0 CC(C)(Cc1ccc(NC(=O)CCCN)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1016/j.bmcl.2009.06.104
CHEMBL577702 205271 0 None -3 2 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelAgonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP level
ChEMBL 456 10 6 7 2.0 CC(C)(Cc1ccc(NC(=O)CCCN)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1016/j.bmcl.2009.06.104
45484585 20870 0 None -3 2 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelAgonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP level
ChEMBL 556 13 6 7 1.9 CC(C)(Cc1ccc(NC(=O)CCCNC(=O)C[N+](C)(C)C)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1016/j.bmcl.2009.06.104
CHEMBL1197807 20870 0 None -3 2 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelAgonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP level
ChEMBL 556 13 6 7 1.9 CC(C)(Cc1ccc(NC(=O)CCCNC(=O)C[N+](C)(C)C)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1016/j.bmcl.2009.06.104
CHEMBL587197 20870 0 None -3 2 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelAgonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP level
ChEMBL 556 13 6 7 1.9 CC(C)(Cc1ccc(NC(=O)CCCNC(=O)C[N+](C)(C)C)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1016/j.bmcl.2009.06.104
24936626 24181 0 None -173 3 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assayAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assay
ChEMBL 506 9 4 9 3.6 OCc1cc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)ccc1O 10.1016/j.bmcl.2010.08.039
CHEMBL1257555 24181 0 None -173 3 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assayAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assay
ChEMBL 506 9 4 9 3.6 OCc1cc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)ccc1O 10.1016/j.bmcl.2010.08.039
45483814 204051 0 None -5 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 440 7 4 6 3.3 CC(C)(Cc1ccc(OC(F)(F)F)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1016/j.bmcl.2009.10.013
CHEMBL568531 204051 0 None -5 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 440 7 4 6 3.3 CC(C)(Cc1ccc(OC(F)(F)F)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1016/j.bmcl.2009.10.013
44392212 175148 0 None 12 2 Human 8.4 pEC50 = 8.4 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptor
ChEMBL 405 10 4 4 3.9 O=C(Nc1ccccc1)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmcl.2004.11.001
CHEMBL1204383 175148 0 None 12 2 Human 8.4 pEC50 = 8.4 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptor
ChEMBL 405 10 4 4 3.9 O=C(Nc1ccccc1)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmcl.2004.11.001
CHEMBL434524 175148 0 None 12 2 Human 8.4 pEC50 = 8.4 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptor
ChEMBL 405 10 4 4 3.9 O=C(Nc1ccccc1)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmcl.2004.11.001
56597179 95044 0 None 2754 3 Human 8.4 pEC50 = 8.4 Functional
Partial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrsPartial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrs
ChEMBL 473 14 5 7 2.9 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccc(O)cc1 10.1021/jm400348g
CHEMBL2348219 95044 0 None 2754 3 Human 8.4 pEC50 = 8.4 Functional
Partial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrsPartial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrs
ChEMBL 473 14 5 7 2.9 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccc(O)cc1 10.1021/jm400348g
45483868 204001 0 None -6 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 424 6 4 5 3.4 CC(C)(Cc1cccc(C(F)(F)F)c1)NCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1016/j.bmcl.2009.10.013
CHEMBL568273 204001 0 None -6 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 424 6 4 5 3.4 CC(C)(Cc1cccc(C(F)(F)F)c1)NCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1016/j.bmcl.2009.10.013
45483864 205688 0 None -9 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 424 6 4 5 3.4 CC(C)(Cc1ccc(C(F)(F)F)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1016/j.bmcl.2009.10.013
CHEMBL584498 205688 0 None -9 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 424 6 4 5 3.4 CC(C)(Cc1ccc(C(F)(F)F)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1016/j.bmcl.2009.10.013
24823624 165940 0 None 1 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 410 9 4 4 4.6 O=C(O)c1ccc(Nc2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)cc1 10.1021/jm701324c
CHEMBL409827 165940 0 None 1 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 410 9 4 4 4.6 O=C(O)c1ccc(Nc2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)cc1 10.1021/jm701324c
16049028 70859 0 None -50 3 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at adrenergic beta1 receptorAgonist activity at adrenergic beta1 receptor
ChEMBL 462 14 4 7 3.7 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCSCCCOCCc3ccccc3)c2s1 10.1016/j.bmcl.2011.05.097
CHEMBL1807819 70859 0 None -50 3 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at adrenergic beta1 receptorAgonist activity at adrenergic beta1 receptor
ChEMBL 462 14 4 7 3.7 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCSCCCOCCc3ccccc3)c2s1 10.1016/j.bmcl.2011.05.097
11592062 119234 0 None -25 3 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 550 11 6 7 5.0 COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1-c1cccc(CN)c1 10.1016/j.bmcl.2014.04.095
CHEMBL3298325 119234 0 None -25 3 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 550 11 6 7 5.0 COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1-c1cccc(CN)c1 10.1016/j.bmcl.2014.04.095
24822645 102268 0 None -15 2 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 429 8 3 3 5.2 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)c(Cl)c1 10.1021/jm701324c
CHEMBL257297 102268 0 None -15 2 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 429 8 3 3 5.2 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)c(Cl)c1 10.1021/jm701324c
45269866 202073 0 None 1 3 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 455 10 4 4 4.7 O[C@@H](CNCCc1ccc(NC(=S)Nc2ccc(Cl)cc2)cc1)COc1ccccc1 10.1016/j.bmc.2009.06.031
CHEMBL2448072 202073 0 None 1 3 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 455 10 4 4 4.7 O[C@@H](CNCCc1ccc(NC(=S)Nc2ccc(Cl)cc2)cc1)COc1ccccc1 10.1016/j.bmc.2009.06.031
CHEMBL551389 202073 0 None 1 3 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 455 10 4 4 4.7 O[C@@H](CNCCc1ccc(NC(=S)Nc2ccc(Cl)cc2)cc1)COc1ccccc1 10.1016/j.bmc.2009.06.031
45269025 202926 0 None -3 3 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 500 11 5 6 2.7 NS(=O)(=O)c1ccc(NC(=S)Nc2ccc(CCNC[C@H](O)COc3ccccc3)cc2)cc1 10.1016/j.bmc.2009.06.031
CHEMBL1203991 202926 0 None -3 3 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 500 11 5 6 2.7 NS(=O)(=O)c1ccc(NC(=S)Nc2ccc(CCNC[C@H](O)COc3ccccc3)cc2)cc1 10.1016/j.bmc.2009.06.031
CHEMBL561173 202926 0 None -3 3 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 500 11 5 6 2.7 NS(=O)(=O)c1ccc(NC(=S)Nc2ccc(CCNC[C@H](O)COc3ccccc3)cc2)cc1 10.1016/j.bmc.2009.06.031
45267257 203461 0 None -3 3 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 449 12 4 4 3.8 O[C@@H](CNCCc1ccc(NC(=S)NCCc2ccccc2)cc1)COc1ccccc1 10.1016/j.bmc.2009.06.031
CHEMBL1203987 203461 0 None -3 3 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 449 12 4 4 3.8 O[C@@H](CNCCc1ccc(NC(=S)NCCc2ccccc2)cc1)COc1ccccc1 10.1016/j.bmc.2009.06.031
CHEMBL564648 203461 0 None -3 3 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 449 12 4 4 3.8 O[C@@H](CNCCc1ccc(NC(=S)NCCc2ccccc2)cc1)COc1ccccc1 10.1016/j.bmc.2009.06.031
10283146 114050 0 None -2 3 Human 7.5 pEC50 = 7.5 Functional
Beta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptorBeta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptor
ChEMBL 656 12 5 9 3.1 CS(=O)(=O)Nc1cc([C@@H](O)CNCC2CCN(S(=O)(=O)c3ccc(-n4cc(CC(=O)O)c5ccccc54)cc3)CC2)ccc1O 10.1016/s0960-894x(02)00608-x
CHEMBL317003 114050 0 None -2 3 Human 7.5 pEC50 = 7.5 Functional
Beta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptorBeta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptor
ChEMBL 656 12 5 9 3.1 CS(=O)(=O)Nc1cc([C@@H](O)CNCC2CCN(S(=O)(=O)c3ccc(-n4cc(CC(=O)O)c5ccccc54)cc3)CC2)ccc1O 10.1016/s0960-894x(02)00608-x
1960 9632 67 None -38 19 Guinea pig 7.5 pEC50 = 7.5 Functional
Effective concentration for Beta-1 adrenergic receptor mediated inhibition of neurotransmission in field-stimulated reserpine pretreated guinea pig ileum.Effective concentration for Beta-1 adrenergic receptor mediated inhibition of neurotransmission in field-stimulated reserpine pretreated guinea pig ileum.
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00019a001
439260 9632 67 None -38 19 Guinea pig 7.5 pEC50 = 7.5 Functional
Effective concentration for Beta-1 adrenergic receptor mediated inhibition of neurotransmission in field-stimulated reserpine pretreated guinea pig ileum.Effective concentration for Beta-1 adrenergic receptor mediated inhibition of neurotransmission in field-stimulated reserpine pretreated guinea pig ileum.
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00019a001
505 9632 67 None -38 19 Guinea pig 7.5 pEC50 = 7.5 Functional
Effective concentration for Beta-1 adrenergic receptor mediated inhibition of neurotransmission in field-stimulated reserpine pretreated guinea pig ileum.Effective concentration for Beta-1 adrenergic receptor mediated inhibition of neurotransmission in field-stimulated reserpine pretreated guinea pig ileum.
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00019a001
CHEMBL1437 9632 67 None -38 19 Guinea pig 7.5 pEC50 = 7.5 Functional
Effective concentration for Beta-1 adrenergic receptor mediated inhibition of neurotransmission in field-stimulated reserpine pretreated guinea pig ileum.Effective concentration for Beta-1 adrenergic receptor mediated inhibition of neurotransmission in field-stimulated reserpine pretreated guinea pig ileum.
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00019a001
DB00368 9632 67 None -38 19 Guinea pig 7.5 pEC50 = 7.5 Functional
Effective concentration for Beta-1 adrenergic receptor mediated inhibition of neurotransmission in field-stimulated reserpine pretreated guinea pig ileum.Effective concentration for Beta-1 adrenergic receptor mediated inhibition of neurotransmission in field-stimulated reserpine pretreated guinea pig ileum.
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00019a001
164623583 195355 0 None -316 2 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 352 7 4 4 2.8 Cc1ccc(CCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)cc1 10.1016/j.ejmech.2021.113697
CHEMBL4873280 195355 0 None -316 2 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 352 7 4 4 2.8 Cc1ccc(CCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)cc1 10.1016/j.ejmech.2021.113697
CHEMBL5028767 195355 0 None -316 2 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 352 7 4 4 2.8 Cc1ccc(CCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)cc1 10.1016/j.ejmech.2021.113697
24822970 164899 0 None -9 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 409 9 3 3 4.5 O=C(O)Cc1ccc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)cc1 10.1021/jm701324c
CHEMBL408694 164899 0 None -9 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 409 9 3 3 4.5 O=C(O)Cc1ccc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)cc1 10.1021/jm701324c
11224220 179746 0 None -2137 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 431 10 3 3 5.5 CC(C)Cc1cc(-c2ccc(CCN[C@@H](C)[C@H](O)c3ccccc3)cc2)ccc1C(=O)O 10.1021/jm8000345
CHEMBL451760 179746 0 None -2137 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 431 10 3 3 5.5 CC(C)Cc1cc(-c2ccc(CCN[C@@H](C)[C@H](O)c3ccccc3)cc2)ccc1C(=O)O 10.1021/jm8000345
172745 106899 7 None 234 2 Guinea pig 6.5 pEC50 = 6.5 Functional
Beta-1 adrenergic receptor agonist activity by stimulation of contraction rate of isolated guinea pig atrial preparationsBeta-1 adrenergic receptor agonist activity by stimulation of contraction rate of isolated guinea pig atrial preparations
ChEMBL 187 2 4 4 0.2 NCC(O)c1ccc(O)c(O)c1F 10.1021/jm00118a019
CHEMBL287587 106899 7 None 234 2 Guinea pig 6.5 pEC50 = 6.5 Functional
Beta-1 adrenergic receptor agonist activity by stimulation of contraction rate of isolated guinea pig atrial preparationsBeta-1 adrenergic receptor agonist activity by stimulation of contraction rate of isolated guinea pig atrial preparations
ChEMBL 187 2 4 4 0.2 NCC(O)c1ccc(O)c(O)c1F 10.1021/jm00118a019
44268268 25423 1 None -301 3 Human 6.5 pEC50 = 6.5 Functional
Compound was tested for agonist activity against cloned human beta-1 adrenergic receptorCompound was tested for agonist activity against cloned human beta-1 adrenergic receptor
ChEMBL 493 11 4 7 3.3 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1cnc2ccccc2c1 10.1016/s0960-894x(98)00169-3
CHEMBL12769 25423 1 None -301 3 Human 6.5 pEC50 = 6.5 Functional
Compound was tested for agonist activity against cloned human beta-1 adrenergic receptorCompound was tested for agonist activity against cloned human beta-1 adrenergic receptor
ChEMBL 493 11 4 7 3.3 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1cnc2ccccc2c1 10.1016/s0960-894x(98)00169-3
16049377 70872 0 None -112 3 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at adrenergic beta1 receptorAgonist activity at adrenergic beta1 receptor
ChEMBL 465 13 5 7 2.8 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCOCCCNCCc3cccc(Cl)c3)c2s1 10.1016/j.bmcl.2011.05.097
CHEMBL1807832 70872 0 None -112 3 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at adrenergic beta1 receptorAgonist activity at adrenergic beta1 receptor
ChEMBL 465 13 5 7 2.8 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCOCCCNCCc3cccc(Cl)c3)c2s1 10.1016/j.bmcl.2011.05.097
56665368 73233 0 None -31 4 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 501 18 6 6 4.2 CCNC(=O)Nc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1016/j.bmc.2011.08.043
CHEMBL1835854 73233 0 None -31 4 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 501 18 6 6 4.2 CCNC(=O)Nc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1016/j.bmc.2011.08.043
CHEMBL1852119 73233 0 None -31 4 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 501 18 6 6 4.2 CCNC(=O)Nc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1016/j.bmc.2011.08.043
56672271 73315 0 None -125 4 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 530 19 7 7 2.7 NC(=O)CNC(=O)Nc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1016/j.bmc.2011.08.043
CHEMBL1835859 73315 0 None -125 4 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 530 19 7 7 2.7 NC(=O)CNC(=O)Nc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1016/j.bmc.2011.08.043
CHEMBL1852407 73315 0 None -125 4 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 530 19 7 7 2.7 NC(=O)CNC(=O)Nc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1016/j.bmc.2011.08.043
56672269 73361 0 None -50 3 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 515 19 6 6 3.9 CCNC(=O)NCc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1016/j.bmc.2011.08.043
CHEMBL1835858 73361 0 None -50 3 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 515 19 6 6 3.9 CCNC(=O)NCc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1016/j.bmc.2011.08.043
CHEMBL1852564 73361 0 None -50 3 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 515 19 6 6 3.9 CCNC(=O)NCc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1016/j.bmc.2011.08.043
56658405 73362 0 None -63 3 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 501 18 6 6 4.2 CCNC(=O)Nc1ccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc1 10.1016/j.bmc.2011.08.043
CHEMBL1835856 73362 0 None -63 3 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 501 18 6 6 4.2 CCNC(=O)Nc1ccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc1 10.1016/j.bmc.2011.08.043
CHEMBL1852565 73362 0 None -63 3 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 501 18 6 6 4.2 CCNC(=O)Nc1ccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc1 10.1016/j.bmc.2011.08.043
46832505 21007 1 None -12 3 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 417 16 4 6 3.3 OCc1cc([C@@H](O)CNCCCCCCOCCOCc2ccccc2)ccc1O 10.1021/jm100326d
CHEMBL1085395 21007 1 None -12 3 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 417 16 4 6 3.3 OCc1cc([C@@H](O)CNCCCCCCOCCOCc2ccccc2)ccc1O 10.1021/jm100326d
CHEMBL1199261 21007 1 None -12 3 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 417 16 4 6 3.3 OCc1cc([C@@H](O)CNCCCCCCOCCOCc2ccccc2)ccc1O 10.1021/jm100326d
46889854 14080 0 None -9 3 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human adrenergic beta-1 receptor expressed in CHOK1 cells assessed as cAMP accumulation by HTRF assayAgonist activity at human adrenergic beta-1 receptor expressed in CHOK1 cells assessed as cAMP accumulation by HTRF assay
ChEMBL 446 7 2 4 4.8 O=C(c1ccc(F)cc1)C1CCN(CC(O)COc2cccc3[nH]c4ccccc4c23)CC1 10.1016/j.bmcl.2010.04.009
CHEMBL1086077 14080 0 None -9 3 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human adrenergic beta-1 receptor expressed in CHOK1 cells assessed as cAMP accumulation by HTRF assayAgonist activity at human adrenergic beta-1 receptor expressed in CHOK1 cells assessed as cAMP accumulation by HTRF assay
ChEMBL 446 7 2 4 4.8 O=C(c1ccc(F)cc1)C1CCN(CC(O)COc2cccc3[nH]c4ccccc4c23)CC1 10.1016/j.bmcl.2010.04.009
24949728 182019 0 None -436 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 479 8 3 4 5.7 CC(C)Oc1cc(-c2ccc3c(c2)C[C@@H](NC[C@H](O)c2ccc(Cl)cc2)CC3)ccc1C(=O)O 10.1021/jm800222k
CHEMBL457199 182019 0 None -436 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 479 8 3 4 5.7 CC(C)Oc1cc(-c2ccc3c(c2)C[C@@H](NC[C@H](O)c2ccc(Cl)cc2)CC3)ccc1C(=O)O 10.1021/jm800222k
44127679 202241 0 None -37 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 422 11 4 7 1.9 O=C(Cc1cnccn1)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/j.ejmech.2009.01.022
CHEMBL552497 202241 0 None -37 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 422 11 4 7 1.9 O=C(Cc1cnccn1)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/j.ejmech.2009.01.022
9891927 190976 9 None -1995 4 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 494 17 5 7 2.8 NS(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm801016j
CHEMBL446840 190976 9 None -1995 4 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 494 17 5 7 2.8 NS(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm801016j
CHEMBL483200 190976 9 None -1995 4 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 494 17 5 7 2.8 NS(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm801016j
CHEMBL483201 190976 9 None -1995 4 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 494 17 5 7 2.8 NS(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm801016j
9891927 190976 9 None -1995 4 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 494 17 5 7 2.8 NS(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm100326d
CHEMBL446840 190976 9 None -1995 4 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 494 17 5 7 2.8 NS(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm100326d
CHEMBL483200 190976 9 None -1995 4 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 494 17 5 7 2.8 NS(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm100326d
CHEMBL483201 190976 9 None -1995 4 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 494 17 5 7 2.8 NS(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm100326d
44331302 215107 0 None -630 3 Human 5.5 pEC50 = 5.5 Functional
Beta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptorBeta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptor
ChEMBL 667 12 6 8 3.1 CS(=O)(=O)Nc1cc([C@@H](O)CNCC2CCN(S(=O)(=O)c3ccc(NC(=O)NCc4cc(F)ccc4F)cc3)CC2)ccc1O 10.1016/s0960-894x(02)00608-x
CHEMBL99219 215107 0 None -630 3 Human 5.5 pEC50 = 5.5 Functional
Beta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptorBeta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptor
ChEMBL 667 12 6 8 3.1 CS(=O)(=O)Nc1cc([C@@H](O)CNCC2CCN(S(=O)(=O)c3ccc(NC(=O)NCc4cc(F)ccc4F)cc3)CC2)ccc1O 10.1016/s0960-894x(02)00608-x
11661536 82751 0 None -50 3 Human 5.5 pEC50 = 5.5 Functional
Activity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP productionActivity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP production
ChEMBL 411 9 4 5 3.8 O=C(O)c1cncc(-c2cccc(NCCNC[C@H](O)c3cccc(Cl)c3)c2)c1 10.1021/jm0509445
CHEMBL205389 82751 0 None -50 3 Human 5.5 pEC50 = 5.5 Functional
Activity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP productionActivity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP production
ChEMBL 411 9 4 5 3.8 O=C(O)c1cncc(-c2cccc(NCCNC[C@H](O)c3cccc(Cl)c3)c2)c1 10.1021/jm0509445
145987415 174027 0 None -1258 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 358 6 4 4 2.8 O=c1ccc2c(C(CO)NCCc3cccc(Cl)c3)ccc(O)c2[nH]1 10.1016/j.ejmech.2018.04.041
CHEMBL4292648 174027 0 None -1258 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 358 6 4 4 2.8 O=c1ccc2c(C(CO)NCCc3cccc(Cl)c3)ccc(O)c2[nH]1 10.1016/j.ejmech.2018.04.041
24895192 196643 0 None -151 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 437 10 3 4 4.8 CC(C)Oc1cc(-c2ccc(CCNC[C@H](O)c3cccc(F)c3)cc2)ccc1C(=O)O 10.1021/jm8000345
CHEMBL516804 196643 0 None -151 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 437 10 3 4 4.8 CC(C)Oc1cc(-c2ccc(CCNC[C@H](O)c3cccc(F)c3)cc2)ccc1C(=O)O 10.1021/jm8000345
42639969 19344 0 None -1584 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 496 11 4 7 3.1 CC(C)Nc1cc(-c2ccc(CCNC[C@H](O)c3cccnc3)cc2)ccc1C(=O)NS(C)(=O)=O 10.1021/jm9000709
CHEMBL1186809 19344 0 None -1584 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 496 11 4 7 3.1 CC(C)Nc1cc(-c2ccc(CCNC[C@H](O)c3cccnc3)cc2)ccc1C(=O)NS(C)(=O)=O 10.1021/jm9000709
CHEMBL479530 19344 0 None -1584 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 496 11 4 7 3.1 CC(C)Nc1cc(-c2ccc(CCNC[C@H](O)c3cccnc3)cc2)ccc1C(=O)NS(C)(=O)=O 10.1021/jm9000709
16118894 9023 5 None -147 3 Human 6.5 pEC50 = 6.5 Functional
Compound was tested for agonist activity against cloned human beta-1 adrenergic receptorCompound was tested for agonist activity against cloned human beta-1 adrenergic receptor
ChEMBL 568 11 4 6 3.4 O[C@H](COc1ccc(cc1)O)CNCCc1ccc(cc1)NS(=O)(=O)c1ccc(cc1)I 10.1016/s0960-894x(98)00169-3
3467 9023 5 None -147 3 Human 6.5 pEC50 = 6.5 Functional
Compound was tested for agonist activity against cloned human beta-1 adrenergic receptorCompound was tested for agonist activity against cloned human beta-1 adrenergic receptor
ChEMBL 568 11 4 6 3.4 O[C@H](COc1ccc(cc1)O)CNCCc1ccc(cc1)NS(=O)(=O)c1ccc(cc1)I 10.1016/s0960-894x(98)00169-3
CHEMBL276257 9023 5 None -147 3 Human 6.5 pEC50 = 6.5 Functional
Compound was tested for agonist activity against cloned human beta-1 adrenergic receptorCompound was tested for agonist activity against cloned human beta-1 adrenergic receptor
ChEMBL 568 11 4 6 3.4 O[C@H](COc1ccc(cc1)O)CNCCc1ccc(cc1)NS(=O)(=O)c1ccc(cc1)I 10.1016/s0960-894x(98)00169-3
45483815 205221 0 None -11 2 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 400 7 5 6 2.1 CC(C)(Cc1ccc(C(=O)O)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1016/j.bmcl.2009.10.013
CHEMBL577289 205221 0 None -11 2 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 400 7 5 6 2.1 CC(C)(Cc1ccc(C(=O)O)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1016/j.bmcl.2009.10.013
44574721 185330 0 None 1 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 419 11 3 5 3.1 Cc1cccnc1CC(=O)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.03.044
CHEMBL466924 185330 0 None 1 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 419 11 3 5 3.1 Cc1cccnc1CC(=O)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.03.044
24950238 181733 0 None -69 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 437 7 3 4 5.0 O=C(O)c1cccc(Oc2ccc3c(c2)C[C@@H](NC[C@H](O)c2ccc(Cl)cc2)CC3)c1 10.1021/jm800222k
CHEMBL456578 181733 0 None -69 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 437 7 3 4 5.0 O=C(O)c1cccc(Oc2ccc3c(c2)C[C@@H](NC[C@H](O)c2ccc(Cl)cc2)CC3)c1 10.1021/jm800222k
45270697 201949 0 None -20 3 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay
ChEMBL 451 11 4 5 4.1 COc1ccccc1NC(=S)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.06.031
CHEMBL1203995 201949 0 None -20 3 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay
ChEMBL 451 11 4 5 4.1 COc1ccccc1NC(=S)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.06.031
CHEMBL550444 201949 0 None -20 3 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay
ChEMBL 451 11 4 5 4.1 COc1ccccc1NC(=S)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.06.031
24949568 196462 0 None -338 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 536 9 4 6 5.6 O=C(O)c1cc(NC2CCOCC2)cc(Oc2ccc3c(c2)C[C@@H](NC[C@H](O)c2cccc(Cl)c2)CC3)c1 10.1021/jm800222k
CHEMBL515349 196462 0 None -338 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 536 9 4 6 5.6 O=C(O)c1cc(NC2CCOCC2)cc(Oc2ccc3c(c2)C[C@@H](NC[C@H](O)c2cccc(Cl)c2)CC3)c1 10.1021/jm800222k
10075383 103880 0 None -537 3 Human 6.5 pEC50 = 6.5 Functional
Compound was tested for agonist activity against cloned human beta-1 adrenergic receptorCompound was tested for agonist activity against cloned human beta-1 adrenergic receptor
ChEMBL 520 11 4 6 3.5 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1ccc(Br)cc1 10.1016/s0960-894x(98)00169-3
CHEMBL267545 103880 0 None -537 3 Human 6.5 pEC50 = 6.5 Functional
Compound was tested for agonist activity against cloned human beta-1 adrenergic receptorCompound was tested for agonist activity against cloned human beta-1 adrenergic receptor
ChEMBL 520 11 4 6 3.5 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1ccc(Br)cc1 10.1016/s0960-894x(98)00169-3
46232768 206413 0 None -14 2 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 356 6 4 5 2.4 CC(C)(Cc1ccccc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2 10.1016/j.bmcl.2009.12.087
CHEMBL592879 206413 0 None -14 2 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 356 6 4 5 2.4 CC(C)(Cc1ccccc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2 10.1016/j.bmcl.2009.12.087
164624092 195360 0 None -794 2 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 442 10 4 7 2.9 COc1cc(CCC(C)NCC(O)c2ccc(O)c3[nH]c(=O)ccc23)cc(OC)c1OC 10.1016/j.ejmech.2021.113697
CHEMBL4865514 195360 0 None -794 2 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 442 10 4 7 2.9 COc1cc(CCC(C)NCC(O)c2ccc(O)c3[nH]c(=O)ccc23)cc(OC)c1OC 10.1016/j.ejmech.2021.113697
CHEMBL5028807 195360 0 None -794 2 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 442 10 4 7 2.9 COc1cc(CCC(C)NCC(O)c2ccc(O)c3[nH]c(=O)ccc23)cc(OC)c1OC 10.1016/j.ejmech.2021.113697
145986105 172149 0 None -25 3 Human 7.4 pEC50 = 7.4 Functional
Antagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assayAntagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assay
ChEMBL 429 10 4 4 4.0 O=C(Nc1ccc(CCNC[C@H](O)COc2cccc3[nH]ccc23)cc1)c1ccccc1 10.1016/j.ejmech.2018.03.032
CHEMBL4237453 172149 0 None -25 3 Human 7.4 pEC50 = 7.4 Functional
Antagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assayAntagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assay
ChEMBL 429 10 4 4 4.0 O=C(Nc1ccc(CCNC[C@H](O)COc2cccc3[nH]ccc23)cc1)c1ccccc1 10.1016/j.ejmech.2018.03.032
44219641 185218 0 None -5 3 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 498 13 3 6 4.1 CC(Cc1ccc(NC(=O)Cc2nccn2Cc2ccccc2)cc1)NC[C@H](O)COc1ccccc1 10.1016/j.bmc.2009.03.044
CHEMBL466088 185218 0 None -5 3 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 498 13 3 6 4.1 CC(Cc1ccc(NC(=O)Cc2nccn2Cc2ccccc2)cc1)NC[C@H](O)COc1ccccc1 10.1016/j.bmc.2009.03.044
24822815 104718 0 None -588 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 467 11 3 4 5.6 CC(C)COc1cc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)ccc1C(=O)O 10.1021/jm701324c
CHEMBL272583 104718 0 None -588 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 467 11 3 4 5.6 CC(C)COc1cc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)ccc1C(=O)O 10.1021/jm701324c
44127678 203081 0 None -2 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 471 11 4 6 3.7 O=C(Cc1cc2ccccc2cn1)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/j.ejmech.2009.01.022
CHEMBL562153 203081 0 None -2 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 471 11 4 6 3.7 O=C(Cc1cc2ccccc2cn1)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/j.ejmech.2009.01.022
1960 9632 67 None -38 19 Guinea pig 6.5 pEC50 = 6.5 Functional
Agonistic potency at beta-1 adrenergic receptor for the percent maximal increase in contraction rate of isolated guinea pig atriaAgonistic potency at beta-1 adrenergic receptor for the percent maximal increase in contraction rate of isolated guinea pig atria
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
439260 9632 67 None -38 19 Guinea pig 6.5 pEC50 = 6.5 Functional
Agonistic potency at beta-1 adrenergic receptor for the percent maximal increase in contraction rate of isolated guinea pig atriaAgonistic potency at beta-1 adrenergic receptor for the percent maximal increase in contraction rate of isolated guinea pig atria
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
505 9632 67 None -38 19 Guinea pig 6.5 pEC50 = 6.5 Functional
Agonistic potency at beta-1 adrenergic receptor for the percent maximal increase in contraction rate of isolated guinea pig atriaAgonistic potency at beta-1 adrenergic receptor for the percent maximal increase in contraction rate of isolated guinea pig atria
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
CHEMBL1437 9632 67 None -38 19 Guinea pig 6.5 pEC50 = 6.5 Functional
Agonistic potency at beta-1 adrenergic receptor for the percent maximal increase in contraction rate of isolated guinea pig atriaAgonistic potency at beta-1 adrenergic receptor for the percent maximal increase in contraction rate of isolated guinea pig atria
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
DB00368 9632 67 None -38 19 Guinea pig 6.5 pEC50 = 6.5 Functional
Agonistic potency at beta-1 adrenergic receptor for the percent maximal increase in contraction rate of isolated guinea pig atriaAgonistic potency at beta-1 adrenergic receptor for the percent maximal increase in contraction rate of isolated guinea pig atria
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
10275157 12149 0 None -7 2 Human 6.5 pEC50 = 6.5 Functional
In vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptorIn vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptor
ChEMBL 442 10 5 6 2.2 CNC(=O)N1CCC(Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)CC1 10.1016/s0960-894x(01)00645-x
CHEMBL107012 12149 0 None -7 2 Human 6.5 pEC50 = 6.5 Functional
In vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptorIn vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptor
ChEMBL 442 10 5 6 2.2 CNC(=O)N1CCC(Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)CC1 10.1016/s0960-894x(01)00645-x
10283539 174644 0 None -1479 3 Human 6.5 pEC50 = 6.5 Functional
In vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptorIn vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptor
ChEMBL 697 14 6 9 2.8 CS(=O)(=O)Nc1cc(OC[C@@H](O)CNCC2CCN(S(=O)(=O)c3ccc(NC(=O)NCc4cc(F)ccc4F)cc3)CC2)ccc1O 10.1016/s0960-894x(02)00607-8
CHEMBL431048 174644 0 None -1479 3 Human 6.5 pEC50 = 6.5 Functional
In vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptorIn vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptor
ChEMBL 697 14 6 9 2.8 CS(=O)(=O)Nc1cc(OC[C@@H](O)CNCC2CCN(S(=O)(=O)c3ccc(NC(=O)NCc4cc(F)ccc4F)cc3)CC2)ccc1O 10.1016/s0960-894x(02)00607-8
9800339 207932 11 None -251 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 386 7 4 6 2.4 COc1ccc(CC(C)(C)NCC(O)c2cc(O)cc3c2OCC(=O)N3)cc1 10.1016/j.bmcl.2009.12.087
CHEMBL603271 207932 11 None -251 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 386 7 4 6 2.4 COc1ccc(CC(C)(C)NCC(O)c2cc(O)cc3c2OCC(=O)N3)cc1 10.1016/j.bmcl.2009.12.087
24823626 104822 0 None -6 2 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 410 9 4 4 4.6 O=C(O)c1cccc(Nc2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)c1 10.1021/jm701324c
CHEMBL273098 104822 0 None -6 2 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 410 9 4 4 4.6 O=C(O)c1cccc(Nc2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)c1 10.1021/jm701324c
155557083 181320 0 None -724 2 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 354 7 5 5 2.2 O=c1ccc2c(C(O)CNCCCc3ccc(O)cc3)ccc(O)c2[nH]1 10.1016/j.bmc.2018.10.043
CHEMBL4556022 181320 0 None -724 2 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 354 7 5 5 2.2 O=c1ccc2c(C(O)CNCCCc3ccc(O)cc3)ccc(O)c2[nH]1 10.1016/j.bmc.2018.10.043
145982607 172499 0 None -4 3 Human 7.4 pEC50 = 7.4 Functional
Antagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assayAntagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assay
ChEMBL 432 12 3 4 4.0 CCc1ccccc1OC[C@@H](O)CNCCc1ccc(NC(=O)Cc2ccccc2)cc1 10.1016/j.ejmech.2018.03.032
CHEMBL4245968 172499 0 None -4 3 Human 7.4 pEC50 = 7.4 Functional
Antagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assayAntagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assay
ChEMBL 432 12 3 4 4.0 CCc1ccccc1OC[C@@H](O)CNCCc1ccc(NC(=O)Cc2ccccc2)cc1 10.1016/j.ejmech.2018.03.032
24949566 181651 1 None -281 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 494 8 4 5 5.0 CC(=O)Nc1cc(Oc2ccc3c(c2)C[C@@H](NC[C@H](O)c2cccc(Cl)c2)CC3)cc(C(=O)O)c1 10.1021/jm800222k
CHEMBL456353 181651 1 None -281 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 494 8 4 5 5.0 CC(=O)Nc1cc(Oc2ccc3c(c2)C[C@@H](NC[C@H](O)c2cccc(Cl)c2)CC3)cc(C(=O)O)c1 10.1021/jm800222k
1862 6949 18 None -9 2 Guinea pig 4.4 pEC50 = 4.4 Functional
Beta-1 adrenergic receptor agonist activity by stimulation of contraction rate of isolated guinea pig atrial preparationsBeta-1 adrenergic receptor agonist activity by stimulation of contraction rate of isolated guinea pig atrial preparations
ChEMBL 187 2 4 4 0.2 NCC(c1cc(O)c(cc1F)O)O 10.1021/jm00118a019
510 6949 18 None -9 2 Guinea pig 4.4 pEC50 = 4.4 Functional
Beta-1 adrenergic receptor agonist activity by stimulation of contraction rate of isolated guinea pig atrial preparationsBeta-1 adrenergic receptor agonist activity by stimulation of contraction rate of isolated guinea pig atrial preparations
ChEMBL 187 2 4 4 0.2 NCC(c1cc(O)c(cc1F)O)O 10.1021/jm00118a019
CHEMBL281232 6949 18 None -9 2 Guinea pig 4.4 pEC50 = 4.4 Functional
Beta-1 adrenergic receptor agonist activity by stimulation of contraction rate of isolated guinea pig atrial preparationsBeta-1 adrenergic receptor agonist activity by stimulation of contraction rate of isolated guinea pig atrial preparations
ChEMBL 187 2 4 4 0.2 NCC(c1cc(O)c(cc1F)O)O 10.1021/jm00118a019
24824079 19665 0 None 1 2 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 441 11 3 5 4.5 O=C(O)COc1ccc(Oc2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)cc1 10.1021/jm701324c
CHEMBL1188934 19665 0 None 1 2 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 441 11 3 5 4.5 O=C(O)COc1ccc(Oc2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)cc1 10.1021/jm701324c
CHEMBL537693 19665 0 None 1 2 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 441 11 3 5 4.5 O=C(O)COc1ccc(Oc2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)cc1 10.1021/jm701324c
24895357 193074 0 None -194 2 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 467 10 3 4 5.7 CC(C)Oc1cc(-c2ccc(C[C@@H](C)NC[C@H](O)c3cccc(Cl)c3)cc2)ccc1C(=O)O 10.1021/jm8000345
CHEMBL487443 193074 0 None -194 2 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 467 10 3 4 5.7 CC(C)Oc1cc(-c2ccc(C[C@@H](C)NC[C@H](O)c3cccc(Cl)c3)cc2)ccc1C(=O)O 10.1021/jm8000345
42639965 19490 0 None -691 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 534 11 3 5 5.0 CS(=O)(=O)NC(=O)c1ccc(-c2ccc(CCNC[C@H](O)c3ccccc3)cc2)cc1CC1CCCCC1 10.1021/jm9000709
CHEMBL1187643 19490 0 None -691 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 534 11 3 5 5.0 CS(=O)(=O)NC(=O)c1ccc(-c2ccc(CCNC[C@H](O)c3ccccc3)cc2)cc1CC1CCCCC1 10.1021/jm9000709
CHEMBL513419 19490 0 None -691 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 534 11 3 5 5.0 CS(=O)(=O)NC(=O)c1ccc(-c2ccc(CCNC[C@H](O)c3ccccc3)cc2)cc1CC1CCCCC1 10.1021/jm9000709
44457929 91552 0 None -114 3 Human 6.4 pEC50 = 6.4 Functional
Agonistic activity against the cloned human Beta-1 adrenergic receptor was measured by its by its ability to stimulate adenylyl cyclaseAgonistic activity against the cloned human Beta-1 adrenergic receptor was measured by its by its ability to stimulate adenylyl cyclase
ChEMBL 593 17 3 10 3.9 CCCCCCCCn1nnn(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)c1=O 10.1016/s0960-894x(99)00182-1
CHEMBL22318 91552 0 None -114 3 Human 6.4 pEC50 = 6.4 Functional
Agonistic activity against the cloned human Beta-1 adrenergic receptor was measured by its by its ability to stimulate adenylyl cyclaseAgonistic activity against the cloned human Beta-1 adrenergic receptor was measured by its by its ability to stimulate adenylyl cyclase
ChEMBL 593 17 3 10 3.9 CCCCCCCCn1nnn(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)c1=O 10.1016/s0960-894x(99)00182-1
2419 10236 84 None -1174 14 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.ejmech.2021.113697
5152 10236 84 None -1174 14 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.ejmech.2021.113697
559 10236 84 None -1174 14 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.ejmech.2021.113697
CHEMBL1263 10236 84 None -1174 14 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.ejmech.2021.113697
DB00938 10236 84 None -1174 14 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.ejmech.2021.113697
24823130 104480 0 None -38 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 413 8 3 3 4.7 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)cc1F 10.1021/jm701324c
CHEMBL271367 104480 0 None -38 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 413 8 3 3 4.7 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)cc1F 10.1021/jm701324c
44580011 193579 0 None -52 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 468 10 4 5 4.7 CC(=O)Nc1ccc(Oc2cccc(CCNC[C@H](O)c3cccc(Cl)c3)c2)cc1C(=O)O 10.1016/j.bmcl.2008.08.009
CHEMBL489200 193579 0 None -52 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 468 10 4 5 4.7 CC(=O)Nc1ccc(Oc2cccc(CCNC[C@H](O)c3cccc(Cl)c3)c2)cc1C(=O)O 10.1016/j.bmcl.2008.08.009
9997789 193080 1 None -107 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at beta1 adrenoceptor (unknown origin)Agonist activity at beta1 adrenoceptor (unknown origin)
ChEMBL 310 3 3 3 3.4 CC(C)(C)NC(CO)c1cc(Cl)c(N)c(C(F)(F)F)c1 10.1021/acs.jmedchem.0c01195
CHEMBL4874511 193080 1 None -107 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at beta1 adrenoceptor (unknown origin)Agonist activity at beta1 adrenoceptor (unknown origin)
ChEMBL 310 3 3 3 3.4 CC(C)(C)NC(CO)c1cc(Cl)c(N)c(C(F)(F)F)c1 10.1021/acs.jmedchem.0c01195
CHEMBL5192245 193080 1 None -107 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at beta1 adrenoceptor (unknown origin)Agonist activity at beta1 adrenoceptor (unknown origin)
ChEMBL 310 3 3 3 3.4 CC(C)(C)NC(CO)c1cc(Cl)c(N)c(C(F)(F)F)c1 10.1021/acs.jmedchem.0c01195
24895263 201329 0 None -1122 3 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 475 10 4 6 4.6 Nc1ccc([C@@H](O)CNCCc2ccc(-c3ccc(C(=O)O)c(OC4CCCCC4)c3)cc2)cn1 10.1021/jm8000345
CHEMBL529659 201329 0 None -1122 3 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 475 10 4 6 4.6 Nc1ccc([C@@H](O)CNCCc2ccc(-c3ccc(C(=O)O)c(OC4CCCCC4)c3)cc2)cn1 10.1021/jm8000345
44591508 185774 0 None -1122 3 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 475 10 4 6 4.6 Nc1ccncc1[C@@H](O)CNCCc1ccc(-c2ccc(C(=O)O)c(OC3CCCCC3)c2)cc1 10.1021/jm9000709
CHEMBL470857 185774 0 None -1122 3 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 475 10 4 6 4.6 Nc1ccncc1[C@@H](O)CNCCc1ccc(-c2ccc(C(=O)O)c(OC3CCCCC3)c2)cc1 10.1021/jm9000709
319 8106 44 None -43 18 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at adrenergic beta1 receptorAgonist activity at adrenergic beta1 receptor
ChEMBL 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 10.1016/j.bmcl.2011.05.097
321 8106 44 None -43 18 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at adrenergic beta1 receptorAgonist activity at adrenergic beta1 receptor
ChEMBL 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 10.1016/j.bmcl.2011.05.097
444031 8106 44 None -43 18 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at adrenergic beta1 receptorAgonist activity at adrenergic beta1 receptor
ChEMBL 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 10.1016/j.bmcl.2011.05.097
784 8106 44 None -43 18 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at adrenergic beta1 receptorAgonist activity at adrenergic beta1 receptor
ChEMBL 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 10.1016/j.bmcl.2011.05.097
CHEMBL1346 8106 44 None -43 18 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at adrenergic beta1 receptorAgonist activity at adrenergic beta1 receptor
ChEMBL 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 10.1016/j.bmcl.2011.05.097
DB00496 8106 44 None -43 18 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at adrenergic beta1 receptorAgonist activity at adrenergic beta1 receptor
ChEMBL 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 10.1016/j.bmcl.2011.05.097
56670158 70870 0 None -15 2 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at adrenergic beta1 receptorAgonist activity at adrenergic beta1 receptor
ChEMBL 497 13 5 7 2.5 O=c1[nH]c2c(O)ccc([C@@H](O)CNCC[S+]([O-])CCCNCCc3cccc(Cl)c3)c2s1 10.1016/j.bmcl.2011.05.097
CHEMBL1807830 70870 0 None -15 2 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at adrenergic beta1 receptorAgonist activity at adrenergic beta1 receptor
ChEMBL 497 13 5 7 2.5 O=c1[nH]c2c(O)ccc([C@@H](O)CNCC[S+]([O-])CCCNCCc3cccc(Cl)c3)c2s1 10.1016/j.bmcl.2011.05.097
16049309 70874 0 None -100 3 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at adrenergic beta1 receptorAgonist activity at adrenergic beta1 receptor
ChEMBL 481 13 5 7 3.5 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCSCCNCCc3ccccc3Cl)c2s1 10.1016/j.bmcl.2011.05.097
CHEMBL1807870 70874 0 None -100 3 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at adrenergic beta1 receptorAgonist activity at adrenergic beta1 receptor
ChEMBL 481 13 5 7 3.5 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCSCCNCCc3ccccc3Cl)c2s1 10.1016/j.bmcl.2011.05.097
56663238 70876 0 None -251 2 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at adrenergic beta1 receptorAgonist activity at adrenergic beta1 receptor
ChEMBL 465 13 5 7 2.8 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCOCCNCCc3cccc(Cl)c3)c2s1 10.1016/j.bmcl.2011.05.097
CHEMBL1807872 70876 0 None -251 2 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at adrenergic beta1 receptorAgonist activity at adrenergic beta1 receptor
ChEMBL 465 13 5 7 2.8 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCOCCNCCc3cccc(Cl)c3)c2s1 10.1016/j.bmcl.2011.05.097
1239 8458 55 None -67 5 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmc.2011.05.064
3410 8458 55 None -67 5 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmc.2011.05.064
3465 8458 55 None -67 5 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmc.2011.05.064
CHEMBL1256786 8458 55 None -67 5 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmc.2011.05.064
DB00983 8458 55 None -67 5 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmc.2011.05.064
3083544 33582 51 None -199 6 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1016/j.bmc.2011.08.043
CHEMBL1200811 33582 51 None -199 6 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1016/j.bmc.2011.08.043
CHEMBL1363 33582 51 None -199 6 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1016/j.bmc.2011.08.043
CHEMBL1951071 33582 51 None -199 6 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1016/j.bmc.2011.08.043
CHEMBL605993 33582 51 None -199 6 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1016/j.bmc.2011.08.043
10288976 73354 0 None -251 4 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 487 17 6 6 3.9 Cc1cc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc(NC(N)=O)c1 10.1016/j.bmc.2011.08.043
CHEMBL1835862 73354 0 None -251 4 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 487 17 6 6 3.9 Cc1cc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc(NC(N)=O)c1 10.1016/j.bmc.2011.08.043
CHEMBL1852543 73354 0 None -251 4 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 487 17 6 6 3.9 Cc1cc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc(NC(N)=O)c1 10.1016/j.bmc.2011.08.043
1239 8458 55 None -67 5 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1021/jm801016j
3410 8458 55 None -67 5 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1021/jm801016j
3465 8458 55 None -67 5 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1021/jm801016j
CHEMBL1256786 8458 55 None -67 5 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1021/jm801016j
DB00983 8458 55 None -67 5 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1021/jm801016j
3083544 33582 51 None -199 6 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1021/jm100326d
CHEMBL1200811 33582 51 None -199 6 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1021/jm100326d
CHEMBL1363 33582 51 None -199 6 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1021/jm100326d
CHEMBL1951071 33582 51 None -199 6 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1021/jm100326d
CHEMBL605993 33582 51 None -199 6 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1021/jm100326d
49861320 61740 0 None -6 3 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 426 11 3 5 3.1 O=S(=O)(Nc1ccccc1)c1ccc(CCNC[C@@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.06.031
CHEMBL1204003 61740 0 None -6 3 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 426 11 3 5 3.1 O=S(=O)(Nc1ccccc1)c1ccc(CCNC[C@@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.06.031
CHEMBL1615579 61740 0 None -6 3 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 426 11 3 5 3.1 O=S(=O)(Nc1ccccc1)c1ccc(CCNC[C@@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.06.031
44565932 193790 0 None -4897 3 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 528 11 4 8 3.4 CC(C)Sc1cc(-c2ccc(CCNC[C@H](O)c3cnccc3N)cc2)ccc1C(=O)NS(C)(=O)=O 10.1021/jm9000709
CHEMBL490733 193790 0 None -4897 3 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 528 11 4 8 3.4 CC(C)Sc1cc(-c2ccc(CCNC[C@H](O)c3cnccc3N)cc2)ccc1C(=O)NS(C)(=O)=O 10.1021/jm9000709
10305108 118220 0 None -77 3 Human 6.4 pEC50 = 6.4 Functional
In vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptorIn vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptor
ChEMBL 659 17 6 8 4.2 CCCCCCCCNC(=O)Nc1ccc(S(=O)(=O)N2CCC(CNC[C@H](O)COc3ccc(O)c4c3CCC(=O)N4)CC2)cc1 10.1016/s0960-894x(02)00607-8
CHEMBL327519 118220 0 None -77 3 Human 6.4 pEC50 = 6.4 Functional
In vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptorIn vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptor
ChEMBL 659 17 6 8 4.2 CCCCCCCCNC(=O)Nc1ccc(S(=O)(=O)N2CCC(CNC[C@H](O)COc3ccc(O)c4c3CCC(=O)N4)CC2)cc1 10.1016/s0960-894x(02)00607-8
44441233 154835 0 None -100 3 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 415 9 4 6 3.8 C[C@H](CNc1cccc(-c2ocnc2C(=O)O)c1)NC[C@H](O)c1cccc(Cl)c1 10.1016/j.bmcl.2007.05.069
CHEMBL393471 154835 0 None -100 3 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 415 9 4 6 3.8 C[C@H](CNc1cccc(-c2ocnc2C(=O)O)c1)NC[C@H](O)c1cccc(Cl)c1 10.1016/j.bmcl.2007.05.069
10184665 10763 51 None -173 10 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 485 16 4 6 4.6 OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O 10.1016/j.bmc.2011.08.043
4799 10763 51 None -173 10 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 485 16 4 6 4.6 OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O 10.1016/j.bmc.2011.08.043
7353 10763 51 None -173 10 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 485 16 4 6 4.6 OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O 10.1016/j.bmc.2011.08.043
CHEMBL1198857 10763 51 None -173 10 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 485 16 4 6 4.6 OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O 10.1016/j.bmc.2011.08.043
DB09082 10763 51 None -173 10 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 485 16 4 6 4.6 OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O 10.1016/j.bmc.2011.08.043
10184665 10763 51 None -173 10 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 485 16 4 6 4.6 OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O 10.1021/jm100326d
4799 10763 51 None -173 10 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 485 16 4 6 4.6 OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O 10.1021/jm100326d
7353 10763 51 None -173 10 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 485 16 4 6 4.6 OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O 10.1021/jm100326d
CHEMBL1198857 10763 51 None -173 10 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 485 16 4 6 4.6 OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O 10.1021/jm100326d
DB09082 10763 51 None -173 10 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 485 16 4 6 4.6 OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O 10.1021/jm100326d
11038599 54642 0 None -25 3 Human 6.4 pEC50 = 6.4 Functional
Concentration that causes 50% inhibition of human beta 1 adrenergic receptor (AR), expressed in CHO cells.Concentration that causes 50% inhibition of human beta 1 adrenergic receptor (AR), expressed in CHO cells.
ChEMBL 516 11 5 6 3.7 C[C@H](CNc1cccc(CNC(=O)NS(=O)(=O)c2ccccc2)c1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm0101500
CHEMBL154906 54642 0 None -25 3 Human 6.4 pEC50 = 6.4 Functional
Concentration that causes 50% inhibition of human beta 1 adrenergic receptor (AR), expressed in CHO cells.Concentration that causes 50% inhibition of human beta 1 adrenergic receptor (AR), expressed in CHO cells.
ChEMBL 516 11 5 6 3.7 C[C@H](CNc1cccc(CNC(=O)NS(=O)(=O)c2ccccc2)c1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm0101500
9512 10408 42 None -1202 3 Human 5.4 pEC50 = 5.4 Functional
Activity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP productionActivity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP production
ChEMBL 410 9 4 4 4.4 Clc1cccc(c1)[C@H](CNCCNc1cccc(c1)c1cccc(c1)C(=O)O)O 10.1021/jm0509445
9887812 10408 42 None -1202 3 Human 5.4 pEC50 = 5.4 Functional
Activity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP productionActivity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP production
ChEMBL 410 9 4 4 4.4 Clc1cccc(c1)[C@H](CNCCNc1cccc(c1)c1cccc(c1)C(=O)O)O 10.1021/jm0509445
CHEMBL208427 10408 42 None -1202 3 Human 5.4 pEC50 = 5.4 Functional
Activity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP productionActivity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP production
ChEMBL 410 9 4 4 4.4 Clc1cccc(c1)[C@H](CNCCNc1cccc(c1)c1cccc(c1)C(=O)O)O 10.1021/jm0509445
DB06190 10408 42 None -1202 3 Human 5.4 pEC50 = 5.4 Functional
Activity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP productionActivity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP production
ChEMBL 410 9 4 4 4.4 Clc1cccc(c1)[C@H](CNCCNc1cccc(c1)c1cccc(c1)C(=O)O)O 10.1021/jm0509445
44441236 100198 0 None -3162 3 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 416 9 4 5 4.5 O=C(O)c1ccsc1-c1cccc(NCCNC[C@H](O)c2cccc(Cl)c2)c1 10.1016/j.bmcl.2007.05.069
CHEMBL245875 100198 0 None -3162 3 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 416 9 4 5 4.5 O=C(O)c1ccsc1-c1cccc(NCCNC[C@H](O)c2cccc(Cl)c2)c1 10.1016/j.bmcl.2007.05.069
10298567 72727 0 None -5 2 Human 8.4 pEC50 = 8.4 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptor
ChEMBL 465 12 5 6 3.3 COc1cccc(NC(=O)Nc2ccc(C[C@@H](CO)NC[C@H](O)COc3ccccc3)cc2)c1 10.1016/j.bmcl.2004.11.001
CHEMBL183611 72727 0 None -5 2 Human 8.4 pEC50 = 8.4 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptor
ChEMBL 465 12 5 6 3.3 COc1cccc(NC(=O)Nc2ccc(C[C@@H](CO)NC[C@H](O)COc3ccccc3)cc2)c1 10.1016/j.bmcl.2004.11.001
164625303 195368 0 None -316 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 366 7 4 4 3.2 Cc1cccc(CCC(C)NCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1 10.1016/j.ejmech.2021.113697
CHEMBL4873082 195368 0 None -316 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 366 7 4 4 3.2 Cc1cccc(CCC(C)NCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1 10.1016/j.ejmech.2021.113697
CHEMBL5028871 195368 0 None -316 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 366 7 4 4 3.2 Cc1cccc(CCC(C)NCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1 10.1016/j.ejmech.2021.113697
164623918 195357 0 None -199 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 374 7 4 4 2.8 O=c1ccc2c(C(O)CNCCCc3cc(F)cc(F)c3)ccc(O)c2[nH]1 10.1016/j.ejmech.2021.113697
CHEMBL4872480 195357 0 None -199 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 374 7 4 4 2.8 O=c1ccc2c(C(O)CNCCCc3cc(F)cc(F)c3)ccc(O)c2[nH]1 10.1016/j.ejmech.2021.113697
CHEMBL5028793 195357 0 None -199 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 374 7 4 4 2.8 O=c1ccc2c(C(O)CNCCCc3cc(F)cc(F)c3)ccc(O)c2[nH]1 10.1016/j.ejmech.2021.113697
164608750 195237 0 None -181 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 356 7 4 4 2.6 O=c1ccc2c(C(O)CNCCCc3cccc(F)c3)ccc(O)c2[nH]1 10.1016/j.ejmech.2021.113697
CHEMBL4846631 195237 0 None -181 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 356 7 4 4 2.6 O=c1ccc2c(C(O)CNCCCc3cccc(F)c3)ccc(O)c2[nH]1 10.1016/j.ejmech.2021.113697
CHEMBL5027923 195237 0 None -181 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 356 7 4 4 2.6 O=c1ccc2c(C(O)CNCCCc3cccc(F)c3)ccc(O)c2[nH]1 10.1016/j.ejmech.2021.113697
164615474 195287 0 None -61 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 386 7 4 4 3.5 CC(CCc1cccc(Cl)c1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
CHEMBL4847767 195287 0 None -61 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 386 7 4 4 3.5 CC(CCc1cccc(Cl)c1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
CHEMBL5028315 195287 0 None -61 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 386 7 4 4 3.5 CC(CCc1cccc(Cl)c1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
164617688 195301 0 None -416 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 368 7 5 5 2.6 CC(CCc1ccc(O)cc1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
CHEMBL4847536 195301 0 None -416 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 368 7 5 5 2.6 CC(CCc1ccc(O)cc1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
CHEMBL5028449 195301 0 None -416 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 368 7 5 5 2.6 CC(CCc1ccc(O)cc1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
56598967 95036 0 None 2238 3 Human 8.4 pEC50 = 8.4 Functional
Partial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrsPartial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrs
ChEMBL 457 14 4 6 3.2 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccccc1 10.1021/jm400348g
CHEMBL2348211 95036 0 None 2238 3 Human 8.4 pEC50 = 8.4 Functional
Partial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrsPartial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrs
ChEMBL 457 14 4 6 3.2 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccccc1 10.1021/jm400348g
45101520 205563 0 None -3 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelAgonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP level
ChEMBL 513 12 7 8 1.2 CC(C)(Cc1ccc(NC(=O)CCCNC(=O)CN)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1016/j.bmcl.2009.06.104
CHEMBL583235 205563 0 None -3 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelAgonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP level
ChEMBL 513 12 7 8 1.2 CC(C)(Cc1ccc(NC(=O)CCCNC(=O)CN)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1016/j.bmcl.2009.06.104
46232769 207619 0 None -6 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 370 6 4 5 2.7 Cc1ccccc1CC(C)(C)NCC(O)c1cc(O)cc2c1OCC(=O)N2 10.1016/j.bmcl.2009.12.087
CHEMBL601036 207619 0 None -6 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 370 6 4 5 2.7 Cc1ccccc1CC(C)(C)NCC(O)c1cc(O)cc2c1OCC(=O)N2 10.1016/j.bmcl.2009.12.087
164614743 195278 0 None -134 2 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 386 7 4 4 3.5 CC(CCc1ccccc1Cl)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
CHEMBL4860764 195278 0 None -134 2 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 386 7 4 4 3.5 CC(CCc1ccccc1Cl)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
CHEMBL5028269 195278 0 None -134 2 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 386 7 4 4 3.5 CC(CCc1ccccc1Cl)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
45484536 203993 0 None -5 2 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelAgonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP level
ChEMBL 527 13 7 8 1.6 CC(C)(Cc1ccc(NC(=O)CCCNC(=O)CCN)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1016/j.bmcl.2009.06.104
CHEMBL568239 203993 0 None -5 2 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelAgonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP level
ChEMBL 527 13 7 8 1.6 CC(C)(Cc1ccc(NC(=O)CCCNC(=O)CCN)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1016/j.bmcl.2009.06.104
559926 103782 5 None 27 2 Guinea pig 8.3 pEC50 = 8.3 Functional
Agonistic activity (beta-1 adrenergic receptor) for the percent maximal increase in contraction rate of isolated guinea pig atriaAgonistic activity (beta-1 adrenergic receptor) for the percent maximal increase in contraction rate of isolated guinea pig atria
ChEMBL 255 5 4 5 1.2 CC(C)(C)NCC(O)COc1ccc(O)c(O)c1 10.1021/jm00107a027
CHEMBL266619 103782 5 None 27 2 Guinea pig 8.3 pEC50 = 8.3 Functional
Agonistic activity (beta-1 adrenergic receptor) for the percent maximal increase in contraction rate of isolated guinea pig atriaAgonistic activity (beta-1 adrenergic receptor) for the percent maximal increase in contraction rate of isolated guinea pig atria
ChEMBL 255 5 4 5 1.2 CC(C)(C)NCC(O)COc1ccc(O)c(O)c1 10.1021/jm00107a027
45270673 202203 0 None 58 2 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 406 10 3 5 3.9 O=C(Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1)Oc1ccccc1 10.1016/j.bmc.2009.06.031
CHEMBL1203992 202203 0 None 58 2 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 406 10 3 5 3.9 O=C(Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1)Oc1ccccc1 10.1016/j.bmc.2009.06.031
CHEMBL552253 202203 0 None 58 2 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 406 10 3 5 3.9 O=C(Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1)Oc1ccccc1 10.1016/j.bmc.2009.06.031
45273280 202498 0 None -1 3 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 435 11 4 4 3.7 O[C@@H](CNCCc1ccc(NC(=S)NCc2ccccc2)cc1)COc1ccccc1 10.1016/j.bmc.2009.06.031
CHEMBL1204006 202498 0 None -1 3 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 435 11 4 4 3.7 O[C@@H](CNCCc1ccc(NC(=S)NCc2ccccc2)cc1)COc1ccccc1 10.1016/j.bmc.2009.06.031
CHEMBL557095 202498 0 None -1 3 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 435 11 4 4 3.7 O[C@@H](CNCCc1ccc(NC(=S)NCc2ccccc2)cc1)COc1ccccc1 10.1016/j.bmc.2009.06.031
44396513 73497 0 None -30 3 Human 7.4 pEC50 = 7.4 Functional
Agonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptorAgonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptor
ChEMBL 577 12 4 8 4.4 CC(C)S(=O)(=O)Oc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)c[nH]c12 10.1016/j.bmcl.2004.10.035
CHEMBL185660 73497 0 None -30 3 Human 7.4 pEC50 = 7.4 Functional
Agonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptorAgonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptor
ChEMBL 577 12 4 8 4.4 CC(C)S(=O)(=O)Oc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)c[nH]c12 10.1016/j.bmcl.2004.10.035
10420352 175519 10 None 83 2 Guinea pig 7.4 pEC50 = 7.4 Functional
Agonistic potency at beta-1 adrenergic receptor for the percent maximal increase in contraction rate of isolated guinea pig atriaAgonistic potency at beta-1 adrenergic receptor for the percent maximal increase in contraction rate of isolated guinea pig atria
ChEMBL 201 3 4 4 0.5 CNCC(O)c1ccc(O)c(O)c1F 10.1021/jm00118a019
CHEMBL43711 175519 10 None 83 2 Guinea pig 7.4 pEC50 = 7.4 Functional
Agonistic potency at beta-1 adrenergic receptor for the percent maximal increase in contraction rate of isolated guinea pig atriaAgonistic potency at beta-1 adrenergic receptor for the percent maximal increase in contraction rate of isolated guinea pig atria
ChEMBL 201 3 4 4 0.5 CNCC(O)c1ccc(O)c(O)c1F 10.1021/jm00118a019
10076548 170043 0 None -4 3 Human 7.4 pEC50 = 7.4 Functional
Increased cAMP levels of Chinese hamster ovary (CHO) cells expressing human beta 1 Adrenergic receptorIncreased cAMP levels of Chinese hamster ovary (CHO) cells expressing human beta 1 Adrenergic receptor
ChEMBL 562 13 5 8 2.7 CCCCN(C(=O)CC(=O)O)c1ccc(N2CCC(NC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)CC2)cc1 10.1021/jm000544b
CHEMBL418600 170043 0 None -4 3 Human 7.4 pEC50 = 7.4 Functional
Increased cAMP levels of Chinese hamster ovary (CHO) cells expressing human beta 1 Adrenergic receptorIncreased cAMP levels of Chinese hamster ovary (CHO) cells expressing human beta 1 Adrenergic receptor
ChEMBL 562 13 5 8 2.7 CCCCN(C(=O)CC(=O)O)c1ccc(N2CCC(NC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)CC2)cc1 10.1021/jm000544b
24893966 183518 0 None -724 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 449 12 3 5 4.8 CC(C)COc1cc(-c2ccc(OCCNC[C@H](O)c3ccccc3)cc2)ccc1C(=O)O 10.1021/jm8000345
CHEMBL460257 183518 0 None -724 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 449 12 3 5 4.8 CC(C)COc1cc(-c2ccc(OCCNC[C@H](O)c3ccccc3)cc2)ccc1C(=O)O 10.1021/jm8000345
44331766 11430 0 None -2 2 Human 6.4 pEC50 = 6.4 Functional
In vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptorIn vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptor
ChEMBL 449 9 3 4 4.3 O[C@@H](CNCC1CCN(CCC(F)(F)F)CC1)COc1cccc2[nH]c3ccccc3c12 10.1016/s0960-894x(02)00607-8
CHEMBL103137 11430 0 None -2 2 Human 6.4 pEC50 = 6.4 Functional
In vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptorIn vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptor
ChEMBL 449 9 3 4 4.3 O[C@@H](CNCC1CCN(CCC(F)(F)F)CC1)COc1cccc2[nH]c3ccccc3c12 10.1016/s0960-894x(02)00607-8
22063464 207789 0 None -10 2 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 370 6 4 5 2.7 Cc1cccc(CC(C)(C)NCC(O)c2cc(O)cc3c2OCC(=O)N3)c1 10.1016/j.bmcl.2009.12.087
CHEMBL602257 207789 0 None -10 2 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 370 6 4 5 2.7 Cc1cccc(CC(C)(C)NCC(O)c2cc(O)cc3c2OCC(=O)N3)c1 10.1016/j.bmcl.2009.12.087
10189730 12049 0 None -426 2 Human 6.4 pEC50 = 6.4 Functional
In vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptorIn vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptor
ChEMBL 647 14 6 8 3.4 CS(=O)(=O)Nc1cc(OC[C@@H](O)CNCCc2ccc(NC3CCN(C(=O)NCc4cc(F)ccc4F)CC3)cc2)ccc1O 10.1016/s0960-894x(01)00645-x
CHEMBL106511 12049 0 None -426 2 Human 6.4 pEC50 = 6.4 Functional
In vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptorIn vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptor
ChEMBL 647 14 6 8 3.4 CS(=O)(=O)Nc1cc(OC[C@@H](O)CNCCc2ccc(NC3CCN(C(=O)NCc4cc(F)ccc4F)CC3)cc2)ccc1O 10.1016/s0960-894x(01)00645-x
145984324 172618 0 None -7 3 Human 6.4 pEC50 = 6.4 Functional
Antagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assayAntagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assay
ChEMBL 449 11 4 4 4.6 CCc1ccccc1OC[C@@H](O)CNCCc1ccc(NC(=S)Nc2ccccc2)cc1 10.1016/j.ejmech.2018.03.032
CHEMBL4248727 172618 0 None -7 3 Human 6.4 pEC50 = 6.4 Functional
Antagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assayAntagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assay
ChEMBL 449 11 4 4 4.6 CCc1ccccc1OC[C@@H](O)CNCCc1ccc(NC(=S)Nc2ccccc2)cc1 10.1016/j.ejmech.2018.03.032
44574723 185302 0 None 1 2 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 439 11 3 5 3.5 O=C(Cc1cccc(Cl)n1)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.03.044
CHEMBL466726 185302 0 None 1 2 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 439 11 3 5 3.5 O=C(Cc1cccc(Cl)n1)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.03.044
155567283 182749 0 None -588 2 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 368 8 4 5 2.5 COc1ccc(CCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)cc1 10.1016/j.bmc.2018.10.043
CHEMBL4588479 182749 0 None -588 2 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 368 8 4 5 2.5 COc1ccc(CCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)cc1 10.1016/j.bmc.2018.10.043
44377771 172326 0 None -70 3 Human 6.4 pEC50 = 6.4 Functional
Agonistic activity as cAMP accumulation in CHO cells expressing human beta-1-adrenergic receptorAgonistic activity as cAMP accumulation in CHO cells expressing human beta-1-adrenergic receptor
ChEMBL 596 10 5 9 3.4 O=C1NC(=O)C(Cc2ccc(N3CCC(NC[C@H](O)c4ccc(O)c(NS(=O)(=O)c5ccccc5)c4)CC3)cc2)S1 10.1016/s0960-894x(01)00063-4
CHEMBL424167 172326 0 None -70 3 Human 6.4 pEC50 = 6.4 Functional
Agonistic activity as cAMP accumulation in CHO cells expressing human beta-1-adrenergic receptorAgonistic activity as cAMP accumulation in CHO cells expressing human beta-1-adrenergic receptor
ChEMBL 596 10 5 9 3.4 O=C1NC(=O)C(Cc2ccc(N3CCC(NC[C@H](O)c4ccc(O)c(NS(=O)(=O)c5ccccc5)c4)CC3)cc2)S1 10.1016/s0960-894x(01)00063-4
1028 7079 71 None -6 19 Guinea pig 6.4 pEC50 = 6.4 Functional
Effective dose required to stimulate contractions in isolated guinea pig atrium.Effective dose required to stimulate contractions in isolated guinea pig atrium.
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00019a001
139148732 7079 71 None -6 19 Guinea pig 6.4 pEC50 = 6.4 Functional
Effective dose required to stimulate contractions in isolated guinea pig atrium.Effective dose required to stimulate contractions in isolated guinea pig atrium.
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00019a001
479 7079 71 None -6 19 Guinea pig 6.4 pEC50 = 6.4 Functional
Effective dose required to stimulate contractions in isolated guinea pig atrium.Effective dose required to stimulate contractions in isolated guinea pig atrium.
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00019a001
5816 7079 71 None -6 19 Guinea pig 6.4 pEC50 = 6.4 Functional
Effective dose required to stimulate contractions in isolated guinea pig atrium.Effective dose required to stimulate contractions in isolated guinea pig atrium.
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00019a001
CHEMBL679 7079 71 None -6 19 Guinea pig 6.4 pEC50 = 6.4 Functional
Effective dose required to stimulate contractions in isolated guinea pig atrium.Effective dose required to stimulate contractions in isolated guinea pig atrium.
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00019a001
DB00668 7079 71 None -6 19 Guinea pig 6.4 pEC50 = 6.4 Functional
Effective dose required to stimulate contractions in isolated guinea pig atrium.Effective dose required to stimulate contractions in isolated guinea pig atrium.
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00019a001
46232856 208122 0 None -128 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 424 6 4 5 3.4 CC(C)(Cc1cccc(C(F)(F)F)c1)NCC(O)c1cc(O)cc2c1OCC(=O)N2 10.1016/j.bmcl.2009.12.087
CHEMBL604333 208122 0 None -128 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 424 6 4 5 3.4 CC(C)(Cc1cccc(C(F)(F)F)c1)NCC(O)c1cc(O)cc2c1OCC(=O)N2 10.1016/j.bmcl.2009.12.087
10651147 117460 0 None -10964 3 Human 4.4 pEC50 = 4.4 Functional
Increased cAMP levels of Chinese hamster ovary (CHO) cells expressing human beta 1 Adrenergic receptorIncreased cAMP levels of Chinese hamster ovary (CHO) cells expressing human beta 1 Adrenergic receptor
ChEMBL 596 12 6 8 2.5 CS(=O)(=O)Nc1cc([C@@H](O)CNC2CCN(c3ccc(C(=O)N[C@@H](Cc4ccccc4)C(=O)O)cc3)CC2)ccc1O 10.1021/jm000544b
CHEMBL32599 117460 0 None -10964 3 Human 4.4 pEC50 = 4.4 Functional
Increased cAMP levels of Chinese hamster ovary (CHO) cells expressing human beta 1 Adrenergic receptorIncreased cAMP levels of Chinese hamster ovary (CHO) cells expressing human beta 1 Adrenergic receptor
ChEMBL 596 12 6 8 2.5 CS(=O)(=O)Nc1cc([C@@H](O)CNC2CCN(c3ccc(C(=O)N[C@@H](Cc4ccccc4)C(=O)O)cc3)CC2)ccc1O 10.1021/jm000544b
44392542 72636 0 None -6 3 Human 7.4 pEC50 = 7.4 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cells expressing human beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cells expressing human beta-1 adrenergic receptor
ChEMBL 543 11 4 6 5.5 C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1cccc(NCc2ccc3ccccc3c2)c1 10.1016/j.bmcl.2004.12.033
CHEMBL183552 72636 0 None -6 3 Human 7.4 pEC50 = 7.4 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cells expressing human beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cells expressing human beta-1 adrenergic receptor
ChEMBL 543 11 4 6 5.5 C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1cccc(NCc2ccc3ccccc3c2)c1 10.1016/j.bmcl.2004.12.033
11432806 72971 0 None -134 3 Human 7.4 pEC50 = 7.4 Functional
Agonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptorAgonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptor
ChEMBL 549 11 4 8 3.6 C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1016/j.bmcl.2004.09.054
11432806 72971 0 None -134 3 Human 7.4 pEC50 = 7.4 Functional
Agonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptorAgonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptor
ChEMBL 549 11 4 8 3.6 C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1016/j.bmcl.2004.10.035
CHEMBL184407 72971 0 None -134 3 Human 7.4 pEC50 = 7.4 Functional
Agonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptorAgonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptor
ChEMBL 549 11 4 8 3.6 C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1016/j.bmcl.2004.09.054
CHEMBL184407 72971 0 None -134 3 Human 7.4 pEC50 = 7.4 Functional
Agonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptorAgonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptor
ChEMBL 549 11 4 8 3.6 C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1016/j.bmcl.2004.10.035
164612025 195256 0 None -2454 2 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 382 8 4 5 2.9 COc1ccc(CCC(C)NCC(O)c2ccc(O)c3[nH]c(=O)ccc23)cc1 10.1016/j.ejmech.2021.113697
CHEMBL4860454 195256 0 None -2454 2 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 382 8 4 5 2.9 COc1ccc(CCC(C)NCC(O)c2ccc(O)c3[nH]c(=O)ccc23)cc1 10.1016/j.ejmech.2021.113697
CHEMBL5028117 195256 0 None -2454 2 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 382 8 4 5 2.9 COc1ccc(CCC(C)NCC(O)c2ccc(O)c3[nH]c(=O)ccc23)cc1 10.1016/j.ejmech.2021.113697
24895669 197446 0 None -7079 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 435 10 4 5 4.4 CC(C)Oc1cc(-c2ccc(CCNC[C@H](O)c3cccc(O)c3)cc2)ccc1C(=O)O 10.1021/jm8000345
CHEMBL518168 197446 0 None -7079 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 435 10 4 5 4.4 CC(C)Oc1cc(-c2ccc(CCNC[C@H](O)c3cccc(O)c3)cc2)ccc1C(=O)O 10.1021/jm8000345
44392575 71146 0 None -2 3 Human 7.4 pEC50 = 7.4 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cells expressing human beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cells expressing human beta-1 adrenergic receptor
ChEMBL 441 10 4 6 2.8 C#CCNc1cccc([C@@H](O)CN[C@H](C)Cc2c[nH]c3c(OS(C)(=O)=O)cccc23)c1 10.1016/j.bmcl.2004.12.033
CHEMBL181300 71146 0 None -2 3 Human 7.4 pEC50 = 7.4 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cells expressing human beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cells expressing human beta-1 adrenergic receptor
ChEMBL 441 10 4 6 2.8 C#CCNc1cccc([C@@H](O)CN[C@H](C)Cc2c[nH]c3c(OS(C)(=O)=O)cccc23)c1 10.1016/j.bmcl.2004.12.033
52949489 24319 0 None -21 3 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assayAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assay
ChEMBL 490 9 2 8 4.4 COc1cccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)c1 10.1016/j.bmcl.2010.08.039
CHEMBL1258024 24319 0 None -21 3 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assayAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assay
ChEMBL 490 9 2 8 4.4 COc1cccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)c1 10.1016/j.bmcl.2010.08.039
44268324 23556 0 None -141 3 Human 6.4 pEC50 = 6.4 Functional
Compound was tested for agonist activity against cloned human beta-1 adrenergic receptorCompound was tested for agonist activity against cloned human beta-1 adrenergic receptor
ChEMBL 476 11 4 6 3.4 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1ccc(Cl)cc1 10.1016/s0960-894x(98)00169-3
CHEMBL12450 23556 0 None -141 3 Human 6.4 pEC50 = 6.4 Functional
Compound was tested for agonist activity against cloned human beta-1 adrenergic receptorCompound was tested for agonist activity against cloned human beta-1 adrenergic receptor
ChEMBL 476 11 4 6 3.4 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1ccc(Cl)cc1 10.1016/s0960-894x(98)00169-3
10626150 106802 0 None -295 3 Human 5.4 pEC50 = 5.4 Functional
Increased cAMP levels of Chinese hamster ovary (CHO) cells expressing human beta 1 Adrenergic receptorIncreased cAMP levels of Chinese hamster ovary (CHO) cells expressing human beta 1 Adrenergic receptor
ChEMBL 534 11 5 9 1.3 CCOC(=O)CNC(=O)c1ccc(N2CCC(NC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)CC2)cc1 10.1021/jm000544b
CHEMBL286868 106802 0 None -295 3 Human 5.4 pEC50 = 5.4 Functional
Increased cAMP levels of Chinese hamster ovary (CHO) cells expressing human beta 1 Adrenergic receptorIncreased cAMP levels of Chinese hamster ovary (CHO) cells expressing human beta 1 Adrenergic receptor
ChEMBL 534 11 5 9 1.3 CCOC(=O)CNC(=O)c1ccc(N2CCC(NC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)CC2)cc1 10.1021/jm000544b
44336180 13241 0 None -15 2 Human 6.3 pEC50 = 6.3 Functional
In vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptorIn vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptor
ChEMBL 554 12 5 6 4.0 O=C(NCc1ccc(F)cc1F)N1CCC(Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)CC1 10.1016/s0960-894x(01)00645-x
CHEMBL108263 13241 0 None -15 2 Human 6.3 pEC50 = 6.3 Functional
In vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptorIn vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptor
ChEMBL 554 12 5 6 4.0 O=C(NCc1ccc(F)cc1F)N1CCC(Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)CC1 10.1016/s0960-894x(01)00645-x
11270071 105766 0 None 1 3 Human 7.3 pEC50 = 7.3 Functional
Agonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-ARAgonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-AR
ChEMBL 328 6 3 2 4.1 C[C@H](Cc1c[nH]c2ccccc12)NC[C@@H](O)c1cccc(Cl)c1 10.1016/s0960-894x(03)00073-8
CHEMBL279931 105766 0 None 1 3 Human 7.3 pEC50 = 7.3 Functional
Agonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-ARAgonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-AR
ChEMBL 328 6 3 2 4.1 C[C@H](Cc1c[nH]c2ccccc12)NC[C@@H](O)c1cccc(Cl)c1 10.1016/s0960-894x(03)00073-8
24949564 196300 0 None -147 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 452 7 4 5 4.6 Nc1cc(Oc2ccc3c(c2)C[C@@H](NC[C@H](O)c2cccc(Cl)c2)CC3)cc(C(=O)O)c1 10.1021/jm800222k
CHEMBL514094 196300 0 None -147 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 452 7 4 5 4.6 Nc1cc(Oc2ccc3c(c2)C[C@@H](NC[C@H](O)c2cccc(Cl)c2)CC3)cc(C(=O)O)c1 10.1021/jm800222k
24893964 193444 0 None -1862 3 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 460 10 3 5 5.0 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1OC1CCCCC1 10.1021/jm8000345
CHEMBL488224 193444 0 None -1862 3 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 460 10 3 5 5.0 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1OC1CCCCC1 10.1021/jm8000345
24893964 193444 0 None -1862 3 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 460 10 3 5 5.0 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1OC1CCCCC1 10.1021/jm9000709
CHEMBL488224 193444 0 None -1862 3 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 460 10 3 5 5.0 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1OC1CCCCC1 10.1021/jm9000709
3038500 16112 12 None -831 6 Human 5.3 pEC50 = 5.3 Functional
In vitro functional efficacy in stimulating increase in cAMP in chinese hamster ovary (CHO) cells expressing the cloned human beta-1 receptor.In vitro functional efficacy in stimulating increase in cAMP in chinese hamster ovary (CHO) cells expressing the cloned human beta-1 receptor.
ChEMBL 624 11 3 7 6.6 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1 10.1021/jm000286i
CHEMBL111201 16112 12 None -831 6 Human 5.3 pEC50 = 5.3 Functional
In vitro functional efficacy in stimulating increase in cAMP in chinese hamster ovary (CHO) cells expressing the cloned human beta-1 receptor.In vitro functional efficacy in stimulating increase in cAMP in chinese hamster ovary (CHO) cells expressing the cloned human beta-1 receptor.
ChEMBL 624 11 3 7 6.6 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1 10.1021/jm000286i
10187653 11108 0 None -3 2 Human 6.3 pEC50 = 6.3 Functional
In vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptorIn vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptor
ChEMBL 554 11 5 7 3.5 O=C(Nc1ccccc1)Nc1ccc(S(=O)(=O)N2CCC(CNC[C@H](O)COc3ccc(O)cc3)CC2)cc1 10.1016/s0960-894x(02)00607-8
CHEMBL100970 11108 0 None -3 2 Human 6.3 pEC50 = 6.3 Functional
In vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptorIn vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptor
ChEMBL 554 11 5 7 3.5 O=C(Nc1ccccc1)Nc1ccc(S(=O)(=O)N2CCC(CNC[C@H](O)COc3ccc(O)cc3)CC2)cc1 10.1016/s0960-894x(02)00607-8
44396736 73642 0 None -11 3 Human 7.3 pEC50 = 7.3 Functional
Agonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptorAgonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptor
ChEMBL 617 12 4 9 5.1 C[C@H](Cc1c[nH]c2c(OS(=O)(=O)c3cccs3)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1016/j.bmcl.2004.10.035
CHEMBL186271 73642 0 None -11 3 Human 7.3 pEC50 = 7.3 Functional
Agonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptorAgonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptor
ChEMBL 617 12 4 9 5.1 C[C@H](Cc1c[nH]c2c(OS(=O)(=O)c3cccs3)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1016/j.bmcl.2004.10.035
44127056 202144 0 None 1 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 426 11 4 6 3.2 O=C(Cc1ccsc1)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/j.ejmech.2009.01.022
CHEMBL551892 202144 0 None 1 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 426 11 4 6 3.2 O=C(Cc1ccsc1)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/j.ejmech.2009.01.022
24949420 194894 1 None -51 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 422 6 3 4 4.3 O=C(O)c1ccc(-c2ccc3c(c2)C[C@@H](NC[C@H](O)c2cccc(Cl)c2)CC3)nc1 10.1021/jm800222k
CHEMBL498304 194894 1 None -51 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 422 6 3 4 4.3 O=C(O)c1ccc(-c2ccc3c(c2)C[C@@H](NC[C@H](O)c2cccc(Cl)c2)CC3)nc1 10.1021/jm800222k
42639652 19503 0 None -1513 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 495 11 3 6 3.5 CC(C)Cc1cc(-c2ccc(CCNC[C@H](O)c3cccnc3)cc2)ccc1C(=O)NS(C)(=O)=O 10.1021/jm9000709
CHEMBL1187716 19503 0 None -1513 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 495 11 3 6 3.5 CC(C)Cc1cc(-c2ccc(CCNC[C@H](O)c3cccnc3)cc2)ccc1C(=O)NS(C)(=O)=O 10.1021/jm9000709
CHEMBL516209 19503 0 None -1513 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 495 11 3 6 3.5 CC(C)Cc1cc(-c2ccc(CCNC[C@H](O)c3cccnc3)cc2)ccc1C(=O)NS(C)(=O)=O 10.1021/jm9000709
45483847 203591 0 None -2 2 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 432 7 4 5 4.0 CC(C)(Cc1ccc(-c2ccccc2)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1016/j.bmcl.2009.10.013
CHEMBL565686 203591 0 None -2 2 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 432 7 4 5 4.0 CC(C)(Cc1ccc(-c2ccccc2)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1016/j.bmcl.2009.10.013
45483816 203915 0 None -12 2 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 370 6 4 5 2.7 Cc1cccc(CC(C)(C)NCC(O)c2ccc(O)c3c2OCC(=O)N3)c1 10.1016/j.bmcl.2009.10.013
CHEMBL567833 203915 0 None -12 2 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 370 6 4 5 2.7 Cc1cccc(CC(C)(C)NCC(O)c2ccc(O)c3c2OCC(=O)N3)c1 10.1016/j.bmcl.2009.10.013
52947562 24459 0 None 3 3 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assayAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assay
ChEMBL 384 7 2 7 2.7 OC(CNC1CCN(c2ncnc3sccc23)CC1)COc1ccccc1 10.1016/j.bmcl.2010.08.039
CHEMBL1258486 24459 0 None 3 3 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assayAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assay
ChEMBL 384 7 2 7 2.7 OC(CNC1CCN(c2ncnc3sccc23)CC1)COc1ccccc1 10.1016/j.bmcl.2010.08.039
11026016 53474 0 None 1 3 Human 8.3 pEC50 = 8.3 Functional
Ability to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentrationAbility to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentration
ChEMBL 411 10 4 5 2.5 C[C@H](CNc1ccc(CNS(C)(=O)=O)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm0101500
CHEMBL153916 53474 0 None 1 3 Human 8.3 pEC50 = 8.3 Functional
Ability to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentrationAbility to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentration
ChEMBL 411 10 4 5 2.5 C[C@H](CNc1ccc(CNS(C)(=O)=O)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm0101500
10902809 54851 0 None 1 3 Human 8.3 pEC50 = 8.3 Functional
Ability to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentrationAbility to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentration
ChEMBL 304 7 3 3 3.5 C[C@H](CNc1ccccc1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm0101500
CHEMBL155072 54851 0 None 1 3 Human 8.3 pEC50 = 8.3 Functional
Ability to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentrationAbility to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentration
ChEMBL 304 7 3 3 3.5 C[C@H](CNc1ccccc1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm0101500
2419 10236 84 None -10 14 Guinea pig 8.3 pEC50 = 8.3 Functional
Agonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contractionAgonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contraction
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/jm801016j
5152 10236 84 None -10 14 Guinea pig 8.3 pEC50 = 8.3 Functional
Agonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contractionAgonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contraction
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/jm801016j
559 10236 84 None -10 14 Guinea pig 8.3 pEC50 = 8.3 Functional
Agonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contractionAgonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contraction
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/jm801016j
CHEMBL1263 10236 84 None -10 14 Guinea pig 8.3 pEC50 = 8.3 Functional
Agonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contractionAgonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contraction
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/jm801016j
DB00938 10236 84 None -10 14 Guinea pig 8.3 pEC50 = 8.3 Functional
Agonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contractionAgonist activity at beta-1 adrenergic receptor in guinea pig trachea assessed as inhibition of electrical stimulation-induced muscle contraction
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/jm801016j
155543358 181552 0 None -102 2 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 354 7 5 5 2.2 O=c1ccc2c(C(O)CNCCCc3ccccc3O)ccc(O)c2[nH]1 10.1016/j.bmc.2018.10.043
CHEMBL4561253 181552 0 None -102 2 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 354 7 5 5 2.2 O=c1ccc2c(C(O)CNCCCc3ccccc3O)ccc(O)c2[nH]1 10.1016/j.bmc.2018.10.043
45484568 205129 0 None -10 2 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelAgonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP level
ChEMBL 541 13 6 8 1.8 CN(C)CC(=O)NCCCC(=O)Nc1ccc(CC(C)(C)NCC(O)c2ccc(O)c3c2OCC(=O)N3)cc1 10.1016/j.bmcl.2009.06.104
CHEMBL576428 205129 0 None -10 2 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelAgonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP level
ChEMBL 541 13 6 8 1.8 CN(C)CC(=O)NCCCC(=O)Nc1ccc(CC(C)(C)NCC(O)c2ccc(O)c3c2OCC(=O)N3)cc1 10.1016/j.bmcl.2009.06.104
45483843 203815 0 None -9 2 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 384 7 4 5 2.9 CCc1ccc(CC(C)(C)NCC(O)c2ccc(O)c3c2OCC(=O)N3)cc1 10.1016/j.bmcl.2009.10.013
CHEMBL567192 203815 0 None -9 2 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 384 7 4 5 2.9 CCc1ccc(CC(C)(C)NCC(O)c2ccc(O)c3c2OCC(=O)N3)cc1 10.1016/j.bmcl.2009.10.013
45484569 204413 0 None -4 2 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelAgonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP level
ChEMBL 596 13 6 9 1.5 CN1CCN(CC(=O)NCCCC(=O)Nc2ccc(CC(C)(C)NCC(O)c3ccc(O)c4c3OCC(=O)N4)cc2)CC1 10.1016/j.bmcl.2009.06.104
CHEMBL570834 204413 0 None -4 2 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelAgonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP level
ChEMBL 596 13 6 9 1.5 CN1CCN(CC(=O)NCCCC(=O)Nc2ccc(CC(C)(C)NCC(O)c3ccc(O)c4c3OCC(=O)N4)cc2)CC1 10.1016/j.bmcl.2009.06.104
45268128 203101 0 None -1 3 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 427 10 4 4 3.9 O[C@@H](CNCCc1ccc(NC(=S)NC2CCCCC2)cc1)COc1ccccc1 10.1016/j.bmc.2009.06.031
CHEMBL1203988 203101 0 None -1 3 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 427 10 4 4 3.9 O[C@@H](CNCCc1ccc(NC(=S)NC2CCCCC2)cc1)COc1ccccc1 10.1016/j.bmc.2009.06.031
CHEMBL562315 203101 0 None -1 3 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 427 10 4 4 3.9 O[C@@H](CNCCc1ccc(NC(=S)NC2CCCCC2)cc1)COc1ccccc1 10.1016/j.bmc.2009.06.031
10233153 11001 0 None -5 3 Human 7.3 pEC50 = 7.3 Functional
Beta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptorBeta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptor
ChEMBL 642 11 5 9 3.1 CS(=O)(=O)Nc1cc([C@@H](O)CNCC2CCN(S(=O)(=O)c3ccc(-n4ccc5c(C(=O)O)cccc54)cc3)CC2)ccc1O 10.1016/s0960-894x(02)00608-x
CHEMBL100351 11001 0 None -5 3 Human 7.3 pEC50 = 7.3 Functional
Beta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptorBeta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptor
ChEMBL 642 11 5 9 3.1 CS(=O)(=O)Nc1cc([C@@H](O)CNCC2CCN(S(=O)(=O)c3ccc(-n4ccc5c(C(=O)O)cccc54)cc3)CC2)ccc1O 10.1016/s0960-894x(02)00608-x
10553602 133930 0 None -1 3 Human 7.3 pEC50 = 7.3 Functional
Increased cAMP levels of Chinese hamster ovary (CHO) cells expressing human beta 1 Adrenergic receptorIncreased cAMP levels of Chinese hamster ovary (CHO) cells expressing human beta 1 Adrenergic receptor
ChEMBL 506 10 6 8 0.9 CS(=O)(=O)Nc1cc([C@@H](O)CNC2CCN(c3ccc(C(=O)NCC(=O)O)cc3)CC2)ccc1O 10.1021/jm000544b
CHEMBL36568 133930 0 None -1 3 Human 7.3 pEC50 = 7.3 Functional
Increased cAMP levels of Chinese hamster ovary (CHO) cells expressing human beta 1 Adrenergic receptorIncreased cAMP levels of Chinese hamster ovary (CHO) cells expressing human beta 1 Adrenergic receptor
ChEMBL 506 10 6 8 0.9 CS(=O)(=O)Nc1cc([C@@H](O)CNC2CCN(c3ccc(C(=O)NCC(=O)O)cc3)CC2)ccc1O 10.1021/jm000544b
9893058 73156 0 None -39 3 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 525 17 5 8 2.9 O=c1ccn(-c2cccc(CCCCOCCCCCCNC[C@H](O)c3ccc(O)c(CO)c3)c2)c(=O)[nH]1 10.1016/j.bmc.2011.05.064
CHEMBL1814267 73156 0 None -39 3 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 525 17 5 8 2.9 O=c1ccn(-c2cccc(CCCCOCCCCCCNC[C@H](O)c3ccc(O)c(CO)c3)c2)c(=O)[nH]1 10.1016/j.bmc.2011.05.064
CHEMBL1851721 73156 0 None -39 3 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 525 17 5 8 2.9 O=c1ccn(-c2cccc(CCCCOCCCCCCNC[C@H](O)c3ccc(O)c(CO)c3)c2)c(=O)[nH]1 10.1016/j.bmc.2011.05.064
56678849 73400 0 None -63 3 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 541 18 5 8 2.7 O=C1NC(=O)N(Cc2cccc(CCCCOCCCCCCNC[C@H](O)c3ccc(O)c(CO)c3)c2)C1=O 10.1016/j.bmc.2011.05.064
CHEMBL1814275 73400 0 None -63 3 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 541 18 5 8 2.7 O=C1NC(=O)N(Cc2cccc(CCCCOCCCCCCNC[C@H](O)c3ccc(O)c(CO)c3)c2)C1=O 10.1016/j.bmc.2011.05.064
CHEMBL1852744 73400 0 None -63 3 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 541 18 5 8 2.7 O=C1NC(=O)N(Cc2cccc(CCCCOCCCCCCNC[C@H](O)c3ccc(O)c(CO)c3)c2)C1=O 10.1016/j.bmc.2011.05.064
56675663 73363 0 None -50 3 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 541 17 6 6 4.6 NC(=O)Nc1cc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc(C(F)(F)F)c1 10.1016/j.bmc.2011.08.043
CHEMBL1835861 73363 0 None -50 3 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 541 17 6 6 4.6 NC(=O)Nc1cc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc(C(F)(F)F)c1 10.1016/j.bmc.2011.08.043
CHEMBL1852575 73363 0 None -50 3 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 541 17 6 6 4.6 NC(=O)Nc1cc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc(C(F)(F)F)c1 10.1016/j.bmc.2011.08.043
46833102 20978 0 None -31 3 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 496 17 5 8 1.9 NS(=O)(=O)c1cccc(COCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm100326d
CHEMBL1084656 20978 0 None -31 3 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 496 17 5 8 1.9 NS(=O)(=O)c1cccc(COCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm100326d
CHEMBL1198882 20978 0 None -31 3 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 496 17 5 8 1.9 NS(=O)(=O)c1cccc(COCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm100326d
44574913 185355 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 526 15 2 6 4.5 CCCN(C(=O)Cc1nccn1Cc1ccccc1)c1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.03.044
CHEMBL467117 185355 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 526 15 2 6 4.5 CCCN(C(=O)Cc1nccn1Cc1ccccc1)c1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.03.044
24895667 183630 0 None -208 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 453 10 3 4 5.4 CC(C)Oc1cc(-c2ccc(CCNC[C@H](O)c3ccc(Cl)cc3)cc2)ccc1C(=O)O 10.1021/jm8000345
CHEMBL461282 183630 0 None -208 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 453 10 3 4 5.4 CC(C)Oc1cc(-c2ccc(CCNC[C@H](O)c3ccc(Cl)cc3)cc2)ccc1C(=O)O 10.1021/jm8000345
10003858 195874 1 None -3548 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 449 10 4 5 4.8 CC(C)Oc1cc(-c2ccc(CCN[C@@H](C)[C@H](O)c3ccc(O)cc3)cc2)ccc1C(=O)O 10.1021/jm8000345
CHEMBL510100 195874 1 None -3548 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 449 10 4 5 4.8 CC(C)Oc1cc(-c2ccc(CCN[C@@H](C)[C@H](O)c3ccc(O)cc3)cc2)ccc1C(=O)O 10.1021/jm8000345
42625513 19331 0 None -1000 4 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 494 17 5 7 2.8 NS(=O)(=O)c1ccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc1 10.1021/jm801016j
CHEMBL1186722 19331 0 None -1000 4 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 494 17 5 7 2.8 NS(=O)(=O)c1ccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc1 10.1021/jm801016j
CHEMBL475389 19331 0 None -1000 4 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 494 17 5 7 2.8 NS(=O)(=O)c1ccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc1 10.1021/jm801016j
42625515 19502 0 None -794 3 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 508 18 5 7 3.0 CNS(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm801016j
CHEMBL1187711 19502 0 None -794 3 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 508 18 5 7 3.0 CNS(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm801016j
CHEMBL516056 19502 0 None -794 3 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 508 18 5 7 3.0 CNS(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm801016j
11718543 172611 0 None -125 3 Human 5.3 pEC50 = 5.3 Functional
Activity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP productionActivity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP production
ChEMBL 411 9 4 5 3.8 O=C(O)c1cccc(-c2cccc(NCCNC[C@H](O)c3cccc(Cl)c3)c2)n1 10.1021/jm0509445
CHEMBL424866 172611 0 None -125 3 Human 5.3 pEC50 = 5.3 Functional
Activity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP productionActivity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP production
ChEMBL 411 9 4 5 3.8 O=C(O)c1cccc(-c2cccc(NCCNC[C@H](O)c3cccc(Cl)c3)c2)n1 10.1021/jm0509445
9801145 100197 0 None -630 3 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 400 9 4 5 4.0 O=C(O)c1ccoc1-c1cccc(NCCNC[C@H](O)c2cccc(Cl)c2)c1 10.1016/j.bmcl.2007.05.069
CHEMBL245874 100197 0 None -630 3 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 400 9 4 5 4.0 O=C(O)c1ccoc1-c1cccc(NCCNC[C@H](O)c2cccc(Cl)c2)c1 10.1016/j.bmcl.2007.05.069
11605652 19327 0 None -501 3 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 494 17 5 7 2.8 NS(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm801016j
CHEMBL1186715 19327 0 None -501 3 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 494 17 5 7 2.8 NS(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm801016j
CHEMBL475236 19327 0 None -501 3 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 494 17 5 7 2.8 NS(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm801016j
44392240 71093 0 None -6 2 Human 7.3 pEC50 = 7.3 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptor
ChEMBL 401 12 5 5 2.2 CCCNC(=O)Nc1ccc(C[C@@H](CO)NC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmcl.2004.11.001
CHEMBL181115 71093 0 None -6 2 Human 7.3 pEC50 = 7.3 Functional
Agonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptorAgonistic activity was assessed by measuring cAMP accumulation in CHO cell lines expressing cloned human Beta-1 adrenergic receptor
ChEMBL 401 12 5 5 2.2 CCCNC(=O)Nc1ccc(C[C@@H](CO)NC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmcl.2004.11.001
44580010 193578 0 None -46 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 441 10 3 5 4.7 COc1ccc(Oc2cccc(CCNC[C@H](O)c3cccc(Cl)c3)c2)cc1C(=O)O 10.1016/j.bmcl.2008.08.009
CHEMBL489199 193578 0 None -46 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 441 10 3 5 4.7 COc1ccc(Oc2cccc(CCNC[C@H](O)c3cccc(Cl)c3)c2)cc1C(=O)O 10.1016/j.bmcl.2008.08.009
24894319 196638 0 None -213 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 435 11 3 5 4.5 CC(C)Oc1cc(-c2ccc(OCCNC[C@H](O)c3ccccc3)cc2)ccc1C(=O)O 10.1021/jm8000345
CHEMBL516785 196638 0 None -213 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 435 11 3 5 4.5 CC(C)Oc1cc(-c2ccc(OCCNC[C@H](O)c3ccccc3)cc2)ccc1C(=O)O 10.1021/jm8000345
10202842 170938 0 None -16 2 Human 6.3 pEC50 = 6.3 Functional
In vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptorIn vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptor
ChEMBL 428 10 5 6 1.9 NC(=O)N1CCC(Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)CC1 10.1016/s0960-894x(01)00645-x
CHEMBL421030 170938 0 None -16 2 Human 6.3 pEC50 = 6.3 Functional
In vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptorIn vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptor
ChEMBL 428 10 5 6 1.9 NC(=O)N1CCC(Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)CC1 10.1016/s0960-894x(01)00645-x
24895561 183632 0 None -194 2 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 509 11 3 5 6.1 O=C(O)c1ccc(-c2ccc(OCCNC[C@H](O)c3cccc(Cl)c3)cc2)cc1OC1CCCCC1 10.1021/jm8000345
CHEMBL461301 183632 0 None -194 2 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 509 11 3 5 6.1 O=C(O)c1ccc(-c2ccc(OCCNC[C@H](O)c3cccc(Cl)c3)cc2)cc1OC1CCCCC1 10.1021/jm8000345
44331443 11221 0 None -26 3 Human 6.3 pEC50 = 6.3 Functional
Beta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptorBeta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptor
ChEMBL 689 14 7 9 2.3 CS(=O)(=O)Nc1cc([C@@H](O)CNCC2CCN(S(=O)(=O)c3ccc(NC(=O)N[C@@H](Cc4ccccc4)C(=O)O)cc3)CC2)ccc1O 10.1016/s0960-894x(02)00608-x
CHEMBL101674 11221 0 None -26 3 Human 6.3 pEC50 = 6.3 Functional
Beta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptorBeta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptor
ChEMBL 689 14 7 9 2.3 CS(=O)(=O)Nc1cc([C@@H](O)CNCC2CCN(S(=O)(=O)c3ccc(NC(=O)N[C@@H](Cc4ccccc4)C(=O)O)cc3)CC2)ccc1O 10.1016/s0960-894x(02)00608-x
44331351 214920 0 None -16 3 Human 6.3 pEC50 = 6.3 Functional
Beta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptorBeta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptor
ChEMBL 610 13 6 8 2.7 CS(=O)(=O)Nc1cc([C@@H](O)CNCC2CCN(c3ccc(C(=O)N[C@@H](Cc4ccccc4)C(=O)O)cc3)CC2)ccc1O 10.1016/s0960-894x(02)00608-x
CHEMBL98088 214920 0 None -16 3 Human 6.3 pEC50 = 6.3 Functional
Beta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptorBeta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptor
ChEMBL 610 13 6 8 2.7 CS(=O)(=O)Nc1cc([C@@H](O)CNCC2CCN(c3ccc(C(=O)N[C@@H](Cc4ccccc4)C(=O)O)cc3)CC2)ccc1O 10.1016/s0960-894x(02)00608-x
10209574 12211 0 None -22 2 Human 6.3 pEC50 = 6.3 Functional
In vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptorIn vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptor
ChEMBL 554 12 5 6 4.0 O=C(NCc1cc(F)ccc1F)N1CCC(Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)CC1 10.1016/s0960-894x(01)00645-x
CHEMBL107382 12211 0 None -22 2 Human 6.3 pEC50 = 6.3 Functional
In vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptorIn vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptor
ChEMBL 554 12 5 6 4.0 O=C(NCc1cc(F)ccc1F)N1CCC(Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)CC1 10.1016/s0960-894x(01)00645-x
10304565 114154 0 None -11 2 Human 6.3 pEC50 = 6.3 Functional
In vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptorIn vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptor
ChEMBL 622 12 5 7 3.6 O=C(NCc1cc(F)ccc1F)Nc1ccc(S(=O)(=O)N2CCC(CNC[C@H](O)COc3ccc(O)c(F)c3)CC2)cc1 10.1016/s0960-894x(02)00607-8
CHEMBL317809 114154 0 None -11 2 Human 6.3 pEC50 = 6.3 Functional
In vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptorIn vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptor
ChEMBL 622 12 5 7 3.6 O=C(NCc1cc(F)ccc1F)Nc1ccc(S(=O)(=O)N2CCC(CNC[C@H](O)COc3ccc(O)c(F)c3)CC2)cc1 10.1016/s0960-894x(02)00607-8
44396577 73726 0 None -25 3 Human 7.3 pEC50 = 7.3 Functional
Agonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptorAgonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptor
ChEMBL 561 12 4 6 5.9 C[C@H](Cc1c[nH]c2c(OCc3ccccc3)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1016/j.bmcl.2004.10.035
CHEMBL186676 73726 0 None -25 3 Human 7.3 pEC50 = 7.3 Functional
Agonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptorAgonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptor
ChEMBL 561 12 4 6 5.9 C[C@H](Cc1c[nH]c2c(OCc3ccccc3)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1016/j.bmcl.2004.10.035
24822817 102070 0 None -120 2 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 493 10 3 4 6.3 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)cc1OC1CCCCC1 10.1021/jm701324c
CHEMBL256418 102070 0 None -120 2 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 493 10 3 4 6.3 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)cc1OC1CCCCC1 10.1021/jm701324c
24822817 102070 0 None -120 2 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 493 10 3 4 6.3 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)cc1OC1CCCCC1 10.1021/jm8000345
CHEMBL256418 102070 0 None -120 2 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 493 10 3 4 6.3 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)cc1OC1CCCCC1 10.1021/jm8000345
24822817 102070 0 None -120 2 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 493 10 3 4 6.3 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)cc1OC1CCCCC1 10.1021/jm9000709
CHEMBL256418 102070 0 None -120 2 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 493 10 3 4 6.3 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)cc1OC1CCCCC1 10.1021/jm9000709
44237613 65007 0 None -2754 2 Rat 6.3 pEC50 = 6.3 Functional
Agonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effectAgonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effect
ChEMBL 502 10 6 6 3.4 COc1ccccc1CNC(=O)Nc1cccc(CCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1 10.1016/j.bmcl.2010.12.096
CHEMBL1682215 65007 0 None -2754 2 Rat 6.3 pEC50 = 6.3 Functional
Agonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effectAgonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effect
ChEMBL 502 10 6 6 3.4 COc1ccccc1CNC(=O)Nc1cccc(CCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1 10.1016/j.bmcl.2010.12.096
44580009 193580 0 None -42 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 425 9 3 4 5.0 Cc1ccc(Oc2cccc(CCNC[C@H](O)c3cccc(Cl)c3)c2)cc1C(=O)O 10.1016/j.bmcl.2008.08.009
CHEMBL489201 193580 0 None -42 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 425 9 3 4 5.0 Cc1ccc(Oc2cccc(CCNC[C@H](O)c3cccc(Cl)c3)c2)cc1C(=O)O 10.1016/j.bmcl.2008.08.009
44127575 201603 0 None -1 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 426 11 4 6 3.2 O=C(Cc1cccs1)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/j.ejmech.2009.01.022
CHEMBL539226 201603 0 None -1 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 426 11 4 6 3.2 O=C(Cc1cccs1)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/j.ejmech.2009.01.022
45270391 202233 0 None -1 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 459 11 4 6 3.8 O=C(CC1C=Nc2ccccc21)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/j.ejmech.2009.01.022
CHEMBL552434 202233 0 None -1 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 459 11 4 6 3.8 O=C(CC1C=Nc2ccccc21)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/j.ejmech.2009.01.022
45273276 202463 0 None -2 3 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay
ChEMBL 429 10 4 5 3.6 N#C/N=C(\Nc1ccccc1)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.06.031
CHEMBL1204005 202463 0 None -2 3 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay
ChEMBL 429 10 4 5 3.6 N#C/N=C(\Nc1ccccc1)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.06.031
CHEMBL556689 202463 0 None -2 3 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay
ChEMBL 429 10 4 5 3.6 N#C/N=C(\Nc1ccccc1)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.06.031
24822472 104189 0 None -38 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 409 8 3 3 4.9 Cc1cc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)ccc1C(=O)O 10.1021/jm701324c
CHEMBL269920 104189 0 None -38 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 409 8 3 3 4.9 Cc1cc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)ccc1C(=O)O 10.1021/jm701324c
44237670 65011 0 None -8128 2 Rat 5.2 pEC50 = 5.2 Functional
Agonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effectAgonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effect
ChEMBL 534 9 6 5 5.4 O=C(Nc1cccc(CCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1)Nc1ccccc1-c1ccccc1 10.1016/j.bmcl.2010.12.096
CHEMBL1682219 65011 0 None -8128 2 Rat 5.2 pEC50 = 5.2 Functional
Agonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effectAgonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effect
ChEMBL 534 9 6 5 5.4 O=C(Nc1cccc(CCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1)Nc1ccccc1-c1ccccc1 10.1016/j.bmcl.2010.12.096
44396737 73632 0 None -47 3 Human 7.2 pEC50 = 7.2 Functional
Agonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptorAgonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptor
ChEMBL 683 14 4 10 5.2 CCOC(=O)c1ccc(S(=O)(=O)Oc2cccc3c(C[C@@H](C)NC[C@H](O)c4cccc(NS(=O)(=O)c5cccs5)c4)c[nH]c23)cc1 10.1016/j.bmcl.2004.10.035
CHEMBL186236 73632 0 None -47 3 Human 7.2 pEC50 = 7.2 Functional
Agonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptorAgonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptor
ChEMBL 683 14 4 10 5.2 CCOC(=O)c1ccc(S(=O)(=O)Oc2cccc3c(C[C@@H](C)NC[C@H](O)c4cccc(NS(=O)(=O)c5cccs5)c4)c[nH]c23)cc1 10.1016/j.bmcl.2004.10.035
44444173 100756 0 None -8 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP levelAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP level
ChEMBL 516 11 4 7 3.3 CC(C)(Cc1ccc(Oc2ccc(C(N)=O)cn2)cc1)NC[C@H](O)COc1cccc2c1C1(CC1)C(=O)N2 10.1016/j.bmcl.2007.09.011
CHEMBL248547 100756 0 None -8 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP levelAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP level
ChEMBL 516 11 4 7 3.3 CC(C)(Cc1ccc(Oc2ccc(C(N)=O)cn2)cc1)NC[C@H](O)COc1cccc2c1C1(CC1)C(=O)N2 10.1016/j.bmcl.2007.09.011
44331426 11195 0 None -114 3 Human 6.2 pEC50 = 6.2 Functional
Beta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptorBeta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptor
ChEMBL 578 13 7 9 1.0 CS(=O)(=O)Nc1cc([C@@H](O)CNCC2CCN(c3ccc(C(=O)N[C@@H](CC(=O)O)C(=O)O)cc3)CC2)ccc1O 10.1016/s0960-894x(02)00608-x
CHEMBL101521 11195 0 None -114 3 Human 6.2 pEC50 = 6.2 Functional
Beta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptorBeta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptor
ChEMBL 578 13 7 9 1.0 CS(=O)(=O)Nc1cc([C@@H](O)CNCC2CCN(c3ccc(C(=O)N[C@@H](CC(=O)O)C(=O)O)cc3)CC2)ccc1O 10.1016/s0960-894x(02)00608-x
44127048 202134 0 None 1 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 436 11 5 6 2.6 O=C(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)C(O)c1ccccc1 10.1016/j.ejmech.2009.01.022
CHEMBL551832 202134 0 None 1 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 436 11 5 6 2.6 O=C(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)C(O)c1ccccc1 10.1016/j.ejmech.2009.01.022
1499 8872 47 None -60 38 Guinea pig 8.2 pEC50 = 8.2 Functional
Agonistic activity (beta-1 adrenergic receptor) for the percent maximal increase in contraction rate of isolated guinea pig atriaAgonistic activity (beta-1 adrenergic receptor) for the percent maximal increase in contraction rate of isolated guinea pig atria
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm00107a027
3779 8872 47 None -60 38 Guinea pig 8.2 pEC50 = 8.2 Functional
Agonistic activity (beta-1 adrenergic receptor) for the percent maximal increase in contraction rate of isolated guinea pig atriaAgonistic activity (beta-1 adrenergic receptor) for the percent maximal increase in contraction rate of isolated guinea pig atria
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm00107a027
536 8872 47 None -60 38 Guinea pig 8.2 pEC50 = 8.2 Functional
Agonistic activity (beta-1 adrenergic receptor) for the percent maximal increase in contraction rate of isolated guinea pig atriaAgonistic activity (beta-1 adrenergic receptor) for the percent maximal increase in contraction rate of isolated guinea pig atria
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm00107a027
CHEMBL434 8872 47 None -60 38 Guinea pig 8.2 pEC50 = 8.2 Functional
Agonistic activity (beta-1 adrenergic receptor) for the percent maximal increase in contraction rate of isolated guinea pig atriaAgonistic activity (beta-1 adrenergic receptor) for the percent maximal increase in contraction rate of isolated guinea pig atria
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm00107a027
DB01064 8872 47 None -60 38 Guinea pig 8.2 pEC50 = 8.2 Functional
Agonistic activity (beta-1 adrenergic receptor) for the percent maximal increase in contraction rate of isolated guinea pig atriaAgonistic activity (beta-1 adrenergic receptor) for the percent maximal increase in contraction rate of isolated guinea pig atria
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm00107a027
24936491 24292 0 None -2 3 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assayAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assay
ChEMBL 494 8 3 8 4.2 Oc1ccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccc(F)cc5)c34)CC2)cc1 10.1016/j.bmcl.2010.08.039
CHEMBL1257916 24292 0 None -2 3 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assayAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assay
ChEMBL 494 8 3 8 4.2 Oc1ccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccc(F)cc5)c34)CC2)cc1 10.1016/j.bmcl.2010.08.039
9845282 82727 0 None -63 3 Human 8.2 pEC50 = 8.2 Functional
Activity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP productionActivity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP production
ChEMBL 424 9 4 4 4.8 C[C@H](CNc1cccc(-c2cccc(C(=O)O)c2)c1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm0509445
CHEMBL205224 82727 0 None -63 3 Human 8.2 pEC50 = 8.2 Functional
Activity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP productionActivity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP production
ChEMBL 424 9 4 4 4.8 C[C@H](CNc1cccc(-c2cccc(C(=O)O)c2)c1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm0509445
155564079 182190 0 None -97 2 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 442 8 4 4 4.9 CC(C)(CC(c1ccccc1)c1ccccc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.bmc.2018.10.043
CHEMBL4575759 182190 0 None -97 2 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 442 8 4 4 4.9 CC(C)(CC(c1ccccc1)c1ccccc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.bmc.2018.10.043
56943515 119221 0 None -7 3 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 478 13 6 7 3.7 CC(C)(N)COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c(NC=O)c3)cc2)cc1 10.1016/j.bmcl.2014.04.095
CHEMBL3298213 119221 0 None -7 3 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 478 13 6 7 3.7 CC(C)(N)COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c(NC=O)c3)cc2)cc1 10.1016/j.bmcl.2014.04.095
11169365 119289 0 None -22 3 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 502 11 6 7 4.0 CC(C)(N)COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1 10.1016/j.bmcl.2014.04.095
CHEMBL3298986 119289 0 None -22 3 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 502 11 6 7 4.0 CC(C)(N)COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1 10.1016/j.bmcl.2014.04.095
164612262 195258 0 None -190 2 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 386 7 4 4 3.5 CC(CCc1ccc(Cl)cc1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
CHEMBL4853372 195258 0 None -190 2 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 386 7 4 4 3.5 CC(CCc1ccc(Cl)cc1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
CHEMBL5028127 195258 0 None -190 2 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 386 7 4 4 3.5 CC(CCc1ccc(Cl)cc1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
5493324 105678 24 None -208 3 Human 8.2 pEC50 = 8.2 Functional
Agonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-ARAgonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-AR
ChEMBL 402 9 4 4 3.5 C[C@H](Cc1c[nH]c2c(OCC(=O)O)cccc12)NC[C@H](O)c1cccc(Cl)c1 10.1016/s0960-894x(03)00073-8
CHEMBL279260 105678 24 None -208 3 Human 8.2 pEC50 = 8.2 Functional
Agonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-ARAgonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-AR
ChEMBL 402 9 4 4 3.5 C[C@H](Cc1c[nH]c2c(OCC(=O)O)cccc12)NC[C@H](O)c1cccc(Cl)c1 10.1016/s0960-894x(03)00073-8
24822972 104307 0 None 1 2 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 425 9 3 4 4.6 COc1cc(CCNC[C@H](O)c2cccc(Cl)c2)ccc1-c1ccc(C(=O)O)cc1 10.1021/jm701324c
CHEMBL270460 104307 0 None 1 2 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 425 9 3 4 4.6 COc1cc(CCNC[C@H](O)c2cccc(Cl)c2)ccc1-c1ccc(C(=O)O)cc1 10.1021/jm701324c
52948056 24291 0 None 1 3 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assayAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assay
ChEMBL 478 8 2 7 4.5 OC(CNC1CCN(c2ncnc3scc(-c4ccc(F)cc4)c23)CC1)COc1ccccc1 10.1016/j.bmcl.2010.08.039
CHEMBL1257915 24291 0 None 1 3 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assayAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assay
ChEMBL 478 8 2 7 4.5 OC(CNC1CCN(c2ncnc3scc(-c4ccc(F)cc4)c23)CC1)COc1ccccc1 10.1016/j.bmcl.2010.08.039
45483844 205175 0 None -4 2 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 398 7 4 5 3.5 CC(C)c1ccc(CC(C)(C)NCC(O)c2ccc(O)c3c2OCC(=O)N3)cc1 10.1016/j.bmcl.2009.10.013
CHEMBL576848 205175 0 None -4 2 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 398 7 4 5 3.5 CC(C)c1ccc(CC(C)(C)NCC(O)c2ccc(O)c3c2OCC(=O)N3)cc1 10.1016/j.bmcl.2009.10.013
155513474 176519 0 None -83 2 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 478 8 4 4 5.1 CC(C)(CC(c1ccc(F)cc1)c1ccc(F)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.bmc.2018.10.043
CHEMBL4438531 176519 0 None -83 2 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 478 8 4 4 5.1 CC(C)(CC(c1ccc(F)cc1)c1ccc(F)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.bmc.2018.10.043
164618278 195306 0 None -389 2 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 366 7 4 4 3.2 Cc1ccccc1CCC(C)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
CHEMBL4848018 195306 0 None -389 2 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 366 7 4 4 3.2 Cc1ccccc1CCC(C)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
CHEMBL5028489 195306 0 None -389 2 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 366 7 4 4 3.2 Cc1ccccc1CCC(C)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12 10.1016/j.ejmech.2021.113697
45271518 201863 0 None -6 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 479 11 4 6 3.9 COC(=O)c1ccc(NC(=S)Nc2ccc(CCNC[C@H](O)COc3ccccc3)cc2)cc1 10.1016/j.bmc.2009.06.031
CHEMBL1203999 201863 0 None -6 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 479 11 4 6 3.9 COC(=O)c1ccc(NC(=S)Nc2ccc(CCNC[C@H](O)COc3ccccc3)cc2)cc1 10.1016/j.bmc.2009.06.031
CHEMBL549689 201863 0 None -6 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 479 11 4 6 3.9 COC(=O)c1ccc(NC(=S)Nc2ccc(CCNC[C@H](O)COc3ccccc3)cc2)cc1 10.1016/j.bmc.2009.06.031
45270690 201900 0 None -3 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 466 11 4 6 4.0 O=[N+]([O-])c1ccccc1NC(=S)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.06.031
CHEMBL1203994 201900 0 None -3 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 466 11 4 6 4.0 O=[N+]([O-])c1ccccc1NC(=S)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.06.031
CHEMBL550037 201900 0 None -3 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 466 11 4 6 4.0 O=[N+]([O-])c1ccccc1NC(=S)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.06.031
45273281 202517 0 None -1 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 455 10 4 4 4.7 O[C@@H](CNCCc1ccc(NC(=S)Nc2ccccc2Cl)cc1)COc1ccccc1 10.1016/j.bmc.2009.06.031
CHEMBL2448075 202517 0 None -1 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 455 10 4 4 4.7 O[C@@H](CNCCc1ccc(NC(=S)Nc2ccccc2Cl)cc1)COc1ccccc1 10.1016/j.bmc.2009.06.031
CHEMBL557295 202517 0 None -1 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 455 10 4 4 4.7 O[C@@H](CNCCc1ccc(NC(=S)Nc2ccccc2Cl)cc1)COc1ccccc1 10.1016/j.bmc.2009.06.031
10008017 106648 10 None -7 3 Human 7.2 pEC50 = 7.2 Functional
Increased cAMP levels of Chinese hamster ovary (CHO) cells expressing human beta 1 Adrenergic receptorIncreased cAMP levels of Chinese hamster ovary (CHO) cells expressing human beta 1 Adrenergic receptor
ChEMBL 562 12 6 8 2.3 CC(C)C[C@H](NC(=O)c1ccc(N2CCC(NC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)CC2)cc1)C(=O)O 10.1021/jm000544b
CHEMBL285881 106648 10 None -7 3 Human 7.2 pEC50 = 7.2 Functional
Increased cAMP levels of Chinese hamster ovary (CHO) cells expressing human beta 1 Adrenergic receptorIncreased cAMP levels of Chinese hamster ovary (CHO) cells expressing human beta 1 Adrenergic receptor
ChEMBL 562 12 6 8 2.3 CC(C)C[C@H](NC(=O)c1ccc(N2CCC(NC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)CC2)cc1)C(=O)O 10.1021/jm000544b
44127782 203454 0 None -1 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 470 11 4 5 4.3 O=C(Cc1cccc2ccccc12)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/j.ejmech.2009.01.022
CHEMBL564556 203454 0 None -1 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 470 11 4 5 4.3 O=C(Cc1cccc2ccccc12)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/j.ejmech.2009.01.022
52944986 24385 0 None -72 3 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assayAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assay
ChEMBL 478 8 2 7 4.5 OC(CNC1CCN(c2ncnc3scc(-c4ccccc4)c23)CC1)COc1ccccc1F 10.1016/j.bmcl.2010.08.039
CHEMBL1258257 24385 0 None -72 3 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assayAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assay
ChEMBL 478 8 2 7 4.5 OC(CNC1CCN(c2ncnc3scc(-c4ccccc4)c23)CC1)COc1ccccc1F 10.1016/j.bmcl.2010.08.039
10187201 11953 0 None -77 2 Human 6.2 pEC50 = 6.2 Functional
In vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptorIn vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptor
ChEMBL 540 17 5 6 4.9 CCCCCCCCNC(=O)N1CCC(Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)CC1 10.1016/s0960-894x(01)00645-x
CHEMBL106022 11953 0 None -77 2 Human 6.2 pEC50 = 6.2 Functional
In vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptorIn vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptor
ChEMBL 540 17 5 6 4.9 CCCCCCCCNC(=O)N1CCC(Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)CC1 10.1016/s0960-894x(01)00645-x
44312924 171605 0 None -123 3 Human 5.2 pEC50 = 5.2 Functional
Compound was evaluated for its inhibitory activity against human beta-1 adrenergic receptor (AR)Compound was evaluated for its inhibitory activity against human beta-1 adrenergic receptor (AR)
ChEMBL 421 6 3 6 4.2 COc1cc(-c2ccc(CC3NCCc4cc(O)c(O)cc43)cc2)cc(OC)c1OC 10.1016/s0960-894x(00)00459-5
CHEMBL421871 171605 0 None -123 3 Human 5.2 pEC50 = 5.2 Functional
Compound was evaluated for its inhibitory activity against human beta-1 adrenergic receptor (AR)Compound was evaluated for its inhibitory activity against human beta-1 adrenergic receptor (AR)
ChEMBL 421 6 3 6 4.2 COc1cc(-c2ccc(CC3NCCc4cc(O)c(O)cc43)cc2)cc(OC)c1OC 10.1016/s0960-894x(00)00459-5
44219641 185218 0 None -5 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 498 13 3 6 4.1 CC(Cc1ccc(NC(=O)Cc2nccn2Cc2ccccc2)cc1)NC[C@H](O)COc1ccccc1 10.1016/j.bmc.2009.03.044
CHEMBL466088 185218 0 None -5 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 498 13 3 6 4.1 CC(Cc1ccc(NC(=O)Cc2nccn2Cc2ccccc2)cc1)NC[C@H](O)COc1ccccc1 10.1016/j.bmc.2009.03.044
24895791 193419 0 None -199 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 419 10 3 4 4.7 CCOc1cc(-c2ccc(C[C@@H](C)NC[C@H](O)c3ccccc3)cc2)ccc1C(=O)O 10.1021/jm8000345
CHEMBL488051 193419 0 None -199 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 419 10 3 4 4.7 CCOc1cc(-c2ccc(C[C@@H](C)NC[C@H](O)c3ccccc3)cc2)ccc1C(=O)O 10.1021/jm8000345
44580040 193899 0 None -389 3 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 510 10 4 5 5.7 CC(C)(C)C(=O)Nc1ccc(Oc2cccc(CCNC[C@H](O)c3cccc(Cl)c3)c2)cc1C(=O)O 10.1016/j.bmcl.2008.08.009
CHEMBL491645 193899 0 None -389 3 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 510 10 4 5 5.7 CC(C)(C)C(=O)Nc1ccc(Oc2cccc(CCNC[C@H](O)c3cccc(Cl)c3)c2)cc1C(=O)O 10.1016/j.bmcl.2008.08.009
24950560 179523 0 None -16 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 421 6 3 3 4.9 O=C(O)c1ccc(-c2ccc3c(c2)C[C@@H](NC[C@H](O)c2ccccc2Cl)CC3)cc1 10.1021/jm800222k
CHEMBL450842 179523 0 None -16 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 421 6 3 3 4.9 O=C(O)c1ccc(-c2ccc3c(c2)C[C@@H](NC[C@H](O)c2ccccc2Cl)CC3)cc1 10.1021/jm800222k
145984042 172454 0 None -1348 3 Human 5.2 pEC50 = 5.2 Functional
Antagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assayAntagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assay
ChEMBL 475 13 4 5 3.1 CC(=O)NCc1cccc(OC[C@@H](O)CNCCc2ccc(NC(=O)Cc3ccccc3)cc2)c1 10.1016/j.ejmech.2018.03.032
CHEMBL4244929 172454 0 None -1348 3 Human 5.2 pEC50 = 5.2 Functional
Antagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assayAntagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assay
ChEMBL 475 13 4 5 3.1 CC(=O)NCc1cccc(OC[C@@H](O)CNCCc2ccc(NC(=O)Cc3ccccc3)cc2)c1 10.1016/j.ejmech.2018.03.032
24824225 19595 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 454 11 3 5 4.4 CN(c1ccc(CCNC[C@H](O)c2cccc(Cl)c2)cc1)c1ccc(OCC(=O)O)cc1 10.1021/jm701324c
CHEMBL1188359 19595 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 454 11 3 5 4.4 CN(c1ccc(CCNC[C@H](O)c2cccc(Cl)c2)cc1)c1ccc(OCC(=O)O)cc1 10.1021/jm701324c
CHEMBL536108 19595 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 454 11 3 5 4.4 CN(c1ccc(CCNC[C@H](O)c2cccc(Cl)c2)cc1)c1ccc(OCC(=O)O)cc1 10.1021/jm701324c
10092953 104811 0 None -34 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 409 8 3 3 4.9 Cc1cc(C(=O)O)ccc1-c1ccc(CCNC[C@H](O)c2cccc(Cl)c2)cc1 10.1021/jm701324c
CHEMBL273028 104811 0 None -34 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 409 8 3 3 4.9 Cc1cc(C(=O)O)ccc1-c1ccc(CCNC[C@H](O)c2cccc(Cl)c2)cc1 10.1021/jm701324c
16049376 70875 0 None -44 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at adrenergic beta1 receptorAgonist activity at adrenergic beta1 receptor
ChEMBL 515 13 5 7 4.2 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCSCCNCCc3cccc(Cl)c3Cl)c2s1 10.1016/j.bmcl.2011.05.097
CHEMBL1807871 70875 0 None -44 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at adrenergic beta1 receptorAgonist activity at adrenergic beta1 receptor
ChEMBL 515 13 5 7 4.2 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCSCCNCCc3cccc(Cl)c3Cl)c2s1 10.1016/j.bmcl.2011.05.097
10238776 73250 0 None -79 4 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 473 17 6 6 3.6 NC(=O)Nc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1016/j.bmc.2011.08.043
CHEMBL1835853 73250 0 None -79 4 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 473 17 6 6 3.6 NC(=O)Nc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1016/j.bmc.2011.08.043
CHEMBL1852214 73250 0 None -79 4 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 473 17 6 6 3.6 NC(=O)Nc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1016/j.bmc.2011.08.043
24900689 77138 0 None -112 5 Human 7.2 pEC50 = 7.2 Functional
Binding affinity to beta1 adrenoceptor expressed in CHO cells by cAMP accumulation assayBinding affinity to beta1 adrenoceptor expressed in CHO cells by cAMP accumulation assay
ChEMBL 479 11 5 7 3.5 COc1ccccc1CNCc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1 10.1016/j.bmcl.2011.10.049
CHEMBL1945039 77138 0 None -112 5 Human 7.2 pEC50 = 7.2 Functional
Binding affinity to beta1 adrenoceptor expressed in CHO cells by cAMP accumulation assayBinding affinity to beta1 adrenoceptor expressed in CHO cells by cAMP accumulation assay
ChEMBL 479 11 5 7 3.5 COc1ccccc1CNCc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1 10.1016/j.bmcl.2011.10.049
11002571 54873 0 None 1 3 Human 6.2 pEC50 = 6.2 Functional
Ability to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentrationAbility to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentration
ChEMBL 348 8 4 4 3.2 C[C@H](CNc1ccc(C(=O)O)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm0101500
CHEMBL155092 54873 0 None 1 3 Human 6.2 pEC50 = 6.2 Functional
Ability to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentrationAbility to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentration
ChEMBL 348 8 4 4 3.2 C[C@H](CNc1ccc(C(=O)O)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm0101500
10346448 126608 0 None -891 3 Human 6.2 pEC50 = 6.2 Functional
Ability to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentrationAbility to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentration
ChEMBL 515 11 4 6 3.8 Cc1ccc(S(=O)(=O)NC(=O)Cc2ccc(NC[C@@H](C)NC[C@H](O)c3cccc(Cl)c3)cc2)cc1 10.1021/jm0101500
CHEMBL348501 126608 0 None -891 3 Human 6.2 pEC50 = 6.2 Functional
Ability to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentrationAbility to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentration
ChEMBL 515 11 4 6 3.8 Cc1ccc(S(=O)(=O)NC(=O)Cc2ccc(NC[C@@H](C)NC[C@H](O)c3cccc(Cl)c3)cc2)cc1 10.1021/jm0101500
11647543 145014 0 None -2511 3 Human 6.2 pEC50 = 6.2 Functional
Activity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP productionActivity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP production
ChEMBL 424 9 4 4 4.8 C[C@H](CNc1cccc(-c2ccccc2C(=O)O)c1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm0509445
CHEMBL377028 145014 0 None -2511 3 Human 6.2 pEC50 = 6.2 Functional
Activity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP productionActivity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP production
ChEMBL 424 9 4 4 4.8 C[C@H](CNc1cccc(-c2ccccc2C(=O)O)c1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm0509445
145987168 173994 0 None -316 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 354 7 4 5 2.1 COc1cccc(CCNC(CO)c2ccc(O)c3[nH]c(=O)ccc23)c1 10.1016/j.ejmech.2018.04.041
CHEMBL4291941 173994 0 None -316 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 354 7 4 5 2.1 COc1cccc(CCNC(CO)c2ccc(O)c3[nH]c(=O)ccc23)c1 10.1016/j.ejmech.2018.04.041
42625897 19248 0 None -501 3 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 564 18 4 8 3.1 O=S(=O)(c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1)N1CCOCC1 10.1021/jm801016j
CHEMBL1186265 19248 0 None -501 3 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 564 18 4 8 3.1 O=S(=O)(c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1)N1CCOCC1 10.1021/jm801016j
CHEMBL456485 19248 0 None -501 3 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 564 18 4 8 3.1 O=S(=O)(c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1)N1CCOCC1 10.1021/jm801016j
42625821 19316 0 None -630 3 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 522 18 4 7 3.4 CN(C)S(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm801016j
CHEMBL1186678 19316 0 None -630 3 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 522 18 4 7 3.4 CN(C)S(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm801016j
CHEMBL474393 19316 0 None -630 3 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 522 18 4 7 3.4 CN(C)S(=O)(=O)c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm801016j
44237614 65008 0 None -31622 2 Rat 5.2 pEC50 = 5.2 Functional
Agonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effectAgonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effect
ChEMBL 490 9 6 5 3.6 O=C(NCc1ccc(F)cc1)Nc1cccc(CCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1 10.1016/j.bmcl.2010.12.096
CHEMBL1682216 65008 0 None -31622 2 Rat 5.2 pEC50 = 5.2 Functional
Agonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effectAgonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effect
ChEMBL 490 9 6 5 3.6 O=C(NCc1ccc(F)cc1)Nc1cccc(CCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1 10.1016/j.bmcl.2010.12.096
44331444 11042 0 None -524 3 Human 5.2 pEC50 = 5.2 Functional
Beta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptorBeta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptor
ChEMBL 709 13 5 8 4.2 CC(C)N(Cc1cc(F)ccc1F)C(=O)Nc1ccc(S(=O)(=O)N2CCC(CNC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)CC2)cc1 10.1016/s0960-894x(02)00608-x
CHEMBL100589 11042 0 None -524 3 Human 5.2 pEC50 = 5.2 Functional
Beta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptorBeta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptor
ChEMBL 709 13 5 8 4.2 CC(C)N(Cc1cc(F)ccc1F)C(=O)Nc1ccc(S(=O)(=O)N2CCC(CNC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)CC2)cc1 10.1016/s0960-894x(02)00608-x
24824226 104218 0 None -1 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 439 11 3 4 4.3 O=C(O)COc1ccc(Cc2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)cc1 10.1021/jm701324c
CHEMBL270027 104218 0 None -1 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 439 11 3 4 4.3 O=C(O)COc1ccc(Cc2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)cc1 10.1021/jm701324c
44579925 191104 0 None -6 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 445 9 3 4 5.4 O=C(O)c1cc(Oc2cccc(CCNC[C@H](O)c3cccc(Cl)c3)c2)ccc1Cl 10.1016/j.bmcl.2008.08.009
CHEMBL484265 191104 0 None -6 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 445 9 3 4 5.4 O=C(O)c1cc(Oc2cccc(CCNC[C@H](O)c3cccc(Cl)c3)c2)ccc1Cl 10.1016/j.bmcl.2008.08.009
45483849 203956 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 388 6 3 3 4.5 CC(C)(Cc1cc(F)cc(F)c1)NCC(O)c1cc(Cl)c(N)c(Cl)c1 10.1016/j.bmcl.2009.10.013
CHEMBL568060 203956 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 388 6 3 3 4.5 CC(C)(Cc1cc(F)cc(F)c1)NCC(O)c1cc(Cl)c(N)c(Cl)c1 10.1016/j.bmcl.2009.10.013
24936488 24421 0 None -3 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assayAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assay
ChEMBL 414 7 3 8 2.7 Cc1csc2ncnc(N3CCC(NCC(O)COc4ccc(O)cc4)CC3)c12 10.1016/j.bmcl.2010.08.039
CHEMBL1258373 24421 0 None -3 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assayAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assay
ChEMBL 414 7 3 8 2.7 Cc1csc2ncnc(N3CCC(NCC(O)COc4ccc(O)cc4)CC3)c12 10.1016/j.bmcl.2010.08.039
44574759 185347 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 470 12 3 6 3.6 O=C(Cc1nccn1-c1ccccc1)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.03.044
CHEMBL467082 185347 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 470 12 3 6 3.6 O=C(Cc1nccn1-c1ccccc1)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.03.044
24950570 182209 0 None -794 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 439 6 3 3 5.0 O=C(O)c1ccc(-c2ccc3c(c2)C[C@@H](NC[C@H](O)c2ccc(Cl)cc2)CC3)cc1F 10.1021/jm800222k
CHEMBL457629 182209 0 None -794 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 439 6 3 3 5.0 O=C(O)c1ccc(-c2ccc3c(c2)C[C@@H](NC[C@H](O)c2ccc(Cl)cc2)CC3)cc1F 10.1021/jm800222k
44396532 73530 0 None -42 3 Human 7.2 pEC50 = 7.2 Functional
Agonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptorAgonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptor
ChEMBL 455 9 4 5 4.3 C[C@H](Cc1c[nH]c2ccccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1016/j.bmcl.2004.10.035
CHEMBL185836 73530 0 None -42 3 Human 7.2 pEC50 = 7.2 Functional
Agonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptorAgonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptor
ChEMBL 455 9 4 5 4.3 C[C@H](Cc1c[nH]c2ccccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1016/j.bmcl.2004.10.035
44127478 201993 0 None 1 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 435 11 5 6 2.6 NC(C(=O)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1ccccc1 10.1016/j.ejmech.2009.01.022
CHEMBL550743 201993 0 None 1 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 435 11 5 6 2.6 NC(C(=O)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1ccccc1 10.1016/j.ejmech.2009.01.022
2419 10236 84 None -1174 14 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human beta1 adrenoceptor expressed in CHO cells assessed as increase in intracellular cAMP level incubated for 1 hr by alphascreen technologyAgonist activity at human beta1 adrenoceptor expressed in CHO cells assessed as increase in intracellular cAMP level incubated for 1 hr by alphascreen technology
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/acs.jmedchem.0c01195
5152 10236 84 None -1174 14 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human beta1 adrenoceptor expressed in CHO cells assessed as increase in intracellular cAMP level incubated for 1 hr by alphascreen technologyAgonist activity at human beta1 adrenoceptor expressed in CHO cells assessed as increase in intracellular cAMP level incubated for 1 hr by alphascreen technology
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/acs.jmedchem.0c01195
559 10236 84 None -1174 14 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human beta1 adrenoceptor expressed in CHO cells assessed as increase in intracellular cAMP level incubated for 1 hr by alphascreen technologyAgonist activity at human beta1 adrenoceptor expressed in CHO cells assessed as increase in intracellular cAMP level incubated for 1 hr by alphascreen technology
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/acs.jmedchem.0c01195
CHEMBL1263 10236 84 None -1174 14 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human beta1 adrenoceptor expressed in CHO cells assessed as increase in intracellular cAMP level incubated for 1 hr by alphascreen technologyAgonist activity at human beta1 adrenoceptor expressed in CHO cells assessed as increase in intracellular cAMP level incubated for 1 hr by alphascreen technology
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/acs.jmedchem.0c01195
DB00938 10236 84 None -1174 14 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human beta1 adrenoceptor expressed in CHO cells assessed as increase in intracellular cAMP level incubated for 1 hr by alphascreen technologyAgonist activity at human beta1 adrenoceptor expressed in CHO cells assessed as increase in intracellular cAMP level incubated for 1 hr by alphascreen technology
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/acs.jmedchem.0c01195
24950053 194766 0 None -117 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 443 7 3 5 5.1 O=C(O)c1ccc(Oc2ccc3c(c2)C[C@@H](NC[C@H](O)c2cccc(Cl)c2)CC3)s1 10.1021/jm800222k
CHEMBL497280 194766 0 None -117 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 443 7 3 5 5.1 O=C(O)c1ccc(Oc2ccc3c(c2)C[C@@H](NC[C@H](O)c2cccc(Cl)c2)CC3)s1 10.1021/jm800222k
24950236 195851 0 None -89 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 534 9 4 5 6.8 O=C(O)c1cc(NC2CCCCC2)cc(Oc2ccc3c(c2)C[C@@H](NC[C@H](O)c2cccc(Cl)c2)CC3)c1 10.1021/jm800222k
CHEMBL509729 195851 0 None -89 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 534 9 4 5 6.8 O=C(O)c1cc(NC2CCCCC2)cc(Oc2ccc3c(c2)C[C@@H](NC[C@H](O)c2cccc(Cl)c2)CC3)c1 10.1021/jm800222k
44579649 193746 0 None -12 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 408 10 3 6 3.4 COc1ccc(Oc2cccc(CCNC[C@H](O)c3cccnc3)c2)cc1C(=O)O 10.1016/j.bmcl.2008.08.009
CHEMBL490415 193746 0 None -12 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 408 10 3 6 3.4 COc1ccc(Oc2cccc(CCNC[C@H](O)c3cccnc3)c2)cc1C(=O)O 10.1016/j.bmcl.2008.08.009
11224275 180273 0 None -1621 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 433 11 3 4 5.1 CCCOc1cc(-c2ccc(CCN[C@@H](C)[C@H](O)c3ccccc3)cc2)ccc1C(=O)O 10.1021/jm8000345
CHEMBL453048 180273 0 None -1621 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 433 11 3 4 5.1 CCCOc1cc(-c2ccc(CCN[C@@H](C)[C@H](O)c3ccccc3)cc2)ccc1C(=O)O 10.1021/jm8000345
45483839 203712 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 380 7 3 3 4.8 CCc1ccc(CC(C)(C)NCC(O)c2cc(Cl)c(N)c(Cl)c2)cc1 10.1016/j.bmcl.2009.10.013
CHEMBL566353 203712 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 380 7 3 3 4.8 CCc1ccc(CC(C)(C)NCC(O)c2cc(Cl)c(N)c(Cl)c2)cc1 10.1016/j.bmcl.2009.10.013
45483852 203536 0 None -14 2 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 392 6 4 5 2.6 CC(C)(Cc1cc(F)cc(F)c1)NCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1016/j.bmcl.2009.10.013
CHEMBL565267 203536 0 None -14 2 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 392 6 4 5 2.6 CC(C)(Cc1cc(F)cc(F)c1)NCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1016/j.bmcl.2009.10.013
155564766 182268 0 None -181 2 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 368 8 4 5 2.5 COc1cccc(CCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1 10.1016/j.bmc.2018.10.043
CHEMBL4577508 182268 0 None -181 2 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 368 8 4 5 2.5 COc1cccc(CCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1 10.1016/j.bmc.2018.10.043
12578 7723 61 None 186 3 Human 8.1 pEC50 = 8.1 Functional
Partial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrsPartial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrs
ChEMBL 219 4 3 4 1.2 CC(C)NCC(C1=CC(=C(C=C1)N)C#N)O 10.1021/jm400348g
2755 7723 61 None 186 3 Human 8.1 pEC50 = 8.1 Functional
Partial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrsPartial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrs
ChEMBL 219 4 3 4 1.2 CC(C)NCC(C1=CC(=C(C=C1)N)C#N)O 10.1021/jm400348g
CHEMBL1374751 7723 61 None 186 3 Human 8.1 pEC50 = 8.1 Functional
Partial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrsPartial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrs
ChEMBL 219 4 3 4 1.2 CC(C)NCC(C1=CC(=C(C=C1)N)C#N)O 10.1021/jm400348g
164620479 195323 0 None -288 2 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 396 8 4 5 3.3 COc1cccc(CCC(C)(C)NCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1 10.1016/j.ejmech.2021.113697
CHEMBL4863847 195323 0 None -288 2 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 396 8 4 5 3.3 COc1cccc(CCC(C)(C)NCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1 10.1016/j.ejmech.2021.113697
CHEMBL5028596 195323 0 None -288 2 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 396 8 4 5 3.3 COc1cccc(CCC(C)(C)NCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1 10.1016/j.ejmech.2021.113697
145985242 172324 0 None -6 3 Human 8.1 pEC50 = 8.1 Functional
Antagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assayAntagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assay
ChEMBL 443 11 4 4 3.9 O=C(Cc1ccccc1)Nc1ccc(CCNC[C@H](O)COc2cccc3[nH]ccc23)cc1 10.1016/j.ejmech.2018.03.032
CHEMBL4241613 172324 0 None -6 3 Human 8.1 pEC50 = 8.1 Functional
Antagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assayAntagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assay
ChEMBL 443 11 4 4 3.9 O=C(Cc1ccccc1)Nc1ccc(CCNC[C@H](O)COc2cccc3[nH]ccc23)cc1 10.1016/j.ejmech.2018.03.032
164617235 195298 0 None -251 2 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 396 8 4 5 3.3 COc1ccc(CCC(C)(C)NCC(O)c2ccc(O)c3[nH]c(=O)ccc23)cc1 10.1016/j.ejmech.2021.113697
CHEMBL4848775 195298 0 None -251 2 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 396 8 4 5 3.3 COc1ccc(CCC(C)(C)NCC(O)c2ccc(O)c3[nH]c(=O)ccc23)cc1 10.1016/j.ejmech.2021.113697
CHEMBL5028422 195298 0 None -251 2 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 396 8 4 5 3.3 COc1ccc(CCC(C)(C)NCC(O)c2ccc(O)c3[nH]c(=O)ccc23)cc1 10.1016/j.ejmech.2021.113697
11810896 126260 0 None -2 3 Human 8.1 pEC50 = 8.1 Functional
Ability to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentrationAbility to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentration
ChEMBL 375 9 4 4 3.1 CC(=O)NCc1ccc(NC[C@@H](C)NC[C@H](O)c2cccc(Cl)c2)cc1 10.1021/jm0101500
CHEMBL345304 126260 0 None -2 3 Human 8.1 pEC50 = 8.1 Functional
Ability to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentrationAbility to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentration
ChEMBL 375 9 4 4 3.1 CC(=O)NCc1ccc(NC[C@@H](C)NC[C@H](O)c2cccc(Cl)c2)cc1 10.1021/jm0101500
1499 8872 47 None -58 38 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmc.2011.05.064
3779 8872 47 None -58 38 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmc.2011.05.064
536 8872 47 None -58 38 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmc.2011.05.064
CHEMBL434 8872 47 None -58 38 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmc.2011.05.064
DB01064 8872 47 None -58 38 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmc.2011.05.064
9871386 119048 5 None -35 4 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 521 10 5 6 5.5 COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1-c1ccccc1 10.1016/j.bmcl.2014.04.095
CHEMBL3290999 119048 5 None -35 4 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 521 10 5 6 5.5 COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1-c1ccccc1 10.1016/j.bmcl.2014.04.095
66796015 119237 0 None -35 3 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 474 11 6 7 3.2 NCCOc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1 10.1016/j.bmcl.2014.04.095
CHEMBL3298328 119237 0 None -35 3 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 474 11 6 7 3.2 NCCOc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1 10.1016/j.bmcl.2014.04.095
56943518 119238 0 None -25 3 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 488 12 6 7 3.6 NCCCOc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1 10.1016/j.bmcl.2014.04.095
CHEMBL3298329 119238 0 None -25 3 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 488 12 6 7 3.6 NCCCOc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1 10.1016/j.bmcl.2014.04.095
56943545 119239 0 None -28 3 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 502 13 6 7 4.0 NCCCCOc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1 10.1016/j.bmcl.2014.04.095
CHEMBL3298330 119239 0 None -28 3 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 502 13 6 7 4.0 NCCCCOc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1 10.1016/j.bmcl.2014.04.095
56943546 119255 0 None -25 3 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 518 14 6 8 3.2 NCCOCCOc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1 10.1016/j.bmcl.2014.04.095
CHEMBL3298691 119255 0 None -25 3 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 518 14 6 8 3.2 NCCOCCOc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1 10.1016/j.bmcl.2014.04.095
56943517 119281 0 None -3 3 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 621 13 5 9 2.8 CS(=O)(=O)N1CCN(CCOc2ccc(Nc3ccc(CCNC[C@H](O)c4ccc(O)c5[nH]c(=O)ccc45)cc3)cc2)CC1 10.1016/j.bmcl.2014.04.095
CHEMBL3298832 119281 0 None -3 3 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assayAgonist activity at human beta1 adrenergic receptor expressed in cells by cAMP accumulation assay
ChEMBL 621 13 5 9 2.8 CS(=O)(=O)N1CCN(CCOc2ccc(Nc3ccc(CCNC[C@H](O)c4ccc(O)c5[nH]c(=O)ccc45)cc3)cc2)CC1 10.1016/j.bmcl.2014.04.095
1499 8872 47 None -58 38 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmc.2011.08.043
3779 8872 47 None -58 38 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmc.2011.08.043
536 8872 47 None -58 38 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmc.2011.08.043
CHEMBL434 8872 47 None -58 38 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmc.2011.08.043
DB01064 8872 47 None -58 38 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmc.2011.08.043
56678973 73353 0 None -7 3 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 555 18 6 6 5.6 O=C(Nc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1)NC1CCCCC1 10.1016/j.bmc.2011.08.043
CHEMBL1835855 73353 0 None -7 3 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 555 18 6 6 5.6 O=C(Nc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1)NC1CCCCC1 10.1016/j.bmc.2011.08.043
CHEMBL1852541 73353 0 None -7 3 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 555 18 6 6 5.6 O=C(Nc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1)NC1CCCCC1 10.1016/j.bmc.2011.08.043
56658407 73412 0 None -15 3 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 487 18 6 6 3.3 NC(=O)NCc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1016/j.bmc.2011.08.043
CHEMBL1835857 73412 0 None -15 3 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 487 18 6 6 3.3 NC(=O)NCc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1016/j.bmc.2011.08.043
CHEMBL1852796 73412 0 None -15 3 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 487 18 6 6 3.3 NC(=O)NCc1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1016/j.bmc.2011.08.043
1499 8872 47 None -58 38 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm801016j
3779 8872 47 None -58 38 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm801016j
536 8872 47 None -58 38 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm801016j
CHEMBL434 8872 47 None -58 38 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm801016j
DB01064 8872 47 None -58 38 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm801016j
1499 8872 47 None -58 38 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm100326d
3779 8872 47 None -58 38 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm100326d
536 8872 47 None -58 38 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm100326d
CHEMBL434 8872 47 None -58 38 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm100326d
DB01064 8872 47 None -58 38 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm100326d
10225563 20981 0 None -19 3 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 445 16 4 6 3.9 Cc1cc(C)cc(COCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm100326d
CHEMBL1084891 20981 0 None -19 3 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 445 16 4 6 3.9 Cc1cc(C)cc(COCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm100326d
CHEMBL1198889 20981 0 None -19 3 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 445 16 4 6 3.9 Cc1cc(C)cc(COCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm100326d
9871386 119048 5 None -35 4 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human recombinant beta1 receptor assessed as cAMP accumulation by radioimmunoassay and cell based assayAgonist activity at human recombinant beta1 receptor assessed as cAMP accumulation by radioimmunoassay and cell based assay
ChEMBL 521 10 5 6 5.5 COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1-c1ccccc1 10.1016/j.bmcl.2014.04.069
CHEMBL3290999 119048 5 None -35 4 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human recombinant beta1 receptor assessed as cAMP accumulation by radioimmunoassay and cell based assayAgonist activity at human recombinant beta1 receptor assessed as cAMP accumulation by radioimmunoassay and cell based assay
ChEMBL 521 10 5 6 5.5 COc1ccc(Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1-c1ccccc1 10.1016/j.bmcl.2014.04.069
45271517 201830 0 None -3 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 499 10 4 4 4.8 O[C@@H](CNCCc1ccc(NC(=S)Nc2ccc(Br)cc2)cc1)COc1ccccc1 10.1016/j.bmc.2009.06.031
CHEMBL1203998 201830 0 None -3 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 499 10 4 4 4.8 O[C@@H](CNCCc1ccc(NC(=S)Nc2ccc(Br)cc2)cc1)COc1ccccc1 10.1016/j.bmc.2009.06.031
CHEMBL549487 201830 0 None -3 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 499 10 4 4 4.8 O[C@@H](CNCCc1ccc(NC(=S)Nc2ccc(Br)cc2)cc1)COc1ccccc1 10.1016/j.bmc.2009.06.031
45272431 201888 0 None -6 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 547 10 4 4 4.7 O[C@@H](CNCCc1ccc(NC(=S)Nc2ccc(I)cc2)cc1)COc1ccccc1 10.1016/j.bmc.2009.06.031
CHEMBL1204002 201888 0 None -6 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 547 10 4 4 4.7 O[C@@H](CNCCc1ccc(NC(=S)Nc2ccc(I)cc2)cc1)COc1ccccc1 10.1016/j.bmc.2009.06.031
CHEMBL549960 201888 0 None -6 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 547 10 4 4 4.7 O[C@@H](CNCCc1ccc(NC(=S)Nc2ccc(I)cc2)cc1)COc1ccccc1 10.1016/j.bmc.2009.06.031
44517694 201950 0 None -3 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 451 11 4 5 4.1 COc1cccc(NC(=S)Nc2ccc(CCNC[C@H](O)COc3ccccc3)cc2)c1 10.1016/j.bmc.2009.06.031
CHEMBL1203996 201950 0 None -3 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 451 11 4 5 4.1 COc1cccc(NC(=S)Nc2ccc(CCNC[C@H](O)COc3ccccc3)cc2)c1 10.1016/j.bmc.2009.06.031
CHEMBL550445 201950 0 None -3 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 451 11 4 5 4.1 COc1cccc(NC(=S)Nc2ccc(CCNC[C@H](O)COc3ccccc3)cc2)c1 10.1016/j.bmc.2009.06.031
44517696 202550 0 None -3 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 451 11 4 5 4.1 COc1ccc(NC(=S)Nc2ccc(CCNC[C@H](O)COc3ccccc3)cc2)cc1 10.1016/j.bmc.2009.06.031
CHEMBL1204007 202550 0 None -3 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 451 11 4 5 4.1 COc1ccc(NC(=S)Nc2ccc(CCNC[C@H](O)COc3ccccc3)cc2)cc1 10.1016/j.bmc.2009.06.031
CHEMBL557705 202550 0 None -3 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 451 11 4 5 4.1 COc1ccc(NC(=S)Nc2ccc(CCNC[C@H](O)COc3ccccc3)cc2)cc1 10.1016/j.bmc.2009.06.031
24949891 194947 0 None -46 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 438 7 3 5 4.4 O=C(O)c1ccc(Oc2ccc3c(c2)C[C@@H](NC[C@H](O)c2cccc(Cl)c2)CC3)nc1 10.1021/jm800222k
CHEMBL498703 194947 0 None -46 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 438 7 3 5 4.4 O=C(O)c1ccc(Oc2ccc3c(c2)C[C@@H](NC[C@H](O)c2cccc(Cl)c2)CC3)nc1 10.1021/jm800222k
24937269 24419 0 None -2 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assayAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assay
ChEMBL 490 9 3 8 3.8 OCc1cccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)c1 10.1016/j.bmcl.2010.08.039
CHEMBL1258371 24419 0 None -2 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assayAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assay
ChEMBL 490 9 3 8 3.8 OCc1cccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)c1 10.1016/j.bmcl.2010.08.039
44127481 202931 0 None -1 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 450 12 4 6 3.2 COc1cccc(CC(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)c1 10.1016/j.ejmech.2009.01.022
CHEMBL561211 202931 0 None -1 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 450 12 4 6 3.2 COc1cccc(CC(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)c1 10.1016/j.ejmech.2009.01.022
11189433 207662 0 None -57 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 424 6 4 5 3.4 CC(C)(Cc1ccc(C(F)(F)F)cc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2 10.1016/j.bmcl.2009.12.087
CHEMBL601430 207662 0 None -57 2 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 424 6 4 5 3.4 CC(C)(Cc1ccc(C(F)(F)F)cc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2 10.1016/j.bmcl.2009.12.087
44396779 73835 0 None -17 3 Human 7.1 pEC50 = 7.1 Functional
Agonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptorAgonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptor
ChEMBL 611 12 4 8 5.1 C[C@H](Cc1c[nH]c2c(OS(=O)(=O)c3ccccc3)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1016/j.bmcl.2004.10.035
CHEMBL187209 73835 0 None -17 3 Human 7.1 pEC50 = 7.1 Functional
Agonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptorAgonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptor
ChEMBL 611 12 4 8 5.1 C[C@H](Cc1c[nH]c2c(OS(=O)(=O)c3ccccc3)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1016/j.bmcl.2004.10.035
155551133 180775 0 None -446 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 340 7 4 5 1.9 O=c1ccc2c(C(O)CNCCOc3ccccc3)ccc(O)c2[nH]1 10.1016/j.bmc.2018.10.043
CHEMBL4542430 180775 0 None -446 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 340 7 4 5 1.9 O=c1ccc2c(C(O)CNCCOc3ccccc3)ccc(O)c2[nH]1 10.1016/j.bmc.2018.10.043
24823127 104719 0 None -724 3 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 453 10 3 4 5.4 CC(C)Oc1cc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)ccc1C(=O)O 10.1021/jm701324c
CHEMBL272584 104719 0 None -724 3 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 453 10 3 4 5.4 CC(C)Oc1cc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)ccc1C(=O)O 10.1021/jm701324c
24823127 104719 0 None -724 3 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 453 10 3 4 5.4 CC(C)Oc1cc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)ccc1C(=O)O 10.1016/j.bmcl.2008.08.009
CHEMBL272584 104719 0 None -724 3 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 453 10 3 4 5.4 CC(C)Oc1cc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)ccc1C(=O)O 10.1016/j.bmcl.2008.08.009
44127050 203452 0 None 1 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 454 11 4 5 3.8 O=C(Cc1ccccc1Cl)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/j.ejmech.2009.01.022
CHEMBL564544 203452 0 None 1 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 454 11 4 5 3.8 O=C(Cc1ccccc1Cl)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/j.ejmech.2009.01.022
24823127 104719 0 None -724 3 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 453 10 3 4 5.4 CC(C)Oc1cc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)ccc1C(=O)O 10.1021/jm8000345
CHEMBL272584 104719 0 None -724 3 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 453 10 3 4 5.4 CC(C)Oc1cc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)ccc1C(=O)O 10.1021/jm8000345
24823127 104719 0 None -724 3 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 453 10 3 4 5.4 CC(C)Oc1cc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)ccc1C(=O)O 10.1021/jm9000709
CHEMBL272584 104719 0 None -724 3 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 453 10 3 4 5.4 CC(C)Oc1cc(-c2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)ccc1C(=O)O 10.1021/jm9000709
44589400 201359 0 None -3 3 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at adrenergic beta-1 receptorAgonist activity at adrenergic beta-1 receptor
ChEMBL 446 11 2 5 4.2 COc1ccc(CCNCC(O)COc2ccc3c(c2)CCCN3Cc2ccccc2)cc1 10.1016/j.bmc.2008.11.030
CHEMBL530556 201359 0 None -3 3 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at adrenergic beta-1 receptorAgonist activity at adrenergic beta-1 receptor
ChEMBL 446 11 2 5 4.2 COc1ccc(CCNCC(O)COc2ccc3c(c2)CCCN3Cc2ccccc2)cc1 10.1016/j.bmc.2008.11.030
45271886 202094 0 None -724 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as stimulation of cAMP level after 1 hr by enzyme immunoassayAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as stimulation of cAMP level after 1 hr by enzyme immunoassay
ChEMBL 508 11 3 5 4.5 CC(C)Cc1cc(-c2ccc(C[C@@H](C)NC[C@H](O)c3ccccc3)cc2)ccc1C(=O)NS(C)(=O)=O 10.1016/j.bmcl.2009.06.083
CHEMBL551532 202094 0 None -724 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as stimulation of cAMP level after 1 hr by enzyme immunoassayAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as stimulation of cAMP level after 1 hr by enzyme immunoassay
ChEMBL 508 11 3 5 4.5 CC(C)Cc1cc(-c2ccc(C[C@@H](C)NC[C@H](O)c3ccccc3)cc2)ccc1C(=O)NS(C)(=O)=O 10.1016/j.bmcl.2009.06.083
42639806 19290 0 None -40 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 468 10 3 6 2.9 COc1cc(-c2ccc(CCNC[C@H](O)c3ccccc3)cc2)ccc1C(=O)NS(C)(=O)=O 10.1021/jm9000709
CHEMBL1186584 19290 0 None -40 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 468 10 3 6 2.9 COc1cc(-c2ccc(CCNC[C@H](O)c3ccccc3)cc2)ccc1C(=O)NS(C)(=O)=O 10.1021/jm9000709
CHEMBL470858 19290 0 None -40 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 468 10 3 6 2.9 COc1cc(-c2ccc(CCNC[C@H](O)c3ccccc3)cc2)ccc1C(=O)NS(C)(=O)=O 10.1021/jm9000709
44331346 215168 0 None -120 3 Human 6.1 pEC50 = 6.1 Functional
Beta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptorBeta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptor
ChEMBL 638 17 5 8 4.2 CCCCCCCCC(=O)Nc1ccc(S(=O)(=O)N2CCC(CNC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)CC2)cc1 10.1016/s0960-894x(02)00608-x
CHEMBL99599 215168 0 None -120 3 Human 6.1 pEC50 = 6.1 Functional
Beta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptorBeta-1 adrenergic receptor agonist activity as increased cAMP levels in CHO cells expressing human Beta-1-adrenoceptor
ChEMBL 638 17 5 8 4.2 CCCCCCCCC(=O)Nc1ccc(S(=O)(=O)N2CCC(CNC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)CC2)cc1 10.1016/s0960-894x(02)00608-x
44560791 195875 0 None -154 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 376 8 3 4 3.7 C[C@H](Cc1ccc(-c2ccc(C(=O)O)cc2)cc1)NC[C@H](O)c1cccnc1 10.1021/jm8000345
CHEMBL510102 195875 0 None -154 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 376 8 3 4 3.7 C[C@H](Cc1ccc(-c2ccc(C(=O)O)cc2)cc1)NC[C@H](O)c1cccnc1 10.1021/jm8000345
42639808 19297 0 None -1230 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 522 11 3 6 4.2 CS(=O)(=O)NC(=O)c1ccc(-c2ccc(CCNC[C@H](O)c3ccccc3)cc2)cc1OC1CCCC1 10.1021/jm9000709
CHEMBL1186601 19297 0 None -1230 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 522 11 3 6 4.2 CS(=O)(=O)NC(=O)c1ccc(-c2ccc(CCNC[C@H](O)c3ccccc3)cc2)cc1OC1CCCC1 10.1021/jm9000709
CHEMBL472090 19297 0 None -1230 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 522 11 3 6 4.2 CS(=O)(=O)NC(=O)c1ccc(-c2ccc(CCNC[C@H](O)c3ccccc3)cc2)cc1OC1CCCC1 10.1021/jm9000709
10302915 12120 0 None -23 2 Human 6.1 pEC50 = 6.1 Functional
In vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptorIn vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptor
ChEMBL 554 12 5 6 4.0 O=C(NCc1c(F)cccc1F)N1CCC(Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)CC1 10.1016/s0960-894x(01)00645-x
CHEMBL106884 12120 0 None -23 2 Human 6.1 pEC50 = 6.1 Functional
In vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptorIn vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptor
ChEMBL 554 12 5 6 4.0 O=C(NCc1c(F)cccc1F)N1CCC(Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)CC1 10.1016/s0960-894x(01)00645-x
44127681 201995 0 None 2 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 420 11 4 5 3.1 O=C(Cc1ccccc1)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/j.ejmech.2009.01.022
CHEMBL550746 201995 0 None 2 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 420 11 4 5 3.1 O=C(Cc1ccccc1)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/j.ejmech.2009.01.022
164623544 195353 0 None -2754 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 406 7 4 4 3.5 O=c1ccc2c(C(O)CNCCCc3cccc(C(F)(F)F)c3)ccc(O)c2[nH]1 10.1016/j.ejmech.2021.113697
CHEMBL4872653 195353 0 None -2754 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 406 7 4 4 3.5 O=c1ccc2c(C(O)CNCCCc3cccc(C(F)(F)F)c3)ccc(O)c2[nH]1 10.1016/j.ejmech.2021.113697
CHEMBL5028764 195353 0 None -2754 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulationAgonist activity at human beta1 adrenoreceptor overexpressed in HEK293 cells assessed as cAMP accumulation
ChEMBL 406 7 4 4 3.5 O=c1ccc2c(C(O)CNCCCc3cccc(C(F)(F)F)c3)ccc(O)c2[nH]1 10.1016/j.ejmech.2021.113697
24949722 182310 0 None -223 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 455 6 3 3 5.3 O=C(O)c1ccc(-c2ccc3c(c2)C[C@@H](NC[C@H](O)c2ccc(C(F)(F)F)cc2)CC3)cc1 10.1021/jm800222k
CHEMBL457839 182310 0 None -223 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 455 6 3 3 5.3 O=C(O)c1ccc(-c2ccc3c(c2)C[C@@H](NC[C@H](O)c2ccc(C(F)(F)F)cc2)CC3)cc1 10.1021/jm800222k
11476004 180272 0 None -954 3 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 433 10 3 4 5.1 CC(C)Oc1cc(-c2ccc(CCN[C@@H](C)[C@H](O)c3ccccc3)cc2)ccc1C(=O)O 10.1021/jm8000345
CHEMBL453047 180272 0 None -954 3 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 433 10 3 4 5.1 CC(C)Oc1cc(-c2ccc(CCN[C@@H](C)[C@H](O)c3ccccc3)cc2)ccc1C(=O)O 10.1021/jm8000345
45269853 203347 0 None -4 2 Human 4.1 pEC50 = 4.1 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay
ChEMBL 426 11 3 5 3.1 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1)c1ccccc1 10.1016/j.bmc.2009.06.031
CHEMBL563872 203347 0 None -4 2 Human 4.1 pEC50 = 4.1 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay
ChEMBL 426 11 3 5 3.1 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1)c1ccccc1 10.1016/j.bmc.2009.06.031
9799092 54080 0 None -17 3 Human 7.1 pEC50 = 7.1 Functional
Ability to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentrationAbility to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentration
ChEMBL 362 9 4 4 3.1 C[C@H](CNc1ccc(CC(=O)O)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm0101500
CHEMBL154419 54080 0 None -17 3 Human 7.1 pEC50 = 7.1 Functional
Ability to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentrationAbility to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentration
ChEMBL 362 9 4 4 3.1 C[C@H](CNc1ccc(CC(=O)O)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm0101500
9799092 54080 0 None -17 3 Human 7.1 pEC50 = 7.1 Functional
Activity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP productionActivity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP production
ChEMBL 362 9 4 4 3.1 C[C@H](CNc1ccc(CC(=O)O)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm0509445
CHEMBL154419 54080 0 None -17 3 Human 7.1 pEC50 = 7.1 Functional
Activity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP productionActivity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP production
ChEMBL 362 9 4 4 3.1 C[C@H](CNc1ccc(CC(=O)O)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm0509445
56678847 73151 0 None -125 3 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 527 18 5 7 3.2 O=C1CN(Cc2cccc(CCCCOCCCCCCNC[C@H](O)c3ccc(O)c(CO)c3)c2)C(=O)N1 10.1016/j.bmc.2011.05.064
CHEMBL1814274 73151 0 None -125 3 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 527 18 5 7 3.2 O=C1CN(Cc2cccc(CCCCOCCCCCCNC[C@H](O)c3ccc(O)c(CO)c3)c2)C(=O)N1 10.1016/j.bmc.2011.05.064
CHEMBL1851691 73151 0 None -125 3 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 527 18 5 7 3.2 O=C1CN(Cc2cccc(CCCCOCCCCCCNC[C@H](O)c3ccc(O)c(CO)c3)c2)C(=O)N1 10.1016/j.bmc.2011.05.064
56678845 73180 0 None -39 3 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 513 17 5 7 3.2 O=C1CNC(=O)N1c1ccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc1 10.1016/j.bmc.2011.05.064
CHEMBL1814269 73180 0 None -39 3 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 513 17 5 7 3.2 O=C1CNC(=O)N1c1ccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc1 10.1016/j.bmc.2011.05.064
CHEMBL1851839 73180 0 None -39 3 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 513 17 5 7 3.2 O=C1CNC(=O)N1c1ccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc1 10.1016/j.bmc.2011.05.064
9871096 73424 0 None -125 4 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 513 17 5 7 3.2 O=C1CNC(=O)N1c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1016/j.bmc.2011.05.064
CHEMBL1814268 73424 0 None -125 4 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 513 17 5 7 3.2 O=C1CNC(=O)N1c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1016/j.bmc.2011.05.064
CHEMBL1852860 73424 0 None -125 4 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 513 17 5 7 3.2 O=C1CNC(=O)N1c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1016/j.bmc.2011.05.064
9799092 54080 0 None -17 3 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 362 9 4 4 3.1 C[C@H](CNc1ccc(CC(=O)O)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1016/j.bmcl.2007.05.069
CHEMBL154419 54080 0 None -17 3 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 362 9 4 4 3.1 C[C@H](CNc1ccc(CC(=O)O)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1016/j.bmcl.2007.05.069
44441229 100524 0 None -100 3 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 431 9 4 6 4.3 C[C@H](CNc1cccc(-c2nc(C(=O)O)cs2)c1)NC[C@H](O)c1cccc(Cl)c1 10.1016/j.bmcl.2007.05.069
CHEMBL247315 100524 0 None -100 3 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 431 9 4 6 4.3 C[C@H](CNc1cccc(-c2nc(C(=O)O)cs2)c1)NC[C@H](O)c1cccc(Cl)c1 10.1016/j.bmcl.2007.05.069
46833103 14185 0 None -10 3 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 433 16 5 7 3.0 OCc1cc([C@@H](O)CNCCCCCCOCCOCc2ccc(O)cc2)ccc1O 10.1021/jm100326d
CHEMBL1086535 14185 0 None -10 3 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 433 16 5 7 3.0 OCc1cc([C@@H](O)CNCCCCCCOCCOCc2ccc(O)cc2)ccc1O 10.1021/jm100326d
11060184 126508 0 None -1000 3 Human 6.1 pEC50 = 6.1 Functional
Ability to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentrationAbility to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentration
ChEMBL 501 11 4 6 3.5 C[C@H](CNc1ccc(CC(=O)NS(=O)(=O)c2ccccc2)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm0101500
CHEMBL347616 126508 0 None -1000 3 Human 6.1 pEC50 = 6.1 Functional
Ability to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentrationAbility to cause cAMP accumulation in CHO cells expressing human beta-1 AR expressed as the negative logarithm of the molar drug concentration
ChEMBL 501 11 4 6 3.5 C[C@H](CNc1ccc(CC(=O)NS(=O)(=O)c2ccccc2)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm0101500
9823696 82550 0 None -501 3 Human 6.1 pEC50 = 6.1 Functional
Activity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP productionActivity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP production
ChEMBL 424 9 4 4 4.7 Cc1ccc(C(=O)O)cc1-c1cccc(NCCNC[C@H](O)c2cccc(Cl)c2)c1 10.1021/jm0509445
CHEMBL204827 82550 0 None -501 3 Human 6.1 pEC50 = 6.1 Functional
Activity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP productionActivity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP production
ChEMBL 424 9 4 4 4.7 Cc1ccc(C(=O)O)cc1-c1cccc(NCCNC[C@H](O)c2cccc(Cl)c2)c1 10.1021/jm0509445
11495581 84097 0 None -25 3 Human 6.1 pEC50 = 6.1 Functional
Activity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP productionActivity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP production
ChEMBL 425 9 4 5 4.2 C[C@H](CNc1cccc(-c2ncccc2C(=O)O)c1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm0509445
CHEMBL208328 84097 0 None -25 3 Human 6.1 pEC50 = 6.1 Functional
Activity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP productionActivity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP production
ChEMBL 425 9 4 5 4.2 C[C@H](CNc1cccc(-c2ncccc2C(=O)O)c1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm0509445
11546349 148111 0 None -25 3 Human 6.1 pEC50 = 6.1 Functional
Activity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP productionActivity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP production
ChEMBL 424 9 4 4 4.8 C[C@H](CNc1cccc(-c2ccc(C(=O)O)cc2)c1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm0509445
CHEMBL383511 148111 0 None -25 3 Human 6.1 pEC50 = 6.1 Functional
Activity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP productionActivity at human beta-1 adrenergic receptor expressed in CHO cells by stimulation of cAMP production
ChEMBL 424 9 4 4 4.8 C[C@H](CNc1cccc(-c2ccc(C(=O)O)cc2)c1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm0509445
2419 10236 84 None -1174 14 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at adrenergic beta1 receptorAgonist activity at adrenergic beta1 receptor
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2011.05.097
5152 10236 84 None -1174 14 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at adrenergic beta1 receptorAgonist activity at adrenergic beta1 receptor
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2011.05.097
559 10236 84 None -1174 14 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at adrenergic beta1 receptorAgonist activity at adrenergic beta1 receptor
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2011.05.097
CHEMBL1263 10236 84 None -1174 14 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at adrenergic beta1 receptorAgonist activity at adrenergic beta1 receptor
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2011.05.097
DB00938 10236 84 None -1174 14 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at adrenergic beta1 receptorAgonist activity at adrenergic beta1 receptor
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2011.05.097
2419 10236 84 None -1174 14 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmc.2011.05.064
5152 10236 84 None -1174 14 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmc.2011.05.064
559 10236 84 None -1174 14 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmc.2011.05.064
CHEMBL1263 10236 84 None -1174 14 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmc.2011.05.064
DB00938 10236 84 None -1174 14 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human adrenergic beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmc.2011.05.064
2419 10236 84 None -1174 14 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmc.2011.08.043
5152 10236 84 None -1174 14 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmc.2011.08.043
559 10236 84 None -1174 14 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmc.2011.08.043
CHEMBL1263 10236 84 None -1174 14 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmc.2011.08.043
DB00938 10236 84 None -1174 14 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmc.2011.08.043
2419 10236 84 None -1174 14 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/jm801016j
5152 10236 84 None -1174 14 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/jm801016j
559 10236 84 None -1174 14 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/jm801016j
CHEMBL1263 10236 84 None -1174 14 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/jm801016j
DB00938 10236 84 None -1174 14 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/jm801016j
2419 10236 84 None -1174 14 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/jm100326d
5152 10236 84 None -1174 14 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/jm100326d
559 10236 84 None -1174 14 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/jm100326d
CHEMBL1263 10236 84 None -1174 14 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/jm100326d
DB00938 10236 84 None -1174 14 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 minsAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation after 30 to 45 mins
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/jm100326d
10940242 171977 0 None -79 3 Human 6.1 pEC50 = 6.1 Functional
Concentration that causes 50% inhibition of human beta 1 adrenergic receptor (AR), expressed in CHO cells.Concentration that causes 50% inhibition of human beta 1 adrenergic receptor (AR), expressed in CHO cells.
ChEMBL 515 12 4 6 3.8 C[C@H](CNc1ccc(CCS(=O)(=O)NC(=O)c2ccccc2)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm0101500
CHEMBL422876 171977 0 None -79 3 Human 6.1 pEC50 = 6.1 Functional
Concentration that causes 50% inhibition of human beta 1 adrenergic receptor (AR), expressed in CHO cells.Concentration that causes 50% inhibition of human beta 1 adrenergic receptor (AR), expressed in CHO cells.
ChEMBL 515 12 4 6 3.8 C[C@H](CNc1ccc(CCS(=O)(=O)NC(=O)c2ccccc2)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm0101500
42625743 19373 0 None -39 3 Human 4.1 pEC50 = 4.1 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 494 17 5 7 2.8 NS(=O)(=O)c1cccc(CCCCCCOCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm801016j
CHEMBL1186943 19373 0 None -39 3 Human 4.1 pEC50 = 4.1 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 494 17 5 7 2.8 NS(=O)(=O)c1cccc(CCCCCCOCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm801016j
CHEMBL483407 19373 0 None -39 3 Human 4.1 pEC50 = 4.1 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assayAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as induction of intracellular cAMP accumulation by beta-galactosidase based whole cell assay
ChEMBL 494 17 5 7 2.8 NS(=O)(=O)c1cccc(CCCCCCOCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1 10.1021/jm801016j
559929 11672 11 None 4 2 Guinea pig 8.1 pEC50 = 8.1 Functional
Agonistic activity (beta-1 adrenergic receptor) for the percent maximal increase in contraction rate of isolated guinea pig atriaAgonistic activity (beta-1 adrenergic receptor) for the percent maximal increase in contraction rate of isolated guinea pig atria
ChEMBL 273 5 4 5 1.4 CC(C)(C)NCC(O)COc1ccc(O)c(O)c1F 10.1021/jm00107a027
CHEMBL10453 11672 11 None 4 2 Guinea pig 8.1 pEC50 = 8.1 Functional
Agonistic activity (beta-1 adrenergic receptor) for the percent maximal increase in contraction rate of isolated guinea pig atriaAgonistic activity (beta-1 adrenergic receptor) for the percent maximal increase in contraction rate of isolated guinea pig atria
ChEMBL 273 5 4 5 1.4 CC(C)(C)NCC(O)COc1ccc(O)c(O)c1F 10.1021/jm00107a027
44419332 148538 0 None -1 3 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP levelsAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP levels
ChEMBL 505 11 4 8 2.5 Cn1c(=O)[nH]c2cccc(OC[C@@H](O)CNC(C)(C)Cc3ccc(Oc4ccc(C(N)=O)cn4)cc3)c21 10.1016/j.bmcl.2006.08.010
CHEMBL386016 148538 0 None -1 3 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP levelsAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP levels
ChEMBL 505 11 4 8 2.5 Cn1c(=O)[nH]c2cccc(OC[C@@H](O)CNC(C)(C)Cc3ccc(Oc4ccc(C(N)=O)cn4)cc3)c21 10.1016/j.bmcl.2006.08.010
46889771 13766 0 None 1 3 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human adrenergic beta-1 receptor expressed in CHOK1 cells assessed as cAMP accumulation by HTRF assayAgonist activity at human adrenergic beta-1 receptor expressed in CHOK1 cells assessed as cAMP accumulation by HTRF assay
ChEMBL 549 7 3 6 4.9 O=C1c2cccc3cc(O)cc(c23)C(=O)N1CC1CCN(CC(O)COc2cccc3[nH]c4ccccc4c23)CC1 10.1016/j.bmcl.2010.04.009
CHEMBL1084706 13766 0 None 1 3 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human adrenergic beta-1 receptor expressed in CHOK1 cells assessed as cAMP accumulation by HTRF assayAgonist activity at human adrenergic beta-1 receptor expressed in CHOK1 cells assessed as cAMP accumulation by HTRF assay
ChEMBL 549 7 3 6 4.9 O=C1c2cccc3cc(O)cc(c23)C(=O)N1CC1CCN(CC(O)COc2cccc3[nH]c4ccccc4c23)CC1 10.1016/j.bmcl.2010.04.009
45268136 203164 0 None -2 3 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 466 11 4 6 4.0 O=[N+]([O-])c1cccc(NC(=S)Nc2ccc(CCNC[C@H](O)COc3ccccc3)cc2)c1 10.1016/j.bmc.2009.06.031
CHEMBL1203989 203164 0 None -2 3 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 466 11 4 6 4.0 O=[N+]([O-])c1cccc(NC(=S)Nc2ccc(CCNC[C@H](O)COc3ccccc3)cc2)c1 10.1016/j.bmc.2009.06.031
CHEMBL562669 203164 0 None -2 3 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 466 11 4 6 4.0 O=[N+]([O-])c1cccc(NC(=S)Nc2ccc(CCNC[C@H](O)COc3ccccc3)cc2)c1 10.1016/j.bmc.2009.06.031
44560792 180167 0 None -794 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 434 10 3 5 4.5 CC(C)Oc1cc(-c2ccc(C[C@@H](C)NC[C@H](O)c3cccnc3)cc2)ccc1C(=O)O 10.1021/jm8000345
CHEMBL452798 180167 0 None -794 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 434 10 3 5 4.5 CC(C)Oc1cc(-c2ccc(C[C@@H](C)NC[C@H](O)c3cccnc3)cc2)ccc1C(=O)O 10.1021/jm8000345
24950718 182777 0 None -398 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 435 6 3 3 5.2 Cc1cc(C(=O)O)ccc1-c1ccc2c(c1)C[C@@H](NC[C@H](O)c1ccc(Cl)cc1)CC2 10.1021/jm800222k
CHEMBL458927 182777 0 None -398 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 435 6 3 3 5.2 Cc1cc(C(=O)O)ccc1-c1ccc2c(c1)C[C@@H](NC[C@H](O)c1ccc(Cl)cc1)CC2 10.1021/jm800222k
11272641 19215 0 None -6165 3 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 537 11 3 7 4.0 CS(=O)(=O)NC(=O)c1ccc(-c2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1OC1CCCCC1 10.1021/jm9000709
CHEMBL1186009 19215 0 None -6165 3 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 537 11 3 7 4.0 CS(=O)(=O)NC(=O)c1ccc(-c2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1OC1CCCCC1 10.1021/jm9000709
CHEMBL445481 19215 0 None -6165 3 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 537 11 3 7 4.0 CS(=O)(=O)NC(=O)c1ccc(-c2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1OC1CCCCC1 10.1021/jm9000709
25071020 199964 0 None -251 3 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 469 11 3 5 5.5 CC(C)Oc1ccc(Oc2cccc(CCNC[C@H](O)c3cccc(Cl)c3)c2)cc1C(=O)O 10.1016/j.bmcl.2008.08.009
CHEMBL523265 199964 0 None -251 3 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 469 11 3 5 5.5 CC(C)Oc1ccc(Oc2cccc(CCNC[C@H](O)c3cccc(Cl)c3)c2)cc1C(=O)O 10.1016/j.bmcl.2008.08.009
24949726 196319 0 None -457 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 435 6 3 3 5.2 Cc1cc(-c2ccc3c(c2)C[C@@H](NC[C@H](O)c2ccc(Cl)cc2)CC3)ccc1C(=O)O 10.1021/jm800222k
CHEMBL514265 196319 0 None -457 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 435 6 3 3 5.2 Cc1cc(-c2ccc3c(c2)C[C@@H](NC[C@H](O)c2ccc(Cl)cc2)CC3)ccc1C(=O)O 10.1021/jm800222k
44127479 202958 0 None 10 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 454 11 4 5 3.8 O=C(Cc1cccc(Cl)c1)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/j.ejmech.2009.01.022
CHEMBL561348 202958 0 None 10 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 454 11 4 5 3.8 O=C(Cc1cccc(Cl)c1)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/j.ejmech.2009.01.022
24895359 199273 0 None -104 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 405 9 3 4 4.3 COc1cc(-c2ccc(C[C@@H](C)NC[C@H](O)c3ccccc3)cc2)ccc1C(=O)O 10.1021/jm8000345
CHEMBL520903 199273 0 None -104 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 405 9 3 4 4.3 COc1cc(-c2ccc(C[C@@H](C)NC[C@H](O)c3ccccc3)cc2)ccc1C(=O)O 10.1021/jm8000345
145989075 173871 0 None -524 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 324 6 4 4 2.1 O=c1ccc2c(C(CO)NCCc3ccccc3)ccc(O)c2[nH]1 10.1016/j.ejmech.2018.04.041
CHEMBL4289813 173871 0 None -524 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 324 6 4 4 2.1 O=c1ccc2c(C(CO)NCCc3ccccc3)ccc(O)c2[nH]1 10.1016/j.ejmech.2018.04.041
145994130 174160 0 None -83 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 338 7 4 4 2.5 O=c1ccc2c(C(CO)NCCCc3ccccc3)ccc(O)c2[nH]1 10.1016/j.ejmech.2018.04.041
CHEMBL4294937 174160 0 None -83 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 338 7 4 4 2.5 O=c1ccc2c(C(CO)NCCCc3ccccc3)ccc(O)c2[nH]1 10.1016/j.ejmech.2018.04.041
24894315 179752 0 None -165 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 469 11 3 5 5.2 CC(C)Oc1cc(-c2ccc(OCCNC[C@H](O)c3cccc(Cl)c3)cc2)ccc1C(=O)O 10.1021/jm8000345
CHEMBL451772 179752 0 None -165 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 469 11 3 5 5.2 CC(C)Oc1cc(-c2ccc(OCCNC[C@H](O)c3cccc(Cl)c3)cc2)ccc1C(=O)O 10.1021/jm8000345
44580042 199878 0 None -26 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 396 9 3 5 3.6 O=C(O)c1cc(Oc2cccc(CCNC[C@H](O)c3cccnc3)c2)ccc1F 10.1016/j.bmcl.2008.08.009
CHEMBL522641 199878 0 None -26 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 396 9 3 5 3.6 O=C(O)c1cc(Oc2cccc(CCNC[C@H](O)c3cccnc3)c2)ccc1F 10.1016/j.bmcl.2008.08.009
42639491 19343 0 None -1659 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 552 11 3 6 5.3 CS(=O)(=O)NC(=O)c1ccc(-c2ccc(CCNC[C@H](O)c3ccccc3)cc2)cc1SC1CCCCC1 10.1021/jm9000709
CHEMBL1186805 19343 0 None -1659 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 552 11 3 6 5.3 CS(=O)(=O)NC(=O)c1ccc(-c2ccc(CCNC[C@H](O)c3ccccc3)cc2)cc1SC1CCCCC1 10.1021/jm9000709
CHEMBL479342 19343 0 None -1659 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 552 11 3 6 5.3 CS(=O)(=O)NC(=O)c1ccc(-c2ccc(CCNC[C@H](O)c3ccccc3)cc2)cc1SC1CCCCC1 10.1021/jm9000709
44396738 130662 0 None -77 3 Human 7.1 pEC50 = 7.1 Functional
Agonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptorAgonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptor
ChEMBL 655 13 5 9 4.8 C[C@H](Cc1c[nH]c2c(OS(=O)(=O)c3ccc(C(=O)O)cc3)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1016/j.bmcl.2004.10.035
CHEMBL362763 130662 0 None -77 3 Human 7.1 pEC50 = 7.1 Functional
Agonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptorAgonistic activity was determined by measuring cAMP accumulation in CHO cells expressing cloned human Beta-1 adrenergic receptor
ChEMBL 655 13 5 9 4.8 C[C@H](Cc1c[nH]c2c(OS(=O)(=O)c3ccc(C(=O)O)cc3)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1016/j.bmcl.2004.10.035
10142284 11661 0 None -1 2 Human 7.1 pEC50 = 7.1 Functional
In vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptorIn vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptor
ChEMBL 510 11 5 6 3.9 O=C(NC1CCCCC1)N1CCC(Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)CC1 10.1016/s0960-894x(01)00645-x
CHEMBL104481 11661 0 None -1 2 Human 7.1 pEC50 = 7.1 Functional
In vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptorIn vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptor
ChEMBL 510 11 5 6 3.9 O=C(NC1CCCCC1)N1CCC(Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)CC1 10.1016/s0960-894x(01)00645-x
1239 8458 55 None -67 5 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2009.10.013
3410 8458 55 None -67 5 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2009.10.013
3465 8458 55 None -67 5 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2009.10.013
CHEMBL1256786 8458 55 None -67 5 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2009.10.013
DB00983 8458 55 None -67 5 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulationAgonist activity at human adrenergic beta 1 expressed in CHO-K1 cells assessed as intracellular cAMP accumulation
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2009.10.013
1239 8458 55 None -67 5 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelAgonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP level
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2009.06.104
3410 8458 55 None -67 5 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelAgonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP level
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2009.06.104
3465 8458 55 None -67 5 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelAgonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP level
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2009.06.104
CHEMBL1256786 8458 55 None -67 5 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelAgonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP level
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2009.06.104
DB00983 8458 55 None -67 5 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelAgonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP level
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2009.06.104
1239 8458 55 None -67 5 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2009.12.087
3410 8458 55 None -67 5 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2009.12.087
3465 8458 55 None -67 5 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2009.12.087
CHEMBL1256786 8458 55 None -67 5 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2009.12.087
DB00983 8458 55 None -67 5 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2009.12.087
24895361 192153 0 None -933 3 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 433 10 3 4 5.1 CC(C)Oc1cc(-c2ccc(C[C@@H](C)NC[C@H](O)c3ccccc3)cc2)ccc1C(=O)O 10.1021/jm8000345
CHEMBL486051 192153 0 None -933 3 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 433 10 3 4 5.1 CC(C)Oc1cc(-c2ccc(C[C@@H](C)NC[C@H](O)c3ccccc3)cc2)ccc1C(=O)O 10.1021/jm8000345
155550964 180729 0 None -575 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 352 8 4 4 2.9 O=c1ccc2c(C(O)CNCCCCc3ccccc3)ccc(O)c2[nH]1 10.1016/j.bmc.2018.10.043
CHEMBL4541263 180729 0 None -575 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 352 8 4 4 2.9 O=c1ccc2c(C(O)CNCCCCc3ccccc3)ccc(O)c2[nH]1 10.1016/j.bmc.2018.10.043
10232593 12169 0 None -1 2 Human 7.1 pEC50 = 7.1 Functional
In vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptorIn vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptor
ChEMBL 609 17 6 7 4.8 CCCCCCCCNC(=O)N1CCC(Nc2ccc(CCNC[C@H](O)COc3ccc(O)c4c3CCC(=O)N4)cc2)CC1 10.1016/s0960-894x(01)00645-x
CHEMBL107129 12169 0 None -1 2 Human 7.1 pEC50 = 7.1 Functional
In vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptorIn vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptor
ChEMBL 609 17 6 7 4.8 CCCCCCCCNC(=O)N1CCC(Nc2ccc(CCNC[C@H](O)COc3ccc(O)c4c3CCC(=O)N4)cc2)CC1 10.1016/s0960-894x(01)00645-x
9873245 11288 0 None -38 3 Human 6.1 pEC50 = 6.1 Functional
In vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptorIn vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptor
ChEMBL 590 17 5 7 4.3 CCCCCCCCNC(=O)Nc1ccc(S(=O)(=O)N2CCC(CNC[C@H](O)COc3ccc(O)cc3)CC2)cc1 10.1016/s0960-894x(02)00607-8
CHEMBL102194 11288 0 None -38 3 Human 6.1 pEC50 = 6.1 Functional
In vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptorIn vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-1 adrenergic receptor
ChEMBL 590 17 5 7 4.3 CCCCCCCCNC(=O)Nc1ccc(S(=O)(=O)N2CCC(CNC[C@H](O)COc3ccc(O)cc3)CC2)cc1 10.1016/s0960-894x(02)00607-8
10028830 9026 40 None -323 3 Human 6.1 pEC50 = 6.1 Functional
Antagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assayAntagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assay
ChEMBL 497 13 4 6 2.7 O[C@H](COc1cccc(c1)CNC(=O)C)CNCCc1ccc(cc1)NS(=O)(=O)c1ccccc1 10.1016/j.ejmech.2018.03.032
3932 9026 40 None -323 3 Human 6.1 pEC50 = 6.1 Functional
Antagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assayAntagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assay
ChEMBL 497 13 4 6 2.7 O[C@H](COc1cccc(c1)CNC(=O)C)CNCCc1ccc(cc1)NS(=O)(=O)c1ccccc1 10.1016/j.ejmech.2018.03.032
CHEMBL4238084 9026 40 None -323 3 Human 6.1 pEC50 = 6.1 Functional
Antagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assayAntagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induced intercellular calcium mobilization pre-incubated for 10 mins before isoproterenol addition by Fluo-4AM dye-based fluorescence assay
ChEMBL 497 13 4 6 2.7 O[C@H](COc1cccc(c1)CNC(=O)C)CNCCc1ccc(cc1)NS(=O)(=O)c1ccccc1 10.1016/j.ejmech.2018.03.032
44237666 65010 0 None -44668 2 Rat 5.1 pEC50 = 5.1 Functional
Agonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effectAgonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effect
ChEMBL 548 10 6 5 5.0 O=C(Nc1cccc(CCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1)NC(c1ccccc1)c1ccccc1 10.1016/j.bmcl.2010.12.096
CHEMBL1682218 65010 0 None -44668 2 Rat 5.1 pEC50 = 5.1 Functional
Agonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effectAgonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effect
ChEMBL 548 10 6 5 5.0 O=C(Nc1cccc(CCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1)NC(c1ccccc1)c1ccccc1 10.1016/j.bmcl.2010.12.096
24950059 181649 0 None -169 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 467 8 3 5 5.0 COc1cc(Oc2ccc3c(c2)C[C@@H](NC[C@H](O)c2cccc(Cl)c2)CC3)cc(C(=O)O)c1 10.1021/jm800222k
CHEMBL456352 181649 0 None -169 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 467 8 3 5 5.0 COc1cc(Oc2ccc3c(c2)C[C@@H](NC[C@H](O)c2cccc(Cl)c2)CC3)cc(C(=O)O)c1 10.1021/jm800222k
24823466 19603 0 None 1 2 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 440 11 4 5 4.4 O=C(O)COc1ccc(Nc2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)cc1 10.1021/jm701324c
CHEMBL1188436 19603 0 None 1 2 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 440 11 4 5 4.4 O=C(O)COc1ccc(Nc2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)cc1 10.1021/jm701324c
CHEMBL536330 19603 0 None 1 2 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 440 11 4 5 4.4 O=C(O)COc1ccc(Nc2ccc(CCNC[C@H](O)c3cccc(Cl)c3)cc2)cc1 10.1021/jm701324c
11270069 102476 0 None 6 2 Human 8.0 pEC50 = 8.0 Functional
Agonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-ARAgonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-AR
ChEMBL 328 6 3 2 4.1 C[C@@H](Cc1c[nH]c2ccccc12)NC[C@H](O)c1cccc(Cl)c1 10.1016/s0960-894x(03)00073-8
CHEMBL25823 102476 0 None 6 2 Human 8.0 pEC50 = 8.0 Functional
Agonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-ARAgonistic activity against human Beta-1 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing beta3-AR
ChEMBL 328 6 3 2 4.1 C[C@@H](Cc1c[nH]c2ccccc12)NC[C@H](O)c1cccc(Cl)c1 10.1016/s0960-894x(03)00073-8
52949488 24318 0 None -3 3 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assayAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assay
ChEMBL 490 9 2 8 4.4 COc1ccccc1OCC(O)CNC1CCN(c2ncnc3scc(-c4ccccc4)c23)CC1 10.1016/j.bmcl.2010.08.039
CHEMBL1258023 24318 0 None -3 3 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assayAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cyclic AMP formation by HTRF assay
ChEMBL 490 9 2 8 4.4 COc1ccccc1OCC(O)CNC1CCN(c2ncnc3scc(-c4ccccc4)c23)CC1 10.1016/j.bmcl.2010.08.039
155548071 180528 0 None -131 2 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 338 7 4 4 2.5 O=c1ccc2c(C(O)CNCCCc3ccccc3)ccc(O)c2[nH]1 10.1016/j.bmc.2018.10.043
CHEMBL4536813 180528 0 None -131 2 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assayAgonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay
ChEMBL 338 7 4 4 2.5 O=c1ccc2c(C(O)CNCCCc3ccccc3)ccc(O)c2[nH]1 10.1016/j.bmc.2018.10.043
56598831 95918 0 None 1023 3 Human 8.0 pEC50 = 8.0 Functional
Partial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrsPartial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrs
ChEMBL 459 15 5 7 2.3 O=C(NCCNCC(O)COc1ccc(OCCOCC2CC2)cc1)Nc1ccc(O)cc1 10.1021/jm400348g
CHEMBL2348220 95918 0 None 1023 3 Human 8.0 pEC50 = 8.0 Functional
Partial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrsPartial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrs
ChEMBL 459 15 5 7 2.3 O=C(NCCNCC(O)COc1ccc(OCCOCC2CC2)cc1)Nc1ccc(O)cc1 10.1021/jm400348g
CHEMBL2365796 95918 0 None 1023 3 Human 8.0 pEC50 = 8.0 Functional
Partial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrsPartial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrs
ChEMBL 459 15 5 7 2.3 O=C(NCCNCC(O)COc1ccc(OCCOCC2CC2)cc1)Nc1ccc(O)cc1 10.1021/jm400348g
45101522 205796 0 None -5 2 Human 8.0 pEC50 = 8 Functional
Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelAgonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP level
ChEMBL 578 15 7 9 2.0 CC(C)(Cc1ccc(NC(=O)CCCNCCCS(=O)(=O)O)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1016/j.bmcl.2009.06.104
CHEMBL585751 205796 0 None -5 2 Human 8.0 pEC50 = 8 Functional
Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP levelAgonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP level
ChEMBL 578 15 7 9 2.0 CC(C)(Cc1ccc(NC(=O)CCCNCCCS(=O)(=O)O)cc1)NCC(O)c1ccc(O)c2c1OCC(=O)N2 10.1016/j.bmcl.2009.06.104
45272430 202223 0 None -8 3 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 439 10 4 4 4.2 O[C@@H](CNCCc1ccc(NC(=S)Nc2ccc(F)cc2)cc1)COc1ccccc1 10.1016/j.bmc.2009.06.031
CHEMBL1204001 202223 0 None -8 3 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 439 10 4 4 4.2 O[C@@H](CNCCc1ccc(NC(=S)Nc2ccc(F)cc2)cc1)COc1ccccc1 10.1016/j.bmc.2009.06.031
CHEMBL552374 202223 0 None -8 3 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 439 10 4 4 4.2 O[C@@H](CNCCc1ccc(NC(=S)Nc2ccc(F)cc2)cc1)COc1ccccc1 10.1016/j.bmc.2009.06.031
44517692 203448 0 None -4 3 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 466 11 4 6 4.0 O=[N+]([O-])c1ccc(NC(=S)Nc2ccc(CCNC[C@H](O)COc3ccccc3)cc2)cc1 10.1016/j.bmc.2009.06.031
CHEMBL1203990 203448 0 None -4 3 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 466 11 4 6 4.0 O=[N+]([O-])c1ccc(NC(=S)Nc2ccc(CCNC[C@H](O)COc3ccccc3)cc2)cc1 10.1016/j.bmc.2009.06.031
CHEMBL564516 203448 0 None -4 3 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenolAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as [125I]cAMP accumulation after 2 days by radioimmunoassay relative to isoproterenol
ChEMBL 466 11 4 6 4.0 O=[N+]([O-])c1ccc(NC(=S)Nc2ccc(CCNC[C@H](O)COc3ccccc3)cc2)cc1 10.1016/j.bmc.2009.06.031
44237612 65003 0 None -4466 2 Rat 6.1 pEC50 = 6.1 Functional
Agonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effectAgonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effect
ChEMBL 472 9 6 5 3.4 O=C(NCc1ccccc1)Nc1cccc(CCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1 10.1016/j.bmcl.2010.12.096
CHEMBL1682211 65003 0 None -4466 2 Rat 6.1 pEC50 = 6.1 Functional
Agonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effectAgonist activity at beta1 adrenoceptor in rat left atria assessed as induction of ionotropic effect
ChEMBL 472 9 6 5 3.4 O=C(NCc1ccccc1)Nc1cccc(CCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)c1 10.1016/j.bmcl.2010.12.096
11398536 19247 0 None -6309 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 535 11 4 6 4.7 CS(=O)(=O)NC(=O)c1ccc(-c2ccc(CCNC[C@H](O)c3ccccc3)cc2)cc1NC1CCCCC1 10.1021/jm9000709
CHEMBL1186241 19247 0 None -6309 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 535 11 4 6 4.7 CS(=O)(=O)NC(=O)c1ccc(-c2ccc(CCNC[C@H](O)c3ccccc3)cc2)cc1NC1CCCCC1 10.1021/jm9000709
CHEMBL455773 19247 0 None -6309 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 535 11 4 6 4.7 CS(=O)(=O)NC(=O)c1ccc(-c2ccc(CCNC[C@H](O)c3ccccc3)cc2)cc1NC1CCCCC1 10.1021/jm9000709
24895565 183474 0 None -575 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 475 11 3 5 5.5 O=C(O)c1ccc(-c2ccc(OCCNC[C@H](O)c3ccccc3)cc2)cc1OC1CCCCC1 10.1021/jm8000345
CHEMBL459862 183474 0 None -575 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay
ChEMBL 475 11 3 5 5.5 O=C(O)c1ccc(-c2ccc(OCCNC[C@H](O)c3ccccc3)cc2)cc1OC1CCCCC1 10.1021/jm8000345
44127167 203035 0 None 1 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 421 11 4 6 2.5 O=C(Cc1cccnc1)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/j.ejmech.2009.01.022
CHEMBL561818 203035 0 None 1 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 421 11 4 6 2.5 O=C(Cc1cccnc1)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/j.ejmech.2009.01.022
24949720 196301 0 None -2398 3 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 421 6 3 3 4.9 O=C(O)c1ccc(-c2ccc3c(c2)C[C@@H](NC[C@H](O)c2ccc(Cl)cc2)CC3)cc1 10.1021/jm800222k
CHEMBL514102 196301 0 None -2398 3 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 421 6 3 3 4.9 O=C(O)c1ccc(-c2ccc3c(c2)C[C@@H](NC[C@H](O)c2ccc(Cl)cc2)CC3)cc1 10.1021/jm800222k
44565907 199949 0 None -138 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 498 11 4 8 2.3 CCOc1cc(-c2ccc(CCNC[C@H](O)c3cnccc3N)cc2)ccc1C(=O)NS(C)(=O)=O 10.1021/jm9000709
CHEMBL523149 199949 0 None -138 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 498 11 4 8 2.3 CCOc1cc(-c2ccc(CCNC[C@H](O)c3cnccc3N)cc2)ccc1C(=O)NS(C)(=O)=O 10.1021/jm9000709
10205463 12274 0 None -10 2 Human 6.0 pEC50 = 6.0 Functional
In vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptorIn vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptor
ChEMBL 470 11 5 6 3.0 CC(C)NC(=O)N1CCC(Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)CC1 10.1016/s0960-894x(01)00645-x
CHEMBL107633 12274 0 None -10 2 Human 6.0 pEC50 = 6.0 Functional
In vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptorIn vitro agonistic activity assessed by measurement of cAMP accumulation level in CHO cells expressing human beta1-AR receptor
ChEMBL 470 11 5 6 3.0 CC(C)NC(=O)N1CCC(Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)CC1 10.1016/s0960-894x(01)00645-x
44127052 202515 0 None -2 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 450 12 4 6 3.2 COc1ccccc1CC(=O)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/j.ejmech.2009.01.022
CHEMBL557269 202515 0 None -2 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassayAgonist activity at human cloned adrenergic beta-1 receptor expressed in CHO cells assessed as increase in cAMP production after 2 days by radioimmunoassay
ChEMBL 450 12 4 6 3.2 COc1ccccc1CC(=O)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/j.ejmech.2009.01.022
44574758 185322 0 None -18 2 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 394 11 4 5 2.2 O=C(Cc1ncc[nH]1)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.03.044
CHEMBL466879 185322 0 None -18 2 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 394 11 4 5 2.2 O=C(Cc1ncc[nH]1)Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1 10.1016/j.bmc.2009.03.044
9896817 109662 0 None -22 3 Human 6.0 pEC50 = 6.0 Functional
Compound was evaluated for its inhibitory activity against human beta-1 adrenergic receptor (AR)Compound was evaluated for its inhibitory activity against human beta-1 adrenergic receptor (AR)
ChEMBL 628 12 6 6 6.7 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2cccc(-c3ccc(CC4NCCc5cc(O)c(O)cc54)cc3)c2)cc1 10.1016/s0960-894x(00)00459-5
CHEMBL305891 109662 0 None -22 3 Human 6.0 pEC50 = 6.0 Functional
Compound was evaluated for its inhibitory activity against human beta-1 adrenergic receptor (AR)Compound was evaluated for its inhibitory activity against human beta-1 adrenergic receptor (AR)
ChEMBL 628 12 6 6 6.7 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2cccc(-c3ccc(CC4NCCc5cc(O)c(O)cc54)cc3)c2)cc1 10.1016/s0960-894x(00)00459-5
24823296 104808 0 None -2884 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 453 10 3 4 5.7 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3ccccc3)cc2)cc1Oc1ccccc1 10.1021/jm701324c
CHEMBL273006 104808 0 None -2884 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIAAgonist activity at human beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by EIA
ChEMBL 453 10 3 4 5.7 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3ccccc3)cc2)cc1Oc1ccccc1 10.1021/jm701324c
24949883 182874 0 None -691 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 439 6 3 3 5.0 O=C(O)c1ccc(-c2ccc3c(c2)C[C@@H](NC[C@H](O)c2ccc(Cl)cc2)CC3)c(F)c1 10.1021/jm800222k
CHEMBL459133 182874 0 None -691 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human cloned beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 439 6 3 3 5.0 O=C(O)c1ccc(-c2ccc3c(c2)C[C@@H](NC[C@H](O)c2ccc(Cl)cc2)CC3)c(F)c1 10.1021/jm800222k
24823296 104808 0 None -2884 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 453 10 3 4 5.7 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3ccccc3)cc2)cc1Oc1ccccc1 10.1021/jm9000709
CHEMBL273006 104808 0 None -2884 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassayAgonist activity at human recombinant beta-1 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immunoassay
ChEMBL 453 10 3 4 5.7 O=C(O)c1ccc(-c2ccc(CCNC[C@H](O)c3ccccc3)cc2)cc1Oc1ccccc1 10.1021/jm9000709
10648298 106495 0 None -251 3 Human 5.0 pEC50 = 5.0 Functional
Increased cAMP levels of Chinese hamster ovary (CHO) cells expressing human beta 1 Adrenergic receptorIncreased cAMP levels of Chinese hamster ovary (CHO) cells expressing human beta 1 Adrenergic receptor
ChEMBL 477 10 5 7 2.1 CS(=O)(=O)Nc1cc([C@@H](O)CNC2CCN(c3ccc(CCC(=O)O)cc3)CC2)ccc1O 10.1021/jm000544b
CHEMBL284788 106495 0 None -251 3 Human 5.0 pEC50 = 5.0 Functional
Increased cAMP levels of Chinese hamster ovary (CHO) cells expressing human beta 1 Adrenergic receptorIncreased cAMP levels of Chinese hamster ovary (CHO) cells expressing human beta 1 Adrenergic receptor
ChEMBL 477 10 5 7 2.1 CS(=O)(=O)Nc1cc([C@@H](O)CNC2CCN(c3ccc(CCC(=O)O)cc3)CC2)ccc1O 10.1021/jm000544b
46232815 208460 0 None 5 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 412 6 4 5 3.7 CC(C)(Cc1ccc(C(C)(C)C)cc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2 10.1016/j.bmcl.2009.12.087
CHEMBL606208 208460 0 None 5 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulationAgonist activity at human recombinant adrenergic beta-1 receptor expressed in CHO cells assessed as cAMP accumulation
ChEMBL 412 6 4 5 3.7 CC(C)(Cc1ccc(C(C)(C)C)cc1)NCC(O)c1cc(O)cc2c1OCC(=O)N2 10.1016/j.bmcl.2009.12.087
9896817 109662 0 None -22 3 Human 5.0 pIC50 = 5 Functional
Compound was evaluated for its inhibitory activity against CHO cells expressing the cloned human beta-1 adrenergic receptor (AR) in the presence of [125I]iodocyanopindololCompound was evaluated for its inhibitory activity against CHO cells expressing the cloned human beta-1 adrenergic receptor (AR) in the presence of [125I]iodocyanopindolol
ChEMBL 628 12 6 6 6.7 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2cccc(-c3ccc(CC4NCCc5cc(O)c(O)cc54)cc3)c2)cc1 10.1016/s0960-894x(00)00459-5
CHEMBL305891 109662 0 None -22 3 Human 5.0 pIC50 = 5 Functional
Compound was evaluated for its inhibitory activity against CHO cells expressing the cloned human beta-1 adrenergic receptor (AR) in the presence of [125I]iodocyanopindololCompound was evaluated for its inhibitory activity against CHO cells expressing the cloned human beta-1 adrenergic receptor (AR) in the presence of [125I]iodocyanopindolol
ChEMBL 628 12 6 6 6.7 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2cccc(-c3ccc(CC4NCCc5cc(O)c(O)cc54)cc3)c2)cc1 10.1016/s0960-894x(00)00459-5
9962058 211561 0 None -165 3 Human 4.0 pIC50 = 4 Functional
Compound was evaluated for its inhibitory activity against CHO cells expressing the cloned human beta-1 adrenergic receptor (AR) in the presence of [125I]iodocyanopindololCompound was evaluated for its inhibitory activity against CHO cells expressing the cloned human beta-1 adrenergic receptor (AR) in the presence of [125I]iodocyanopindolol
ChEMBL 628 12 6 6 6.7 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(-c3cccc(CC4NCCc5cc(O)c(O)cc54)c3)cc2)cc1 10.1016/s0960-894x(00)00459-5
CHEMBL74860 211561 0 None -165 3 Human 4.0 pIC50 = 4 Functional
Compound was evaluated for its inhibitory activity against CHO cells expressing the cloned human beta-1 adrenergic receptor (AR) in the presence of [125I]iodocyanopindololCompound was evaluated for its inhibitory activity against CHO cells expressing the cloned human beta-1 adrenergic receptor (AR) in the presence of [125I]iodocyanopindolol
ChEMBL 628 12 6 6 6.7 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(-c3cccc(CC4NCCc5cc(O)c(O)cc54)c3)cc2)cc1 10.1016/s0960-894x(00)00459-5
53318280 65429 0 None -95 3 Human 6.0 pIC50 = 6.0 Functional
Agonist activity at human beta1 adrenergic receptorAgonist activity at human beta1 adrenergic receptor
ChEMBL 623 11 3 6 7.2 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2ccccc2)cc1)c1ccc(-c2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1 10.1016/j.bmcl.2010.12.087
CHEMBL1684578 65429 0 None -95 3 Human 6.0 pIC50 = 6.0 Functional
Agonist activity at human beta1 adrenergic receptorAgonist activity at human beta1 adrenergic receptor
ChEMBL 623 11 3 6 7.2 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2ccccc2)cc1)c1ccc(-c2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1 10.1016/j.bmcl.2010.12.087
11722516 97666 0 None - 1 Guinea pig 5.9 pIC50 = 5.9 Functional
Tested for beta-1-adrenergic blocking effect by measuring the ability to inhibit the positive inotropic effect of isoproterenol on the isolated right atrium of guinea pigsTested for beta-1-adrenergic blocking effect by measuring the ability to inhibit the positive inotropic effect of isoproterenol on the isolated right atrium of guinea pigs
ChEMBL 303 9 2 4 2.2 COCCc1ccc(OC(F)(F)[C@@H](O)CNC(C)C)cc1 10.1016/S0960-894X(97)00207-2
CHEMBL23929 97666 0 None - 1 Guinea pig 5.9 pIC50 = 5.9 Functional
Tested for beta-1-adrenergic blocking effect by measuring the ability to inhibit the positive inotropic effect of isoproterenol on the isolated right atrium of guinea pigsTested for beta-1-adrenergic blocking effect by measuring the ability to inhibit the positive inotropic effect of isoproterenol on the isolated right atrium of guinea pigs
ChEMBL 303 9 2 4 2.2 COCCc1ccc(OC(F)(F)[C@@H](O)CNC(C)C)cc1 10.1016/S0960-894X(97)00207-2
44268214 25341 0 None 4 3 Human 7.8 pIC50 = 7.8 Functional
Compound was tested for agonist activity against cloned human beta-1 adrenergic receptorCompound was tested for agonist activity against cloned human beta-1 adrenergic receptor
ChEMBL 331 10 3 5 2.4 COc1ccc(CCCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/s0960-894x(98)00169-3
CHEMBL12762 25341 0 None 4 3 Human 7.8 pIC50 = 7.8 Functional
Compound was tested for agonist activity against cloned human beta-1 adrenergic receptorCompound was tested for agonist activity against cloned human beta-1 adrenergic receptor
ChEMBL 331 10 3 5 2.4 COc1ccc(CCCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/s0960-894x(98)00169-3
53319639 65432 0 None -1 3 Human 5.8 pIC50 = 5.8 Functional
Agonist activity at human beta1 adrenergic receptorAgonist activity at human beta1 adrenergic receptor
ChEMBL 649 9 3 6 7.7 O=S(=O)(Nc1ccc(CC2CC[C@H]([C@@H](O)c3ccccc3)N2)cc1)c1ccc(-c2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1 10.1016/j.bmcl.2010.12.087
CHEMBL1684582 65432 0 None -1 3 Human 5.8 pIC50 = 5.8 Functional
Agonist activity at human beta1 adrenergic receptorAgonist activity at human beta1 adrenergic receptor
ChEMBL 649 9 3 6 7.7 O=S(=O)(Nc1ccc(CC2CC[C@H]([C@@H](O)c3ccccc3)N2)cc1)c1ccc(-c2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1 10.1016/j.bmcl.2010.12.087
145990586 173622 0 None -1 3 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells assessed as decrease in isoproterenol-induced cAMP accumulation after 15 mins by HTRF assayAntagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells assessed as decrease in isoproterenol-induced cAMP accumulation after 15 mins by HTRF assay
ChEMBL 297 2 2 4 2.6 COc1cc2c3c(c1OC)-c1ccccc1[C@@H](O)[C@@H]3NCC2 10.1039/C7MD00656J
CHEMBL4285281 173622 0 None -1 3 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells assessed as decrease in isoproterenol-induced cAMP accumulation after 15 mins by HTRF assayAntagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells assessed as decrease in isoproterenol-induced cAMP accumulation after 15 mins by HTRF assay
ChEMBL 297 2 2 4 2.6 COc1cc2c3c(c1OC)-c1ccccc1[C@@H](O)[C@@H]3NCC2 10.1039/C7MD00656J
53326196 65430 0 None 1 3 Human 5.8 pIC50 = 5.8 Functional
Agonist activity at human beta1 adrenergic receptorAgonist activity at human beta1 adrenergic receptor
ChEMBL 649 9 3 6 7.7 O=S(=O)(Nc1ccc(CC2CC[C@@H]([C@@H](O)c3ccccc3)N2)cc1)c1ccc(-c2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1 10.1016/j.bmcl.2010.12.087
CHEMBL1684580 65430 0 None 1 3 Human 5.8 pIC50 = 5.8 Functional
Agonist activity at human beta1 adrenergic receptorAgonist activity at human beta1 adrenergic receptor
ChEMBL 649 9 3 6 7.7 O=S(=O)(Nc1ccc(CC2CC[C@@H]([C@@H](O)c3ccccc3)N2)cc1)c1ccc(-c2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1 10.1016/j.bmcl.2010.12.087
567 7512 16 None -186 7 Rat 6.7 pIC50 = 6.7 Functional
In vitro beta-adrenergic activity against beta-1 adrenergic receptor by the inhibition of insulin stimulated [14C]- glucose incorporation into glycogen in isolated rat soleus muscleIn vitro beta-adrenergic activity against beta-1 adrenergic receptor by the inhibition of insulin stimulated [14C]- glucose incorporation into glycogen in isolated rat soleus muscle
ChEMBL 363 9 3 4 3.1 C[C@H](Cc1ccc(cc1)OCC(=O)O)NC[C@@H](c1cccc(c1)Cl)O 10.1021/jm00094a025
9841972 7512 16 None -186 7 Rat 6.7 pIC50 = 6.7 Functional
In vitro beta-adrenergic activity against beta-1 adrenergic receptor by the inhibition of insulin stimulated [14C]- glucose incorporation into glycogen in isolated rat soleus muscleIn vitro beta-adrenergic activity against beta-1 adrenergic receptor by the inhibition of insulin stimulated [14C]- glucose incorporation into glycogen in isolated rat soleus muscle
ChEMBL 363 9 3 4 3.1 C[C@H](Cc1ccc(cc1)OCC(=O)O)NC[C@@H](c1cccc(c1)Cl)O 10.1021/jm00094a025
CHEMBL284782 7512 16 None -186 7 Rat 6.7 pIC50 = 6.7 Functional
In vitro beta-adrenergic activity against beta-1 adrenergic receptor by the inhibition of insulin stimulated [14C]- glucose incorporation into glycogen in isolated rat soleus muscleIn vitro beta-adrenergic activity against beta-1 adrenergic receptor by the inhibition of insulin stimulated [14C]- glucose incorporation into glycogen in isolated rat soleus muscle
ChEMBL 363 9 3 4 3.1 C[C@H](Cc1ccc(cc1)OCC(=O)O)NC[C@@H](c1cccc(c1)Cl)O 10.1021/jm00094a025
1786 9298 85 None -4 7 Guinea pig 6.7 pIC50 = 6.7 Functional
Tested for beta-1-adrenergic blocking effect by measuring the ability to inhibit the positive inotropic effect of isoproterenol on the isolated right atrium of guinea pigsTested for beta-1-adrenergic blocking effect by measuring the ability to inhibit the positive inotropic effect of isoproterenol on the isolated right atrium of guinea pigs
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1016/S0960-894X(97)00207-2
4171 9298 85 None -4 7 Guinea pig 6.7 pIC50 = 6.7 Functional
Tested for beta-1-adrenergic blocking effect by measuring the ability to inhibit the positive inotropic effect of isoproterenol on the isolated right atrium of guinea pigsTested for beta-1-adrenergic blocking effect by measuring the ability to inhibit the positive inotropic effect of isoproterenol on the isolated right atrium of guinea pigs
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1016/S0960-894X(97)00207-2
553 9298 85 None -4 7 Guinea pig 6.7 pIC50 = 6.7 Functional
Tested for beta-1-adrenergic blocking effect by measuring the ability to inhibit the positive inotropic effect of isoproterenol on the isolated right atrium of guinea pigsTested for beta-1-adrenergic blocking effect by measuring the ability to inhibit the positive inotropic effect of isoproterenol on the isolated right atrium of guinea pigs
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1016/S0960-894X(97)00207-2
CHEMBL13 9298 85 None -4 7 Guinea pig 6.7 pIC50 = 6.7 Functional
Tested for beta-1-adrenergic blocking effect by measuring the ability to inhibit the positive inotropic effect of isoproterenol on the isolated right atrium of guinea pigsTested for beta-1-adrenergic blocking effect by measuring the ability to inhibit the positive inotropic effect of isoproterenol on the isolated right atrium of guinea pigs
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1016/S0960-894X(97)00207-2
DB00264 9298 85 None -4 7 Guinea pig 6.7 pIC50 = 6.7 Functional
Tested for beta-1-adrenergic blocking effect by measuring the ability to inhibit the positive inotropic effect of isoproterenol on the isolated right atrium of guinea pigsTested for beta-1-adrenergic blocking effect by measuring the ability to inhibit the positive inotropic effect of isoproterenol on the isolated right atrium of guinea pigs
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1016/S0960-894X(97)00207-2
127034967 143266 0 None -1 3 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human beta1 receptor expressed in CHO-K1 cells assessed as isoproterenol-induced cAMP level by HTRF assayAntagonist activity at human beta1 receptor expressed in CHO-K1 cells assessed as isoproterenol-induced cAMP level by HTRF assay
ChEMBL 260 5 2 4 1.6 CB1C=Cc2c(cccc2OCC(O)CN(C)C)N1 10.1021/acs.jmedchem.5b01088
CHEMBL3736156 143266 0 None -1 3 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human beta1 receptor expressed in CHO-K1 cells assessed as isoproterenol-induced cAMP level by HTRF assayAntagonist activity at human beta1 receptor expressed in CHO-K1 cells assessed as isoproterenol-induced cAMP level by HTRF assay
ChEMBL 260 5 2 4 1.6 CB1C=Cc2c(cccc2OCC(O)CN(C)C)N1 10.1021/acs.jmedchem.5b01088
53326839 65431 0 None -26 3 Human 5.7 pIC50 = 5.7 Functional
Agonist activity at human beta1 adrenergic receptorAgonist activity at human beta1 adrenergic receptor
ChEMBL 649 9 3 6 7.7 O=S(=O)(Nc1ccc(CC2CC[C@@H]([C@H](O)c3ccccc3)N2)cc1)c1ccc(-c2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1 10.1016/j.bmcl.2010.12.087
CHEMBL1684581 65431 0 None -26 3 Human 5.7 pIC50 = 5.7 Functional
Agonist activity at human beta1 adrenergic receptorAgonist activity at human beta1 adrenergic receptor
ChEMBL 649 9 3 6 7.7 O=S(=O)(Nc1ccc(CC2CC[C@@H]([C@H](O)c3ccccc3)N2)cc1)c1ccc(-c2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1 10.1016/j.bmcl.2010.12.087
11722516 97666 0 None - 1 Guinea pig 5.7 pIC50 = 5.7 Functional
Tested for beta-2-adrenergic blocking effect by measuring the ability to inhibit the relaxing effect of epinephrine on the isolated tracheal muscle of guinea pigsTested for beta-2-adrenergic blocking effect by measuring the ability to inhibit the relaxing effect of epinephrine on the isolated tracheal muscle of guinea pigs
ChEMBL 303 9 2 4 2.2 COCCc1ccc(OC(F)(F)[C@@H](O)CNC(C)C)cc1 10.1016/S0960-894X(97)00207-2
CHEMBL23929 97666 0 None - 1 Guinea pig 5.7 pIC50 = 5.7 Functional
Tested for beta-2-adrenergic blocking effect by measuring the ability to inhibit the relaxing effect of epinephrine on the isolated tracheal muscle of guinea pigsTested for beta-2-adrenergic blocking effect by measuring the ability to inhibit the relaxing effect of epinephrine on the isolated tracheal muscle of guinea pigs
ChEMBL 303 9 2 4 2.2 COCCc1ccc(OC(F)(F)[C@@H](O)CNC(C)C)cc1 10.1016/S0960-894X(97)00207-2
51346867 65433 0 None -537 3 Human 5.7 pIC50 = 5.7 Functional
Agonist activity at human beta1 adrenergic receptorAgonist activity at human beta1 adrenergic receptor
ChEMBL 649 9 3 6 7.7 O=S(=O)(Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3ccccc3)N2)cc1)c1ccc(-c2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1 10.1016/j.bmcl.2010.12.087
CHEMBL1684583 65433 0 None -537 3 Human 5.7 pIC50 = 5.7 Functional
Agonist activity at human beta1 adrenergic receptorAgonist activity at human beta1 adrenergic receptor
ChEMBL 649 9 3 6 7.7 O=S(=O)(Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3ccccc3)N2)cc1)c1ccc(-c2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1 10.1016/j.bmcl.2010.12.087
53326197 65434 0 None -28 3 Human 6.6 pIC50 = 6.6 Functional
Agonist activity at human beta1 adrenergic receptorAgonist activity at human beta1 adrenergic receptor
ChEMBL 649 9 3 6 7.7 O=S(=O)(Nc1ccc(C[C@H]2CC[C@H]([C@H](O)c3ccccc3)N2)cc1)c1ccc(-c2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1 10.1016/j.bmcl.2010.12.087
CHEMBL1684584 65434 0 None -28 3 Human 6.6 pIC50 = 6.6 Functional
Agonist activity at human beta1 adrenergic receptorAgonist activity at human beta1 adrenergic receptor
ChEMBL 649 9 3 6 7.7 O=S(=O)(Nc1ccc(C[C@H]2CC[C@H]([C@H](O)c3ccccc3)N2)cc1)c1ccc(-c2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1 10.1016/j.bmcl.2010.12.087
2303 9961 68 None -6 20 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human beta1 receptor expressed in CHO-K1 cells assessed as isoproterenol-induced cAMP level by HTRF assayAntagonist activity at human beta1 receptor expressed in CHO-K1 cells assessed as isoproterenol-induced cAMP level by HTRF assay
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/acs.jmedchem.5b01088
4946 9961 68 None -6 20 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human beta1 receptor expressed in CHO-K1 cells assessed as isoproterenol-induced cAMP level by HTRF assayAntagonist activity at human beta1 receptor expressed in CHO-K1 cells assessed as isoproterenol-induced cAMP level by HTRF assay
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/acs.jmedchem.5b01088
564 9961 68 None -6 20 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human beta1 receptor expressed in CHO-K1 cells assessed as isoproterenol-induced cAMP level by HTRF assayAntagonist activity at human beta1 receptor expressed in CHO-K1 cells assessed as isoproterenol-induced cAMP level by HTRF assay
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/acs.jmedchem.5b01088
63 9961 68 None -6 20 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human beta1 receptor expressed in CHO-K1 cells assessed as isoproterenol-induced cAMP level by HTRF assayAntagonist activity at human beta1 receptor expressed in CHO-K1 cells assessed as isoproterenol-induced cAMP level by HTRF assay
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/acs.jmedchem.5b01088
91536 9961 68 None -6 20 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human beta1 receptor expressed in CHO-K1 cells assessed as isoproterenol-induced cAMP level by HTRF assayAntagonist activity at human beta1 receptor expressed in CHO-K1 cells assessed as isoproterenol-induced cAMP level by HTRF assay
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/acs.jmedchem.5b01088
CHEMBL27 9961 68 None -6 20 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human beta1 receptor expressed in CHO-K1 cells assessed as isoproterenol-induced cAMP level by HTRF assayAntagonist activity at human beta1 receptor expressed in CHO-K1 cells assessed as isoproterenol-induced cAMP level by HTRF assay
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/acs.jmedchem.5b01088
CHEMBL452861 9961 68 None -6 20 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human beta1 receptor expressed in CHO-K1 cells assessed as isoproterenol-induced cAMP level by HTRF assayAntagonist activity at human beta1 receptor expressed in CHO-K1 cells assessed as isoproterenol-induced cAMP level by HTRF assay
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/acs.jmedchem.5b01088
DB00571 9961 68 None -6 20 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human beta1 receptor expressed in CHO-K1 cells assessed as isoproterenol-induced cAMP level by HTRF assayAntagonist activity at human beta1 receptor expressed in CHO-K1 cells assessed as isoproterenol-induced cAMP level by HTRF assay
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/acs.jmedchem.5b01088
9873245 11288 0 None -38 3 Human 7.6 pIC50 = 7.6 Functional
Compound was tested for the antagonistic activity against Beta-1 adrenergic receptorCompound was tested for the antagonistic activity against Beta-1 adrenergic receptor
ChEMBL 590 17 5 7 4.3 CCCCCCCCNC(=O)Nc1ccc(S(=O)(=O)N2CCC(CNC[C@H](O)COc3ccc(O)cc3)CC2)cc1 10.1016/s0960-894x(02)00607-8
CHEMBL102194 11288 0 None -38 3 Human 7.6 pIC50 = 7.6 Functional
Compound was tested for the antagonistic activity against Beta-1 adrenergic receptorCompound was tested for the antagonistic activity against Beta-1 adrenergic receptor
ChEMBL 590 17 5 7 4.3 CCCCCCCCNC(=O)Nc1ccc(S(=O)(=O)N2CCC(CNC[C@H](O)COc3ccc(O)cc3)CC2)cc1 10.1016/s0960-894x(02)00607-8
14739907 170912 0 None 1 2 Human 6.6 pIC50 = 6.6 Functional
Tested for beta1-receptor selectivity in canine cardiac tissue in anesthetized dogsTested for beta1-receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 367 10 2 6 2.6 Cc1cccc(OCC(O)CNCCOc2ccc(-n3ccnc3)cc2)c1 10.1021/jm00172a033
CHEMBL421005 170912 0 None 1 2 Human 6.6 pIC50 = 6.6 Functional
Tested for beta1-receptor selectivity in canine cardiac tissue in anesthetized dogsTested for beta1-receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 367 10 2 6 2.6 Cc1cccc(OCC(O)CNCCOc2ccc(-n3ccnc3)cc2)c1 10.1021/jm00172a033
14739906 214466 0 None 16 2 Human 6.6 pIC50 = 6.6 Functional
Tested for beta1-receptor selectivity in canine cardiac tissue in anesthetized dogsTested for beta1-receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 411 13 2 7 2.5 COCCc1ccc(OCC(O)CNCCOc2ccc(-n3ccnc3)cc2)cc1 10.1021/jm00172a033
CHEMBL95457 214466 0 None 16 2 Human 6.6 pIC50 = 6.6 Functional
Tested for beta1-receptor selectivity in canine cardiac tissue in anesthetized dogsTested for beta1-receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 411 13 2 7 2.5 COCCc1ccc(OCC(O)CNCCOc2ccc(-n3ccnc3)cc2)cc1 10.1021/jm00172a033
53326195 65428 0 None -194 3 Human 5.5 pIC50 = 5.5 Functional
Agonist activity at human beta1 adrenergic receptorAgonist activity at human beta1 adrenergic receptor
ChEMBL 649 9 3 6 7.7 O=S(=O)(Nc1ccc(CC2CC[C@H]([C@H](O)c3ccccc3)N2)cc1)c1ccc(-c2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1 10.1016/j.bmcl.2010.12.087
CHEMBL1684577 65428 0 None -194 3 Human 5.5 pIC50 = 5.5 Functional
Agonist activity at human beta1 adrenergic receptorAgonist activity at human beta1 adrenergic receptor
ChEMBL 649 9 3 6 7.7 O=S(=O)(Nc1ccc(CC2CC[C@H]([C@H](O)c3ccccc3)N2)cc1)c1ccc(-c2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1 10.1016/j.bmcl.2010.12.087
9853471 211633 0 None -389 3 Human 5.5 pIC50 = 5.5 Functional
Compound was evaluated for its inhibitory activity against CHO cells expressing the cloned human beta-1 adrenergic receptor (AR) in the presence of [125I]iodocyanopindololCompound was evaluated for its inhibitory activity against CHO cells expressing the cloned human beta-1 adrenergic receptor (AR) in the presence of [125I]iodocyanopindolol
ChEMBL 628 12 6 6 6.7 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(-c3ccc(CC4NCCc5cc(O)c(O)cc54)cc3)cc2)cc1 10.1016/s0960-894x(00)00459-5
CHEMBL75604 211633 0 None -389 3 Human 5.5 pIC50 = 5.5 Functional
Compound was evaluated for its inhibitory activity against CHO cells expressing the cloned human beta-1 adrenergic receptor (AR) in the presence of [125I]iodocyanopindololCompound was evaluated for its inhibitory activity against CHO cells expressing the cloned human beta-1 adrenergic receptor (AR) in the presence of [125I]iodocyanopindolol
ChEMBL 628 12 6 6 6.7 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(-c3ccc(CC4NCCc5cc(O)c(O)cc54)cc3)cc2)cc1 10.1016/s0960-894x(00)00459-5
146015362 7734 10 None -53703 5 Rat 4.5 pIC50 = 4.5 Functional
In vitro beta-adrenergic activity against beta-1 adrenergic receptor by the inhibition of insulin stimulated [14C]- glucose incorporation into glycogen in isolated rat soleus muscleIn vitro beta-adrenergic activity against beta-1 adrenergic receptor by the inhibition of insulin stimulated [14C]- glucose incorporation into glycogen in isolated rat soleus muscle
ChEMBL 421 8 4 6 2.2 C[C@H](Cc1ccc2c(c1)OC(O2)(C(=O)O)C(=O)O)NC[C@@H](c1cccc(c1)Cl)O 10.1021/jm00094a025
3462 7734 10 None -53703 5 Rat 4.5 pIC50 = 4.5 Functional
In vitro beta-adrenergic activity against beta-1 adrenergic receptor by the inhibition of insulin stimulated [14C]- glucose incorporation into glycogen in isolated rat soleus muscleIn vitro beta-adrenergic activity against beta-1 adrenergic receptor by the inhibition of insulin stimulated [14C]- glucose incorporation into glycogen in isolated rat soleus muscle
ChEMBL 421 8 4 6 2.2 C[C@H](Cc1ccc2c(c1)OC(O2)(C(=O)O)C(=O)O)NC[C@@H](c1cccc(c1)Cl)O 10.1021/jm00094a025
5486546 7734 10 None -53703 5 Rat 4.5 pIC50 = 4.5 Functional
In vitro beta-adrenergic activity against beta-1 adrenergic receptor by the inhibition of insulin stimulated [14C]- glucose incorporation into glycogen in isolated rat soleus muscleIn vitro beta-adrenergic activity against beta-1 adrenergic receptor by the inhibition of insulin stimulated [14C]- glucose incorporation into glycogen in isolated rat soleus muscle
ChEMBL 421 8 4 6 2.2 C[C@H](Cc1ccc2c(c1)OC(O2)(C(=O)O)C(=O)O)NC[C@@H](c1cccc(c1)Cl)O 10.1021/jm00094a025
CHEMBL1204876 7734 10 None -53703 5 Rat 4.5 pIC50 = 4.5 Functional
In vitro beta-adrenergic activity against beta-1 adrenergic receptor by the inhibition of insulin stimulated [14C]- glucose incorporation into glycogen in isolated rat soleus muscleIn vitro beta-adrenergic activity against beta-1 adrenergic receptor by the inhibition of insulin stimulated [14C]- glucose incorporation into glycogen in isolated rat soleus muscle
ChEMBL 421 8 4 6 2.2 C[C@H](Cc1ccc2c(c1)OC(O2)(C(=O)O)C(=O)O)NC[C@@H](c1cccc(c1)Cl)O 10.1021/jm00094a025
1786 9298 85 None -4 7 Guinea pig 6.5 pIC50 = 6.5 Functional
Tested for beta-2-adrenergic blocking effect by measuring the ability to inhibit the relaxing effect of epinephrine on the isolated tracheal muscle of guinea pigsTested for beta-2-adrenergic blocking effect by measuring the ability to inhibit the relaxing effect of epinephrine on the isolated tracheal muscle of guinea pigs
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1016/S0960-894X(97)00207-2
4171 9298 85 None -4 7 Guinea pig 6.5 pIC50 = 6.5 Functional
Tested for beta-2-adrenergic blocking effect by measuring the ability to inhibit the relaxing effect of epinephrine on the isolated tracheal muscle of guinea pigsTested for beta-2-adrenergic blocking effect by measuring the ability to inhibit the relaxing effect of epinephrine on the isolated tracheal muscle of guinea pigs
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1016/S0960-894X(97)00207-2
553 9298 85 None -4 7 Guinea pig 6.5 pIC50 = 6.5 Functional
Tested for beta-2-adrenergic blocking effect by measuring the ability to inhibit the relaxing effect of epinephrine on the isolated tracheal muscle of guinea pigsTested for beta-2-adrenergic blocking effect by measuring the ability to inhibit the relaxing effect of epinephrine on the isolated tracheal muscle of guinea pigs
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1016/S0960-894X(97)00207-2
CHEMBL13 9298 85 None -4 7 Guinea pig 6.5 pIC50 = 6.5 Functional
Tested for beta-2-adrenergic blocking effect by measuring the ability to inhibit the relaxing effect of epinephrine on the isolated tracheal muscle of guinea pigsTested for beta-2-adrenergic blocking effect by measuring the ability to inhibit the relaxing effect of epinephrine on the isolated tracheal muscle of guinea pigs
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1016/S0960-894X(97)00207-2
DB00264 9298 85 None -4 7 Guinea pig 6.5 pIC50 = 6.5 Functional
Tested for beta-2-adrenergic blocking effect by measuring the ability to inhibit the relaxing effect of epinephrine on the isolated tracheal muscle of guinea pigsTested for beta-2-adrenergic blocking effect by measuring the ability to inhibit the relaxing effect of epinephrine on the isolated tracheal muscle of guinea pigs
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1016/S0960-894X(97)00207-2
3687256 13606 7 None 3 2 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human adrenergic beta-1 receptor expressed in CHOK1 cells assessed as inhibition of cAMP accumulation by HTRF assayAntagonist activity at human adrenergic beta-1 receptor expressed in CHOK1 cells assessed as inhibition of cAMP accumulation by HTRF assay
ChEMBL 500 8 1 5 5.0 Cc1ccc(C(C)C)c(OCC(O)CN2CCC(CN3C(=O)c4cccc5cccc(c45)C3=O)CC2)c1 10.1016/j.bmcl.2010.04.009
CHEMBL1083994 13606 7 None 3 2 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human adrenergic beta-1 receptor expressed in CHOK1 cells assessed as inhibition of cAMP accumulation by HTRF assayAntagonist activity at human adrenergic beta-1 receptor expressed in CHOK1 cells assessed as inhibition of cAMP accumulation by HTRF assay
ChEMBL 500 8 1 5 5.0 Cc1ccc(C(C)C)c(OCC(O)CN2CCC(CN3C(=O)c4cccc5cccc(c45)C3=O)CC2)c1 10.1016/j.bmcl.2010.04.009
14739905 215064 0 None 7 2 Human 7.4 pIC50 = 7.4 Functional
Tested for beta1-receptor selectivity in canine cardiac tissue in anesthetized dogsTested for beta1-receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 353 10 2 6 2.3 OC(CNCCOc1ccc(-n2ccnc2)cc1)COc1ccccc1 10.1021/jm00172a033
CHEMBL98975 215064 0 None 7 2 Human 7.4 pIC50 = 7.4 Functional
Tested for beta1-receptor selectivity in canine cardiac tissue in anesthetized dogsTested for beta1-receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 353 10 2 6 2.3 OC(CNCCOc1ccc(-n2ccnc2)cc1)COc1ccccc1 10.1021/jm00172a033
1499 8872 47 None -269 38 Rat 8.3 pIC50 = 8.3 Functional
In vitro beta-adrenergic activity against beta-1 adrenergic receptor by the inhibition of insulin stimulated [14C]- glucose incorporation into glycogen in isolated rat soleus muscleIn vitro beta-adrenergic activity against beta-1 adrenergic receptor by the inhibition of insulin stimulated [14C]- glucose incorporation into glycogen in isolated rat soleus muscle
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm00094a025
3779 8872 47 None -269 38 Rat 8.3 pIC50 = 8.3 Functional
In vitro beta-adrenergic activity against beta-1 adrenergic receptor by the inhibition of insulin stimulated [14C]- glucose incorporation into glycogen in isolated rat soleus muscleIn vitro beta-adrenergic activity against beta-1 adrenergic receptor by the inhibition of insulin stimulated [14C]- glucose incorporation into glycogen in isolated rat soleus muscle
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm00094a025
536 8872 47 None -269 38 Rat 8.3 pIC50 = 8.3 Functional
In vitro beta-adrenergic activity against beta-1 adrenergic receptor by the inhibition of insulin stimulated [14C]- glucose incorporation into glycogen in isolated rat soleus muscleIn vitro beta-adrenergic activity against beta-1 adrenergic receptor by the inhibition of insulin stimulated [14C]- glucose incorporation into glycogen in isolated rat soleus muscle
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm00094a025
CHEMBL434 8872 47 None -269 38 Rat 8.3 pIC50 = 8.3 Functional
In vitro beta-adrenergic activity against beta-1 adrenergic receptor by the inhibition of insulin stimulated [14C]- glucose incorporation into glycogen in isolated rat soleus muscleIn vitro beta-adrenergic activity against beta-1 adrenergic receptor by the inhibition of insulin stimulated [14C]- glucose incorporation into glycogen in isolated rat soleus muscle
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm00094a025
DB01064 8872 47 None -269 38 Rat 8.3 pIC50 = 8.3 Functional
In vitro beta-adrenergic activity against beta-1 adrenergic receptor by the inhibition of insulin stimulated [14C]- glucose incorporation into glycogen in isolated rat soleus muscleIn vitro beta-adrenergic activity against beta-1 adrenergic receptor by the inhibition of insulin stimulated [14C]- glucose incorporation into glycogen in isolated rat soleus muscle
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm00094a025
14823035 148341 2 None -10 4 Rat 6.3 pIC50 = 6.3 Functional
In vitro beta-adrenergic activity against beta-1 adrenergic receptor by the inhibition of insulin stimulated [14C]- glucose incorporation into glycogen in isolated rat soleus muscleIn vitro beta-adrenergic activity against beta-1 adrenergic receptor by the inhibition of insulin stimulated [14C]- glucose incorporation into glycogen in isolated rat soleus muscle
ChEMBL 377 9 2 5 3.1 COC(=O)COc1ccc(C[C@@H](C)NC[C@H](O)c2cccc(Cl)c2)cc1 10.1021/jm00094a025
CHEMBL38486 148341 2 None -10 4 Rat 6.3 pIC50 = 6.3 Functional
In vitro beta-adrenergic activity against beta-1 adrenergic receptor by the inhibition of insulin stimulated [14C]- glucose incorporation into glycogen in isolated rat soleus muscleIn vitro beta-adrenergic activity against beta-1 adrenergic receptor by the inhibition of insulin stimulated [14C]- glucose incorporation into glycogen in isolated rat soleus muscle
ChEMBL 377 9 2 5 3.1 COC(=O)COc1ccc(C[C@@H](C)NC[C@H](O)c2cccc(Cl)c2)cc1 10.1021/jm00094a025
14739908 114023 0 None 1 2 Human 5.3 pIC50 = 5.3 Functional
Tested for beta1-receptor selectivity in canine cardiac tissue in anesthetized dogsTested for beta1-receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 416 10 3 7 1.9 CS(=O)(=O)Nc1ccc(C(O)CNCCOc2ccc(-n3ccnc3)cc2)cc1 10.1021/jm00172a033
CHEMBL316868 114023 0 None 1 2 Human 5.3 pIC50 = 5.3 Functional
Tested for beta1-receptor selectivity in canine cardiac tissue in anesthetized dogsTested for beta1-receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 416 10 3 7 1.9 CS(=O)(=O)Nc1ccc(C(O)CNCCOc2ccc(-n3ccnc3)cc2)cc1 10.1021/jm00172a033
44313150 110554 0 None -6 3 Human 6.3 pIC50 = 6.3 Functional
Compound was evaluated for its inhibitory activity against CHO cells expressing the cloned human beta-1 adrenergic receptor (AR) in the presence of [125I]iodocyanopindololCompound was evaluated for its inhibitory activity against CHO cells expressing the cloned human beta-1 adrenergic receptor (AR) in the presence of [125I]iodocyanopindolol
ChEMBL 628 12 6 6 6.7 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2cccc(-c3cccc(CC4NCCc5cc(O)c(O)cc54)c3)c2)cc1 10.1016/s0960-894x(00)00459-5
CHEMBL308868 110554 0 None -6 3 Human 6.3 pIC50 = 6.3 Functional
Compound was evaluated for its inhibitory activity against CHO cells expressing the cloned human beta-1 adrenergic receptor (AR) in the presence of [125I]iodocyanopindololCompound was evaluated for its inhibitory activity against CHO cells expressing the cloned human beta-1 adrenergic receptor (AR) in the presence of [125I]iodocyanopindolol
ChEMBL 628 12 6 6 6.7 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2cccc(-c3cccc(CC4NCCc5cc(O)c(O)cc54)c3)c2)cc1 10.1016/s0960-894x(00)00459-5
65772 67177 8 None -5 11 Human 8.2 pIC50 = 8.2 Functional
Compound was evaluated for its inhibitory activity against CHO cells expressing the cloned human beta-1 adrenergic receptor (AR) in the presence of [125I]iodocyanopindololCompound was evaluated for its inhibitory activity against CHO cells expressing the cloned human beta-1 adrenergic receptor (AR) in the presence of [125I]iodocyanopindolol
ChEMBL 345 5 3 6 2.6 COc1cc(C[C@@H]2NCCc3cc(O)c(O)cc32)cc(OC)c1OC 10.1016/s0960-894x(00)00459-5
CHEMBL174984 67177 8 None -5 11 Human 8.2 pIC50 = 8.2 Functional
Compound was evaluated for its inhibitory activity against CHO cells expressing the cloned human beta-1 adrenergic receptor (AR) in the presence of [125I]iodocyanopindololCompound was evaluated for its inhibitory activity against CHO cells expressing the cloned human beta-1 adrenergic receptor (AR) in the presence of [125I]iodocyanopindolol
ChEMBL 345 5 3 6 2.6 COc1cc(C[C@@H]2NCCc3cc(O)c(O)cc32)cc(OC)c1OC 10.1016/s0960-894x(00)00459-5
10283539 174644 0 None -1479 3 Human 5.2 pIC50 = 5.2 Functional
Compound was tested for the antagonistic activity against Beta-1 adrenergic receptorCompound was tested for the antagonistic activity against Beta-1 adrenergic receptor
ChEMBL 697 14 6 9 2.8 CS(=O)(=O)Nc1cc(OC[C@@H](O)CNCC2CCN(S(=O)(=O)c3ccc(NC(=O)NCc4cc(F)ccc4F)cc3)CC2)ccc1O 10.1016/s0960-894x(02)00607-8
CHEMBL431048 174644 0 None -1479 3 Human 5.2 pIC50 = 5.2 Functional
Compound was tested for the antagonistic activity against Beta-1 adrenergic receptorCompound was tested for the antagonistic activity against Beta-1 adrenergic receptor
ChEMBL 697 14 6 9 2.8 CS(=O)(=O)Nc1cc(OC[C@@H](O)CNCC2CCN(S(=O)(=O)c3ccc(NC(=O)NCc4cc(F)ccc4F)cc3)CC2)ccc1O 10.1016/s0960-894x(02)00607-8
127034966 143305 0 None -1 2 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human beta1 receptor expressed in CHO-K1 cells assessed as isoproterenol-induced cAMP level by HTRF assayAntagonist activity at human beta1 receptor expressed in CHO-K1 cells assessed as isoproterenol-induced cAMP level by HTRF assay
ChEMBL 260 5 2 4 1.6 CB1C=Cc2cccc(OCC(O)CN(C)C)c2N1 10.1021/acs.jmedchem.5b01088
CHEMBL3736433 143305 0 None -1 2 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human beta1 receptor expressed in CHO-K1 cells assessed as isoproterenol-induced cAMP level by HTRF assayAntagonist activity at human beta1 receptor expressed in CHO-K1 cells assessed as isoproterenol-induced cAMP level by HTRF assay
ChEMBL 260 5 2 4 1.6 CB1C=Cc2cccc(OCC(O)CN(C)C)c2N1 10.1021/acs.jmedchem.5b01088
187238 84895 10 None - 0 Rat 10.2 pKd = 10.2 Functional
Antagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cells
ChEMBL 413 5 3 4 2.8 CC(C)(C)NCC(O)COc1cccc2[nH]c(C#N)c(I)c12 10.1021/jm050624l
CHEMBL210309 84895 10 None - 0 Rat 10.2 pKd = 10.2 Functional
Antagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cells
ChEMBL 413 5 3 4 2.8 CC(C)(C)NCC(O)COc1cccc2[nH]c(C#N)c(I)c12 10.1021/jm050624l
187238 84895 10 None - 0 Rat 10.2 pKd = 10.2 Functional
Antagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cells
ChEMBL 413 5 3 4 2.8 CC(C)(C)NCC(O)COc1cccc2[nH]c(C#N)c(I)c12 10.1021/jm050624l
CHEMBL210309 84895 10 None - 0 Rat 10.2 pKd = 10.2 Functional
Antagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cells
ChEMBL 413 5 3 4 2.8 CC(C)(C)NCC(O)COc1cccc2[nH]c(C#N)c(I)c12 10.1021/jm050624l
187238 84895 10 None - 0 Rat 10.2 pKd = 10.2 Functional
Antagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cellsAntagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 413 5 3 4 2.8 CC(C)(C)NCC(O)COc1cccc2[nH]c(C#N)c(I)c12 10.1021/jm050624l
CHEMBL210309 84895 10 None - 0 Rat 10.2 pKd = 10.2 Functional
Antagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cellsAntagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 413 5 3 4 2.8 CC(C)(C)NCC(O)COc1cccc2[nH]c(C#N)c(I)c12 10.1021/jm050624l
187238 84895 10 None - 0 Rat 10.1 pKd = 10.1 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cells
ChEMBL 413 5 3 4 2.8 CC(C)(C)NCC(O)COc1cccc2[nH]c(C#N)c(I)c12 10.1021/jm050624l
CHEMBL210309 84895 10 None - 0 Rat 10.1 pKd = 10.1 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cells
ChEMBL 413 5 3 4 2.8 CC(C)(C)NCC(O)COc1cccc2[nH]c(C#N)c(I)c12 10.1021/jm050624l
13040915 109709 0 None - 0 Guinea pig 10.0 pKd = 10 Functional
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparation at a duration of 3hAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation at a duration of 3h
ChEMBL 325 10 2 7 0.8 CCOC(=O)CCNCC(O)COc1ccccc1C(=O)OC 10.1021/jm00354a003
CHEMBL30622 109709 0 None - 0 Guinea pig 10.0 pKd = 10 Functional
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparation at a duration of 3hAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation at a duration of 3h
ChEMBL 325 10 2 7 0.8 CCOC(=O)CCNCC(O)COc1ccccc1C(=O)OC 10.1021/jm00354a003
3047497 20171 10 None - 0 Rat 9.6 pKd = 9.6 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atriaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atria
ChEMBL 321 11 2 4 2.8 CC(C)NCC(O)COc1ccc(CCOCC2CCC2)cc1 10.1021/jm00389a008
CHEMBL1192675 20171 10 None - 0 Rat 9.6 pKd = 9.6 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atriaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atria
ChEMBL 321 11 2 4 2.8 CC(C)NCC(O)COc1ccc(CCOCC2CCC2)cc1 10.1021/jm00389a008
CHEMBL543955 20171 10 None - 0 Rat 9.6 pKd = 9.6 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atriaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atria
ChEMBL 321 11 2 4 2.8 CC(C)NCC(O)COc1ccc(CCOCC2CCC2)cc1 10.1021/jm00389a008
3047497 20171 10 None - 0 Rat 9.6 pKd = 9.6 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 321 11 2 4 2.8 CC(C)NCC(O)COc1ccc(CCOCC2CCC2)cc1 10.1021/jm00389a008
CHEMBL1192675 20171 10 None - 0 Rat 9.6 pKd = 9.6 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 321 11 2 4 2.8 CC(C)NCC(O)COc1ccc(CCOCC2CCC2)cc1 10.1021/jm00389a008
CHEMBL543955 20171 10 None - 0 Rat 9.6 pKd = 9.6 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 321 11 2 4 2.8 CC(C)NCC(O)COc1ccc(CCOCC2CCC2)cc1 10.1021/jm00389a008
187238 84895 10 None - 0 Rat 9.5 pKd = 9.5 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cells
ChEMBL 413 5 3 4 2.8 CC(C)(C)NCC(O)COc1cccc2[nH]c(C#N)c(I)c12 10.1021/jm050624l
CHEMBL210309 84895 10 None - 0 Rat 9.5 pKd = 9.5 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cells
ChEMBL 413 5 3 4 2.8 CC(C)(C)NCC(O)COc1cccc2[nH]c(C#N)c(I)c12 10.1021/jm050624l
2685 7677 21 None - 1 Human 9.5 pKd = 9.5 Functional
Antagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrsAntagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrs
ChEMBL 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10.1021/jm400348g
541 7677 21 None - 1 Human 9.5 pKd = 9.5 Functional
Antagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrsAntagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrs
ChEMBL 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10.1021/jm400348g
CHEMBL280822 7677 21 None - 1 Human 9.5 pKd = 9.5 Functional
Antagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrsAntagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrs
ChEMBL 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10.1021/jm400348g
123686 8762 51 None 74 3 Human 9.5 pKd = 9.5 Functional
Antagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrsAntagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrs
ChEMBL 354 9 4 5 1.7 C1=CC=C(C=C1)NC(=O)NCCNCC(COC2=CC=CC=C2C#N)O 10.1021/jm400348g
12581 8762 51 None 74 3 Human 9.5 pKd = 9.5 Functional
Antagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrsAntagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrs
ChEMBL 354 9 4 5 1.7 C1=CC=C(C=C1)NC(=O)NCCNCC(COC2=CC=CC=C2C#N)O 10.1021/jm400348g
CHEMBL11268 8762 51 None 74 3 Human 9.5 pKd = 9.5 Functional
Antagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrsAntagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrs
ChEMBL 354 9 4 5 1.7 C1=CC=C(C=C1)NC(=O)NCCNCC(COC2=CC=CC=C2C#N)O 10.1021/jm400348g
33624 10593 34 None - 6 Guinea pig 9.4 pKd = 9.4 Functional
Compound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atriaCompound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atria
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm00350a009
4061 10593 34 None - 6 Guinea pig 9.4 pKd = 9.4 Functional
Compound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atriaCompound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atria
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm00350a009
565 10593 34 None - 6 Guinea pig 9.4 pKd = 9.4 Functional
Compound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atriaCompound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atria
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm00350a009
CHEMBL499 10593 34 None - 6 Guinea pig 9.4 pKd = 9.4 Functional
Compound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atriaCompound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atria
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm00350a009
DB00373 10593 34 None - 6 Guinea pig 9.4 pKd = 9.4 Functional
Compound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atriaCompound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atria
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm00350a009
13187527 103866 0 None - 0 Rat 9.3 pKd = 9.3 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 321 10 2 4 2.9 CC(C)NCC(O)COc1ccc(CCOC2CCCC2)cc1 10.1021/jm00389a008
CHEMBL267375 103866 0 None - 0 Rat 9.3 pKd = 9.3 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 321 10 2 4 2.9 CC(C)NCC(O)COc1ccc(CCOC2CCCC2)cc1 10.1021/jm00389a008
CHEMBL542536 103866 0 None - 0 Rat 9.3 pKd = 9.3 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 321 10 2 4 2.9 CC(C)NCC(O)COc1ccc(CCOC2CCCC2)cc1 10.1021/jm00389a008
56598832 95043 0 None 4365 3 Human 9.0 pKd = 9 Functional
Antagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrsAntagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrs
ChEMBL 527 16 5 7 3.3 O=C(NCCNCC(O)COc1ccc(OCCOCCc2ccc(F)cc2)cc1)Nc1ccc(O)cc1 10.1021/jm400348g
CHEMBL2348218 95043 0 None 4365 3 Human 9.0 pKd = 9 Functional
Antagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrsAntagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrs
ChEMBL 527 16 5 7 3.3 O=C(NCCNCC(O)COc1ccc(OCCOCCc2ccc(F)cc2)cc1)Nc1ccc(O)cc1 10.1021/jm400348g
66653268 95026 0 None 3311 3 Human 8.8 pKd = 8.8 Functional
Antagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrsAntagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrs
ChEMBL 491 14 4 6 3.8 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1cccc(Cl)c1 10.1021/jm400348g
CHEMBL2348201 95026 0 None 3311 3 Human 8.8 pKd = 8.8 Functional
Antagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrsAntagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrs
ChEMBL 491 14 4 6 3.8 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1cccc(Cl)c1 10.1021/jm400348g
5311116 9114 9 None 4365 3 Human 8.8 pKd = 8.8 Functional
Antagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrsAntagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrs
ChEMBL 484 15 5 8 2.2 N#Cc1cc(OCCOCC2CC2)ccc1OCC(CNCCNC(=O)Nc1ccc(cc1)O)O 10.1021/jm400348g
544 9114 9 None 4365 3 Human 8.8 pKd = 8.8 Functional
Antagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrsAntagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrs
ChEMBL 484 15 5 8 2.2 N#Cc1cc(OCCOCC2CC2)ccc1OCC(CNCCNC(=O)Nc1ccc(cc1)O)O 10.1021/jm400348g
CHEMBL207802 9114 9 None 4365 3 Human 8.8 pKd = 8.8 Functional
Antagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrsAntagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrs
ChEMBL 484 15 5 8 2.2 N#Cc1cc(OCCOCC2CC2)ccc1OCC(CNCCNC(=O)Nc1ccc(cc1)O)O 10.1021/jm400348g
2303 9961 68 None -6 20 Human 8.7 pKd = 8.7 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm2008562
4946 9961 68 None -6 20 Human 8.7 pKd = 8.7 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm2008562
564 9961 68 None -6 20 Human 8.7 pKd = 8.7 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm2008562
63 9961 68 None -6 20 Human 8.7 pKd = 8.7 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm2008562
91536 9961 68 None -6 20 Human 8.7 pKd = 8.7 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm2008562
CHEMBL27 9961 68 None -6 20 Human 8.7 pKd = 8.7 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm2008562
CHEMBL452861 9961 68 None -6 20 Human 8.7 pKd = 8.7 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm2008562
DB00571 9961 68 None -6 20 Human 8.7 pKd = 8.7 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm2008562
12733305 67161 0 None - 0 Guinea pig 8.7 pKd = 8.7 Functional
Antagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atriaAntagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atria
ChEMBL 357 8 2 6 2.5 COc1ccc(CCNCC(O)C2=COc3ccccc3O2)cc1OC 10.1021/jm00140a015
CHEMBL174853 67161 0 None - 0 Guinea pig 8.7 pKd = 8.7 Functional
Antagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atriaAntagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atria
ChEMBL 357 8 2 6 2.5 COc1ccc(CCNCC(O)C2=COc3ccccc3O2)cc1OC 10.1021/jm00140a015
13187527 103866 0 None - 0 Rat 8.7 pKd = 8.7 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 321 10 2 4 2.9 CC(C)NCC(O)COc1ccc(CCOC2CCCC2)cc1 10.1021/jm00389a008
CHEMBL267375 103866 0 None - 0 Rat 8.7 pKd = 8.7 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 321 10 2 4 2.9 CC(C)NCC(O)COc1ccc(CCOC2CCCC2)cc1 10.1021/jm00389a008
CHEMBL542536 103866 0 None - 0 Rat 8.7 pKd = 8.7 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 321 10 2 4 2.9 CC(C)NCC(O)COc1ccc(CCOC2CCCC2)cc1 10.1021/jm00389a008
44288749 171049 0 None - 0 Rat 8.0 pKd = 8.0 Functional
Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for S-enantiomer)Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for S-enantiomer)
ChEMBL 330 8 2 4 4.0 CC(C)(C)c1ccc(NCC(O)CON=C(C2CC2)C2CC2)cc1 10.1021/jm970338c
CHEMBL42117 171049 0 None - 0 Rat 8.0 pKd = 8.0 Functional
Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for S-enantiomer)Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for S-enantiomer)
ChEMBL 330 8 2 4 4.0 CC(C)(C)c1ccc(NCC(O)CON=C(C2CC2)C2CC2)cc1 10.1021/jm970338c
44288749 171049 0 None - 0 Rat 8.0 pKd = 8.0 Functional
Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for R-enantiomer)Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for R-enantiomer)
ChEMBL 330 8 2 4 4.0 CC(C)(C)c1ccc(NCC(O)CON=C(C2CC2)C2CC2)cc1 10.1021/jm970338c
CHEMBL42117 171049 0 None - 0 Rat 8.0 pKd = 8.0 Functional
Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for R-enantiomer)Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for R-enantiomer)
ChEMBL 330 8 2 4 4.0 CC(C)(C)c1ccc(NCC(O)CON=C(C2CC2)C2CC2)cc1 10.1021/jm970338c
11722868 111156 0 None - 0 Guinea pig 7.0 pKd = 7 Functional
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparation at a duration of 40 minAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation at a duration of 40 min
ChEMBL 309 8 2 5 1.9 COC(=O)CCc1ccc(OCC(O)CNC(C)(C)C)cc1 10.1021/jm00354a003
CHEMBL31025 111156 0 None - 0 Guinea pig 7.0 pKd = 7 Functional
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparation at a duration of 40 minAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation at a duration of 40 min
ChEMBL 309 8 2 5 1.9 COC(=O)CCc1ccc(OCC(O)CNC(C)(C)C)cc1 10.1021/jm00354a003
13040919 112844 0 None - 0 Guinea pig 5.0 pKd = 5 Functional
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparation at a duration of 3hAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation at a duration of 3h
ChEMBL 339 9 2 7 1.1 CCOC(=O)C(C)(C)NCC(O)COc1ccccc1C(=O)OC 10.1021/jm00354a003
CHEMBL31335 112844 0 None - 0 Guinea pig 5.0 pKd = 5 Functional
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparation at a duration of 3hAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation at a duration of 3h
ChEMBL 339 9 2 7 1.1 CCOC(=O)C(C)(C)NCC(O)COc1ccccc1C(=O)OC 10.1021/jm00354a003
44371562 56492 0 None - 0 Guinea pig 5.0 pKd = 5.0 Functional
Antagonist activity against beta-1 adrenergic receptor in isolated guinea pig atriaAntagonist activity against beta-1 adrenergic receptor in isolated guinea pig atria
ChEMBL 257 7 2 5 1.2 CC(C)NCC(O)COC(=O)Cc1cccs1 10.1021/jm00387a006
CHEMBL156683 56492 0 None - 0 Guinea pig 5.0 pKd = 5.0 Functional
Antagonist activity against beta-1 adrenergic receptor in isolated guinea pig atriaAntagonist activity against beta-1 adrenergic receptor in isolated guinea pig atria
ChEMBL 257 7 2 5 1.2 CC(C)NCC(O)COC(=O)Cc1cccs1 10.1021/jm00387a006
20554487 20071 0 None - 0 Rat 7.9 pKd = 7.9 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 369 11 2 5 2.2 CC(C)NCC(O)COc1ccc(CCS(=O)(=O)CC2CCC2)cc1 10.1021/jm00389a008
CHEMBL1191855 20071 0 None - 0 Rat 7.9 pKd = 7.9 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 369 11 2 5 2.2 CC(C)NCC(O)COc1ccc(CCS(=O)(=O)CC2CCC2)cc1 10.1021/jm00389a008
CHEMBL543011 20071 0 None - 0 Rat 7.9 pKd = 7.9 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 369 11 2 5 2.2 CC(C)NCC(O)COc1ccc(CCS(=O)(=O)CC2CCC2)cc1 10.1021/jm00389a008
54757126 72267 0 None - 0 Human 7.0 pKd = 7.0 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 893 26 4 10 6.8 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCOCCOCCNCC(O)COc1cccc2ccccc12 10.1021/jm2008562
CHEMBL1830492 72267 0 None - 0 Human 7.0 pKd = 7.0 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 893 26 4 10 6.8 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCOCCOCCNCC(O)COc1cccc2ccccc12 10.1021/jm2008562
14856222 179428 0 None - 0 Guinea pig 4.9 pKd = 4.9 Functional
Antagonist activity against beta-1 adrenergic receptor in isolated guinea pig atriaAntagonist activity against beta-1 adrenergic receptor in isolated guinea pig atria
ChEMBL 217 5 2 4 0.9 CC(C)C(=O)OCC(O)CNC(C)(C)C 10.1021/jm00387a006
CHEMBL449651 179428 0 None - 0 Guinea pig 4.9 pKd = 4.9 Functional
Antagonist activity against beta-1 adrenergic receptor in isolated guinea pig atriaAntagonist activity against beta-1 adrenergic receptor in isolated guinea pig atria
ChEMBL 217 5 2 4 0.9 CC(C)C(=O)OCC(O)CNC(C)(C)C 10.1021/jm00387a006
12733304 135015 0 None - 0 Guinea pig 5.9 pKd = 5.9 Functional
Antagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atriaAntagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atria
ChEMBL 275 3 1 4 2.5 OC(CN1CCCCCC1)C1=COc2ccccc2O1 10.1021/jm00140a015
CHEMBL366558 135015 0 None - 0 Guinea pig 5.9 pKd = 5.9 Functional
Antagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atriaAntagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atria
ChEMBL 275 3 1 4 2.5 OC(CN1CCCCCC1)C1=COc2ccccc2O1 10.1021/jm00140a015
44288217 161932 0 None - 0 Rat 7.9 pKd = 7.9 Functional
Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for R-enantiomer)Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for R-enantiomer)
ChEMBL 288 8 2 4 3.0 Cc1ccc(NCC(O)CON=C(C2CC2)C2CC2)cc1 10.1021/jm970338c
CHEMBL40217 161932 0 None - 0 Rat 7.9 pKd = 7.9 Functional
Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for R-enantiomer)Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for R-enantiomer)
ChEMBL 288 8 2 4 3.0 Cc1ccc(NCC(O)CON=C(C2CC2)C2CC2)cc1 10.1021/jm970338c
2303 9961 68 None -22 20 Guinea pig 7.9 pKd = 7.9 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig tracheaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig trachea
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00389a008
4946 9961 68 None -22 20 Guinea pig 7.9 pKd = 7.9 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig tracheaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig trachea
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00389a008
564 9961 68 None -22 20 Guinea pig 7.9 pKd = 7.9 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig tracheaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig trachea
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00389a008
63 9961 68 None -22 20 Guinea pig 7.9 pKd = 7.9 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig tracheaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig trachea
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00389a008
91536 9961 68 None -22 20 Guinea pig 7.9 pKd = 7.9 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig tracheaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig trachea
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00389a008
CHEMBL27 9961 68 None -22 20 Guinea pig 7.9 pKd = 7.9 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig tracheaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig trachea
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00389a008
CHEMBL452861 9961 68 None -22 20 Guinea pig 7.9 pKd = 7.9 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig tracheaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig trachea
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00389a008
DB00571 9961 68 None -22 20 Guinea pig 7.9 pKd = 7.9 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig tracheaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig trachea
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00389a008
44371486 21018 0 None - 0 Guinea pig 6.9 pKd = 6.9 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 230 7 2 4 1.9 CCC/C(C)=N\OCC(O)CNC(C)(C)C 10.1021/jm00180a007
CHEMBL1161387 21018 0 None - 0 Guinea pig 6.9 pKd = 6.9 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 230 7 2 4 1.9 CCC/C(C)=N\OCC(O)CNC(C)(C)C 10.1021/jm00180a007
CHEMBL1199437 21018 0 None - 0 Guinea pig 6.9 pKd = 6.9 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 230 7 2 4 1.9 CCC/C(C)=N\OCC(O)CNC(C)(C)C 10.1021/jm00180a007
54757229 72289 0 None - 0 Human 6.9 pKd = 6.9 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 795 22 4 8 6.3 C=CCc1ccccc1OCC(O)CNCCNC(=O)CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1 10.1021/jm2008562
CHEMBL1830617 72289 0 None - 0 Human 6.9 pKd = 6.9 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 795 22 4 8 6.3 C=CCc1ccccc1OCC(O)CNCCNC(=O)CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1 10.1021/jm2008562
44371537 57443 0 None - 0 Guinea pig 4.9 pKd = 4.9 Functional
Antagonist activity against beta-1 adrenergic receptor in isolated guinea pig atriaAntagonist activity against beta-1 adrenergic receptor in isolated guinea pig atria
ChEMBL 243 6 2 4 1.5 CC(C)NCC(O)COC(=O)C1CCCCC1 10.1021/jm00387a006
CHEMBL157557 57443 0 None - 0 Guinea pig 4.9 pKd = 4.9 Functional
Antagonist activity against beta-1 adrenergic receptor in isolated guinea pig atriaAntagonist activity against beta-1 adrenergic receptor in isolated guinea pig atria
ChEMBL 243 6 2 4 1.5 CC(C)NCC(O)COC(=O)C1CCCCC1 10.1021/jm00387a006
12348305 103771 0 None - 0 Guinea pig 6.9 pKd = 6.9 Functional
Antagonist activity against beta-1 adrenergic receptor in isolated guinea pig atriaAntagonist activity against beta-1 adrenergic receptor in isolated guinea pig atria
ChEMBL 281 6 2 6 0.9 CC(C)NCC(O)COC(=O)c1ccc2c(c1)OCO2 10.1021/jm00387a006
CHEMBL266548 103771 0 None - 0 Guinea pig 6.9 pKd = 6.9 Functional
Antagonist activity against beta-1 adrenergic receptor in isolated guinea pig atriaAntagonist activity against beta-1 adrenergic receptor in isolated guinea pig atria
ChEMBL 281 6 2 6 0.9 CC(C)NCC(O)COC(=O)c1ccc2c(c1)OCO2 10.1021/jm00387a006
2369 7409 80 None - 2 Rat 6.9 pKd = 6.9 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00389a008
356 7409 80 None - 2 Rat 6.9 pKd = 6.9 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00389a008
549 7409 80 None - 2 Rat 6.9 pKd = 6.9 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00389a008
CHEMBL423 7409 80 None - 2 Rat 6.9 pKd = 6.9 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00389a008
DB00195 7409 80 None - 2 Rat 6.9 pKd = 6.9 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00389a008
12606708 19852 0 None - 0 Guinea pig 5.9 pKd = 5.9 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 282 6 2 4 2.6 CC(C)NCC(O)CO/N=C1\CC2CCC1(C)C2(C)C 10.1021/jm00180a007
CHEMBL1190195 19852 0 None - 0 Guinea pig 5.9 pKd = 5.9 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 282 6 2 4 2.6 CC(C)NCC(O)CO/N=C1\CC2CCC1(C)C2(C)C 10.1021/jm00180a007
CHEMBL540337 19852 0 None - 0 Guinea pig 5.9 pKd = 5.9 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 282 6 2 4 2.6 CC(C)NCC(O)CO/N=C1\CC2CCC1(C)C2(C)C 10.1021/jm00180a007
44287476 18784 0 None - 0 Guinea pig 5.9 pKd = 5.9 Functional
Antagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atriaAntagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atria
ChEMBL 230 7 2 4 1.9 CCC(CC)=NOCC(O)CNC(C)(C)C 10.1021/jm00380a001
CHEMBL1183311 18784 0 None - 0 Guinea pig 5.9 pKd = 5.9 Functional
Antagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atriaAntagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atria
ChEMBL 230 7 2 4 1.9 CCC(CC)=NOCC(O)CNC(C)(C)C 10.1021/jm00380a001
CHEMBL289858 18784 0 None - 0 Guinea pig 5.9 pKd = 5.9 Functional
Antagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atriaAntagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atria
ChEMBL 230 7 2 4 1.9 CCC(CC)=NOCC(O)CNC(C)(C)C 10.1021/jm00380a001
3047527 210401 1 None - 0 Rat 6.9 pKd = 6.9 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 335 11 2 4 3.2 CC(C)NCC(O)COc1ccc(CCOCC2CCCC2)cc1 10.1021/jm00389a008
CHEMBL6712 210401 1 None - 0 Rat 6.9 pKd = 6.9 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 335 11 2 4 3.2 CC(C)NCC(O)COc1ccc(CCOCC2CCCC2)cc1 10.1021/jm00389a008
2447486 69834 1 None - 2 Guinea pig 7.9 pKd = 7.9 Functional
Compound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atriaCompound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atria
ChEMBL 324 5 2 4 3.2 CC(C)(C)NC[C@@H](O)CON=C1c2ccccc2-c2ccccc21 10.1021/jm00350a009
CHEMBL1788270 69834 1 None - 2 Guinea pig 7.9 pKd = 7.9 Functional
Compound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atriaCompound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atria
ChEMBL 324 5 2 4 3.2 CC(C)(C)NC[C@@H](O)CON=C1c2ccccc2-c2ccccc21 10.1021/jm00350a009
54756927 72261 0 None - 0 Human 7.9 pKd = 7.9 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 833 22 4 8 7.5 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCCCNC[C@H](O)COc1cccc2ccccc12 10.1021/jm2008562
CHEMBL1830486 72261 0 None - 0 Human 7.9 pKd = 7.9 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 833 22 4 8 7.5 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCCCNC[C@H](O)COc1cccc2ccccc12 10.1021/jm2008562
44288217 161932 0 None - 0 Rat 7.9 pKd = 7.9 Functional
Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for S-enantiomer)Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for S-enantiomer)
ChEMBL 288 8 2 4 3.0 Cc1ccc(NCC(O)CON=C(C2CC2)C2CC2)cc1 10.1021/jm970338c
CHEMBL40217 161932 0 None - 0 Rat 7.9 pKd = 7.9 Functional
Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for S-enantiomer)Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for S-enantiomer)
ChEMBL 288 8 2 4 3.0 Cc1ccc(NCC(O)CON=C(C2CC2)C2CC2)cc1 10.1021/jm970338c
12606686 99634 3 None - 0 Guinea pig 4.9 pKd = 4.9 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 189 5 2 3 1.2 CC(C)OCC(O)CNC(C)(C)C 10.1021/jm00180a007
CHEMBL1161385 99634 3 None - 0 Guinea pig 4.9 pKd = 4.9 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 189 5 2 3 1.2 CC(C)OCC(O)CNC(C)(C)C 10.1021/jm00180a007
CHEMBL24391 99634 3 None - 0 Guinea pig 4.9 pKd = 4.9 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 189 5 2 3 1.2 CC(C)OCC(O)CNC(C)(C)C 10.1021/jm00180a007
1786 9298 85 None -4 7 Guinea pig 7.8 pKd = 7.8 Functional
Compound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig arteriaCompound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig arteria
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00350a009
4171 9298 85 None -4 7 Guinea pig 7.8 pKd = 7.8 Functional
Compound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig arteriaCompound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig arteria
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00350a009
553 9298 85 None -4 7 Guinea pig 7.8 pKd = 7.8 Functional
Compound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig arteriaCompound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig arteria
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00350a009
CHEMBL13 9298 85 None -4 7 Guinea pig 7.8 pKd = 7.8 Functional
Compound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig arteriaCompound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig arteria
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00350a009
DB00264 9298 85 None -4 7 Guinea pig 7.8 pKd = 7.8 Functional
Compound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig arteriaCompound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig arteria
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00350a009
12733308 129329 0 None - 0 Guinea pig 6.8 pKd = 6.8 Functional
Antagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atriaAntagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atria
ChEMBL 393 4 2 7 3.1 Oc1nc2ccccc2n1C1CCN(CC(O)C2=COc3ccccc3O2)CC1 10.1021/jm00140a015
CHEMBL360139 129329 0 None - 0 Guinea pig 6.8 pKd = 6.8 Functional
Antagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atriaAntagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atria
ChEMBL 393 4 2 7 3.1 Oc1nc2ccccc2n1C1CCN(CC(O)C2=COc3ccccc3O2)CC1 10.1021/jm00140a015
3047500 20049 1 None - 0 Rat 6.8 pKd = 6.8 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 349 11 2 4 3.6 CC(C)NCC(O)COc1ccc(CCOCC2CCCCC2)cc1 10.1021/jm00389a008
CHEMBL1191645 20049 1 None - 0 Rat 6.8 pKd = 6.8 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 349 11 2 4 3.6 CC(C)NCC(O)COc1ccc(CCOCC2CCCCC2)cc1 10.1021/jm00389a008
CHEMBL542776 20049 1 None - 0 Rat 6.8 pKd = 6.8 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 349 11 2 4 3.6 CC(C)NCC(O)COc1ccc(CCOCC2CCCCC2)cc1 10.1021/jm00389a008
3047500 20049 1 None - 0 Rat 6.8 pKd = 6.8 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atriaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atria
ChEMBL 349 11 2 4 3.6 CC(C)NCC(O)COc1ccc(CCOCC2CCCCC2)cc1 10.1021/jm00389a008
CHEMBL1191645 20049 1 None - 0 Rat 6.8 pKd = 6.8 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atriaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atria
ChEMBL 349 11 2 4 3.6 CC(C)NCC(O)COc1ccc(CCOCC2CCCCC2)cc1 10.1021/jm00389a008
CHEMBL542776 20049 1 None - 0 Rat 6.8 pKd = 6.8 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atriaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atria
ChEMBL 349 11 2 4 3.6 CC(C)NCC(O)COc1ccc(CCOCC2CCCCC2)cc1 10.1021/jm00389a008
44287622 18773 0 None - 0 Guinea pig 4.8 pKd = 4.8 Functional
Antagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atriaAntagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atria
ChEMBL 258 7 2 4 2.4 CC(C)C(=NOCC(O)CNC(C)(C)C)C(C)C 10.1021/jm00380a001
CHEMBL1183276 18773 0 None - 0 Guinea pig 4.8 pKd = 4.8 Functional
Antagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atriaAntagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atria
ChEMBL 258 7 2 4 2.4 CC(C)C(=NOCC(O)CNC(C)(C)C)C(C)C 10.1021/jm00380a001
CHEMBL288140 18773 0 None - 0 Guinea pig 4.8 pKd = 4.8 Functional
Antagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atriaAntagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atria
ChEMBL 258 7 2 4 2.4 CC(C)C(=NOCC(O)CNC(C)(C)C)C(C)C 10.1021/jm00380a001
10403687 9289 3 None - 2 Guinea pig 4.8 pKd = 4.8 Functional
Compound was evaluated for its antagonist affinity towards Beta-1 adrenergic receptor of guinea pigCompound was evaluated for its antagonist affinity towards Beta-1 adrenergic receptor of guinea pig
ChEMBL 319 8 2 2 3.9 CNCCc1cnc([nH]1)CCC(c1ccccc1)c1ccccc1 10.1021/jm991056a
1205 9289 3 None - 2 Guinea pig 4.8 pKd = 4.8 Functional
Compound was evaluated for its antagonist affinity towards Beta-1 adrenergic receptor of guinea pigCompound was evaluated for its antagonist affinity towards Beta-1 adrenergic receptor of guinea pig
ChEMBL 319 8 2 2 3.9 CNCCc1cnc([nH]1)CCC(c1ccccc1)c1ccccc1 10.1021/jm991056a
CHEMBL275035 9289 3 None - 2 Guinea pig 4.8 pKd = 4.8 Functional
Compound was evaluated for its antagonist affinity towards Beta-1 adrenergic receptor of guinea pigCompound was evaluated for its antagonist affinity towards Beta-1 adrenergic receptor of guinea pig
ChEMBL 319 8 2 2 3.9 CNCCc1cnc([nH]1)CCC(c1ccccc1)c1ccccc1 10.1021/jm991056a
12733301 67184 1 None - 0 Guinea pig 7.8 pKd = 7.8 Functional
Antagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atriaAntagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atria
ChEMBL 235 4 2 4 1.7 CC(C)NCC(O)C1=COc2ccccc2O1 10.1021/jm00140a015
CHEMBL175010 67184 1 None - 0 Guinea pig 7.8 pKd = 7.8 Functional
Antagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atriaAntagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atria
ChEMBL 235 4 2 4 1.7 CC(C)NCC(O)C1=COc2ccccc2O1 10.1021/jm00140a015
44371406 18436 0 None - 0 Guinea pig 6.8 pKd = 6.8 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 278 9 2 4 2.4 C/C(CCc1ccccc1)=N/OCC(O)CNC(C)C 10.1021/jm00180a007
CHEMBL1181107 18436 0 None - 0 Guinea pig 6.8 pKd = 6.8 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 278 9 2 4 2.4 C/C(CCc1ccccc1)=N/OCC(O)CNC(C)C 10.1021/jm00180a007
CHEMBL155714 18436 0 None - 0 Guinea pig 6.8 pKd = 6.8 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 278 9 2 4 2.4 C/C(CCc1ccccc1)=N/OCC(O)CNC(C)C 10.1021/jm00180a007
44264144 20050 0 None - 0 Rat 6.8 pKd = 6.8 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 385 11 2 6 1.6 CC(C)NCC(O)COc1ccc(CCS(=O)(=O)CC2CCCO2)cc1 10.1021/jm00389a008
CHEMBL1191646 20050 0 None - 0 Rat 6.8 pKd = 6.8 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 385 11 2 6 1.6 CC(C)NCC(O)COc1ccc(CCS(=O)(=O)CC2CCCO2)cc1 10.1021/jm00389a008
CHEMBL542777 20050 0 None - 0 Rat 6.8 pKd = 6.8 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 385 11 2 6 1.6 CC(C)NCC(O)COc1ccc(CCS(=O)(=O)CC2CCCO2)cc1 10.1021/jm00389a008
361497 55854 2 None - 0 Guinea pig 5.8 pKd = 5.8 Functional
Antagonist activity against beta-1 adrenergic receptor in isolated guinea pig atriaAntagonist activity against beta-1 adrenergic receptor in isolated guinea pig atria
ChEMBL 243 6 2 5 1.3 CC(C)NCC(O)COC(=O)c1cccs1 10.1021/jm00387a006
CHEMBL156147 55854 2 None - 0 Guinea pig 5.8 pKd = 5.8 Functional
Antagonist activity against beta-1 adrenergic receptor in isolated guinea pig atriaAntagonist activity against beta-1 adrenergic receptor in isolated guinea pig atria
ChEMBL 243 6 2 5 1.3 CC(C)NCC(O)COC(=O)c1cccs1 10.1021/jm00387a006
12778441 85141 0 None - 0 Guinea pig 7.8 pKd = 7.8 Functional
Compound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atriaCompound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atria
ChEMBL 338 7 2 4 3.6 CCC(C)(C)NC[C@H](O)CON=C1c2ccccc2-c2ccccc21 10.1021/jm00350a009
CHEMBL2110257 85141 0 None - 0 Guinea pig 7.8 pKd = 7.8 Functional
Compound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atriaCompound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atria
ChEMBL 338 7 2 4 3.6 CCC(C)(C)NC[C@H](O)CON=C1c2ccccc2-c2ccccc21 10.1021/jm00350a009
3486 9931 56 None - 2 Guinea pig 5.8 pKd = 5.8 Functional
Antagonist activity against beta-1 adrenergic receptor in isolated guinea pig atriaAntagonist activity against beta-1 adrenergic receptor in isolated guinea pig atria
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00387a006
4883 9931 56 None - 2 Guinea pig 5.8 pKd = 5.8 Functional
Antagonist activity against beta-1 adrenergic receptor in isolated guinea pig atriaAntagonist activity against beta-1 adrenergic receptor in isolated guinea pig atria
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00387a006
555 9931 56 None - 2 Guinea pig 5.8 pKd = 5.8 Functional
Antagonist activity against beta-1 adrenergic receptor in isolated guinea pig atriaAntagonist activity against beta-1 adrenergic receptor in isolated guinea pig atria
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00387a006
CHEMBL6995 9931 56 None - 2 Guinea pig 5.8 pKd = 5.8 Functional
Antagonist activity against beta-1 adrenergic receptor in isolated guinea pig atriaAntagonist activity against beta-1 adrenergic receptor in isolated guinea pig atria
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00387a006
DB01297 9931 56 None - 2 Guinea pig 5.8 pKd = 5.8 Functional
Antagonist activity against beta-1 adrenergic receptor in isolated guinea pig atriaAntagonist activity against beta-1 adrenergic receptor in isolated guinea pig atria
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00387a006
3486 9931 56 None - 2 Guinea pig 5.8 pKd = 5.8 Functional
Antagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atriaAntagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atria
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00380a001
4883 9931 56 None - 2 Guinea pig 5.8 pKd = 5.8 Functional
Antagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atriaAntagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atria
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00380a001
555 9931 56 None - 2 Guinea pig 5.8 pKd = 5.8 Functional
Antagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atriaAntagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atria
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00380a001
CHEMBL6995 9931 56 None - 2 Guinea pig 5.8 pKd = 5.8 Functional
Antagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atriaAntagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atria
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00380a001
DB01297 9931 56 None - 2 Guinea pig 5.8 pKd = 5.8 Functional
Antagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atriaAntagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atria
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00380a001
12606710 20168 0 None - 0 Guinea pig 4.8 pKd = 4.8 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 204 6 3 4 0.7 CC(C)NOCC(O)CNC(C)(C)C 10.1021/jm00180a007
CHEMBL1192661 20168 0 None - 0 Guinea pig 4.8 pKd = 4.8 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 204 6 3 4 0.7 CC(C)NOCC(O)CNC(C)(C)C 10.1021/jm00180a007
CHEMBL543940 20168 0 None - 0 Guinea pig 4.8 pKd = 4.8 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 204 6 3 4 0.7 CC(C)NOCC(O)CNC(C)(C)C 10.1021/jm00180a007
44287431 18000 0 None - 0 Guinea pig 4.8 pKd = 4.8 Functional
Antagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atriaAntagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atria
ChEMBL 244 8 2 4 2.0 CC(C)NCC(O)CON=C(C(C)C)C(C)C 10.1021/jm00380a001
CHEMBL1178793 18000 0 None - 0 Guinea pig 4.8 pKd = 4.8 Functional
Antagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atriaAntagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atria
ChEMBL 244 8 2 4 2.0 CC(C)NCC(O)CON=C(C(C)C)C(C)C 10.1021/jm00380a001
CHEMBL41839 18000 0 None - 0 Guinea pig 4.8 pKd = 4.8 Functional
Antagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atriaAntagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atria
ChEMBL 244 8 2 4 2.0 CC(C)NCC(O)CON=C(C(C)C)C(C)C 10.1021/jm00380a001
54757331 72291 0 None - 0 Human 7.8 pKd = 7.8 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 883 28 4 10 6.3 C=CCc1ccccc1OCC(O)CNCCOCCOCCNC(=O)CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1 10.1021/jm2008562
CHEMBL1830619 72291 0 None - 0 Human 7.8 pKd = 7.8 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 883 28 4 10 6.3 C=CCc1ccccc1OCC(O)CNCCOCCOCCNC(=O)CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1 10.1021/jm2008562
155774 10868 40 None 42 3 Human 7.8 pKd = 7.8 Functional
Antagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrsAntagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrs
ChEMBL 339 8 4 6 -0.2 OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1 10.1021/jm400348g
2848 10868 40 None 42 3 Human 7.8 pKd = 7.8 Functional
Antagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrsAntagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrs
ChEMBL 339 8 4 6 -0.2 OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1 10.1021/jm400348g
538 10868 40 None 42 3 Human 7.8 pKd = 7.8 Functional
Antagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrsAntagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrs
ChEMBL 339 8 4 6 -0.2 OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1 10.1021/jm400348g
CHEMBL75753 10868 40 None 42 3 Human 7.8 pKd = 7.8 Functional
Antagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrsAntagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrs
ChEMBL 339 8 4 6 -0.2 OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1 10.1021/jm400348g
DB13781 10868 40 None 42 3 Human 7.8 pKd = 7.8 Functional
Antagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrsAntagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrs
ChEMBL 339 8 4 6 -0.2 OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1 10.1021/jm400348g
56598831 95918 0 None 1023 3 Human 7.8 pKd = 7.8 Functional
Antagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrsAntagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrs
ChEMBL 459 15 5 7 2.3 O=C(NCCNCC(O)COc1ccc(OCCOCC2CC2)cc1)Nc1ccc(O)cc1 10.1021/jm400348g
CHEMBL2348220 95918 0 None 1023 3 Human 7.8 pKd = 7.8 Functional
Antagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrsAntagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrs
ChEMBL 459 15 5 7 2.3 O=C(NCCNCC(O)COc1ccc(OCCOCC2CC2)cc1)Nc1ccc(O)cc1 10.1021/jm400348g
CHEMBL2365796 95918 0 None 1023 3 Human 7.8 pKd = 7.8 Functional
Antagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrsAntagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrs
ChEMBL 459 15 5 7 2.3 O=C(NCCNCC(O)COc1ccc(OCCOCC2CC2)cc1)Nc1ccc(O)cc1 10.1021/jm400348g
44264411 20172 0 None - 0 Rat 7.8 pKd = 7.8 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 443 15 2 6 3.6 COc1ccc(CCNCC(O)COc2ccc(CCOCC3CCC3)cc2)cc1OC 10.1021/jm00389a008
CHEMBL1192677 20172 0 None - 0 Rat 7.8 pKd = 7.8 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 443 15 2 6 3.6 COc1ccc(CCNCC(O)COc2ccc(CCOCC3CCC3)cc2)cc1OC 10.1021/jm00389a008
CHEMBL543957 20172 0 None - 0 Rat 7.8 pKd = 7.8 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 443 15 2 6 3.6 COc1ccc(CCNCC(O)COc2ccc(CCOCC3CCC3)cc2)cc1OC 10.1021/jm00389a008
3486 9931 56 None - 2 Guinea pig 6.8 pKd = 6.8 Functional
Antagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atriaAntagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atria
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00140a015
4883 9931 56 None - 2 Guinea pig 6.8 pKd = 6.8 Functional
Antagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atriaAntagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atria
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00140a015
555 9931 56 None - 2 Guinea pig 6.8 pKd = 6.8 Functional
Antagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atriaAntagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atria
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00140a015
CHEMBL6995 9931 56 None - 2 Guinea pig 6.8 pKd = 6.8 Functional
Antagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atriaAntagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atria
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00140a015
DB01297 9931 56 None - 2 Guinea pig 6.8 pKd = 6.8 Functional
Antagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atriaAntagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atria
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00140a015
137 7158 52 None -3 8 Human 6.8 pKd = 6.8 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1021/jm2008562
2119 7158 52 None -3 8 Human 6.8 pKd = 6.8 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1021/jm2008562
563 7158 52 None -3 8 Human 6.8 pKd = 6.8 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1021/jm2008562
66368 7158 52 None -3 8 Human 6.8 pKd = 6.8 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1021/jm2008562
CHEMBL266195 7158 52 None -3 8 Human 6.8 pKd = 6.8 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1021/jm2008562
DB00866 7158 52 None -3 8 Human 6.8 pKd = 6.8 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1021/jm2008562
54756927 72261 0 None - 0 Human 6.7 pKd = 6.7 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 833 22 4 8 7.5 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCCCNC[C@H](O)COc1cccc2ccccc12 10.1021/jm2008562
CHEMBL1830486 72261 0 None - 0 Human 6.7 pKd = 6.7 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 833 22 4 8 7.5 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCCCNC[C@H](O)COc1cccc2ccccc12 10.1021/jm2008562
12606701 17999 0 None - 0 Guinea pig 5.7 pKd = 5.7 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 228 6 2 4 1.7 CC(C)NCC(O)CON=C1CCCCC1 10.1021/jm00180a007
CHEMBL1178787 17999 0 None - 0 Guinea pig 5.7 pKd = 5.7 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 228 6 2 4 1.7 CC(C)NCC(O)CON=C1CCCCC1 10.1021/jm00180a007
CHEMBL41378 17999 0 None - 0 Guinea pig 5.7 pKd = 5.7 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 228 6 2 4 1.7 CC(C)NCC(O)CON=C1CCCCC1 10.1021/jm00180a007
44371426 21079 0 None - 0 Guinea pig 6.7 pKd = 6.7 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 216 6 2 4 1.5 CC/C(C)=N\OCC(O)CNC(C)(C)C 10.1021/jm00180a007
CHEMBL1161384 21079 0 None - 0 Guinea pig 6.7 pKd = 6.7 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 216 6 2 4 1.5 CC/C(C)=N\OCC(O)CNC(C)(C)C 10.1021/jm00180a007
CHEMBL1199902 21079 0 None - 0 Guinea pig 6.7 pKd = 6.7 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 216 6 2 4 1.5 CC/C(C)=N\OCC(O)CNC(C)(C)C 10.1021/jm00180a007
2303 9961 68 None -6 20 Human 6.7 pKd = 6.7 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm2008562
4946 9961 68 None -6 20 Human 6.7 pKd = 6.7 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm2008562
564 9961 68 None -6 20 Human 6.7 pKd = 6.7 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm2008562
63 9961 68 None -6 20 Human 6.7 pKd = 6.7 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm2008562
91536 9961 68 None -6 20 Human 6.7 pKd = 6.7 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm2008562
CHEMBL27 9961 68 None -6 20 Human 6.7 pKd = 6.7 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm2008562
CHEMBL452861 9961 68 None -6 20 Human 6.7 pKd = 6.7 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm2008562
DB00571 9961 68 None -6 20 Human 6.7 pKd = 6.7 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm2008562
11768868 19933 4 None - 0 Guinea pig 4.7 pKd = 4.7 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 161 4 2 3 0.4 COCC(O)CNC(C)(C)C 10.1021/jm00180a007
CHEMBL1190805 19933 4 None - 0 Guinea pig 4.7 pKd = 4.7 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 161 4 2 3 0.4 COCC(O)CNC(C)(C)C 10.1021/jm00180a007
CHEMBL541607 19933 4 None - 0 Guinea pig 4.7 pKd = 4.7 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 161 4 2 3 0.4 COCC(O)CNC(C)(C)C 10.1021/jm00180a007
12606701 17999 0 None - 0 Guinea pig 4.7 pKd = 4.7 Functional
Antagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atriaAntagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atria
ChEMBL 228 6 2 4 1.7 CC(C)NCC(O)CON=C1CCCCC1 10.1021/jm00380a001
CHEMBL1178787 17999 0 None - 0 Guinea pig 4.7 pKd = 4.7 Functional
Antagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atriaAntagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atria
ChEMBL 228 6 2 4 1.7 CC(C)NCC(O)CON=C1CCCCC1 10.1021/jm00380a001
CHEMBL41378 17999 0 None - 0 Guinea pig 4.7 pKd = 4.7 Functional
Antagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atriaAntagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atria
ChEMBL 228 6 2 4 1.7 CC(C)NCC(O)CON=C1CCCCC1 10.1021/jm00380a001
2303 9961 68 None -22 20 Guinea pig 8.6 pKd = 8.6 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00180a007
4946 9961 68 None -22 20 Guinea pig 8.6 pKd = 8.6 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00180a007
564 9961 68 None -22 20 Guinea pig 8.6 pKd = 8.6 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00180a007
63 9961 68 None -22 20 Guinea pig 8.6 pKd = 8.6 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00180a007
91536 9961 68 None -22 20 Guinea pig 8.6 pKd = 8.6 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00180a007
CHEMBL27 9961 68 None -22 20 Guinea pig 8.6 pKd = 8.6 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00180a007
CHEMBL452861 9961 68 None -22 20 Guinea pig 8.6 pKd = 8.6 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00180a007
DB00571 9961 68 None -22 20 Guinea pig 8.6 pKd = 8.6 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00180a007
2176 9901 68 None -1 8 Human 8.6 pKd = 8.6 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 10.1021/jm2008562
4828 9901 68 None -1 8 Human 8.6 pKd = 8.6 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 10.1021/jm2008562
91 9901 68 None -1 8 Human 8.6 pKd = 8.6 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 10.1021/jm2008562
CHEMBL500 9901 68 None -1 8 Human 8.6 pKd = 8.6 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 10.1021/jm2008562
DB00960 9901 68 None -1 8 Human 8.6 pKd = 8.6 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 10.1021/jm2008562
2303 9961 68 None - 20 Rat 8.6 pKd = 8.6 Functional
Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for R-enantiomer)Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for R-enantiomer)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm970338c
4946 9961 68 None - 20 Rat 8.6 pKd = 8.6 Functional
Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for R-enantiomer)Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for R-enantiomer)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm970338c
564 9961 68 None - 20 Rat 8.6 pKd = 8.6 Functional
Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for R-enantiomer)Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for R-enantiomer)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm970338c
63 9961 68 None - 20 Rat 8.6 pKd = 8.6 Functional
Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for R-enantiomer)Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for R-enantiomer)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm970338c
91536 9961 68 None - 20 Rat 8.6 pKd = 8.6 Functional
Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for R-enantiomer)Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for R-enantiomer)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm970338c
CHEMBL27 9961 68 None - 20 Rat 8.6 pKd = 8.6 Functional
Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for R-enantiomer)Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for R-enantiomer)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm970338c
CHEMBL452861 9961 68 None - 20 Rat 8.6 pKd = 8.6 Functional
Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for R-enantiomer)Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for R-enantiomer)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm970338c
DB00571 9961 68 None - 20 Rat 8.6 pKd = 8.6 Functional
Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for R-enantiomer)Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for R-enantiomer)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm970338c
56597179 95044 0 None 2754 3 Human 8.6 pKd = 8.6 Functional
Antagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrsAntagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrs
ChEMBL 473 14 5 7 2.9 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccc(O)cc1 10.1021/jm400348g
CHEMBL2348219 95044 0 None 2754 3 Human 8.6 pKd = 8.6 Functional
Antagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrsAntagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrs
ChEMBL 473 14 5 7 2.9 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccc(O)cc1 10.1021/jm400348g
2369 7409 80 None - 2 Rat 8.5 pKd = 8.5 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00389a008
356 7409 80 None - 2 Rat 8.5 pKd = 8.5 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00389a008
549 7409 80 None - 2 Rat 8.5 pKd = 8.5 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00389a008
CHEMBL423 7409 80 None - 2 Rat 8.5 pKd = 8.5 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00389a008
DB00195 7409 80 None - 2 Rat 8.5 pKd = 8.5 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00389a008
44264404 20196 0 None - 0 Rat 8.5 pKd = 8.5 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 319 11 2 4 2.5 OC(CNC1CC1)COc1ccc(CCOCC2CCC2)cc1 10.1021/jm00389a008
CHEMBL1192875 20196 0 None - 0 Rat 8.5 pKd = 8.5 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 319 11 2 4 2.5 OC(CNC1CC1)COc1ccc(CCOCC2CCC2)cc1 10.1021/jm00389a008
CHEMBL544190 20196 0 None - 0 Rat 8.5 pKd = 8.5 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 319 11 2 4 2.5 OC(CNC1CC1)COc1ccc(CCOCC2CCC2)cc1 10.1021/jm00389a008
2369 7409 80 None - 2 Rat 8.5 pKd = 8.5 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atriaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atria
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00389a008
356 7409 80 None - 2 Rat 8.5 pKd = 8.5 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atriaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atria
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00389a008
549 7409 80 None - 2 Rat 8.5 pKd = 8.5 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atriaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atria
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00389a008
CHEMBL423 7409 80 None - 2 Rat 8.5 pKd = 8.5 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atriaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atria
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00389a008
DB00195 7409 80 None - 2 Rat 8.5 pKd = 8.5 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atriaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atria
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00389a008
44287522 17996 0 None - 0 Guinea pig 4.7 pKd = 4.7 Functional
Antagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atriaAntagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atria
ChEMBL 244 10 2 4 2.3 CCCC(CCC)=NOCC(O)CNC(C)C 10.1021/jm00380a001
CHEMBL1178778 17996 0 None - 0 Guinea pig 4.7 pKd = 4.7 Functional
Antagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atriaAntagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atria
ChEMBL 244 10 2 4 2.3 CCCC(CCC)=NOCC(O)CNC(C)C 10.1021/jm00380a001
CHEMBL40783 17996 0 None - 0 Guinea pig 4.7 pKd = 4.7 Functional
Antagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atriaAntagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atria
ChEMBL 244 10 2 4 2.3 CCCC(CCC)=NOCC(O)CNC(C)C 10.1021/jm00380a001
54757027 72265 0 None - 0 Human 6.7 pKd = 6.7 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 889 26 4 8 9.1 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCCCCCCCNCC(O)COc1cccc2ccccc12 10.1021/jm2008562
CHEMBL1830490 72265 0 None - 0 Human 6.7 pKd = 6.7 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 889 26 4 8 9.1 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCCCCCCCNCC(O)COc1cccc2ccccc12 10.1021/jm2008562
1786 9298 85 None - 7 Rat 7.6 pKd = 7.6 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00389a008
4171 9298 85 None - 7 Rat 7.6 pKd = 7.6 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00389a008
553 9298 85 None - 7 Rat 7.6 pKd = 7.6 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00389a008
CHEMBL13 9298 85 None - 7 Rat 7.6 pKd = 7.6 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00389a008
DB00264 9298 85 None - 7 Rat 7.6 pKd = 7.6 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00389a008
1786 9298 85 None - 7 Rat 7.6 pKd = 7.6 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atriaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atria
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00389a008
4171 9298 85 None - 7 Rat 7.6 pKd = 7.6 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atriaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atria
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00389a008
553 9298 85 None - 7 Rat 7.6 pKd = 7.6 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atriaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atria
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00389a008
CHEMBL13 9298 85 None - 7 Rat 7.6 pKd = 7.6 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atriaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atria
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00389a008
DB00264 9298 85 None - 7 Rat 7.6 pKd = 7.6 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atriaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atria
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00389a008
54757026 72264 0 None - 0 Human 6.6 pKd = 6.6 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 833 22 4 8 7.5 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCCCNCC(O)COc1cccc2ccccc12 10.1021/jm2008562
CHEMBL1830489 72264 0 None - 0 Human 6.6 pKd = 6.6 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 833 22 4 8 7.5 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCCCNCC(O)COc1cccc2ccccc12 10.1021/jm2008562
44287498 19175 0 None - 0 Guinea pig 4.6 pKd = 4.6 Functional
Antagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atriaAntagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atria
ChEMBL 214 6 2 4 1.3 CC(C)NCC(O)CON=C1CCCC1 10.1021/jm00380a001
CHEMBL1185760 19175 0 None - 0 Guinea pig 4.6 pKd = 4.6 Functional
Antagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atriaAntagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atria
ChEMBL 214 6 2 4 1.3 CC(C)NCC(O)CON=C1CCCC1 10.1021/jm00380a001
CHEMBL431713 19175 0 None - 0 Guinea pig 4.6 pKd = 4.6 Functional
Antagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atriaAntagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atria
ChEMBL 214 6 2 4 1.3 CC(C)NCC(O)CON=C1CCCC1 10.1021/jm00380a001
127940 211663 6 None - 0 Human 6.6 pKd = 6.6 Functional
The compound was evaluated for the antagonistic activity against alpha-1 adrenergic receptor.The compound was evaluated for the antagonistic activity against alpha-1 adrenergic receptor.
ChEMBL 351 8 4 3 2.9 CC(CCc1ccccc1)NCC(O)c1cc(C(N)=O)c2[nH]ccc2c1 10.1021/jm00156a019
CHEMBL7585 211663 6 None - 0 Human 6.6 pKd = 6.6 Functional
The compound was evaluated for the antagonistic activity against alpha-1 adrenergic receptor.The compound was evaluated for the antagonistic activity against alpha-1 adrenergic receptor.
ChEMBL 351 8 4 3 2.9 CC(CCc1ccccc1)NCC(O)c1cc(C(N)=O)c2[nH]ccc2c1 10.1021/jm00156a019
56598833 95042 0 None 436 3 Human 7.6 pKd = 7.6 Functional
Antagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrsAntagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrs
ChEMBL 433 14 5 7 2.0 CCOCCOc1ccc(OCC(O)CNCCNC(=O)Nc2ccc(O)cc2)cc1 10.1021/jm400348g
CHEMBL2348217 95042 0 None 436 3 Human 7.6 pKd = 7.6 Functional
Antagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrsAntagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrs
ChEMBL 433 14 5 7 2.0 CCOCCOc1ccc(OCC(O)CNCCNC(=O)Nc2ccc(O)cc2)cc1 10.1021/jm400348g
168613 67095 24 None - 0 Guinea pig 7.6 pKd = 7.6 Functional
Compound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atriaCompound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atria
ChEMBL 316 6 2 8 0.5 CC(C)(C)NC[C@@H](O)COc1nsnc1N1CCOCC1 10.1021/jm00350a009
CHEMBL1744069 67095 24 None - 0 Guinea pig 7.6 pKd = 7.6 Functional
Compound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atriaCompound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atria
ChEMBL 316 6 2 8 0.5 CC(C)(C)NC[C@@H](O)COc1nsnc1N1CCOCC1 10.1021/jm00350a009
12733306 66855 0 None - 0 Guinea pig 6.6 pKd = 6.6 Functional
Antagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atriaAntagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atria
ChEMBL 368 5 1 6 2.5 COc1ccccc1N1CCN(CC(O)C2=COc3ccccc3O2)CC1 10.1021/jm00140a015
CHEMBL173882 66855 0 None - 0 Guinea pig 6.6 pKd = 6.6 Functional
Antagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atriaAntagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atria
ChEMBL 368 5 1 6 2.5 COc1ccccc1N1CCN(CC(O)C2=COc3ccccc3O2)CC1 10.1021/jm00140a015
2303 9961 68 None - 20 Rat 5.6 pKd = 5.6 Functional
Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for S-enantiomer)Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for S-enantiomer)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm970338c
4946 9961 68 None - 20 Rat 5.6 pKd = 5.6 Functional
Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for S-enantiomer)Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for S-enantiomer)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm970338c
564 9961 68 None - 20 Rat 5.6 pKd = 5.6 Functional
Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for S-enantiomer)Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for S-enantiomer)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm970338c
63 9961 68 None - 20 Rat 5.6 pKd = 5.6 Functional
Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for S-enantiomer)Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for S-enantiomer)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm970338c
91536 9961 68 None - 20 Rat 5.6 pKd = 5.6 Functional
Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for S-enantiomer)Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for S-enantiomer)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm970338c
CHEMBL27 9961 68 None - 20 Rat 5.6 pKd = 5.6 Functional
Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for S-enantiomer)Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for S-enantiomer)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm970338c
CHEMBL452861 9961 68 None - 20 Rat 5.6 pKd = 5.6 Functional
Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for S-enantiomer)Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for S-enantiomer)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm970338c
DB00571 9961 68 None - 20 Rat 5.6 pKd = 5.6 Functional
Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for S-enantiomer)Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for S-enantiomer)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm970338c
10042467 8208 1 None - 2 Guinea pig 4.6 pKd = 4.6 Functional
Compound was evaluated for its antagonist affinity towards Beta-1 adrenergic receptor of guinea pigCompound was evaluated for its antagonist affinity towards Beta-1 adrenergic receptor of guinea pig
ChEMBL 333 8 1 2 4.3 CN(CCc1cnc([nH]1)CCC(c1ccccc1)c1ccccc1)C 10.1021/jm991056a
1203 8208 1 None - 2 Guinea pig 4.6 pKd = 4.6 Functional
Compound was evaluated for its antagonist affinity towards Beta-1 adrenergic receptor of guinea pigCompound was evaluated for its antagonist affinity towards Beta-1 adrenergic receptor of guinea pig
ChEMBL 333 8 1 2 4.3 CN(CCc1cnc([nH]1)CCC(c1ccccc1)c1ccccc1)C 10.1021/jm991056a
CHEMBL11553 8208 1 None - 2 Guinea pig 4.6 pKd = 4.6 Functional
Compound was evaluated for its antagonist affinity towards Beta-1 adrenergic receptor of guinea pigCompound was evaluated for its antagonist affinity towards Beta-1 adrenergic receptor of guinea pig
ChEMBL 333 8 1 2 4.3 CN(CCc1cnc([nH]1)CCC(c1ccccc1)c1ccccc1)C 10.1021/jm991056a
44371642 55992 0 None - 0 Guinea pig 4.6 pKd = 4.6 Functional
Antagonist activity against beta-1 adrenergic receptor in isolated guinea pig atriaAntagonist activity against beta-1 adrenergic receptor in isolated guinea pig atria
ChEMBL 203 6 2 4 0.5 CC(C)NCC(O)COC(=O)C(C)C 10.1021/jm00387a006
CHEMBL156271 55992 0 None - 0 Guinea pig 4.6 pKd = 4.6 Functional
Antagonist activity against beta-1 adrenergic receptor in isolated guinea pig atriaAntagonist activity against beta-1 adrenergic receptor in isolated guinea pig atria
ChEMBL 203 6 2 4 0.5 CC(C)NCC(O)COC(=O)C(C)C 10.1021/jm00387a006
12606702 18785 0 None - 0 Guinea pig 6.6 pKd = 6.6 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 242 5 2 4 2.1 CC(C)(C)NCC(O)CON=C1CCCCC1 10.1021/jm00180a007
CHEMBL1161383 18785 0 None - 0 Guinea pig 6.6 pKd = 6.6 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 242 5 2 4 2.1 CC(C)(C)NCC(O)CON=C1CCCCC1 10.1021/jm00180a007
CHEMBL1183312 18785 0 None - 0 Guinea pig 6.6 pKd = 6.6 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 242 5 2 4 2.1 CC(C)(C)NCC(O)CON=C1CCCCC1 10.1021/jm00180a007
CHEMBL289868 18785 0 None - 0 Guinea pig 6.6 pKd = 6.6 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 242 5 2 4 2.1 CC(C)(C)NCC(O)CON=C1CCCCC1 10.1021/jm00180a007
12606704 21088 0 None - 0 Guinea pig 6.6 pKd = 6.6 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 290 7 2 4 2.8 CC(/C=C/c1ccccc1)=N\OCC(O)CNC(C)(C)C 10.1021/jm00180a007
CHEMBL1161386 21088 0 None - 0 Guinea pig 6.6 pKd = 6.6 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 290 7 2 4 2.8 CC(/C=C/c1ccccc1)=N\OCC(O)CNC(C)(C)C 10.1021/jm00180a007
CHEMBL1199951 21088 0 None - 0 Guinea pig 6.6 pKd = 6.6 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 290 7 2 4 2.8 CC(/C=C/c1ccccc1)=N\OCC(O)CNC(C)(C)C 10.1021/jm00180a007
44371312 56032 2 None - 0 Guinea pig 4.6 pKd = 4.6 Functional
Antagonist activity against beta-1 adrenergic receptor in isolated guinea pig atriaAntagonist activity against beta-1 adrenergic receptor in isolated guinea pig atria
ChEMBL 203 5 2 4 0.7 CCC(=O)OCC(O)CNC(C)(C)C 10.1021/jm00387a006
CHEMBL156304 56032 2 None - 0 Guinea pig 4.6 pKd = 4.6 Functional
Antagonist activity against beta-1 adrenergic receptor in isolated guinea pig atriaAntagonist activity against beta-1 adrenergic receptor in isolated guinea pig atria
ChEMBL 203 5 2 4 0.7 CCC(=O)OCC(O)CNC(C)(C)C 10.1021/jm00387a006
44264509 210467 0 None - 0 Rat 5.5 pKd = 5.5 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 429 14 2 4 4.5 CC(CCc1ccc(F)cc1)NCC(O)COc1ccc(CCOCC2CCC2)cc1 10.1021/jm00389a008
CHEMBL6749 210467 0 None - 0 Rat 5.5 pKd = 5.5 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 429 14 2 4 4.5 CC(CCc1ccc(F)cc1)NCC(O)COc1ccc(CCOCC2CCC2)cc1 10.1021/jm00389a008
3047492 210745 8 None - 0 Guinea pig 5.5 pKd = 5.5 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig tracheaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig trachea
ChEMBL 293 10 2 4 2.4 CC(C)NCC(O)COc1ccc(COCC2CC2)cc1 10.1021/jm00389a008
CHEMBL6939 210745 8 None - 0 Guinea pig 5.5 pKd = 5.5 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig tracheaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig trachea
ChEMBL 293 10 2 4 2.4 CC(C)NCC(O)COc1ccc(COCC2CC2)cc1 10.1021/jm00389a008
2303 9961 68 None -22 20 Guinea pig 8.5 pKd = 8.5 Functional
Compound was evaluated for competitive antagonism of beta-1 adrenergic receptor in guinea pig atria measured as pA2 (-log KB)Compound was evaluated for competitive antagonism of beta-1 adrenergic receptor in guinea pig atria measured as pA2 (-log KB)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00373a008
4946 9961 68 None -22 20 Guinea pig 8.5 pKd = 8.5 Functional
Compound was evaluated for competitive antagonism of beta-1 adrenergic receptor in guinea pig atria measured as pA2 (-log KB)Compound was evaluated for competitive antagonism of beta-1 adrenergic receptor in guinea pig atria measured as pA2 (-log KB)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00373a008
564 9961 68 None -22 20 Guinea pig 8.5 pKd = 8.5 Functional
Compound was evaluated for competitive antagonism of beta-1 adrenergic receptor in guinea pig atria measured as pA2 (-log KB)Compound was evaluated for competitive antagonism of beta-1 adrenergic receptor in guinea pig atria measured as pA2 (-log KB)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00373a008
63 9961 68 None -22 20 Guinea pig 8.5 pKd = 8.5 Functional
Compound was evaluated for competitive antagonism of beta-1 adrenergic receptor in guinea pig atria measured as pA2 (-log KB)Compound was evaluated for competitive antagonism of beta-1 adrenergic receptor in guinea pig atria measured as pA2 (-log KB)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00373a008
91536 9961 68 None -22 20 Guinea pig 8.5 pKd = 8.5 Functional
Compound was evaluated for competitive antagonism of beta-1 adrenergic receptor in guinea pig atria measured as pA2 (-log KB)Compound was evaluated for competitive antagonism of beta-1 adrenergic receptor in guinea pig atria measured as pA2 (-log KB)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00373a008
CHEMBL27 9961 68 None -22 20 Guinea pig 8.5 pKd = 8.5 Functional
Compound was evaluated for competitive antagonism of beta-1 adrenergic receptor in guinea pig atria measured as pA2 (-log KB)Compound was evaluated for competitive antagonism of beta-1 adrenergic receptor in guinea pig atria measured as pA2 (-log KB)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00373a008
CHEMBL452861 9961 68 None -22 20 Guinea pig 8.5 pKd = 8.5 Functional
Compound was evaluated for competitive antagonism of beta-1 adrenergic receptor in guinea pig atria measured as pA2 (-log KB)Compound was evaluated for competitive antagonism of beta-1 adrenergic receptor in guinea pig atria measured as pA2 (-log KB)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00373a008
DB00571 9961 68 None -22 20 Guinea pig 8.5 pKd = 8.5 Functional
Compound was evaluated for competitive antagonism of beta-1 adrenergic receptor in guinea pig atria measured as pA2 (-log KB)Compound was evaluated for competitive antagonism of beta-1 adrenergic receptor in guinea pig atria measured as pA2 (-log KB)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00373a008
54669764 72266 0 None - 0 Human 8.5 pKd = 8.5 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 893 26 4 10 6.8 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCOCCOCCNC[C@H](O)COc1cccc2ccccc12 10.1021/jm2008562
CHEMBL1830491 72266 0 None - 0 Human 8.5 pKd = 8.5 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 893 26 4 10 6.8 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCOCCOCCNC[C@H](O)COc1cccc2ccccc12 10.1021/jm2008562
56598967 95036 0 None 2238 3 Human 8.5 pKd = 8.5 Functional
Antagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrsAntagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrs
ChEMBL 457 14 4 6 3.2 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccccc1 10.1021/jm400348g
CHEMBL2348211 95036 0 None 2238 3 Human 8.5 pKd = 8.5 Functional
Antagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrsAntagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrs
ChEMBL 457 14 4 6 3.2 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccccc1 10.1021/jm400348g
54757026 72264 0 None - 0 Human 7.5 pKd = 7.5 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 833 22 4 8 7.5 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCCCNCC(O)COc1cccc2ccccc12 10.1021/jm2008562
CHEMBL1830489 72264 0 None - 0 Human 7.5 pKd = 7.5 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 833 22 4 8 7.5 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCCCNCC(O)COc1cccc2ccccc12 10.1021/jm2008562
54758320 72292 0 None - 0 Human 6.5 pKd = 6.5 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 794 20 5 8 6.1 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCNCC(O)COc1cccc2[nH]ccc12 10.1021/jm2008562
CHEMBL1830620 72292 0 None - 0 Human 6.5 pKd = 6.5 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 794 20 5 8 6.1 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCNCC(O)COc1cccc2[nH]ccc12 10.1021/jm2008562
12606706 100008 0 None - 0 Guinea pig 6.5 pKd = 6.5 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 202 5 2 4 1.1 CC(C)=NOCC(O)CNC(C)(C)C 10.1021/jm00180a007
CHEMBL24480 100008 0 None - 0 Guinea pig 6.5 pKd = 6.5 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 202 5 2 4 1.1 CC(C)=NOCC(O)CNC(C)(C)C 10.1021/jm00180a007
CHEMBL555848 100008 0 None - 0 Guinea pig 6.5 pKd = 6.5 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 202 5 2 4 1.1 CC(C)=NOCC(O)CNC(C)(C)C 10.1021/jm00180a007
1531 9046 69 None - 12 Guinea pig 7.5 pKd = 7.5 Functional
The compound was evaluated for the antagonistic activity against beta-1 adrenergic receptor.The compound was evaluated for the antagonistic activity against beta-1 adrenergic receptor.
ChEMBL 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O 10.1021/jm00156a019
3869 9046 69 None - 12 Guinea pig 7.5 pKd = 7.5 Functional
The compound was evaluated for the antagonistic activity against beta-1 adrenergic receptor.The compound was evaluated for the antagonistic activity against beta-1 adrenergic receptor.
ChEMBL 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O 10.1021/jm00156a019
7207 9046 69 None - 12 Guinea pig 7.5 pKd = 7.5 Functional
The compound was evaluated for the antagonistic activity against beta-1 adrenergic receptor.The compound was evaluated for the antagonistic activity against beta-1 adrenergic receptor.
ChEMBL 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O 10.1021/jm00156a019
CHEMBL429 9046 69 None - 12 Guinea pig 7.5 pKd = 7.5 Functional
The compound was evaluated for the antagonistic activity against beta-1 adrenergic receptor.The compound was evaluated for the antagonistic activity against beta-1 adrenergic receptor.
ChEMBL 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O 10.1021/jm00156a019
DB00598 9046 69 None - 12 Guinea pig 7.5 pKd = 7.5 Functional
The compound was evaluated for the antagonistic activity against beta-1 adrenergic receptor.The compound was evaluated for the antagonistic activity against beta-1 adrenergic receptor.
ChEMBL 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O 10.1021/jm00156a019
121848 137488 4 None - 2 Guinea pig 7.5 pKd = 7.5 Functional
Compound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atriaCompound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atria
ChEMBL 324 5 2 4 3.2 CC(C)(C)NCC(O)CON=C1c2ccccc2-c2ccccc21 10.1021/jm00350a009
CHEMBL368457 137488 4 None - 2 Guinea pig 7.5 pKd = 7.5 Functional
Compound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atriaCompound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atria
ChEMBL 324 5 2 4 3.2 CC(C)(C)NCC(O)CON=C1c2ccccc2-c2ccccc21 10.1021/jm00350a009
44264298 20146 0 None - 0 Rat 6.5 pKd = 6.5 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 346 12 2 5 2.7 CC(CC#N)NCC(O)COc1ccc(CCOCC2CCC2)cc1 10.1021/jm00389a008
CHEMBL1192477 20146 0 None - 0 Rat 6.5 pKd = 6.5 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 346 12 2 5 2.7 CC(CC#N)NCC(O)COc1ccc(CCOCC2CCC2)cc1 10.1021/jm00389a008
CHEMBL543717 20146 0 None - 0 Rat 6.5 pKd = 6.5 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 346 12 2 5 2.7 CC(CC#N)NCC(O)COc1ccc(CCOCC2CCC2)cc1 10.1021/jm00389a008
12778440 66946 0 None - 0 Guinea pig 7.5 pKd = 7.5 Functional
Compound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atriaCompound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atria
ChEMBL 338 7 2 4 3.6 CCC(C)(C)NCC(O)CON=C1c2ccccc2-c2ccccc21 10.1021/jm00350a009
CHEMBL173976 66946 0 None - 0 Guinea pig 7.5 pKd = 7.5 Functional
Compound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atriaCompound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atria
ChEMBL 338 7 2 4 3.6 CCC(C)(C)NCC(O)CON=C1c2ccccc2-c2ccccc21 10.1021/jm00350a009
54756929 72263 0 None - 0 Human 6.5 pKd = 6.5 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 805 20 4 8 6.7 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCNCC(O)COc1cccc2ccccc12 10.1021/jm2008562
CHEMBL1830488 72263 0 None - 0 Human 6.5 pKd = 6.5 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 805 20 4 8 6.7 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCNCC(O)COc1cccc2ccccc12 10.1021/jm2008562
44263933 20429 0 None - 0 Rat 7.4 pKd = 7.4 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 307 10 2 4 2.7 CC(C)NCC(O)COc1ccc(COCC2CCC2)cc1 10.1021/jm00389a008
CHEMBL1194583 20429 0 None - 0 Rat 7.4 pKd = 7.4 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 307 10 2 4 2.7 CC(C)NCC(O)COc1ccc(COCC2CCC2)cc1 10.1021/jm00389a008
CHEMBL552898 20429 0 None - 0 Rat 7.4 pKd = 7.4 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 307 10 2 4 2.7 CC(C)NCC(O)COc1ccc(COCC2CCC2)cc1 10.1021/jm00389a008
2447484 109545 2 None - 2 Guinea pig 7.4 pKd = 7.4 Functional
Compound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atriaCompound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atria
ChEMBL 324 5 2 4 3.2 CC(C)(C)NC[C@H](O)CON=C1c2ccccc2-c2ccccc21 10.1021/jm00350a009
CHEMBL305153 109545 2 None - 2 Guinea pig 7.4 pKd = 7.4 Functional
Compound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atriaCompound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atria
ChEMBL 324 5 2 4 3.2 CC(C)(C)NC[C@H](O)CON=C1c2ccccc2-c2ccccc21 10.1021/jm00350a009
54758415 72293 0 None - 0 Human 7.4 pKd = 7.4 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 882 26 5 10 6.1 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCOCCOCCNCC(O)COc1cccc2[nH]ccc12 10.1021/jm2008562
CHEMBL1830621 72293 0 None - 0 Human 7.4 pKd = 7.4 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 882 26 5 10 6.1 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCOCCOCCNCC(O)COc1cccc2[nH]ccc12 10.1021/jm2008562
12606709 21115 0 None - 0 Guinea pig 5.4 pKd = 5.4 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 296 5 2 4 3.0 CC(C)(C)NCC(O)CO/N=C1\CC2CCC1(C)C2(C)C 10.1021/jm00180a007
CHEMBL1161382 21115 0 None - 0 Guinea pig 5.4 pKd = 5.4 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 296 5 2 4 3.0 CC(C)(C)NCC(O)CO/N=C1\CC2CCC1(C)C2(C)C 10.1021/jm00180a007
CHEMBL1200073 21115 0 None - 0 Guinea pig 5.4 pKd = 5.4 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 296 5 2 4 3.0 CC(C)(C)NCC(O)CO/N=C1\CC2CCC1(C)C2(C)C 10.1021/jm00180a007
3047500 20049 1 None - 0 Guinea pig 5.4 pKd = 5.4 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig tracheaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig trachea
ChEMBL 349 11 2 4 3.6 CC(C)NCC(O)COc1ccc(CCOCC2CCCCC2)cc1 10.1021/jm00389a008
CHEMBL1191645 20049 1 None - 0 Guinea pig 5.4 pKd = 5.4 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig tracheaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig trachea
ChEMBL 349 11 2 4 3.6 CC(C)NCC(O)COc1ccc(CCOCC2CCCCC2)cc1 10.1021/jm00389a008
CHEMBL542776 20049 1 None - 0 Guinea pig 5.4 pKd = 5.4 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig tracheaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig trachea
ChEMBL 349 11 2 4 3.6 CC(C)NCC(O)COc1ccc(CCOCC2CCCCC2)cc1 10.1021/jm00389a008
44371514 18473 0 None - 0 Guinea pig 6.4 pKd = 6.4 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 216 8 2 4 1.5 CCC/C(C)=N\OCC(O)CNC(C)C 10.1021/jm00180a007
CHEMBL1181235 18473 0 None - 0 Guinea pig 6.4 pKd = 6.4 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 216 8 2 4 1.5 CCC/C(C)=N\OCC(O)CNC(C)C 10.1021/jm00180a007
CHEMBL160282 18473 0 None - 0 Guinea pig 6.4 pKd = 6.4 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 216 8 2 4 1.5 CCC/C(C)=N\OCC(O)CNC(C)C 10.1021/jm00180a007
127940 211663 6 None - 0 Guinea pig 7.4 pKd = 7.4 Functional
The compound was evaluated for the antagonistic activity against beta-1 adrenergic receptorThe compound was evaluated for the antagonistic activity against beta-1 adrenergic receptor
ChEMBL 351 8 4 3 2.9 CC(CCc1ccccc1)NCC(O)c1cc(C(N)=O)c2[nH]ccc2c1 10.1021/jm00156a019
CHEMBL7585 211663 6 None - 0 Guinea pig 7.4 pKd = 7.4 Functional
The compound was evaluated for the antagonistic activity against beta-1 adrenergic receptorThe compound was evaluated for the antagonistic activity against beta-1 adrenergic receptor
ChEMBL 351 8 4 3 2.9 CC(CCc1ccccc1)NCC(O)c1cc(C(N)=O)c2[nH]ccc2c1 10.1021/jm00156a019
2369 7409 80 None - 2 Guinea pig 5.4 pKd = 5.4 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig tracheaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig trachea
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00389a008
356 7409 80 None - 2 Guinea pig 5.4 pKd = 5.4 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig tracheaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig trachea
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00389a008
549 7409 80 None - 2 Guinea pig 5.4 pKd = 5.4 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig tracheaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig trachea
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00389a008
CHEMBL423 7409 80 None - 2 Guinea pig 5.4 pKd = 5.4 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig tracheaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig trachea
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00389a008
DB00195 7409 80 None - 2 Guinea pig 5.4 pKd = 5.4 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig tracheaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig trachea
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00389a008
137 7158 52 None -3 8 Human 8.4 pKd = 8.4 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1021/jm2008562
2119 7158 52 None -3 8 Human 8.4 pKd = 8.4 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1021/jm2008562
563 7158 52 None -3 8 Human 8.4 pKd = 8.4 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1021/jm2008562
66368 7158 52 None -3 8 Human 8.4 pKd = 8.4 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1021/jm2008562
CHEMBL266195 7158 52 None -3 8 Human 8.4 pKd = 8.4 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1021/jm2008562
DB00866 7158 52 None -3 8 Human 8.4 pKd = 8.4 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1021/jm2008562
2303 9961 68 None - 20 Rat 8.4 pKd = 8.4 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00389a008
4946 9961 68 None - 20 Rat 8.4 pKd = 8.4 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00389a008
564 9961 68 None - 20 Rat 8.4 pKd = 8.4 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00389a008
63 9961 68 None - 20 Rat 8.4 pKd = 8.4 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00389a008
91536 9961 68 None - 20 Rat 8.4 pKd = 8.4 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00389a008
CHEMBL27 9961 68 None - 20 Rat 8.4 pKd = 8.4 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00389a008
CHEMBL452861 9961 68 None - 20 Rat 8.4 pKd = 8.4 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00389a008
DB00571 9961 68 None - 20 Rat 8.4 pKd = 8.4 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00389a008
2303 9961 68 None - 20 Rat 8.4 pKd = 8.4 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atriaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00389a008
4946 9961 68 None - 20 Rat 8.4 pKd = 8.4 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atriaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00389a008
564 9961 68 None - 20 Rat 8.4 pKd = 8.4 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atriaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00389a008
63 9961 68 None - 20 Rat 8.4 pKd = 8.4 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atriaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00389a008
91536 9961 68 None - 20 Rat 8.4 pKd = 8.4 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atriaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00389a008
CHEMBL27 9961 68 None - 20 Rat 8.4 pKd = 8.4 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atriaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00389a008
CHEMBL452861 9961 68 None - 20 Rat 8.4 pKd = 8.4 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atriaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00389a008
DB00571 9961 68 None - 20 Rat 8.4 pKd = 8.4 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atriaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00389a008
54757232 72290 0 None - 0 Human 7.4 pKd = 7.4 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 883 28 4 10 6.3 C=CCc1ccccc1OC[C@@H](O)CNCCOCCOCCNC(=O)CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1 10.1021/jm2008562
CHEMBL1830618 72290 0 None - 0 Human 7.4 pKd = 7.4 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 883 28 4 10 6.3 C=CCc1ccccc1OC[C@@H](O)CNCCOCCOCCNC(=O)CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1 10.1021/jm2008562
54757126 72267 0 None - 0 Human 7.4 pKd = 7.4 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 893 26 4 10 6.8 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCOCCOCCNCC(O)COc1cccc2ccccc12 10.1021/jm2008562
CHEMBL1830492 72267 0 None - 0 Human 7.4 pKd = 7.4 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 893 26 4 10 6.8 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCOCCOCCNCC(O)COc1cccc2ccccc12 10.1021/jm2008562
44264188 210689 0 None - 0 Rat 7.4 pKd = 7.4 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 325 10 2 4 2.1 CC(C)NCC(O)COc1ccc(C[S+]([O-])CC2CC2)cc1 10.1021/jm00389a008
CHEMBL6902 210689 0 None - 0 Rat 7.4 pKd = 7.4 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 325 10 2 4 2.1 CC(C)NCC(O)COc1ccc(C[S+]([O-])CC2CC2)cc1 10.1021/jm00389a008
54757229 72289 0 None - 0 Human 7.4 pKd = 7.4 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 795 22 4 8 6.3 C=CCc1ccccc1OCC(O)CNCCNC(=O)CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1 10.1021/jm2008562
CHEMBL1830617 72289 0 None - 0 Human 7.4 pKd = 7.4 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 795 22 4 8 6.3 C=CCc1ccccc1OCC(O)CNCCNC(=O)CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1 10.1021/jm2008562
12606687 18993 0 None - 0 Guinea pig 5.4 pKd = 5.4 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 175 6 2 3 0.8 CC(C)NCC(O)COC(C)C 10.1021/jm00180a007
CHEMBL1184385 18993 0 None - 0 Guinea pig 5.4 pKd = 5.4 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 175 6 2 3 0.8 CC(C)NCC(O)COC(C)C 10.1021/jm00180a007
CHEMBL346972 18993 0 None - 0 Guinea pig 5.4 pKd = 5.4 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 175 6 2 3 0.8 CC(C)NCC(O)COC(C)C 10.1021/jm00180a007
134495 7536 24 None - 2 Guinea pig 4.4 pKd = 4.4 Functional
Antagonist activity against beta-1 adrenergic receptor in isolated guinea pig atriaAntagonist activity against beta-1 adrenergic receptor in isolated guinea pig atria
ChEMBL 267 5 2 4 2.5 COc1ccc(cc1C(C(NC(C)(C)C)C)O)OC 10.1021/jm00387a006
18026 7536 24 None - 2 Guinea pig 4.4 pKd = 4.4 Functional
Antagonist activity against beta-1 adrenergic receptor in isolated guinea pig atriaAntagonist activity against beta-1 adrenergic receptor in isolated guinea pig atria
ChEMBL 267 5 2 4 2.5 COc1ccc(cc1C(C(NC(C)(C)C)C)O)OC 10.1021/jm00387a006
9809 7536 24 None - 2 Guinea pig 4.4 pKd = 4.4 Functional
Antagonist activity against beta-1 adrenergic receptor in isolated guinea pig atriaAntagonist activity against beta-1 adrenergic receptor in isolated guinea pig atria
ChEMBL 267 5 2 4 2.5 COc1ccc(cc1C(C(NC(C)(C)C)C)O)OC 10.1021/jm00387a006
CHEMBL289093 7536 24 None - 2 Guinea pig 4.4 pKd = 4.4 Functional
Antagonist activity against beta-1 adrenergic receptor in isolated guinea pig atriaAntagonist activity against beta-1 adrenergic receptor in isolated guinea pig atria
ChEMBL 267 5 2 4 2.5 COc1ccc(cc1C(C(NC(C)(C)C)C)O)OC 10.1021/jm00387a006
134495 7536 24 None - 2 Guinea pig 4.4 pKd = 4.4 Functional
Antagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atriaAntagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atria
ChEMBL 267 5 2 4 2.5 COc1ccc(cc1C(C(NC(C)(C)C)C)O)OC 10.1021/jm00380a001
18026 7536 24 None - 2 Guinea pig 4.4 pKd = 4.4 Functional
Antagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atriaAntagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atria
ChEMBL 267 5 2 4 2.5 COc1ccc(cc1C(C(NC(C)(C)C)C)O)OC 10.1021/jm00380a001
9809 7536 24 None - 2 Guinea pig 4.4 pKd = 4.4 Functional
Antagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atriaAntagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atria
ChEMBL 267 5 2 4 2.5 COc1ccc(cc1C(C(NC(C)(C)C)C)O)OC 10.1021/jm00380a001
CHEMBL289093 7536 24 None - 2 Guinea pig 4.4 pKd = 4.4 Functional
Antagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atriaAntagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atria
ChEMBL 267 5 2 4 2.5 COc1ccc(cc1C(C(NC(C)(C)C)C)O)OC 10.1021/jm00380a001
44371383 56388 1 None - 0 Guinea pig 6.3 pKd = 6.3 Functional
Antagonist activity against beta-1 adrenergic receptor in isolated guinea pig atriaAntagonist activity against beta-1 adrenergic receptor in isolated guinea pig atria
ChEMBL 257 5 2 5 1.7 CC(C)(C)NCC(O)COC(=O)c1cccs1 10.1021/jm00387a006
CHEMBL156603 56388 1 None - 0 Guinea pig 6.3 pKd = 6.3 Functional
Antagonist activity against beta-1 adrenergic receptor in isolated guinea pig atriaAntagonist activity against beta-1 adrenergic receptor in isolated guinea pig atria
ChEMBL 257 5 2 5 1.7 CC(C)(C)NCC(O)COC(=O)c1cccs1 10.1021/jm00387a006
10447834 8714 4 None - 3 Guinea pig 4.3 pKd = 4.3 Functional
Compound was evaluated for its antagonist affinity towards Beta-1 adrenergic receptor of guinea pigCompound was evaluated for its antagonist affinity towards Beta-1 adrenergic receptor of guinea pig
ChEMBL 305 7 2 2 3.7 NCCc1cnc([nH]1)CCC(c1ccccc1)c1ccccc1 10.1021/jm991056a
4026 8714 4 None - 3 Guinea pig 4.3 pKd = 4.3 Functional
Compound was evaluated for its antagonist affinity towards Beta-1 adrenergic receptor of guinea pigCompound was evaluated for its antagonist affinity towards Beta-1 adrenergic receptor of guinea pig
ChEMBL 305 7 2 2 3.7 NCCc1cnc([nH]1)CCC(c1ccccc1)c1ccccc1 10.1021/jm991056a
CHEMBL275507 8714 4 None - 3 Guinea pig 4.3 pKd = 4.3 Functional
Compound was evaluated for its antagonist affinity towards Beta-1 adrenergic receptor of guinea pigCompound was evaluated for its antagonist affinity towards Beta-1 adrenergic receptor of guinea pig
ChEMBL 305 7 2 2 3.7 NCCc1cnc([nH]1)CCC(c1ccccc1)c1ccccc1 10.1021/jm991056a
54757129 72268 0 None - 0 Human 7.3 pKd = 7.3 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 795 22 4 8 6.3 C=CCc1ccccc1OC[C@@H](O)CNCCNC(=O)CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1 10.1021/jm2008562
CHEMBL1830493 72268 0 None - 0 Human 7.3 pKd = 7.3 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 795 22 4 8 6.3 C=CCc1ccccc1OC[C@@H](O)CNCCNC(=O)CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1 10.1021/jm2008562
44287469 18769 0 None - 0 Guinea pig 5.3 pKd = 5.3 Functional
Antagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atriaAntagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atria
ChEMBL 258 9 2 4 2.7 CCCC(CCC)=NOCC(O)CNC(C)(C)C 10.1021/jm00380a001
CHEMBL1183268 18769 0 None - 0 Guinea pig 5.3 pKd = 5.3 Functional
Antagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atriaAntagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atria
ChEMBL 258 9 2 4 2.7 CCCC(CCC)=NOCC(O)CNC(C)(C)C 10.1021/jm00380a001
CHEMBL287766 18769 0 None - 0 Guinea pig 5.3 pKd = 5.3 Functional
Antagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atriaAntagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atria
ChEMBL 258 9 2 4 2.7 CCCC(CCC)=NOCC(O)CNC(C)(C)C 10.1021/jm00380a001
44288489 175682 0 None - 0 Rat 7.3 pKd = 7.3 Functional
Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for S-enantiomer)Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for S-enantiomer)
ChEMBL 314 8 3 5 2.5 OC(CNc1nc2ccccc2[nH]1)CON=C(C1CC1)C1CC1 10.1021/jm970338c
CHEMBL43850 175682 0 None - 0 Rat 7.3 pKd = 7.3 Functional
Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for S-enantiomer)Beta-1 adrenergic receptor-Antagonism in isolated rat heart ventricle. ( for S-enantiomer)
ChEMBL 314 8 3 5 2.5 OC(CNc1nc2ccccc2[nH]1)CON=C(C1CC1)C1CC1 10.1021/jm970338c
12606684 102849 3 None - 0 Guinea pig 6.3 pKd = 6.3 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 203 6 2 3 1.4 CC(C)COCC(O)CNC(C)(C)C 10.1021/jm00180a007
CHEMBL1161388 102849 3 None - 0 Guinea pig 6.3 pKd = 6.3 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 203 6 2 3 1.4 CC(C)COCC(O)CNC(C)(C)C 10.1021/jm00180a007
CHEMBL26003 102849 3 None - 0 Guinea pig 6.3 pKd = 6.3 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 203 6 2 3 1.4 CC(C)COCC(O)CNC(C)(C)C 10.1021/jm00180a007
60657 21258 34 None - 0 Rat 8.3 pKd = 8.3 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 307 11 2 4 2.4 CC(C)NC[C@H](O)COc1ccc(CCOCC2CC2)cc1 10.1021/jm00389a008
CHEMBL1201274 21258 34 None - 0 Rat 8.3 pKd = 8.3 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 307 11 2 4 2.4 CC(C)NC[C@H](O)COc1ccc(CCOCC2CC2)cc1 10.1021/jm00389a008
44371512 18443 0 None - 0 Guinea pig 8.3 pKd = 8.3 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 292 8 2 4 2.8 C/C(CCc1ccccc1)=N/OCC(O)CNC(C)(C)C 10.1021/jm00180a007
CHEMBL1181139 18443 0 None - 0 Guinea pig 8.3 pKd = 8.3 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 292 8 2 4 2.8 C/C(CCc1ccccc1)=N/OCC(O)CNC(C)(C)C 10.1021/jm00180a007
CHEMBL156871 18443 0 None - 0 Guinea pig 8.3 pKd = 8.3 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 292 8 2 4 2.8 C/C(CCc1ccccc1)=N/OCC(O)CNC(C)(C)C 10.1021/jm00180a007
91565 16572 23 None - 0 Guinea pig 8.2 pKd = 8.2 Functional
Compound was evaluated for competitive antagonism of beta-1 adrenergic receptor in guinea pig atria measured as pA2 (-log KB)Compound was evaluated for competitive antagonism of beta-1 adrenergic receptor in guinea pig atria measured as pA2 (-log KB)
ChEMBL 275 6 3 4 2.3 CC(C)NCC(O)COc1ccc(O)c2ccccc12 10.1021/jm00373a008
CHEMBL1137 16572 23 None - 0 Guinea pig 8.2 pKd = 8.2 Functional
Compound was evaluated for competitive antagonism of beta-1 adrenergic receptor in guinea pig atria measured as pA2 (-log KB)Compound was evaluated for competitive antagonism of beta-1 adrenergic receptor in guinea pig atria measured as pA2 (-log KB)
ChEMBL 275 6 3 4 2.3 CC(C)NCC(O)COc1ccc(O)c2ccccc12 10.1021/jm00373a008
13187531 211270 0 None - 0 Rat 8.2 pKd = 8.2 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 335 10 2 4 3.3 CC(C)NCC(O)COc1ccc(CCOC2CCCCC2)cc1 10.1021/jm00389a008
CHEMBL7250 211270 0 None - 0 Rat 8.2 pKd = 8.2 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 335 10 2 4 3.3 CC(C)NCC(O)COc1ccc(CCOC2CCCCC2)cc1 10.1021/jm00389a008
44381395 66262 0 None - 0 Guinea pig 7.3 pKd = 7.3 Functional
Compound was evaluated for competitive antagonism of beta-1 adrenergic receptor in guinea pig atria measured as pA2 (-log KB)Compound was evaluated for competitive antagonism of beta-1 adrenergic receptor in guinea pig atria measured as pA2 (-log KB)
ChEMBL 289 6 2 5 1.2 CC(C)NCC(O)COC1=CC(=O)C(=O)c2ccccc21 10.1021/jm00373a008
CHEMBL171432 66262 0 None - 0 Guinea pig 7.3 pKd = 7.3 Functional
Compound was evaluated for competitive antagonism of beta-1 adrenergic receptor in guinea pig atria measured as pA2 (-log KB)Compound was evaluated for competitive antagonism of beta-1 adrenergic receptor in guinea pig atria measured as pA2 (-log KB)
ChEMBL 289 6 2 5 1.2 CC(C)NCC(O)COC1=CC(=O)C(=O)c2ccccc21 10.1021/jm00373a008
54756928 72262 0 None - 0 Human 7.3 pKd = 7.3 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 889 26 4 8 9.1 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCCCCCCCNC[C@H](O)COc1cccc2ccccc12 10.1021/jm2008562
CHEMBL1830487 72262 0 None - 0 Human 7.3 pKd = 7.3 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 889 26 4 8 9.1 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCCCCCCCNC[C@H](O)COc1cccc2ccccc12 10.1021/jm2008562
44287620 17997 0 None - 0 Guinea pig 4.3 pKd = 4.3 Functional
Antagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atriaAntagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atria
ChEMBL 228 5 2 4 1.7 CC(C)(C)NCC(O)CON=C1CCCC1 10.1021/jm00380a001
CHEMBL1178780 17997 0 None - 0 Guinea pig 4.3 pKd = 4.3 Functional
Antagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atriaAntagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atria
ChEMBL 228 5 2 4 1.7 CC(C)(C)NCC(O)CON=C1CCCC1 10.1021/jm00380a001
CHEMBL40971 17997 0 None - 0 Guinea pig 4.3 pKd = 4.3 Functional
Antagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atriaAntagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atria
ChEMBL 228 5 2 4 1.7 CC(C)(C)NCC(O)CON=C1CCCC1 10.1021/jm00380a001
12606705 18702 0 None - 0 Guinea pig 6.2 pKd = 6.2 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 188 6 2 4 0.8 CC(C)=NOCC(O)CNC(C)C 10.1021/jm00180a007
CHEMBL1182729 18702 0 None - 0 Guinea pig 6.2 pKd = 6.2 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 188 6 2 4 0.8 CC(C)=NOCC(O)CNC(C)C 10.1021/jm00180a007
CHEMBL263065 18702 0 None - 0 Guinea pig 6.2 pKd = 6.2 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 188 6 2 4 0.8 CC(C)=NOCC(O)CNC(C)C 10.1021/jm00180a007
2685 7677 21 None - 1 Human 7.2 pKd = 7.2 Functional
Antagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of CGP12177-induced [3H]cAMP accumulationAntagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of CGP12177-induced [3H]cAMP accumulation
ChEMBL 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10.1021/jm400348g
541 7677 21 None - 1 Human 7.2 pKd = 7.2 Functional
Antagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of CGP12177-induced [3H]cAMP accumulationAntagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of CGP12177-induced [3H]cAMP accumulation
ChEMBL 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10.1021/jm400348g
CHEMBL280822 7677 21 None - 1 Human 7.2 pKd = 7.2 Functional
Antagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of CGP12177-induced [3H]cAMP accumulationAntagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of CGP12177-induced [3H]cAMP accumulation
ChEMBL 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10.1021/jm400348g
20554490 20122 0 None - 0 Rat 7.2 pKd = 7.2 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 364 13 3 5 1.5 CC(=O)NCCNCC(O)COc1ccc(CCOCC2CCC2)cc1 10.1021/jm00389a008
CHEMBL1192270 20122 0 None - 0 Rat 7.2 pKd = 7.2 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 364 13 3 5 1.5 CC(=O)NCCNCC(O)COc1ccc(CCOCC2CCC2)cc1 10.1021/jm00389a008
CHEMBL543484 20122 0 None - 0 Rat 7.2 pKd = 7.2 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 364 13 3 5 1.5 CC(=O)NCCNCC(O)COc1ccc(CCOCC2CCC2)cc1 10.1021/jm00389a008
12733303 67167 0 None - 0 Guinea pig 6.2 pKd = 6.2 Functional
Antagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atriaAntagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atria
ChEMBL 261 3 1 4 2.1 OC(CN1CCCCC1)C1=COc2ccccc2O1 10.1021/jm00140a015
CHEMBL174882 67167 0 None - 0 Guinea pig 6.2 pKd = 6.2 Functional
Antagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atriaAntagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atria
ChEMBL 261 3 1 4 2.1 OC(CN1CCCCC1)C1=COc2ccccc2O1 10.1021/jm00140a015
54669764 72266 0 None - 0 Human 7.2 pKd = 7.2 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 893 26 4 10 6.8 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCOCCOCCNC[C@H](O)COc1cccc2ccccc12 10.1021/jm2008562
CHEMBL1830491 72266 0 None - 0 Human 7.2 pKd = 7.2 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 893 26 4 10 6.8 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCOCCOCCNC[C@H](O)COc1cccc2ccccc12 10.1021/jm2008562
44264149 20254 0 None - 0 Rat 8.1 pKd = 8.1 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 397 11 2 5 3.0 CC(C)NCC(O)COc1ccc(CCS(=O)(=O)CC2CCCCC2)cc1 10.1021/jm00389a008
CHEMBL1193283 20254 0 None - 0 Rat 8.1 pKd = 8.1 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 397 11 2 5 3.0 CC(C)NCC(O)COc1ccc(CCS(=O)(=O)CC2CCCCC2)cc1 10.1021/jm00389a008
CHEMBL544661 20254 0 None - 0 Rat 8.1 pKd = 8.1 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 397 11 2 5 3.0 CC(C)NCC(O)COc1ccc(CCS(=O)(=O)CC2CCCCC2)cc1 10.1021/jm00389a008
54757232 72290 0 None - 0 Human 8.1 pKd = 8.1 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 883 28 4 10 6.3 C=CCc1ccccc1OC[C@@H](O)CNCCOCCOCCNC(=O)CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1 10.1021/jm2008562
CHEMBL1830618 72290 0 None - 0 Human 8.1 pKd = 8.1 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 883 28 4 10 6.3 C=CCc1ccccc1OC[C@@H](O)CNCCOCCOCCNC(=O)CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1 10.1021/jm2008562
157716 47290 42 None - 0 Guinea pig 8.1 pKd = 8.1 Functional
Compound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig arteriaCompound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig arteria
ChEMBL 267 9 2 4 1.6 COCCc1ccc(OC[C@@H](O)CNC(C)C)cc1 10.1021/jm00350a009
CHEMBL148306 47290 42 None - 0 Guinea pig 8.1 pKd = 8.1 Functional
Compound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig arteriaCompound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig arteria
ChEMBL 267 9 2 4 1.6 COCCc1ccc(OC[C@@H](O)CNC(C)C)cc1 10.1021/jm00350a009
44371389 18987 0 None - 0 Guinea pig 6.1 pKd = 6.1 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 202 7 2 4 1.1 CC/C(C)=N\OCC(O)CNC(C)C 10.1021/jm00180a007
CHEMBL1184362 18987 0 None - 0 Guinea pig 6.1 pKd = 6.1 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 202 7 2 4 1.1 CC/C(C)=N\OCC(O)CNC(C)C 10.1021/jm00180a007
CHEMBL346326 18987 0 None - 0 Guinea pig 6.1 pKd = 6.1 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 202 7 2 4 1.1 CC/C(C)=N\OCC(O)CNC(C)C 10.1021/jm00180a007
1786 9298 85 None -4 7 Guinea pig 6.1 pKd = 6.1 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig tracheaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig trachea
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00389a008
4171 9298 85 None -4 7 Guinea pig 6.1 pKd = 6.1 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig tracheaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig trachea
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00389a008
553 9298 85 None -4 7 Guinea pig 6.1 pKd = 6.1 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig tracheaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig trachea
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00389a008
CHEMBL13 9298 85 None -4 7 Guinea pig 6.1 pKd = 6.1 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig tracheaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig trachea
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00389a008
DB00264 9298 85 None -4 7 Guinea pig 6.1 pKd = 6.1 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig tracheaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig trachea
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00389a008
54757129 72268 0 None - 0 Human 7.1 pKd = 7.1 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 795 22 4 8 6.3 C=CCc1ccccc1OC[C@@H](O)CNCCNC(=O)CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1 10.1021/jm2008562
CHEMBL1830493 72268 0 None - 0 Human 7.1 pKd = 7.1 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 795 22 4 8 6.3 C=CCc1ccccc1OC[C@@H](O)CNCCNC(=O)CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1 10.1021/jm2008562
157717 67016 38 None - 1 Guinea pig 6.1 pKd = 6.1 Functional
Compound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig arteriaCompound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig arteria
ChEMBL 267 9 2 4 1.6 COCCc1ccc(OC[C@H](O)CNC(C)C)cc1 10.1021/jm00350a009
CHEMBL1741004 67016 38 None - 1 Guinea pig 6.1 pKd = 6.1 Functional
Compound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig arteriaCompound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig arteria
ChEMBL 267 9 2 4 1.6 COCCc1ccc(OC[C@H](O)CNC(C)C)cc1 10.1021/jm00350a009
CHEMBL2062339 67016 38 None - 1 Guinea pig 6.1 pKd = 6.1 Functional
Compound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig arteriaCompound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig arteria
ChEMBL 267 9 2 4 1.6 COCCc1ccc(OC[C@H](O)CNC(C)C)cc1 10.1021/jm00350a009
54756929 72263 0 None - 0 Human 7.1 pKd = 7.1 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 805 20 4 8 6.7 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCNCC(O)COc1cccc2ccccc12 10.1021/jm2008562
CHEMBL1830488 72263 0 None - 0 Human 7.1 pKd = 7.1 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 805 20 4 8 6.7 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCNCC(O)COc1cccc2ccccc12 10.1021/jm2008562
54757331 72291 0 None - 0 Human 7.1 pKd = 7.1 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 883 28 4 10 6.3 C=CCc1ccccc1OCC(O)CNCCOCCOCCNC(=O)CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1 10.1021/jm2008562
CHEMBL1830619 72291 0 None - 0 Human 7.1 pKd = 7.1 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 883 28 4 10 6.3 C=CCc1ccccc1OCC(O)CNCCOCCOCCNC(=O)CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1 10.1021/jm2008562
20554484 210915 0 None - 0 Rat 7.1 pKd = 7.1 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 337 11 2 4 3.5 CC(C)NCC(O)COc1ccc(CCSCC2CCC2)cc1 10.1021/jm00389a008
CHEMBL7043 210915 0 None - 0 Rat 7.1 pKd = 7.1 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 337 11 2 4 3.5 CC(C)NCC(O)COc1ccc(CCSCC2CCC2)cc1 10.1021/jm00389a008
44264171 103844 0 None - 0 Rat 5.1 pKd = 5.1 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 411 14 2 4 4.4 CC(CCc1ccccc1)NCC(O)COc1ccc(CCOCC2CCC2)cc1 10.1021/jm00389a008
CHEMBL267220 103844 0 None - 0 Rat 5.1 pKd = 5.1 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 411 14 2 4 4.4 CC(CCc1ccccc1)NCC(O)COc1ccc(CCOCC2CCC2)cc1 10.1021/jm00389a008
54756928 72262 0 None - 0 Human 6.1 pKd = 6.1 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 889 26 4 8 9.1 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCCCCCCCNC[C@H](O)COc1cccc2ccccc12 10.1021/jm2008562
CHEMBL1830487 72262 0 None - 0 Human 6.1 pKd = 6.1 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 889 26 4 8 9.1 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCCCCCCCNC[C@H](O)COc1cccc2ccccc12 10.1021/jm2008562
44371561 56491 0 None - 0 Guinea pig 5.1 pKd = 5.1 Functional
Antagonist activity against beta-1 adrenergic receptor in isolated guinea pig atriaAntagonist activity against beta-1 adrenergic receptor in isolated guinea pig atria
ChEMBL 257 5 2 4 1.9 CC(C)(C)NCC(O)COC(=O)C1CCCCC1 10.1021/jm00387a006
CHEMBL156682 56491 0 None - 0 Guinea pig 5.1 pKd = 5.1 Functional
Antagonist activity against beta-1 adrenergic receptor in isolated guinea pig atriaAntagonist activity against beta-1 adrenergic receptor in isolated guinea pig atria
ChEMBL 257 5 2 4 1.9 CC(C)(C)NCC(O)COC(=O)C1CCCCC1 10.1021/jm00387a006
54758417 72260 0 None - 0 Human 8.1 pKd = 8.1 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 805 20 4 8 6.7 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCNC[C@H](O)COc1cccc2ccccc12 10.1021/jm2008562
CHEMBL1830485 72260 0 None - 0 Human 8.1 pKd = 8.1 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in cimeterol-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 805 20 4 8 6.7 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCNC[C@H](O)COc1cccc2ccccc12 10.1021/jm2008562
12733302 173122 1 None - 0 Guinea pig 8.1 pKd = 8.1 Functional
Antagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atriaAntagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atria
ChEMBL 249 3 2 4 2.0 CC(C)(C)NCC(O)C1=COc2ccccc2O1 10.1021/jm00140a015
CHEMBL427310 173122 1 None - 0 Guinea pig 8.1 pKd = 8.1 Functional
Antagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atriaAntagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atria
ChEMBL 249 3 2 4 2.0 CC(C)(C)NCC(O)C1=COc2ccccc2O1 10.1021/jm00140a015
2303 9961 68 None -22 20 Guinea pig 8.1 pKd = 8.1 Functional
Antagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atriaAntagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00140a015
4946 9961 68 None -22 20 Guinea pig 8.1 pKd = 8.1 Functional
Antagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atriaAntagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00140a015
564 9961 68 None -22 20 Guinea pig 8.1 pKd = 8.1 Functional
Antagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atriaAntagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00140a015
63 9961 68 None -22 20 Guinea pig 8.1 pKd = 8.1 Functional
Antagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atriaAntagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00140a015
91536 9961 68 None -22 20 Guinea pig 8.1 pKd = 8.1 Functional
Antagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atriaAntagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00140a015
CHEMBL27 9961 68 None -22 20 Guinea pig 8.1 pKd = 8.1 Functional
Antagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atriaAntagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00140a015
CHEMBL452861 9961 68 None -22 20 Guinea pig 8.1 pKd = 8.1 Functional
Antagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atriaAntagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00140a015
DB00571 9961 68 None -22 20 Guinea pig 8.1 pKd = 8.1 Functional
Antagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atriaAntagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00140a015
12606702 18785 0 None - 0 Guinea pig 5.1 pKd = 5.1 Functional
Antagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atriaAntagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atria
ChEMBL 242 5 2 4 2.1 CC(C)(C)NCC(O)CON=C1CCCCC1 10.1021/jm00380a001
CHEMBL1161383 18785 0 None - 0 Guinea pig 5.1 pKd = 5.1 Functional
Antagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atriaAntagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atria
ChEMBL 242 5 2 4 2.1 CC(C)(C)NCC(O)CON=C1CCCCC1 10.1021/jm00380a001
CHEMBL1183312 18785 0 None - 0 Guinea pig 5.1 pKd = 5.1 Functional
Antagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atriaAntagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atria
ChEMBL 242 5 2 4 2.1 CC(C)(C)NCC(O)CON=C1CCCCC1 10.1021/jm00380a001
CHEMBL289868 18785 0 None - 0 Guinea pig 5.1 pKd = 5.1 Functional
Antagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atriaAntagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atria
ChEMBL 242 5 2 4 2.1 CC(C)(C)NCC(O)CON=C1CCCCC1 10.1021/jm00380a001
3486 9931 56 None - 2 Guinea pig 5.1 pKd = 5.1 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig tracheaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig trachea
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00389a008
4883 9931 56 None - 2 Guinea pig 5.1 pKd = 5.1 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig tracheaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig trachea
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00389a008
555 9931 56 None - 2 Guinea pig 5.1 pKd = 5.1 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig tracheaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig trachea
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00389a008
CHEMBL6995 9931 56 None - 2 Guinea pig 5.1 pKd = 5.1 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig tracheaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig trachea
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00389a008
DB01297 9931 56 None - 2 Guinea pig 5.1 pKd = 5.1 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig tracheaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig trachea
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00389a008
12606703 20357 0 None - 0 Guinea pig 6.1 pKd = 6.1 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 276 8 2 4 2.5 CC(/C=C/c1ccccc1)=N\OCC(O)CNC(C)C 10.1021/jm00180a007
CHEMBL1194069 20357 0 None - 0 Guinea pig 6.1 pKd = 6.1 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 276 8 2 4 2.5 CC(/C=C/c1ccccc1)=N\OCC(O)CNC(C)C 10.1021/jm00180a007
CHEMBL545575 20357 0 None - 0 Guinea pig 6.1 pKd = 6.1 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 276 8 2 4 2.5 CC(/C=C/c1ccccc1)=N\OCC(O)CNC(C)C 10.1021/jm00180a007
3047492 210745 8 None - 0 Rat 8.0 pKd = 8.0 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 293 10 2 4 2.4 CC(C)NCC(O)COc1ccc(COCC2CC2)cc1 10.1021/jm00389a008
CHEMBL6939 210745 8 None - 0 Rat 8.0 pKd = 8.0 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 293 10 2 4 2.4 CC(C)NCC(O)COc1ccc(COCC2CC2)cc1 10.1021/jm00389a008
3047492 210745 8 None - 0 Rat 8.0 pKd = 8.0 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atriaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atria
ChEMBL 293 10 2 4 2.4 CC(C)NCC(O)COc1ccc(COCC2CC2)cc1 10.1021/jm00389a008
CHEMBL6939 210745 8 None - 0 Rat 8.0 pKd = 8.0 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atriaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated rat atria
ChEMBL 293 10 2 4 2.4 CC(C)NCC(O)COc1ccc(COCC2CC2)cc1 10.1021/jm00389a008
54758417 72260 0 None - 0 Human 7.0 pKd = 7.0 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 805 20 4 8 6.7 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCNC[C@H](O)COc1cccc2ccccc12 10.1021/jm2008562
CHEMBL1830485 72260 0 None - 0 Human 7.0 pKd = 7.0 Functional
Antagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysisAntagonist activity at human beta-1 adrenergic receptor site 1 expressed in CGP 12177-stimulated CHO-K1 cells assessed as CRE-SPAP level by fluorescence correlation spectroscopic analysis
ChEMBL 805 20 4 8 6.7 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCNC[C@H](O)COc1cccc2ccccc12 10.1021/jm2008562
110857 18989 61 None - 0 Guinea pig 4.0 pKd = 4.0 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 133 4 3 3 -0.7 CC(C)NCC(O)CO 10.1021/jm00180a007
CHEMBL1184370 18989 61 None - 0 Guinea pig 4.0 pKd = 4.0 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 133 4 3 3 -0.7 CC(C)NCC(O)CO 10.1021/jm00180a007
CHEMBL346539 18989 61 None - 0 Guinea pig 4.0 pKd = 4.0 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 133 4 3 3 -0.7 CC(C)NCC(O)CO 10.1021/jm00180a007
44264446 17849 0 None - 0 Rat 7.0 pKd = 7.0 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 335 12 2 4 3.2 CC(C)NCC(O)COc1ccc(CCCOCC2CCC2)cc1 10.1021/jm00389a008
CHEMBL1177932 17849 0 None - 0 Rat 7.0 pKd = 7.0 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 335 12 2 4 3.2 CC(C)NCC(O)COc1ccc(CCCOCC2CCC2)cc1 10.1021/jm00389a008
CHEMBL7209 17849 0 None - 0 Rat 7.0 pKd = 7.0 Functional
Antagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atriaAntagonist activity was determined against beta-1 adrenergic receptor in spontaneously beating rat atria
ChEMBL 335 12 2 4 3.2 CC(C)NCC(O)COc1ccc(CCCOCC2CCC2)cc1 10.1021/jm00389a008
44287467 17995 0 None - 0 Guinea pig 6.0 pKd = 6.0 Functional
Antagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atriaAntagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atria
ChEMBL 216 8 2 4 1.5 CCC(CC)=NOCC(O)CNC(C)C 10.1021/jm00380a001
CHEMBL1178777 17995 0 None - 0 Guinea pig 6.0 pKd = 6.0 Functional
Antagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atriaAntagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atria
ChEMBL 216 8 2 4 1.5 CCC(CC)=NOCC(O)CNC(C)C 10.1021/jm00380a001
CHEMBL40626 17995 0 None - 0 Guinea pig 6.0 pKd = 6.0 Functional
Antagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atriaAntagonistic activity against beta-1 adrenergic receptor of isolated guinea pig atria
ChEMBL 216 8 2 4 1.5 CCC(CC)=NOCC(O)CNC(C)C 10.1021/jm00380a001
3047497 20171 10 None - 0 Guinea pig 6.0 pKd = 6.0 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig tracheaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig trachea
ChEMBL 321 11 2 4 2.8 CC(C)NCC(O)COc1ccc(CCOCC2CCC2)cc1 10.1021/jm00389a008
CHEMBL1192675 20171 10 None - 0 Guinea pig 6.0 pKd = 6.0 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig tracheaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig trachea
ChEMBL 321 11 2 4 2.8 CC(C)NCC(O)COc1ccc(CCOCC2CCC2)cc1 10.1021/jm00389a008
CHEMBL543955 20171 10 None - 0 Guinea pig 6.0 pKd = 6.0 Functional
Cardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig tracheaCardioselectivity for the beta-1 adrenergic receptor was determined against isoprenaline (antagonism) in isolated guinea pig trachea
ChEMBL 321 11 2 4 2.8 CC(C)NCC(O)COc1ccc(CCOCC2CCC2)cc1 10.1021/jm00389a008
44276727 104089 0 None - 2 Guinea pig 7.0 pKd = 7.0 Functional
Compound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atriaCompound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atria
ChEMBL 263 6 2 3 2.2 Cc1ccc(OCC(O)CNC(C)C)c2c1CCC2 10.1021/jm00350a009
CHEMBL26917 104089 0 None - 2 Guinea pig 7.0 pKd = 7.0 Functional
Compound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atriaCompound was tested for its Beta-1 adrenergic receptor antagonistic activity on guinea pig atria
ChEMBL 263 6 2 3 2.2 Cc1ccc(OCC(O)CNC(C)C)c2c1CCC2 10.1021/jm00350a009
12606685 18439 0 None - 0 Guinea pig 6.0 pKd = 6.0 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 189 7 2 3 1.0 CC(C)COCC(O)CNC(C)C 10.1021/jm00180a007
CHEMBL1181117 18439 0 None - 0 Guinea pig 6.0 pKd = 6.0 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 189 7 2 3 1.0 CC(C)COCC(O)CNC(C)C 10.1021/jm00180a007
CHEMBL156258 18439 0 None - 0 Guinea pig 6.0 pKd = 6.0 Functional
Antagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pigAntagonism of the isoprenaline-induced positive chronotropic effect on the atria of guinea pig
ChEMBL 189 7 2 3 1.0 CC(C)COCC(O)CNC(C)C 10.1021/jm00180a007
132 8058 13 None - 0 Rat 10.4 pKi = 10.4 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cells
ChEMBL 287 5 3 4 2.2 N#Cc1[nH]c2c(c1)c(OCC(CNC(C)(C)C)O)ccc2 10.1021/jm050624l
155346 8058 13 None - 0 Rat 10.4 pKi = 10.4 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cells
ChEMBL 287 5 3 4 2.2 N#Cc1[nH]c2c(c1)c(OCC(CNC(C)(C)C)O)ccc2 10.1021/jm050624l
CHEMBL378501 8058 13 None - 0 Rat 10.4 pKi = 10.4 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cells
ChEMBL 287 5 3 4 2.2 N#Cc1[nH]c2c(c1)c(OCC(CNC(C)(C)C)O)ccc2 10.1021/jm050624l
132 8058 13 None - 0 Rat 10.3 pKi = 10.3 Functional
Antagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cellsAntagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 287 5 3 4 2.2 N#Cc1[nH]c2c(c1)c(OCC(CNC(C)(C)C)O)ccc2 10.1021/jm050624l
155346 8058 13 None - 0 Rat 10.3 pKi = 10.3 Functional
Antagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cellsAntagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 287 5 3 4 2.2 N#Cc1[nH]c2c(c1)c(OCC(CNC(C)(C)C)O)ccc2 10.1021/jm050624l
CHEMBL378501 8058 13 None - 0 Rat 10.3 pKi = 10.3 Functional
Antagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cellsAntagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 287 5 3 4 2.2 N#Cc1[nH]c2c(c1)c(OCC(CNC(C)(C)C)O)ccc2 10.1021/jm050624l
132 8058 13 None - 0 Rat 9.9 pKi = 9.9 Functional
Antagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cells
ChEMBL 287 5 3 4 2.2 N#Cc1[nH]c2c(c1)c(OCC(CNC(C)(C)C)O)ccc2 10.1021/jm050624l
155346 8058 13 None - 0 Rat 9.9 pKi = 9.9 Functional
Antagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cells
ChEMBL 287 5 3 4 2.2 N#Cc1[nH]c2c(c1)c(OCC(CNC(C)(C)C)O)ccc2 10.1021/jm050624l
CHEMBL378501 8058 13 None - 0 Rat 9.9 pKi = 9.9 Functional
Antagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cells
ChEMBL 287 5 3 4 2.2 N#Cc1[nH]c2c(c1)c(OCC(CNC(C)(C)C)O)ccc2 10.1021/jm050624l
132 8058 13 None - 0 Rat 9.5 pKi = 9.5 Functional
Antagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cells
ChEMBL 287 5 3 4 2.2 N#Cc1[nH]c2c(c1)c(OCC(CNC(C)(C)C)O)ccc2 10.1021/jm050624l
155346 8058 13 None - 0 Rat 9.5 pKi = 9.5 Functional
Antagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cells
ChEMBL 287 5 3 4 2.2 N#Cc1[nH]c2c(c1)c(OCC(CNC(C)(C)C)O)ccc2 10.1021/jm050624l
CHEMBL378501 8058 13 None - 0 Rat 9.5 pKi = 9.5 Functional
Antagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cells
ChEMBL 287 5 3 4 2.2 N#Cc1[nH]c2c(c1)c(OCC(CNC(C)(C)C)O)ccc2 10.1021/jm050624l
2685 7677 21 None - 1 Rat 8.9 pKi = 8.9 Functional
Antagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cellsAntagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10.1021/jm050624l
541 7677 21 None - 1 Rat 8.9 pKi = 8.9 Functional
Antagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cellsAntagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10.1021/jm050624l
CHEMBL280822 7677 21 None - 1 Rat 8.9 pKi = 8.9 Functional
Antagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cellsAntagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10.1021/jm050624l
2685 7677 21 None - 1 Rat 8.7 pKi = 8.7 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cells
ChEMBL 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10.1021/jm050624l
541 7677 21 None - 1 Rat 8.7 pKi = 8.7 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cells
ChEMBL 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10.1021/jm050624l
CHEMBL280822 7677 21 None - 1 Rat 8.7 pKi = 8.7 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cells
ChEMBL 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10.1021/jm050624l
2303 9961 68 None - 20 Rat 8.0 pKi = 8 Functional
Antagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
4946 9961 68 None - 20 Rat 8.0 pKi = 8 Functional
Antagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
564 9961 68 None - 20 Rat 8.0 pKi = 8 Functional
Antagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
63 9961 68 None - 20 Rat 8.0 pKi = 8 Functional
Antagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
91536 9961 68 None - 20 Rat 8.0 pKi = 8 Functional
Antagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
CHEMBL27 9961 68 None - 20 Rat 8.0 pKi = 8 Functional
Antagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
CHEMBL452861 9961 68 None - 20 Rat 8.0 pKi = 8 Functional
Antagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
DB00571 9961 68 None - 20 Rat 8.0 pKi = 8 Functional
Antagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
5311116 9114 9 None - 3 Rat 7.0 pKi = 7 Functional
Antagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cells
ChEMBL 484 15 5 8 2.2 N#Cc1cc(OCCOCC2CC2)ccc1OCC(CNCCNC(=O)Nc1ccc(cc1)O)O 10.1021/jm050624l
544 9114 9 None - 3 Rat 7.0 pKi = 7 Functional
Antagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cells
ChEMBL 484 15 5 8 2.2 N#Cc1cc(OCCOCC2CC2)ccc1OCC(CNCCNC(=O)Nc1ccc(cc1)O)O 10.1021/jm050624l
CHEMBL207802 9114 9 None - 3 Rat 7.0 pKi = 7 Functional
Antagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cells
ChEMBL 484 15 5 8 2.2 N#Cc1cc(OCCOCC2CC2)ccc1OCC(CNCCNC(=O)Nc1ccc(cc1)O)O 10.1021/jm050624l
9909993 84068 0 None - 0 Rat 7.0 pKi = 7 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cells
ChEMBL 419 15 2 7 2.7 CCOCCOc1ccc(OC[C@@H](O)CNCCc2ccc(OC)c(OC)c2)cc1 10.1021/jm050624l
CHEMBL208185 84068 0 None - 0 Rat 7.0 pKi = 7 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cells
ChEMBL 419 15 2 7 2.7 CCOCCOc1ccc(OC[C@@H](O)CNCCc2ccc(OC)c(OC)c2)cc1 10.1021/jm050624l
2685 7677 21 None - 1 Rat 5.0 pKi = 5 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cells
ChEMBL 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10.1021/jm050624l
541 7677 21 None - 1 Rat 5.0 pKi = 5 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cells
ChEMBL 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10.1021/jm050624l
CHEMBL280822 7677 21 None - 1 Rat 5.0 pKi = 5 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cells
ChEMBL 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10.1021/jm050624l
9909993 84068 0 None - 0 Rat 4.9 pKi = 4.9 Functional
Antagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cells
ChEMBL 419 15 2 7 2.7 CCOCCOc1ccc(OC[C@@H](O)CNCCc2ccc(OC)c(OC)c2)cc1 10.1021/jm050624l
CHEMBL208185 84068 0 None - 0 Rat 4.9 pKi = 4.9 Functional
Antagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cells
ChEMBL 419 15 2 7 2.7 CCOCCOc1ccc(OC[C@@H](O)CNCCc2ccc(OC)c(OC)c2)cc1 10.1021/jm050624l
33624 10593 34 None - 6 Rat 7.8 pKi = 7.8 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cells
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm050624l
4061 10593 34 None - 6 Rat 7.8 pKi = 7.8 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cells
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm050624l
565 10593 34 None - 6 Rat 7.8 pKi = 7.8 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cells
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm050624l
CHEMBL499 10593 34 None - 6 Rat 7.8 pKi = 7.8 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cells
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm050624l
DB00373 10593 34 None - 6 Rat 7.8 pKi = 7.8 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cells
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm050624l
2303 9961 68 None - 20 Rat 6.7 pKi = 6.7 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
4946 9961 68 None - 20 Rat 6.7 pKi = 6.7 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
564 9961 68 None - 20 Rat 6.7 pKi = 6.7 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
63 9961 68 None - 20 Rat 6.7 pKi = 6.7 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
91536 9961 68 None - 20 Rat 6.7 pKi = 6.7 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
CHEMBL27 9961 68 None - 20 Rat 6.7 pKi = 6.7 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
CHEMBL452861 9961 68 None - 20 Rat 6.7 pKi = 6.7 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
DB00571 9961 68 None - 20 Rat 6.7 pKi = 6.7 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
1786 9298 85 None - 7 Rat 5.6 pKi = 5.6 Functional
Antagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cells
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm050624l
4171 9298 85 None - 7 Rat 5.6 pKi = 5.6 Functional
Antagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cells
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm050624l
553 9298 85 None - 7 Rat 5.6 pKi = 5.6 Functional
Antagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cells
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm050624l
CHEMBL13 9298 85 None - 7 Rat 5.6 pKi = 5.6 Functional
Antagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cells
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm050624l
DB00264 9298 85 None - 7 Rat 5.6 pKi = 5.6 Functional
Antagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cells
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm050624l
1786 9298 85 None - 7 Rat 5.6 pKi = 5.6 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cells
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm050624l
4171 9298 85 None - 7 Rat 5.6 pKi = 5.6 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cells
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm050624l
553 9298 85 None - 7 Rat 5.6 pKi = 5.6 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cells
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm050624l
CHEMBL13 9298 85 None - 7 Rat 5.6 pKi = 5.6 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cells
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm050624l
DB00264 9298 85 None - 7 Rat 5.6 pKi = 5.6 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cells
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm050624l
2303 9961 68 None - 20 Rat 8.5 pKi = 8.5 Functional
Antagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cellsAntagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
4946 9961 68 None - 20 Rat 8.5 pKi = 8.5 Functional
Antagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cellsAntagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
564 9961 68 None - 20 Rat 8.5 pKi = 8.5 Functional
Antagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cellsAntagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
63 9961 68 None - 20 Rat 8.5 pKi = 8.5 Functional
Antagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cellsAntagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
91536 9961 68 None - 20 Rat 8.5 pKi = 8.5 Functional
Antagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cellsAntagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
CHEMBL27 9961 68 None - 20 Rat 8.5 pKi = 8.5 Functional
Antagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cellsAntagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
CHEMBL452861 9961 68 None - 20 Rat 8.5 pKi = 8.5 Functional
Antagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cellsAntagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
DB00571 9961 68 None - 20 Rat 8.5 pKi = 8.5 Functional
Antagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cellsAntagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
33624 10593 34 None - 6 Rat 8.5 pKi = 8.5 Functional
Antagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cellsAntagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm050624l
4061 10593 34 None - 6 Rat 8.5 pKi = 8.5 Functional
Antagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cellsAntagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm050624l
565 10593 34 None - 6 Rat 8.5 pKi = 8.5 Functional
Antagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cellsAntagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm050624l
CHEMBL499 10593 34 None - 6 Rat 8.5 pKi = 8.5 Functional
Antagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cellsAntagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm050624l
DB00373 10593 34 None - 6 Rat 8.5 pKi = 8.5 Functional
Antagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cellsAntagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm050624l
33624 10593 34 None - 6 Rat 7.5 pKi = 7.5 Functional
Antagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cells
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm050624l
4061 10593 34 None - 6 Rat 7.5 pKi = 7.5 Functional
Antagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cells
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm050624l
565 10593 34 None - 6 Rat 7.5 pKi = 7.5 Functional
Antagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cells
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm050624l
CHEMBL499 10593 34 None - 6 Rat 7.5 pKi = 7.5 Functional
Antagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cells
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm050624l
DB00373 10593 34 None - 6 Rat 7.5 pKi = 7.5 Functional
Antagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cells
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm050624l
2303 9961 68 None - 20 Rat 7.5 pKi = 7.5 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
4946 9961 68 None - 20 Rat 7.5 pKi = 7.5 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
564 9961 68 None - 20 Rat 7.5 pKi = 7.5 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
63 9961 68 None - 20 Rat 7.5 pKi = 7.5 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
91536 9961 68 None - 20 Rat 7.5 pKi = 7.5 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
CHEMBL27 9961 68 None - 20 Rat 7.5 pKi = 7.5 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
CHEMBL452861 9961 68 None - 20 Rat 7.5 pKi = 7.5 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
DB00571 9961 68 None - 20 Rat 7.5 pKi = 7.5 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
132 8058 13 None - 0 Rat 6.5 pKi = 6.5 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cells
ChEMBL 287 5 3 4 2.2 N#Cc1[nH]c2c(c1)c(OCC(CNC(C)(C)C)O)ccc2 10.1021/jm050624l
155346 8058 13 None - 0 Rat 6.5 pKi = 6.5 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cells
ChEMBL 287 5 3 4 2.2 N#Cc1[nH]c2c(c1)c(OCC(CNC(C)(C)C)O)ccc2 10.1021/jm050624l
CHEMBL378501 8058 13 None - 0 Rat 6.5 pKi = 6.5 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cells
ChEMBL 287 5 3 4 2.2 N#Cc1[nH]c2c(c1)c(OCC(CNC(C)(C)C)O)ccc2 10.1021/jm050624l
2303 9961 68 None - 20 Rat 7.4 pKi = 7.4 Functional
Antagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
4946 9961 68 None - 20 Rat 7.4 pKi = 7.4 Functional
Antagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
564 9961 68 None - 20 Rat 7.4 pKi = 7.4 Functional
Antagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
63 9961 68 None - 20 Rat 7.4 pKi = 7.4 Functional
Antagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
91536 9961 68 None - 20 Rat 7.4 pKi = 7.4 Functional
Antagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
CHEMBL27 9961 68 None - 20 Rat 7.4 pKi = 7.4 Functional
Antagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
CHEMBL452861 9961 68 None - 20 Rat 7.4 pKi = 7.4 Functional
Antagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
DB00571 9961 68 None - 20 Rat 7.4 pKi = 7.4 Functional
Antagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm050624l
1786 9298 85 None - 7 Rat 6.4 pKi = 6.4 Functional
Antagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cellsAntagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm050624l
4171 9298 85 None - 7 Rat 6.4 pKi = 6.4 Functional
Antagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cellsAntagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm050624l
553 9298 85 None - 7 Rat 6.4 pKi = 6.4 Functional
Antagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cellsAntagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm050624l
CHEMBL13 9298 85 None - 7 Rat 6.4 pKi = 6.4 Functional
Antagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cellsAntagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm050624l
DB00264 9298 85 None - 7 Rat 6.4 pKi = 6.4 Functional
Antagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cellsAntagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm050624l
9909993 84068 0 None - 0 Rat 7.3 pKi = 7.3 Functional
Antagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cellsAntagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 419 15 2 7 2.7 CCOCCOc1ccc(OC[C@@H](O)CNCCc2ccc(OC)c(OC)c2)cc1 10.1021/jm050624l
CHEMBL208185 84068 0 None - 0 Rat 7.3 pKi = 7.3 Functional
Antagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cellsAntagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 419 15 2 7 2.7 CCOCCOc1ccc(OC[C@@H](O)CNCCc2ccc(OC)c(OC)c2)cc1 10.1021/jm050624l
1786 9298 85 None - 7 Rat 5.3 pKi = 5.3 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cells
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm050624l
4171 9298 85 None - 7 Rat 5.3 pKi = 5.3 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cells
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm050624l
553 9298 85 None - 7 Rat 5.3 pKi = 5.3 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cells
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm050624l
CHEMBL13 9298 85 None - 7 Rat 5.3 pKi = 5.3 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cells
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm050624l
DB00264 9298 85 None - 7 Rat 5.3 pKi = 5.3 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cells
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm050624l
5311116 9114 9 None - 3 Rat 7.2 pKi = 7.2 Functional
Antagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cells
ChEMBL 484 15 5 8 2.2 N#Cc1cc(OCCOCC2CC2)ccc1OCC(CNCCNC(=O)Nc1ccc(cc1)O)O 10.1021/jm050624l
544 9114 9 None - 3 Rat 7.2 pKi = 7.2 Functional
Antagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cells
ChEMBL 484 15 5 8 2.2 N#Cc1cc(OCCOCC2CC2)ccc1OCC(CNCCNC(=O)Nc1ccc(cc1)O)O 10.1021/jm050624l
CHEMBL207802 9114 9 None - 3 Rat 7.2 pKi = 7.2 Functional
Antagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cells
ChEMBL 484 15 5 8 2.2 N#Cc1cc(OCCOCC2CC2)ccc1OCC(CNCCNC(=O)Nc1ccc(cc1)O)O 10.1021/jm050624l
1786 9298 85 None - 7 Rat 6.2 pKi = 6.2 Functional
Antagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cells
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm050624l
4171 9298 85 None - 7 Rat 6.2 pKi = 6.2 Functional
Antagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cells
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm050624l
553 9298 85 None - 7 Rat 6.2 pKi = 6.2 Functional
Antagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cells
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm050624l
CHEMBL13 9298 85 None - 7 Rat 6.2 pKi = 6.2 Functional
Antagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cells
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm050624l
DB00264 9298 85 None - 7 Rat 6.2 pKi = 6.2 Functional
Antagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cells
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm050624l
33624 10593 34 None - 6 Rat 6.2 pKi = 6.2 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cells
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm050624l
4061 10593 34 None - 6 Rat 6.2 pKi = 6.2 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cells
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm050624l
565 10593 34 None - 6 Rat 6.2 pKi = 6.2 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cells
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm050624l
CHEMBL499 10593 34 None - 6 Rat 6.2 pKi = 6.2 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cells
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm050624l
DB00373 10593 34 None - 6 Rat 6.2 pKi = 6.2 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cells
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm050624l
44331346 215168 0 None -120 3 Human 5.2 pKi = 5.2 Functional
Binding affinity of compound against Beta-1 adrenergic receptor was determinedBinding affinity of compound against Beta-1 adrenergic receptor was determined
ChEMBL 638 17 5 8 4.2 CCCCCCCCC(=O)Nc1ccc(S(=O)(=O)N2CCC(CNC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)CC2)cc1 10.1016/s0960-894x(02)00608-x
CHEMBL99599 215168 0 None -120 3 Human 5.2 pKi = 5.2 Functional
Binding affinity of compound against Beta-1 adrenergic receptor was determinedBinding affinity of compound against Beta-1 adrenergic receptor was determined
ChEMBL 638 17 5 8 4.2 CCCCCCCCC(=O)Nc1ccc(S(=O)(=O)N2CCC(CNC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)CC2)cc1 10.1016/s0960-894x(02)00608-x
2685 7677 21 None - 1 Rat 8.1 pKi = 8.1 Functional
Antagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cells
ChEMBL 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10.1021/jm050624l
541 7677 21 None - 1 Rat 8.1 pKi = 8.1 Functional
Antagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cells
ChEMBL 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10.1021/jm050624l
CHEMBL280822 7677 21 None - 1 Rat 8.1 pKi = 8.1 Functional
Antagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cells
ChEMBL 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10.1021/jm050624l
33624 10593 34 None - 6 Rat 8.1 pKi = 8.1 Functional
Antagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cells
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm050624l
4061 10593 34 None - 6 Rat 8.1 pKi = 8.1 Functional
Antagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cells
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm050624l
565 10593 34 None - 6 Rat 8.1 pKi = 8.1 Functional
Antagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cells
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm050624l
CHEMBL499 10593 34 None - 6 Rat 8.1 pKi = 8.1 Functional
Antagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cells
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm050624l
DB00373 10593 34 None - 6 Rat 8.1 pKi = 8.1 Functional
Antagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cells
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm050624l
5311116 9114 9 None - 3 Rat 8.1 pKi = 8.1 Functional
Antagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cellsAntagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 484 15 5 8 2.2 N#Cc1cc(OCCOCC2CC2)ccc1OCC(CNCCNC(=O)Nc1ccc(cc1)O)O 10.1021/jm050624l
544 9114 9 None - 3 Rat 8.1 pKi = 8.1 Functional
Antagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cellsAntagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 484 15 5 8 2.2 N#Cc1cc(OCCOCC2CC2)ccc1OCC(CNCCNC(=O)Nc1ccc(cc1)O)O 10.1021/jm050624l
CHEMBL207802 9114 9 None - 3 Rat 8.1 pKi = 8.1 Functional
Antagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cellsAntagonist activity at rat wild type beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 484 15 5 8 2.2 N#Cc1cc(OCCOCC2CC2)ccc1OCC(CNCCNC(=O)Nc1ccc(cc1)O)O 10.1021/jm050624l
9909993 84068 0 None - 0 Rat 7.1 pKi = 7.1 Functional
Antagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cells
ChEMBL 419 15 2 7 2.7 CCOCCOc1ccc(OC[C@@H](O)CNCCc2ccc(OC)c(OC)c2)cc1 10.1021/jm050624l
CHEMBL208185 84068 0 None - 0 Rat 7.1 pKi = 7.1 Functional
Antagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor W134A mutant expressed in CHO cells
ChEMBL 419 15 2 7 2.7 CCOCCOc1ccc(OC[C@@H](O)CNCCc2ccc(OC)c(OC)c2)cc1 10.1021/jm050624l
5311116 9114 9 None - 3 Rat 7.1 pKi = 7.1 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cells
ChEMBL 484 15 5 8 2.2 N#Cc1cc(OCCOCC2CC2)ccc1OCC(CNCCNC(=O)Nc1ccc(cc1)O)O 10.1021/jm050624l
544 9114 9 None - 3 Rat 7.1 pKi = 7.1 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cells
ChEMBL 484 15 5 8 2.2 N#Cc1cc(OCCOCC2CC2)ccc1OCC(CNCCNC(=O)Nc1ccc(cc1)O)O 10.1021/jm050624l
CHEMBL207802 9114 9 None - 3 Rat 7.1 pKi = 7.1 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356F mutant expressed in CHO cells
ChEMBL 484 15 5 8 2.2 N#Cc1cc(OCCOCC2CC2)ccc1OCC(CNCCNC(=O)Nc1ccc(cc1)O)O 10.1021/jm050624l
2685 7677 21 None - 1 Rat 6.1 pKi = 6.1 Functional
Antagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cells
ChEMBL 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10.1021/jm050624l
541 7677 21 None - 1 Rat 6.1 pKi = 6.1 Functional
Antagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cells
ChEMBL 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10.1021/jm050624l
CHEMBL280822 7677 21 None - 1 Rat 6.1 pKi = 6.1 Functional
Antagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor S190A mutant expressed in CHO cells
ChEMBL 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10.1021/jm050624l
9909993 84068 0 None - 0 Rat 6.1 pKi = 6.1 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cells
ChEMBL 419 15 2 7 2.7 CCOCCOc1ccc(OC[C@@H](O)CNCCc2ccc(OC)c(OC)c2)cc1 10.1021/jm050624l
CHEMBL208185 84068 0 None - 0 Rat 6.1 pKi = 6.1 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cells
ChEMBL 419 15 2 7 2.7 CCOCCOc1ccc(OC[C@@H](O)CNCCc2ccc(OC)c(OC)c2)cc1 10.1021/jm050624l
5311116 9114 9 None - 3 Rat 4.1 pKi = 4.1 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cells
ChEMBL 484 15 5 8 2.2 N#Cc1cc(OCCOCC2CC2)ccc1OCC(CNCCNC(=O)Nc1ccc(cc1)O)O 10.1021/jm050624l
544 9114 9 None - 3 Rat 4.1 pKi = 4.1 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cells
ChEMBL 484 15 5 8 2.2 N#Cc1cc(OCCOCC2CC2)ccc1OCC(CNCCNC(=O)Nc1ccc(cc1)O)O 10.1021/jm050624l
CHEMBL207802 9114 9 None - 3 Rat 4.1 pKi = 4.1 Functional
Antagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cellsAntagonist activity at rat beta-1 adrenergic receptor Y356A mutant expressed in CHO cells
ChEMBL 484 15 5 8 2.2 N#Cc1cc(OCCOCC2CC2)ccc1OCC(CNCCNC(=O)Nc1ccc(cc1)O)O 10.1021/jm050624l
41835 224494 0 None 54 2 Human 7.8 pA2 = 7.8 Functional
NoneNone
Drug Central 372 8 4 6 1.9 CC(CCC1=CC2=C(OCO2)C=C1)NCC(O)C1=CC(C(N)=O)=C(O)C=C1 None
2249 7300 111 None -18 5 Rat 6.8 pA2 = 6.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 31837330
255 7300 111 None -18 5 Rat 6.8 pA2 = 6.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 31837330
548 7300 111 None -18 5 Rat 6.8 pA2 = 6.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 31837330
CHEMBL24 7300 111 None -18 5 Rat 6.8 pA2 = 6.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 31837330
DB00335 7300 111 None -18 5 Rat 6.8 pA2 = 6.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 31837330
2475 7528 0 None - 1 Rat 9.0 pA2 = 9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 271 5 2 3 2.8 OC(COc1cc(C)ccc1Cl)CNC(C)(C)C 31837330
433 7528 0 None - 1 Rat 9.0 pA2 = 9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 271 5 2 3 2.8 OC(COc1cc(C)ccc1Cl)CNC(C)(C)C 31837330
550 7528 0 None - 1 Rat 9.0 pA2 = 9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 271 5 2 3 2.8 OC(COc1cc(C)ccc1Cl)CNC(C)(C)C 31837330
CHEMBL305380 7528 0 None - 1 Rat 9.0 pA2 = 9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 271 5 2 3 2.8 OC(COc1cc(C)ccc1Cl)CNC(C)(C)C 31837330
DB08808 7528 0 None - 1 Rat 9.0 pA2 = 9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 271 5 2 3 2.8 OC(COc1cc(C)ccc1Cl)CNC(C)(C)C 31837330
36811 8236 37 None -11 17 Human 8.3 pEC50 = 8.3 Functional
NoneNone
Drug Central 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O None
535 8236 37 None -11 17 Human 8.3 pEC50 = 8.3 Functional
NoneNone
Drug Central 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O None
937 8236 37 None -11 17 Human 8.3 pEC50 = 8.3 Functional
NoneNone
Drug Central 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O None
CHEMBL926 8236 37 None -11 17 Human 8.3 pEC50 = 8.3 Functional
NoneNone
Drug Central 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O None
DB00841 8236 37 None -11 17 Human 8.3 pEC50 = 8.3 Functional
NoneNone
Drug Central 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O None
10184665 10763 51 None -173 10 Human 8.2 pEC50 = 8.2 Functional
NoneNone
Drug Central 485 16 4 6 4.6 OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O None
4799 10763 51 None -173 10 Human 8.2 pEC50 = 8.2 Functional
NoneNone
Drug Central 485 16 4 6 4.6 OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O None
7353 10763 51 None -173 10 Human 8.2 pEC50 = 8.2 Functional
NoneNone
Drug Central 485 16 4 6 4.6 OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O None
CHEMBL1198857 10763 51 None -173 10 Human 8.2 pEC50 = 8.2 Functional
NoneNone
Drug Central 485 16 4 6 4.6 OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O None
DB09082 10763 51 None -173 10 Human 8.2 pEC50 = 8.2 Functional
NoneNone
Drug Central 485 16 4 6 4.6 OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O None
65772 67177 8 None -20 11 Guinea pig 8.2 pEC50 = 8.2 Functional
NoneNone
Drug Central 345 5 3 6 2.6 COc1cc(C[C@@H]2NCCc3cc(O)c(O)cc32)cc(OC)c1OC None
CHEMBL174984 67177 8 None -20 11 Guinea pig 8.2 pEC50 = 8.2 Functional
NoneNone
Drug Central 345 5 3 6 2.6 COc1cc(C[C@@H]2NCCc3cc(O)c(O)cc32)cc(OC)c1OC None
443372 17006 26 None -2 9 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
Drug Central 211 4 4 4 1.1 CC(C)NC[C@H](O)c1ccc(O)c(O)c1 None
CHEMBL1160723 17006 26 None -2 9 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
Drug Central 211 4 4 4 1.1 CC(C)NC[C@H](O)c1ccc(O)c(O)c1 None
CHEMBL2062275 17006 26 None -2 9 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
Drug Central 211 4 4 4 1.1 CC(C)NC[C@H](O)c1ccc(O)c(O)c1 None
1499 8872 47 None -58 38 Human 8.1 pEC50 = 8.1 Functional
NoneNone
Drug Central 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C None
3779 8872 47 None -58 38 Human 8.1 pEC50 = 8.1 Functional
NoneNone
Drug Central 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C None
536 8872 47 None -58 38 Human 8.1 pEC50 = 8.1 Functional
NoneNone
Drug Central 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C None
CHEMBL434 8872 47 None -58 38 Human 8.1 pEC50 = 8.1 Functional
NoneNone
Drug Central 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C None
DB01064 8872 47 None -58 38 Human 8.1 pEC50 = 8.1 Functional
NoneNone
Drug Central 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C None
12065 7415 26 None -6 2 Human 9.2 pEC50 = 9.2 Functional
Determined in an intracellular cAMP accumulation assay in CHO-K1 cells expressing hβ1-ARDetermined in an intracellular cAMP accumulation assay in CHO-K1 cells expressing hβ1-AR
Guide to Pharmacology 370 6 4 5 2.7 Cc1ccccc1CC(C)(C)NCC(c1c2c(c(cc1)O)NC(=O)CO2)O 19875286
12065 7415 26 None -6 2 Human 9.2 pEC50 = 9.2 Functional
Determined in an intracellular cAMP accumulation assay in CHO-K1 cells expressing hβ1-ARDetermined in an intracellular cAMP accumulation assay in CHO-K1 cells expressing hβ1-AR
Guide to Pharmacology 370 6 4 5 2.7 Cc1ccccc1CC(C)(C)NCC(c1c2c(c(cc1)O)NC(=O)CO2)O 33093660
45483813 7415 26 None -6 2 Human 9.2 pEC50 = 9.2 Functional
Determined in an intracellular cAMP accumulation assay in CHO-K1 cells expressing hβ1-ARDetermined in an intracellular cAMP accumulation assay in CHO-K1 cells expressing hβ1-AR
Guide to Pharmacology 370 6 4 5 2.7 Cc1ccccc1CC(C)(C)NCC(c1c2c(c(cc1)O)NC(=O)CO2)O 19875286
45483813 7415 26 None -6 2 Human 9.2 pEC50 = 9.2 Functional
Determined in an intracellular cAMP accumulation assay in CHO-K1 cells expressing hβ1-ARDetermined in an intracellular cAMP accumulation assay in CHO-K1 cells expressing hβ1-AR
Guide to Pharmacology 370 6 4 5 2.7 Cc1ccccc1CC(C)(C)NCC(c1c2c(c(cc1)O)NC(=O)CO2)O 33093660
CHEMBL579394 7415 26 None -6 2 Human 9.2 pEC50 = 9.2 Functional
Determined in an intracellular cAMP accumulation assay in CHO-K1 cells expressing hβ1-ARDetermined in an intracellular cAMP accumulation assay in CHO-K1 cells expressing hβ1-AR
Guide to Pharmacology 370 6 4 5 2.7 Cc1ccccc1CC(C)(C)NCC(c1c2c(c(cc1)O)NC(=O)CO2)O 19875286
CHEMBL579394 7415 26 None -6 2 Human 9.2 pEC50 = 9.2 Functional
Determined in an intracellular cAMP accumulation assay in CHO-K1 cells expressing hβ1-ARDetermined in an intracellular cAMP accumulation assay in CHO-K1 cells expressing hβ1-AR
Guide to Pharmacology 370 6 4 5 2.7 Cc1ccccc1CC(C)(C)NCC(c1c2c(c(cc1)O)NC(=O)CO2)O 33093660
9512 10408 42 None -1202 3 Human 5.4 pEC50 = 5.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 410 9 4 4 4.4 Clc1cccc(c1)[C@H](CNCCNc1cccc(c1)c1cccc(c1)C(=O)O)O 16640337
9887812 10408 42 None -1202 3 Human 5.4 pEC50 = 5.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 410 9 4 4 4.4 Clc1cccc(c1)[C@H](CNCCNc1cccc(c1)c1cccc(c1)C(=O)O)O 16640337
CHEMBL208427 10408 42 None -1202 3 Human 5.4 pEC50 = 5.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 410 9 4 4 4.4 Clc1cccc(c1)[C@H](CNCCNc1cccc(c1)c1cccc(c1)C(=O)O)O 16640337
DB06190 10408 42 None -1202 3 Human 5.4 pEC50 = 5.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 410 9 4 4 4.4 Clc1cccc(c1)[C@H](CNCCNc1cccc(c1)c1cccc(c1)C(=O)O)O 16640337
2598 10550 58 None -1 2 Human 5.8 pEC50 = 5.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 225 3 4 4 1.5 OC(c1cc(O)cc(c1)O)CNC(C)(C)C 20590599
5403 10550 58 None -1 2 Human 5.8 pEC50 = 5.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 225 3 4 4 1.5 OC(c1cc(O)cc(c1)O)CNC(C)(C)C 20590599
560 10550 58 None -1 2 Human 5.8 pEC50 = 5.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 225 3 4 4 1.5 OC(c1cc(O)cc(c1)O)CNC(C)(C)C 20590599
CHEMBL1760 10550 58 None -1 2 Human 5.8 pEC50 = 5.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 225 3 4 4 1.5 OC(c1cc(O)cc(c1)O)CNC(C)(C)C 20590599
DB00871 10550 58 None -1 2 Human 5.8 pEC50 = 5.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 225 3 4 4 1.5 OC(c1cc(O)cc(c1)O)CNC(C)(C)C 20590599
123600 9094 0 None -2 3 Human 6.2 pEC50 = 6.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 239 4 4 4 1.3 OCc1cc(ccc1O)[C@H](CNC(C)(C)C)O 20590599
1575 9094 0 None -2 3 Human 6.2 pEC50 = 6.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 239 4 4 4 1.3 OCc1cc(ccc1O)[C@H](CNC(C)(C)C)O 20590599
9816 9094 0 None -2 3 Human 6.2 pEC50 = 6.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 239 4 4 4 1.3 OCc1cc(ccc1O)[C@H](CNC(C)(C)C)O 20590599
CHEMBL1002 9094 0 None -2 3 Human 6.2 pEC50 = 6.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 239 4 4 4 1.3 OCc1cc(ccc1O)[C@H](CNC(C)(C)C)O 20590599
DB13139 9094 0 None -2 3 Human 6.2 pEC50 = 6.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 239 4 4 4 1.3 OCc1cc(ccc1O)[C@H](CNC(C)(C)C)O 20590599
567 7512 16 None -323 7 Human 6.5 pEC50 = 6.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 363 9 3 4 3.1 C[C@H](Cc1ccc(cc1)OCC(=O)O)NC[C@@H](c1cccc(c1)Cl)O 20590599
9841972 7512 16 None -323 7 Human 6.5 pEC50 = 6.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 363 9 3 4 3.1 C[C@H](Cc1ccc(cc1)OCC(=O)O)NC[C@@H](c1cccc(c1)Cl)O 20590599
CHEMBL284782 7512 16 None -323 7 Human 6.5 pEC50 = 6.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 363 9 3 4 3.1 C[C@H](Cc1ccc(cc1)OCC(=O)O)NC[C@@H](c1cccc(c1)Cl)O 20590599
36811 8236 37 None -11 17 Human 6.8 pEC50 = 6.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 20590599
535 8236 37 None -11 17 Human 6.8 pEC50 = 6.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 20590599
937 8236 37 None -11 17 Human 6.8 pEC50 = 6.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 20590599
CHEMBL926 8236 37 None -11 17 Human 6.8 pEC50 = 6.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 20590599
DB00841 8236 37 None -11 17 Human 6.8 pEC50 = 6.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 20590599
1155 8410 53 None -17 11 Human 7.5 pEC50 = 7.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 20590599
3343 8410 53 None -17 11 Human 7.5 pEC50 = 7.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 20590599
557 8410 53 None -17 11 Human 7.5 pEC50 = 7.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 20590599
CHEMBL32800 8410 53 None -17 11 Human 7.5 pEC50 = 7.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 20590599
DB01288 8410 53 None -17 11 Human 7.5 pEC50 = 7.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 20590599
1028 7079 71 None -10 19 Human 7.6 pEC50 = 7.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 20590599
139148732 7079 71 None -10 19 Human 7.6 pEC50 = 7.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 20590599
479 7079 71 None -10 19 Human 7.6 pEC50 = 7.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 20590599
5816 7079 71 None -10 19 Human 7.6 pEC50 = 7.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 20590599
CHEMBL679 7079 71 None -10 19 Human 7.6 pEC50 = 7.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 20590599
DB00668 7079 71 None -10 19 Human 7.6 pEC50 = 7.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 20590599
5311064 8148 46 None 3 7 Human 7.7 pEC50 = 7.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 317 8 3 5 2.3 COc1cc(CCNC[C@@H](c2ccc(cc2)O)O)ccc1OC 20590599
534 8148 46 None 3 7 Human 7.7 pEC50 = 7.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 317 8 3 5 2.3 COc1cc(CCNC[C@@H](c2ccc(cc2)O)O)ccc1OC 20590599
806 8148 46 None 3 7 Human 7.7 pEC50 = 7.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 317 8 3 5 2.3 COc1cc(CCNC[C@@H](c2ccc(cc2)O)O)ccc1OC 20590599
CHEMBL493682 8148 46 None 3 7 Human 7.7 pEC50 = 7.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 317 8 3 5 2.3 COc1cc(CCNC[C@@H](c2ccc(cc2)O)O)ccc1OC 20590599
1960 9632 67 None -1 19 Human 7.9 pEC50 = 7.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 20590599
439260 9632 67 None -1 19 Human 7.9 pEC50 = 7.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 20590599
505 9632 67 None -1 19 Human 7.9 pEC50 = 7.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 20590599
CHEMBL1437 9632 67 None -1 19 Human 7.9 pEC50 = 7.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 20590599
DB00368 9632 67 None -1 19 Human 7.9 pEC50 = 7.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 20590599
1239 8458 55 None -67 5 Human 8.3 pEC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 20590599
3410 8458 55 None -67 5 Human 8.3 pEC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 20590599
3465 8458 55 None -67 5 Human 8.3 pEC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 20590599
CHEMBL1256786 8458 55 None -67 5 Human 8.3 pEC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 20590599
DB00983 8458 55 None -67 5 Human 8.3 pEC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 20590599
12578 7723 61 None 186 3 Human 8.4 pEC50 = 8.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 219 4 3 4 1.2 CC(C)NCC(C1=CC(=C(C=C1)N)C#N)O 20590599
2755 7723 61 None 186 3 Human 8.4 pEC50 = 8.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 219 4 3 4 1.2 CC(C)NCC(C1=CC(=C(C=C1)N)C#N)O 20590599
CHEMBL1374751 7723 61 None 186 3 Human 8.4 pEC50 = 8.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 219 4 3 4 1.2 CC(C)NCC(C1=CC(=C(C=C1)N)C#N)O 20590599
1499 8872 47 None -58 38 Human 8.6 pEC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 20590599
3779 8872 47 None -58 38 Human 8.6 pEC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 20590599
536 8872 47 None -58 38 Human 8.6 pEC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 20590599
CHEMBL434 8872 47 None -58 38 Human 8.6 pEC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 20590599
DB01064 8872 47 None -58 38 Human 8.6 pEC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 20590599
12582 7737 45 None -1 7 Human 9.2 pEC50 = 9.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O 20590599
2783 7737 45 None -1 7 Human 9.2 pEC50 = 9.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O 20590599
CHEMBL49080 7737 45 None -1 7 Human 9.2 pEC50 = 9.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O 20590599
DB01407 7737 45 None -1 7 Human 9.2 pEC50 = 9.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O 20590599
4382 9317 0 None -1698 6 Human 5.0 pEC50 > 5.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 396 9 4 6 2.8 O=C(Cc1csc(n1)N)Nc1ccc(cc1)CCNC[C@@H](c1ccccc1)O 17293563
4382 9317 0 None -1698 6 Human 5.0 pEC50 > 5.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 396 9 4 6 2.8 O=C(Cc1csc(n1)N)Nc1ccc(cc1)CCNC[C@@H](c1ccccc1)O 32813332
7445 9317 0 None -1698 6 Human 5.0 pEC50 > 5.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 396 9 4 6 2.8 O=C(Cc1csc(n1)N)Nc1ccc(cc1)CCNC[C@@H](c1ccccc1)O 17293563
7445 9317 0 None -1698 6 Human 5.0 pEC50 > 5.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 396 9 4 6 2.8 O=C(Cc1csc(n1)N)Nc1ccc(cc1)CCNC[C@@H](c1ccccc1)O 32813332
9865528 9317 0 None -1698 6 Human 5.0 pEC50 > 5.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 396 9 4 6 2.8 O=C(Cc1csc(n1)N)Nc1ccc(cc1)CCNC[C@@H](c1ccccc1)O 17293563
9865528 9317 0 None -1698 6 Human 5.0 pEC50 > 5.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 396 9 4 6 2.8 O=C(Cc1csc(n1)N)Nc1ccc(cc1)CCNC[C@@H](c1ccccc1)O 32813332
CHEMBL2095212 9317 0 None -1698 6 Human 5.0 pEC50 > 5.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 396 9 4 6 2.8 O=C(Cc1csc(n1)N)Nc1ccc(cc1)CCNC[C@@H](c1ccccc1)O 17293563
CHEMBL2095212 9317 0 None -1698 6 Human 5.0 pEC50 > 5.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 396 9 4 6 2.8 O=C(Cc1csc(n1)N)Nc1ccc(cc1)CCNC[C@@H](c1ccccc1)O 32813332
DB08893 9317 0 None -1698 6 Human 5.0 pEC50 > 5.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 396 9 4 6 2.8 O=C(Cc1csc(n1)N)Nc1ccc(cc1)CCNC[C@@H](c1ccccc1)O 17293563
DB08893 9317 0 None -1698 6 Human 5.0 pEC50 > 5.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 396 9 4 6 2.8 O=C(Cc1csc(n1)N)Nc1ccc(cc1)CCNC[C@@H](c1ccccc1)O 32813332
176 7186 66 None -4 40 Human 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 None
2157 7186 66 None -4 40 Human 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 None
2566 7186 66 None -4 40 Human 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 None
CHEMBL633 7186 66 None -4 40 Human 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 None
DB01118 7186 66 None -4 40 Human 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 None
1499 8872 47 None -269 38 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C None
3779 8872 47 None -269 38 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C None
536 8872 47 None -269 38 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C None
CHEMBL434 8872 47 None -269 38 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C None
DB01064 8872 47 None -269 38 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C None
319 8106 44 None -43 18 Human 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 None
321 8106 44 None -43 18 Human 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 None
444031 8106 44 None -43 18 Human 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 None
784 8106 44 None -43 18 Human 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 None
CHEMBL1346 8106 44 None -43 18 Human 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 None
DB00496 8106 44 None -43 18 Human 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 None




Ligands (move mouse cursor over ligand name to see structure) Receptor Assay information Chemical information
Sel. page Similar-
ity
Common
name
GPCRdb
ID
#Vendors

Reference
ligand
Fold
selectivity
# Tested
GPCRs
Species

p-value
(-log)
Activity
Type
Activity
Relation
Activity
Value
Assay
Type
Assay
Description
Source

Mol
weight
Rot
Bonds
H don

H acc

LogP

Smiles

DOI

9906822 168816 0 None - 0 Human 9.9 pEC50 = 9.9 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 358 7 3 3 4.1 COc1cccc2c(CC(C)NC[C@H](O)c3cccc(Cl)c3)c[nH]c12 10.1007/s00044-009-9257-x
CHEMBL416012 168816 0 None - 0 Human 9.9 pEC50 = 9.9 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 358 7 3 3 4.1 COc1cccc2c(CC(C)NC[C@H](O)c3cccc(Cl)c3)c[nH]c12 10.1007/s00044-009-9257-x
44396736 73642 0 None - 0 Human 8.9 pEC50 = 8.9 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 617 12 4 9 5.1 C[C@H](Cc1c[nH]c2c(OS(=O)(=O)c3cccs3)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1007/s00044-009-9257-x
CHEMBL186271 73642 0 None - 0 Human 8.9 pEC50 = 8.9 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 617 12 4 9 5.1 C[C@H](Cc1c[nH]c2c(OS(=O)(=O)c3cccs3)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1007/s00044-009-9257-x
44396715 74225 0 None - 0 Human 8.9 pEC50 = 8.9 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 612 12 4 9 4.4 C[C@H](Cc1c[nH]c2c(OS(=O)(=O)c3cccnc3)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1007/s00044-009-9257-x
CHEMBL189081 74225 0 None - 0 Human 8.9 pEC50 = 8.9 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 612 12 4 9 4.4 C[C@H](Cc1c[nH]c2c(OS(=O)(=O)c3cccnc3)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1007/s00044-009-9257-x
2303 9961 68 None -9 26 Human 8.7 pEC50 = 8.7 Binding
Displacement of [125I]cyanopindolol from human recombinant adrenergic beta-1 receptor expressed in Rex16 cellsDisplacement of [125I]cyanopindolol from human recombinant adrenergic beta-1 receptor expressed in Rex16 cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/np058114h
4946 9961 68 None -9 26 Human 8.7 pEC50 = 8.7 Binding
Displacement of [125I]cyanopindolol from human recombinant adrenergic beta-1 receptor expressed in Rex16 cellsDisplacement of [125I]cyanopindolol from human recombinant adrenergic beta-1 receptor expressed in Rex16 cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/np058114h
564 9961 68 None -9 26 Human 8.7 pEC50 = 8.7 Binding
Displacement of [125I]cyanopindolol from human recombinant adrenergic beta-1 receptor expressed in Rex16 cellsDisplacement of [125I]cyanopindolol from human recombinant adrenergic beta-1 receptor expressed in Rex16 cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/np058114h
63 9961 68 None -9 26 Human 8.7 pEC50 = 8.7 Binding
Displacement of [125I]cyanopindolol from human recombinant adrenergic beta-1 receptor expressed in Rex16 cellsDisplacement of [125I]cyanopindolol from human recombinant adrenergic beta-1 receptor expressed in Rex16 cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/np058114h
91536 9961 68 None -9 26 Human 8.7 pEC50 = 8.7 Binding
Displacement of [125I]cyanopindolol from human recombinant adrenergic beta-1 receptor expressed in Rex16 cellsDisplacement of [125I]cyanopindolol from human recombinant adrenergic beta-1 receptor expressed in Rex16 cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/np058114h
CHEMBL27 9961 68 None -9 26 Human 8.7 pEC50 = 8.7 Binding
Displacement of [125I]cyanopindolol from human recombinant adrenergic beta-1 receptor expressed in Rex16 cellsDisplacement of [125I]cyanopindolol from human recombinant adrenergic beta-1 receptor expressed in Rex16 cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/np058114h
CHEMBL452861 9961 68 None -9 26 Human 8.7 pEC50 = 8.7 Binding
Displacement of [125I]cyanopindolol from human recombinant adrenergic beta-1 receptor expressed in Rex16 cellsDisplacement of [125I]cyanopindolol from human recombinant adrenergic beta-1 receptor expressed in Rex16 cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/np058114h
DB00571 9961 68 None -9 26 Human 8.7 pEC50 = 8.7 Binding
Displacement of [125I]cyanopindolol from human recombinant adrenergic beta-1 receptor expressed in Rex16 cellsDisplacement of [125I]cyanopindolol from human recombinant adrenergic beta-1 receptor expressed in Rex16 cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/np058114h
9927453 103462 0 None - 0 Human 8.7 pEC50 = 8.7 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 328 6 3 2 4.1 C[C@H](Cc1c[nH]c2ccccc12)NC[C@H](O)c1cccc(Cl)c1 10.1007/s00044-009-9257-x
CHEMBL26393 103462 0 None - 0 Human 8.7 pEC50 = 8.7 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 328 6 3 2 4.1 C[C@H](Cc1c[nH]c2ccccc12)NC[C@H](O)c1cccc(Cl)c1 10.1007/s00044-009-9257-x
44392457 172736 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 457 11 4 6 3.7 C/C=C/CNc1cccc([C@@H](O)CN[C@H](C)Cc2c[nH]c3c(OS(C)(=O)=O)cccc23)c1 10.1007/s00044-009-9257-x
CHEMBL425161 172736 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 457 11 4 6 3.7 C/C=C/CNc1cccc([C@@H](O)CN[C@H](C)Cc2c[nH]c3c(OS(C)(=O)=O)cccc23)c1 10.1007/s00044-009-9257-x
44328703 17001 0 None - 2 Human 6.0 pEC50 = 6 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK2 and coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK2 and coelenterazine 400a by BRET assay
ChEMBL 241 6 4 5 0.8 CC(C)NC[C@H](O)COc1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
CHEMBL1160694 17001 0 None - 2 Human 6.0 pEC50 = 6 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK2 and coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK2 and coelenterazine 400a by BRET assay
ChEMBL 241 6 4 5 0.8 CC(C)NC[C@H](O)COc1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
10347461 113057 0 None - 0 Human 6.0 pEC50 = 6 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 547 18 4 7 4.8 O=S(=O)(c1ccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc1)C1CCCC1 10.1021/jm401532g
CHEMBL3126384 113057 0 None - 0 Human 6.0 pEC50 = 6 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 547 18 4 7 4.8 O=S(=O)(c1ccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc1)C1CCCC1 10.1021/jm401532g
CHEMBL3139025 113057 0 None - 0 Human 6.0 pEC50 = 6 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 547 18 4 7 4.8 O=S(=O)(c1ccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc1)C1CCCC1 10.1021/jm401532g
146025803 182956 0 None - 2 Human 5.0 pEC50 = 5 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of coelenterazine 400a by BRET assay
ChEMBL 467 14 4 7 3.7 COc1cc(CCNC[C@H](O)COc2ccc(O)c(O)c2)ccc1OCCCc1ccccc1 10.1021/acs.jmedchem.9b00349
CHEMBL4593181 182956 0 None - 2 Human 5.0 pEC50 = 5 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of coelenterazine 400a by BRET assay
ChEMBL 467 14 4 7 3.7 COc1cc(CCNC[C@H](O)COc2ccc(O)c(O)c2)ccc1OCCCc1ccccc1 10.1021/acs.jmedchem.9b00349
76333795 92090 0 None - 0 Human 7.9 pEC50 = 7.9 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 558 11 5 8 3.1 C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccc(N)c2)c1 10.1007/s00044-009-9257-x
CHEMBL2260985 92090 0 None - 0 Human 7.9 pEC50 = 7.9 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 558 11 5 8 3.1 C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccc(N)c2)c1 10.1007/s00044-009-9257-x
10482960 113166 0 None - 0 Human 6.8 pEC50 = 6.8 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 561 18 4 7 5.1 Cc1cc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc(S(=O)(=O)C2CCCC2)c1 10.1021/jm401532g
CHEMBL3126383 113166 0 None - 0 Human 6.8 pEC50 = 6.8 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 561 18 4 7 5.1 Cc1cc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc(S(=O)(=O)C2CCCC2)c1 10.1021/jm401532g
CHEMBL3139365 113166 0 None - 0 Human 6.8 pEC50 = 6.8 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 561 18 4 7 5.1 Cc1cc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc(S(=O)(=O)C2CCCC2)c1 10.1021/jm401532g
567 7512 16 None -13 5 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 363 9 3 4 3.1 C[C@H](Cc1ccc(cc1)OCC(=O)O)NC[C@@H](c1cccc(c1)Cl)O 10.1007/s00044-009-9257-x
9841972 7512 16 None -13 5 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 363 9 3 4 3.1 C[C@H](Cc1ccc(cc1)OCC(=O)O)NC[C@@H](c1cccc(c1)Cl)O 10.1007/s00044-009-9257-x
CHEMBL284782 7512 16 None -13 5 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 363 9 3 4 3.1 C[C@H](Cc1ccc(cc1)OCC(=O)O)NC[C@@H](c1cccc(c1)Cl)O 10.1007/s00044-009-9257-x
65772 67177 8 None -4 6 Guinea pig 6.8 pEC50 = 6.8 Binding
Inhibitory activity against Beta-1 adrenergic receptor in guinea pig atria after treatment with the compoundInhibitory activity against Beta-1 adrenergic receptor in guinea pig atria after treatment with the compound
ChEMBL 345 5 3 6 2.6 COc1cc(C[C@@H]2NCCc3cc(O)c(O)cc32)cc(OC)c1OC 10.1021/jm00081a007
CHEMBL174984 67177 8 None -4 6 Guinea pig 6.8 pEC50 = 6.8 Binding
Inhibitory activity against Beta-1 adrenergic receptor in guinea pig atria after treatment with the compoundInhibitory activity against Beta-1 adrenergic receptor in guinea pig atria after treatment with the compound
ChEMBL 345 5 3 6 2.6 COc1cc(C[C@@H]2NCCc3cc(O)c(O)cc32)cc(OC)c1OC 10.1021/jm00081a007
11432806 72971 0 None -16 3 Human 7.8 pEC50 = 7.8 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 549 11 4 8 3.6 C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1007/s00044-009-9257-x
CHEMBL184407 72971 0 None -16 3 Human 7.8 pEC50 = 7.8 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 549 11 4 8 3.6 C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1007/s00044-009-9257-x
44396568 74060 0 None -28 3 Human 7.7 pEC50 = 7.7 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 529 12 5 7 3.7 C[C@H](Cc1c[nH]c2c(OCC(=O)O)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1007/s00044-009-9257-x
CHEMBL188196 74060 0 None -28 3 Human 7.7 pEC50 = 7.7 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 529 12 5 7 3.7 C[C@H](Cc1c[nH]c2c(OCC(=O)O)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1007/s00044-009-9257-x
76315638 92091 0 None - 0 Human 7.7 pEC50 = 7.7 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 543 11 4 7 3.6 C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1ccc(S(=O)(=O)Nc2ccccc2)cc1 10.1007/s00044-009-9257-x
CHEMBL2260986 92091 0 None - 0 Human 7.7 pEC50 = 7.7 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 543 11 4 7 3.6 C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1ccc(S(=O)(=O)Nc2ccccc2)cc1 10.1007/s00044-009-9257-x
2419 10236 84 None -154 6 Human 6.7 pEC50 = 6.7 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK5 and coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK5 and coelenterazine 400a by BRET assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/acs.jmedchem.9b00349
5152 10236 84 None -154 6 Human 6.7 pEC50 = 6.7 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK5 and coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK5 and coelenterazine 400a by BRET assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/acs.jmedchem.9b00349
559 10236 84 None -154 6 Human 6.7 pEC50 = 6.7 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK5 and coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK5 and coelenterazine 400a by BRET assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/acs.jmedchem.9b00349
CHEMBL1263 10236 84 None -154 6 Human 6.7 pEC50 = 6.7 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK5 and coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK5 and coelenterazine 400a by BRET assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/acs.jmedchem.9b00349
DB00938 10236 84 None -154 6 Human 6.7 pEC50 = 6.7 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK5 and coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK5 and coelenterazine 400a by BRET assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/acs.jmedchem.9b00349
127046950 146823 0 None - 6 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assay
ChEMBL 437 12 4 6 4.0 COc1cc(CCNC[C@H](O)c2ccc(O)c(O)c2)ccc1OCCCc1ccccc1 10.1021/acs.jmedchem.9b00349
CHEMBL3800303 146823 0 None - 6 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assay
ChEMBL 437 12 4 6 4.0 COc1cc(CCNC[C@H](O)c2ccc(O)c(O)c2)ccc1OCCCc1ccccc1 10.1021/acs.jmedchem.9b00349
11318107 113165 0 None - 0 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 505 16 4 7 3.4 O=S1(=O)CCc2ccc(CCCCOCCCCCCNC[C@H](O)c3ccc(O)c(CO)c3)cc21 10.1021/jm401532g
CHEMBL3126386 113165 0 None - 0 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 505 16 4 7 3.4 O=S1(=O)CCc2ccc(CCCCOCCCCCCNC[C@H](O)c3ccc(O)c(CO)c3)cc21 10.1021/jm401532g
CHEMBL3139364 113165 0 None - 0 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 505 16 4 7 3.4 O=S1(=O)CCc2ccc(CCCCOCCCCCCNC[C@H](O)c3ccc(O)c(CO)c3)cc21 10.1021/jm401532g
11318358 113209 0 None - 0 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 519 16 4 7 3.8 O=S1(=O)CCCc2ccc(CCCCOCCCCCCNC[C@H](O)c3ccc(O)c(CO)c3)cc21 10.1021/jm401532g
CHEMBL3126387 113209 0 None - 0 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 519 16 4 7 3.8 O=S1(=O)CCCc2ccc(CCCCOCCCCCCNC[C@H](O)c3ccc(O)c(CO)c3)cc21 10.1021/jm401532g
CHEMBL3139613 113209 0 None - 0 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 519 16 4 7 3.8 O=S1(=O)CCCc2ccc(CCCCOCCCCCCNC[C@H](O)c3ccc(O)c(CO)c3)cc21 10.1021/jm401532g
10393774 127521 0 None - 0 Human 5.7 pEC50 = 5.7 Binding
In vitro activity to increase cAMP levels in Chinese hamster ovary (CHO) cells expressing the cloned human beta 1 Adrenergic receptorIn vitro activity to increase cAMP levels in Chinese hamster ovary (CHO) cells expressing the cloned human beta 1 Adrenergic receptor
ChEMBL 598 14 5 9 2.1 CCCCN(c1ccc(N2CCC(NC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)CC2)cc1)S(=O)(=O)CC(=O)O 10.1021/jm000544b
CHEMBL35500 127521 0 None - 0 Human 5.7 pEC50 = 5.7 Binding
In vitro activity to increase cAMP levels in Chinese hamster ovary (CHO) cells expressing the cloned human beta 1 Adrenergic receptorIn vitro activity to increase cAMP levels in Chinese hamster ovary (CHO) cells expressing the cloned human beta 1 Adrenergic receptor
ChEMBL 598 14 5 9 2.1 CCCCN(c1ccc(N2CCC(NC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)CC2)cc1)S(=O)(=O)CC(=O)O 10.1021/jm000544b
44396532 73530 0 None -3 3 Human 7.7 pEC50 = 7.7 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 455 9 4 5 4.3 C[C@H](Cc1c[nH]c2ccccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1007/s00044-009-9257-x
CHEMBL185836 73530 0 None -3 3 Human 7.7 pEC50 = 7.7 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 455 9 4 5 4.3 C[C@H](Cc1c[nH]c2ccccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1007/s00044-009-9257-x
164612037 192156 0 None -1 20 Human 4.7 pEC50 = 4.7 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]CGP12177 from human beta-1 adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 326 8 4 4 1.8 CCCCCNC(=O)/N=C(\N)NCCCc1sc(N)nc1C 10.1021/acs.jmedchem.1c00692
CHEMBL4860528 192156 0 None -1 20 Human 4.7 pEC50 = 4.7 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]CGP12177 from human beta-1 adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 326 8 4 4 1.8 CCCCCNC(=O)/N=C(\N)NCCCc1sc(N)nc1C 10.1021/acs.jmedchem.1c00692
76315640 92093 0 None - 0 Human 7.7 pEC50 = 7.7 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 575 12 3 7 5.8 COc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)cn(Cc3ccccc3)c12 10.1007/s00044-009-9257-x
CHEMBL2260988 92093 0 None - 0 Human 7.7 pEC50 = 7.7 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 575 12 3 7 5.8 COc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)cn(Cc3ccccc3)c12 10.1007/s00044-009-9257-x
13720716 69827 0 None -1 2 Guinea pig 6.6 pEC50 = 6.6 Binding
Inhibitory activity against Beta-1 adrenergic receptor in guinea pig atriaInhibitory activity against Beta-1 adrenergic receptor in guinea pig atria
ChEMBL 363 5 3 6 2.7 COc1cc(C[C@@H]2NCCc3cc(O)c(O)c(F)c32)cc(OC)c1OC 10.1021/jm00081a007
CHEMBL1788251 69827 0 None -1 2 Guinea pig 6.6 pEC50 = 6.6 Binding
Inhibitory activity against Beta-1 adrenergic receptor in guinea pig atriaInhibitory activity against Beta-1 adrenergic receptor in guinea pig atria
ChEMBL 363 5 3 6 2.7 COc1cc(C[C@@H]2NCCc3cc(O)c(O)c(F)c32)cc(OC)c1OC 10.1021/jm00081a007
443372 17006 26 None - 3 Human 7.6 pEC50 = 7.6 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assay
ChEMBL 211 4 4 4 1.1 CC(C)NC[C@H](O)c1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
CHEMBL1160723 17006 26 None - 3 Human 7.6 pEC50 = 7.6 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assay
ChEMBL 211 4 4 4 1.1 CC(C)NC[C@H](O)c1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
CHEMBL2062275 17006 26 None - 3 Human 7.6 pEC50 = 7.6 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assay
ChEMBL 211 4 4 4 1.1 CC(C)NC[C@H](O)c1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
10370605 113210 0 None - 0 Human 6.6 pEC50 = 6.6 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 561 18 4 7 5.2 O=S(=O)(c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1)C1CCCCC1 10.1021/jm401532g
CHEMBL3126385 113210 0 None - 0 Human 6.6 pEC50 = 6.6 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 561 18 4 7 5.2 O=S(=O)(c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1)C1CCCCC1 10.1021/jm401532g
CHEMBL3139615 113210 0 None - 0 Human 6.6 pEC50 = 6.6 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 561 18 4 7 5.2 O=S(=O)(c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1)C1CCCCC1 10.1021/jm401532g
146025803 182956 0 None - 2 Human 5.6 pEC50 = 5.6 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK2 and coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK2 and coelenterazine 400a by BRET assay
ChEMBL 467 14 4 7 3.7 COc1cc(CCNC[C@H](O)COc2ccc(O)c(O)c2)ccc1OCCCc1ccccc1 10.1021/acs.jmedchem.9b00349
CHEMBL4593181 182956 0 None - 2 Human 5.6 pEC50 = 5.6 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK2 and coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK2 and coelenterazine 400a by BRET assay
ChEMBL 467 14 4 7 3.7 COc1cc(CCNC[C@H](O)COc2ccc(O)c(O)c2)ccc1OCCCc1ccccc1 10.1021/acs.jmedchem.9b00349
146025803 182956 0 None - 2 Human 5.6 pEC50 = 5.6 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assay
ChEMBL 467 14 4 7 3.7 COc1cc(CCNC[C@H](O)COc2ccc(O)c(O)c2)ccc1OCCCc1ccccc1 10.1021/acs.jmedchem.9b00349
CHEMBL4593181 182956 0 None - 2 Human 5.6 pEC50 = 5.6 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assay
ChEMBL 467 14 4 7 3.7 COc1cc(CCNC[C@H](O)COc2ccc(O)c(O)c2)ccc1OCCCc1ccccc1 10.1021/acs.jmedchem.9b00349
15133335 42070 0 None - 0 Guinea pig 5.6 pEC50 = 5.6 Binding
Inhibitory activity against Beta-1 adrenergic receptor in guinea pig atria after treatment with the compoundInhibitory activity against Beta-1 adrenergic receptor in guinea pig atria after treatment with the compound
ChEMBL 413 5 3 6 3.6 COc1cc(CC2NCCc3c2cc(O)c(O)c3C(F)(F)F)cc(OC)c1OC 10.1021/jm00081a007
CHEMBL143645 42070 0 None - 0 Guinea pig 5.6 pEC50 = 5.6 Binding
Inhibitory activity against Beta-1 adrenergic receptor in guinea pig atria after treatment with the compoundInhibitory activity against Beta-1 adrenergic receptor in guinea pig atria after treatment with the compound
ChEMBL 413 5 3 6 3.6 COc1cc(CC2NCCc3c2cc(O)c(O)c3C(F)(F)F)cc(OC)c1OC 10.1021/jm00081a007
15133334 125363 0 None - 0 Guinea pig 5.5 pEC50 = 5.5 Binding
Inhibitory activity against Beta-1 adrenergic receptor in guinea pig atria after treatment with the compoundInhibitory activity against Beta-1 adrenergic receptor in guinea pig atria after treatment with the compound
ChEMBL 471 5 3 6 3.2 COc1cc(CC2NCCc3cc(O)c(O)c(I)c32)cc(OC)c1OC 10.1021/jm00081a007
CHEMBL341654 125363 0 None - 0 Guinea pig 5.5 pEC50 = 5.5 Binding
Inhibitory activity against Beta-1 adrenergic receptor in guinea pig atria after treatment with the compoundInhibitory activity against Beta-1 adrenergic receptor in guinea pig atria after treatment with the compound
ChEMBL 471 5 3 6 3.2 COc1cc(CC2NCCc3cc(O)c(O)c(I)c32)cc(OC)c1OC 10.1021/jm00081a007
44583033 192309 0 None - 0 Human 8.5 pEC50 = 8.5 Binding
Binding affinity to beta-1 adrenoceptorBinding affinity to beta-1 adrenoceptor
ChEMBL 385 9 4 5 2.2 COc1ccc(CC(C)(C)NC[C@H](O)COc2cccc3[nH]c(=O)[nH]c23)cc1 10.1021/jm900364m
CHEMBL486278 192309 0 None - 0 Human 8.5 pEC50 = 8.5 Binding
Binding affinity to beta-1 adrenoceptorBinding affinity to beta-1 adrenoceptor
ChEMBL 385 9 4 5 2.2 COc1ccc(CC(C)(C)NC[C@H](O)COc2cccc3[nH]c(=O)[nH]c23)cc1 10.1021/jm900364m
44396779 73835 0 None - 0 Human 8.5 pEC50 = 8.5 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 611 12 4 8 5.1 C[C@H](Cc1c[nH]c2c(OS(=O)(=O)c3ccccc3)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1007/s00044-009-9257-x
CHEMBL187209 73835 0 None - 0 Human 8.5 pEC50 = 8.5 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 611 12 4 8 5.1 C[C@H](Cc1c[nH]c2c(OS(=O)(=O)c3ccccc3)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1007/s00044-009-9257-x
146025802 176357 0 None - 2 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assay
ChEMBL 349 10 4 7 1.5 COc1ccccc1OCCNC[C@H](O)COc1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
CHEMBL4435895 176357 0 None - 2 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assay
ChEMBL 349 10 4 7 1.5 COc1ccccc1OCCNC[C@H](O)COc1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
44328703 17001 0 None - 2 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK5 and coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK5 and coelenterazine 400a by BRET assay
ChEMBL 241 6 4 5 0.8 CC(C)NC[C@H](O)COc1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
CHEMBL1160694 17001 0 None - 2 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK5 and coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK5 and coelenterazine 400a by BRET assay
ChEMBL 241 6 4 5 0.8 CC(C)NC[C@H](O)COc1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
146025802 176357 0 None - 2 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of coelenterazine 400a by BRET assay
ChEMBL 349 10 4 7 1.5 COc1ccccc1OCCNC[C@H](O)COc1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
CHEMBL4435895 176357 0 None - 2 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of coelenterazine 400a by BRET assay
ChEMBL 349 10 4 7 1.5 COc1ccccc1OCCNC[C@H](O)COc1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
3931 9028 48 None -3 2 Human 6.5 pEC50 = 6.5 Binding
In vitro activity to increase cAMP levels in Chinese hamster ovary (CHO) cells expressing the cloned human beta 1 Adrenergic receptorIn vitro activity to increase cAMP levels in Chinese hamster ovary (CHO) cells expressing the cloned human beta 1 Adrenergic receptor
ChEMBL 584 17 6 7 4.5 CCCCCCNC(=O)Nc1ccc(cc1)S(=O)(=O)Nc1ccc(cc1)CCNC[C@@H](COc1ccc(cc1)O)O 10.1021/jm000544b
9829836 9028 48 None -3 2 Human 6.5 pEC50 = 6.5 Binding
In vitro activity to increase cAMP levels in Chinese hamster ovary (CHO) cells expressing the cloned human beta 1 Adrenergic receptorIn vitro activity to increase cAMP levels in Chinese hamster ovary (CHO) cells expressing the cloned human beta 1 Adrenergic receptor
ChEMBL 584 17 6 7 4.5 CCCCCCNC(=O)Nc1ccc(cc1)S(=O)(=O)Nc1ccc(cc1)CCNC[C@@H](COc1ccc(cc1)O)O 10.1021/jm000544b
CHEMBL12998 9028 48 None -3 2 Human 6.5 pEC50 = 6.5 Binding
In vitro activity to increase cAMP levels in Chinese hamster ovary (CHO) cells expressing the cloned human beta 1 Adrenergic receptorIn vitro activity to increase cAMP levels in Chinese hamster ovary (CHO) cells expressing the cloned human beta 1 Adrenergic receptor
ChEMBL 584 17 6 7 4.5 CCCCCCNC(=O)Nc1ccc(cc1)S(=O)(=O)Nc1ccc(cc1)CCNC[C@@H](COc1ccc(cc1)O)O 10.1021/jm000544b
44392558 72029 0 None - 0 Human 7.4 pEC50 = 7.4 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 471 11 4 6 4.1 CC(C)=CCNc1cccc([C@@H](O)CN[C@H](C)Cc2c[nH]c3c(OS(C)(=O)=O)cccc23)c1 10.1007/s00044-009-9257-x
CHEMBL182770 72029 0 None - 0 Human 7.4 pEC50 = 7.4 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 471 11 4 6 4.1 CC(C)=CCNc1cccc([C@@H](O)CN[C@H](C)Cc2c[nH]c3c(OS(C)(=O)=O)cccc23)c1 10.1007/s00044-009-9257-x
11962616 7009 14 None - 0 Human 7.4 pEC50 = 7.4 Binding
Inhibition of 3H]CGP12177 binding to human beta1 adrenoceptor expressed in sf9 cell membranes incubated for 60 mins by scintillation counting methodInhibition of 3H]CGP12177 binding to human beta1 adrenoceptor expressed in sf9 cell membranes incubated for 60 mins by scintillation counting method
ChEMBL 460 13 4 5 4.2 O=c1ccc2c([nH]1)c(O)ccc2[C@H](CNCCCCCCOCC(c1ccccc1)(F)F)O 10.1021/acs.jmedchem.0c01195
9326 7009 14 None - 0 Human 7.4 pEC50 = 7.4 Binding
Inhibition of 3H]CGP12177 binding to human beta1 adrenoceptor expressed in sf9 cell membranes incubated for 60 mins by scintillation counting methodInhibition of 3H]CGP12177 binding to human beta1 adrenoceptor expressed in sf9 cell membranes incubated for 60 mins by scintillation counting method
ChEMBL 460 13 4 5 4.2 O=c1ccc2c([nH]1)c(O)ccc2[C@H](CNCCCCCCOCC(c1ccccc1)(F)F)O 10.1021/acs.jmedchem.0c01195
CHEMBL3039530 7009 14 None - 0 Human 7.4 pEC50 = 7.4 Binding
Inhibition of 3H]CGP12177 binding to human beta1 adrenoceptor expressed in sf9 cell membranes incubated for 60 mins by scintillation counting methodInhibition of 3H]CGP12177 binding to human beta1 adrenoceptor expressed in sf9 cell membranes incubated for 60 mins by scintillation counting method
ChEMBL 460 13 4 5 4.2 O=c1ccc2c([nH]1)c(O)ccc2[C@H](CNCCCCCCOCC(c1ccccc1)(F)F)O 10.1021/acs.jmedchem.0c01195
DB12100 7009 14 None - 0 Human 7.4 pEC50 = 7.4 Binding
Inhibition of 3H]CGP12177 binding to human beta1 adrenoceptor expressed in sf9 cell membranes incubated for 60 mins by scintillation counting methodInhibition of 3H]CGP12177 binding to human beta1 adrenoceptor expressed in sf9 cell membranes incubated for 60 mins by scintillation counting method
ChEMBL 460 13 4 5 4.2 O=c1ccc2c([nH]1)c(O)ccc2[C@H](CNCCCCCCOCC(c1ccccc1)(F)F)O 10.1021/acs.jmedchem.0c01195
127045855 146442 0 None - 6 Human 7.4 pEC50 = 7.4 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assay
ChEMBL 319 8 4 6 1.8 COc1ccccc1OCCNC[C@H](O)c1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
CHEMBL3797876 146442 0 None - 6 Human 7.4 pEC50 = 7.4 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assay
ChEMBL 319 8 4 6 1.8 COc1ccccc1OCCNC[C@H](O)c1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
3083544 33582 51 None -5 5 Human 7.4 pEC50 = 7.4 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1021/jm401532g
CHEMBL1200811 33582 51 None -5 5 Human 7.4 pEC50 = 7.4 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1021/jm401532g
CHEMBL1363 33582 51 None -5 5 Human 7.4 pEC50 = 7.4 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1021/jm401532g
CHEMBL1951071 33582 51 None -5 5 Human 7.4 pEC50 = 7.4 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1021/jm401532g
CHEMBL605993 33582 51 None -5 5 Human 7.4 pEC50 = 7.4 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1021/jm401532g
146025802 176357 0 None - 2 Human 6.4 pEC50 = 6.4 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK2 and coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK2 and coelenterazine 400a by BRET assay
ChEMBL 349 10 4 7 1.5 COc1ccccc1OCCNC[C@H](O)COc1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
CHEMBL4435895 176357 0 None - 2 Human 6.4 pEC50 = 6.4 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK2 and coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK2 and coelenterazine 400a by BRET assay
ChEMBL 349 10 4 7 1.5 COc1ccccc1OCCNC[C@H](O)COc1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
146025802 176357 0 None - 2 Human 6.4 pEC50 = 6.4 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK5 and coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK5 and coelenterazine 400a by BRET assay
ChEMBL 349 10 4 7 1.5 COc1ccccc1OCCNC[C@H](O)COc1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
CHEMBL4435895 176357 0 None - 2 Human 6.4 pEC50 = 6.4 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK5 and coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK5 and coelenterazine 400a by BRET assay
ChEMBL 349 10 4 7 1.5 COc1ccccc1OCCNC[C@H](O)COc1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
10184665 10763 51 None - 0 Human 6.4 pEC50 = 6.4 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 485 16 4 6 4.6 OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O 10.1021/jm401532g
4799 10763 51 None - 0 Human 6.4 pEC50 = 6.4 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 485 16 4 6 4.6 OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O 10.1021/jm401532g
7353 10763 51 None - 0 Human 6.4 pEC50 = 6.4 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 485 16 4 6 4.6 OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O 10.1021/jm401532g
CHEMBL1198857 10763 51 None - 0 Human 6.4 pEC50 = 6.4 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 485 16 4 6 4.6 OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O 10.1021/jm401532g
DB09082 10763 51 None - 0 Human 6.4 pEC50 = 6.4 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 485 16 4 6 4.6 OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O 10.1021/jm401532g
9917962 174735 0 None - 0 Human 7.4 pEC50 = 7.4 Binding
Binding affinity towards human Beta-1 adrenergic receptorBinding affinity towards human Beta-1 adrenergic receptor
ChEMBL 684 11 4 9 6.8 N#CN/C(=N\c1ccc2c(c1)CCN2c1nc(-c2ccc(OC(F)(F)F)cc2)cs1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/s0960-894x(00)00669-7
CHEMBL431678 174735 0 None - 0 Human 7.4 pEC50 = 7.4 Binding
Binding affinity towards human Beta-1 adrenergic receptorBinding affinity towards human Beta-1 adrenergic receptor
ChEMBL 684 11 4 9 6.8 N#CN/C(=N\c1ccc2c(c1)CCN2c1nc(-c2ccc(OC(F)(F)F)cc2)cs1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/s0960-894x(00)00669-7
443372 17006 26 None - 3 Human 7.4 pEC50 = 7.4 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK5 and coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK5 and coelenterazine 400a by BRET assay
ChEMBL 211 4 4 4 1.1 CC(C)NC[C@H](O)c1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
CHEMBL1160723 17006 26 None - 3 Human 7.4 pEC50 = 7.4 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK5 and coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK5 and coelenterazine 400a by BRET assay
ChEMBL 211 4 4 4 1.1 CC(C)NC[C@H](O)c1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
CHEMBL2062275 17006 26 None - 3 Human 7.4 pEC50 = 7.4 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK5 and coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK5 and coelenterazine 400a by BRET assay
ChEMBL 211 4 4 4 1.1 CC(C)NC[C@H](O)c1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
76322965 92094 0 None - 0 Human 7.4 pEC50 = 7.4 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 511 9 3 7 4.5 C[C@H](Cc1cn2c3c(cccc13)OCCC2)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1007/s00044-009-9257-x
CHEMBL2260989 92094 0 None - 0 Human 7.4 pEC50 = 7.4 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 511 9 3 7 4.5 C[C@H](Cc1cn2c3c(cccc13)OCCC2)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1007/s00044-009-9257-x
11270071 105766 0 None - 0 Human 7.3 pEC50 = 7.3 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 328 6 3 2 4.1 C[C@H](Cc1c[nH]c2ccccc12)NC[C@@H](O)c1cccc(Cl)c1 10.1007/s00044-009-9257-x
CHEMBL279931 105766 0 None - 0 Human 7.3 pEC50 = 7.3 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 328 6 3 2 4.1 C[C@H](Cc1c[nH]c2ccccc12)NC[C@@H](O)c1cccc(Cl)c1 10.1007/s00044-009-9257-x
9803765 106423 0 None - 0 Human 4.3 pEC50 = 4.3 Binding
In vitro activity to increase cAMP levels in Chinese hamster ovary (CHO) cells expressing the cloned human beta 1 Adrenergic receptorIn vitro activity to increase cAMP levels in Chinese hamster ovary (CHO) cells expressing the cloned human beta 1 Adrenergic receptor
ChEMBL 449 8 5 7 1.8 CS(=O)(=O)Nc1cc([C@@H](O)CNC2CCN(c3ccc(C(=O)O)cc3)CC2)ccc1O 10.1021/jm000544b
CHEMBL284311 106423 0 None - 0 Human 4.3 pEC50 = 4.3 Binding
In vitro activity to increase cAMP levels in Chinese hamster ovary (CHO) cells expressing the cloned human beta 1 Adrenergic receptorIn vitro activity to increase cAMP levels in Chinese hamster ovary (CHO) cells expressing the cloned human beta 1 Adrenergic receptor
ChEMBL 449 8 5 7 1.8 CS(=O)(=O)Nc1cc([C@@H](O)CNC2CCN(c3ccc(C(=O)O)cc3)CC2)ccc1O 10.1021/jm000544b
168290235 199747 0 None -5 20 Human 4.3 pEC50 = 4.3 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]CGP12177 from human beta-1 adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 315 6 4 3 1.1 C[C@@H](NC(=O)/N=C(\N)NCCCc1ncn[nH]1)c1ccccc1 10.1021/acs.jmedchem.1c00692
CHEMBL5201074 199747 0 None -5 20 Human 4.3 pEC50 = 4.3 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]CGP12177 from human beta-1 adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 315 6 4 3 1.1 C[C@@H](NC(=O)/N=C(\N)NCCCc1ncn[nH]1)c1ccccc1 10.1021/acs.jmedchem.1c00692
CHEMBL5222491 199747 0 None -5 20 Human 4.3 pEC50 = 4.3 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]CGP12177 from human beta-1 adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 315 6 4 3 1.1 C[C@@H](NC(=O)/N=C(\N)NCCCc1ncn[nH]1)c1ccccc1 10.1021/acs.jmedchem.1c00692
44396531 73609 0 None - 0 Human 8.3 pEC50 = 8.3 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 647 18 4 8 6.4 CCCCCCCCS(=O)(=O)Oc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)c[nH]c12 10.1007/s00044-009-9257-x
CHEMBL186135 73609 0 None - 0 Human 8.3 pEC50 = 8.3 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 647 18 4 8 6.4 CCCCCCCCS(=O)(=O)Oc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)c[nH]c12 10.1007/s00044-009-9257-x
443372 17006 26 None - 3 Human 7.3 pEC50 = 7.3 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK2 and coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK2 and coelenterazine 400a by BRET assay
ChEMBL 211 4 4 4 1.1 CC(C)NC[C@H](O)c1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
CHEMBL1160723 17006 26 None - 3 Human 7.3 pEC50 = 7.3 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK2 and coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK2 and coelenterazine 400a by BRET assay
ChEMBL 211 4 4 4 1.1 CC(C)NC[C@H](O)c1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
CHEMBL2062275 17006 26 None - 3 Human 7.3 pEC50 = 7.3 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK2 and coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK2 and coelenterazine 400a by BRET assay
ChEMBL 211 4 4 4 1.1 CC(C)NC[C@H](O)c1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
127046950 146823 0 None - 6 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK5 and coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK5 and coelenterazine 400a by BRET assay
ChEMBL 437 12 4 6 4.0 COc1cc(CCNC[C@H](O)c2ccc(O)c(O)c2)ccc1OCCCc1ccccc1 10.1021/acs.jmedchem.9b00349
CHEMBL3800303 146823 0 None - 6 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK5 and coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK5 and coelenterazine 400a by BRET assay
ChEMBL 437 12 4 6 4.0 COc1cc(CCNC[C@H](O)c2ccc(O)c(O)c2)ccc1OCCCc1ccccc1 10.1021/acs.jmedchem.9b00349
10053159 113058 0 None - 0 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 545 18 4 7 4.6 O=S(=O)(c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1)C1CC=CC1 10.1021/jm401532g
CHEMBL3124955 113058 0 None - 0 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 545 18 4 7 4.6 O=S(=O)(c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1)C1CC=CC1 10.1021/jm401532g
CHEMBL3139033 113058 0 None - 0 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 545 18 4 7 4.6 O=S(=O)(c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1)C1CC=CC1 10.1021/jm401532g
10076176 113212 0 None - 0 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 547 18 4 7 4.8 O=S(=O)(c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1)C1CCCC1 10.1021/jm401532g
CHEMBL3126382 113212 0 None - 0 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 547 18 4 7 4.8 O=S(=O)(c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1)C1CCCC1 10.1021/jm401532g
CHEMBL3139683 113212 0 None - 0 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 547 18 4 7 4.8 O=S(=O)(c1cccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)c1)C1CCCC1 10.1021/jm401532g
10339796 128459 0 None - 0 Guinea pig 6.3 pEC50 = 6.3 Binding
Inhibitory activity against Beta-1 adrenergic receptor in guinea pig atria after treatment with the compoundInhibitory activity against Beta-1 adrenergic receptor in guinea pig atria after treatment with the compound
ChEMBL 381 5 3 6 2.8 COc1cc(CC2NCCc3c(F)c(O)c(O)c(F)c32)cc(OC)c1OC 10.1021/jm00081a007
CHEMBL358648 128459 0 None - 0 Guinea pig 6.3 pEC50 = 6.3 Binding
Inhibitory activity against Beta-1 adrenergic receptor in guinea pig atria after treatment with the compoundInhibitory activity against Beta-1 adrenergic receptor in guinea pig atria after treatment with the compound
ChEMBL 381 5 3 6 2.8 COc1cc(CC2NCCc3c(F)c(O)c(O)c(F)c32)cc(OC)c1OC 10.1021/jm00081a007
2419 10236 84 None -154 6 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/acs.jmedchem.9b00349
5152 10236 84 None -154 6 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/acs.jmedchem.9b00349
559 10236 84 None -154 6 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/acs.jmedchem.9b00349
CHEMBL1263 10236 84 None -154 6 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/acs.jmedchem.9b00349
DB00938 10236 84 None -154 6 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/acs.jmedchem.9b00349
127045855 146442 0 None - 6 Human 7.3 pEC50 = 7.3 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK5 and coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK5 and coelenterazine 400a by BRET assay
ChEMBL 319 8 4 6 1.8 COc1ccccc1OCCNC[C@H](O)c1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
CHEMBL3797876 146442 0 None - 6 Human 7.3 pEC50 = 7.3 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK5 and coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK5 and coelenterazine 400a by BRET assay
ChEMBL 319 8 4 6 1.8 COc1ccccc1OCCNC[C@H](O)c1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
443372 17006 26 None - 3 Human 7.3 pEC50 = 7.3 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of coelenterazine 400a by BRET assay
ChEMBL 211 4 4 4 1.1 CC(C)NC[C@H](O)c1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
CHEMBL1160723 17006 26 None - 3 Human 7.3 pEC50 = 7.3 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of coelenterazine 400a by BRET assay
ChEMBL 211 4 4 4 1.1 CC(C)NC[C@H](O)c1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
CHEMBL2062275 17006 26 None - 3 Human 7.3 pEC50 = 7.3 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of coelenterazine 400a by BRET assay
ChEMBL 211 4 4 4 1.1 CC(C)NC[C@H](O)c1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
44396513 73497 0 None - 0 Human 8.2 pEC50 = 8.2 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 577 12 4 8 4.4 CC(C)S(=O)(=O)Oc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)c[nH]c12 10.1007/s00044-009-9257-x
CHEMBL185660 73497 0 None - 0 Human 8.2 pEC50 = 8.2 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 577 12 4 8 4.4 CC(C)S(=O)(=O)Oc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)c[nH]c12 10.1007/s00044-009-9257-x
6916441 106103 1 None - 0 Human 8.2 pEC50 = 8.2 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 402 9 4 4 3.5 CC(Cc1c[nH]c2c(OCC(=O)O)cccc12)NC[C@H](O)c1cccc(Cl)c1 10.1007/s00044-009-9257-x
CHEMBL282190 106103 1 None - 0 Human 8.2 pEC50 = 8.2 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 402 9 4 4 3.5 CC(Cc1c[nH]c2c(OCC(=O)O)cccc12)NC[C@H](O)c1cccc(Cl)c1 10.1007/s00044-009-9257-x
44396577 73726 0 None - 0 Human 8.2 pEC50 = 8.2 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 561 12 4 6 5.9 C[C@H](Cc1c[nH]c2c(OCc3ccccc3)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1007/s00044-009-9257-x
CHEMBL186676 73726 0 None - 0 Human 8.2 pEC50 = 8.2 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 561 12 4 6 5.9 C[C@H](Cc1c[nH]c2c(OCc3ccccc3)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1007/s00044-009-9257-x
44396596 130078 0 None -3 3 Human 8.2 pEC50 = 8.2 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 485 10 4 6 4.3 COc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)c[nH]c12 10.1007/s00044-009-9257-x
CHEMBL361505 130078 0 None -3 3 Human 8.2 pEC50 = 8.2 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 485 10 4 6 4.3 COc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)c[nH]c12 10.1007/s00044-009-9257-x
76319327 92101 0 None - 0 Human 8.2 pEC50 = 8.2 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 584 14 4 7 4.5 CCN(CC)C(=O)COc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)c[nH]c12 10.1007/s00044-009-9257-x
CHEMBL2261203 92101 0 None - 0 Human 8.2 pEC50 = 8.2 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 584 14 4 7 4.5 CCN(CC)C(=O)COc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)c[nH]c12 10.1007/s00044-009-9257-x
13720717 84626 0 None -3 2 Guinea pig 5.2 pEC50 = 5.2 Binding
Inhibitory activity against Beta-1 adrenergic receptor in guinea pig atriaInhibitory activity against Beta-1 adrenergic receptor in guinea pig atria
ChEMBL 363 5 3 6 2.7 COc1cc(C[C@H]2NCCc3cc(O)c(O)c(F)c32)cc(OC)c1OC 10.1021/jm00081a007
CHEMBL2092996 84626 0 None -3 2 Guinea pig 5.2 pEC50 = 5.2 Binding
Inhibitory activity against Beta-1 adrenergic receptor in guinea pig atriaInhibitory activity against Beta-1 adrenergic receptor in guinea pig atria
ChEMBL 363 5 3 6 2.7 COc1cc(C[C@H]2NCCc3cc(O)c(O)c(F)c32)cc(OC)c1OC 10.1021/jm00081a007
127045855 146442 0 None - 6 Human 7.2 pEC50 = 7.2 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK2 and coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK2 and coelenterazine 400a by BRET assay
ChEMBL 319 8 4 6 1.8 COc1ccccc1OCCNC[C@H](O)c1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
CHEMBL3797876 146442 0 None - 6 Human 7.2 pEC50 = 7.2 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK2 and coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK2 and coelenterazine 400a by BRET assay
ChEMBL 319 8 4 6 1.8 COc1ccccc1OCCNC[C@H](O)c1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
44328703 17001 0 None - 2 Human 6.2 pEC50 = 6.2 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of coelenterazine 400a by BRET assay
ChEMBL 241 6 4 5 0.8 CC(C)NC[C@H](O)COc1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
CHEMBL1160694 17001 0 None - 2 Human 6.2 pEC50 = 6.2 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of coelenterazine 400a by BRET assay
ChEMBL 241 6 4 5 0.8 CC(C)NC[C@H](O)COc1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
44328703 17001 0 None - 2 Human 6.2 pEC50 = 6.2 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assay
ChEMBL 241 6 4 5 0.8 CC(C)NC[C@H](O)COc1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
CHEMBL1160694 17001 0 None - 2 Human 6.2 pEC50 = 6.2 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assay
ChEMBL 241 6 4 5 0.8 CC(C)NC[C@H](O)COc1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
76329060 113213 0 None - 0 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 493 17 4 7 3.5 CS(=O)(=O)c1ccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc1 10.1021/jm401532g
CHEMBL3126381 113213 0 None - 0 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 493 17 4 7 3.5 CS(=O)(=O)c1ccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc1 10.1021/jm401532g
CHEMBL3139685 113213 0 None - 0 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 493 17 4 7 3.5 CS(=O)(=O)c1ccc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)cc1 10.1021/jm401532g
76315639 92092 0 None - 0 Human 7.2 pEC50 = 7.2 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 507 10 4 6 4.0 C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1ccc(C(=O)Nc2ccccc2)cc1 10.1007/s00044-009-9257-x
CHEMBL2260987 92092 0 None - 0 Human 7.2 pEC50 = 7.2 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 507 10 4 6 4.0 C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1ccc(C(=O)Nc2ccccc2)cc1 10.1007/s00044-009-9257-x
76315637 92089 0 None - 0 Human 8.1 pEC50 = 8.1 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 607 12 4 10 4.2 CCOC(=O)S(=O)(=O)Oc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)c[nH]c12 10.1007/s00044-009-9257-x
CHEMBL2260984 92089 0 None - 0 Human 8.1 pEC50 = 8.1 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 607 12 4 10 4.2 CCOC(=O)S(=O)(=O)Oc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)c[nH]c12 10.1007/s00044-009-9257-x
44396530 73862 0 None - 0 Human 8.1 pEC50 = 8.1 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 591 14 4 8 4.8 CCCCS(=O)(=O)Oc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)c[nH]c12 10.1007/s00044-009-9257-x
CHEMBL187317 73862 0 None - 0 Human 8.1 pEC50 = 8.1 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 591 14 4 8 4.8 CCCCS(=O)(=O)Oc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)c[nH]c12 10.1007/s00044-009-9257-x
44392542 72636 0 None - 0 Human 8.1 pEC50 = 8.1 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 543 11 4 6 5.5 C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1cccc(NCc2ccc3ccccc3c2)c1 10.1007/s00044-009-9257-x
CHEMBL183552 72636 0 None - 0 Human 8.1 pEC50 = 8.1 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 543 11 4 6 5.5 C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1cccc(NCc2ccc3ccccc3c2)c1 10.1007/s00044-009-9257-x
443372 17006 26 None - 3 Human 8.1 pEC50 = 8.1 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 211 4 4 4 1.1 CC(C)NC[C@H](O)c1ccc(O)c(O)c1 10.1021/jm401532g
CHEMBL1160723 17006 26 None - 3 Human 8.1 pEC50 = 8.1 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 211 4 4 4 1.1 CC(C)NC[C@H](O)c1ccc(O)c(O)c1 10.1021/jm401532g
CHEMBL2062275 17006 26 None - 3 Human 8.1 pEC50 = 8.1 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 211 4 4 4 1.1 CC(C)NC[C@H](O)c1ccc(O)c(O)c1 10.1021/jm401532g
127045855 146442 0 None - 6 Human 7.1 pEC50 = 7.1 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of coelenterazine 400a by BRET assay
ChEMBL 319 8 4 6 1.8 COc1ccccc1OCCNC[C@H](O)c1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
CHEMBL3797876 146442 0 None - 6 Human 7.1 pEC50 = 7.1 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of coelenterazine 400a by BRET assay
ChEMBL 319 8 4 6 1.8 COc1ccccc1OCCNC[C@H](O)c1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
127046950 146823 0 None - 6 Human 6.1 pEC50 = 6.1 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK2 and coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK2 and coelenterazine 400a by BRET assay
ChEMBL 437 12 4 6 4.0 COc1cc(CCNC[C@H](O)c2ccc(O)c(O)c2)ccc1OCCCc1ccccc1 10.1021/acs.jmedchem.9b00349
CHEMBL3800303 146823 0 None - 6 Human 6.1 pEC50 = 6.1 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK2 and coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK2 and coelenterazine 400a by BRET assay
ChEMBL 437 12 4 6 4.0 COc1cc(CCNC[C@H](O)c2ccc(O)c(O)c2)ccc1OCCCc1ccccc1 10.1021/acs.jmedchem.9b00349
127046950 146823 0 None - 6 Human 6.1 pEC50 = 6.1 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of coelenterazine 400a by BRET assay
ChEMBL 437 12 4 6 4.0 COc1cc(CCNC[C@H](O)c2ccc(O)c(O)c2)ccc1OCCCc1ccccc1 10.1021/acs.jmedchem.9b00349
CHEMBL3800303 146823 0 None - 6 Human 6.1 pEC50 = 6.1 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of coelenterazine 400a by BRET assay
ChEMBL 437 12 4 6 4.0 COc1cc(CCNC[C@H](O)c2ccc(O)c(O)c2)ccc1OCCCc1ccccc1 10.1021/acs.jmedchem.9b00349
146025802 176357 0 None - 2 Human 6.1 pEC50 = 6.1 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assay
ChEMBL 349 10 4 7 1.5 COc1ccccc1OCCNC[C@H](O)COc1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
CHEMBL4435895 176357 0 None - 2 Human 6.1 pEC50 = 6.1 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring Rluc2-117-GalphaS/GFP10-Ggamma/Gbeta1 assessed as activation of GalphaS incubated for 5 mins in presence of coelenterazine 400a by BRET assay
ChEMBL 349 10 4 7 1.5 COc1ccccc1OCCNC[C@H](O)COc1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
2419 10236 84 None -154 6 Human 6.1 pEC50 = 6.1 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/jm401532g
5152 10236 84 None -154 6 Human 6.1 pEC50 = 6.1 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/jm401532g
559 10236 84 None -154 6 Human 6.1 pEC50 = 6.1 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/jm401532g
CHEMBL1263 10236 84 None -154 6 Human 6.1 pEC50 = 6.1 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/jm401532g
DB00938 10236 84 None -154 6 Human 6.1 pEC50 = 6.1 Binding
Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assayAgonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/jm401532g
146025803 182956 0 None - 2 Human 5.1 pEC50 = 5.1 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK5 and coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK5 and coelenterazine 400a by BRET assay
ChEMBL 467 14 4 7 3.7 COc1cc(CCNC[C@H](O)COc2ccc(O)c(O)c2)ccc1OCCCc1ccccc1 10.1021/acs.jmedchem.9b00349
CHEMBL4593181 182956 0 None - 2 Human 5.1 pEC50 = 5.1 Binding
Agonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK5 and coelenterazine 400a by BRET assayAgonist activity at beta1-adrenergic receptor (unknown origin) expressed in HEK293T cells harboring GFP/Rluc2-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment incubated for 5 mins in presence of GRK5 and coelenterazine 400a by BRET assay
ChEMBL 467 14 4 7 3.7 COc1cc(CCNC[C@H](O)COc2ccc(O)c(O)c2)ccc1OCCCc1ccccc1 10.1021/acs.jmedchem.9b00349
44392575 71146 0 None - 0 Human 8.0 pEC50 = 8.0 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 441 10 4 6 2.8 C#CCNc1cccc([C@@H](O)CN[C@H](C)Cc2c[nH]c3c(OS(C)(=O)=O)cccc23)c1 10.1007/s00044-009-9257-x
CHEMBL181300 71146 0 None - 0 Human 8.0 pEC50 = 8.0 Binding
Agonist activity at Homo sapiens (human) beta1 adrenoreceptorAgonist activity at Homo sapiens (human) beta1 adrenoreceptor
ChEMBL 441 10 4 6 2.8 C#CCNc1cccc([C@@H](O)CN[C@H](C)Cc2c[nH]c3c(OS(C)(=O)=O)cccc23)c1 10.1007/s00044-009-9257-x
53494950 79875 0 None - 0 Human 10.4 pIC50 = 10.4 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 416 12 4 6 2.1 N#Cc1ccccc1OC[C@@H](O)CNCCNC(=O)Nc1cccc(OCCF)c1 10.1021/ml1002458
CHEMBL2011218 79875 0 None - 0 Human 10.4 pIC50 = 10.4 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 416 12 4 6 2.1 N#Cc1ccccc1OC[C@@H](O)CNCCNC(=O)Nc1cccc(OCCF)c1 10.1021/ml1002458
70683109 79883 0 None - 0 Human 10.3 pIC50 = 10.3 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 481 9 4 6 1.7 N#Cc1ccccc1OC[C@@H](O)CNCCNC(=O)Nc1ccc(I)nc1 10.1021/ml1002458
CHEMBL2011226 79883 0 None - 0 Human 10.3 pIC50 = 10.3 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 481 9 4 6 1.7 N#Cc1ccccc1OC[C@@H](O)CNCCNC(=O)Nc1ccc(I)nc1 10.1021/ml1002458
70693600 79884 0 None - 0 Human 10.3 pIC50 = 10.3 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 433 9 4 6 1.9 N#Cc1ccccc1OC[C@@H](O)CNCCNC(=O)Nc1ccc(Br)nc1 10.1021/ml1002458
CHEMBL2011227 79884 0 None - 0 Human 10.3 pIC50 = 10.3 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 433 9 4 6 1.9 N#Cc1ccccc1OC[C@@H](O)CNCCNC(=O)Nc1ccc(Br)nc1 10.1021/ml1002458
11546170 79873 0 None - 0 Human 10.1 pIC50 = 10.1 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 416 12 4 6 2.1 N#Cc1ccccc1OC[C@@H](O)CNCCNC(=O)Nc1ccc(OCCF)cc1 10.1021/ml1002458
CHEMBL2011216 79873 0 None - 0 Human 10.1 pIC50 = 10.1 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 416 12 4 6 2.1 N#Cc1ccccc1OC[C@@H](O)CNCCNC(=O)Nc1ccc(OCCF)cc1 10.1021/ml1002458
70691507 79872 0 None - 0 Human 10.0 pIC50 = 10 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 372 9 4 5 1.8 N#Cc1ccccc1OC[C@@H](O)CNCCNC(=O)Nc1ccc(F)cc1 10.1021/ml1002458
CHEMBL2011215 79872 0 None - 0 Human 10.0 pIC50 = 10 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 372 9 4 5 1.8 N#Cc1ccccc1OC[C@@H](O)CNCCNC(=O)Nc1ccc(F)cc1 10.1021/ml1002458
70683108 79881 0 None - 0 Human 10.0 pIC50 = 10 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 417 12 4 7 1.5 N#Cc1ccccc1OC[C@@H](O)CNCCNC(=O)Nc1ccc(OCCF)nc1 10.1021/ml1002458
CHEMBL2011224 79881 0 None - 0 Human 10.0 pIC50 = 10 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 417 12 4 7 1.5 N#Cc1ccccc1OC[C@@H](O)CNCCNC(=O)Nc1ccc(OCCF)nc1 10.1021/ml1002458
11523842 79870 0 None - 0 Human 10.0 pIC50 = 10.0 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 384 10 4 6 1.7 COc1ccc(NC(=O)NCCNC[C@H](O)COc2ccccc2C#N)cc1 10.1021/ml1002458
CHEMBL2011213 79870 0 None - 0 Human 10.0 pIC50 = 10.0 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 384 10 4 6 1.7 COc1ccc(NC(=O)NCCNC[C@H](O)COc2ccccc2C#N)cc1 10.1021/ml1002458
70680984 79891 0 None - 0 Human 9.9 pIC50 = 9.9 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 371 10 3 5 1.4 N#Cc1ccccc1OC[C@@H](O)CNCCNC(=O)Cc1ccc(F)cc1 10.1021/ml1002458
CHEMBL2011235 79891 0 None - 0 Human 9.9 pIC50 = 9.9 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 371 10 3 5 1.4 N#Cc1ccccc1OC[C@@H](O)CNCCNC(=O)Cc1ccc(F)cc1 10.1021/ml1002458
2585 7590 103 None -1 22 Human 9.8 pIC50 = 9.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
522 7590 103 None -1 22 Human 9.8 pIC50 = 9.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
551 7590 103 None -1 22 Human 9.8 pIC50 = 9.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
CHEMBL723 7590 103 None -1 22 Human 9.8 pIC50 = 9.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
DB01136 7590 103 None -1 22 Human 9.8 pIC50 = 9.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
70687345 79871 0 None - 0 Human 9.7 pIC50 = 9.7 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 372 9 4 5 1.8 N#Cc1ccccc1OC[C@@H](O)CNCCNC(=O)Nc1ccccc1F 10.1021/ml1002458
CHEMBL2011214 79871 0 None - 0 Human 9.7 pIC50 = 9.7 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 372 9 4 5 1.8 N#Cc1ccccc1OC[C@@H](O)CNCCNC(=O)Nc1ccccc1F 10.1021/ml1002458
70683106 79874 0 None - 0 Human 9.6 pIC50 = 9.6 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 430 13 4 6 2.4 N#Cc1ccccc1OC[C@@H](O)CNCCNC(=O)Nc1ccc(OCCCF)cc1 10.1021/ml1002458
CHEMBL2011217 79874 0 None - 0 Human 9.6 pIC50 = 9.6 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 430 13 4 6 2.4 N#Cc1ccccc1OC[C@@H](O)CNCCNC(=O)Nc1ccc(OCCCF)cc1 10.1021/ml1002458
70680982 79882 0 None - 0 Human 9.5 pIC50 = 9.5 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 373 9 4 6 1.2 N#Cc1ccccc1OC[C@@H](O)CNCCNC(=O)Nc1ccc(F)nc1 10.1021/ml1002458
CHEMBL2011225 79882 0 None - 0 Human 9.5 pIC50 = 9.5 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 373 9 4 6 1.2 N#Cc1ccccc1OC[C@@H](O)CNCCNC(=O)Nc1ccc(F)nc1 10.1021/ml1002458
70693601 79885 0 None - 0 Human 9.5 pIC50 = 9.5 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 434 9 4 7 1.3 N#Cc1ccccc1OC[C@@H](O)CNCCNC(=O)Nc1cnc(Br)cn1 10.1021/ml1002458
CHEMBL2011228 79885 0 None - 0 Human 9.5 pIC50 = 9.5 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 434 9 4 7 1.3 N#Cc1ccccc1OC[C@@H](O)CNCCNC(=O)Nc1cnc(Br)cn1 10.1021/ml1002458
127 9900 52 None 2 15 Human 9.1 pIC50 = 9.1 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 248 6 3 3 1.9 O[C@H](COc1cccc2c1cc[nH]2)CNC(C)C nan
688095 9900 52 None 2 15 Human 9.1 pIC50 = 9.1 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 248 6 3 3 1.9 O[C@H](COc1cccc2c1cc[nH]2)CNC(C)C nan
CHEMBL117405 9900 52 None 2 15 Human 9.1 pIC50 = 9.1 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 248 6 3 3 1.9 O[C@H](COc1cccc2c1cc[nH]2)CNC(C)C nan
2176 9901 68 None -4 27 Human 9.0 pIC50 = 9.0 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C nan
4828 9901 68 None -4 27 Human 9.0 pIC50 = 9.0 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C nan
91 9901 68 None -4 27 Human 9.0 pIC50 = 9.0 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C nan
CHEMBL500 9901 68 None -4 27 Human 9.0 pIC50 = 9.0 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C nan
DB00960 9901 68 None -4 27 Human 9.0 pIC50 = 9.0 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C nan
70689402 79879 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 416 10 5 6 1.5 N#Cc1ccccc1OC[C@@H](O)CNCCNC(=O)Nc1ccc(C(=O)O)c(F)c1 10.1021/ml1002458
CHEMBL2011222 79879 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 416 10 5 6 1.5 N#Cc1ccccc1OC[C@@H](O)CNCCNC(=O)Nc1ccc(C(=O)O)c(F)c1 10.1021/ml1002458
70680981 79876 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 429 12 5 6 2.5 CC(CF)Nc1ccc(NC(=O)NCCNC[C@H](O)COc2ccccc2C#N)cc1 10.1021/ml1002458
CHEMBL2011219 79876 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 429 12 5 6 2.5 CC(CF)Nc1ccc(NC(=O)NCCNC[C@H](O)COc2ccccc2C#N)cc1 10.1021/ml1002458
145990586 173622 0 None -1 11 Human 8.8 pIC50 = 8.8 Binding
Displacement of [3H]-CGP-12177 from human beta1-adrenergic receptorDisplacement of [3H]-CGP-12177 from human beta1-adrenergic receptor
ChEMBL 297 2 2 4 2.6 COc1cc2c3c(c1OC)-c1ccccc1[C@@H](O)[C@@H]3NCC2 10.1039/C7MD00656J
CHEMBL4285281 173622 0 None -1 11 Human 8.8 pIC50 = 8.8 Binding
Displacement of [3H]-CGP-12177 from human beta1-adrenergic receptorDisplacement of [3H]-CGP-12177 from human beta1-adrenergic receptor
ChEMBL 297 2 2 4 2.6 COc1cc2c3c(c1OC)-c1ccccc1[C@@H](O)[C@@H]3NCC2 10.1039/C7MD00656J
2249 7300 111 None -5 12 Human 8.8 pIC50 = 8.8 Binding
Percent inhibition against Beta-1 adrenergic receptor at 1 uMPercent inhibition against Beta-1 adrenergic receptor at 1 uM
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm058018d
255 7300 111 None -5 12 Human 8.8 pIC50 = 8.8 Binding
Percent inhibition against Beta-1 adrenergic receptor at 1 uMPercent inhibition against Beta-1 adrenergic receptor at 1 uM
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm058018d
548 7300 111 None -5 12 Human 8.8 pIC50 = 8.8 Binding
Percent inhibition against Beta-1 adrenergic receptor at 1 uMPercent inhibition against Beta-1 adrenergic receptor at 1 uM
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm058018d
CHEMBL24 7300 111 None -5 12 Human 8.8 pIC50 = 8.8 Binding
Percent inhibition against Beta-1 adrenergic receptor at 1 uMPercent inhibition against Beta-1 adrenergic receptor at 1 uM
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm058018d
DB00335 7300 111 None -5 12 Human 8.8 pIC50 = 8.8 Binding
Percent inhibition against Beta-1 adrenergic receptor at 1 uMPercent inhibition against Beta-1 adrenergic receptor at 1 uM
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm058018d
2303 9961 68 None -9 26 Human 8.7 pIC50 = 8.7 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C nan
4946 9961 68 None -9 26 Human 8.7 pIC50 = 8.7 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C nan
564 9961 68 None -9 26 Human 8.7 pIC50 = 8.7 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C nan
63 9961 68 None -9 26 Human 8.7 pIC50 = 8.7 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C nan
91536 9961 68 None -9 26 Human 8.7 pIC50 = 8.7 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C nan
CHEMBL27 9961 68 None -9 26 Human 8.7 pIC50 = 8.7 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C nan
CHEMBL452861 9961 68 None -9 26 Human 8.7 pIC50 = 8.7 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C nan
DB00571 9961 68 None -9 26 Human 8.7 pIC50 = 8.7 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C nan
24901416 77134 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 481 11 5 6 3.6 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3ccccc3CNCCc3ccccc3F)c2s1 10.1016/j.bmcl.2011.10.049
CHEMBL1945035 77134 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 481 11 5 6 3.6 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3ccccc3CNCCc3ccccc3F)c2s1 10.1016/j.bmcl.2011.10.049
44268305 105073 0 None - 0 Human 8.0 pIC50 = 8 Binding
Compound was tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]-iodocyanopindolol as radioligandCompound was tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]-iodocyanopindolol as radioligand
ChEMBL 345 10 3 5 2.8 COc1ccc(CC[C@H](C)NC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/s0960-894x(98)00169-3
CHEMBL274782 105073 0 None - 0 Human 8.0 pIC50 = 8 Binding
Compound was tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]-iodocyanopindolol as radioligandCompound was tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]-iodocyanopindolol as radioligand
ChEMBL 345 10 3 5 2.8 COc1ccc(CC[C@H](C)NC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/s0960-894x(98)00169-3
1531 9046 69 None -1 16 Human 8.0 pIC50 = 8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O nan
3869 9046 69 None -1 16 Human 8.0 pIC50 = 8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O nan
7207 9046 69 None -1 16 Human 8.0 pIC50 = 8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O nan
CHEMBL429 9046 69 None -1 16 Human 8.0 pIC50 = 8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O nan
DB00598 9046 69 None -1 16 Human 8.0 pIC50 = 8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O nan
70685188 79887 0 None - 0 Human 8.0 pIC50 = 8 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 392 11 4 9 -0.3 N#Cc1ccccc1OC[C@@H](O)CNCCNC(=O)Nc1nnn(CCF)n1 10.1021/ml1002458
CHEMBL2011230 79887 0 None - 0 Human 8.0 pIC50 = 8 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 392 11 4 9 -0.3 N#Cc1ccccc1OC[C@@H](O)CNCCNC(=O)Nc1nnn(CCF)n1 10.1021/ml1002458
70687347 79889 0 None - 0 Human 8.0 pIC50 = 8 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 358 9 3 6 0.9 N#Cc1ccccc1OC[C@@H](O)CNCCNC(=O)c1ccc(F)nc1 10.1021/ml1002458
CHEMBL2011233 79889 0 None - 0 Human 8.0 pIC50 = 8 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 358 9 3 6 0.9 N#Cc1ccccc1OC[C@@H](O)CNCCNC(=O)c1ccc(F)nc1 10.1021/ml1002458
24901143 77140 0 None - 0 Human 8.0 pIC50 = 8 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 483 10 5 6 4.1 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCc4ccccc4Cl)c3)c2s1 10.1016/j.bmcl.2011.10.049
CHEMBL1945041 77140 0 None - 0 Human 8.0 pIC50 = 8 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 483 10 5 6 4.1 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCc4ccccc4Cl)c3)c2s1 10.1016/j.bmcl.2011.10.049
24900750 77154 0 None - 0 Human 8.0 pIC50 = 8 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 479 11 5 7 3.5 COc1ccc(CNCc2cccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)sc34)c2)cc1 10.1016/j.bmcl.2011.10.049
CHEMBL1945289 77154 0 None - 0 Human 8.0 pIC50 = 8 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 479 11 5 7 3.5 COc1ccc(CNCc2cccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)sc34)c2)cc1 10.1016/j.bmcl.2011.10.049
16049162 70866 0 None - 0 Human 7.0 pIC50 = 7 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 515 13 5 7 3.9 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCSCCCNCCc3cccc(C(F)(F)F)c3)c2s1 10.1016/j.bmcl.2011.05.097
CHEMBL1807826 70866 0 None - 0 Human 7.0 pIC50 = 7 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 515 13 5 7 3.9 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCSCCCNCCc3cccc(C(F)(F)F)c3)c2s1 10.1016/j.bmcl.2011.05.097
16049377 70872 0 None - 0 Human 7.0 pIC50 = 7 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 465 13 5 7 2.8 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCOCCCNCCc3cccc(Cl)c3)c2s1 10.1016/j.bmcl.2011.05.097
CHEMBL1807832 70872 0 None - 0 Human 7.0 pIC50 = 7 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 465 13 5 7 2.8 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCOCCCNCCc3cccc(Cl)c3)c2s1 10.1016/j.bmcl.2011.05.097
24900751 77155 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 493 12 5 7 3.8 CCOc1ccccc1CNCc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1 10.1016/j.bmcl.2011.10.049
CHEMBL1945290 77155 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 493 12 5 7 3.8 CCOc1ccccc1CNCc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1 10.1016/j.bmcl.2011.10.049
44268277 29080 0 None - 0 Human 7.0 pIC50 = 7 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 408 11 4 6 2.1 CC(C)S(=O)(=O)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/s0960-894x(98)00169-3
CHEMBL13238 29080 0 None - 0 Human 7.0 pIC50 = 7 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 408 11 4 6 2.1 CC(C)S(=O)(=O)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/s0960-894x(98)00169-3
44281371 106896 0 None - 0 Human 6.0 pIC50 = 6 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 655 14 3 10 5.3 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(COc3ccc(OC(F)(F)F)cc3)n2)cc1 10.1016/s0960-894x(00)00268-7
CHEMBL287567 106896 0 None - 0 Human 6.0 pIC50 = 6 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 655 14 3 10 5.3 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(COc3ccc(OC(F)(F)F)cc3)n2)cc1 10.1016/s0960-894x(00)00268-7
44377315 64149 0 None - 0 Human 6.0 pIC50 = 6 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 605 14 3 6 5.4 O=C1N(CCCC2CCCCC2)CCN1c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(99)00072-4
CHEMBL165177 64149 0 None - 0 Human 6.0 pIC50 = 6 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 605 14 3 6 5.4 O=C1N(CCCC2CCCCC2)CCN1c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(99)00072-4
44313090 109947 0 None - 0 Human 6.0 pIC50 = 6 Binding
Compound was evaluated for its inhibitory activity against CHO cells expressing the cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindololCompound was evaluated for its inhibitory activity against CHO cells expressing the cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol
ChEMBL 568 12 6 7 4.9 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(OCC3NCCc4cc(O)c(O)cc43)cc2)cc1 10.1016/s0960-894x(00)00459-5
CHEMBL308126 109947 0 None - 0 Human 6.0 pIC50 = 6 Binding
Compound was evaluated for its inhibitory activity against CHO cells expressing the cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindololCompound was evaluated for its inhibitory activity against CHO cells expressing the cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol
ChEMBL 568 12 6 7 4.9 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(OCC3NCCc4cc(O)c(O)cc43)cc2)cc1 10.1016/s0960-894x(00)00459-5
44312949 210543 0 None - 0 Human 6.0 pIC50 = 6 Binding
Compound was evaluated for its inhibitory activity against CHO cells expressing the cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindololCompound was evaluated for its inhibitory activity against CHO cells expressing the cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol
ChEMBL 602 11 6 6 6.2 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc3cc(CC4NCCc5cc(O)c(O)cc54)ccc3c2)cc1 10.1016/s0960-894x(00)00459-5
CHEMBL67998 210543 0 None - 0 Human 6.0 pIC50 = 6 Binding
Compound was evaluated for its inhibitory activity against CHO cells expressing the cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindololCompound was evaluated for its inhibitory activity against CHO cells expressing the cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol
ChEMBL 602 11 6 6 6.2 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc3cc(CC4NCCc5cc(O)c(O)cc54)ccc3c2)cc1 10.1016/s0960-894x(00)00459-5
3038500 16112 12 None - 0 Human 6.0 pIC50 = 6 Binding
Displacement of [125]I-cyanopindolol from recombinant human beta1 adrenergic receptor after 1 hr by scintillation counting methodDisplacement of [125]I-cyanopindolol from recombinant human beta1 adrenergic receptor after 1 hr by scintillation counting method
ChEMBL 624 11 3 7 6.6 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1 10.1021/acs.jmedchem.5b01372
CHEMBL111201 16112 12 None - 0 Human 6.0 pIC50 = 6 Binding
Displacement of [125]I-cyanopindolol from recombinant human beta1 adrenergic receptor after 1 hr by scintillation counting methodDisplacement of [125]I-cyanopindolol from recombinant human beta1 adrenergic receptor after 1 hr by scintillation counting method
ChEMBL 624 11 3 7 6.6 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1 10.1021/acs.jmedchem.5b01372
44307007 107555 0 None - 0 Human 6.0 pIC50 = 6 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 469 12 3 6 3.6 CC(C)c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3cccnc3)cc2)cc1 10.1016/s0960-894x(98)00381-3
CHEMBL292947 107555 0 None - 0 Human 6.0 pIC50 = 6 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 469 12 3 6 3.6 CC(C)c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3cccnc3)cc2)cc1 10.1016/s0960-894x(98)00381-3
10437614 107719 12 None - 0 Human 6.0 pIC50 = 6 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 553 11 3 6 3.1 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2cccnc2)cc1)c1ccc(I)cc1 10.1016/s0960-894x(98)00381-3
CHEMBL294042 107719 12 None - 0 Human 6.0 pIC50 = 6 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 553 11 3 6 3.1 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2cccnc2)cc1)c1ccc(I)cc1 10.1016/s0960-894x(98)00381-3
44303198 209937 0 None - 0 Human 6.0 pIC50 = 6 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 568 11 4 7 2.6 Nc1ccc(OC[C@@H](O)CNCCc2ccc(NS(=O)(=O)c3ccc(I)cc3)cc2)cn1 10.1016/s0960-894x(98)00381-3
CHEMBL64201 209937 0 None - 0 Human 6.0 pIC50 = 6 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 568 11 4 7 2.6 Nc1ccc(OC[C@@H](O)CNCCc2ccc(NS(=O)(=O)c3ccc(I)cc3)cc2)cn1 10.1016/s0960-894x(98)00381-3
44307065 210111 0 None - 0 Human 6.0 pIC50 = 6 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 445 11 3 6 2.6 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2cccnc2)cc1)c1ccc(F)cc1 10.1016/s0960-894x(98)00381-3
CHEMBL64932 210111 0 None - 0 Human 6.0 pIC50 = 6 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 445 11 3 6 2.6 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2cccnc2)cc1)c1ccc(F)cc1 10.1016/s0960-894x(98)00381-3
44307064 210114 0 None - 0 Human 6.0 pIC50 = 6 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 461 11 3 6 3.1 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2cccnc2)cc1)c1ccc(Cl)cc1 10.1016/s0960-894x(98)00381-3
CHEMBL64936 210114 0 None - 0 Human 6.0 pIC50 = 6 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 461 11 3 6 3.1 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2cccnc2)cc1)c1ccc(Cl)cc1 10.1016/s0960-894x(98)00381-3
44307343 210382 0 None - 0 Human 6.0 pIC50 = 6 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 457 12 3 7 2.5 COc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3cccnc3)cc2)cc1 10.1016/s0960-894x(98)00381-3
CHEMBL66964 210382 0 None - 0 Human 6.0 pIC50 = 6 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 457 12 3 7 2.5 COc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3cccnc3)cc2)cc1 10.1016/s0960-894x(98)00381-3
44268572 32437 0 None - 0 Human 6.0 pIC50 = 6 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 572 16 6 8 2.9 COCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
CHEMBL13521 32437 0 None - 0 Human 6.0 pIC50 = 6 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 572 16 6 8 2.9 COCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
44268482 104875 0 None - 0 Human 6.0 pIC50 = 6 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 499 12 5 7 2.7 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
CHEMBL273428 104875 0 None - 0 Human 6.0 pIC50 = 6 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 499 12 5 7 2.7 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
12017016 106942 0 None - 0 Human 6.0 pIC50 = 6 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 574 14 3 7 5.9 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2cnc(CCCC3CCCC3)o2)cc1 10.1016/s0960-894x(00)00277-8
CHEMBL287947 106942 0 None - 0 Human 6.0 pIC50 = 6 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 574 14 3 7 5.9 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2cnc(CCCC3CCCC3)o2)cc1 10.1016/s0960-894x(00)00277-8
44298497 201478 0 None - 0 Human 6.0 pIC50 = 6 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 464 11 1 5 5.9 CCCCCCCCc1ccnc(N2CCc3cc(S(=O)(=O)Nc4ccccc4)ccc32)n1 10.1016/s0960-894x(99)00277-2
CHEMBL53359 201478 0 None - 0 Human 6.0 pIC50 = 6 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 464 11 1 5 5.9 CCCCCCCCc1ccnc(N2CCc3cc(S(=O)(=O)Nc4ccccc4)ccc32)n1 10.1016/s0960-894x(99)00277-2
44298731 204860 0 None - 0 Human 6.0 pIC50 = 6 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 429 10 2 3 4.9 CCCCCCCCNC(=O)N1CCc2cc(S(=O)(=O)Nc3ccccc3)ccc21 10.1016/s0960-894x(99)00277-2
CHEMBL57430 204860 0 None - 0 Human 6.0 pIC50 = 6 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 429 10 2 3 4.9 CCCCCCCCNC(=O)N1CCc2cc(S(=O)(=O)Nc3ccccc3)ccc21 10.1016/s0960-894x(99)00277-2
9799092 54080 0 None - 0 Human 6.0 pIC50 = 6 Binding
Receptor binding assay(Beta-1 adrenergic receptor) carried out with membranes prepared from human recombinant Sf9 cells expressing the cloned human receptor in the presence of [125I]iodocyanopindololReceptor binding assay(Beta-1 adrenergic receptor) carried out with membranes prepared from human recombinant Sf9 cells expressing the cloned human receptor in the presence of [125I]iodocyanopindolol
ChEMBL 362 9 4 4 3.1 C[C@H](CNc1ccc(CC(=O)O)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm0101500
CHEMBL154419 54080 0 None - 0 Human 6.0 pIC50 = 6 Binding
Receptor binding assay(Beta-1 adrenergic receptor) carried out with membranes prepared from human recombinant Sf9 cells expressing the cloned human receptor in the presence of [125I]iodocyanopindololReceptor binding assay(Beta-1 adrenergic receptor) carried out with membranes prepared from human recombinant Sf9 cells expressing the cloned human receptor in the presence of [125I]iodocyanopindolol
ChEMBL 362 9 4 4 3.1 C[C@H](CNc1ccc(CC(=O)O)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1021/jm0101500
44268281 23650 0 None - 0 Human 6.0 pIC50 = 6 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 436 14 4 6 2.9 CCCCCS(=O)(=O)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/s0960-894x(98)00169-3
CHEMBL12498 23650 0 None - 0 Human 6.0 pIC50 = 6 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 436 14 4 6 2.9 CCCCCS(=O)(=O)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/s0960-894x(98)00169-3
44268275 26385 0 None - 0 Human 6.0 pIC50 = 6 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 484 14 4 6 3.3 O=S(=O)(CCCc1ccccc1)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/s0960-894x(98)00169-3
CHEMBL13003 26385 0 None - 0 Human 6.0 pIC50 = 6 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 484 14 4 6 3.3 O=S(=O)(CCCc1ccccc1)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/s0960-894x(98)00169-3
44268254 26785 0 None - 0 Human 6.0 pIC50 = 6 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 302 8 4 5 1.5 Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/s0960-894x(98)00169-3
CHEMBL13034 26785 0 None - 0 Human 6.0 pIC50 = 6 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 302 8 4 5 1.5 Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/s0960-894x(98)00169-3
44268295 105320 0 None - 0 Human 6.0 pIC50 = 6 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 408 12 4 6 2.1 CCCS(=O)(=O)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/s0960-894x(98)00169-3
CHEMBL276480 105320 0 None - 0 Human 6.0 pIC50 = 6 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 408 12 4 6 2.1 CCCS(=O)(=O)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/s0960-894x(98)00169-3
44268324 23556 0 None - 0 Human 6.0 pIC50 = 6 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand.Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand.
ChEMBL 476 11 4 6 3.4 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1ccc(Cl)cc1 10.1016/s0960-894x(98)00169-3
CHEMBL12450 23556 0 None - 0 Human 6.0 pIC50 = 6 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand.Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand.
ChEMBL 476 11 4 6 3.4 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1ccc(Cl)cc1 10.1016/s0960-894x(98)00169-3
44268274 25622 0 None - 0 Human 6.0 pIC50 = 6 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand.Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand.
ChEMBL 476 11 4 6 3.4 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1cccc(Cl)c1 10.1016/s0960-894x(98)00169-3
CHEMBL12813 25622 0 None - 0 Human 6.0 pIC50 = 6 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand.Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand.
ChEMBL 476 11 4 6 3.4 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1cccc(Cl)c1 10.1016/s0960-894x(98)00169-3
44335572 11945 0 None - 0 Human 5.0 pIC50 = 5 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 475 9 3 5 3.5 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(Br)cc1 10.1016/s0960-894x(98)00571-x
CHEMBL105968 11945 0 None - 0 Human 5.0 pIC50 = 5 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 475 9 3 5 3.5 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(Br)cc1 10.1016/s0960-894x(98)00571-x
44335498 114320 0 None - 0 Human 5.0 pIC50 = 5 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 447 9 3 5 3.9 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc2ccccc2c1 10.1016/s0960-894x(98)00571-x
CHEMBL318802 114320 0 None - 0 Human 5.0 pIC50 = 5 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 447 9 3 5 3.9 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc2ccccc2c1 10.1016/s0960-894x(98)00571-x
44335562 115318 0 None - 0 Human 5.0 pIC50 = 5 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 558 14 4 6 4.7 O=C(CCCc1ccccc1)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(98)00571-x
CHEMBL320138 115318 0 None - 0 Human 5.0 pIC50 = 5 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 558 14 4 6 4.7 O=C(CCCc1ccccc1)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(98)00571-x
44303192 210064 0 None - 0 Human 5.0 pIC50 = 5 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 523 9 3 5 3.4 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(I)cc1 10.1016/s0960-894x(98)00571-x
CHEMBL64697 210064 0 None - 0 Human 5.0 pIC50 = 5 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 523 9 3 5 3.4 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(I)cc1 10.1016/s0960-894x(98)00571-x
12049923 210450 0 None - 0 Human 5.0 pIC50 = 5 Binding
Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.
ChEMBL 608 12 3 8 4.3 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(Cc3c(F)cc(F)cc3F)n2)cc1 10.1016/s0960-894x(00)00422-4
CHEMBL67404 210450 0 None - 0 Human 5.0 pIC50 = 5 Binding
Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.
ChEMBL 608 12 3 8 4.3 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(Cc3c(F)cc(F)cc3F)n2)cc1 10.1016/s0960-894x(00)00422-4
44461468 112405 0 None - 0 Human 5.0 pIC50 = 5 Binding
Binding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindololBinding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol
ChEMBL 608 17 4 9 3.7 CCCCCCCCn1c(=O)[nH]n(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)c1=O 10.1016/s0960-894x(99)00073-6
CHEMBL312364 112405 0 None - 0 Human 5.0 pIC50 = 5 Binding
Binding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindololBinding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol
ChEMBL 608 17 4 9 3.7 CCCCCCCCn1c(=O)[nH]n(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)c1=O 10.1016/s0960-894x(99)00073-6
44377412 126932 0 None - 0 Human 5.0 pIC50 = 5 Binding
Binding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindololBinding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol
ChEMBL 580 15 4 9 3.0 CCCCCCn1c(=O)[nH]n(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)c1=O 10.1016/s0960-894x(99)00073-6
CHEMBL351467 126932 0 None - 0 Human 5.0 pIC50 = 5 Binding
Binding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindololBinding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol
ChEMBL 580 15 4 9 3.0 CCCCCCn1c(=O)[nH]n(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)c1=O 10.1016/s0960-894x(99)00073-6
44281037 120115 0 None - 0 Human 5.0 pIC50 = 5 Binding
Binding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindololBinding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 479 10 3 8 3.1 Cc1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1 10.1016/s0960-894x(00)00267-5
CHEMBL33168 120115 0 None - 0 Human 5.0 pIC50 = 5 Binding
Binding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindololBinding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 479 10 3 8 3.1 Cc1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1 10.1016/s0960-894x(00)00267-5
12043158 170008 0 None - 0 Human 5.0 pIC50 = 5 Binding
Binding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindololBinding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 551 14 4 9 3.5 CC(O)CCCc1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1 10.1016/s0960-894x(00)00267-5
CHEMBL418411 170008 0 None - 0 Human 5.0 pIC50 = 5 Binding
Binding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindololBinding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 551 14 4 9 3.5 CC(O)CCCc1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1 10.1016/s0960-894x(00)00267-5
44377677 63654 0 None - 0 Human 5.0 pIC50 = 5 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 495 10 3 6 2.6 CN1CCN(c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)C1=O 10.1016/s0960-894x(99)00072-4
CHEMBL164401 63654 0 None - 0 Human 5.0 pIC50 = 5 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 495 10 3 6 2.6 CN1CCN(c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)C1=O 10.1016/s0960-894x(99)00072-4
44377517 64006 0 None - 0 Human 5.0 pIC50 = 5 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 551 14 3 6 4.2 CCCCCN1CCN(c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)C1=O 10.1016/s0960-894x(99)00072-4
CHEMBL165015 64006 0 None - 0 Human 5.0 pIC50 = 5 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 551 14 3 6 4.2 CCCCCN1CCN(c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)C1=O 10.1016/s0960-894x(99)00072-4
44377957 64275 0 None - 0 Human 5.0 pIC50 = 5 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 537 13 3 6 3.8 CCCCN1CCN(c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)C1=O 10.1016/s0960-894x(99)00072-4
CHEMBL166013 64275 0 None - 0 Human 5.0 pIC50 = 5 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 537 13 3 6 3.8 CCCCN1CCN(c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)C1=O 10.1016/s0960-894x(99)00072-4
44377650 126983 0 None - 0 Human 5.0 pIC50 = 5 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 577 13 3 6 4.6 O=C1N(CCC2CCCC2)CCN1c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(99)00072-4
CHEMBL351967 126983 0 None - 0 Human 5.0 pIC50 = 5 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 577 13 3 6 4.6 O=C1N(CCC2CCCC2)CCN1c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(99)00072-4
44461489 212131 0 None - 0 Human 5.0 pIC50 = 5 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 591 13 3 6 4.3 O=C1N(CCCC(F)(F)F)CCN1c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(99)00072-4
CHEMBL79675 212131 0 None - 0 Human 5.0 pIC50 = 5 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 591 13 3 6 4.3 O=C1N(CCCC(F)(F)F)CCN1c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(99)00072-4
44461719 212643 0 None - 0 Human 5.0 pIC50 = 5 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 641 14 3 6 5.0 O=C1N(CCCC(F)(F)C(F)(F)F)CCN1c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(99)00072-4
CHEMBL83754 212643 0 None - 0 Human 5.0 pIC50 = 5 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 641 14 3 6 5.0 O=C1N(CCCC(F)(F)C(F)(F)F)CCN1c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(99)00072-4
44306992 210540 0 None - 0 Human 5.0 pIC50 = 5 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 442 11 4 7 2.0 Nc1ccc(OC[C@@H](O)CNCCc2ccc(NS(=O)(=O)c3ccccc3)cc2)cn1 10.1016/s0960-894x(98)00381-3
CHEMBL67993 210540 0 None - 0 Human 5.0 pIC50 = 5 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 442 11 4 7 2.0 Nc1ccc(OC[C@@H](O)CNCCc2ccc(NS(=O)(=O)c3ccccc3)cc2)cn1 10.1016/s0960-894x(98)00381-3
44298767 107676 0 None - 0 Human 5.0 pIC50 = 5 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 553 15 4 6 4.5 CCCCCCNC(=O)N(C)c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(99)00277-2
CHEMBL293818 107676 0 None - 0 Human 5.0 pIC50 = 5 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 553 15 4 6 4.5 CCCCCCNC(=O)N(C)c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(99)00277-2
44298306 108776 0 None - 0 Human 5.0 pIC50 = 5 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 435 6 1 3 4.1 CN(CCc1ccccc1)C(=O)N1CCc2cc(S(=O)(=O)Nc3ccccc3)ccc21 10.1016/s0960-894x(99)00277-2
CHEMBL301594 108776 0 None - 0 Human 5.0 pIC50 = 5 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 435 6 1 3 4.1 CN(CCc1ccccc1)C(=O)N1CCc2cc(S(=O)(=O)Nc3ccccc3)ccc21 10.1016/s0960-894x(99)00277-2
44298752 203637 0 None - 0 Human 5.0 pIC50 = 5 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 415 8 1 3 4.5 CCCCCCN(C)C(=O)N1CCc2cc(S(=O)(=O)Nc3ccccc3)ccc21 10.1016/s0960-894x(99)00277-2
CHEMBL56594 203637 0 None - 0 Human 5.0 pIC50 = 5 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 415 8 1 3 4.5 CCCCCCN(C)C(=O)N1CCc2cc(S(=O)(=O)Nc3ccccc3)ccc21 10.1016/s0960-894x(99)00277-2
44298718 203866 0 None - 0 Human 5.0 pIC50 = 5 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 386 8 1 3 4.3 CCCCCCC(=O)N1CCc2cc(S(=O)(=O)Nc3ccccc3)ccc21 10.1016/s0960-894x(99)00277-2
CHEMBL56752 203866 0 None - 0 Human 5.0 pIC50 = 5 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 386 8 1 3 4.3 CCCCCCC(=O)N1CCc2cc(S(=O)(=O)Nc3ccccc3)ccc21 10.1016/s0960-894x(99)00277-2
44335844 11643 0 None - 0 Human 4.0 pIC50 = 4 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 363 9 3 5 2.1 CC(C)S(=O)(=O)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/s0960-894x(98)00571-x
CHEMBL104377 11643 0 None - 0 Human 4.0 pIC50 = 4 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 363 9 3 5 2.1 CC(C)S(=O)(=O)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/s0960-894x(98)00571-x
44335882 11676 0 None - 0 Human 4.0 pIC50 = 4 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 425 11 3 5 2.9 O=S(=O)(CCc1ccccc1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/s0960-894x(98)00571-x
CHEMBL104551 11676 0 None - 0 Human 4.0 pIC50 = 4 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 425 11 3 5 2.9 O=S(=O)(CCc1ccccc1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/s0960-894x(98)00571-x
44335833 12353 0 None - 0 Human 4.0 pIC50 = 4 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 448 9 3 6 3.3 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1cnc2ccccc2c1 10.1016/s0960-894x(98)00571-x
CHEMBL107681 12353 0 None - 0 Human 4.0 pIC50 = 4 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 448 9 3 6 3.3 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1cnc2ccccc2c1 10.1016/s0960-894x(98)00571-x
44301881 107311 0 None - 0 Human 4.0 pIC50 = 4 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 612 11 3 8 6.8 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3cc4ccccc4s3)cs2)cc1 10.1016/s0960-894x(00)00390-5
CHEMBL291306 107311 0 None - 0 Human 4.0 pIC50 = 4 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 612 11 3 8 6.8 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3cc4ccccc4s3)cs2)cc1 10.1016/s0960-894x(00)00390-5
44377755 126732 0 None - 0 Human 4.0 pIC50 = 4 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 589 13 3 8 4.0 O=c1n(CCCC(F)(F)F)ccn1-c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(99)00072-4
CHEMBL349689 126732 0 None - 0 Human 4.0 pIC50 = 4 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 589 13 3 8 4.0 O=c1n(CCCC(F)(F)F)ccn1-c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(99)00072-4
44461488 212154 0 None - 0 Human 4.0 pIC50 = 4 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 606 13 3 7 3.0 O=C(CCN1CCN(c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)C1=O)N1CCCC1 10.1016/s0960-894x(99)00072-4
CHEMBL79915 212154 0 None - 0 Human 4.0 pIC50 = 4 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 606 13 3 7 3.0 O=C(CCN1CCN(c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)C1=O)N1CCCC1 10.1016/s0960-894x(99)00072-4
44298761 201793 0 None - 0 Human 4.0 pIC50 = 4 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 331 3 2 3 2.2 CNC(=O)N1CCc2cc(S(=O)(=O)Nc3ccccc3)ccc21 10.1016/s0960-894x(99)00277-2
CHEMBL54885 201793 0 None - 0 Human 4.0 pIC50 = 4 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 331 3 2 3 2.2 CNC(=O)N1CCc2cc(S(=O)(=O)Nc3ccccc3)ccc21 10.1016/s0960-894x(99)00277-2
145947241 174411 0 None -8 2 Rat 7.0 pIC50 = 7.0 Binding
Displacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysisDisplacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysis
ChEMBL 449 10 2 7 3.5 COc1ccc(CCNCC(O)COc2cccc3c(=O)c4ccccc4oc23)cc1OC 10.1016/j.bmc.2018.04.038
CHEMBL4128940 174411 0 None -8 2 Rat 7.0 pIC50 = 7.0 Binding
Displacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysisDisplacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysis
ChEMBL 449 10 2 7 3.5 COc1ccc(CCNCC(O)COc2cccc3c(=O)c4ccccc4oc23)cc1OC 10.1016/j.bmc.2018.04.038
CHEMBL4301544 174411 0 None -8 2 Rat 7.0 pIC50 = 7.0 Binding
Displacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysisDisplacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysis
ChEMBL 449 10 2 7 3.5 COc1ccc(CCNCC(O)COc2cccc3c(=O)c4ccccc4oc23)cc1OC 10.1016/j.bmc.2018.04.038
44349588 123740 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 628 16 4 7 8.0 CCCCCCCCc1csc(N2CCc3cc(N/C(S)=N/c4ccc(CCNC[C@H](O)c5cccnc5)cc4)ccc32)n1 10.1016/s0960-894x(00)00669-7
CHEMBL338664 123740 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 628 16 4 7 8.0 CCCCCCCCc1csc(N2CCc3cc(N/C(S)=N/c4ccc(CCNC[C@H](O)c5cccnc5)cc4)ccc32)n1 10.1016/s0960-894x(00)00669-7
9912580 24857 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 470 13 4 6 2.9 O=S(=O)(CCc1ccccc1)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/s0960-894x(98)00169-3
CHEMBL12674 24857 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 470 13 4 6 2.9 O=S(=O)(CCc1ccccc1)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/s0960-894x(98)00169-3
44301818 209529 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 572 11 4 8 5.2 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc(O)cc3)cs2)cc1 10.1016/s0960-894x(00)00390-5
CHEMBL61962 209529 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 572 11 4 8 5.2 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc(O)cc3)cs2)cc1 10.1016/s0960-894x(00)00390-5
14998855 62475 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 402 6 2 5 1.3 CN(c1ccc(C(=O)NCC2CN(c3ccccc3)CCN2)cc1)S(C)(=O)=O 10.1021/jm00082a016
CHEMBL162200 62475 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 402 6 2 5 1.3 CN(c1ccc(C(=O)NCC2CN(c3ccccc3)CCN2)cc1)S(C)(=O)=O 10.1021/jm00082a016
14998858 126824 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 422 6 3 5 1.9 CS(=O)(=O)Nc1ccc(C(=O)NCC2CN(c3cccc(Cl)c3)CCN2)cc1 10.1021/jm00082a016
CHEMBL350432 126824 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 422 6 3 5 1.9 CS(=O)(=O)Nc1ccc(C(=O)NCC2CN(c3cccc(Cl)c3)CCN2)cc1 10.1021/jm00082a016
44349378 25297 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 545 11 4 7 4.2 O=[N+]([O-])/C=C(\Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)Nc1cccc(I)c1 10.1016/s0960-894x(00)00669-7
CHEMBL127428 25297 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 545 11 4 7 4.2 O=[N+]([O-])/C=C(\Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)Nc1cccc(I)c1 10.1016/s0960-894x(00)00669-7
46881651 13633 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 458 10 3 6 4.3 O=C(Cc1nc(-c2ccccc2)cs1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/j.bmcl.2010.01.130
CHEMBL1084137 13633 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 458 10 3 6 4.3 O=C(Cc1nc(-c2ccccc2)cs1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/j.bmcl.2010.01.130
46881753 14037 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 443 10 3 6 3.4 Cn1c(CCC(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)nc2ccccc21 10.1016/j.bmcl.2010.01.130
CHEMBL1085929 14037 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 443 10 3 6 3.4 Cn1c(CCC(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)nc2ccccc21 10.1016/j.bmcl.2010.01.130
2812 11551 101 None -38 34 Human 5.0 pIC50 = 5.0 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 344 4 0 2 5.4 Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1 nan
CHEMBL104 11551 101 None -38 34 Human 5.0 pIC50 = 5.0 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 344 4 0 2 5.4 Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1 nan
5806 109955 20 None 1 3 Rat 6.9 pIC50 = 6.9 Binding
Antagonist activity at rat brain membrane adrenergic beta-1 receptorAntagonist activity at rat brain membrane adrenergic beta-1 receptor
ChEMBL 247 4 2 2 3.0 CC(C)NCC(O)c1ccc(Cl)c(Cl)c1 10.1021/acs.jmedchem.1c01215
CHEMBL30816 109955 20 None 1 3 Rat 6.9 pIC50 = 6.9 Binding
Antagonist activity at rat brain membrane adrenergic beta-1 receptorAntagonist activity at rat brain membrane adrenergic beta-1 receptor
ChEMBL 247 4 2 2 3.0 CC(C)NCC(O)c1ccc(Cl)c(Cl)c1 10.1021/acs.jmedchem.1c01215
5806 109955 20 None - 3 Guinea pig 6.9 pIC50 = 6.9 Binding
Inhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atriaInhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atria
ChEMBL 247 4 2 2 3.0 CC(C)NCC(O)c1ccc(Cl)c(Cl)c1 10.1021/jm00036a018
CHEMBL30816 109955 20 None - 3 Guinea pig 6.9 pIC50 = 6.9 Binding
Inhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atriaInhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atria
ChEMBL 247 4 2 2 3.0 CC(C)NCC(O)c1ccc(Cl)c(Cl)c1 10.1021/jm00036a018
24901141 77314 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 531 11 5 6 4.8 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCCc4c(Cl)cccc4Cl)c3)c2s1 10.1016/j.bmcl.2011.10.049
CHEMBL1947157 77314 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 531 11 5 6 4.8 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCCc4c(Cl)cccc4Cl)c3)c2s1 10.1016/j.bmcl.2011.10.049
12582 7737 45 None -3 5 Human 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O nan
2783 7737 45 None -3 5 Human 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O nan
CHEMBL49080 7737 45 None -3 5 Human 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O nan
DB01407 7737 45 None -3 5 Human 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O nan
44338637 116302 0 None - 0 Guinea pig 5.9 pIC50 = 5.9 Binding
Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)
ChEMBL 346 7 2 5 2.8 COC12CCCCC1c1ccccc1/C2=N/OCC(O)CNC(C)C 10.1021/jm00122a008
CHEMBL322130 116302 0 None - 0 Guinea pig 5.9 pIC50 = 5.9 Binding
Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)
ChEMBL 346 7 2 5 2.8 COC12CCCCC1c1ccccc1/C2=N/OCC(O)CNC(C)C 10.1021/jm00122a008
10416656 25381 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 636 16 4 8 7.2 CCCCCCCCc1csc(N2CCc3c(N/C(=N/c4ccc(CCNC[C@H](O)c5cccnc5)cc4)NC#N)cccc32)n1 10.1016/s0960-894x(00)00669-7
CHEMBL127656 25381 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 636 16 4 8 7.2 CCCCCCCCc1csc(N2CCc3c(N/C(=N/c4ccc(CCNC[C@H](O)c5cccnc5)cc4)NC#N)cccc32)n1 10.1016/s0960-894x(00)00669-7
9831168 211481 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Compound was evaluated for its inhibitory activity against CHO cells expressing the cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindololCompound was evaluated for its inhibitory activity against CHO cells expressing the cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol
ChEMBL 552 11 6 6 5.0 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CC3NCCc4cc(O)c(O)cc43)cc2)cc1 10.1016/s0960-894x(00)00459-5
CHEMBL74085 211481 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Compound was evaluated for its inhibitory activity against CHO cells expressing the cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindololCompound was evaluated for its inhibitory activity against CHO cells expressing the cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol
ChEMBL 552 11 6 6 5.0 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CC3NCCc4cc(O)c(O)cc43)cc2)cc1 10.1016/s0960-894x(00)00459-5
12017012 106598 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 622 12 3 7 6.0 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2coc(Cc3ccc(C(F)(F)F)cc3)n2)cc1 10.1016/s0960-894x(00)00277-8
CHEMBL285520 106598 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 622 12 3 7 6.0 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2coc(Cc3ccc(C(F)(F)F)cc3)n2)cc1 10.1016/s0960-894x(00)00277-8
44338131 115442 0 None - 0 Guinea pig 4.9 pIC50 = 4.9 Binding
Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)
ChEMBL 360 6 2 5 3.2 COC12CCCCC1c1ccccc1/C2=N/OCC(O)CNC(C)(C)C 10.1021/jm00122a008
CHEMBL320761 115442 0 None - 0 Guinea pig 4.9 pIC50 = 4.9 Binding
Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)
ChEMBL 360 6 2 5 3.2 COC12CCCCC1c1ccccc1/C2=N/OCC(O)CNC(C)(C)C 10.1021/jm00122a008
83111 64148 84 None - 0 Human 4.9 pIC50 = 4.9 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 176 1 1 2 1.4 Cc1cccc(N2CCNCC2)c1 10.1021/jm00082a016
CHEMBL165175 64148 84 None - 0 Human 4.9 pIC50 = 4.9 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 176 1 1 2 1.4 Cc1cccc(N2CCNCC2)c1 10.1021/jm00082a016
415628 214971 95 None - 5 Human 4.9 pIC50 = 4.9 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 196 1 1 2 1.8 Clc1ccccc1N1CCNCC1 10.1021/jm00082a016
CHEMBL9841 214971 95 None - 5 Human 4.9 pIC50 = 4.9 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 196 1 1 2 1.8 Clc1ccccc1N1CCNCC1 10.1021/jm00082a016
46881981 12512 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 454 11 3 5 4.2 O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccccc1CCn1cccc1 10.1016/j.bmcl.2010.01.130
CHEMBL1078395 12512 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 454 11 3 5 4.2 O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccccc1CCn1cccc1 10.1016/j.bmcl.2010.01.130
46845698 12554 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 444 9 3 5 4.1 Cc1ccc(N2CCCC2)c(C(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)c1 10.1016/j.bmcl.2010.01.130
CHEMBL1078696 12554 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 444 9 3 5 4.1 Cc1ccc(N2CCCC2)c(C(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)c1 10.1016/j.bmcl.2010.01.130
10464801 17985 0 None - 2 Guinea pig 4.9 pIC50 = 4.9 Binding
Inhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atriaInhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atria
ChEMBL 174 6 2 4 0.4 CCO/N=C/C(O)CNC(C)C 10.1021/jm00036a018
CHEMBL1178754 17985 0 None - 2 Guinea pig 4.9 pIC50 = 4.9 Binding
Inhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atriaInhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atria
ChEMBL 174 6 2 4 0.4 CCO/N=C/C(O)CNC(C)C 10.1021/jm00036a018
CHEMBL39682 17985 0 None - 2 Guinea pig 4.9 pIC50 = 4.9 Binding
Inhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atriaInhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atria
ChEMBL 174 6 2 4 0.4 CCO/N=C/C(O)CNC(C)C 10.1021/jm00036a018
16049160 70865 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 491 15 5 8 3.3 CCOc1ccc(CCNCCCSCCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1 10.1016/j.bmcl.2011.05.097
CHEMBL1807825 70865 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 491 15 5 8 3.3 CCOc1ccc(CCNCCCSCCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1 10.1016/j.bmcl.2011.05.097
16049234 70868 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 481 13 5 7 3.5 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCSCCCNCCc3ccccc3Cl)c2s1 10.1016/j.bmcl.2011.05.097
CHEMBL1807828 70868 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 481 13 5 7 3.5 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCSCCCNCCc3ccccc3Cl)c2s1 10.1016/j.bmcl.2011.05.097
16049374 70873 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 481 13 5 7 3.5 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCSCCNCCc3cccc(Cl)c3)c2s1 10.1016/j.bmcl.2011.05.097
CHEMBL1807869 70873 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 481 13 5 7 3.5 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCSCCNCCc3cccc(Cl)c3)c2s1 10.1016/j.bmcl.2011.05.097
24900811 77139 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 479 11 5 7 3.5 COc1ccccc1CNCc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1 10.1016/j.bmcl.2011.10.049
CHEMBL1945040 77139 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 479 11 5 7 3.5 COc1ccccc1CNCc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1 10.1016/j.bmcl.2011.10.049
57401436 77176 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 479 11 5 7 3.5 COc1ccccc1CNCc1ccc(CCNC[C@@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1 10.1016/j.bmcl.2011.10.049
CHEMBL1945504 77176 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 479 11 5 7 3.5 COc1ccccc1CNCc1ccc(CCNC[C@@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1 10.1016/j.bmcl.2011.10.049
4189 213701 96 None -38 34 Human 4.9 pIC50 = 4.9 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 414 6 0 3 6.5 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 nan
CHEMBL1559 213701 96 None -38 34 Human 4.9 pIC50 = 4.9 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 414 6 0 3 6.5 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 nan
CHEMBL91 213701 96 None -38 34 Human 4.9 pIC50 = 4.9 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 414 6 0 3 6.5 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 nan
3198 212292 76 None -38 34 Human 4.9 pIC50 = 4.9 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 nan
CHEMBL1201049 212292 76 None -38 34 Human 4.9 pIC50 = 4.9 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 nan
CHEMBL808 212292 76 None -38 34 Human 4.9 pIC50 = 4.9 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 nan
10054896 120916 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 639 13 3 9 5.3 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(Cc3ccc(OC(F)(F)F)cc3)n2)cc1 10.1016/s0960-894x(00)00268-7
CHEMBL33292 120916 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 639 13 3 9 5.3 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(Cc3ccc(OC(F)(F)F)cc3)n2)cc1 10.1016/s0960-894x(00)00268-7
12049918 108987 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.
ChEMBL 624 12 3 9 4.9 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(-c3ccc(OC(F)(F)F)cc3)n2)cc1 10.1016/s0960-894x(00)00422-4
CHEMBL302893 108987 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.
ChEMBL 624 12 3 9 4.9 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(-c3ccc(OC(F)(F)F)cc3)n2)cc1 10.1016/s0960-894x(00)00422-4
44307379 210425 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 427 11 3 6 2.5 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2cccnc2)cc1)c1ccccc1 10.1016/s0960-894x(98)00381-3
CHEMBL67251 210425 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 427 11 3 6 2.5 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2cccnc2)cc1)c1ccccc1 10.1016/s0960-894x(98)00381-3
44307378 210579 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 478 11 3 7 3.0 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2cccnc2)cc1)c1cnc2ccccc2c1 10.1016/s0960-894x(98)00381-3
CHEMBL68334 210579 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 478 11 3 7 3.0 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2cccnc2)cc1)c1cnc2ccccc2c1 10.1016/s0960-894x(98)00381-3
44338562 16200 0 None - 0 Guinea pig 4.9 pIC50 = 4.9 Binding
Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)
ChEMBL 482 11 2 7 4.1 COc1cc(CCNCC(O)CO/N=C2/c3ccccc3C3CCCCCC23OC)cc(OC)c1 10.1021/jm00122a008
CHEMBL111706 16200 0 None - 0 Guinea pig 4.9 pIC50 = 4.9 Binding
Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)
ChEMBL 482 11 2 7 4.1 COc1cc(CCNCC(O)CO/N=C2/c3ccccc3C3CCCCCC23OC)cc(OC)c1 10.1021/jm00122a008
44301842 205650 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 606 11 3 7 6.7 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc4ccccc4c3)cs2)cc1 10.1016/s0960-894x(00)00390-5
CHEMBL58407 205650 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 606 11 3 7 6.7 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc4ccccc4c3)cs2)cc1 10.1016/s0960-894x(00)00390-5
80447 64002 119 None - 0 Human 4.9 pIC50 = 4.9 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 207 2 1 4 1.0 O=[N+]([O-])c1ccc(N2CCNCC2)cc1 10.1021/jm00082a016
CHEMBL165012 64002 119 None - 0 Human 4.9 pIC50 = 4.9 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 207 2 1 4 1.0 O=[N+]([O-])c1ccc(N2CCNCC2)cc1 10.1021/jm00082a016
46881899 14559 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 437 9 3 4 4.9 O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccccc1-c1ccccc1 10.1016/j.bmcl.2010.01.130
CHEMBL1089395 14559 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 437 9 3 4 4.9 O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccccc1-c1ccccc1 10.1016/j.bmcl.2010.01.130
2249 7300 111 None -5 12 Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C nan
255 7300 111 None -5 12 Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C nan
548 7300 111 None -5 12 Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C nan
CHEMBL24 7300 111 None -5 12 Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C nan
DB00335 7300 111 None -5 12 Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C nan
76332892 112691 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Displacement of [125I]-cyanopindolol from recombinant human beta-1 adrenergic receptor expressed in CHO cell membranes after 1 hr by scintillation counting analysisDisplacement of [125I]-cyanopindolol from recombinant human beta-1 adrenergic receptor expressed in CHO cell membranes after 1 hr by scintillation counting analysis
ChEMBL 528 7 3 6 5.4 O=C(Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3cccnc3)N2)cc1)[C@@H]1CCc2sc(-c3ccc(F)cc3)nc21 10.1021/jm4017224
CHEMBL3128185 112691 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Displacement of [125I]-cyanopindolol from recombinant human beta-1 adrenergic receptor expressed in CHO cell membranes after 1 hr by scintillation counting analysisDisplacement of [125I]-cyanopindolol from recombinant human beta-1 adrenergic receptor expressed in CHO cell membranes after 1 hr by scintillation counting analysis
ChEMBL 528 7 3 6 5.4 O=C(Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3cccnc3)N2)cc1)[C@@H]1CCc2sc(-c3ccc(F)cc3)nc21 10.1021/jm4017224
10375227 17989 0 None - 2 Guinea pig 4.9 pIC50 = 4.9 Binding
Inhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atriaInhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atria
ChEMBL 188 5 2 4 0.8 C/C=N/OCC(O)CNC(C)(C)C 10.1021/jm00036a018
CHEMBL1178761 17989 0 None - 2 Guinea pig 4.9 pIC50 = 4.9 Binding
Inhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atriaInhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atria
ChEMBL 188 5 2 4 0.8 C/C=N/OCC(O)CNC(C)(C)C 10.1021/jm00036a018
CHEMBL39873 17989 0 None - 2 Guinea pig 4.9 pIC50 = 4.9 Binding
Inhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atriaInhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atria
ChEMBL 188 5 2 4 0.8 C/C=N/OCC(O)CNC(C)(C)C 10.1021/jm00036a018
10012704 17993 0 None - 2 Guinea pig 4.9 pIC50 = 4.9 Binding
Inhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atriaInhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atria
ChEMBL 188 5 2 4 0.8 CCO/N=C/C(O)CNC(C)(C)C 10.1021/jm00036a018
CHEMBL1178768 17993 0 None - 2 Guinea pig 4.9 pIC50 = 4.9 Binding
Inhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atriaInhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atria
ChEMBL 188 5 2 4 0.8 CCO/N=C/C(O)CNC(C)(C)C 10.1021/jm00036a018
CHEMBL39987 17993 0 None - 2 Guinea pig 4.9 pIC50 = 4.9 Binding
Inhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atriaInhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atria
ChEMBL 188 5 2 4 0.8 CCO/N=C/C(O)CNC(C)(C)C 10.1021/jm00036a018
44268308 24881 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand.Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand.
ChEMBL 472 12 4 7 2.8 COc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00169-3
CHEMBL12686 24881 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand.Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand.
ChEMBL 472 12 4 7 2.8 COc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00169-3
46881698 13940 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 458 10 3 5 2.9 O=C(CN1CC(c2ccccc2)CC1=O)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/j.bmcl.2010.01.130
CHEMBL1085444 13940 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 458 10 3 5 2.9 O=C(CN1CC(c2ccccc2)CC1=O)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/j.bmcl.2010.01.130
44298288 108360 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 441 9 1 5 5.8 CCCCCCc1csc(N2CCc3cc(S(=O)(=O)Nc4ccccc4)ccc32)n1 10.1016/s0960-894x(99)00277-2
CHEMBL298594 108360 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 441 9 1 5 5.8 CCCCCCc1csc(N2CCc3cc(S(=O)(=O)Nc4ccccc4)ccc32)n1 10.1016/s0960-894x(99)00277-2
44298515 202627 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 436 9 1 5 5.1 CCCCCCc1ccnc(N2CCc3cc(S(=O)(=O)Nc4ccccc4)ccc32)n1 10.1016/s0960-894x(99)00277-2
CHEMBL55852 202627 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 436 9 1 5 5.1 CCCCCCc1ccnc(N2CCc3cc(S(=O)(=O)Nc4ccccc4)ccc32)n1 10.1016/s0960-894x(99)00277-2
44457929 91552 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Inhibitory activity against cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol in CHO cells by receptor binding assayInhibitory activity against cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol in CHO cells by receptor binding assay
ChEMBL 593 17 3 10 3.9 CCCCCCCCn1nnn(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)c1=O 10.1016/s0960-894x(99)00182-1
CHEMBL22318 91552 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Inhibitory activity against cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol in CHO cells by receptor binding assayInhibitory activity against cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol in CHO cells by receptor binding assay
ChEMBL 593 17 3 10 3.9 CCCCCCCCn1nnn(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)c1=O 10.1016/s0960-894x(99)00182-1
91965 214809 96 None - 2 Human 4.9 pIC50 = 4.9 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 176 1 1 2 1.4 Cc1ccccc1N1CCNCC1 10.1021/jm00082a016
CHEMBL9746 214809 96 None - 2 Human 4.9 pIC50 = 4.9 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 176 1 1 2 1.4 Cc1ccccc1N1CCNCC1 10.1021/jm00082a016
145946965 174375 0 None - 1 Rat 5.9 pIC50 = 5.9 Binding
Displacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysisDisplacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysis
ChEMBL 431 6 1 7 2.9 O=c1c2ccccc2oc2c(OCC(O)CN3CCN(c4ccccn4)CC3)cccc12 10.1016/j.bmc.2018.04.038
CHEMBL4126588 174375 0 None - 1 Rat 5.9 pIC50 = 5.9 Binding
Displacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysisDisplacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysis
ChEMBL 431 6 1 7 2.9 O=c1c2ccccc2oc2c(OCC(O)CN3CCN(c4ccccn4)CC3)cccc12 10.1016/j.bmc.2018.04.038
CHEMBL4300897 174375 0 None - 1 Rat 5.9 pIC50 = 5.9 Binding
Displacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysisDisplacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysis
ChEMBL 431 6 1 7 2.9 O=c1c2ccccc2oc2c(OCC(O)CN3CCN(c4ccccn4)CC3)cccc12 10.1016/j.bmc.2018.04.038
2464 10412 58 None -2 6 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C nan
5253 10412 58 None -2 6 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C nan
7297 10412 58 None -2 6 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C nan
CHEMBL471 10412 58 None -2 6 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C nan
DB00489 10412 58 None -2 6 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C nan
44268249 26286 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 331 9 4 5 2.4 C[C@@H](CCc1ccc(O)cc1)NC[C@H](O)COc1ccc(O)cc1 10.1016/s0960-894x(98)00169-3
CHEMBL12994 26286 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 331 9 4 5 2.4 C[C@@H](CCc1ccc(O)cc1)NC[C@H](O)COc1ccc(O)cc1 10.1016/s0960-894x(98)00169-3
44268495 31802 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 612 19 6 7 5.2 CCCCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
CHEMBL13467 31802 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 612 19 6 7 5.2 CCCCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
44268496 105151 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 542 13 6 7 3.3 CC(C)NC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
CHEMBL275291 105151 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 542 13 6 7 3.3 CC(C)NC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
44268320 25198 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand.Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand.
ChEMBL 456 11 4 6 3.1 Cc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00169-3
CHEMBL12718 25198 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand.Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand.
ChEMBL 456 11 4 6 3.1 Cc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00169-3
44301618 205860 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 574 11 3 7 5.7 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc(F)cc3)cs2)cc1 10.1016/s0960-894x(00)00390-5
CHEMBL58798 205860 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 574 11 3 7 5.7 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc(F)cc3)cs2)cc1 10.1016/s0960-894x(00)00390-5
46881618 14786 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 458 10 3 6 4.3 O=C(Cc1csc(-c2ccccc2)n1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/j.bmcl.2010.01.130
CHEMBL1090746 14786 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 458 10 3 6 4.3 O=C(Cc1csc(-c2ccccc2)n1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/j.bmcl.2010.01.130
44298769 203886 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 457 12 1 5 6.6 CCCCCCCCc1csc(N(C)c2ccc(S(=O)(=O)Nc3ccccc3)cc2)n1 10.1016/s0960-894x(99)00277-2
CHEMBL56767 203886 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 457 12 1 5 6.6 CCCCCCCCc1csc(N(C)c2ccc(S(=O)(=O)Nc3ccccc3)cc2)n1 10.1016/s0960-894x(99)00277-2
97478 16701 100 None - 0 Human 4.8 pIC50 = 4.8 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 196 1 1 2 1.8 Clc1ccc(N2CCNCC2)cc1 10.1021/jm00082a016
CHEMBL114478 16701 100 None - 0 Human 4.8 pIC50 = 4.8 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 196 1 1 2 1.8 Clc1ccc(N2CCNCC2)cc1 10.1021/jm00082a016
10103956 17972 0 None - 2 Guinea pig 4.8 pIC50 = 4.8 Binding
Inhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atriaInhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atria
ChEMBL 188 7 2 4 0.8 CC/C=N/OCC(O)CNC(C)C 10.1021/jm00036a018
CHEMBL1178707 17972 0 None - 2 Guinea pig 4.8 pIC50 = 4.8 Binding
Inhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atriaInhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atria
ChEMBL 188 7 2 4 0.8 CC/C=N/OCC(O)CNC(C)C 10.1021/jm00036a018
CHEMBL38114 17972 0 None - 2 Guinea pig 4.8 pIC50 = 4.8 Binding
Inhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atriaInhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atria
ChEMBL 188 7 2 4 0.8 CC/C=N/OCC(O)CNC(C)C 10.1021/jm00036a018
9990035 18793 0 None - 2 Guinea pig 4.8 pIC50 = 4.8 Binding
Inhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atriaInhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atria
ChEMBL 188 7 2 4 0.8 CCCO/N=C/C(O)CNC(C)C 10.1021/jm00036a018
CHEMBL1183337 18793 0 None - 2 Guinea pig 4.8 pIC50 = 4.8 Binding
Inhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atriaInhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atria
ChEMBL 188 7 2 4 0.8 CCCO/N=C/C(O)CNC(C)C 10.1021/jm00036a018
CHEMBL291115 18793 0 None - 2 Guinea pig 4.8 pIC50 = 4.8 Binding
Inhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atriaInhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atria
ChEMBL 188 7 2 4 0.8 CCCO/N=C/C(O)CNC(C)C 10.1021/jm00036a018
16049450 70867 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 481 13 5 7 3.5 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCSCCCNCCc3cccc(Cl)c3)c2s1 10.1016/j.bmcl.2011.05.097
CHEMBL1807827 70867 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 481 13 5 7 3.5 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCSCCCNCCc3cccc(Cl)c3)c2s1 10.1016/j.bmcl.2011.05.097
56670158 70870 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 497 13 5 7 2.5 O=c1[nH]c2c(O)ccc([C@@H](O)CNCC[S+]([O-])CCCNCCc3cccc(Cl)c3)c2s1 10.1016/j.bmcl.2011.05.097
CHEMBL1807830 70870 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 497 13 5 7 2.5 O=c1[nH]c2c(O)ccc([C@@H](O)CNCC[S+]([O-])CCCNCCc3cccc(Cl)c3)c2s1 10.1016/j.bmcl.2011.05.097
24901210 77103 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 497 11 5 6 4.1 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCCc4ccccc4Cl)c3)c2s1 10.1016/j.bmcl.2011.10.049
CHEMBL1944690 77103 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 497 11 5 6 4.1 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCCc4ccccc4Cl)c3)c2s1 10.1016/j.bmcl.2011.10.049
24900685 77132 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 464 11 5 7 2.9 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCCc4ccccn4)c3)c2s1 10.1016/j.bmcl.2011.10.049
CHEMBL1945033 77132 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 464 11 5 7 2.9 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCCc4ccccn4)c3)c2s1 10.1016/j.bmcl.2011.10.049
24901283 77157 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 417 11 5 7 1.9 COCCNCc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1 10.1016/j.bmcl.2011.10.049
CHEMBL1945292 77157 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 417 11 5 7 1.9 COCCNCc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1 10.1016/j.bmcl.2011.10.049
10282871 23321 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 636 16 4 8 7.2 CCCCCCCCc1csc(N2CCc3cc(N/C(=N/c4ccc(CCNC[C@H](O)c5cccnc5)cc4)NC#N)ccc32)n1 10.1016/s0960-894x(00)00669-7
CHEMBL123745 23321 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 636 16 4 8 7.2 CCCCCCCCc1csc(N2CCc3cc(N/C(=N/c4ccc(CCNC[C@H](O)c5cccnc5)cc4)NC#N)ccc32)n1 10.1016/s0960-894x(00)00669-7
44335534 11598 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 559 13 5 6 4.1 O=C(NCCc1ccccc1)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(98)00571-x
CHEMBL104193 11598 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 559 13 5 6 4.1 O=C(NCCc1ccccc1)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(98)00571-x
44338543 12713 0 None - 0 Guinea pig 6.8 pIC50 = 6.8 Binding
Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)
ChEMBL 374 6 2 5 3.6 COC12CCCCCC1c1ccccc1/C2=N/OCC(O)CNC(C)(C)C 10.1021/jm00122a008
CHEMBL107981 12713 0 None - 0 Guinea pig 6.8 pIC50 = 6.8 Binding
Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)
ChEMBL 374 6 2 5 3.6 COC12CCCCCC1c1ccccc1/C2=N/OCC(O)CNC(C)(C)C 10.1021/jm00122a008
131847 62852 7 None - 0 Human 6.8 pIC50 = 6.8 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 388 6 3 5 1.3 CS(=O)(=O)Nc1ccc(C(=O)NCC2CN(c3ccccc3)CCN2)cc1 10.1021/jm00082a016
CHEMBL162513 62852 7 None - 0 Human 6.8 pIC50 = 6.8 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 388 6 3 5 1.3 CS(=O)(=O)Nc1ccc(C(=O)NCC2CN(c3ccccc3)CCN2)cc1 10.1021/jm00082a016
44301819 107839 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 612 11 3 7 6.8 CC(C)(C)c1ccc(-c2csc(-c3ccc(S(=O)(=O)Nc4ccc(CCNC[C@H](O)c5cccnc5)cc4)cc3)n2)cc1 10.1016/s0960-894x(00)00390-5
CHEMBL294753 107839 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 612 11 3 7 6.8 CC(C)(C)c1ccc(-c2csc(-c3ccc(S(=O)(=O)Nc4ccc(CCNC[C@H](O)c5cccnc5)cc4)cc3)n2)cc1 10.1016/s0960-894x(00)00390-5
208932 20329 8 None - 0 Human 5.8 pIC50 = 5.8 Binding
Tested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogsTested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 446 12 3 8 1.7 CS(=O)(=O)Nc1ccc(OC[C@@H](O)CNCCOc2ccc(-n3ccnc3)cc2)cc1 10.1021/jm00172a033
CHEMBL1193886 20329 8 None - 0 Human 5.8 pIC50 = 5.8 Binding
Tested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogsTested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 446 12 3 8 1.7 CS(=O)(=O)Nc1ccc(OC[C@@H](O)CNCCOc2ccc(-n3ccnc3)cc2)cc1 10.1021/jm00172a033
CHEMBL545363 20329 8 None - 0 Human 5.8 pIC50 = 5.8 Binding
Tested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogsTested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 446 12 3 8 1.7 CS(=O)(=O)Nc1ccc(OC[C@@H](O)CNCCOc2ccc(-n3ccnc3)cc2)cc1 10.1021/jm00172a033
44281531 107298 0 None - 0 Human 4.8 pIC50 = 4.8 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 601 13 3 9 5.1 CSc1ccc(Cc2nc(-c3ccc(S(=O)(=O)Nc4ccc(CCNC[C@H](O)c5cccnc5)cc4)cc3)no2)cc1 10.1016/s0960-894x(00)00268-7
CHEMBL291246 107298 0 None - 0 Human 4.8 pIC50 = 4.8 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 601 13 3 9 5.1 CSc1ccc(Cc2nc(-c3ccc(S(=O)(=O)Nc4ccc(CCNC[C@H](O)c5cccnc5)cc4)cc3)no2)cc1 10.1016/s0960-894x(00)00268-7
46881796 12370 0 None - 0 Human 4.8 pIC50 = 4.8 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 401 8 3 6 2.8 O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1cccc2ccnn12 10.1016/j.bmcl.2010.01.130
CHEMBL1077273 12370 0 None - 0 Human 4.8 pIC50 = 4.8 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 401 8 3 6 2.8 O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1cccc2ccnn12 10.1016/j.bmcl.2010.01.130
2249 7300 111 None -5 12 Human 5.8 pIC50 = 5.8 Binding
Inhibition of human alpha1 adrenoceptorInhibition of human alpha1 adrenoceptor
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1016/j.bmc.2010.07.034
255 7300 111 None -5 12 Human 5.8 pIC50 = 5.8 Binding
Inhibition of human alpha1 adrenoceptorInhibition of human alpha1 adrenoceptor
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1016/j.bmc.2010.07.034
548 7300 111 None -5 12 Human 5.8 pIC50 = 5.8 Binding
Inhibition of human alpha1 adrenoceptorInhibition of human alpha1 adrenoceptor
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1016/j.bmc.2010.07.034
CHEMBL24 7300 111 None -5 12 Human 5.8 pIC50 = 5.8 Binding
Inhibition of human alpha1 adrenoceptorInhibition of human alpha1 adrenoceptor
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1016/j.bmc.2010.07.034
DB00335 7300 111 None -5 12 Human 5.8 pIC50 = 5.8 Binding
Inhibition of human alpha1 adrenoceptorInhibition of human alpha1 adrenoceptor
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1016/j.bmc.2010.07.034
16118894 9023 5 None - 0 Human 6.8 pIC50 = 6.8 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 568 11 4 6 3.4 O[C@H](COc1ccc(cc1)O)CNCCc1ccc(cc1)NS(=O)(=O)c1ccc(cc1)I 10.1016/s0960-894x(98)00381-3
3467 9023 5 None - 0 Human 6.8 pIC50 = 6.8 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 568 11 4 6 3.4 O[C@H](COc1ccc(cc1)O)CNCCc1ccc(cc1)NS(=O)(=O)c1ccc(cc1)I 10.1016/s0960-894x(98)00381-3
CHEMBL276257 9023 5 None - 0 Human 6.8 pIC50 = 6.8 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 568 11 4 6 3.4 O[C@H](COc1ccc(cc1)O)CNCCc1ccc(cc1)NS(=O)(=O)c1ccc(cc1)I 10.1016/s0960-894x(98)00381-3
16118894 9023 5 None - 0 Human 6.8 pIC50 = 6.8 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 568 11 4 6 3.4 O[C@H](COc1ccc(cc1)O)CNCCc1ccc(cc1)NS(=O)(=O)c1ccc(cc1)I 10.1016/s0960-894x(98)00169-3
3467 9023 5 None - 0 Human 6.8 pIC50 = 6.8 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 568 11 4 6 3.4 O[C@H](COc1ccc(cc1)O)CNCCc1ccc(cc1)NS(=O)(=O)c1ccc(cc1)I 10.1016/s0960-894x(98)00169-3
CHEMBL276257 9023 5 None - 0 Human 6.8 pIC50 = 6.8 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 568 11 4 6 3.4 O[C@H](COc1ccc(cc1)O)CNCCc1ccc(cc1)NS(=O)(=O)c1ccc(cc1)I 10.1016/s0960-894x(98)00169-3
11758172 107711 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 592 11 3 7 5.8 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc(F)c(F)c3)cs2)cc1 10.1016/s0960-894x(00)00390-5
CHEMBL293994 107711 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 592 11 3 7 5.8 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc(F)c(F)c3)cs2)cc1 10.1016/s0960-894x(00)00390-5
14998849 63289 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 418 7 3 6 1.3 COc1cccc(N2CCNC(CNC(=O)c3ccc(NS(C)(=O)=O)cc3)C2)c1 10.1021/jm00082a016
CHEMBL163587 63289 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 418 7 3 6 1.3 COc1cccc(N2CCNC(CNC(=O)c3ccc(NS(C)(=O)=O)cc3)C2)c1 10.1021/jm00082a016
11758172 107711 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Binding affinity was evaluated on chinese hamster ovary (CHO) cells expressing the cloned human beta-1 adrenergic receptor in the presence of [125I]- iodocyanopindolol.Binding affinity was evaluated on chinese hamster ovary (CHO) cells expressing the cloned human beta-1 adrenergic receptor in the presence of [125I]- iodocyanopindolol.
ChEMBL 592 11 3 7 5.8 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc(F)c(F)c3)cs2)cc1 10.1021/jm000286i
CHEMBL293994 107711 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Binding affinity was evaluated on chinese hamster ovary (CHO) cells expressing the cloned human beta-1 adrenergic receptor in the presence of [125I]- iodocyanopindolol.Binding affinity was evaluated on chinese hamster ovary (CHO) cells expressing the cloned human beta-1 adrenergic receptor in the presence of [125I]- iodocyanopindolol.
ChEMBL 592 11 3 7 5.8 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc(F)c(F)c3)cs2)cc1 10.1021/jm000286i
46881983 12539 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 477 9 4 5 4.7 O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccccc1-c1nc2ccccc2[nH]1 10.1016/j.bmcl.2010.01.130
CHEMBL1078575 12539 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 477 9 4 5 4.7 O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccccc1-c1nc2ccccc2[nH]1 10.1016/j.bmcl.2010.01.130
208932 20329 8 None - 0 Human 5.8 pIC50 = 5.8 Binding
In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)
ChEMBL 446 12 3 8 1.7 CS(=O)(=O)Nc1ccc(OC[C@@H](O)CNCCOc2ccc(-n3ccnc3)cc2)cc1 10.1021/jm00166a002
CHEMBL1193886 20329 8 None - 0 Human 5.8 pIC50 = 5.8 Binding
In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)
ChEMBL 446 12 3 8 1.7 CS(=O)(=O)Nc1ccc(OC[C@@H](O)CNCCOc2ccc(-n3ccnc3)cc2)cc1 10.1021/jm00166a002
CHEMBL545363 20329 8 None - 0 Human 5.8 pIC50 = 5.8 Binding
In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)
ChEMBL 446 12 3 8 1.7 CS(=O)(=O)Nc1ccc(OC[C@@H](O)CNCCOc2ccc(-n3ccnc3)cc2)cc1 10.1021/jm00166a002
71612644 140141 0 None 2 2 Human 4.8 pIC50 = 4.8 Binding
Inhibition Assay: Human recombinant adrenergic β1 receptors expressed in CHO-K1 cells are used in modified Tris-HCl buffer pH 7.4. A 25 aliquot is incubated with 0.03 nM [125I]Cyanopindolol for 120 minutes at 25° C. Non-specific binding is estimated in the presence of 100 μM S(−)-Propranolol. Receptors are filtered and washed, the filters are then counted to determine [125I]Cyanopindolol specifically bound. Compounds are screened at 10 μM.Inhibition Assay: Human recombinant adrenergic β1 receptors expressed in CHO-K1 cells are used in modified Tris-HCl buffer pH 7.4. A 25 aliquot is incubated with 0.03 nM [125I]Cyanopindolol for 120 minutes at 25° C. Non-specific binding is estimated in the presence of 100 μM S(−)-Propranolol. Receptors are filtered and washed, the filters are then counted to determine [125I]Cyanopindolol specifically bound. Compounds are screened at 10 μM.
ChEMBL 303 7 2 5 0.5 N#CC1CCCN1C(=O)CNCC(O)COc1ccccc1 nan
CHEMBL3704833 140141 0 None 2 2 Human 4.8 pIC50 = 4.8 Binding
Inhibition Assay: Human recombinant adrenergic β1 receptors expressed in CHO-K1 cells are used in modified Tris-HCl buffer pH 7.4. A 25 aliquot is incubated with 0.03 nM [125I]Cyanopindolol for 120 minutes at 25° C. Non-specific binding is estimated in the presence of 100 μM S(−)-Propranolol. Receptors are filtered and washed, the filters are then counted to determine [125I]Cyanopindolol specifically bound. Compounds are screened at 10 μM.Inhibition Assay: Human recombinant adrenergic β1 receptors expressed in CHO-K1 cells are used in modified Tris-HCl buffer pH 7.4. A 25 aliquot is incubated with 0.03 nM [125I]Cyanopindolol for 120 minutes at 25° C. Non-specific binding is estimated in the presence of 100 μM S(−)-Propranolol. Receptors are filtered and washed, the filters are then counted to determine [125I]Cyanopindolol specifically bound. Compounds are screened at 10 μM.
ChEMBL 303 7 2 5 0.5 N#CC1CCCN1C(=O)CNCC(O)COc1ccccc1 nan
1016 10519 78 None -43 35 Human 4.8 pIC50 = 4.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
2561 10519 78 None -43 35 Human 4.8 pIC50 = 4.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
2733526 10519 78 None -43 35 Human 4.8 pIC50 = 4.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
5384 10519 78 None -43 35 Human 4.8 pIC50 = 4.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
CHEMBL83 10519 78 None -43 35 Human 4.8 pIC50 = 4.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
DB00675 10519 78 None -43 35 Human 4.8 pIC50 = 4.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
2247 7293 81 None -128 42 Human 4.8 pIC50 = 4.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
249 7293 81 None -128 42 Human 4.8 pIC50 = 4.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
2603 7293 81 None -128 42 Human 4.8 pIC50 = 4.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
CHEMBL296419 7293 81 None -128 42 Human 4.8 pIC50 = 4.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
DB00637 7293 81 None -128 42 Human 4.8 pIC50 = 4.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
2249 7300 111 None -5 12 Human 5.8 pIC50 = 5.8 Binding
Inhibition of human beta 1 adrenergic receptorInhibition of human beta 1 adrenergic receptor
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm701575k
255 7300 111 None -5 12 Human 5.8 pIC50 = 5.8 Binding
Inhibition of human beta 1 adrenergic receptorInhibition of human beta 1 adrenergic receptor
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm701575k
548 7300 111 None -5 12 Human 5.8 pIC50 = 5.8 Binding
Inhibition of human beta 1 adrenergic receptorInhibition of human beta 1 adrenergic receptor
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm701575k
CHEMBL24 7300 111 None -5 12 Human 5.8 pIC50 = 5.8 Binding
Inhibition of human beta 1 adrenergic receptorInhibition of human beta 1 adrenergic receptor
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm701575k
DB00335 7300 111 None -5 12 Human 5.8 pIC50 = 5.8 Binding
Inhibition of human beta 1 adrenergic receptorInhibition of human beta 1 adrenergic receptor
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm701575k
1786 9298 85 None -1 11 Human 6.8 pIC50 = 6.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O nan
4171 9298 85 None -1 11 Human 6.8 pIC50 = 6.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O nan
553 9298 85 None -1 11 Human 6.8 pIC50 = 6.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O nan
CHEMBL13 9298 85 None -1 11 Human 6.8 pIC50 = 6.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O nan
DB00264 9298 85 None -1 11 Human 6.8 pIC50 = 6.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O nan
145946488 174316 0 None -46 2 Rat 6.8 pIC50 = 6.8 Binding
Displacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysisDisplacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysis
ChEMBL 435 10 2 7 3.4 COc1ccccc1OCCNCC(O)COc1cccc2c(=O)c3ccccc3oc12 10.1016/j.bmc.2018.04.038
CHEMBL4127540 174316 0 None -46 2 Rat 6.8 pIC50 = 6.8 Binding
Displacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysisDisplacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysis
ChEMBL 435 10 2 7 3.4 COc1ccccc1OCCNCC(O)COc1cccc2c(=O)c3ccccc3oc12 10.1016/j.bmc.2018.04.038
CHEMBL4300195 174316 0 None -46 2 Rat 6.8 pIC50 = 6.8 Binding
Displacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysisDisplacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysis
ChEMBL 435 10 2 7 3.4 COc1ccccc1OCCNCC(O)COc1cccc2c(=O)c3ccccc3oc12 10.1016/j.bmc.2018.04.038
145947665 174461 0 None 10 2 Rat 6.8 pIC50 = 6.8 Binding
Displacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysisDisplacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysis
ChEMBL 405 8 2 6 3.5 COc1ccccc1CNCC(O)COc1cccc2c(=O)c3ccccc3oc12 10.1016/j.bmc.2018.04.038
CHEMBL4128794 174461 0 None 10 2 Rat 6.8 pIC50 = 6.8 Binding
Displacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysisDisplacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysis
ChEMBL 405 8 2 6 3.5 COc1ccccc1CNCC(O)COc1cccc2c(=O)c3ccccc3oc12 10.1016/j.bmc.2018.04.038
CHEMBL4302144 174461 0 None 10 2 Rat 6.8 pIC50 = 6.8 Binding
Displacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysisDisplacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysis
ChEMBL 405 8 2 6 3.5 COc1ccccc1CNCC(O)COc1cccc2c(=O)c3ccccc3oc12 10.1016/j.bmc.2018.04.038
2303 9961 68 None -9 26 Human 7.8 pIC50 = 7.8 Binding
Tested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogsTested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00172a033
4946 9961 68 None -9 26 Human 7.8 pIC50 = 7.8 Binding
Tested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogsTested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00172a033
564 9961 68 None -9 26 Human 7.8 pIC50 = 7.8 Binding
Tested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogsTested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00172a033
63 9961 68 None -9 26 Human 7.8 pIC50 = 7.8 Binding
Tested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogsTested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00172a033
91536 9961 68 None -9 26 Human 7.8 pIC50 = 7.8 Binding
Tested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogsTested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00172a033
CHEMBL27 9961 68 None -9 26 Human 7.8 pIC50 = 7.8 Binding
Tested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogsTested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00172a033
CHEMBL452861 9961 68 None -9 26 Human 7.8 pIC50 = 7.8 Binding
Tested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogsTested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00172a033
DB00571 9961 68 None -9 26 Human 7.8 pIC50 = 7.8 Binding
Tested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogsTested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00172a033
9933039 169824 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 442 11 4 6 2.8 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1ccccc1 10.1016/s0960-894x(98)00169-3
CHEMBL417613 169824 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 442 11 4 6 2.8 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1ccccc1 10.1016/s0960-894x(98)00169-3
44349356 123762 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 469 11 4 7 4.7 O=[N+]([O-])/C=C(\Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)Nc1cccc2ccccc12 10.1016/s0960-894x(00)00669-7
CHEMBL338748 123762 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 469 11 4 7 4.7 O=[N+]([O-])/C=C(\Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)Nc1cccc2ccccc12 10.1016/s0960-894x(00)00669-7
10627736 123774 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Binding affinity was evaluated on chinese hamster ovary (CHO) cells expressing the cloned human beta-1 adrenergic receptor in the presence of [125I]- iodocyanopindolol.Binding affinity was evaluated on chinese hamster ovary (CHO) cells expressing the cloned human beta-1 adrenergic receptor in the presence of [125I]- iodocyanopindolol.
ChEMBL 624 11 3 7 6.6 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3cccc(C(F)(F)F)c3)cs2)cc1 10.1021/jm000286i
CHEMBL338794 123774 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Binding affinity was evaluated on chinese hamster ovary (CHO) cells expressing the cloned human beta-1 adrenergic receptor in the presence of [125I]- iodocyanopindolol.Binding affinity was evaluated on chinese hamster ovary (CHO) cells expressing the cloned human beta-1 adrenergic receptor in the presence of [125I]- iodocyanopindolol.
ChEMBL 624 11 3 7 6.6 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3cccc(C(F)(F)F)c3)cs2)cc1 10.1021/jm000286i
44312924 171605 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Compound was evaluated for its inhibitory activity against CHO cells expressing the cloned human beta-1 adrenergic receptor (AR) in the presence of [125I]-iodocyanopindololCompound was evaluated for its inhibitory activity against CHO cells expressing the cloned human beta-1 adrenergic receptor (AR) in the presence of [125I]-iodocyanopindolol
ChEMBL 421 6 3 6 4.2 COc1cc(-c2ccc(CC3NCCc4cc(O)c(O)cc43)cc2)cc(OC)c1OC 10.1016/s0960-894x(00)00459-5
CHEMBL421871 171605 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Compound was evaluated for its inhibitory activity against CHO cells expressing the cloned human beta-1 adrenergic receptor (AR) in the presence of [125I]-iodocyanopindololCompound was evaluated for its inhibitory activity against CHO cells expressing the cloned human beta-1 adrenergic receptor (AR) in the presence of [125I]-iodocyanopindolol
ChEMBL 421 6 3 6 4.2 COc1cc(-c2ccc(CC3NCCc4cc(O)c(O)cc43)cc2)cc(OC)c1OC 10.1016/s0960-894x(00)00459-5
9826638 210078 1 None - 0 Human 5.8 pIC50 = 5.8 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 484 12 4 7 3.2 CC(C)c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(N)nc3)cc2)cc1 10.1016/s0960-894x(98)00381-3
CHEMBL64760 210078 1 None - 0 Human 5.8 pIC50 = 5.8 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 484 12 4 7 3.2 CC(C)c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(N)nc3)cc2)cc1 10.1016/s0960-894x(98)00381-3
44298695 107712 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 414 10 1 3 5.1 CCCCCCCCC(=O)N1CCc2cc(S(=O)(=O)Nc3ccccc3)ccc21 10.1016/s0960-894x(99)00277-2
CHEMBL294008 107712 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 414 10 1 3 5.1 CCCCCCCCC(=O)N1CCc2cc(S(=O)(=O)Nc3ccccc3)ccc21 10.1016/s0960-894x(99)00277-2
44298843 203442 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 435 9 1 4 5.7 CCCCCCc1ccc(N2CCc3cc(S(=O)(=O)Nc4ccccc4)ccc32)nc1 10.1016/s0960-894x(99)00277-2
CHEMBL56449 203442 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 435 9 1 4 5.7 CCCCCCc1ccc(N2CCc3cc(S(=O)(=O)Nc4ccccc4)ccc32)nc1 10.1016/s0960-894x(99)00277-2
10347866 91782 1 None - 0 Human 4.8 pIC50 = 4.8 Binding
Binding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindololBinding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol
ChEMBL 563 15 3 8 4.3 CCCCCCn1ccn(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)c1=O 10.1016/s0960-894x(99)00073-6
CHEMBL22386 91782 1 None - 0 Human 4.8 pIC50 = 4.8 Binding
Binding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindololBinding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol
ChEMBL 563 15 3 8 4.3 CCCCCCn1ccn(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)c1=O 10.1016/s0960-894x(99)00073-6
10347866 91782 1 None - 0 Human 4.8 pIC50 = 4.8 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 563 15 3 8 4.3 CCCCCCn1ccn(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)c1=O 10.1016/s0960-894x(99)00072-4
CHEMBL22386 91782 1 None - 0 Human 4.8 pIC50 = 4.8 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 563 15 3 8 4.3 CCCCCCn1ccn(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)c1=O 10.1016/s0960-894x(99)00072-4
14664347 20403 0 None - 0 Human 4.8 pIC50 = 4.8 Binding
In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)
ChEMBL 474 12 2 8 2.0 Cc1nccn1-c1ccc(OCCNCC(O)COc2ccc(N(C)S(C)(=O)=O)cc2)cc1 10.1021/jm00166a002
CHEMBL11944 20403 0 None - 0 Human 4.8 pIC50 = 4.8 Binding
In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)
ChEMBL 474 12 2 8 2.0 Cc1nccn1-c1ccc(OCCNCC(O)COc2ccc(N(C)S(C)(=O)=O)cc2)cc1 10.1021/jm00166a002
44276727 104089 0 None - 3 Human 6.7 pIC50 = 6.7 Binding
Compound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heart.Compound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heart.
ChEMBL 263 6 2 3 2.2 Cc1ccc(OCC(O)CNC(C)C)c2c1CCC2 10.1021/jm00350a009
CHEMBL26917 104089 0 None - 3 Human 6.7 pIC50 = 6.7 Binding
Compound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heart.Compound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heart.
ChEMBL 263 6 2 3 2.2 Cc1ccc(OCC(O)CNC(C)C)c2c1CCC2 10.1021/jm00350a009
24900426 77136 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 477 12 5 6 3.9 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCCCc4ccccc4)c3)c2s1 10.1016/j.bmcl.2011.10.049
CHEMBL1945037 77136 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 477 12 5 6 3.9 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCCCc4ccccc4)c3)c2s1 10.1016/j.bmcl.2011.10.049
24901285 77162 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 545 11 5 6 5.2 CC(Cc1cccc(CNCCc2c(Cl)cccc2Cl)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12 10.1016/j.bmcl.2011.10.049
CHEMBL1945297 77162 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 545 11 5 6 5.2 CC(Cc1cccc(CNCCc2c(Cl)cccc2Cl)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12 10.1016/j.bmcl.2011.10.049
44268464 26183 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 585 17 5 8 4.9 CCCCCCOC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
CHEMBL12939 26183 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 585 17 5 8 4.9 CCCCCCOC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
44268520 28011 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 591 14 5 8 4.5 O=C(Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1)OCc1ccccc1 10.1016/s0960-894x(98)00170-x
CHEMBL13132 28011 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 591 14 5 8 4.5 O=C(Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1)OCc1ccccc1 10.1016/s0960-894x(98)00170-x
10746499 121236 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Binding affinity was evaluated on chinese hamster ovary (CHO) cells expressing the cloned human beta-1 adrenergic receptor in the presence of [125I]- iodocyanopindolol.Binding affinity was evaluated on chinese hamster ovary (CHO) cells expressing the cloned human beta-1 adrenergic receptor in the presence of [125I]- iodocyanopindolol.
ChEMBL 624 11 3 7 6.6 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccccc3C(F)(F)F)cs2)cc1 10.1021/jm000286i
CHEMBL333417 121236 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Binding affinity was evaluated on chinese hamster ovary (CHO) cells expressing the cloned human beta-1 adrenergic receptor in the presence of [125I]- iodocyanopindolol.Binding affinity was evaluated on chinese hamster ovary (CHO) cells expressing the cloned human beta-1 adrenergic receptor in the presence of [125I]- iodocyanopindolol.
ChEMBL 624 11 3 7 6.6 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccccc3C(F)(F)F)cs2)cc1 10.1021/jm000286i
46882084 12553 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 465 11 3 4 5.0 O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(CCc2ccccc2)cc1 10.1016/j.bmcl.2010.01.130
CHEMBL1078695 12553 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 465 11 3 4 5.0 O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(CCc2ccccc2)cc1 10.1016/j.bmcl.2010.01.130
46881901 14617 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 437 9 3 4 4.9 O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2ccccc2)cc1 10.1016/j.bmcl.2010.01.130
CHEMBL1089734 14617 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 437 9 3 4 4.9 O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2ccccc2)cc1 10.1016/j.bmcl.2010.01.130
12017007 165157 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 576 11 3 7 5.3 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2coc(-c3ccc(F)c(F)c3)n2)cc1 10.1016/s0960-894x(00)00277-8
CHEMBL40898 165157 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 576 11 3 7 5.3 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2coc(-c3ccc(F)c(F)c3)n2)cc1 10.1016/s0960-894x(00)00277-8
44338579 170081 0 None - 0 Guinea pig 4.7 pIC50 = 4.7 Binding
Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)
ChEMBL 364 7 2 5 3.0 COC12CCCCC1c1ccc(F)cc1/C2=N/OCC(O)CNC(C)C 10.1021/jm00122a008
CHEMBL418819 170081 0 None - 0 Guinea pig 4.7 pIC50 = 4.7 Binding
Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)
ChEMBL 364 7 2 5 3.0 COC12CCCCC1c1ccc(F)cc1/C2=N/OCC(O)CNC(C)C 10.1021/jm00122a008
44301979 107639 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 607 11 3 8 6.1 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3cnc4ccccc4c3)cs2)cc1 10.1016/s0960-894x(00)00390-5
CHEMBL293577 107639 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 607 11 3 8 6.1 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3cnc4ccccc4c3)cs2)cc1 10.1016/s0960-894x(00)00390-5
7096 214257 119 None -21 4 Human 4.7 pIC50 = 4.7 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 162 1 1 2 1.1 c1ccc(N2CCNCC2)cc1 10.1021/jm00082a016
CHEMBL9434 214257 119 None -21 4 Human 4.7 pIC50 = 4.7 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 162 1 1 2 1.1 c1ccc(N2CCNCC2)cc1 10.1021/jm00082a016
46845699 12576 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 444 9 3 5 4.1 Cc1ccc(C(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)c(N2CCCC2)c1 10.1016/j.bmcl.2010.01.130
CHEMBL1078876 12576 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 444 9 3 5 4.1 Cc1ccc(C(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)c(N2CCCC2)c1 10.1016/j.bmcl.2010.01.130
46881573 15045 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 415 9 3 6 2.9 O=C(Cn1ncc2ccccc21)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/j.bmcl.2010.01.130
CHEMBL1092502 15045 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 415 9 3 6 2.9 O=C(Cn1ncc2ccccc21)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/j.bmcl.2010.01.130
14739897 215115 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Tested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogsTested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 419 8 2 6 1.9 Cc1cccc(OCC(O)CN2CCN(c3ccc(NS(C)(=O)=O)cc3)CC2)c1 10.1021/jm00172a033
CHEMBL99331 215115 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Tested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogsTested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 419 8 2 6 1.9 Cc1cccc(OCC(O)CN2CCN(c3ccc(NS(C)(=O)=O)cc3)CC2)c1 10.1021/jm00172a033
36811 8236 37 None -109 7 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O nan
535 8236 37 None -109 7 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O nan
937 8236 37 None -109 7 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O nan
CHEMBL926 8236 37 None -109 7 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O nan
DB00841 8236 37 None -109 7 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O nan
1054 8367 54 None -1 3 Human 6.7 pIC50 = 6.7 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O nan
59768 8367 54 None -1 3 Human 6.7 pIC50 = 6.7 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O nan
7178 8367 54 None -1 3 Human 6.7 pIC50 = 6.7 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O nan
CHEMBL768 8367 54 None -1 3 Human 6.7 pIC50 = 6.7 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O nan
DB00187 8367 54 None -1 3 Human 6.7 pIC50 = 6.7 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O nan
12043157 123528 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Binding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindololBinding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 589 14 3 8 5.7 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(CCCC3CCCCC3)n2)cc1 10.1016/s0960-894x(00)00267-5
CHEMBL33755 123528 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Binding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindololBinding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 589 14 3 8 5.7 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(CCCC3CCCCC3)n2)cc1 10.1016/s0960-894x(00)00267-5
24900749 77156 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 493 11 4 7 3.8 COc1ccccc1CN(C)Cc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1 10.1016/j.bmcl.2011.10.049
CHEMBL1945291 77156 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 493 11 4 7 3.8 COc1ccccc1CN(C)Cc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1 10.1016/j.bmcl.2011.10.049
57400229 77163 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 497 12 5 7 3.5 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCOc3cccc(CNCCc4ccccc4F)c3)c2s1 10.1016/j.bmcl.2011.10.049
CHEMBL1945298 77163 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 497 12 5 7 3.5 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCOc3cccc(CNCCc4ccccc4F)c3)c2s1 10.1016/j.bmcl.2011.10.049
10346448 126608 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Receptor binding assay(Beta-1 adrenergic receptor) carried out with membranes prepared from human recombinant Sf9 cells expressing the cloned human receptor in the presence of [125I]iodocyanopindololReceptor binding assay(Beta-1 adrenergic receptor) carried out with membranes prepared from human recombinant Sf9 cells expressing the cloned human receptor in the presence of [125I]iodocyanopindolol
ChEMBL 515 11 4 6 3.8 Cc1ccc(S(=O)(=O)NC(=O)Cc2ccc(NC[C@@H](C)NC[C@H](O)c3cccc(Cl)c3)cc2)cc1 10.1021/jm0101500
CHEMBL348501 126608 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Receptor binding assay(Beta-1 adrenergic receptor) carried out with membranes prepared from human recombinant Sf9 cells expressing the cloned human receptor in the presence of [125I]iodocyanopindololReceptor binding assay(Beta-1 adrenergic receptor) carried out with membranes prepared from human recombinant Sf9 cells expressing the cloned human receptor in the presence of [125I]iodocyanopindolol
ChEMBL 515 11 4 6 3.8 Cc1ccc(S(=O)(=O)NC(=O)Cc2ccc(NC[C@@H](C)NC[C@H](O)c3cccc(Cl)c3)cc2)cc1 10.1021/jm0101500
70683107 79878 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 416 10 5 6 1.5 N#Cc1ccc(F)cc1OC[C@@H](O)CNCCNC(=O)Nc1ccc(C(=O)O)cc1 10.1021/ml1002458
CHEMBL2011221 79878 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 416 10 5 6 1.5 N#Cc1ccc(F)cc1OC[C@@H](O)CNCCNC(=O)Nc1ccc(C(=O)O)cc1 10.1021/ml1002458
70693599 79880 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 416 11 4 6 2.2 CCOc1ccc(NC(=O)NCCNC[C@H](O)COc2cccc(F)c2C#N)cc1 10.1021/ml1002458
CHEMBL2011223 79880 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 416 11 4 6 2.2 CCOc1ccc(NC(=O)NCCNC[C@H](O)COc2cccc(F)c2C#N)cc1 10.1021/ml1002458
2303 9961 68 None -9 26 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]Cynopindolol from human recombinant beta1 adrenergic receptor expressed in CHOK1 cells after 2 hrsDisplacement of [125I]Cynopindolol from human recombinant beta1 adrenergic receptor expressed in CHOK1 cells after 2 hrs
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmcl.2013.01.025
4946 9961 68 None -9 26 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]Cynopindolol from human recombinant beta1 adrenergic receptor expressed in CHOK1 cells after 2 hrsDisplacement of [125I]Cynopindolol from human recombinant beta1 adrenergic receptor expressed in CHOK1 cells after 2 hrs
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmcl.2013.01.025
564 9961 68 None -9 26 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]Cynopindolol from human recombinant beta1 adrenergic receptor expressed in CHOK1 cells after 2 hrsDisplacement of [125I]Cynopindolol from human recombinant beta1 adrenergic receptor expressed in CHOK1 cells after 2 hrs
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmcl.2013.01.025
63 9961 68 None -9 26 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]Cynopindolol from human recombinant beta1 adrenergic receptor expressed in CHOK1 cells after 2 hrsDisplacement of [125I]Cynopindolol from human recombinant beta1 adrenergic receptor expressed in CHOK1 cells after 2 hrs
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmcl.2013.01.025
91536 9961 68 None -9 26 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]Cynopindolol from human recombinant beta1 adrenergic receptor expressed in CHOK1 cells after 2 hrsDisplacement of [125I]Cynopindolol from human recombinant beta1 adrenergic receptor expressed in CHOK1 cells after 2 hrs
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmcl.2013.01.025
CHEMBL27 9961 68 None -9 26 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]Cynopindolol from human recombinant beta1 adrenergic receptor expressed in CHOK1 cells after 2 hrsDisplacement of [125I]Cynopindolol from human recombinant beta1 adrenergic receptor expressed in CHOK1 cells after 2 hrs
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmcl.2013.01.025
CHEMBL452861 9961 68 None -9 26 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]Cynopindolol from human recombinant beta1 adrenergic receptor expressed in CHOK1 cells after 2 hrsDisplacement of [125I]Cynopindolol from human recombinant beta1 adrenergic receptor expressed in CHOK1 cells after 2 hrs
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmcl.2013.01.025
DB00571 9961 68 None -9 26 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]Cynopindolol from human recombinant beta1 adrenergic receptor expressed in CHOK1 cells after 2 hrsDisplacement of [125I]Cynopindolol from human recombinant beta1 adrenergic receptor expressed in CHOK1 cells after 2 hrs
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmcl.2013.01.025
2303 9961 68 None -9 26 Human 8.6 pIC50 = 8.6 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C nan
4946 9961 68 None -9 26 Human 8.6 pIC50 = 8.6 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C nan
564 9961 68 None -9 26 Human 8.6 pIC50 = 8.6 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C nan
63 9961 68 None -9 26 Human 8.6 pIC50 = 8.6 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C nan
91536 9961 68 None -9 26 Human 8.6 pIC50 = 8.6 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C nan
CHEMBL27 9961 68 None -9 26 Human 8.6 pIC50 = 8.6 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C nan
CHEMBL452861 9961 68 None -9 26 Human 8.6 pIC50 = 8.6 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C nan
DB00571 9961 68 None -9 26 Human 8.6 pIC50 = 8.6 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C nan
33624 10593 34 None -6 9 Human 8.6 pIC50 = 8.6 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C nan
4061 10593 34 None -6 9 Human 8.6 pIC50 = 8.6 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C nan
565 10593 34 None -6 9 Human 8.6 pIC50 = 8.6 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C nan
CHEMBL499 10593 34 None -6 9 Human 8.6 pIC50 = 8.6 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C nan
DB00373 10593 34 None -6 9 Human 8.6 pIC50 = 8.6 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C nan
70680983 79888 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 348 8 3 6 -0.1 N#Cc1ccccc1OC[C@@H](O)CNCCNC(=O)N1CCOCC1 10.1021/ml1002458
CHEMBL2011232 79888 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 348 8 3 6 -0.1 N#Cc1ccccc1OC[C@@H](O)CNCCNC(=O)N1CCOCC1 10.1021/ml1002458
3931 9028 48 None -3 2 Human 6.7 pIC50 = 6.7 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 584 17 6 7 4.5 CCCCCCNC(=O)Nc1ccc(cc1)S(=O)(=O)Nc1ccc(cc1)CCNC[C@@H](COc1ccc(cc1)O)O 10.1016/s0960-894x(98)00170-x
9829836 9028 48 None -3 2 Human 6.7 pIC50 = 6.7 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 584 17 6 7 4.5 CCCCCCNC(=O)Nc1ccc(cc1)S(=O)(=O)Nc1ccc(cc1)CCNC[C@@H](COc1ccc(cc1)O)O 10.1016/s0960-894x(98)00170-x
CHEMBL12998 9028 48 None -3 2 Human 6.7 pIC50 = 6.7 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 584 17 6 7 4.5 CCCCCCNC(=O)Nc1ccc(cc1)S(=O)(=O)Nc1ccc(cc1)CCNC[C@@H](COc1ccc(cc1)O)O 10.1016/s0960-894x(98)00170-x
44268604 43398 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 598 18 6 7 4.9 CCCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
CHEMBL144870 43398 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 598 18 6 7 4.9 CCCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
44285529 157697 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 534 14 3 7 5.1 CCCCCc1ncc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)o1 10.1016/s0960-894x(00)00277-8
CHEMBL39577 157697 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 534 14 3 7 5.1 CCCCCc1ncc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)o1 10.1016/s0960-894x(00)00277-8
44335618 11559 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 497 12 5 6 3.3 CCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(98)00571-x
CHEMBL104061 11559 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 497 12 5 6 3.3 CCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(98)00571-x
44335560 12087 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 469 10 5 6 2.5 CNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(98)00571-x
CHEMBL106746 12087 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 469 10 5 6 2.5 CNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(98)00571-x
44335589 116165 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 540 15 4 7 4.9 CCCCCCOC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(98)00571-x
CHEMBL321957 116165 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 540 15 4 7 4.9 CCCCCCOC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(98)00571-x
1346 6871 117 None - 9 Human 5.7 pIC50 = 5.7 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 192 2 1 3 1.1 COc1ccccc1N1CCNCC1 10.1021/jm00082a016
280 6871 117 None - 9 Human 5.7 pIC50 = 5.7 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 192 2 1 3 1.1 COc1ccccc1N1CCNCC1 10.1021/jm00082a016
9899402 6871 117 None - 9 Human 5.7 pIC50 = 5.7 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 192 2 1 3 1.1 COc1ccccc1N1CCNCC1 10.1021/jm00082a016
CHEMBL9666 6871 117 None - 9 Human 5.7 pIC50 = 5.7 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 192 2 1 3 1.1 COc1ccccc1N1CCNCC1 10.1021/jm00082a016
1355 8792 88 None - 16 Human 5.7 pIC50 = 5.7 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 196 1 1 2 1.8 Clc1cccc(c1)N1CCNCC1 10.1021/jm00082a016
142 8792 88 None - 16 Human 5.7 pIC50 = 5.7 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 196 1 1 2 1.8 Clc1cccc(c1)N1CCNCC1 10.1021/jm00082a016
CHEMBL478 8792 88 None - 16 Human 5.7 pIC50 = 5.7 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 196 1 1 2 1.8 Clc1cccc(c1)N1CCNCC1 10.1021/jm00082a016
DB12110 8792 88 None - 16 Human 5.7 pIC50 = 5.7 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 196 1 1 2 1.8 Clc1cccc(c1)N1CCNCC1 10.1021/jm00082a016
10438390 210181 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.
ChEMBL 590 12 3 8 4.2 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(Cc3ccc(F)c(F)c3)n2)cc1 10.1016/s0960-894x(00)00422-4
CHEMBL65513 210181 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.
ChEMBL 590 12 3 8 4.2 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(Cc3ccc(F)c(F)c3)n2)cc1 10.1016/s0960-894x(00)00422-4
44281344 106620 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 628 14 4 10 4.3 CC(=O)Nc1ccc(OCc2nc(-c3ccc(S(=O)(=O)Nc4ccc(CCNC[C@H](O)c5cccnc5)cc4)cc3)no2)cc1 10.1016/s0960-894x(00)00268-7
CHEMBL285704 106620 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 628 14 4 10 4.3 CC(=O)Nc1ccc(OCc2nc(-c3ccc(S(=O)(=O)Nc4ccc(CCNC[C@H](O)c5cccnc5)cc4)cc3)no2)cc1 10.1016/s0960-894x(00)00268-7
44281255 122272 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 639 13 3 9 5.3 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(Cc3cccc(OC(F)(F)F)c3)n2)cc1 10.1016/s0960-894x(00)00268-7
CHEMBL33515 122272 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 639 13 3 9 5.3 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(Cc3cccc(OC(F)(F)F)c3)n2)cc1 10.1016/s0960-894x(00)00268-7
44281384 126090 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 601 14 3 10 4.4 COc1ccc(OCc2nc(-c3ccc(S(=O)(=O)Nc4ccc(CCNC[C@H](O)c5cccnc5)cc4)cc3)no2)cc1 10.1016/s0960-894x(00)00268-7
CHEMBL34406 126090 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 601 14 3 10 4.4 COc1ccc(OCc2nc(-c3ccc(S(=O)(=O)Nc4ccc(CCNC[C@H](O)c5cccnc5)cc4)cc3)no2)cc1 10.1016/s0960-894x(00)00268-7
44281467 126144 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 648 14 4 10 3.8 CS(=O)(=O)Nc1ccc(Cc2nc(-c3ccc(S(=O)(=O)Nc4ccc(CCNC[C@H](O)c5cccnc5)cc4)cc3)no2)cc1 10.1016/s0960-894x(00)00268-7
CHEMBL34441 126144 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 648 14 4 10 3.8 CS(=O)(=O)Nc1ccc(Cc2nc(-c3ccc(S(=O)(=O)Nc4ccc(CCNC[C@H](O)c5cccnc5)cc4)cc3)no2)cc1 10.1016/s0960-894x(00)00268-7
44281468 168661 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 623 12 3 8 5.4 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(Cc3ccc(C(F)(F)F)cc3)n2)cc1 10.1016/s0960-894x(00)00268-7
CHEMBL415039 168661 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 623 12 3 8 5.4 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(Cc3ccc(C(F)(F)F)cc3)n2)cc1 10.1016/s0960-894x(00)00268-7
44377513 63284 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Binding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindololBinding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol
ChEMBL 592 17 3 9 4.5 CCCCCCCCn1ncn(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)c1=O 10.1016/s0960-894x(99)00073-6
CHEMBL163531 63284 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Binding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindololBinding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol
ChEMBL 592 17 3 9 4.5 CCCCCCCCn1ncn(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)c1=O 10.1016/s0960-894x(99)00073-6
44461717 112457 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Binding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindololBinding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol
ChEMBL 577 15 3 8 4.6 CCCCCCn1c(C)cn(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)c1=O 10.1016/s0960-894x(99)00073-6
CHEMBL312546 112457 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Binding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindololBinding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol
ChEMBL 577 15 3 8 4.6 CCCCCCn1c(C)cn(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)c1=O 10.1016/s0960-894x(99)00073-6
44461716 212091 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Binding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindololBinding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol
ChEMBL 605 17 3 8 5.4 CCCCCCCCn1c(C)cn(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)c1=O 10.1016/s0960-894x(99)00073-6
CHEMBL79363 212091 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Binding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindololBinding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol
ChEMBL 605 17 3 8 5.4 CCCCCCCCn1c(C)cn(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)c1=O 10.1016/s0960-894x(99)00073-6
44281276 106594 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Binding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindololBinding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 549 15 3 8 4.9 CCCCCCc1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1 10.1016/s0960-894x(00)00267-5
CHEMBL285481 106594 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Binding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindololBinding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 549 15 3 8 4.9 CCCCCCc1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1 10.1016/s0960-894x(00)00267-5
44281277 106954 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Binding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindololBinding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 563 16 3 8 5.3 CCCCCCCc1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1 10.1016/s0960-894x(00)00267-5
CHEMBL288083 106954 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Binding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindololBinding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 563 16 3 8 5.3 CCCCCCCc1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1 10.1016/s0960-894x(00)00267-5
44377637 62305 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 633 14 3 6 5.3 O=C1N(CCCc2ccc(Cl)cc2)CCN1c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(99)00072-4
CHEMBL162043 62305 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 633 14 3 6 5.3 O=C1N(CCCc2ccc(Cl)cc2)CCN1c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(99)00072-4
10841426 123650 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Binding affinity was evaluated on chinese hamster ovary (CHO) cells expressing the cloned human beta-1 adrenergic receptor in the presence of [125I]- iodocyanopindolol.Binding affinity was evaluated on chinese hamster ovary (CHO) cells expressing the cloned human beta-1 adrenergic receptor in the presence of [125I]- iodocyanopindolol.
ChEMBL 610 11 3 7 6.0 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3cc(F)c(F)c(F)c3)cs2)cc1 10.1021/jm000286i
CHEMBL338216 123650 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Binding affinity was evaluated on chinese hamster ovary (CHO) cells expressing the cloned human beta-1 adrenergic receptor in the presence of [125I]- iodocyanopindolol.Binding affinity was evaluated on chinese hamster ovary (CHO) cells expressing the cloned human beta-1 adrenergic receptor in the presence of [125I]- iodocyanopindolol.
ChEMBL 610 11 3 7 6.0 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3cc(F)c(F)c(F)c3)cs2)cc1 10.1021/jm000286i
9832011 112258 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Compound was evaluated for its inhibitory activity against CHO cells expressing the cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindololCompound was evaluated for its inhibitory activity against CHO cells expressing the cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol
ChEMBL 644 13 6 7 6.5 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(-c3ccc(OCC4NCCc5cc(O)c(O)cc54)cc3)cc2)cc1 10.1016/s0960-894x(00)00459-5
CHEMBL312074 112258 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Compound was evaluated for its inhibitory activity against CHO cells expressing the cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindololCompound was evaluated for its inhibitory activity against CHO cells expressing the cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol
ChEMBL 644 13 6 7 6.5 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(-c3ccc(OCC4NCCc5cc(O)c(O)cc54)cc3)cc2)cc1 10.1016/s0960-894x(00)00459-5
44307063 210113 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 505 11 3 6 3.2 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2cccnc2)cc1)c1ccc(Br)cc1 10.1016/s0960-894x(98)00381-3
CHEMBL64935 210113 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 505 11 3 6 3.2 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2cccnc2)cc1)c1ccc(Br)cc1 10.1016/s0960-894x(98)00381-3
44306979 210474 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 476 11 4 7 2.7 Nc1ccc(OC[C@@H](O)CNCCc2ccc(NS(=O)(=O)c3ccc(Cl)cc3)cc2)cn1 10.1016/s0960-894x(98)00381-3
CHEMBL67534 210474 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 476 11 4 7 2.7 Nc1ccc(OC[C@@H](O)CNCCc2ccc(NS(=O)(=O)c3ccc(Cl)cc3)cc2)cn1 10.1016/s0960-894x(98)00381-3
44306985 210498 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 460 11 4 7 2.2 Nc1ccc(OC[C@@H](O)CNCCc2ccc(NS(=O)(=O)c3ccc(F)cc3)cc2)cn1 10.1016/s0960-894x(98)00381-3
CHEMBL67672 210498 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 460 11 4 7 2.2 Nc1ccc(OC[C@@H](O)CNCCc2ccc(NS(=O)(=O)c3ccc(F)cc3)cc2)cn1 10.1016/s0960-894x(98)00381-3
12017005 107045 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 560 13 3 7 5.5 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2coc(CCC3CCCC3)n2)cc1 10.1016/s0960-894x(00)00277-8
CHEMBL288917 107045 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 560 13 3 7 5.5 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2coc(CCC3CCCC3)n2)cc1 10.1016/s0960-894x(00)00277-8
12017014 107089 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 608 12 3 7 5.4 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2cnc(Cc3cc(F)c(F)c(F)c3)o2)cc1 10.1016/s0960-894x(00)00277-8
CHEMBL289316 107089 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 608 12 3 7 5.4 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2cnc(Cc3cc(F)c(F)c(F)c3)o2)cc1 10.1016/s0960-894x(00)00277-8
44285225 160355 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 562 13 3 7 5.8 CC(C)(C)CCCc1ncc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)o1 10.1016/s0960-894x(00)00277-8
CHEMBL39804 160355 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 562 13 3 7 5.8 CC(C)(C)CCCc1ncc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)o1 10.1016/s0960-894x(00)00277-8
44268327 105075 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 448 11 4 6 3.0 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)C1CCCCC1 10.1016/s0960-894x(98)00169-3
CHEMBL274807 105075 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 448 11 4 6 3.0 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)C1CCCCC1 10.1016/s0960-894x(98)00169-3
44335497 11594 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 397 9 3 5 2.7 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccccc1 10.1016/s0960-894x(98)00571-x
CHEMBL104180 11594 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 397 9 3 5 2.7 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccccc1 10.1016/s0960-894x(98)00571-x
10416448 210172 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.
ChEMBL 622 12 3 8 4.9 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(Cc3ccc(C(F)(F)F)cc3)n2)cc1 10.1016/s0960-894x(00)00422-4
CHEMBL65461 210172 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.
ChEMBL 622 12 3 8 4.9 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(Cc3ccc(C(F)(F)F)cc3)n2)cc1 10.1016/s0960-894x(00)00422-4
70693598 79877 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 416 10 5 6 1.5 N#Cc1c(F)cccc1OC[C@@H](O)CNCCNC(=O)Nc1ccc(C(=O)O)cc1 10.1021/ml1002458
CHEMBL2011220 79877 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 416 10 5 6 1.5 N#Cc1c(F)cccc1OC[C@@H](O)CNCCNC(=O)Nc1ccc(C(=O)O)cc1 10.1021/ml1002458
2249 7300 111 None -5 12 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H](-)CGP12177 from human recombinant Beta-1 adrenergic receptor expressed in HEK293 cellsDisplacement of [3H](-)CGP12177 from human recombinant Beta-1 adrenergic receptor expressed in HEK293 cells
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1016/j.bmc.2016.03.006
255 7300 111 None -5 12 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H](-)CGP12177 from human recombinant Beta-1 adrenergic receptor expressed in HEK293 cellsDisplacement of [3H](-)CGP12177 from human recombinant Beta-1 adrenergic receptor expressed in HEK293 cells
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1016/j.bmc.2016.03.006
548 7300 111 None -5 12 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H](-)CGP12177 from human recombinant Beta-1 adrenergic receptor expressed in HEK293 cellsDisplacement of [3H](-)CGP12177 from human recombinant Beta-1 adrenergic receptor expressed in HEK293 cells
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1016/j.bmc.2016.03.006
CHEMBL24 7300 111 None -5 12 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H](-)CGP12177 from human recombinant Beta-1 adrenergic receptor expressed in HEK293 cellsDisplacement of [3H](-)CGP12177 from human recombinant Beta-1 adrenergic receptor expressed in HEK293 cells
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1016/j.bmc.2016.03.006
DB00335 7300 111 None -5 12 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H](-)CGP12177 from human recombinant Beta-1 adrenergic receptor expressed in HEK293 cellsDisplacement of [3H](-)CGP12177 from human recombinant Beta-1 adrenergic receptor expressed in HEK293 cells
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1016/j.bmc.2016.03.006
2249 7300 111 None -5 12 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]CGP 12177 from human recombinant beta1 adrenergic receptor expressed in HEK293 cells measured after 60 mins by scintillation counting methodDisplacement of [3H]CGP 12177 from human recombinant beta1 adrenergic receptor expressed in HEK293 cells measured after 60 mins by scintillation counting method
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1016/j.bmc.2016.11.014
255 7300 111 None -5 12 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]CGP 12177 from human recombinant beta1 adrenergic receptor expressed in HEK293 cells measured after 60 mins by scintillation counting methodDisplacement of [3H]CGP 12177 from human recombinant beta1 adrenergic receptor expressed in HEK293 cells measured after 60 mins by scintillation counting method
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1016/j.bmc.2016.11.014
548 7300 111 None -5 12 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]CGP 12177 from human recombinant beta1 adrenergic receptor expressed in HEK293 cells measured after 60 mins by scintillation counting methodDisplacement of [3H]CGP 12177 from human recombinant beta1 adrenergic receptor expressed in HEK293 cells measured after 60 mins by scintillation counting method
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1016/j.bmc.2016.11.014
CHEMBL24 7300 111 None -5 12 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]CGP 12177 from human recombinant beta1 adrenergic receptor expressed in HEK293 cells measured after 60 mins by scintillation counting methodDisplacement of [3H]CGP 12177 from human recombinant beta1 adrenergic receptor expressed in HEK293 cells measured after 60 mins by scintillation counting method
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1016/j.bmc.2016.11.014
DB00335 7300 111 None -5 12 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]CGP 12177 from human recombinant beta1 adrenergic receptor expressed in HEK293 cells measured after 60 mins by scintillation counting methodDisplacement of [3H]CGP 12177 from human recombinant beta1 adrenergic receptor expressed in HEK293 cells measured after 60 mins by scintillation counting method
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1016/j.bmc.2016.11.014
44280904 106737 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 632 13 3 9 5.5 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(Cc3ccc(-c4ccccn4)cc3)n2)cc1 10.1016/s0960-894x(00)00268-7
CHEMBL286438 106737 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 632 13 3 9 5.5 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(Cc3ccc(-c4ccccn4)cc3)n2)cc1 10.1016/s0960-894x(00)00268-7
12017006 107173 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 608 11 3 7 6.1 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2coc(-c3ccc(C(F)(F)F)cc3)n2)cc1 10.1016/s0960-894x(00)00277-8
CHEMBL290053 107173 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 608 11 3 7 6.1 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2coc(-c3ccc(C(F)(F)F)cc3)n2)cc1 10.1016/s0960-894x(00)00277-8
10483845 209851 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.
ChEMBL 608 11 3 8 5.0 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(-c3ccc(C(F)(F)F)cc3)n2)cc1 10.1016/s0960-894x(00)00422-4
CHEMBL63760 209851 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.
ChEMBL 608 11 3 8 5.0 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(-c3ccc(C(F)(F)F)cc3)n2)cc1 10.1016/s0960-894x(00)00422-4
14664345 20025 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)
ChEMBL 460 12 2 8 1.7 CN(c1ccc(OCC(O)CNCCOc2ccc(-n3ccnc3)cc2)cc1)S(C)(=O)=O 10.1021/jm00166a002
CHEMBL1191442 20025 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)
ChEMBL 460 12 2 8 1.7 CN(c1ccc(OCC(O)CNCCOc2ccc(-n3ccnc3)cc2)cc1)S(C)(=O)=O 10.1021/jm00166a002
CHEMBL542544 20025 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)
ChEMBL 460 12 2 8 1.7 CN(c1ccc(OCC(O)CNCCOc2ccc(-n3ccnc3)cc2)cc1)S(C)(=O)=O 10.1021/jm00166a002
44268534 26136 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 529 13 5 8 3.3 CCOC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
CHEMBL12911 26136 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 529 13 5 8 3.3 CCOC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
44268478 169593 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 561 13 5 7 4.0 O=C(Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1)c1ccccc1 10.1016/s0960-894x(98)00170-x
CHEMBL417250 169593 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 561 13 5 7 4.0 O=C(Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1)c1ccccc1 10.1016/s0960-894x(98)00170-x
44298851 107330 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 463 11 1 4 6.5 CCCCCCCCc1cccc(N2CCc3cc(S(=O)(=O)Nc4ccccc4)ccc32)n1 10.1016/s0960-894x(99)00277-2
CHEMBL291467 107330 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 463 11 1 4 6.5 CCCCCCCCc1cccc(N2CCc3cc(S(=O)(=O)Nc4ccccc4)ccc32)n1 10.1016/s0960-894x(99)00277-2
448537 167029 89 None -50 25 Human 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 nan
CHEMBL411 167029 89 None -50 25 Human 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 nan
14998850 126771 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 418 7 3 6 1.3 COc1ccccc1N1CCNC(CNC(=O)c2ccc(NS(C)(=O)=O)cc2)C1 10.1021/jm00082a016
CHEMBL349978 126771 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 418 7 3 6 1.3 COc1ccccc1N1CCNC(CNC(=O)c2ccc(NS(C)(=O)=O)cc2)C1 10.1021/jm00082a016
9871525 23683 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 526 8 4 5 3.7 N#CN/C(=N\c1cccc(I)c1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/s0960-894x(00)00669-7
CHEMBL125168 23683 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 526 8 4 5 3.7 N#CN/C(=N\c1cccc(I)c1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/s0960-894x(00)00669-7
14998852 62452 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 360 6 3 5 1.9 CS(=O)(=O)Nc1ccc(NCC2CN(c3ccccc3)CCN2)cc1 10.1021/jm00082a016
CHEMBL162182 62452 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 360 6 3 5 1.9 CS(=O)(=O)Nc1ccc(NCC2CN(c3ccccc3)CCN2)cc1 10.1021/jm00082a016
9810596 23571 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 734 11 4 9 8.0 N#CN/C(=N\c1ccc2c(c1)CCN2c1nc(-c2ccc(OC(F)(F)F)cc2)cs1)Nc1ccc2cc(CCNC[C@H](O)c3cccnc3)ccc2c1 10.1016/s0960-894x(00)00669-7
CHEMBL124597 23571 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 734 11 4 9 8.0 N#CN/C(=N\c1ccc2c(c1)CCN2c1nc(-c2ccc(OC(F)(F)F)cc2)cs1)Nc1ccc2cc(CCNC[C@H](O)c3cccnc3)ccc2c1 10.1016/s0960-894x(00)00669-7
10371216 106523 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 591 12 3 8 4.7 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(Cc3ccc(F)c(F)c3)n2)cc1 10.1016/s0960-894x(00)00268-7
CHEMBL285001 106523 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 591 12 3 8 4.7 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(Cc3ccc(F)c(F)c3)n2)cc1 10.1016/s0960-894x(00)00268-7
3038500 16112 12 None - 0 Human 5.6 pIC50 = 5.6 Binding
Binding affinity was evaluated on chinese hamster ovary (CHO) cells expressing the cloned human beta-1 adrenergic receptor in the presence of [125I]- iodocyanopindolol.Binding affinity was evaluated on chinese hamster ovary (CHO) cells expressing the cloned human beta-1 adrenergic receptor in the presence of [125I]- iodocyanopindolol.
ChEMBL 624 11 3 7 6.6 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1 10.1021/jm000286i
CHEMBL111201 16112 12 None - 0 Human 5.6 pIC50 = 5.6 Binding
Binding affinity was evaluated on chinese hamster ovary (CHO) cells expressing the cloned human beta-1 adrenergic receptor in the presence of [125I]- iodocyanopindolol.Binding affinity was evaluated on chinese hamster ovary (CHO) cells expressing the cloned human beta-1 adrenergic receptor in the presence of [125I]- iodocyanopindolol.
ChEMBL 624 11 3 7 6.6 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1 10.1021/jm000286i
3038500 16112 12 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 624 11 3 7 6.6 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1 10.1016/j.bmcl.2010.01.130
CHEMBL111201 16112 12 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 624 11 3 7 6.6 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1 10.1016/j.bmcl.2010.01.130
25020250 22208 12 None - 0 Human 5.6 pIC50 = 5.6 Binding
Inhibition of beta-1 adrenoceptor ( assessed as residual activity at 1 uM )Inhibition of beta-1 adrenoceptor ( assessed as residual activity at 1 uM )
ChEMBL 388 4 2 6 3.8 c1cc2c(N3CCNCC3)nc(-c3ccnc(NC4CCCCC4)c3)cc2cn1 10.1021/jm100075z
CHEMBL1214998 22208 12 None - 0 Human 5.6 pIC50 = 5.6 Binding
Inhibition of beta-1 adrenoceptor ( assessed as residual activity at 1 uM )Inhibition of beta-1 adrenoceptor ( assessed as residual activity at 1 uM )
ChEMBL 388 4 2 6 3.8 c1cc2c(N3CCNCC3)nc(-c3ccnc(NC4CCCCC4)c3)cc2cn1 10.1021/jm100075z
10206782 23627 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 492 10 4 6 4.9 N#CN/C(=N\c1cccc(Oc2ccccc2)c1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/s0960-894x(00)00669-7
CHEMBL124863 23627 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 492 10 4 6 4.9 N#CN/C(=N\c1cccc(Oc2ccccc2)c1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/s0960-894x(00)00669-7
44268479 27661 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 543 13 5 8 3.7 CC(C)OC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
CHEMBL13106 27661 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 543 13 5 8 3.7 CC(C)OC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
10054165 91551 1 None - 0 Human 5.6 pIC50 = 5.6 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 591 14 3 6 5.0 O=C1N(CCCC2CCCC2)CCN1c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(99)00072-4
CHEMBL22317 91551 1 None - 0 Human 5.6 pIC50 = 5.6 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 591 14 3 6 5.0 O=C1N(CCCC2CCCC2)CCN1c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(99)00072-4
31101 7516 40 None -245 35 Human 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
35 7516 40 None -245 35 Human 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
403 7516 40 None -245 35 Human 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
CHEMBL493 7516 40 None -245 35 Human 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
DB01200 7516 40 None -245 35 Human 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
46881982 12524 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 465 11 3 4 5.0 O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccccc1CCc1ccccc1 10.1016/j.bmcl.2010.01.130
CHEMBL1078465 12524 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 465 11 3 4 5.0 O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccccc1CCc1ccccc1 10.1016/j.bmcl.2010.01.130
130400 215164 10 None - 0 Human 5.6 pIC50 = 5.6 Binding
In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)
ChEMBL 446 12 3 8 1.7 CS(=O)(=O)Nc1ccc(OCC(O)CNCCOc2ccc(-n3ccnc3)cc2)cc1 10.1021/jm00166a002
CHEMBL552615 215164 10 None - 0 Human 5.6 pIC50 = 5.6 Binding
In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)
ChEMBL 446 12 3 8 1.7 CS(=O)(=O)Nc1ccc(OCC(O)CNCCOc2ccc(-n3ccnc3)cc2)cc1 10.1021/jm00166a002
CHEMBL99585 215164 10 None - 0 Human 5.6 pIC50 = 5.6 Binding
In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)
ChEMBL 446 12 3 8 1.7 CS(=O)(=O)Nc1ccc(OCC(O)CNCCOc2ccc(-n3ccnc3)cc2)cc1 10.1021/jm00166a002
12017011 107141 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 590 12 3 7 5.3 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2coc(Cc3ccc(F)c(F)c3)n2)cc1 10.1016/s0960-894x(00)00277-8
CHEMBL289689 107141 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 590 12 3 7 5.3 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2coc(Cc3ccc(F)c(F)c3)n2)cc1 10.1016/s0960-894x(00)00277-8
14739889 214548 1 None - 0 Human 5.6 pIC50 = 5.6 Binding
Tested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogsTested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 364 9 3 5 1.9 Cc1cccc(OCC(O)CNCc2ccc(NS(C)(=O)=O)cc2)c1 10.1021/jm00172a033
CHEMBL95966 214548 1 None - 0 Human 5.6 pIC50 = 5.6 Binding
Tested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogsTested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 364 9 3 5 1.9 Cc1cccc(OCC(O)CNCc2ccc(NS(C)(=O)=O)cc2)c1 10.1021/jm00172a033
130400 215164 10 None - 0 Human 5.6 pIC50 = 5.6 Binding
Tested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogsTested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 446 12 3 8 1.7 CS(=O)(=O)Nc1ccc(OCC(O)CNCCOc2ccc(-n3ccnc3)cc2)cc1 10.1021/jm00172a033
CHEMBL552615 215164 10 None - 0 Human 5.6 pIC50 = 5.6 Binding
Tested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogsTested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 446 12 3 8 1.7 CS(=O)(=O)Nc1ccc(OCC(O)CNCCOc2ccc(-n3ccnc3)cc2)cc1 10.1021/jm00172a033
CHEMBL99585 215164 10 None - 0 Human 5.6 pIC50 = 5.6 Binding
Tested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogsTested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 446 12 3 8 1.7 CS(=O)(=O)Nc1ccc(OCC(O)CNCCOc2ccc(-n3ccnc3)cc2)cc1 10.1021/jm00172a033
44281424 107082 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 587 12 3 9 4.2 O=C(c1ccc(F)cc1)c1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1 10.1016/s0960-894x(00)00268-7
CHEMBL289249 107082 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 587 12 3 9 4.2 O=C(c1ccc(F)cc1)c1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1 10.1016/s0960-894x(00)00268-7
44268367 27609 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 344 9 4 5 1.9 CC(=O)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/s0960-894x(98)00169-3
CHEMBL13102 27609 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 344 9 4 5 1.9 CC(=O)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/s0960-894x(98)00169-3
44268556 30907 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 515 12 5 8 2.9 COC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
CHEMBL13389 30907 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 515 12 5 8 2.9 COC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
11342656 209438 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 634 13 3 7 6.5 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(Cc2nc(Cc3ccc4ccccc4c3)cs2)cc1 10.1016/s0960-894x(00)00390-5
CHEMBL61429 209438 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 634 13 3 7 6.5 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(Cc2nc(Cc3ccc4ccccc4c3)cs2)cc1 10.1016/s0960-894x(00)00390-5
12049920 109409 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.
ChEMBL 572 12 3 8 4.1 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(Cc3ccc(F)cc3)n2)cc1 10.1016/s0960-894x(00)00422-4
CHEMBL304298 109409 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.
ChEMBL 572 12 3 8 4.1 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(Cc3ccc(F)cc3)n2)cc1 10.1016/s0960-894x(00)00422-4
10258518 108728 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 633 17 3 8 6.8 CCCCCCCCc1csc(N2CCc3cc(S(=O)(=O)Nc4ccc(CCNC[C@H](O)c5cccnc5)cc4)ccc32)n1 10.1016/s0960-894x(00)00669-7
CHEMBL301231 108728 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 633 17 3 8 6.8 CCCCCCCCc1csc(N2CCc3cc(S(=O)(=O)Nc4ccc(CCNC[C@H](O)c5cccnc5)cc4)ccc32)n1 10.1016/s0960-894x(00)00669-7
44281372 106894 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 621 13 3 9 5.5 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(COc3ccc4ccccc4c3)n2)cc1 10.1016/s0960-894x(00)00268-7
CHEMBL287562 106894 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 621 13 3 9 5.5 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(COc3ccc4ccccc4c3)n2)cc1 10.1016/s0960-894x(00)00268-7
44461705 212634 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Binding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindololBinding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol
ChEMBL 607 17 3 7 4.9 CCCCCCCCN1C(=O)CN(c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)C1=O 10.1016/s0960-894x(99)00073-6
CHEMBL83698 212634 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Binding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindololBinding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol
ChEMBL 607 17 3 7 4.9 CCCCCCCCN1C(=O)CN(c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)C1=O 10.1016/s0960-894x(99)00073-6
10841171 123802 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Binding affinity was evaluated on chinese hamster ovary (CHO) cells expressing the cloned human beta-1 adrenergic receptor in the presence of [125I]- iodocyanopindolol.Binding affinity was evaluated on chinese hamster ovary (CHO) cells expressing the cloned human beta-1 adrenergic receptor in the presence of [125I]- iodocyanopindolol.
ChEMBL 592 11 3 7 5.8 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc(F)cc3F)cs2)cc1 10.1021/jm000286i
CHEMBL338976 123802 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Binding affinity was evaluated on chinese hamster ovary (CHO) cells expressing the cloned human beta-1 adrenergic receptor in the presence of [125I]- iodocyanopindolol.Binding affinity was evaluated on chinese hamster ovary (CHO) cells expressing the cloned human beta-1 adrenergic receptor in the presence of [125I]- iodocyanopindolol.
ChEMBL 592 11 3 7 5.8 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc(F)cc3F)cs2)cc1 10.1021/jm000286i
44298823 108056 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 462 11 1 3 7.1 CCCCCCCCc1cccc(N2CCc3cc(S(=O)(=O)Nc4ccccc4)ccc32)c1 10.1016/s0960-894x(99)00277-2
CHEMBL296380 108056 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 462 11 1 3 7.1 CCCCCCCCc1cccc(N2CCc3cc(S(=O)(=O)Nc4ccccc4)ccc32)c1 10.1016/s0960-894x(99)00277-2
44281074 121907 0 None - 0 Human 4.6 pIC50 = 4.6 Binding
Binding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindololBinding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 549 14 3 9 3.7 CCC(=O)CCc1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1 10.1016/s0960-894x(00)00267-5
CHEMBL33438 121907 0 None - 0 Human 4.6 pIC50 = 4.6 Binding
Binding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindololBinding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 549 14 3 9 3.7 CCC(=O)CCc1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1 10.1016/s0960-894x(00)00267-5
16049090 70863 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 447 13 5 7 2.9 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCSCCCNCCc3ccccc3)c2s1 10.1016/j.bmcl.2011.05.097
CHEMBL1807823 70863 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 447 13 5 7 2.9 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCSCCCNCCc3ccccc3)c2s1 10.1016/j.bmcl.2011.05.097
24901211 77106 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 493 12 5 7 3.5 COc1ccccc1CCNCc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1 10.1016/j.bmcl.2011.10.049
CHEMBL1944693 77106 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 493 12 5 7 3.5 COc1ccccc1CCNCc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1 10.1016/j.bmcl.2011.10.049
2810 74376 55 None -1 2 Human 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 213 4 2 2 2.4 CC(C)NCC(O)c1ccccc1Cl nan
CHEMBL1902627 74376 55 None -1 2 Human 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 213 4 2 2 2.4 CC(C)NCC(O)c1ccccc1Cl nan
70691508 79886 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 361 9 4 7 1.2 N#Cc1ccccc1OC[C@@H](O)CNCCNC(=O)Nc1nccs1 10.1021/ml1002458
CHEMBL2011229 79886 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 361 9 4 7 1.2 N#Cc1ccccc1OC[C@@H](O)CNCCNC(=O)Nc1nccs1 10.1021/ml1002458
2249 7300 111 None -5 12 Human 6.6 pIC50 = 6.6 Binding
Binding affinity to human adrenergic beta1 receptor by radioligand displacement assayBinding affinity to human adrenergic beta1 receptor by radioligand displacement assay
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1016/j.ejmech.2013.01.044
255 7300 111 None -5 12 Human 6.6 pIC50 = 6.6 Binding
Binding affinity to human adrenergic beta1 receptor by radioligand displacement assayBinding affinity to human adrenergic beta1 receptor by radioligand displacement assay
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1016/j.ejmech.2013.01.044
548 7300 111 None -5 12 Human 6.6 pIC50 = 6.6 Binding
Binding affinity to human adrenergic beta1 receptor by radioligand displacement assayBinding affinity to human adrenergic beta1 receptor by radioligand displacement assay
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1016/j.ejmech.2013.01.044
CHEMBL24 7300 111 None -5 12 Human 6.6 pIC50 = 6.6 Binding
Binding affinity to human adrenergic beta1 receptor by radioligand displacement assayBinding affinity to human adrenergic beta1 receptor by radioligand displacement assay
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1016/j.ejmech.2013.01.044
DB00335 7300 111 None -5 12 Human 6.6 pIC50 = 6.6 Binding
Binding affinity to human adrenergic beta1 receptor by radioligand displacement assayBinding affinity to human adrenergic beta1 receptor by radioligand displacement assay
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1016/j.ejmech.2013.01.044
44268571 31403 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 582 13 6 7 4.2 O=C(Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1)NC1CCCCC1 10.1016/s0960-894x(98)00170-x
CHEMBL13432 31403 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 582 13 6 7 4.2 O=C(Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1)NC1CCCCC1 10.1016/s0960-894x(98)00170-x
12049922 109518 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.
ChEMBL 638 13 3 9 4.8 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(Cc3ccc(OC(F)(F)F)cc3)n2)cc1 10.1016/s0960-894x(00)00422-4
CHEMBL304991 109518 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.
ChEMBL 638 13 3 9 4.8 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(Cc3ccc(OC(F)(F)F)cc3)n2)cc1 10.1016/s0960-894x(00)00422-4
12049916 209773 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.
ChEMBL 576 11 3 8 4.3 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(-c3ccc(F)c(F)c3)n2)cc1 10.1016/s0960-894x(00)00422-4
CHEMBL63138 209773 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.
ChEMBL 576 11 3 8 4.3 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(-c3ccc(F)c(F)c3)n2)cc1 10.1016/s0960-894x(00)00422-4
44281408 120091 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 646 13 4 10 4.4 COC(=O)NC(c1ccc(F)cc1)c1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1 10.1016/s0960-894x(00)00268-7
CHEMBL33155 120091 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 646 13 4 10 4.4 COC(=O)NC(c1ccc(F)cc1)c1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1 10.1016/s0960-894x(00)00268-7
10651078 24714 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Binding affinity was evaluated on chinese hamster ovary (CHO) cells expressing the cloned human beta-1 adrenergic receptor in the presence of [125I]- iodocyanopindolol.Binding affinity was evaluated on chinese hamster ovary (CHO) cells expressing the cloned human beta-1 adrenergic receptor in the presence of [125I]- iodocyanopindolol.
ChEMBL 592 11 3 7 5.8 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3cccc(F)c3F)cs2)cc1 10.1021/jm000286i
CHEMBL125963 24714 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Binding affinity was evaluated on chinese hamster ovary (CHO) cells expressing the cloned human beta-1 adrenergic receptor in the presence of [125I]- iodocyanopindolol.Binding affinity was evaluated on chinese hamster ovary (CHO) cells expressing the cloned human beta-1 adrenergic receptor in the presence of [125I]- iodocyanopindolol.
ChEMBL 592 11 3 7 5.8 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3cccc(F)c3F)cs2)cc1 10.1021/jm000286i
14664348 19622 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)
ChEMBL 474 12 3 8 2.4 CC(C)(COc1ccc(-n2ccnc2)cc1)NCC(O)COc1ccc(NS(C)(=O)=O)cc1 10.1021/jm00166a002
CHEMBL1188606 19622 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)
ChEMBL 474 12 3 8 2.4 CC(C)(COc1ccc(-n2ccnc2)cc1)NCC(O)COc1ccc(NS(C)(=O)=O)cc1 10.1021/jm00166a002
CHEMBL536800 19622 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)
ChEMBL 474 12 3 8 2.4 CC(C)(COc1ccc(-n2ccnc2)cc1)NCC(O)COc1ccc(NS(C)(=O)=O)cc1 10.1021/jm00166a002
44298533 201783 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 469 11 1 5 6.5 CCCCCCCCc1csc(N2CCc3cc(S(=O)(=O)Nc4ccccc4)ccc32)n1 10.1016/s0960-894x(99)00277-2
CHEMBL54821 201783 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 469 11 1 5 6.5 CCCCCCCCc1csc(N2CCc3cc(S(=O)(=O)Nc4ccccc4)ccc32)n1 10.1016/s0960-894x(99)00277-2
14998853 126904 0 None - 0 Human 4.6 pIC50 = 4.6 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 360 6 3 5 1.9 CS(=O)(=O)Nc1ccc(NCC2CNCCN2c2ccccc2)cc1 10.1021/jm00082a016
CHEMBL351183 126904 0 None - 0 Human 4.6 pIC50 = 4.6 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 360 6 3 5 1.9 CS(=O)(=O)Nc1ccc(NCC2CNCCN2c2ccccc2)cc1 10.1021/jm00082a016
12043155 106518 0 None - 0 Human 4.6 pIC50 = 4.6 Binding
Binding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindololBinding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 549 14 3 8 4.8 CC(C)CCCc1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1 10.1016/s0960-894x(00)00267-5
CHEMBL284965 106518 0 None - 0 Human 4.6 pIC50 = 4.6 Binding
Binding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindololBinding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 549 14 3 8 4.8 CC(C)CCCc1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1 10.1016/s0960-894x(00)00267-5
10081581 17971 0 None 2 2 Rat 4.6 pIC50 = 4.6 Binding
Antagonist activity at rat brain membrane adrenergic beta-1 receptorAntagonist activity at rat brain membrane adrenergic beta-1 receptor
ChEMBL 202 6 2 4 1.1 CC/C=N/OCC(O)CNC(C)(C)C 10.1021/acs.jmedchem.1c01215
CHEMBL1178704 17971 0 None 2 2 Rat 4.6 pIC50 = 4.6 Binding
Antagonist activity at rat brain membrane adrenergic beta-1 receptorAntagonist activity at rat brain membrane adrenergic beta-1 receptor
ChEMBL 202 6 2 4 1.1 CC/C=N/OCC(O)CNC(C)(C)C 10.1021/acs.jmedchem.1c01215
CHEMBL38033 17971 0 None 2 2 Rat 4.6 pIC50 = 4.6 Binding
Antagonist activity at rat brain membrane adrenergic beta-1 receptorAntagonist activity at rat brain membrane adrenergic beta-1 receptor
ChEMBL 202 6 2 4 1.1 CC/C=N/OCC(O)CNC(C)(C)C 10.1021/acs.jmedchem.1c01215
10081581 17971 0 None - 2 Guinea pig 4.6 pIC50 = 4.6 Binding
Inhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atriaInhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atria
ChEMBL 202 6 2 4 1.1 CC/C=N/OCC(O)CNC(C)(C)C 10.1021/jm00036a018
CHEMBL1178704 17971 0 None - 2 Guinea pig 4.6 pIC50 = 4.6 Binding
Inhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atriaInhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atria
ChEMBL 202 6 2 4 1.1 CC/C=N/OCC(O)CNC(C)(C)C 10.1021/jm00036a018
CHEMBL38033 17971 0 None - 2 Guinea pig 4.6 pIC50 = 4.6 Binding
Inhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atriaInhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atria
ChEMBL 202 6 2 4 1.1 CC/C=N/OCC(O)CNC(C)(C)C 10.1021/jm00036a018
44377753 126708 0 None - 0 Human 4.6 pIC50 = 4.6 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 605 12 3 8 4.0 O=c1n(Cc2ccc(F)c(F)c2)ccn1-c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(99)00072-4
CHEMBL349505 126708 0 None - 0 Human 4.6 pIC50 = 4.6 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 605 12 3 8 4.0 O=c1n(Cc2ccc(F)c(F)c2)ccn1-c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(99)00072-4
44338499 115413 0 None - 0 Guinea pig 5.6 pIC50 = 5.6 Binding
Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)
ChEMBL 346 5 3 5 2.6 CC(C)(C)NCC(O)CO/N=C1/c2ccccc2C2CCCCC12O 10.1021/jm00122a008
CHEMBL320704 115413 0 None - 0 Guinea pig 5.6 pIC50 = 5.6 Binding
Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)
ChEMBL 346 5 3 5 2.6 CC(C)(C)NCC(O)CO/N=C1/c2ccccc2C2CCCCC12O 10.1021/jm00122a008
14664343 17878 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)
ChEMBL 460 12 3 8 2.0 Cc1nccn1-c1ccc(OCCNCC(O)COc2ccc(NS(C)(=O)=O)cc2)cc1 10.1021/jm00166a002
CHEMBL11629 17878 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)
ChEMBL 460 12 3 8 2.0 Cc1nccn1-c1ccc(OCCNCC(O)COc2ccc(NS(C)(=O)=O)cc2)cc1 10.1021/jm00166a002
CHEMBL1178024 17878 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)
ChEMBL 460 12 3 8 2.0 Cc1nccn1-c1ccc(OCCNCC(O)COc2ccc(NS(C)(=O)=O)cc2)cc1 10.1021/jm00166a002
12049921 210356 0 None - 0 Human 4.6 pIC50 = 4.6 Binding
Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.
ChEMBL 590 12 3 8 4.2 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(Cc3c(F)cccc3F)n2)cc1 10.1016/s0960-894x(00)00422-4
CHEMBL66789 210356 0 None - 0 Human 4.6 pIC50 = 4.6 Binding
Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.
ChEMBL 590 12 3 8 4.2 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(Cc3c(F)cccc3F)n2)cc1 10.1016/s0960-894x(00)00422-4
2447484 109545 2 None - 2 Human 7.5 pIC50 = 7.5 Binding
Compound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heart.Compound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heart.
ChEMBL 324 5 2 4 3.2 CC(C)(C)NC[C@H](O)CON=C1c2ccccc2-c2ccccc21 10.1021/jm00350a009
CHEMBL305153 109545 2 None - 2 Human 7.5 pIC50 = 7.5 Binding
Compound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heart.Compound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heart.
ChEMBL 324 5 2 4 3.2 CC(C)(C)NC[C@H](O)CON=C1c2ccccc2-c2ccccc21 10.1021/jm00350a009
10205362 123732 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 468 8 4 5 4.4 N#CN/C(=N\c1cc(Cl)cc(Cl)c1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/s0960-894x(00)00669-7
CHEMBL338618 123732 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 468 8 4 5 4.4 N#CN/C(=N\c1cc(Cl)cc(Cl)c1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/s0960-894x(00)00669-7
44306956 210126 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 495 11 3 6 3.8 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2cccnc2)cc1)c1ccc(Cl)c(Cl)c1 10.1016/s0960-894x(98)00381-3
CHEMBL65042 210126 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 495 11 3 6 3.8 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2cccnc2)cc1)c1ccc(Cl)c(Cl)c1 10.1016/s0960-894x(98)00381-3
72548703 168346 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [3H](-)CGP 12177 from human beta1 adrenoceptor after 60 mins by scintillation counting analysisDisplacement of [3H](-)CGP 12177 from human beta1 adrenoceptor after 60 mins by scintillation counting analysis
ChEMBL 583 8 3 6 5.8 CC(C)(C)NS(=O)(=O)c1ccc(-c2sc(C(=O)N[C@H]3C[C@H](C(=O)O)C3)nc2CC2CCCCC2)c2ccccc12 10.1016/j.bmcl.2018.03.093
CHEMBL4128926 168346 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [3H](-)CGP 12177 from human beta1 adrenoceptor after 60 mins by scintillation counting analysisDisplacement of [3H](-)CGP 12177 from human beta1 adrenoceptor after 60 mins by scintillation counting analysis
ChEMBL 583 8 3 6 5.8 CC(C)(C)NS(=O)(=O)c1ccc(-c2sc(C(=O)N[C@H]3C[C@H](C(=O)O)C3)nc2CC2CCCCC2)c2ccccc12 10.1016/j.bmcl.2018.03.093
70695718 79890 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 372 10 3 6 1.8 N#Cc1ccccc1OC[C@@H](O)CNCCCC(=O)Nc1ccc(F)nc1 10.1021/ml1002458
CHEMBL2011234 79890 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 372 10 3 6 1.8 N#Cc1ccccc1OC[C@@H](O)CNCCCC(=O)Nc1ccc(F)nc1 10.1021/ml1002458
16049026 70861 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 432 13 4 7 2.6 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCOCCOCCc3ccccc3)c2s1 10.1016/j.bmcl.2011.05.097
CHEMBL1807821 70861 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 432 13 4 7 2.6 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCOCCOCCc3ccccc3)c2s1 10.1016/j.bmcl.2011.05.097
16049029 70862 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 482 13 4 7 3.7 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCOCCOCCc3cccc4ccccc34)c2s1 10.1016/j.bmcl.2011.05.097
CHEMBL1807822 70862 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 482 13 4 7 3.7 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCOCCOCCc3cccc4ccccc34)c2s1 10.1016/j.bmcl.2011.05.097
16049028 70859 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 462 14 4 7 3.7 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCSCCCOCCc3ccccc3)c2s1 10.1016/j.bmcl.2011.05.097
CHEMBL1807819 70859 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 462 14 4 7 3.7 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCSCCCOCCc3ccccc3)c2s1 10.1016/j.bmcl.2011.05.097
44268568 31707 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 570 16 6 7 4.1 CCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
CHEMBL13459 31707 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 570 16 6 7 4.1 CCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
44338529 115412 0 None - 0 Guinea pig 5.5 pIC50 = 5.5 Binding
Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)
ChEMBL 360 7 2 5 3.2 COC12CCCCCC1c1ccccc1/C2=N/OCC(O)CNC(C)C 10.1021/jm00122a008
CHEMBL320696 115412 0 None - 0 Guinea pig 5.5 pIC50 = 5.5 Binding
Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)
ChEMBL 360 7 2 5 3.2 COC12CCCCCC1c1ccccc1/C2=N/OCC(O)CNC(C)C 10.1021/jm00122a008
44301803 174585 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 588 12 3 7 5.6 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(Cc3ccc(F)cc3)cs2)cc1 10.1016/s0960-894x(00)00390-5
CHEMBL430594 174585 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 588 12 3 7 5.6 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(Cc3ccc(F)cc3)cs2)cc1 10.1016/s0960-894x(00)00390-5
14998846 63159 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 374 7 3 5 1.6 CS(=O)(=O)Nc1ccc(CNCC2CN(c3ccccc3)CCN2)cc1 10.1021/jm00082a016
CHEMBL163153 63159 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 374 7 3 5 1.6 CS(=O)(=O)Nc1ccc(CNCC2CN(c3ccccc3)CCN2)cc1 10.1021/jm00082a016
12049919 209878 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.
ChEMBL 572 12 3 8 4.1 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(Cc3cccc(F)c3)n2)cc1 10.1016/s0960-894x(00)00422-4
CHEMBL63963 209878 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.
ChEMBL 572 12 3 8 4.1 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(Cc3cccc(F)c3)n2)cc1 10.1016/s0960-894x(00)00422-4
44349323 23568 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 437 11 4 7 3.7 O=[N+]([O-])/C=C(\Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)Nc1cccc(F)c1 10.1016/s0960-894x(00)00669-7
CHEMBL124584 23568 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 437 11 4 7 3.7 O=[N+]([O-])/C=C(\Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)Nc1cccc(F)c1 10.1016/s0960-894x(00)00669-7
44281530 106596 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 609 12 3 8 4.8 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(Cc3cc(F)c(F)c(F)c3)n2)cc1 10.1016/s0960-894x(00)00268-7
CHEMBL285499 106596 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 609 12 3 8 4.8 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(Cc3cc(F)c(F)c(F)c3)n2)cc1 10.1016/s0960-894x(00)00268-7
9938030 106801 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 573 12 3 8 4.5 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(Cc3ccc(F)cc3)n2)cc1 10.1016/s0960-894x(00)00268-7
CHEMBL286859 106801 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 573 12 3 8 4.5 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(Cc3ccc(F)cc3)n2)cc1 10.1016/s0960-894x(00)00268-7
44281425 107083 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 612 13 4 9 4.3 CC(=O)Nc1ccc(Cc2nc(-c3ccc(S(=O)(=O)Nc4ccc(CCNC[C@H](O)c5cccnc5)cc4)cc3)no2)cc1 10.1016/s0960-894x(00)00268-7
CHEMBL289250 107083 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 612 13 4 9 4.3 CC(=O)Nc1ccc(Cc2nc(-c3ccc(S(=O)(=O)Nc4ccc(CCNC[C@H](O)c5cccnc5)cc4)cc3)no2)cc1 10.1016/s0960-894x(00)00268-7
44377687 64218 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 579 16 3 6 5.0 CCCCCCCN1CCN(c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)C1=O 10.1016/s0960-894x(99)00072-4
CHEMBL165513 64218 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 579 16 3 6 5.0 CCCCCCCN1CCN(c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)C1=O 10.1016/s0960-894x(99)00072-4
46881700 13635 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 443 9 3 7 2.3 O=C(Cn1c(=O)ncc2ccccc21)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/j.bmcl.2010.01.130
CHEMBL1084144 13635 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 443 9 3 7 2.3 O=C(Cn1c(=O)ncc2ccccc21)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/j.bmcl.2010.01.130
46881529 14034 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 375 9 3 4 3.1 O=C(Cc1ccccc1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/j.bmcl.2010.01.130
CHEMBL1085898 14034 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 375 9 3 4 3.1 O=C(Cc1ccccc1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/j.bmcl.2010.01.130
12017001 153823 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 540 11 3 7 5.1 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2cnc(-c3ccccc3)o2)cc1 10.1016/s0960-894x(00)00277-8
CHEMBL39269 153823 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 540 11 3 7 5.1 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2cnc(-c3ccccc3)o2)cc1 10.1016/s0960-894x(00)00277-8
44298850 174962 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 461 8 1 4 6.1 O=S(=O)(Nc1ccccc1)c1ccc2c(c1)CCN2c1cccc(CCCC2CCCC2)n1 10.1016/s0960-894x(99)00277-2
CHEMBL433252 174962 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 461 8 1 4 6.1 O=S(=O)(Nc1ccccc1)c1ccc2c(c1)CCN2c1cccc(CCCC2CCCC2)n1 10.1016/s0960-894x(99)00277-2
44298281 201508 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 463 6 1 3 4.9 CN(C(=O)N1CCc2cc(S(=O)(=O)Nc3ccccc3)ccc21)C(C)(C)Cc1ccccc1 10.1016/s0960-894x(99)00277-2
CHEMBL53517 201508 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 463 6 1 3 4.9 CN(C(=O)N1CCc2cc(S(=O)(=O)Nc3ccccc3)ccc21)C(C)(C)Cc1ccccc1 10.1016/s0960-894x(99)00277-2
44335499 11764 0 None - 0 Human 4.5 pIC50 = 4.5 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 439 10 3 5 3.9 CC(C)c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(98)00571-x
CHEMBL104981 11764 0 None - 0 Human 4.5 pIC50 = 4.5 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 439 10 3 5 3.9 CC(C)c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(98)00571-x
44335651 115336 0 None - 0 Human 4.5 pIC50 = 4.5 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 431 9 3 5 3.4 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(Cl)cc1 10.1016/s0960-894x(98)00571-x
CHEMBL320228 115336 0 None - 0 Human 4.5 pIC50 = 4.5 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 431 9 3 5 3.4 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(Cl)cc1 10.1016/s0960-894x(98)00571-x
44302005 107337 0 None - 0 Human 4.5 pIC50 = 4.5 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 595 11 4 7 6.0 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3c[nH]c4ccccc34)cs2)cc1 10.1016/s0960-894x(00)00390-5
CHEMBL291516 107337 0 None - 0 Human 4.5 pIC50 = 4.5 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 595 11 4 7 6.0 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3c[nH]c4ccccc34)cs2)cc1 10.1016/s0960-894x(00)00390-5
44280957 119328 0 None - 0 Human 4.5 pIC50 = 4.5 Binding
Binding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindololBinding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 590 13 3 9 3.4 O=C(CCc1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1)N1CCCC1 10.1016/s0960-894x(00)00267-5
CHEMBL32996 119328 0 None - 0 Human 4.5 pIC50 = 4.5 Binding
Binding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindololBinding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 590 13 3 9 3.4 O=C(CCc1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1)N1CCCC1 10.1016/s0960-894x(00)00267-5
11819522 18788 0 None - 2 Guinea pig 4.5 pIC50 = 4.5 Binding
Inhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atriaInhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atria
ChEMBL 174 6 2 4 0.4 C/C=N/OCC(O)CNC(C)C 10.1021/jm00036a018
CHEMBL1183318 18788 0 None - 2 Guinea pig 4.5 pIC50 = 4.5 Binding
Inhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atriaInhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atria
ChEMBL 174 6 2 4 0.4 C/C=N/OCC(O)CNC(C)C 10.1021/jm00036a018
CHEMBL290153 18788 0 None - 2 Guinea pig 4.5 pIC50 = 4.5 Binding
Inhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atriaInhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atria
ChEMBL 174 6 2 4 0.4 C/C=N/OCC(O)CNC(C)C 10.1021/jm00036a018
46881574 14555 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 415 9 3 6 2.9 O=C(Cn1cc2ccccc2n1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/j.bmcl.2010.01.130
CHEMBL1089386 14555 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 415 9 3 6 2.9 O=C(Cn1cc2ccccc2n1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/j.bmcl.2010.01.130
14998847 62354 0 None - 0 Human 4.5 pIC50 = 4.5 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 388 6 3 5 1.3 CS(=O)(=O)Nc1ccc(C(=O)NCC2CNCCN2c2ccccc2)cc1 10.1021/jm00082a016
CHEMBL162095 62354 0 None - 0 Human 4.5 pIC50 = 4.5 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 388 6 3 5 1.3 CS(=O)(=O)Nc1ccc(C(=O)NCC2CNCCN2c2ccccc2)cc1 10.1021/jm00082a016
12017003 148708 0 None - 0 Human 4.5 pIC50 = 4.5 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 576 11 3 7 5.3 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2cnc(-c3ccc(F)c(F)c3)o2)cc1 10.1016/s0960-894x(00)00277-8
CHEMBL38704 148708 0 None - 0 Human 4.5 pIC50 = 4.5 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 576 11 3 7 5.3 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2cnc(-c3ccc(F)c(F)c3)o2)cc1 10.1016/s0960-894x(00)00277-8
319 8106 44 None -154 9 Human 6.5 pIC50 = 6.5 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 10.1016/j.bmcl.2011.05.097
321 8106 44 None -154 9 Human 6.5 pIC50 = 6.5 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 10.1016/j.bmcl.2011.05.097
444031 8106 44 None -154 9 Human 6.5 pIC50 = 6.5 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 10.1016/j.bmcl.2011.05.097
784 8106 44 None -154 9 Human 6.5 pIC50 = 6.5 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 10.1016/j.bmcl.2011.05.097
CHEMBL1346 8106 44 None -154 9 Human 6.5 pIC50 = 6.5 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 10.1016/j.bmcl.2011.05.097
DB00496 8106 44 None -154 9 Human 6.5 pIC50 = 6.5 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 10.1016/j.bmcl.2011.05.097
4183 8806 68 None -2 3 Human 6.5 pIC50 = 6.5 Binding
Binding affinity to beta1 adrenoceptorBinding affinity to beta1 adrenoceptor
ChEMBL 392 6 4 4 3.1 CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O 10.1016/j.bmcl.2011.10.049
6918554 8806 68 None -2 3 Human 6.5 pIC50 = 6.5 Binding
Binding affinity to beta1 adrenoceptorBinding affinity to beta1 adrenoceptor
ChEMBL 392 6 4 4 3.1 CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O 10.1016/j.bmcl.2011.10.049
7455 8806 68 None -2 3 Human 6.5 pIC50 = 6.5 Binding
Binding affinity to beta1 adrenoceptorBinding affinity to beta1 adrenoceptor
ChEMBL 392 6 4 4 3.1 CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O 10.1016/j.bmcl.2011.10.049
CHEMBL1095777 8806 68 None -2 3 Human 6.5 pIC50 = 6.5 Binding
Binding affinity to beta1 adrenoceptorBinding affinity to beta1 adrenoceptor
ChEMBL 392 6 4 4 3.1 CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O 10.1016/j.bmcl.2011.10.049
DB05039 8806 68 None -2 3 Human 6.5 pIC50 = 6.5 Binding
Binding affinity to beta1 adrenoceptorBinding affinity to beta1 adrenoceptor
ChEMBL 392 6 4 4 3.1 CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O 10.1016/j.bmcl.2011.10.049
24901351 77107 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 493 12 5 7 3.5 COc1ccccc1CCNCc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1 10.1016/j.bmcl.2011.10.049
CHEMBL1944694 77107 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 493 12 5 7 3.5 COc1ccccc1CCNCc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1 10.1016/j.bmcl.2011.10.049
24901413 77131 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 516 11 6 6 4.3 Cc1cccc2c(CCNCc3ccc(CCNC[C@H](O)c4ccc(O)c5[nH]c(=O)sc45)cc3)c[nH]c12 10.1016/j.bmcl.2011.10.049
CHEMBL1945032 77131 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 516 11 6 6 4.3 Cc1cccc2c(CCNCc3ccc(CCNC[C@H](O)c4ccc(O)c5[nH]c(=O)sc45)cc3)c[nH]c12 10.1016/j.bmcl.2011.10.049
24900937 77159 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 413 8 4 6 2.8 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CN4CCCC4)c3)c2s1 10.1016/j.bmcl.2011.10.049
CHEMBL1945294 77159 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 413 8 4 6 2.8 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CN4CCCC4)c3)c2s1 10.1016/j.bmcl.2011.10.049
57401435 77175 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 458 11 5 6 2.8 O=c1ccc2c([C@@H](O)CNCCc3cccc(CNCCc4ccccn4)c3)ccc(O)c2[nH]1 10.1016/j.bmcl.2011.10.049
CHEMBL1945503 77175 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 458 11 5 6 2.8 O=c1ccc2c([C@@H](O)CNCCc3cccc(CNCCc4ccccn4)c3)ccc(O)c2[nH]1 10.1016/j.bmcl.2011.10.049
44298314 107937 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 452 8 1 6 5.1 O=S(=O)(Nc1ccccc1)c1ccc2c(c1)CCN2c1noc(CCCC2CCCC2)n1 10.1016/s0960-894x(99)00277-2
CHEMBL295502 107937 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 452 8 1 6 5.1 O=S(=O)(Nc1ccccc1)c1ccc2c(c1)CCN2c1noc(CCCC2CCCC2)n1 10.1016/s0960-894x(99)00277-2
11556330 169990 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 620 12 3 7 6.6 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(Cc3ccc4ccccc4c3)cs2)cc1 10.1016/s0960-894x(00)00390-5
CHEMBL418308 169990 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 620 12 3 7 6.6 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(Cc3ccc4ccccc4c3)cs2)cc1 10.1016/s0960-894x(00)00390-5
14998851 126838 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 361 6 2 5 1.9 CS(=O)(=O)Nc1ccc(OCC2CN(c3ccccc3)CCN2)cc1 10.1021/jm00082a016
CHEMBL350581 126838 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 361 6 2 5 1.9 CS(=O)(=O)Nc1ccc(OCC2CN(c3ccccc3)CCN2)cc1 10.1021/jm00082a016
567 7512 16 None - 5 Rat 5.5 pIC50 = 5.5 Binding
Compound was evaluated for its binding affinity towards Beta-1 adrenergic receptor in rat heart membrane by displacing [125I]- iodocyanopindololCompound was evaluated for its binding affinity towards Beta-1 adrenergic receptor in rat heart membrane by displacing [125I]- iodocyanopindolol
ChEMBL 363 9 3 4 3.1 C[C@H](Cc1ccc(cc1)OCC(=O)O)NC[C@@H](c1cccc(c1)Cl)O 10.1021/jm00094a025
9841972 7512 16 None - 5 Rat 5.5 pIC50 = 5.5 Binding
Compound was evaluated for its binding affinity towards Beta-1 adrenergic receptor in rat heart membrane by displacing [125I]- iodocyanopindololCompound was evaluated for its binding affinity towards Beta-1 adrenergic receptor in rat heart membrane by displacing [125I]- iodocyanopindolol
ChEMBL 363 9 3 4 3.1 C[C@H](Cc1ccc(cc1)OCC(=O)O)NC[C@@H](c1cccc(c1)Cl)O 10.1021/jm00094a025
CHEMBL284782 7512 16 None - 5 Rat 5.5 pIC50 = 5.5 Binding
Compound was evaluated for its binding affinity towards Beta-1 adrenergic receptor in rat heart membrane by displacing [125I]- iodocyanopindololCompound was evaluated for its binding affinity towards Beta-1 adrenergic receptor in rat heart membrane by displacing [125I]- iodocyanopindolol
ChEMBL 363 9 3 4 3.1 C[C@H](Cc1ccc(cc1)OCC(=O)O)NC[C@@H](c1cccc(c1)Cl)O 10.1021/jm00094a025
14739901 214514 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Tested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogsTested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 419 8 2 6 1.9 Cc1ccccc1OCC(O)CN1CCN(c2ccc(NS(C)(=O)=O)cc2)CC1 10.1021/jm00172a033
CHEMBL95754 214514 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Tested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogsTested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 419 8 2 6 1.9 Cc1ccccc1OCC(O)CN1CCN(c2ccc(NS(C)(=O)=O)cc2)CC1 10.1021/jm00172a033
14739893 11050 0 None - 0 Human 4.5 pIC50 = 4.5 Binding
Tested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogsTested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 416 10 3 7 1.8 CS(=O)(=O)Nc1ccc(OCC(O)CNCc2ccc(-n3ccnc3)cc2)cc1 10.1021/jm00172a033
CHEMBL100624 11050 0 None - 0 Human 4.5 pIC50 = 4.5 Binding
Tested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogsTested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 416 10 3 7 1.8 CS(=O)(=O)Nc1ccc(OCC(O)CNCc2ccc(-n3ccnc3)cc2)cc1 10.1021/jm00172a033
1499 8872 47 None -53 17 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C nan
3779 8872 47 None -53 17 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C nan
536 8872 47 None -53 17 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C nan
CHEMBL434 8872 47 None -53 17 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C nan
DB01064 8872 47 None -53 17 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C nan
12828562 116483 0 None - 2 Guinea pig 4.5 pIC50 = 4.5 Binding
Inhibitory activity against beta-1 adrenergic receptor in guinea pig atria is determinedInhibitory activity against beta-1 adrenergic receptor in guinea pig atria is determined
ChEMBL 237 3 3 4 1.7 CC(C)NCC1OCCc2cc(O)c(O)cc21 10.1021/jm00073a006
CHEMBL322842 116483 0 None - 2 Guinea pig 4.5 pIC50 = 4.5 Binding
Inhibitory activity against beta-1 adrenergic receptor in guinea pig atria is determinedInhibitory activity against beta-1 adrenergic receptor in guinea pig atria is determined
ChEMBL 237 3 3 4 1.7 CC(C)NCC1OCCc2cc(O)c(O)cc21 10.1021/jm00073a006
2303 9961 68 None -15 26 Guinea pig 7.5 pIC50 = 7.5 Binding
Inhibitory activity against beta-1 adrenergic receptor in guinea pig atria is determinedInhibitory activity against beta-1 adrenergic receptor in guinea pig atria is determined
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00073a006
4946 9961 68 None -15 26 Guinea pig 7.5 pIC50 = 7.5 Binding
Inhibitory activity against beta-1 adrenergic receptor in guinea pig atria is determinedInhibitory activity against beta-1 adrenergic receptor in guinea pig atria is determined
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00073a006
564 9961 68 None -15 26 Guinea pig 7.5 pIC50 = 7.5 Binding
Inhibitory activity against beta-1 adrenergic receptor in guinea pig atria is determinedInhibitory activity against beta-1 adrenergic receptor in guinea pig atria is determined
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00073a006
63 9961 68 None -15 26 Guinea pig 7.5 pIC50 = 7.5 Binding
Inhibitory activity against beta-1 adrenergic receptor in guinea pig atria is determinedInhibitory activity against beta-1 adrenergic receptor in guinea pig atria is determined
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00073a006
91536 9961 68 None -15 26 Guinea pig 7.5 pIC50 = 7.5 Binding
Inhibitory activity against beta-1 adrenergic receptor in guinea pig atria is determinedInhibitory activity against beta-1 adrenergic receptor in guinea pig atria is determined
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00073a006
CHEMBL27 9961 68 None -15 26 Guinea pig 7.5 pIC50 = 7.5 Binding
Inhibitory activity against beta-1 adrenergic receptor in guinea pig atria is determinedInhibitory activity against beta-1 adrenergic receptor in guinea pig atria is determined
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00073a006
CHEMBL452861 9961 68 None -15 26 Guinea pig 7.5 pIC50 = 7.5 Binding
Inhibitory activity against beta-1 adrenergic receptor in guinea pig atria is determinedInhibitory activity against beta-1 adrenergic receptor in guinea pig atria is determined
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00073a006
DB00571 9961 68 None -15 26 Guinea pig 7.5 pIC50 = 7.5 Binding
Inhibitory activity against beta-1 adrenergic receptor in guinea pig atria is determinedInhibitory activity against beta-1 adrenergic receptor in guinea pig atria is determined
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00073a006
44338613 118154 0 None - 0 Guinea pig 6.5 pIC50 = 6.5 Binding
Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)
ChEMBL 360 5 3 5 2.9 CC(C)(C)NCC(O)CO/N=C1/c2ccccc2C2CCCCCC12O 10.1021/jm00122a008
CHEMBL327091 118154 0 None - 0 Guinea pig 6.5 pIC50 = 6.5 Binding
Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)
ChEMBL 360 5 3 5 2.9 CC(C)(C)NCC(O)CO/N=C1/c2ccccc2C2CCCCCC12O 10.1021/jm00122a008
44268563 103960 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 569 17 5 7 4.7 CCCCCCC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
CHEMBL268289 103960 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 569 17 5 7 4.7 CCCCCCC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
46881699 12365 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 443 9 3 7 2.3 O=C(Cn1cnc2ccccc2c1=O)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/j.bmcl.2010.01.130
CHEMBL1077238 12365 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 443 9 3 7 2.3 O=C(Cn1cnc2ccccc2c1=O)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/j.bmcl.2010.01.130
9873257 91720 16 None - 0 Human 5.5 pIC50 = 5.5 Binding
Inhibitory activity against cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol expressed in CHO cells by receptor binding assayInhibitory activity against cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol expressed in CHO cells by receptor binding assay
ChEMBL 591 14 3 10 3.5 O=c1n(CCCC2CCCC2)nnn1-c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(99)00182-1
CHEMBL22375 91720 16 None - 0 Human 5.5 pIC50 = 5.5 Binding
Inhibitory activity against cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol expressed in CHO cells by receptor binding assayInhibitory activity against cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol expressed in CHO cells by receptor binding assay
ChEMBL 591 14 3 10 3.5 O=c1n(CCCC2CCCC2)nnn1-c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(99)00182-1
44268632 30999 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 514 12 6 7 2.5 CNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
CHEMBL13398 30999 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 514 12 6 7 2.5 CNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
44285634 107184 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 576 17 3 7 6.3 CCCCCCCCc1ncc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)o1 10.1016/s0960-894x(00)00277-8
CHEMBL290131 107184 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 576 17 3 7 6.3 CCCCCCCCc1ncc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)o1 10.1016/s0960-894x(00)00277-8
44281097 121511 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 607 13 3 9 4.7 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(COc3ccc(F)c(F)c3)no2)cc1 10.1016/s0960-894x(00)00268-7
CHEMBL33384 121511 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 607 13 3 9 4.7 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(COc3ccc(F)c(F)c3)no2)cc1 10.1016/s0960-894x(00)00268-7
2291 9958 58 None -11 12 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O nan
2561 9958 58 None -11 12 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O nan
4932 9958 58 None -11 12 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O nan
CHEMBL631 9958 58 None -11 12 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O nan
DB01182 9958 58 None -11 12 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O nan
11811722 16837 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Binding affinity against beta-1 adrenergic receptorBinding affinity against beta-1 adrenergic receptor
ChEMBL 413 5 1 4 4.4 O=C1NCN(c2ccccc2)C12CCN(Cc1cccc(Oc3ccccc3)c1)CC2 10.1021/jm010878g
CHEMBL115280 16837 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Binding affinity against beta-1 adrenergic receptorBinding affinity against beta-1 adrenergic receptor
ChEMBL 413 5 1 4 4.4 O=C1NCN(c2ccccc2)C12CCN(Cc1cccc(Oc3ccccc3)c1)CC2 10.1021/jm010878g
46881701 13636 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 477 9 3 8 3.0 Cc1sc2ncn(CC(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)c(=O)c2c1C 10.1016/j.bmcl.2010.01.130
CHEMBL1084145 13636 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 477 9 3 8 3.0 Cc1sc2ncn(CC(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)c(=O)c2c1C 10.1016/j.bmcl.2010.01.130
44281400 117136 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 607 13 3 9 4.7 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(COc3ccc(F)c(F)c3)n2)cc1 10.1016/s0960-894x(00)00268-7
CHEMBL32411 117136 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 607 13 3 9 4.7 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(COc3ccc(F)c(F)c3)n2)cc1 10.1016/s0960-894x(00)00268-7
2369 7409 80 None 3 8 Human 7.4 pIC50 = 7.4 Binding
Compound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heartCompound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heart
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00350a009
356 7409 80 None 3 8 Human 7.4 pIC50 = 7.4 Binding
Compound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heartCompound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heart
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00350a009
549 7409 80 None 3 8 Human 7.4 pIC50 = 7.4 Binding
Compound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heartCompound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heart
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00350a009
CHEMBL423 7409 80 None 3 8 Human 7.4 pIC50 = 7.4 Binding
Compound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heartCompound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heart
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00350a009
DB00195 7409 80 None 3 8 Human 7.4 pIC50 = 7.4 Binding
Compound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heartCompound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heart
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00350a009
121848 137488 4 None - 2 Human 7.4 pIC50 = 7.4 Binding
Compound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heart.Compound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heart.
ChEMBL 324 5 2 4 3.2 CC(C)(C)NCC(O)CON=C1c2ccccc2-c2ccccc21 10.1021/jm00350a009
CHEMBL368457 137488 4 None - 2 Human 7.4 pIC50 = 7.4 Binding
Compound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heart.Compound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heart.
ChEMBL 324 5 2 4 3.2 CC(C)(C)NCC(O)CON=C1c2ccccc2-c2ccccc21 10.1021/jm00350a009
21138 105227 39 None -4 7 Human 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 CC(C)NC[C@@H](O)COc1cccc2ccccc12 nan
CHEMBL275742 105227 39 None -4 7 Human 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 CC(C)NC[C@@H](O)COc1cccc2ccccc12 nan
44301832 207854 1 None - 0 Human 5.4 pIC50 = 5.4 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 592 17 3 7 6.8 CCCCCCCCc1csc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)n1 10.1016/s0960-894x(00)00390-5
CHEMBL60281 207854 1 None - 0 Human 5.4 pIC50 = 5.4 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 592 17 3 7 6.8 CCCCCCCCc1csc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)n1 10.1016/s0960-894x(00)00390-5
44285692 144005 0 None - 0 Human 4.4 pIC50 = 4.4 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 478 10 3 7 3.7 Cc1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)co1 10.1016/s0960-894x(00)00277-8
CHEMBL37512 144005 0 None - 0 Human 4.4 pIC50 = 4.4 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 478 10 3 7 3.7 Cc1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)co1 10.1016/s0960-894x(00)00277-8
44267518 20096 1 None - 0 Human 4.4 pIC50 = 4.4 Binding
Tested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogsTested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 446 12 3 8 1.7 CS(=O)(=O)Nc1ccc(OC[C@H](O)CNCCOc2ccc(-n3ccnc3)cc2)cc1 10.1021/jm00172a033
CHEMBL1192069 20096 1 None - 0 Human 4.4 pIC50 = 4.4 Binding
Tested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogsTested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 446 12 3 8 1.7 CS(=O)(=O)Nc1ccc(OC[C@H](O)CNCCOc2ccc(-n3ccnc3)cc2)cc1 10.1021/jm00172a033
CHEMBL543251 20096 1 None - 0 Human 4.4 pIC50 = 4.4 Binding
Tested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogsTested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 446 12 3 8 1.7 CS(=O)(=O)Nc1ccc(OC[C@H](O)CNCCOc2ccc(-n3ccnc3)cc2)cc1 10.1021/jm00172a033
44349367 23693 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 487 11 4 7 4.9 O=[N+]([O-])/C=C(\Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)Nc1cc(Cl)cc(Cl)c1 10.1016/s0960-894x(00)00669-7
CHEMBL125246 23693 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 487 11 4 7 4.9 O=[N+]([O-])/C=C(\Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)Nc1cc(Cl)cc(Cl)c1 10.1016/s0960-894x(00)00669-7
83113 64208 91 None - 0 Human 4.4 pIC50 = 4.4 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 176 1 1 2 1.4 Cc1ccc(N2CCNCC2)cc1 10.1021/jm00082a016
CHEMBL165462 64208 91 None - 0 Human 4.4 pIC50 = 4.4 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 176 1 1 2 1.4 Cc1ccc(N2CCNCC2)cc1 10.1021/jm00082a016
269722 206760 108 None - 1 Human 4.4 pIC50 = 4.4 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 192 2 1 3 1.1 COc1ccc(N2CCNCC2)cc1 10.1021/jm00082a016
CHEMBL59517 206760 108 None - 1 Human 4.4 pIC50 = 4.4 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 192 2 1 3 1.1 COc1ccc(N2CCNCC2)cc1 10.1021/jm00082a016
44267518 20096 1 None - 0 Human 4.4 pIC50 = 4.4 Binding
In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)
ChEMBL 446 12 3 8 1.7 CS(=O)(=O)Nc1ccc(OC[C@H](O)CNCCOc2ccc(-n3ccnc3)cc2)cc1 10.1021/jm00166a002
CHEMBL1192069 20096 1 None - 0 Human 4.4 pIC50 = 4.4 Binding
In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)
ChEMBL 446 12 3 8 1.7 CS(=O)(=O)Nc1ccc(OC[C@H](O)CNCCOc2ccc(-n3ccnc3)cc2)cc1 10.1021/jm00166a002
CHEMBL543251 20096 1 None - 0 Human 4.4 pIC50 = 4.4 Binding
In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)
ChEMBL 446 12 3 8 1.7 CS(=O)(=O)Nc1ccc(OC[C@H](O)CNCCOc2ccc(-n3ccnc3)cc2)cc1 10.1021/jm00166a002
16049309 70874 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 481 13 5 7 3.5 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCSCCNCCc3ccccc3Cl)c2s1 10.1016/j.bmcl.2011.05.097
CHEMBL1807870 70874 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 481 13 5 7 3.5 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCSCCNCCc3ccccc3Cl)c2s1 10.1016/j.bmcl.2011.05.097
56670092 70878 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 445 13 4 7 2.5 CN(CCOCCCNC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12)CCc1ccccc1 10.1016/j.bmcl.2011.05.097
CHEMBL1807874 70878 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 445 13 4 7 2.5 CN(CCOCCCNC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12)CCc1ccccc1 10.1016/j.bmcl.2011.05.097
24901348 77102 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 531 11 5 6 4.8 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3ccc(CNCCc4c(Cl)cccc4Cl)cc3)c2s1 10.1016/j.bmcl.2011.10.049
CHEMBL1944689 77102 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 531 11 5 6 4.8 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3ccc(CNCCc4c(Cl)cccc4Cl)cc3)c2s1 10.1016/j.bmcl.2011.10.049
24901349 77105 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 481 11 5 6 3.6 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3ccc(CNCCc4ccccc4F)cc3)c2s1 10.1016/j.bmcl.2011.10.049
CHEMBL1944692 77105 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 481 11 5 6 3.6 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3ccc(CNCCc4ccccc4F)cc3)c2s1 10.1016/j.bmcl.2011.10.049
24901347 77108 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 463 11 5 6 3.5 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3ccc(CNCCc4ccccc4)cc3)c2s1 10.1016/j.bmcl.2011.10.049
CHEMBL1944695 77108 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 463 11 5 6 3.5 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3ccc(CNCCc4ccccc4)cc3)c2s1 10.1016/j.bmcl.2011.10.049
137 7158 52 None -19 12 Human 8.3 pIC50 = 8.3 Binding
Compound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heart.Compound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heart.
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1021/jm00350a009
2119 7158 52 None -19 12 Human 8.3 pIC50 = 8.3 Binding
Compound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heart.Compound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heart.
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1021/jm00350a009
563 7158 52 None -19 12 Human 8.3 pIC50 = 8.3 Binding
Compound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heart.Compound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heart.
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1021/jm00350a009
66368 7158 52 None -19 12 Human 8.3 pIC50 = 8.3 Binding
Compound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heart.Compound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heart.
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1021/jm00350a009
CHEMBL266195 7158 52 None -19 12 Human 8.3 pIC50 = 8.3 Binding
Compound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heart.Compound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heart.
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1021/jm00350a009
DB00866 7158 52 None -19 12 Human 8.3 pIC50 = 8.3 Binding
Compound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heart.Compound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heart.
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1021/jm00350a009
15483883 107008 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 589 13 3 9 4.5 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(COc3ccc(F)cc3)no2)cc1 10.1016/s0960-894x(00)00268-7
CHEMBL288550 107008 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 589 13 3 9 4.5 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(COc3ccc(F)cc3)no2)cc1 10.1016/s0960-894x(00)00268-7
44281219 118791 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 588 12 4 9 4.0 NC(c1ccc(F)cc1)c1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1 10.1016/s0960-894x(00)00268-7
CHEMBL32891 118791 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 588 12 4 9 4.0 NC(c1ccc(F)cc1)c1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1 10.1016/s0960-894x(00)00268-7
15523861 64299 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 599 14 3 6 4.6 O=C1N(CCCc2ccccc2)CCN1c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(99)00072-4
CHEMBL166188 64299 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 599 14 3 6 4.6 O=C1N(CCCc2ccccc2)CCN1c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(99)00072-4
44377316 126840 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 591 13 3 6 5.0 O=C1N(CCC2CCCCC2)CCN1c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(99)00072-4
CHEMBL350590 126840 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 591 13 3 6 5.0 O=C1N(CCC2CCCCC2)CCN1c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(99)00072-4
46882031 12567 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 465 11 3 4 5.0 O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1cccc(CCc2ccccc2)c1 10.1016/j.bmcl.2010.01.130
CHEMBL1078749 12567 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 465 11 3 4 5.0 O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1cccc(CCc2ccccc2)c1 10.1016/j.bmcl.2010.01.130
44298290 174985 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 371 4 1 5 3.9 Cc1csc(N2CCc3cc(S(=O)(=O)Nc4ccccc4)ccc32)n1 10.1016/s0960-894x(99)00277-2
CHEMBL433454 174985 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 371 4 1 5 3.9 Cc1csc(N2CCc3cc(S(=O)(=O)Nc4ccccc4)ccc32)n1 10.1016/s0960-894x(99)00277-2
44298822 201775 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 460 8 1 3 6.7 O=S(=O)(Nc1ccccc1)c1ccc2c(c1)CCN2c1cccc(CCCC2CCCC2)c1 10.1016/s0960-894x(99)00277-2
CHEMBL54750 201775 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 460 8 1 3 6.7 O=S(=O)(Nc1ccccc1)c1ccc2c(c1)CCN2c1cccc(CCCC2CCCC2)c1 10.1016/s0960-894x(99)00277-2
44298516 202368 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 467 8 1 5 6.2 O=S(=O)(Nc1ccccc1)c1ccc2c(c1)CCN2c1nc(CCCC2CCCC2)cs1 10.1016/s0960-894x(99)00277-2
CHEMBL55541 202368 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 467 8 1 5 6.2 O=S(=O)(Nc1ccccc1)c1ccc2c(c1)CCN2c1nc(CCCC2CCCC2)cs1 10.1016/s0960-894x(99)00277-2
44301764 107408 0 None - 0 Human 4.4 pIC50 = 4.4 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 564 15 3 7 6.0 CCCCCCc1csc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)n1 10.1016/s0960-894x(00)00390-5
CHEMBL291992 107408 0 None - 0 Human 4.4 pIC50 = 4.4 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 564 15 3 7 6.0 CCCCCCc1csc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)n1 10.1016/s0960-894x(00)00390-5
12049915 109616 0 None - 0 Human 4.4 pIC50 = 4.4 Binding
Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.
ChEMBL 558 11 3 8 4.1 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(-c3ccc(F)cc3)n2)cc1 10.1016/s0960-894x(00)00422-4
CHEMBL305558 109616 0 None - 0 Human 4.4 pIC50 = 4.4 Binding
Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.
ChEMBL 558 11 3 8 4.1 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(-c3ccc(F)cc3)n2)cc1 10.1016/s0960-894x(00)00422-4
44298728 201562 0 None - 0 Human 4.4 pIC50 = 4.4 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 401 8 2 3 4.1 CCCCCCNC(=O)N1CCc2cc(S(=O)(=O)Nc3ccccc3)ccc21 10.1016/s0960-894x(99)00277-2
CHEMBL53842 201562 0 None - 0 Human 4.4 pIC50 = 4.4 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 401 8 2 3 4.1 CCCCCCNC(=O)N1CCc2cc(S(=O)(=O)Nc3ccccc3)ccc21 10.1016/s0960-894x(99)00277-2
44190762 183659 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of radioligand from adrenergic beta-1 receptorDisplacement of radioligand from adrenergic beta-1 receptor
ChEMBL 531 8 1 5 6.6 Cc1c(C(=O)c2ccc(Cl)cc2)c2ccc(OC(F)(F)F)cc2n1Cc1cccc(O[C@H](C)C(=O)O)c1 10.1016/j.bmcl.2008.07.103
CHEMBL461571 183659 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of radioligand from adrenergic beta-1 receptorDisplacement of radioligand from adrenergic beta-1 receptor
ChEMBL 531 8 1 5 6.6 Cc1c(C(=O)c2ccc(Cl)cc2)c2ccc(OC(F)(F)F)cc2n1Cc1cccc(O[C@H](C)C(=O)O)c1 10.1016/j.bmcl.2008.07.103
46882030 12540 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 427 9 4 5 3.6 O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1cccc(-c2ncc[nH]2)c1 10.1016/j.bmcl.2010.01.130
CHEMBL1078576 12540 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 427 9 4 5 3.6 O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1cccc(-c2ncc[nH]2)c1 10.1016/j.bmcl.2010.01.130
1043 8363 14 None -26302 29 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
149 8363 14 None -26302 29 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
8223 8363 14 None -26302 29 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
CHEMBL442 8363 14 None -26302 29 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
DB00696 8363 14 None -26302 29 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
44298821 201774 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 453 11 1 5 6.1 CCCCCCCCc1cnc(N2CCc3cc(S(=O)(=O)Nc4ccccc4)ccc32)o1 10.1016/s0960-894x(99)00277-2
CHEMBL54749 201774 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 453 11 1 5 6.1 CCCCCCCCc1cnc(N2CCc3cc(S(=O)(=O)Nc4ccccc4)ccc32)o1 10.1016/s0960-894x(99)00277-2
12017018 149116 0 None - 0 Human 4.4 pIC50 = 4.4 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 638 13 3 8 6.0 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2coc(COc3ccc(C(F)(F)F)cc3)n2)cc1 10.1016/s0960-894x(00)00277-8
CHEMBL38861 149116 0 None - 0 Human 4.4 pIC50 = 4.4 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 638 13 3 8 6.0 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2coc(COc3ccc(C(F)(F)F)cc3)n2)cc1 10.1016/s0960-894x(00)00277-8
145947927 174529 0 None -16 2 Rat 6.4 pIC50 = 6.4 Binding
Displacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysisDisplacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysis
ChEMBL 419 9 2 6 3.5 COc1ccccc1CCNCC(O)COc1cccc2c(=O)c3ccccc3oc12 10.1016/j.bmc.2018.04.038
CHEMBL4130151 174529 0 None -16 2 Rat 6.4 pIC50 = 6.4 Binding
Displacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysisDisplacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysis
ChEMBL 419 9 2 6 3.5 COc1ccccc1CCNCC(O)COc1cccc2c(=O)c3ccccc3oc12 10.1016/j.bmc.2018.04.038
CHEMBL4302997 174529 0 None -16 2 Rat 6.4 pIC50 = 6.4 Binding
Displacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysisDisplacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysis
ChEMBL 419 9 2 6 3.5 COc1ccccc1CCNCC(O)COc1cccc2c(=O)c3ccccc3oc12 10.1016/j.bmc.2018.04.038
2447486 69834 1 None - 2 Human 7.4 pIC50 = 7.4 Binding
Compound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heart.Compound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heart.
ChEMBL 324 5 2 4 3.2 CC(C)(C)NC[C@@H](O)CON=C1c2ccccc2-c2ccccc21 10.1021/jm00350a009
CHEMBL1788270 69834 1 None - 2 Human 7.4 pIC50 = 7.4 Binding
Compound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heart.Compound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-1 adrenergic receptor in dog heart.
ChEMBL 324 5 2 4 3.2 CC(C)(C)NC[C@@H](O)CON=C1c2ccccc2-c2ccccc21 10.1021/jm00350a009
76322045 112690 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [125I]-cyanopindolol from recombinant human beta-1 adrenergic receptor expressed in CHO cell membranes after 1 hr by scintillation counting analysisDisplacement of [125I]-cyanopindolol from recombinant human beta-1 adrenergic receptor expressed in CHO cell membranes after 1 hr by scintillation counting analysis
ChEMBL 527 7 3 5 6.0 O=C(Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3ccccc3)N2)cc1)[C@@H]1CCc2sc(-c3ccc(F)cc3)nc21 10.1021/jm4017224
CHEMBL3128184 112690 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [125I]-cyanopindolol from recombinant human beta-1 adrenergic receptor expressed in CHO cell membranes after 1 hr by scintillation counting analysisDisplacement of [125I]-cyanopindolol from recombinant human beta-1 adrenergic receptor expressed in CHO cell membranes after 1 hr by scintillation counting analysis
ChEMBL 527 7 3 5 6.0 O=C(Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3ccccc3)N2)cc1)[C@@H]1CCc2sc(-c3ccc(F)cc3)nc21 10.1021/jm4017224
176 7186 66 None -660 31 Human 4.4 pIC50 = 4.4 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 nan
2157 7186 66 None -660 31 Human 4.4 pIC50 = 4.4 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 nan
2566 7186 66 None -660 31 Human 4.4 pIC50 = 4.4 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 nan
CHEMBL633 7186 66 None -660 31 Human 4.4 pIC50 = 4.4 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 nan
DB01118 7186 66 None -660 31 Human 4.4 pIC50 = 4.4 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 nan
44307340 109372 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 470 12 4 7 2.6 CCc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(N)nc3)cc2)cc1 10.1016/s0960-894x(98)00381-3
CHEMBL304090 109372 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 470 12 4 7 2.6 CCc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(N)nc3)cc2)cc1 10.1016/s0960-894x(98)00381-3
44281218 162490 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 645 13 5 9 4.0 CNC(=O)NC(c1ccc(F)cc1)c1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1 10.1016/s0960-894x(00)00268-7
CHEMBL405245 162490 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 645 13 5 9 4.0 CNC(=O)NC(c1ccc(F)cc1)c1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1 10.1016/s0960-894x(00)00268-7
44112 128068 48 None -2 7 Human 7.3 pIC50 = 7.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 380 7 2 4 4.5 Cc1cc2c(OCC(CNC(C)(C)C)OC(=O)c3ccccc3)cccc2[nH]1 nan
CHEMBL357995 128068 48 None -2 7 Human 7.3 pIC50 = 7.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 380 7 2 4 4.5 Cc1cc2c(OCC(CNC(C)(C)C)OC(=O)c3ccccc3)cccc2[nH]1 nan
44307196 210366 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 510 11 4 7 3.3 Nc1ccc(OC[C@@H](O)CNCCc2ccc(NS(=O)(=O)c3ccc(Cl)c(Cl)c3)cc2)cn1 10.1016/s0960-894x(98)00381-3
CHEMBL66859 210366 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 510 11 4 7 3.3 Nc1ccc(OC[C@@H](O)CNCCc2ccc(NS(=O)(=O)c3ccc(Cl)c(Cl)c3)cc2)cn1 10.1016/s0960-894x(98)00381-3
12017010 169980 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 572 12 3 7 5.1 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2coc(Cc3ccc(F)cc3)n2)cc1 10.1016/s0960-894x(00)00277-8
CHEMBL418234 169980 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 572 12 3 7 5.1 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2coc(Cc3ccc(F)cc3)n2)cc1 10.1016/s0960-894x(00)00277-8
10138809 175864 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 450 8 4 5 4.3 N#CN/C(=N\c1cccc2ccccc12)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/s0960-894x(00)00669-7
CHEMBL439794 175864 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 450 8 4 5 4.3 N#CN/C(=N\c1cccc2ccccc12)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/s0960-894x(00)00669-7
10099346 147851 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 560 13 3 7 5.5 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2cnc(CCC3CCCC3)o2)cc1 10.1016/s0960-894x(00)00277-8
CHEMBL38254 147851 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 560 13 3 7 5.5 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2cnc(CCC3CCCC3)o2)cc1 10.1016/s0960-894x(00)00277-8
46881900 14560 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 437 9 3 4 4.9 O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1cccc(-c2ccccc2)c1 10.1016/j.bmcl.2010.01.130
CHEMBL1089396 14560 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 437 9 3 4 4.9 O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1cccc(-c2ccccc2)c1 10.1016/j.bmcl.2010.01.130
70687348 79892 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 393 10 3 6 1.0 N#Cc1ccccc1OC[C@@H](O)CNCCNS(=O)(=O)c1ccccc1F 10.1021/ml1002458
CHEMBL2011236 79892 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assayDisplacement of [3H](-)-CGP-12177 from adrenergic beta1 receptor by cell based assay
ChEMBL 393 10 3 6 1.0 N#Cc1ccccc1OC[C@@H](O)CNCCNS(=O)(=O)c1ccccc1F 10.1021/ml1002458
16049158 70864 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 475 14 5 7 3.4 CCc1ccc(CCNCCCSCCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1 10.1016/j.bmcl.2011.05.097
CHEMBL1807824 70864 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 475 14 5 7 3.4 CCc1ccc(CCNCCCSCCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1 10.1016/j.bmcl.2011.05.097
56673609 70877 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 499 13 5 7 3.5 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCOCCNCCc3cccc(Cl)c3Cl)c2s1 10.1016/j.bmcl.2011.05.097
CHEMBL1807873 70877 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 499 13 5 7 3.5 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCOCCNCCc3cccc(Cl)c3Cl)c2s1 10.1016/j.bmcl.2011.05.097
24900689 77138 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 479 11 5 7 3.5 COc1ccccc1CNCc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1 10.1016/j.bmcl.2011.10.049
CHEMBL1945039 77138 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 479 11 5 7 3.5 COc1ccccc1CNCc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1 10.1016/j.bmcl.2011.10.049
44268268 25423 1 None - 0 Human 6.3 pIC50 = 6.3 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand.Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand.
ChEMBL 493 11 4 7 3.3 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1cnc2ccccc2c1 10.1016/s0960-894x(98)00169-3
CHEMBL12769 25423 1 None - 0 Human 6.3 pIC50 = 6.3 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand.Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand.
ChEMBL 493 11 4 7 3.3 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1cnc2ccccc2c1 10.1016/s0960-894x(98)00169-3
567 7512 16 None -13 5 Human 5.3 pIC50 = 5.3 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 363 9 3 4 3.1 C[C@H](Cc1ccc(cc1)OCC(=O)O)NC[C@@H](c1cccc(c1)Cl)O 10.1016/s0960-894x(98)00571-x
9841972 7512 16 None -13 5 Human 5.3 pIC50 = 5.3 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 363 9 3 4 3.1 C[C@H](Cc1ccc(cc1)OCC(=O)O)NC[C@@H](c1cccc(c1)Cl)O 10.1016/s0960-894x(98)00571-x
CHEMBL284782 7512 16 None -13 5 Human 5.3 pIC50 = 5.3 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 363 9 3 4 3.1 C[C@H](Cc1ccc(cc1)OCC(=O)O)NC[C@@H](c1cccc(c1)Cl)O 10.1016/s0960-894x(98)00571-x
15483880 106388 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 591 12 3 8 4.7 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(Cc3ccc(F)c(F)c3)no2)cc1 10.1016/s0960-894x(00)00268-7
CHEMBL28405 106388 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 591 12 3 8 4.7 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(Cc3ccc(F)c(F)c3)no2)cc1 10.1016/s0960-894x(00)00268-7
44281469 106893 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 573 12 3 8 4.5 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(Cc3cccc(F)c3)n2)cc1 10.1016/s0960-894x(00)00268-7
CHEMBL287561 106893 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 573 12 3 8 4.5 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(Cc3cccc(F)c3)n2)cc1 10.1016/s0960-894x(00)00268-7
44308088 210376 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Binding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindololBinding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol
ChEMBL 607 17 3 7 4.9 CCCCCCCCN1CC(=O)N(c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)C1=O 10.1016/s0960-894x(99)00073-6
CHEMBL66936 210376 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Binding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindololBinding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol
ChEMBL 607 17 3 7 4.9 CCCCCCCCN1CC(=O)N(c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)C1=O 10.1016/s0960-894x(99)00073-6
10099459 212475 1 None - 0 Human 5.3 pIC50 = 5.3 Binding
Binding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindololBinding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol
ChEMBL 565 15 3 6 4.6 CCCCCCN1CCN(c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)C1=O 10.1016/s0960-894x(99)00073-6
CHEMBL82296 212475 1 None - 0 Human 5.3 pIC50 = 5.3 Binding
Binding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindololBinding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol
ChEMBL 565 15 3 6 4.6 CCCCCCN1CCN(c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)C1=O 10.1016/s0960-894x(99)00073-6
44377636 126876 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 607 12 3 6 4.5 O=C1N(Cc2ccc(F)c(F)c2)CCN1c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(99)00072-4
CHEMBL350931 126876 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 607 12 3 6 4.5 O=C1N(Cc2ccc(F)c(F)c2)CCN1c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(99)00072-4
10099459 212475 1 None - 0 Human 5.3 pIC50 = 5.3 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 565 15 3 6 4.6 CCCCCCN1CCN(c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)C1=O 10.1016/s0960-894x(99)00072-4
CHEMBL82296 212475 1 None - 0 Human 5.3 pIC50 = 5.3 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 565 15 3 6 4.6 CCCCCCN1CCN(c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)C1=O 10.1016/s0960-894x(99)00072-4
46881937 13536 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 494 9 3 6 5.5 O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccccc1-c1nc2ccccc2s1 10.1016/j.bmcl.2010.01.130
CHEMBL1083831 13536 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 494 9 3 6 5.5 O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccccc1-c1nc2ccccc2s1 10.1016/j.bmcl.2010.01.130
44458134 91608 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Inhibitory activity against cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol in CHO cells by receptor binding assayInhibitory activity against cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol in CHO cells by receptor binding assay
ChEMBL 565 15 3 10 3.1 CCCCCCn1nnn(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)c1=O 10.1016/s0960-894x(99)00182-1
CHEMBL22345 91608 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Inhibitory activity against cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol in CHO cells by receptor binding assayInhibitory activity against cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol in CHO cells by receptor binding assay
ChEMBL 565 15 3 10 3.1 CCCCCCn1nnn(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)c1=O 10.1016/s0960-894x(99)00182-1
44301886 107856 0 None - 0 Human 4.3 pIC50 = 4.3 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 607 16 4 8 4.7 CC(=O)NCCCCCc1csc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)n1 10.1016/s0960-894x(00)00390-5
CHEMBL294849 107856 0 None - 0 Human 4.3 pIC50 = 4.3 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 607 16 4 8 4.7 CC(=O)NCCCCCc1csc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)n1 10.1016/s0960-894x(00)00390-5
44377665 175112 0 None - 0 Human 4.3 pIC50 = 4.3 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 567 15 3 7 3.4 COCCCCN1CCN(c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)C1=O 10.1016/s0960-894x(99)00072-4
CHEMBL434284 175112 0 None - 0 Human 4.3 pIC50 = 4.3 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 567 15 3 7 3.4 COCCCCN1CCN(c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)C1=O 10.1016/s0960-894x(99)00072-4
2419 10236 84 None -154 6 Human 6.3 pIC50 = 6.3 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2011.05.097
5152 10236 84 None -154 6 Human 6.3 pIC50 = 6.3 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2011.05.097
559 10236 84 None -154 6 Human 6.3 pIC50 = 6.3 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2011.05.097
CHEMBL1263 10236 84 None -154 6 Human 6.3 pIC50 = 6.3 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2011.05.097
DB00938 10236 84 None -154 6 Human 6.3 pIC50 = 6.3 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2011.05.097
2419 10236 84 None -154 6 Human 6.3 pIC50 = 6.3 Binding
Binding affinity to beta1 adrenoceptorBinding affinity to beta1 adrenoceptor
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2011.10.049
5152 10236 84 None -154 6 Human 6.3 pIC50 = 6.3 Binding
Binding affinity to beta1 adrenoceptorBinding affinity to beta1 adrenoceptor
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2011.10.049
559 10236 84 None -154 6 Human 6.3 pIC50 = 6.3 Binding
Binding affinity to beta1 adrenoceptorBinding affinity to beta1 adrenoceptor
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2011.10.049
CHEMBL1263 10236 84 None -154 6 Human 6.3 pIC50 = 6.3 Binding
Binding affinity to beta1 adrenoceptorBinding affinity to beta1 adrenoceptor
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2011.10.049
DB00938 10236 84 None -154 6 Human 6.3 pIC50 = 6.3 Binding
Binding affinity to beta1 adrenoceptorBinding affinity to beta1 adrenoceptor
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2011.10.049
57398562 77135 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 477 11 5 6 4.1 CC(CNCc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1)c1ccccc1 10.1016/j.bmcl.2011.10.049
CHEMBL1945036 77135 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 477 11 5 6 4.1 CC(CNCc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1)c1ccccc1 10.1016/j.bmcl.2011.10.049
9984028 126504 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Receptor binding assay(Beta-1 adrenergic receptor) carried out with membranes prepared from human recombinant Sf9 cells expressing the cloned human receptor in the presence of [125I]iodocyanopindololReceptor binding assay(Beta-1 adrenergic receptor) carried out with membranes prepared from human recombinant Sf9 cells expressing the cloned human receptor in the presence of [125I]iodocyanopindolol
ChEMBL 515 11 4 6 3.8 Cc1ccc(S(=O)(=O)NC(=O)Cc2cccc(NC[C@@H](C)NC[C@H](O)c3cccc(Cl)c3)c2)cc1 10.1021/jm0101500
CHEMBL347582 126504 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Receptor binding assay(Beta-1 adrenergic receptor) carried out with membranes prepared from human recombinant Sf9 cells expressing the cloned human receptor in the presence of [125I]iodocyanopindololReceptor binding assay(Beta-1 adrenergic receptor) carried out with membranes prepared from human recombinant Sf9 cells expressing the cloned human receptor in the presence of [125I]iodocyanopindolol
ChEMBL 515 11 4 6 3.8 Cc1ccc(S(=O)(=O)NC(=O)Cc2cccc(NC[C@@H](C)NC[C@H](O)c3cccc(Cl)c3)c2)cc1 10.1021/jm0101500
44268498 105123 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 612 17 4 7 4.8 CCCCCCN(C)C(=O)N(C)c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
CHEMBL275114 105123 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 612 17 4 7 4.8 CCCCCCN(C)C(=O)N(C)c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
10075383 103880 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 520 11 4 6 3.5 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1ccc(Br)cc1 10.1016/s0960-894x(98)00169-3
CHEMBL267545 103880 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 520 11 4 6 3.5 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1ccc(Br)cc1 10.1016/s0960-894x(98)00169-3
44301617 205494 0 None - 0 Human 4.3 pIC50 = 4.3 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 640 16 3 7 7.7 CCCCCCc1ccc(-c2csc(-c3ccc(S(=O)(=O)Nc4ccc(CCNC[C@H](O)c5cccnc5)cc4)cc3)n2)cc1 10.1016/s0960-894x(00)00390-5
CHEMBL58241 205494 0 None - 0 Human 4.3 pIC50 = 4.3 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 640 16 3 7 7.7 CCCCCCc1ccc(-c2csc(-c3ccc(S(=O)(=O)Nc4ccc(CCNC[C@H](O)c5cccnc5)cc4)cc3)n2)cc1 10.1016/s0960-894x(00)00390-5
44268470 31642 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 527 14 5 7 3.5 CCCC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
CHEMBL13453 31642 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 527 14 5 7 3.5 CCCC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
44377754 126728 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 589 14 3 8 4.7 O=c1n(CCCC2CCCC2)ccn1-c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(99)00072-4
CHEMBL349651 126728 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 589 14 3 8 4.7 O=c1n(CCCC2CCCC2)ccn1-c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(99)00072-4
44306959 209862 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 520 11 4 7 2.8 Nc1ccc(OC[C@@H](O)CNCCc2ccc(NS(=O)(=O)c3ccc(Br)cc3)cc2)cn1 10.1016/s0960-894x(98)00381-3
CHEMBL63842 209862 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 520 11 4 7 2.8 Nc1ccc(OC[C@@H](O)CNCCc2ccc(NS(=O)(=O)c3ccc(Br)cc3)cc2)cn1 10.1016/s0960-894x(98)00381-3
14998848 126865 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 361 5 2 5 2.1 O=C(NCC1CN(c2ccccc2)CCN1)c1ccc(-n2ccnc2)cc1 10.1021/jm00082a016
CHEMBL350847 126865 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 361 5 2 5 2.1 O=C(NCC1CN(c2ccccc2)CCN1)c1ccc(-n2ccnc2)cc1 10.1021/jm00082a016
44268605 105190 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 542 14 6 7 3.3 CCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
CHEMBL275511 105190 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 542 14 6 7 3.3 CCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
44280903 106736 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 605 12 3 8 5.5 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(Cc3ccc4ccccc4c3)n2)cc1 10.1016/s0960-894x(00)00268-7
CHEMBL286437 106736 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 605 12 3 8 5.5 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(Cc3ccc4ccccc4c3)n2)cc1 10.1016/s0960-894x(00)00268-7
44461718 212642 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Binding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindololBinding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol
ChEMBL 591 17 3 8 5.1 CCCCCCCCn1ccn(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)c1=O 10.1016/s0960-894x(99)00073-6
CHEMBL83753 212642 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Binding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindololBinding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol
ChEMBL 591 17 3 8 5.1 CCCCCCCCn1ccn(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)c1=O 10.1016/s0960-894x(99)00073-6
10007337 123478 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Binding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindololBinding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 535 14 3 8 4.5 CCCCCc1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1 10.1016/s0960-894x(00)00267-5
CHEMBL33725 123478 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Binding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindololBinding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 535 14 3 8 4.5 CCCCCc1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1 10.1016/s0960-894x(00)00267-5
12043156 174928 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Binding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindololBinding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 575 14 3 8 5.3 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(CCCC3CCCC3)n2)cc1 10.1016/s0960-894x(00)00267-5
CHEMBL433042 174928 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Binding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindololBinding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 575 14 3 8 5.3 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(CCCC3CCCC3)n2)cc1 10.1016/s0960-894x(00)00267-5
44461718 212642 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 591 17 3 8 5.1 CCCCCCCCn1ccn(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)c1=O 10.1016/s0960-894x(99)00072-4
CHEMBL83753 212642 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 591 17 3 8 5.1 CCCCCCCCn1ccn(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)c1=O 10.1016/s0960-894x(99)00072-4
44307333 210453 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 472 12 4 8 2.0 COc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(N)nc3)cc2)cc1 10.1016/s0960-894x(98)00381-3
CHEMBL67416 210453 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 472 12 4 8 2.0 COc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(N)nc3)cc2)cc1 10.1016/s0960-894x(98)00381-3
44280860 106690 0 None - 0 Human 4.3 pIC50 = 4.3 Binding
Binding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindololBinding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 521 13 3 8 4.1 CCCCc1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1 10.1016/s0960-894x(00)00267-5
CHEMBL286139 106690 0 None - 0 Human 4.3 pIC50 = 4.3 Binding
Binding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindololBinding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 521 13 3 8 4.1 CCCCc1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1 10.1016/s0960-894x(00)00267-5
1588 9105 27 None -151 44 Human 6.3 pIC50 = 6.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
28864 9105 27 None -151 44 Human 6.3 pIC50 = 6.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
43 9105 27 None -151 44 Human 6.3 pIC50 = 6.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
CHEMBL157138 9105 27 None -151 44 Human 6.3 pIC50 = 6.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
DB00589 9105 27 None -151 44 Human 6.3 pIC50 = 6.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
12049917 209805 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.
ChEMBL 588 12 3 9 4.1 COc1ccc(-c2cnn(-c3ccc(S(=O)(=O)Nc4ccc(CCNC[C@H](O)c5cccnc5)cc4)cc3)n2)cc1F 10.1016/s0960-894x(00)00422-4
CHEMBL63357 209805 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.
ChEMBL 588 12 3 9 4.1 COc1ccc(-c2cnn(-c3ccc(S(=O)(=O)Nc4ccc(CCNC[C@H](O)c5cccnc5)cc4)cc3)n2)cc1F 10.1016/s0960-894x(00)00422-4
44281073 125984 0 None - 0 Human 4.3 pIC50 = 4.3 Binding
Binding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindololBinding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 551 14 4 9 3.5 CCC(O)CCc1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1 10.1016/s0960-894x(00)00267-5
CHEMBL34328 125984 0 None - 0 Human 4.3 pIC50 = 4.3 Binding
Binding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindololBinding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 551 14 4 9 3.5 CCC(O)CCc1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1 10.1016/s0960-894x(00)00267-5
45482789 205704 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Inhibition of adrenergic beta-1 receptorInhibition of adrenergic beta-1 receptor
ChEMBL 428 4 2 2 4.5 CCN(CC)C(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C(=O)Nc2ccccc2)C1 10.1016/j.bmcl.2009.09.002
CHEMBL584554 205704 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Inhibition of adrenergic beta-1 receptorInhibition of adrenergic beta-1 receptor
ChEMBL 428 4 2 2 4.5 CCN(CC)C(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C(=O)Nc2ccccc2)C1 10.1016/j.bmcl.2009.09.002
15523859 212712 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Binding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindololBinding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol
ChEMBL 593 17 3 6 5.4 CCCCCCCCN1CCN(c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)C1=O 10.1016/s0960-894x(99)00073-6
CHEMBL84190 212712 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Binding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindololBinding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol
ChEMBL 593 17 3 6 5.4 CCCCCCCCN1CCN(c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)C1=O 10.1016/s0960-894x(99)00073-6
15523859 212712 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 593 17 3 6 5.4 CCCCCCCCN1CCN(c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)C1=O 10.1016/s0960-894x(99)00072-4
CHEMBL84190 212712 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 593 17 3 6 5.4 CCCCCCCCN1CCN(c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)C1=O 10.1016/s0960-894x(99)00072-4
44298315 200077 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 454 11 1 6 5.5 CCCCCCCCc1nc(N2CCc3cc(S(=O)(=O)Nc4ccccc4)ccc32)no1 10.1016/s0960-894x(99)00277-2
CHEMBL52407 200077 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 454 11 1 6 5.5 CCCCCCCCc1nc(N2CCc3cc(S(=O)(=O)Nc4ccccc4)ccc32)no1 10.1016/s0960-894x(99)00277-2
14823035 148341 2 None - 3 Rat 7.2 pIC50 = 7.2 Binding
Compound was evaluated for its binding affinity towards Beta-1 adrenergic receptor in rat heart membrane by displacing [125I]- iodocyanopindololCompound was evaluated for its binding affinity towards Beta-1 adrenergic receptor in rat heart membrane by displacing [125I]- iodocyanopindolol
ChEMBL 377 9 2 5 3.1 COC(=O)COc1ccc(C[C@@H](C)NC[C@H](O)c2cccc(Cl)c2)cc1 10.1021/jm00094a025
CHEMBL38486 148341 2 None - 3 Rat 7.2 pIC50 = 7.2 Binding
Compound was evaluated for its binding affinity towards Beta-1 adrenergic receptor in rat heart membrane by displacing [125I]- iodocyanopindololCompound was evaluated for its binding affinity towards Beta-1 adrenergic receptor in rat heart membrane by displacing [125I]- iodocyanopindolol
ChEMBL 377 9 2 5 3.1 COC(=O)COc1ccc(C[C@@H](C)NC[C@H](O)c2cccc(Cl)c2)cc1 10.1021/jm00094a025
10112732 23584 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 418 8 4 5 3.3 N#CN/C(=N\c1cccc(F)c1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/s0960-894x(00)00669-7
CHEMBL124668 23584 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 418 8 4 5 3.3 N#CN/C(=N\c1cccc(F)c1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/s0960-894x(00)00669-7
44307186 210547 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 455 12 3 6 3.0 CCc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3cccnc3)cc2)cc1 10.1016/s0960-894x(98)00381-3
CHEMBL68021 210547 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 455 12 3 6 3.0 CCc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3cccnc3)cc2)cc1 10.1016/s0960-894x(98)00381-3
24900813 77141 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 467 10 5 6 3.6 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCc4ccccc4F)c3)c2s1 10.1016/j.bmcl.2011.10.049
CHEMBL1945042 77141 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 467 10 5 6 3.6 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCc4ccccc4F)c3)c2s1 10.1016/j.bmcl.2011.10.049
44268365 105345 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 406 10 4 5 3.2 O=C(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1ccccc1 10.1016/s0960-894x(98)00169-3
CHEMBL276659 105345 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 406 10 4 5 3.2 O=C(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1ccccc1 10.1016/s0960-894x(98)00169-3
3914 7527 35 None -3 7 Human 8.2 pIC50 = 8.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 291 5 2 4 2.3 CC(C)(C)NCC(COC1=CC=CC2=C1CCCC2=O)O nan
39468 7527 35 None -3 7 Human 8.2 pIC50 = 8.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 291 5 2 4 2.3 CC(C)(C)NCC(COC1=CC=CC2=C1CCCC2=O)O nan
431 7527 35 None -3 7 Human 8.2 pIC50 = 8.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 291 5 2 4 2.3 CC(C)(C)NCC(COC1=CC=CC2=C1CCCC2=O)O nan
570 7527 35 None -3 7 Human 8.2 pIC50 = 8.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 291 5 2 4 2.3 CC(C)(C)NCC(COC1=CC=CC2=C1CCCC2=O)O nan
CHEMBL1201237 7527 35 None -3 7 Human 8.2 pIC50 = 8.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 291 5 2 4 2.3 CC(C)(C)NCC(COC1=CC=CC2=C1CCCC2=O)O nan
CHEMBL293030 7527 35 None -3 7 Human 8.2 pIC50 = 8.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 291 5 2 4 2.3 CC(C)(C)NCC(COC1=CC=CC2=C1CCCC2=O)O nan
DB01210 7527 35 None -3 7 Human 8.2 pIC50 = 8.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 291 5 2 4 2.3 CC(C)(C)NCC(COC1=CC=CC2=C1CCCC2=O)O nan
44268349 27348 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 456 12 4 6 2.9 O=S(=O)(Cc1ccccc1)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/s0960-894x(98)00169-3
CHEMBL13079 27348 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 456 12 4 6 2.9 O=S(=O)(Cc1ccccc1)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/s0960-894x(98)00169-3
1499 8872 47 None -33 17 Rat 6.2 pIC50 = 6.2 Binding
Compound was evaluated for its binding affinity towards beta-1 adrenergic receptor in rat heart membrane by displacing [125I]- iodocyanopindololCompound was evaluated for its binding affinity towards beta-1 adrenergic receptor in rat heart membrane by displacing [125I]- iodocyanopindolol
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm00094a025
3779 8872 47 None -33 17 Rat 6.2 pIC50 = 6.2 Binding
Compound was evaluated for its binding affinity towards beta-1 adrenergic receptor in rat heart membrane by displacing [125I]- iodocyanopindololCompound was evaluated for its binding affinity towards beta-1 adrenergic receptor in rat heart membrane by displacing [125I]- iodocyanopindolol
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm00094a025
536 8872 47 None -33 17 Rat 6.2 pIC50 = 6.2 Binding
Compound was evaluated for its binding affinity towards beta-1 adrenergic receptor in rat heart membrane by displacing [125I]- iodocyanopindololCompound was evaluated for its binding affinity towards beta-1 adrenergic receptor in rat heart membrane by displacing [125I]- iodocyanopindolol
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm00094a025
CHEMBL434 8872 47 None -33 17 Rat 6.2 pIC50 = 6.2 Binding
Compound was evaluated for its binding affinity towards beta-1 adrenergic receptor in rat heart membrane by displacing [125I]- iodocyanopindololCompound was evaluated for its binding affinity towards beta-1 adrenergic receptor in rat heart membrane by displacing [125I]- iodocyanopindolol
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm00094a025
DB01064 8872 47 None -33 17 Rat 6.2 pIC50 = 6.2 Binding
Compound was evaluated for its binding affinity towards beta-1 adrenergic receptor in rat heart membrane by displacing [125I]- iodocyanopindololCompound was evaluated for its binding affinity towards beta-1 adrenergic receptor in rat heart membrane by displacing [125I]- iodocyanopindolol
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm00094a025
46881576 14616 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 416 9 3 6 3.3 O=C(Cc1nc2ccccc2o1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/j.bmcl.2010.01.130
CHEMBL1089725 14616 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 416 9 3 6 3.3 O=C(Cc1nc2ccccc2o1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/j.bmcl.2010.01.130
2249 7300 111 None -5 12 Human 6.2 pIC50 = 6.2 Binding
Displacement of radiolabeled atenolol from human adrenergic beta-1 receptorDisplacement of radiolabeled atenolol from human adrenergic beta-1 receptor
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm8007618
255 7300 111 None -5 12 Human 6.2 pIC50 = 6.2 Binding
Displacement of radiolabeled atenolol from human adrenergic beta-1 receptorDisplacement of radiolabeled atenolol from human adrenergic beta-1 receptor
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm8007618
548 7300 111 None -5 12 Human 6.2 pIC50 = 6.2 Binding
Displacement of radiolabeled atenolol from human adrenergic beta-1 receptorDisplacement of radiolabeled atenolol from human adrenergic beta-1 receptor
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm8007618
CHEMBL24 7300 111 None -5 12 Human 6.2 pIC50 = 6.2 Binding
Displacement of radiolabeled atenolol from human adrenergic beta-1 receptorDisplacement of radiolabeled atenolol from human adrenergic beta-1 receptor
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm8007618
DB00335 7300 111 None -5 12 Human 6.2 pIC50 = 6.2 Binding
Displacement of radiolabeled atenolol from human adrenergic beta-1 receptorDisplacement of radiolabeled atenolol from human adrenergic beta-1 receptor
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm8007618
44307144 210388 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 569 17 5 7 4.2 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3cccnc3)cc2)cc1 10.1016/s0960-894x(98)00381-3
CHEMBL67015 210388 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 569 17 5 7 4.2 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3cccnc3)cc2)cc1 10.1016/s0960-894x(98)00381-3
44298256 203891 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 426 9 1 6 4.7 CCCCCCc1nc(N2CCc3cc(S(=O)(=O)Nc4ccccc4)ccc32)no1 10.1016/s0960-894x(99)00277-2
CHEMBL56768 203891 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 426 9 1 6 4.7 CCCCCCc1nc(N2CCc3cc(S(=O)(=O)Nc4ccccc4)ccc32)no1 10.1016/s0960-894x(99)00277-2
44301806 107496 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 607 11 3 8 6.1 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc4ncccc4c3)cs2)cc1 10.1016/s0960-894x(00)00390-5
CHEMBL292598 107496 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 607 11 3 8 6.1 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc4ncccc4c3)cs2)cc1 10.1016/s0960-894x(00)00390-5
46881938 13537 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 443 9 3 4 5.2 O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccccc1C1CCCCC1 10.1016/j.bmcl.2010.01.130
CHEMBL1083832 13537 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 443 9 3 4 5.2 O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccccc1C1CCCCC1 10.1016/j.bmcl.2010.01.130
44285226 106624 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 548 15 3 7 5.5 CCCCCCc1ncc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)o1 10.1016/s0960-894x(00)00277-8
CHEMBL285713 106624 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 548 15 3 7 5.5 CCCCCCc1ncc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)o1 10.1016/s0960-894x(00)00277-8
44335628 11608 0 None - 0 Human 4.2 pIC50 = 4.2 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 498 12 4 7 3.7 CCCOC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(98)00571-x
CHEMBL104222 11608 0 None - 0 Human 4.2 pIC50 = 4.2 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 498 12 4 7 3.7 CCCOC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(98)00571-x
44335588 12045 0 None - 0 Human 4.2 pIC50 = 4.2 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 496 13 4 6 3.9 CCCCC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(98)00571-x
CHEMBL106487 12045 0 None - 0 Human 4.2 pIC50 = 4.2 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 496 13 4 6 3.9 CCCCC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(98)00571-x
44268273 103855 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 476 11 4 6 3.4 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1ccccc1Cl 10.1016/s0960-894x(98)00169-3
CHEMBL267306 103855 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 476 11 4 6 3.4 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1ccccc1Cl 10.1016/s0960-894x(98)00169-3
44349645 120295 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 684 11 4 9 6.8 N#CN/C(=N\c1ccc2c(c1)N(c1nc(-c3ccc(OC(F)(F)F)cc3)cs1)CC2)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/s0960-894x(00)00669-7
CHEMBL332132 120295 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 684 11 4 9 6.8 N#CN/C(=N\c1ccc2c(c1)N(c1nc(-c3ccc(OC(F)(F)F)cc3)cs1)CC2)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/s0960-894x(00)00669-7
12049926 209861 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.
ChEMBL 654 14 3 10 4.8 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(COc3ccc(OC(F)(F)F)cc3)n2)cc1 10.1016/s0960-894x(00)00422-4
CHEMBL63825 209861 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.
ChEMBL 654 14 3 10 4.8 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(COc3ccc(OC(F)(F)F)cc3)n2)cc1 10.1016/s0960-894x(00)00422-4
56663238 70876 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 465 13 5 7 2.8 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCOCCNCCc3cccc(Cl)c3)c2s1 10.1016/j.bmcl.2011.05.097
CHEMBL1807872 70876 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 465 13 5 7 2.8 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCOCCNCCc3cccc(Cl)c3)c2s1 10.1016/j.bmcl.2011.05.097
24901144 77104 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 481 11 5 6 3.6 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCCc4ccccc4F)c3)c2s1 10.1016/j.bmcl.2011.10.049
CHEMBL1944691 77104 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 481 11 5 6 3.6 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCCc4ccccc4F)c3)c2s1 10.1016/j.bmcl.2011.10.049
24900872 77137 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 478 12 5 7 3.3 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCCCc4ccccn4)c3)c2s1 10.1016/j.bmcl.2011.10.049
CHEMBL1945038 77137 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 478 12 5 7 3.3 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCCCc4ccccn4)c3)c2s1 10.1016/j.bmcl.2011.10.049
57391554 77143 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 479 11 5 7 3.5 COc1cccc(CNCc2cccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)sc34)c2)c1 10.1016/j.bmcl.2011.10.049
CHEMBL1945044 77143 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 479 11 5 7 3.5 COc1cccc(CNCc2cccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)sc34)c2)c1 10.1016/j.bmcl.2011.10.049
24900942 77164 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 493 12 5 7 3.5 COc1ccccc1CNCCc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1 10.1016/j.bmcl.2011.10.049
CHEMBL1945299 77164 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 493 12 5 7 3.5 COc1ccccc1CNCCc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1 10.1016/j.bmcl.2011.10.049
44306991 210461 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 493 11 4 8 2.6 Nc1ccc(OC[C@@H](O)CNCCc2ccc(NS(=O)(=O)c3cnc4ccccc4c3)cc2)cn1 10.1016/s0960-894x(98)00381-3
CHEMBL67461 210461 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 493 11 4 8 2.6 Nc1ccc(OC[C@@H](O)CNCCc2ccc(NS(=O)(=O)c3cnc4ccccc4c3)cc2)cn1 10.1016/s0960-894x(98)00381-3
9917962 174735 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 684 11 4 9 6.8 N#CN/C(=N\c1ccc2c(c1)CCN2c1nc(-c2ccc(OC(F)(F)F)cc2)cs1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/s0960-894x(00)00669-7
CHEMBL431678 174735 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 684 11 4 9 6.8 N#CN/C(=N\c1ccc2c(c1)CCN2c1nc(-c2ccc(OC(F)(F)F)cc2)cs1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/s0960-894x(00)00669-7
44298787 201528 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 443 12 2 5 6.6 CCCCCCCCc1csc(Nc2ccc(S(=O)(=O)Nc3ccccc3)cc2)n1 10.1016/s0960-894x(99)00277-2
CHEMBL53679 201528 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 443 12 2 5 6.6 CCCCCCCCc1csc(Nc2ccc(S(=O)(=O)Nc3ccccc3)cc2)n1 10.1016/s0960-894x(99)00277-2
44301804 174960 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 557 11 3 8 4.9 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccccn3)cs2)cc1 10.1016/s0960-894x(00)00390-5
CHEMBL433248 174960 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 557 11 3 8 4.9 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccccn3)cs2)cc1 10.1016/s0960-894x(00)00390-5
44313161 110552 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Compound was evaluated for its inhibitory activity against CHO cells expressing the cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindololCompound was evaluated for its inhibitory activity against CHO cells expressing the cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol
ChEMBL 644 13 6 7 6.5 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2cccc(-c3ccc(OCC4NCCc5cc(O)c(O)cc54)cc3)c2)cc1 10.1016/s0960-894x(00)00459-5
CHEMBL308860 110552 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Compound was evaluated for its inhibitory activity against CHO cells expressing the cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindololCompound was evaluated for its inhibitory activity against CHO cells expressing the cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol
ChEMBL 644 13 6 7 6.5 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2cccc(-c3ccc(OCC4NCCc5cc(O)c(O)cc54)cc3)c2)cc1 10.1016/s0960-894x(00)00459-5
12017017 134259 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 606 13 3 8 5.3 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2coc(COc3ccc(F)c(F)c3)n2)cc1 10.1016/s0960-894x(00)00277-8
CHEMBL36609 134259 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 606 13 3 8 5.3 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2coc(COc3ccc(F)c(F)c3)n2)cc1 10.1016/s0960-894x(00)00277-8
12017013 143059 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 588 13 3 8 5.1 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2coc(COc3ccc(F)cc3)n2)cc1 10.1016/s0960-894x(00)00277-8
CHEMBL37335 143059 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 588 13 3 8 5.1 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2coc(COc3ccc(F)cc3)n2)cc1 10.1016/s0960-894x(00)00277-8
12017002 148477 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 558 11 3 7 5.2 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2cnc(-c3ccc(F)cc3)o2)cc1 10.1016/s0960-894x(00)00277-8
CHEMBL38562 148477 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 558 11 3 7 5.2 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2cnc(-c3ccc(F)cc3)o2)cc1 10.1016/s0960-894x(00)00277-8
44281470 120351 0 None - 0 Human 4.2 pIC50 = 4.2 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 589 12 4 9 4.0 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(C(O)c3ccc(F)cc3)n2)cc1 10.1016/s0960-894x(00)00268-7
CHEMBL33224 120351 0 None - 0 Human 4.2 pIC50 = 4.2 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 589 12 4 9 4.0 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(C(O)c3ccc(F)cc3)n2)cc1 10.1016/s0960-894x(00)00268-7
13864381 215123 3 None - 4 Guinea pig 4.2 pIC50 = 4.2 Binding
Inhibitory activity against beta-1 adrenergic receptor in guinea pig atria is determinedInhibitory activity against beta-1 adrenergic receptor in guinea pig atria is determined
ChEMBL 195 1 3 4 0.7 NCC1OCCc2c1ccc(O)c2O 10.1021/jm00073a006
CHEMBL542683 215123 3 None - 4 Guinea pig 4.2 pIC50 = 4.2 Binding
Inhibitory activity against beta-1 adrenergic receptor in guinea pig atria is determinedInhibitory activity against beta-1 adrenergic receptor in guinea pig atria is determined
ChEMBL 195 1 3 4 0.7 NCC1OCCc2c1ccc(O)c2O 10.1021/jm00073a006
CHEMBL99361 215123 3 None - 4 Guinea pig 4.2 pIC50 = 4.2 Binding
Inhibitory activity against beta-1 adrenergic receptor in guinea pig atria is determinedInhibitory activity against beta-1 adrenergic receptor in guinea pig atria is determined
ChEMBL 195 1 3 4 0.7 NCC1OCCc2c1ccc(O)c2O 10.1021/jm00073a006
13864389 11838 2 None - 2 Guinea pig 5.2 pIC50 = 5.2 Binding
Inhibitory activity against beta-1 adrenergic receptor in guinea pig atria is determinedInhibitory activity against beta-1 adrenergic receptor in guinea pig atria is determined
ChEMBL 195 1 3 4 0.7 NCC1OCCc2cc(O)c(O)cc21 10.1021/jm00073a006
CHEMBL105383 11838 2 None - 2 Guinea pig 5.2 pIC50 = 5.2 Binding
Inhibitory activity against beta-1 adrenergic receptor in guinea pig atria is determinedInhibitory activity against beta-1 adrenergic receptor in guinea pig atria is determined
ChEMBL 195 1 3 4 0.7 NCC1OCCc2cc(O)c(O)cc21 10.1021/jm00073a006
15123375 64265 3 None - 0 Human 6.2 pIC50 = 6.2 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 295 4 2 3 1.9 O=C(NCC1CN(c2ccccc2)CCN1)c1ccccc1 10.1021/jm00082a016
CHEMBL165901 64265 3 None - 0 Human 6.2 pIC50 = 6.2 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 295 4 2 3 1.9 O=C(NCC1CN(c2ccccc2)CCN1)c1ccccc1 10.1021/jm00082a016
16049087 70857 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 448 13 4 7 3.3 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCSCCCOCCc3ccccc3)c2s1 10.1016/j.bmcl.2011.05.097
CHEMBL1807817 70857 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 448 13 4 7 3.3 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCSCCCOCCc3ccccc3)c2s1 10.1016/j.bmcl.2011.05.097
16049088 70858 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 448 13 4 7 3.3 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCSCCOCCc3ccccc3)c2s1 10.1016/j.bmcl.2011.05.097
CHEMBL1807818 70858 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 448 13 4 7 3.3 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCSCCOCCc3ccccc3)c2s1 10.1016/j.bmcl.2011.05.097
16049024 70860 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 498 13 4 7 4.5 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCSCCOCCc3cccc4ccccc34)c2s1 10.1016/j.bmcl.2011.05.097
CHEMBL1807820 70860 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 498 13 4 7 4.5 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCSCCOCCc3cccc4ccccc34)c2s1 10.1016/j.bmcl.2011.05.097
24901284 77161 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 545 12 5 6 5.2 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCc3cccc(CNCCc4c(Cl)cccc4Cl)c3)c2s1 10.1016/j.bmcl.2011.10.049
CHEMBL1945296 77161 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 545 12 5 6 5.2 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCc3cccc(CNCCc4c(Cl)cccc4Cl)c3)c2s1 10.1016/j.bmcl.2011.10.049
46881872 14519 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 411 10 4 7 2.6 CNc1nc(CC(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cs1 10.1016/j.bmcl.2010.01.130
CHEMBL1089052 14519 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 411 10 4 7 2.6 CNc1nc(CC(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cs1 10.1016/j.bmcl.2010.01.130
44298849 203231 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 434 9 1 3 6.3 CCCCCCc1cccc(N2CCc3cc(S(=O)(=O)Nc4ccccc4)ccc32)c1 10.1016/s0960-894x(99)00277-2
CHEMBL56308 203231 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 434 9 1 3 6.3 CCCCCCc1cccc(N2CCc3cc(S(=O)(=O)Nc4ccccc4)ccc32)c1 10.1016/s0960-894x(99)00277-2
44335663 11562 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 560 13 4 7 4.5 O=C(Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1)OCCc1ccccc1 10.1016/s0960-894x(98)00571-x
CHEMBL104076 11562 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 560 13 4 7 4.5 O=C(Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1)OCCc1ccccc1 10.1016/s0960-894x(98)00571-x
44335496 11573 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 335 8 3 5 1.3 CS(=O)(=O)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/s0960-894x(98)00571-x
CHEMBL104127 11573 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 335 8 3 5 1.3 CS(=O)(=O)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/s0960-894x(98)00571-x
44301831 107740 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 590 14 3 7 6.4 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(CCCC3CCCC3)cs2)cc1 10.1016/s0960-894x(00)00390-5
CHEMBL294172 107740 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 590 14 3 7 6.4 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(CCCC3CCCC3)cs2)cc1 10.1016/s0960-894x(00)00390-5
44301805 107793 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 557 11 3 8 4.9 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3cccnc3)cs2)cc1 10.1016/s0960-894x(00)00390-5
CHEMBL294492 107793 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 557 11 3 8 4.9 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3cccnc3)cs2)cc1 10.1016/s0960-894x(00)00390-5
44281407 107081 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 666 14 4 10 3.6 CS(=O)(=O)NC(c1ccc(F)cc1)c1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1 10.1016/s0960-894x(00)00268-7
CHEMBL289248 107081 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 666 14 4 10 3.6 CS(=O)(=O)NC(c1ccc(F)cc1)c1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1 10.1016/s0960-894x(00)00268-7
44461706 212702 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Binding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindololBinding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol
ChEMBL 579 15 3 7 4.1 CCCCCCN1C(=O)CN(c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)C1=O 10.1016/s0960-894x(99)00073-6
CHEMBL84117 212702 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Binding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindololBinding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol
ChEMBL 579 15 3 7 4.1 CCCCCCN1C(=O)CN(c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)C1=O 10.1016/s0960-894x(99)00073-6
44285685 106991 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 478 10 3 7 3.7 Cc1ncc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)o1 10.1016/s0960-894x(00)00277-8
CHEMBL288418 106991 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 478 10 3 7 3.7 Cc1ncc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)o1 10.1016/s0960-894x(00)00277-8
12043159 106789 0 None - 0 Human 4.2 pIC50 = 4.2 Binding
Binding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindololBinding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 549 14 3 9 3.7 CC(=O)CCCc1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1 10.1016/s0960-894x(00)00267-5
CHEMBL286800 106789 0 None - 0 Human 4.2 pIC50 = 4.2 Binding
Binding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindololBinding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 549 14 3 9 3.7 CC(=O)CCCc1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1 10.1016/s0960-894x(00)00267-5
44281396 106735 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 589 13 3 9 4.5 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(COc3ccc(F)cc3)n2)cc1 10.1016/s0960-894x(00)00268-7
CHEMBL286435 106735 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 589 13 3 9 4.5 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(COc3ccc(F)cc3)n2)cc1 10.1016/s0960-894x(00)00268-7
10119061 24728 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 526 8 4 5 3.7 N#CN/C(=N\c1ccc(I)cc1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/s0960-894x(00)00669-7
CHEMBL126055 24728 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 526 8 4 5 3.7 N#CN/C(=N\c1ccc(I)cc1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/s0960-894x(00)00669-7
44268539 27199 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 527 13 5 7 3.4 CC(C)C(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
CHEMBL13068 27199 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 527 13 5 7 3.4 CC(C)C(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
14739891 214509 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Tested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogsTested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 408 12 3 6 1.8 COCCc1ccc(OCC(O)CNCc2ccc(NS(C)(=O)=O)cc2)cc1 10.1021/jm00172a033
CHEMBL95727 214509 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Tested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogsTested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 408 12 3 6 1.8 COCCc1ccc(OCC(O)CNCc2ccc(NS(C)(=O)=O)cc2)cc1 10.1021/jm00172a033
1978 7038 60 None -15 6 Human 6.1 pIC50 = 6.1 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 336 10 3 5 3.0 CCCC(=Nc1ccc(c(c1)C(=O)C)OCC(CNC(C)C)O)O nan
40 7038 60 None -15 6 Human 6.1 pIC50 = 6.1 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 336 10 3 5 3.0 CCCC(=Nc1ccc(c(c1)C(=O)C)OCC(CNC(C)C)O)O nan
7107 7038 60 None -15 6 Human 6.1 pIC50 = 6.1 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 336 10 3 5 3.0 CCCC(=Nc1ccc(c(c1)C(=O)C)OCC(CNC(C)C)O)O nan
CHEMBL642 7038 60 None -15 6 Human 6.1 pIC50 = 6.1 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 336 10 3 5 3.0 CCCC(=Nc1ccc(c(c1)C(=O)C)OCC(CNC(C)C)O)O nan
DB01193 7038 60 None -15 6 Human 6.1 pIC50 = 6.1 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 336 10 3 5 3.0 CCCC(=Nc1ccc(c(c1)C(=O)C)OCC(CNC(C)C)O)O nan
44349646 23641 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 636 16 4 8 7.2 CCCCCCCCc1csc(N2CCc3ccc(N/C(=N/c4ccc(CCNC[C@H](O)c5cccnc5)cc4)NC#N)cc32)n1 10.1016/s0960-894x(00)00669-7
CHEMBL124929 23641 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 636 16 4 8 7.2 CCCCCCCCc1csc(N2CCc3ccc(N/C(=N/c4ccc(CCNC[C@H](O)c5cccnc5)cc4)NC#N)cc32)n1 10.1016/s0960-894x(00)00669-7
44349629 25296 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 450 8 4 5 4.3 N#CN/C(=N\c1ccc2ccccc2c1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/s0960-894x(00)00669-7
CHEMBL127422 25296 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 450 8 4 5 4.3 N#CN/C(=N\c1ccc2ccccc2c1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/s0960-894x(00)00669-7
44268569 104970 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 598 17 5 7 4.5 CCCCCCNC(=O)N(C)c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
CHEMBL274143 104970 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 598 17 5 7 4.5 CCCCCCNC(=O)N(C)c1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
12017004 106932 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 590 12 3 7 5.3 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2cnc(Cc3ccc(F)c(F)c3)o2)cc1 10.1016/s0960-894x(00)00277-8
CHEMBL287880 106932 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 590 12 3 7 5.3 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2cnc(Cc3ccc(F)c(F)c3)o2)cc1 10.1016/s0960-894x(00)00277-8
46881575 14556 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 416 9 3 7 2.3 O=C(Cn1nc2ccccc2n1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/j.bmcl.2010.01.130
CHEMBL1089387 14556 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 416 9 3 7 2.3 O=C(Cn1nc2ccccc2n1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/j.bmcl.2010.01.130
9958539 109882 0 None -1 3 Human 6.1 pIC50 = 6.1 Binding
Compound was evaluated for its inhibitory activity against CHO cells expressing the cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindololCompound was evaluated for its inhibitory activity against CHO cells expressing the cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol
ChEMBL 527 3 2 5 3.4 COc1c(I)cc(CC2NCCc3nc(N)sc32)cc1I 10.1016/s0960-894x(00)00459-5
CHEMBL307647 109882 0 None -1 3 Human 6.1 pIC50 = 6.1 Binding
Compound was evaluated for its inhibitory activity against CHO cells expressing the cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindololCompound was evaluated for its inhibitory activity against CHO cells expressing the cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol
ChEMBL 527 3 2 5 3.4 COc1c(I)cc(CC2NCCc3nc(N)sc32)cc1I 10.1016/s0960-894x(00)00459-5
145947596 174478 0 None - 1 Rat 6.1 pIC50 = 6.1 Binding
Displacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysisDisplacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysis
ChEMBL 355 5 2 5 3.4 Cc1cccc2c(=O)c3ccc(OCC(O)CNC(C)(C)C)cc3oc12 10.1016/j.bmc.2018.04.038
CHEMBL4128231 174478 0 None - 1 Rat 6.1 pIC50 = 6.1 Binding
Displacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysisDisplacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysis
ChEMBL 355 5 2 5 3.4 Cc1cccc2c(=O)c3ccc(OCC(O)CNC(C)(C)C)cc3oc12 10.1016/j.bmc.2018.04.038
CHEMBL4302343 174478 0 None - 1 Rat 6.1 pIC50 = 6.1 Binding
Displacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysisDisplacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysis
ChEMBL 355 5 2 5 3.4 Cc1cccc2c(=O)c3ccc(OCC(O)CNC(C)(C)C)cc3oc12 10.1016/j.bmc.2018.04.038
16049448 70869 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 515 13 5 7 4.2 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCSCCCNCCc3cccc(Cl)c3Cl)c2s1 10.1016/j.bmcl.2011.05.097
CHEMBL1807829 70869 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 515 13 5 7 4.2 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCSCCCNCCc3cccc(Cl)c3Cl)c2s1 10.1016/j.bmcl.2011.05.097
16049376 70875 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 515 13 5 7 4.2 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCSCCNCCc3cccc(Cl)c3Cl)c2s1 10.1016/j.bmcl.2011.05.097
CHEMBL1807871 70875 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 515 13 5 7 4.2 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCSCCNCCc3cccc(Cl)c3Cl)c2s1 10.1016/j.bmcl.2011.05.097
24901209 77130 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 516 11 6 6 4.3 Cc1cccc2c(CCNCc3cccc(CCNC[C@H](O)c4ccc(O)c5[nH]c(=O)sc45)c3)c[nH]c12 10.1016/j.bmcl.2011.10.049
CHEMBL1945031 77130 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 516 11 6 6 4.3 Cc1cccc2c(CCNCc3cccc(CCNC[C@H](O)c4ccc(O)c5[nH]c(=O)sc45)c3)c[nH]c12 10.1016/j.bmcl.2011.10.049
24900812 77142 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 450 10 5 7 2.8 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCc4ccccn4)c3)c2s1 10.1016/j.bmcl.2011.10.049
CHEMBL1945043 77142 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 450 10 5 7 2.8 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCc4ccccn4)c3)c2s1 10.1016/j.bmcl.2011.10.049
44349379 25300 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 462 12 5 8 2.6 NC(=O)c1cccc(N/C(=C/[N+](=O)[O-])Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)c1 10.1016/s0960-894x(00)00669-7
CHEMBL127451 25300 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 462 12 5 8 2.6 NC(=O)c1cccc(N/C(=C/[N+](=O)[O-])Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)c1 10.1016/s0960-894x(00)00669-7
56673674 70871 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 513 13 5 8 2.2 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCS(=O)(=O)CCCNCCc3cccc(Cl)c3)c2s1 10.1016/j.bmcl.2011.05.097
CHEMBL1807831 70871 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Binding affinity to adrenergic beta1 receptorBinding affinity to adrenergic beta1 receptor
ChEMBL 513 13 5 8 2.2 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCS(=O)(=O)CCCNCCc3cccc(Cl)c3)c2s1 10.1016/j.bmcl.2011.05.097
24900874 77158 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 417 11 5 7 1.9 COCCNCc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1 10.1016/j.bmcl.2011.10.049
CHEMBL1945293 77158 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of radiolabeled iodocyanopindolol from beta1 adrenoceptorDisplacement of radiolabeled iodocyanopindolol from beta1 adrenoceptor
ChEMBL 417 11 5 7 1.9 COCCNCc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1 10.1016/j.bmcl.2011.10.049
44307113 176162 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 552 11 3 5 3.7 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1)c1ccc(I)cc1 10.1016/s0960-894x(98)00381-3
CHEMBL442172 176162 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 552 11 3 5 3.7 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccccc2)cc1)c1ccc(I)cc1 10.1016/s0960-894x(98)00381-3
44268570 104971 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 598 17 5 7 4.8 CCCCCCN(C)C(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
CHEMBL274144 104971 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 598 17 5 7 4.8 CCCCCCN(C)C(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
14739892 215029 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Tested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogsTested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 337 8 2 5 2.7 Cc1ccccc1OCC(O)CNCc1ccc(-n2ccnc2)cc1 10.1021/jm00172a033
CHEMBL98773 215029 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Tested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogsTested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 337 8 2 5 2.7 Cc1ccccc1OCC(O)CNCc1ccc(-n2ccnc2)cc1 10.1021/jm00172a033
44335603 114207 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 538 16 4 6 5.0 CCCCCCCC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(98)00571-x
CHEMBL318165 114207 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 538 16 4 6 5.0 CCCCCCCC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(98)00571-x
9915238 204945 2 None - 0 Human 5.1 pIC50 = 5.1 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 539 15 5 6 4.5 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(98)00571-x
CHEMBL57486 204945 2 None - 0 Human 5.1 pIC50 = 5.1 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 539 15 5 6 4.5 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(98)00571-x
81430 206872 109 None - 1 Human 5.1 pIC50 = 5.1 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 192 2 1 3 1.1 COc1cccc(N2CCNCC2)c1 10.1021/jm00082a016
CHEMBL59597 206872 109 None - 1 Human 5.1 pIC50 = 5.1 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 192 2 1 3 1.1 COc1cccc(N2CCNCC2)c1 10.1021/jm00082a016
15483879 106559 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 573 12 3 8 4.5 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(Cc3ccc(F)cc3)no2)cc1 10.1016/s0960-894x(00)00268-7
CHEMBL285240 106559 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 573 12 3 8 4.5 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(Cc3ccc(F)cc3)no2)cc1 10.1016/s0960-894x(00)00268-7
44281395 106706 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 587 13 4 10 4.1 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(COc3ccccc3O)n2)cc1 10.1016/s0960-894x(00)00268-7
CHEMBL286231 106706 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 587 13 4 10 4.1 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(COc3ccccc3O)n2)cc1 10.1016/s0960-894x(00)00268-7
12017015 129872 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 546 12 3 7 5.1 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2cnc(CC3CCCC3)o2)cc1 10.1016/s0960-894x(00)00277-8
CHEMBL36101 129872 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.
ChEMBL 546 12 3 7 5.1 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2cnc(CC3CCCC3)o2)cc1 10.1016/s0960-894x(00)00277-8
9915238 204945 2 None - 0 Human 5.1 pIC50 = 5.1 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 539 15 5 6 4.5 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(99)00277-2
CHEMBL57486 204945 2 None - 0 Human 5.1 pIC50 = 5.1 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 539 15 5 6 4.5 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(99)00277-2
9896742 211723 0 None - 0 Human 4.1 pIC50 = 4.1 Binding
Compound was evaluated for its inhibitory activity against CHO cells expressing the cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindololCompound was evaluated for its inhibitory activity against CHO cells expressing the cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol
ChEMBL 618 12 6 7 6.0 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc3cc(OCC4NCCc5cc(O)c(O)cc54)ccc3c2)cc1 10.1016/s0960-894x(00)00459-5
CHEMBL76403 211723 0 None - 0 Human 4.1 pIC50 = 4.1 Binding
Compound was evaluated for its inhibitory activity against CHO cells expressing the cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindololCompound was evaluated for its inhibitory activity against CHO cells expressing the cloned human Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol
ChEMBL 618 12 6 7 6.0 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc3cc(OCC4NCCc5cc(O)c(O)cc54)ccc3c2)cc1 10.1016/s0960-894x(00)00459-5
44268266 24780 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 317 8 4 5 2.1 C[C@@H](Cc1ccc(O)cc1)NC[C@H](O)COc1ccc(O)cc1 10.1016/s0960-894x(98)00169-3
CHEMBL12633 24780 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 317 8 4 5 2.1 C[C@@H](Cc1ccc(O)cc1)NC[C@H](O)COc1ccc(O)cc1 10.1016/s0960-894x(98)00169-3
44349357 166688 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 469 11 4 7 4.7 O=[N+]([O-])/C=C(\Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)Nc1ccc2ccccc2c1 10.1016/s0960-894x(00)00669-7
CHEMBL410702 166688 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 469 11 4 7 4.7 O=[N+]([O-])/C=C(\Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)Nc1ccc2ccccc2c1 10.1016/s0960-894x(00)00669-7
44338578 117352 0 None - 0 Guinea pig 6.1 pIC50 = 6.1 Binding
Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)
ChEMBL 378 6 2 5 3.4 COC12CCCCC1c1ccc(F)cc1/C2=N/OCC(O)CNC(C)(C)C 10.1021/jm00122a008
CHEMBL325371 117352 0 None - 0 Guinea pig 6.1 pIC50 = 6.1 Binding
Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)
ChEMBL 378 6 2 5 3.4 COC12CCCCC1c1ccc(F)cc1/C2=N/OCC(O)CNC(C)(C)C 10.1021/jm00122a008
44349237 170218 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 511 13 4 8 5.3 O=[N+]([O-])/C=C(\Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)Nc1cccc(Oc2ccccc2)c1 10.1016/s0960-894x(00)00669-7
CHEMBL419787 170218 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 511 13 4 8 5.3 O=[N+]([O-])/C=C(\Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)Nc1cccc(Oc2ccccc2)c1 10.1016/s0960-894x(00)00669-7
44268352 22311 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 380 10 4 6 1.3 CS(=O)(=O)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/s0960-894x(98)00169-3
CHEMBL12188 22311 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 380 10 4 6 1.3 CS(=O)(=O)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/s0960-894x(98)00169-3
46881617 14715 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 397 9 4 7 2.2 Nc1nc(CC(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cs1 10.1016/j.bmcl.2010.01.130
CHEMBL1090425 14715 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 397 9 4 7 2.2 Nc1nc(CC(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cs1 10.1016/j.bmcl.2010.01.130
46901383 22209 23 None - 0 Human 5.1 pIC50 = 5.1 Binding
Inhibition of beta-1 adrenoceptorInhibition of beta-1 adrenoceptor
ChEMBL 380 5 3 6 2.4 NC(=O)c1cc(-c2ccnc(NC3CCCCC3)c2)nc(N2CCNCC2)c1 10.1021/jm100076w
CHEMBL1214999 22209 23 None - 0 Human 5.1 pIC50 = 5.1 Binding
Inhibition of beta-1 adrenoceptorInhibition of beta-1 adrenoceptor
ChEMBL 380 5 3 6 2.4 NC(=O)c1cc(-c2ccnc(NC3CCCCC3)c2)nc(N2CCNCC2)c1 10.1021/jm100076w
10012704 17993 0 None 1 2 Rat 5.1 pIC50 = 5.1 Binding
Antagonist activity at rat brain membrane adrenergic beta-1 receptorAntagonist activity at rat brain membrane adrenergic beta-1 receptor
ChEMBL 188 5 2 4 0.8 CCO/N=C/C(O)CNC(C)(C)C 10.1021/acs.jmedchem.1c01215
CHEMBL1178768 17993 0 None 1 2 Rat 5.1 pIC50 = 5.1 Binding
Antagonist activity at rat brain membrane adrenergic beta-1 receptorAntagonist activity at rat brain membrane adrenergic beta-1 receptor
ChEMBL 188 5 2 4 0.8 CCO/N=C/C(O)CNC(C)(C)C 10.1021/acs.jmedchem.1c01215
CHEMBL39987 17993 0 None 1 2 Rat 5.1 pIC50 = 5.1 Binding
Antagonist activity at rat brain membrane adrenergic beta-1 receptorAntagonist activity at rat brain membrane adrenergic beta-1 receptor
ChEMBL 188 5 2 4 0.8 CCO/N=C/C(O)CNC(C)(C)C 10.1021/acs.jmedchem.1c01215
10442852 17986 0 None - 2 Guinea pig 5.1 pIC50 = 5.1 Binding
Inhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atriaInhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atria
ChEMBL 202 6 2 4 1.1 CCCO/N=C/C(O)CNC(C)(C)C 10.1021/jm00036a018
CHEMBL1178755 17986 0 None - 2 Guinea pig 5.1 pIC50 = 5.1 Binding
Inhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atriaInhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atria
ChEMBL 202 6 2 4 1.1 CCCO/N=C/C(O)CNC(C)(C)C 10.1021/jm00036a018
CHEMBL39706 17986 0 None - 2 Guinea pig 5.1 pIC50 = 5.1 Binding
Inhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atriaInhibitory concentration against beta-1-adrenergic receptor in isolated guinea pig atria
ChEMBL 202 6 2 4 1.1 CCCO/N=C/C(O)CNC(C)(C)C 10.1021/jm00036a018
10076885 106560 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Binding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindololBinding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 577 14 3 9 4.3 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(CCOC3CCCC3)n2)cc1 10.1016/s0960-894x(00)00267-5
CHEMBL285242 106560 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Binding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindololBinding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 577 14 3 9 4.3 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(CCOC3CCCC3)n2)cc1 10.1016/s0960-894x(00)00267-5
46881752 14036 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 431 9 4 6 3.6 O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)OCc1nc2ccccc2[nH]1 10.1016/j.bmcl.2010.01.130
CHEMBL1085928 14036 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 431 9 4 6 3.6 O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)OCc1nc2ccccc2[nH]1 10.1016/j.bmcl.2010.01.130
10101116 21304 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 684 11 4 9 6.8 N#CN/C(=N\c1cccc2c1CCN2c1nc(-c2ccc(OC(F)(F)F)cc2)cs1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/s0960-894x(00)00669-7
CHEMBL120238 21304 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 684 11 4 9 6.8 N#CN/C(=N\c1cccc2c1CCN2c1nc(-c2ccc(OC(F)(F)F)cc2)cs1)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/s0960-894x(00)00669-7
10722793 120124 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Binding affinity was evaluated on chinese hamster ovary (CHO) cells expressing the cloned human beta-1 adrenergic receptor in the presence of [125I]- iodocyanopindolol.Binding affinity was evaluated on chinese hamster ovary (CHO) cells expressing the cloned human beta-1 adrenergic receptor in the presence of [125I]- iodocyanopindolol.
ChEMBL 640 12 3 8 6.4 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc(OC(F)(F)F)cc3)cs2)cc1 10.1021/jm000286i
CHEMBL331744 120124 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Binding affinity was evaluated on chinese hamster ovary (CHO) cells expressing the cloned human beta-1 adrenergic receptor in the presence of [125I]- iodocyanopindolol.Binding affinity was evaluated on chinese hamster ovary (CHO) cells expressing the cloned human beta-1 adrenergic receptor in the presence of [125I]- iodocyanopindolol.
ChEMBL 640 12 3 8 6.4 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3ccc(OC(F)(F)F)cc3)cs2)cc1 10.1021/jm000286i
44338127 14432 0 None - 0 Guinea pig 6.1 pIC50 = 6.1 Binding
Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)
ChEMBL 390 8 3 6 2.6 CC(C)(C)NCC(O)CO/N=C1/c2ccccc2C2CCCCC12OCCO 10.1021/jm00122a008
CHEMBL108843 14432 0 None - 0 Guinea pig 6.1 pIC50 = 6.1 Binding
Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)
ChEMBL 390 8 3 6 2.6 CC(C)(C)NCC(O)CO/N=C1/c2ccccc2C2CCCCC12OCCO 10.1021/jm00122a008
44301866 107351 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 606 18 3 7 6.7 CCCCCCCCc1csc(Cc2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)n1 10.1016/s0960-894x(00)00390-5
CHEMBL291593 107351 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 606 18 3 7 6.7 CCCCCCCCc1csc(Cc2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)n1 10.1016/s0960-894x(00)00390-5
44377514 63288 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Binding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindololBinding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol
ChEMBL 592 17 3 9 4.5 CCCCCCCCn1cnn(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)c1=O 10.1016/s0960-894x(99)00073-6
CHEMBL163579 63288 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Binding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindololBinding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol
ChEMBL 592 17 3 9 4.5 CCCCCCCCn1cnn(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)c1=O 10.1016/s0960-894x(99)00073-6
44461486 212142 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Binding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindololBinding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol
ChEMBL 564 15 3 9 3.7 CCCCCCn1cnn(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)c1=O 10.1016/s0960-894x(99)00073-6
CHEMBL79806 212142 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Binding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindololBinding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol
ChEMBL 564 15 3 9 3.7 CCCCCCn1cnn(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)c1=O 10.1016/s0960-894x(99)00073-6
44280795 119354 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Binding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindololBinding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 507 12 3 8 3.8 CCCc1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1 10.1016/s0960-894x(00)00267-5
CHEMBL33013 119354 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Binding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindololBinding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 507 12 3 8 3.8 CCCc1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1 10.1016/s0960-894x(00)00267-5
15523860 126949 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 593 15 3 6 5.2 CCCCC(C)(C)CN1CCN(c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)C1=O 10.1016/s0960-894x(99)00072-4
CHEMBL351596 126949 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindololBinding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol
ChEMBL 593 15 3 6 5.2 CCCCC(C)(C)CN1CCN(c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)C1=O 10.1016/s0960-894x(99)00072-4
44307396 210529 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 582 12 3 6 3.7 COc1ccc(OC[C@@H](O)CNCCc2ccc(NS(=O)(=O)c3ccc(I)cc3)cc2)cc1 10.1016/s0960-894x(98)00381-3
CHEMBL67886 210529 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 582 12 3 6 3.7 COc1ccc(OC[C@@H](O)CNCCc2ccc(NS(=O)(=O)c3ccc(I)cc3)cc2)cc1 10.1016/s0960-894x(98)00381-3
46881750 13996 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 401 8 4 5 3.1 O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1nc2ccccc2[nH]1 10.1016/j.bmcl.2010.01.130
CHEMBL1085693 13996 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 401 8 4 5 3.1 O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1nc2ccccc2[nH]1 10.1016/j.bmcl.2010.01.130
12049914 210372 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.
ChEMBL 558 11 3 8 4.1 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(-c3cccc(F)c3)n2)cc1 10.1016/s0960-894x(00)00422-4
CHEMBL66908 210372 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.
ChEMBL 558 11 3 8 4.1 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(-c3cccc(F)c3)n2)cc1 10.1016/s0960-894x(00)00422-4
44268509 26193 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 513 13 5 7 3.1 CCC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
CHEMBL12943 26193 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.In vitro affinity at Beta-1 adrenergic receptor in the presence of [125I]iodocyanopindolol.
ChEMBL 513 13 5 7 3.1 CCC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1 10.1016/s0960-894x(98)00170-x
44338133 16004 0 None - 0 Guinea pig 6.1 pIC50 = 6.1 Binding
Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)
ChEMBL 346 6 3 5 2.6 CC(C)NCC(O)CO/N=C1/c2ccccc2C2CCCCCC12O 10.1021/jm00122a008
CHEMBL110659 16004 0 None - 0 Guinea pig 6.1 pIC50 = 6.1 Binding
Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)Beta-1 adrenergic receptor blocking was assessed from 50% inhibition of the isoproterenol submaximal response on isolated Guinea pig atria(IA)
ChEMBL 346 6 3 5 2.6 CC(C)NCC(O)CO/N=C1/c2ccccc2C2CCCCCC12O 10.1021/jm00122a008
2464 10412 58 None -2 6 Human 5.1 pIC50 = 5.1 Binding
Tested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogsTested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C 10.1021/jm00172a033
5253 10412 58 None -2 6 Human 5.1 pIC50 = 5.1 Binding
Tested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogsTested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C 10.1021/jm00172a033
7297 10412 58 None -2 6 Human 5.1 pIC50 = 5.1 Binding
Tested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogsTested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C 10.1021/jm00172a033
CHEMBL471 10412 58 None -2 6 Human 5.1 pIC50 = 5.1 Binding
Tested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogsTested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C 10.1021/jm00172a033
DB00489 10412 58 None -2 6 Human 5.1 pIC50 = 5.1 Binding
Tested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogsTested for Beta-1 adrenergic receptor selectivity in canine cardiac tissue in anesthetized dogs
ChEMBL 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C 10.1021/jm00172a033
44307205 210595 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 584 17 6 8 3.7 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(N)nc3)cc2)cc1 10.1016/s0960-894x(98)00381-3
CHEMBL68408 210595 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 584 17 6 8 3.7 CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(N)nc3)cc2)cc1 10.1016/s0960-894x(98)00381-3
44298852 108520 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 435 9 1 4 5.7 CCCCCCc1cccc(N2CCc3cc(S(=O)(=O)Nc4ccccc4)ccc32)n1 10.1016/s0960-894x(99)00277-2
CHEMBL299719 108520 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 435 9 1 4 5.7 CCCCCCc1cccc(N2CCc3cc(S(=O)(=O)Nc4ccccc4)ccc32)n1 10.1016/s0960-894x(99)00277-2
44268322 25744 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 303 8 4 5 1.7 Oc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/s0960-894x(98)00169-3
CHEMBL12876 25744 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligandTested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand
ChEMBL 303 8 4 5 1.7 Oc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1 10.1016/s0960-894x(98)00169-3
44301843 206387 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 584 13 3 7 5.7 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(CCc3ccccc3)cs2)cc1 10.1016/s0960-894x(00)00390-5
CHEMBL59270 206387 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 584 13 3 7 5.7 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(CCc3ccccc3)cs2)cc1 10.1016/s0960-894x(00)00390-5
2464 10412 58 None -2 6 Human 5.1 pIC50 = 5.1 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C 10.1021/jm00082a016
5253 10412 58 None -2 6 Human 5.1 pIC50 = 5.1 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C 10.1021/jm00082a016
7297 10412 58 None -2 6 Human 5.1 pIC50 = 5.1 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C 10.1021/jm00082a016
CHEMBL471 10412 58 None -2 6 Human 5.1 pIC50 = 5.1 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C 10.1021/jm00082a016
DB00489 10412 58 None -2 6 Human 5.1 pIC50 = 5.1 Binding
Binding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterolBinding affinity for Beta-1 adrenergic receptor by displacing [3H]dihydroalprenolol, in partially purified membrane fractions from canine ventricular muscle in the presence of 1 uM zinterol
ChEMBL 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C 10.1021/jm00082a016
44281343 117146 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 639 14 3 13 5.2 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(COc3ccc(C4N=NN=N4)cc3)n2)cc1 10.1016/s0960-894x(00)00268-7
CHEMBL32418 117146 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Binding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindololBinding affinity to recombinant human beta-1 adrenergic receptor expressed in CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 639 14 3 13 5.2 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2noc(COc3ccc(C4N=NN=N4)cc3)n2)cc1 10.1016/s0960-894x(00)00268-7
44280858 106589 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Binding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindololBinding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 577 17 3 8 5.7 CCCCCCCCc1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1 10.1016/s0960-894x(00)00267-5
CHEMBL285458 106589 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Binding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindololBinding affinity towards cloned human Beta-1 adrenergic receptor prepared from CHO cells in the presence of [125I]iodocyanopindolol
ChEMBL 577 17 3 8 5.7 CCCCCCCCc1nc(-c2ccc(S(=O)(=O)Nc3ccc(CCNC[C@H](O)c4cccnc4)cc3)cc2)no1 10.1016/s0960-894x(00)00267-5
2464 10412 58 None -2 6 Human 5.1 pIC50 = 5.1 Binding
In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)
ChEMBL 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C 10.1021/jm00166a002
5253 10412 58 None -2 6 Human 5.1 pIC50 = 5.1 Binding
In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)
ChEMBL 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C 10.1021/jm00166a002
7297 10412 58 None -2 6 Human 5.1 pIC50 = 5.1 Binding
In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)
ChEMBL 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C 10.1021/jm00166a002
CHEMBL471 10412 58 None -2 6 Human 5.1 pIC50 = 5.1 Binding
In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)
ChEMBL 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C 10.1021/jm00166a002
DB00489 10412 58 None -2 6 Human 5.1 pIC50 = 5.1 Binding
In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)In vitro Beta-1 adrenergic receptor affinity in partially purified membrane fractions from canine cardiac tissue using [SH]dihydroalprenolol (4.5 nM)
ChEMBL 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C 10.1021/jm00166a002
44298700 108723 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 345 3 1 3 2.5 CN(C)C(=O)N1CCc2cc(S(=O)(=O)Nc3ccccc3)ccc21 10.1016/s0960-894x(99)00277-2
CHEMBL301202 108723 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 345 3 1 3 2.5 CN(C)C(=O)N1CCc2cc(S(=O)(=O)Nc3ccccc3)ccc21 10.1016/s0960-894x(99)00277-2
44268341 29529 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand.Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand.
ChEMBL 492 11 4 6 3.9 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1ccc2ccccc2c1 10.1016/s0960-894x(98)00169-3
CHEMBL13278 29529 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand.Tested for binding affinity against cloned human beta-1 adrenergic receptor from CHO cells using [125I]iodocyanopindolol as the radioligand.
ChEMBL 492 11 4 6 3.9 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1)c1ccc2ccccc2c1 10.1016/s0960-894x(98)00169-3
44301880 205418 0 None - 0 Human 4.1 pIC50 = 4.1 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 596 11 3 8 6.3 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3cc4ccccc4o3)cs2)cc1 10.1016/s0960-894x(00)00390-5
CHEMBL57908 205418 0 None - 0 Human 4.1 pIC50 = 4.1 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 596 11 3 8 6.3 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-c2nc(-c3cc4ccccc4o3)cs2)cc1 10.1016/s0960-894x(00)00390-5
44307166 109498 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 570 11 3 5 3.8 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(F)cc2)cc1)c1ccc(I)cc1 10.1016/s0960-894x(98)00381-3
CHEMBL304878 109498 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Evaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cellEvaluated for its agonist activity and the binding affinity against human Beta-1 adrenergic receptor in membranes from chinese hamster ovary cell
ChEMBL 570 11 3 5 3.8 O=S(=O)(Nc1ccc(CCNC[C@H](O)COc2ccc(F)cc2)cc1)c1ccc(I)cc1 10.1016/s0960-894x(98)00381-3
12049925 105470 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.
ChEMBL 638 13 3 9 4.9 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(COc3ccc(C(F)(F)F)cc3)n2)cc1 10.1016/s0960-894x(00)00422-4
CHEMBL277613 105470 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.
ChEMBL 638 13 3 9 4.9 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(COc3ccc(C(F)(F)F)cc3)n2)cc1 10.1016/s0960-894x(00)00422-4
12049924 210576 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.
ChEMBL 606 13 3 9 4.2 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(COc3ccc(F)c(F)c3)n2)cc1 10.1016/s0960-894x(00)00422-4
CHEMBL68301 210576 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.Binding affinity for cloned human Beta-1 adrenergic receptor expressed in CHO cells, tested in the presence of I-iodocyanopindolol.
ChEMBL 606 13 3 9 4.2 O=S(=O)(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccc(-n2ncc(COc3ccc(F)c(F)c3)n2)cc1 10.1016/s0960-894x(00)00422-4
44301867 107352 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 613 12 4 8 5.5 CC(=O)Nc1ccc(-c2csc(-c3ccc(S(=O)(=O)Nc4ccc(CCNC[C@H](O)c5cccnc5)cc4)cc3)n2)cc1 10.1016/s0960-894x(00)00390-5
CHEMBL291594 107352 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Binding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cellsBinding affinity (measured using [125I]iodocyanopindolol) against human Beta-1 adrenergic receptor expressed in CHO cells
ChEMBL 613 12 4 8 5.5 CC(=O)Nc1ccc(-c2csc(-c3ccc(S(=O)(=O)Nc4ccc(CCNC[C@H](O)c5cccnc5)cc4)cc3)n2)cc1 10.1016/s0960-894x(00)00390-5
46881531 13761 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 415 9 4 5 3.0 O=C(Cc1n[nH]c2ccccc12)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/j.bmcl.2010.01.130
CHEMBL1084667 13761 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 415 9 4 5 3.0 O=C(Cc1n[nH]c2ccccc12)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1 10.1016/j.bmcl.2010.01.130
56645363 128268 12 None -3 4 Human 5.0 pIC50 = 5.0 Binding
Selectivity interaction (Enzyme panel (Eurofins-Panlabs radioligand binding assays)) EUB0000313b ADRB1Selectivity interaction (Enzyme panel (Eurofins-Panlabs radioligand binding assays)) EUB0000313b ADRB1
ChEMBL 311 3 1 4 3.8 CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1 10.6019/CHEMBL5212743
CHEMBL3582478 128268 12 None -3 4 Human 5.0 pIC50 = 5.0 Binding
Selectivity interaction (Enzyme panel (Eurofins-Panlabs radioligand binding assays)) EUB0000313b ADRB1Selectivity interaction (Enzyme panel (Eurofins-Panlabs radioligand binding assays)) EUB0000313b ADRB1
ChEMBL 311 3 1 4 3.8 CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1 10.6019/CHEMBL5212743
44335548 116542 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 567 17 5 6 5.2 CCCCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(98)00571-x
CHEMBL323113 116542 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Beta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindololBeta-1 adrenergic receptor binding affinity in CHO cells expressing cloned human receptor in the presence of 125 I-iodocyanopindolol
ChEMBL 567 17 5 6 5.2 CCCCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1 10.1016/s0960-894x(98)00571-x
44298781 107470 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 443 10 1 3 5.3 CCCCCCCCN(C)C(=O)N1CCc2cc(S(=O)(=O)Nc3ccccc3)ccc21 10.1016/s0960-894x(99)00277-2
CHEMBL292407 107470 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
In vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cellsIn vitro binding affinity towards cloned human beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells
ChEMBL 443 10 1 3 5.3 CCCCCCCCN(C)C(=O)N1CCc2cc(S(=O)(=O)Nc3ccccc3)ccc21 10.1016/s0960-894x(99)00277-2
10160636 120275 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 443 9 5 6 2.2 N#CN/C(=N\c1ccc(CCNC[C@H](O)c2cccnc2)cc1)Nc1cccc(C(N)=O)c1 10.1016/s0960-894x(00)00669-7
CHEMBL332010 120275 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Binding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cellsBinding affinity for human Beta-1 adrenergic receptor using [125I]iodocyanopindolol as radioligand in CHO cells
ChEMBL 443 9 5 6 2.2 N#CN/C(=N\c1ccc(CCNC[C@H](O)c2cccnc2)cc1)Nc1cccc(C(N)=O)c1 10.1016/s0960-894x(00)00669-7
46882028 12530 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 467 11 3 5 4.8 O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccccc1COc1ccccc1 10.1016/j.bmcl.2010.01.130
CHEMBL1078495 12530 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counterDisplacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter
ChEMBL 467 11 3 5 4.8 O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccccc1COc1ccccc1 10.1016/j.bmcl.2010.01.130
164612037 192156 0 None -1 20 Human 10.1 pKd = 10.1 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]CGP12177 from human beta-1 adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 326 8 4 4 1.8 CCCCCNC(=O)/N=C(\N)NCCCc1sc(N)nc1C 10.1021/acs.jmedchem.1c00692
CHEMBL4860528 192156 0 None -1 20 Human 10.1 pKd = 10.1 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]CGP12177 from human beta-1 adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 326 8 4 4 1.8 CCCCCNC(=O)/N=C(\N)NCCCc1sc(N)nc1C 10.1021/acs.jmedchem.1c00692
168290235 199747 0 None -5 20 Human 10.1 pKd = 10.1 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]CGP12177 from human beta-1 adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 315 6 4 3 1.1 C[C@@H](NC(=O)/N=C(\N)NCCCc1ncn[nH]1)c1ccccc1 10.1021/acs.jmedchem.1c00692
CHEMBL5201074 199747 0 None -5 20 Human 10.1 pKd = 10.1 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]CGP12177 from human beta-1 adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 315 6 4 3 1.1 C[C@@H](NC(=O)/N=C(\N)NCCCc1ncn[nH]1)c1ccccc1 10.1021/acs.jmedchem.1c00692
CHEMBL5222491 199747 0 None -5 20 Human 10.1 pKd = 10.1 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]CGP12177 from human beta-1 adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 315 6 4 3 1.1 C[C@@H](NC(=O)/N=C(\N)NCCCc1ncn[nH]1)c1ccccc1 10.1021/acs.jmedchem.1c00692
168294767 199798 0 None -1 20 Human 10.1 pKd = 10.1 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]CGP12177 from human beta-1 adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 313 8 4 5 0.9 CCCCCNC(=O)/N=C(\N)NCCCc1nnc(N)s1 10.1021/acs.jmedchem.1c00692
CHEMBL5207281 199798 0 None -1 20 Human 10.1 pKd = 10.1 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]CGP12177 from human beta-1 adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 313 8 4 5 0.9 CCCCCNC(=O)/N=C(\N)NCCCc1nnc(N)s1 10.1021/acs.jmedchem.1c00692
CHEMBL5222802 199798 0 None -1 20 Human 10.1 pKd = 10.1 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]CGP12177 from human beta-1 adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 313 8 4 5 0.9 CCCCCNC(=O)/N=C(\N)NCCCc1nnc(N)s1 10.1021/acs.jmedchem.1c00692
168295528 199810 0 None -1 20 Human 10.1 pKd = 10.1 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]CGP12177 from human beta-1 adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 333 6 4 5 0.9 N/C(=N\C(=O)NCc1ccccc1)NCCCc1nnc(N)s1 10.1021/acs.jmedchem.1c00692
CHEMBL5206565 199810 0 None -1 20 Human 10.1 pKd = 10.1 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]CGP12177 from human beta-1 adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 333 6 4 5 0.9 N/C(=N\C(=O)NCc1ccccc1)NCCCc1nnc(N)s1 10.1021/acs.jmedchem.1c00692
CHEMBL5222872 199810 0 None -1 20 Human 10.1 pKd = 10.1 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]CGP12177 from human beta-1 adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 333 6 4 5 0.9 N/C(=N\C(=O)NCc1ccccc1)NCCCc1nnc(N)s1 10.1021/acs.jmedchem.1c00692
21595418 109416 0 None -2 2 Guinea pig 9.8 pKd = 9.8 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 271 4 2 3 2.7 O[C@H](COc1cccc2ccccc12)[C@@H]1CCCCN1 10.1021/jm00119a011
CHEMBL304344 109416 0 None -2 2 Guinea pig 9.8 pKd = 9.8 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 271 4 2 3 2.7 O[C@H](COc1cccc2ccccc12)[C@@H]1CCCCN1 10.1021/jm00119a011
33624 10593 34 None -3 9 Guinea pig 9.4 pKd = 9.4 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm00361a004
4061 10593 34 None -3 9 Guinea pig 9.4 pKd = 9.4 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm00361a004
565 10593 34 None -3 9 Guinea pig 9.4 pKd = 9.4 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm00361a004
CHEMBL499 10593 34 None -3 9 Guinea pig 9.4 pKd = 9.4 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm00361a004
DB00373 10593 34 None -3 9 Guinea pig 9.4 pKd = 9.4 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm00361a004
33624 10593 34 None -3 9 Guinea pig 9.4 pKd = 9.4 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm00156a028
4061 10593 34 None -3 9 Guinea pig 9.4 pKd = 9.4 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm00156a028
565 10593 34 None -3 9 Guinea pig 9.4 pKd = 9.4 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm00156a028
CHEMBL499 10593 34 None -3 9 Guinea pig 9.4 pKd = 9.4 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm00156a028
DB00373 10593 34 None -3 9 Guinea pig 9.4 pKd = 9.4 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/jm00156a028
12179890 101409 1 None 3 2 Human 9.4 pKd = 9.4 Binding
Binding affinity to beta-1 adrenergic receptorBinding affinity to beta-1 adrenergic receptor
ChEMBL 223 6 2 3 1.7 Cc1cccc(OC[C@@H](O)CNC(C)C)c1 10.1021/jm800227h
CHEMBL252319 101409 1 None 3 2 Human 9.4 pKd = 9.4 Binding
Binding affinity to beta-1 adrenergic receptorBinding affinity to beta-1 adrenergic receptor
ChEMBL 223 6 2 3 1.7 Cc1cccc(OC[C@@H](O)CNC(C)C)c1 10.1021/jm800227h
12878481 66763 0 None 169 2 Guinea pig 9.1 pKd = 9.1 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 341 7 3 4 2.6 OC(CNC1CC1)COc1ccc(-c2nc(C(F)(F)F)c[nH]2)cc1 10.1021/jm00361a004
CHEMBL173424 66763 0 None 169 2 Guinea pig 9.1 pKd = 9.1 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 341 7 3 4 2.6 OC(CNC1CC1)COc1ccc(-c2nc(C(F)(F)F)c[nH]2)cc1 10.1021/jm00361a004
13157386 69951 3 None 138 2 Guinea pig 9.1 pKd = 9.1 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 479 12 3 7 4.4 COc1ccc(CCNC[C@H](O)COc2ccc(-c3nc(-c4cccs4)c[nH]3)cc2)cc1OC 10.1021/jm00361a004
CHEMBL1788320 69951 3 None 138 2 Guinea pig 9.1 pKd = 9.1 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 479 12 3 7 4.4 COc1ccc(CCNC[C@H](O)COc2ccc(-c3nc(-c4cccs4)c[nH]3)cc2)cc1OC 10.1021/jm00361a004
CHEMBL1789879 69951 3 None 138 2 Guinea pig 9.1 pKd = 9.1 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 479 12 3 7 4.4 COc1ccc(CCNC[C@H](O)COc2ccc(-c3nc(-c4cccs4)c[nH]3)cc2)cc1OC 10.1021/jm00361a004
135079 17274 1 None 9772 2 Guinea pig 9.1 pKd = 9.1 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 479 12 3 7 4.4 COc1ccc(CCNCC(O)COc2ccc(-c3nc(-c4cccs4)c[nH]3)cc2)cc1OC 10.1021/jm00156a028
CHEMBL11671 17274 1 None 9772 2 Guinea pig 9.1 pKd = 9.1 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 479 12 3 7 4.4 COc1ccc(CCNCC(O)COc2ccc(-c3nc(-c4cccs4)c[nH]3)cc2)cc1OC 10.1021/jm00156a028
12878477 110311 0 None 10 2 Guinea pig 9.1 pKd = 9.1 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 357 6 3 4 3.2 CC(C)(C)NC[C@H](O)COc1ccc(-c2nc(C(F)(F)F)c[nH]2)cc1 10.1021/jm00361a004
CHEMBL3085291 110311 0 None 10 2 Guinea pig 9.1 pKd = 9.1 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 357 6 3 4 3.2 CC(C)(C)NC[C@H](O)COc1ccc(-c2nc(C(F)(F)F)c[nH]2)cc1 10.1021/jm00361a004
123686 8762 51 None 1 9 Guinea pig 9.0 pKd = 9.0 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 354 9 4 5 1.7 C1=CC=C(C=C1)NC(=O)NCCNCC(COC2=CC=CC=C2C#N)O 10.1021/jm00156a028
12581 8762 51 None 1 9 Guinea pig 9.0 pKd = 9.0 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 354 9 4 5 1.7 C1=CC=C(C=C1)NC(=O)NCCNCC(COC2=CC=CC=C2C#N)O 10.1021/jm00156a028
CHEMBL11268 8762 51 None 1 9 Guinea pig 9.0 pKd = 9.0 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 354 9 4 5 1.7 C1=CC=C(C=C1)NC(=O)NCCNCC(COC2=CC=CC=C2C#N)O 10.1021/jm00156a028
25271869 165410 4 None -38 2 Human 9.0 pKd = 9.0 Binding
Displacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting methodDisplacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting method
ChEMBL 299 6 2 3 3.5 CC(C)(C)NC[C@@H](O)COc1ccccc1-c1ccccc1 10.1021/acsmedchemlett.6b00363
CHEMBL4092412 165410 4 None -38 2 Human 9.0 pKd = 9.0 Binding
Displacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting methodDisplacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting method
ChEMBL 299 6 2 3 3.5 CC(C)(C)NC[C@@H](O)COc1ccccc1-c1ccccc1 10.1021/acsmedchemlett.6b00363
2685 7677 21 None -1 7 Human 9.0 pKd = 9.0 Binding
Displacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting methodDisplacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting method
ChEMBL 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10.1021/acsmedchemlett.6b00363
541 7677 21 None -1 7 Human 9.0 pKd = 9.0 Binding
Displacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting methodDisplacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting method
ChEMBL 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10.1021/acsmedchemlett.6b00363
CHEMBL280822 7677 21 None -1 7 Human 9.0 pKd = 9.0 Binding
Displacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting methodDisplacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting method
ChEMBL 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10.1021/acsmedchemlett.6b00363
13157406 16202 0 None 144 2 Guinea pig 8.9 pKd = 8.9 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 357 8 3 5 3.5 CC(C)NCC(O)COc1ccc(-c2nc(-c3cccs3)c[nH]2)cc1 10.1021/jm00361a004
CHEMBL11171 16202 0 None 144 2 Guinea pig 8.9 pKd = 8.9 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 357 8 3 5 3.5 CC(C)NCC(O)COc1ccc(-c2nc(-c3cccs3)c[nH]2)cc1 10.1021/jm00361a004
13157406 16202 0 None 144 2 Guinea pig 8.9 pKd = 8.9 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 357 8 3 5 3.5 CC(C)NCC(O)COc1ccc(-c2nc(-c3cccs3)c[nH]2)cc1 10.1021/jm00156a028
CHEMBL11171 16202 0 None 144 2 Guinea pig 8.9 pKd = 8.9 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 357 8 3 5 3.5 CC(C)NCC(O)COc1ccc(-c2nc(-c3cccs3)c[nH]2)cc1 10.1021/jm00156a028
13157406 16202 0 None 144 2 Guinea pig 8.9 pKd = 8.9 Binding
Activity at beta-1 adrenergic receptorActivity at beta-1 adrenergic receptor
ChEMBL 357 8 3 5 3.5 CC(C)NCC(O)COc1ccc(-c2nc(-c3cccs3)c[nH]2)cc1 10.1021/jm00103a004
CHEMBL11171 16202 0 None 144 2 Guinea pig 8.9 pKd = 8.9 Binding
Activity at beta-1 adrenergic receptorActivity at beta-1 adrenergic receptor
ChEMBL 357 8 3 5 3.5 CC(C)NCC(O)COc1ccc(-c2nc(-c3cccs3)c[nH]2)cc1 10.1021/jm00103a004
13621703 16155 0 None - 1 Guinea pig 8.8 pKd = 8.8 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 439 12 3 6 3.8 COc1ccc(CCNCC(O)COc2ccc(-c3nc(C(C)C)c[nH]3)cc2)cc1OC 10.1021/jm00156a028
CHEMBL11145 16155 0 None - 1 Guinea pig 8.8 pKd = 8.8 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 439 12 3 6 3.8 COc1ccc(CCNCC(O)COc2ccc(-c3nc(C(C)C)c[nH]3)cc2)cc1OC 10.1021/jm00156a028
13040879 30627 0 None -1 2 Guinea pig 8.8 pKd = 8.8 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 281 6 2 5 1.6 COC(=O)c1ccccc1OCC(O)CNC(C)(C)C 10.1021/jm00354a003
CHEMBL13365 30627 0 None -1 2 Guinea pig 8.8 pKd = 8.8 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 281 6 2 5 1.6 COC(=O)c1ccccc1OCC(O)CNC(C)(C)C 10.1021/jm00354a003
2369 7409 80 None 3 8 Human 8.8 pKd = 8.8 Binding
Antagonist activity against beta-1 adrenergic receptor (unknown origin)Antagonist activity against beta-1 adrenergic receptor (unknown origin)
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/acs.jmedchem.5b00201
356 7409 80 None 3 8 Human 8.8 pKd = 8.8 Binding
Antagonist activity against beta-1 adrenergic receptor (unknown origin)Antagonist activity against beta-1 adrenergic receptor (unknown origin)
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/acs.jmedchem.5b00201
549 7409 80 None 3 8 Human 8.8 pKd = 8.8 Binding
Antagonist activity against beta-1 adrenergic receptor (unknown origin)Antagonist activity against beta-1 adrenergic receptor (unknown origin)
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/acs.jmedchem.5b00201
CHEMBL423 7409 80 None 3 8 Human 8.8 pKd = 8.8 Binding
Antagonist activity against beta-1 adrenergic receptor (unknown origin)Antagonist activity against beta-1 adrenergic receptor (unknown origin)
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/acs.jmedchem.5b00201
DB00195 7409 80 None 3 8 Human 8.8 pKd = 8.8 Binding
Antagonist activity against beta-1 adrenergic receptor (unknown origin)Antagonist activity against beta-1 adrenergic receptor (unknown origin)
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/acs.jmedchem.5b00201
12521601 135424 0 None 20 2 Guinea pig 8.8 pKd = 8.8 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 371 7 3 5 3.9 CC(C)(C)NCC(O)COc1ccc(-c2nc(-c3cccs3)c[nH]2)cc1 10.1021/jm00361a004
CHEMBL366769 135424 0 None 20 2 Guinea pig 8.8 pKd = 8.8 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 371 7 3 5 3.9 CC(C)(C)NCC(O)COc1ccc(-c2nc(-c3cccs3)c[nH]2)cc1 10.1021/jm00361a004
2685 7677 21 None -1 7 Human 8.8 pKd = 8.8 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10.1021/jm400348g
541 7677 21 None -1 7 Human 8.8 pKd = 8.8 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10.1021/jm400348g
CHEMBL280822 7677 21 None -1 7 Human 8.8 pKd = 8.8 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10.1021/jm400348g
3123920 9602 85 None 2 6 Guinea pig 8.8 pKd = 8.8 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 209 6 2 3 1.4 OC(COc1ccccc1)CNC(C)C 10.1021/jm00119a011
546 9602 85 None 2 6 Guinea pig 8.8 pKd = 8.8 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 209 6 2 3 1.4 OC(COc1ccccc1)CNC(C)C 10.1021/jm00119a011
CHEMBL7154 9602 85 None 2 6 Guinea pig 8.8 pKd = 8.8 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 209 6 2 3 1.4 OC(COc1ccccc1)CNC(C)C 10.1021/jm00119a011
2369 7409 80 None -12 8 Guinea pig 8.8 pKd = 8.8 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00361a004
356 7409 80 None -12 8 Guinea pig 8.8 pKd = 8.8 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00361a004
549 7409 80 None -12 8 Guinea pig 8.8 pKd = 8.8 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00361a004
CHEMBL423 7409 80 None -12 8 Guinea pig 8.8 pKd = 8.8 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00361a004
DB00195 7409 80 None -12 8 Guinea pig 8.8 pKd = 8.8 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00361a004
2303 9961 68 None -15 26 Guinea pig 8.8 pKd = 8.8 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00361a004
4946 9961 68 None -15 26 Guinea pig 8.8 pKd = 8.8 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00361a004
564 9961 68 None -15 26 Guinea pig 8.8 pKd = 8.8 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00361a004
63 9961 68 None -15 26 Guinea pig 8.8 pKd = 8.8 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00361a004
91536 9961 68 None -15 26 Guinea pig 8.8 pKd = 8.8 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00361a004
CHEMBL27 9961 68 None -15 26 Guinea pig 8.8 pKd = 8.8 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00361a004
CHEMBL452861 9961 68 None -15 26 Guinea pig 8.8 pKd = 8.8 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00361a004
DB00571 9961 68 None -15 26 Guinea pig 8.8 pKd = 8.8 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00361a004
2369 7409 80 None -12 8 Guinea pig 8.8 pKd = 8.8 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00156a028
356 7409 80 None -12 8 Guinea pig 8.8 pKd = 8.8 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00156a028
549 7409 80 None -12 8 Guinea pig 8.8 pKd = 8.8 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00156a028
CHEMBL423 7409 80 None -12 8 Guinea pig 8.8 pKd = 8.8 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00156a028
DB00195 7409 80 None -12 8 Guinea pig 8.8 pKd = 8.8 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00156a028
2303 9961 68 None -15 26 Guinea pig 8.8 pKd = 8.8 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00156a028
4946 9961 68 None -15 26 Guinea pig 8.8 pKd = 8.8 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00156a028
564 9961 68 None -15 26 Guinea pig 8.8 pKd = 8.8 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00156a028
63 9961 68 None -15 26 Guinea pig 8.8 pKd = 8.8 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00156a028
91536 9961 68 None -15 26 Guinea pig 8.8 pKd = 8.8 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00156a028
CHEMBL27 9961 68 None -15 26 Guinea pig 8.8 pKd = 8.8 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00156a028
CHEMBL452861 9961 68 None -15 26 Guinea pig 8.8 pKd = 8.8 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00156a028
DB00571 9961 68 None -15 26 Guinea pig 8.8 pKd = 8.8 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00156a028
18047 210397 21 None 2 5 Guinea pig 8.8 pKd = 8.8 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 223 6 2 3 1.7 Cc1cccc(OCC(O)CNC(C)C)c1 10.1021/jm00119a011
CHEMBL67096 210397 21 None 2 5 Guinea pig 8.8 pKd = 8.8 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 223 6 2 3 1.7 Cc1cccc(OCC(O)CNC(C)C)c1 10.1021/jm00119a011
13267804 210783 0 None -1 2 Guinea pig 8.8 pKd = 8.8 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 271 4 2 3 2.7 O[C@H](COc1cccc2ccccc12)[C@H]1CCCCN1 10.1021/jm00119a011
CHEMBL69635 210783 0 None -1 2 Guinea pig 8.8 pKd = 8.8 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 271 4 2 3 2.7 O[C@H](COc1cccc2ccccc12)[C@H]1CCCCN1 10.1021/jm00119a011
123686 8762 51 None -1 9 Human 8.8 pKd = 8.8 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 354 9 4 5 1.7 C1=CC=C(C=C1)NC(=O)NCCNCC(COC2=CC=CC=C2C#N)O 10.1021/jm400348g
12581 8762 51 None -1 9 Human 8.8 pKd = 8.8 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 354 9 4 5 1.7 C1=CC=C(C=C1)NC(=O)NCCNCC(COC2=CC=CC=C2C#N)O 10.1021/jm400348g
CHEMBL11268 8762 51 None -1 9 Human 8.8 pKd = 8.8 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 354 9 4 5 1.7 C1=CC=C(C=C1)NC(=O)NCCNCC(COC2=CC=CC=C2C#N)O 10.1021/jm400348g
13157364 84742 0 None 30 2 Guinea pig 8.7 pKd = 8.7 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 341 7 3 4 2.6 O[C@@H](CNC1CC1)COc1ccc(-c2nc(C(F)(F)F)c[nH]2)cc1 10.1021/jm00361a004
CHEMBL2096752 84742 0 None 30 2 Guinea pig 8.7 pKd = 8.7 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 341 7 3 4 2.6 O[C@@H](CNC1CC1)COc1ccc(-c2nc(C(F)(F)F)c[nH]2)cc1 10.1021/jm00361a004
13621676 15989 0 None 1122 2 Guinea pig 8.7 pKd = 8.7 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 475 11 3 6 3.4 COc1ccc(CCNCC(O)COc2ccc(-c3nc(Br)c[nH]3)cc2)cc1OC 10.1021/jm00156a028
CHEMBL11051 15989 0 None 1122 2 Guinea pig 8.7 pKd = 8.7 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 475 11 3 6 3.4 COc1ccc(CCNCC(O)COc2ccc(-c3nc(Br)c[nH]3)cc2)cc1OC 10.1021/jm00156a028
2303 9961 68 None -15 26 Guinea pig 8.7 pKd = 8.7 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00354a003
4946 9961 68 None -15 26 Guinea pig 8.7 pKd = 8.7 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00354a003
564 9961 68 None -15 26 Guinea pig 8.7 pKd = 8.7 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00354a003
63 9961 68 None -15 26 Guinea pig 8.7 pKd = 8.7 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00354a003
91536 9961 68 None -15 26 Guinea pig 8.7 pKd = 8.7 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00354a003
CHEMBL27 9961 68 None -15 26 Guinea pig 8.7 pKd = 8.7 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00354a003
CHEMBL452861 9961 68 None -15 26 Guinea pig 8.7 pKd = 8.7 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00354a003
DB00571 9961 68 None -15 26 Guinea pig 8.7 pKd = 8.7 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00354a003
2303 9961 68 None -15 26 Guinea pig 8.7 pKd = 8.7 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00208a015
4946 9961 68 None -15 26 Guinea pig 8.7 pKd = 8.7 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00208a015
564 9961 68 None -15 26 Guinea pig 8.7 pKd = 8.7 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00208a015
63 9961 68 None -15 26 Guinea pig 8.7 pKd = 8.7 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00208a015
91536 9961 68 None -15 26 Guinea pig 8.7 pKd = 8.7 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00208a015
CHEMBL27 9961 68 None -15 26 Guinea pig 8.7 pKd = 8.7 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00208a015
CHEMBL452861 9961 68 None -15 26 Guinea pig 8.7 pKd = 8.7 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00208a015
DB00571 9961 68 None -15 26 Guinea pig 8.7 pKd = 8.7 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00208a015
105110 106906 5 None -1 2 Guinea pig 8.7 pKd = 8.7 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 273 7 2 3 2.8 CC(C)CNCC(O)COc1cccc2ccccc12 10.1021/jm00354a002
CHEMBL287651 106906 5 None -1 2 Guinea pig 8.7 pKd = 8.7 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 273 7 2 3 2.8 CC(C)CNCC(O)COc1cccc2ccccc12 10.1021/jm00354a002
13040919 112844 0 None -19 2 Guinea pig 8.0 pKd = 8 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 339 9 2 7 1.1 CCOC(=O)C(C)(C)NCC(O)COc1ccccc1C(=O)OC 10.1021/jm00354a003
CHEMBL31335 112844 0 None -19 2 Guinea pig 8.0 pKd = 8 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 339 9 2 7 1.1 CCOC(=O)C(C)(C)NCC(O)COc1ccccc1C(=O)OC 10.1021/jm00354a003
12462222 119418 0 None 39 2 Guinea pig 8.0 pKd = 8 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 223 5 2 3 2.0 COc1cc(C)ccc1C(O)CNC(C)C 10.1021/jm00208a015
CHEMBL3246232 119418 0 None 39 2 Guinea pig 8.0 pKd = 8 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 223 5 2 3 2.0 COc1cc(C)ccc1C(O)CNC(C)C 10.1021/jm00208a015
CHEMBL3302868 119418 0 None 39 2 Guinea pig 8.0 pKd = 8 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 223 5 2 3 2.0 COc1cc(C)ccc1C(O)CNC(C)C 10.1021/jm00208a015
235055 114200 8 None 3 2 Guinea pig 8.0 pKd = 8 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 223 7 2 3 1.7 CC(C)CNCC(O)COc1ccccc1 10.1021/jm00354a002
CHEMBL31811 114200 8 None 3 2 Guinea pig 8.0 pKd = 8 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 223 7 2 3 1.7 CC(C)CNCC(O)COc1ccccc1 10.1021/jm00354a002
13621706 15830 0 None 154 2 Guinea pig 8.0 pKd = 8 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 317 8 3 4 2.9 CC(C)NCC(O)COc1ccc(-c2nc(C(C)C)c[nH]2)cc1 10.1021/jm00156a028
CHEMBL10988 15830 0 None 154 2 Guinea pig 8.0 pKd = 8 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 317 8 3 4 2.9 CC(C)NCC(O)COc1ccc(-c2nc(C(C)C)c[nH]2)cc1 10.1021/jm00156a028
5464103 98311 20 None 1 2 Guinea pig 8.0 pKd = 8.0 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 228 6 2 4 1.5 C/C(=N/OCC(O)CNC(C)(C)C)C1CC1 10.1021/jm00376a011
CHEMBL24045 98311 20 None 1 2 Guinea pig 8.0 pKd = 8.0 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 228 6 2 4 1.5 C/C(=N/OCC(O)CNC(C)(C)C)C1CC1 10.1021/jm00376a011
6917762 16096 9 None -1 2 Guinea pig 8.0 pKd = 8.0 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atria
ChEMBL 228 6 2 4 1.5 C/C(=N\OCC(O)CNC(C)(C)C)C1CC1 10.1021/jm00145a008
CHEMBL111103 16096 9 None -1 2 Guinea pig 8.0 pKd = 8.0 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atria
ChEMBL 228 6 2 4 1.5 C/C(=N\OCC(O)CNC(C)(C)C)C1CC1 10.1021/jm00145a008
6917762 16096 9 None -1 2 Guinea pig 8.0 pKd = 8.0 Binding
The compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig left atriaThe compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig left atria
ChEMBL 228 6 2 4 1.5 C/C(=N\OCC(O)CNC(C)(C)C)C1CC1 10.1021/jm00115a008
CHEMBL111103 16096 9 None -1 2 Guinea pig 8.0 pKd = 8.0 Binding
The compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig left atriaThe compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig left atria
ChEMBL 228 6 2 4 1.5 C/C(=N\OCC(O)CNC(C)(C)C)C1CC1 10.1021/jm00115a008
6917762 16096 9 None -1 2 Guinea pig 8.0 pKd = 8.0 Binding
The compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atriaThe compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atria
ChEMBL 228 6 2 4 1.5 C/C(=N\OCC(O)CNC(C)(C)C)C1CC1 10.1021/jm00115a008
CHEMBL111103 16096 9 None -1 2 Guinea pig 8.0 pKd = 8.0 Binding
The compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atriaThe compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atria
ChEMBL 228 6 2 4 1.5 C/C(=N\OCC(O)CNC(C)(C)C)C1CC1 10.1021/jm00115a008
13157371 66815 0 None 3235 2 Guinea pig 8.0 pKd = 8.0 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 397 11 3 6 2.7 COc1ccc(CCNCC(O)COc2ccc(-c3ncc[nH]3)cc2)cc1OC 10.1021/jm00361a004
CHEMBL173629 66815 0 None 3235 2 Guinea pig 8.0 pKd = 8.0 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 397 11 3 6 2.7 COc1ccc(CCNCC(O)COc2ccc(-c3ncc[nH]3)cc2)cc1OC 10.1021/jm00361a004
13621757 210219 0 None - 1 Guinea pig 8.0 pKd = 8.0 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 453 13 3 7 2.8 COc1ccc(CCNC[C@H](O)COc2ccc(Cc3nc(C(C)=O)c[nH]3)cc2)cc1OC 10.1021/jm00156a028
CHEMBL65774 210219 0 None - 1 Guinea pig 8.0 pKd = 8.0 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 453 13 3 7 2.8 COc1ccc(CCNC[C@H](O)COc2ccc(Cc3nc(C(C)=O)c[nH]3)cc2)cc1OC 10.1021/jm00156a028
13621651 15911 0 None - 1 Guinea pig 8.0 pKd = 8.0 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 441 13 3 7 2.8 COCc1c[nH]c(-c2ccc(OCC(O)CNCCc3ccc(OC)c(OC)c3)cc2)n1 10.1021/jm00156a028
CHEMBL10998 15911 0 None - 1 Guinea pig 8.0 pKd = 8.0 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 441 13 3 7 2.8 COCc1c[nH]c(-c2ccc(OCC(O)CNCCc3ccc(OC)c(OC)c3)cc2)n1 10.1021/jm00156a028
1054 8367 54 None 1 3 Guinea pig 7.0 pKd = 7 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00354a003
59768 8367 54 None 1 3 Guinea pig 7.0 pKd = 7 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00354a003
7178 8367 54 None 1 3 Guinea pig 7.0 pKd = 7 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00354a003
CHEMBL768 8367 54 None 1 3 Guinea pig 7.0 pKd = 7 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00354a003
DB00187 8367 54 None 1 3 Guinea pig 7.0 pKd = 7 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00354a003
1054 8367 54 None 1 3 Guinea pig 7.0 pKd = 7 Binding
Activity at beta-1 adrenergic receptorActivity at beta-1 adrenergic receptor
ChEMBL 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00103a004
59768 8367 54 None 1 3 Guinea pig 7.0 pKd = 7 Binding
Activity at beta-1 adrenergic receptorActivity at beta-1 adrenergic receptor
ChEMBL 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00103a004
7178 8367 54 None 1 3 Guinea pig 7.0 pKd = 7 Binding
Activity at beta-1 adrenergic receptorActivity at beta-1 adrenergic receptor
ChEMBL 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00103a004
CHEMBL768 8367 54 None 1 3 Guinea pig 7.0 pKd = 7 Binding
Activity at beta-1 adrenergic receptorActivity at beta-1 adrenergic receptor
ChEMBL 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00103a004
DB00187 8367 54 None 1 3 Guinea pig 7.0 pKd = 7 Binding
Activity at beta-1 adrenergic receptorActivity at beta-1 adrenergic receptor
ChEMBL 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00103a004
44307782 210339 3 None 2 2 Guinea pig 7.0 pKd = 7 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 223 6 1 3 1.8 CC(C)N(C)CC(O)COc1ccccc1 10.1021/jm00119a011
CHEMBL66662 210339 3 None 2 2 Guinea pig 7.0 pKd = 7 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 223 6 1 3 1.8 CC(C)N(C)CC(O)COc1ccccc1 10.1021/jm00119a011
44279341 106875 0 None - 1 Guinea pig 7.0 pKd = 7 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 403 13 2 7 2.2 COc1ccc(CCOC(=O)CCNCC(O)COc2ccccc2)cc1OC 10.1021/jm00354a002
CHEMBL287452 106875 0 None - 1 Guinea pig 7.0 pKd = 7 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 403 13 2 7 2.2 COc1ccc(CCOC(=O)CCNCC(O)COc2ccccc2)cc1OC 10.1021/jm00354a002
3486 9931 56 None -6 11 Guinea pig 6.0 pKd = 6 Binding
Activity at beta-1 adrenergic receptorActivity at beta-1 adrenergic receptor
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00103a004
4883 9931 56 None -6 11 Guinea pig 6.0 pKd = 6 Binding
Activity at beta-1 adrenergic receptorActivity at beta-1 adrenergic receptor
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00103a004
555 9931 56 None -6 11 Guinea pig 6.0 pKd = 6 Binding
Activity at beta-1 adrenergic receptorActivity at beta-1 adrenergic receptor
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00103a004
CHEMBL6995 9931 56 None -6 11 Guinea pig 6.0 pKd = 6 Binding
Activity at beta-1 adrenergic receptorActivity at beta-1 adrenergic receptor
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00103a004
DB01297 9931 56 None -6 11 Guinea pig 6.0 pKd = 6 Binding
Activity at beta-1 adrenergic receptorActivity at beta-1 adrenergic receptor
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00103a004
12484287 116493 0 None -2 2 Guinea pig 6.0 pKd = 6 Binding
Competitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial beat rateCompetitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial beat rate
ChEMBL 249 6 3 4 1.3 CC(C)NCC(O)COc1ccc2[nH]cnc2c1 10.1021/jm00188a019
CHEMBL3228930 116493 0 None -2 2 Guinea pig 6.0 pKd = 6 Binding
Competitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial beat rateCompetitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial beat rate
ChEMBL 249 6 3 4 1.3 CC(C)NCC(O)COc1ccc2[nH]cnc2c1 10.1021/jm00188a019
214809 117245 5 None 1 2 Rat 5.0 pKd = 5 Binding
Antagonist activity at beta1 adrenergic receptor in isolated rat atriaAntagonist activity at beta1 adrenergic receptor in isolated rat atria
ChEMBL 252 7 3 4 0.5 CC(C)NCC(O)COc1ccc(C(N)=O)cc1 10.1021/jm00207a025
CHEMBL3247302 117245 5 None 1 2 Rat 5.0 pKd = 5 Binding
Antagonist activity at beta1 adrenergic receptor in isolated rat atriaAntagonist activity at beta1 adrenergic receptor in isolated rat atria
ChEMBL 252 7 3 4 0.5 CC(C)NCC(O)COc1ccc(C(N)=O)cc1 10.1021/jm00207a025
44383643 172413 1 None -15 2 Guinea pig 4.0 pKd = 4 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atria
ChEMBL 238 7 1 3 3.0 CC(C)(C)NCCCON=C(C1CC1)C1CC1 10.1021/jm00145a008
CHEMBL424369 172413 1 None -15 2 Guinea pig 4.0 pKd = 4 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atria
ChEMBL 238 7 1 3 3.0 CC(C)(C)NCCCON=C(C1CC1)C1CC1 10.1021/jm00145a008
56597178 95034 0 None 10 2 Human 7.0 pKd = 7.0 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 473 14 5 7 2.9 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccccc1O 10.1021/jm400348g
CHEMBL2348209 95034 0 None 10 2 Human 7.0 pKd = 7.0 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 473 14 5 7 2.9 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccccc1O 10.1021/jm400348g
13974078 16196 0 None - 1 Guinea pig 6.0 pKd = 6.0 Binding
The compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atriaThe compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atria
ChEMBL 388 7 4 6 2.5 CC(C)(C)NCC(O)COCC1CN=C(Nc2c(Cl)cccc2Cl)N1 10.1021/jm00115a008
CHEMBL111697 16196 0 None - 1 Guinea pig 6.0 pKd = 6.0 Binding
The compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atriaThe compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atria
ChEMBL 388 7 4 6 2.5 CC(C)(C)NCC(O)COCC1CN=C(Nc2c(Cl)cccc2Cl)N1 10.1021/jm00115a008
3486 9931 56 None -6 11 Guinea pig 7.0 pKd = 7.0 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00361a004
4883 9931 56 None -6 11 Guinea pig 7.0 pKd = 7.0 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00361a004
555 9931 56 None -6 11 Guinea pig 7.0 pKd = 7.0 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00361a004
CHEMBL6995 9931 56 None -6 11 Guinea pig 7.0 pKd = 7.0 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00361a004
DB01297 9931 56 None -6 11 Guinea pig 7.0 pKd = 7.0 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00361a004
551640 210295 21 None 1 2 Guinea pig 6.0 pKd = 6.0 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 223 7 2 3 1.6 CC(C)NCC(O)COCc1ccccc1 10.1021/jm00119a011
CHEMBL66331 210295 21 None 1 2 Guinea pig 6.0 pKd = 6.0 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 223 7 2 3 1.6 CC(C)NCC(O)COCc1ccccc1 10.1021/jm00119a011
137 7158 52 None -19 12 Human 8.0 pKd = 8.0 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1021/jm2008562
2119 7158 52 None -19 12 Human 8.0 pKd = 8.0 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1021/jm2008562
563 7158 52 None -19 12 Human 8.0 pKd = 8.0 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1021/jm2008562
66368 7158 52 None -19 12 Human 8.0 pKd = 8.0 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1021/jm2008562
CHEMBL266195 7158 52 None -19 12 Human 8.0 pKd = 8.0 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1021/jm2008562
DB00866 7158 52 None -19 12 Human 8.0 pKd = 8.0 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1021/jm2008562
71662249 95027 0 None 109 2 Human 8.0 pKd = 8.0 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 491 14 4 6 3.8 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccc(Cl)cc1 10.1021/jm400348g
CHEMBL2348202 95027 0 None 109 2 Human 8.0 pKd = 8.0 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 491 14 4 6 3.8 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccc(Cl)cc1 10.1021/jm400348g
13621642 12977 1 None 2754 2 Guinea pig 7.9 pKd = 7.9 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 453 12 3 7 3.2 COc1ccc(CCNCC(O)COc2ccc(-c3nc(C(C)=O)c(C)[nH]3)cc2)cc1OC 10.1021/jm00156a028
CHEMBL10813 12977 1 None 2754 2 Guinea pig 7.9 pKd = 7.9 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 453 12 3 7 3.2 COc1ccc(CCNCC(O)COc2ccc(-c3nc(C(C)=O)c(C)[nH]3)cc2)cc1OC 10.1021/jm00156a028
13590033 16609 0 None 19 2 Guinea pig 6.0 pKd = 6.0 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 398 11 2 7 2.9 COc1ccc(CCNCC(O)COc2ccc(-c3ncco3)cc2)cc1OC 10.1021/jm00156a028
CHEMBL11401 16609 0 None 19 2 Guinea pig 6.0 pKd = 6.0 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 398 11 2 7 2.9 COc1ccc(CCNCC(O)COc2ccc(-c3ncco3)cc2)cc1OC 10.1021/jm00156a028
71662410 95031 0 None 12 2 Human 6.9 pKd = 6.9 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 525 14 4 6 4.2 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccccc1C(F)(F)F 10.1021/jm400348g
CHEMBL2348206 95031 0 None 12 2 Human 6.9 pKd = 6.9 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 525 14 4 6 4.2 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccccc1C(F)(F)F 10.1021/jm400348g
13621767 16101 0 None - 1 Guinea pig 5.9 pKd = 5.9 Binding
In vitro inhibitory activity against beta-2 adrenergic receptor was measured by the inhibition of isoproterenol-induced relaxation of PGF2-alpha contracted guinea pig tracheaIn vitro inhibitory activity against beta-2 adrenergic receptor was measured by the inhibition of isoproterenol-induced relaxation of PGF2-alpha contracted guinea pig trachea
ChEMBL 503 13 3 6 3.5 COc1ccc(CCNCC(O)COc2ccc(CCc3nc(Br)c[nH]3)cc2)cc1OC 10.1021/jm00156a028
CHEMBL11112 16101 0 None - 1 Guinea pig 5.9 pKd = 5.9 Binding
In vitro inhibitory activity against beta-2 adrenergic receptor was measured by the inhibition of isoproterenol-induced relaxation of PGF2-alpha contracted guinea pig tracheaIn vitro inhibitory activity against beta-2 adrenergic receptor was measured by the inhibition of isoproterenol-induced relaxation of PGF2-alpha contracted guinea pig trachea
ChEMBL 503 13 3 6 3.5 COc1ccc(CCNCC(O)COc2ccc(CCc3nc(Br)c[nH]3)cc2)cc1OC 10.1021/jm00156a028
71662409 95029 0 None 85 2 Human 7.9 pKd = 7.9 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 535 14 4 6 3.9 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1cccc(Br)c1 10.1021/jm400348g
CHEMBL2348204 95029 0 None 85 2 Human 7.9 pKd = 7.9 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 535 14 4 6 3.9 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1cccc(Br)c1 10.1021/jm400348g
70695511 84635 1 None 1 2 Guinea pig 7.9 pKd = 7.9 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atria
ChEMBL 254 7 2 4 1.9 CC(C)(C)NC[C@H](O)CON=C(C1CC1)C1CC1 10.1021/jm00145a008
CHEMBL2093060 84635 1 None 1 2 Guinea pig 7.9 pKd = 7.9 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atria
ChEMBL 254 7 2 4 1.9 CC(C)(C)NC[C@H](O)CON=C(C1CC1)C1CC1 10.1021/jm00145a008
56598967 95036 0 None 275 2 Human 7.9 pKd = 7.9 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 457 14 4 6 3.2 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccccc1 10.1021/jm400348g
CHEMBL2348211 95036 0 None 275 2 Human 7.9 pKd = 7.9 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 457 14 4 6 3.2 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccccc1 10.1021/jm400348g
13040886 106511 0 None -1 2 Guinea pig 7.9 pKd = 7.9 Binding
The compound was tested in vitro for its ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationThe compound was tested in vitro for its ability to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 279 8 2 5 1.7 C=COC(=O)c1ccccc1OCC(O)CNC(C)C 10.1021/jm00354a003
CHEMBL284909 106511 0 None -1 2 Guinea pig 7.9 pKd = 7.9 Binding
The compound was tested in vitro for its ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationThe compound was tested in vitro for its ability to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 279 8 2 5 1.7 C=COC(=O)c1ccccc1OCC(O)CNC(C)C 10.1021/jm00354a003
66653395 95035 0 None 109 2 Human 7.9 pKd = 7.9 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 473 14 5 7 2.9 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1cccc(O)c1 10.1021/jm400348g
CHEMBL2348210 95035 0 None 109 2 Human 7.9 pKd = 7.9 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 473 14 5 7 2.9 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1cccc(O)c1 10.1021/jm400348g
13621715 11906 1 None 436 2 Guinea pig 7.9 pKd = 7.9 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 387 11 3 6 3.2 CCOCCNCC(O)COc1ccc(-c2nc(-c3cccs3)c[nH]2)cc1 10.1021/jm00156a028
CHEMBL10574 11906 1 None 436 2 Guinea pig 7.9 pKd = 7.9 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 387 11 3 6 3.2 CCOCCNCC(O)COc1ccc(-c2nc(-c3cccs3)c[nH]2)cc1 10.1021/jm00156a028
13621721 168906 1 None 2630 2 Guinea pig 7.9 pKd = 7.9 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 420 10 3 6 3.8 OC(CNCCc1ccncc1)COc1ccc(-c2nc(-c3cccs3)c[nH]2)cc1 10.1021/jm00156a028
CHEMBL416151 168906 1 None 2630 2 Guinea pig 7.9 pKd = 7.9 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 420 10 3 6 3.8 OC(CNCCc1ccncc1)COc1ccc(-c2nc(-c3cccs3)c[nH]2)cc1 10.1021/jm00156a028
9816183 107323 6 None -5 2 Human 6.9 pKd = 6.9 Binding
Compound was tested for its binding affinity to human Beta-1 adrenergic receptor by using the radioligand [3H]CGP-12177Compound was tested for its binding affinity to human Beta-1 adrenergic receptor by using the radioligand [3H]CGP-12177
ChEMBL 240 3 4 6 1.0 CNCC(O)c1ccc(O)c2nc(O)sc12 10.1016/s0960-894x(99)00205-x
CHEMBL29141 107323 6 None -5 2 Human 6.9 pKd = 6.9 Binding
Compound was tested for its binding affinity to human Beta-1 adrenergic receptor by using the radioligand [3H]CGP-12177Compound was tested for its binding affinity to human Beta-1 adrenergic receptor by using the radioligand [3H]CGP-12177
ChEMBL 240 3 4 6 1.0 CNCC(O)c1ccc(O)c2nc(O)sc12 10.1016/s0960-894x(99)00205-x
44459582 100333 0 None -13 2 Guinea pig 6.9 pKd = 6.9 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 312 8 2 5 2.5 CC(C)(C)NCC(O)CO/N=C(/CC(=O)C(C)(C)C)C1CC1 10.1021/jm00376a011
CHEMBL24644 100333 0 None -13 2 Guinea pig 6.9 pKd = 6.9 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 312 8 2 5 2.5 CC(C)(C)NCC(O)CO/N=C(/CC(=O)C(C)(C)C)C1CC1 10.1021/jm00376a011
192962 117219 13 None 2 2 Guinea pig 6.9 pKd = 6.9 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 193 4 2 2 2.0 Cc1ccc(C(O)CNC(C)C)cc1 10.1021/jm00208a015
CHEMBL3246231 117219 13 None 2 2 Guinea pig 6.9 pKd = 6.9 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 193 4 2 2 2.0 Cc1ccc(C(O)CNC(C)C)cc1 10.1021/jm00208a015
2725073 105921 57 None 10 2 Guinea pig 6.9 pKd = 6.9 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 167 4 2 3 0.4 NCC(O)COc1ccccc1 10.1021/jm00354a002
CHEMBL281109 105921 57 None 10 2 Guinea pig 6.9 pKd = 6.9 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 167 4 2 3 0.4 NCC(O)COc1ccccc1 10.1021/jm00354a002
15569840 170072 0 None - 1 Guinea pig 6.9 pKd = 6.9 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 329 8 2 5 2.3 COC(=O)c1ccc(CNCC(O)COc2ccccc2C)cc1 10.1021/jm00354a002
CHEMBL418770 170072 0 None - 1 Guinea pig 6.9 pKd = 6.9 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 329 8 2 5 2.3 COC(=O)c1ccc(CNCC(O)COc2ccccc2C)cc1 10.1021/jm00354a002
13040888 113645 0 None -1 2 Guinea pig 6.9 pKd = 6.9 Binding
The compound was tested in vitro for its ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationThe compound was tested in vitro for its ability to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 279 8 2 5 1.7 C=COC(=O)c1cccc(OCC(O)CNC(C)C)c1 10.1021/jm00354a003
CHEMBL31450 113645 0 None -1 2 Guinea pig 6.9 pKd = 6.9 Binding
The compound was tested in vitro for its ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationThe compound was tested in vitro for its ability to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 279 8 2 5 1.7 C=COC(=O)c1cccc(OCC(O)CNC(C)C)c1 10.1021/jm00354a003
13040905 113329 0 None 10 2 Guinea pig 5.9 pKd = 5.9 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 343 10 2 5 2.3 COC(=O)CCc1ccc(OCC(O)CNCc2ccccc2)cc1 10.1021/jm00354a003
CHEMBL31416 113329 0 None 10 2 Guinea pig 5.9 pKd = 5.9 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 343 10 2 5 2.3 COC(=O)CCc1ccc(OCC(O)CNCc2ccccc2)cc1 10.1021/jm00354a003
13040911 114011 0 None - 1 Guinea pig 5.9 pKd = 5.9 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 353 12 2 7 1.1 CCOC(=O)CCNCC(O)COc1ccc(CCC(=O)OC)cc1 10.1021/jm00354a003
CHEMBL31677 114011 0 None - 1 Guinea pig 5.9 pKd = 5.9 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 353 12 2 7 1.1 CCOC(=O)CCNCC(O)COc1ccc(CCC(=O)OC)cc1 10.1021/jm00354a003
15578602 106147 2 None -1 2 Guinea pig 5.9 pKd = 5.9 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 267 8 2 5 0.9 CCOC(=O)CNCC(O)COc1ccccc1C 10.1021/jm00354a002
CHEMBL282537 106147 2 None -1 2 Guinea pig 5.9 pKd = 5.9 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 267 8 2 5 0.9 CCOC(=O)CNCC(O)COc1ccccc1C 10.1021/jm00354a002
15578567 113749 0 None - 1 Guinea pig 5.9 pKd = 5.9 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 339 10 2 7 0.8 CCOC(=O)C(NCC(O)COc1ccccc1C)C(=O)OCC 10.1021/jm00354a002
CHEMBL31508 113749 0 None - 1 Guinea pig 5.9 pKd = 5.9 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 339 10 2 7 0.8 CCOC(=O)C(NCC(O)COc1ccccc1C)C(=O)OCC 10.1021/jm00354a002
15578620 113871 0 None - 1 Guinea pig 5.9 pKd = 5.9 Binding
The compound was tested in vitro for its ability to block Beta-1 adrenergic receptor n guinea pig tracheaThe compound was tested in vitro for its ability to block Beta-1 adrenergic receptor n guinea pig trachea
ChEMBL 343 9 2 5 2.7 CCOC(=O)c1ccc(CNCC(O)COc2ccccc2C)cc1 10.1021/jm00354a002
CHEMBL31591 113871 0 None - 1 Guinea pig 5.9 pKd = 5.9 Binding
The compound was tested in vitro for its ability to block Beta-1 adrenergic receptor n guinea pig tracheaThe compound was tested in vitro for its ability to block Beta-1 adrenergic receptor n guinea pig trachea
ChEMBL 343 9 2 5 2.7 CCOC(=O)c1ccc(CNCC(O)COc2ccccc2C)cc1 10.1021/jm00354a002
44459632 103228 0 None -2 2 Guinea pig 4.9 pKd = 4.9 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 230 7 3 4 1.1 CC(NOCC(O)CNC(C)(C)C)C1CC1 10.1021/jm00376a011
CHEMBL26224 103228 0 None -2 2 Guinea pig 4.9 pKd = 4.9 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 230 7 3 4 1.1 CC(NOCC(O)CNC(C)(C)C)C1CC1 10.1021/jm00376a011
13621656 16064 0 None 1348 2 Guinea pig 7.9 pKd = 7.9 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 455 14 3 7 3.2 CCOCc1c[nH]c(-c2ccc(OCC(O)CNCCc3ccc(OC)c(OC)c3)cc2)n1 10.1021/jm00156a028
CHEMBL11093 16064 0 None 1348 2 Guinea pig 7.9 pKd = 7.9 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 455 14 3 7 3.2 CCOCc1c[nH]c(-c2ccc(OCC(O)CNCCc3ccc(OC)c(OC)c3)cc2)n1 10.1021/jm00156a028
5487795 100051 2 None -79 2 Guinea pig 5.9 pKd = 5.9 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 284 5 2 4 3.0 CC1C/C(=N/OCC(O)CNC(C)(C)C)CC(C)(C)C1 10.1021/jm00376a011
CHEMBL24500 100051 2 None -79 2 Guinea pig 5.9 pKd = 5.9 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 284 5 2 4 3.0 CC1C/C(=N/OCC(O)CNC(C)(C)C)CC(C)(C)C1 10.1021/jm00376a011
12606686 99634 3 None -31 2 Guinea pig 4.9 pKd = 4.9 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 189 5 2 3 1.2 CC(C)OCC(O)CNC(C)(C)C 10.1021/jm00376a011
CHEMBL1161385 99634 3 None -31 2 Guinea pig 4.9 pKd = 4.9 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 189 5 2 3 1.2 CC(C)OCC(O)CNC(C)(C)C 10.1021/jm00376a011
CHEMBL24391 99634 3 None -31 2 Guinea pig 4.9 pKd = 4.9 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 189 5 2 3 1.2 CC(C)OCC(O)CNC(C)(C)C 10.1021/jm00376a011
5473526 165122 2 None -2 2 Human 4.9 pKd = 4.9 Binding
Displacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting methodDisplacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting method
ChEMBL 286 2 0 1 4.6 C[n+]1c(/C=C/c2ccccc2Cl)sc2ccccc21 10.1021/acsmedchemlett.6b00363
CHEMBL4089434 165122 2 None -2 2 Human 4.9 pKd = 4.9 Binding
Displacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting methodDisplacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting method
ChEMBL 286 2 0 1 4.6 C[n+]1c(/C=C/c2ccccc2Cl)sc2ccccc21 10.1021/acsmedchemlett.6b00363
2303 9961 68 None -15 26 Guinea pig 7.9 pKd = 7.9 Binding
Competitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial contractile forceCompetitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial contractile force
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00188a019
4946 9961 68 None -15 26 Guinea pig 7.9 pKd = 7.9 Binding
Competitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial contractile forceCompetitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial contractile force
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00188a019
564 9961 68 None -15 26 Guinea pig 7.9 pKd = 7.9 Binding
Competitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial contractile forceCompetitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial contractile force
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00188a019
63 9961 68 None -15 26 Guinea pig 7.9 pKd = 7.9 Binding
Competitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial contractile forceCompetitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial contractile force
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00188a019
91536 9961 68 None -15 26 Guinea pig 7.9 pKd = 7.9 Binding
Competitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial contractile forceCompetitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial contractile force
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00188a019
CHEMBL27 9961 68 None -15 26 Guinea pig 7.9 pKd = 7.9 Binding
Competitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial contractile forceCompetitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial contractile force
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00188a019
CHEMBL452861 9961 68 None -15 26 Guinea pig 7.9 pKd = 7.9 Binding
Competitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial contractile forceCompetitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial contractile force
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00188a019
DB00571 9961 68 None -15 26 Guinea pig 7.9 pKd = 7.9 Binding
Competitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial contractile forceCompetitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial contractile force
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00188a019
1786 9298 85 None -2 11 Guinea pig 7.8 pKd = 7.8 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00361a004
4171 9298 85 None -2 11 Guinea pig 7.8 pKd = 7.8 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00361a004
553 9298 85 None -2 11 Guinea pig 7.8 pKd = 7.8 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00361a004
CHEMBL13 9298 85 None -2 11 Guinea pig 7.8 pKd = 7.8 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00361a004
DB00264 9298 85 None -2 11 Guinea pig 7.8 pKd = 7.8 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00361a004
1786 9298 85 None -2 11 Guinea pig 7.8 pKd = 7.8 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00156a028
4171 9298 85 None -2 11 Guinea pig 7.8 pKd = 7.8 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00156a028
553 9298 85 None -2 11 Guinea pig 7.8 pKd = 7.8 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00156a028
CHEMBL13 9298 85 None -2 11 Guinea pig 7.8 pKd = 7.8 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00156a028
DB00264 9298 85 None -2 11 Guinea pig 7.8 pKd = 7.8 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00156a028
13621620 15760 0 None 1174 2 Guinea pig 7.8 pKd = 7.8 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 425 11 3 6 3.3 COc1ccc(CCNCC(O)COc2ccc(-c3nc(C)c(C)[nH]3)cc2)cc1OC 10.1021/jm00156a028
CHEMBL10983 15760 0 None 1174 2 Guinea pig 7.8 pKd = 7.8 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 425 11 3 6 3.3 COc1ccc(CCNCC(O)COc2ccc(-c3nc(C)c(C)[nH]3)cc2)cc1OC 10.1021/jm00156a028
15112598 16093 0 None 2 3 Guinea pig 5.8 pKd = 5.8 Binding
The compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig left atriaThe compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig left atria
ChEMBL 444 9 3 7 3.3 C/C(=N\OCC(O)CNC(C)(C)C)c1cc(Cl)c(OC(C)C2=NCCN2)c(Cl)c1 10.1021/jm00115a008
CHEMBL111090 16093 0 None 2 3 Guinea pig 5.8 pKd = 5.8 Binding
The compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig left atriaThe compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig left atria
ChEMBL 444 9 3 7 3.3 C/C(=N\OCC(O)CNC(C)(C)C)c1cc(Cl)c(OC(C)C2=NCCN2)c(Cl)c1 10.1021/jm00115a008
12462220 119391 2 None -1 2 Guinea pig 5.8 pKd = 5.8 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 287 5 2 3 2.5 COc1ccc(Br)cc1C(O)CNC(C)C 10.1021/jm00208a015
CHEMBL3246230 119391 2 None -1 2 Guinea pig 5.8 pKd = 5.8 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 287 5 2 3 2.5 COc1ccc(Br)cc1C(O)CNC(C)C 10.1021/jm00208a015
CHEMBL3302368 119391 2 None -1 2 Guinea pig 5.8 pKd = 5.8 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 287 5 2 3 2.5 COc1ccc(Br)cc1C(O)CNC(C)C 10.1021/jm00208a015
15112598 16093 0 None 2 3 Guinea pig 5.8 pKd = 5.8 Binding
The compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atriaThe compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atria
ChEMBL 444 9 3 7 3.3 C/C(=N\OCC(O)CNC(C)(C)C)c1cc(Cl)c(OC(C)C2=NCCN2)c(Cl)c1 10.1021/jm00115a008
CHEMBL111090 16093 0 None 2 3 Guinea pig 5.8 pKd = 5.8 Binding
The compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atriaThe compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atria
ChEMBL 444 9 3 7 3.3 C/C(=N\OCC(O)CNC(C)(C)C)c1cc(Cl)c(OC(C)C2=NCCN2)c(Cl)c1 10.1021/jm00115a008
71662248 95022 0 None 75 2 Human 7.8 pKd = 7.8 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 475 14 4 6 3.3 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccccc1F 10.1021/jm400348g
CHEMBL2348197 95022 0 None 75 2 Human 7.8 pKd = 7.8 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 475 14 4 6 3.3 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccccc1F 10.1021/jm400348g
1786 9298 85 None -1 11 Human 7.8 pKd = 7.8 Binding
Antagonist activity against beta-1 adrenergic receptor (unknown origin)Antagonist activity against beta-1 adrenergic receptor (unknown origin)
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/acs.jmedchem.5b00201
4171 9298 85 None -1 11 Human 7.8 pKd = 7.8 Binding
Antagonist activity against beta-1 adrenergic receptor (unknown origin)Antagonist activity against beta-1 adrenergic receptor (unknown origin)
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/acs.jmedchem.5b00201
553 9298 85 None -1 11 Human 7.8 pKd = 7.8 Binding
Antagonist activity against beta-1 adrenergic receptor (unknown origin)Antagonist activity against beta-1 adrenergic receptor (unknown origin)
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/acs.jmedchem.5b00201
CHEMBL13 9298 85 None -1 11 Human 7.8 pKd = 7.8 Binding
Antagonist activity against beta-1 adrenergic receptor (unknown origin)Antagonist activity against beta-1 adrenergic receptor (unknown origin)
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/acs.jmedchem.5b00201
DB00264 9298 85 None -1 11 Human 7.8 pKd = 7.8 Binding
Antagonist activity against beta-1 adrenergic receptor (unknown origin)Antagonist activity against beta-1 adrenergic receptor (unknown origin)
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/acs.jmedchem.5b00201
56599097 95021 0 None 87 2 Human 7.8 pKd = 7.8 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 487 15 4 7 3.2 COc1ccc(NC(=O)NCCNCC(O)COc2ccc(OCCOC3CCCC3)cc2)cc1 10.1021/jm400348g
CHEMBL2348196 95021 0 None 87 2 Human 7.8 pKd = 7.8 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 487 15 4 7 3.2 COc1ccc(NC(=O)NCCNCC(O)COc2ccc(OCCOC3CCCC3)cc2)cc1 10.1021/jm400348g
15578610 118931 0 None 2 2 Guinea pig 7.8 pKd = 7.8 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 309 11 2 5 2.1 CCOC(=O)CCCCNCC(O)COc1ccccc1C 10.1021/jm00354a002
CHEMBL32902 118931 0 None 2 2 Guinea pig 7.8 pKd = 7.8 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 309 11 2 5 2.1 CCOC(=O)CCCCNCC(O)COc1ccccc1C 10.1021/jm00354a002
13621720 105078 1 None 407 2 Guinea pig 7.8 pKd = 7.8 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 357 9 3 5 3.5 CCCNCC(O)COc1ccc(-c2nc(-c3cccs3)c[nH]2)cc1 10.1021/jm00156a028
CHEMBL274830 105078 1 None 407 2 Guinea pig 7.8 pKd = 7.8 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 357 9 3 5 3.5 CCCNCC(O)COc1ccc(-c2nc(-c3cccs3)c[nH]2)cc1 10.1021/jm00156a028
2892936 102695 6 None -15 2 Guinea pig 5.8 pKd = 5.8 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 271 5 2 3 3.0 CC1CC(OCC(O)CNC(C)(C)C)CC(C)(C)C1 10.1021/jm00376a011
CHEMBL25929 102695 6 None -15 2 Guinea pig 5.8 pKd = 5.8 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 271 5 2 3 3.0 CC1CC(OCC(O)CNC(C)(C)C)CC(C)(C)C1 10.1021/jm00376a011
12238214 32243 13 None 19 2 Guinea pig 6.8 pKd = 6.8 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 267 7 2 5 1.2 COC(=O)c1ccc(OCC(O)CNC(C)C)cc1 10.1021/jm00354a003
CHEMBL13504 32243 13 None 19 2 Guinea pig 6.8 pKd = 6.8 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 267 7 2 5 1.2 COC(=O)c1ccc(OCC(O)CNC(C)C)cc1 10.1021/jm00354a003
13040900 114135 8 None - 1 Guinea pig 6.8 pKd = 6.8 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 322 10 3 4 1.9 CC(C)NCC(O)COc1ccc(CCC(=O)NC(C)C)cc1 10.1021/jm00354a003
CHEMBL31768 114135 8 None - 1 Guinea pig 6.8 pKd = 6.8 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 322 10 3 4 1.9 CC(C)NCC(O)COc1ccc(CCC(=O)NC(C)C)cc1 10.1021/jm00354a003
2249 7300 111 None 2 12 Guinea pig 6.8 pKd = 6.8 Binding
Activity at beta-1 adrenergic receptorActivity at beta-1 adrenergic receptor
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm00103a004
255 7300 111 None 2 12 Guinea pig 6.8 pKd = 6.8 Binding
Activity at beta-1 adrenergic receptorActivity at beta-1 adrenergic receptor
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm00103a004
548 7300 111 None 2 12 Guinea pig 6.8 pKd = 6.8 Binding
Activity at beta-1 adrenergic receptorActivity at beta-1 adrenergic receptor
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm00103a004
CHEMBL24 7300 111 None 2 12 Guinea pig 6.8 pKd = 6.8 Binding
Activity at beta-1 adrenergic receptorActivity at beta-1 adrenergic receptor
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm00103a004
DB00335 7300 111 None 2 12 Guinea pig 6.8 pKd = 6.8 Binding
Activity at beta-1 adrenergic receptorActivity at beta-1 adrenergic receptor
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm00103a004
62773144 117217 3 None 1 2 Guinea pig 6.8 pKd = 6.8 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 257 4 2 2 2.5 CC(C)NCC(O)c1ccc(Br)cc1 10.1021/jm00208a015
CHEMBL3246227 117217 3 None 1 2 Guinea pig 6.8 pKd = 6.8 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 257 4 2 2 2.5 CC(C)NCC(O)c1ccc(Br)cc1 10.1021/jm00208a015
14201557 210347 0 None -1 2 Guinea pig 6.8 pKd = 6.8 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 235 4 1 3 1.9 CN1CCCC[C@@H]1[C@H](O)COc1ccccc1 10.1021/jm00119a011
CHEMBL66724 210347 0 None -1 2 Guinea pig 6.8 pKd = 6.8 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 235 4 1 3 1.9 CN1CCCC[C@@H]1[C@H](O)COc1ccccc1 10.1021/jm00119a011
15578598 107007 2 None 7 2 Guinea pig 5.8 pKd = 5.8 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 297 10 2 6 1.0 CCOC(=O)CCNCC(O)COc1ccc(OC)cc1 10.1021/jm00354a002
CHEMBL288546 107007 2 None 7 2 Guinea pig 5.8 pKd = 5.8 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 297 10 2 6 1.0 CCOC(=O)CCNCC(O)COc1ccc(OC)cc1 10.1021/jm00354a002
3025067 106158 64 None -812 15 Human 4.8 pKd = 4.8 Binding
Binding affinity to His-tagged human beta1 adrenergic receptor expressed in HEK293 cell membranes by surface plasmon resonance analysisBinding affinity to His-tagged human beta1 adrenergic receptor expressed in HEK293 cell membranes by surface plasmon resonance analysis
ChEMBL 220 1 1 4 0.9 c1cc2c(c(N3CCNCC3)c1)OCCO2 10.1021/jm400140q
65853 106158 64 None -812 15 Human 4.8 pKd = 4.8 Binding
Binding affinity to His-tagged human beta1 adrenergic receptor expressed in HEK293 cell membranes by surface plasmon resonance analysisBinding affinity to His-tagged human beta1 adrenergic receptor expressed in HEK293 cell membranes by surface plasmon resonance analysis
ChEMBL 220 1 1 4 0.9 c1cc2c(c(N3CCNCC3)c1)OCCO2 10.1021/jm400140q
CHEMBL282614 106158 64 None -812 15 Human 4.8 pKd = 4.8 Binding
Binding affinity to His-tagged human beta1 adrenergic receptor expressed in HEK293 cell membranes by surface plasmon resonance analysisBinding affinity to His-tagged human beta1 adrenergic receptor expressed in HEK293 cell membranes by surface plasmon resonance analysis
ChEMBL 220 1 1 4 0.9 c1cc2c(c(N3CCNCC3)c1)OCCO2 10.1021/jm400140q
13621774 105256 0 None 208 2 Guinea pig 7.8 pKd = 7.8 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 427 13 3 7 2.6 COc1ccc(CCNCC(O)COc2ccc(OCc3ncc[nH]3)cc2)cc1OC 10.1021/jm00156a028
CHEMBL275934 105256 0 None 208 2 Guinea pig 7.8 pKd = 7.8 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 427 13 3 7 2.6 COc1ccc(CCNCC(O)COc2ccc(OCc3ncc[nH]3)cc2)cc1OC 10.1021/jm00156a028
56599231 95030 0 None 81 2 Human 7.8 pKd = 7.8 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 535 14 4 6 3.9 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccc(Br)cc1 10.1021/jm400348g
CHEMBL2348205 95030 0 None 81 2 Human 7.8 pKd = 7.8 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 535 14 4 6 3.9 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccc(Br)cc1 10.1021/jm400348g
56599232 95032 0 None 81 2 Human 7.8 pKd = 7.8 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 525 14 4 6 4.2 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1cccc(C(F)(F)F)c1 10.1021/jm400348g
CHEMBL2348207 95032 0 None 81 2 Human 7.8 pKd = 7.8 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 525 14 4 6 4.2 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1cccc(C(F)(F)F)c1 10.1021/jm400348g
13621653 82722 1 None 2238 2 Guinea pig 7.8 pKd = 7.8 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 441 13 3 7 2.8 COCc1c[nH]c(-c2ccc(OC[C@@H](O)CNCCc3ccc(OC)c(OC)c3)cc2)n1 10.1021/jm00156a028
CHEMBL2052004 82722 1 None 2238 2 Guinea pig 7.8 pKd = 7.8 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 441 13 3 7 2.8 COCc1c[nH]c(-c2ccc(OC[C@@H](O)CNCCc3ccc(OC)c(OC)c3)cc2)n1 10.1021/jm00156a028
3025067 106158 64 None -812 15 Human 4.8 pKd = 4.8 Binding
Binding affinity to His-tagged human beta1 adrenergic receptor expressed in HEK293 cell membranes by surface plasmon resonance analysisBinding affinity to His-tagged human beta1 adrenergic receptor expressed in HEK293 cell membranes by surface plasmon resonance analysis
ChEMBL 220 1 1 4 0.9 c1cc2c(c(N3CCNCC3)c1)OCCO2 10.1021/jm400140q
65853 106158 64 None -812 15 Human 4.8 pKd = 4.8 Binding
Binding affinity to His-tagged human beta1 adrenergic receptor expressed in HEK293 cell membranes by surface plasmon resonance analysisBinding affinity to His-tagged human beta1 adrenergic receptor expressed in HEK293 cell membranes by surface plasmon resonance analysis
ChEMBL 220 1 1 4 0.9 c1cc2c(c(N3CCNCC3)c1)OCCO2 10.1021/jm400140q
CHEMBL282614 106158 64 None -812 15 Human 4.8 pKd = 4.8 Binding
Binding affinity to His-tagged human beta1 adrenergic receptor expressed in HEK293 cell membranes by surface plasmon resonance analysisBinding affinity to His-tagged human beta1 adrenergic receptor expressed in HEK293 cell membranes by surface plasmon resonance analysis
ChEMBL 220 1 1 4 0.9 c1cc2c(c(N3CCNCC3)c1)OCCO2 10.1021/jm400140q
54669764 72266 0 None -37 3 Human 7.8 pKd = 7.8 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 893 26 4 10 6.8 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCOCCOCCNC[C@H](O)COc1cccc2ccccc12 10.1021/jm2008562
CHEMBL1830491 72266 0 None -37 3 Human 7.8 pKd = 7.8 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 893 26 4 10 6.8 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCOCCOCCNC[C@H](O)COc1cccc2ccccc12 10.1021/jm2008562
56599099 95039 0 None 91 2 Human 7.8 pKd = 7.8 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 471 14 4 6 3.5 Cc1ccc(NC(=O)NCCNCC(O)COc2ccc(OCCOC3CCCC3)cc2)cc1 10.1021/jm400348g
CHEMBL2348214 95039 0 None 91 2 Human 7.8 pKd = 7.8 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 471 14 4 6 3.5 Cc1ccc(NC(=O)NCCNCC(O)COc2ccc(OCCOC3CCCC3)cc2)cc1 10.1021/jm400348g
71662247 95041 0 None 51 2 Human 7.8 pKd = 7.8 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 487 15 4 7 3.2 COc1cccc(NC(=O)NCCNCC(O)COc2ccc(OCCOC3CCCC3)cc2)c1 10.1021/jm400348g
CHEMBL2348216 95041 0 None 51 2 Human 7.8 pKd = 7.8 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 487 15 4 7 3.2 COc1cccc(NC(=O)NCCNCC(O)COc2ccc(OCCOC3CCCC3)cc2)c1 10.1021/jm400348g
13621700 209817 0 None 3630 2 Guinea pig 7.8 pKd = 7.8 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 439 12 3 7 2.9 COc1ccc(CCNC[C@H](O)COc2ccc(-c3nc(C(C)=O)c[nH]3)cc2)cc1OC 10.1021/jm00156a028
CHEMBL63421 209817 0 None 3630 2 Guinea pig 7.8 pKd = 7.8 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 439 12 3 7 2.9 COc1ccc(CCNC[C@H](O)COc2ccc(-c3nc(C(C)=O)c[nH]3)cc2)cc1OC 10.1021/jm00156a028
12398051 117311 0 None -43 2 Guinea pig 4.8 pKd = 4.8 Binding
Inhibition of beta1-adrenergic receptor in guinea pig auricle assessed as reversal of isoproterenol-induced effectInhibition of beta1-adrenergic receptor in guinea pig auricle assessed as reversal of isoproterenol-induced effect
ChEMBL 245 2 2 2 2.8 CC1(C)NC1C(O)c1ccc(Cl)c(Cl)c1 10.1021/jm00199a012
CHEMBL3251299 117311 0 None -43 2 Guinea pig 4.8 pKd = 4.8 Binding
Inhibition of beta1-adrenergic receptor in guinea pig auricle assessed as reversal of isoproterenol-induced effectInhibition of beta1-adrenergic receptor in guinea pig auricle assessed as reversal of isoproterenol-induced effect
ChEMBL 245 2 2 2 2.8 CC1(C)NC1C(O)c1ccc(Cl)c(Cl)c1 10.1021/jm00199a012
13621671 176208 1 None 234 2 Guinea pig 7.7 pKd = 7.7 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 496 13 3 8 2.5 COc1ccc(CCNCC(O)COc2ccc(-c3nc(CN4CCOCC4)c[nH]3)cc2)cc1OC 10.1021/jm00156a028
CHEMBL442522 176208 1 None 234 2 Guinea pig 7.7 pKd = 7.7 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 496 13 3 8 2.5 COc1ccc(CCNCC(O)COc2ccc(-c3nc(CN4CCOCC4)c[nH]3)cc2)cc1OC 10.1021/jm00156a028
44459891 102939 0 None -7 2 Guinea pig 6.7 pKd = 6.7 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 217 5 2 3 1.8 CC(C)(C)COCC(O)CNC(C)(C)C 10.1021/jm00376a011
CHEMBL26059 102939 0 None -7 2 Guinea pig 6.7 pKd = 6.7 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 217 5 2 3 1.8 CC(C)(C)COCC(O)CNC(C)(C)C 10.1021/jm00376a011
5311179 8755 21 None -85 3 Human 6.7 pKd = 6.7 Binding
Displacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting methodDisplacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting method
ChEMBL 277 6 2 3 2.6 Cc1c2CCCc2c(cc1)OC[C@H]([C@H](C)NC(C)C)O 10.1021/acsmedchemlett.6b00363
543 8755 21 None -85 3 Human 6.7 pKd = 6.7 Binding
Displacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting methodDisplacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting method
ChEMBL 277 6 2 3 2.6 Cc1c2CCCc2c(cc1)OC[C@H]([C@H](C)NC(C)C)O 10.1021/acsmedchemlett.6b00363
5484725 8755 21 None -85 3 Human 6.7 pKd = 6.7 Binding
Displacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting methodDisplacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting method
ChEMBL 277 6 2 3 2.6 Cc1c2CCCc2c(cc1)OC[C@H]([C@H](C)NC(C)C)O 10.1021/acsmedchemlett.6b00363
CHEMBL1233766 8755 21 None -85 3 Human 6.7 pKd = 6.7 Binding
Displacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting methodDisplacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting method
ChEMBL 277 6 2 3 2.6 Cc1c2CCCc2c(cc1)OC[C@H]([C@H](C)NC(C)C)O 10.1021/acsmedchemlett.6b00363
CHEMBL198059 8755 21 None -85 3 Human 6.7 pKd = 6.7 Binding
Displacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting methodDisplacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting method
ChEMBL 277 6 2 3 2.6 Cc1c2CCCc2c(cc1)OC[C@H]([C@H](C)NC(C)C)O 10.1021/acsmedchemlett.6b00363
90672832 117247 0 None 2 2 Rat 4.7 pKd = 4.7 Binding
Antagonist activity at beta1 adrenergic receptor in isolated rat atriaAntagonist activity at beta1 adrenergic receptor in isolated rat atria
ChEMBL 294 6 3 5 0.5 CC(C)NCC(O)COc1ccc2c(c1)OCCNC2=O 10.1021/jm00207a025
CHEMBL3247304 117247 0 None 2 2 Rat 4.7 pKd = 4.7 Binding
Antagonist activity at beta1 adrenergic receptor in isolated rat atriaAntagonist activity at beta1 adrenergic receptor in isolated rat atria
ChEMBL 294 6 3 5 0.5 CC(C)NCC(O)COc1ccc2c(c1)OCCNC2=O 10.1021/jm00207a025
54756928 72262 0 None -57 3 Human 6.7 pKd = 6.7 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 889 26 4 8 9.1 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCCCCCCCNC[C@H](O)COc1cccc2ccccc12 10.1021/jm2008562
CHEMBL1830487 72262 0 None -57 3 Human 6.7 pKd = 6.7 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 889 26 4 8 9.1 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCCCCCCCNC[C@H](O)COc1cccc2ccccc12 10.1021/jm2008562
13157407 67061 0 None 245 2 Guinea pig 6.7 pKd = 6.7 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 419 10 3 5 4.4 OC(CNCCc1ccccc1)COc1ccc(-c2nc(-c3cccs3)c[nH]2)cc1 10.1021/jm00361a004
CHEMBL174259 67061 0 None 245 2 Guinea pig 6.7 pKd = 6.7 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 419 10 3 5 4.4 OC(CNCCc1ccccc1)COc1ccc(-c2nc(-c3cccs3)c[nH]2)cc1 10.1021/jm00361a004
13621761 16140 0 None 10 2 Guinea pig 7.7 pKd = 7.7 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 385 8 3 5 3.9 CC(C)(C)NCC(O)COc1ccc(Cc2nc(-c3cccs3)c[nH]2)cc1 10.1021/jm00156a028
CHEMBL11135 16140 0 None 10 2 Guinea pig 7.7 pKd = 7.7 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 385 8 3 5 3.9 CC(C)(C)NCC(O)COc1ccc(Cc2nc(-c3cccs3)c[nH]2)cc1 10.1021/jm00156a028
2769826 210598 28 None -1 2 Guinea pig 7.7 pKd = 7.7 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 259 6 2 3 2.6 CC(C)NCC(O)COc1ccc2ccccc2c1 10.1021/jm00119a011
CHEMBL68419 210598 28 None -1 2 Guinea pig 7.7 pKd = 7.7 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 259 6 2 3 2.6 CC(C)NCC(O)COc1ccc2ccccc2c1 10.1021/jm00119a011
56599102 95024 0 None 60 2 Human 7.7 pKd = 7.7 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 475 14 4 6 3.3 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccc(F)cc1 10.1021/jm400348g
CHEMBL2348199 95024 0 None 60 2 Human 7.7 pKd = 7.7 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 475 14 4 6 3.3 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccc(F)cc1 10.1021/jm400348g
56599233 95033 0 None 87 2 Human 7.7 pKd = 7.7 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 525 14 4 6 4.2 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccc(C(F)(F)F)cc1 10.1021/jm400348g
CHEMBL2348208 95033 0 None 87 2 Human 7.7 pKd = 7.7 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 525 14 4 6 4.2 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccc(C(F)(F)F)cc1 10.1021/jm400348g
13621712 82724 0 None 1288 2 Guinea pig 7.7 pKd = 7.7 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 453 11 3 6 4.0 COc1ccc(CCNC[C@H](O)COc2ccc(-c3nc(C(C)(C)C)c[nH]3)cc2)cc1OC 10.1021/jm00156a028
CHEMBL2052006 82724 0 None 1288 2 Guinea pig 7.7 pKd = 7.7 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 453 11 3 6 4.0 COc1ccc(CCNC[C@H](O)COc2ccc(-c3nc(C(C)(C)C)c[nH]3)cc2)cc1OC 10.1021/jm00156a028
54757027 72265 0 None -53 3 Human 6.7 pKd = 6.7 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 889 26 4 8 9.1 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCCCCCCCNCC(O)COc1cccc2ccccc12 10.1021/jm2008562
CHEMBL1830490 72265 0 None -53 3 Human 6.7 pKd = 6.7 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 889 26 4 8 9.1 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCCCCCCCNCC(O)COc1cccc2ccccc12 10.1021/jm2008562
157736 105742 8 None 31 2 Guinea pig 6.7 pKd = 6.7 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 309 10 2 5 1.9 CCOC(=O)CCc1ccc(OCC(O)CNC(C)C)cc1 10.1021/jm00354a003
CHEMBL279777 105742 8 None 31 2 Guinea pig 6.7 pKd = 6.7 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 309 10 2 5 1.9 CCOC(=O)CCc1ccc(OCC(O)CNC(C)C)cc1 10.1021/jm00354a003
90672835 117249 0 None -10 2 Rat 6.7 pKd = 6.7 Binding
Antagonist activity at beta1 adrenergic receptor in isolated rat atriaAntagonist activity at beta1 adrenergic receptor in isolated rat atria
ChEMBL 279 8 2 4 2.5 C/C=C\c1ccc(OCC(O)CNC(C)C)c(OC)c1 10.1021/jm00207a025
CHEMBL3247309 117249 0 None -10 2 Rat 6.7 pKd = 6.7 Binding
Antagonist activity at beta1 adrenergic receptor in isolated rat atriaAntagonist activity at beta1 adrenergic receptor in isolated rat atria
ChEMBL 279 8 2 4 2.5 C/C=C\c1ccc(OCC(O)CNC(C)C)c(OC)c1 10.1021/jm00207a025
15578594 113840 2 None 1 2 Guinea pig 6.7 pKd = 6.7 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 281 9 2 5 1.3 CCOC(=O)CCNCC(O)COc1cccc(C)c1 10.1021/jm00354a002
CHEMBL31568 113840 2 None 1 2 Guinea pig 6.7 pKd = 6.7 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 281 9 2 5 1.3 CCOC(=O)CCNCC(O)COc1cccc(C)c1 10.1021/jm00354a002
15569840 170072 0 None - 1 Guinea pig 6.7 pKd = 6.7 Binding
The compound was tested in vitro for its ability to block Beta-1 adrenergic receptor in guinea pig tracheaThe compound was tested in vitro for its ability to block Beta-1 adrenergic receptor in guinea pig trachea
ChEMBL 329 8 2 5 2.3 COC(=O)c1ccc(CNCC(O)COc2ccccc2C)cc1 10.1021/jm00354a002
CHEMBL418770 170072 0 None - 1 Guinea pig 6.7 pKd = 6.7 Binding
The compound was tested in vitro for its ability to block Beta-1 adrenergic receptor in guinea pig tracheaThe compound was tested in vitro for its ability to block Beta-1 adrenergic receptor in guinea pig trachea
ChEMBL 329 8 2 5 2.3 COC(=O)c1ccc(CNCC(O)COc2ccccc2C)cc1 10.1021/jm00354a002
15578618 109590 0 None - 1 Guinea pig 5.7 pKd = 5.7 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 321 9 2 5 1.5 O=C(CCNCC(O)COc1ccccc1)OCC(F)(F)F 10.1021/jm00354a002
CHEMBL30538 109590 0 None - 1 Guinea pig 5.7 pKd = 5.7 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 321 9 2 5 1.5 O=C(CCNCC(O)COc1ccccc1)OCC(F)(F)F 10.1021/jm00354a002
15578555 113125 3 None 1 2 Guinea pig 5.7 pKd = 5.7 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 253 8 2 5 0.6 CCOC(=O)CNCC(O)COc1ccccc1 10.1021/jm00354a002
CHEMBL31392 113125 3 None 1 2 Guinea pig 5.7 pKd = 5.7 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 253 8 2 5 0.6 CCOC(=O)CNCC(O)COc1ccccc1 10.1021/jm00354a002
15578616 111372 0 None - 1 Guinea pig 5.7 pKd = 5.7 Binding
The compound was tested in vitro for its ability to block Beta-1 adrenergic receptor in guinea pig right atriaThe compound was tested in vitro for its ability to block Beta-1 adrenergic receptor in guinea pig right atria
ChEMBL 333 9 2 5 2.2 O=C(CCNCC(O)COc1ccccc1)Oc1ccc(F)cc1 10.1021/jm00354a002
CHEMBL31047 111372 0 None - 1 Guinea pig 5.7 pKd = 5.7 Binding
The compound was tested in vitro for its ability to block Beta-1 adrenergic receptor in guinea pig right atriaThe compound was tested in vitro for its ability to block Beta-1 adrenergic receptor in guinea pig right atria
ChEMBL 333 9 2 5 2.2 O=C(CCNCC(O)COc1ccccc1)Oc1ccc(F)cc1 10.1021/jm00354a002
133620 211771 21 None - 1 Guinea pig 4.7 pKd = 4.7 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 281 9 3 4 1.4 CC(C)NCC(O)COc1ccc(CCC(=O)O)cc1 10.1021/jm00354a003
CHEMBL767 211771 21 None - 1 Guinea pig 4.7 pKd = 4.7 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 281 9 3 4 1.4 CC(C)NCC(O)COc1ccc(CCC(=O)O)cc1 10.1021/jm00354a003
13621680 168901 1 None 446 2 Guinea pig 8.7 pKd = 8.7 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 431 11 3 6 3.3 COc1ccc(CCNCC(O)COc2ccc(-c3nc(Cl)c[nH]3)cc2)cc1OC 10.1021/jm00156a028
CHEMBL416150 168901 1 None 446 2 Guinea pig 8.7 pKd = 8.7 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 431 11 3 6 3.3 COc1ccc(CCNCC(O)COc2ccc(-c3nc(Cl)c[nH]3)cc2)cc1OC 10.1021/jm00156a028
2303 9961 68 None -15 26 Guinea pig 8.6 pKd = 8.6 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00376a011
4946 9961 68 None -15 26 Guinea pig 8.6 pKd = 8.6 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00376a011
564 9961 68 None -15 26 Guinea pig 8.6 pKd = 8.6 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00376a011
63 9961 68 None -15 26 Guinea pig 8.6 pKd = 8.6 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00376a011
91536 9961 68 None -15 26 Guinea pig 8.6 pKd = 8.6 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00376a011
CHEMBL27 9961 68 None -15 26 Guinea pig 8.6 pKd = 8.6 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00376a011
CHEMBL452861 9961 68 None -15 26 Guinea pig 8.6 pKd = 8.6 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00376a011
DB00571 9961 68 None -15 26 Guinea pig 8.6 pKd = 8.6 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00376a011
2303 9961 68 None -15 26 Guinea pig 8.6 pKd = 8.6 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00145a008
4946 9961 68 None -15 26 Guinea pig 8.6 pKd = 8.6 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00145a008
564 9961 68 None -15 26 Guinea pig 8.6 pKd = 8.6 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00145a008
63 9961 68 None -15 26 Guinea pig 8.6 pKd = 8.6 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00145a008
91536 9961 68 None -15 26 Guinea pig 8.6 pKd = 8.6 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00145a008
CHEMBL27 9961 68 None -15 26 Guinea pig 8.6 pKd = 8.6 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00145a008
CHEMBL452861 9961 68 None -15 26 Guinea pig 8.6 pKd = 8.6 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00145a008
DB00571 9961 68 None -15 26 Guinea pig 8.6 pKd = 8.6 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atria
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00145a008
9904228 106064 0 None -1 2 Guinea pig 8.6 pKd = 8.6 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 295 9 2 5 1.5 COC(=O)CCc1ccccc1OCC(O)CNC(C)C 10.1021/jm00354a003
CHEMBL281967 106064 0 None -1 2 Guinea pig 8.6 pKd = 8.6 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 295 9 2 5 1.5 COC(=O)CCc1ccccc1OCC(O)CNC(C)C 10.1021/jm00354a003
2303 9961 68 None -15 26 Guinea pig 8.6 pKd = 8.6 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00119a011
4946 9961 68 None -15 26 Guinea pig 8.6 pKd = 8.6 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00119a011
564 9961 68 None -15 26 Guinea pig 8.6 pKd = 8.6 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00119a011
63 9961 68 None -15 26 Guinea pig 8.6 pKd = 8.6 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00119a011
91536 9961 68 None -15 26 Guinea pig 8.6 pKd = 8.6 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00119a011
CHEMBL27 9961 68 None -15 26 Guinea pig 8.6 pKd = 8.6 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00119a011
CHEMBL452861 9961 68 None -15 26 Guinea pig 8.6 pKd = 8.6 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00119a011
DB00571 9961 68 None -15 26 Guinea pig 8.6 pKd = 8.6 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00119a011
44279657 111153 1 None 2 2 Guinea pig 8.6 pKd = 8.6 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 237 7 2 3 2.0 Cc1ccccc1OCC(O)CNCC(C)C 10.1021/jm00354a002
CHEMBL31021 111153 1 None 2 2 Guinea pig 8.6 pKd = 8.6 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 237 7 2 3 2.0 Cc1ccccc1OCC(O)CNCC(C)C 10.1021/jm00354a002
2176 9901 68 None -4 27 Human 8.6 pKd = 8.6 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 10.1021/jm2008562
4828 9901 68 None -4 27 Human 8.6 pKd = 8.6 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 10.1021/jm2008562
91 9901 68 None -4 27 Human 8.6 pKd = 8.6 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 10.1021/jm2008562
CHEMBL500 9901 68 None -4 27 Human 8.6 pKd = 8.6 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 10.1021/jm2008562
DB00960 9901 68 None -4 27 Human 8.6 pKd = 8.6 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 10.1021/jm2008562
13621767 16101 0 None - 1 Guinea pig 8.5 pKd = 8.5 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 503 13 3 6 3.5 COc1ccc(CCNCC(O)COc2ccc(CCc3nc(Br)c[nH]3)cc2)cc1OC 10.1021/jm00156a028
CHEMBL11112 16101 0 None - 1 Guinea pig 8.5 pKd = 8.5 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 503 13 3 6 3.5 COc1ccc(CCNCC(O)COc2ccc(CCc3nc(Br)c[nH]3)cc2)cc1OC 10.1021/jm00156a028
13621749 16268 0 None - 1 Guinea pig 8.5 pKd = 8.5 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 493 13 3 7 4.3 COc1ccc(CCNCC(O)COc2ccc(Cc3nc(-c4cccs4)c[nH]3)cc2)cc1OC 10.1021/jm00156a028
CHEMBL11205 16268 0 None - 1 Guinea pig 8.5 pKd = 8.5 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 493 13 3 7 4.3 COc1ccc(CCNCC(O)COc2ccc(Cc3nc(-c4cccs4)c[nH]3)cc2)cc1OC 10.1021/jm00156a028
2369 7409 80 None -4 8 Rat 8.5 pKd = 8.5 Binding
Antagonist activity at rat beta1 adrenoceptorAntagonist activity at rat beta1 adrenoceptor
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/acs.jmedchem.6b00472
356 7409 80 None -4 8 Rat 8.5 pKd = 8.5 Binding
Antagonist activity at rat beta1 adrenoceptorAntagonist activity at rat beta1 adrenoceptor
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/acs.jmedchem.6b00472
549 7409 80 None -4 8 Rat 8.5 pKd = 8.5 Binding
Antagonist activity at rat beta1 adrenoceptorAntagonist activity at rat beta1 adrenoceptor
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/acs.jmedchem.6b00472
CHEMBL423 7409 80 None -4 8 Rat 8.5 pKd = 8.5 Binding
Antagonist activity at rat beta1 adrenoceptorAntagonist activity at rat beta1 adrenoceptor
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/acs.jmedchem.6b00472
DB00195 7409 80 None -4 8 Rat 8.5 pKd = 8.5 Binding
Antagonist activity at rat beta1 adrenoceptorAntagonist activity at rat beta1 adrenoceptor
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/acs.jmedchem.6b00472
13157374 84741 0 None 1412 2 Guinea pig 7.7 pKd = 7.7 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 397 11 3 6 2.7 COc1ccc(CCNC[C@H](O)COc2ccc(-c3ncc[nH]3)cc2)cc1OC 10.1021/jm00361a004
CHEMBL2096751 84741 0 None 1412 2 Guinea pig 7.7 pKd = 7.7 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 397 11 3 6 2.7 COc1ccc(CCNC[C@H](O)COc2ccc(-c3ncc[nH]3)cc2)cc1OC 10.1021/jm00361a004
13621752 104128 0 None 144 2 Guinea pig 7.7 pKd = 7.7 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 425 12 3 6 2.9 COc1ccc(CCNCC(O)COc2ccc(Cc3nc(C)c[nH]3)cc2)cc1OC 10.1021/jm00156a028
CHEMBL269467 104128 0 None 144 2 Guinea pig 7.7 pKd = 7.7 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 425 12 3 6 2.9 COc1ccc(CCNCC(O)COc2ccc(Cc3nc(C)c[nH]3)cc2)cc1OC 10.1021/jm00156a028
3486 9931 56 None -6 11 Guinea pig 6.7 pKd = 6.7 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00208a015
4883 9931 56 None -6 11 Guinea pig 6.7 pKd = 6.7 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00208a015
555 9931 56 None -6 11 Guinea pig 6.7 pKd = 6.7 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00208a015
CHEMBL6995 9931 56 None -6 11 Guinea pig 6.7 pKd = 6.7 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00208a015
DB01297 9931 56 None -6 11 Guinea pig 6.7 pKd = 6.7 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00208a015
54757232 72290 0 None -30 3 Human 7.7 pKd = 7.7 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 883 28 4 10 6.3 C=CCc1ccccc1OC[C@@H](O)CNCCOCCOCCNC(=O)CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1 10.1021/jm2008562
CHEMBL1830618 72290 0 None -30 3 Human 7.7 pKd = 7.7 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 883 28 4 10 6.3 C=CCc1ccccc1OC[C@@H](O)CNCCOCCOCCNC(=O)CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1 10.1021/jm2008562
13621710 16071 0 None 478 2 Guinea pig 7.7 pKd = 7.7 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 453 11 3 6 4.0 COc1ccc(CCNCC(O)COc2ccc(-c3nc(C(C)(C)C)c[nH]3)cc2)cc1OC 10.1021/jm00156a028
CHEMBL11097 16071 0 None 478 2 Guinea pig 7.7 pKd = 7.7 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 453 11 3 6 4.0 COc1ccc(CCNCC(O)COc2ccc(-c3nc(C(C)(C)C)c[nH]3)cc2)cc1OC 10.1021/jm00156a028
1786 9298 85 None -21 11 Rat 7.6 pKd = 7.6 Binding
Antagonist activity at rat beta1 adrenoceptorAntagonist activity at rat beta1 adrenoceptor
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/acs.jmedchem.6b00472
4171 9298 85 None -21 11 Rat 7.6 pKd = 7.6 Binding
Antagonist activity at rat beta1 adrenoceptorAntagonist activity at rat beta1 adrenoceptor
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/acs.jmedchem.6b00472
553 9298 85 None -21 11 Rat 7.6 pKd = 7.6 Binding
Antagonist activity at rat beta1 adrenoceptorAntagonist activity at rat beta1 adrenoceptor
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/acs.jmedchem.6b00472
CHEMBL13 9298 85 None -21 11 Rat 7.6 pKd = 7.6 Binding
Antagonist activity at rat beta1 adrenoceptorAntagonist activity at rat beta1 adrenoceptor
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/acs.jmedchem.6b00472
DB00264 9298 85 None -21 11 Rat 7.6 pKd = 7.6 Binding
Antagonist activity at rat beta1 adrenoceptorAntagonist activity at rat beta1 adrenoceptor
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1021/acs.jmedchem.6b00472
2030 10444 10 None -316 10 Human 6.7 pKd = 6.7 Binding
Binding affinity to human adrenergic beta-1 receptorBinding affinity to human adrenergic beta-1 receptor
ChEMBL 464 4 0 6 3.0 COc1cccc2c1C[C@H]1C[C@H](CN([C@@H]1C2)C)C(=O)N1CCN(CC1)c1ccc(cc1)[N+](=O)[O-] 10.1016/j.bmcl.2007.04.086
5311377 10444 10 None -316 10 Human 6.7 pKd = 6.7 Binding
Binding affinity to human adrenergic beta-1 receptorBinding affinity to human adrenergic beta-1 receptor
ChEMBL 464 4 0 6 3.0 COc1cccc2c1C[C@H]1C[C@H](CN([C@@H]1C2)C)C(=O)N1CCN(CC1)c1ccc(cc1)[N+](=O)[O-] 10.1016/j.bmcl.2007.04.086
CHEMBL251541 10444 10 None -316 10 Human 6.7 pKd = 6.7 Binding
Binding affinity to human adrenergic beta-1 receptorBinding affinity to human adrenergic beta-1 receptor
ChEMBL 464 4 0 6 3.0 COc1cccc2c1C[C@H]1C[C@H](CN([C@@H]1C2)C)C(=O)N1CCN(CC1)c1ccc(cc1)[N+](=O)[O-] 10.1016/j.bmcl.2007.04.086
6917762 16096 9 None -1 2 Guinea pig 7.6 pKd = 7.6 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atria
ChEMBL 228 6 2 4 1.5 C/C(=N\OCC(O)CNC(C)(C)C)C1CC1 10.1021/jm00145a008
CHEMBL111103 16096 9 None -1 2 Guinea pig 7.6 pKd = 7.6 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atria
ChEMBL 228 6 2 4 1.5 C/C(=N\OCC(O)CNC(C)(C)C)C1CC1 10.1021/jm00145a008
13621722 104096 5 None 229 2 Guinea pig 7.6 pKd = 7.6 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 275 7 3 4 1.8 CC(C)NCC(O)COc1ccc(-c2ncc[nH]2)cc1 10.1021/jm00156a028
CHEMBL269219 104096 5 None 229 2 Guinea pig 7.6 pKd = 7.6 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 275 7 3 4 1.8 CC(C)NCC(O)COc1ccc(-c2ncc[nH]2)cc1 10.1021/jm00156a028
2249 7300 111 None 2 12 Guinea pig 7.6 pKd = 7.6 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm00361a004
255 7300 111 None 2 12 Guinea pig 7.6 pKd = 7.6 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm00361a004
548 7300 111 None 2 12 Guinea pig 7.6 pKd = 7.6 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm00361a004
CHEMBL24 7300 111 None 2 12 Guinea pig 7.6 pKd = 7.6 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm00361a004
DB00335 7300 111 None 2 12 Guinea pig 7.6 pKd = 7.6 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm00361a004
13157412 67023 0 None - 1 Guinea pig 7.6 pKd = 7.6 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 411 11 3 6 3.0 COc1ccc(CCNCC(O)COc2ccc(-c3nc(C)c[nH]3)cc2)cc1OC 10.1021/jm00361a004
CHEMBL174106 67023 0 None - 1 Guinea pig 7.6 pKd = 7.6 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 411 11 3 6 3.0 COc1ccc(CCNCC(O)COc2ccc(-c3nc(C)c[nH]3)cc2)cc1OC 10.1021/jm00361a004
2249 7300 111 None 2 12 Guinea pig 7.6 pKd = 7.6 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm00156a028
255 7300 111 None 2 12 Guinea pig 7.6 pKd = 7.6 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm00156a028
548 7300 111 None 2 12 Guinea pig 7.6 pKd = 7.6 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm00156a028
CHEMBL24 7300 111 None 2 12 Guinea pig 7.6 pKd = 7.6 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm00156a028
DB00335 7300 111 None 2 12 Guinea pig 7.6 pKd = 7.6 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm00156a028
3682 196216 12 None -229 8 Human 6.6 pKd = 6.6 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 277 6 2 3 2.6 Cc1ccc(OCC(O)C(C)NC(C)C)c2c1CCC2 10.1021/jm400348g
CHEMBL1256784 196216 12 None -229 8 Human 6.6 pKd = 6.6 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 277 6 2 3 2.6 Cc1ccc(OCC(O)C(C)NC(C)C)c2c1CCC2 10.1021/jm400348g
CHEMBL513389 196216 12 None -229 8 Human 6.6 pKd = 6.6 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 277 6 2 3 2.6 Cc1ccc(OCC(O)C(C)NC(C)C)c2c1CCC2 10.1021/jm400348g
13621638 16636 0 None 2137 2 Guinea pig 7.6 pKd = 7.6 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 455 13 3 7 3.1 COCc1[nH]c(-c2ccc(OCC(O)CNCCc3ccc(OC)c(OC)c3)cc2)nc1C 10.1021/jm00156a028
CHEMBL11414 16636 0 None 2137 2 Guinea pig 7.6 pKd = 7.6 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 455 13 3 7 3.1 COCc1[nH]c(-c2ccc(OCC(O)CNCCc3ccc(OC)c(OC)c3)cc2)nc1C 10.1021/jm00156a028
13621722 104096 5 None 229 2 Guinea pig 7.6 pKd = 7.6 Binding
Activity at beta-1 adrenergic receptorActivity at beta-1 adrenergic receptor
ChEMBL 275 7 3 4 1.8 CC(C)NCC(O)COc1ccc(-c2ncc[nH]2)cc1 10.1021/jm00103a004
CHEMBL269219 104096 5 None 229 2 Guinea pig 7.6 pKd = 7.6 Binding
Activity at beta-1 adrenergic receptorActivity at beta-1 adrenergic receptor
ChEMBL 275 7 3 4 1.8 CC(C)NCC(O)COc1ccc(-c2ncc[nH]2)cc1 10.1021/jm00103a004
2834366 119437 5 None 6 2 Rat 7.6 pKd = 7.6 Binding
Antagonist activity at beta1 adrenergic receptor in isolated rat atriaAntagonist activity at beta1 adrenergic receptor in isolated rat atria
ChEMBL 251 8 2 3 2.4 CCCc1ccc(OCC(O)CNC(C)C)cc1 10.1021/jm00207a025
CHEMBL3247307 119437 5 None 6 2 Rat 7.6 pKd = 7.6 Binding
Antagonist activity at beta1 adrenergic receptor in isolated rat atriaAntagonist activity at beta1 adrenergic receptor in isolated rat atria
ChEMBL 251 8 2 3 2.4 CCCc1ccc(OCC(O)CNC(C)C)cc1 10.1021/jm00207a025
CHEMBL3303501 119437 5 None 6 2 Rat 7.6 pKd = 7.6 Binding
Antagonist activity at beta1 adrenergic receptor in isolated rat atriaAntagonist activity at beta1 adrenergic receptor in isolated rat atria
ChEMBL 251 8 2 3 2.4 CCCc1ccc(OCC(O)CNC(C)C)cc1 10.1021/jm00207a025
3486 9931 56 None -6 11 Guinea pig 6.6 pKd = 6.6 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00354a003
4883 9931 56 None -6 11 Guinea pig 6.6 pKd = 6.6 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00354a003
555 9931 56 None -6 11 Guinea pig 6.6 pKd = 6.6 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00354a003
CHEMBL6995 9931 56 None -6 11 Guinea pig 6.6 pKd = 6.6 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00354a003
DB01297 9931 56 None -6 11 Guinea pig 6.6 pKd = 6.6 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00354a003
13040894 106805 0 None 12 2 Guinea pig 6.6 pKd = 6.6 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 309 10 2 5 1.9 COC(=O)CCCc1ccc(OCC(O)CNC(C)C)cc1 10.1021/jm00354a003
CHEMBL286894 106805 0 None 12 2 Guinea pig 6.6 pKd = 6.6 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 309 10 2 5 1.9 COC(=O)CCCc1ccc(OCC(O)CNC(C)C)cc1 10.1021/jm00354a003
13040915 109709 0 None 50 2 Guinea pig 6.6 pKd = 6.6 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 325 10 2 7 0.8 CCOC(=O)CCNCC(O)COc1ccccc1C(=O)OC 10.1021/jm00354a003
CHEMBL30622 109709 0 None 50 2 Guinea pig 6.6 pKd = 6.6 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 325 10 2 7 0.8 CCOC(=O)CCNCC(O)COc1ccccc1C(=O)OC 10.1021/jm00354a003
12797747 210316 3 None -2 2 Guinea pig 6.6 pKd = 6.6 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 251 9 2 3 2.0 CC(C)NCC(O)COCCCc1ccccc1 10.1021/jm00119a011
CHEMBL66449 210316 3 None -2 2 Guinea pig 6.6 pKd = 6.6 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 251 9 2 3 2.0 CC(C)NCC(O)COCCCc1ccccc1 10.1021/jm00119a011
15578575 106498 2 None 3 2 Guinea pig 6.6 pKd = 6.6 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 281 10 2 5 1.4 CCOC(=O)CCCNCC(O)COc1ccccc1 10.1021/jm00354a002
CHEMBL284808 106498 2 None 3 2 Guinea pig 6.6 pKd = 6.6 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 281 10 2 5 1.4 CCOC(=O)CCCNCC(O)COc1ccccc1 10.1021/jm00354a002
15578620 113871 0 None - 1 Guinea pig 6.6 pKd = 6.6 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 343 9 2 5 2.7 CCOC(=O)c1ccc(CNCC(O)COc2ccccc2C)cc1 10.1021/jm00354a002
CHEMBL31591 113871 0 None - 1 Guinea pig 6.6 pKd = 6.6 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 343 9 2 5 2.7 CCOC(=O)c1ccc(CNCC(O)COc2ccccc2C)cc1 10.1021/jm00354a002
44279341 106875 0 None - 1 Guinea pig 6.6 pKd = 6.6 Binding
The compound was tested in vitro for its ability to block beta-2-adrenergic receptor in guinea pig tracheaThe compound was tested in vitro for its ability to block beta-2-adrenergic receptor in guinea pig trachea
ChEMBL 403 13 2 7 2.2 COc1ccc(CCOC(=O)CCNCC(O)COc2ccccc2)cc1OC 10.1021/jm00354a002
CHEMBL287452 106875 0 None - 1 Guinea pig 6.6 pKd = 6.6 Binding
The compound was tested in vitro for its ability to block beta-2-adrenergic receptor in guinea pig tracheaThe compound was tested in vitro for its ability to block beta-2-adrenergic receptor in guinea pig trachea
ChEMBL 403 13 2 7 2.2 COc1ccc(CCOC(=O)CCNCC(O)COc2ccccc2)cc1OC 10.1021/jm00354a002
12462226 119416 1 None -1 2 Guinea pig 5.6 pKd = 5.6 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 223 5 2 3 2.0 COc1ccc(C)cc1C(O)CNC(C)C 10.1021/jm00208a015
CHEMBL3246235 119416 1 None -1 2 Guinea pig 5.6 pKd = 5.6 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 223 5 2 3 2.0 COc1ccc(C)cc1C(O)CNC(C)C 10.1021/jm00208a015
CHEMBL3302805 119416 1 None -1 2 Guinea pig 5.6 pKd = 5.6 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 223 5 2 3 2.0 COc1ccc(C)cc1C(O)CNC(C)C 10.1021/jm00208a015
14348818 116551 0 None -5 3 Guinea pig 4.6 pKd = 4.6 Binding
The compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig left atriaThe compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig left atria
ChEMBL 415 7 4 7 2.9 C/C(=N\OCC(O)CNC(C)(C)C)c1cc(Cl)c(NC2=NCCN2)c(Cl)c1 10.1021/jm00115a008
CHEMBL323176 116551 0 None -5 3 Guinea pig 4.6 pKd = 4.6 Binding
The compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig left atriaThe compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig left atria
ChEMBL 415 7 4 7 2.9 C/C(=N\OCC(O)CNC(C)(C)C)c1cc(Cl)c(NC2=NCCN2)c(Cl)c1 10.1021/jm00115a008
2303 9961 68 None -15 26 Guinea pig 6.6 pKd = 6.6 Binding
Inhibition of beta1-adrenergic receptor in guinea pig auricle assessed as reversal of isoproterenol-induced effectInhibition of beta1-adrenergic receptor in guinea pig auricle assessed as reversal of isoproterenol-induced effect
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00199a012
4946 9961 68 None -15 26 Guinea pig 6.6 pKd = 6.6 Binding
Inhibition of beta1-adrenergic receptor in guinea pig auricle assessed as reversal of isoproterenol-induced effectInhibition of beta1-adrenergic receptor in guinea pig auricle assessed as reversal of isoproterenol-induced effect
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00199a012
564 9961 68 None -15 26 Guinea pig 6.6 pKd = 6.6 Binding
Inhibition of beta1-adrenergic receptor in guinea pig auricle assessed as reversal of isoproterenol-induced effectInhibition of beta1-adrenergic receptor in guinea pig auricle assessed as reversal of isoproterenol-induced effect
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00199a012
63 9961 68 None -15 26 Guinea pig 6.6 pKd = 6.6 Binding
Inhibition of beta1-adrenergic receptor in guinea pig auricle assessed as reversal of isoproterenol-induced effectInhibition of beta1-adrenergic receptor in guinea pig auricle assessed as reversal of isoproterenol-induced effect
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00199a012
91536 9961 68 None -15 26 Guinea pig 6.6 pKd = 6.6 Binding
Inhibition of beta1-adrenergic receptor in guinea pig auricle assessed as reversal of isoproterenol-induced effectInhibition of beta1-adrenergic receptor in guinea pig auricle assessed as reversal of isoproterenol-induced effect
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00199a012
CHEMBL27 9961 68 None -15 26 Guinea pig 6.6 pKd = 6.6 Binding
Inhibition of beta1-adrenergic receptor in guinea pig auricle assessed as reversal of isoproterenol-induced effectInhibition of beta1-adrenergic receptor in guinea pig auricle assessed as reversal of isoproterenol-induced effect
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00199a012
CHEMBL452861 9961 68 None -15 26 Guinea pig 6.6 pKd = 6.6 Binding
Inhibition of beta1-adrenergic receptor in guinea pig auricle assessed as reversal of isoproterenol-induced effectInhibition of beta1-adrenergic receptor in guinea pig auricle assessed as reversal of isoproterenol-induced effect
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00199a012
DB00571 9961 68 None -15 26 Guinea pig 6.6 pKd = 6.6 Binding
Inhibition of beta1-adrenergic receptor in guinea pig auricle assessed as reversal of isoproterenol-induced effectInhibition of beta1-adrenergic receptor in guinea pig auricle assessed as reversal of isoproterenol-induced effect
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00199a012
29057685 165612 12 None -1 2 Human 4.6 pKd = 4.6 Binding
Displacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting methodDisplacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting method
ChEMBL 394 4 1 6 3.1 COc1cccc(/C=C2\Oc3c(CN4CCN(C)CC4)c(O)cc(C)c3C2=O)c1 10.1021/acsmedchemlett.6b00363
8056725 165612 12 None -1 2 Human 4.6 pKd = 4.6 Binding
Displacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting methodDisplacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting method
ChEMBL 394 4 1 6 3.1 COc1cccc(/C=C2\Oc3c(CN4CCN(C)CC4)c(O)cc(C)c3C2=O)c1 10.1021/acsmedchemlett.6b00363
CHEMBL4094678 165612 12 None -1 2 Human 4.6 pKd = 4.6 Binding
Displacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting methodDisplacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting method
ChEMBL 394 4 1 6 3.1 COc1cccc(/C=C2\Oc3c(CN4CCN(C)CC4)c(O)cc(C)c3C2=O)c1 10.1021/acsmedchemlett.6b00363
44383465 127534 2 None -2 2 Guinea pig 7.6 pKd = 7.6 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atria
ChEMBL 228 6 2 4 1.5 C/C(=N\OC[C@@H](O)CNC(C)(C)C)C1CC1 10.1021/jm00145a008
CHEMBL355100 127534 2 None -2 2 Guinea pig 7.6 pKd = 7.6 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atria
ChEMBL 228 6 2 4 1.5 C/C(=N\OC[C@@H](O)CNC(C)(C)C)C1CC1 10.1021/jm00145a008
21595423 210294 0 None -10 2 Guinea pig 6.6 pKd = 6.6 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 263 7 2 3 2.1 O[C@H](COCCCc1ccccc1)[C@@H]1CCCCN1 10.1021/jm00119a011
CHEMBL66324 210294 0 None -10 2 Guinea pig 6.6 pKd = 6.6 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 263 7 2 3 2.1 O[C@H](COCCCc1ccccc1)[C@@H]1CCCCN1 10.1021/jm00119a011
2297435 62380 6 None -10 2 Human 4.6 pKd = 4.6 Binding
Displacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting methodDisplacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting method
ChEMBL 253 7 1 2 3.5 C=CCNCCOc1ccccc1-c1ccccc1 10.1021/acsmedchemlett.6b00363
CHEMBL1621144 62380 6 None -10 2 Human 4.6 pKd = 4.6 Binding
Displacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting methodDisplacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting method
ChEMBL 253 7 1 2 3.5 C=CCNCCOc1ccccc1-c1ccccc1 10.1021/acsmedchemlett.6b00363
13157386 69951 3 None 138 2 Guinea pig 7.5 pKd = 7.5 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 479 12 3 7 4.4 COc1ccc(CCNC[C@H](O)COc2ccc(-c3nc(-c4cccs4)c[nH]3)cc2)cc1OC 10.1021/jm00156a028
CHEMBL1788320 69951 3 None 138 2 Guinea pig 7.5 pKd = 7.5 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 479 12 3 7 4.4 COc1ccc(CCNC[C@H](O)COc2ccc(-c3nc(-c4cccs4)c[nH]3)cc2)cc1OC 10.1021/jm00156a028
CHEMBL1789879 69951 3 None 138 2 Guinea pig 7.5 pKd = 7.5 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 479 12 3 7 4.4 COc1ccc(CCNC[C@H](O)COc2ccc(-c3nc(-c4cccs4)c[nH]3)cc2)cc1OC 10.1021/jm00156a028
13621764 168799 0 None 1288 2 Guinea pig 8.5 pKd = 8.5 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 507 14 3 7 4.5 COc1ccc(CCNCC(O)COc2ccc(CCc3nc(-c4cccs4)c[nH]3)cc2)cc1OC 10.1021/jm00156a028
CHEMBL415970 168799 0 None 1288 2 Guinea pig 8.5 pKd = 8.5 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 507 14 3 7 4.5 COc1ccc(CCNCC(O)COc2ccc(CCc3nc(-c4cccs4)c[nH]3)cc2)cc1OC 10.1021/jm00156a028
13040881 105950 0 None -1 2 Guinea pig 8.5 pKd = 8.5 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 295 7 2 5 2.0 CCOC(=O)c1ccccc1OCC(O)CNC(C)(C)C 10.1021/jm00354a003
CHEMBL281294 105950 0 None -1 2 Guinea pig 8.5 pKd = 8.5 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 295 7 2 5 2.0 CCOC(=O)c1ccccc1OCC(O)CNC(C)(C)C 10.1021/jm00354a003
56598832 95043 0 None 588 3 Human 8.5 pKd = 8.5 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 527 16 5 7 3.3 O=C(NCCNCC(O)COc1ccc(OCCOCCc2ccc(F)cc2)cc1)Nc1ccc(O)cc1 10.1021/jm400348g
CHEMBL2348218 95043 0 None 588 3 Human 8.5 pKd = 8.5 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 527 16 5 7 3.3 O=C(NCCNCC(O)COc1ccc(OCCOCCc2ccc(F)cc2)cc1)Nc1ccc(O)cc1 10.1021/jm400348g
15578565 113778 0 None 2 2 Guinea pig 8.5 pKd = 8.5 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 309 9 2 5 2.1 CCOC(=O)CC(C)(C)NCC(O)COc1ccccc1C 10.1021/jm00354a002
CHEMBL31529 113778 0 None 2 2 Guinea pig 8.5 pKd = 8.5 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 309 9 2 5 2.1 CCOC(=O)CC(C)(C)NCC(O)COc1ccccc1C 10.1021/jm00354a002
13621770 16121 0 None 7 2 Guinea pig 8.5 pKd = 8.5 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor was measured by the inhibition of the positive chronotropic effect of isoproterenolin in isolated guinea pig atria.In vitro inhibitory activity against beta-1 adrenergic receptor was measured by the inhibition of the positive chronotropic effect of isoproterenolin in isolated guinea pig atria.
ChEMBL 367 8 3 4 2.5 CC(C)NCC(O)COc1ccc(Cc2nc(Br)c[nH]2)cc1 10.1021/jm00156a028
CHEMBL11125 16121 0 None 7 2 Guinea pig 8.5 pKd = 8.5 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor was measured by the inhibition of the positive chronotropic effect of isoproterenolin in isolated guinea pig atria.In vitro inhibitory activity against beta-1 adrenergic receptor was measured by the inhibition of the positive chronotropic effect of isoproterenolin in isolated guinea pig atria.
ChEMBL 367 8 3 4 2.5 CC(C)NCC(O)COc1ccc(Cc2nc(Br)c[nH]2)cc1 10.1021/jm00156a028
13621602 16601 0 None 1096 2 Guinea pig 8.5 pKd = 8.5 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 493 12 3 7 4.7 COc1ccc(CCNCC(O)COc2ccc(-c3nc(-c4cccs4)c[nH]3)cc2C)cc1OC 10.1021/jm00156a028
CHEMBL11396 16601 0 None 1096 2 Guinea pig 8.5 pKd = 8.5 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 493 12 3 7 4.7 COc1ccc(CCNCC(O)COc2ccc(-c3nc(-c4cccs4)c[nH]3)cc2C)cc1OC 10.1021/jm00156a028
2840793 210409 30 None 1 2 Guinea pig 8.4 pKd = 8.4 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 223 6 2 3 1.7 Cc1ccc(OCC(O)CNC(C)C)cc1 10.1021/jm00119a011
CHEMBL67151 210409 30 None 1 2 Guinea pig 8.4 pKd = 8.4 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 223 6 2 3 1.7 Cc1ccc(OCC(O)CNC(C)C)cc1 10.1021/jm00119a011
12484297 116494 0 None -15 2 Guinea pig 7.5 pKd = 7.5 Binding
Competitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial contractile forceCompetitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial contractile force
ChEMBL 249 6 3 4 1.3 CC(C)NCC(O)COc1cccc2[nH]cnc12 10.1021/jm00188a019
CHEMBL3228931 116494 0 None -15 2 Guinea pig 7.5 pKd = 7.5 Binding
Competitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial contractile forceCompetitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial contractile force
ChEMBL 249 6 3 4 1.3 CC(C)NCC(O)COc1cccc2[nH]cnc12 10.1021/jm00188a019
13621690 16657 0 None 1318 2 Guinea pig 7.5 pKd = 7.5 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 440 12 4 7 1.8 COc1ccc(CCNCC(O)COc2ccc(-c3nc(C(N)=O)c[nH]3)cc2)cc1OC 10.1021/jm00156a028
CHEMBL11427 16657 0 None 1318 2 Guinea pig 7.5 pKd = 7.5 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 440 12 4 7 1.8 COc1ccc(CCNCC(O)COc2ccc(-c3nc(C(N)=O)c[nH]3)cc2)cc1OC 10.1021/jm00156a028
13621631 16463 0 None 169 2 Guinea pig 7.5 pKd = 7.5 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor was measured by the inhibition of isoproterenol-induced relaxation of PGF2-alpha contracted guinea pig tracheaIn vitro inhibitory activity against beta-1 adrenergic receptor was measured by the inhibition of isoproterenol-induced relaxation of PGF2-alpha contracted guinea pig trachea
ChEMBL 489 11 3 6 3.7 COc1ccc(CCNCC(O)COc2ccc(-c3nc(Br)c(C)[nH]3)cc2)cc1OC 10.1021/jm00156a028
CHEMBL11307 16463 0 None 169 2 Guinea pig 7.5 pKd = 7.5 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor was measured by the inhibition of isoproterenol-induced relaxation of PGF2-alpha contracted guinea pig tracheaIn vitro inhibitory activity against beta-1 adrenergic receptor was measured by the inhibition of isoproterenol-induced relaxation of PGF2-alpha contracted guinea pig trachea
ChEMBL 489 11 3 6 3.7 COc1ccc(CCNCC(O)COc2ccc(-c3nc(Br)c(C)[nH]3)cc2)cc1OC 10.1021/jm00156a028
12606706 100008 0 None -13 2 Guinea pig 6.5 pKd = 6.5 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 202 5 2 4 1.1 CC(C)=NOCC(O)CNC(C)(C)C 10.1021/jm00376a011
CHEMBL24480 100008 0 None -13 2 Guinea pig 6.5 pKd = 6.5 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 202 5 2 4 1.1 CC(C)=NOCC(O)CNC(C)(C)C 10.1021/jm00376a011
CHEMBL555848 100008 0 None -13 2 Guinea pig 6.5 pKd = 6.5 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 202 5 2 4 1.1 CC(C)=NOCC(O)CNC(C)(C)C 10.1021/jm00376a011
3869259 164232 3 None -3 2 Human 5.5 pKd = 5.5 Binding
Displacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting methodDisplacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting method
ChEMBL 419 4 0 5 5.5 CCOC(=O)c1cc(/C=C/c2sc3ccccc3[n+]2C)c2sc3ccccc3n12 10.1021/acsmedchemlett.6b00363
45052940 164232 3 None -3 2 Human 5.5 pKd = 5.5 Binding
Displacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting methodDisplacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting method
ChEMBL 419 4 0 5 5.5 CCOC(=O)c1cc(/C=C/c2sc3ccccc3[n+]2C)c2sc3ccccc3n12 10.1021/acsmedchemlett.6b00363
5942882 164232 3 None -3 2 Human 5.5 pKd = 5.5 Binding
Displacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting methodDisplacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting method
ChEMBL 419 4 0 5 5.5 CCOC(=O)c1cc(/C=C/c2sc3ccccc3[n+]2C)c2sc3ccccc3n12 10.1021/acsmedchemlett.6b00363
CHEMBL4079127 164232 3 None -3 2 Human 5.5 pKd = 5.5 Binding
Displacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting methodDisplacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting method
ChEMBL 419 4 0 5 5.5 CCOC(=O)c1cc(/C=C/c2sc3ccccc3[n+]2C)c2sc3ccccc3n12 10.1021/acsmedchemlett.6b00363
21296271 103710 3 None -1 2 Guinea pig 4.5 pKd = 4.5 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 241 7 2 3 1.9 CC(C)(C)NCC(O)COC(C1CC1)C1CC1 10.1021/jm00376a011
CHEMBL26607 103710 3 None -1 2 Guinea pig 4.5 pKd = 4.5 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 241 7 2 3 1.9 CC(C)(C)NCC(O)COC(C1CC1)C1CC1 10.1021/jm00376a011
54757331 72291 0 None -39 3 Human 7.5 pKd = 7.5 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 883 28 4 10 6.3 C=CCc1ccccc1OCC(O)CNCCOCCOCCNC(=O)CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1 10.1021/jm2008562
CHEMBL1830619 72291 0 None -39 3 Human 7.5 pKd = 7.5 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 883 28 4 10 6.3 C=CCc1ccccc1OCC(O)CNCCOCCOCCNC(=O)CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1 10.1021/jm2008562
15578592 106277 2 None 1 2 Guinea pig 7.5 pKd = 7.5 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 281 9 2 5 1.3 CCOC(=O)CCNCC(O)COc1ccccc1C 10.1021/jm00354a002
CHEMBL283289 106277 2 None 1 2 Guinea pig 7.5 pKd = 7.5 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 281 9 2 5 1.3 CCOC(=O)CCNCC(O)COc1ccccc1C 10.1021/jm00354a002
15578606 114743 2 None 3 2 Guinea pig 7.5 pKd = 7.5 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 267 8 2 5 0.9 COC(=O)CCNCC(O)COc1ccccc1C 10.1021/jm00354a002
CHEMBL31938 114743 2 None 3 2 Guinea pig 7.5 pKd = 7.5 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 267 8 2 5 0.9 COC(=O)CCNCC(O)COc1ccccc1C 10.1021/jm00354a002
559935 110574 7 None 12 2 Guinea pig 6.5 pKd = 6.5 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 281 6 2 5 1.6 COC(=O)c1ccc(OCC(O)CNC(C)(C)C)cc1 10.1021/jm00354a003
CHEMBL30899 110574 7 None 12 2 Guinea pig 6.5 pKd = 6.5 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 281 6 2 5 1.6 COC(=O)c1ccc(OCC(O)CNC(C)(C)C)cc1 10.1021/jm00354a003
11722868 111156 0 None 7 2 Guinea pig 6.5 pKd = 6.5 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 309 8 2 5 1.9 COC(=O)CCc1ccc(OCC(O)CNC(C)(C)C)cc1 10.1021/jm00354a003
CHEMBL31025 111156 0 None 7 2 Guinea pig 6.5 pKd = 6.5 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 309 8 2 5 1.9 COC(=O)CCc1ccc(OCC(O)CNC(C)(C)C)cc1 10.1021/jm00354a003
12238216 113900 0 None 2 2 Guinea pig 6.5 pKd = 6.5 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 281 8 2 5 1.6 CCOC(=O)c1ccc(OCC(O)CNC(C)C)cc1 10.1021/jm00354a003
CHEMBL31608 113900 0 None 2 2 Guinea pig 6.5 pKd = 6.5 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 281 8 2 5 1.6 CCOC(=O)c1ccc(OCC(O)CNC(C)C)cc1 10.1021/jm00354a003
13040909 113949 0 None 19 2 Guinea pig 6.5 pKd = 6.5 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 417 13 2 7 2.4 COC(=O)CCc1ccc(OCC(O)CNCCc2ccc(OC)c(OC)c2)cc1 10.1021/jm00354a003
CHEMBL31638 113949 0 None 19 2 Guinea pig 6.5 pKd = 6.5 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 417 13 2 7 2.4 COC(=O)CCc1ccc(OCC(O)CNCCc2ccc(OC)c(OC)c2)cc1 10.1021/jm00354a003
12238216 113900 0 None 2 2 Guinea pig 6.5 pKd = 6.5 Binding
Activity at beta-1 adrenergic receptorActivity at beta-1 adrenergic receptor
ChEMBL 281 8 2 5 1.6 CCOC(=O)c1ccc(OCC(O)CNC(C)C)cc1 10.1021/jm00103a004
CHEMBL31608 113900 0 None 2 2 Guinea pig 6.5 pKd = 6.5 Binding
Activity at beta-1 adrenergic receptorActivity at beta-1 adrenergic receptor
ChEMBL 281 8 2 5 1.6 CCOC(=O)c1ccc(OCC(O)CNC(C)C)cc1 10.1021/jm00103a004
159899 114332 34 None 1 2 Guinea pig 6.5 pKd = 6.5 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 217 4 2 3 1.5 NCC(O)COc1cccc2ccccc12 10.1021/jm00354a002
CHEMBL31888 114332 34 None 1 2 Guinea pig 6.5 pKd = 6.5 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 217 4 2 3 1.5 NCC(O)COc1cccc2ccccc12 10.1021/jm00354a002
13040917 106557 0 None - 1 Guinea pig 5.5 pKd = 5.5 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 383 11 2 9 0.3 CCOC(=O)C(NCC(O)COc1ccccc1C(=O)OC)C(=O)OCC 10.1021/jm00354a003
CHEMBL285233 106557 0 None - 1 Guinea pig 5.5 pKd = 5.5 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 383 11 2 9 0.3 CCOC(=O)C(NCC(O)COc1ccccc1C(=O)OC)C(=O)OCC 10.1021/jm00354a003
15578604 113881 1 None -1 2 Guinea pig 5.5 pKd = 5.5 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 253 7 2 5 0.5 COC(=O)CNCC(O)COc1ccccc1C 10.1021/jm00354a002
CHEMBL31598 113881 1 None -1 2 Guinea pig 5.5 pKd = 5.5 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 253 7 2 5 0.5 COC(=O)CNCC(O)COc1ccccc1C 10.1021/jm00354a002
56598831 95918 0 None 295 2 Human 7.5 pKd = 7.5 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 459 15 5 7 2.3 O=C(NCCNCC(O)COc1ccc(OCCOCC2CC2)cc1)Nc1ccc(O)cc1 10.1021/jm400348g
CHEMBL2348220 95918 0 None 295 2 Human 7.5 pKd = 7.5 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 459 15 5 7 2.3 O=C(NCCNCC(O)COc1ccc(OCCOCC2CC2)cc1)Nc1ccc(O)cc1 10.1021/jm400348g
CHEMBL2365796 95918 0 None 295 2 Human 7.5 pKd = 7.5 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 459 15 5 7 2.3 O=C(NCCNCC(O)COc1ccc(OCCOCC2CC2)cc1)Nc1ccc(O)cc1 10.1021/jm400348g
54756927 72261 0 None -97 3 Human 7.5 pKd = 7.5 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 833 22 4 8 7.5 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCCCNC[C@H](O)COc1cccc2ccccc12 10.1021/jm2008562
CHEMBL1830486 72261 0 None -97 3 Human 7.5 pKd = 7.5 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 833 22 4 8 7.5 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCCCNC[C@H](O)COc1cccc2ccccc12 10.1021/jm2008562
54579961 69835 1 None -3 2 Guinea pig 7.5 pKd = 7.5 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atria
ChEMBL 254 7 2 4 1.9 CC(C)(C)NC[C@@H](O)CON=C(C1CC1)C1CC1 10.1021/jm00145a008
CHEMBL1788274 69835 1 None -3 2 Guinea pig 7.5 pKd = 7.5 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atria
ChEMBL 254 7 2 4 1.9 CC(C)(C)NC[C@@H](O)CON=C(C1CC1)C1CC1 10.1021/jm00145a008
3486 9931 56 None -1 11 Rat 6.5 pKd = 6.5 Binding
Antagonist activity at beta1 adrenergic receptor in isolated rat atriaAntagonist activity at beta1 adrenergic receptor in isolated rat atria
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00207a025
4883 9931 56 None -1 11 Rat 6.5 pKd = 6.5 Binding
Antagonist activity at beta1 adrenergic receptor in isolated rat atriaAntagonist activity at beta1 adrenergic receptor in isolated rat atria
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00207a025
555 9931 56 None -1 11 Rat 6.5 pKd = 6.5 Binding
Antagonist activity at beta1 adrenergic receptor in isolated rat atriaAntagonist activity at beta1 adrenergic receptor in isolated rat atria
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00207a025
CHEMBL6995 9931 56 None -1 11 Rat 6.5 pKd = 6.5 Binding
Antagonist activity at beta1 adrenergic receptor in isolated rat atriaAntagonist activity at beta1 adrenergic receptor in isolated rat atria
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00207a025
DB01297 9931 56 None -1 11 Rat 6.5 pKd = 6.5 Binding
Antagonist activity at beta1 adrenergic receptor in isolated rat atriaAntagonist activity at beta1 adrenergic receptor in isolated rat atria
ChEMBL 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10.1021/jm00207a025
44274622 106568 0 None -3 2 Guinea pig 5.5 pKd = 5.5 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 215 6 2 3 1.6 CC(OCC(O)CNC(C)(C)C)C1CC1 10.1021/jm00376a011
CHEMBL285309 106568 0 None -3 2 Guinea pig 5.5 pKd = 5.5 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 215 6 2 3 1.6 CC(OCC(O)CNC(C)(C)C)C1CC1 10.1021/jm00376a011
29072430 166249 12 None -6 2 Human 4.5 pKd = 4.5 Binding
Displacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting methodDisplacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting method
ChEMBL 365 4 1 5 3.9 COc1cccc(/C=C2\Oc3c(CN4CCCC4)c(O)cc(C)c3C2=O)c1 10.1021/acsmedchemlett.6b00363
8071397 166249 12 None -6 2 Human 4.5 pKd = 4.5 Binding
Displacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting methodDisplacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting method
ChEMBL 365 4 1 5 3.9 COc1cccc(/C=C2\Oc3c(CN4CCCC4)c(O)cc(C)c3C2=O)c1 10.1021/acsmedchemlett.6b00363
CHEMBL4101524 166249 12 None -6 2 Human 4.5 pKd = 4.5 Binding
Displacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting methodDisplacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting method
ChEMBL 365 4 1 5 3.9 COc1cccc(/C=C2\Oc3c(CN4CCCC4)c(O)cc(C)c3C2=O)c1 10.1021/acsmedchemlett.6b00363
54758417 72260 0 None -38 3 Human 7.4 pKd = 7.4 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 805 20 4 8 6.7 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCNC[C@H](O)COc1cccc2ccccc12 10.1021/jm2008562
CHEMBL1830485 72260 0 None -38 3 Human 7.4 pKd = 7.4 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 805 20 4 8 6.7 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCNC[C@H](O)COc1cccc2ccccc12 10.1021/jm2008562
214004 117244 3 None - 1 Rat 5.4 pKd = 5.4 Binding
Antagonist activity at beta1 adrenergic receptor in isolated rat atriaAntagonist activity at beta1 adrenergic receptor in isolated rat atria
ChEMBL 266 7 3 4 0.8 CNC(=O)c1ccc(OCC(O)CNC(C)C)cc1 10.1021/jm00207a025
CHEMBL3247301 117244 3 None - 1 Rat 5.4 pKd = 5.4 Binding
Antagonist activity at beta1 adrenergic receptor in isolated rat atriaAntagonist activity at beta1 adrenergic receptor in isolated rat atria
ChEMBL 266 7 3 4 0.8 CNC(=O)c1ccc(OCC(O)CNC(C)C)cc1 10.1021/jm00207a025
3067050 100194 1 None -3 2 Guinea pig 4.4 pKd = 4.4 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 215 6 2 3 1.7 C=CC(C)(C)OCC(O)CNC(C)(C)C 10.1021/jm00376a011
CHEMBL24586 100194 1 None -3 2 Guinea pig 4.4 pKd = 4.4 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 215 6 2 3 1.7 C=CC(C)(C)OCC(O)CNC(C)(C)C 10.1021/jm00376a011
14201550 108939 0 None - 1 Guinea pig 6.4 pKd = 6.4 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 263 7 2 3 2.1 O[C@H](COCCCc1ccccc1)[C@H]1CCCCN1 10.1021/jm00119a011
CHEMBL302605 108939 0 None - 1 Guinea pig 6.4 pKd = 6.4 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 263 7 2 3 2.1 O[C@H](COCCCc1ccccc1)[C@H]1CCCCN1 10.1021/jm00119a011
16415941 165843 12 None -2 2 Human 4.4 pKd = 4.4 Binding
Displacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting methodDisplacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting method
ChEMBL 375 3 1 5 4.7 Cc1cc(O)c(CN2CCCC2)c2c1C(=O)/C(=C/c1cc3ccccc3o1)O2 10.1021/acsmedchemlett.6b00363
16415942 165843 12 None -2 2 Human 4.4 pKd = 4.4 Binding
Displacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting methodDisplacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting method
ChEMBL 375 3 1 5 4.7 Cc1cc(O)c(CN2CCCC2)c2c1C(=O)/C(=C/c1cc3ccccc3o1)O2 10.1021/acsmedchemlett.6b00363
CHEMBL4097144 165843 12 None -2 2 Human 4.4 pKd = 4.4 Binding
Displacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting methodDisplacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting method
ChEMBL 375 3 1 5 4.7 Cc1cc(O)c(CN2CCCC2)c2c1C(=O)/C(=C/c1cc3ccccc3o1)O2 10.1021/acsmedchemlett.6b00363
12484297 116494 0 None -15 2 Guinea pig 7.4 pKd = 7.4 Binding
Competitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial beat rateCompetitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial beat rate
ChEMBL 249 6 3 4 1.3 CC(C)NCC(O)COc1cccc2[nH]cnc12 10.1021/jm00188a019
CHEMBL3228931 116494 0 None -15 2 Guinea pig 7.4 pKd = 7.4 Binding
Competitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial beat rateCompetitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial beat rate
ChEMBL 249 6 3 4 1.3 CC(C)NCC(O)COc1cccc2[nH]cnc12 10.1021/jm00188a019
2369 7409 80 None -12 8 Guinea pig 7.4 pKd = 7.4 Binding
Compound was tested for the biological activity at the Beta-1 adrenergic receptorCompound was tested for the biological activity at the Beta-1 adrenergic receptor
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00103a004
356 7409 80 None -12 8 Guinea pig 7.4 pKd = 7.4 Binding
Compound was tested for the biological activity at the Beta-1 adrenergic receptorCompound was tested for the biological activity at the Beta-1 adrenergic receptor
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00103a004
549 7409 80 None -12 8 Guinea pig 7.4 pKd = 7.4 Binding
Compound was tested for the biological activity at the Beta-1 adrenergic receptorCompound was tested for the biological activity at the Beta-1 adrenergic receptor
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00103a004
CHEMBL423 7409 80 None -12 8 Guinea pig 7.4 pKd = 7.4 Binding
Compound was tested for the biological activity at the Beta-1 adrenergic receptorCompound was tested for the biological activity at the Beta-1 adrenergic receptor
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00103a004
DB00195 7409 80 None -12 8 Guinea pig 7.4 pKd = 7.4 Binding
Compound was tested for the biological activity at the Beta-1 adrenergic receptorCompound was tested for the biological activity at the Beta-1 adrenergic receptor
ChEMBL 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10.1021/jm00103a004
15578563 106849 0 None 1 2 Guinea pig 7.4 pKd = 7.4 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 317 9 2 5 2.1 CCOC(=O)CCNCC(O)COc1cccc2ccccc12 10.1021/jm00354a002
CHEMBL287242 106849 0 None 1 2 Guinea pig 7.4 pKd = 7.4 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 317 9 2 5 2.1 CCOC(=O)CCNCC(O)COc1cccc2ccccc12 10.1021/jm00354a002
15578588 110904 2 None 6 2 Guinea pig 7.4 pKd = 7.4 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 301 9 2 5 1.6 CCOC(=O)CCNCC(O)COc1ccccc1Cl 10.1021/jm00354a002
CHEMBL30942 110904 2 None 6 2 Guinea pig 7.4 pKd = 7.4 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 301 9 2 5 1.6 CCOC(=O)CCNCC(O)COc1ccccc1Cl 10.1021/jm00354a002
15578608 114276 2 None 5 2 Guinea pig 7.4 pKd = 7.4 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 295 10 2 5 1.7 CCOC(=O)CCCNCC(O)COc1ccccc1C 10.1021/jm00354a002
CHEMBL31857 114276 2 None 5 2 Guinea pig 7.4 pKd = 7.4 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 295 10 2 5 1.7 CCOC(=O)CCCNCC(O)COc1ccccc1C 10.1021/jm00354a002
15578590 168830 2 None 5 2 Guinea pig 7.4 pKd = 7.4 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 301 9 2 5 1.6 CCOC(=O)CCNCC(O)COc1cccc(Cl)c1 10.1021/jm00354a002
CHEMBL416030 168830 2 None 5 2 Guinea pig 7.4 pKd = 7.4 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 301 9 2 5 1.6 CCOC(=O)CCNCC(O)COc1cccc(Cl)c1 10.1021/jm00354a002
12941056 108993 0 None 10 2 Guinea pig 6.4 pKd = 6.4 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 281 8 2 5 1.1 COC(=O)Cc1ccc(OCC(O)CNC(C)C)cc1 10.1021/jm00354a003
CHEMBL30292 108993 0 None 10 2 Guinea pig 6.4 pKd = 6.4 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 281 8 2 5 1.1 COC(=O)Cc1ccc(OCC(O)CNC(C)C)cc1 10.1021/jm00354a003
193122 8691 6 None -3 2 Guinea pig 6.4 pKd = 6.4 Binding
Compound was tested for the biological activity at the Beta-1 adrenergic receptorCompound was tested for the biological activity at the Beta-1 adrenergic receptor
ChEMBL 283 10 2 5 1.5 COCCOc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00103a004
542 8691 6 None -3 2 Guinea pig 6.4 pKd = 6.4 Binding
Compound was tested for the biological activity at the Beta-1 adrenergic receptorCompound was tested for the biological activity at the Beta-1 adrenergic receptor
ChEMBL 283 10 2 5 1.5 COCCOc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00103a004
CHEMBL142773 8691 6 None -3 2 Guinea pig 6.4 pKd = 6.4 Binding
Compound was tested for the biological activity at the Beta-1 adrenergic receptorCompound was tested for the biological activity at the Beta-1 adrenergic receptor
ChEMBL 283 10 2 5 1.5 COCCOc1ccc(cc1)OCC(CNC(C)C)O 10.1021/jm00103a004
15569837 113322 2 None 6 2 Guinea pig 6.4 pKd = 6.4 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 301 9 2 5 1.6 CCOC(=O)CCNCC(O)COc1ccc(Cl)cc1 10.1021/jm00354a002
CHEMBL31411 113322 2 None 6 2 Guinea pig 6.4 pKd = 6.4 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 301 9 2 5 1.6 CCOC(=O)CCNCC(O)COc1ccc(Cl)cc1 10.1021/jm00354a002
15578596 118200 2 None -1 2 Guinea pig 6.4 pKd = 6.4 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 297 10 2 6 1.0 CCOC(=O)CCNCC(O)COc1cccc(OC)c1 10.1021/jm00354a002
CHEMBL32736 118200 2 None -1 2 Guinea pig 6.4 pKd = 6.4 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 297 10 2 6 1.0 CCOC(=O)CCNCC(O)COc1cccc(OC)c1 10.1021/jm00354a002
15578614 109621 0 None - 1 Guinea pig 6.4 pKd = 6.4 Binding
The compound was tested in vitro for its ability to block Beta-1 adrenergic receptor in guinea pig right atriaThe compound was tested in vitro for its ability to block Beta-1 adrenergic receptor in guinea pig right atria
ChEMBL 315 9 2 5 2.0 O=C(CCNCC(O)COc1ccccc1)Oc1ccccc1 10.1021/jm00354a002
CHEMBL30558 109621 0 None - 1 Guinea pig 6.4 pKd = 6.4 Binding
The compound was tested in vitro for its ability to block Beta-1 adrenergic receptor in guinea pig right atriaThe compound was tested in vitro for its ability to block Beta-1 adrenergic receptor in guinea pig right atria
ChEMBL 315 9 2 5 2.0 O=C(CCNCC(O)COc1ccccc1)Oc1ccccc1 10.1021/jm00354a002
13040902 111664 0 None 1 2 Guinea pig 5.4 pKd = 5.4 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 323 11 2 5 2.3 CCCOC(=O)CCc1ccc(OCC(O)CNC(C)C)cc1 10.1021/jm00354a003
CHEMBL31117 111664 0 None 1 2 Guinea pig 5.4 pKd = 5.4 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 323 11 2 5 2.3 CCCOC(=O)CCc1ccc(OCC(O)CNC(C)C)cc1 10.1021/jm00354a003
14348818 116551 0 None -5 3 Guinea pig 4.4 pKd = 4.4 Binding
The compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig left atriaThe compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig left atria
ChEMBL 415 7 4 7 2.9 C/C(=N\OCC(O)CNC(C)(C)C)c1cc(Cl)c(NC2=NCCN2)c(Cl)c1 10.1021/jm00115a008
CHEMBL323176 116551 0 None -5 3 Guinea pig 4.4 pKd = 4.4 Binding
The compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig left atriaThe compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig left atria
ChEMBL 415 7 4 7 2.9 C/C(=N\OCC(O)CNC(C)(C)C)c1cc(Cl)c(NC2=NCCN2)c(Cl)c1 10.1021/jm00115a008
2803 7742 58 None -134 19 Guinea pig 4.4 pKd = 4.4 Binding
The compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atriaThe compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atria
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm00115a008
516 7742 58 None -134 19 Guinea pig 4.4 pKd = 4.4 Binding
The compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atriaThe compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atria
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm00115a008
704 7742 58 None -134 19 Guinea pig 4.4 pKd = 4.4 Binding
The compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atriaThe compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atria
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm00115a008
CHEMBL134 7742 58 None -134 19 Guinea pig 4.4 pKd = 4.4 Binding
The compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atriaThe compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atria
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm00115a008
DB00575 7742 58 None -134 19 Guinea pig 4.4 pKd = 4.4 Binding
The compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atriaThe compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atria
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm00115a008
14348818 116551 0 None -5 3 Guinea pig 4.4 pKd = 4.4 Binding
The compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atriaThe compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atria
ChEMBL 415 7 4 7 2.9 C/C(=N\OCC(O)CNC(C)(C)C)c1cc(Cl)c(NC2=NCCN2)c(Cl)c1 10.1021/jm00115a008
CHEMBL323176 116551 0 None -5 3 Guinea pig 4.4 pKd = 4.4 Binding
The compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atriaThe compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atria
ChEMBL 415 7 4 7 2.9 C/C(=N\OCC(O)CNC(C)(C)C)c1cc(Cl)c(NC2=NCCN2)c(Cl)c1 10.1021/jm00115a008
135079 17274 1 None 9772 2 Guinea pig 8.4 pKd = 8.4 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 479 12 3 7 4.4 COc1ccc(CCNCC(O)COc2ccc(-c3nc(-c4cccs4)c[nH]3)cc2)cc1OC 10.1021/jm00361a004
CHEMBL11671 17274 1 None 9772 2 Guinea pig 8.4 pKd = 8.4 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 479 12 3 7 4.4 COc1ccc(CCNCC(O)COc2ccc(-c3nc(-c4cccs4)c[nH]3)cc2)cc1OC 10.1021/jm00361a004
14201539 210302 0 None 1 2 Guinea pig 7.4 pKd = 7.4 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 271 4 2 3 2.7 O[C@H](COc1ccc2ccccc2c1)[C@H]1CCCCN1 10.1021/jm00119a011
CHEMBL66384 210302 0 None 1 2 Guinea pig 7.4 pKd = 7.4 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 271 4 2 3 2.7 O[C@H](COc1ccc2ccccc2c1)[C@H]1CCCCN1 10.1021/jm00119a011
2249 7300 111 None 2 12 Guinea pig 7.4 pKd = 7.4 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm00208a015
255 7300 111 None 2 12 Guinea pig 7.4 pKd = 7.4 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm00208a015
548 7300 111 None 2 12 Guinea pig 7.4 pKd = 7.4 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm00208a015
CHEMBL24 7300 111 None 2 12 Guinea pig 7.4 pKd = 7.4 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm00208a015
DB00335 7300 111 None 2 12 Guinea pig 7.4 pKd = 7.4 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm00208a015
13621723 16725 0 None 1698 2 Guinea pig 7.4 pKd = 7.4 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 395 10 5 5 2.2 O=C(NCCNCC(O)COc1ccc(-c2ncc[nH]2)cc1)Nc1ccccc1 10.1021/jm00156a028
CHEMBL11467 16725 0 None 1698 2 Guinea pig 7.4 pKd = 7.4 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 395 10 5 5 2.2 O=C(NCCNCC(O)COc1ccc(-c2ncc[nH]2)cc1)Nc1ccccc1 10.1021/jm00156a028
13621665 105273 0 None 1412 2 Guinea pig 7.4 pKd = 7.4 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 455 14 3 7 2.9 COCCc1c[nH]c(-c2ccc(OCC(O)CNCCc3ccc(OC)c(OC)c3)cc2)n1 10.1021/jm00156a028
CHEMBL276029 105273 0 None 1412 2 Guinea pig 7.4 pKd = 7.4 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 455 14 3 7 2.9 COCCc1c[nH]c(-c2ccc(OCC(O)CNCCc3ccc(OC)c(OC)c3)cc2)n1 10.1021/jm00156a028
328583 117310 2 None -676 2 Guinea pig 4.4 pKd = 4.4 Binding
Inhibition of beta1-adrenergic receptor in guinea pig auricle assessed as reversal of isoproterenol-induced effectInhibition of beta1-adrenergic receptor in guinea pig auricle assessed as reversal of isoproterenol-induced effect
ChEMBL 177 2 2 2 1.5 CC1(C)NC1C(O)c1ccccc1 10.1021/jm00199a012
CHEMBL3251298 117310 2 None -676 2 Guinea pig 4.4 pKd = 4.4 Binding
Inhibition of beta1-adrenergic receptor in guinea pig auricle assessed as reversal of isoproterenol-induced effectInhibition of beta1-adrenergic receptor in guinea pig auricle assessed as reversal of isoproterenol-induced effect
ChEMBL 177 2 2 2 1.5 CC1(C)NC1C(O)c1ccccc1 10.1021/jm00199a012
29074692 166518 13 None -2 2 Human 4.4 pKd = 4.4 Binding
Displacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting methodDisplacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting method
ChEMBL 339 4 1 5 3.4 COc1cccc(/C=C2\Oc3c(CN(C)C)c(O)cc(C)c3C2=O)c1 10.1021/acsmedchemlett.6b00363
8073977 166518 13 None -2 2 Human 4.4 pKd = 4.4 Binding
Displacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting methodDisplacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting method
ChEMBL 339 4 1 5 3.4 COc1cccc(/C=C2\Oc3c(CN(C)C)c(O)cc(C)c3C2=O)c1 10.1021/acsmedchemlett.6b00363
CHEMBL4104850 166518 13 None -2 2 Human 4.4 pKd = 4.4 Binding
Displacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting methodDisplacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting method
ChEMBL 339 4 1 5 3.4 COc1cccc(/C=C2\Oc3c(CN(C)C)c(O)cc(C)c3C2=O)c1 10.1021/acsmedchemlett.6b00363
2184756 62670 3 None -12 2 Human 4.3 pKd = 4.3 Binding
Displacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting methodDisplacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting method
ChEMBL 285 8 0 3 3.3 CN(C)CCOCCOc1ccccc1-c1ccccc1 10.1021/acsmedchemlett.6b00363
CHEMBL1623548 62670 3 None -12 2 Human 4.3 pKd = 4.3 Binding
Displacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting methodDisplacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting method
ChEMBL 285 8 0 3 3.3 CN(C)CCOCCOc1ccccc1-c1ccccc1 10.1021/acsmedchemlett.6b00363
71662246 95037 0 None 11 2 Human 7.3 pKd = 7.3 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 471 14 4 6 3.5 Cc1ccccc1NC(=O)NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1 10.1021/jm400348g
CHEMBL2348212 95037 0 None 11 2 Human 7.3 pKd = 7.3 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 471 14 4 6 3.5 Cc1ccccc1NC(=O)NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1 10.1021/jm400348g
29057664 164904 13 None -1 2 Human 4.3 pKd = 4.3 Binding
Displacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting methodDisplacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting method
ChEMBL 309 3 1 4 3.4 Cc1cc(O)c(CN(C)C)c2c1C(=O)/C(=C/c1ccccc1)O2 10.1021/acsmedchemlett.6b00363
8035384 164904 13 None -1 2 Human 4.3 pKd = 4.3 Binding
Displacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting methodDisplacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting method
ChEMBL 309 3 1 4 3.4 Cc1cc(O)c(CN(C)C)c2c1C(=O)/C(=C/c1ccccc1)O2 10.1021/acsmedchemlett.6b00363
CHEMBL4086982 164904 13 None -1 2 Human 4.3 pKd = 4.3 Binding
Displacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting methodDisplacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting method
ChEMBL 309 3 1 4 3.4 Cc1cc(O)c(CN(C)C)c2c1C(=O)/C(=C/c1ccccc1)O2 10.1021/acsmedchemlett.6b00363
44459922 103588 0 None 4 2 Guinea pig 7.3 pKd = 7.3 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 230 6 2 4 1.8 C/C(=N/OCC(O)CNC(C)(C)C)C(C)C 10.1021/jm00376a011
CHEMBL26506 103588 0 None 4 2 Guinea pig 7.3 pKd = 7.3 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 230 6 2 4 1.8 C/C(=N/OCC(O)CNC(C)(C)C)C(C)C 10.1021/jm00376a011
13302060 19607 0 None 112 2 Guinea pig 6.3 pKd = 6.3 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 411 11 2 7 2.7 COc1ccc(CCNCC(O)COc2ccc(-c3nccn3C)cc2)cc1OC 10.1021/jm00156a028
CHEMBL1188509 19607 0 None 112 2 Guinea pig 6.3 pKd = 6.3 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 411 11 2 7 2.7 COc1ccc(CCNCC(O)COc2ccc(-c3nccn3C)cc2)cc1OC 10.1021/jm00156a028
CHEMBL536552 19607 0 None 112 2 Guinea pig 6.3 pKd = 6.3 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 411 11 2 7 2.7 COc1ccc(CCNCC(O)COc2ccc(-c3nccn3C)cc2)cc1OC 10.1021/jm00156a028
21595422 108995 0 None 2 2 Guinea pig 7.3 pKd = 7.3 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 235 5 2 3 1.7 O[C@H](COCc1ccccc1)[C@@H]1CCCCN1 10.1021/jm00119a011
CHEMBL302935 108995 0 None 2 2 Guinea pig 7.3 pKd = 7.3 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 235 5 2 3 1.7 O[C@H](COCc1ccccc1)[C@@H]1CCCCN1 10.1021/jm00119a011
12606684 102849 3 None -15 2 Guinea pig 6.3 pKd = 6.3 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 203 6 2 3 1.4 CC(C)COCC(O)CNC(C)(C)C 10.1021/jm00376a011
CHEMBL1161388 102849 3 None -15 2 Guinea pig 6.3 pKd = 6.3 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 203 6 2 3 1.4 CC(C)COCC(O)CNC(C)(C)C 10.1021/jm00376a011
CHEMBL26003 102849 3 None -15 2 Guinea pig 6.3 pKd = 6.3 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 203 6 2 3 1.4 CC(C)COCC(O)CNC(C)(C)C 10.1021/jm00376a011
12548683 29614 0 None 2 2 Guinea pig 8.3 pKd = 8.3 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 267 7 2 5 1.2 COC(=O)c1ccccc1OCC(O)CNC(C)C 10.1021/jm00354a003
CHEMBL13284 29614 0 None 2 2 Guinea pig 8.3 pKd = 8.3 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 267 7 2 5 1.2 COC(=O)c1ccccc1OCC(O)CNC(C)C 10.1021/jm00354a003
10467512 106664 0 None -2 2 Guinea pig 8.3 pKd = 8.3 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 254 7 2 4 1.9 CC(C)(C)NCC(O)CON=C(C1CC1)C1CC1 10.1021/jm00376a011
CHEMBL285972 106664 0 None -2 2 Guinea pig 8.3 pKd = 8.3 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 254 7 2 4 1.9 CC(C)(C)NCC(O)CON=C(C1CC1)C1CC1 10.1021/jm00376a011
13621599 16669 0 None 3981 2 Guinea pig 8.3 pKd = 8.3 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 513 12 3 7 5.0 COc1ccc(CCNCC(O)COc2ccc(-c3nc(-c4cccs4)c[nH]3)cc2Cl)cc1OC 10.1021/jm00156a028
CHEMBL11431 16669 0 None 3981 2 Guinea pig 8.3 pKd = 8.3 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 513 12 3 7 5.0 COc1ccc(CCNCC(O)COc2ccc(-c3nc(-c4cccs4)c[nH]3)cc2Cl)cc1OC 10.1021/jm00156a028
13040884 30554 0 None 15 2 Guinea pig 8.3 pKd = 8.3 Binding
The compound was tested in vitro for its ability to block Beta-1 adrenergic receptor in guinea pig right atriaThe compound was tested in vitro for its ability to block Beta-1 adrenergic receptor in guinea pig right atria
ChEMBL 389 11 2 7 2.1 COC(=O)c1ccccc1OCC(O)CNCCc1ccc(OC)c(OC)c1 10.1021/jm00354a003
CHEMBL13358 30554 0 None 15 2 Guinea pig 8.3 pKd = 8.3 Binding
The compound was tested in vitro for its ability to block Beta-1 adrenergic receptor in guinea pig right atriaThe compound was tested in vitro for its ability to block Beta-1 adrenergic receptor in guinea pig right atria
ChEMBL 389 11 2 7 2.1 COC(=O)c1ccccc1OCC(O)CNCCc1ccc(OC)c(OC)c1 10.1021/jm00354a003
13621796 16220 0 None 1659 2 Guinea pig 8.3 pKd = 8.3 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 480 12 3 8 3.8 COc1ccc(CCNCC(O)COc2ccc(-c3nc(-c4cccs4)c[nH]3)cn2)cc1OC 10.1021/jm00156a028
CHEMBL11178 16220 0 None 1659 2 Guinea pig 8.3 pKd = 8.3 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 480 12 3 8 3.8 COc1ccc(CCNCC(O)COc2ccc(-c3nc(-c4cccs4)c[nH]3)cn2)cc1OC 10.1021/jm00156a028
13157365 134587 0 None 239 2 Guinea pig 8.3 pKd = 8.3 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 465 11 3 6 3.7 COc1ccc(CCNCC(O)COc2ccc(-c3nc(C(F)(F)F)c[nH]3)cc2)cc1OC 10.1021/jm00361a004
CHEMBL366389 134587 0 None 239 2 Guinea pig 8.3 pKd = 8.3 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 465 11 3 6 3.7 COc1ccc(CCNCC(O)COc2ccc(-c3nc(C(F)(F)F)c[nH]3)cc2)cc1OC 10.1021/jm00361a004
12462216 119446 0 None 2 2 Guinea pig 8.2 pKd = 8.2 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 287 5 2 3 2.5 COc1cc(Br)ccc1C(O)CNC(C)C 10.1021/jm00208a015
CHEMBL3246228 119446 0 None 2 2 Guinea pig 8.2 pKd = 8.2 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 287 5 2 3 2.5 COc1cc(Br)ccc1C(O)CNC(C)C 10.1021/jm00208a015
CHEMBL3303705 119446 0 None 2 2 Guinea pig 8.2 pKd = 8.2 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 287 5 2 3 2.5 COc1cc(Br)ccc1C(O)CNC(C)C 10.1021/jm00208a015
13040883 105951 1 None -1 2 Guinea pig 7.3 pKd = 7.3 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 297 8 3 6 0.6 COC(=O)c1ccccc1OCC(O)CNC(C)(C)CO 10.1021/jm00354a003
CHEMBL281298 105951 1 None -1 2 Guinea pig 7.3 pKd = 7.3 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 297 8 3 6 0.6 COC(=O)c1ccccc1OCC(O)CNC(C)(C)CO 10.1021/jm00354a003
13040896 108985 2 None 15 2 Guinea pig 7.3 pKd = 7.3 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 293 8 2 5 1.6 COC(=O)/C=C/c1ccc(OCC(O)CNC(C)C)cc1 10.1021/jm00354a003
CHEMBL30289 108985 2 None 15 2 Guinea pig 7.3 pKd = 7.3 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 293 8 2 5 1.6 COC(=O)/C=C/c1ccc(OCC(O)CNC(C)C)cc1 10.1021/jm00354a003
9970852 117248 0 None 25 2 Rat 7.3 pKd = 7.3 Binding
Antagonist activity at beta1 adrenergic receptor in isolated rat atriaAntagonist activity at beta1 adrenergic receptor in isolated rat atria
ChEMBL 279 8 2 4 2.5 C/C=C/c1ccc(OCC(O)CNC(C)C)c(OC)c1 10.1021/jm00207a025
CHEMBL3247308 117248 0 None 25 2 Rat 7.3 pKd = 7.3 Binding
Antagonist activity at beta1 adrenergic receptor in isolated rat atriaAntagonist activity at beta1 adrenergic receptor in isolated rat atria
ChEMBL 279 8 2 4 2.5 C/C=C/c1ccc(OCC(O)CNC(C)C)c(OC)c1 10.1021/jm00207a025
15578573 114139 2 None 25 2 Guinea pig 7.3 pKd = 7.3 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 267 9 2 5 1.0 CCOC(=O)CCNCC(O)COc1ccccc1 10.1021/jm00354a002
CHEMBL31772 114139 2 None 25 2 Guinea pig 7.3 pKd = 7.3 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 267 9 2 5 1.0 CCOC(=O)CCNCC(O)COc1ccccc1 10.1021/jm00354a002
13621595 14366 0 None 575 2 Guinea pig 7.3 pKd = 7.3 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 489 11 3 6 3.7 COc1ccc(CCNCC(O)COc2ccc(-c3nc(C)c[nH]3)cc2Br)cc1OC 10.1021/jm00156a028
CHEMBL10879 14366 0 None 575 2 Guinea pig 7.3 pKd = 7.3 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 489 11 3 6 3.7 COc1ccc(CCNCC(O)COc2ccc(-c3nc(C)c[nH]3)cc2Br)cc1OC 10.1021/jm00156a028
13040890 111191 0 None 3 2 Guinea pig 6.3 pKd = 6.3 Binding
Activity at beta-1 adrenergic receptorActivity at beta-1 adrenergic receptor
ChEMBL 279 8 2 5 1.7 C=COC(=O)c1ccc(OCC(O)CNC(C)C)cc1 10.1021/jm00103a004
CHEMBL31036 111191 0 None 3 2 Guinea pig 6.3 pKd = 6.3 Binding
Activity at beta-1 adrenergic receptorActivity at beta-1 adrenergic receptor
ChEMBL 279 8 2 5 1.7 C=COC(=O)c1ccc(OCC(O)CNC(C)C)cc1 10.1021/jm00103a004
13040890 111191 0 None 3 2 Guinea pig 6.3 pKd = 6.3 Binding
The compound was tested in vitro for its ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationThe compound was tested in vitro for its ability to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 279 8 2 5 1.7 C=COC(=O)c1ccc(OCC(O)CNC(C)C)cc1 10.1021/jm00354a003
CHEMBL31036 111191 0 None 3 2 Guinea pig 6.3 pKd = 6.3 Binding
The compound was tested in vitro for its ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationThe compound was tested in vitro for its ability to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 279 8 2 5 1.7 C=COC(=O)c1ccc(OCC(O)CNC(C)C)cc1 10.1021/jm00354a003
14348818 116551 0 None -5 3 Guinea pig 4.3 pKd = 4.3 Binding
The compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig left atriaThe compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig left atria
ChEMBL 415 7 4 7 2.9 C/C(=N\OCC(O)CNC(C)(C)C)c1cc(Cl)c(NC2=NCCN2)c(Cl)c1 10.1021/jm00115a008
CHEMBL323176 116551 0 None -5 3 Guinea pig 4.3 pKd = 4.3 Binding
The compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig left atriaThe compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig left atria
ChEMBL 415 7 4 7 2.9 C/C(=N\OCC(O)CNC(C)(C)C)c1cc(Cl)c(NC2=NCCN2)c(Cl)c1 10.1021/jm00115a008
14348819 16195 0 None - 1 Guinea pig 4.3 pKd = 4.3 Binding
The compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atriaThe compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atria
ChEMBL 374 6 4 6 2.5 CC(C)(C)NCC(O)COc1cc(Cl)c(NC2=NCCN2)c(Cl)c1 10.1021/jm00115a008
CHEMBL111694 16195 0 None - 1 Guinea pig 4.3 pKd = 4.3 Binding
The compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atriaThe compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atria
ChEMBL 374 6 4 6 2.5 CC(C)(C)NCC(O)COc1cc(Cl)c(NC2=NCCN2)c(Cl)c1 10.1021/jm00115a008
14348818 116551 0 None -5 3 Guinea pig 4.3 pKd = 4.3 Binding
The compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atriaThe compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atria
ChEMBL 415 7 4 7 2.9 C/C(=N\OCC(O)CNC(C)(C)C)c1cc(Cl)c(NC2=NCCN2)c(Cl)c1 10.1021/jm00115a008
CHEMBL323176 116551 0 None -5 3 Guinea pig 4.3 pKd = 4.3 Binding
The compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atriaThe compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atria
ChEMBL 415 7 4 7 2.9 C/C(=N\OCC(O)CNC(C)(C)C)c1cc(Cl)c(NC2=NCCN2)c(Cl)c1 10.1021/jm00115a008
13157384 85114 0 None - 1 Guinea pig 7.3 pKd = 7.3 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 479 12 3 7 4.4 COc1ccc(CCNC[C@@H](O)COc2ccc(-c3nc(-c4cccs4)c[nH]3)cc2)cc1OC 10.1021/jm00361a004
CHEMBL2093062 85114 0 None - 1 Guinea pig 7.3 pKd = 7.3 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 479 12 3 7 4.4 COc1ccc(CCNC[C@@H](O)COc2ccc(-c3nc(-c4cccs4)c[nH]3)cc2)cc1OC 10.1021/jm00361a004
CHEMBL2109975 85114 0 None - 1 Guinea pig 7.3 pKd = 7.3 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 479 12 3 7 4.4 COc1ccc(CCNC[C@@H](O)COc2ccc(-c3nc(-c4cccs4)c[nH]3)cc2)cc1OC 10.1021/jm00361a004
54757229 72289 0 None -33 3 Human 7.3 pKd = 7.3 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 795 22 4 8 6.3 C=CCc1ccccc1OCC(O)CNCCNC(=O)CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1 10.1021/jm2008562
CHEMBL1830617 72289 0 None -33 3 Human 7.3 pKd = 7.3 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 795 22 4 8 6.3 C=CCc1ccccc1OCC(O)CNCCNC(=O)CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1 10.1021/jm2008562
44307572 209833 0 None 1 2 Guinea pig 7.3 pKd = 7.3 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 235 4 1 3 1.9 CN1CCCC[C@H]1[C@H](O)COc1ccccc1 10.1021/jm00119a011
CHEMBL63582 209833 0 None 1 2 Guinea pig 7.3 pKd = 7.3 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 235 4 1 3 1.9 CN1CCCC[C@H]1[C@H](O)COc1ccccc1 10.1021/jm00119a011
54757026 72264 0 None -74 3 Human 7.3 pKd = 7.3 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 833 22 4 8 7.5 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCCCNCC(O)COc1cccc2ccccc12 10.1021/jm2008562
CHEMBL1830489 72264 0 None -74 3 Human 7.3 pKd = 7.3 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 833 22 4 8 7.5 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCCCNCC(O)COc1cccc2ccccc12 10.1021/jm2008562
173 10036 95 None -69 23 Human 5.3 pKd = 5.3 Binding
Binding affinity to His-tagged human beta1 adrenergic receptor expressed in HEK293 cell membranes by surface plasmon resonance analysisBinding affinity to His-tagged human beta1 adrenergic receptor expressed in HEK293 cell membranes by surface plasmon resonance analysis
ChEMBL 213 1 1 3 1.6 N1CCN(CC1)c1ccc2c(n1)cccc2 10.1021/jm400140q
5011 10036 95 None -69 23 Human 5.3 pKd = 5.3 Binding
Binding affinity to His-tagged human beta1 adrenergic receptor expressed in HEK293 cell membranes by surface plasmon resonance analysisBinding affinity to His-tagged human beta1 adrenergic receptor expressed in HEK293 cell membranes by surface plasmon resonance analysis
ChEMBL 213 1 1 3 1.6 N1CCN(CC1)c1ccc2c(n1)cccc2 10.1021/jm400140q
CHEMBL18772 10036 95 None -69 23 Human 5.3 pKd = 5.3 Binding
Binding affinity to His-tagged human beta1 adrenergic receptor expressed in HEK293 cell membranes by surface plasmon resonance analysisBinding affinity to His-tagged human beta1 adrenergic receptor expressed in HEK293 cell membranes by surface plasmon resonance analysis
ChEMBL 213 1 1 3 1.6 N1CCN(CC1)c1ccc2c(n1)cccc2 10.1021/jm400140q
173 10036 95 None -69 23 Human 5.3 pKd = 5.3 Binding
Binding affinity to His-tagged human beta1 adrenergic receptor expressed in HEK293 cell membranes by surface plasmon resonance analysisBinding affinity to His-tagged human beta1 adrenergic receptor expressed in HEK293 cell membranes by surface plasmon resonance analysis
ChEMBL 213 1 1 3 1.6 N1CCN(CC1)c1ccc2c(n1)cccc2 10.1021/jm400140q
5011 10036 95 None -69 23 Human 5.3 pKd = 5.3 Binding
Binding affinity to His-tagged human beta1 adrenergic receptor expressed in HEK293 cell membranes by surface plasmon resonance analysisBinding affinity to His-tagged human beta1 adrenergic receptor expressed in HEK293 cell membranes by surface plasmon resonance analysis
ChEMBL 213 1 1 3 1.6 N1CCN(CC1)c1ccc2c(n1)cccc2 10.1021/jm400140q
CHEMBL18772 10036 95 None -69 23 Human 5.3 pKd = 5.3 Binding
Binding affinity to His-tagged human beta1 adrenergic receptor expressed in HEK293 cell membranes by surface plasmon resonance analysisBinding affinity to His-tagged human beta1 adrenergic receptor expressed in HEK293 cell membranes by surface plasmon resonance analysis
ChEMBL 213 1 1 3 1.6 N1CCN(CC1)c1ccc2c(n1)cccc2 10.1021/jm400140q
21595420 210491 0 None -1 2 Guinea pig 7.2 pKd = 7.2 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 235 4 2 3 1.9 Cc1ccc(OC[C@@H](O)[C@@H]2CCCCN2)cc1 10.1021/jm00119a011
CHEMBL67631 210491 0 None -1 2 Guinea pig 7.2 pKd = 7.2 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 235 4 2 3 1.9 Cc1ccc(OC[C@@H](O)[C@@H]2CCCCN2)cc1 10.1021/jm00119a011
13590031 16172 0 None - 1 Guinea pig 7.2 pKd = 7.2 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 414 11 2 7 3.4 COc1ccc(CCNCC(O)COc2ccc(-c3nccs3)cc2)cc1OC 10.1021/jm00156a028
CHEMBL11155 16172 0 None - 1 Guinea pig 7.2 pKd = 7.2 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 414 11 2 7 3.4 COc1ccc(CCNCC(O)COc2ccc(-c3nccs3)cc2)cc1OC 10.1021/jm00156a028
2303 9961 68 None -9 26 Human 8.2 pKd = 8.2 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm2008562
4946 9961 68 None -9 26 Human 8.2 pKd = 8.2 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm2008562
564 9961 68 None -9 26 Human 8.2 pKd = 8.2 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm2008562
63 9961 68 None -9 26 Human 8.2 pKd = 8.2 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm2008562
91536 9961 68 None -9 26 Human 8.2 pKd = 8.2 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm2008562
CHEMBL27 9961 68 None -9 26 Human 8.2 pKd = 8.2 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm2008562
CHEMBL452861 9961 68 None -9 26 Human 8.2 pKd = 8.2 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm2008562
DB00571 9961 68 None -9 26 Human 8.2 pKd = 8.2 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm2008562
13157380 68911 0 None 2041 2 Guinea pig 8.2 pKd = 8.2 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 493 12 3 7 4.8 COc1ccc(CC(C)NCC(O)COc2ccc(-c3nc(-c4cccs4)c[nH]3)cc2)cc1OC 10.1021/jm00361a004
CHEMBL177765 68911 0 None 2041 2 Guinea pig 8.2 pKd = 8.2 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 493 12 3 7 4.8 COc1ccc(CC(C)NCC(O)COc2ccc(-c3nc(-c4cccs4)c[nH]3)cc2)cc1OC 10.1021/jm00361a004
13621686 16619 0 None 575 2 Guinea pig 8.2 pKd = 8.2 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 469 13 3 8 2.8 CCOC(=O)c1c[nH]c(-c2ccc(OCC(O)CNCCc3ccc(OC)c(OC)c3)cc2)n1 10.1021/jm00156a028
CHEMBL11406 16619 0 None 575 2 Guinea pig 8.2 pKd = 8.2 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 469 13 3 8 2.8 CCOC(=O)c1c[nH]c(-c2ccc(OCC(O)CNCCc3ccc(OC)c(OC)c3)cc2)n1 10.1021/jm00156a028
66653268 95026 0 None 426 3 Human 8.2 pKd = 8.2 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 491 14 4 6 3.8 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1cccc(Cl)c1 10.1021/jm400348g
CHEMBL2348201 95026 0 None 426 3 Human 8.2 pKd = 8.2 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 491 14 4 6 3.8 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1cccc(Cl)c1 10.1021/jm400348g
13157405 84740 0 None 141 2 Guinea pig 8.2 pKd = 8.2 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 355 8 3 5 3.3 O[C@@H](CNC1CC1)COc1ccc(-c2nc(-c3cccs3)c[nH]2)cc1 10.1021/jm00361a004
CHEMBL2096750 84740 0 None 141 2 Guinea pig 8.2 pKd = 8.2 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 355 8 3 5 3.3 O[C@@H](CNC1CC1)COc1ccc(-c2nc(-c3cccs3)c[nH]2)cc1 10.1021/jm00361a004
135817 175071 15 None - 1 Guinea pig 8.2 pKd = 8.2 Binding
Activity at beta-1 adrenergic receptorActivity at beta-1 adrenergic receptor
ChEMBL 391 13 2 5 3.2 CC(C)NCC(O)COc1ccc(OCCOCCc2ccc(F)cc2)cc1 10.1021/jm00103a004
CHEMBL43405 175071 15 None - 1 Guinea pig 8.2 pKd = 8.2 Binding
Activity at beta-1 adrenergic receptorActivity at beta-1 adrenergic receptor
ChEMBL 391 13 2 5 3.2 CC(C)NCC(O)COc1ccc(OCCOCCc2ccc(F)cc2)cc1 10.1021/jm00103a004
13157402 175125 0 None 398 2 Guinea pig 8.2 pKd = 8.2 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 355 8 3 5 3.3 OC(CNC1CC1)COc1ccc(-c2nc(-c3cccs3)c[nH]2)cc1 10.1021/jm00361a004
CHEMBL434360 175125 0 None 398 2 Guinea pig 8.2 pKd = 8.2 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 355 8 3 5 3.3 OC(CNC1CC1)COc1ccc(-c2nc(-c3cccs3)c[nH]2)cc1 10.1021/jm00361a004
13621716 82723 0 None 165 2 Guinea pig 8.2 pKd = 8.2 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 387 11 3 6 3.2 CCOCCNC[C@H](O)COc1ccc(-c2nc(-c3cccs3)c[nH]2)cc1 10.1021/jm00156a028
CHEMBL2052005 82723 0 None 165 2 Guinea pig 8.2 pKd = 8.2 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 387 11 3 6 3.2 CCOCCNC[C@H](O)COc1ccc(-c2nc(-c3cccs3)c[nH]2)cc1 10.1021/jm00156a028
56599101 95023 0 None 42 2 Human 8.2 pKd = 8.2 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 475 14 4 6 3.3 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1cccc(F)c1 10.1021/jm400348g
CHEMBL2348198 95023 0 None 42 2 Human 8.2 pKd = 8.2 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 475 14 4 6 3.3 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1cccc(F)c1 10.1021/jm400348g
10467512 106664 0 None -2 2 Guinea pig 8.2 pKd = 8.2 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atria
ChEMBL 254 7 2 4 1.9 CC(C)(C)NCC(O)CON=C(C1CC1)C1CC1 10.1021/jm00145a008
CHEMBL285972 106664 0 None -2 2 Guinea pig 8.2 pKd = 8.2 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atria
ChEMBL 254 7 2 4 1.9 CC(C)(C)NCC(O)CON=C(C1CC1)C1CC1 10.1021/jm00145a008
13621772 16035 0 None 301 2 Guinea pig 8.2 pKd = 8.2 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 441 14 3 7 2.7 COc1ccc(CCNCC(O)COc2ccc(COCc3ncc[nH]3)cc2)cc1OC 10.1021/jm00156a028
CHEMBL11080 16035 0 None 301 2 Guinea pig 8.2 pKd = 8.2 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 441 14 3 7 2.7 COc1ccc(CCNCC(O)COc2ccc(COCc3ncc[nH]3)cc2)cc1OC 10.1021/jm00156a028
12521588 67155 0 None 10 2 Guinea pig 7.2 pKd = 7.2 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 289 6 3 4 2.2 CC(C)(C)NCC(O)COc1ccc(-c2ncc[nH]2)cc1 10.1021/jm00361a004
CHEMBL174783 67155 0 None 10 2 Guinea pig 7.2 pKd = 7.2 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 289 6 3 4 2.2 CC(C)(C)NCC(O)COc1ccc(-c2ncc[nH]2)cc1 10.1021/jm00361a004
13157410 135114 0 None 446 2 Guinea pig 7.2 pKd = 7.2 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 287 7 3 4 1.9 Cc1c[nH]c(-c2ccc(OCC(O)CNC3CC3)cc2)n1 10.1021/jm00361a004
CHEMBL366573 135114 0 None 446 2 Guinea pig 7.2 pKd = 7.2 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 287 7 3 4 1.9 Cc1c[nH]c(-c2ccc(OCC(O)CNC3CC3)cc2)n1 10.1021/jm00361a004
12521605 173118 0 None 9 2 Guinea pig 7.2 pKd = 7.2 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 303 6 3 4 2.5 Cc1c[nH]c(-c2ccc(OCC(O)CNC(C)(C)C)cc2)n1 10.1021/jm00361a004
CHEMBL427297 173118 0 None 9 2 Guinea pig 7.2 pKd = 7.2 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 303 6 3 4 2.5 Cc1c[nH]c(-c2ccc(OCC(O)CNC(C)(C)C)cc2)n1 10.1021/jm00361a004
13621758 16556 0 None 3 2 Guinea pig 7.2 pKd = 7.2 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 317 7 3 4 2.4 Cc1c[nH]c(Cc2ccc(OCC(O)CNC(C)(C)C)cc2)n1 10.1021/jm00156a028
CHEMBL11362 16556 0 None 3 2 Guinea pig 7.2 pKd = 7.2 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 317 7 3 4 2.4 Cc1c[nH]c(Cc2ccc(OCC(O)CNC(C)(C)C)cc2)n1 10.1021/jm00156a028
24208809 117216 35 None -5 2 Guinea pig 6.2 pKd = 6.2 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 209 5 2 3 1.7 COc1ccccc1C(O)CNC(C)C 10.1021/jm00208a015
CHEMBL3246226 117216 35 None -5 2 Guinea pig 6.2 pKd = 6.2 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 209 5 2 3 1.7 COc1ccccc1C(O)CNC(C)C 10.1021/jm00208a015
2834364 41925 21 None -1 3 Guinea pig 7.2 pKd = 7.2 Binding
Activity at beta-1 adrenergic receptorActivity at beta-1 adrenergic receptor
ChEMBL 237 7 2 3 2.0 CCc1ccc(OCC(O)CNC(C)C)cc1 10.1021/jm00103a004
CHEMBL143467 41925 21 None -1 3 Guinea pig 7.2 pKd = 7.2 Binding
Activity at beta-1 adrenergic receptorActivity at beta-1 adrenergic receptor
ChEMBL 237 7 2 3 2.0 CCc1ccc(OCC(O)CNC(C)C)cc1 10.1021/jm00103a004
2834364 41925 21 None -1 3 Rat 7.2 pKd = 7.2 Binding
Antagonist activity at beta1 adrenergic receptor in isolated rat atriaAntagonist activity at beta1 adrenergic receptor in isolated rat atria
ChEMBL 237 7 2 3 2.0 CCc1ccc(OCC(O)CNC(C)C)cc1 10.1021/jm00207a025
CHEMBL143467 41925 21 None -1 3 Rat 7.2 pKd = 7.2 Binding
Antagonist activity at beta1 adrenergic receptor in isolated rat atriaAntagonist activity at beta1 adrenergic receptor in isolated rat atria
ChEMBL 237 7 2 3 2.0 CCc1ccc(OCC(O)CNC(C)C)cc1 10.1021/jm00207a025
60903220 117218 2 None 1 2 Guinea pig 6.2 pKd = 6.2 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 257 4 2 2 2.5 CC(C)NCC(O)c1cccc(Br)c1 10.1021/jm00208a015
CHEMBL3246229 117218 2 None 1 2 Guinea pig 6.2 pKd = 6.2 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 257 4 2 2 2.5 CC(C)NCC(O)c1cccc(Br)c1 10.1021/jm00208a015
15578561 111636 0 None -1 2 Guinea pig 6.2 pKd = 6.2 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 274 7 3 4 0.7 NC(=O)CNCC(O)COc1cccc2ccccc12 10.1021/jm00354a002
CHEMBL31099 111636 0 None -1 2 Guinea pig 6.2 pKd = 6.2 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 274 7 3 4 0.7 NC(=O)CNCC(O)COc1cccc2ccccc12 10.1021/jm00354a002
15578559 113909 0 None -1 2 Guinea pig 6.2 pKd = 6.2 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 303 8 2 5 1.7 CCOC(=O)CNCC(O)COc1cccc2ccccc12 10.1021/jm00354a002
CHEMBL31611 113909 0 None -1 2 Guinea pig 6.2 pKd = 6.2 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 303 8 2 5 1.7 CCOC(=O)CNCC(O)COc1cccc2ccccc12 10.1021/jm00354a002
15578570 106661 0 None - 1 Guinea pig 5.2 pKd = 5.2 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 329 8 2 5 3.0 CCOC(=O)c1cccc(NCC(O)COc2ccccc2C)c1 10.1021/jm00354a002
CHEMBL285958 106661 0 None - 1 Guinea pig 5.2 pKd = 5.2 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 329 8 2 5 3.0 CCOC(=O)c1cccc(NCC(O)COc2ccccc2C)c1 10.1021/jm00354a002
2803 7742 58 None -134 19 Guinea pig 4.2 pKd = 4.2 Binding
The compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig left atriaThe compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig left atria
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm00115a008
516 7742 58 None -134 19 Guinea pig 4.2 pKd = 4.2 Binding
The compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig left atriaThe compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig left atria
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm00115a008
704 7742 58 None -134 19 Guinea pig 4.2 pKd = 4.2 Binding
The compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig left atriaThe compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig left atria
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm00115a008
CHEMBL134 7742 58 None -134 19 Guinea pig 4.2 pKd = 4.2 Binding
The compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig left atriaThe compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig left atria
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm00115a008
DB00575 7742 58 None -134 19 Guinea pig 4.2 pKd = 4.2 Binding
The compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig left atriaThe compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig left atria
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm00115a008
13157369 66505 2 None - 1 Guinea pig 6.2 pKd = 6.2 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 273 7 3 4 1.6 OC(CNC1CC1)COc1ccc(-c2ncc[nH]2)cc1 10.1021/jm00361a004
CHEMBL172431 66505 2 None - 1 Guinea pig 6.2 pKd = 6.2 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 273 7 3 4 1.6 OC(CNC1CC1)COc1ccc(-c2ncc[nH]2)cc1 10.1021/jm00361a004
56597179 95044 0 None 501 2 Human 8.1 pKd = 8.1 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 473 14 5 7 2.9 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccc(O)cc1 10.1021/jm400348g
CHEMBL2348219 95044 0 None 501 2 Human 8.1 pKd = 8.1 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 473 14 5 7 2.9 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccc(O)cc1 10.1021/jm400348g
13621593 16062 0 None 204 2 Guinea pig 8.1 pKd = 8.1 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 509 11 3 6 4.1 COc1ccc(CCNCC(O)COc2ccc(-c3nc(Br)c[nH]3)cc2Cl)cc1OC 10.1021/jm00156a028
CHEMBL11092 16062 0 None 204 2 Guinea pig 8.1 pKd = 8.1 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 509 11 3 6 4.1 COc1ccc(CCNCC(O)COc2ccc(-c3nc(Br)c[nH]3)cc2Cl)cc1OC 10.1021/jm00156a028
13621626 16305 0 None 741 2 Guinea pig 8.1 pKd = 8.1 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 445 11 3 6 3.6 COc1ccc(CCNCC(O)COc2ccc(-c3nc(C)c(Cl)[nH]3)cc2)cc1OC 10.1021/jm00156a028
CHEMBL11224 16305 0 None 741 2 Guinea pig 8.1 pKd = 8.1 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 445 11 3 6 3.6 COc1ccc(CCNCC(O)COc2ccc(-c3nc(C)c(Cl)[nH]3)cc2)cc1OC 10.1021/jm00156a028
54757126 72267 0 None -57 3 Human 7.1 pKd = 7.1 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 893 26 4 10 6.8 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCOCCOCCNCC(O)COc1cccc2ccccc12 10.1021/jm2008562
CHEMBL1830492 72267 0 None -57 3 Human 7.1 pKd = 7.1 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 893 26 4 10 6.8 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCOCCOCCNCC(O)COc1cccc2ccccc12 10.1021/jm2008562
56599229 95025 0 None 37 2 Human 7.1 pKd = 7.1 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 491 14 4 6 3.8 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccccc1Cl 10.1021/jm400348g
CHEMBL2348200 95025 0 None 37 2 Human 7.1 pKd = 7.1 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 491 14 4 6 3.8 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccccc1Cl 10.1021/jm400348g
56599230 95028 0 None 10 2 Human 7.1 pKd = 7.1 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 535 14 4 6 3.9 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccccc1Br 10.1021/jm400348g
CHEMBL2348203 95028 0 None 10 2 Human 7.1 pKd = 7.1 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 535 14 4 6 3.9 O=C(NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1)Nc1ccccc1Br 10.1021/jm400348g
15578577 179350 0 None 1 2 Guinea pig 7.1 pKd = 7.1 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 303 8 2 5 1.7 COC(=O)CCNCC(O)COc1cccc2ccccc12 10.1021/jm00354a002
CHEMBL448775 179350 0 None 1 2 Guinea pig 7.1 pKd = 7.1 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 303 8 2 5 1.7 COC(=O)CCNCC(O)COc1cccc2ccccc12 10.1021/jm00354a002
13040907 113855 0 None 19 2 Guinea pig 6.1 pKd = 6.1 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 371 12 2 5 2.8 COC(=O)CCc1ccc(OCC(O)CNCCCc2ccccc2)cc1 10.1021/jm00354a003
CHEMBL31583 113855 0 None 19 2 Guinea pig 6.1 pKd = 6.1 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
ChEMBL 371 12 2 5 2.8 COC(=O)CCc1ccc(OCC(O)CNCCCc2ccccc2)cc1 10.1021/jm00354a003
59373811 117220 7 None 2 2 Guinea pig 6.1 pKd = 6.1 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 193 4 2 2 2.0 Cc1cccc(C(O)CNC(C)C)c1 10.1021/jm00208a015
CHEMBL3246233 117220 7 None 2 2 Guinea pig 6.1 pKd = 6.1 Binding
Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 minsAntagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins
ChEMBL 193 4 2 2 2.0 Cc1cccc(C(O)CNC(C)C)c1 10.1021/jm00208a015
44279490 111425 0 None 1 2 Guinea pig 6.1 pKd = 6.1 Binding
The compound was tested in vitro for its ability to block Beta-1 adrenergic receptor in guinea pig right atriaThe compound was tested in vitro for its ability to block Beta-1 adrenergic receptor in guinea pig right atria
ChEMBL 297 9 2 5 1.8 CCOC(=O)CCNCC(O)COC1=CC=CCC1(C)C 10.1021/jm00354a002
CHEMBL31050 111425 0 None 1 2 Guinea pig 6.1 pKd = 6.1 Binding
The compound was tested in vitro for its ability to block Beta-1 adrenergic receptor in guinea pig right atriaThe compound was tested in vitro for its ability to block Beta-1 adrenergic receptor in guinea pig right atria
ChEMBL 297 9 2 5 1.8 CCOC(=O)CCNCC(O)COC1=CC=CCC1(C)C 10.1021/jm00354a002
15578569 117314 0 None - 1 Guinea pig 5.1 pKd = 5.1 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 329 8 2 5 3.0 CCOC(=O)c1ccc(NCC(O)COc2ccccc2C)cc1 10.1021/jm00354a002
CHEMBL32514 117314 0 None - 1 Guinea pig 5.1 pKd = 5.1 Binding
In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.In vitro ability to block beta-1 adrenergic receptor in guinea pig right atria.
ChEMBL 329 8 2 5 3.0 CCOC(=O)c1ccc(NCC(O)COc2ccccc2C)cc1 10.1021/jm00354a002
9576814 66196 6 None 2 2 Guinea pig 8.1 pKd = 8.1 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atria
ChEMBL 228 6 2 4 1.5 C/C(=N\OC[C@H](O)CNC(C)(C)C)C1CC1 10.1021/jm00145a008
CHEMBL171059 66196 6 None 2 2 Guinea pig 8.1 pKd = 8.1 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atria
ChEMBL 228 6 2 4 1.5 C/C(=N\OC[C@H](O)CNC(C)(C)C)C1CC1 10.1021/jm00145a008
21595419 108892 0 None 1 2 Guinea pig 8.1 pKd = 8.1 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 271 4 2 3 2.7 O[C@H](COc1ccc2ccccc2c1)[C@@H]1CCCCN1 10.1021/jm00119a011
CHEMBL302339 108892 0 None 1 2 Guinea pig 8.1 pKd = 8.1 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 271 4 2 3 2.7 O[C@H](COc1ccc2ccccc2c1)[C@@H]1CCCCN1 10.1021/jm00119a011
14201547 210344 0 None -2 2 Guinea pig 7.1 pKd = 7.1 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 235 5 2 3 1.7 O[C@H](COCc1ccccc1)[C@H]1CCCCN1 10.1021/jm00119a011
CHEMBL66702 210344 0 None -2 2 Guinea pig 7.1 pKd = 7.1 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 235 5 2 3 1.7 O[C@H](COCc1ccccc1)[C@H]1CCCCN1 10.1021/jm00119a011
44274623 103591 3 None 7 2 Guinea pig 7.1 pKd = 7.1 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 201 6 2 3 1.2 CC(C)(C)NCC(O)COCC1CC1 10.1021/jm00376a011
CHEMBL26507 103591 3 None 7 2 Guinea pig 7.1 pKd = 7.1 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 201 6 2 3 1.2 CC(C)(C)NCC(O)COCC1CC1 10.1021/jm00376a011
155774 10868 40 None 6 3 Human 7.1 pKd = 7.1 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 339 8 4 6 -0.2 OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1 10.1021/jm400348g
2848 10868 40 None 6 3 Human 7.1 pKd = 7.1 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 339 8 4 6 -0.2 OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1 10.1021/jm400348g
538 10868 40 None 6 3 Human 7.1 pKd = 7.1 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 339 8 4 6 -0.2 OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1 10.1021/jm400348g
CHEMBL75753 10868 40 None 6 3 Human 7.1 pKd = 7.1 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 339 8 4 6 -0.2 OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1 10.1021/jm400348g
DB13781 10868 40 None 6 3 Human 7.1 pKd = 7.1 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 339 8 4 6 -0.2 OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1 10.1021/jm400348g
44459541 102918 0 None -1 2 Guinea pig 7.1 pKd = 7.1 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 242 7 2 4 1.9 C/C(CC1CC1)=N/OCC(O)CNC(C)(C)C 10.1021/jm00376a011
CHEMBL26049 102918 0 None -1 2 Guinea pig 7.1 pKd = 7.1 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 242 7 2 4 1.9 C/C(CC1CC1)=N/OCC(O)CNC(C)(C)C 10.1021/jm00376a011
12484287 116493 0 None -2 2 Guinea pig 6.1 pKd = 6.1 Binding
Competitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial contractile forceCompetitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial contractile force
ChEMBL 249 6 3 4 1.3 CC(C)NCC(O)COc1ccc2[nH]cnc2c1 10.1021/jm00188a019
CHEMBL3228930 116493 0 None -2 2 Guinea pig 6.1 pKd = 6.1 Binding
Competitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial contractile forceCompetitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial contractile force
ChEMBL 249 6 3 4 1.3 CC(C)NCC(O)COc1ccc2[nH]cnc2c1 10.1021/jm00188a019
54758320 72292 0 None -13 3 Human 6.1 pKd = 6.1 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 794 20 5 8 6.1 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCNCC(O)COc1cccc2[nH]ccc12 10.1021/jm2008562
CHEMBL1830620 72292 0 None -13 3 Human 6.1 pKd = 6.1 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 794 20 5 8 6.1 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCNCC(O)COc1cccc2[nH]ccc12 10.1021/jm2008562
54756929 72263 0 None -50 3 Human 7.1 pKd = 7.1 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 805 20 4 8 6.7 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCNCC(O)COc1cccc2ccccc12 10.1021/jm2008562
CHEMBL1830488 72263 0 None -50 3 Human 7.1 pKd = 7.1 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 805 20 4 8 6.7 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCNCC(O)COc1cccc2ccccc12 10.1021/jm2008562
5311116 9114 9 None 48 3 Human 8.0 pKd = 8.0 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 484 15 5 8 2.2 N#Cc1cc(OCCOCC2CC2)ccc1OCC(CNCCNC(=O)Nc1ccc(cc1)O)O 10.1021/jm400348g
544 9114 9 None 48 3 Human 8.0 pKd = 8.0 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 484 15 5 8 2.2 N#Cc1cc(OCCOCC2CC2)ccc1OCC(CNCCNC(=O)Nc1ccc(cc1)O)O 10.1021/jm400348g
CHEMBL207802 9114 9 None 48 3 Human 8.0 pKd = 8.0 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 484 15 5 8 2.2 N#Cc1cc(OCCOCC2CC2)ccc1OCC(CNCCNC(=O)Nc1ccc(cc1)O)O 10.1021/jm400348g
56599098 95038 0 None 95 2 Human 8.0 pKd = 8.0 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 471 14 4 6 3.5 Cc1cccc(NC(=O)NCCNCC(O)COc2ccc(OCCOC3CCCC3)cc2)c1 10.1021/jm400348g
CHEMBL2348213 95038 0 None 95 2 Human 8.0 pKd = 8.0 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 471 14 4 6 3.5 Cc1cccc(NC(=O)NCCNCC(O)COc2ccc(OCCOC3CCCC3)cc2)c1 10.1021/jm400348g
13157382 69034 0 None 3981 2 Guinea pig 8.0 pKd = 8.0 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 507 12 3 7 5.2 COc1ccc(CC(C)(C)NCC(O)COc2ccc(-c3nc(-c4cccs4)c[nH]3)cc2)cc1OC 10.1021/jm00361a004
CHEMBL177860 69034 0 None 3981 2 Guinea pig 8.0 pKd = 8.0 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
ChEMBL 507 12 3 7 5.2 COc1ccc(CC(C)(C)NCC(O)COc2ccc(-c3nc(-c4cccs4)c[nH]3)cc2)cc1OC 10.1021/jm00361a004
2303 9961 68 None -15 26 Guinea pig 8.0 pKd = 8.0 Binding
Competitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial beat rateCompetitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial beat rate
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00188a019
4946 9961 68 None -15 26 Guinea pig 8.0 pKd = 8.0 Binding
Competitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial beat rateCompetitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial beat rate
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00188a019
564 9961 68 None -15 26 Guinea pig 8.0 pKd = 8.0 Binding
Competitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial beat rateCompetitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial beat rate
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00188a019
63 9961 68 None -15 26 Guinea pig 8.0 pKd = 8.0 Binding
Competitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial beat rateCompetitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial beat rate
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00188a019
91536 9961 68 None -15 26 Guinea pig 8.0 pKd = 8.0 Binding
Competitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial beat rateCompetitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial beat rate
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00188a019
CHEMBL27 9961 68 None -15 26 Guinea pig 8.0 pKd = 8.0 Binding
Competitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial beat rateCompetitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial beat rate
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00188a019
CHEMBL452861 9961 68 None -15 26 Guinea pig 8.0 pKd = 8.0 Binding
Competitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial beat rateCompetitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial beat rate
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00188a019
DB00571 9961 68 None -15 26 Guinea pig 8.0 pKd = 8.0 Binding
Competitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial beat rateCompetitive antagonist activity at beta-1 adrenergic receptor in guinea pig assessed as inhibition of isoproterenol-induced atrial beat rate
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00188a019
44459890 106785 0 None 8 2 Guinea pig 8.0 pKd = 8.0 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 214 6 2 4 1.1 CC(C)(C)NCC(O)CO/N=C\C1CC1 10.1021/jm00376a011
CHEMBL286783 106785 0 None 8 2 Guinea pig 8.0 pKd = 8.0 Binding
Beta-1 adrenergic receptor blocking activity in atria of guinea pig.Beta-1 adrenergic receptor blocking activity in atria of guinea pig.
ChEMBL 214 6 2 4 1.1 CC(C)(C)NCC(O)CO/N=C\C1CC1 10.1021/jm00376a011
54757129 72268 0 None -29 3 Human 7.0 pKd = 7.0 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 795 22 4 8 6.3 C=CCc1ccccc1OC[C@@H](O)CNCCNC(=O)CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1 10.1021/jm2008562
CHEMBL1830493 72268 0 None -29 3 Human 7.0 pKd = 7.0 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 795 22 4 8 6.3 C=CCc1ccccc1OC[C@@H](O)CNCCNC(=O)CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1 10.1021/jm2008562
56598833 95042 0 None - 1 Human 7.0 pKd = 7.0 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 433 14 5 7 2.0 CCOCCOc1ccc(OCC(O)CNCCNC(=O)Nc2ccc(O)cc2)cc1 10.1021/jm400348g
CHEMBL2348217 95042 0 None - 1 Human 7.0 pKd = 7.0 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 433 14 5 7 2.0 CCOCCOc1ccc(OCC(O)CNCCNC(=O)Nc2ccc(O)cc2)cc1 10.1021/jm400348g
13621725 16294 1 None - 1 Guinea pig 7.0 pKd = 7.0 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 389 12 5 5 1.8 CCCCNC(=O)NCCNCC(O)COc1ccc(-c2nc(C)c[nH]2)cc1 10.1021/jm00156a028
CHEMBL11219 16294 1 None - 1 Guinea pig 7.0 pKd = 7.0 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria
ChEMBL 389 12 5 5 1.8 CCCCNC(=O)NCCNCC(O)COc1ccc(-c2nc(C)c[nH]2)cc1 10.1021/jm00156a028
21595421 170247 0 None -28 2 Guinea pig 7.0 pKd = 7.0 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 235 4 2 3 1.9 Cc1cccc(OC[C@@H](O)[C@@H]2CCCCN2)c1 10.1021/jm00119a011
CHEMBL419994 170247 0 None -28 2 Guinea pig 7.0 pKd = 7.0 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
ChEMBL 235 4 2 3 1.9 Cc1cccc(OC[C@@H](O)[C@@H]2CCCCN2)c1 10.1021/jm00119a011
56599100 95040 0 None 12 2 Human 7.0 pKd = 7.0 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 487 15 4 7 3.2 COc1ccccc1NC(=O)NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1 10.1021/jm400348g
CHEMBL2348215 95040 0 None 12 2 Human 7.0 pKd = 7.0 Binding
Displacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-CGP12177 from human beta1 adrenoceptor expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 487 15 4 7 3.2 COc1ccccc1NC(=O)NCCNCC(O)COc1ccc(OCCOC2CCCC2)cc1 10.1021/jm400348g
6917762 16096 9 None -1 2 Guinea pig 7.0 pKd = 7.0 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atria
ChEMBL 228 6 2 4 1.5 C/C(=N\OCC(O)CNC(C)(C)C)C1CC1 10.1021/jm00145a008
CHEMBL111103 16096 9 None -1 2 Guinea pig 7.0 pKd = 7.0 Binding
In vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atriaIn vitro inhibitory activity against beta-1 adrenergic receptor determined as pA2 in guinea pig atria
ChEMBL 228 6 2 4 1.5 C/C(=N\OCC(O)CNC(C)(C)C)C1CC1 10.1021/jm00145a008
54758415 72293 0 None -6 3 Human 7.0 pKd = 7.0 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 882 26 5 10 6.1 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCOCCOCCNCC(O)COc1cccc2[nH]ccc12 10.1021/jm2008562
CHEMBL1830621 72293 0 None -6 3 Human 7.0 pKd = 7.0 Binding
Displacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cellsDisplacement of [3H]-CGP 12177 from human beta-1 adrenergic receptor expressed in CHOK1 cells
ChEMBL 882 26 5 10 6.1 O=C(CCCCCNC(=O)COc1ccc(/C=C/c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCOCCOCCNCC(O)COc1cccc2[nH]ccc12 10.1021/jm2008562
20986823 163635 8 None -4 2 Human 4.0 pKd = 4.0 Binding
Displacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting methodDisplacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting method
ChEMBL 243 5 0 3 2.6 CN(C)CCOc1ccc2ccccc2c1C=O 10.1021/acsmedchemlett.6b00363
CHEMBL4071616 163635 8 None -4 2 Human 4.0 pKd = 4.0 Binding
Displacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting methodDisplacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting method
ChEMBL 243 5 0 3 2.6 CN(C)CCOc1ccc2ccccc2c1C=O 10.1021/acsmedchemlett.6b00363
9849699 80039 16 None -1 2 Human 10.6 pKi = 10.6 Binding
Displacement of [125I]Iodocyanopindolol from human adrenergic beta1 receptor expressed in insect sf9 cells by scintillation countingDisplacement of [125I]Iodocyanopindolol from human adrenergic beta1 receptor expressed in insect sf9 cells by scintillation counting
ChEMBL 524 11 4 6 5.0 CC(C)(Cc1ccc(Oc2ccc(C(N)=O)cn2)cc1)NC[C@H](O)COc1cccc2[nH]c3ccccc3c12 10.1021/ml200071k
CHEMBL2012520 80039 16 None -1 2 Human 10.6 pKi = 10.6 Binding
Displacement of [125I]Iodocyanopindolol from human adrenergic beta1 receptor expressed in insect sf9 cells by scintillation countingDisplacement of [125I]Iodocyanopindolol from human adrenergic beta1 receptor expressed in insect sf9 cells by scintillation counting
ChEMBL 524 11 4 6 5.0 CC(C)(Cc1ccc(Oc2ccc(C(N)=O)cn2)cc1)NC[C@H](O)COc1cccc2[nH]c3ccccc3c12 10.1021/ml200071k
CHEMBL2012521 80039 16 None -1 2 Human 10.6 pKi = 10.6 Binding
Displacement of [125I]Iodocyanopindolol from human adrenergic beta1 receptor expressed in insect sf9 cells by scintillation countingDisplacement of [125I]Iodocyanopindolol from human adrenergic beta1 receptor expressed in insect sf9 cells by scintillation counting
ChEMBL 524 11 4 6 5.0 CC(C)(Cc1ccc(Oc2ccc(C(N)=O)cn2)cc1)NC[C@H](O)COc1cccc2[nH]c3ccccc3c12 10.1021/ml200071k
CHEMBL2012522 80039 16 None -1 2 Human 10.6 pKi = 10.6 Binding
Displacement of [125I]Iodocyanopindolol from human adrenergic beta1 receptor expressed in insect sf9 cells by scintillation countingDisplacement of [125I]Iodocyanopindolol from human adrenergic beta1 receptor expressed in insect sf9 cells by scintillation counting
ChEMBL 524 11 4 6 5.0 CC(C)(Cc1ccc(Oc2ccc(C(N)=O)cn2)cc1)NC[C@H](O)COc1cccc2[nH]c3ccccc3c12 10.1021/ml200071k
487 7580 71 None -8 7 Mouse 10.1 pKi = 10.1 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 298 6 3 3 3.1 OC(COc1cccc2c1c1ccccc1[nH]2)CNC(C)C 10.1021/acs.jmedchem.9b00349
569 7580 71 None -8 7 Mouse 10.1 pKi = 10.1 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 298 6 3 3 3.1 OC(COc1cccc2c1c1ccccc1[nH]2)CNC(C)C 10.1021/acs.jmedchem.9b00349
71739 7580 71 None -8 7 Mouse 10.1 pKi = 10.1 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 298 6 3 3 3.1 OC(COc1cccc2c1c1ccccc1[nH]2)CNC(C)C 10.1021/acs.jmedchem.9b00349
CHEMBL324665 7580 71 None -8 7 Mouse 10.1 pKi = 10.1 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 298 6 3 3 3.1 OC(COc1cccc2c1c1ccccc1[nH]2)CNC(C)C 10.1021/acs.jmedchem.9b00349
46889772 13767 0 None 79 3 Human 10.0 pKi = 10 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 563 8 2 6 5.2 COc1cc2c3c(cccc3c1)C(=O)N(CC1CCN(CC(O)COc3cccc4[nH]c5ccccc5c34)CC1)C2=O 10.1016/j.bmcl.2010.04.009
CHEMBL1084707 13767 0 None 79 3 Human 10.0 pKi = 10 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 563 8 2 6 5.2 COc1cc2c3c(cccc3c1)C(=O)N(CC1CCN(CC(O)COc3cccc4[nH]c5ccccc5c34)CC1)C2=O 10.1016/j.bmcl.2010.04.009
2585 7590 103 None -1 22 Human 10.0 pKi = 10.0 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
522 7590 103 None -1 22 Human 10.0 pKi = 10.0 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
551 7590 103 None -1 22 Human 10.0 pKi = 10.0 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
CHEMBL723 7590 103 None -1 22 Human 10.0 pKi = 10.0 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
DB01136 7590 103 None -1 22 Human 10.0 pKi = 10.0 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
185395 146624 45 None -6 3 Mouse 9.7 pKi = 9.7 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNC[C@H](O)COc1cccc2[nH]c3ccccc3c12 10.1021/acs.jmedchem.9b00349
CHEMBL3799125 146624 45 None -6 3 Mouse 9.7 pKi = 9.7 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNC[C@H](O)COc1cccc2[nH]c3ccccc3c12 10.1021/acs.jmedchem.9b00349
6603756 129682 4 None -2 2 Human 9.6 pKi = 9.6 Binding
Inhibition of I-iodocyanopindolol binding to human beta 1 adrenergic receptorsInhibition of I-iodocyanopindolol binding to human beta 1 adrenergic receptors
ChEMBL 279 5 4 5 1.4 CC(C)(C)NC[C@H](O)COc1cccc2[nH]c(O)nc12 10.1021/jm000544b
CHEMBL36060 129682 4 None -2 2 Human 9.6 pKi = 9.6 Binding
Inhibition of I-iodocyanopindolol binding to human beta 1 adrenergic receptorsInhibition of I-iodocyanopindolol binding to human beta 1 adrenergic receptors
ChEMBL 279 5 4 5 1.4 CC(C)(C)NC[C@H](O)COc1cccc2[nH]c(O)nc12 10.1021/jm000544b
127 9900 52 None 2 15 Human 9.4 pKi = 9.4 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 248 6 3 3 1.9 O[C@H](COc1cccc2c1cc[nH]2)CNC(C)C nan
688095 9900 52 None 2 15 Human 9.4 pKi = 9.4 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 248 6 3 3 1.9 O[C@H](COc1cccc2c1cc[nH]2)CNC(C)C nan
CHEMBL117405 9900 52 None 2 15 Human 9.4 pKi = 9.4 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 248 6 3 3 1.9 O[C@H](COc1cccc2c1cc[nH]2)CNC(C)C nan
155548437 180550 0 None -3 2 Mouse 9.3 pKi = 9.3 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 502 16 3 8 4.1 COc1cc(CCNC[C@H](O)COc2cccc3ccccc23)ccc1OCCSSCCN 10.1016/j.bmc.2019.05.034
CHEMBL4537221 180550 0 None -3 2 Mouse 9.3 pKi = 9.3 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 502 16 3 8 4.1 COc1cc(CCNC[C@H](O)COc2cccc3ccccc23)ccc1OCCSSCCN 10.1016/j.bmc.2019.05.034
2176 9901 68 None -4 27 Human 9.3 pKi = 9.3 Binding
Binding affinity at human adrenergic beta-1 receptorBinding affinity at human adrenergic beta-1 receptor
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 10.1016/j.bmcl.2007.07.086
4828 9901 68 None -4 27 Human 9.3 pKi = 9.3 Binding
Binding affinity at human adrenergic beta-1 receptorBinding affinity at human adrenergic beta-1 receptor
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 10.1016/j.bmcl.2007.07.086
91 9901 68 None -4 27 Human 9.3 pKi = 9.3 Binding
Binding affinity at human adrenergic beta-1 receptorBinding affinity at human adrenergic beta-1 receptor
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 10.1016/j.bmcl.2007.07.086
CHEMBL500 9901 68 None -4 27 Human 9.3 pKi = 9.3 Binding
Binding affinity at human adrenergic beta-1 receptorBinding affinity at human adrenergic beta-1 receptor
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 10.1016/j.bmcl.2007.07.086
DB00960 9901 68 None -4 27 Human 9.3 pKi = 9.3 Binding
Binding affinity at human adrenergic beta-1 receptorBinding affinity at human adrenergic beta-1 receptor
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 10.1016/j.bmcl.2007.07.086
2176 9901 68 None -4 27 Human 9.3 pKi = 9.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C nan
4828 9901 68 None -4 27 Human 9.3 pKi = 9.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C nan
91 9901 68 None -4 27 Human 9.3 pKi = 9.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C nan
CHEMBL500 9901 68 None -4 27 Human 9.3 pKi = 9.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C nan
DB00960 9901 68 None -4 27 Human 9.3 pKi = 9.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C nan
118710940 120527 0 None -1 3 Human 9.1 pKi = 9.1 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 398 7 4 5 3.7 O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@@H]3CCC[C@@H]3CCc3ccccc3)c2s1 10.1016/j.bmcl.2014.06.014
CHEMBL3323658 120527 0 None -1 3 Human 9.1 pKi = 9.1 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 398 7 4 5 3.7 O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@@H]3CCC[C@@H]3CCc3ccccc3)c2s1 10.1016/j.bmcl.2014.06.014
2585 7590 103 None -4 22 Rat 9.1 pKi = 9.1 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation methodDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation method
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10.1016/j.ejmech.2008.05.019
522 7590 103 None -4 22 Rat 9.1 pKi = 9.1 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation methodDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation method
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10.1016/j.ejmech.2008.05.019
551 7590 103 None -4 22 Rat 9.1 pKi = 9.1 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation methodDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation method
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10.1016/j.ejmech.2008.05.019
CHEMBL723 7590 103 None -4 22 Rat 9.1 pKi = 9.1 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation methodDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation method
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10.1016/j.ejmech.2008.05.019
DB01136 7590 103 None -4 22 Rat 9.1 pKi = 9.1 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation methodDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation method
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10.1016/j.ejmech.2008.05.019
49864395 22409 0 None -1 2 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 400 7 4 6 3.1 O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@@H]3CCC[C@H]3OCc3ccccc3)c2s1 10.1016/j.bmcl.2010.06.136
CHEMBL1221680 22409 0 None -1 2 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 400 7 4 6 3.1 O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@@H]3CCC[C@H]3OCc3ccccc3)c2s1 10.1016/j.bmcl.2010.06.136
46889812 13228 0 None -10 3 Human 9.0 pKi = 9 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 415 7 2 4 4.4 OC(COc1cccc2[nH]c3ccccc3c12)CN1CCC(Cc2cccnc2)CC1 10.1016/j.bmcl.2010.04.009
CHEMBL1082501 13228 0 None -10 3 Human 9.0 pKi = 9 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 415 7 2 4 4.4 OC(COc1cccc2[nH]c3ccccc3c12)CN1CCC(Cc2cccnc2)CC1 10.1016/j.bmcl.2010.04.009
155525244 177774 0 None -15 2 Mouse 9.0 pKi = 9.0 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 516 17 3 8 4.5 COc1cc(CCNC[C@H](O)COc2cccc3ccccc23)ccc1OCCCSSCCN 10.1016/j.bmc.2019.05.034
CHEMBL4456301 177774 0 None -15 2 Mouse 9.0 pKi = 9.0 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 516 17 3 8 4.5 COc1cc(CCNC[C@H](O)COc2cccc3ccccc23)ccc1OCCCSSCCN 10.1016/j.bmc.2019.05.034
2303 9961 68 None -9 26 Human 9.0 pKi = 9.0 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C nan
4946 9961 68 None -9 26 Human 9.0 pKi = 9.0 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C nan
564 9961 68 None -9 26 Human 9.0 pKi = 9.0 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C nan
63 9961 68 None -9 26 Human 9.0 pKi = 9.0 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C nan
91536 9961 68 None -9 26 Human 9.0 pKi = 9.0 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C nan
CHEMBL27 9961 68 None -9 26 Human 9.0 pKi = 9.0 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C nan
CHEMBL452861 9961 68 None -9 26 Human 9.0 pKi = 9.0 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C nan
DB00571 9961 68 None -9 26 Human 9.0 pKi = 9.0 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C nan
2685 7677 21 None -1 7 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]CGP12177 from human beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from human beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10.1016/j.bmc.2019.05.034
541 7677 21 None -1 7 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]CGP12177 from human beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from human beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10.1016/j.bmc.2019.05.034
CHEMBL280822 7677 21 None -1 7 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]CGP12177 from human beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from human beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10.1016/j.bmc.2019.05.034
2303 9961 68 None -9 26 Human 8.9 pKi = 8.9 Binding
Displacement of [125I]Cynopindolol from human recombinant beta1 adrenergic receptor expressed in CHOK1 cells after 2 hrsDisplacement of [125I]Cynopindolol from human recombinant beta1 adrenergic receptor expressed in CHOK1 cells after 2 hrs
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmcl.2013.01.025
4946 9961 68 None -9 26 Human 8.9 pKi = 8.9 Binding
Displacement of [125I]Cynopindolol from human recombinant beta1 adrenergic receptor expressed in CHOK1 cells after 2 hrsDisplacement of [125I]Cynopindolol from human recombinant beta1 adrenergic receptor expressed in CHOK1 cells after 2 hrs
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmcl.2013.01.025
564 9961 68 None -9 26 Human 8.9 pKi = 8.9 Binding
Displacement of [125I]Cynopindolol from human recombinant beta1 adrenergic receptor expressed in CHOK1 cells after 2 hrsDisplacement of [125I]Cynopindolol from human recombinant beta1 adrenergic receptor expressed in CHOK1 cells after 2 hrs
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmcl.2013.01.025
63 9961 68 None -9 26 Human 8.9 pKi = 8.9 Binding
Displacement of [125I]Cynopindolol from human recombinant beta1 adrenergic receptor expressed in CHOK1 cells after 2 hrsDisplacement of [125I]Cynopindolol from human recombinant beta1 adrenergic receptor expressed in CHOK1 cells after 2 hrs
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmcl.2013.01.025
91536 9961 68 None -9 26 Human 8.9 pKi = 8.9 Binding
Displacement of [125I]Cynopindolol from human recombinant beta1 adrenergic receptor expressed in CHOK1 cells after 2 hrsDisplacement of [125I]Cynopindolol from human recombinant beta1 adrenergic receptor expressed in CHOK1 cells after 2 hrs
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmcl.2013.01.025
CHEMBL27 9961 68 None -9 26 Human 8.9 pKi = 8.9 Binding
Displacement of [125I]Cynopindolol from human recombinant beta1 adrenergic receptor expressed in CHOK1 cells after 2 hrsDisplacement of [125I]Cynopindolol from human recombinant beta1 adrenergic receptor expressed in CHOK1 cells after 2 hrs
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmcl.2013.01.025
CHEMBL452861 9961 68 None -9 26 Human 8.9 pKi = 8.9 Binding
Displacement of [125I]Cynopindolol from human recombinant beta1 adrenergic receptor expressed in CHOK1 cells after 2 hrsDisplacement of [125I]Cynopindolol from human recombinant beta1 adrenergic receptor expressed in CHOK1 cells after 2 hrs
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmcl.2013.01.025
DB00571 9961 68 None -9 26 Human 8.9 pKi = 8.9 Binding
Displacement of [125I]Cynopindolol from human recombinant beta1 adrenergic receptor expressed in CHOK1 cells after 2 hrsDisplacement of [125I]Cynopindolol from human recombinant beta1 adrenergic receptor expressed in CHOK1 cells after 2 hrs
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmcl.2013.01.025
49864380 22405 0 None 1 2 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 380 5 4 5 3.8 C[C@@H](NC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12)c1ccc2ccccc2c1 10.1016/j.bmcl.2010.06.136
CHEMBL1221637 22405 0 None 1 2 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 380 5 4 5 3.8 C[C@@H](NC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12)c1ccc2ccccc2c1 10.1016/j.bmcl.2010.06.136
2303 9961 68 None -9 26 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]CGP12177 from human beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from human beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmc.2019.05.034
4946 9961 68 None -9 26 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]CGP12177 from human beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from human beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmc.2019.05.034
564 9961 68 None -9 26 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]CGP12177 from human beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from human beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmc.2019.05.034
63 9961 68 None -9 26 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]CGP12177 from human beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from human beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmc.2019.05.034
91536 9961 68 None -9 26 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]CGP12177 from human beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from human beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmc.2019.05.034
CHEMBL27 9961 68 None -9 26 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]CGP12177 from human beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from human beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmc.2019.05.034
CHEMBL452861 9961 68 None -9 26 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]CGP12177 from human beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from human beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmc.2019.05.034
DB00571 9961 68 None -9 26 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]CGP12177 from human beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from human beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmc.2019.05.034
2685 7677 21 None 1 7 Mouse 8.9 pKi = 8.9 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10.1016/j.bmc.2019.05.034
541 7677 21 None 1 7 Mouse 8.9 pKi = 8.9 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10.1016/j.bmc.2019.05.034
CHEMBL280822 7677 21 None 1 7 Mouse 8.9 pKi = 8.9 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10.1016/j.bmc.2019.05.034
10075766 107198 0 None - 1 Human 8.9 pKi = 8.9 Binding
Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.
ChEMBL 532 11 5 8 0.2 NS(=O)(=O)c1cc(S(=O)(=O)NCCNCC(O)COc2cccc3c2CCC(=O)N3)ccc1Cl 10.1021/jm00053a020
CHEMBL290313 107198 0 None - 1 Human 8.9 pKi = 8.9 Binding
Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.
ChEMBL 532 11 5 8 0.2 NS(=O)(=O)c1cc(S(=O)(=O)NCCNCC(O)COc2cccc3c2CCC(=O)N3)ccc1Cl 10.1021/jm00053a020
2303 9961 68 None -9 26 Human 8.8 pKi = 8.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C nan
4946 9961 68 None -9 26 Human 8.8 pKi = 8.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C nan
564 9961 68 None -9 26 Human 8.8 pKi = 8.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C nan
63 9961 68 None -9 26 Human 8.8 pKi = 8.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C nan
91536 9961 68 None -9 26 Human 8.8 pKi = 8.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C nan
CHEMBL27 9961 68 None -9 26 Human 8.8 pKi = 8.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C nan
CHEMBL452861 9961 68 None -9 26 Human 8.8 pKi = 8.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C nan
DB00571 9961 68 None -9 26 Human 8.8 pKi = 8.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C nan
49864333 22385 0 None -1 2 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 336 5 4 5 2.9 C[C@@H](NC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12)C1CCCCC1 10.1016/j.bmcl.2010.06.136
CHEMBL1221541 22385 0 None -1 2 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 336 5 4 5 2.9 C[C@@H](NC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12)C1CCCCC1 10.1016/j.bmcl.2010.06.136
33624 10593 34 None -6 9 Human 8.8 pKi = 8.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C nan
4061 10593 34 None -6 9 Human 8.8 pKi = 8.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C nan
565 10593 34 None -6 9 Human 8.8 pKi = 8.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C nan
CHEMBL499 10593 34 None -6 9 Human 8.8 pKi = 8.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C nan
DB00373 10593 34 None -6 9 Human 8.8 pKi = 8.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C nan
49864460 22423 0 None 1 2 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 396 7 4 6 3.4 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCSc3ccc(Cl)cc3)c2s1 10.1016/j.bmcl.2010.06.136
CHEMBL1221861 22423 0 None 1 2 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 396 7 4 6 3.4 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCSc3ccc(Cl)cc3)c2s1 10.1016/j.bmcl.2010.06.136
11617407 22396 0 None -4 2 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 358 6 4 5 2.9 CC(C)(Cc1ccccc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12 10.1016/j.bmcl.2010.06.136
CHEMBL1221590 22396 0 None -4 2 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 358 6 4 5 2.9 CC(C)(Cc1ccccc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12 10.1016/j.bmcl.2010.06.136
11625619 84394 0 None -4 2 Human 8.7 pKi = 8.7 Binding
Binding affinity to human beta1-adrenoceptor by radioligand binding assayBinding affinity to human beta1-adrenoceptor by radioligand binding assay
ChEMBL 406 6 4 4 3.5 CCc1cc2c(cc1CC)CC(C)(NC[C@H](O)c1ccc(O)c3[nH]c(=O)ccc13)C2 10.1016/j.bmcl.2012.07.096
CHEMBL2088201 84394 0 None -4 2 Human 8.7 pKi = 8.7 Binding
Binding affinity to human beta1-adrenoceptor by radioligand binding assayBinding affinity to human beta1-adrenoceptor by radioligand binding assay
ChEMBL 406 6 4 4 3.5 CCc1cc2c(cc1CC)CC(C)(NC[C@H](O)c1ccc(O)c3[nH]c(=O)ccc13)C2 10.1016/j.bmcl.2012.07.096
2583 212673 51 None 2 2 Human 8.7 pKi = 8.7 Binding
Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.
ChEMBL 292 5 3 4 1.7 CC(C)(C)NCC(O)COc1cccc2c1CCC(=O)N2 10.1021/jm00053a020
CHEMBL839 212673 51 None 2 2 Human 8.7 pKi = 8.7 Binding
Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.
ChEMBL 292 5 3 4 1.7 CC(C)(C)NCC(O)COc1cccc2c1CCC(=O)N2 10.1021/jm00053a020
145947665 174461 0 None 10 2 Rat 8.0 pKi = 8.0 Binding
Displacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysisDisplacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysis
ChEMBL 405 8 2 6 3.5 COc1ccccc1CNCC(O)COc1cccc2c(=O)c3ccccc3oc12 10.1016/j.bmc.2018.04.038
CHEMBL4128794 174461 0 None 10 2 Rat 8.0 pKi = 8.0 Binding
Displacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysisDisplacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysis
ChEMBL 405 8 2 6 3.5 COc1ccccc1CNCC(O)COc1cccc2c(=O)c3ccccc3oc12 10.1016/j.bmc.2018.04.038
CHEMBL4302144 174461 0 None 10 2 Rat 8.0 pKi = 8.0 Binding
Displacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysisDisplacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysis
ChEMBL 405 8 2 6 3.5 COc1ccccc1CNCC(O)COc1cccc2c(=O)c3ccccc3oc12 10.1016/j.bmc.2018.04.038
52948805 24527 0 None -10 3 Human 7.0 pKi = 7 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 502 9 2 7 5.5 CC(C)c1ccccc1OCC(O)CNC1CCN(c2ncnc3scc(-c4ccccc4)c23)CC1 10.1016/j.bmcl.2010.08.039
CHEMBL1258704 24527 0 None -10 3 Human 7.0 pKi = 7 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 502 9 2 7 5.5 CC(C)c1ccccc1OCC(O)CNC1CCN(c2ncnc3scc(-c4ccccc4)c23)CC1 10.1016/j.bmcl.2010.08.039
10132882 101284 0 None 1 2 Human 7.0 pKi = 7 Binding
Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 355 8 2 6 3.2 Cc1nc(-c2ccc(OCCNC[C@H](O)c3cccnc3)cc2)cs1 10.1016/j.bmcl.2007.06.072
CHEMBL251599 101284 0 None 1 2 Human 7.0 pKi = 7 Binding
Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 355 8 2 6 3.2 Cc1nc(-c2ccc(OCCNC[C@H](O)c3cccnc3)cc2)cs1 10.1016/j.bmcl.2007.06.072
10201549 101285 1 None - 1 Human 7.0 pKi = 7 Binding
Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 409 8 2 6 3.9 O[C@@H](CNCCOc1ccc(-c2csc(C(F)(F)F)n2)cc1)c1cccnc1 10.1016/j.bmcl.2007.06.072
CHEMBL251600 101285 1 None - 1 Human 7.0 pKi = 7 Binding
Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 409 8 2 6 3.9 O[C@@H](CNCCOc1ccc(-c2csc(C(F)(F)F)n2)cc1)c1cccnc1 10.1016/j.bmcl.2007.06.072
155519891 177172 0 None -3 6 Human 6.0 pKi = 6 Binding
Displacement of [125I]-pindolol from human recombinant adrenergic Beta1 receptor expressed in Flp-In CHO cells after 90 mins by microbeta scintillation counting methodDisplacement of [125I]-pindolol from human recombinant adrenergic Beta1 receptor expressed in Flp-In CHO cells after 90 mins by microbeta scintillation counting method
ChEMBL 249 2 1 4 1.9 COc1cc(OC)c2c(c1)OC[C@@]1(C)NCC[C@@H]21 10.1021/acsmedchemlett.9b00225
CHEMBL4447975 177172 0 None -3 6 Human 6.0 pKi = 6 Binding
Displacement of [125I]-pindolol from human recombinant adrenergic Beta1 receptor expressed in Flp-In CHO cells after 90 mins by microbeta scintillation counting methodDisplacement of [125I]-pindolol from human recombinant adrenergic Beta1 receptor expressed in Flp-In CHO cells after 90 mins by microbeta scintillation counting method
ChEMBL 249 2 1 4 1.9 COc1cc(OC)c2c(c1)OC[C@@]1(C)NCC[C@@H]21 10.1021/acsmedchemlett.9b00225
3687256 13606 7 None -12 3 Human 6.0 pKi = 6 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 500 8 1 5 5.0 Cc1ccc(C(C)C)c(OCC(O)CN2CCC(CN3C(=O)c4cccc5cccc(c45)C3=O)CC2)c1 10.1016/j.bmcl.2010.04.009
CHEMBL1083994 13606 7 None -12 3 Human 6.0 pKi = 6 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 500 8 1 5 5.0 Cc1ccc(C(C)C)c(OCC(O)CN2CCC(CN3C(=O)c4cccc5cccc(c45)C3=O)CC2)c1 10.1016/j.bmcl.2010.04.009
44444185 161537 0 None -112 3 Human 6.0 pKi = 6 Binding
Displacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 514 13 4 7 3.6 COc1ccc([C@H](CCc2ccccc2)NC[C@H](O)Cc2ccc(O)c(NS(C)(=O)=O)c2)cc1OC 10.1016/j.bmcl.2007.05.030
CHEMBL400067 161537 0 None -112 3 Human 6.0 pKi = 6 Binding
Displacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 514 13 4 7 3.6 COc1ccc([C@H](CCc2ccccc2)NC[C@H](O)Cc2ccc(O)c(NS(C)(=O)=O)c2)cc1OC 10.1016/j.bmcl.2007.05.030
681 8247 72 None -44 38 Rat 5.0 pKi = 5 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 153 2 3 3 0.6 NCCc1ccc(c(c1)O)O 10.1021/jm990599h
940 8247 72 None -44 38 Rat 5.0 pKi = 5 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 153 2 3 3 0.6 NCCc1ccc(c(c1)O)O 10.1021/jm990599h
947 8247 72 None -44 38 Rat 5.0 pKi = 5 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 153 2 3 3 0.6 NCCc1ccc(c(c1)O)O 10.1021/jm990599h
CHEMBL59 8247 72 None -44 38 Rat 5.0 pKi = 5 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 153 2 3 3 0.6 NCCc1ccc(c(c1)O)O 10.1021/jm990599h
DB00988 8247 72 None -44 38 Rat 5.0 pKi = 5 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 153 2 3 3 0.6 NCCc1ccc(c(c1)O)O 10.1021/jm990599h
9892481 77008 14 None -3162 2 Human 5.0 pKi = 5 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 435 12 6 6 3.0 O=CNc1cc([C@@H](O)CNCCc2ccc(NC[C@H](O)c3ccccc3)cc2)ccc1O 10.1016/j.bmcl.2014.04.069
CHEMBL1940832 77008 14 None -3162 2 Human 5.0 pKi = 5 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 435 12 6 6 3.0 O=CNc1cc([C@@H](O)CNCCc2ccc(NC[C@H](O)c3ccccc3)cc2)ccc1O 10.1016/j.bmcl.2014.04.069
59119466 119045 0 None -39 2 Human 5.0 pKi = 5 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 436 10 5 7 3.3 COC(=O)c1ccc(Nc2ccc(CCNCC(O)c3ccc(O)c(CO)c3)cc2)cc1 10.1016/j.bmcl.2014.04.069
CHEMBL3290996 119045 0 None -39 2 Human 5.0 pKi = 5 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 436 10 5 7 3.3 COC(=O)c1ccc(Nc2ccc(CCNCC(O)c3ccc(O)c(CO)c3)cc2)cc1 10.1016/j.bmcl.2014.04.069
2247 7293 81 None -128 42 Human 5.0 pKi = 5 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
249 7293 81 None -128 42 Human 5.0 pKi = 5 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
2603 7293 81 None -128 42 Human 5.0 pKi = 5 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
CHEMBL296419 7293 81 None -128 42 Human 5.0 pKi = 5 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
DB00637 7293 81 None -128 42 Human 5.0 pKi = 5 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
16735274 166814 0 None -1 2 Rat 5.0 pKi = 5.0 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 267 8 4 4 2.7 CCCCC[C@@H](C)NC[C@H](O)c1cc(O)cc(O)c1 nan
CHEMBL4108123 166814 0 None -1 2 Rat 5.0 pKi = 5.0 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 267 8 4 4 2.7 CCCCC[C@@H](C)NC[C@H](O)c1cc(O)cc(O)c1 nan
1786 9298 85 None -1 11 Human 7.0 pKi = 7.0 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O nan
4171 9298 85 None -1 11 Human 7.0 pKi = 7.0 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O nan
553 9298 85 None -1 11 Human 7.0 pKi = 7.0 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O nan
CHEMBL13 9298 85 None -1 11 Human 7.0 pKi = 7.0 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O nan
DB00264 9298 85 None -1 11 Human 7.0 pKi = 7.0 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O nan
44424578 172825 0 None -1 2 Rat 5.0 pKi = 5.0 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 253 7 4 4 2.3 CCCC[C@@H](C)NC[C@H](O)c1cc(O)cc(O)c1 10.1021/jm070030d
CHEMBL425658 172825 0 None -1 2 Rat 5.0 pKi = 5.0 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 253 7 4 4 2.3 CCCC[C@@H](C)NC[C@H](O)c1cc(O)cc(O)c1 10.1021/jm070030d
137640201 163740 2 None -8128 13 Human 5.0 pKi = 5.0 Binding
Displacement of [3H]CGP12177 from human recombinant beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by beta counting methodDisplacement of [3H]CGP12177 from human recombinant beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by beta counting method
ChEMBL 362 6 0 2 4.3 O=C1CCc2ccccc2N1CCCN1CCC(Cc2ccccc2)CC1 10.1021/acs.jmedchem.8b00265
CHEMBL4072818 163740 2 None -8128 13 Human 5.0 pKi = 5.0 Binding
Displacement of [3H]CGP12177 from human recombinant beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by beta counting methodDisplacement of [3H]CGP12177 from human recombinant beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by beta counting method
ChEMBL 362 6 0 2 4.3 O=C1CCc2ccccc2N1CCCN1CCC(Cc2ccccc2)CC1 10.1021/acs.jmedchem.8b00265
44350012 24796 0 None -6 3 Guinea pig 5.0 pKi = 5.0 Binding
Binding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacementBinding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacement
ChEMBL 363 4 3 7 0.4 CC1CN=C2C(N3CCNCC3)=NC=CN21.O=C(O)C/C=C\CC(=O)O 10.1021/jm00099a012
CHEMBL126394 24796 0 None -6 3 Guinea pig 5.0 pKi = 5.0 Binding
Binding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacementBinding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacement
ChEMBL 363 4 3 7 0.4 CC1CN=C2C(N3CCNCC3)=NC=CN21.O=C(O)C/C=C\CC(=O)O 10.1021/jm00099a012
10464801 17985 0 None 3 2 Rat 6.0 pKi = 6.0 Binding
Binding affinity against beta-1-adrenergic receptor in rat brainBinding affinity against beta-1-adrenergic receptor in rat brain
ChEMBL 174 6 2 4 0.4 CCO/N=C/C(O)CNC(C)C 10.1021/jm00036a018
CHEMBL1178754 17985 0 None 3 2 Rat 6.0 pKi = 6.0 Binding
Binding affinity against beta-1-adrenergic receptor in rat brainBinding affinity against beta-1-adrenergic receptor in rat brain
ChEMBL 174 6 2 4 0.4 CCO/N=C/C(O)CNC(C)C 10.1021/jm00036a018
CHEMBL39682 17985 0 None 3 2 Rat 6.0 pKi = 6.0 Binding
Binding affinity against beta-1-adrenergic receptor in rat brainBinding affinity against beta-1-adrenergic receptor in rat brain
ChEMBL 174 6 2 4 0.4 CCO/N=C/C(O)CNC(C)C 10.1021/jm00036a018
145946294 174284 0 None 3 2 Human 5.0 pKi = 5.0 Binding
Displacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation countingDisplacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation counting
ChEMBL 302 8 3 5 0.3 CNCC(O)COc1ccc(S(=O)(=O)NC(C)C)cc1 10.1021/acs.jmedchem.8b00625
CHEMBL4174345 174284 0 None 3 2 Human 5.0 pKi = 5.0 Binding
Displacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation countingDisplacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation counting
ChEMBL 302 8 3 5 0.3 CNCC(O)COc1ccc(S(=O)(=O)NC(C)C)cc1 10.1021/acs.jmedchem.8b00625
CHEMBL4299816 174284 0 None 3 2 Human 5.0 pKi = 5.0 Binding
Displacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation countingDisplacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation counting
ChEMBL 302 8 3 5 0.3 CNCC(O)COc1ccc(S(=O)(=O)NC(C)C)cc1 10.1021/acs.jmedchem.8b00625
24936882 24354 0 None -52 3 Human 6.0 pKi = 6.0 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 512 9 4 10 3.6 OCc1cc(OCC(O)CNC2CCN(c3ncnc4scc(-c5cccs5)c34)CC2)ccc1O 10.1016/j.bmcl.2010.08.039
CHEMBL1258143 24354 0 None -52 3 Human 6.0 pKi = 6.0 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 512 9 4 10 3.6 OCc1cc(OCC(O)CNC2CCN(c3ncnc4scc(-c5cccs5)c34)CC2)ccc1O 10.1016/j.bmcl.2010.08.039
46889699 13420 0 None -26 3 Human 6.0 pKi = 6.0 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 470 8 1 5 4.1 C=CCc1ccccc1OCC(O)CN1CCC(N2C(=O)c3cccc4cccc(c34)C2=O)CC1 10.1016/j.bmcl.2010.04.009
CHEMBL1083364 13420 0 None -26 3 Human 6.0 pKi = 6.0 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 470 8 1 5 4.1 C=CCc1ccccc1OCC(O)CN1CCC(N2C(=O)c3cccc4cccc(c34)C2=O)CC1 10.1016/j.bmcl.2010.04.009
44444195 101311 0 None -87 3 Human 6.0 pKi = 6.0 Binding
Displacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 548 13 4 7 4.3 COc1ccc([C@H](CCc2ccc(Cl)cc2)NC[C@H](O)Cc2ccc(O)c(NS(C)(=O)=O)c2)cc1OC 10.1016/j.bmcl.2007.05.030
CHEMBL251764 101311 0 None -87 3 Human 6.0 pKi = 6.0 Binding
Displacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 548 13 4 7 4.3 COc1ccc([C@H](CCc2ccc(Cl)cc2)NC[C@H](O)Cc2ccc(O)c(NS(C)(=O)=O)c2)cc1OC 10.1016/j.bmcl.2007.05.030
49864413 22415 0 None -2 2 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 414 7 4 6 3.4 O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@H]3CCCC[C@@H]3OCc3ccccc3)c2s1 10.1016/j.bmcl.2010.06.136
CHEMBL1221733 22415 0 None -2 2 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 414 7 4 6 3.4 O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@H]3CCCC[C@@H]3OCc3ccccc3)c2s1 10.1016/j.bmcl.2010.06.136
10527469 163044 3 None -22908 16 Human 5.0 pKi = 5.0 Binding
Binding affinity against Beta-1 adrenergic receptor using [3H]DHA as radioligandBinding affinity against Beta-1 adrenergic receptor using [3H]DHA as radioligand
ChEMBL 448 4 1 7 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cccnc54)c3=O)C[C@@H]21 10.1021/jm970364a
CHEMBL40650 163044 3 None -22908 16 Human 5.0 pKi = 5.0 Binding
Binding affinity against Beta-1 adrenergic receptor using [3H]DHA as radioligandBinding affinity against Beta-1 adrenergic receptor using [3H]DHA as radioligand
ChEMBL 448 4 1 7 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cccnc54)c3=O)C[C@@H]21 10.1021/jm970364a
11647002 22410 0 None -22 3 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 400 7 4 6 3.1 O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@H]3CCC[C@@H]3OCc3ccccc3)c2s1 10.1016/j.bmcl.2010.06.136
CHEMBL1221681 22410 0 None -22 3 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 400 7 4 6 3.1 O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@H]3CCC[C@@H]3OCc3ccccc3)c2s1 10.1016/j.bmcl.2010.06.136
851833 40813 92 None 1 3 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysisDisplacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis
ChEMBL 230 1 1 2 2.4 Clc1cccc(N2CCNCC2)c1Cl 10.1021/jm400140q
CHEMBL1424807 40813 92 None 1 3 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysisDisplacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis
ChEMBL 230 1 1 2 2.4 Clc1cccc(N2CCNCC2)c1Cl 10.1021/jm400140q
10012704 17993 0 None 1 2 Rat 6.0 pKi = 6.0 Binding
Binding affinity against beta-1-adrenergic receptor in rat brainBinding affinity against beta-1-adrenergic receptor in rat brain
ChEMBL 188 5 2 4 0.8 CCO/N=C/C(O)CNC(C)(C)C 10.1021/jm00036a018
CHEMBL1178768 17993 0 None 1 2 Rat 6.0 pKi = 6.0 Binding
Binding affinity against beta-1-adrenergic receptor in rat brainBinding affinity against beta-1-adrenergic receptor in rat brain
ChEMBL 188 5 2 4 0.8 CCO/N=C/C(O)CNC(C)(C)C 10.1021/jm00036a018
CHEMBL39987 17993 0 None 1 2 Rat 6.0 pKi = 6.0 Binding
Binding affinity against beta-1-adrenergic receptor in rat brainBinding affinity against beta-1-adrenergic receptor in rat brain
ChEMBL 188 5 2 4 0.8 CCO/N=C/C(O)CNC(C)(C)C 10.1021/jm00036a018
25242459 19511 0 None - 1 Rat 8.0 pKi = 8.0 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation counting
ChEMBL 391 7 3 6 2.7 CC(C)(CO)NCC(O)COc1cccc2c(=O)c3ccc(Cl)cc3oc12 10.1016/j.bmc.2008.12.031
CHEMBL1187782 19511 0 None - 1 Rat 8.0 pKi = 8.0 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation counting
ChEMBL 391 7 3 6 2.7 CC(C)(CO)NCC(O)COc1cccc2c(=O)c3ccc(Cl)cc3oc12 10.1016/j.bmc.2008.12.031
CHEMBL520600 19511 0 None - 1 Rat 8.0 pKi = 8.0 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation counting
ChEMBL 391 7 3 6 2.7 CC(C)(CO)NCC(O)COc1cccc2c(=O)c3ccc(Cl)cc3oc12 10.1016/j.bmc.2008.12.031
2303 9961 68 None -9 26 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation countingDisplacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation counting
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/acs.jmedchem.8b00625
4946 9961 68 None -9 26 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation countingDisplacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation counting
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/acs.jmedchem.8b00625
564 9961 68 None -9 26 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation countingDisplacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation counting
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/acs.jmedchem.8b00625
63 9961 68 None -9 26 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation countingDisplacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation counting
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/acs.jmedchem.8b00625
91536 9961 68 None -9 26 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation countingDisplacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation counting
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/acs.jmedchem.8b00625
CHEMBL27 9961 68 None -9 26 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation countingDisplacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation counting
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/acs.jmedchem.8b00625
CHEMBL452861 9961 68 None -9 26 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation countingDisplacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation counting
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/acs.jmedchem.8b00625
DB00571 9961 68 None -9 26 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation countingDisplacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation counting
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/acs.jmedchem.8b00625
44396532 73530 0 None -3 3 Human 7.0 pKi = 7.0 Binding
Binding inhibition constant was determined by inhibition of [125I]iodocyanopindolol binding to Beta-1 adrenergic receptorBinding inhibition constant was determined by inhibition of [125I]iodocyanopindolol binding to Beta-1 adrenergic receptor
ChEMBL 455 9 4 5 4.3 C[C@H](Cc1c[nH]c2ccccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1016/j.bmcl.2004.10.035
CHEMBL185836 73530 0 None -3 3 Human 7.0 pKi = 7.0 Binding
Binding inhibition constant was determined by inhibition of [125I]iodocyanopindolol binding to Beta-1 adrenergic receptorBinding inhibition constant was determined by inhibition of [125I]iodocyanopindolol binding to Beta-1 adrenergic receptor
ChEMBL 455 9 4 5 4.3 C[C@H](Cc1c[nH]c2ccccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1016/j.bmcl.2004.10.035
72544566 99906 0 None -5 5 Pig 7.0 pKi = 7.0 Binding
Displacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortexDisplacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortex
ChEMBL 375 10 0 6 3.1 COc1ccccc1N1CCN(Cc2cn(CCCCCCF)nn2)CC1 10.1016/j.bmcl.2013.09.026
CHEMBL2443009 99906 0 None -5 5 Pig 7.0 pKi = 7.0 Binding
Displacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortexDisplacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortex
ChEMBL 375 10 0 6 3.1 COc1ccccc1N1CCN(Cc2cn(CCCCCCF)nn2)CC1 10.1016/j.bmcl.2013.09.026
1028 7079 71 None -66 30 Rat 6.0 pKi = 6.0 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm990599h
139148732 7079 71 None -66 30 Rat 6.0 pKi = 6.0 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm990599h
479 7079 71 None -66 30 Rat 6.0 pKi = 6.0 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm990599h
5816 7079 71 None -66 30 Rat 6.0 pKi = 6.0 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm990599h
CHEMBL679 7079 71 None -66 30 Rat 6.0 pKi = 6.0 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm990599h
DB00668 7079 71 None -66 30 Rat 6.0 pKi = 6.0 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm990599h
44423644 92184 0 None -13 3 Human 6.0 pKi = 6.0 Binding
Displacement of [125I]CYP from human adrenergic beta 1 receptor transfected in CHO cells in presence of 100 uM GTPDisplacement of [125I]CYP from human adrenergic beta 1 receptor transfected in CHO cells in presence of 100 uM GTP
ChEMBL 426 10 2 7 2.6 CCOC(=O)COc1ccc(C[C@@H](C)NC[C@@H](O)c2cc(Br)no2)cc1 10.1016/j.bmc.2007.01.056
CHEMBL226348 92184 0 None -13 3 Human 6.0 pKi = 6.0 Binding
Displacement of [125I]CYP from human adrenergic beta 1 receptor transfected in CHO cells in presence of 100 uM GTPDisplacement of [125I]CYP from human adrenergic beta 1 receptor transfected in CHO cells in presence of 100 uM GTP
ChEMBL 426 10 2 7 2.6 CCOC(=O)COc1ccc(C[C@@H](C)NC[C@@H](O)c2cc(Br)no2)cc1 10.1016/j.bmc.2007.01.056
49864377 22402 0 None -12 2 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 356 4 4 5 3.0 O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@@H]3CCCc4ccccc43)c2s1 10.1016/j.bmcl.2010.06.136
CHEMBL1221634 22402 0 None -12 2 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 356 4 4 5 3.0 O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@@H]3CCCc4ccccc43)c2s1 10.1016/j.bmcl.2010.06.136
36811 8236 37 None -109 7 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O nan
535 8236 37 None -109 7 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O nan
937 8236 37 None -109 7 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O nan
CHEMBL926 8236 37 None -109 7 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O nan
DB00841 8236 37 None -109 7 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O nan
1054 8367 54 None -1 3 Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O nan
59768 8367 54 None -1 3 Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O nan
7178 8367 54 None -1 3 Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O nan
CHEMBL768 8367 54 None -1 3 Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O nan
DB00187 8367 54 None -1 3 Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O nan
567 7512 16 None -13 5 Human 6.0 pKi = 6.0 Binding
Ability to bind to human Beta-1 adrenergic receptor using membranes of stably transfected CHO cellsAbility to bind to human Beta-1 adrenergic receptor using membranes of stably transfected CHO cells
ChEMBL 363 9 3 4 3.1 C[C@H](Cc1ccc(cc1)OCC(=O)O)NC[C@@H](c1cccc(c1)Cl)O 10.1016/S0960-894X(97)00266-7
9841972 7512 16 None -13 5 Human 6.0 pKi = 6.0 Binding
Ability to bind to human Beta-1 adrenergic receptor using membranes of stably transfected CHO cellsAbility to bind to human Beta-1 adrenergic receptor using membranes of stably transfected CHO cells
ChEMBL 363 9 3 4 3.1 C[C@H](Cc1ccc(cc1)OCC(=O)O)NC[C@@H](c1cccc(c1)Cl)O 10.1016/S0960-894X(97)00266-7
CHEMBL284782 7512 16 None -13 5 Human 6.0 pKi = 6.0 Binding
Ability to bind to human Beta-1 adrenergic receptor using membranes of stably transfected CHO cellsAbility to bind to human Beta-1 adrenergic receptor using membranes of stably transfected CHO cells
ChEMBL 363 9 3 4 3.1 C[C@H](Cc1ccc(cc1)OCC(=O)O)NC[C@@H](c1cccc(c1)Cl)O 10.1016/S0960-894X(97)00266-7
567 7512 16 None -13 5 Human 5.0 pKi = 5.0 Binding
Compound was tested for its binding affinity against Beta-1 adrenergic receptor in CHO cell membrane using [125I]iodocyanopindolol as the radioligand.Compound was tested for its binding affinity against Beta-1 adrenergic receptor in CHO cell membrane using [125I]iodocyanopindolol as the radioligand.
ChEMBL 363 9 3 4 3.1 C[C@H](Cc1ccc(cc1)OCC(=O)O)NC[C@@H](c1cccc(c1)Cl)O 10.1016/0960-894X(96)00417-9
9841972 7512 16 None -13 5 Human 5.0 pKi = 5.0 Binding
Compound was tested for its binding affinity against Beta-1 adrenergic receptor in CHO cell membrane using [125I]iodocyanopindolol as the radioligand.Compound was tested for its binding affinity against Beta-1 adrenergic receptor in CHO cell membrane using [125I]iodocyanopindolol as the radioligand.
ChEMBL 363 9 3 4 3.1 C[C@H](Cc1ccc(cc1)OCC(=O)O)NC[C@@H](c1cccc(c1)Cl)O 10.1016/0960-894X(96)00417-9
CHEMBL284782 7512 16 None -13 5 Human 5.0 pKi = 5.0 Binding
Compound was tested for its binding affinity against Beta-1 adrenergic receptor in CHO cell membrane using [125I]iodocyanopindolol as the radioligand.Compound was tested for its binding affinity against Beta-1 adrenergic receptor in CHO cell membrane using [125I]iodocyanopindolol as the radioligand.
ChEMBL 363 9 3 4 3.1 C[C@H](Cc1ccc(cc1)OCC(=O)O)NC[C@@H](c1cccc(c1)Cl)O 10.1016/0960-894X(96)00417-9
52948056 24291 0 None -6 3 Human 6.9 pKi = 6.9 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 478 8 2 7 4.5 OC(CNC1CCN(c2ncnc3scc(-c4ccc(F)cc4)c23)CC1)COc1ccccc1 10.1016/j.bmcl.2010.08.039
CHEMBL1257915 24291 0 None -6 3 Human 6.9 pKi = 6.9 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 478 8 2 7 4.5 OC(CNC1CCN(c2ncnc3scc(-c4ccc(F)cc4)c23)CC1)COc1ccccc1 10.1016/j.bmcl.2010.08.039
2769774 13490 17 None -16 3 Human 6.9 pKi = 6.9 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 277 7 1 4 1.5 C=CCc1ccccc1OCC(O)CN1CCOCC1 10.1016/j.bmcl.2010.04.009
CHEMBL1083667 13490 17 None -16 3 Human 6.9 pKi = 6.9 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 277 7 1 4 1.5 C=CCc1ccccc1OCC(O)CN1CCOCC1 10.1016/j.bmcl.2010.04.009
13720717 84626 0 None -3 2 Guinea pig 5.9 pKi = 5.9 Binding
Binding affinity against Beta-1 adrenergic receptor in guinea pig left ventricleBinding affinity against Beta-1 adrenergic receptor in guinea pig left ventricle
ChEMBL 363 5 3 6 2.7 COc1cc(C[C@H]2NCCc3cc(O)c(O)c(F)c32)cc(OC)c1OC 10.1021/jm00081a007
CHEMBL2092996 84626 0 None -3 2 Guinea pig 5.9 pKi = 5.9 Binding
Binding affinity against Beta-1 adrenergic receptor in guinea pig left ventricleBinding affinity against Beta-1 adrenergic receptor in guinea pig left ventricle
ChEMBL 363 5 3 6 2.7 COc1cc(C[C@H]2NCCc3cc(O)c(O)c(F)c32)cc(OC)c1OC 10.1021/jm00081a007
4080436 13491 3 None -10 3 Human 7.9 pKi = 7.9 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 279 6 1 4 1.9 CC(C)c1ccccc1OCC(O)CN1CCOCC1 10.1016/j.bmcl.2010.04.009
CHEMBL1083668 13491 3 None -10 3 Human 7.9 pKi = 7.9 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 279 6 1 4 1.9 CC(C)c1ccccc1OCC(O)CN1CCOCC1 10.1016/j.bmcl.2010.04.009
146025802 176357 0 None 1 2 Mouse 7.9 pKi = 7.9 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 349 10 4 7 1.5 COc1ccccc1OCCNC[C@H](O)COc1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
CHEMBL4435895 176357 0 None 1 2 Mouse 7.9 pKi = 7.9 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 349 10 4 7 1.5 COc1ccccc1OCCNC[C@H](O)COc1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
559926 103782 5 None - 1 Rat 6.9 pKi = 6.9 Binding
Compound was evaluated for the inhibition of binding of [3H]dihydroalprenolol from beta-1 adrenergic receptor of rat cerebral cortical membranesCompound was evaluated for the inhibition of binding of [3H]dihydroalprenolol from beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 255 5 4 5 1.2 CC(C)(C)NCC(O)COc1ccc(O)c(O)c1 10.1021/jm00107a027
CHEMBL266619 103782 5 None - 1 Rat 6.9 pKi = 6.9 Binding
Compound was evaluated for the inhibition of binding of [3H]dihydroalprenolol from beta-1 adrenergic receptor of rat cerebral cortical membranesCompound was evaluated for the inhibition of binding of [3H]dihydroalprenolol from beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 255 5 4 5 1.2 CC(C)(C)NCC(O)COc1ccc(O)c(O)c1 10.1021/jm00107a027
44444378 101030 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 418 9 2 7 4.0 O[C@@H](CNCCOc1ccc(-c2csc(-c3cccnc3)n2)cc1)c1cccnc1 10.1016/j.bmcl.2007.06.072
CHEMBL250146 101030 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 418 9 2 7 4.0 O[C@@H](CNCCOc1ccc(-c2csc(-c3cccnc3)n2)cc1)c1cccnc1 10.1016/j.bmcl.2007.06.072
72545011 99901 0 None -8 5 Pig 6.9 pKi = 6.9 Binding
Displacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortexDisplacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortex
ChEMBL 411 8 0 7 2.9 COc1ccccc1N1CCN(Cc2cn(-c3ccc(OCCF)cc3)nn2)CC1 10.1016/j.bmcl.2013.09.026
CHEMBL2443004 99901 0 None -8 5 Pig 6.9 pKi = 6.9 Binding
Displacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortexDisplacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortex
ChEMBL 411 8 0 7 2.9 COc1ccccc1N1CCN(Cc2cn(-c3ccc(OCCF)cc3)nn2)CC1 10.1016/j.bmcl.2013.09.026
72545239 99903 0 None -1 5 Pig 6.9 pKi = 6.9 Binding
Displacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortexDisplacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortex
ChEMBL 499 14 0 9 3.0 COc1ccccc1N1CCN(Cc2cn(-c3ccc(OCCOCCOCCF)cc3)nn2)CC1 10.1016/j.bmcl.2013.09.026
CHEMBL2443006 99903 0 None -1 5 Pig 6.9 pKi = 6.9 Binding
Displacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortexDisplacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortex
ChEMBL 499 14 0 9 3.0 COc1ccccc1N1CCN(Cc2cn(-c3ccc(OCCOCCOCCF)cc3)nn2)CC1 10.1016/j.bmcl.2013.09.026
155512924 176478 0 None -1 2 Mouse 5.9 pKi = 5.9 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 451 14 3 6 4.7 COc1cc(CCNCCCOc2ccc(O)c(O)c2)ccc1OCCCc1ccccc1 10.1021/acs.jmedchem.9b00349
CHEMBL4437939 176478 0 None -1 2 Mouse 5.9 pKi = 5.9 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 451 14 3 6 4.7 COc1cc(CCNCCCOc2ccc(O)c(O)c2)ccc1OCCCc1ccccc1 10.1021/acs.jmedchem.9b00349
1028 7079 71 None -66 30 Rat 5.9 pKi = 5.9 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00076a024
139148732 7079 71 None -66 30 Rat 5.9 pKi = 5.9 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00076a024
479 7079 71 None -66 30 Rat 5.9 pKi = 5.9 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00076a024
5816 7079 71 None -66 30 Rat 5.9 pKi = 5.9 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00076a024
CHEMBL679 7079 71 None -66 30 Rat 5.9 pKi = 5.9 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00076a024
DB00668 7079 71 None -66 30 Rat 5.9 pKi = 5.9 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00076a024
49864416 22418 0 None -30 2 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 376 5 4 5 3.7 O=c1[nH]c2c(O)ccc([C@@H](O)CNC3CCCC3C3CCCCC3)c2s1 10.1016/j.bmcl.2010.06.136
CHEMBL1221736 22418 0 None -30 2 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 376 5 4 5 3.7 O=c1[nH]c2c(O)ccc([C@@H](O)CNC3CCCC3C3CCCCC3)c2s1 10.1016/j.bmcl.2010.06.136
9990035 18793 0 None 4 2 Rat 5.9 pKi = 5.9 Binding
Binding affinity against beta-1-adrenergic receptor in rat brainBinding affinity against beta-1-adrenergic receptor in rat brain
ChEMBL 188 7 2 4 0.8 CCCO/N=C/C(O)CNC(C)C 10.1021/jm00036a018
CHEMBL1183337 18793 0 None 4 2 Rat 5.9 pKi = 5.9 Binding
Binding affinity against beta-1-adrenergic receptor in rat brainBinding affinity against beta-1-adrenergic receptor in rat brain
ChEMBL 188 7 2 4 0.8 CCCO/N=C/C(O)CNC(C)C 10.1021/jm00036a018
CHEMBL291115 18793 0 None 4 2 Rat 5.9 pKi = 5.9 Binding
Binding affinity against beta-1-adrenergic receptor in rat brainBinding affinity against beta-1-adrenergic receptor in rat brain
ChEMBL 188 7 2 4 0.8 CCCO/N=C/C(O)CNC(C)C 10.1021/jm00036a018
44286965 167188 0 None -4 3 Human 5.9 pKi = 5.9 Binding
Ability to bind to human Beta-1 adrenergic receptor using membranes of stably transfected CHO cellsAbility to bind to human Beta-1 adrenergic receptor using membranes of stably transfected CHO cells
ChEMBL 349 9 3 4 3.0 C[C@H](Cc1ccc(OCCO)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1016/S0960-894X(97)00266-7
CHEMBL41113 167188 0 None -4 3 Human 5.9 pKi = 5.9 Binding
Ability to bind to human Beta-1 adrenergic receptor using membranes of stably transfected CHO cellsAbility to bind to human Beta-1 adrenergic receptor using membranes of stably transfected CHO cells
ChEMBL 349 9 3 4 3.0 C[C@H](Cc1ccc(OCCO)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1016/S0960-894X(97)00266-7
11178830 154905 0 None -794 9 Human 5.9 pKi = 5.9 Binding
Binding affinity at adrenergic beta 1 receptorBinding affinity at adrenergic beta 1 receptor
ChEMBL 467 6 1 5 4.5 Cc1ccc2c(OCCN3CCC(Cc4ccc5c(c4F)NC(=O)CO5)CC3)cc(F)cc2n1 10.1016/j.bmcl.2006.11.031
CHEMBL393539 154905 0 None -794 9 Human 5.9 pKi = 5.9 Binding
Binding affinity at adrenergic beta 1 receptorBinding affinity at adrenergic beta 1 receptor
ChEMBL 467 6 1 5 4.5 Cc1ccc2c(OCCN3CCC(Cc4ccc5c(c4F)NC(=O)CO5)CC3)cc(F)cc2n1 10.1016/j.bmcl.2006.11.031
770558 94310 65 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysisDisplacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis
ChEMBL 298 1 1 2 3.1 FC(F)(F)c1cc(N2CCNCC2)cc(C(F)(F)F)c1 10.1021/jm400140q
CHEMBL2335162 94310 65 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysisDisplacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis
ChEMBL 298 1 1 2 3.1 FC(F)(F)c1cc(N2CCNCC2)cc(C(F)(F)F)c1 10.1021/jm400140q
59119467 119031 0 None -39 2 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 428 9 5 5 4.6 OCc1cc(C(O)CNCCc2ccc(Nc3ccc4ccccc4c3)cc2)ccc1O 10.1016/j.bmcl.2014.04.069
CHEMBL3290983 119031 0 None -39 2 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 428 9 5 5 4.6 OCc1cc(C(O)CNCCc2ccc(Nc3ccc4ccccc4c3)cc2)ccc1O 10.1016/j.bmcl.2014.04.069
59119417 119035 0 None -39 2 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 454 10 5 5 5.2 OCc1cc(C(O)CNCCc2ccc(Nc3ccc(-c4ccccc4)cc3)cc2)ccc1O 10.1016/j.bmcl.2014.04.069
CHEMBL3290987 119035 0 None -39 2 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 454 10 5 5 5.2 OCc1cc(C(O)CNCCc2ccc(Nc3ccc(-c4ccccc4)cc3)cc2)ccc1O 10.1016/j.bmcl.2014.04.069
10310564 119036 0 None -39 2 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 454 10 5 5 5.2 OCc1cc(C(O)CNCCc2ccc(Nc3cccc(-c4ccccc4)c3)cc2)ccc1O 10.1016/j.bmcl.2014.04.069
CHEMBL3290988 119036 0 None -39 2 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 454 10 5 5 5.2 OCc1cc(C(O)CNCCc2ccc(Nc3cccc(-c4ccccc4)c3)cc2)ccc1O 10.1016/j.bmcl.2014.04.069
59119455 119039 0 None -19 2 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 408 10 5 6 3.5 COc1cccc(Nc2ccc(CCNCC(O)c3ccc(O)c(CO)c3)cc2)c1 10.1016/j.bmcl.2014.04.069
CHEMBL3290990 119039 0 None -19 2 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 408 10 5 6 3.5 COc1cccc(Nc2ccc(CCNCC(O)c3ccc(O)c(CO)c3)cc2)c1 10.1016/j.bmcl.2014.04.069
1960 9632 67 None -144 26 Rat 6.9 pKi = 6.9 Binding
Compound was evaluated for beta adrenergic binding affinity towards Beta-1 adrenergic receptor of rat brainCompound was evaluated for beta adrenergic binding affinity towards Beta-1 adrenergic receptor of rat brain
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00084a006
439260 9632 67 None -144 26 Rat 6.9 pKi = 6.9 Binding
Compound was evaluated for beta adrenergic binding affinity towards Beta-1 adrenergic receptor of rat brainCompound was evaluated for beta adrenergic binding affinity towards Beta-1 adrenergic receptor of rat brain
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00084a006
505 9632 67 None -144 26 Rat 6.9 pKi = 6.9 Binding
Compound was evaluated for beta adrenergic binding affinity towards Beta-1 adrenergic receptor of rat brainCompound was evaluated for beta adrenergic binding affinity towards Beta-1 adrenergic receptor of rat brain
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00084a006
CHEMBL1437 9632 67 None -144 26 Rat 6.9 pKi = 6.9 Binding
Compound was evaluated for beta adrenergic binding affinity towards Beta-1 adrenergic receptor of rat brainCompound was evaluated for beta adrenergic binding affinity towards Beta-1 adrenergic receptor of rat brain
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00084a006
DB00368 9632 67 None -144 26 Rat 6.9 pKi = 6.9 Binding
Compound was evaluated for beta adrenergic binding affinity towards Beta-1 adrenergic receptor of rat brainCompound was evaluated for beta adrenergic binding affinity towards Beta-1 adrenergic receptor of rat brain
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00084a006
1960 9632 67 None -144 26 Rat 6.9 pKi = 6.9 Binding
Tested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligandTested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligand
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00073a006
439260 9632 67 None -144 26 Rat 6.9 pKi = 6.9 Binding
Tested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligandTested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligand
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00073a006
505 9632 67 None -144 26 Rat 6.9 pKi = 6.9 Binding
Tested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligandTested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligand
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00073a006
CHEMBL1437 9632 67 None -144 26 Rat 6.9 pKi = 6.9 Binding
Tested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligandTested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligand
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00073a006
DB00368 9632 67 None -144 26 Rat 6.9 pKi = 6.9 Binding
Tested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligandTested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligand
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00073a006
448537 167029 89 None -50 25 Human 4.9 pKi = 4.9 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 nan
CHEMBL411 167029 89 None -50 25 Human 4.9 pKi = 4.9 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 nan
24936492 24321 0 None -4 3 Human 6.9 pKi = 6.9 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 482 8 3 9 4.1 Oc1ccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5cccs5)c34)CC2)cc1 10.1016/j.bmcl.2010.08.039
CHEMBL1258026 24321 0 None -4 3 Human 6.9 pKi = 6.9 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 482 8 3 9 4.1 Oc1ccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5cccs5)c34)CC2)cc1 10.1016/j.bmcl.2010.08.039
46889853 13305 0 None -64 3 Human 7.9 pKi = 7.9 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 458 8 2 5 4.7 COc1ccc(C(=O)C2CCN(CC(O)COc3cccc4[nH]c5ccccc5c34)CC2)cc1 10.1016/j.bmcl.2010.04.009
CHEMBL1082828 13305 0 None -64 3 Human 7.9 pKi = 7.9 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 458 8 2 5 4.7 COc1ccc(C(=O)C2CCN(CC(O)COc3cccc4[nH]c5ccccc5c34)CC2)cc1 10.1016/j.bmcl.2010.04.009
118710949 120538 0 None -3 3 Human 7.9 pKi = 7.9 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 402 10 4 6 3.3 CCCCOc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1 10.1016/j.bmcl.2014.06.014
CHEMBL3323669 120538 0 None -3 3 Human 7.9 pKi = 7.9 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 402 10 4 6 3.3 CCCCOc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1 10.1016/j.bmcl.2014.06.014
10352428 107882 1 None -1 4 Rat 6.9 pKi = 6.9 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 187 2 4 4 0.2 NC[C@H](O)c1ccc(O)c(O)c1F 10.1021/jm990599h
CHEMBL295072 107882 1 None -1 4 Rat 6.9 pKi = 6.9 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 187 2 4 4 0.2 NC[C@H](O)c1ccc(O)c(O)c1F 10.1021/jm990599h
10136220 161603 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 409 9 2 6 4.6 O[C@@H](CNCCOc1ccc(-c2csc(C3CCCC3)n2)cc1)c1cccnc1 10.1016/j.bmcl.2007.06.072
CHEMBL400392 161603 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 409 9 2 6 4.6 O[C@@H](CNCCOc1ccc(-c2csc(C3CCCC3)n2)cc1)c1cccnc1 10.1016/j.bmcl.2007.06.072
72545238 99902 0 None -25 5 Pig 6.9 pKi = 6.9 Binding
Displacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortexDisplacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortex
ChEMBL 425 9 0 7 3.3 COc1ccccc1N1CCN(Cc2cn(-c3ccc(OCCCF)cc3)nn2)CC1 10.1016/j.bmcl.2013.09.026
CHEMBL2443005 99902 0 None -25 5 Pig 6.9 pKi = 6.9 Binding
Displacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortexDisplacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortex
ChEMBL 425 9 0 7 3.3 COc1ccccc1N1CCN(Cc2cn(-c3ccc(OCCCF)cc3)nn2)CC1 10.1016/j.bmcl.2013.09.026
1960 9632 67 None -144 26 Rat 5.9 pKi = 5.9 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm990599h
439260 9632 67 None -144 26 Rat 5.9 pKi = 5.9 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm990599h
505 9632 67 None -144 26 Rat 5.9 pKi = 5.9 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm990599h
CHEMBL1437 9632 67 None -144 26 Rat 5.9 pKi = 5.9 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm990599h
DB00368 9632 67 None -144 26 Rat 5.9 pKi = 5.9 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm990599h
9821129 211219 0 None -1 3 Human 5.9 pKi = 5.9 Binding
Compound was tested for its binding affinity against Beta-1 adrenergic receptor in CHO cell membrane using [125I]iodocyanopindolol as the radioligand.Compound was tested for its binding affinity against Beta-1 adrenergic receptor in CHO cell membrane using [125I]iodocyanopindolol as the radioligand.
ChEMBL 378 12 3 6 2.5 C[C@H](Cc1ncc(CCCC(=O)O)s1)NC[C@H](O)COc1ccccc1 10.1016/0960-894X(96)00417-9
CHEMBL72169 211219 0 None -1 3 Human 5.9 pKi = 5.9 Binding
Compound was tested for its binding affinity against Beta-1 adrenergic receptor in CHO cell membrane using [125I]iodocyanopindolol as the radioligand.Compound was tested for its binding affinity against Beta-1 adrenergic receptor in CHO cell membrane using [125I]iodocyanopindolol as the radioligand.
ChEMBL 378 12 3 6 2.5 C[C@H](Cc1ncc(CCCC(=O)O)s1)NC[C@H](O)COc1ccccc1 10.1016/0960-894X(96)00417-9
72545008 99898 0 None -1 5 Pig 5.9 pKi = 5.9 Binding
Displacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortexDisplacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortex
ChEMBL 451 15 0 9 1.6 COc1ccccc1N1CCN(Cc2cn(CCOCCOCCOCCF)nn2)CC1 10.1016/j.bmcl.2013.09.026
CHEMBL2443001 99898 0 None -1 5 Pig 5.9 pKi = 5.9 Binding
Displacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortexDisplacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortex
ChEMBL 451 15 0 9 1.6 COc1ccccc1N1CCN(Cc2cn(CCOCCOCCOCCF)nn2)CC1 10.1016/j.bmcl.2013.09.026
247704 7078 31 None -12 5 Rat 4.9 pKi = 4.9 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 183 3 4 4 0.4 CNC[C@H](c1ccc(c(c1)O)O)O 10.1021/jm990599h
4450 7078 31 None -12 5 Rat 4.9 pKi = 4.9 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 183 3 4 4 0.4 CNC[C@H](c1ccc(c(c1)O)O)O 10.1021/jm990599h
CHEMBL42280 7078 31 None -12 5 Rat 4.9 pKi = 4.9 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 183 3 4 4 0.4 CNC[C@H](c1ccc(c(c1)O)O)O 10.1021/jm990599h
155515982 176789 0 None -51286 17 Human 4.9 pKi = 4.9 Binding
Displacement of [3H] CGP12177 from beta1 adrenergic receptor (unknown origin)Displacement of [3H] CGP12177 from beta1 adrenergic receptor (unknown origin)
ChEMBL 473 10 2 5 4.1 COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccccc2)c2ccccc2)CC1 10.1021/acs.jmedchem.9b01085
CHEMBL4442460 176789 0 None -51286 17 Human 4.9 pKi = 4.9 Binding
Displacement of [3H] CGP12177 from beta1 adrenergic receptor (unknown origin)Displacement of [3H] CGP12177 from beta1 adrenergic receptor (unknown origin)
ChEMBL 473 10 2 5 4.1 COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccccc2)c2ccccc2)CC1 10.1021/acs.jmedchem.9b01085
2146 9874 67 None -3 9 Rat 4.9 pKi = 4.9 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1021/jm00076a024
485 9874 67 None -3 9 Rat 4.9 pKi = 4.9 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1021/jm00076a024
6041 9874 67 None -3 9 Rat 4.9 pKi = 4.9 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1021/jm00076a024
CHEMBL1215 9874 67 None -3 9 Rat 4.9 pKi = 4.9 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1021/jm00076a024
DB00388 9874 67 None -3 9 Rat 4.9 pKi = 4.9 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1021/jm00076a024
11188590 84395 0 None -1 2 Human 6.9 pKi = 6.9 Binding
Binding affinity to human beta1-adrenoceptor by radioligand binding assayBinding affinity to human beta1-adrenoceptor by radioligand binding assay
ChEMBL 394 6 4 4 4.2 CCC1=C(CC)CC2=C(C1)CC(NC[C@H](O)c1ccc(O)c3[nH]c(=O)ccc13)C2 10.1016/j.bmcl.2012.07.096
CHEMBL2088202 84395 0 None -1 2 Human 6.9 pKi = 6.9 Binding
Binding affinity to human beta1-adrenoceptor by radioligand binding assayBinding affinity to human beta1-adrenoceptor by radioligand binding assay
ChEMBL 394 6 4 4 4.2 CCC1=C(CC)CC2=C(C1)CC(NC[C@H](O)c1ccc(O)c3[nH]c(=O)ccc13)C2 10.1016/j.bmcl.2012.07.096
7096 214257 119 None -21 4 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysisDisplacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis
ChEMBL 162 1 1 2 1.1 c1ccc(N2CCNCC2)cc1 10.1021/jm400140q
CHEMBL9434 214257 119 None -21 4 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysisDisplacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis
ChEMBL 162 1 1 2 1.1 c1ccc(N2CCNCC2)cc1 10.1021/jm400140q
145946710 174336 0 None -2 2 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation countingDisplacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation counting
ChEMBL 316 7 3 5 0.7 CNCC(O)COc1ccc(S(=O)(=O)NC(C)(C)C)cc1 10.1021/acs.jmedchem.8b00625
CHEMBL4161638 174336 0 None -2 2 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation countingDisplacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation counting
ChEMBL 316 7 3 5 0.7 CNCC(O)COc1ccc(S(=O)(=O)NC(C)(C)C)cc1 10.1021/acs.jmedchem.8b00625
CHEMBL4300393 174336 0 None -2 2 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation countingDisplacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation counting
ChEMBL 316 7 3 5 0.7 CNCC(O)COc1ccc(S(=O)(=O)NC(C)(C)C)cc1 10.1021/acs.jmedchem.8b00625
4143663 13664 13 None -1 3 Human 5.9 pKi = 5.9 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 514 10 1 6 4.3 C=CCc1ccc(OCC(O)CN2CCC(CN3C(=O)c4cccc5cccc(c45)C3=O)CC2)c(OC)c1 10.1016/j.bmcl.2010.04.009
CHEMBL1084274 13664 13 None -1 3 Human 5.9 pKi = 5.9 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 514 10 1 6 4.3 C=CCc1ccc(OCC(O)CN2CCC(CN3C(=O)c4cccc5cccc(c45)C3=O)CC2)c(OC)c1 10.1016/j.bmcl.2010.04.009
31101 7516 40 None -245 35 Human 5.9 pKi = 5.9 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
35 7516 40 None -245 35 Human 5.9 pKi = 5.9 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
403 7516 40 None -245 35 Human 5.9 pKi = 5.9 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
CHEMBL493 7516 40 None -245 35 Human 5.9 pKi = 5.9 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
DB01200 7516 40 None -245 35 Human 5.9 pKi = 5.9 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
46889810 14188 0 None -28 3 Human 7.9 pKi = 7.9 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 414 7 2 3 5.0 OC(COc1cccc2[nH]c3ccccc3c12)CN1CCC(Cc2ccccc2)CC1 10.1016/j.bmcl.2010.04.009
CHEMBL1086542 14188 0 None -28 3 Human 7.9 pKi = 7.9 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 414 7 2 3 5.0 OC(COc1cccc2[nH]c3ccccc3c12)CN1CCC(Cc2ccccc2)CC1 10.1016/j.bmcl.2010.04.009
44328703 17001 0 None -1 2 Mouse 7.9 pKi = 7.9 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 241 6 4 5 0.8 CC(C)NC[C@H](O)COc1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
CHEMBL1160694 17001 0 None -1 2 Mouse 7.9 pKi = 7.9 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 241 6 4 5 0.8 CC(C)NC[C@H](O)COc1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
1621 9207 17 None -102 44 Human 6.9 pKi = 6.9 Binding
Binding affinity towards Beta-1 adrenergic receptorBinding affinity towards Beta-1 adrenergic receptor
ChEMBL 323 3 1 2 2.9 CCN(C(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 10.1021/jm020153s
17 9207 17 None -102 44 Human 6.9 pKi = 6.9 Binding
Binding affinity towards Beta-1 adrenergic receptorBinding affinity towards Beta-1 adrenergic receptor
ChEMBL 323 3 1 2 2.9 CCN(C(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 10.1021/jm020153s
5761 9207 17 None -102 44 Human 6.9 pKi = 6.9 Binding
Binding affinity towards Beta-1 adrenergic receptorBinding affinity towards Beta-1 adrenergic receptor
ChEMBL 323 3 1 2 2.9 CCN(C(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 10.1021/jm020153s
CHEMBL263881 9207 17 None -102 44 Human 6.9 pKi = 6.9 Binding
Binding affinity towards Beta-1 adrenergic receptorBinding affinity towards Beta-1 adrenergic receptor
ChEMBL 323 3 1 2 2.9 CCN(C(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 10.1021/jm020153s
DB04829 9207 17 None -102 44 Human 6.9 pKi = 6.9 Binding
Binding affinity towards Beta-1 adrenergic receptorBinding affinity towards Beta-1 adrenergic receptor
ChEMBL 323 3 1 2 2.9 CCN(C(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 10.1021/jm020153s
10291064 101255 0 None -14 2 Human 6.9 pKi = 6.9 Binding
Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 341 8 2 6 2.9 O[C@@H](CNCCOc1ccc(-c2cscn2)cc1)c1cccnc1 10.1016/j.bmcl.2007.06.072
CHEMBL251392 101255 0 None -14 2 Human 6.9 pKi = 6.9 Binding
Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 341 8 2 6 2.9 O[C@@H](CNCCOc1ccc(-c2cscn2)cc1)c1cccnc1 10.1016/j.bmcl.2007.06.072
10436455 162702 0 None - 1 Human 6.9 pKi = 6.9 Binding
Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.
ChEMBL 512 7 3 8 1.6 NS(=O)(=O)c1cc(N2CCN(CC(O)COc3cccc4c3SCC(=O)N4)CC2)ccc1Cl 10.1021/jm00053a020
CHEMBL40609 162702 0 None - 1 Human 6.9 pKi = 6.9 Binding
Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.
ChEMBL 512 7 3 8 1.6 NS(=O)(=O)c1cc(N2CCN(CC(O)COc3cccc4c3SCC(=O)N4)CC2)ccc1Cl 10.1021/jm00053a020
52946430 24597 0 None -4 3 Human 5.9 pKi = 5.9 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 517 9 3 8 3.7 CNC(=O)c1cccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)c1 10.1016/j.bmcl.2010.08.039
CHEMBL1258940 24597 0 None -4 3 Human 5.9 pKi = 5.9 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 517 9 3 8 3.7 CNC(=O)c1cccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)c1 10.1016/j.bmcl.2010.08.039
25266786 188478 0 None - 1 Rat 6.8 pKi = 6.8 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation methodDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation method
ChEMBL 356 10 3 5 2.6 COc1ccccc1OCCNC[C@@H](O)COc1cccc2[nH]ccc12 10.1016/j.ejmech.2008.05.019
CHEMBL477672 188478 0 None - 1 Rat 6.8 pKi = 6.8 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation methodDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation method
ChEMBL 356 10 3 5 2.6 COc1ccccc1OCCNC[C@@H](O)COc1cccc2[nH]ccc12 10.1016/j.ejmech.2008.05.019
4376990 199788 5 None -588 11 Human 5.8 pKi = 5.8 Binding
Binding affinity to beta1 receptor (unknown origin) assessed as inhibition constantBinding affinity to beta1 receptor (unknown origin) assessed as inhibition constant
ChEMBL 372 4 2 4 4.1 COc1cc(OC)c(C2NCCc3c2[nH]c2ccc(Cl)cc32)cc1OC 10.1021/acsmedchemlett.1c00694
CHEMBL5207529 199788 5 None -588 11 Human 5.8 pKi = 5.8 Binding
Binding affinity to beta1 receptor (unknown origin) assessed as inhibition constantBinding affinity to beta1 receptor (unknown origin) assessed as inhibition constant
ChEMBL 372 4 2 4 4.1 COc1cc(OC)c(C2NCCc3c2[nH]c2ccc(Cl)cc32)cc1OC 10.1021/acsmedchemlett.1c00694
CHEMBL5222754 199788 5 None -588 11 Human 5.8 pKi = 5.8 Binding
Binding affinity to beta1 receptor (unknown origin) assessed as inhibition constantBinding affinity to beta1 receptor (unknown origin) assessed as inhibition constant
ChEMBL 372 4 2 4 4.1 COc1cc(OC)c(C2NCCc3c2[nH]c2ccc(Cl)cc32)cc1OC 10.1021/acsmedchemlett.1c00694
688468 149110 10 None -190 2 Rat 4.8 pKi = 4.8 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 303 6 5 5 2.1 C[C@H](Cc1ccc(O)cc1)NC[C@H](O)c1cc(O)cc(O)c1 nan
CHEMBL388570 149110 10 None -190 2 Rat 4.8 pKi = 4.8 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 303 6 5 5 2.1 C[C@H](Cc1ccc(O)cc1)NC[C@H](O)c1cc(O)cc(O)c1 nan
11819522 18788 0 None 4 2 Rat 5.8 pKi = 5.8 Binding
Binding affinity against beta-1-adrenergic receptor in rat brainBinding affinity against beta-1-adrenergic receptor in rat brain
ChEMBL 174 6 2 4 0.4 C/C=N/OCC(O)CNC(C)C 10.1021/jm00036a018
CHEMBL1183318 18788 0 None 4 2 Rat 5.8 pKi = 5.8 Binding
Binding affinity against beta-1-adrenergic receptor in rat brainBinding affinity against beta-1-adrenergic receptor in rat brain
ChEMBL 174 6 2 4 0.4 C/C=N/OCC(O)CNC(C)C 10.1021/jm00036a018
CHEMBL290153 18788 0 None 4 2 Rat 5.8 pKi = 5.8 Binding
Binding affinity against beta-1-adrenergic receptor in rat brainBinding affinity against beta-1-adrenergic receptor in rat brain
ChEMBL 174 6 2 4 0.4 C/C=N/OCC(O)CNC(C)C 10.1021/jm00036a018
24937014 24180 0 None -58 3 Human 5.8 pKi = 5.8 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 506 9 4 9 3.6 OCc1cc(O)ccc1OCC(O)CNC1CCN(c2ncnc3scc(-c4ccccc4)c23)CC1 10.1016/j.bmcl.2010.08.039
CHEMBL1257554 24180 0 None -58 3 Human 5.8 pKi = 5.8 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 506 9 4 9 3.6 OCc1cc(O)ccc1OCC(O)CNC1CCN(c2ncnc3scc(-c4ccccc4)c23)CC1 10.1016/j.bmcl.2010.08.039
688468 149110 10 None -190 2 Rat 4.8 pKi = 4.8 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 303 6 5 5 2.1 C[C@H](Cc1ccc(O)cc1)NC[C@H](O)c1cc(O)cc(O)c1 10.1021/jm070030d
CHEMBL388570 149110 10 None -190 2 Rat 4.8 pKi = 4.8 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 303 6 5 5 2.1 C[C@H](Cc1ccc(O)cc1)NC[C@H](O)c1cc(O)cc(O)c1 10.1021/jm070030d
56677231 70413 0 None -234 2 Rat 4.8 pKi = 4.8 Binding
Displacement of [3H]CGP-12177 from beta1-adrenergic receptor in Sprague-Dawley rat cortical membrane after 2 hrsDisplacement of [3H]CGP-12177 from beta1-adrenergic receptor in Sprague-Dawley rat cortical membrane after 2 hrs
ChEMBL 367 7 4 5 3.5 COc1ccc(C[C@H](C)NC[C@H](O)c2cc(O)cc(O)c2)c2ccccc12 10.1016/j.bmc.2009.11.062
CHEMBL1800934 70413 0 None -234 2 Rat 4.8 pKi = 4.8 Binding
Displacement of [3H]CGP-12177 from beta1-adrenergic receptor in Sprague-Dawley rat cortical membrane after 2 hrsDisplacement of [3H]CGP-12177 from beta1-adrenergic receptor in Sprague-Dawley rat cortical membrane after 2 hrs
ChEMBL 367 7 4 5 3.5 COc1ccc(C[C@H](C)NC[C@H](O)c2cc(O)cc(O)c2)c2ccccc12 10.1016/j.bmc.2009.11.062
12828562 116483 0 None 3 2 Rat 5.8 pKi = 5.8 Binding
Tested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligandTested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligand
ChEMBL 237 3 3 4 1.7 CC(C)NCC1OCCc2cc(O)c(O)cc21 10.1021/jm00073a006
CHEMBL322842 116483 0 None 3 2 Rat 5.8 pKi = 5.8 Binding
Tested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligandTested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligand
ChEMBL 237 3 3 4 1.7 CC(C)NCC1OCCc2cc(O)c(O)cc21 10.1021/jm00073a006
2810 74376 55 None -1 2 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 213 4 2 2 2.4 CC(C)NCC(O)c1ccccc1Cl nan
CHEMBL1902627 74376 55 None -1 2 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 213 4 2 2 2.4 CC(C)NCC(O)c1ccccc1Cl nan
2303 9961 68 None -46 26 Rat 7.8 pKi = 7.8 Binding
Displacement of [3H]-CGP-12177 from beta1-adrenergic receptor in rat brain cortex after 1 hr by Microbeta scintillation counting methodDisplacement of [3H]-CGP-12177 from beta1-adrenergic receptor in rat brain cortex after 1 hr by Microbeta scintillation counting method
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.ejmech.2018.01.093
4946 9961 68 None -46 26 Rat 7.8 pKi = 7.8 Binding
Displacement of [3H]-CGP-12177 from beta1-adrenergic receptor in rat brain cortex after 1 hr by Microbeta scintillation counting methodDisplacement of [3H]-CGP-12177 from beta1-adrenergic receptor in rat brain cortex after 1 hr by Microbeta scintillation counting method
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.ejmech.2018.01.093
564 9961 68 None -46 26 Rat 7.8 pKi = 7.8 Binding
Displacement of [3H]-CGP-12177 from beta1-adrenergic receptor in rat brain cortex after 1 hr by Microbeta scintillation counting methodDisplacement of [3H]-CGP-12177 from beta1-adrenergic receptor in rat brain cortex after 1 hr by Microbeta scintillation counting method
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.ejmech.2018.01.093
63 9961 68 None -46 26 Rat 7.8 pKi = 7.8 Binding
Displacement of [3H]-CGP-12177 from beta1-adrenergic receptor in rat brain cortex after 1 hr by Microbeta scintillation counting methodDisplacement of [3H]-CGP-12177 from beta1-adrenergic receptor in rat brain cortex after 1 hr by Microbeta scintillation counting method
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.ejmech.2018.01.093
91536 9961 68 None -46 26 Rat 7.8 pKi = 7.8 Binding
Displacement of [3H]-CGP-12177 from beta1-adrenergic receptor in rat brain cortex after 1 hr by Microbeta scintillation counting methodDisplacement of [3H]-CGP-12177 from beta1-adrenergic receptor in rat brain cortex after 1 hr by Microbeta scintillation counting method
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.ejmech.2018.01.093
CHEMBL27 9961 68 None -46 26 Rat 7.8 pKi = 7.8 Binding
Displacement of [3H]-CGP-12177 from beta1-adrenergic receptor in rat brain cortex after 1 hr by Microbeta scintillation counting methodDisplacement of [3H]-CGP-12177 from beta1-adrenergic receptor in rat brain cortex after 1 hr by Microbeta scintillation counting method
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.ejmech.2018.01.093
CHEMBL452861 9961 68 None -46 26 Rat 7.8 pKi = 7.8 Binding
Displacement of [3H]-CGP-12177 from beta1-adrenergic receptor in rat brain cortex after 1 hr by Microbeta scintillation counting methodDisplacement of [3H]-CGP-12177 from beta1-adrenergic receptor in rat brain cortex after 1 hr by Microbeta scintillation counting method
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.ejmech.2018.01.093
DB00571 9961 68 None -46 26 Rat 7.8 pKi = 7.8 Binding
Displacement of [3H]-CGP-12177 from beta1-adrenergic receptor in rat brain cortex after 1 hr by Microbeta scintillation counting methodDisplacement of [3H]-CGP-12177 from beta1-adrenergic receptor in rat brain cortex after 1 hr by Microbeta scintillation counting method
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.ejmech.2018.01.093
49864379 22404 0 None -8 2 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 358 8 4 5 2.9 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCCc3ccccc3)c2s1 10.1016/j.bmcl.2010.06.136
CHEMBL1221636 22404 0 None -8 2 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 358 8 4 5 2.9 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCCc3ccccc3)c2s1 10.1016/j.bmcl.2010.06.136
10049403 162079 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.
ChEMBL 449 10 4 6 2.6 NS(=O)(=O)c1cc(NCCNCC(O)COc2cccc3ccccc23)ccc1Cl 10.1021/jm00053a020
CHEMBL40297 162079 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.
ChEMBL 449 10 4 6 2.6 NS(=O)(=O)c1cc(NCCNCC(O)COc2cccc3ccccc23)ccc1Cl 10.1021/jm00053a020
10082625 20565 0 None 1 3 Guinea pig 6.8 pKi = 6.8 Binding
Binding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacementBinding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacement
ChEMBL 231 1 1 5 0.8 Cc1cn2c(C)cnc2c(N2CCNCC2)n1 10.1021/jm00099a012
CHEMBL1195526 20565 0 None 1 3 Guinea pig 6.8 pKi = 6.8 Binding
Binding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacementBinding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacement
ChEMBL 231 1 1 5 0.8 Cc1cn2c(C)cnc2c(N2CCNCC2)n1 10.1021/jm00099a012
CHEMBL554785 20565 0 None 1 3 Guinea pig 6.8 pKi = 6.8 Binding
Binding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacementBinding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacement
ChEMBL 231 1 1 5 0.8 Cc1cn2c(C)cnc2c(N2CCNCC2)n1 10.1021/jm00099a012
2249 7300 111 None -5 12 Human 6.8 pKi = 6.8 Binding
Binding affinity to human adrenergic beta1 receptor by radioligand displacement assayBinding affinity to human adrenergic beta1 receptor by radioligand displacement assay
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1016/j.ejmech.2013.01.044
255 7300 111 None -5 12 Human 6.8 pKi = 6.8 Binding
Binding affinity to human adrenergic beta1 receptor by radioligand displacement assayBinding affinity to human adrenergic beta1 receptor by radioligand displacement assay
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1016/j.ejmech.2013.01.044
548 7300 111 None -5 12 Human 6.8 pKi = 6.8 Binding
Binding affinity to human adrenergic beta1 receptor by radioligand displacement assayBinding affinity to human adrenergic beta1 receptor by radioligand displacement assay
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1016/j.ejmech.2013.01.044
CHEMBL24 7300 111 None -5 12 Human 6.8 pKi = 6.8 Binding
Binding affinity to human adrenergic beta1 receptor by radioligand displacement assayBinding affinity to human adrenergic beta1 receptor by radioligand displacement assay
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1016/j.ejmech.2013.01.044
DB00335 7300 111 None -5 12 Human 6.8 pKi = 6.8 Binding
Binding affinity to human adrenergic beta1 receptor by radioligand displacement assayBinding affinity to human adrenergic beta1 receptor by radioligand displacement assay
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1016/j.ejmech.2013.01.044
52943919 24493 0 None -25 3 Human 6.8 pKi = 6.8 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 500 10 2 7 5.1 C=CCc1ccccc1OCC(O)CNC1CCN(c2ncnc3scc(-c4ccccc4)c23)CC1 10.1016/j.bmcl.2010.08.039
CHEMBL1258597 24493 0 None -25 3 Human 6.8 pKi = 6.8 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 500 10 2 7 5.1 C=CCc1ccccc1OCC(O)CNC1CCN(c2ncnc3scc(-c4ccccc4)c23)CC1 10.1016/j.bmcl.2010.08.039
10273469 101029 0 None 3 2 Human 6.8 pKi = 6.8 Binding
Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 417 9 2 6 4.6 O[C@@H](CNCCOc1ccc(-c2csc(-c3ccccc3)n2)cc1)c1cccnc1 10.1016/j.bmcl.2007.06.072
CHEMBL250144 101029 0 None 3 2 Human 6.8 pKi = 6.8 Binding
Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 417 9 2 6 4.6 O[C@@H](CNCCOc1ccc(-c2csc(-c3ccccc3)n2)cc1)c1cccnc1 10.1016/j.bmcl.2007.06.072
155521165 177336 0 None 14 2 Mouse 6.8 pKi = 6.8 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 600 17 3 10 4.4 COc1cc(CCNC[C@H](O)COc2ccc(-c3nc(C(F)(F)F)cn3C)cc2)ccc1OCCSSCCN 10.1016/j.bmc.2019.05.034
CHEMBL4450085 177336 0 None 14 2 Mouse 6.8 pKi = 6.8 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 600 17 3 10 4.4 COc1cc(CCNC[C@H](O)COc2ccc(-c3nc(C(F)(F)F)cn3C)cc2)ccc1OCCSSCCN 10.1016/j.bmc.2019.05.034
127046949 146687 0 None -23 6 Mouse 6.8 pKi = 6.8 Binding
Displacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cellsDisplacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cells
ChEMBL 472 12 3 5 4.6 COc1cc(CCNCCc2ccc(O)c3[nH]c(=O)ccc23)ccc1OCCCc1ccccc1 10.1016/j.bmc.2016.04.028
CHEMBL3799455 146687 0 None -23 6 Mouse 6.8 pKi = 6.8 Binding
Displacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cellsDisplacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cells
ChEMBL 472 12 3 5 4.6 COc1cc(CCNCCc2ccc(O)c3[nH]c(=O)ccc23)ccc1OCCCc1ccccc1 10.1016/j.bmc.2016.04.028
6603820 102549 19 None -162 12 Human 5.8 pKi = 5.8 Binding
Binding affinity against Beta-1 adrenergic receptorBinding affinity against Beta-1 adrenergic receptor
ChEMBL 267 0 3 3 2.6 Oc1cc2c(cc1O)[C@H]1c3ccccc3CN[C@@H]1CC2 10.1021/jm00018a002
CHEMBL25856 102549 19 None -162 12 Human 5.8 pKi = 5.8 Binding
Binding affinity against Beta-1 adrenergic receptorBinding affinity against Beta-1 adrenergic receptor
ChEMBL 267 0 3 3 2.6 Oc1cc2c(cc1O)[C@H]1c3ccccc3CN[C@@H]1CC2 10.1021/jm00018a002
44444179 100917 0 None -39 3 Human 5.8 pKi = 5.8 Binding
Displacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 508 10 4 5 4.5 CS(=O)(=O)Nc1cc(C[C@H](O)CN[C@H](Cc2ccccc2)c2ccc(Cl)c(Cl)c2)ccc1O 10.1016/j.bmcl.2007.05.030
CHEMBL249359 100917 0 None -39 3 Human 5.8 pKi = 5.8 Binding
Displacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 508 10 4 5 4.5 CS(=O)(=O)Nc1cc(C[C@H](O)CN[C@H](Cc2ccccc2)c2ccc(Cl)c(Cl)c2)ccc1O 10.1016/j.bmcl.2007.05.030
127047221 146708 0 None -6 6 Mouse 5.8 pKi = 5.8 Binding
Displacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cellsDisplacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cells
ChEMBL 319 8 4 6 1.8 COc1ccccc1OCCNC[C@@H](O)c1ccc(O)c(O)c1 10.1016/j.bmc.2016.04.028
CHEMBL3799593 146708 0 None -6 6 Mouse 5.8 pKi = 5.8 Binding
Displacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cellsDisplacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cells
ChEMBL 319 8 4 6 1.8 COc1ccccc1OCCNC[C@@H](O)c1ccc(O)c(O)c1 10.1016/j.bmc.2016.04.028
594115 26147 2 None 3 2 Rat 5.8 pKi = 5.8 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
ChEMBL 187 2 4 4 0.2 NCC(O)c1cc(O)c(O)c(F)c1 10.1021/jm00076a024
CHEMBL129190 26147 2 None 3 2 Rat 5.8 pKi = 5.8 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
ChEMBL 187 2 4 4 0.2 NCC(O)c1cc(O)c(O)c(F)c1 10.1021/jm00076a024
3042920 211787 10 None -1 2 Rat 4.8 pKi = 4.8 Binding
Compound was evaluated for beta adrenergic binding affinity towards beta-1 receptor of rat brainCompound was evaluated for beta adrenergic binding affinity towards beta-1 receptor of rat brain
ChEMBL 195 1 3 4 0.8 Oc1ccc(C2CNCCO2)cc1O 10.1021/jm00084a006
CHEMBL7681 211787 10 None -1 2 Rat 4.8 pKi = 4.8 Binding
Compound was evaluated for beta adrenergic binding affinity towards beta-1 receptor of rat brainCompound was evaluated for beta adrenergic binding affinity towards beta-1 receptor of rat brain
ChEMBL 195 1 3 4 0.8 Oc1ccc(C2CNCCO2)cc1O 10.1021/jm00084a006
49864414 22416 0 None -37 2 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 362 4 4 5 3.1 CC1(C)[C@@H]2CC[C@]1(C)[C@@H](NC[C@H](O)c1ccc(O)c3[nH]c(=O)sc13)C2 10.1016/j.bmcl.2010.06.136
CHEMBL1221734 22416 0 None -37 2 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 362 4 4 5 3.1 CC1(C)[C@@H]2CC[C@]1(C)[C@@H](NC[C@H](O)c1ccc(O)c3[nH]c(=O)sc13)C2 10.1016/j.bmcl.2010.06.136
2249 7300 111 None -5 12 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation countingDisplacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation counting
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/acs.jmedchem.8b00625
255 7300 111 None -5 12 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation countingDisplacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation counting
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/acs.jmedchem.8b00625
548 7300 111 None -5 12 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation countingDisplacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation counting
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/acs.jmedchem.8b00625
CHEMBL24 7300 111 None -5 12 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation countingDisplacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation counting
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/acs.jmedchem.8b00625
DB00335 7300 111 None -5 12 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation countingDisplacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation counting
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/acs.jmedchem.8b00625
145946991 174390 0 None 1 2 Human 4.8 pKi = 4.8 Binding
Displacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation countingDisplacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation counting
ChEMBL 330 9 3 5 1.0 CNCC(O)COc1ccc(S(=O)(=O)NC(C)C(C)C)cc1 10.1021/acs.jmedchem.8b00625
CHEMBL4163665 174390 0 None 1 2 Human 4.8 pKi = 4.8 Binding
Displacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation countingDisplacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation counting
ChEMBL 330 9 3 5 1.0 CNCC(O)COc1ccc(S(=O)(=O)NC(C)C(C)C)cc1 10.1021/acs.jmedchem.8b00625
CHEMBL4301131 174390 0 None 1 2 Human 4.8 pKi = 4.8 Binding
Displacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation countingDisplacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation counting
ChEMBL 330 9 3 5 1.0 CNCC(O)COc1ccc(S(=O)(=O)NC(C)C(C)C)cc1 10.1021/acs.jmedchem.8b00625
44444393 173194 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 353 8 2 6 3.1 Cc1nc(-c2ccc(OCCNC[C@H](O)c3cccnc3)cc2)c(C)o1 10.1016/j.bmcl.2007.06.072
CHEMBL427711 173194 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 353 8 2 6 3.1 Cc1nc(-c2ccc(OCCNC[C@H](O)c3cccnc3)cc2)c(C)o1 10.1016/j.bmcl.2007.06.072
145947060 174398 0 None - 1 Rat 5.8 pKi = 5.8 Binding
Displacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysisDisplacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysis
ChEMBL 431 6 1 7 2.9 O=c1c2ccccc2oc2cc(OCC(O)CN3CCN(c4ccccn4)CC3)ccc12 10.1016/j.bmc.2018.04.038
CHEMBL4126157 174398 0 None - 1 Rat 5.8 pKi = 5.8 Binding
Displacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysisDisplacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysis
ChEMBL 431 6 1 7 2.9 O=c1c2ccccc2oc2cc(OCC(O)CN3CCN(c4ccccn4)CC3)ccc12 10.1016/j.bmc.2018.04.038
CHEMBL4301323 174398 0 None - 1 Rat 5.8 pKi = 5.8 Binding
Displacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysisDisplacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysis
ChEMBL 431 6 1 7 2.9 O=c1c2ccccc2oc2cc(OCC(O)CN3CCN(c4ccccn4)CC3)ccc12 10.1016/j.bmc.2018.04.038
16735272 92587 0 None -46 2 Rat 4.8 pKi = 4.8 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 337 6 4 4 3.5 C[C@@H](Cc1cccc2ccccc12)NC[C@H](O)c1cc(O)cc(O)c1 nan
CHEMBL229614 92587 0 None -46 2 Rat 4.8 pKi = 4.8 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 337 6 4 4 3.5 C[C@@H](Cc1cccc2ccccc12)NC[C@H](O)c1cc(O)cc(O)c1 nan
16735272 92587 0 None -46 2 Rat 4.8 pKi = 4.8 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 337 6 4 4 3.5 C[C@@H](Cc1cccc2ccccc12)NC[C@H](O)c1cc(O)cc(O)c1 10.1021/jm070030d
CHEMBL229614 92587 0 None -46 2 Rat 4.8 pKi = 4.8 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 337 6 4 4 3.5 C[C@@H](Cc1cccc2ccccc12)NC[C@H](O)c1cc(O)cc(O)c1 10.1021/jm070030d
1499 8872 47 None -53 17 Human 5.8 pKi = 5.8 Binding
Binding Affinity against human Beta-1 adrenergic receptor expressed in Chinese hamster ovary(CHO) cells was measured by using [125I]ICYP radioligandBinding Affinity against human Beta-1 adrenergic receptor expressed in Chinese hamster ovary(CHO) cells was measured by using [125I]ICYP radioligand
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm990012z
3779 8872 47 None -53 17 Human 5.8 pKi = 5.8 Binding
Binding Affinity against human Beta-1 adrenergic receptor expressed in Chinese hamster ovary(CHO) cells was measured by using [125I]ICYP radioligandBinding Affinity against human Beta-1 adrenergic receptor expressed in Chinese hamster ovary(CHO) cells was measured by using [125I]ICYP radioligand
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm990012z
536 8872 47 None -53 17 Human 5.8 pKi = 5.8 Binding
Binding Affinity against human Beta-1 adrenergic receptor expressed in Chinese hamster ovary(CHO) cells was measured by using [125I]ICYP radioligandBinding Affinity against human Beta-1 adrenergic receptor expressed in Chinese hamster ovary(CHO) cells was measured by using [125I]ICYP radioligand
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm990012z
CHEMBL434 8872 47 None -53 17 Human 5.8 pKi = 5.8 Binding
Binding Affinity against human Beta-1 adrenergic receptor expressed in Chinese hamster ovary(CHO) cells was measured by using [125I]ICYP radioligandBinding Affinity against human Beta-1 adrenergic receptor expressed in Chinese hamster ovary(CHO) cells was measured by using [125I]ICYP radioligand
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm990012z
DB01064 8872 47 None -53 17 Human 5.8 pKi = 5.8 Binding
Binding Affinity against human Beta-1 adrenergic receptor expressed in Chinese hamster ovary(CHO) cells was measured by using [125I]ICYP radioligandBinding Affinity against human Beta-1 adrenergic receptor expressed in Chinese hamster ovary(CHO) cells was measured by using [125I]ICYP radioligand
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm990012z
44439167 97332 0 None -158 10 Human 5.8 pKi = 5.8 Binding
Binding affinity at adrenergic beta 1 receptorBinding affinity at adrenergic beta 1 receptor
ChEMBL 483 6 1 5 5.0 Cc1ccc2c(OCCN3CCC(Cc4cc(F)c5c(c4)NC(=O)CO5)CC3)cc(Cl)cc2n1 10.1016/j.bmcl.2006.11.031
CHEMBL238732 97332 0 None -158 10 Human 5.8 pKi = 5.8 Binding
Binding affinity at adrenergic beta 1 receptorBinding affinity at adrenergic beta 1 receptor
ChEMBL 483 6 1 5 5.0 Cc1ccc2c(OCCN3CCC(Cc4cc(F)c5c(c4)NC(=O)CO5)CC3)cc(Cl)cc2n1 10.1016/j.bmcl.2006.11.031
2736205 94311 76 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysisDisplacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis
ChEMBL 222 3 1 4 1.1 COc1cc(OC)cc(N2CCNCC2)c1 10.1021/jm400140q
CHEMBL2335163 94311 76 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysisDisplacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis
ChEMBL 222 3 1 4 1.1 COc1cc(OC)cc(N2CCNCC2)c1 10.1021/jm400140q
702318 94313 76 None -19 2 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysisDisplacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis
ChEMBL 227 1 1 3 2.0 Cc1cc(N2CCNCC2)c2ccccc2n1 10.1021/jm400140q
CHEMBL2335165 94313 76 None -19 2 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysisDisplacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis
ChEMBL 227 1 1 3 2.0 Cc1cc(N2CCNCC2)c2ccccc2n1 10.1021/jm400140q
59119410 119042 0 None -158 2 Human 4.8 pKi = 4.8 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 436 11 5 6 4.3 CC(C)Oc1ccc(Nc2ccc(CCNCC(O)c3ccc(O)c(CO)c3)cc2)cc1 10.1016/j.bmcl.2014.04.069
CHEMBL3290993 119042 0 None -158 2 Human 4.8 pKi = 4.8 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 436 11 5 6 4.3 CC(C)Oc1ccc(Nc2ccc(CCNCC(O)c3ccc(O)c(CO)c3)cc2)cc1 10.1016/j.bmcl.2014.04.069
24885648 23908 0 None -17 3 Human 6.8 pKi = 6.8 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 460 8 2 7 4.4 OC(CNC1CCN(c2ncnc3scc(-c4ccccc4)c23)CC1)COc1ccccc1 10.1016/j.bmcl.2010.08.039
CHEMBL1255596 23908 0 None -17 3 Human 6.8 pKi = 6.8 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 460 8 2 7 4.4 OC(CNC1CCN(c2ncnc3scc(-c4ccccc4)c23)CC1)COc1ccccc1 10.1016/j.bmcl.2010.08.039
46889852 13304 0 None -79 3 Human 7.8 pKi = 7.8 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 428 7 2 4 4.7 O=C(c1ccccc1)C1CCN(CC(O)COc2cccc3[nH]c4ccccc4c23)CC1 10.1016/j.bmcl.2010.04.009
CHEMBL1082827 13304 0 None -79 3 Human 7.8 pKi = 7.8 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 428 7 2 4 4.7 O=C(c1ccccc1)C1CCN(CC(O)COc2cccc3[nH]c4ccccc4c23)CC1 10.1016/j.bmcl.2010.04.009
127045855 146442 0 None -1 6 Mouse 6.8 pKi = 6.8 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 319 8 4 6 1.8 COc1ccccc1OCCNC[C@H](O)c1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
CHEMBL3797876 146442 0 None -1 6 Mouse 6.8 pKi = 6.8 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 319 8 4 6 1.8 COc1ccccc1OCCNC[C@H](O)c1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
127045855 146442 0 None -1 6 Mouse 6.8 pKi = 6.8 Binding
Displacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cellsDisplacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cells
ChEMBL 319 8 4 6 1.8 COc1ccccc1OCCNC[C@H](O)c1ccc(O)c(O)c1 10.1016/j.bmc.2016.04.028
CHEMBL3797876 146442 0 None -1 6 Mouse 6.8 pKi = 6.8 Binding
Displacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cellsDisplacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cells
ChEMBL 319 8 4 6 1.8 COc1ccccc1OCCNC[C@H](O)c1ccc(O)c(O)c1 10.1016/j.bmc.2016.04.028
10459124 174772 0 None - 1 Human 6.8 pKi = 6.8 Binding
Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.
ChEMBL 513 11 4 7 1.4 NS(=O)(=O)c1cc(S(=O)(=O)NCCNCC(O)COc2cccc3ccccc23)ccc1Cl 10.1021/jm00053a020
CHEMBL43196 174772 0 None - 1 Human 6.8 pKi = 6.8 Binding
Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.
ChEMBL 513 11 4 7 1.4 NS(=O)(=O)c1cc(S(=O)(=O)NCCNCC(O)COc2cccc3ccccc23)ccc1Cl 10.1021/jm00053a020
1960 9632 67 None -144 26 Rat 5.8 pKi = 5.8 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00076a024
439260 9632 67 None -144 26 Rat 5.8 pKi = 5.8 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00076a024
505 9632 67 None -144 26 Rat 5.8 pKi = 5.8 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00076a024
CHEMBL1437 9632 67 None -144 26 Rat 5.8 pKi = 5.8 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00076a024
DB00368 9632 67 None -144 26 Rat 5.8 pKi = 5.8 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00076a024
53379897 70420 0 None -40 2 Rat 4.8 pKi = 4.8 Binding
Displacement of [3H]CGP-12177 from beta1-adrenergic receptor in Sprague-Dawley rat cortical membrane after 2 hrsDisplacement of [3H]CGP-12177 from beta1-adrenergic receptor in Sprague-Dawley rat cortical membrane after 2 hrs
ChEMBL 337 6 4 4 3.5 C[C@H](Cc1ccc2ccccc2c1)NC[C@H](O)c1cc(O)cc(O)c1 10.1016/j.bmc.2009.11.062
CHEMBL1800961 70420 0 None -40 2 Rat 4.8 pKi = 4.8 Binding
Displacement of [3H]CGP-12177 from beta1-adrenergic receptor in Sprague-Dawley rat cortical membrane after 2 hrsDisplacement of [3H]CGP-12177 from beta1-adrenergic receptor in Sprague-Dawley rat cortical membrane after 2 hrs
ChEMBL 337 6 4 4 3.5 C[C@H](Cc1ccc2ccccc2c1)NC[C@H](O)c1cc(O)cc(O)c1 10.1016/j.bmc.2009.11.062
49864332 22384 0 None -6 2 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 310 7 4 5 2.4 CCC(CC)CNC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12 10.1016/j.bmcl.2010.06.136
CHEMBL1221540 22384 0 None -6 2 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 310 7 4 5 2.4 CCC(CC)CNC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12 10.1016/j.bmcl.2010.06.136
49864396 22411 0 None -25 3 Human 7.8 pKi = 7.8 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 362 5 4 5 3.3 O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@@H]3CCC[C@@H]3C3CCCC3)c2s1 10.1016/j.bmcl.2014.06.014
CHEMBL1221682 22411 0 None -25 3 Human 7.8 pKi = 7.8 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 362 5 4 5 3.3 O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@@H]3CCC[C@@H]3C3CCCC3)c2s1 10.1016/j.bmcl.2014.06.014
49864396 22411 0 None -25 3 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 362 5 4 5 3.3 O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@@H]3CCC[C@@H]3C3CCCC3)c2s1 10.1016/j.bmcl.2010.06.136
CHEMBL1221682 22411 0 None -25 3 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 362 5 4 5 3.3 O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@@H]3CCC[C@@H]3C3CCCC3)c2s1 10.1016/j.bmcl.2010.06.136
49864441 22421 0 None -4 2 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 346 7 4 6 2.0 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCOc3ccccc3)c2s1 10.1016/j.bmcl.2010.06.136
CHEMBL1221803 22421 0 None -4 2 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 346 7 4 6 2.0 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCOc3ccccc3)c2s1 10.1016/j.bmcl.2010.06.136
14823035 148341 2 None -52 3 Human 6.8 pKi = 6.8 Binding
Ability to bind to human Beta-1 adrenergic receptor using membranes of stably transfected CHO cellsAbility to bind to human Beta-1 adrenergic receptor using membranes of stably transfected CHO cells
ChEMBL 377 9 2 5 3.1 COC(=O)COc1ccc(C[C@@H](C)NC[C@H](O)c2cccc(Cl)c2)cc1 10.1016/S0960-894X(97)00266-7
CHEMBL38486 148341 2 None -52 3 Human 6.8 pKi = 6.8 Binding
Ability to bind to human Beta-1 adrenergic receptor using membranes of stably transfected CHO cellsAbility to bind to human Beta-1 adrenergic receptor using membranes of stably transfected CHO cells
ChEMBL 377 9 2 5 3.1 COC(=O)COc1ccc(C[C@@H](C)NC[C@H](O)c2cccc(Cl)c2)cc1 10.1016/S0960-894X(97)00266-7
10379016 23264 2 None 1 3 Guinea pig 6.8 pKi = 6.8 Binding
Binding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacementBinding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacement
ChEMBL 281 1 1 5 0.9 Brc1cnc(N2CCNCC2)c2nccn12 10.1021/jm00099a012
CHEMBL123566 23264 2 None 1 3 Guinea pig 6.8 pKi = 6.8 Binding
Binding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacementBinding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacement
ChEMBL 281 1 1 5 0.9 Brc1cnc(N2CCNCC2)c2nccn12 10.1021/jm00099a012
90469115 192621 4 None -56 17 Human 6.8 pKi = 6.8 Binding
Binding affinity to human adrenergic beta1 receptorBinding affinity to human adrenergic beta1 receptor
ChEMBL 410 3 1 6 3.0 O=S(=O)(c1cccc(F)c1)n1ccc2c(N3CCNCC3)nc3ccccc3c21 10.1021/acs.jmedchem.1c00224
CHEMBL4867565 192621 4 None -56 17 Human 6.8 pKi = 6.8 Binding
Binding affinity to human adrenergic beta1 receptorBinding affinity to human adrenergic beta1 receptor
ChEMBL 410 3 1 6 3.0 O=S(=O)(c1cccc(F)c1)n1ccc2c(N3CCNCC3)nc3ccccc3c21 10.1021/acs.jmedchem.1c00224
46889701 13849 0 None -1 3 Human 6.8 pKi = 6.8 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 500 9 2 6 4.0 C=CCc1ccccc1OCC(O)CN1CCC(CN2C(=O)c3cccc4cc(O)cc(c34)C2=O)CC1 10.1016/j.bmcl.2010.04.009
CHEMBL1085014 13849 0 None -1 3 Human 6.8 pKi = 6.8 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 500 9 2 6 4.0 C=CCc1ccccc1OCC(O)CN1CCC(CN2C(=O)c3cccc4cc(O)cc(c34)C2=O)CC1 10.1016/j.bmcl.2010.04.009
10131985 161419 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 339 8 2 6 2.7 Cc1ocnc1-c1ccc(OCCNC[C@H](O)c2cccnc2)cc1 10.1016/j.bmcl.2007.06.072
CHEMBL399440 161419 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 339 8 2 6 2.7 Cc1ocnc1-c1ccc(OCCNC[C@H](O)c2cccnc2)cc1 10.1016/j.bmcl.2007.06.072
2249 7300 111 None -5 12 Human 6.8 pKi = 6.8 Binding
Displacement of [3H](-)-CGP12177 from human adrenergic beta1 receptorDisplacement of [3H](-)-CGP12177 from human adrenergic beta1 receptor
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm2006782
255 7300 111 None -5 12 Human 6.8 pKi = 6.8 Binding
Displacement of [3H](-)-CGP12177 from human adrenergic beta1 receptorDisplacement of [3H](-)-CGP12177 from human adrenergic beta1 receptor
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm2006782
548 7300 111 None -5 12 Human 6.8 pKi = 6.8 Binding
Displacement of [3H](-)-CGP12177 from human adrenergic beta1 receptorDisplacement of [3H](-)-CGP12177 from human adrenergic beta1 receptor
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm2006782
CHEMBL24 7300 111 None -5 12 Human 6.8 pKi = 6.8 Binding
Displacement of [3H](-)-CGP12177 from human adrenergic beta1 receptorDisplacement of [3H](-)-CGP12177 from human adrenergic beta1 receptor
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm2006782
DB00335 7300 111 None -5 12 Human 6.8 pKi = 6.8 Binding
Displacement of [3H](-)-CGP12177 from human adrenergic beta1 receptorDisplacement of [3H](-)-CGP12177 from human adrenergic beta1 receptor
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm2006782
16736094 92559 0 None -9 2 Rat 4.8 pKi = 4.8 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 302 6 5 5 1.9 C[C@H](Cc1ccc(N)cc1)NC[C@H](O)c1cc(O)cc(O)c1 10.1021/jm070030d
CHEMBL229391 92559 0 None -9 2 Rat 4.8 pKi = 4.8 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 302 6 5 5 1.9 C[C@H](Cc1ccc(N)cc1)NC[C@H](O)c1cc(O)cc(O)c1 10.1021/jm070030d
123133224 167491 0 None -9 2 Rat 4.8 pKi = 4.8 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 302 6 5 5 1.9 C[C@H](Cc1cccc(N)c1)NC[C@H](O)c1cc(O)cc(O)c1 nan
CHEMBL4113713 167491 0 None -9 2 Rat 4.8 pKi = 4.8 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 302 6 5 5 1.9 C[C@H](Cc1cccc(N)c1)NC[C@H](O)c1cc(O)cc(O)c1 nan
118710936 120523 0 None -29 3 Human 7.8 pKi = 7.8 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 362 5 4 5 3.3 O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@H]3CCC[C@@H]3C3CCCC3)c2s1 10.1016/j.bmcl.2014.06.014
CHEMBL3323654 120523 0 None -29 3 Human 7.8 pKi = 7.8 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 362 5 4 5 3.3 O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@H]3CCC[C@@H]3C3CCCC3)c2s1 10.1016/j.bmcl.2014.06.014
319 8106 44 None -154 9 Human 6.8 pKi = 6.8 Binding
Binding affinity to human beta1-adrenoceptor by radioligand binding assayBinding affinity to human beta1-adrenoceptor by radioligand binding assay
ChEMBL 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 10.1016/j.bmcl.2012.07.096
321 8106 44 None -154 9 Human 6.8 pKi = 6.8 Binding
Binding affinity to human beta1-adrenoceptor by radioligand binding assayBinding affinity to human beta1-adrenoceptor by radioligand binding assay
ChEMBL 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 10.1016/j.bmcl.2012.07.096
444031 8106 44 None -154 9 Human 6.8 pKi = 6.8 Binding
Binding affinity to human beta1-adrenoceptor by radioligand binding assayBinding affinity to human beta1-adrenoceptor by radioligand binding assay
ChEMBL 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 10.1016/j.bmcl.2012.07.096
784 8106 44 None -154 9 Human 6.8 pKi = 6.8 Binding
Binding affinity to human beta1-adrenoceptor by radioligand binding assayBinding affinity to human beta1-adrenoceptor by radioligand binding assay
ChEMBL 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 10.1016/j.bmcl.2012.07.096
CHEMBL1346 8106 44 None -154 9 Human 6.8 pKi = 6.8 Binding
Binding affinity to human beta1-adrenoceptor by radioligand binding assayBinding affinity to human beta1-adrenoceptor by radioligand binding assay
ChEMBL 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 10.1016/j.bmcl.2012.07.096
DB00496 8106 44 None -154 9 Human 6.8 pKi = 6.8 Binding
Binding affinity to human beta1-adrenoceptor by radioligand binding assayBinding affinity to human beta1-adrenoceptor by radioligand binding assay
ChEMBL 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 10.1016/j.bmcl.2012.07.096
127045854 146342 0 None -13 6 Mouse 6.8 pKi = 6.8 Binding
Displacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cellsDisplacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cells
ChEMBL 492 12 4 7 3.6 COc1cc(CCNC[C@@H](O)c2ccc(O)c3c2OCC(=O)N3)ccc1OCCCc1ccccc1 10.1016/j.bmc.2016.04.028
CHEMBL3797205 146342 0 None -13 6 Mouse 6.8 pKi = 6.8 Binding
Displacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cellsDisplacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cells
ChEMBL 492 12 4 7 3.6 COc1cc(CCNC[C@@H](O)c2ccc(O)c3c2OCC(=O)N3)ccc1OCCCc1ccccc1 10.1016/j.bmc.2016.04.028
10420352 175519 10 None -6 4 Guinea pig 5.8 pKi = 5.8 Binding
Binding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenololBinding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenolol
ChEMBL 201 3 4 4 0.5 CNCC(O)c1ccc(O)c(O)c1F 10.1021/jm00118a019
CHEMBL43711 175519 10 None -6 4 Guinea pig 5.8 pKi = 5.8 Binding
Binding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenololBinding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenolol
ChEMBL 201 3 4 4 0.5 CNCC(O)c1ccc(O)c(O)c1F 10.1021/jm00118a019
10420352 175519 10 None -6 4 Rat 5.8 pKi = 5.8 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 201 3 4 4 0.5 CNCC(O)c1ccc(O)c(O)c1F 10.1021/jm990599h
CHEMBL43711 175519 10 None -6 4 Rat 5.8 pKi = 5.8 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 201 3 4 4 0.5 CNCC(O)c1ccc(O)c(O)c1F 10.1021/jm990599h
10420352 175519 10 None -6 4 Rat 5.8 pKi = 5.8 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
ChEMBL 201 3 4 4 0.5 CNCC(O)c1ccc(O)c(O)c1F 10.1021/jm00076a024
CHEMBL43711 175519 10 None -6 4 Rat 5.8 pKi = 5.8 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
ChEMBL 201 3 4 4 0.5 CNCC(O)c1ccc(O)c(O)c1F 10.1021/jm00076a024
10051943 23097 0 None -602 3 Human 6.7 pKi = 6.7 Binding
Binding affinity for human Beta-1 adrenergic receptor expressed in CHO cells by radioligand competition binding assays using [125I]iodocyanopindolol (ICYP).) PR = potency ratio relative to TMQBinding affinity for human Beta-1 adrenergic receptor expressed in CHO cells by radioligand competition binding assays using [125I]iodocyanopindolol (ICYP).) PR = potency ratio relative to TMQ
ChEMBL 507 2 3 3 3.7 Oc1cc2c(cc1O)C(Cc1cc(I)cc(I)c1)NCC2 10.1021/jm960208o
CHEMBL122757 23097 0 None -602 3 Human 6.7 pKi = 6.7 Binding
Binding affinity for human Beta-1 adrenergic receptor expressed in CHO cells by radioligand competition binding assays using [125I]iodocyanopindolol (ICYP).) PR = potency ratio relative to TMQBinding affinity for human Beta-1 adrenergic receptor expressed in CHO cells by radioligand competition binding assays using [125I]iodocyanopindolol (ICYP).) PR = potency ratio relative to TMQ
ChEMBL 507 2 3 3 3.7 Oc1cc2c(cc1O)C(Cc1cc(I)cc(I)c1)NCC2 10.1021/jm960208o
70684846 84389 11 None -4 2 Human 6.7 pKi = 6.7 Binding
Binding affinity to human beta1-adrenoceptor by radioligand binding assayBinding affinity to human beta1-adrenoceptor by radioligand binding assay
ChEMBL 394 6 4 4 3.2 CCc1cc2c(cc1CC)CC(NC[C@H](O)c1ccc(O)c3c1CCC(=O)N3)C2 10.1016/j.bmcl.2012.07.096
CHEMBL2088197 84389 11 None -4 2 Human 6.7 pKi = 6.7 Binding
Binding affinity to human beta1-adrenoceptor by radioligand binding assayBinding affinity to human beta1-adrenoceptor by radioligand binding assay
ChEMBL 394 6 4 4 3.2 CCc1cc2c(cc1CC)CC(NC[C@H](O)c1ccc(O)c3c1CCC(=O)N3)C2 10.1016/j.bmcl.2012.07.096
49864440 22420 0 None -29 2 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 434 7 4 7 2.3 O=c1[nH]c2c(O)ccc([C@@H](O)CNC3CCN(CCN4CCCCCC4)CC3)c2s1 10.1016/j.bmcl.2010.06.136
CHEMBL1221802 22420 0 None -29 2 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 434 7 4 7 2.3 O=c1[nH]c2c(O)ccc([C@@H](O)CNC3CCN(CCN4CCCCCC4)CC3)c2s1 10.1016/j.bmcl.2010.06.136
52916803 177761 18 None - 1 Human 5.7 pKi = 5.7 Binding
Selectivity interaction (GPCR panel (PDSP screen)) EUB0000352a ADRB1Selectivity interaction (GPCR panel (PDSP screen)) EUB0000352a ADRB1
ChEMBL 451 5 1 7 2.8 CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1 10.6019/CHEMBL5212743
CHEMBL4456123 177761 18 None - 1 Human 5.7 pKi = 5.7 Binding
Selectivity interaction (GPCR panel (PDSP screen)) EUB0000352a ADRB1Selectivity interaction (GPCR panel (PDSP screen)) EUB0000352a ADRB1
ChEMBL 451 5 1 7 2.8 CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1 10.6019/CHEMBL5212743
127035062 143229 0 None -66 19 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]CGP12177 human recombinant beta 1 adrenergic recptor expressed in CHO Flp-In cells after 90 mins by scintillation counting methodDisplacement of [3H]CGP12177 human recombinant beta 1 adrenergic recptor expressed in CHO Flp-In cells after 90 mins by scintillation counting method
ChEMBL 447 12 0 5 5.2 COc1ccc(CCN(CCCc2ccccc2)CCc2ccc3c(c2)OCO3)cc1OC 10.1039/C4MD00418C
CHEMBL3735756 143229 0 None -66 19 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]CGP12177 human recombinant beta 1 adrenergic recptor expressed in CHO Flp-In cells after 90 mins by scintillation counting methodDisplacement of [3H]CGP12177 human recombinant beta 1 adrenergic recptor expressed in CHO Flp-In cells after 90 mins by scintillation counting method
ChEMBL 447 12 0 5 5.2 COc1ccc(CCN(CCCc2ccccc2)CCc2ccc3c(c2)OCO3)cc1OC 10.1039/C4MD00418C
688467 92573 4 None -14 2 Rat 4.7 pKi = 4.7 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 303 6 5 5 2.1 C[C@@H](Cc1ccc(O)cc1)NC[C@H](O)c1cc(O)cc(O)c1 10.1021/jm070030d
CHEMBL229476 92573 4 None -14 2 Rat 4.7 pKi = 4.7 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 303 6 5 5 2.1 C[C@@H](Cc1ccc(O)cc1)NC[C@H](O)c1cc(O)cc(O)c1 10.1021/jm070030d
688467 92573 4 None -14 2 Rat 4.7 pKi = 4.7 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 303 6 5 5 2.1 C[C@@H](Cc1ccc(O)cc1)NC[C@H](O)c1cc(O)cc(O)c1 nan
CHEMBL229476 92573 4 None -14 2 Rat 4.7 pKi = 4.7 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 303 6 5 5 2.1 C[C@@H](Cc1ccc(O)cc1)NC[C@H](O)c1cc(O)cc(O)c1 nan
132060734 169903 0 None -6 3 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]-Pindolol from human adrenergic beta1 receptor expressed in Flp-In CHO cells after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-Pindolol from human adrenergic beta1 receptor expressed in Flp-In CHO cells after 90 mins by microbeta scintillation counting method
ChEMBL 391 5 0 4 4.0 C=C(C)CN1CCN(c2ccc3c(c2)CN(C(=O)OCc2ccccc2)C3)CC1 10.1016/j.ejmech.2018.02.024
CHEMBL4177497 169903 0 None -6 3 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]-Pindolol from human adrenergic beta1 receptor expressed in Flp-In CHO cells after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-Pindolol from human adrenergic beta1 receptor expressed in Flp-In CHO cells after 90 mins by microbeta scintillation counting method
ChEMBL 391 5 0 4 4.0 C=C(C)CN1CCN(c2ccc3c(c2)CN(C(=O)OCc2ccccc2)C3)CC1 10.1016/j.ejmech.2018.02.024
145990586 173622 0 None -1 11 Human 7.7 pKi = 7.7 Binding
Binding affinity to andrenergic beta1 receptor (unknown origin) assessed as inhibition of radioligand binding by radioligand competition binding assayBinding affinity to andrenergic beta1 receptor (unknown origin) assessed as inhibition of radioligand binding by radioligand competition binding assay
ChEMBL 297 2 2 4 2.6 COc1cc2c3c(c1OC)-c1ccccc1[C@@H](O)[C@@H]3NCC2 10.1039/C7MD00656J
CHEMBL4285281 173622 0 None -1 11 Human 7.7 pKi = 7.7 Binding
Binding affinity to andrenergic beta1 receptor (unknown origin) assessed as inhibition of radioligand binding by radioligand competition binding assayBinding affinity to andrenergic beta1 receptor (unknown origin) assessed as inhibition of radioligand binding by radioligand competition binding assay
ChEMBL 297 2 2 4 2.6 COc1cc2c3c(c1OC)-c1ccccc1[C@@H](O)[C@@H]3NCC2 10.1039/C7MD00656J
46889729 13850 0 None -3 3 Human 6.7 pKi = 6.7 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 434 9 1 5 3.2 C=CCc1ccccc1OCC(O)CN1CCC(CN2C(=O)c3ccccc3C2=O)CC1 10.1016/j.bmcl.2010.04.009
CHEMBL1085016 13850 0 None -3 3 Human 6.7 pKi = 6.7 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 434 9 1 5 3.2 C=CCc1ccccc1OCC(O)CN1CCC(CN2C(=O)c3ccccc3C2=O)CC1 10.1016/j.bmcl.2010.04.009
205951 162009 19 None - 1 Rat 4.7 pKi = 4.7 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 171 2 3 3 0.7 NCCc1ccc(O)c(O)c1F 10.1021/jm990599h
CHEMBL40268 162009 19 None - 1 Rat 4.7 pKi = 4.7 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 171 2 3 3 0.7 NCCc1ccc(O)c(O)c1F 10.1021/jm990599h
1499 8872 47 None -53 17 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C nan
3779 8872 47 None -53 17 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C nan
536 8872 47 None -53 17 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C nan
CHEMBL434 8872 47 None -53 17 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C nan
DB01064 8872 47 None -53 17 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C nan
8029710 94314 10 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysisDisplacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis
ChEMBL 320 2 1 6 2.7 CSc1nc(N2CCNCC2)c2sc3c(c2n1)CCCC3 10.1021/jm400140q
CHEMBL2335166 94314 10 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysisDisplacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis
ChEMBL 320 2 1 6 2.7 CSc1nc(N2CCNCC2)c2sc3c(c2n1)CCCC3 10.1021/jm400140q
1239 8458 55 None -53 4 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2014.04.069
3410 8458 55 None -53 4 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2014.04.069
3465 8458 55 None -53 4 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2014.04.069
CHEMBL1256786 8458 55 None -53 4 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2014.04.069
DB00983 8458 55 None -53 4 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2014.04.069
10311070 119037 0 None -316 2 Human 4.7 pKi = 4.7 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 484 11 5 6 5.2 COc1ccc(Nc2ccc(CCNCC(O)c3ccc(O)c(CO)c3)cc2)cc1-c1ccccc1 10.1016/j.bmcl.2014.04.069
CHEMBL3290989 119037 0 None -316 2 Human 4.7 pKi = 4.7 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 484 11 5 6 5.2 COc1ccc(Nc2ccc(CCNCC(O)c3ccc(O)c(CO)c3)cc2)cc1-c1ccccc1 10.1016/j.bmcl.2014.04.069
25266787 188421 0 None - 1 Rat 8.7 pKi = 8.7 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation methodDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation method
ChEMBL 356 10 3 5 2.6 COc1ccccc1OCCNC[C@H](O)COc1cccc2[nH]ccc12 10.1016/j.ejmech.2008.05.019
CHEMBL477466 188421 0 None - 1 Rat 8.7 pKi = 8.7 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation methodDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation method
ChEMBL 356 10 3 5 2.6 COc1ccccc1OCCNC[C@H](O)COc1cccc2[nH]ccc12 10.1016/j.ejmech.2008.05.019
49864358 22395 0 None -1 2 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 344 7 4 5 2.6 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCc3ccccc3)c2s1 10.1016/j.bmcl.2010.06.136
CHEMBL1221589 22395 0 None -1 2 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 344 7 4 5 2.6 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCc3ccccc3)c2s1 10.1016/j.bmcl.2010.06.136
9871887 109977 0 None -6 4 Human 8.7 pKi = 8.7 Binding
Binding affinity for human Beta-1 adrenergic receptor expressed in CHO cells by radioligand competition binding assays using [125I]iodocyanopindolol (ICYP).) PR = potency ratio relative to TMQBinding affinity for human Beta-1 adrenergic receptor expressed in CHO cells by radioligand competition binding assays using [125I]iodocyanopindolol (ICYP).) PR = potency ratio relative to TMQ
ChEMBL 537 3 3 4 3.7 COc1c(I)cc(CC2NCCc3cc(O)c(O)cc32)cc1I 10.1021/jm960208o
CHEMBL308351 109977 0 None -6 4 Human 8.7 pKi = 8.7 Binding
Binding affinity for human Beta-1 adrenergic receptor expressed in CHO cells by radioligand competition binding assays using [125I]iodocyanopindolol (ICYP).) PR = potency ratio relative to TMQBinding affinity for human Beta-1 adrenergic receptor expressed in CHO cells by radioligand competition binding assays using [125I]iodocyanopindolol (ICYP).) PR = potency ratio relative to TMQ
ChEMBL 537 3 3 4 3.7 COc1c(I)cc(CC2NCCc3cc(O)c(O)cc32)cc1I 10.1021/jm960208o
2303 9961 68 None -9 26 Human 8.6 pKi = 8.6 Binding
Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00053a020
4946 9961 68 None -9 26 Human 8.6 pKi = 8.6 Binding
Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00053a020
564 9961 68 None -9 26 Human 8.6 pKi = 8.6 Binding
Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00053a020
63 9961 68 None -9 26 Human 8.6 pKi = 8.6 Binding
Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00053a020
91536 9961 68 None -9 26 Human 8.6 pKi = 8.6 Binding
Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00053a020
CHEMBL27 9961 68 None -9 26 Human 8.6 pKi = 8.6 Binding
Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00053a020
CHEMBL452861 9961 68 None -9 26 Human 8.6 pKi = 8.6 Binding
Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00053a020
DB00571 9961 68 None -9 26 Human 8.6 pKi = 8.6 Binding
Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1021/jm00053a020
9860739 155040 1 None 1 3 Human 8.6 pKi = 8.6 Binding
Binding affinity at human adrenergic beta-1 receptorBinding affinity at human adrenergic beta-1 receptor
ChEMBL 288 6 3 3 2.8 O[C@@H](CNC1CCCCC1)COc1cccc2[nH]ccc12 10.1016/j.bmcl.2007.07.086
CHEMBL393648 155040 1 None 1 3 Human 8.6 pKi = 8.6 Binding
Binding affinity at human adrenergic beta-1 receptorBinding affinity at human adrenergic beta-1 receptor
ChEMBL 288 6 3 3 2.8 O[C@@H](CNC1CCCCC1)COc1cccc2[nH]ccc12 10.1016/j.bmcl.2007.07.086
2303 9961 68 None -10 26 Mouse 8.6 pKi = 8.6 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmc.2019.05.034
4946 9961 68 None -10 26 Mouse 8.6 pKi = 8.6 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmc.2019.05.034
564 9961 68 None -10 26 Mouse 8.6 pKi = 8.6 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmc.2019.05.034
63 9961 68 None -10 26 Mouse 8.6 pKi = 8.6 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmc.2019.05.034
91536 9961 68 None -10 26 Mouse 8.6 pKi = 8.6 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmc.2019.05.034
CHEMBL27 9961 68 None -10 26 Mouse 8.6 pKi = 8.6 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmc.2019.05.034
CHEMBL452861 9961 68 None -10 26 Mouse 8.6 pKi = 8.6 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmc.2019.05.034
DB00571 9961 68 None -10 26 Mouse 8.6 pKi = 8.6 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmc.2019.05.034
155512746 176451 0 None 19 2 Mouse 8.6 pKi = 8.6 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 568 22 3 10 3.9 COc1cc(CCNC[C@H](O)COc2ccc(COCCOC(C)C)cc2)ccc1OCCSSCCN 10.1016/j.bmc.2019.05.034
CHEMBL4437569 176451 0 None 19 2 Mouse 8.6 pKi = 8.6 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 568 22 3 10 3.9 COc1cc(CCNC[C@H](O)COc2ccc(COCCOC(C)C)cc2)ccc1OCCSSCCN 10.1016/j.bmc.2019.05.034
131645 38927 7 None 1 2 Rat 7.7 pKi = 7.7 Binding
Compound was evaluated for its Beta-1 adrenergic receptor binding affinity by measuring the displacement of [3H]dihydroalprenolol binding in rat heartCompound was evaluated for its Beta-1 adrenergic receptor binding affinity by measuring the displacement of [3H]dihydroalprenolol binding in rat heart
ChEMBL 310 5 3 5 1.9 CC(C)(C)NCC(O)COc1cccc2c1SCC(=O)N2 10.1016/s0960-894x(00)00016-0
CHEMBL140908 38927 7 None 1 2 Rat 7.7 pKi = 7.7 Binding
Compound was evaluated for its Beta-1 adrenergic receptor binding affinity by measuring the displacement of [3H]dihydroalprenolol binding in rat heartCompound was evaluated for its Beta-1 adrenergic receptor binding affinity by measuring the displacement of [3H]dihydroalprenolol binding in rat heart
ChEMBL 310 5 3 5 1.9 CC(C)(C)NCC(O)COc1cccc2c1SCC(=O)N2 10.1016/s0960-894x(00)00016-0
9858463 100909 0 None -19 2 Human 6.7 pKi = 6.7 Binding
Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 325 8 2 6 2.4 O[C@@H](CNCCOc1ccc(-c2cocn2)cc1)c1cccnc1 10.1016/j.bmcl.2007.06.072
CHEMBL249336 100909 0 None -19 2 Human 6.7 pKi = 6.7 Binding
Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 325 8 2 6 2.4 O[C@@H](CNCCOc1ccc(-c2cocn2)cc1)c1cccnc1 10.1016/j.bmcl.2007.06.072
52943969 24567 0 None -23 3 Human 5.7 pKi = 5.7 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 517 9 3 8 4.3 CC(=O)Nc1cccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)c1 10.1016/j.bmcl.2010.08.039
CHEMBL1258825 24567 0 None -23 3 Human 5.7 pKi = 5.7 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 517 9 3 8 4.3 CC(=O)Nc1cccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)c1 10.1016/j.bmcl.2010.08.039
2291 9958 58 None -11 12 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O nan
2561 9958 58 None -11 12 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O nan
4932 9958 58 None -11 12 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O nan
CHEMBL631 9958 58 None -11 12 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O nan
DB01182 9958 58 None -11 12 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O nan
46889728 13489 0 None -5 3 Human 6.7 pKi = 6.7 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 516 9 1 6 4.7 COc1cc2c3c(cccc3c1)C(=O)N(CC1CCN(CC(O)COc3ccccc3C(C)C)CC1)C2=O 10.1016/j.bmcl.2010.04.009
CHEMBL1083666 13489 0 None -5 3 Human 6.7 pKi = 6.7 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 516 9 1 6 4.7 COc1cc2c3c(cccc3c1)C(=O)N(CC1CCN(CC(O)COc3ccccc3C(C)C)CC1)C2=O 10.1016/j.bmcl.2010.04.009
118710951 120540 0 None 1 2 Human 7.7 pKi = 7.7 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 358 6 4 5 2.8 Cc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1C 10.1016/j.bmcl.2014.06.014
CHEMBL3323671 120540 0 None 1 2 Human 7.7 pKi = 7.7 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 358 6 4 5 2.8 Cc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1C 10.1016/j.bmcl.2014.06.014
172745 106899 7 None -5 6 Rat 6.7 pKi = 6.7 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 187 2 4 4 0.2 NCC(O)c1ccc(O)c(O)c1F 10.1021/jm990599h
CHEMBL287587 106899 7 None -5 6 Rat 6.7 pKi = 6.7 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 187 2 4 4 0.2 NCC(O)c1ccc(O)c(O)c1F 10.1021/jm990599h
10155942 101091 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 369 10 2 7 2.6 COCc1nc(-c2ccc(OCCNC[C@H](O)c3cccnc3)cc2)co1 10.1016/j.bmcl.2007.06.072
CHEMBL250559 101091 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 369 10 2 7 2.6 COCc1nc(-c2ccc(OCCNC[C@H](O)c3cccnc3)cc2)co1 10.1016/j.bmcl.2007.06.072
72544787 99905 0 None -6 5 Pig 6.7 pKi = 6.7 Binding
Displacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortexDisplacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortex
ChEMBL 587 12 3 12 1.2 COc1ccccc1N1CCN(Cc2cn(-c3ccc(OCCCOC4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4F)cc3)nn2)CC1 10.1016/j.bmcl.2013.09.026
CHEMBL2443008 99905 0 None -6 5 Pig 6.7 pKi = 6.7 Binding
Displacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortexDisplacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortex
ChEMBL 587 12 3 12 1.2 COc1ccccc1N1CCN(Cc2cn(-c3ccc(OCCCOC4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4F)cc3)nn2)CC1 10.1016/j.bmcl.2013.09.026
72544789 99907 0 None -9 5 Pig 6.7 pKi = 6.7 Binding
Displacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortexDisplacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortex
ChEMBL 363 9 0 7 1.6 COc1ccccc1N1CCN(Cc2cn(CCOCCF)nn2)CC1 10.1016/j.bmcl.2013.09.026
CHEMBL2443010 99907 0 None -9 5 Pig 6.7 pKi = 6.7 Binding
Displacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortexDisplacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortex
ChEMBL 363 9 0 7 1.6 COc1ccccc1N1CCN(Cc2cn(CCOCCF)nn2)CC1 10.1016/j.bmcl.2013.09.026
1028 7079 71 None -66 30 Rat 5.7 pKi = 5.7 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm990599h
139148732 7079 71 None -66 30 Rat 5.7 pKi = 5.7 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm990599h
479 7079 71 None -66 30 Rat 5.7 pKi = 5.7 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm990599h
5816 7079 71 None -66 30 Rat 5.7 pKi = 5.7 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm990599h
CHEMBL679 7079 71 None -66 30 Rat 5.7 pKi = 5.7 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm990599h
DB00668 7079 71 None -66 30 Rat 5.7 pKi = 5.7 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm990599h
145946965 174375 0 None - 1 Rat 6.7 pKi = 6.7 Binding
Displacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysisDisplacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysis
ChEMBL 431 6 1 7 2.9 O=c1c2ccccc2oc2c(OCC(O)CN3CCN(c4ccccn4)CC3)cccc12 10.1016/j.bmc.2018.04.038
CHEMBL4126588 174375 0 None - 1 Rat 6.7 pKi = 6.7 Binding
Displacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysisDisplacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysis
ChEMBL 431 6 1 7 2.9 O=c1c2ccccc2oc2c(OCC(O)CN3CCN(c4ccccn4)CC3)cccc12 10.1016/j.bmc.2018.04.038
CHEMBL4300897 174375 0 None - 1 Rat 6.7 pKi = 6.7 Binding
Displacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysisDisplacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysis
ChEMBL 431 6 1 7 2.9 O=c1c2ccccc2oc2c(OCC(O)CN3CCN(c4ccccn4)CC3)cccc12 10.1016/j.bmc.2018.04.038
93601 94306 101 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysisDisplacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis
ChEMBL 230 1 1 2 2.4 Clc1ccc(N2CCNCC2)cc1Cl 10.1021/jm400140q
CHEMBL2335159 94306 101 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysisDisplacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis
ChEMBL 230 1 1 2 2.4 Clc1ccc(N2CCNCC2)cc1Cl 10.1021/jm400140q
21138 105227 39 None -4 7 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 CC(C)NC[C@@H](O)COc1cccc2ccccc12 nan
CHEMBL275742 105227 39 None -4 7 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 259 6 2 3 2.6 CC(C)NC[C@@H](O)COc1cccc2ccccc12 nan
52949488 24318 0 None -19 3 Human 6.7 pKi = 6.7 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 490 9 2 8 4.4 COc1ccccc1OCC(O)CNC1CCN(c2ncnc3scc(-c4ccccc4)c23)CC1 10.1016/j.bmcl.2010.08.039
CHEMBL1258023 24318 0 None -19 3 Human 6.7 pKi = 6.7 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 490 9 2 8 4.4 COc1ccccc1OCC(O)CNC1CCN(c2ncnc3scc(-c4ccccc4)c23)CC1 10.1016/j.bmcl.2010.08.039
44423646 92013 0 None -4 3 Human 5.7 pKi = 5.7 Binding
Displacement of [125I]CYP from human adrenergic beta 1 receptor transfected in CHO cells in presence of 100 uM GTPDisplacement of [125I]CYP from human adrenergic beta 1 receptor transfected in CHO cells in presence of 100 uM GTP
ChEMBL 396 10 2 5 3.9 CCCCOc1ccc(C[C@@H](C)NC[C@@H](O)c2cc(Br)no2)cc1 10.1016/j.bmc.2007.01.056
CHEMBL225775 92013 0 None -4 3 Human 5.7 pKi = 5.7 Binding
Displacement of [125I]CYP from human adrenergic beta 1 receptor transfected in CHO cells in presence of 100 uM GTPDisplacement of [125I]CYP from human adrenergic beta 1 receptor transfected in CHO cells in presence of 100 uM GTP
ChEMBL 396 10 2 5 3.9 CCCCOc1ccc(C[C@@H](C)NC[C@@H](O)c2cc(Br)no2)cc1 10.1016/j.bmc.2007.01.056
16735257 92506 0 None -151 2 Rat 4.7 pKi = 4.7 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 317 7 4 5 2.4 COc1ccc(C[C@@H](C)NC[C@H](O)c2cc(O)cc(O)c2)cc1 10.1021/jm070030d
CHEMBL228992 92506 0 None -151 2 Rat 4.7 pKi = 4.7 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 317 7 4 5 2.4 COc1ccc(C[C@@H](C)NC[C@H](O)c2cc(O)cc(O)c2)cc1 10.1021/jm070030d
16735257 92506 0 None -151 2 Rat 4.7 pKi = 4.7 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 317 7 4 5 2.4 COc1ccc(C[C@@H](C)NC[C@H](O)c2cc(O)cc(O)c2)cc1 nan
CHEMBL228992 92506 0 None -151 2 Rat 4.7 pKi = 4.7 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 317 7 4 5 2.4 COc1ccc(C[C@@H](C)NC[C@H](O)c2cc(O)cc(O)c2)cc1 nan
155561031 181774 0 None -1 2 Mouse 7.7 pKi = 7.7 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 524 20 3 9 3.6 COCCc1ccc(OC[C@@H](O)CNCCc2ccc(OCCCSSCCN)c(OC)c2)cc1 10.1016/j.bmc.2019.05.034
CHEMBL4566666 181774 0 None -1 2 Mouse 7.7 pKi = 7.7 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 524 20 3 9 3.6 COCCc1ccc(OC[C@@H](O)CNCCc2ccc(OCCCSSCCN)c(OC)c2)cc1 10.1016/j.bmc.2019.05.034
10465942 20317 0 None -1 3 Guinea pig 6.7 pKi = 6.7 Binding
Binding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacementBinding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacement
ChEMBL 217 1 1 5 0.4 Cc1cn2ccnc2c(N2CCNCC2)n1 10.1021/jm00099a012
CHEMBL1193821 20317 0 None -1 3 Guinea pig 6.7 pKi = 6.7 Binding
Binding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacementBinding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacement
ChEMBL 217 1 1 5 0.4 Cc1cn2ccnc2c(N2CCNCC2)n1 10.1021/jm00099a012
CHEMBL545289 20317 0 None -1 3 Guinea pig 6.7 pKi = 6.7 Binding
Binding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacementBinding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacement
ChEMBL 217 1 1 5 0.4 Cc1cn2ccnc2c(N2CCNCC2)n1 10.1021/jm00099a012
598754 55654 65 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to beta1 adrenergic receptor (unknown origin)Binding affinity to beta1 adrenergic receptor (unknown origin)
ChEMBL 227 1 1 3 2.0 Cc1cc(N2CCNCC2)nc2ccccc12 10.1021/jm400561w
CHEMBL1559535 55654 65 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to beta1 adrenergic receptor (unknown origin)Binding affinity to beta1 adrenergic receptor (unknown origin)
ChEMBL 227 1 1 3 2.0 Cc1cc(N2CCNCC2)nc2ccccc12 10.1021/jm400561w
443372 17006 26 None -1 3 Mouse 6.7 pKi = 6.7 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 211 4 4 4 1.1 CC(C)NC[C@H](O)c1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
CHEMBL1160723 17006 26 None -1 3 Mouse 6.7 pKi = 6.7 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 211 4 4 4 1.1 CC(C)NC[C@H](O)c1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
CHEMBL2062275 17006 26 None -1 3 Mouse 6.7 pKi = 6.7 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 211 4 4 4 1.1 CC(C)NC[C@H](O)c1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
155536406 178936 0 None 1 2 Mouse 6.7 pKi = 6.7 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 524 20 3 9 3.6 COCCc1ccc(OC[C@H](O)CNCCc2ccc(OCCCSSCCN)c(OC)c2)cc1 10.1016/j.bmc.2019.05.034
CHEMBL4473272 178936 0 None 1 2 Mouse 6.7 pKi = 6.7 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 524 20 3 9 3.6 COCCc1ccc(OC[C@H](O)CNCCc2ccc(OCCCSSCCN)c(OC)c2)cc1 10.1016/j.bmc.2019.05.034
1499 8872 47 None -5 17 Mouse 6.7 pKi = 6.7 Binding
Displacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cellsDisplacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cells
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmc.2016.04.028
3779 8872 47 None -5 17 Mouse 6.7 pKi = 6.7 Binding
Displacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cellsDisplacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cells
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmc.2016.04.028
536 8872 47 None -5 17 Mouse 6.7 pKi = 6.7 Binding
Displacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cellsDisplacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cells
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmc.2016.04.028
CHEMBL434 8872 47 None -5 17 Mouse 6.7 pKi = 6.7 Binding
Displacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cellsDisplacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cells
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmc.2016.04.028
DB01064 8872 47 None -5 17 Mouse 6.7 pKi = 6.7 Binding
Displacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cellsDisplacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cells
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1016/j.bmc.2016.04.028
10103956 17972 0 None 2 2 Rat 5.7 pKi = 5.7 Binding
Binding affinity against beta-1-adrenergic receptor in rat brainBinding affinity against beta-1-adrenergic receptor in rat brain
ChEMBL 188 7 2 4 0.8 CC/C=N/OCC(O)CNC(C)C 10.1021/jm00036a018
CHEMBL1178707 17972 0 None 2 2 Rat 5.7 pKi = 5.7 Binding
Binding affinity against beta-1-adrenergic receptor in rat brainBinding affinity against beta-1-adrenergic receptor in rat brain
ChEMBL 188 7 2 4 0.8 CC/C=N/OCC(O)CNC(C)C 10.1021/jm00036a018
CHEMBL38114 17972 0 None 2 2 Rat 5.7 pKi = 5.7 Binding
Binding affinity against beta-1-adrenergic receptor in rat brainBinding affinity against beta-1-adrenergic receptor in rat brain
ChEMBL 188 7 2 4 0.8 CC/C=N/OCC(O)CNC(C)C 10.1021/jm00036a018
2389 10104 118 None -851 66 Rat 4.7 pKi = 4.7 Binding
Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1021/jm9810396
5073 10104 118 None -851 66 Rat 4.7 pKi = 4.7 Binding
Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1021/jm9810396
96 10104 118 None -851 66 Rat 4.7 pKi = 4.7 Binding
Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1021/jm9810396
CHEMBL85 10104 118 None -851 66 Rat 4.7 pKi = 4.7 Binding
Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1021/jm9810396
DB00734 10104 118 None -851 66 Rat 4.7 pKi = 4.7 Binding
Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1021/jm9810396
598754 55654 65 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysisDisplacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis
ChEMBL 227 1 1 3 2.0 Cc1cc(N2CCNCC2)nc2ccccc12 10.1021/jm400140q
CHEMBL1559535 55654 65 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysisDisplacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis
ChEMBL 227 1 1 3 2.0 Cc1cc(N2CCNCC2)nc2ccccc12 10.1021/jm400140q
9866060 84388 0 None 1 2 Human 6.6 pKi = 6.6 Binding
Binding affinity to human beta1-adrenoceptor by radioligand binding assayBinding affinity to human beta1-adrenoceptor by radioligand binding assay
ChEMBL 406 6 4 4 3.5 CCc1cc2c(cc1CC)CC(NCC(O)c1ccc(O)c3[nH]c(=O)c(C)cc13)C2 10.1016/j.bmcl.2012.07.096
CHEMBL2088196 84388 0 None 1 2 Human 6.6 pKi = 6.6 Binding
Binding affinity to human beta1-adrenoceptor by radioligand binding assayBinding affinity to human beta1-adrenoceptor by radioligand binding assay
ChEMBL 406 6 4 4 3.5 CCc1cc2c(cc1CC)CC(NCC(O)c1ccc(O)c3[nH]c(=O)c(C)cc13)C2 10.1016/j.bmcl.2012.07.096
44423643 148834 0 None -8 3 Human 7.6 pKi = 7.6 Binding
Displacement of [125I]CYP from human adrenergic beta 1 receptor transfected in CHO cells in presence of 100 uM GTPDisplacement of [125I]CYP from human adrenergic beta 1 receptor transfected in CHO cells in presence of 100 uM GTP
ChEMBL 426 10 2 7 2.6 CCOC(=O)COc1ccc(C[C@@H](C)NC[C@H](O)c2cc(Br)no2)cc1 10.1016/j.bmc.2007.01.056
CHEMBL387852 148834 0 None -8 3 Human 7.6 pKi = 7.6 Binding
Displacement of [125I]CYP from human adrenergic beta 1 receptor transfected in CHO cells in presence of 100 uM GTPDisplacement of [125I]CYP from human adrenergic beta 1 receptor transfected in CHO cells in presence of 100 uM GTP
ChEMBL 426 10 2 7 2.6 CCOC(=O)COc1ccc(C[C@@H](C)NC[C@H](O)c2cc(Br)no2)cc1 10.1016/j.bmc.2007.01.056
44396659 74138 0 None -6 3 Human 6.6 pKi = 6.6 Binding
Binding inhibition constant was determined by inhibition of [125I]-iodocyanopindolol binding to Beta-1 adrenergic receptorBinding inhibition constant was determined by inhibition of [125I]-iodocyanopindolol binding to Beta-1 adrenergic receptor
ChEMBL 535 11 4 8 3.2 CS(=O)(=O)Oc1cccc2c(CCNC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)c[nH]c12 10.1016/j.bmcl.2004.09.054
CHEMBL188622 74138 0 None -6 3 Human 6.6 pKi = 6.6 Binding
Binding inhibition constant was determined by inhibition of [125I]-iodocyanopindolol binding to Beta-1 adrenergic receptorBinding inhibition constant was determined by inhibition of [125I]-iodocyanopindolol binding to Beta-1 adrenergic receptor
ChEMBL 535 11 4 8 3.2 CS(=O)(=O)Oc1cccc2c(CCNC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)c[nH]c12 10.1016/j.bmcl.2004.09.054
52947060 24355 0 None -2 3 Human 6.6 pKi = 6.6 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 474 8 2 7 4.7 Cc1c(-c2ccccc2)sc2ncnc(N3CCC(NCC(O)COc4ccccc4)CC3)c12 10.1016/j.bmcl.2010.08.039
CHEMBL1258144 24355 0 None -2 3 Human 6.6 pKi = 6.6 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 474 8 2 7 4.7 Cc1c(-c2ccccc2)sc2ncnc(N3CCC(NCC(O)COc4ccccc4)CC3)c12 10.1016/j.bmcl.2010.08.039
2419 10236 84 None -154 6 Human 5.6 pKi = 5.6 Binding
Displacement of [125I]-CYP from human beta1-adrenergic receptor expressed in COS-7 cells by gamma countingDisplacement of [125I]-CYP from human beta1-adrenergic receptor expressed in COS-7 cells by gamma counting
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmc.2009.11.062
5152 10236 84 None -154 6 Human 5.6 pKi = 5.6 Binding
Displacement of [125I]-CYP from human beta1-adrenergic receptor expressed in COS-7 cells by gamma countingDisplacement of [125I]-CYP from human beta1-adrenergic receptor expressed in COS-7 cells by gamma counting
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmc.2009.11.062
559 10236 84 None -154 6 Human 5.6 pKi = 5.6 Binding
Displacement of [125I]-CYP from human beta1-adrenergic receptor expressed in COS-7 cells by gamma countingDisplacement of [125I]-CYP from human beta1-adrenergic receptor expressed in COS-7 cells by gamma counting
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmc.2009.11.062
CHEMBL1263 10236 84 None -154 6 Human 5.6 pKi = 5.6 Binding
Displacement of [125I]-CYP from human beta1-adrenergic receptor expressed in COS-7 cells by gamma countingDisplacement of [125I]-CYP from human beta1-adrenergic receptor expressed in COS-7 cells by gamma counting
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmc.2009.11.062
DB00938 10236 84 None -154 6 Human 5.6 pKi = 5.6 Binding
Displacement of [125I]-CYP from human beta1-adrenergic receptor expressed in COS-7 cells by gamma countingDisplacement of [125I]-CYP from human beta1-adrenergic receptor expressed in COS-7 cells by gamma counting
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmc.2009.11.062
10431900 70414 0 None -10 2 Human 5.6 pKi = 5.6 Binding
Displacement of [125I]-CYP from human beta1-adrenergic receptor expressed in COS-7 cells by gamma countingDisplacement of [125I]-CYP from human beta1-adrenergic receptor expressed in COS-7 cells by gamma counting
ChEMBL 413 16 4 4 5.3 OCc1cc(C(O)CNCCCCCCCCCCCc2ccccc2)ccc1O 10.1016/j.bmc.2009.11.062
CHEMBL1800935 70414 0 None -10 2 Human 5.6 pKi = 5.6 Binding
Displacement of [125I]-CYP from human beta1-adrenergic receptor expressed in COS-7 cells by gamma countingDisplacement of [125I]-CYP from human beta1-adrenergic receptor expressed in COS-7 cells by gamma counting
ChEMBL 413 16 4 4 5.3 OCc1cc(C(O)CNCCCCCCCCCCCc2ccccc2)ccc1O 10.1016/j.bmc.2009.11.062
53387674 71937 0 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [125I]-Iodopindolol from beta1-adrenergic receptor after 1.5 hrs by liquid scintillation countingDisplacement of [125I]-Iodopindolol from beta1-adrenergic receptor after 1.5 hrs by liquid scintillation counting
ChEMBL 415 9 2 7 2.3 COc1ccc2nc(-c3ccc(OCC(O)CNC(C)CF)cc3)n(C)c(=O)c2c1 10.1016/j.bmcl.2011.06.106
CHEMBL1824265 71937 0 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [125I]-Iodopindolol from beta1-adrenergic receptor after 1.5 hrs by liquid scintillation countingDisplacement of [125I]-Iodopindolol from beta1-adrenergic receptor after 1.5 hrs by liquid scintillation counting
ChEMBL 415 9 2 7 2.3 COc1ccc2nc(-c3ccc(OCC(O)CNC(C)CF)cc3)n(C)c(=O)c2c1 10.1016/j.bmcl.2011.06.106
127046952 146879 0 None -190 6 Mouse 5.6 pKi = 5.6 Binding
Displacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cellsDisplacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cells
ChEMBL 421 12 3 5 4.5 COc1cc(CCNCCc2ccc(O)c(O)c2)ccc1OCCCc1ccccc1 10.1016/j.bmc.2016.04.028
CHEMBL3800636 146879 0 None -190 6 Mouse 5.6 pKi = 5.6 Binding
Displacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cellsDisplacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cells
ChEMBL 421 12 3 5 4.5 COc1cc(CCNCCc2ccc(O)c(O)c2)ccc1OCCCc1ccccc1 10.1016/j.bmc.2016.04.028
541614 24786 1 None -3 2 Rat 5.6 pKi = 5.6 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
ChEMBL 219 3 4 4 0.6 CNCC(O)c1cc(F)c(O)c(O)c1F 10.1021/jm00076a024
CHEMBL126347 24786 1 None -3 2 Rat 5.6 pKi = 5.6 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
ChEMBL 219 3 4 4 0.6 CNCC(O)c1cc(F)c(O)c(O)c1F 10.1021/jm00076a024
11218492 94303 53 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysisDisplacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis
ChEMBL 231 1 1 3 1.5 FC(F)(F)c1ccnc(N2CCNCC2)c1 10.1021/jm400140q
CHEMBL2335156 94303 53 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysisDisplacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis
ChEMBL 231 1 1 3 1.5 FC(F)(F)c1ccnc(N2CCNCC2)c1 10.1021/jm400140q
24937013 24221 0 None -33 3 Human 6.6 pKi = 6.6 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 504 9 3 8 4.6 CCc1cc(O)ccc1OCC(O)CNC1CCN(c2ncnc3scc(-c4ccccc4)c23)CC1 10.1016/j.bmcl.2010.08.039
CHEMBL1257676 24221 0 None -33 3 Human 6.6 pKi = 6.6 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 504 9 3 8 4.6 CCc1cc(O)ccc1OCC(O)CNC1CCN(c2ncnc3scc(-c4ccccc4)c23)CC1 10.1016/j.bmcl.2010.08.039
56645363 128268 12 None -3 4 Human 5.6 pKi = 5.6 Binding
Selectivity interaction (GPCR panel (PDSP screen)) EUB0000313b ADRB1Selectivity interaction (GPCR panel (PDSP screen)) EUB0000313b ADRB1
ChEMBL 311 3 1 4 3.8 CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1 10.6019/CHEMBL5212743
CHEMBL3582478 128268 12 None -3 4 Human 5.6 pKi = 5.6 Binding
Selectivity interaction (GPCR panel (PDSP screen)) EUB0000313b ADRB1Selectivity interaction (GPCR panel (PDSP screen)) EUB0000313b ADRB1
ChEMBL 311 3 1 4 3.8 CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1 10.6019/CHEMBL5212743
1043 8363 14 None -26302 29 Human 5.6 pKi = 5.6 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
149 8363 14 None -26302 29 Human 5.6 pKi = 5.6 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
8223 8363 14 None -26302 29 Human 5.6 pKi = 5.6 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
CHEMBL442 8363 14 None -26302 29 Human 5.6 pKi = 5.6 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
DB00696 8363 14 None -26302 29 Human 5.6 pKi = 5.6 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
15461453 179590 0 None -4 2 Mouse 7.6 pKi = 7.6 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 390 10 2 4 4.8 COc1ccccc1OCCNCCCOc1cccc2[nH]c3ccccc3c12 10.1021/acs.jmedchem.9b00349
CHEMBL4513932 179590 0 None -4 2 Mouse 7.6 pKi = 7.6 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 390 10 2 4 4.8 COc1ccccc1OCCNCCCOc1cccc2[nH]c3ccccc3c12 10.1021/acs.jmedchem.9b00349
44288393 178433 0 None - 1 Human 7.6 pKi = 7.6 Binding
Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.
ChEMBL 310 5 3 5 2.7 CC(C)(C)Nc1cccc2c1SC(OCCCO)C(=O)N2 10.1021/jm00053a020
CHEMBL446609 178433 0 None - 1 Human 7.6 pKi = 7.6 Binding
Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.
ChEMBL 310 5 3 5 2.7 CC(C)(C)Nc1cccc2c1SC(OCCCO)C(=O)N2 10.1021/jm00053a020
10283146 114050 0 None -1 2 Human 6.6 pKi = 6.6 Binding
Binding affinity of compound against Beta-1 adrenergic receptor was determinedBinding affinity of compound against Beta-1 adrenergic receptor was determined
ChEMBL 656 12 5 9 3.1 CS(=O)(=O)Nc1cc([C@@H](O)CNCC2CCN(S(=O)(=O)c3ccc(-n4cc(CC(=O)O)c5ccccc54)cc3)CC2)ccc1O 10.1016/s0960-894x(02)00608-x
CHEMBL317003 114050 0 None -1 2 Human 6.6 pKi = 6.6 Binding
Binding affinity of compound against Beta-1 adrenergic receptor was determinedBinding affinity of compound against Beta-1 adrenergic receptor was determined
ChEMBL 656 12 5 9 3.1 CS(=O)(=O)Nc1cc([C@@H](O)CNCC2CCN(S(=O)(=O)c3ccc(-n4cc(CC(=O)O)c5ccccc54)cc3)CC2)ccc1O 10.1016/s0960-894x(02)00608-x
68770 51425 54 None 1 2 Human 6.6 pKi = 6.6 Binding
Binding affinity to beta1 adrenergic receptor (unknown origin) by radioligand binding assayBinding affinity to beta1 adrenergic receptor (unknown origin) by radioligand binding assay
ChEMBL 363 7 4 4 3.3 CC(C)(C)NCC(O)COc1ccc(NC(=O)NC2CCCCC2)cc1 10.1021/acsmedchemlett.9b00075
CHEMBL152067 51425 54 None 1 2 Human 6.6 pKi = 6.6 Binding
Binding affinity to beta1 adrenergic receptor (unknown origin) by radioligand binding assayBinding affinity to beta1 adrenergic receptor (unknown origin) by radioligand binding assay
ChEMBL 363 7 4 4 3.3 CC(C)(C)NCC(O)COc1ccc(NC(=O)NC2CCCCC2)cc1 10.1021/acsmedchemlett.9b00075
46889700 13848 0 None -18 3 Human 6.6 pKi = 6.6 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 472 7 1 5 4.5 CC(C)c1ccccc1OCC(O)CN1CCC(N2C(=O)c3cccc4cccc(c34)C2=O)CC1 10.1016/j.bmcl.2010.04.009
CHEMBL1085013 13848 0 None -18 3 Human 6.6 pKi = 6.6 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 472 7 1 5 4.5 CC(C)c1ccccc1OCC(O)CN1CCC(N2C(=O)c3cccc4cccc(c34)C2=O)CC1 10.1016/j.bmcl.2010.04.009
10082076 20632 0 None -10 3 Guinea pig 5.6 pKi = 5.6 Binding
Binding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacementBinding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacement
ChEMBL 217 1 1 5 0.4 Cc1cnc2c(N3CCNCC3)nccn12 10.1021/jm00099a012
CHEMBL1195953 20632 0 None -10 3 Guinea pig 5.6 pKi = 5.6 Binding
Binding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacementBinding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacement
ChEMBL 217 1 1 5 0.4 Cc1cnc2c(N3CCNCC3)nccn12 10.1021/jm00099a012
CHEMBL555637 20632 0 None -10 3 Guinea pig 5.6 pKi = 5.6 Binding
Binding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacementBinding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacement
ChEMBL 217 1 1 5 0.4 Cc1cnc2c(N3CCNCC3)nccn12 10.1021/jm00099a012
15580747 71936 0 None 2 3 Human 5.6 pKi = 5.6 Binding
Displacement of [125I]-Iodopindolol from beta1-adrenergic receptor after 1.5 hrs by liquid scintillation countingDisplacement of [125I]-Iodopindolol from beta1-adrenergic receptor after 1.5 hrs by liquid scintillation counting
ChEMBL 397 8 2 7 2.3 COc1ccc2nc(-c3ccc(OCC(O)CNC(C)C)cc3)n(C)c(=O)c2c1 10.1016/j.bmcl.2011.06.106
CHEMBL1824264 71936 0 None 2 3 Human 5.6 pKi = 5.6 Binding
Displacement of [125I]-Iodopindolol from beta1-adrenergic receptor after 1.5 hrs by liquid scintillation countingDisplacement of [125I]-Iodopindolol from beta1-adrenergic receptor after 1.5 hrs by liquid scintillation counting
ChEMBL 397 8 2 7 2.3 COc1ccc2nc(-c3ccc(OCC(O)CNC(C)C)cc3)n(C)c(=O)c2c1 10.1016/j.bmcl.2011.06.106
155526662 177965 0 None -3 2 Mouse 5.6 pKi = 5.6 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 333 9 4 6 1.7 COc1ccccc1OCCNC[C@@H](O)Cc1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
CHEMBL4459109 177965 0 None -3 2 Mouse 5.6 pKi = 5.6 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 333 9 4 6 1.7 COc1ccccc1OCCNC[C@@H](O)Cc1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
6603724 162110 3 None 1 3 Rat 4.6 pKi = 4.6 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 187 2 4 4 0.2 NC[C@H](O)c1cc(O)c(O)cc1F 10.1021/jm990599h
CHEMBL40317 162110 3 None 1 3 Rat 4.6 pKi = 4.6 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 187 2 4 4 0.2 NC[C@H](O)c1cc(O)c(O)cc1F 10.1021/jm990599h
46889768 13847 0 None -27 3 Human 6.6 pKi = 6.6 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 402 8 1 5 2.8 CC(C)c1ccccc1OCC(O)CN1CCC(CN2C(=O)CCCC2=O)CC1 10.1016/j.bmcl.2010.04.009
CHEMBL1085010 13847 0 None -27 3 Human 6.6 pKi = 6.6 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 402 8 1 5 2.8 CC(C)c1ccccc1OCC(O)CN1CCC(CN2C(=O)CCCC2=O)CC1 10.1016/j.bmcl.2010.04.009
16737411 149979 0 None -8 2 Rat 4.6 pKi = 4.6 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 287 6 4 4 2.4 C[C@H](Cc1ccccc1)NC[C@H](O)c1cc(O)cc(O)c1 10.1021/jm070030d
CHEMBL389629 149979 0 None -8 2 Rat 4.6 pKi = 4.6 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 287 6 4 4 2.4 C[C@H](Cc1ccccc1)NC[C@H](O)c1cc(O)cc(O)c1 10.1021/jm070030d
16737411 149979 0 None -8 2 Rat 4.6 pKi = 4.6 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 287 6 4 4 2.4 C[C@H](Cc1ccccc1)NC[C@H](O)c1cc(O)cc(O)c1 nan
CHEMBL389629 149979 0 None -8 2 Rat 4.6 pKi = 4.6 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 287 6 4 4 2.4 C[C@H](Cc1ccccc1)NC[C@H](O)c1cc(O)cc(O)c1 nan
24321330 13608 0 None -1 3 Human 6.6 pKi = 6.6 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 486 8 1 5 4.7 CC(C)c1ccccc1OCC(O)CN1CCC(CN2C(=O)c3cccc4cccc(c34)C2=O)CC1 10.1016/j.bmcl.2010.04.009
CHEMBL1083996 13608 0 None -1 3 Human 6.6 pKi = 6.6 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 486 8 1 5 4.7 CC(C)c1ccccc1OCC(O)CN1CCC(CN2C(=O)c3cccc4cccc(c34)C2=O)CC1 10.1016/j.bmcl.2010.04.009
46889771 13766 0 None -6 3 Human 6.6 pKi = 6.6 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 549 7 3 6 4.9 O=C1c2cccc3cc(O)cc(c23)C(=O)N1CC1CCN(CC(O)COc2cccc3[nH]c4ccccc4c23)CC1 10.1016/j.bmcl.2010.04.009
CHEMBL1084706 13766 0 None -6 3 Human 6.6 pKi = 6.6 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 549 7 3 6 4.9 O=C1c2cccc3cc(O)cc(c23)C(=O)N1CC1CCN(CC(O)COc2cccc3[nH]c4ccccc4c23)CC1 10.1016/j.bmcl.2010.04.009
72545010 99900 0 None -7 5 Pig 5.6 pKi = 5.6 Binding
Displacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortexDisplacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortex
ChEMBL 437 6 3 10 -0.4 COc1ccccc1N1CCN(Cc2cn([C@@H]3O[C@H](CF)[C@@H](O)[C@H](O)[C@H]3O)nn2)CC1 10.1016/j.bmcl.2013.09.026
CHEMBL2443003 99900 0 None -7 5 Pig 5.6 pKi = 5.6 Binding
Displacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortexDisplacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortex
ChEMBL 437 6 3 10 -0.4 COc1ccccc1N1CCN(Cc2cn([C@@H]3O[C@H](CF)[C@@H](O)[C@H](O)[C@H]3O)nn2)CC1 10.1016/j.bmcl.2013.09.026
172745 106899 7 None -5 6 Rat 5.6 pKi = 5.6 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
ChEMBL 187 2 4 4 0.2 NCC(O)c1ccc(O)c(O)c1F 10.1021/jm00076a024
CHEMBL287587 106899 7 None -5 6 Rat 5.6 pKi = 5.6 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
ChEMBL 187 2 4 4 0.2 NCC(O)c1ccc(O)c(O)c1F 10.1021/jm00076a024
24733400 94312 1 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysisDisplacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis
ChEMBL 295 2 1 4 3.4 c1csc(-c2cccc3ccc(N4CCNCC4)nc23)c1 10.1021/jm400140q
CHEMBL2335164 94312 1 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysisDisplacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis
ChEMBL 295 2 1 4 3.4 c1csc(-c2cccc3ccc(N4CCNCC4)nc23)c1 10.1021/jm400140q
10296414 10304 15 None -1995 9 Human 5.6 pKi = 5.6 Binding
Binding affinity at adrenergic beta 1 receptorBinding affinity at adrenergic beta 1 receptor
ChEMBL 431 6 1 5 4.2 O=C1COc2c(N1)cc(cc2)CC1CCN(CC1)CCOc1cccc2c1ccc(n2)C 10.1016/j.bmcl.2006.11.031
76 10304 15 None -1995 9 Human 5.6 pKi = 5.6 Binding
Binding affinity at adrenergic beta 1 receptorBinding affinity at adrenergic beta 1 receptor
ChEMBL 431 6 1 5 4.2 O=C1COc2c(N1)cc(cc2)CC1CCN(CC1)CCOc1cccc2c1ccc(n2)C 10.1016/j.bmcl.2006.11.031
CHEMBL183460 10304 15 None -1995 9 Human 5.6 pKi = 5.6 Binding
Binding affinity at adrenergic beta 1 receptorBinding affinity at adrenergic beta 1 receptor
ChEMBL 431 6 1 5 4.2 O=C1COc2c(N1)cc(cc2)CC1CCN(CC1)CCOc1cccc2c1ccc(n2)C 10.1016/j.bmcl.2006.11.031
44439165 152531 0 None -1000 8 Human 5.6 pKi = 5.6 Binding
Binding affinity at adrenergic beta 1 receptorBinding affinity at adrenergic beta 1 receptor
ChEMBL 483 6 1 5 5.0 Cc1ccc2c(OCCN3CCC(Cc4cc5c(cc4F)OCC(=O)N5)CC3)cc(Cl)cc2n1 10.1016/j.bmcl.2006.11.031
CHEMBL391661 152531 0 None -1000 8 Human 5.6 pKi = 5.6 Binding
Binding affinity at adrenergic beta 1 receptorBinding affinity at adrenergic beta 1 receptor
ChEMBL 483 6 1 5 5.0 Cc1ccc2c(OCCN3CCC(Cc4cc5c(cc4F)OCC(=O)N5)CC3)cc(Cl)cc2n1 10.1016/j.bmcl.2006.11.031
2419 10236 84 None -154 6 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2014.04.069
5152 10236 84 None -154 6 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2014.04.069
559 10236 84 None -154 6 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2014.04.069
CHEMBL1263 10236 84 None -154 6 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2014.04.069
DB00938 10236 84 None -154 6 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2014.04.069
2778334 94304 101 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysisDisplacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis
ChEMBL 232 1 1 4 0.9 FC(F)(F)c1ccnc(N2CCNCC2)n1 10.1021/jm400140q
CHEMBL2335157 94304 101 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysisDisplacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis
ChEMBL 232 1 1 4 0.9 FC(F)(F)c1ccnc(N2CCNCC2)n1 10.1021/jm400140q
59119472 119034 0 None -31 2 Human 4.6 pKi = 4.6 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 418 9 5 5 4.0 OCc1cc(C(O)CNCCc2ccc(Nc3ccc4c(c3)CCC4)cc2)ccc1O 10.1016/j.bmcl.2014.04.069
CHEMBL3290986 119034 0 None -31 2 Human 4.6 pKi = 4.6 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 418 9 5 5 4.0 OCc1cc(C(O)CNCCc2ccc(Nc3ccc4c(c3)CCC4)cc2)ccc1O 10.1016/j.bmcl.2014.04.069
176 7186 66 None -660 31 Human 4.6 pKi = 4.6 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 nan
2157 7186 66 None -660 31 Human 4.6 pKi = 4.6 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 nan
2566 7186 66 None -660 31 Human 4.6 pKi = 4.6 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 nan
CHEMBL633 7186 66 None -660 31 Human 4.6 pKi = 4.6 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 nan
DB01118 7186 66 None -660 31 Human 4.6 pKi = 4.6 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 nan
52943968 24566 0 None -69 3 Human 5.6 pKi = 5.6 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 518 9 4 8 3.8 NC(=O)Nc1cccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)c1 10.1016/j.bmcl.2010.08.039
CHEMBL1258824 24566 0 None -69 3 Human 5.6 pKi = 5.6 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 518 9 4 8 3.8 NC(=O)Nc1cccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)c1 10.1016/j.bmcl.2010.08.039
70691181 84391 0 None -13 2 Human 6.6 pKi = 6.6 Binding
Binding affinity to human beta1-adrenoceptor by radioligand binding assayBinding affinity to human beta1-adrenoceptor by radioligand binding assay
ChEMBL 392 7 4 4 3.4 CCCCc1ccc2c(c1)CC(NC[C@H](O)c1ccc(O)c3[nH]c(=O)ccc13)C2 10.1016/j.bmcl.2012.07.096
CHEMBL2088199 84391 0 None -13 2 Human 6.6 pKi = 6.6 Binding
Binding affinity to human beta1-adrenoceptor by radioligand binding assayBinding affinity to human beta1-adrenoceptor by radioligand binding assay
ChEMBL 392 7 4 4 3.4 CCCCc1ccc2c(c1)CC(NC[C@H](O)c1ccc(O)c3[nH]c(=O)ccc13)C2 10.1016/j.bmcl.2012.07.096
46889769 13492 0 None -109 3 Human 6.6 pKi = 6.6 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 304 8 2 4 1.8 C=CCc1ccccc1OCC(O)CNC1CCN(C)CC1 10.1016/j.bmcl.2010.04.009
CHEMBL1083669 13492 0 None -109 3 Human 6.6 pKi = 6.6 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 304 8 2 4 1.8 C=CCc1ccccc1OCC(O)CNC1CCN(C)CC1 10.1016/j.bmcl.2010.04.009
72545240 99904 0 None -16 5 Pig 6.6 pKi = 6.6 Binding
Displacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortexDisplacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortex
ChEMBL 469 12 0 8 3.4 COc1ccccc1N1CCN(Cc2cn(-c3ccc(OCCCOCCF)cc3)nn2)CC1 10.1016/j.bmcl.2013.09.026
CHEMBL2443007 99904 0 None -16 5 Pig 6.6 pKi = 6.6 Binding
Displacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortexDisplacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortex
ChEMBL 469 12 0 8 3.4 COc1ccccc1N1CCN(Cc2cn(-c3ccc(OCCCOCCF)cc3)nn2)CC1 10.1016/j.bmcl.2013.09.026
9960584 161408 0 None -436 3 Human 5.6 pKi = 5.6 Binding
Displacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 500 12 4 7 3.3 COc1ccc([C@@H](Cc2ccccc2)NC[C@@H](O)Cc2ccc(O)c(NS(C)(=O)=O)c2)cc1OC 10.1016/j.bmcl.2007.05.030
CHEMBL399329 161408 0 None -436 3 Human 5.6 pKi = 5.6 Binding
Displacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 500 12 4 7 3.3 COc1ccc([C@@H](Cc2ccccc2)NC[C@@H](O)Cc2ccc(O)c(NS(C)(=O)=O)c2)cc1OC 10.1016/j.bmcl.2007.05.030
44571262 19347 0 None - 1 Rat 5.6 pKi = 5.6 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation counting
ChEMBL 341 7 2 5 3.1 CC(C)(CO)NCCCOc1cccc2c(=O)c3ccccc3oc12 10.1016/j.bmc.2008.12.031
CHEMBL1186815 19347 0 None - 1 Rat 5.6 pKi = 5.6 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation counting
ChEMBL 341 7 2 5 3.1 CC(C)(CO)NCCCOc1cccc2c(=O)c3ccccc3oc12 10.1016/j.bmc.2008.12.031
CHEMBL479644 19347 0 None - 1 Rat 5.6 pKi = 5.6 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation counting
ChEMBL 341 7 2 5 3.1 CC(C)(CO)NCCCOc1cccc2c(=O)c3ccccc3oc12 10.1016/j.bmc.2008.12.031
135398737 7745 93 None -144 90 Rat 4.6 pKi = 4.6 Binding
Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm9810396
38 7745 93 None -144 90 Rat 4.6 pKi = 4.6 Binding
Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm9810396
722 7745 93 None -144 90 Rat 4.6 pKi = 4.6 Binding
Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm9810396
CHEMBL42 7745 93 None -144 90 Rat 4.6 pKi = 4.6 Binding
Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm9810396
DB00363 7745 93 None -144 90 Rat 4.6 pKi = 4.6 Binding
Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm9810396
1960 9632 67 None -144 26 Rat 4.6 pKi = 4.6 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm990599h
439260 9632 67 None -144 26 Rat 4.6 pKi = 4.6 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm990599h
505 9632 67 None -144 26 Rat 4.6 pKi = 4.6 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm990599h
CHEMBL1437 9632 67 None -144 26 Rat 4.6 pKi = 4.6 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm990599h
DB00368 9632 67 None -144 26 Rat 4.6 pKi = 4.6 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm990599h
24886595 24418 0 None -4 3 Human 6.6 pKi = 6.6 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 478 8 2 7 4.5 OC(CNC1CCN(c2ncnc3scc(-c4ccccc4)c23)CC1)COc1ccc(F)cc1 10.1016/j.bmcl.2010.08.039
CHEMBL1258370 24418 0 None -4 3 Human 6.6 pKi = 6.6 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 478 8 2 7 4.5 OC(CNC1CCN(c2ncnc3scc(-c4ccccc4)c23)CC1)COc1ccc(F)cc1 10.1016/j.bmcl.2010.08.039
145947253 174430 0 None 1 2 Human 4.6 pKi = 4.6 Binding
Displacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation countingDisplacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation counting
ChEMBL 364 10 3 5 1.2 CNCC(O)COc1ccc(S(=O)(=O)NCCc2ccccc2)cc1 10.1021/acs.jmedchem.8b00625
CHEMBL4162590 174430 0 None 1 2 Human 4.6 pKi = 4.6 Binding
Displacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation countingDisplacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation counting
ChEMBL 364 10 3 5 1.2 CNCC(O)COc1ccc(S(=O)(=O)NCCc2ccccc2)cc1 10.1021/acs.jmedchem.8b00625
CHEMBL4301724 174430 0 None 1 2 Human 4.6 pKi = 4.6 Binding
Displacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation countingDisplacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation counting
ChEMBL 364 10 3 5 1.2 CNCC(O)COc1ccc(S(=O)(=O)NCCc2ccccc2)cc1 10.1021/acs.jmedchem.8b00625
44112 128068 48 None -2 7 Human 7.6 pKi = 7.6 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 380 7 2 4 4.5 Cc1cc2c(OCC(CNC(C)(C)C)OC(=O)c3ccccc3)cccc2[nH]1 nan
CHEMBL357995 128068 48 None -2 7 Human 7.6 pKi = 7.6 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 380 7 2 4 4.5 Cc1cc2c(OCC(CNC(C)(C)C)OC(=O)c3ccccc3)cccc2[nH]1 nan
46889643 13422 0 None 4 3 Human 7.6 pKi = 7.6 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 483 7 2 5 4.1 O=C1c2cccc3cccc(c23)C(=O)N1CC1CCN(CC(O)COc2cccc3[nH]ccc23)CC1 10.1016/j.bmcl.2010.04.009
CHEMBL1083368 13422 0 None 4 3 Human 7.6 pKi = 7.6 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 483 7 2 5 4.1 O=C1c2cccc3cccc(c23)C(=O)N1CC1CCN(CC(O)COc2cccc3[nH]ccc23)CC1 10.1016/j.bmcl.2010.04.009
155555687 181227 0 None 2 2 Mouse 7.6 pKi = 7.6 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 510 19 3 9 3.2 COCCc1ccc(OC[C@@H](O)CNCCc2ccc(OCCSSCCN)c(OC)c2)cc1 10.1016/j.bmc.2019.05.034
CHEMBL4553747 181227 0 None 2 2 Mouse 7.6 pKi = 7.6 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 510 19 3 9 3.2 COCCc1ccc(OC[C@@H](O)CNCCc2ccc(OCCSSCCN)c(OC)c2)cc1 10.1016/j.bmc.2019.05.034
9924779 101215 0 None -8 2 Human 6.6 pKi = 6.6 Binding
Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 355 9 3 7 1.9 OCc1nc(-c2ccc(OCCNC[C@H](O)c3cccnc3)cc2)co1 10.1016/j.bmcl.2007.06.072
CHEMBL251180 101215 0 None -8 2 Human 6.6 pKi = 6.6 Binding
Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 355 9 3 7 1.9 OCc1nc(-c2ccc(OCCNC[C@H](O)c3cccnc3)cc2)co1 10.1016/j.bmcl.2007.06.072
44444191 179212 0 None -38 3 Human 6.6 pKi = 6.6 Binding
Displacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 548 13 4 7 4.3 COc1ccc([C@H](CCc2ccccc2Cl)NC[C@H](O)Cc2ccc(O)c(NS(C)(=O)=O)c2)cc1OC 10.1016/j.bmcl.2007.05.030
CHEMBL447786 179212 0 None -38 3 Human 6.6 pKi = 6.6 Binding
Displacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 548 13 4 7 4.3 COc1ccc([C@H](CCc2ccccc2Cl)NC[C@H](O)Cc2ccc(O)c(NS(C)(=O)=O)c2)cc1OC 10.1016/j.bmcl.2007.05.030
1960 9632 67 None -144 26 Rat 5.6 pKi = 5.6 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm990599h
439260 9632 67 None -144 26 Rat 5.6 pKi = 5.6 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm990599h
505 9632 67 None -144 26 Rat 5.6 pKi = 5.6 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm990599h
CHEMBL1437 9632 67 None -144 26 Rat 5.6 pKi = 5.6 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm990599h
DB00368 9632 67 None -144 26 Rat 5.6 pKi = 5.6 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm990599h
42629372 70421 0 None -52 2 Rat 4.6 pKi = 4.6 Binding
Displacement of [3H]CGP-12177 from beta1-adrenergic receptor in Sprague-Dawley rat cortical membrane after 2 hrsDisplacement of [3H]CGP-12177 from beta1-adrenergic receptor in Sprague-Dawley rat cortical membrane after 2 hrs
ChEMBL 337 6 4 4 3.5 C[C@@H](Cc1ccc2ccccc2c1)NC[C@H](O)c1cc(O)cc(O)c1 10.1016/j.bmc.2009.11.062
CHEMBL1800962 70421 0 None -52 2 Rat 4.6 pKi = 4.6 Binding
Displacement of [3H]CGP-12177 from beta1-adrenergic receptor in Sprague-Dawley rat cortical membrane after 2 hrsDisplacement of [3H]CGP-12177 from beta1-adrenergic receptor in Sprague-Dawley rat cortical membrane after 2 hrs
ChEMBL 337 6 4 4 3.5 C[C@@H](Cc1ccc2ccccc2c1)NC[C@H](O)c1cc(O)cc(O)c1 10.1016/j.bmc.2009.11.062
10406968 120534 0 None -1 3 Human 7.6 pKi = 7.6 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 372 8 4 5 3.1 CCCc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1 10.1016/j.bmcl.2014.06.014
CHEMBL3323665 120534 0 None -1 3 Human 7.6 pKi = 7.6 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 372 8 4 5 3.1 CCCc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1 10.1016/j.bmcl.2014.06.014
10466448 119660 2 None -34 2 Guinea pig 5.6 pKi = 5.6 Binding
Binding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacementBinding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacement
ChEMBL 231 1 0 5 0.8 Cc1cnc(N2CCN(C)CC2)c2nccn12 10.1021/jm00099a012
CHEMBL330994 119660 2 None -34 2 Guinea pig 5.6 pKi = 5.6 Binding
Binding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacementBinding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacement
ChEMBL 231 1 0 5 0.8 Cc1cnc(N2CCN(C)CC2)c2nccn12 10.1021/jm00099a012
24936763 24388 0 None -30 3 Human 5.6 pKi = 5.6 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 520 9 4 9 3.9 Cc1c(-c2ccccc2)sc2ncnc(N3CCC(NCC(O)COc4ccc(O)c(CO)c4)CC3)c12 10.1016/j.bmcl.2010.08.039
CHEMBL1258260 24388 0 None -30 3 Human 5.6 pKi = 5.6 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 520 9 4 9 3.9 Cc1c(-c2ccccc2)sc2ncnc(N3CCC(NCC(O)COc4ccc(O)c(CO)c4)CC3)c12 10.1016/j.bmcl.2010.08.039
24936885 24255 0 None -32 3 Human 6.5 pKi = 6.5 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 504 9 3 8 4.6 CCc1cc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)ccc1O 10.1016/j.bmcl.2010.08.039
CHEMBL1257797 24255 0 None -32 3 Human 6.5 pKi = 6.5 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 504 9 3 8 4.6 CCc1cc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)ccc1O 10.1016/j.bmcl.2010.08.039
12828570 11846 0 None -1 2 Rat 4.5 pKi = 4.5 Binding
Tested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligandTested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligand
ChEMBL 237 3 3 4 1.7 CC(C)NCC1OCCc2c1ccc(O)c2O 10.1021/jm00073a006
CHEMBL105434 11846 0 None -1 2 Rat 4.5 pKi = 4.5 Binding
Tested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligandTested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligand
ChEMBL 237 3 3 4 1.7 CC(C)NCC1OCCc2c1ccc(O)c2O 10.1021/jm00073a006
52941476 24457 0 None -28 3 Human 6.5 pKi = 6.5 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 488 9 2 7 4.9 CCc1cccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)c1 10.1016/j.bmcl.2010.08.039
CHEMBL1258484 24457 0 None -28 3 Human 6.5 pKi = 6.5 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 488 9 2 7 4.9 CCc1cccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)c1 10.1016/j.bmcl.2010.08.039
155529446 178231 0 None -8 2 Mouse 7.5 pKi = 7.5 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 502 16 3 8 4.1 COc1cc(CCNC[C@@H](O)COc2cccc3ccccc23)ccc1OCCSSCCN 10.1016/j.bmc.2019.05.034
CHEMBL4463246 178231 0 None -8 2 Mouse 7.5 pKi = 7.5 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 502 16 3 8 4.1 COc1cc(CCNC[C@@H](O)COc2cccc3ccccc23)ccc1OCCSSCCN 10.1016/j.bmc.2019.05.034
52941603 24071 0 None -21 3 Human 5.5 pKi = 5.5 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 573 9 2 9 3.8 O=C(c1cccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)c1)N1CCOCC1 10.1016/j.bmcl.2010.08.039
CHEMBL1257204 24071 0 None -21 3 Human 5.5 pKi = 5.5 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 573 9 2 9 3.8 O=C(c1cccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)c1)N1CCOCC1 10.1016/j.bmcl.2010.08.039
52947443 24386 0 None -17 3 Human 6.5 pKi = 6.5 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 478 8 2 7 4.5 OC(CNC1CCN(c2ncnc3scc(-c4ccccc4)c23)CC1)COc1cccc(F)c1 10.1016/j.bmcl.2010.08.039
CHEMBL1258258 24386 0 None -17 3 Human 6.5 pKi = 6.5 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 478 8 2 7 4.5 OC(CNC1CCN(c2ncnc3scc(-c4ccccc4)c23)CC1)COc1cccc(F)c1 10.1016/j.bmcl.2010.08.039
2770390 13494 10 None -1 3 Human 6.5 pKi = 6.5 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 499 10 1 6 3.2 C=CCc1ccccc1OCC(O)CN1CCN(CCN2C(=O)c3cccc4cccc(c34)C2=O)CC1 10.1016/j.bmcl.2010.04.009
CHEMBL1083672 13494 10 None -1 3 Human 6.5 pKi = 6.5 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 499 10 1 6 3.2 C=CCc1ccccc1OCC(O)CN1CCN(CCN2C(=O)c3cccc4cccc(c34)C2=O)CC1 10.1016/j.bmcl.2010.04.009
10083242 20606 1 None -8 3 Guinea pig 5.5 pKi = 5.5 Binding
Binding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacementBinding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacement
ChEMBL 245 2 1 5 1.3 CC(C)c1cnc2c(N3CCNCC3)nccn12 10.1021/jm00099a012
CHEMBL1195814 20606 1 None -8 3 Guinea pig 5.5 pKi = 5.5 Binding
Binding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacementBinding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacement
ChEMBL 245 2 1 5 1.3 CC(C)c1cnc2c(N3CCNCC3)nccn12 10.1021/jm00099a012
CHEMBL555391 20606 1 None -8 3 Guinea pig 5.5 pKi = 5.5 Binding
Binding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacementBinding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacement
ChEMBL 245 2 1 5 1.3 CC(C)c1cnc2c(N3CCNCC3)nccn12 10.1021/jm00099a012
44582475 188420 0 None - 1 Rat 8.5 pKi = 8.5 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation methodDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation method
ChEMBL 356 10 3 5 2.6 COc1ccccc1OCCNCC(O)COc1cccc2[nH]ccc12 10.1016/j.ejmech.2008.05.019
CHEMBL477465 188420 0 None - 1 Rat 8.5 pKi = 8.5 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation methodDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation method
ChEMBL 356 10 3 5 2.6 COc1ccccc1OCCNCC(O)COc1cccc2[nH]ccc12 10.1016/j.ejmech.2008.05.019
2303 9961 68 None -46 26 Rat 8.5 pKi = 8.5 Binding
Displacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation counting
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1007/s00044-008-9094-3
4946 9961 68 None -46 26 Rat 8.5 pKi = 8.5 Binding
Displacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation counting
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1007/s00044-008-9094-3
564 9961 68 None -46 26 Rat 8.5 pKi = 8.5 Binding
Displacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation counting
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1007/s00044-008-9094-3
63 9961 68 None -46 26 Rat 8.5 pKi = 8.5 Binding
Displacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation counting
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1007/s00044-008-9094-3
91536 9961 68 None -46 26 Rat 8.5 pKi = 8.5 Binding
Displacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation counting
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1007/s00044-008-9094-3
CHEMBL27 9961 68 None -46 26 Rat 8.5 pKi = 8.5 Binding
Displacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation counting
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1007/s00044-008-9094-3
CHEMBL452861 9961 68 None -46 26 Rat 8.5 pKi = 8.5 Binding
Displacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation counting
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1007/s00044-008-9094-3
DB00571 9961 68 None -46 26 Rat 8.5 pKi = 8.5 Binding
Displacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation counting
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1007/s00044-008-9094-3
46889811 13227 0 None -16 3 Human 8.5 pKi = 8.5 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 444 8 2 4 5.0 COc1ccc(CC2CCN(CC(O)COc3cccc4[nH]c5ccccc5c34)CC2)cc1 10.1016/j.bmcl.2010.04.009
CHEMBL1082500 13227 0 None -16 3 Human 8.5 pKi = 8.5 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 444 8 2 4 5.0 COc1ccc(CC2CCN(CC(O)COc3cccc4[nH]c5ccccc5c34)CC2)cc1 10.1016/j.bmcl.2010.04.009
185394 146466 41 None -3 5 Mouse 8.5 pKi = 8.5 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNC[C@@H](O)COc1cccc2[nH]c3ccccc3c12 10.1021/acs.jmedchem.9b00349
CHEMBL3798017 146466 41 None -3 5 Mouse 8.5 pKi = 8.5 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNC[C@@H](O)COc1cccc2[nH]c3ccccc3c12 10.1021/acs.jmedchem.9b00349
49864356 22393 0 None -2 2 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 330 6 4 5 2.2 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3ccccc3)c2s1 10.1016/j.bmcl.2010.06.136
CHEMBL1221587 22393 0 None -2 2 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 330 6 4 5 2.2 O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3ccccc3)c2s1 10.1016/j.bmcl.2010.06.136
12147227 68766 0 None 1 2 Human 8.4 pKi = 8.4 Binding
Inhibition of 125 I-Iodocyanopindolol binding to Beta-1 adrenergic receptorInhibition of 125 I-Iodocyanopindolol binding to Beta-1 adrenergic receptor
ChEMBL 578 8 6 9 2.3 CN(C)C(=N)NC1=NC(=O)/C(=C/c2ccc(N3CCC(NC[C@H](O)COc4cccc5[nH]c(O)nc45)CC3)cc2)S1 10.1016/s0960-894x(01)00147-0
142109147 68766 0 None 1 2 Human 8.4 pKi = 8.4 Binding
Inhibition of 125 I-Iodocyanopindolol binding to Beta-1 adrenergic receptorInhibition of 125 I-Iodocyanopindolol binding to Beta-1 adrenergic receptor
ChEMBL 578 8 6 9 2.3 CN(C)C(=N)NC1=NC(=O)/C(=C/c2ccc(N3CCC(NC[C@H](O)COc4cccc5[nH]c(O)nc45)CC3)cc2)S1 10.1016/s0960-894x(01)00147-0
44386630 68766 0 None 1 2 Human 8.4 pKi = 8.4 Binding
Inhibition of 125 I-Iodocyanopindolol binding to Beta-1 adrenergic receptorInhibition of 125 I-Iodocyanopindolol binding to Beta-1 adrenergic receptor
ChEMBL 578 8 6 9 2.3 CN(C)C(=N)NC1=NC(=O)/C(=C/c2ccc(N3CCC(NC[C@H](O)COc4cccc5[nH]c(O)nc45)CC3)cc2)S1 10.1016/s0960-894x(01)00147-0
69921317 68766 0 None 1 2 Human 8.4 pKi = 8.4 Binding
Inhibition of 125 I-Iodocyanopindolol binding to Beta-1 adrenergic receptorInhibition of 125 I-Iodocyanopindolol binding to Beta-1 adrenergic receptor
ChEMBL 578 8 6 9 2.3 CN(C)C(=N)NC1=NC(=O)/C(=C/c2ccc(N3CCC(NC[C@H](O)COc4cccc5[nH]c(O)nc45)CC3)cc2)S1 10.1016/s0960-894x(01)00147-0
CHEMBL177442 68766 0 None 1 2 Human 8.4 pKi = 8.4 Binding
Inhibition of 125 I-Iodocyanopindolol binding to Beta-1 adrenergic receptorInhibition of 125 I-Iodocyanopindolol binding to Beta-1 adrenergic receptor
ChEMBL 578 8 6 9 2.3 CN(C)C(=N)NC1=NC(=O)/C(=C/c2ccc(N3CCC(NC[C@H](O)COc4cccc5[nH]c(O)nc45)CC3)cc2)S1 10.1016/s0960-894x(01)00147-0
3914 7527 35 None -3 7 Human 8.4 pKi = 8.4 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 291 5 2 4 2.3 CC(C)(C)NCC(COC1=CC=CC2=C1CCCC2=O)O nan
39468 7527 35 None -3 7 Human 8.4 pKi = 8.4 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 291 5 2 4 2.3 CC(C)(C)NCC(COC1=CC=CC2=C1CCCC2=O)O nan
431 7527 35 None -3 7 Human 8.4 pKi = 8.4 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 291 5 2 4 2.3 CC(C)(C)NCC(COC1=CC=CC2=C1CCCC2=O)O nan
570 7527 35 None -3 7 Human 8.4 pKi = 8.4 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 291 5 2 4 2.3 CC(C)(C)NCC(COC1=CC=CC2=C1CCCC2=O)O nan
CHEMBL1201237 7527 35 None -3 7 Human 8.4 pKi = 8.4 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 291 5 2 4 2.3 CC(C)(C)NCC(COC1=CC=CC2=C1CCCC2=O)O nan
CHEMBL293030 7527 35 None -3 7 Human 8.4 pKi = 8.4 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 291 5 2 4 2.3 CC(C)(C)NCC(COC1=CC=CC2=C1CCCC2=O)O nan
DB01210 7527 35 None -3 7 Human 8.4 pKi = 8.4 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 291 5 2 4 2.3 CC(C)(C)NCC(COC1=CC=CC2=C1CCCC2=O)O nan
52946537 24495 0 None -2 3 Human 7.5 pKi = 7.5 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 384 7 2 7 2.7 OC(CNC1CCN(c2ncnc3ccsc23)CC1)COc1ccccc1 10.1016/j.bmcl.2010.08.039
CHEMBL1258599 24495 0 None -2 3 Human 7.5 pKi = 7.5 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 384 7 2 7 2.7 OC(CNC1CCN(c2ncnc3ccsc23)CC1)COc1ccccc1 10.1016/j.bmcl.2010.08.039
118710941 120528 0 None -5 3 Human 7.5 pKi = 7.5 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 370 5 4 5 3.3 O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@@H]3CCC[C@@H]3c3ccccc3)c2s1 10.1016/j.bmcl.2014.06.014
CHEMBL3323659 120528 0 None -5 3 Human 7.5 pKi = 7.5 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 370 5 4 5 3.3 O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@@H]3CCC[C@@H]3c3ccccc3)c2s1 10.1016/j.bmcl.2014.06.014
164451 109954 14 None 1 3 Human 6.5 pKi = 6.5 Binding
Compound was tested for its binding affinity against Beta-1 adrenergic receptor in CHO cell membrane using [125I]iodocyanopindolol as the radioligand.Compound was tested for its binding affinity against Beta-1 adrenergic receptor in CHO cell membrane using [125I]iodocyanopindolol as the radioligand.
ChEMBL 361 12 3 6 1.6 O=C(O)COc1ccc(OCCNC[C@H](O)COc2ccccc2)cc1 10.1016/0960-894X(96)00417-9
CHEMBL308150 109954 14 None 1 3 Human 6.5 pKi = 6.5 Binding
Compound was tested for its binding affinity against Beta-1 adrenergic receptor in CHO cell membrane using [125I]iodocyanopindolol as the radioligand.Compound was tested for its binding affinity against Beta-1 adrenergic receptor in CHO cell membrane using [125I]iodocyanopindolol as the radioligand.
ChEMBL 361 12 3 6 1.6 O=C(O)COc1ccc(OCCNC[C@H](O)COc2ccccc2)cc1 10.1016/0960-894X(96)00417-9
46889727 13421 0 None -3 3 Human 6.5 pKi = 6.5 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 514 10 1 6 4.3 C=CCc1ccccc1OCC(O)CN1CCC(CN2C(=O)c3cccc4cc(OC)cc(c34)C2=O)CC1 10.1016/j.bmcl.2010.04.009
CHEMBL1083366 13421 0 None -3 3 Human 6.5 pKi = 6.5 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 514 10 1 6 4.3 C=CCc1ccccc1OCC(O)CN1CCC(CN2C(=O)c3cccc4cc(OC)cc(c34)C2=O)CC1 10.1016/j.bmcl.2010.04.009
127046948 146848 0 None -13 6 Mouse 6.5 pKi = 6.5 Binding
Displacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cellsDisplacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cells
ChEMBL 488 12 4 6 4.1 COc1cc(CCNC[C@@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc1OCCCc1ccccc1 10.1016/j.bmc.2016.04.028
CHEMBL3800468 146848 0 None -13 6 Mouse 6.5 pKi = 6.5 Binding
Displacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cellsDisplacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cells
ChEMBL 488 12 4 6 4.1 COc1cc(CCNC[C@@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc1OCCCc1ccccc1 10.1016/j.bmc.2016.04.028
15077955 162154 0 None - 1 Human 6.5 pKi = 6.5 Binding
Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.
ChEMBL 496 10 5 7 0.6 NS(=O)(=O)c1cc(C(=O)NCCNCC(O)COc2cccc3c2CCC(=O)N3)ccc1Cl 10.1021/jm00053a020
CHEMBL40343 162154 0 None - 1 Human 6.5 pKi = 6.5 Binding
Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.
ChEMBL 496 10 5 7 0.6 NS(=O)(=O)c1cc(C(=O)NCCNCC(O)COc2cccc3c2CCC(=O)N3)ccc1Cl 10.1021/jm00053a020
1028 7079 71 None -23 30 Guinea pig 5.5 pKi = 5.5 Binding
Binding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenololBinding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenolol
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
139148732 7079 71 None -23 30 Guinea pig 5.5 pKi = 5.5 Binding
Binding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenololBinding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenolol
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
479 7079 71 None -23 30 Guinea pig 5.5 pKi = 5.5 Binding
Binding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenololBinding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenolol
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
5816 7079 71 None -23 30 Guinea pig 5.5 pKi = 5.5 Binding
Binding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenololBinding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenolol
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
CHEMBL679 7079 71 None -23 30 Guinea pig 5.5 pKi = 5.5 Binding
Binding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenololBinding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenolol
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
DB00668 7079 71 None -23 30 Guinea pig 5.5 pKi = 5.5 Binding
Binding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenololBinding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenolol
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
53387673 71938 0 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of [125I]-Iodopindolol from beta1-adrenergic receptor after 1.5 hrs by liquid scintillation countingDisplacement of [125I]-Iodopindolol from beta1-adrenergic receptor after 1.5 hrs by liquid scintillation counting
ChEMBL 415 9 2 7 2.3 COc1ccc2nc(-c3ccc(OC[C@@H](O)CNC(C)CF)cc3)n(C)c(=O)c2c1 10.1016/j.bmcl.2011.06.106
CHEMBL1824266 71938 0 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of [125I]-Iodopindolol from beta1-adrenergic receptor after 1.5 hrs by liquid scintillation countingDisplacement of [125I]-Iodopindolol from beta1-adrenergic receptor after 1.5 hrs by liquid scintillation counting
ChEMBL 415 9 2 7 2.3 COc1ccc2nc(-c3ccc(OC[C@@H](O)CNC(C)CF)cc3)n(C)c(=O)c2c1 10.1016/j.bmcl.2011.06.106
16736091 92507 0 None -66 2 Rat 4.5 pKi = 4.5 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 317 7 4 5 2.4 COc1ccc(C[C@H](C)NC[C@H](O)c2cc(O)cc(O)c2)cc1 nan
CHEMBL228996 92507 0 None -66 2 Rat 4.5 pKi = 4.5 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 317 7 4 5 2.4 COc1ccc(C[C@H](C)NC[C@H](O)c2cc(O)cc(O)c2)cc1 nan
16736091 92507 0 None -66 2 Rat 4.5 pKi = 4.5 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 317 7 4 5 2.4 COc1ccc(C[C@H](C)NC[C@H](O)c2cc(O)cc(O)c2)cc1 10.1021/jm070030d
CHEMBL228996 92507 0 None -66 2 Rat 4.5 pKi = 4.5 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 317 7 4 5 2.4 COc1ccc(C[C@H](C)NC[C@H](O)c2cc(O)cc(O)c2)cc1 10.1021/jm070030d
25198751 19361 0 None - 1 Rat 4.5 pKi = 4.5 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation counting
ChEMBL 325 7 2 5 2.5 C=CCNCC(O)COc1ccc2oc3ccccc3c(=O)c2c1 10.1016/j.bmc.2008.12.031
CHEMBL1186872 19361 0 None - 1 Rat 4.5 pKi = 4.5 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation counting
ChEMBL 325 7 2 5 2.5 C=CCNCC(O)COc1ccc2oc3ccccc3c(=O)c2c1 10.1016/j.bmc.2008.12.031
CHEMBL481415 19361 0 None - 1 Rat 4.5 pKi = 4.5 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation counting
ChEMBL 325 7 2 5 2.5 C=CCNCC(O)COc1ccc2oc3ccccc3c(=O)c2c1 10.1016/j.bmc.2008.12.031
10457669 168063 0 None - 1 Human 7.5 pKi = 7.5 Binding
Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.
ChEMBL 475 7 2 6 2.7 NS(=O)(=O)c1cc(N2CCN(CC(O)COc3cccc4ccccc34)CC2)ccc1Cl 10.1021/jm00053a020
CHEMBL41214 168063 0 None - 1 Human 7.5 pKi = 7.5 Binding
Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.
ChEMBL 475 7 2 6 2.7 NS(=O)(=O)c1cc(N2CCN(CC(O)COc3cccc4ccccc34)CC2)ccc1Cl 10.1021/jm00053a020
49864461 22424 0 None -1 2 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 381 12 4 6 2.8 CCCCN(CCCC)CCNC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12 10.1016/j.bmcl.2010.06.136
CHEMBL1221862 22424 0 None -1 2 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 381 12 4 6 2.8 CCCCN(CCCC)CCNC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12 10.1016/j.bmcl.2010.06.136
44287337 157937 0 None -2 3 Human 6.5 pKi = 6.5 Binding
Ability to bind to human Beta-1 adrenergic receptor using membranes of stably transfected CHO cellsAbility to bind to human Beta-1 adrenergic receptor using membranes of stably transfected CHO cells
ChEMBL 378 9 4 5 2.5 C[C@H](Cc1ccc(OCC(=O)NO)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1016/S0960-894X(97)00266-7
CHEMBL39596 157937 0 None -2 3 Human 6.5 pKi = 6.5 Binding
Ability to bind to human Beta-1 adrenergic receptor using membranes of stably transfected CHO cellsAbility to bind to human Beta-1 adrenergic receptor using membranes of stably transfected CHO cells
ChEMBL 378 9 4 5 2.5 C[C@H](Cc1ccc(OCC(=O)NO)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1016/S0960-894X(97)00266-7
11820657 20216 1 None -6 2 Guinea pig 6.5 pKi = 6.5 Binding
Binding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacementBinding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacement
ChEMBL 217 1 1 5 0.4 Cc1cn2ccnc(N3CCNCC3)c2n1 10.1021/jm00099a012
CHEMBL1193017 20216 1 None -6 2 Guinea pig 6.5 pKi = 6.5 Binding
Binding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacementBinding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacement
ChEMBL 217 1 1 5 0.4 Cc1cn2ccnc(N3CCNCC3)c2n1 10.1021/jm00099a012
CHEMBL544354 20216 1 None -6 2 Guinea pig 6.5 pKi = 6.5 Binding
Binding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacementBinding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacement
ChEMBL 217 1 1 5 0.4 Cc1cn2ccnc(N3CCNCC3)c2n1 10.1021/jm00099a012
155534529 178742 0 None -2 2 Mouse 6.5 pKi = 6.5 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 467 14 4 7 3.7 COc1cc(CCNC[C@@H](O)COc2ccc(O)c(O)c2)ccc1OCCCc1ccccc1 10.1021/acs.jmedchem.9b00349
CHEMBL4470694 178742 0 None -2 2 Mouse 6.5 pKi = 6.5 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 467 14 4 7 3.7 COc1cc(CCNC[C@@H](O)COc2ccc(O)c(O)c2)ccc1OCCCc1ccccc1 10.1021/acs.jmedchem.9b00349
16737412 92557 0 None -3 2 Rat 4.5 pKi = 4.5 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 287 6 4 4 2.4 C[C@@H](Cc1ccccc1)NC[C@H](O)c1cc(O)cc(O)c1 10.1021/jm070030d
CHEMBL229388 92557 0 None -3 2 Rat 4.5 pKi = 4.5 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 287 6 4 4 2.4 C[C@@H](Cc1ccccc1)NC[C@H](O)c1cc(O)cc(O)c1 10.1021/jm070030d
16737412 92557 0 None -3 2 Rat 4.5 pKi = 4.5 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 287 6 4 4 2.4 C[C@@H](Cc1ccccc1)NC[C@H](O)c1cc(O)cc(O)c1 nan
CHEMBL229388 92557 0 None -3 2 Rat 4.5 pKi = 4.5 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 287 6 4 4 2.4 C[C@@H](Cc1ccccc1)NC[C@H](O)c1cc(O)cc(O)c1 nan
16736092 92558 0 None -1 2 Rat 4.5 pKi = 4.5 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 287 6 4 4 2.4 C[C@@H](Cc1ccccc1)NC[C@@H](O)c1cc(O)cc(O)c1 10.1021/jm070030d
CHEMBL229390 92558 0 None -1 2 Rat 4.5 pKi = 4.5 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 287 6 4 4 2.4 C[C@@H](Cc1ccccc1)NC[C@@H](O)c1cc(O)cc(O)c1 10.1021/jm070030d
16736092 92558 0 None -1 2 Rat 4.5 pKi = 4.5 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 287 6 4 4 2.4 C[C@@H](Cc1ccccc1)NC[C@@H](O)c1cc(O)cc(O)c1 nan
CHEMBL229390 92558 0 None -1 2 Rat 4.5 pKi = 4.5 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 287 6 4 4 2.4 C[C@@H](Cc1ccccc1)NC[C@@H](O)c1cc(O)cc(O)c1 nan
1239 8458 55 None -53 4 Human 6.5 pKi = 6.5 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2014.06.014
3410 8458 55 None -53 4 Human 6.5 pKi = 6.5 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2014.06.014
3465 8458 55 None -53 4 Human 6.5 pKi = 6.5 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2014.06.014
CHEMBL1256786 8458 55 None -53 4 Human 6.5 pKi = 6.5 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2014.06.014
DB00983 8458 55 None -53 4 Human 6.5 pKi = 6.5 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2014.06.014
153287553 177883 0 None -501 6 Human 5.5 pKi = 5.5 Binding
Displacement of [125I]-pindolol from human recombinant adrenergic Beta1 receptor expressed in Flp-In CHO cells after 90 mins by microbeta scintillation counting methodDisplacement of [125I]-pindolol from human recombinant adrenergic Beta1 receptor expressed in Flp-In CHO cells after 90 mins by microbeta scintillation counting method
ChEMBL 264 1 1 2 3.7 C[C@@]12CN(c3ccccc3)c3ccccc3[C@@H]1CCN2 10.1021/acsmedchemlett.9b00225
CHEMBL4457754 177883 0 None -501 6 Human 5.5 pKi = 5.5 Binding
Displacement of [125I]-pindolol from human recombinant adrenergic Beta1 receptor expressed in Flp-In CHO cells after 90 mins by microbeta scintillation counting methodDisplacement of [125I]-pindolol from human recombinant adrenergic Beta1 receptor expressed in Flp-In CHO cells after 90 mins by microbeta scintillation counting method
ChEMBL 264 1 1 2 3.7 C[C@@]12CN(c3ccccc3)c3ccccc3[C@@H]1CCN2 10.1021/acsmedchemlett.9b00225
10287658 119032 0 None -25 2 Human 4.5 pKi = 4.5 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 408 10 5 6 3.5 COc1ccc(Nc2ccc(CCNCC(O)c3ccc(O)c(CO)c3)cc2)cc1 10.1016/j.bmcl.2014.04.069
CHEMBL3290984 119032 0 None -25 2 Human 4.5 pKi = 4.5 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 408 10 5 6 3.5 COc1ccc(Nc2ccc(CCNCC(O)c3ccc(O)c(CO)c3)cc2)cc1 10.1016/j.bmcl.2014.04.069
90644154 119033 0 None -5 2 Human 4.5 pKi = 4.5 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 428 9 5 5 4.6 OCc1cc(C(O)CNCCc2ccc(Nc3cccc4ccccc34)cc2)ccc1O 10.1016/j.bmcl.2014.04.069
CHEMBL3290985 119033 0 None -5 2 Human 4.5 pKi = 4.5 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 428 9 5 5 4.6 OCc1cc(C(O)CNCCc2ccc(Nc3cccc4ccccc34)cc2)ccc1O 10.1016/j.bmcl.2014.04.069
10310047 119040 0 None -199 2 Human 4.5 pKi = 4.5 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 422 11 5 6 3.9 CCOc1ccc(Nc2ccc(CCNCC(O)c3ccc(O)c(CO)c3)cc2)cc1 10.1016/j.bmcl.2014.04.069
CHEMBL3290991 119040 0 None -199 2 Human 4.5 pKi = 4.5 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 422 11 5 6 3.9 CCOc1ccc(Nc2ccc(CCNCC(O)c3ccc(O)c(CO)c3)cc2)cc1 10.1016/j.bmcl.2014.04.069
1239 8458 55 None -53 4 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2010.06.136
3410 8458 55 None -53 4 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2010.06.136
3465 8458 55 None -53 4 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2010.06.136
CHEMBL1256786 8458 55 None -53 4 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2010.06.136
DB00983 8458 55 None -53 4 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 10.1016/j.bmcl.2010.06.136
46889854 14080 0 None -104 3 Human 7.5 pKi = 7.5 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 446 7 2 4 4.8 O=C(c1ccc(F)cc1)C1CCN(CC(O)COc2cccc3[nH]c4ccccc4c23)CC1 10.1016/j.bmcl.2010.04.009
CHEMBL1086077 14080 0 None -104 3 Human 7.5 pKi = 7.5 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 446 7 2 4 4.8 O=C(c1ccc(F)cc1)C1CCN(CC(O)COc2cccc3[nH]c4ccccc4c23)CC1 10.1016/j.bmcl.2010.04.009
10140996 161697 0 None -398 3 Human 5.5 pKi = 5.5 Binding
Displacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 486 11 5 7 3.0 COc1ccc([C@@H](Cc2ccccc2)NC[C@@H](O)Cc2ccc(O)c(NS(C)(=O)=O)c2)cc1O 10.1016/j.bmcl.2007.05.030
CHEMBL400947 161697 0 None -398 3 Human 5.5 pKi = 5.5 Binding
Displacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 486 11 5 7 3.0 COc1ccc([C@@H](Cc2ccccc2)NC[C@@H](O)Cc2ccc(O)c(NS(C)(=O)=O)c2)cc1O 10.1016/j.bmcl.2007.05.030
1588 9105 27 None -151 44 Human 6.5 pKi = 6.5 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
28864 9105 27 None -151 44 Human 6.5 pKi = 6.5 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
43 9105 27 None -151 44 Human 6.5 pKi = 6.5 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
CHEMBL157138 9105 27 None -151 44 Human 6.5 pKi = 6.5 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
DB00589 9105 27 None -151 44 Human 6.5 pKi = 6.5 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
65772 67177 8 None -2 6 Human 6.5 pKi = 6.5 Binding
Binding Affinity against human Beta-1 adrenergic receptor expressed in Chinese hamster ovary(CHO) cells was measured by using [125I]ICYP radioligandBinding Affinity against human Beta-1 adrenergic receptor expressed in Chinese hamster ovary(CHO) cells was measured by using [125I]ICYP radioligand
ChEMBL 345 5 3 6 2.6 COc1cc(C[C@@H]2NCCc3cc(O)c(O)cc32)cc(OC)c1OC 10.1021/jm990012z
CHEMBL174984 67177 8 None -2 6 Human 6.5 pKi = 6.5 Binding
Binding Affinity against human Beta-1 adrenergic receptor expressed in Chinese hamster ovary(CHO) cells was measured by using [125I]ICYP radioligandBinding Affinity against human Beta-1 adrenergic receptor expressed in Chinese hamster ovary(CHO) cells was measured by using [125I]ICYP radioligand
ChEMBL 345 5 3 6 2.6 COc1cc(C[C@@H]2NCCc3cc(O)c(O)cc32)cc(OC)c1OC 10.1021/jm990012z
65772 67177 8 None -2 6 Human 6.5 pKi = 6.5 Binding
Binding affinity for human Beta-1 adrenergic receptor expressed in CHO cells by radioligand competition binding assays using [125I]iodocyanopindolol (ICYP).) PR = potency ratio relative to TMQBinding affinity for human Beta-1 adrenergic receptor expressed in CHO cells by radioligand competition binding assays using [125I]iodocyanopindolol (ICYP).) PR = potency ratio relative to TMQ
ChEMBL 345 5 3 6 2.6 COc1cc(C[C@@H]2NCCc3cc(O)c(O)cc32)cc(OC)c1OC 10.1021/jm960208o
CHEMBL174984 67177 8 None -2 6 Human 6.5 pKi = 6.5 Binding
Binding affinity for human Beta-1 adrenergic receptor expressed in CHO cells by radioligand competition binding assays using [125I]iodocyanopindolol (ICYP).) PR = potency ratio relative to TMQBinding affinity for human Beta-1 adrenergic receptor expressed in CHO cells by radioligand competition binding assays using [125I]iodocyanopindolol (ICYP).) PR = potency ratio relative to TMQ
ChEMBL 345 5 3 6 2.6 COc1cc(C[C@@H]2NCCc3cc(O)c(O)cc32)cc(OC)c1OC 10.1021/jm960208o
14925759 164817 6 None -11220 13 Human 4.5 pKi = 4.5 Binding
Displacement of [3H]CGP12177 from human recombinant beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by beta counting methodDisplacement of [3H]CGP12177 from human recombinant beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by beta counting method
ChEMBL 349 5 0 3 3.2 O=C1CCc2ccccc2N1CCCN1CCN(c2ccccc2)CC1 10.1021/acs.jmedchem.8b00265
CHEMBL4085780 164817 6 None -11220 13 Human 4.5 pKi = 4.5 Binding
Displacement of [3H]CGP12177 from human recombinant beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by beta counting methodDisplacement of [3H]CGP12177 from human recombinant beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by beta counting method
ChEMBL 349 5 0 3 3.2 O=C1CCc2ccccc2N1CCCN1CCN(c2ccccc2)CC1 10.1021/acs.jmedchem.8b00265
52943362 24320 0 None -8 3 Human 7.5 pKi = 7.5 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 466 8 2 8 4.4 OC(CNC1CCN(c2ncnc3scc(-c4cccs4)c23)CC1)COc1ccccc1 10.1016/j.bmcl.2010.08.039
CHEMBL1258025 24320 0 None -8 3 Human 7.5 pKi = 7.5 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 466 8 2 8 4.4 OC(CNC1CCN(c2ncnc3scc(-c4cccs4)c23)CC1)COc1ccccc1 10.1016/j.bmcl.2010.08.039
118710945 120532 0 None -2 3 Human 7.5 pKi = 7.5 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 398 6 4 5 3.8 CCc1cccc([C@H]2CCC[C@H]2NC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1 10.1016/j.bmcl.2014.06.014
CHEMBL3323663 120532 0 None -2 3 Human 7.5 pKi = 7.5 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 398 6 4 5 3.8 CCc1cccc([C@H]2CCC[C@H]2NC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1 10.1016/j.bmcl.2014.06.014
155529870 178284 0 None -30 2 Mouse 7.5 pKi = 7.5 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 516 17 3 8 4.5 COc1cc(CCNC[C@@H](O)COc2cccc3ccccc23)ccc1OCCCSSCCN 10.1016/j.bmc.2019.05.034
CHEMBL4463925 178284 0 None -30 2 Mouse 7.5 pKi = 7.5 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 516 17 3 8 4.5 COc1cc(CCNC[C@@H](O)COc2cccc3ccccc23)ccc1OCCCSSCCN 10.1016/j.bmc.2019.05.034
49864381 22406 0 None 1 2 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 380 5 4 5 3.8 C[C@H](NC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12)c1ccc2ccccc2c1 10.1016/j.bmcl.2010.06.136
CHEMBL1221638 22406 0 None 1 2 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 380 5 4 5 3.8 C[C@H](NC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12)c1ccc2ccccc2c1 10.1016/j.bmcl.2010.06.136
44361777 125358 0 None -3 2 Rat 6.5 pKi = 6.5 Binding
Compound was evaluated for its Beta-1 adrenergic receptor binding affinity by measuring the displacement of [3H]dihydroalprenolol binding in rat heartCompound was evaluated for its Beta-1 adrenergic receptor binding affinity by measuring the displacement of [3H]dihydroalprenolol binding in rat heart
ChEMBL 429 7 2 7 2.3 COc1ccccc1N1CCN(CC(O)COc2cccc3c2SCC(=O)N3)CC1 10.1016/s0960-894x(00)00016-0
CHEMBL341614 125358 0 None -3 2 Rat 6.5 pKi = 6.5 Binding
Compound was evaluated for its Beta-1 adrenergic receptor binding affinity by measuring the displacement of [3H]dihydroalprenolol binding in rat heartCompound was evaluated for its Beta-1 adrenergic receptor binding affinity by measuring the displacement of [3H]dihydroalprenolol binding in rat heart
ChEMBL 429 7 2 7 2.3 COc1ccccc1N1CCN(CC(O)COc2cccc3c2SCC(=O)N3)CC1 10.1016/s0960-894x(00)00016-0
155511898 176378 0 None -12 2 Mouse 6.5 pKi = 6.5 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 360 8 2 3 4.5 COc1ccccc1OCCNCCc1cccc2[nH]c3ccccc3c12 10.1021/acs.jmedchem.9b00349
CHEMBL4436343 176378 0 None -12 2 Mouse 6.5 pKi = 6.5 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 360 8 2 3 4.5 COc1ccccc1OCCNCCc1cccc2[nH]c3ccccc3c12 10.1021/acs.jmedchem.9b00349
123133225 151587 0 None -5 2 Rat 4.5 pKi = 4.5 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 302 6 5 5 1.9 C[C@@H](Cc1cccc(N)c1)NC[C@H](O)c1cc(O)cc(O)c1 nan
CHEMBL3909417 151587 0 None -5 2 Rat 4.5 pKi = 4.5 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 302 6 5 5 1.9 C[C@@H](Cc1cccc(N)c1)NC[C@H](O)c1cc(O)cc(O)c1 nan
16735263 92567 0 None -5 2 Rat 4.5 pKi = 4.5 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 302 6 5 5 1.9 C[C@@H](Cc1ccc(N)cc1)NC[C@H](O)c1cc(O)cc(O)c1 10.1021/jm070030d
CHEMBL229442 92567 0 None -5 2 Rat 4.5 pKi = 4.5 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 302 6 5 5 1.9 C[C@@H](Cc1ccc(N)cc1)NC[C@H](O)c1cc(O)cc(O)c1 10.1021/jm070030d
123133222 166826 0 None -6 2 Rat 4.5 pKi = 4.5 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 317 7 4 5 2.4 COc1cccc(C[C@@H](C)NC[C@@H](O)c2cc(O)cc(O)c2)c1 nan
CHEMBL4108239 166826 0 None -6 2 Rat 4.5 pKi = 4.5 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 317 7 4 5 2.4 COc1cccc(C[C@@H](C)NC[C@@H](O)c2cc(O)cc(O)c2)c1 nan
16735261 92508 0 None -47 2 Rat 4.5 pKi = 4.5 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 317 7 4 5 2.4 COc1ccc(C[C@@H](C)NC[C@@H](O)c2cc(O)cc(O)c2)cc1 10.1021/jm070030d
CHEMBL228998 92508 0 None -47 2 Rat 4.5 pKi = 4.5 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 317 7 4 5 2.4 COc1ccc(C[C@@H](C)NC[C@@H](O)c2cc(O)cc(O)c2)cc1 10.1021/jm070030d
16735495 92561 0 None -14 2 Rat 5.5 pKi = 5.5 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 337 6 4 4 3.5 C[C@H](Cc1cccc2ccccc12)NC[C@H](O)c1cc(O)cc(O)c1 nan
CHEMBL229401 92561 0 None -14 2 Rat 5.5 pKi = 5.5 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 337 6 4 4 3.5 C[C@H](Cc1cccc2ccccc12)NC[C@H](O)c1cc(O)cc(O)c1 nan
16735495 92561 0 None -14 2 Rat 5.5 pKi = 5.5 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 337 6 4 4 3.5 C[C@H](Cc1cccc2ccccc12)NC[C@H](O)c1cc(O)cc(O)c1 10.1021/jm070030d
CHEMBL229401 92561 0 None -14 2 Rat 5.5 pKi = 5.5 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 337 6 4 4 3.5 C[C@H](Cc1cccc2ccccc12)NC[C@H](O)c1cc(O)cc(O)c1 10.1021/jm070030d
44396798 176171 0 None -30 3 Human 7.5 pKi = 7.5 Binding
Binding inhibition constant was determined by inhibition of [125I]-iodocyanopindolol binding to Beta-1 adrenergic receptorBinding inhibition constant was determined by inhibition of [125I]-iodocyanopindolol binding to Beta-1 adrenergic receptor
ChEMBL 542 10 5 7 3.2 C[C@H](Cc1c[nH]c2c(S(C)(=O)=O)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccc(N)c2)c1 10.1016/j.bmcl.2004.09.054
CHEMBL442225 176171 0 None -30 3 Human 7.5 pKi = 7.5 Binding
Binding inhibition constant was determined by inhibition of [125I]-iodocyanopindolol binding to Beta-1 adrenergic receptorBinding inhibition constant was determined by inhibition of [125I]-iodocyanopindolol binding to Beta-1 adrenergic receptor
ChEMBL 542 10 5 7 3.2 C[C@H](Cc1c[nH]c2c(S(C)(=O)=O)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccc(N)c2)c1 10.1016/j.bmcl.2004.09.054
155521528 177383 0 None -1 2 Mouse 6.5 pKi = 6.5 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 376 8 3 4 4.0 COc1ccccc1OCCNC[C@@H](O)c1cccc2[nH]c3ccccc3c12 10.1021/acs.jmedchem.9b00349
CHEMBL4450756 177383 0 None -1 2 Mouse 6.5 pKi = 6.5 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 376 8 3 4 4.0 COc1ccccc1OCCNC[C@@H](O)c1cccc2[nH]c3ccccc3c12 10.1021/acs.jmedchem.9b00349
118710944 120531 0 None -2 3 Human 6.5 pKi = 6.5 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 384 5 4 5 3.6 Cc1ccc([C@H]2CCC[C@H]2NC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1 10.1016/j.bmcl.2014.06.014
CHEMBL3323662 120531 0 None -2 3 Human 6.5 pKi = 6.5 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 384 5 4 5 3.6 Cc1ccc([C@H]2CCC[C@H]2NC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1 10.1016/j.bmcl.2014.06.014
15221053 211375 0 None -2 3 Human 5.5 pKi = 5.5 Binding
Compound was tested for its binding affinity against Beta-1 adrenergic receptor in CHO cell membrane using [125I]iodocyanopindolol as the radioligand.Compound was tested for its binding affinity against Beta-1 adrenergic receptor in CHO cell membrane using [125I]iodocyanopindolol as the radioligand.
ChEMBL 364 11 3 6 2.1 C[C@H](Cc1ncc(CCC(=O)O)s1)NC[C@H](O)COc1ccccc1 10.1016/0960-894X(96)00417-9
CHEMBL73220 211375 0 None -2 3 Human 5.5 pKi = 5.5 Binding
Compound was tested for its binding affinity against Beta-1 adrenergic receptor in CHO cell membrane using [125I]iodocyanopindolol as the radioligand.Compound was tested for its binding affinity against Beta-1 adrenergic receptor in CHO cell membrane using [125I]iodocyanopindolol as the radioligand.
ChEMBL 364 11 3 6 2.1 C[C@H](Cc1ncc(CCC(=O)O)s1)NC[C@H](O)COc1ccccc1 10.1016/0960-894X(96)00417-9
24937269 24419 0 None -1949 3 Human 4.5 pKi = 4.5 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 490 9 3 8 3.8 OCc1cccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)c1 10.1016/j.bmcl.2010.08.039
CHEMBL1258371 24419 0 None -1949 3 Human 4.5 pKi = 4.5 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 490 9 3 8 3.8 OCc1cccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)c1 10.1016/j.bmcl.2010.08.039
13864389 11838 2 None 8 2 Rat 5.5 pKi = 5.5 Binding
Tested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligandTested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligand
ChEMBL 195 1 3 4 0.7 NCC1OCCc2cc(O)c(O)cc21 10.1021/jm00073a006
CHEMBL105383 11838 2 None 8 2 Rat 5.5 pKi = 5.5 Binding
Tested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligandTested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligand
ChEMBL 195 1 3 4 0.7 NCC1OCCc2cc(O)c(O)cc21 10.1021/jm00073a006
16736096 148874 0 None -19 2 Rat 4.5 pKi = 4.5 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 337 6 4 4 3.5 C[C@H](Cc1cccc2ccccc12)NC[C@@H](O)c1cc(O)cc(O)c1 10.1021/jm070030d
CHEMBL388177 148874 0 None -19 2 Rat 4.5 pKi = 4.5 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 337 6 4 4 3.5 C[C@H](Cc1cccc2ccccc12)NC[C@@H](O)c1cc(O)cc(O)c1 10.1021/jm070030d
16736096 148874 0 None -19 2 Rat 4.5 pKi = 4.5 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 337 6 4 4 3.5 C[C@H](Cc1cccc2ccccc12)NC[C@@H](O)c1cc(O)cc(O)c1 nan
CHEMBL388177 148874 0 None -19 2 Rat 4.5 pKi = 4.5 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 337 6 4 4 3.5 C[C@H](Cc1cccc2ccccc12)NC[C@@H](O)c1cc(O)cc(O)c1 nan
49864355 22392 0 None -1 2 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 374 5 4 5 3.1 O=c1[nH]c2c(O)ccc([C@@H](O)CNCC34CC5CC(CC(C5)C3)C4)c2s1 10.1016/j.bmcl.2010.06.136
CHEMBL1221586 22392 0 None -1 2 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 374 5 4 5 3.1 O=c1[nH]c2c(O)ccc([C@@H](O)CNCC34CC5CC(CC(C5)C3)C4)c2s1 10.1016/j.bmcl.2010.06.136
172745 106899 7 None -2 6 Guinea pig 6.5 pKi = 6.5 Binding
Binding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenololBinding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenolol
ChEMBL 187 2 4 4 0.2 NCC(O)c1ccc(O)c(O)c1F 10.1021/jm00118a019
CHEMBL287587 106899 7 None -2 6 Guinea pig 6.5 pKi = 6.5 Binding
Binding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenololBinding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenolol
ChEMBL 187 2 4 4 0.2 NCC(O)c1ccc(O)c(O)c1F 10.1021/jm00118a019
24936488 24421 0 None -2 3 Human 5.5 pKi = 5.5 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 414 7 3 8 2.7 Cc1csc2ncnc(N3CCC(NCC(O)COc4ccc(O)cc4)CC3)c12 10.1016/j.bmcl.2010.08.039
CHEMBL1258373 24421 0 None -2 3 Human 5.5 pKi = 5.5 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 414 7 3 8 2.7 Cc1csc2ncnc(N3CCC(NCC(O)COc4ccc(O)cc4)CC3)c12 10.1016/j.bmcl.2010.08.039
145947241 174411 0 None -8 2 Rat 6.5 pKi = 6.5 Binding
Displacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysisDisplacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysis
ChEMBL 449 10 2 7 3.5 COc1ccc(CCNCC(O)COc2cccc3c(=O)c4ccccc4oc23)cc1OC 10.1016/j.bmc.2018.04.038
CHEMBL4128940 174411 0 None -8 2 Rat 6.5 pKi = 6.5 Binding
Displacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysisDisplacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysis
ChEMBL 449 10 2 7 3.5 COc1ccc(CCNCC(O)COc2cccc3c(=O)c4ccccc4oc23)cc1OC 10.1016/j.bmc.2018.04.038
CHEMBL4301544 174411 0 None -8 2 Rat 6.5 pKi = 6.5 Binding
Displacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysisDisplacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysis
ChEMBL 449 10 2 7 3.5 COc1ccc(CCNCC(O)COc2cccc3c(=O)c4ccccc4oc23)cc1OC 10.1016/j.bmc.2018.04.038
145947927 174529 0 None -16 2 Rat 6.5 pKi = 6.5 Binding
Displacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysisDisplacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysis
ChEMBL 419 9 2 6 3.5 COc1ccccc1CCNCC(O)COc1cccc2c(=O)c3ccccc3oc12 10.1016/j.bmc.2018.04.038
CHEMBL4130151 174529 0 None -16 2 Rat 6.5 pKi = 6.5 Binding
Displacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysisDisplacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysis
ChEMBL 419 9 2 6 3.5 COc1ccccc1CCNCC(O)COc1cccc2c(=O)c3ccccc3oc12 10.1016/j.bmc.2018.04.038
CHEMBL4302997 174529 0 None -16 2 Rat 6.5 pKi = 6.5 Binding
Displacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysisDisplacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysis
ChEMBL 419 9 2 6 3.5 COc1ccccc1CCNCC(O)COc1cccc2c(=O)c3ccccc3oc12 10.1016/j.bmc.2018.04.038
10376053 19907 0 None -2 3 Guinea pig 6.4 pKi = 6.4 Binding
Binding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacementBinding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacement
ChEMBL 217 1 1 5 0.4 Cc1cnc(N2CCNCC2)c2nccn12 10.1021/jm00099a012
CHEMBL1190547 19907 0 None -2 3 Guinea pig 6.4 pKi = 6.4 Binding
Binding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacementBinding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacement
ChEMBL 217 1 1 5 0.4 Cc1cnc(N2CCNCC2)c2nccn12 10.1021/jm00099a012
CHEMBL541088 19907 0 None -2 3 Guinea pig 6.4 pKi = 6.4 Binding
Binding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacementBinding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacement
ChEMBL 217 1 1 5 0.4 Cc1cnc(N2CCNCC2)c2nccn12 10.1021/jm00099a012
10292413 101054 0 None -7 2 Human 6.4 pKi = 6.4 Binding
Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 367 9 2 6 3.6 CC(C)c1nc(-c2ccc(OCCNC[C@H](O)c3cccnc3)cc2)co1 10.1016/j.bmcl.2007.06.072
CHEMBL250352 101054 0 None -7 2 Human 6.4 pKi = 6.4 Binding
Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 367 9 2 6 3.6 CC(C)c1nc(-c2ccc(OCCNC[C@H](O)c3cccnc3)cc2)co1 10.1016/j.bmcl.2007.06.072
10162297 160686 0 None -33 3 Human 5.4 pKi = 5.4 Binding
Displacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 470 11 4 6 3.2 COc1cccc([C@@H](Cc2ccccc2)NC[C@@H](O)Cc2ccc(O)c(NS(C)(=O)=O)c2)c1 10.1016/j.bmcl.2007.05.030
CHEMBL398322 160686 0 None -33 3 Human 5.4 pKi = 5.4 Binding
Displacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 470 11 4 6 3.2 COc1cccc([C@@H](Cc2ccccc2)NC[C@@H](O)Cc2ccc(O)c(NS(C)(=O)=O)c2)c1 10.1016/j.bmcl.2007.05.030
9947512 161485 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 369 9 2 6 3.5 CCc1nc(-c2ccc(OCCNC[C@H](O)c3cccnc3)cc2)cs1 10.1016/j.bmcl.2007.06.072
CHEMBL399785 161485 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 369 9 2 6 3.5 CCc1nc(-c2ccc(OCCNC[C@H](O)c3cccnc3)cc2)cs1 10.1016/j.bmcl.2007.06.072
1534 109817 53 None -37 12 Human 5.4 pKi = 5.4 Binding
Displacement of [125I]Iodopindolol from human recombinant adrenergic beta1 receptor expressed in CHO cells coexpressing FLP-IN after 1 to 1.5 hrs by scintillation counting analysisDisplacement of [125I]Iodopindolol from human recombinant adrenergic beta1 receptor expressed in CHO cells coexpressing FLP-IN after 1 to 1.5 hrs by scintillation counting analysis
ChEMBL 174 2 2 1 2.1 CC(N)Cc1c[nH]c2ccccc12 10.1016/j.bmcl.2013.03.066
9287 109817 53 None -37 12 Human 5.4 pKi = 5.4 Binding
Displacement of [125I]Iodopindolol from human recombinant adrenergic beta1 receptor expressed in CHO cells coexpressing FLP-IN after 1 to 1.5 hrs by scintillation counting analysisDisplacement of [125I]Iodopindolol from human recombinant adrenergic beta1 receptor expressed in CHO cells coexpressing FLP-IN after 1 to 1.5 hrs by scintillation counting analysis
ChEMBL 174 2 2 1 2.1 CC(N)Cc1c[nH]c2ccccc12 10.1016/j.bmcl.2013.03.066
CHEMBL30713 109817 53 None -37 12 Human 5.4 pKi = 5.4 Binding
Displacement of [125I]Iodopindolol from human recombinant adrenergic beta1 receptor expressed in CHO cells coexpressing FLP-IN after 1 to 1.5 hrs by scintillation counting analysisDisplacement of [125I]Iodopindolol from human recombinant adrenergic beta1 receptor expressed in CHO cells coexpressing FLP-IN after 1 to 1.5 hrs by scintillation counting analysis
ChEMBL 174 2 2 1 2.1 CC(N)Cc1c[nH]c2ccccc12 10.1016/j.bmcl.2013.03.066
1534 109817 53 None -37 12 Human 5.4 pKi = 5.4 Binding
Displacement of [125I]Iodopindolol from human recombinant adrenergic beta1 receptor expressed in CHO cells coexpressing FLP-IN after 1 to 1.5 hrs by scintillation counting analysisDisplacement of [125I]Iodopindolol from human recombinant adrenergic beta1 receptor expressed in CHO cells coexpressing FLP-IN after 1 to 1.5 hrs by scintillation counting analysis
ChEMBL 174 2 2 1 2.1 CC(N)Cc1c[nH]c2ccccc12 10.1016/j.bmcl.2013.03.066
9287 109817 53 None -37 12 Human 5.4 pKi = 5.4 Binding
Displacement of [125I]Iodopindolol from human recombinant adrenergic beta1 receptor expressed in CHO cells coexpressing FLP-IN after 1 to 1.5 hrs by scintillation counting analysisDisplacement of [125I]Iodopindolol from human recombinant adrenergic beta1 receptor expressed in CHO cells coexpressing FLP-IN after 1 to 1.5 hrs by scintillation counting analysis
ChEMBL 174 2 2 1 2.1 CC(N)Cc1c[nH]c2ccccc12 10.1016/j.bmcl.2013.03.066
CHEMBL30713 109817 53 None -37 12 Human 5.4 pKi = 5.4 Binding
Displacement of [125I]Iodopindolol from human recombinant adrenergic beta1 receptor expressed in CHO cells coexpressing FLP-IN after 1 to 1.5 hrs by scintillation counting analysisDisplacement of [125I]Iodopindolol from human recombinant adrenergic beta1 receptor expressed in CHO cells coexpressing FLP-IN after 1 to 1.5 hrs by scintillation counting analysis
ChEMBL 174 2 2 1 2.1 CC(N)Cc1c[nH]c2ccccc12 10.1016/j.bmcl.2013.03.066
25032872 92126 0 None -102 2 Rat 4.4 pKi = 4.4 Binding
Displacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation counting
ChEMBL 397 6 1 6 0.9 O=C1C2C3C=CC(C3)C2C(=O)N1OCC(O)CN1CCN(c2ccccc2)CC1 10.1007/s00044-008-9094-3
CHEMBL2261429 92126 0 None -102 2 Rat 4.4 pKi = 4.4 Binding
Displacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation counting
ChEMBL 397 6 1 6 0.9 O=C1C2C3C=CC(C3)C2C(=O)N1OCC(O)CN1CCN(c2ccccc2)CC1 10.1007/s00044-008-9094-3
49864334 22386 0 None -1 2 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 336 5 4 5 2.9 C[C@H](NC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12)C1CCCCC1 10.1016/j.bmcl.2010.06.136
CHEMBL1221542 22386 0 None -1 2 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 336 5 4 5 2.9 C[C@H](NC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12)C1CCCCC1 10.1016/j.bmcl.2010.06.136
118710938 120525 0 None -6 3 Human 6.4 pKi = 6.4 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 376 5 4 5 3.7 O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@H]3CCC[C@H]3C3CCCCC3)c2s1 10.1016/j.bmcl.2014.06.014
CHEMBL3323656 120525 0 None -6 3 Human 6.4 pKi = 6.4 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 376 5 4 5 3.7 O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@H]3CCC[C@H]3C3CCCCC3)c2s1 10.1016/j.bmcl.2014.06.014
183812 212518 24 None -977 2 Human 5.4 pKi = 5.4 Binding
Binding affinity to human beta1-adrenoceptor by radioligand binding assayBinding affinity to human beta1-adrenoceptor by radioligand binding assay
ChEMBL 464 13 3 8 2.9 O=S(=O)(CCCOCCc1ccccc1)CCNCCc1ccc(O)c2nc(O)sc12 10.1016/j.bmcl.2012.07.096
CHEMBL82663 212518 24 None -977 2 Human 5.4 pKi = 5.4 Binding
Binding affinity to human beta1-adrenoceptor by radioligand binding assayBinding affinity to human beta1-adrenoceptor by radioligand binding assay
ChEMBL 464 13 3 8 2.9 O=S(=O)(CCCOCCc1ccccc1)CCNCCc1ccc(O)c2nc(O)sc12 10.1016/j.bmcl.2012.07.096
24937137 24530 0 None -23 3 Human 5.4 pKi = 5.4 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 430 8 4 9 1.9 OCc1cc(OCC(O)CNC2CCN(c3ncnc4ccsc34)CC2)ccc1O 10.1016/j.bmcl.2010.08.039
CHEMBL1258707 24530 0 None -23 3 Human 5.4 pKi = 5.4 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 430 8 4 9 1.9 OCc1cc(OCC(O)CNC2CCN(c3ncnc4ccsc34)CC2)ccc1O 10.1016/j.bmcl.2010.08.039
11248705 97070 0 None -158 10 Human 6.4 pKi = 6.4 Binding
Binding affinity at adrenergic beta 1 receptorBinding affinity at adrenergic beta 1 receptor
ChEMBL 483 6 1 5 5.0 Cc1ccc2c(OCCN3CCC(Cc4ccc5c(c4F)NC(=O)CO5)CC3)cc(Cl)cc2n1 10.1016/j.bmcl.2006.11.031
CHEMBL238519 97070 0 None -158 10 Human 6.4 pKi = 6.4 Binding
Binding affinity at adrenergic beta 1 receptorBinding affinity at adrenergic beta 1 receptor
ChEMBL 483 6 1 5 5.0 Cc1ccc2c(OCCN3CCC(Cc4ccc5c(c4F)NC(=O)CO5)CC3)cc(Cl)cc2n1 10.1016/j.bmcl.2006.11.031
9512 10408 42 None 3 2 Human 6.4 pKi = 6.4 Binding
Displacement of [125I]cyanopindolol from human cloned beta-1 adrenergic receptor expressed in Sf9 cellsDisplacement of [125I]cyanopindolol from human cloned beta-1 adrenergic receptor expressed in Sf9 cells
ChEMBL 410 9 4 4 4.4 Clc1cccc(c1)[C@H](CNCCNc1cccc(c1)c1cccc(c1)C(=O)O)O 10.1021/jm0509445
9887812 10408 42 None 3 2 Human 6.4 pKi = 6.4 Binding
Displacement of [125I]cyanopindolol from human cloned beta-1 adrenergic receptor expressed in Sf9 cellsDisplacement of [125I]cyanopindolol from human cloned beta-1 adrenergic receptor expressed in Sf9 cells
ChEMBL 410 9 4 4 4.4 Clc1cccc(c1)[C@H](CNCCNc1cccc(c1)c1cccc(c1)C(=O)O)O 10.1021/jm0509445
CHEMBL208427 10408 42 None 3 2 Human 6.4 pKi = 6.4 Binding
Displacement of [125I]cyanopindolol from human cloned beta-1 adrenergic receptor expressed in Sf9 cellsDisplacement of [125I]cyanopindolol from human cloned beta-1 adrenergic receptor expressed in Sf9 cells
ChEMBL 410 9 4 4 4.4 Clc1cccc(c1)[C@H](CNCCNc1cccc(c1)c1cccc(c1)C(=O)O)O 10.1021/jm0509445
DB06190 10408 42 None 3 2 Human 6.4 pKi = 6.4 Binding
Displacement of [125I]cyanopindolol from human cloned beta-1 adrenergic receptor expressed in Sf9 cellsDisplacement of [125I]cyanopindolol from human cloned beta-1 adrenergic receptor expressed in Sf9 cells
ChEMBL 410 9 4 4 4.4 Clc1cccc(c1)[C@H](CNCCNc1cccc(c1)c1cccc(c1)C(=O)O)O 10.1021/jm0509445
90644140 119043 0 None -25 2 Human 4.4 pKi = 4.4 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 394 9 6 6 3.2 OCc1cc(C(O)CNCCc2ccc(Nc3ccc(O)cc3)cc2)ccc1O 10.1016/j.bmcl.2014.04.069
CHEMBL3290994 119043 0 None -25 2 Human 4.4 pKi = 4.4 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 394 9 6 6 3.2 OCc1cc(C(O)CNCCc2ccc(Nc3ccc(O)cc3)cc2)ccc1O 10.1016/j.bmcl.2014.04.069
25242457 19370 0 None - 1 Rat 8.4 pKi = 8.4 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation counting
ChEMBL 373 8 4 7 1.0 CC(CO)(CO)NCC(O)COc1cccc2c(=O)c3ccccc3oc12 10.1016/j.bmc.2008.12.031
CHEMBL1186915 19370 0 None - 1 Rat 8.4 pKi = 8.4 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation counting
ChEMBL 373 8 4 7 1.0 CC(CO)(CO)NCC(O)COc1cccc2c(=O)c3ccccc3oc12 10.1016/j.bmc.2008.12.031
CHEMBL482397 19370 0 None - 1 Rat 8.4 pKi = 8.4 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation counting
ChEMBL 373 8 4 7 1.0 CC(CO)(CO)NCC(O)COc1cccc2c(=O)c3ccccc3oc12 10.1016/j.bmc.2008.12.031
118710950 120539 0 None -2 3 Human 8.4 pKi = 8.4 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 402 10 4 6 3.3 CCCCOc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1 10.1016/j.bmcl.2014.06.014
CHEMBL3323670 120539 0 None -2 3 Human 8.4 pKi = 8.4 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 402 10 4 6 3.3 CCCCOc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1 10.1016/j.bmcl.2014.06.014
118710937 120524 0 None -19 3 Human 7.4 pKi = 7.4 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 376 5 4 5 3.7 O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@@H]3CCC[C@@H]3C3CCCCC3)c2s1 10.1016/j.bmcl.2014.06.014
CHEMBL3323655 120524 0 None -19 3 Human 7.4 pKi = 7.4 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 376 5 4 5 3.7 O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@@H]3CCC[C@@H]3C3CCCCC3)c2s1 10.1016/j.bmcl.2014.06.014
49864412 22414 0 None -5 2 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 414 7 4 6 3.4 O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@@H]3CCCC[C@H]3OCc3ccccc3)c2s1 10.1016/j.bmcl.2010.06.136
CHEMBL1221732 22414 0 None -5 2 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 414 7 4 6 3.4 O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@@H]3CCCC[C@H]3OCc3ccccc3)c2s1 10.1016/j.bmcl.2010.06.136
10947658 35475 0 None -363 16 Human 6.4 pKi = 6.4 Binding
Binding affinity against Beta-1 adrenergic receptorBinding affinity against Beta-1 adrenergic receptor
ChEMBL 335 1 1 2 3.0 C[C@H]1C[C@@H](C)N1C(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)CC2N(C)C1 10.1021/jm020153s
CHEMBL137781 35475 0 None -363 16 Human 6.4 pKi = 6.4 Binding
Binding affinity against Beta-1 adrenergic receptorBinding affinity against Beta-1 adrenergic receptor
ChEMBL 335 1 1 2 3.0 C[C@H]1C[C@@H](C)N1C(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)CC2N(C)C1 10.1021/jm020153s
1960 9632 67 None -10 26 Guinea pig 6.4 pKi = 6.4 Binding
Binding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenololBinding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenolol
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
439260 9632 67 None -10 26 Guinea pig 6.4 pKi = 6.4 Binding
Binding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenololBinding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenolol
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
505 9632 67 None -10 26 Guinea pig 6.4 pKi = 6.4 Binding
Binding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenololBinding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenolol
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
CHEMBL1437 9632 67 None -10 26 Guinea pig 6.4 pKi = 6.4 Binding
Binding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenololBinding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenolol
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
DB00368 9632 67 None -10 26 Guinea pig 6.4 pKi = 6.4 Binding
Binding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenololBinding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenolol
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
10376607 20132 0 None -1 2 Guinea pig 6.4 pKi = 6.4 Binding
Binding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacementBinding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacement
ChEMBL 231 1 1 5 0.8 Cc1cnc(N2CCNCC2)c2ncc(C)n12 10.1021/jm00099a012
CHEMBL1192423 20132 0 None -1 2 Guinea pig 6.4 pKi = 6.4 Binding
Binding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacementBinding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacement
ChEMBL 231 1 1 5 0.8 Cc1cnc(N2CCNCC2)c2ncc(C)n12 10.1021/jm00099a012
CHEMBL543653 20132 0 None -1 2 Guinea pig 6.4 pKi = 6.4 Binding
Binding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacementBinding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacement
ChEMBL 231 1 1 5 0.8 Cc1cnc(N2CCNCC2)c2ncc(C)n12 10.1021/jm00099a012
131268 119679 27 None -26 3 Guinea pig 6.4 pKi = 6.4 Binding
Binding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacementBinding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacement
ChEMBL 203 1 1 5 0.1 c1cn2ccnc2c(N2CCNCC2)n1 10.1021/jm00099a012
CHEMBL331036 119679 27 None -26 3 Guinea pig 6.4 pKi = 6.4 Binding
Binding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacementBinding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacement
ChEMBL 203 1 1 5 0.1 c1cn2ccnc2c(N2CCNCC2)n1 10.1021/jm00099a012
9967732 100939 0 None -19 2 Human 6.4 pKi = 6.4 Binding
Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 339 8 2 6 2.7 Cc1nc(-c2ccc(OCCNC[C@H](O)c3cccnc3)cc2)co1 10.1016/j.bmcl.2007.06.072
CHEMBL249534 100939 0 None -19 2 Human 6.4 pKi = 6.4 Binding
Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 339 8 2 6 2.7 Cc1nc(-c2ccc(OCCNC[C@H](O)c3cccnc3)cc2)co1 10.1016/j.bmcl.2007.06.072
9946573 161532 0 None -10 2 Human 6.4 pKi = 6.4 Binding
Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 353 9 2 6 3.0 CCc1nc(-c2ccc(OCCNC[C@H](O)c3cccnc3)cc2)co1 10.1016/j.bmcl.2007.06.072
CHEMBL400049 161532 0 None -10 2 Human 6.4 pKi = 6.4 Binding
Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 353 9 2 6 3.0 CCc1nc(-c2ccc(OCCNC[C@H](O)c3cccnc3)cc2)co1 10.1016/j.bmcl.2007.06.072
127901 108911 12 None - 1 Rat 5.4 pKi = 5.4 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
ChEMBL 185 3 3 3 0.8 CNCC(O)c1cccc(O)c1F 10.1021/jm00076a024
CHEMBL302451 108911 12 None - 1 Rat 5.4 pKi = 5.4 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
ChEMBL 185 3 3 3 0.8 CNCC(O)c1cccc(O)c1F 10.1021/jm00076a024
13864381 215123 3 None -39 4 Rat 4.4 pKi = 4.4 Binding
Tested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligandTested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligand
ChEMBL 195 1 3 4 0.7 NCC1OCCc2c1ccc(O)c2O 10.1021/jm00073a006
CHEMBL542683 215123 3 None -39 4 Rat 4.4 pKi = 4.4 Binding
Tested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligandTested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligand
ChEMBL 195 1 3 4 0.7 NCC1OCCc2c1ccc(O)c2O 10.1021/jm00073a006
CHEMBL99361 215123 3 None -39 4 Rat 4.4 pKi = 4.4 Binding
Tested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligandTested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligand
ChEMBL 195 1 3 4 0.7 NCC1OCCc2c1ccc(O)c2O 10.1021/jm00073a006
122237 169969 16 None - 1 Rat 4.4 pKi = 4.4 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 171 2 3 3 0.7 NCCc1cc(O)c(O)cc1F 10.1021/jm990599h
CHEMBL41818 169969 16 None - 1 Rat 4.4 pKi = 4.4 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 171 2 3 3 0.7 NCCc1cc(O)c(O)cc1F 10.1021/jm990599h
44444193 160594 0 None -15 3 Human 6.4 pKi = 6.4 Binding
Displacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 548 13 4 7 4.3 COc1ccc([C@H](CCc2cccc(Cl)c2)NC[C@H](O)Cc2ccc(O)c(NS(C)(=O)=O)c2)cc1OC 10.1016/j.bmcl.2007.05.030
CHEMBL398241 160594 0 None -15 3 Human 6.4 pKi = 6.4 Binding
Displacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 548 13 4 7 4.3 COc1ccc([C@H](CCc2cccc(Cl)c2)NC[C@H](O)Cc2ccc(O)c(NS(C)(=O)=O)c2)cc1OC 10.1016/j.bmcl.2007.05.030
11625333 84393 0 None -2 2 Human 6.4 pKi = 6.4 Binding
Binding affinity to human beta1-adrenoceptor by radioligand binding assayBinding affinity to human beta1-adrenoceptor by radioligand binding assay
ChEMBL 392 4 4 4 3.3 Cc1c(C)c(C)c2c(c1C)CC(NC[C@H](O)c1ccc(O)c3[nH]c(=O)ccc13)C2 10.1016/j.bmcl.2012.07.096
CHEMBL2088200 84393 0 None -2 2 Human 6.4 pKi = 6.4 Binding
Binding affinity to human beta1-adrenoceptor by radioligand binding assayBinding affinity to human beta1-adrenoceptor by radioligand binding assay
ChEMBL 392 4 4 4 3.3 Cc1c(C)c(C)c2c(c1C)CC(NC[C@H](O)c1ccc(O)c3[nH]c(=O)ccc13)C2 10.1016/j.bmcl.2012.07.096
1978 7038 60 None -15 6 Human 6.4 pKi = 6.4 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 336 10 3 5 3.0 CCCC(=Nc1ccc(c(c1)C(=O)C)OCC(CNC(C)C)O)O nan
40 7038 60 None -15 6 Human 6.4 pKi = 6.4 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 336 10 3 5 3.0 CCCC(=Nc1ccc(c(c1)C(=O)C)OCC(CNC(C)C)O)O nan
7107 7038 60 None -15 6 Human 6.4 pKi = 6.4 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 336 10 3 5 3.0 CCCC(=Nc1ccc(c(c1)C(=O)C)OCC(CNC(C)C)O)O nan
CHEMBL642 7038 60 None -15 6 Human 6.4 pKi = 6.4 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 336 10 3 5 3.0 CCCC(=Nc1ccc(c(c1)C(=O)C)OCC(CNC(C)C)O)O nan
DB01193 7038 60 None -15 6 Human 6.4 pKi = 6.4 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 336 10 3 5 3.0 CCCC(=Nc1ccc(c(c1)C(=O)C)OCC(CNC(C)C)O)O nan
16737588 92591 0 None -4 2 Rat 4.4 pKi = 4.4 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 273 6 4 4 2.0 Oc1cc(O)cc([C@@H](O)CNCCc2ccccc2)c1 nan
CHEMBL229620 92591 0 None -4 2 Rat 4.4 pKi = 4.4 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 273 6 4 4 2.0 Oc1cc(O)cc([C@@H](O)CNCCc2ccccc2)c1 nan
16737588 92591 0 None -4 2 Rat 4.4 pKi = 4.4 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 273 6 4 4 2.0 Oc1cc(O)cc([C@@H](O)CNCCc2ccccc2)c1 10.1021/jm070030d
CHEMBL229620 92591 0 None -4 2 Rat 4.4 pKi = 4.4 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 273 6 4 4 2.0 Oc1cc(O)cc([C@@H](O)CNCCc2ccccc2)c1 10.1021/jm070030d
44396596 130078 0 None -3 3 Human 7.4 pKi = 7.4 Binding
Binding inhibition constant was determined by inhibition of [125I]iodocyanopindolol binding to Beta-1 adrenergic receptorBinding inhibition constant was determined by inhibition of [125I]iodocyanopindolol binding to Beta-1 adrenergic receptor
ChEMBL 485 10 4 6 4.3 COc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)c[nH]c12 10.1016/j.bmcl.2004.10.035
CHEMBL361505 130078 0 None -3 3 Human 7.4 pKi = 7.4 Binding
Binding inhibition constant was determined by inhibition of [125I]iodocyanopindolol binding to Beta-1 adrenergic receptorBinding inhibition constant was determined by inhibition of [125I]iodocyanopindolol binding to Beta-1 adrenergic receptor
ChEMBL 485 10 4 6 4.3 COc1cccc2c(C[C@@H](C)NC[C@H](O)c3cccc(NS(=O)(=O)c4cccs4)c3)c[nH]c12 10.1016/j.bmcl.2004.10.035
2249 7300 111 None -5 12 Human 6.4 pKi = 6.4 Binding
Displacement of radiolabeled atenolol from human adrenergic beta-1 receptorDisplacement of radiolabeled atenolol from human adrenergic beta-1 receptor
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm8007618
255 7300 111 None -5 12 Human 6.4 pKi = 6.4 Binding
Displacement of radiolabeled atenolol from human adrenergic beta-1 receptorDisplacement of radiolabeled atenolol from human adrenergic beta-1 receptor
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm8007618
548 7300 111 None -5 12 Human 6.4 pKi = 6.4 Binding
Displacement of radiolabeled atenolol from human adrenergic beta-1 receptorDisplacement of radiolabeled atenolol from human adrenergic beta-1 receptor
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm8007618
CHEMBL24 7300 111 None -5 12 Human 6.4 pKi = 6.4 Binding
Displacement of radiolabeled atenolol from human adrenergic beta-1 receptorDisplacement of radiolabeled atenolol from human adrenergic beta-1 receptor
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm8007618
DB00335 7300 111 None -5 12 Human 6.4 pKi = 6.4 Binding
Displacement of radiolabeled atenolol from human adrenergic beta-1 receptorDisplacement of radiolabeled atenolol from human adrenergic beta-1 receptor
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10.1021/jm8007618
52944986 24385 0 None -30 3 Human 6.4 pKi = 6.4 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 478 8 2 7 4.5 OC(CNC1CCN(c2ncnc3scc(-c4ccccc4)c23)CC1)COc1ccccc1F 10.1016/j.bmcl.2010.08.039
CHEMBL1258257 24385 0 None -30 3 Human 6.4 pKi = 6.4 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 478 8 2 7 4.5 OC(CNC1CCN(c2ncnc3scc(-c4ccccc4)c23)CC1)COc1ccccc1F 10.1016/j.bmcl.2010.08.039
118710946 120533 0 None -1 2 Human 6.4 pKi = 6.4 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 414 7 4 6 3.7 CCOc1cccc([C@H]2CCC[C@H]2NC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1 10.1016/j.bmcl.2014.06.014
CHEMBL3323664 120533 0 None -1 2 Human 6.4 pKi = 6.4 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 414 7 4 6 3.7 CCOc1cccc([C@H]2CCC[C@H]2NC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1 10.1016/j.bmcl.2014.06.014
44312421 170117 0 None -2 3 Human 6.4 pKi = 6.4 Binding
Compound was tested for its binding affinity against Beta-1 adrenergic receptor in CHO cell membrane using [125I]iodocyanopindolol as the radioligand.Compound was tested for its binding affinity against Beta-1 adrenergic receptor in CHO cell membrane using [125I]iodocyanopindolol as the radioligand.
ChEMBL 392 13 3 6 2.9 C[C@H](Cc1ncc(CCCCC(=O)O)s1)NC[C@H](O)COc1ccccc1 10.1016/0960-894X(96)00417-9
CHEMBL419085 170117 0 None -2 3 Human 6.4 pKi = 6.4 Binding
Compound was tested for its binding affinity against Beta-1 adrenergic receptor in CHO cell membrane using [125I]iodocyanopindolol as the radioligand.Compound was tested for its binding affinity against Beta-1 adrenergic receptor in CHO cell membrane using [125I]iodocyanopindolol as the radioligand.
ChEMBL 392 13 3 6 2.9 C[C@H](Cc1ncc(CCCCC(=O)O)s1)NC[C@H](O)COc1ccccc1 10.1016/0960-894X(96)00417-9
46889767 13845 0 None -5 3 Human 6.4 pKi = 6.4 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 400 9 1 5 2.4 C=CCc1ccccc1OCC(O)CN1CCC(CN2C(=O)CCCC2=O)CC1 10.1016/j.bmcl.2010.04.009
CHEMBL1085009 13845 0 None -5 3 Human 6.4 pKi = 6.4 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 400 9 1 5 2.4 C=CCc1ccccc1OCC(O)CN1CCC(CN2C(=O)CCCC2=O)CC1 10.1016/j.bmcl.2010.04.009
49783415 24450 0 None -5888 12 Rat 5.4 pKi = 5.4 Binding
Binding affinity to rat adrenergic beta-1 receptorBinding affinity to rat adrenergic beta-1 receptor
ChEMBL 320 7 1 5 2.9 CCCCN1CCC(COC(=O)c2ccc(N)c(OC)c2)CC1 10.1021/jm100668r
CHEMBL1258452 24450 0 None -5888 12 Rat 5.4 pKi = 5.4 Binding
Binding affinity to rat adrenergic beta-1 receptorBinding affinity to rat adrenergic beta-1 receptor
ChEMBL 320 7 1 5 2.9 CCCCN1CCC(COC(=O)c2ccc(N)c(OC)c2)CC1 10.1021/jm100668r
10381669 19360 0 None - 1 Rat 4.4 pKi = 4.4 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation counting
ChEMBL 325 7 2 5 2.5 C=CCNCC(O)COc1ccc2c(=O)c3ccccc3oc2c1 10.1016/j.bmc.2008.12.031
CHEMBL1186871 19360 0 None - 1 Rat 4.4 pKi = 4.4 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation counting
ChEMBL 325 7 2 5 2.5 C=CCNCC(O)COc1ccc2c(=O)c3ccccc3oc2c1 10.1016/j.bmc.2008.12.031
CHEMBL481414 19360 0 None - 1 Rat 4.4 pKi = 4.4 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation counting
ChEMBL 325 7 2 5 2.5 C=CCNCC(O)COc1ccc2c(=O)c3ccccc3oc2c1 10.1016/j.bmc.2008.12.031
52949934 24420 0 None -5 3 Human 6.4 pKi = 6.4 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 398 7 2 7 3.0 Cc1csc2ncnc(N3CCC(NCC(O)COc4ccccc4)CC3)c12 10.1016/j.bmcl.2010.08.039
CHEMBL1258372 24420 0 None -5 3 Human 6.4 pKi = 6.4 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 398 7 2 7 3.0 Cc1csc2ncnc(N3CCC(NCC(O)COc4ccccc4)CC3)c12 10.1016/j.bmcl.2010.08.039
49864415 22417 0 None -117 2 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 362 4 4 5 3.1 CC1(C)[C@@H]2CC[C@@]1(C)[C@@H](NC[C@H](O)c1ccc(O)c3[nH]c(=O)sc13)C2 10.1016/j.bmcl.2010.06.136
CHEMBL1221735 22417 0 None -117 2 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 362 4 4 5 3.1 CC1(C)[C@@H]2CC[C@@]1(C)[C@@H](NC[C@H](O)c1ccc(O)c3[nH]c(=O)sc13)C2 10.1016/j.bmcl.2010.06.136
1862 6949 18 None -52 7 Rat 4.4 pKi = 4.4 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
ChEMBL 187 2 4 4 0.2 NCC(c1cc(O)c(cc1F)O)O 10.1021/jm00076a024
510 6949 18 None -52 7 Rat 4.4 pKi = 4.4 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
ChEMBL 187 2 4 4 0.2 NCC(c1cc(O)c(cc1F)O)O 10.1021/jm00076a024
CHEMBL281232 6949 18 None -52 7 Rat 4.4 pKi = 4.4 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
ChEMBL 187 2 4 4 0.2 NCC(c1cc(O)c(cc1F)O)O 10.1021/jm00076a024
46889642 13727 0 None -3 3 Human 5.3 pKi = 5.3 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 483 7 2 5 4.1 O=C1c2cccc3cccc(c23)C(=O)N1CC1CCN(CC(O)COc2ccc3[nH]ccc3c2)CC1 10.1016/j.bmcl.2010.04.009
CHEMBL1084527 13727 0 None -3 3 Human 5.3 pKi = 5.3 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 483 7 2 5 4.1 O=C1c2cccc3cccc(c23)C(=O)N1CC1CCN(CC(O)COc2ccc3[nH]ccc3c2)CC1 10.1016/j.bmcl.2010.04.009
4806 10780 88 None -2 13 Human 7.3 pKi = 7.3 Binding
Binding affinity to human beta 1 adrenergic receptorBinding affinity to human beta 1 adrenergic receptor
ChEMBL 298 3 1 3 3.9 Cc1ccc(c(c1)C)Sc1ccccc1N1CCNCC1 10.1021/jm101459g
7351 10780 88 None -2 13 Human 7.3 pKi = 7.3 Binding
Binding affinity to human beta 1 adrenergic receptorBinding affinity to human beta 1 adrenergic receptor
ChEMBL 298 3 1 3 3.9 Cc1ccc(c(c1)C)Sc1ccccc1N1CCNCC1 10.1021/jm101459g
9966051 10780 88 None -2 13 Human 7.3 pKi = 7.3 Binding
Binding affinity to human beta 1 adrenergic receptorBinding affinity to human beta 1 adrenergic receptor
ChEMBL 298 3 1 3 3.9 Cc1ccc(c(c1)C)Sc1ccccc1N1CCNCC1 10.1021/jm101459g
CHEMBL2104993 10780 88 None -2 13 Human 7.3 pKi = 7.3 Binding
Binding affinity to human beta 1 adrenergic receptorBinding affinity to human beta 1 adrenergic receptor
ChEMBL 298 3 1 3 3.9 Cc1ccc(c(c1)C)Sc1ccccc1N1CCNCC1 10.1021/jm101459g
DB09068 10780 88 None -2 13 Human 7.3 pKi = 7.3 Binding
Binding affinity to human beta 1 adrenergic receptorBinding affinity to human beta 1 adrenergic receptor
ChEMBL 298 3 1 3 3.9 Cc1ccc(c(c1)C)Sc1ccccc1N1CCNCC1 10.1021/jm101459g
52948792 24492 0 None -5 3 Human 6.3 pKi = 6.3 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 488 9 2 7 4.9 CCc1ccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)cc1 10.1016/j.bmcl.2010.08.039
CHEMBL1258596 24492 0 None -5 3 Human 6.3 pKi = 6.3 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 488 9 2 7 4.9 CCc1ccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)cc1 10.1016/j.bmcl.2010.08.039
44571264 19364 0 None - 1 Rat 7.3 pKi = 7.3 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation counting
ChEMBL 407 8 4 7 1.7 CC(CO)(CO)NCC(O)COc1cccc2c(=O)c3ccc(Cl)cc3oc12 10.1016/j.bmc.2008.12.031
CHEMBL1186886 19364 0 None - 1 Rat 7.3 pKi = 7.3 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation counting
ChEMBL 407 8 4 7 1.7 CC(CO)(CO)NCC(O)COc1cccc2c(=O)c3ccc(Cl)cc3oc12 10.1016/j.bmc.2008.12.031
CHEMBL481799 19364 0 None - 1 Rat 7.3 pKi = 7.3 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation counting
ChEMBL 407 8 4 7 1.7 CC(CO)(CO)NCC(O)COc1cccc2c(=O)c3ccc(Cl)cc3oc12 10.1016/j.bmc.2008.12.031
10207209 176005 0 None -309 3 Human 4.3 pKi = 4.3 Binding
Displacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 500 12 4 7 3.3 COc1ccc([C@H](Cc2ccccc2)NC[C@H](O)Cc2ccc(O)c(NS(C)(=O)=O)c2)cc1OC 10.1016/j.bmcl.2007.05.030
CHEMBL440961 176005 0 None -309 3 Human 4.3 pKi = 4.3 Binding
Displacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 500 12 4 7 3.3 COc1ccc([C@H](Cc2ccccc2)NC[C@H](O)Cc2ccc(O)c(NS(C)(=O)=O)c2)cc1OC 10.1016/j.bmcl.2007.05.030
10324985 83556 8 None -354 17 Human 6.3 pKi = 6.3 Binding
Binding affinity to adrenergic beta-1 receptorBinding affinity to adrenergic beta-1 receptor
ChEMBL 423 7 0 8 1.7 COc1ccc2cccc(N3CCN(CCCCn4ncc(=O)n(C)c4=O)CC3)c2c1 10.1021/jm050725j
CHEMBL199824 83556 8 None -354 17 Human 6.3 pKi = 6.3 Binding
Binding affinity to adrenergic beta-1 receptorBinding affinity to adrenergic beta-1 receptor
ChEMBL 423 7 0 8 1.7 COc1ccc2cccc(N3CCN(CCCCn4ncc(=O)n(C)c4=O)CC3)c2c1 10.1021/jm050725j
CHEMBL2068762 83556 8 None -354 17 Human 6.3 pKi = 6.3 Binding
Binding affinity to adrenergic beta-1 receptorBinding affinity to adrenergic beta-1 receptor
ChEMBL 423 7 0 8 1.7 COc1ccc2cccc(N3CCN(CCCCn4ncc(=O)n(C)c4=O)CC3)c2c1 10.1021/jm050725j
16717791 84390 0 None -1 2 Human 6.3 pKi = 6.3 Binding
Binding affinity to human beta1-adrenoceptor by radioligand binding assayBinding affinity to human beta1-adrenoceptor by radioligand binding assay
ChEMBL 376 6 3 3 3.7 CCc1cc2c(cc1CC)CC(NCCc1ccc(O)c3[nH]c(=O)ccc13)C2 10.1016/j.bmcl.2012.07.096
CHEMBL2088198 84390 0 None -1 2 Human 6.3 pKi = 6.3 Binding
Binding affinity to human beta1-adrenoceptor by radioligand binding assayBinding affinity to human beta1-adrenoceptor by radioligand binding assay
ChEMBL 376 6 3 3 3.7 CCc1cc2c(cc1CC)CC(NCCc1ccc(O)c3[nH]c(=O)ccc13)C2 10.1016/j.bmcl.2012.07.096
10236758 122550 5 None -48977 13 Human 4.3 pKi = 4.3 Binding
Displacement of [3H]CGP12177 from human recombinant beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by beta counting methodDisplacement of [3H]CGP12177 from human recombinant beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by beta counting method
ChEMBL 328 7 0 2 4.3 CCCCC1CCN(CCCN2C(=O)CCc3ccccc32)CC1 10.1021/acs.jmedchem.8b00265
CHEMBL3354065 122550 5 None -48977 13 Human 4.3 pKi = 4.3 Binding
Displacement of [3H]CGP12177 from human recombinant beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by beta counting methodDisplacement of [3H]CGP12177 from human recombinant beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by beta counting method
ChEMBL 328 7 0 2 4.3 CCCCC1CCN(CCCN2C(=O)CCc3ccccc32)CC1 10.1021/acs.jmedchem.8b00265
44396568 74060 0 None -28 3 Human 6.3 pKi = 6.3 Binding
Binding inhibition constant was determined by inhibition of [125I]iodocyanopindolol binding to Beta-1 adrenergic receptorBinding inhibition constant was determined by inhibition of [125I]iodocyanopindolol binding to Beta-1 adrenergic receptor
ChEMBL 529 12 5 7 3.7 C[C@H](Cc1c[nH]c2c(OCC(=O)O)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1016/j.bmcl.2004.10.035
CHEMBL188196 74060 0 None -28 3 Human 6.3 pKi = 6.3 Binding
Binding inhibition constant was determined by inhibition of [125I]iodocyanopindolol binding to Beta-1 adrenergic receptorBinding inhibition constant was determined by inhibition of [125I]iodocyanopindolol binding to Beta-1 adrenergic receptor
ChEMBL 529 12 5 7 3.7 C[C@H](Cc1c[nH]c2c(OCC(=O)O)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1016/j.bmcl.2004.10.035
360400 104041 2 None -1 2 Rat 4.3 pKi = 4.3 Binding
Compound was evaluated for beta adrenergic binding affinity towards beta-1 receptor of rat brainCompound was evaluated for beta adrenergic binding affinity towards beta-1 receptor of rat brain
ChEMBL 237 2 2 4 1.9 CC(C)N1CCOC(c2ccc(O)c(O)c2)C1 10.1021/jm00084a006
CHEMBL268881 104041 2 None -1 2 Rat 4.3 pKi = 4.3 Binding
Compound was evaluated for beta adrenergic binding affinity towards beta-1 receptor of rat brainCompound was evaluated for beta adrenergic binding affinity towards beta-1 receptor of rat brain
ChEMBL 237 2 2 4 1.9 CC(C)N1CCOC(c2ccc(O)c(O)c2)C1 10.1021/jm00084a006
24937389 24220 0 None -478 3 Human 6.3 pKi = 6.3 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 520 10 3 9 4.2 COCc1cc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)ccc1O 10.1016/j.bmcl.2010.08.039
CHEMBL1257675 24220 0 None -478 3 Human 6.3 pKi = 6.3 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 520 10 3 9 4.2 COCc1cc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)ccc1O 10.1016/j.bmcl.2010.08.039
52948728 24219 0 None -8 3 Human 5.3 pKi = 5.3 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 400 7 3 8 2.4 Oc1ccc(OCC(O)CNC2CCN(c3ncnc4sccc34)CC2)cc1 10.1016/j.bmcl.2010.08.039
CHEMBL1257674 24219 0 None -8 3 Human 5.3 pKi = 5.3 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 400 7 3 8 2.4 Oc1ccc(OCC(O)CNC2CCN(c3ncnc4sccc34)CC2)cc1 10.1016/j.bmcl.2010.08.039
1786 9298 85 None 1 11 Mouse 7.3 pKi = 7.3 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1016/j.bmc.2019.05.034
4171 9298 85 None 1 11 Mouse 7.3 pKi = 7.3 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1016/j.bmc.2019.05.034
553 9298 85 None 1 11 Mouse 7.3 pKi = 7.3 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1016/j.bmc.2019.05.034
CHEMBL13 9298 85 None 1 11 Mouse 7.3 pKi = 7.3 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1016/j.bmc.2019.05.034
DB00264 9298 85 None 1 11 Mouse 7.3 pKi = 7.3 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1016/j.bmc.2019.05.034
155516656 176906 0 None 40 2 Mouse 7.3 pKi = 7.3 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 629 18 4 11 3.3 Cn1cc(C(F)(F)F)nc1-c1ccc(OC[C@@H](O)CNCCOc2ccc(OCCSSCCN)c(C(N)=O)c2)cc1 10.1016/j.bmc.2019.05.034
CHEMBL4443911 176906 0 None 40 2 Mouse 7.3 pKi = 7.3 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 629 18 4 11 3.3 Cn1cc(C(F)(F)F)nc1-c1ccc(OC[C@@H](O)CNCCOc2ccc(OCCSSCCN)c(C(N)=O)c2)cc1 10.1016/j.bmc.2019.05.034
44444189 101271 0 None -8 3 Human 6.3 pKi = 6.3 Binding
Displacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 586 15 4 7 4.8 CS(=O)(=O)Nc1cc(C[C@@H](O)CN[C@@H](CCc2ccccc2)c2ccc(OC(F)F)c(OC(F)F)c2)ccc1O 10.1016/j.bmcl.2007.05.030
CHEMBL251555 101271 0 None -8 3 Human 6.3 pKi = 6.3 Binding
Displacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 586 15 4 7 4.8 CS(=O)(=O)Nc1cc(C[C@@H](O)CN[C@@H](CCc2ccccc2)c2ccc(OC(F)F)c(OC(F)F)c2)ccc1O 10.1016/j.bmcl.2007.05.030
72545007 99897 0 None -3 5 Pig 6.3 pKi = 6.3 Binding
Displacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortexDisplacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortex
ChEMBL 407 12 0 8 1.6 COc1ccccc1N1CCN(Cc2cn(CCOCCOCCF)nn2)CC1 10.1016/j.bmcl.2013.09.026
CHEMBL2443000 99897 0 None -3 5 Pig 6.3 pKi = 6.3 Binding
Displacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortexDisplacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortex
ChEMBL 407 12 0 8 1.6 COc1ccccc1N1CCN(Cc2cn(CCOCCOCCF)nn2)CC1 10.1016/j.bmcl.2013.09.026
72545009 99899 0 None 1 5 Pig 6.3 pKi = 6.3 Binding
Displacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortexDisplacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortex
ChEMBL 437 6 3 10 -0.4 COc1ccccc1N1CCN(Cc2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3F)nn2)CC1 10.1016/j.bmcl.2013.09.026
CHEMBL2443002 99899 0 None 1 5 Pig 6.3 pKi = 6.3 Binding
Displacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortexDisplacement of [3H]-prazosin from alpha1-adrenergic receptor in pig cerebral cortex
ChEMBL 437 6 3 10 -0.4 COc1ccccc1N1CCN(Cc2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3F)nn2)CC1 10.1016/j.bmcl.2013.09.026
52946357 24494 0 None -11 3 Human 5.3 pKi = 5.3 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 430 8 4 9 1.9 OCc1cc(OCC(O)CNC2CCN(c3ncnc4sccc34)CC2)ccc1O 10.1016/j.bmcl.2010.08.039
CHEMBL1258598 24494 0 None -11 3 Human 5.3 pKi = 5.3 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 430 8 4 9 1.9 OCc1cc(OCC(O)CNC2CCN(c3ncnc4sccc34)CC2)ccc1O 10.1016/j.bmcl.2010.08.039
127045853 146571 0 None -20 6 Mouse 8.3 pKi = 8.3 Binding
Displacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cellsDisplacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cells
ChEMBL 492 12 4 7 3.6 COc1cc(CCNC[C@H](O)c2ccc(O)c3c2OCC(=O)N3)ccc1OCCCc1ccccc1 10.1016/j.bmc.2016.04.028
CHEMBL3798748 146571 0 None -20 6 Mouse 8.3 pKi = 8.3 Binding
Displacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cellsDisplacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cells
ChEMBL 492 12 4 7 3.6 COc1cc(CCNC[C@H](O)c2ccc(O)c3c2OCC(=O)N3)ccc1OCCCc1ccccc1 10.1016/j.bmc.2016.04.028
11757304 107099 0 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.
ChEMBL 550 11 5 9 0.3 NS(=O)(=O)c1cc(S(=O)(=O)NCCNCC(O)COc2cccc3c2SCC(=O)N3)ccc1Cl 10.1021/jm00053a020
CHEMBL289390 107099 0 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.
ChEMBL 550 11 5 9 0.3 NS(=O)(=O)c1cc(S(=O)(=O)NCCNCC(O)COc2cccc3c2SCC(=O)N3)ccc1Cl 10.1021/jm00053a020
9984829 41918 0 None -1 2 Rat 8.3 pKi = 8.3 Binding
Compound was evaluated for its Beta-1 adrenergic receptor binding affinity by measuring the displacement of [3H]dihydroalprenolol binding in rat heartCompound was evaluated for its Beta-1 adrenergic receptor binding affinity by measuring the displacement of [3H]dihydroalprenolol binding in rat heart
ChEMBL 542 11 2 8 3.5 COc1ccccc1N1CCN(CCCN2C(=O)CSc3c(OCC(O)CNC(C)(C)C)cccc32)CC1 10.1016/s0960-894x(00)00016-0
CHEMBL143463 41918 0 None -1 2 Rat 8.3 pKi = 8.3 Binding
Compound was evaluated for its Beta-1 adrenergic receptor binding affinity by measuring the displacement of [3H]dihydroalprenolol binding in rat heartCompound was evaluated for its Beta-1 adrenergic receptor binding affinity by measuring the displacement of [3H]dihydroalprenolol binding in rat heart
ChEMBL 542 11 2 8 3.5 COc1ccccc1N1CCN(CCCN2C(=O)CSc3c(OCC(O)CNC(C)(C)C)cccc32)CC1 10.1016/s0960-894x(00)00016-0
2405 7452 76 None 2 4 Mouse 8.3 pKi = 8.3 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 325 12 2 5 2.4 OC(COc1ccc(cc1)COCCOC(C)C)CNC(C)C 10.1016/j.bmc.2019.05.034
380 7452 76 None 2 4 Mouse 8.3 pKi = 8.3 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 325 12 2 5 2.4 OC(COc1ccc(cc1)COCCOC(C)C)CNC(C)C 10.1016/j.bmc.2019.05.034
7129 7452 76 None 2 4 Mouse 8.3 pKi = 8.3 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 325 12 2 5 2.4 OC(COc1ccc(cc1)COCCOC(C)C)CNC(C)C 10.1016/j.bmc.2019.05.034
CHEMBL645 7452 76 None 2 4 Mouse 8.3 pKi = 8.3 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 325 12 2 5 2.4 OC(COc1ccc(cc1)COCCOC(C)C)CNC(C)C 10.1016/j.bmc.2019.05.034
DB00612 7452 76 None 2 4 Mouse 8.3 pKi = 8.3 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 325 12 2 5 2.4 OC(COc1ccc(cc1)COCCOC(C)C)CNC(C)C 10.1016/j.bmc.2019.05.034
33624 10593 34 None -6 9 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation countingDisplacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation counting
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/acs.jmedchem.8b00625
4061 10593 34 None -6 9 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation countingDisplacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation counting
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/acs.jmedchem.8b00625
565 10593 34 None -6 9 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation countingDisplacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation counting
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/acs.jmedchem.8b00625
CHEMBL499 10593 34 None -6 9 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation countingDisplacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation counting
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/acs.jmedchem.8b00625
DB00373 10593 34 None -6 9 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation countingDisplacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation counting
ChEMBL 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 10.1021/acs.jmedchem.8b00625
145948125 174518 0 None -17 2 Rat 8.3 pKi = 8.3 Binding
Displacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysisDisplacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysis
ChEMBL 341 5 2 5 3.1 CC(C)(C)NCC(O)COc1cccc2c(=O)c3ccccc3oc12 10.1016/j.bmc.2018.04.038
CHEMBL4129458 174518 0 None -17 2 Rat 8.3 pKi = 8.3 Binding
Displacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysisDisplacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysis
ChEMBL 341 5 2 5 3.1 CC(C)(C)NCC(O)COc1cccc2c(=O)c3ccccc3oc12 10.1016/j.bmc.2018.04.038
CHEMBL4302853 174518 0 None -17 2 Rat 8.3 pKi = 8.3 Binding
Displacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysisDisplacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysis
ChEMBL 341 5 2 5 3.1 CC(C)(C)NCC(O)COc1cccc2c(=O)c3ccccc3oc12 10.1016/j.bmc.2018.04.038
68807656 120535 0 None -1 3 Human 8.3 pKi = 8.3 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 372 8 4 5 3.1 CCCc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1 10.1016/j.bmcl.2014.06.014
CHEMBL3323666 120535 0 None -1 3 Human 8.3 pKi = 8.3 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 372 8 4 5 3.1 CCCc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1 10.1016/j.bmcl.2014.06.014
102262219 146837 0 None -12 6 Mouse 8.2 pKi = 8.2 Binding
Displacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cellsDisplacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cells
ChEMBL 488 12 4 6 4.1 COc1cc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc1OCCCc1ccccc1 10.1016/j.bmc.2016.04.028
CHEMBL3800400 146837 0 None -12 6 Mouse 8.2 pKi = 8.2 Binding
Displacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cellsDisplacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cells
ChEMBL 488 12 4 6 4.1 COc1cc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc1OCCCc1ccccc1 10.1016/j.bmc.2016.04.028
1531 9046 69 None -1 16 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O nan
3869 9046 69 None -1 16 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O nan
7207 9046 69 None -1 16 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O nan
CHEMBL429 9046 69 None -1 16 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O nan
DB00598 9046 69 None -1 16 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O nan
10297331 101141 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 445 12 2 7 4.2 O[C@@H](CNCCOc1ccc(-c2coc(COCc3ccccc3)n2)cc1)c1cccnc1 10.1016/j.bmcl.2007.06.072
CHEMBL250760 101141 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 445 12 2 7 4.2 O[C@@H](CNCCOc1ccc(-c2coc(COCc3ccccc3)n2)cc1)c1cccnc1 10.1016/j.bmcl.2007.06.072
10081581 17971 0 None 2 2 Rat 6.3 pKi = 6.3 Binding
Binding affinity against beta-1-adrenergic receptor in rat brainBinding affinity against beta-1-adrenergic receptor in rat brain
ChEMBL 202 6 2 4 1.1 CC/C=N/OCC(O)CNC(C)(C)C 10.1021/jm00036a018
CHEMBL1178704 17971 0 None 2 2 Rat 6.3 pKi = 6.3 Binding
Binding affinity against beta-1-adrenergic receptor in rat brainBinding affinity against beta-1-adrenergic receptor in rat brain
ChEMBL 202 6 2 4 1.1 CC/C=N/OCC(O)CNC(C)(C)C 10.1021/jm00036a018
CHEMBL38033 17971 0 None 2 2 Rat 6.3 pKi = 6.3 Binding
Binding affinity against beta-1-adrenergic receptor in rat brainBinding affinity against beta-1-adrenergic receptor in rat brain
ChEMBL 202 6 2 4 1.1 CC/C=N/OCC(O)CNC(C)(C)C 10.1021/jm00036a018
10266538 123749 2 None -1 2 Guinea pig 6.3 pKi = 6.3 Binding
Binding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacementBinding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacement
ChEMBL 295 1 0 5 1.2 CN1CCN(c2ncc(Br)n3ccnc23)CC1 10.1021/jm00099a012
CHEMBL338704 123749 2 None -1 2 Guinea pig 6.3 pKi = 6.3 Binding
Binding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacementBinding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacement
ChEMBL 295 1 0 5 1.2 CN1CCN(c2ncc(Br)n3ccnc23)CC1 10.1021/jm00099a012
10081581 17971 0 None 2 2 Rat 6.3 pKi = 6.3 Binding
Binding affinity to rat brain membrane adrenergic beta-1 receptorBinding affinity to rat brain membrane adrenergic beta-1 receptor
ChEMBL 202 6 2 4 1.1 CC/C=N/OCC(O)CNC(C)(C)C 10.1021/acs.jmedchem.1c01215
CHEMBL1178704 17971 0 None 2 2 Rat 6.3 pKi = 6.3 Binding
Binding affinity to rat brain membrane adrenergic beta-1 receptorBinding affinity to rat brain membrane adrenergic beta-1 receptor
ChEMBL 202 6 2 4 1.1 CC/C=N/OCC(O)CNC(C)(C)C 10.1021/acs.jmedchem.1c01215
CHEMBL38033 17971 0 None 2 2 Rat 6.3 pKi = 6.3 Binding
Binding affinity to rat brain membrane adrenergic beta-1 receptorBinding affinity to rat brain membrane adrenergic beta-1 receptor
ChEMBL 202 6 2 4 1.1 CC/C=N/OCC(O)CNC(C)(C)C 10.1021/acs.jmedchem.1c01215
10059780 19731 0 None -9 3 Guinea pig 5.3 pKi = 5.3 Binding
Binding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacementBinding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacement
ChEMBL 231 2 1 5 0.7 CCc1cnc2c(N3CCNCC3)nccn12 10.1021/jm00099a012
CHEMBL1189347 19731 0 None -9 3 Guinea pig 5.3 pKi = 5.3 Binding
Binding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacementBinding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacement
ChEMBL 231 2 1 5 0.7 CCc1cnc2c(N3CCNCC3)nccn12 10.1021/jm00099a012
CHEMBL538537 19731 0 None -9 3 Guinea pig 5.3 pKi = 5.3 Binding
Binding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacementBinding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacement
ChEMBL 231 2 1 5 0.7 CCc1cnc2c(N3CCNCC3)nccn12 10.1021/jm00099a012
127047996 146424 0 None -1122 6 Mouse 5.3 pKi = 5.3 Binding
Displacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cellsDisplacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cells
ChEMBL 303 8 3 5 2.3 COc1ccccc1OCCNCCc1ccc(O)c(O)c1 10.1016/j.bmc.2016.04.028
CHEMBL3797758 146424 0 None -1122 6 Mouse 5.3 pKi = 5.3 Binding
Displacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cellsDisplacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cells
ChEMBL 303 8 3 5 2.3 COc1ccccc1OCCNCCc1ccc(O)c(O)c1 10.1016/j.bmc.2016.04.028
5806 109955 20 None 1 3 Rat 7.3 pKi = 7.3 Binding
Binding affinity against beta-1-adrenergic receptor in rat brainBinding affinity against beta-1-adrenergic receptor in rat brain
ChEMBL 247 4 2 2 3.0 CC(C)NCC(O)c1ccc(Cl)c(Cl)c1 10.1021/jm00036a018
CHEMBL30816 109955 20 None 1 3 Rat 7.3 pKi = 7.3 Binding
Binding affinity against beta-1-adrenergic receptor in rat brainBinding affinity against beta-1-adrenergic receptor in rat brain
ChEMBL 247 4 2 2 3.0 CC(C)NCC(O)c1ccc(Cl)c(Cl)c1 10.1021/jm00036a018
5806 109955 20 None 1 3 Rat 7.3 pKi = 7.3 Binding
Binding affinity to rat brain membrane adrenergic beta-1 receptorBinding affinity to rat brain membrane adrenergic beta-1 receptor
ChEMBL 247 4 2 2 3.0 CC(C)NCC(O)c1ccc(Cl)c(Cl)c1 10.1021/acs.jmedchem.1c01215
CHEMBL30816 109955 20 None 1 3 Rat 7.3 pKi = 7.3 Binding
Binding affinity to rat brain membrane adrenergic beta-1 receptorBinding affinity to rat brain membrane adrenergic beta-1 receptor
ChEMBL 247 4 2 2 3.0 CC(C)NCC(O)c1ccc(Cl)c(Cl)c1 10.1021/acs.jmedchem.1c01215
10773922 164273 0 None -1 2 Rat 4.3 pKi = 4.3 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 187 2 4 4 0.2 NC[C@@H](O)c1ccc(O)c(O)c1F 10.1021/jm990599h
CHEMBL40796 164273 0 None -1 2 Rat 4.3 pKi = 4.3 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 187 2 4 4 0.2 NC[C@@H](O)c1ccc(O)c(O)c1F 10.1021/jm990599h
16736514 150320 0 None -2 2 Rat 4.3 pKi = 4.3 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 273 6 4 4 2.0 Oc1cc(O)cc([C@H](O)CNCCc2ccccc2)c1 nan
CHEMBL389902 150320 0 None -2 2 Rat 4.3 pKi = 4.3 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 273 6 4 4 2.0 Oc1cc(O)cc([C@H](O)CNCCc2ccccc2)c1 nan
16736514 150320 0 None -2 2 Rat 4.3 pKi = 4.3 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 273 6 4 4 2.0 Oc1cc(O)cc([C@H](O)CNCCc2ccccc2)c1 10.1021/jm070030d
CHEMBL389902 150320 0 None -2 2 Rat 4.3 pKi = 4.3 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 273 6 4 4 2.0 Oc1cc(O)cc([C@H](O)CNCCc2ccccc2)c1 10.1021/jm070030d
44424581 150113 0 None 1 2 Rat 4.3 pKi = 4.3 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 253 7 4 4 2.3 CCCC[C@H](C)NC[C@@H](O)c1cc(O)cc(O)c1 10.1021/jm070030d
CHEMBL389734 150113 0 None 1 2 Rat 4.3 pKi = 4.3 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 253 7 4 4 2.3 CCCC[C@H](C)NC[C@@H](O)c1cc(O)cc(O)c1 10.1021/jm070030d
16735276 152760 0 None 1 2 Rat 4.3 pKi = 4.3 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 267 8 4 4 2.7 CCCCC[C@H](C)NC[C@@H](O)c1cc(O)cc(O)c1 nan
CHEMBL3918348 152760 0 None 1 2 Rat 4.3 pKi = 4.3 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 267 8 4 4 2.7 CCCCC[C@H](C)NC[C@@H](O)c1cc(O)cc(O)c1 nan
4276762 13726 10 None -1 3 Human 6.3 pKi = 6.3 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 530 8 1 6 4.9 COc1ccc(OCC(O)CN2CCC(CN3C(=O)c4cccc5cccc(c45)C3=O)CC2)c(C(C)(C)C)c1 10.1016/j.bmcl.2010.04.009
CHEMBL1084526 13726 10 None -1 3 Human 6.3 pKi = 6.3 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 530 8 1 6 4.9 COc1ccc(OCC(O)CN2CCC(CN3C(=O)c4cccc5cccc(c45)C3=O)CC2)c(C(C)(C)C)c1 10.1016/j.bmcl.2010.04.009
127046951 146680 0 None -11 6 Mouse 6.3 pKi = 6.3 Binding
Displacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cellsDisplacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cells
ChEMBL 437 12 4 6 4.0 COc1cc(CCNC[C@@H](O)c2ccc(O)c(O)c2)ccc1OCCCc1ccccc1 10.1016/j.bmc.2016.04.028
CHEMBL3799427 146680 0 None -11 6 Mouse 6.3 pKi = 6.3 Binding
Displacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cellsDisplacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cells
ChEMBL 437 12 4 6 4.0 COc1cc(CCNC[C@@H](O)c2ccc(O)c(O)c2)ccc1OCCCc1ccccc1 10.1016/j.bmc.2016.04.028
70541 94309 89 None 1 2 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysisDisplacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis
ChEMBL 190 1 1 2 1.7 Cc1cccc(N2CCNCC2)c1C 10.1021/jm400140q
CHEMBL2335161 94309 89 None 1 2 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysisDisplacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis
ChEMBL 190 1 1 2 1.7 Cc1cccc(N2CCNCC2)c1C 10.1021/jm400140q
23728722 130330 30 None -1 3 Human 5.3 pKi = 5.3 Binding
Selectivity interaction (GPCR panel (PDSP screen)) EUB0000735a ADRB1Selectivity interaction (GPCR panel (PDSP screen)) EUB0000735a ADRB1
ChEMBL 400 3 1 4 4.1 CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1 10.6019/CHEMBL5212743
CHEMBL3617968 130330 30 None -1 3 Human 5.3 pKi = 5.3 Binding
Selectivity interaction (GPCR panel (PDSP screen)) EUB0000735a ADRB1Selectivity interaction (GPCR panel (PDSP screen)) EUB0000735a ADRB1
ChEMBL 400 3 1 4 4.1 CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1 10.6019/CHEMBL5212743
1786 9298 85 None -1 11 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]CGP12177 from human beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from human beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1016/j.bmc.2019.05.034
4171 9298 85 None -1 11 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]CGP12177 from human beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from human beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1016/j.bmc.2019.05.034
553 9298 85 None -1 11 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]CGP12177 from human beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from human beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1016/j.bmc.2019.05.034
CHEMBL13 9298 85 None -1 11 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]CGP12177 from human beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from human beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1016/j.bmc.2019.05.034
DB00264 9298 85 None -1 11 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]CGP12177 from human beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from human beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1016/j.bmc.2019.05.034
2419 10236 84 None -15 6 Mouse 6.3 pKi = 6.3 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/acs.jmedchem.9b00349
5152 10236 84 None -15 6 Mouse 6.3 pKi = 6.3 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/acs.jmedchem.9b00349
559 10236 84 None -15 6 Mouse 6.3 pKi = 6.3 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/acs.jmedchem.9b00349
CHEMBL1263 10236 84 None -15 6 Mouse 6.3 pKi = 6.3 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/acs.jmedchem.9b00349
DB00938 10236 84 None -15 6 Mouse 6.3 pKi = 6.3 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1021/acs.jmedchem.9b00349
10512270 172138 9 None -5 2 Rat 6.3 pKi = 6.3 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 201 3 4 4 0.5 CNC[C@H](O)c1ccc(O)c(O)c1F 10.1021/jm990599h
CHEMBL42370 172138 9 None -5 2 Rat 6.3 pKi = 6.3 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 201 3 4 4 0.5 CNC[C@H](O)c1ccc(O)c(O)c1F 10.1021/jm990599h
24937390 24387 0 None -2 3 Human 6.3 pKi = 6.3 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 490 8 3 8 4.4 Cc1c(-c2ccccc2)sc2ncnc(N3CCC(NCC(O)COc4ccc(O)cc4)CC3)c12 10.1016/j.bmcl.2010.08.039
CHEMBL1258259 24387 0 None -2 3 Human 6.3 pKi = 6.3 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 490 8 3 8 4.4 Cc1c(-c2ccccc2)sc2ncnc(N3CCC(NCC(O)COc4ccc(O)cc4)CC3)c12 10.1016/j.bmcl.2010.08.039
10207208 160946 0 None -63 3 Human 6.3 pKi = 6.3 Binding
Displacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 500 12 4 7 3.3 COc1ccc([C@H](Cc2ccccc2)NC[C@@H](O)Cc2ccc(O)c(NS(C)(=O)=O)c2)cc1OC 10.1016/j.bmcl.2007.05.030
CHEMBL398557 160946 0 None -63 3 Human 6.3 pKi = 6.3 Binding
Displacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 500 12 4 7 3.3 COc1ccc([C@H](Cc2ccccc2)NC[C@@H](O)Cc2ccc(O)c(NS(C)(=O)=O)c2)cc1OC 10.1016/j.bmcl.2007.05.030
24937016 24529 0 None -5 3 Human 5.3 pKi = 5.3 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 400 7 3 8 2.4 Oc1ccc(OCC(O)CNC2CCN(c3ncnc4ccsc34)CC2)cc1 10.1016/j.bmcl.2010.08.039
CHEMBL1258706 24529 0 None -5 3 Human 5.3 pKi = 5.3 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 400 7 3 8 2.4 Oc1ccc(OCC(O)CNC2CCN(c3ncnc4ccsc34)CC2)cc1 10.1016/j.bmcl.2010.08.039
44351358 123719 5 None - 1 Rat 5.3 pKi = 5.3 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
ChEMBL 205 2 4 4 0.4 NCC(O)c1cc(F)c(O)c(O)c1F 10.1021/jm00076a024
CHEMBL338564 123719 5 None - 1 Rat 5.3 pKi = 5.3 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
ChEMBL 205 2 4 4 0.4 NCC(O)c1cc(F)c(O)c(O)c1F 10.1021/jm00076a024
44444188 101270 0 None -2 3 Human 6.2 pKi = 6.2 Binding
Displacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 484 12 4 6 3.6 COc1cccc([C@H](CCc2ccccc2)NC[C@H](O)Cc2ccc(O)c(NS(C)(=O)=O)c2)c1 10.1016/j.bmcl.2007.05.030
CHEMBL251554 101270 0 None -2 3 Human 6.2 pKi = 6.2 Binding
Displacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 484 12 4 6 3.6 COc1cccc([C@H](CCc2ccccc2)NC[C@H](O)Cc2ccc(O)c(NS(C)(=O)=O)c2)c1 10.1016/j.bmcl.2007.05.030
3931 9028 48 None -3 2 Human 6.2 pKi = 6.2 Binding
Inhibition of I-iodocyanopindolol binding to human beta 1 adrenergic receptorsInhibition of I-iodocyanopindolol binding to human beta 1 adrenergic receptors
ChEMBL 584 17 6 7 4.5 CCCCCCNC(=O)Nc1ccc(cc1)S(=O)(=O)Nc1ccc(cc1)CCNC[C@@H](COc1ccc(cc1)O)O 10.1021/jm000544b
9829836 9028 48 None -3 2 Human 6.2 pKi = 6.2 Binding
Inhibition of I-iodocyanopindolol binding to human beta 1 adrenergic receptorsInhibition of I-iodocyanopindolol binding to human beta 1 adrenergic receptors
ChEMBL 584 17 6 7 4.5 CCCCCCNC(=O)Nc1ccc(cc1)S(=O)(=O)Nc1ccc(cc1)CCNC[C@@H](COc1ccc(cc1)O)O 10.1021/jm000544b
CHEMBL12998 9028 48 None -3 2 Human 6.2 pKi = 6.2 Binding
Inhibition of I-iodocyanopindolol binding to human beta 1 adrenergic receptorsInhibition of I-iodocyanopindolol binding to human beta 1 adrenergic receptors
ChEMBL 584 17 6 7 4.5 CCCCCCNC(=O)Nc1ccc(cc1)S(=O)(=O)Nc1ccc(cc1)CCNC[C@@H](COc1ccc(cc1)O)O 10.1021/jm000544b
118710942 120529 0 None -8 3 Human 7.2 pKi = 7.2 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 384 5 4 5 3.6 Cc1ccccc1[C@H]1CCC[C@H]1NC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12 10.1016/j.bmcl.2014.06.014
CHEMBL3323660 120529 0 None -8 3 Human 7.2 pKi = 7.2 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 384 5 4 5 3.6 Cc1ccccc1[C@H]1CCC[C@H]1NC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12 10.1016/j.bmcl.2014.06.014
49864378 22403 0 None -1 2 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 356 4 4 5 3.0 O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@H]3CCCc4ccccc43)c2s1 10.1016/j.bmcl.2010.06.136
CHEMBL1221635 22403 0 None -1 2 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 356 4 4 5 3.0 O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@H]3CCCc4ccccc43)c2s1 10.1016/j.bmcl.2010.06.136
15221055 211194 0 None -5 2 Human 4.2 pKi = 4.2 Binding
Compound was tested for its binding affinity against Beta-1 adrenergic receptor in CHO cell membrane using [125I]iodocyanopindolol as the radioligand.Compound was tested for its binding affinity against Beta-1 adrenergic receptor in CHO cell membrane using [125I]iodocyanopindolol as the radioligand.
ChEMBL 368 9 3 5 3.1 C[C@H](Cc1ncc(CCC(=O)O)s1)NCC(O)c1cccc(Cl)c1 10.1016/0960-894X(96)00417-9
CHEMBL72060 211194 0 None -5 2 Human 4.2 pKi = 4.2 Binding
Compound was tested for its binding affinity against Beta-1 adrenergic receptor in CHO cell membrane using [125I]iodocyanopindolol as the radioligand.Compound was tested for its binding affinity against Beta-1 adrenergic receptor in CHO cell membrane using [125I]iodocyanopindolol as the radioligand.
ChEMBL 368 9 3 5 3.1 C[C@H](Cc1ncc(CCC(=O)O)s1)NCC(O)c1cccc(Cl)c1 10.1016/0960-894X(96)00417-9
44286983 148488 0 None -3 3 Human 6.2 pKi = 6.2 Binding
Ability to bind to human Beta-1 adrenergic receptor using membranes of stably transfected CHO cellsAbility to bind to human Beta-1 adrenergic receptor using membranes of stably transfected CHO cells
ChEMBL 362 9 3 4 2.5 C[C@H](Cc1ccc(OCC(N)=O)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1016/S0960-894X(97)00266-7
CHEMBL38569 148488 0 None -3 3 Human 6.2 pKi = 6.2 Binding
Ability to bind to human Beta-1 adrenergic receptor using membranes of stably transfected CHO cellsAbility to bind to human Beta-1 adrenergic receptor using membranes of stably transfected CHO cells
ChEMBL 362 9 3 4 2.5 C[C@H](Cc1ccc(OCC(N)=O)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1016/S0960-894X(97)00266-7
118710947 120536 0 None 1 3 Human 8.2 pKi = 8.2 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 386 8 4 5 3.4 CC(C)Cc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1 10.1016/j.bmcl.2014.06.014
CHEMBL3323667 120536 0 None 1 3 Human 8.2 pKi = 8.2 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 386 8 4 5 3.4 CC(C)Cc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1 10.1016/j.bmcl.2014.06.014
146025803 182956 0 None 1 2 Mouse 8.2 pKi = 8.2 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 467 14 4 7 3.7 COc1cc(CCNC[C@H](O)COc2ccc(O)c(O)c2)ccc1OCCCc1ccccc1 10.1021/acs.jmedchem.9b00349
CHEMBL4593181 182956 0 None 1 2 Mouse 8.2 pKi = 8.2 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 467 14 4 7 3.7 COc1cc(CCNC[C@H](O)COc2ccc(O)c(O)c2)ccc1OCCCc1ccccc1 10.1021/acs.jmedchem.9b00349
146025801 177410 0 None -1 2 Mouse 8.2 pKi = 8.2 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 376 8 3 4 4.0 COc1ccccc1OCCNC[C@H](O)c1cccc2[nH]c3ccccc3c12 10.1021/acs.jmedchem.9b00349
CHEMBL4451135 177410 0 None -1 2 Mouse 8.2 pKi = 8.2 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 376 8 3 4 4.0 COc1ccccc1OCCNC[C@H](O)c1cccc2[nH]c3ccccc3c12 10.1021/acs.jmedchem.9b00349
118710935 120522 0 None -9 3 Human 8.2 pKi = 8.2 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 362 5 4 5 3.3 O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@H]3CCC[C@H]3C3CCCC3)c2s1 10.1016/j.bmcl.2014.06.014
CHEMBL3323653 120522 0 None -9 3 Human 8.2 pKi = 8.2 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 362 5 4 5 3.3 O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@H]3CCC[C@H]3C3CCCC3)c2s1 10.1016/j.bmcl.2014.06.014
49864397 22412 0 None -8 2 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 362 5 4 5 3.3 O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@@H]3CCC[C@H]3C3CCCC3)c2s1 10.1016/j.bmcl.2010.06.136
CHEMBL1221683 22412 0 None -8 2 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 362 5 4 5 3.3 O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@@H]3CCC[C@H]3C3CCCC3)c2s1 10.1016/j.bmcl.2010.06.136
559929 11672 11 None - 1 Rat 7.2 pKi = 7.2 Binding
Compound was evaluated for the inhibition of binding of [3H]dihydroalprenolol from beta-1 adrenergic receptor of rat cerebral cortical membranesCompound was evaluated for the inhibition of binding of [3H]dihydroalprenolol from beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 273 5 4 5 1.4 CC(C)(C)NCC(O)COc1ccc(O)c(O)c1F 10.1021/jm00107a027
CHEMBL10453 11672 11 None - 1 Rat 7.2 pKi = 7.2 Binding
Compound was evaluated for the inhibition of binding of [3H]dihydroalprenolol from beta-1 adrenergic receptor of rat cerebral cortical membranesCompound was evaluated for the inhibition of binding of [3H]dihydroalprenolol from beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 273 5 4 5 1.4 CC(C)(C)NCC(O)COc1ccc(O)c(O)c1F 10.1021/jm00107a027
24936881 24289 0 None -10 3 Human 7.2 pKi = 7.2 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 476 8 3 8 4.1 Oc1cccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)c1 10.1016/j.bmcl.2010.08.039
CHEMBL1257913 24289 0 None -10 3 Human 7.2 pKi = 7.2 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 476 8 3 8 4.1 Oc1cccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)c1 10.1016/j.bmcl.2010.08.039
9816183 107323 6 None -5 2 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 240 3 4 6 1.0 CNCC(O)c1ccc(O)c2nc(O)sc12 10.1016/j.bmcl.2010.06.136
CHEMBL29141 107323 6 None -5 2 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 240 3 4 6 1.0 CNCC(O)c1ccc(O)c2nc(O)sc12 10.1016/j.bmcl.2010.06.136
24936491 24292 0 None -7 3 Human 6.2 pKi = 6.2 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 494 8 3 8 4.2 Oc1ccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccc(F)cc5)c34)CC2)cc1 10.1016/j.bmcl.2010.08.039
CHEMBL1257916 24292 0 None -7 3 Human 6.2 pKi = 6.2 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 494 8 3 8 4.2 Oc1ccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccc(F)cc5)c34)CC2)cc1 10.1016/j.bmcl.2010.08.039
10140092 101280 0 None -114 3 Human 5.2 pKi = 5.2 Binding
Displacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 470 11 4 6 3.2 COc1ccc([C@@H](Cc2ccccc2)NC[C@@H](O)Cc2ccc(O)c(NS(C)(=O)=O)c2)cc1 10.1016/j.bmcl.2007.05.030
CHEMBL251581 101280 0 None -114 3 Human 5.2 pKi = 5.2 Binding
Displacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 470 11 4 6 3.2 COc1ccc([C@@H](Cc2ccccc2)NC[C@@H](O)Cc2ccc(O)c(NS(C)(=O)=O)c2)cc1 10.1016/j.bmcl.2007.05.030
13599050 103740 2 None 1 2 Rat 4.2 pKi = 4.2 Binding
Compound was evaluated for beta adrenergic binding affinity towards Beta-1 adrenergic receptor of rat brainCompound was evaluated for beta adrenergic binding affinity towards Beta-1 adrenergic receptor of rat brain
ChEMBL 251 2 3 4 1.8 CC(C)N1CCCC(O)(c2ccc(O)c(O)c2)C1 10.1021/jm00084a006
CHEMBL266290 103740 2 None 1 2 Rat 4.2 pKi = 4.2 Binding
Compound was evaluated for beta adrenergic binding affinity towards Beta-1 adrenergic receptor of rat brainCompound was evaluated for beta adrenergic binding affinity towards Beta-1 adrenergic receptor of rat brain
ChEMBL 251 2 3 4 1.8 CC(C)N1CCCC(O)(c2ccc(O)c(O)c2)C1 10.1021/jm00084a006
44423640 148833 0 None -4 3 Human 7.2 pKi = 7.2 Binding
Displacement of [125I]CYP from human adrenergic beta 1 receptor transfected in CHO cells in presence of 100 uM GTPDisplacement of [125I]CYP from human adrenergic beta 1 receptor transfected in CHO cells in presence of 100 uM GTP
ChEMBL 398 9 3 6 2.2 C[C@H](Cc1ccc(OCC(=O)O)cc1)NC[C@H](O)c1cc(Br)no1 10.1016/j.bmc.2007.01.056
CHEMBL387851 148833 0 None -4 3 Human 7.2 pKi = 7.2 Binding
Displacement of [125I]CYP from human adrenergic beta 1 receptor transfected in CHO cells in presence of 100 uM GTPDisplacement of [125I]CYP from human adrenergic beta 1 receptor transfected in CHO cells in presence of 100 uM GTP
ChEMBL 398 9 3 6 2.2 C[C@H](Cc1ccc(OCC(=O)O)cc1)NC[C@H](O)c1cc(Br)no1 10.1016/j.bmc.2007.01.056
16737587 167071 0 None 1 2 Rat 4.2 pKi = 4.2 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 267 8 4 4 2.7 CCCCC[C@@H](C)NC[C@@H](O)c1cc(O)cc(O)c1 nan
CHEMBL4110387 167071 0 None 1 2 Rat 4.2 pKi = 4.2 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 267 8 4 4 2.7 CCCCC[C@@H](C)NC[C@@H](O)c1cc(O)cc(O)c1 nan
44424580 92589 0 None 1 2 Rat 4.2 pKi = 4.2 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 253 7 4 4 2.3 CCCC[C@@H](C)NC[C@@H](O)c1cc(O)cc(O)c1 10.1021/jm070030d
CHEMBL229616 92589 0 None 1 2 Rat 4.2 pKi = 4.2 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 253 7 4 4 2.3 CCCC[C@@H](C)NC[C@@H](O)c1cc(O)cc(O)c1 10.1021/jm070030d
10544781 211464 0 None -10 3 Human 5.2 pKi = 5.2 Binding
Binding Affinity against human Beta-1 adrenergic receptor expressed in Chinese hamster ovary(CHO) cells was measured by using [125I]ICYP radioligandBinding Affinity against human Beta-1 adrenergic receptor expressed in Chinese hamster ovary(CHO) cells was measured by using [125I]ICYP radioligand
ChEMBL 335 5 2 7 2.2 COc1cc(CC2NCCc3nc(N)sc32)cc(OC)c1OC 10.1021/jm990012z
CHEMBL73917 211464 0 None -10 3 Human 5.2 pKi = 5.2 Binding
Binding Affinity against human Beta-1 adrenergic receptor expressed in Chinese hamster ovary(CHO) cells was measured by using [125I]ICYP radioligandBinding Affinity against human Beta-1 adrenergic receptor expressed in Chinese hamster ovary(CHO) cells was measured by using [125I]ICYP radioligand
ChEMBL 335 5 2 7 2.2 COc1cc(CC2NCCc3nc(N)sc32)cc(OC)c1OC 10.1021/jm990012z
118710939 120526 0 None -14 3 Human 7.2 pKi = 7.2 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 336 5 4 5 2.7 CC(C)[C@H]1CCC[C@H]1NC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12 10.1016/j.bmcl.2014.06.014
CHEMBL3323657 120526 0 None -14 3 Human 7.2 pKi = 7.2 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 336 5 4 5 2.7 CC(C)[C@H]1CCC[C@H]1NC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12 10.1016/j.bmcl.2014.06.014
24936626 24181 0 None -87 3 Human 6.2 pKi = 6.2 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 506 9 4 9 3.6 OCc1cc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)ccc1O 10.1016/j.bmcl.2010.08.039
CHEMBL1257555 24181 0 None -87 3 Human 6.2 pKi = 6.2 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 506 9 4 9 3.6 OCc1cc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)ccc1O 10.1016/j.bmcl.2010.08.039
10316512 23639 2 None 18 2 Guinea pig 6.2 pKi = 6.2 Binding
Binding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacementBinding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacement
ChEMBL 359 1 1 5 1.7 Brc1cnc(N2CCNCC2)c2ncc(Br)n12 10.1021/jm00099a012
CHEMBL124926 23639 2 None 18 2 Guinea pig 6.2 pKi = 6.2 Binding
Binding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacementBinding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacement
ChEMBL 359 1 1 5 1.7 Brc1cnc(N2CCNCC2)c2ncc(Br)n12 10.1021/jm00099a012
11779308 25275 8 None -4 2 Guinea pig 5.2 pKi = 5.2 Binding
Binding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacementBinding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacement
ChEMBL 295 1 0 5 1.2 CN1CCN(c2nccn3c(Br)cnc23)CC1 10.1021/jm00099a012
CHEMBL127318 25275 8 None -4 2 Guinea pig 5.2 pKi = 5.2 Binding
Binding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacementBinding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacement
ChEMBL 295 1 0 5 1.2 CN1CCN(c2nccn3c(Br)cnc23)CC1 10.1021/jm00099a012
541604 172118 10 None -91 4 Guinea pig 4.2 pKi = 4.2 Binding
Binding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenololBinding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenolol
ChEMBL 201 3 4 4 0.5 CNCC(O)c1cc(O)c(O)cc1F 10.1021/jm00118a019
CHEMBL42359 172118 10 None -91 4 Guinea pig 4.2 pKi = 4.2 Binding
Binding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenololBinding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenolol
ChEMBL 201 3 4 4 0.5 CNCC(O)c1cc(O)c(O)cc1F 10.1021/jm00118a019
1862 6949 18 None -52 7 Rat 4.2 pKi = 4.2 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 187 2 4 4 0.2 NCC(c1cc(O)c(cc1F)O)O 10.1021/jm990599h
510 6949 18 None -52 7 Rat 4.2 pKi = 4.2 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 187 2 4 4 0.2 NCC(c1cc(O)c(cc1F)O)O 10.1021/jm990599h
CHEMBL281232 6949 18 None -52 7 Rat 4.2 pKi = 4.2 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 187 2 4 4 0.2 NCC(c1cc(O)c(cc1F)O)O 10.1021/jm990599h
541604 172118 10 None -91 4 Rat 4.2 pKi = 4.2 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
ChEMBL 201 3 4 4 0.5 CNCC(O)c1cc(O)c(O)cc1F 10.1021/jm00076a024
CHEMBL42359 172118 10 None -91 4 Rat 4.2 pKi = 4.2 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
ChEMBL 201 3 4 4 0.5 CNCC(O)c1cc(O)c(O)cc1F 10.1021/jm00076a024
90644153 119030 0 None -19 2 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 470 11 5 6 5.3 OCc1cc(C(O)CNCCc2ccc(Nc3ccc(Oc4ccccc4)cc3)cc2)ccc1O 10.1016/j.bmcl.2014.04.069
CHEMBL3290982 119030 0 None -19 2 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 470 11 5 6 5.3 OCc1cc(C(O)CNCCc2ccc(Nc3ccc(Oc4ccccc4)cc3)cc2)ccc1O 10.1016/j.bmcl.2014.04.069
173 10036 95 None -69 23 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysisDisplacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis
ChEMBL 213 1 1 3 1.6 N1CCN(CC1)c1ccc2c(n1)cccc2 10.1021/jm400140q
5011 10036 95 None -69 23 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysisDisplacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis
ChEMBL 213 1 1 3 1.6 N1CCN(CC1)c1ccc2c(n1)cccc2 10.1021/jm400140q
CHEMBL18772 10036 95 None -69 23 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysisDisplacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis
ChEMBL 213 1 1 3 1.6 N1CCN(CC1)c1ccc2c(n1)cccc2 10.1021/jm400140q
44312269 211218 0 None 2 3 Human 5.2 pKi = 5.2 Binding
Compound was tested for its binding affinity against Beta-1 adrenergic receptor in CHO cell membrane using [125I]iodocyanopindolol as the radioligand.Compound was tested for its binding affinity against Beta-1 adrenergic receptor in CHO cell membrane using [125I]iodocyanopindolol as the radioligand.
ChEMBL 382 10 3 5 3.5 C[C@H](Cc1ncc(CCCC(=O)O)s1)NCC(O)c1cccc(Cl)c1 10.1016/0960-894X(96)00417-9
CHEMBL72168 211218 0 None 2 3 Human 5.2 pKi = 5.2 Binding
Compound was tested for its binding affinity against Beta-1 adrenergic receptor in CHO cell membrane using [125I]iodocyanopindolol as the radioligand.Compound was tested for its binding affinity against Beta-1 adrenergic receptor in CHO cell membrane using [125I]iodocyanopindolol as the radioligand.
ChEMBL 382 10 3 5 3.5 C[C@H](Cc1ncc(CCCC(=O)O)s1)NCC(O)c1cccc(Cl)c1 10.1016/0960-894X(96)00417-9
44423641 92172 0 None -12 2 Human 5.2 pKi = 5.2 Binding
Displacement of [125I]CYP from human adrenergic beta 1 receptor transfected in CHO cells in presence of 100 uM GTPDisplacement of [125I]CYP from human adrenergic beta 1 receptor transfected in CHO cells in presence of 100 uM GTP
ChEMBL 398 9 3 6 2.2 C[C@H](Cc1ccc(OCC(=O)O)cc1)NC[C@@H](O)c1cc(Br)no1 10.1016/j.bmc.2007.01.056
CHEMBL226293 92172 0 None -12 2 Human 5.2 pKi = 5.2 Binding
Displacement of [125I]CYP from human adrenergic beta 1 receptor transfected in CHO cells in presence of 100 uM GTPDisplacement of [125I]CYP from human adrenergic beta 1 receptor transfected in CHO cells in presence of 100 uM GTP
ChEMBL 398 9 3 6 2.2 C[C@H](Cc1ccc(OCC(=O)O)cc1)NC[C@@H](O)c1cc(Br)no1 10.1016/j.bmc.2007.01.056
2812 11551 101 None -38 34 Human 5.2 pKi = 5.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 344 4 0 2 5.4 Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1 nan
CHEMBL104 11551 101 None -38 34 Human 5.2 pKi = 5.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 344 4 0 2 5.4 Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1 nan
11432806 72971 0 None -16 3 Human 7.2 pKi = 7.2 Binding
Binding inhibition constant was determined by inhibition of [125I]-iodocyanopindolol binding to Beta-1 adrenergic receptorBinding inhibition constant was determined by inhibition of [125I]-iodocyanopindolol binding to Beta-1 adrenergic receptor
ChEMBL 549 11 4 8 3.6 C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1016/j.bmcl.2004.09.054
CHEMBL184407 72971 0 None -16 3 Human 7.2 pKi = 7.2 Binding
Binding inhibition constant was determined by inhibition of [125I]-iodocyanopindolol binding to Beta-1 adrenergic receptorBinding inhibition constant was determined by inhibition of [125I]-iodocyanopindolol binding to Beta-1 adrenergic receptor
ChEMBL 549 11 4 8 3.6 C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1016/j.bmcl.2004.09.054
11432806 72971 0 None -16 3 Human 7.2 pKi = 7.2 Binding
Binding inhibition constant was determined by inhibition of [125I]iodocyanopindolol binding to Beta-1 adrenergic receptorBinding inhibition constant was determined by inhibition of [125I]iodocyanopindolol binding to Beta-1 adrenergic receptor
ChEMBL 549 11 4 8 3.6 C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1016/j.bmcl.2004.10.035
CHEMBL184407 72971 0 None -16 3 Human 7.2 pKi = 7.2 Binding
Binding inhibition constant was determined by inhibition of [125I]iodocyanopindolol binding to Beta-1 adrenergic receptorBinding inhibition constant was determined by inhibition of [125I]iodocyanopindolol binding to Beta-1 adrenergic receptor
ChEMBL 549 11 4 8 3.6 C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1cccc(NS(=O)(=O)c2cccs2)c1 10.1016/j.bmcl.2004.10.035
118710935 120522 0 None -9 3 Human 7.2 pKi = 7.2 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 362 5 4 5 3.3 O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@H]3CCC[C@H]3C3CCCC3)c2s1 10.1016/j.bmcl.2014.06.014
CHEMBL3323653 120522 0 None -9 3 Human 7.2 pKi = 7.2 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 362 5 4 5 3.3 O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@H]3CCC[C@H]3C3CCCC3)c2s1 10.1016/j.bmcl.2014.06.014
44423645 92185 0 None -4 3 Human 7.2 pKi = 7.2 Binding
Displacement of [125I]CYP from human adrenergic beta 1 receptor transfected in CHO cells in presence of 100 uM GTPDisplacement of [125I]CYP from human adrenergic beta 1 receptor transfected in CHO cells in presence of 100 uM GTP
ChEMBL 396 10 2 5 3.9 CCCCOc1ccc(C[C@@H](C)NC[C@H](O)c2cc(Br)no2)cc1 10.1016/j.bmc.2007.01.056
CHEMBL226349 92185 0 None -4 3 Human 7.2 pKi = 7.2 Binding
Displacement of [125I]CYP from human adrenergic beta 1 receptor transfected in CHO cells in presence of 100 uM GTPDisplacement of [125I]CYP from human adrenergic beta 1 receptor transfected in CHO cells in presence of 100 uM GTP
ChEMBL 396 10 2 5 3.9 CCCCOc1ccc(C[C@@H](C)NC[C@H](O)c2cc(Br)no2)cc1 10.1016/j.bmc.2007.01.056
145946829 174348 0 None 4 2 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation countingDisplacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation counting
ChEMBL 380 11 3 6 1.0 CNCC(O)COc1ccc(S(=O)(=O)NCCOc2ccccc2)cc1 10.1021/acs.jmedchem.8b00625
CHEMBL4170519 174348 0 None 4 2 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation countingDisplacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation counting
ChEMBL 380 11 3 6 1.0 CNCC(O)COc1ccc(S(=O)(=O)NCCOc2ccccc2)cc1 10.1021/acs.jmedchem.8b00625
CHEMBL4300598 174348 0 None 4 2 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation countingDisplacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation counting
ChEMBL 380 11 3 6 1.0 CNCC(O)COc1ccc(S(=O)(=O)NCCOc2ccccc2)cc1 10.1021/acs.jmedchem.8b00625
49864439 22419 0 None -4 2 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 390 5 4 5 4.1 O=c1[nH]c2c(O)ccc([C@@H](O)CNC3CCCCC3C3CCCCC3)c2s1 10.1016/j.bmcl.2010.06.136
CHEMBL1221801 22419 0 None -4 2 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 390 5 4 5 4.1 O=c1[nH]c2c(O)ccc([C@@H](O)CNC3CCCCC3C3CCCCC3)c2s1 10.1016/j.bmcl.2010.06.136
594590 79625 95 None 39 2 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysisDisplacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis
ChEMBL 201 1 2 2 1.6 c1cc(N2CCNCC2)c2cc[nH]c2c1 10.1021/jm400140q
CHEMBL200234 79625 95 None 39 2 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysisDisplacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis
ChEMBL 201 1 2 2 1.6 c1cc(N2CCNCC2)c2cc[nH]c2c1 10.1021/jm400140q
1499 8872 47 None -33 17 Rat 6.2 pKi = 6.2 Binding
Compound was evaluated for the inhibition of binding of [3H]dihydroalprenolol from beta-1 adrenergic receptor of rat cerebral cortical membranesCompound was evaluated for the inhibition of binding of [3H]dihydroalprenolol from beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm00107a027
3779 8872 47 None -33 17 Rat 6.2 pKi = 6.2 Binding
Compound was evaluated for the inhibition of binding of [3H]dihydroalprenolol from beta-1 adrenergic receptor of rat cerebral cortical membranesCompound was evaluated for the inhibition of binding of [3H]dihydroalprenolol from beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm00107a027
536 8872 47 None -33 17 Rat 6.2 pKi = 6.2 Binding
Compound was evaluated for the inhibition of binding of [3H]dihydroalprenolol from beta-1 adrenergic receptor of rat cerebral cortical membranesCompound was evaluated for the inhibition of binding of [3H]dihydroalprenolol from beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm00107a027
CHEMBL434 8872 47 None -33 17 Rat 6.2 pKi = 6.2 Binding
Compound was evaluated for the inhibition of binding of [3H]dihydroalprenolol from beta-1 adrenergic receptor of rat cerebral cortical membranesCompound was evaluated for the inhibition of binding of [3H]dihydroalprenolol from beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm00107a027
DB01064 8872 47 None -33 17 Rat 6.2 pKi = 6.2 Binding
Compound was evaluated for the inhibition of binding of [3H]dihydroalprenolol from beta-1 adrenergic receptor of rat cerebral cortical membranesCompound was evaluated for the inhibition of binding of [3H]dihydroalprenolol from beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm00107a027
44361634 41424 0 None - 1 Rat 5.2 pKi = 5.2 Binding
Compound was evaluated for its Beta-1 adrenergic receptor binding affinity by measuring the displacement of [3H]dihydroalprenolol binding in rat heartCompound was evaluated for its Beta-1 adrenergic receptor binding affinity by measuring the displacement of [3H]dihydroalprenolol binding in rat heart
ChEMBL 417 6 2 6 2.4 O=C1CSc2c(cccc2OCC(O)CN2CCN(c3ccc(F)cc3)CC2)N1 10.1016/s0960-894x(00)00016-0
CHEMBL142995 41424 0 None - 1 Rat 5.2 pKi = 5.2 Binding
Compound was evaluated for its Beta-1 adrenergic receptor binding affinity by measuring the displacement of [3H]dihydroalprenolol binding in rat heartCompound was evaluated for its Beta-1 adrenergic receptor binding affinity by measuring the displacement of [3H]dihydroalprenolol binding in rat heart
ChEMBL 417 6 2 6 2.4 O=C1CSc2c(cccc2OCC(O)CN2CCN(c3ccc(F)cc3)CC2)N1 10.1016/s0960-894x(00)00016-0
24936625 24256 0 None -1 2 Human 5.2 pKi = 5.2 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 520 9 4 9 3.8 O=C(O)c1cc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)ccc1O 10.1016/j.bmcl.2010.08.039
CHEMBL1257798 24256 0 None -1 2 Human 5.2 pKi = 5.2 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 520 9 4 9 3.8 O=C(O)c1cc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)ccc1O 10.1016/j.bmcl.2010.08.039
3207225 94315 7 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysisDisplacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis
ChEMBL 302 1 1 5 2.5 Cc1nc(N2CCNCC2)c2c3c(sc2n1)CC(C)CC3 10.1021/jm400140q
CHEMBL2335167 94315 7 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysisDisplacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis
ChEMBL 302 1 1 5 2.5 Cc1nc(N2CCNCC2)c2c3c(sc2n1)CC(C)CC3 10.1021/jm400140q
594590 79625 95 None 39 2 Human 7.2 pKi = 7.2 Binding
Binding affinity to beta1 adrenergic receptor (unknown origin)Binding affinity to beta1 adrenergic receptor (unknown origin)
ChEMBL 201 1 2 2 1.6 c1cc(N2CCNCC2)c2cc[nH]c2c1 10.1021/jm400561w
CHEMBL200234 79625 95 None 39 2 Human 7.2 pKi = 7.2 Binding
Binding affinity to beta1 adrenergic receptor (unknown origin)Binding affinity to beta1 adrenergic receptor (unknown origin)
ChEMBL 201 1 2 2 1.6 c1cc(N2CCNCC2)c2cc[nH]c2c1 10.1021/jm400561w
12582 7737 45 None -3 5 Human 7.2 pKi = 7.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O nan
2783 7737 45 None -3 5 Human 7.2 pKi = 7.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O nan
CHEMBL49080 7737 45 None -3 5 Human 7.2 pKi = 7.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O nan
DB01407 7737 45 None -3 5 Human 7.2 pKi = 7.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O nan
10231679 101090 0 None -36 3 Human 6.2 pKi = 6.2 Binding
Displacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 572 14 4 7 4.4 CS(=O)(=O)Nc1cc(C[C@H](O)CN[C@H](Cc2ccccc2)c2ccc(OC(F)F)c(OC(F)F)c2)ccc1O 10.1016/j.bmcl.2007.05.030
CHEMBL250553 101090 0 None -36 3 Human 6.2 pKi = 6.2 Binding
Displacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 572 14 4 7 4.4 CS(=O)(=O)Nc1cc(C[C@H](O)CN[C@H](Cc2ccccc2)c2ccc(OC(F)F)c(OC(F)F)c2)ccc1O 10.1016/j.bmcl.2007.05.030
46889670 13784 0 None -2 3 Human 8.2 pKi = 8.2 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 533 7 2 5 5.2 O=C1c2cccc3cccc(c23)C(=O)N1CC1CCN(CC(O)COc2cccc3[nH]c4ccccc4c23)CC1 10.1016/j.bmcl.2010.04.009
CHEMBL1084772 13784 0 None -2 3 Human 8.2 pKi = 8.2 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 533 7 2 5 5.2 O=C1c2cccc3cccc(c23)C(=O)N1CC1CCN(CC(O)COc2cccc3[nH]c4ccccc4c23)CC1 10.1016/j.bmcl.2010.04.009
2303 9961 68 None -46 26 Rat 8.2 pKi = 8.2 Binding
Displacement of [3H]CGP-12177 from beta1 adrenergic receptor in rat brain cerebral cortex after 60 mins by microbeta scintillation counting methodDisplacement of [3H]CGP-12177 from beta1 adrenergic receptor in rat brain cerebral cortex after 60 mins by microbeta scintillation counting method
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmcl.2016.09.037
4946 9961 68 None -46 26 Rat 8.2 pKi = 8.2 Binding
Displacement of [3H]CGP-12177 from beta1 adrenergic receptor in rat brain cerebral cortex after 60 mins by microbeta scintillation counting methodDisplacement of [3H]CGP-12177 from beta1 adrenergic receptor in rat brain cerebral cortex after 60 mins by microbeta scintillation counting method
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmcl.2016.09.037
564 9961 68 None -46 26 Rat 8.2 pKi = 8.2 Binding
Displacement of [3H]CGP-12177 from beta1 adrenergic receptor in rat brain cerebral cortex after 60 mins by microbeta scintillation counting methodDisplacement of [3H]CGP-12177 from beta1 adrenergic receptor in rat brain cerebral cortex after 60 mins by microbeta scintillation counting method
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmcl.2016.09.037
63 9961 68 None -46 26 Rat 8.2 pKi = 8.2 Binding
Displacement of [3H]CGP-12177 from beta1 adrenergic receptor in rat brain cerebral cortex after 60 mins by microbeta scintillation counting methodDisplacement of [3H]CGP-12177 from beta1 adrenergic receptor in rat brain cerebral cortex after 60 mins by microbeta scintillation counting method
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmcl.2016.09.037
91536 9961 68 None -46 26 Rat 8.2 pKi = 8.2 Binding
Displacement of [3H]CGP-12177 from beta1 adrenergic receptor in rat brain cerebral cortex after 60 mins by microbeta scintillation counting methodDisplacement of [3H]CGP-12177 from beta1 adrenergic receptor in rat brain cerebral cortex after 60 mins by microbeta scintillation counting method
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmcl.2016.09.037
CHEMBL27 9961 68 None -46 26 Rat 8.2 pKi = 8.2 Binding
Displacement of [3H]CGP-12177 from beta1 adrenergic receptor in rat brain cerebral cortex after 60 mins by microbeta scintillation counting methodDisplacement of [3H]CGP-12177 from beta1 adrenergic receptor in rat brain cerebral cortex after 60 mins by microbeta scintillation counting method
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmcl.2016.09.037
CHEMBL452861 9961 68 None -46 26 Rat 8.2 pKi = 8.2 Binding
Displacement of [3H]CGP-12177 from beta1 adrenergic receptor in rat brain cerebral cortex after 60 mins by microbeta scintillation counting methodDisplacement of [3H]CGP-12177 from beta1 adrenergic receptor in rat brain cerebral cortex after 60 mins by microbeta scintillation counting method
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmcl.2016.09.037
DB00571 9961 68 None -46 26 Rat 8.2 pKi = 8.2 Binding
Displacement of [3H]CGP-12177 from beta1 adrenergic receptor in rat brain cerebral cortex after 60 mins by microbeta scintillation counting methodDisplacement of [3H]CGP-12177 from beta1 adrenergic receptor in rat brain cerebral cortex after 60 mins by microbeta scintillation counting method
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmcl.2016.09.037
15077948 148419 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.
ChEMBL 514 10 5 8 0.8 NS(=O)(=O)c1cc(C(=O)NCCNCC(O)COc2cccc3c2SCC(=O)N3)ccc1Cl 10.1021/jm00053a020
CHEMBL38532 148419 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.
ChEMBL 514 10 5 8 0.8 NS(=O)(=O)c1cc(C(=O)NCCNCC(O)COc2cccc3c2SCC(=O)N3)ccc1Cl 10.1021/jm00053a020
9982903 175843 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.
ChEMBL 486 10 5 8 1.5 NS(=O)(=O)c1cc(NCCNCC(O)COc2cccc3c2SCC(=O)N3)ccc1Cl 10.1021/jm00053a020
CHEMBL43968 175843 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.
ChEMBL 486 10 5 8 1.5 NS(=O)(=O)c1cc(NCCNCC(O)COc2cccc3c2SCC(=O)N3)ccc1Cl 10.1021/jm00053a020
118710948 120537 0 None -5 3 Human 8.1 pKi = 8.1 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 386 9 4 5 3.5 CCCCc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1 10.1016/j.bmcl.2014.06.014
CHEMBL3323668 120537 0 None -5 3 Human 8.1 pKi = 8.1 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 386 9 4 5 3.5 CCCCc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1 10.1016/j.bmcl.2014.06.014
44433250 95852 0 None -1 3 Human 8.1 pKi = 8.1 Binding
Binding affinity at human adrenergic beta-1 receptorBinding affinity at human adrenergic beta-1 receptor
ChEMBL 340 6 3 3 3.5 O[C@@H](CNC12CC3CC(CC(C3)C1)C2)COc1cccc2[nH]ccc12 10.1016/j.bmcl.2007.07.086
CHEMBL236514 95852 0 None -1 3 Human 8.1 pKi = 8.1 Binding
Binding affinity at human adrenergic beta-1 receptorBinding affinity at human adrenergic beta-1 receptor
ChEMBL 340 6 3 3 3.5 O[C@@H](CNC12CC3CC(CC(C3)C1)C2)COc1cccc2[nH]ccc12 10.1016/j.bmcl.2007.07.086
11647002 22410 0 None -22 3 Human 7.2 pKi = 7.2 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 400 7 4 6 3.1 O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@H]3CCC[C@@H]3OCc3ccccc3)c2s1 10.1016/j.bmcl.2014.06.014
CHEMBL1221681 22410 0 None -22 3 Human 7.2 pKi = 7.2 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 400 7 4 6 3.1 O=c1[nH]c2c(O)ccc([C@@H](O)CN[C@H]3CCC[C@@H]3OCc3ccccc3)c2s1 10.1016/j.bmcl.2014.06.014
52943932 24528 0 None -16 3 Human 6.2 pKi = 6.2 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 485 8 2 8 4.2 N#Cc1cccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)c1 10.1016/j.bmcl.2010.08.039
CHEMBL1258705 24528 0 None -16 3 Human 6.2 pKi = 6.2 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 485 8 2 8 4.2 N#Cc1cccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)c1 10.1016/j.bmcl.2010.08.039
155564274 182201 0 None 19 2 Mouse 7.2 pKi = 7.2 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 643 19 4 11 3.7 Cn1cc(C(F)(F)F)nc1-c1ccc(OC[C@@H](O)CNCCOc2ccc(OCCCSSCCN)c(C(N)=O)c2)cc1 10.1016/j.bmc.2019.05.034
CHEMBL4576034 182201 0 None 19 2 Mouse 7.2 pKi = 7.2 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 643 19 4 11 3.7 Cn1cc(C(F)(F)F)nc1-c1ccc(OC[C@@H](O)CNCCOc2ccc(OCCCSSCCN)c(C(N)=O)c2)cc1 10.1016/j.bmc.2019.05.034
52947562 24459 0 None 1 3 Human 7.1 pKi = 7.1 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 384 7 2 7 2.7 OC(CNC1CCN(c2ncnc3sccc23)CC1)COc1ccccc1 10.1016/j.bmcl.2010.08.039
CHEMBL1258486 24459 0 None 1 3 Human 7.1 pKi = 7.1 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 384 7 2 7 2.7 OC(CNC1CCN(c2ncnc3sccc23)CC1)COc1ccccc1 10.1016/j.bmcl.2010.08.039
46889730 13901 0 None -42 3 Human 6.1 pKi = 6.1 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 436 8 1 5 3.6 CC(C)c1ccccc1OCC(O)CN1CCC(CN2C(=O)c3ccccc3C2=O)CC1 10.1016/j.bmcl.2010.04.009
CHEMBL1085270 13901 0 None -42 3 Human 6.1 pKi = 6.1 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 436 8 1 5 3.6 CC(C)c1ccccc1OCC(O)CN1CCC(CN2C(=O)c3ccccc3C2=O)CC1 10.1016/j.bmcl.2010.04.009
9958539 109882 0 None -1 3 Human 6.1 pKi = 6.1 Binding
Binding Affinity against human Beta-1 adrenergic receptor expressed in Chinese hamster ovary(CHO) cells was measured by using [125I]ICYP radioligandBinding Affinity against human Beta-1 adrenergic receptor expressed in Chinese hamster ovary(CHO) cells was measured by using [125I]ICYP radioligand
ChEMBL 527 3 2 5 3.4 COc1c(I)cc(CC2NCCc3nc(N)sc32)cc1I 10.1021/jm990012z
CHEMBL307647 109882 0 None -1 3 Human 6.1 pKi = 6.1 Binding
Binding Affinity against human Beta-1 adrenergic receptor expressed in Chinese hamster ovary(CHO) cells was measured by using [125I]ICYP radioligandBinding Affinity against human Beta-1 adrenergic receptor expressed in Chinese hamster ovary(CHO) cells was measured by using [125I]ICYP radioligand
ChEMBL 527 3 2 5 3.4 COc1c(I)cc(CC2NCCc3nc(N)sc32)cc1I 10.1021/jm990012z
4189 213701 96 None -38 34 Human 5.1 pKi = 5.1 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 414 6 0 3 6.5 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 nan
CHEMBL1559 213701 96 None -38 34 Human 5.1 pKi = 5.1 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 414 6 0 3 6.5 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 nan
CHEMBL91 213701 96 None -38 34 Human 5.1 pKi = 5.1 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 414 6 0 3 6.5 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 nan
44444187 101242 0 None -23 3 Human 6.1 pKi = 6.1 Binding
Displacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 484 12 4 6 3.6 COc1ccc([C@H](CCc2ccccc2)NC[C@H](O)Cc2ccc(O)c(NS(C)(=O)=O)c2)cc1 10.1016/j.bmcl.2007.05.030
CHEMBL251347 101242 0 None -23 3 Human 6.1 pKi = 6.1 Binding
Displacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human cloned adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 484 12 4 6 3.6 COc1ccc([C@H](CCc2ccccc2)NC[C@H](O)Cc2ccc(O)c(NS(C)(=O)=O)c2)cc1 10.1016/j.bmcl.2007.05.030
5187268 13349 12 None -10 3 Human 6.1 pKi = 6.1 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 501 9 1 6 3.6 CC(C)c1ccccc1OCC(O)CN1CCN(CCN2C(=O)c3cccc4cccc(c34)C2=O)CC1 10.1016/j.bmcl.2010.04.009
CHEMBL1083053 13349 12 None -10 3 Human 6.1 pKi = 6.1 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 501 9 1 6 3.6 CC(C)c1ccccc1OCC(O)CN1CCN(CCN2C(=O)c3cccc4cccc(c34)C2=O)CC1 10.1016/j.bmcl.2010.04.009
155524756 177783 0 None 1 2 Mouse 6.1 pKi = 6.1 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 510 19 3 9 3.2 COCCc1ccc(OC[C@H](O)CNCCc2ccc(OCCSSCCN)c(OC)c2)cc1 10.1016/j.bmc.2019.05.034
CHEMBL4456505 177783 0 None 1 2 Mouse 6.1 pKi = 6.1 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
ChEMBL 510 19 3 9 3.2 COCCc1ccc(OC[C@H](O)CNCCc2ccc(OCCSSCCN)c(OC)c2)cc1 10.1016/j.bmc.2019.05.034
155540000 179660 0 None 1 2 Mouse 5.1 pKi = 5.1 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 349 10 4 7 1.5 COc1ccccc1OCCNC[C@@H](O)COc1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
CHEMBL4515498 179660 0 None 1 2 Mouse 5.1 pKi = 5.1 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 349 10 4 7 1.5 COc1ccccc1OCCNC[C@@H](O)COc1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
3198 212292 76 None -38 34 Human 5.1 pKi = 5.1 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 nan
CHEMBL1201049 212292 76 None -38 34 Human 5.1 pKi = 5.1 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 nan
CHEMBL808 212292 76 None -38 34 Human 5.1 pKi = 5.1 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 nan
2723782 94308 85 None - 1 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysisDisplacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis
ChEMBL 190 1 1 2 1.7 Cc1ccc(N2CCNCC2)cc1C 10.1021/jm400140q
CHEMBL2335160 94308 85 None - 1 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysisDisplacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis
ChEMBL 190 1 1 2 1.7 Cc1ccc(N2CCNCC2)cc1C 10.1021/jm400140q
13720716 69827 0 None -1 2 Guinea pig 7.1 pKi = 7.1 Binding
Binding affinity against Beta-1 adrenergic receptor in guinea pig left ventricleBinding affinity against Beta-1 adrenergic receptor in guinea pig left ventricle
ChEMBL 363 5 3 6 2.7 COc1cc(C[C@@H]2NCCc3cc(O)c(O)c(F)c32)cc(OC)c1OC 10.1021/jm00081a007
CHEMBL1788251 69827 0 None -1 2 Guinea pig 7.1 pKi = 7.1 Binding
Binding affinity against Beta-1 adrenergic receptor in guinea pig left ventricleBinding affinity against Beta-1 adrenergic receptor in guinea pig left ventricle
ChEMBL 363 5 3 6 2.7 COc1cc(C[C@@H]2NCCc3cc(O)c(O)c(F)c32)cc(OC)c1OC 10.1021/jm00081a007
2249 7300 111 None -5 12 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C nan
255 7300 111 None -5 12 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C nan
548 7300 111 None -5 12 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C nan
CHEMBL24 7300 111 None -5 12 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C nan
DB00335 7300 111 None -5 12 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C nan
10472143 126055 0 None -169 16 Human 7.1 pKi = 7.1 Binding
Binding affinity towards Beta-1 adrenergic receptorBinding affinity towards Beta-1 adrenergic receptor
ChEMBL 335 1 1 2 3.0 C[C@H]1C[C@H](C)N1C(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)CC2N(C)C1 10.1021/jm020153s
CHEMBL343755 126055 0 None -169 16 Human 7.1 pKi = 7.1 Binding
Binding affinity towards Beta-1 adrenergic receptorBinding affinity towards Beta-1 adrenergic receptor
ChEMBL 335 1 1 2 3.0 C[C@H]1C[C@H](C)N1C(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)CC2N(C)C1 10.1021/jm020153s
46889809 13419 0 None -1 3 Human 7.1 pKi = 7.1 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 519 6 2 5 5.0 O=C1c2cccc3cccc(c23)C(=O)N1C1CCN(CC(O)COc2cccc3[nH]c4ccccc4c23)CC1 10.1016/j.bmcl.2010.04.009
CHEMBL1083363 13419 0 None -1 3 Human 7.1 pKi = 7.1 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 519 6 2 5 5.0 O=C1c2cccc3cccc(c23)C(=O)N1C1CCN(CC(O)COc2cccc3[nH]c4ccccc4c23)CC1 10.1016/j.bmcl.2010.04.009
10375227 17989 0 None 2 2 Rat 6.1 pKi = 6.1 Binding
Binding affinity against beta-1-adrenergic receptor in rat brainBinding affinity against beta-1-adrenergic receptor in rat brain
ChEMBL 188 5 2 4 0.8 C/C=N/OCC(O)CNC(C)(C)C 10.1021/jm00036a018
CHEMBL1178761 17989 0 None 2 2 Rat 6.1 pKi = 6.1 Binding
Binding affinity against beta-1-adrenergic receptor in rat brainBinding affinity against beta-1-adrenergic receptor in rat brain
ChEMBL 188 5 2 4 0.8 C/C=N/OCC(O)CNC(C)(C)C 10.1021/jm00036a018
CHEMBL39873 17989 0 None 2 2 Rat 6.1 pKi = 6.1 Binding
Binding affinity against beta-1-adrenergic receptor in rat brainBinding affinity against beta-1-adrenergic receptor in rat brain
ChEMBL 188 5 2 4 0.8 C/C=N/OCC(O)CNC(C)(C)C 10.1021/jm00036a018
12353629 210702 0 None -23 3 Rat 6.1 pKi = 6.1 Binding
Compound was evaluated for beta adrenergic binding affinity towards Beta-1 adrenergic receptor of rat brainCompound was evaluated for beta adrenergic binding affinity towards Beta-1 adrenergic receptor of rat brain
ChEMBL 237 2 4 4 1.4 CC(C)N[C@@H]1CCc2c(ccc(O)c2O)[C@H]1O 10.1021/jm00084a006
CHEMBL6913 210702 0 None -23 3 Rat 6.1 pKi = 6.1 Binding
Compound was evaluated for beta adrenergic binding affinity towards Beta-1 adrenergic receptor of rat brainCompound was evaluated for beta adrenergic binding affinity towards Beta-1 adrenergic receptor of rat brain
ChEMBL 237 2 4 4 1.4 CC(C)N[C@@H]1CCc2c(ccc(O)c2O)[C@H]1O 10.1021/jm00084a006
9908924 148433 0 None -9 3 Human 5.1 pKi = 5.1 Binding
Ability to bind to human Beta-1 adrenergic receptor using membranes of stably transfected CHO cellsAbility to bind to human Beta-1 adrenergic receptor using membranes of stably transfected CHO cells
ChEMBL 399 9 3 5 2.8 C[C@H](Cc1ccc(OCS(=O)(=O)O)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1016/S0960-894X(97)00266-7
CHEMBL38538 148433 0 None -9 3 Human 5.1 pKi = 5.1 Binding
Ability to bind to human Beta-1 adrenergic receptor using membranes of stably transfected CHO cellsAbility to bind to human Beta-1 adrenergic receptor using membranes of stably transfected CHO cells
ChEMBL 399 9 3 5 2.8 C[C@H](Cc1ccc(OCS(=O)(=O)O)cc1)NC[C@H](O)c1cccc(Cl)c1 10.1016/S0960-894X(97)00266-7
75201901 173204 19 None -562 24 Human 5.1 pKi = 5.1 Binding
Displacement of [125I]-pindolol from recombinant human beta1 adrenergic receptor expressed in CHO Flp-In cells measured after 90 mins by microbeta scintillation counting methodDisplacement of [125I]-pindolol from recombinant human beta1 adrenergic receptor expressed in CHO Flp-In cells measured after 90 mins by microbeta scintillation counting method
ChEMBL 356 3 0 6 4.9 Cc1cc(Oc2nccc3occc23)ccc1-c1c(C)ncc2nccn12 10.1021/acs.jmedchem.9b00351
CHEMBL4277264 173204 19 None -562 24 Human 5.1 pKi = 5.1 Binding
Displacement of [125I]-pindolol from recombinant human beta1 adrenergic receptor expressed in CHO Flp-In cells measured after 90 mins by microbeta scintillation counting methodDisplacement of [125I]-pindolol from recombinant human beta1 adrenergic receptor expressed in CHO Flp-In cells measured after 90 mins by microbeta scintillation counting method
ChEMBL 356 3 0 6 4.9 Cc1cc(Oc2nccc3occc23)ccc1-c1c(C)ncc2nccn12 10.1021/acs.jmedchem.9b00351
118710943 120530 0 None -5 3 Human 7.1 pKi = 7.1 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 384 5 4 5 3.6 Cc1cccc([C@H]2CCC[C@H]2NC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1 10.1016/j.bmcl.2014.06.014
CHEMBL3323661 120530 0 None -5 3 Human 7.1 pKi = 7.1 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 384 5 4 5 3.6 Cc1cccc([C@H]2CCC[C@H]2NC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1 10.1016/j.bmcl.2014.06.014
63180 83568 10 None - 1 Rat 7.1 pKi = 7.1 Binding
Displacement of [3H]-CGP12177 from beta1-adrenergic receptor in rat heart membranesDisplacement of [3H]-CGP12177 from beta1-adrenergic receptor in rat heart membranes
ChEMBL 411 7 2 7 2.7 COc1ccc2nc(-c3ccc(OCC(O)CNC(C)(C)C)cc3)n(C)c(=O)c2c1 10.1016/j.bmcl.2011.06.106
CHEMBL1824263 83568 10 None - 1 Rat 7.1 pKi = 7.1 Binding
Displacement of [3H]-CGP12177 from beta1-adrenergic receptor in rat heart membranesDisplacement of [3H]-CGP12177 from beta1-adrenergic receptor in rat heart membranes
ChEMBL 411 7 2 7 2.7 COc1ccc2nc(-c3ccc(OCC(O)CNC(C)(C)C)cc3)n(C)c(=O)c2c1 10.1016/j.bmcl.2011.06.106
CHEMBL2068824 83568 10 None - 1 Rat 7.1 pKi = 7.1 Binding
Displacement of [3H]-CGP12177 from beta1-adrenergic receptor in rat heart membranesDisplacement of [3H]-CGP12177 from beta1-adrenergic receptor in rat heart membranes
ChEMBL 411 7 2 7 2.7 COc1ccc2nc(-c3ccc(OCC(O)CNC(C)(C)C)cc3)n(C)c(=O)c2c1 10.1016/j.bmcl.2011.06.106
44571260 19507 0 None - 1 Rat 5.1 pKi = 5.1 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation counting
ChEMBL 309 7 1 4 3.5 C=CCNCCCOc1cccc2c(=O)c3ccccc3oc12 10.1016/j.bmc.2008.12.031
CHEMBL1187740 19507 0 None - 1 Rat 5.1 pKi = 5.1 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation counting
ChEMBL 309 7 1 4 3.5 C=CCNCCCOc1cccc2c(=O)c3ccccc3oc12 10.1016/j.bmc.2008.12.031
CHEMBL517532 19507 0 None - 1 Rat 5.1 pKi = 5.1 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation counting
ChEMBL 309 7 1 4 3.5 C=CCNCCCOc1cccc2c(=O)c3ccccc3oc12 10.1016/j.bmc.2008.12.031
16735494 148830 0 None -3 2 Rat 4.1 pKi = 4.1 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 287 6 4 4 2.4 C[C@H](Cc1ccccc1)NC[C@@H](O)c1cc(O)cc(O)c1 nan
CHEMBL387825 148830 0 None -3 2 Rat 4.1 pKi = 4.1 Binding
Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.Beta1-AR Binding Assay: Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988). In brief, male Sprague-Dawley rats weighing 250-350 g were decapitated and their brains quickly removed. The cerebral cortices were dissected on ice, weighed and promptly transferred to a 50 ml test tube containing approximately 30 ml of 50 mM Tris-HCl, pH 7.8 (at room temperature). The tissues were homogenized with a polytron and centrifuged at 20,000xg for 12 min at 4° C. The pellet was washed again in the same manner and resuspended at a concentration of 20 mg (original wet wt) per 1 ml in the assay buffer (20 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, 0.1 mM ascorbic acid at pH 7.8). To block the beta2 sites present in the cortical membrane preparation, 30 nM ICI 118-551 was also added to the assay buffer. To wells containing 100 ul of the test drug and 100 ul of [3H]CGP-12177 (1.4 nM final concentration), 0.8 ml of tissue homogenate was added. After 2 hours at 25° C., the incubation was terminated by rapid filtration. Nonspecific binding was determined by 10 uM propranolol.
ChEMBL 287 6 4 4 2.4 C[C@H](Cc1ccccc1)NC[C@@H](O)c1cc(O)cc(O)c1 nan
16735494 148830 0 None -3 2 Rat 4.1 pKi = 4.1 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 287 6 4 4 2.4 C[C@H](Cc1ccccc1)NC[C@@H](O)c1cc(O)cc(O)c1 10.1021/jm070030d
CHEMBL387825 148830 0 None -3 2 Rat 4.1 pKi = 4.1 Binding
Displacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membraneDisplacement of [3H]CGP-12177 from beta-1 adrenergic receptor in Sprague-Dawley rat cortical membrane
ChEMBL 287 6 4 4 2.4 C[C@H](Cc1ccccc1)NC[C@@H](O)c1cc(O)cc(O)c1 10.1021/jm070030d
11776640 20318 0 None -16 3 Guinea pig 5.1 pKi = 5.1 Binding
Binding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacementBinding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacement
ChEMBL 245 3 1 5 1.1 CCCc1cnc2c(N3CCNCC3)nccn12 10.1021/jm00099a012
CHEMBL1193824 20318 0 None -16 3 Guinea pig 5.1 pKi = 5.1 Binding
Binding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacementBinding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacement
ChEMBL 245 3 1 5 1.1 CCCc1cnc2c(N3CCNCC3)nccn12 10.1021/jm00099a012
CHEMBL545293 20318 0 None -16 3 Guinea pig 5.1 pKi = 5.1 Binding
Binding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacementBinding affinity at Beta-1 adrenergic receptor in guinea pigs by [125I]CYP displacement
ChEMBL 245 3 1 5 1.1 CCCc1cnc2c(N3CCNCC3)nccn12 10.1021/jm00099a012
49864394 22408 0 None -6 2 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 322 4 4 5 2.6 O=c1[nH]c2c(O)ccc([C@@H](O)CNC3CCCCCC3)c2s1 10.1016/j.bmcl.2010.06.136
CHEMBL1221679 22408 0 None -6 2 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 322 4 4 5 2.6 O=c1[nH]c2c(O)ccc([C@@H](O)CNC3CCCCCC3)c2s1 10.1016/j.bmcl.2010.06.136
2419 10236 84 None -154 6 Human 6.1 pKi = 6.1 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2014.06.014
5152 10236 84 None -154 6 Human 6.1 pKi = 6.1 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2014.06.014
559 10236 84 None -154 6 Human 6.1 pKi = 6.1 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2014.06.014
CHEMBL1263 10236 84 None -154 6 Human 6.1 pKi = 6.1 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2014.06.014
DB00938 10236 84 None -154 6 Human 6.1 pKi = 6.1 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2014.06.014
127047859 146829 0 None -28 6 Mouse 7.1 pKi = 7.1 Binding
Displacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cellsDisplacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cells
ChEMBL 476 12 3 6 4.1 COc1cc(CCNCCc2ccc(O)c3c2OCC(=O)N3)ccc1OCCCc1ccccc1 10.1016/j.bmc.2016.04.028
CHEMBL3800341 146829 0 None -28 6 Mouse 7.1 pKi = 7.1 Binding
Displacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cellsDisplacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cells
ChEMBL 476 12 3 6 4.1 COc1cc(CCNCCc2ccc(O)c3c2OCC(=O)N3)ccc1OCCCc1ccccc1 10.1016/j.bmc.2016.04.028
9871887 109977 0 None -6 4 Human 7.1 pKi = 7.1 Binding
Binding Affinity against human Beta-1 adrenergic receptor expressed in Chinese hamster ovary(CHO) cells was measured by using [125I]ICYP radioligandBinding Affinity against human Beta-1 adrenergic receptor expressed in Chinese hamster ovary(CHO) cells was measured by using [125I]ICYP radioligand
ChEMBL 537 3 3 4 3.7 COc1c(I)cc(CC2NCCc3cc(O)c(O)cc32)cc1I 10.1021/jm990012z
CHEMBL308351 109977 0 None -6 4 Human 7.1 pKi = 7.1 Binding
Binding Affinity against human Beta-1 adrenergic receptor expressed in Chinese hamster ovary(CHO) cells was measured by using [125I]ICYP radioligandBinding Affinity against human Beta-1 adrenergic receptor expressed in Chinese hamster ovary(CHO) cells was measured by using [125I]ICYP radioligand
ChEMBL 537 3 3 4 3.7 COc1c(I)cc(CC2NCCc3cc(O)c(O)cc32)cc1I 10.1021/jm990012z
9871887 109977 0 None -6 4 Human 7.1 pKi = 7.1 Binding
Binding affinity for human Beta-1 adrenergic receptor expressed in CHO cells by radioligand competition binding assays using [125I]iodocyanopindolol (ICYP).) PR = potency ratio relative to TMQBinding affinity for human Beta-1 adrenergic receptor expressed in CHO cells by radioligand competition binding assays using [125I]iodocyanopindolol (ICYP).) PR = potency ratio relative to TMQ
ChEMBL 537 3 3 4 3.7 COc1c(I)cc(CC2NCCc3cc(O)c(O)cc32)cc1I 10.1021/jm960208o
CHEMBL308351 109977 0 None -6 4 Human 7.1 pKi = 7.1 Binding
Binding affinity for human Beta-1 adrenergic receptor expressed in CHO cells by radioligand competition binding assays using [125I]iodocyanopindolol (ICYP).) PR = potency ratio relative to TMQBinding affinity for human Beta-1 adrenergic receptor expressed in CHO cells by radioligand competition binding assays using [125I]iodocyanopindolol (ICYP).) PR = potency ratio relative to TMQ
ChEMBL 537 3 3 4 3.7 COc1c(I)cc(CC2NCCc3cc(O)c(O)cc32)cc1I 10.1021/jm960208o
9934284 97071 0 None -1995 10 Human 6.1 pKi = 6.1 Binding
Binding affinity at adrenergic beta 1 receptorBinding affinity at adrenergic beta 1 receptor
ChEMBL 467 6 1 5 4.5 Cc1ccc2c(OCCN3CCC(Cc4cc5c(cc4F)OCC(=O)N5)CC3)cc(F)cc2n1 10.1016/j.bmcl.2006.11.031
CHEMBL238520 97071 0 None -1995 10 Human 6.1 pKi = 6.1 Binding
Binding affinity at adrenergic beta 1 receptorBinding affinity at adrenergic beta 1 receptor
ChEMBL 467 6 1 5 4.5 Cc1ccc2c(OCCN3CCC(Cc4cc5c(cc4F)OCC(=O)N5)CC3)cc(F)cc2n1 10.1016/j.bmcl.2006.11.031
90644139 119041 0 None -100 2 Human 5.1 pKi = 5.1 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 424 10 5 6 4.2 CSc1ccc(Nc2ccc(CCNCC(O)c3ccc(O)c(CO)c3)cc2)cc1 10.1016/j.bmcl.2014.04.069
CHEMBL3290992 119041 0 None -100 2 Human 5.1 pKi = 5.1 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 424 10 5 6 4.2 CSc1ccc(Nc2ccc(CCNCC(O)c3ccc(O)c(CO)c3)cc2)cc1 10.1016/j.bmcl.2014.04.069
90644141 119044 0 None -6 2 Human 5.1 pKi = 5.1 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 396 9 5 5 3.6 OCc1cc(C(O)CNCCc2ccc(Nc3ccc(F)cc3)cc2)ccc1O 10.1016/j.bmcl.2014.04.069
CHEMBL3290995 119044 0 None -6 2 Human 5.1 pKi = 5.1 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 396 9 5 5 3.6 OCc1cc(C(O)CNCCc2ccc(Nc3ccc(F)cc3)cc2)ccc1O 10.1016/j.bmcl.2014.04.069
145946259 174303 0 None - 1 Human 4.1 pKi = 4.1 Binding
Displacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation countingDisplacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation counting
ChEMBL 350 9 3 5 1.1 CNCC(O)COc1ccc(S(=O)(=O)NCc2ccccc2)cc1 10.1021/acs.jmedchem.8b00625
CHEMBL4170536 174303 0 None - 1 Human 4.1 pKi = 4.1 Binding
Displacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation countingDisplacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation counting
ChEMBL 350 9 3 5 1.1 CNCC(O)COc1ccc(S(=O)(=O)NCc2ccccc2)cc1 10.1021/acs.jmedchem.8b00625
CHEMBL4300084 174303 0 None - 1 Human 4.1 pKi = 4.1 Binding
Displacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation countingDisplacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation counting
ChEMBL 350 9 3 5 1.1 CNCC(O)COc1ccc(S(=O)(=O)NCc2ccccc2)cc1 10.1021/acs.jmedchem.8b00625
90644146 119022 0 None -5 2 Human 4.1 pKi = 4.1 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 460 10 4 5 4.2 OCc1cc(C(O)CNCCc2ccc(N3CCC(Cc4ccccc4)CC3)cc2)ccc1O 10.1016/j.bmcl.2014.04.069
CHEMBL3290975 119022 0 None -5 2 Human 4.1 pKi = 4.1 Binding
Displacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assayDisplacement of [3H]dihydroalprenolol from beta1 receptor (unknown origin) by liquid scintillation counting and cell based assay
ChEMBL 460 10 4 5 4.2 OCc1cc(C(O)CNCCc2ccc(N3CCC(Cc4ccccc4)CC3)cc2)ccc1O 10.1016/j.bmcl.2014.04.069
49864442 22422 0 None -27 2 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 373 8 4 6 2.4 CN(CCCNC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12)c1ccccc1 10.1016/j.bmcl.2010.06.136
CHEMBL1221804 22422 0 None -27 2 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 373 8 4 6 2.4 CN(CCCNC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12)c1ccccc1 10.1016/j.bmcl.2010.06.136
1499 8872 47 None -33 17 Rat 7.1 pKi = 7.1 Binding
Compound was evaluated for beta adrenergic binding affinity towards Beta-1 adrenergic receptor of rat brainCompound was evaluated for beta adrenergic binding affinity towards Beta-1 adrenergic receptor of rat brain
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm00084a006
3779 8872 47 None -33 17 Rat 7.1 pKi = 7.1 Binding
Compound was evaluated for beta adrenergic binding affinity towards Beta-1 adrenergic receptor of rat brainCompound was evaluated for beta adrenergic binding affinity towards Beta-1 adrenergic receptor of rat brain
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm00084a006
536 8872 47 None -33 17 Rat 7.1 pKi = 7.1 Binding
Compound was evaluated for beta adrenergic binding affinity towards Beta-1 adrenergic receptor of rat brainCompound was evaluated for beta adrenergic binding affinity towards Beta-1 adrenergic receptor of rat brain
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm00084a006
CHEMBL434 8872 47 None -33 17 Rat 7.1 pKi = 7.1 Binding
Compound was evaluated for beta adrenergic binding affinity towards Beta-1 adrenergic receptor of rat brainCompound was evaluated for beta adrenergic binding affinity towards Beta-1 adrenergic receptor of rat brain
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm00084a006
DB01064 8872 47 None -33 17 Rat 7.1 pKi = 7.1 Binding
Compound was evaluated for beta adrenergic binding affinity towards Beta-1 adrenergic receptor of rat brainCompound was evaluated for beta adrenergic binding affinity towards Beta-1 adrenergic receptor of rat brain
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm00084a006
4421983 14051 5 None 1 3 Human 7.1 pKi = 7.1 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 484 9 1 5 4.3 C=CCc1ccccc1OCC(O)CN1CCC(CN2C(=O)c3cccc4cccc(c34)C2=O)CC1 10.1016/j.bmcl.2010.04.009
CHEMBL1086005 14051 5 None 1 3 Human 7.1 pKi = 7.1 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 484 9 1 5 4.3 C=CCc1ccccc1OCC(O)CN1CCC(CN2C(=O)c3cccc4cccc(c34)C2=O)CC1 10.1016/j.bmcl.2010.04.009
1499 8872 47 None -33 17 Rat 7.1 pKi = 7.1 Binding
Tested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligandTested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligand
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm00073a006
3779 8872 47 None -33 17 Rat 7.1 pKi = 7.1 Binding
Tested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligandTested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligand
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm00073a006
536 8872 47 None -33 17 Rat 7.1 pKi = 7.1 Binding
Tested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligandTested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligand
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm00073a006
CHEMBL434 8872 47 None -33 17 Rat 7.1 pKi = 7.1 Binding
Tested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligandTested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligand
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm00073a006
DB01064 8872 47 None -33 17 Rat 7.1 pKi = 7.1 Binding
Tested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligandTested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligand
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1021/jm00073a006
129896798 189446 40 None 1 3 Human 6.1 pKi = 6.1 Binding
Binding affinity to beta1 adrenoceptor (unknown origin)Binding affinity to beta1 adrenoceptor (unknown origin)
ChEMBL 366 7 2 3 4.5 Cc1ccc(CN(CC(O)COc2cccc3[nH]ccc23)C(C)(C)C)cc1 10.1021/acs.jmedchem.0c01450
CHEMBL4789047 189446 40 None 1 3 Human 6.1 pKi = 6.1 Binding
Binding affinity to beta1 adrenoceptor (unknown origin)Binding affinity to beta1 adrenoceptor (unknown origin)
ChEMBL 366 7 2 3 4.5 Cc1ccc(CN(CC(O)COc2cccc3[nH]ccc23)C(C)(C)C)cc1 10.1021/acs.jmedchem.0c01450
12353620 211123 1 None -66 2 Rat 5.1 pKi = 5.1 Binding
Compound was evaluated for beta adrenergic binding affinity towards Beta-1 adrenergic receptor of rat brainCompound was evaluated for beta adrenergic binding affinity towards Beta-1 adrenergic receptor of rat brain
ChEMBL 195 0 4 4 0.4 N[C@@H]1CCc2c(ccc(O)c2O)[C@H]1O 10.1021/jm00084a006
CHEMBL7160 211123 1 None -66 2 Rat 5.1 pKi = 5.1 Binding
Compound was evaluated for beta adrenergic binding affinity towards Beta-1 adrenergic receptor of rat brainCompound was evaluated for beta adrenergic binding affinity towards Beta-1 adrenergic receptor of rat brain
ChEMBL 195 0 4 4 0.4 N[C@@H]1CCc2c(ccc(O)c2O)[C@H]1O 10.1021/jm00084a006
2419 10236 84 None -154 6 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2010.06.136
5152 10236 84 None -154 6 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2010.06.136
559 10236 84 None -154 6 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2010.06.136
CHEMBL1263 10236 84 None -154 6 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2010.06.136
DB00938 10236 84 None -154 6 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1016/j.bmcl.2010.06.136
44351377 124583 1 None - 1 Rat 4.1 pKi = 4.1 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
ChEMBL 203 3 3 3 0.9 CNCC(O)c1c(F)ccc(O)c1F 10.1021/jm00076a024
CHEMBL340189 124583 1 None - 1 Rat 4.1 pKi = 4.1 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
ChEMBL 203 3 3 3 0.9 CNCC(O)c1c(F)ccc(O)c1F 10.1021/jm00076a024
15077956 176007 0 None - 1 Human 6.1 pKi = 6.1 Binding
Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.
ChEMBL 477 10 4 6 1.9 NS(=O)(=O)c1cc(C(=O)NCCNCC(O)COc2cccc3ccccc23)ccc1Cl 10.1021/jm00053a020
CHEMBL44097 176007 0 None - 1 Human 6.1 pKi = 6.1 Binding
Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.Inhibition of [3H]dihydroalprenolol binding to beta 1 adrenoceptor from turkey erythrocyte membranes.
ChEMBL 477 10 4 6 1.9 NS(=O)(=O)c1cc(C(=O)NCCNCC(O)COc2cccc3ccccc23)ccc1Cl 10.1021/jm00053a020
2464 10412 58 None -2 6 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C nan
5253 10412 58 None -2 6 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C nan
7297 10412 58 None -2 6 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C nan
CHEMBL471 10412 58 None -2 6 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C nan
DB00489 10412 58 None -2 6 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C nan
9928332 103955 5 None -416 9 Rat 6.1 pKi = 6.1 Binding
Compound was evaluated for its binding affinity to beta-1 receptor in rat brain using [3H]- DHA radioligand assayCompound was evaluated for its binding affinity to beta-1 receptor in rat brain using [3H]- DHA radioligand assay
ChEMBL 349 6 0 3 5.0 COc1cccc2c1CCC[C@H]2CN(C)CCc1ccc2ccoc2c1 10.1016/0960-894X(95)00398-D
CHEMBL268258 103955 5 None -416 9 Rat 6.1 pKi = 6.1 Binding
Compound was evaluated for its binding affinity to beta-1 receptor in rat brain using [3H]- DHA radioligand assayCompound was evaluated for its binding affinity to beta-1 receptor in rat brain using [3H]- DHA radioligand assay
ChEMBL 349 6 0 3 5.0 COc1cccc2c1CCC[C@H]2CN(C)CCc1ccc2ccoc2c1 10.1016/0960-894X(95)00398-D
44570783 19369 0 None - 1 Rat 7.1 pKi = 7.1 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation counting
ChEMBL 325 7 2 5 2.5 C=CCNCC(O)COc1cccc2c(=O)c3ccccc3oc12 10.1016/j.bmc.2008.12.031
CHEMBL1186914 19369 0 None - 1 Rat 7.1 pKi = 7.1 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation counting
ChEMBL 325 7 2 5 2.5 C=CCNCC(O)COc1cccc2c(=O)c3ccccc3oc12 10.1016/j.bmc.2008.12.031
CHEMBL482396 19369 0 None - 1 Rat 7.1 pKi = 7.1 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation counting
ChEMBL 325 7 2 5 2.5 C=CCNCC(O)COc1cccc2c(=O)c3ccccc3oc12 10.1016/j.bmc.2008.12.031
127046950 146823 0 None -4 6 Mouse 7.1 pKi = 7.1 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 437 12 4 6 4.0 COc1cc(CCNC[C@H](O)c2ccc(O)c(O)c2)ccc1OCCCc1ccccc1 10.1021/acs.jmedchem.9b00349
CHEMBL3800303 146823 0 None -4 6 Mouse 7.1 pKi = 7.1 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 437 12 4 6 4.0 COc1cc(CCNC[C@H](O)c2ccc(O)c(O)c2)ccc1OCCCc1ccccc1 10.1021/acs.jmedchem.9b00349
127046950 146823 0 None -4 6 Mouse 7.1 pKi = 7.1 Binding
Displacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cellsDisplacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cells
ChEMBL 437 12 4 6 4.0 COc1cc(CCNC[C@H](O)c2ccc(O)c(O)c2)ccc1OCCCc1ccccc1 10.1016/j.bmc.2016.04.028
CHEMBL3800303 146823 0 None -4 6 Mouse 7.1 pKi = 7.1 Binding
Displacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cellsDisplacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cells
ChEMBL 437 12 4 6 4.0 COc1cc(CCNC[C@H](O)c2ccc(O)c(O)c2)ccc1OCCCc1ccccc1 10.1016/j.bmc.2016.04.028
2736067 94305 73 None 93 5 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysisDisplacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis
ChEMBL 230 1 1 2 2.4 Clc1cc(Cl)cc(N2CCNCC2)c1 10.1021/jm400140q
CHEMBL2335158 94305 73 None 93 5 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysisDisplacement of [3H]dihydroalprenolol from human wild type beta1 adrenergic receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis
ChEMBL 230 1 1 2 2.4 Clc1cc(Cl)cc(N2CCNCC2)c1 10.1021/jm400140q
10442852 17986 0 None -1 2 Rat 6.1 pKi = 6.1 Binding
Binding affinity against beta-1-adrenergic receptor in rat brainBinding affinity against beta-1-adrenergic receptor in rat brain
ChEMBL 202 6 2 4 1.1 CCCO/N=C/C(O)CNC(C)(C)C 10.1021/jm00036a018
CHEMBL1178755 17986 0 None -1 2 Rat 6.1 pKi = 6.1 Binding
Binding affinity against beta-1-adrenergic receptor in rat brainBinding affinity against beta-1-adrenergic receptor in rat brain
ChEMBL 202 6 2 4 1.1 CCCO/N=C/C(O)CNC(C)(C)C 10.1021/jm00036a018
CHEMBL39706 17986 0 None -1 2 Rat 6.1 pKi = 6.1 Binding
Binding affinity against beta-1-adrenergic receptor in rat brainBinding affinity against beta-1-adrenergic receptor in rat brain
ChEMBL 202 6 2 4 1.1 CCCO/N=C/C(O)CNC(C)(C)C 10.1021/jm00036a018
10012704 17993 0 None 1 2 Rat 6.1 pKi = 6.1 Binding
Binding affinity to rat brain membrane adrenergic beta-1 receptorBinding affinity to rat brain membrane adrenergic beta-1 receptor
ChEMBL 188 5 2 4 0.8 CCO/N=C/C(O)CNC(C)(C)C 10.1021/acs.jmedchem.1c01215
CHEMBL1178768 17993 0 None 1 2 Rat 6.1 pKi = 6.1 Binding
Binding affinity to rat brain membrane adrenergic beta-1 receptorBinding affinity to rat brain membrane adrenergic beta-1 receptor
ChEMBL 188 5 2 4 0.8 CCO/N=C/C(O)CNC(C)(C)C 10.1021/acs.jmedchem.1c01215
CHEMBL39987 17993 0 None 1 2 Rat 6.1 pKi = 6.1 Binding
Binding affinity to rat brain membrane adrenergic beta-1 receptorBinding affinity to rat brain membrane adrenergic beta-1 receptor
ChEMBL 188 5 2 4 0.8 CCO/N=C/C(O)CNC(C)(C)C 10.1021/acs.jmedchem.1c01215
146025727 178464 0 None -316 27 Human 5.1 pKi = 5.1 Binding
Displacement of [125I]-pindolol from recombinant human beta1 adrenergic receptor expressed in CHO Flp-In cells measured after 90 mins by microbeta scintillation counting methodDisplacement of [125I]-pindolol from recombinant human beta1 adrenergic receptor expressed in CHO Flp-In cells measured after 90 mins by microbeta scintillation counting method
ChEMBL 411 3 0 5 6.4 FC(F)(F)c1cc(Oc2nccc3ccsc23)ccc1-c1cccc2nccn12 10.1021/acs.jmedchem.9b00351
CHEMBL4466483 178464 0 None -316 27 Human 5.1 pKi = 5.1 Binding
Displacement of [125I]-pindolol from recombinant human beta1 adrenergic receptor expressed in CHO Flp-In cells measured after 90 mins by microbeta scintillation counting methodDisplacement of [125I]-pindolol from recombinant human beta1 adrenergic receptor expressed in CHO Flp-In cells measured after 90 mins by microbeta scintillation counting method
ChEMBL 411 3 0 5 6.4 FC(F)(F)c1cc(Oc2nccc3ccsc23)ccc1-c1cccc2nccn12 10.1021/acs.jmedchem.9b00351
130442572 178687 0 None -181 24 Human 5.1 pKi = 5.1 Binding
Displacement of [125I]-pindolol from recombinant human beta1 adrenergic receptor expressed in CHO Flp-In cells measured after 90 mins by microbeta scintillation counting methodDisplacement of [125I]-pindolol from recombinant human beta1 adrenergic receptor expressed in CHO Flp-In cells measured after 90 mins by microbeta scintillation counting method
ChEMBL 395 3 0 5 6.0 FC(F)(F)c1cc(Oc2nccc3occc23)ccc1-c1cccc2nccn12 10.1021/acs.jmedchem.9b00351
CHEMBL4469848 178687 0 None -181 24 Human 5.1 pKi = 5.1 Binding
Displacement of [125I]-pindolol from recombinant human beta1 adrenergic receptor expressed in CHO Flp-In cells measured after 90 mins by microbeta scintillation counting methodDisplacement of [125I]-pindolol from recombinant human beta1 adrenergic receptor expressed in CHO Flp-In cells measured after 90 mins by microbeta scintillation counting method
ChEMBL 395 3 0 5 6.0 FC(F)(F)c1cc(Oc2nccc3occc23)ccc1-c1cccc2nccn12 10.1021/acs.jmedchem.9b00351
145946488 174316 0 None -46 2 Rat 6.1 pKi = 6.1 Binding
Displacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysisDisplacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysis
ChEMBL 435 10 2 7 3.4 COc1ccccc1OCCNCC(O)COc1cccc2c(=O)c3ccccc3oc12 10.1016/j.bmc.2018.04.038
CHEMBL4127540 174316 0 None -46 2 Rat 6.1 pKi = 6.1 Binding
Displacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysisDisplacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysis
ChEMBL 435 10 2 7 3.4 COc1ccccc1OCCNCC(O)COc1cccc2c(=O)c3ccccc3oc12 10.1016/j.bmc.2018.04.038
CHEMBL4300195 174316 0 None -46 2 Rat 6.1 pKi = 6.1 Binding
Displacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysisDisplacement of [3H]-CGP-12177 from adrenergic beta1 receptor in Wistar rat cortex incubated for 60 mins by microbeta liquid scintillation counting analysis
ChEMBL 435 10 2 7 3.4 COc1ccccc1OCCNCC(O)COc1cccc2c(=O)c3ccccc3oc12 10.1016/j.bmc.2018.04.038
52943770 24139 0 None -9 3 Human 5.1 pKi = 5.1 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 492 8 4 9 3.8 Oc1ccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)cc1O 10.1016/j.bmcl.2010.08.039
CHEMBL1257438 24139 0 None -9 3 Human 5.1 pKi = 5.1 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 492 8 4 9 3.8 Oc1ccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)cc1O 10.1016/j.bmcl.2010.08.039
181743 185351 5 None -4265 22 Human 5.1 pKi = 5.1 Binding
Displacement of [125I]Iodopindolol from human adrenergic beta-1 receptorDisplacement of [125I]Iodopindolol from human adrenergic beta-1 receptor
ChEMBL 339 2 0 5 3.2 COc1cc2c3c(c1OC)-c1cc4c(cc1CC3N(C)CC2)OCO4 10.1016/j.bmcl.2009.11.053
CHEMBL467094 185351 5 None -4265 22 Human 5.1 pKi = 5.1 Binding
Displacement of [125I]Iodopindolol from human adrenergic beta-1 receptorDisplacement of [125I]Iodopindolol from human adrenergic beta-1 receptor
ChEMBL 339 2 0 5 3.2 COc1cc2c3c(c1OC)-c1cc4c(cc1CC3N(C)CC2)OCO4 10.1016/j.bmcl.2009.11.053
155513731 176572 0 None -2 2 Mouse 6.1 pKi = 6.1 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 241 6 4 5 0.8 CC(C)NC[C@@H](O)COc1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
CHEMBL4439238 176572 0 None -2 2 Mouse 6.1 pKi = 6.1 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
ChEMBL 241 6 4 5 0.8 CC(C)NC[C@@H](O)COc1ccc(O)c(O)c1 10.1021/acs.jmedchem.9b00349
25120700 88014 0 None -5 2 Human 6.1 pKi = 6.1 Binding
Binding affinity to alpha1 adrenoceptorBinding affinity to alpha1 adrenoceptor
ChEMBL 369 7 1 5 3.0 COc1ccc(N2CCN(CC[C@@H](OC(N)=O)c3ccccc3)CC2)cc1 10.1016/j.bmcl.2012.02.023
CHEMBL2158704 88014 0 None -5 2 Human 6.1 pKi = 6.1 Binding
Binding affinity to alpha1 adrenoceptorBinding affinity to alpha1 adrenoceptor
ChEMBL 369 7 1 5 3.0 COc1ccc(N2CCN(CC[C@@H](OC(N)=O)c3ccccc3)CC2)cc1 10.1016/j.bmcl.2012.02.023
65772 67177 8 None -4 6 Guinea pig 7.1 pKi = 7.1 Binding
Binding affinity against Beta-1 adrenergic receptor in guinea pig left ventricleBinding affinity against Beta-1 adrenergic receptor in guinea pig left ventricle
ChEMBL 345 5 3 6 2.6 COc1cc(C[C@@H]2NCCc3cc(O)c(O)cc32)cc(OC)c1OC 10.1021/jm00081a007
CHEMBL174984 67177 8 None -4 6 Guinea pig 7.1 pKi = 7.1 Binding
Binding affinity against Beta-1 adrenergic receptor in guinea pig left ventricleBinding affinity against Beta-1 adrenergic receptor in guinea pig left ventricle
ChEMBL 345 5 3 6 2.6 COc1cc(C[C@@H]2NCCc3cc(O)c(O)cc32)cc(OC)c1OC 10.1021/jm00081a007
131487 11753 13 None - 1 Rat 4.1 pKi = 4.1 Binding
Compound was evaluated for the inhibition of binding of [3H]dihydroalprenolol from beta-1 adrenergic receptor of rat cerebral cortical membranesCompound was evaluated for the inhibition of binding of [3H]dihydroalprenolol from beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 273 5 4 5 1.4 CC(C)(C)NCC(O)COc1cc(O)c(O)cc1F 10.1021/jm00107a027
CHEMBL10494 11753 13 None - 1 Rat 4.1 pKi = 4.1 Binding
Compound was evaluated for the inhibition of binding of [3H]dihydroalprenolol from beta-1 adrenergic receptor of rat cerebral cortical membranesCompound was evaluated for the inhibition of binding of [3H]dihydroalprenolol from beta-1 adrenergic receptor of rat cerebral cortical membranes
ChEMBL 273 5 4 5 1.4 CC(C)(C)NCC(O)COc1cc(O)c(O)cc1F 10.1021/jm00107a027
44396729 73636 0 None -34 3 Human 7.1 pKi = 7.1 Binding
Binding inhibition constant was determined by inhibition of [125I]-iodocyanopindolol binding to Beta-1 adrenergic receptorBinding inhibition constant was determined by inhibition of [125I]-iodocyanopindolol binding to Beta-1 adrenergic receptor
ChEMBL 528 10 5 7 2.8 CS(=O)(=O)c1cccc2c(CCNC[C@H](O)c3cccc(NS(=O)(=O)c4cccc(N)c4)c3)c[nH]c12 10.1016/j.bmcl.2004.09.054
CHEMBL186247 73636 0 None -34 3 Human 7.1 pKi = 7.1 Binding
Binding inhibition constant was determined by inhibition of [125I]-iodocyanopindolol binding to Beta-1 adrenergic receptorBinding inhibition constant was determined by inhibition of [125I]-iodocyanopindolol binding to Beta-1 adrenergic receptor
ChEMBL 528 10 5 7 2.8 CS(=O)(=O)c1cccc2c(CCNC[C@H](O)c3cccc(NS(=O)(=O)c4cccc(N)c4)c3)c[nH]c12 10.1016/j.bmcl.2004.09.054
46889770 13493 0 None -5 3 Human 7.1 pKi = 7.1 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 306 7 2 4 2.2 CC(C)c1ccccc1OCC(O)CNC1CCN(C)CC1 10.1016/j.bmcl.2010.04.009
CHEMBL1083670 13493 0 None -5 3 Human 7.1 pKi = 7.1 Binding
Displacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cellsDisplacement of [125I]cyanopindolol from human adrenergic beta-1 receptor expressed in CHOK1 cells
ChEMBL 306 7 2 4 2.2 CC(C)c1ccccc1OCC(O)CNC1CCN(C)CC1 10.1016/j.bmcl.2010.04.009
49864335 22387 0 None -4 2 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 338 5 4 5 3.1 CC(C)(C)CC(C)(C)NC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12 10.1016/j.bmcl.2010.06.136
CHEMBL1221543 22387 0 None -4 2 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 338 5 4 5 3.1 CC(C)(C)CC(C)(C)NC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12 10.1016/j.bmcl.2010.06.136
49864357 22394 0 None -45 2 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 397 6 4 7 3.1 Cc1onc(-c2ccccc2)c1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12 10.1016/j.bmcl.2010.06.136
CHEMBL1221588 22394 0 None -45 2 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 397 6 4 7 3.1 Cc1onc(-c2ccccc2)c1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12 10.1016/j.bmcl.2010.06.136
4183 8806 68 None -2 3 Human 7.0 pKi = 7.0 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 392 6 4 4 3.1 CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O 10.1016/j.bmcl.2014.06.014
6918554 8806 68 None -2 3 Human 7.0 pKi = 7.0 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 392 6 4 4 3.1 CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O 10.1016/j.bmcl.2014.06.014
7455 8806 68 None -2 3 Human 7.0 pKi = 7.0 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 392 6 4 4 3.1 CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O 10.1016/j.bmcl.2014.06.014
CHEMBL1095777 8806 68 None -2 3 Human 7.0 pKi = 7.0 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 392 6 4 4 3.1 CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O 10.1016/j.bmcl.2014.06.014
DB05039 8806 68 None -2 3 Human 7.0 pKi = 7.0 Binding
Displacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assayDisplacement of [125I]iodo-(+/-)-cyanopindolol from human adrenergic beta1 receptor expressed in CHO cells after 3 hrs by radio-ligand binding assay
ChEMBL 392 6 4 4 3.1 CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O 10.1016/j.bmcl.2014.06.014
4183 8806 68 None -2 3 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 392 6 4 4 3.1 CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O 10.1016/j.bmcl.2010.06.136
6918554 8806 68 None -2 3 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 392 6 4 4 3.1 CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O 10.1016/j.bmcl.2010.06.136
7455 8806 68 None -2 3 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 392 6 4 4 3.1 CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O 10.1016/j.bmcl.2010.06.136
CHEMBL1095777 8806 68 None -2 3 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 392 6 4 4 3.1 CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O 10.1016/j.bmcl.2010.06.136
DB05039 8806 68 None -2 3 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
ChEMBL 392 6 4 4 3.1 CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O 10.1016/j.bmcl.2010.06.136
9894801 127515 0 None -4 2 Human 5.0 pKi = 5.0 Binding
Inhibition of 125 I-Iodocyanopindolol binding to Beta-1 adrenergic receptorInhibition of 125 I-Iodocyanopindolol binding to Beta-1 adrenergic receptor
ChEMBL 592 11 5 10 1.7 CS(=O)(=O)Nc1cc([C@@H](O)CNC2CCN(c3ccc(CC4SC(=O)N(CC(=O)O)C4=O)cc3)CC2)ccc1O 10.1016/s0960-894x(01)00147-0
CHEMBL354906 127515 0 None -4 2 Human 5.0 pKi = 5.0 Binding
Inhibition of 125 I-Iodocyanopindolol binding to Beta-1 adrenergic receptorInhibition of 125 I-Iodocyanopindolol binding to Beta-1 adrenergic receptor
ChEMBL 592 11 5 10 1.7 CS(=O)(=O)Nc1cc([C@@H](O)CNC2CCN(c3ccc(CC4SC(=O)N(CC(=O)O)C4=O)cc3)CC2)ccc1O 10.1016/s0960-894x(01)00147-0
24936627 24458 0 None -41 3 Human 5.0 pKi = 5.0 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 444 8 4 9 2.2 Cc1csc2ncnc(N3CCC(NCC(O)COc4ccc(O)c(CO)c4)CC3)c12 10.1016/j.bmcl.2010.08.039
CHEMBL1258485 24458 0 None -41 3 Human 5.0 pKi = 5.0 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 444 8 4 9 2.2 Cc1csc2ncnc(N3CCC(NCC(O)COc4ccc(O)c(CO)c4)CC3)c12 10.1016/j.bmcl.2010.08.039
52949489 24319 0 None -30 3 Human 6.0 pKi = 6.0 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 490 9 2 8 4.4 COc1cccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)c1 10.1016/j.bmcl.2010.08.039
CHEMBL1258024 24319 0 None -30 3 Human 6.0 pKi = 6.0 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 490 9 2 8 4.4 COc1cccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)c1 10.1016/j.bmcl.2010.08.039
9827999 137682 0 None 7 2 Human 5.0 pKi = 5.0 Binding
Inhibition of 125 I-Iodocyanopindolol binding to Beta-1 adrenergic receptorInhibition of 125 I-Iodocyanopindolol binding to Beta-1 adrenergic receptor
ChEMBL 519 9 5 10 0.5 CS(=O)(=O)Nc1cc([C@@H](O)CNC2CCN(c3ccc(Cn4oc(=O)[nH]c4=O)cc3)CC2)ccc1O 10.1016/s0960-894x(01)00147-0
CHEMBL368584 137682 0 None 7 2 Human 5.0 pKi = 5.0 Binding
Inhibition of 125 I-Iodocyanopindolol binding to Beta-1 adrenergic receptorInhibition of 125 I-Iodocyanopindolol binding to Beta-1 adrenergic receptor
ChEMBL 519 9 5 10 0.5 CS(=O)(=O)Nc1cc([C@@H](O)CNC2CCN(c3ccc(Cn4oc(=O)[nH]c4=O)cc3)CC2)ccc1O 10.1016/s0960-894x(01)00147-0
130442480 182049 0 None -117 24 Human 5.0 pKi = 5.0 Binding
Displacement of [125I]-pindolol from recombinant human beta1 adrenergic receptor expressed in CHO Flp-In cells measured after 90 mins by microbeta scintillation counting methodDisplacement of [125I]-pindolol from recombinant human beta1 adrenergic receptor expressed in CHO Flp-In cells measured after 90 mins by microbeta scintillation counting method
ChEMBL 410 3 0 6 5.7 Cc1ncc2nccn2c1-c1ccc(Oc2nccc3occc23)cc1C(F)(F)F 10.1021/acs.jmedchem.9b00351
CHEMBL4572614 182049 0 None -117 24 Human 5.0 pKi = 5.0 Binding
Displacement of [125I]-pindolol from recombinant human beta1 adrenergic receptor expressed in CHO Flp-In cells measured after 90 mins by microbeta scintillation counting methodDisplacement of [125I]-pindolol from recombinant human beta1 adrenergic receptor expressed in CHO Flp-In cells measured after 90 mins by microbeta scintillation counting method
ChEMBL 410 3 0 6 5.7 Cc1ncc2nccn2c1-c1ccc(Oc2nccc3occc23)cc1C(F)(F)F 10.1021/acs.jmedchem.9b00351
4407909 199645 1 None -16 10 Human 6.0 pKi = 6.0 Binding
Binding affinity to beta1 receptor (unknown origin) assessed as inhibition constantBinding affinity to beta1 receptor (unknown origin) assessed as inhibition constant
ChEMBL 356 4 2 4 3.6 COc1cc(OC)c(C2NCCc3c2[nH]c2ccc(F)cc32)cc1OC 10.1021/acsmedchemlett.1c00694
CHEMBL5182943 199645 1 None -16 10 Human 6.0 pKi = 6.0 Binding
Binding affinity to beta1 receptor (unknown origin) assessed as inhibition constantBinding affinity to beta1 receptor (unknown origin) assessed as inhibition constant
ChEMBL 356 4 2 4 3.6 COc1cc(OC)c(C2NCCc3c2[nH]c2ccc(F)cc32)cc1OC 10.1021/acsmedchemlett.1c00694
CHEMBL5221893 199645 1 None -16 10 Human 6.0 pKi = 6.0 Binding
Binding affinity to beta1 receptor (unknown origin) assessed as inhibition constantBinding affinity to beta1 receptor (unknown origin) assessed as inhibition constant
ChEMBL 356 4 2 4 3.6 COc1cc(OC)c(C2NCCc3c2[nH]c2ccc(F)cc32)cc1OC 10.1021/acsmedchemlett.1c00694
10112744 161434 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 418 9 2 7 4.0 O[C@@H](CNCCOc1ccc(-c2csc(-c3ccncc3)n2)cc1)c1cccnc1 10.1016/j.bmcl.2007.06.072
CHEMBL399522 161434 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]iodocyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 418 9 2 7 4.0 O[C@@H](CNCCOc1ccc(-c2csc(-c3ccncc3)n2)cc1)c1cccnc1 10.1016/j.bmcl.2007.06.072
128658 40749 7 None -11 5 Guinea pig 7.0 pKi = 7.0 Binding
Binding affinity against beta-1 adrenergic receptor in guinea pig left ventricleBinding affinity against beta-1 adrenergic receptor in guinea pig left ventricle
ChEMBL 363 5 3 6 2.7 COc1cc(CC2NCCc3cc(O)c(O)c(F)c32)cc(OC)c1OC 10.1021/jm00081a007
CHEMBL142428 40749 7 None -11 5 Guinea pig 7.0 pKi = 7.0 Binding
Binding affinity against beta-1 adrenergic receptor in guinea pig left ventricleBinding affinity against beta-1 adrenergic receptor in guinea pig left ventricle
ChEMBL 363 5 3 6 2.7 COc1cc(CC2NCCc3cc(O)c(O)c(F)c32)cc(OC)c1OC 10.1021/jm00081a007
2303 9961 68 None -46 26 Rat 5.0 pKi = 5.0 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation counting
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmc.2008.12.031
4946 9961 68 None -46 26 Rat 5.0 pKi = 5.0 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation counting
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmc.2008.12.031
564 9961 68 None -46 26 Rat 5.0 pKi = 5.0 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation counting
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmc.2008.12.031
63 9961 68 None -46 26 Rat 5.0 pKi = 5.0 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation counting
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmc.2008.12.031
91536 9961 68 None -46 26 Rat 5.0 pKi = 5.0 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation counting
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmc.2008.12.031
CHEMBL27 9961 68 None -46 26 Rat 5.0 pKi = 5.0 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation counting
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmc.2008.12.031
CHEMBL452861 9961 68 None -46 26 Rat 5.0 pKi = 5.0 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation counting
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmc.2008.12.031
DB00571 9961 68 None -46 26 Rat 5.0 pKi = 5.0 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation counting
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1016/j.bmc.2008.12.031
24936489 24290 0 None -12 3 Human 6.0 pKi = 6.0 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 476 8 3 8 4.1 Oc1ccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)cc1 10.1016/j.bmcl.2010.08.039
CHEMBL1257914 24290 0 None -12 3 Human 6.0 pKi = 6.0 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 476 8 3 8 4.1 Oc1ccc(OCC(O)CNC2CCN(c3ncnc4scc(-c5ccccc5)c34)CC2)cc1 10.1016/j.bmcl.2010.08.039
71612644 140141 0 None 2 2 Human 5.0 pKi = 5.0 Binding
Inhibition Assay: Human recombinant adrenergic β1 receptors expressed in CHO-K1 cells are used in modified Tris-HCl buffer pH 7.4. A 25 aliquot is incubated with 0.03 nM [125I]Cyanopindolol for 120 minutes at 25° C. Non-specific binding is estimated in the presence of 100 μM S(−)-Propranolol. Receptors are filtered and washed, the filters are then counted to determine [125I]Cyanopindolol specifically bound. Compounds are screened at 10 μM.Inhibition Assay: Human recombinant adrenergic β1 receptors expressed in CHO-K1 cells are used in modified Tris-HCl buffer pH 7.4. A 25 aliquot is incubated with 0.03 nM [125I]Cyanopindolol for 120 minutes at 25° C. Non-specific binding is estimated in the presence of 100 μM S(−)-Propranolol. Receptors are filtered and washed, the filters are then counted to determine [125I]Cyanopindolol specifically bound. Compounds are screened at 10 μM.
ChEMBL 303 7 2 5 0.5 N#CC1CCCN1C(=O)CNCC(O)COc1ccccc1 nan
CHEMBL3704833 140141 0 None 2 2 Human 5.0 pKi = 5.0 Binding
Inhibition Assay: Human recombinant adrenergic β1 receptors expressed in CHO-K1 cells are used in modified Tris-HCl buffer pH 7.4. A 25 aliquot is incubated with 0.03 nM [125I]Cyanopindolol for 120 minutes at 25° C. Non-specific binding is estimated in the presence of 100 μM S(−)-Propranolol. Receptors are filtered and washed, the filters are then counted to determine [125I]Cyanopindolol specifically bound. Compounds are screened at 10 μM.Inhibition Assay: Human recombinant adrenergic β1 receptors expressed in CHO-K1 cells are used in modified Tris-HCl buffer pH 7.4. A 25 aliquot is incubated with 0.03 nM [125I]Cyanopindolol for 120 minutes at 25° C. Non-specific binding is estimated in the presence of 100 μM S(−)-Propranolol. Receptors are filtered and washed, the filters are then counted to determine [125I]Cyanopindolol specifically bound. Compounds are screened at 10 μM.
ChEMBL 303 7 2 5 0.5 N#CC1CCCN1C(=O)CNCC(O)COc1ccccc1 nan
52943383 24353 0 None -16 3 Human 6.0 pKi = 6 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 544 9 2 8 5.3 OC(CNC1CCN(c2ncnc3scc(-c4ccccc4)c23)CC1)COc1cccc(OC(F)(F)F)c1 10.1016/j.bmcl.2010.08.039
CHEMBL1258142 24353 0 None -16 3 Human 6.0 pKi = 6 Binding
Displacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cellsDisplacement of [125I]-cyanopindolol from human adrenergic beta-1 receptor expressed in CHO cells
ChEMBL 544 9 2 8 5.3 OC(CNC1CCN(c2ncnc3scc(-c4ccccc4)c23)CC1)COc1cccc(OC(F)(F)F)c1 10.1016/j.bmcl.2010.08.039
1016 10519 78 None -43 35 Human 5.0 pKi = 5 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
2561 10519 78 None -43 35 Human 5.0 pKi = 5 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
2733526 10519 78 None -43 35 Human 5.0 pKi = 5 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
5384 10519 78 None -43 35 Human 5.0 pKi = 5 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
CHEMBL83 10519 78 None -43 35 Human 5.0 pKi = 5 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
DB00675 10519 78 None -43 35 Human 5.0 pKi = 5 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
11962616 7009 14 None - 0 Human 7.4 pIC50 = 7.4 Binding
Membrane radioligand displacement assay using [<sup>3</sup>H]CGP12177 as tracer.Membrane radioligand displacement assay using [<sup>3</sup>H]CGP12177 as tracer.
Guide to Pharmacology 460 13 4 5 4.2 O=c1ccc2c([nH]1)c(O)ccc2[C@H](CNCCCCCCOCC(c1ccccc1)(F)F)O 22588259
9326 7009 14 None - 0 Human 7.4 pIC50 = 7.4 Binding
Membrane radioligand displacement assay using [<sup>3</sup>H]CGP12177 as tracer.Membrane radioligand displacement assay using [<sup>3</sup>H]CGP12177 as tracer.
Guide to Pharmacology 460 13 4 5 4.2 O=c1ccc2c([nH]1)c(O)ccc2[C@H](CNCCCCCCOCC(c1ccccc1)(F)F)O 22588259
CHEMBL3039530 7009 14 None - 0 Human 7.4 pIC50 = 7.4 Binding
Membrane radioligand displacement assay using [<sup>3</sup>H]CGP12177 as tracer.Membrane radioligand displacement assay using [<sup>3</sup>H]CGP12177 as tracer.
Guide to Pharmacology 460 13 4 5 4.2 O=c1ccc2c([nH]1)c(O)ccc2[C@H](CNCCCCCCOCC(c1ccccc1)(F)F)O 22588259
DB12100 7009 14 None - 0 Human 7.4 pIC50 = 7.4 Binding
Membrane radioligand displacement assay using [<sup>3</sup>H]CGP12177 as tracer.Membrane radioligand displacement assay using [<sup>3</sup>H]CGP12177 as tracer.
Guide to Pharmacology 460 13 4 5 4.2 O=c1ccc2c([nH]1)c(O)ccc2[C@H](CNCCCCCCOCC(c1ccccc1)(F)F)O 22588259
2803 7742 58 None -134 19 Guinea pig 8.4 pKd = 8.4 Binding
The compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atriaThe compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atria
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
516 7742 58 None -134 19 Guinea pig 8.4 pKd = 8.4 Binding
The compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atriaThe compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atria
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
704 7742 58 None -134 19 Guinea pig 8.4 pKd = 8.4 Binding
The compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atriaThe compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atria
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
CHEMBL134 7742 58 None -134 19 Guinea pig 8.4 pKd = 8.4 Binding
The compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atriaThe compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atria
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
DB00575 7742 58 None -134 19 Guinea pig 8.4 pKd = 8.4 Binding
The compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atriaThe compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atria
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
3486 9931 56 None -1 11 Rat 8.2 pKd = 8.2 Binding
Antagonist activity at beta1 adrenergic receptor in isolated rat atriaAntagonist activity at beta1 adrenergic receptor in isolated rat atria
Drug Central 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C None
4883 9931 56 None -1 11 Rat 8.2 pKd = 8.2 Binding
Antagonist activity at beta1 adrenergic receptor in isolated rat atriaAntagonist activity at beta1 adrenergic receptor in isolated rat atria
Drug Central 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C None
555 9931 56 None -1 11 Rat 8.2 pKd = 8.2 Binding
Antagonist activity at beta1 adrenergic receptor in isolated rat atriaAntagonist activity at beta1 adrenergic receptor in isolated rat atria
Drug Central 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C None
CHEMBL6995 9931 56 None -1 11 Rat 8.2 pKd = 8.2 Binding
Antagonist activity at beta1 adrenergic receptor in isolated rat atriaAntagonist activity at beta1 adrenergic receptor in isolated rat atria
Drug Central 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C None
DB01297 9931 56 None -1 11 Rat 8.2 pKd = 8.2 Binding
Antagonist activity at beta1 adrenergic receptor in isolated rat atriaAntagonist activity at beta1 adrenergic receptor in isolated rat atria
Drug Central 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C None
3083544 33582 51 None -5 5 Human 8.2 pKd = 8.2 Binding
displacement of [125I]-iodopindololreceptor in Sf9 cells expressing human recombinant beta2displacement of [125I]-iodopindololreceptor in Sf9 cells expressing human recombinant beta2
Drug Central 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 None
CHEMBL1200811 33582 51 None -5 5 Human 8.2 pKd = 8.2 Binding
displacement of [125I]-iodopindololreceptor in Sf9 cells expressing human recombinant beta2displacement of [125I]-iodopindololreceptor in Sf9 cells expressing human recombinant beta2
Drug Central 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 None
CHEMBL1363 33582 51 None -5 5 Human 8.2 pKd = 8.2 Binding
displacement of [125I]-iodopindololreceptor in Sf9 cells expressing human recombinant beta2displacement of [125I]-iodopindololreceptor in Sf9 cells expressing human recombinant beta2
Drug Central 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 None
CHEMBL1951071 33582 51 None -5 5 Human 8.2 pKd = 8.2 Binding
displacement of [125I]-iodopindololreceptor in Sf9 cells expressing human recombinant beta2displacement of [125I]-iodopindololreceptor in Sf9 cells expressing human recombinant beta2
Drug Central 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 None
CHEMBL605993 33582 51 None -5 5 Human 8.2 pKd = 8.2 Binding
displacement of [125I]-iodopindololreceptor in Sf9 cells expressing human recombinant beta2displacement of [125I]-iodopindololreceptor in Sf9 cells expressing human recombinant beta2
Drug Central 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 None
3486 9931 56 None -6 11 Guinea pig 8.2 pKd = 8.2 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
Drug Central 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C None
4883 9931 56 None -6 11 Guinea pig 8.2 pKd = 8.2 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
Drug Central 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C None
555 9931 56 None -6 11 Guinea pig 8.2 pKd = 8.2 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
Drug Central 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C None
CHEMBL6995 9931 56 None -6 11 Guinea pig 8.2 pKd = 8.2 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
Drug Central 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C None
DB01297 9931 56 None -6 11 Guinea pig 8.2 pKd = 8.2 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
Drug Central 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C None
1054 8367 54 None 1 3 Guinea pig 8.2 pKd = 8.2 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
Drug Central 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O None
59768 8367 54 None 1 3 Guinea pig 8.2 pKd = 8.2 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
Drug Central 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O None
7178 8367 54 None 1 3 Guinea pig 8.2 pKd = 8.2 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
Drug Central 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O None
CHEMBL768 8367 54 None 1 3 Guinea pig 8.2 pKd = 8.2 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
Drug Central 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O None
DB00187 8367 54 None 1 3 Guinea pig 8.2 pKd = 8.2 Binding
Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparationAbility to block Beta-1 adrenergic receptor in guinea pig right atria preparation
Drug Central 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O None
2249 7300 111 None 2 12 Guinea pig 8.1 pKd = 8.1 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
Drug Central 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C None
255 7300 111 None 2 12 Guinea pig 8.1 pKd = 8.1 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
Drug Central 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C None
548 7300 111 None 2 12 Guinea pig 8.1 pKd = 8.1 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
Drug Central 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C None
CHEMBL24 7300 111 None 2 12 Guinea pig 8.1 pKd = 8.1 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
Drug Central 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C None
DB00335 7300 111 None 2 12 Guinea pig 8.1 pKd = 8.1 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
Drug Central 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C None
175540 126033 49 None -1 5 Guinea pig 8.1 pKd = 8.1 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
Drug Central 266 8 3 4 0.5 CC(C)NC[C@H](O)COc1ccc(CC(N)=O)cc1 None
CHEMBL343633 126033 49 None -1 5 Guinea pig 8.1 pKd = 8.1 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
Drug Central 266 8 3 4 0.5 CC(C)NC[C@H](O)COc1ccc(CC(N)=O)cc1 None
155774 10868 40 None 6 3 Human 8.1 pKd = 8.1 Binding
Antagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrsAntagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrs
Drug Central 339 8 4 6 -0.2 OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1 None
2848 10868 40 None 6 3 Human 8.1 pKd = 8.1 Binding
Antagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrsAntagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrs
Drug Central 339 8 4 6 -0.2 OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1 None
538 10868 40 None 6 3 Human 8.1 pKd = 8.1 Binding
Antagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrsAntagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrs
Drug Central 339 8 4 6 -0.2 OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1 None
CHEMBL75753 10868 40 None 6 3 Human 8.1 pKd = 8.1 Binding
Antagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrsAntagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrs
Drug Central 339 8 4 6 -0.2 OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1 None
DB13781 10868 40 None 6 3 Human 8.1 pKd = 8.1 Binding
Antagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrsAntagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrs
Drug Central 339 8 4 6 -0.2 OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1 None
1786 9298 85 None -2 11 Guinea pig 8.1 pKd = 8.1 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
Drug Central 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O None
4171 9298 85 None -2 11 Guinea pig 8.1 pKd = 8.1 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
Drug Central 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O None
553 9298 85 None -2 11 Guinea pig 8.1 pKd = 8.1 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
Drug Central 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O None
CHEMBL13 9298 85 None -2 11 Guinea pig 8.1 pKd = 8.1 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
Drug Central 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O None
DB00264 9298 85 None -2 11 Guinea pig 8.1 pKd = 8.1 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
Drug Central 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O None
2369 7409 80 None -4 8 Rat 8.1 pKd = 8.1 Binding
Antagonist activity at rat beta1 adrenoceptorAntagonist activity at rat beta1 adrenoceptor
Drug Central 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C None
356 7409 80 None -4 8 Rat 8.1 pKd = 8.1 Binding
Antagonist activity at rat beta1 adrenoceptorAntagonist activity at rat beta1 adrenoceptor
Drug Central 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C None
549 7409 80 None -4 8 Rat 8.1 pKd = 8.1 Binding
Antagonist activity at rat beta1 adrenoceptorAntagonist activity at rat beta1 adrenoceptor
Drug Central 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C None
CHEMBL423 7409 80 None -4 8 Rat 8.1 pKd = 8.1 Binding
Antagonist activity at rat beta1 adrenoceptorAntagonist activity at rat beta1 adrenoceptor
Drug Central 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C None
DB00195 7409 80 None -4 8 Rat 8.1 pKd = 8.1 Binding
Antagonist activity at rat beta1 adrenoceptorAntagonist activity at rat beta1 adrenoceptor
Drug Central 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C None
18047 210397 21 None 2 5 Guinea pig 8.1 pKd = 8.1 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
Drug Central 223 6 2 3 1.7 Cc1cccc(OCC(O)CNC(C)C)c1 None
CHEMBL67096 210397 21 None 2 5 Guinea pig 8.1 pKd = 8.1 Binding
Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atriumBeta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium
Drug Central 223 6 2 3 1.7 Cc1cccc(OCC(O)CNC(C)C)c1 None
2369 7409 80 None -12 8 Guinea pig 8.1 pKd = 8.1 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
Drug Central 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C None
356 7409 80 None -12 8 Guinea pig 8.1 pKd = 8.1 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
Drug Central 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C None
549 7409 80 None -12 8 Guinea pig 8.1 pKd = 8.1 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
Drug Central 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C None
CHEMBL423 7409 80 None -12 8 Guinea pig 8.1 pKd = 8.1 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
Drug Central 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C None
DB00195 7409 80 None -12 8 Guinea pig 8.1 pKd = 8.1 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
Drug Central 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C None
2303 9961 68 None -15 26 Guinea pig 8.1 pKd = 8.1 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
Drug Central 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
4946 9961 68 None -15 26 Guinea pig 8.1 pKd = 8.1 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
Drug Central 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
564 9961 68 None -15 26 Guinea pig 8.1 pKd = 8.1 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
Drug Central 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
63 9961 68 None -15 26 Guinea pig 8.1 pKd = 8.1 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
Drug Central 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
91536 9961 68 None -15 26 Guinea pig 8.1 pKd = 8.1 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
Drug Central 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
CHEMBL27 9961 68 None -15 26 Guinea pig 8.1 pKd = 8.1 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
Drug Central 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
CHEMBL452861 9961 68 None -15 26 Guinea pig 8.1 pKd = 8.1 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
Drug Central 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
DB00571 9961 68 None -15 26 Guinea pig 8.1 pKd = 8.1 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
Drug Central 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
2369 7409 80 None 3 8 Human 8.1 pKd = 8.1 Binding
NoneNone
Drug Central 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C None
356 7409 80 None 3 8 Human 8.1 pKd = 8.1 Binding
NoneNone
Drug Central 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C None
549 7409 80 None 3 8 Human 8.1 pKd = 8.1 Binding
NoneNone
Drug Central 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C None
CHEMBL423 7409 80 None 3 8 Human 8.1 pKd = 8.1 Binding
NoneNone
Drug Central 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C None
DB00195 7409 80 None 3 8 Human 8.1 pKd = 8.1 Binding
NoneNone
Drug Central 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C None
18047 210397 21 None -2 5 Human 8.0 pKd = 8.0 Binding
Binding affinity to beta-1 adrenergic receptorBinding affinity to beta-1 adrenergic receptor
Drug Central 223 6 2 3 1.7 Cc1cccc(OCC(O)CNC(C)C)c1 None
CHEMBL67096 210397 21 None -2 5 Human 8.0 pKd = 8.0 Binding
Binding affinity to beta-1 adrenergic receptorBinding affinity to beta-1 adrenergic receptor
Drug Central 223 6 2 3 1.7 Cc1cccc(OCC(O)CNC(C)C)c1 None
33624 10593 34 None -3 9 Guinea pig 8.0 pKd = 8.0 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
Drug Central 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C None
4061 10593 34 None -3 9 Guinea pig 8.0 pKd = 8.0 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
Drug Central 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C None
565 10593 34 None -3 9 Guinea pig 8.0 pKd = 8.0 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
Drug Central 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C None
CHEMBL499 10593 34 None -3 9 Guinea pig 8.0 pKd = 8.0 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
Drug Central 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C None
DB00373 10593 34 None -3 9 Guinea pig 8.0 pKd = 8.0 Binding
In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparationsIn vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
Drug Central 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C None
137 7158 52 None -19 12 Human 8.0 pKd = 8.0 Binding
radioligand [3H]CGP12177 0.15nM competition binding; human recombinant beta-adrenoreceptors in Sf9 cellsradioligand [3H]CGP12177 0.15nM competition binding; human recombinant beta-adrenoreceptors in Sf9 cells
Drug Central 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O None
2119 7158 52 None -19 12 Human 8.0 pKd = 8.0 Binding
radioligand [3H]CGP12177 0.15nM competition binding; human recombinant beta-adrenoreceptors in Sf9 cellsradioligand [3H]CGP12177 0.15nM competition binding; human recombinant beta-adrenoreceptors in Sf9 cells
Drug Central 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O None
563 7158 52 None -19 12 Human 8.0 pKd = 8.0 Binding
radioligand [3H]CGP12177 0.15nM competition binding; human recombinant beta-adrenoreceptors in Sf9 cellsradioligand [3H]CGP12177 0.15nM competition binding; human recombinant beta-adrenoreceptors in Sf9 cells
Drug Central 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O None
66368 7158 52 None -19 12 Human 8.0 pKd = 8.0 Binding
radioligand [3H]CGP12177 0.15nM competition binding; human recombinant beta-adrenoreceptors in Sf9 cellsradioligand [3H]CGP12177 0.15nM competition binding; human recombinant beta-adrenoreceptors in Sf9 cells
Drug Central 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O None
CHEMBL266195 7158 52 None -19 12 Human 8.0 pKd = 8.0 Binding
radioligand [3H]CGP12177 0.15nM competition binding; human recombinant beta-adrenoreceptors in Sf9 cellsradioligand [3H]CGP12177 0.15nM competition binding; human recombinant beta-adrenoreceptors in Sf9 cells
Drug Central 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O None
DB00866 7158 52 None -19 12 Human 8.0 pKd = 8.0 Binding
radioligand [3H]CGP12177 0.15nM competition binding; human recombinant beta-adrenoreceptors in Sf9 cellsradioligand [3H]CGP12177 0.15nM competition binding; human recombinant beta-adrenoreceptors in Sf9 cells
Drug Central 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O None
13191 6971 0 None 1 2 Human 10.4 pKd = 10.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 301 5 3 4 2.5 C(C)(C)(C)NC[C@@H](COC1=C2C=C(NC2=C(C=C1)C)C#N)O 26385885
91885640 6971 0 None 1 2 Human 10.4 pKd = 10.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 301 5 3 4 2.5 C(C)(C)(C)NC[C@@H](COC1=C2C=C(NC2=C(C=C1)C)C#N)O 26385885
132 8058 13 None 13 15 Human 10.5 pKd = 10.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 287 5 3 4 2.2 N#Cc1[nH]c2c(c1)c(OCC(CNC(C)(C)C)O)ccc2 20590599
132 8058 13 None 13 15 Human 10.5 pKd = 10.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 287 5 3 4 2.2 N#Cc1[nH]c2c(c1)c(OCC(CNC(C)(C)C)O)ccc2 26385885
155346 8058 13 None 13 15 Human 10.5 pKd = 10.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 287 5 3 4 2.2 N#Cc1[nH]c2c(c1)c(OCC(CNC(C)(C)C)O)ccc2 20590599
155346 8058 13 None 13 15 Human 10.5 pKd = 10.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 287 5 3 4 2.2 N#Cc1[nH]c2c(c1)c(OCC(CNC(C)(C)C)O)ccc2 26385885
CHEMBL378501 8058 13 None 13 15 Human 10.5 pKd = 10.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 287 5 3 4 2.2 N#Cc1[nH]c2c(c1)c(OCC(CNC(C)(C)C)O)ccc2 20590599
CHEMBL378501 8058 13 None 13 15 Human 10.5 pKd = 10.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 287 5 3 4 2.2 N#Cc1[nH]c2c(c1)c(OCC(CNC(C)(C)C)O)ccc2 26385885
12579 9528 0 None -1 2 Rat 8.1 pKd = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 470 14 4 7 3.7 O[C@@H](CNCCOC1=CC=C(C=C1)C(O)=N)COC2=CC3=C(O[C@H](CCCC4CC4)CO3)C=C2 28400472
167993658 9528 0 None -1 2 Rat 8.1 pKd = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 470 14 4 7 3.7 O[C@@H](CNCCOC1=CC=C(C=C1)C(O)=N)COC2=CC3=C(O[C@H](CCCC4CC4)CO3)C=C2 28400472
12580 9529 0 None -1 2 Rat 8.4 pKd = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 482 13 3 7 3.1 O[C@@H](CNCCOC1=CC=C2C(=O)NCC2=C1)COC3=CC4=C(O[C@H](CCCC5CC5)CO4)C=C3 28400472
167993659 9529 0 None -1 2 Rat 8.4 pKd = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 482 13 3 7 3.1 O[C@@H](CNCCOC1=CC=C2C(=O)NCC2=C1)COC3=CC4=C(O[C@H](CCCC5CC5)CO4)C=C3 28400472
487 7580 71 None 1 7 Human 10.0 pKd = 10.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 298 6 3 3 3.1 OC(COc1cccc2c1c1ccccc1[nH]2)CNC(C)C 20590599
487 7580 71 None 1 7 Human 10.0 pKd = 10.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 298 6 3 3 3.1 OC(COc1cccc2c1c1ccccc1[nH]2)CNC(C)C 26385885
569 7580 71 None 1 7 Human 10.0 pKd = 10.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 298 6 3 3 3.1 OC(COc1cccc2c1c1ccccc1[nH]2)CNC(C)C 20590599
569 7580 71 None 1 7 Human 10.0 pKd = 10.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 298 6 3 3 3.1 OC(COc1cccc2c1c1ccccc1[nH]2)CNC(C)C 26385885
71739 7580 71 None 1 7 Human 10.0 pKd = 10.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 298 6 3 3 3.1 OC(COc1cccc2c1c1ccccc1[nH]2)CNC(C)C 20590599
71739 7580 71 None 1 7 Human 10.0 pKd = 10.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 298 6 3 3 3.1 OC(COc1cccc2c1c1ccccc1[nH]2)CNC(C)C 26385885
CHEMBL324665 7580 71 None 1 7 Human 10.0 pKd = 10.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 298 6 3 3 3.1 OC(COc1cccc2c1c1ccccc1[nH]2)CNC(C)C 20590599
CHEMBL324665 7580 71 None 1 7 Human 10.0 pKd = 10.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 298 6 3 3 3.1 OC(COc1cccc2c1c1ccccc1[nH]2)CNC(C)C 26385885
165193 222724 0 125I-ICYP 3 30 Human 10.7 pKi = 10.7 Binding
NoneNone
PDSP KiDatabase 259 6 2 3 2.6 CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O None
62882 222724 0 125I-ICYP 3 30 Human 10.7 pKi = 10.7 Binding
NoneNone
PDSP KiDatabase 259 6 2 3 2.6 CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O None
66366 222724 0 125I-ICYP 3 30 Human 10.7 pKi = 10.7 Binding
NoneNone
PDSP KiDatabase 259 6 2 3 2.6 CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O None
None 223018 0 125I-Pindolol -2 29 Human 9.9 pKi = 9.9 Binding
NoneNone
PDSP KiDatabase 316 7 3 3 3.0 CC(CF)NCC(COC1=CC=CC2=C1C3=CC=CC=C3N2)O None
None 223262 0 125I-ICYP 3 3 Rat 9.7 pKi = 9.7 Binding
NoneNone
PDSP KiDatabase None None None None None
None 223018 0 125I-Pindolol -2 29 Human 9.4 pKi = 9.4 Binding
NoneNone
PDSP KiDatabase 316 7 3 3 3.0 CC(CF)NCC(COC1=CC=CC2=C1C3=CC=CC=C3N2)O None
2176 9901 68 UNDEFINED -4 27 Human 9.3 pKi = 9.3 Binding
NoneNone
PDSP KiDatabase 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C None
4828 9901 68 UNDEFINED -4 27 Human 9.3 pKi = 9.3 Binding
NoneNone
PDSP KiDatabase 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C None
91 9901 68 UNDEFINED -4 27 Human 9.3 pKi = 9.3 Binding
NoneNone
PDSP KiDatabase 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C None
CHEMBL500 9901 68 UNDEFINED -4 27 Human 9.3 pKi = 9.3 Binding
NoneNone
PDSP KiDatabase 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C None
DB00960 9901 68 UNDEFINED -4 27 Human 9.3 pKi = 9.3 Binding
NoneNone
PDSP KiDatabase 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C None
2176 9901 68 125I-ICYP -2 27 Rat 9.2 pKi = 9.2 Binding
NoneNone
PDSP KiDatabase 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C None
4828 9901 68 125I-ICYP -2 27 Rat 9.2 pKi = 9.2 Binding
NoneNone
PDSP KiDatabase 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C None
91 9901 68 125I-ICYP -2 27 Rat 9.2 pKi = 9.2 Binding
NoneNone
PDSP KiDatabase 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C None
CHEMBL500 9901 68 125I-ICYP -2 27 Rat 9.2 pKi = 9.2 Binding
NoneNone
PDSP KiDatabase 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C None
DB00960 9901 68 125I-ICYP -2 27 Rat 9.2 pKi = 9.2 Binding
NoneNone
PDSP KiDatabase 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C None
2303 9961 68 125I-ICYP -46 26 Rat 9.2 pKi = 9.2 Binding
NoneNone
PDSP KiDatabase 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
4946 9961 68 125I-ICYP -46 26 Rat 9.2 pKi = 9.2 Binding
NoneNone
PDSP KiDatabase 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
564 9961 68 125I-ICYP -46 26 Rat 9.2 pKi = 9.2 Binding
NoneNone
PDSP KiDatabase 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
63 9961 68 125I-ICYP -46 26 Rat 9.2 pKi = 9.2 Binding
NoneNone
PDSP KiDatabase 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
91536 9961 68 125I-ICYP -46 26 Rat 9.2 pKi = 9.2 Binding
NoneNone
PDSP KiDatabase 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
CHEMBL27 9961 68 125I-ICYP -46 26 Rat 9.2 pKi = 9.2 Binding
NoneNone
PDSP KiDatabase 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
CHEMBL452861 9961 68 125I-ICYP -46 26 Rat 9.2 pKi = 9.2 Binding
NoneNone
PDSP KiDatabase 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
DB00571 9961 68 125I-ICYP -46 26 Rat 9.2 pKi = 9.2 Binding
NoneNone
PDSP KiDatabase 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
137 7158 52 3H-DHA -3 12 Rat 9.0 pKi = 9.0 Binding
NoneNone
PDSP KiDatabase 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O None
2119 7158 52 3H-DHA -3 12 Rat 9.0 pKi = 9.0 Binding
NoneNone
PDSP KiDatabase 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O None
563 7158 52 3H-DHA -3 12 Rat 9.0 pKi = 9.0 Binding
NoneNone
PDSP KiDatabase 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O None
66368 7158 52 3H-DHA -3 12 Rat 9.0 pKi = 9.0 Binding
NoneNone
PDSP KiDatabase 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O None
CHEMBL266195 7158 52 3H-DHA -3 12 Rat 9.0 pKi = 9.0 Binding
NoneNone
PDSP KiDatabase 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O None
DB00866 7158 52 3H-DHA -3 12 Rat 9.0 pKi = 9.0 Binding
NoneNone
PDSP KiDatabase 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O None
2585 7590 103 125I-CYP -1 22 Human 8.8 pKi = 8.8 Binding
NoneNone
PDSP KiDatabase 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O None
522 7590 103 125I-CYP -1 22 Human 8.8 pKi = 8.8 Binding
NoneNone
PDSP KiDatabase 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O None
551 7590 103 125I-CYP -1 22 Human 8.8 pKi = 8.8 Binding
NoneNone
PDSP KiDatabase 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O None
CHEMBL723 7590 103 125I-CYP -1 22 Human 8.8 pKi = 8.8 Binding
NoneNone
PDSP KiDatabase 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O None
DB01136 7590 103 125I-CYP -1 22 Human 8.8 pKi = 8.8 Binding
NoneNone
PDSP KiDatabase 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O None
123686 8762 51 125I-Pindolol -1 9 Rat 8.7 pKi = 8.7 Binding
NoneNone
PDSP KiDatabase 354 9 4 5 1.7 C1=CC=C(C=C1)NC(=O)NCCNCC(COC2=CC=CC=C2C#N)O None
12581 8762 51 125I-Pindolol -1 9 Rat 8.7 pKi = 8.7 Binding
NoneNone
PDSP KiDatabase 354 9 4 5 1.7 C1=CC=C(C=C1)NC(=O)NCCNCC(COC2=CC=CC=C2C#N)O None
CHEMBL11268 8762 51 125I-Pindolol -1 9 Rat 8.7 pKi = 8.7 Binding
NoneNone
PDSP KiDatabase 354 9 4 5 1.7 C1=CC=C(C=C1)NC(=O)NCCNCC(COC2=CC=CC=C2C#N)O None
2303 9961 68 125I-CYP -9 26 Human 8.7 pKi = 8.7 Binding
NoneNone
PDSP KiDatabase 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
4946 9961 68 125I-CYP -9 26 Human 8.7 pKi = 8.7 Binding
NoneNone
PDSP KiDatabase 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
564 9961 68 125I-CYP -9 26 Human 8.7 pKi = 8.7 Binding
NoneNone
PDSP KiDatabase 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
63 9961 68 125I-CYP -9 26 Human 8.7 pKi = 8.7 Binding
NoneNone
PDSP KiDatabase 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
91536 9961 68 125I-CYP -9 26 Human 8.7 pKi = 8.7 Binding
NoneNone
PDSP KiDatabase 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
CHEMBL27 9961 68 125I-CYP -9 26 Human 8.7 pKi = 8.7 Binding
NoneNone
PDSP KiDatabase 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
CHEMBL452861 9961 68 125I-CYP -9 26 Human 8.7 pKi = 8.7 Binding
NoneNone
PDSP KiDatabase 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
DB00571 9961 68 125I-CYP -9 26 Human 8.7 pKi = 8.7 Binding
NoneNone
PDSP KiDatabase 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
2176 9901 68 125I-ICYP -4 27 Human 8.7 pKi = 8.7 Binding
NoneNone
PDSP KiDatabase 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C None
4828 9901 68 125I-ICYP -4 27 Human 8.7 pKi = 8.7 Binding
NoneNone
PDSP KiDatabase 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C None
91 9901 68 125I-ICYP -4 27 Human 8.7 pKi = 8.7 Binding
NoneNone
PDSP KiDatabase 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C None
CHEMBL500 9901 68 125I-ICYP -4 27 Human 8.7 pKi = 8.7 Binding
NoneNone
PDSP KiDatabase 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C None
DB00960 9901 68 125I-ICYP -4 27 Human 8.7 pKi = 8.7 Binding
NoneNone
PDSP KiDatabase 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C None
487 7580 71 None -8 7 Mouse 8.0 pKi = 8 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
Drug Central 298 6 3 3 3.1 OC(COc1cccc2c1c1ccccc1[nH]2)CNC(C)C None
569 7580 71 None -8 7 Mouse 8.0 pKi = 8 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
Drug Central 298 6 3 3 3.1 OC(COc1cccc2c1c1ccccc1[nH]2)CNC(C)C None
71739 7580 71 None -8 7 Mouse 8.0 pKi = 8 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
Drug Central 298 6 3 3 3.1 OC(COc1cccc2c1c1ccccc1[nH]2)CNC(C)C None
CHEMBL324665 7580 71 None -8 7 Mouse 8.0 pKi = 8 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
Drug Central 298 6 3 3 3.1 OC(COc1cccc2c1c1ccccc1[nH]2)CNC(C)C None
202 8290 77 UNDEFINED -9 33 Rat 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 297 6 1 3 4.6 CNCC[C@@H](c1cccs1)Oc1cccc2c1cccc2 None
60835 8290 77 UNDEFINED -9 33 Rat 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 297 6 1 3 4.6 CNCC[C@@H](c1cccs1)Oc1cccc2c1cccc2 None
972 8290 77 UNDEFINED -9 33 Rat 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 297 6 1 3 4.6 CNCC[C@@H](c1cccs1)Oc1cccc2c1cccc2 None
CHEMBL1175 8290 77 UNDEFINED -9 33 Rat 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 297 6 1 3 4.6 CNCC[C@@H](c1cccs1)Oc1cccc2c1cccc2 None
DB00476 8290 77 UNDEFINED -9 33 Rat 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 297 6 1 3 4.6 CNCC[C@@H](c1cccs1)Oc1cccc2c1cccc2 None
121881 10263 27 125I-CYP -48977 15 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 382 6 1 6 3.4 CCCCN1CCC(CC1)COC(=O)c1cc(Cl)c(c2c1OCCO2)N None
256 10263 27 125I-CYP -48977 15 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 382 6 1 6 3.4 CCCCN1CCC(CC1)COC(=O)c1cc(Cl)c(c2c1OCCO2)N None
CHEMBL68131 10263 27 125I-CYP -48977 15 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 382 6 1 6 3.4 CCCCN1CCC(CC1)COC(=O)c1cc(Cl)c(c2c1OCCO2)N None
46222048 15756 0 UNDEFINED -4365 13 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 260 4 1 2 4.0 CC(C)(C)c1ccc(SCCc2c[nH]cn2)cc1 None
CHEMBL1098230 15756 0 UNDEFINED -4365 13 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 260 4 1 2 4.0 CC(C)(C)c1ccc(SCCc2c[nH]cn2)cc1 None
5656 209845 87 UNDEFINED -7 43 Rat 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 277 5 1 3 3.0 COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1 None
CHEMBL637 209845 87 UNDEFINED -7 43 Rat 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 277 5 1 3 3.0 COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1 None
54841 209906 52 UNDEFINED -1 30 Rat 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 255 6 1 2 3.7 CNCC[C@@H](Oc1ccccc1C)c1ccccc1 None
CHEMBL641 209906 52 UNDEFINED -1 30 Rat 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 255 6 1 2 3.7 CNCC[C@@H](Oc1ccccc1C)c1ccccc1 None
3075702 224111 0 3H-CPG-12177 (-) -2 37 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 198 3 1 3 1.5 C1CNC1COC2=CN=C(C=C2)Cl None
179 7188 115 125I-Iodopindolol -4365 50 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 369 7 2 6 1.3 CCN1CCCC1CNC(=O)c1cc(c(cc1OC)N)S(=O)(=O)CC None
2159 7188 115 125I-Iodopindolol -4365 50 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 369 7 2 6 1.3 CCN1CCCC1CNC(=O)c1cc(c(cc1OC)N)S(=O)(=O)CC None
963 7188 115 125I-Iodopindolol -4365 50 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 369 7 2 6 1.3 CCN1CCCC1CNC(=O)c1cc(c(cc1OC)N)S(=O)(=O)CC None
CHEMBL243712 7188 115 125I-Iodopindolol -4365 50 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 369 7 2 6 1.3 CCN1CCCC1CNC(=O)c1cc(c(cc1OC)N)S(=O)(=O)CC None
DB06288 7188 115 125I-Iodopindolol -4365 50 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 369 7 2 6 1.3 CCN1CCCC1CNC(=O)c1cc(c(cc1OC)N)S(=O)(=O)CC None
2726 7706 68 125I-Pindolol -5888 72 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
621 7706 68 125I-Pindolol -5888 72 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
83 7706 68 125I-Pindolol -5888 72 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
CHEMBL71 7706 68 125I-Pindolol -5888 72 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
DB00477 7706 68 125I-Pindolol -5888 72 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
135398737 7745 93 125I-Pindolol -269 90 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
38 7745 93 125I-Pindolol -269 90 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
722 7745 93 125I-Pindolol -269 90 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
CHEMBL42 7745 93 125I-Pindolol -269 90 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
DB00363 7745 93 125I-Pindolol -269 90 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
1155 8410 53 125I-CYP -42 5 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O None
3343 8410 53 125I-CYP -42 5 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O None
557 8410 53 125I-CYP -42 5 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O None
CHEMBL32800 8410 53 125I-CYP -42 5 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O None
DB01288 8410 53 125I-CYP -42 5 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O None
1212 8443 50 125I-Pindolol -19952 65 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
204 8443 50 125I-Pindolol -19952 65 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
3372 8443 50 125I-Pindolol -19952 65 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
CHEMBL726 8443 50 125I-Pindolol -19952 65 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
DB00623 8443 50 125I-Pindolol -19952 65 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
1353 8692 93 125I-Pindolol -6918 85 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
3559 8692 93 125I-Pindolol -6918 85 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
86 8692 93 125I-Pindolol -6918 85 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
CHEMBL54 8692 93 125I-Pindolol -6918 85 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
DB00502 8692 93 125I-Pindolol -6918 85 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
3294 8787 111 3H-CGP-12177 -14454 44 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
71360 8787 111 3H-CGP-12177 -14454 44 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
87 8787 111 3H-CGP-12177 -14454 44 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
CHEMBL14376 8787 111 3H-CGP-12177 -14454 44 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
DB04946 8787 111 3H-CGP-12177 -14454 44 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
1613 9127 53 125I-Pindolol -2754 44 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 None
205 9127 53 125I-Pindolol -2754 44 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 None
3964 9127 53 125I-Pindolol -2754 44 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 None
CHEMBL831 9127 53 125I-Pindolol -2754 44 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 None
DB00408 9127 53 125I-Pindolol -2754 44 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 None
134 9292 24 125I-Pindolol -8511 67 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO None
1775 9292 24 125I-Pindolol -8511 67 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO None
9681 9292 24 125I-Pindolol -8511 67 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO None
CHEMBL1065 9292 24 125I-Pindolol -8511 67 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO None
DB00247 9292 24 125I-Pindolol -8511 67 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO None
15897 9637 0 125I-Pindolol -354 36 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 203 2 1 1 2.6 CC(Cc1cccc(c1)C(F)(F)F)N None
215 9637 0 125I-Pindolol -354 36 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 203 2 1 1 2.6 CC(Cc1cccc(c1)C(F)(F)F)N None
CHEMBL1979333 9637 0 125I-Pindolol -354 36 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 203 2 1 1 2.6 CC(Cc1cccc(c1)C(F)(F)F)N None
135398745 9688 112 125I-Pindolol -331 65 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
47 9688 112 125I-Pindolol -331 65 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
CHEMBL715 9688 112 125I-Pindolol -331 65 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
DB00334 9688 112 125I-Pindolol -331 65 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
2105 9828 37 3H-CGP-12177 -3715 32 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 None
47811 9828 37 3H-CGP-12177 -3715 32 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 None
48 9828 37 3H-CGP-12177 -3715 32 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 None
CHEMBL531 9828 37 3H-CGP-12177 -3715 32 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 None
DB01186 9828 37 3H-CGP-12177 -3715 32 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 None
2202 9906 96 3H-CGP-12177 -316 21 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 None
4850 9906 96 3H-CGP-12177 -316 21 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 None
49 9906 96 3H-CGP-12177 -316 21 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 None
CHEMBL1371770 9906 96 3H-CGP-12177 -316 21 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 None
DB12478 9906 96 3H-CGP-12177 -316 21 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 None
119570 9933 96 125I-Pindolol -4570 39 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 211 3 2 4 1.6 CCCN[C@H]1CCc2c(C1)sc(n2)N None
119570 9933 96 3H-CGP-12177 -4570 39 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 211 3 2 4 1.6 CCCN[C@H]1CCc2c(C1)sc(n2)N None
2233 9933 96 125I-Pindolol -4570 39 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 211 3 2 4 1.6 CCCN[C@H]1CCc2c(C1)sc(n2)N None
2233 9933 96 3H-CGP-12177 -4570 39 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 211 3 2 4 1.6 CCCN[C@H]1CCc2c(C1)sc(n2)N None
953 9933 96 125I-Pindolol -4570 39 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 211 3 2 4 1.6 CCCN[C@H]1CCc2c(C1)sc(n2)N None
953 9933 96 3H-CGP-12177 -4570 39 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 211 3 2 4 1.6 CCCN[C@H]1CCc2c(C1)sc(n2)N None
CHEMBL301265 9933 96 125I-Pindolol -4570 39 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 211 3 2 4 1.6 CCCN[C@H]1CCc2c(C1)sc(n2)N None
CHEMBL301265 9933 96 3H-CGP-12177 -4570 39 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 211 3 2 4 1.6 CCCN[C@H]1CCc2c(C1)sc(n2)N None
DB00413 9933 96 125I-Pindolol -4570 39 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 211 3 2 4 1.6 CCCN[C@H]1CCc2c(C1)sc(n2)N None
DB00413 9933 96 3H-CGP-12177 -4570 39 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 211 3 2 4 1.6 CCCN[C@H]1CCc2c(C1)sc(n2)N None
243 9976 91 125I-ICYP -1096 34 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 367 6 2 5 2.1 COCCCN1CCC(CC1)NC(=O)c1cc(Cl)c(c2c1OCC2)N None
3052762 9976 91 125I-ICYP -1096 34 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 367 6 2 5 2.1 COCCCN1CCC(CC1)NC(=O)c1cc(Cl)c(c2c1OCC2)N None
3502 9976 91 125I-ICYP -1096 34 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 367 6 2 5 2.1 COCCCN1CCC(CC1)NC(=O)c1cc(Cl)c(c2c1OCC2)N None
CHEMBL117287 9976 91 125I-ICYP -1096 34 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 367 6 2 5 2.1 COCCCN1CCC(CC1)NC(=O)c1cc(Cl)c(c2c1OCC2)N None
DB06480 9976 91 125I-ICYP -1096 34 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 367 6 2 5 2.1 COCCCN1CCC(CC1)NC(=O)c1cc(Cl)c(c2c1OCC2)N None
2337 10030 77 125I-Pindolol -72 62 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
50 10030 77 125I-Pindolol -72 62 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
5002 10030 77 125I-Pindolol -72 62 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
CHEMBL716 10030 77 125I-Pindolol -72 62 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
DB01224 10030 77 125I-Pindolol -72 62 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
2 10035 23 3H-CGP-12177 -2089 28 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 219 2 1 2 2.0 CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2 None
54562 10035 23 3H-CGP-12177 -2089 28 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 219 2 1 2 2.0 CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2 None
CHEMBL240773 10035 23 3H-CGP-12177 -2089 28 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 219 2 1 2 2.0 CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2 None
2389 10104 118 125I-Pindolol -1737 66 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
5073 10104 118 125I-Pindolol -1737 66 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
96 10104 118 125I-Pindolol -1737 66 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
CHEMBL85 10104 118 125I-Pindolol -1737 66 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
DB00734 10104 118 125I-Pindolol -1737 66 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
2402 10143 62 3H-CGP-12177 -549 24 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 260 7 1 2 3.5 CCCN(CCC)CCc1cccc2c1CC(=N2)O None
5095 10143 62 3H-CGP-12177 -549 24 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 260 7 1 2 3.5 CCCN(CCC)CCc1cccc2c1CC(=N2)O None
7295 10143 62 3H-CGP-12177 -549 24 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 260 7 1 2 3.5 CCCN(CCC)CCc1cccc2c1CC(=N2)O None
CHEMBL589 10143 62 3H-CGP-12177 -549 24 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 260 7 1 2 3.5 CCCN(CCC)CCc1cccc2c1CC(=N2)O None
DB00268 10143 62 3H-CGP-12177 -549 24 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 260 7 1 2 3.5 CCCN(CCC)CCc1cccc2c1CC(=N2)O None
183782 10171 20 3H-CGP-12177 -2398 14 Rat 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 352 8 1 4 4.4 CCCCN1CCC(CC1)CCC(=O)c1cc(Cl)c(cc1OC)N None
237 10171 20 3H-CGP-12177 -2398 14 Rat 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 352 8 1 4 4.4 CCCCN1CCC(CC1)CCC(=O)c1cc(Cl)c(cc1OC)N None
CHEMBL85251 10171 20 3H-CGP-12177 -2398 14 Rat 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 352 8 1 4 4.4 CCCCN1CCC(CC1)CCC(=O)c1cc(Cl)c(cc1OC)N None
128563 10237 33 125I-Pindolol -2398 42 Rat 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 432 3 0 8 3.0 COC(=O)[C@@H]1C[C@H](OC(=O)C)C(=O)[C@H]2[C@@]1(C)CC[C@@H]1[C@]2(C)C[C@H](OC1=O)c1cocc1 None
1666 10237 33 125I-Pindolol -2398 42 Rat 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 432 3 0 8 3.0 COC(=O)[C@@H]1C[C@H](OC(=O)C)C(=O)[C@H]2[C@@]1(C)CC[C@@H]1[C@]2(C)C[C@H](OC1=O)c1cocc1 None
CHEMBL445332 10237 33 125I-Pindolol -2398 42 Rat 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 432 3 0 8 3.0 COC(=O)[C@@H]1C[C@H](OC(=O)C)C(=O)[C@H]2[C@@]1(C)CC[C@@H]1[C@]2(C)C[C@H](OC1=O)c1cocc1 None
DB12327 10237 33 125I-Pindolol -2398 42 Rat 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 432 3 0 8 3.0 COC(=O)[C@@H]1C[C@H](OC(=O)C)C(=O)[C@H]2[C@@]1(C)CC[C@@H]1[C@]2(C)C[C@H](OC1=O)c1cocc1 None
6917970 10463 61 125I-Pindolol -2290 33 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 327 2 2 5 2.8 COc1cc2CCN3[C@H](c2cc1O)Cc1c(C3)c(OC)c(cc1)O None
8370 10463 61 125I-Pindolol -2290 33 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 327 2 2 5 2.8 COc1cc2CCN3[C@H](c2cc1O)Cc1c(C3)c(OC)c(cc1)O None
CHEMBL487387 10463 61 125I-Pindolol -2290 33 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 327 2 2 5 2.8 COc1cc2CCN3[C@H](c2cc1O)Cc1c(C3)c(OC)c(cc1)O None
2598 10550 58 125I-ICYP -67 5 Guinea pig 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 225 3 4 4 1.5 OC(c1cc(O)cc(c1)O)CNC(C)(C)C None
2598 10550 58 125I-CYP -239 5 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 225 3 4 4 1.5 OC(c1cc(O)cc(c1)O)CNC(C)(C)C None
5403 10550 58 125I-ICYP -67 5 Guinea pig 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 225 3 4 4 1.5 OC(c1cc(O)cc(c1)O)CNC(C)(C)C None
5403 10550 58 125I-CYP -239 5 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 225 3 4 4 1.5 OC(c1cc(O)cc(c1)O)CNC(C)(C)C None
560 10550 58 125I-ICYP -67 5 Guinea pig 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 225 3 4 4 1.5 OC(c1cc(O)cc(c1)O)CNC(C)(C)C None
560 10550 58 125I-CYP -239 5 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 225 3 4 4 1.5 OC(c1cc(O)cc(c1)O)CNC(C)(C)C None
CHEMBL1760 10550 58 125I-ICYP -67 5 Guinea pig 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 225 3 4 4 1.5 OC(c1cc(O)cc(c1)O)CNC(C)(C)C None
CHEMBL1760 10550 58 125I-CYP -239 5 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 225 3 4 4 1.5 OC(c1cc(O)cc(c1)O)CNC(C)(C)C None
DB00871 10550 58 125I-ICYP -67 5 Guinea pig 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 225 3 4 4 1.5 OC(c1cc(O)cc(c1)O)CNC(C)(C)C None
DB00871 10550 58 125I-CYP -239 5 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 225 3 4 4 1.5 OC(c1cc(O)cc(c1)O)CNC(C)(C)C None
100 10577 58 125I-Pindolol -4897 54 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
2637 10577 58 125I-Pindolol -4897 54 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
5452 10577 58 125I-Pindolol -4897 54 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
CHEMBL479 10577 58 125I-Pindolol -4897 54 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
DB00679 10577 58 125I-Pindolol -4897 54 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
213 10625 55 125I-Pindolol -912 43 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 None
2717 10625 55 125I-Pindolol -912 43 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 None
5533 10625 55 125I-Pindolol -912 43 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 None
CHEMBL621 10625 55 125I-Pindolol -912 43 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 None
DB00656 10625 55 125I-Pindolol -912 43 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 None
185 10778 60 125I-Pindolol -30902 37 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 373 7 1 4 3.8 COc1cccc(c1OC)[C@@H](C1CCN(CC1)CCc1ccc(cc1)F)O None
5311271 10778 60 125I-Pindolol -30902 37 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 373 7 1 4 3.8 COc1cccc(c1OC)[C@@H](C1CCN(CC1)CCc1ccc(cc1)F)O None
CHEMBL74355 10778 60 125I-Pindolol -30902 37 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 373 7 1 4 3.8 COc1cccc(c1OC)[C@@H](C1CCN(CC1)CCc1ccc(cc1)F)O None
DB16351 10778 60 125I-Pindolol -30902 37 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 373 7 1 4 3.8 COc1cccc(c1OC)[C@@H](C1CCN(CC1)CCc1ccc(cc1)F)O None
2865 10915 73 125I-Pindolol -1071 53 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
59 10915 73 125I-Pindolol -1071 53 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
60854 10915 73 125I-Pindolol -1071 53 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
CHEMBL708 10915 73 125I-Pindolol -1071 53 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
DB00246 10915 73 125I-Pindolol -1071 53 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
103 10925 61 125I-Pindolol -501 53 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
2875 10925 61 125I-Pindolol -501 53 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
5736 10925 61 125I-Pindolol -501 53 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
CHEMBL285802 10925 61 125I-Pindolol -501 53 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
DB09225 10925 61 125I-Pindolol -501 53 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
10297 33885 30 125I-Pindolol -38 43 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 151 2 2 2 1.1 C[C@H](N)[C@H](O)c1ccccc1 None
CHEMBL136560 33885 30 125I-Pindolol -38 43 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 151 2 2 2 1.1 C[C@H](N)[C@H](O)c1ccccc1 None
115237 62359 119 125I-Pindolol -2754 54 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 426 4 1 7 3.1 Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2O None
CHEMBL1621 62359 119 125I-Pindolol -2754 54 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 426 4 1 7 3.1 Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2O None
104870 105656 47 3H-CGP-12177 -549 21 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 209 2 1 4 1.3 C=CCN1CCc2nc(N)sc2CC1 None
5374 105656 47 3H-CGP-12177 -549 21 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 209 2 1 4 1.3 C=CCN1CCc2nc(N)sc2CC1 None
CHEMBL279085 105656 47 3H-CGP-12177 -549 21 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 209 2 1 4 1.3 C=CCN1CCc2nc(N)sc2CC1 None
446220 140299 14 125I-Pindolol -1778 45 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 303 3 0 5 1.9 COC(=O)[C@H]1[C@@H](OC(=O)c2ccccc2)C[C@@H]2CC[C@H]1N2C None
CHEMBL370805 140299 14 125I-Pindolol -1778 45 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 303 3 0 5 1.9 COC(=O)[C@H]1[C@@H](OC(=O)c2ccccc2)C[C@@H]2CC[C@H]1N2C None
44208932 147485 7 UNDEFINED -89125 37 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 475 5 1 3 6.8 Cc1ccc(Cn2nc(C(=O)NC3C4(C)CCC(C4)C3(C)C)cc2-c2ccc(Cl)c(C)c2)cc1 None
CHEMBL381689 147485 7 UNDEFINED -89125 37 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 475 5 1 3 6.8 Cc1ccc(Cn2nc(C(=O)NC3C4(C)CCC(C4)C3(C)C)cc2-c2ccc(Cl)c(C)c2)cc1 None
1615 174570 24 125I-Pindolol -26 44 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 193 3 1 3 1.6 CNC(C)Cc1ccc2c(c1)OCO2 None
1615 174570 24 125I-Pindolol -26 44 Rat 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 193 3 1 3 1.6 CNC(C)Cc1ccc2c(c1)OCO2 None
CHEMBL43048 174570 24 125I-Pindolol -26 44 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 193 3 1 3 1.6 CNC(C)Cc1ccc2c(c1)OCO2 None
CHEMBL43048 174570 24 125I-Pindolol -26 44 Rat 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 193 3 1 3 1.6 CNC(C)Cc1ccc2c(c1)OCO2 None
5280343 195054 124 125I-Pindolol -147 31 Rat 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 302 1 5 7 2.0 O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 None
CHEMBL1520590 195054 124 125I-Pindolol -147 31 Rat 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 302 1 5 7 2.0 O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 None
CHEMBL50 195054 124 125I-Pindolol -147 31 Rat 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 302 1 5 7 2.0 O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 None
162265 209053 22 125I-Pindolol -239 44 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 None
4786 209053 22 125I-Pindolol -239 44 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 None
CHEMBL61006 209053 22 125I-Pindolol -239 44 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 None
5281600 209804 92 125I-Pindolol -275 32 Rat 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 538 3 6 10 5.1 O=c1cc(-c2ccc(O)c(-c3c(O)cc(O)c4c(=O)cc(-c5ccc(O)cc5)oc34)c2)oc2cc(O)cc(O)c12 None
CHEMBL63354 209804 92 125I-Pindolol -275 32 Rat 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 538 3 6 10 5.1 O=c1cc(-c2ccc(O)c(-c3c(O)cc(O)c4c(=O)cc(-c5ccc(O)cc5)oc34)c2)oc2cc(O)cc(O)c12 None
1973 210262 15 3H-CGP-12177 -3 36 Rat 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 462 3 1 7 3.9 Nc1ncnc2nc(-c3ccc(N4CCOCC4)nc3)cc(-c3cccc(Br)c3)c12 None
CHEMBL1394464 210262 15 3H-CGP-12177 -3 36 Rat 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 462 3 1 7 3.9 Nc1ncnc2nc(-c3ccc(N4CCOCC4)nc3)cc(-c3cccc(Br)c3)c12 None
CHEMBL66089 210262 15 3H-CGP-12177 -3 36 Rat 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 462 3 1 7 3.9 Nc1ncnc2nc(-c3ccc(N4CCOCC4)nc3)cc(-c3cccc(Br)c3)c12 None
4054 212280 72 3H-PL17 -1 36 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 179 0 1 1 2.7 CC12CC3CC(C)(C1)CC(N)(C3)C2 None
CHEMBL1699 212280 72 3H-PL17 -1 36 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 179 0 1 1 2.7 CC12CC3CC(C)(C1)CC(N)(C3)C2 None
CHEMBL807 212280 72 3H-PL17 -1 36 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 179 0 1 1 2.7 CC12CC3CC(C)(C1)CC(N)(C3)C2 None
3337 213146 27 125I-Pindolol -58 40 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 None
65801 213146 27 125I-Pindolol -58 40 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 None
66264 213146 27 125I-Pindolol -58 40 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 None
91452 213146 27 125I-Pindolol -58 40 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 None
CHEMBL87493 213146 27 125I-Pindolol -58 40 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 None
11954224 222732 0 125I-Pindolol -3388 59 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 581 4 3 6 2.0 CC1(C(=O)N2C(C(=O)N3CCCC3C2(O1)O)CC4=CC=CC=C4)NC(=O)C5CN(C6CC7=CNC8=CC=CC(=C78)C6=C5)C None
25058166 222739 0 3H-CGP-12177 -5011 26 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 267 0 2 3 2.9 CN1CCC2=CC=CC3=C2C1CC4=C3C(=C(C=C4)O)O None
6852389 222739 0 3H-CGP-12177 -5011 26 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 267 0 2 3 2.9 CN1CCC2=CC=CC3=C2C1CC4=C3C(=C(C=C4)O)O None
11954259 222758 0 125I-Pindolol -33113 43 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 443 5 0 5 3.5 CN1CCN(CC1)CCC=C2C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)(=O)N(C)C None
104911 222798 0 125I-Pindolol -41686 37 Rat 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 530 7 0 5 5.1 COC1=CC=CC=C1N2CCN(CC2)CCN(C3=CC=CC=N3)C(=O)C4CCCCC4.Cl.Cl.Cl None
None 222806 0 3H-CGP-12177 -6309 13 Rat 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 453 9 2 6 2.6 COC1=CC(=C(C=C1C(=O)CCC2CCN(CC2)CCNS(=O)(=O)C)Cl)N.Cl None
None 222948 0 125I-ICYP -2 4 Guinea pig 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 381 5 3 5 -1.5 COC1=CC(=CC(=C1OC)OC)CC2C3=CC(=C(C=C3CC[NH2+]2)O)O.[Cl-] None
25137849 222958 0 125I-Pindolol -4 40 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 165 3 2 2 1.3 CC(C(C1=CC=CC=C1)O)NC None
71290 222958 0 125I-Pindolol -4 40 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 165 3 2 2 1.3 CC(C(C1=CC=CC=C1)O)NC None
None 223090 0 125I-Pindolol -1 34 Rat 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 240 7 4 6 -0.8 C(C(C(=O)O)N)SSCC(C(=O)O)N None
None 223091 0 125I-Pindolol -1 34 Rat 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 149 4 2 3 0.2 CSCCC(C(=O)O)N None
None 223092 0 125I-Pindolol -1 34 Rat 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 135 3 3 3 -0.3 C(CS)C(C(=O)O)N None
None 223093 0 125I-Pindolol -1 34 Rat 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 121 2 3 3 -0.7 C(C(C(=O)O)N)S None
None 223094 0 125I-Pindolol -1 29 Rat 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 117 0 1 3 -0.0 C1CSC(=O)C1N None
None 223095 0 125I-Pindolol -1 40 Rat 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 153 3 3 3 -1.4 C(C(C(=O)O)N)S(=O)O None
None 223096 0 125I-Pindolol -1 39 Rat 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 169 3 3 4 -1.7 C(C(C(=O)O)N)S(=O)(=O)O None
None 223104 0 125I-Pindolol -13 40 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 149 2 1 2 1.2 CC(C(=O)C1=CC=CC=C1)N None
1576 223105 0 125I-Pindolol -16 40 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 163 3 1 2 1.5 CC(C(=O)C1=CC=CC=C1)NC None
None 223106 0 125I-Pindolol -16 27 Rat 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 536 11 1 4 9.0 CC(C)C(=O)C12C(=O)C(=C(C(C1=O)(CC(C2(C)CCC=C(C)C)CC=C(C)C)CC=C(C)C)O)CC=C(C)C None
4978 223107 0 125I-Pindolol -7 27 Rat 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 520 1 7 9 4.3 CC1=CC(=C2C3=C1C4=C5C(=C(C=C4CO)O)C(=O)C6=C(C=C(C7=C6C5=C3C8=C7C(=CC(=C8C2=O)O)O)O)O)O None
None 223108 0 125I-Pindolol -3 27 Rat 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 464 4 8 12 -0.6 C1=CC(=C(C=C1C2=C(C(=C3C(=CC(=O)C=C3O2)O)O)OC4C(C(C(C(O4)CO)O)O)O)O)O None
None 223109 0 125I-Pindolol -281 27 Rat 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 610 6 10 16 -1.7 CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=C(OC4=CC(=CC(=C4C3=O)O)O)C5=CC(=C(C=C5)O)O)O)O)O)O)O)O None
None 223110 0 125I-Pindolol -1 27 Rat 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 448 3 7 11 0.4 CC1C(C(C(C(O1)OC2=C(OC3=CC(=O)C=C(C3=C2O)O)C4=CC(=C(C=C4)O)O)O)O)O None
None 223120 0 3H-CGP-12177 -13182 19 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 451 8 2 4 3.2 CCNC(=O)N(CCCN(C)C)C(=O)C1CC2C(CC3=CNC4=CC=CC2=C34)N(C1)CC=C None
None 223121 0 3H-CGP-12177 -1862 19 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 246 2 1 4 1.6 CCCN1CCCC2C1CC3=CN=C(N=C3C2)N None
None 223176 0 125I-CYP -23 3 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 363 9 3 4 3.1 CC(CC1=CC=C(C=C1)OCC(=O)O)NCC(C2=CC(=CC=C2)Cl)O None
None 223229 0 UNDEFINED -660 28 Guinea pig 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 322 5 2 3 4.1 CC(CC1=CNC2=C1C=C(C=C2)OCC3=CC=CS3)N.Cl None
None 223229 0 Functional -660 28 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 322 5 2 3 4.1 CC(CC1=CNC2=C1C=C(C=C2)OCC3=CC=CS3)N.Cl None
None 223268 0 125I-Pindolol -4570 26 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 347 6 0 3 5.0 CC(=O)N(CC1=CC=CC=C1OC)C2=CC=CC=C2OC3=CC=CC=C3 None
3337 213146 27 125I-Pindolol -58 40 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 None
65801 213146 27 125I-Pindolol -58 40 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 None
66264 213146 27 125I-Pindolol -58 40 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 None
91452 213146 27 125I-Pindolol -58 40 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 None
CHEMBL87493 213146 27 125I-Pindolol -58 40 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 None
5581 108435 11 125I-ICYP -20 4 Guinea pig 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 345 5 3 6 2.6 COc1cc(CC2NCCc3cc(O)c(O)cc32)cc(OC)c1OC None
CHEMBL299175 108435 11 125I-ICYP -20 4 Guinea pig 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 345 5 3 6 2.6 COc1cc(CC2NCCc3cc(O)c(O)cc32)cc(OC)c1OC None
1531 9046 69 125I-ICYP -1 16 Rat 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O None
3869 9046 69 125I-ICYP -1 16 Rat 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O None
7207 9046 69 125I-ICYP -1 16 Rat 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O None
CHEMBL429 9046 69 125I-ICYP -1 16 Rat 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O None
DB00598 9046 69 125I-ICYP -1 16 Rat 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O None
2369 7409 80 125I-ICYP -4 8 Rat 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C None
356 7409 80 125I-ICYP -4 8 Rat 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C None
549 7409 80 125I-ICYP -4 8 Rat 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C None
CHEMBL423 7409 80 125I-ICYP -4 8 Rat 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C None
DB00195 7409 80 125I-ICYP -4 8 Rat 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C None
1978 7038 60 125I-ICYP -19 6 Rat 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 336 10 3 5 3.0 CCCC(=Nc1ccc(c(c1)C(=O)C)OCC(CNC(C)C)O)O None
40 7038 60 125I-ICYP -19 6 Rat 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 336 10 3 5 3.0 CCCC(=Nc1ccc(c(c1)C(=O)C)OCC(CNC(C)C)O)O None
7107 7038 60 125I-ICYP -19 6 Rat 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 336 10 3 5 3.0 CCCC(=Nc1ccc(c(c1)C(=O)C)OCC(CNC(C)C)O)O None
CHEMBL642 7038 60 125I-ICYP -19 6 Rat 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 336 10 3 5 3.0 CCCC(=Nc1ccc(c(c1)C(=O)C)OCC(CNC(C)C)O)O None
DB01193 7038 60 125I-ICYP -19 6 Rat 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 336 10 3 5 3.0 CCCC(=Nc1ccc(c(c1)C(=O)C)OCC(CNC(C)C)O)O None
71149 223177 0 125I-CYP -1 3 Human 5.9 pKi = 5.9 Binding
NoneNone
PDSP KiDatabase 262 3 2 4 1.9 CC(C)(C)NCC(C1=CC(=NO1)Br)O None
3682 196216 12 125I-ICYP -229 8 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 277 6 2 3 2.6 Cc1ccc(OCC(O)C(C)NC(C)C)c2c1CCC2 None
CHEMBL1256784 196216 12 125I-ICYP -229 8 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 277 6 2 3 2.6 Cc1ccc(OCC(O)C(C)NC(C)C)c2c1CCC2 None
CHEMBL513389 196216 12 125I-ICYP -229 8 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 277 6 2 3 2.6 Cc1ccc(OCC(O)C(C)NC(C)C)c2c1CCC2 None
1621 9207 17 125I-Pindolol -457 44 Rat 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 323 3 1 2 2.9 CCN(C(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
17 9207 17 125I-Pindolol -457 44 Rat 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 323 3 1 2 2.9 CCN(C(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
5761 9207 17 125I-Pindolol -457 44 Rat 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 323 3 1 2 2.9 CCN(C(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
CHEMBL263881 9207 17 125I-Pindolol -457 44 Rat 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 323 3 1 2 2.9 CCN(C(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
DB04829 9207 17 125I-Pindolol -457 44 Rat 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 323 3 1 2 2.9 CCN(C(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
242 7258 124 125I-Pindolol -22 51 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
242 7258 124 3H-Pindolol -22 51 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
34 7258 124 125I-Pindolol -22 51 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
34 7258 124 3H-Pindolol -22 51 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
60795 7258 124 125I-Pindolol -22 51 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
60795 7258 124 3H-Pindolol -22 51 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
CHEMBL1112 7258 124 125I-Pindolol -22 51 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
CHEMBL1112 7258 124 3H-Pindolol -22 51 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
DB01238 7258 124 125I-Pindolol -22 51 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
DB01238 7258 124 3H-Pindolol -22 51 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
3682 196216 12 125I-Pindolol -1047 8 Rat 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 277 6 2 3 2.6 Cc1ccc(OCC(O)C(C)NC(C)C)c2c1CCC2 None
CHEMBL1256784 196216 12 125I-Pindolol -1047 8 Rat 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 277 6 2 3 2.6 Cc1ccc(OCC(O)C(C)NC(C)C)c2c1CCC2 None
CHEMBL513389 196216 12 125I-Pindolol -1047 8 Rat 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 277 6 2 3 2.6 Cc1ccc(OCC(O)C(C)NC(C)C)c2c1CCC2 None
2419 10236 84 125I-CYP -154 6 Human 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O None
5152 10236 84 125I-CYP -154 6 Human 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O None
559 10236 84 125I-CYP -154 6 Human 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O None
CHEMBL1263 10236 84 125I-CYP -154 6 Human 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O None
DB00938 10236 84 125I-CYP -154 6 Human 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O None
3083544 33582 51 125I-CYP -5 5 Human 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 None
CHEMBL1200811 33582 51 125I-CYP -5 5 Human 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 None
CHEMBL1363 33582 51 125I-CYP -5 5 Human 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 None
CHEMBL1951071 33582 51 125I-CYP -5 5 Human 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 None
CHEMBL605993 33582 51 125I-CYP -5 5 Human 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 None
3682 196216 12 125I-ICYP -1047 8 Rat 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 277 6 2 3 2.6 Cc1ccc(OCC(O)C(C)NC(C)C)c2c1CCC2 None
CHEMBL1256784 196216 12 125I-ICYP -1047 8 Rat 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 277 6 2 3 2.6 Cc1ccc(OCC(O)C(C)NC(C)C)c2c1CCC2 None
CHEMBL513389 196216 12 125I-ICYP -1047 8 Rat 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 277 6 2 3 2.6 Cc1ccc(OCC(O)C(C)NC(C)C)c2c1CCC2 None
3682 196216 12 125I-ICYP -1047 8 Rat 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 277 6 2 3 2.6 Cc1ccc(OCC(O)C(C)NC(C)C)c2c1CCC2 None
CHEMBL1256784 196216 12 125I-ICYP -1047 8 Rat 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 277 6 2 3 2.6 Cc1ccc(OCC(O)C(C)NC(C)C)c2c1CCC2 None
CHEMBL513389 196216 12 125I-ICYP -1047 8 Rat 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 277 6 2 3 2.6 Cc1ccc(OCC(O)C(C)NC(C)C)c2c1CCC2 None
124433 158210 15 UNDEFINED 1 3 Human 8.6 pKi = 8.6 Binding
NoneNone
PDSP KiDatabase 288 6 3 3 2.8 OC(CNC1CCCCC1)COc1cccc2[nH]ccc12 None
CHEMBL396185 158210 15 UNDEFINED 1 3 Human 8.6 pKi = 8.6 Binding
NoneNone
PDSP KiDatabase 288 6 3 3 2.8 OC(CNC1CCCCC1)COc1cccc2[nH]ccc12 None
2176 9901 68 125I-CYP -4 27 Human 8.6 pKi = 8.6 Binding
NoneNone
PDSP KiDatabase 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C None
4828 9901 68 125I-CYP -4 27 Human 8.6 pKi = 8.6 Binding
NoneNone
PDSP KiDatabase 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C None
91 9901 68 125I-CYP -4 27 Human 8.6 pKi = 8.6 Binding
NoneNone
PDSP KiDatabase 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C None
CHEMBL500 9901 68 125I-CYP -4 27 Human 8.6 pKi = 8.6 Binding
NoneNone
PDSP KiDatabase 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C None
DB00960 9901 68 125I-CYP -4 27 Human 8.6 pKi = 8.6 Binding
NoneNone
PDSP KiDatabase 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C None
165193 222724 0 125I-ICYP 3 30 Human 8.6 pKi = 8.6 Binding
NoneNone
PDSP KiDatabase 259 6 2 3 2.6 CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O None
62882 222724 0 125I-ICYP 3 30 Human 8.6 pKi = 8.6 Binding
NoneNone
PDSP KiDatabase 259 6 2 3 2.6 CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O None
66366 222724 0 125I-ICYP 3 30 Human 8.6 pKi = 8.6 Binding
NoneNone
PDSP KiDatabase 259 6 2 3 2.6 CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O None
165193 222724 0 125I-ICYP -12 30 Rat 8.6 pKi = 8.6 Binding
NoneNone
PDSP KiDatabase 259 6 2 3 2.6 CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O None
62882 222724 0 125I-ICYP -12 30 Rat 8.6 pKi = 8.6 Binding
NoneNone
PDSP KiDatabase 259 6 2 3 2.6 CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O None
66366 222724 0 125I-ICYP -12 30 Rat 8.6 pKi = 8.6 Binding
NoneNone
PDSP KiDatabase 259 6 2 3 2.6 CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O None
2405 7452 76 125I-CYP -2 4 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 325 12 2 5 2.4 OC(COc1ccc(cc1)COCCOC(C)C)CNC(C)C None
380 7452 76 125I-CYP -2 4 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 325 12 2 5 2.4 OC(COc1ccc(cc1)COCCOC(C)C)CNC(C)C None
7129 7452 76 125I-CYP -2 4 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 325 12 2 5 2.4 OC(COc1ccc(cc1)COCCOC(C)C)CNC(C)C None
CHEMBL645 7452 76 125I-CYP -2 4 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 325 12 2 5 2.4 OC(COc1ccc(cc1)COCCOC(C)C)CNC(C)C None
DB00612 7452 76 125I-CYP -2 4 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 325 12 2 5 2.4 OC(COc1ccc(cc1)COCCOC(C)C)CNC(C)C None
2464 10412 58 125I-ICYP -37 6 Rat 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C None
5253 10412 58 125I-ICYP -37 6 Rat 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C None
7297 10412 58 125I-ICYP -37 6 Rat 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C None
CHEMBL471 10412 58 125I-ICYP -37 6 Rat 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C None
DB00489 10412 58 125I-ICYP -37 6 Rat 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C None
1499 8872 47 125I-CYP -53 17 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C None
3779 8872 47 125I-CYP -53 17 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C None
536 8872 47 125I-CYP -53 17 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C None
CHEMBL434 8872 47 125I-CYP -53 17 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C None
DB01064 8872 47 125I-CYP -53 17 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C None
7153 104796 77 125I-Pindolol -123 33 Human 5.6 pKi = 5.6 Binding
NoneNone
PDSP KiDatabase 214 3 1 2 2.5 Cc1cc(Cl)ccc1OC(C)C(=O)O None
CHEMBL272942 104796 77 125I-Pindolol -123 33 Human 5.6 pKi = 5.6 Binding
NoneNone
PDSP KiDatabase 214 3 1 2 2.5 Cc1cc(Cl)ccc1OC(C)C(=O)O None
None 222949 0 125I-ICYP -8 2 Guinea pig 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 363 5 3 6 2.7 COC1=CC(=CC(=C1OC)OC)CC2C3=CC(=C(C(=C3CCN2)F)O)O None
105 10234 91 125I-CYP 1 6 Human 5.6 pKi = 5.6 Binding
NoneNone
PDSP KiDatabase 239 4 4 4 1.3 OCc1cc(ccc1O)C(CNC(C)(C)C)O None
2083 10234 91 125I-CYP 1 6 Human 5.6 pKi = 5.6 Binding
NoneNone
PDSP KiDatabase 239 4 4 4 1.3 OCc1cc(ccc1O)C(CNC(C)(C)C)O None
558 10234 91 125I-CYP 1 6 Human 5.6 pKi = 5.6 Binding
NoneNone
PDSP KiDatabase 239 4 4 4 1.3 OCc1cc(ccc1O)C(CNC(C)(C)C)O None
CHEMBL714 10234 91 125I-CYP 1 6 Human 5.6 pKi = 5.6 Binding
NoneNone
PDSP KiDatabase 239 4 4 4 1.3 OCc1cc(ccc1O)C(CNC(C)(C)C)O None
DB01001 10234 91 125I-CYP 1 6 Human 5.6 pKi = 5.6 Binding
NoneNone
PDSP KiDatabase 239 4 4 4 1.3 OCc1cc(ccc1O)C(CNC(C)(C)C)O None
3486 9931 56 125I-ICYP -1 11 Rat 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C None
4883 9931 56 125I-ICYP -1 11 Rat 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C None
555 9931 56 125I-ICYP -1 11 Rat 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C None
CHEMBL6995 9931 56 125I-ICYP -1 11 Rat 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C None
DB01297 9931 56 125I-ICYP -1 11 Rat 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C None
2865 10915 73 125I-ICYP -1071 53 Human 5.6 pKi = 5.6 Binding
NoneNone
PDSP KiDatabase 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
59 10915 73 125I-ICYP -1071 53 Human 5.6 pKi = 5.6 Binding
NoneNone
PDSP KiDatabase 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
60854 10915 73 125I-ICYP -1071 53 Human 5.6 pKi = 5.6 Binding
NoneNone
PDSP KiDatabase 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
CHEMBL708 10915 73 125I-ICYP -1071 53 Human 5.6 pKi = 5.6 Binding
NoneNone
PDSP KiDatabase 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
DB00246 10915 73 125I-ICYP -1071 53 Human 5.6 pKi = 5.6 Binding
NoneNone
PDSP KiDatabase 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
219050 10146 25 3H-CGP-12177 -16595 21 Human 5.6 pKi = 5.6 Binding
NoneNone
PDSP KiDatabase 346 6 2 2 5.0 Oc1ccc2c(c1)c(CCCCN1CCC(=CC1)c1ccccc1)c[nH]2 None
52 10146 25 3H-CGP-12177 -16595 21 Human 5.6 pKi = 5.6 Binding
NoneNone
PDSP KiDatabase 346 6 2 2 5.0 Oc1ccc2c(c1)c(CCCCN1CCC(=CC1)c1ccccc1)c[nH]2 None
CHEMBL431367 10146 25 3H-CGP-12177 -16595 21 Human 5.6 pKi = 5.6 Binding
NoneNone
PDSP KiDatabase 346 6 2 2 5.0 Oc1ccc2c(c1)c(CCCCN1CCC(=CC1)c1ccccc1)c[nH]2 None
None 222948 0 125I-ICYP 2 4 Human 5.5 pKi = 5.5 Binding
NoneNone
PDSP KiDatabase 381 5 3 5 -1.5 COC1=CC(=CC(=C1OC)OC)CC2C3=CC(=C(C=C3CC[NH2+]2)O)O.[Cl-] None
484 9633 51 125I-CYP -19 35 Human 5.5 pKi = 5.5 Binding
NoneNone
PDSP KiDatabase 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O None
951 9633 51 125I-CYP -19 35 Human 5.5 pKi = 5.5 Binding
NoneNone
PDSP KiDatabase 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O None
CHEMBL432 9633 51 125I-CYP -19 35 Human 5.5 pKi = 5.5 Binding
NoneNone
PDSP KiDatabase 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O None
128658 40749 7 125I-ICYP -4 5 Human 7.4 pKi = 7.4 Binding
NoneNone
PDSP KiDatabase 363 5 3 6 2.7 COc1cc(CC2NCCc3cc(O)c(O)c(F)c32)cc(OC)c1OC None
CHEMBL142428 40749 7 125I-ICYP -4 5 Human 7.4 pKi = 7.4 Binding
NoneNone
PDSP KiDatabase 363 5 3 6 2.7 COc1cc(CC2NCCc3cc(O)c(O)c(F)c32)cc(OC)c1OC None
688390 223264 0 125I-ICYP -7 3 Rat 5.4 pKi = 5.4 Binding
NoneNone
PDSP KiDatabase 267 5 2 4 2.5 C[C@H]([C@H](C1=C(C=CC(=C1)OC)OC)O)NC(C)(C)C None
688390 223264 0 125I-ICYP -7 3 Rat 5.4 pKi = 5.4 Binding
NoneNone
PDSP KiDatabase 267 5 2 4 2.5 C[C@H]([C@H](C1=C(C=CC(=C1)OC)OC)O)NC(C)(C)C None
2249 7300 111 125I-CYP -5 12 Human 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C None
255 7300 111 125I-CYP -5 12 Human 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C None
548 7300 111 125I-CYP -5 12 Human 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C None
CHEMBL24 7300 111 125I-CYP -5 12 Human 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C None
DB00335 7300 111 125I-CYP -5 12 Human 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C None
1028 7079 71 125I-CYP -70 30 Human 5.4 pKi = 5.4 Binding
NoneNone
PDSP KiDatabase 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
139148732 7079 71 125I-CYP -70 30 Human 5.4 pKi = 5.4 Binding
NoneNone
PDSP KiDatabase 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
479 7079 71 125I-CYP -70 30 Human 5.4 pKi = 5.4 Binding
NoneNone
PDSP KiDatabase 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
5816 7079 71 125I-CYP -70 30 Human 5.4 pKi = 5.4 Binding
NoneNone
PDSP KiDatabase 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
CHEMBL679 7079 71 125I-CYP -70 30 Human 5.4 pKi = 5.4 Binding
NoneNone
PDSP KiDatabase 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
DB00668 7079 71 125I-CYP -70 30 Human 5.4 pKi = 5.4 Binding
NoneNone
PDSP KiDatabase 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
137 7158 52 125I-ICYP -3 12 Rat 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O None
2119 7158 52 125I-ICYP -3 12 Rat 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O None
563 7158 52 125I-ICYP -3 12 Rat 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O None
66368 7158 52 125I-ICYP -3 12 Rat 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O None
CHEMBL266195 7158 52 125I-ICYP -3 12 Rat 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O None
DB00866 7158 52 125I-ICYP -3 12 Rat 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O None
123707 223263 0 125I-ICYP 3 3 Rat 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 416 9 3 6 1.8 CC1=C(C=C(C=C1)C(CNCCOC2=CC=CC=C2OC)O)S(=O)(=O)N.Cl None
2687 7676 16 125I-CYP -1 5 Human 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 279 5 4 4 1.0 OC(COc1cccc2c1[nH]c(=O)[nH]2)CNC(C)(C)C None
532 7676 16 125I-CYP -1 5 Human 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 279 5 4 4 1.0 OC(COc1cccc2c1[nH]c(=O)[nH]2)CNC(C)(C)C None
5387 7676 16 125I-CYP -1 5 Human 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 279 5 4 4 1.0 OC(COc1cccc2c1[nH]c(=O)[nH]2)CNC(C)(C)C None
CHEMBL420746 7676 16 125I-CYP -1 5 Human 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 279 5 4 4 1.0 OC(COc1cccc2c1[nH]c(=O)[nH]2)CNC(C)(C)C None
135398737 7745 93 None -144 90 Rat 8.3 pKi = 8.3 Binding
Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
38 7745 93 None -144 90 Rat 8.3 pKi = 8.3 Binding
Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
722 7745 93 None -144 90 Rat 8.3 pKi = 8.3 Binding
Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
CHEMBL42 7745 93 None -144 90 Rat 8.3 pKi = 8.3 Binding
Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
DB00363 7745 93 None -144 90 Rat 8.3 pKi = 8.3 Binding
Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
2389 10104 118 None -851 66 Rat 8.3 pKi = 8.3 Binding
Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
5073 10104 118 None -851 66 Rat 8.3 pKi = 8.3 Binding
Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
96 10104 118 None -851 66 Rat 8.3 pKi = 8.3 Binding
Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
CHEMBL85 10104 118 None -851 66 Rat 8.3 pKi = 8.3 Binding
Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
DB00734 10104 118 None -851 66 Rat 8.3 pKi = 8.3 Binding
Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
2685 7677 21 125I-CYP -1 7 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O None
541 7677 21 125I-CYP -1 7 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O None
CHEMBL280822 7677 21 125I-CYP -1 7 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O None
448537 167029 89 None -50 25 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 None
CHEMBL411 167029 89 None -50 25 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 None
2146 9874 67 None -3 9 Rat 8.3 pKi = 8.3 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
Drug Central 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O None
485 9874 67 None -3 9 Rat 8.3 pKi = 8.3 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
Drug Central 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O None
6041 9874 67 None -3 9 Rat 8.3 pKi = 8.3 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
Drug Central 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O None
CHEMBL1215 9874 67 None -3 9 Rat 8.3 pKi = 8.3 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
Drug Central 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O None
DB00388 9874 67 None -3 9 Rat 8.3 pKi = 8.3 Binding
Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranesDisplacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes
Drug Central 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O None
103 10925 61 125I-ICYP -501 53 Human 5.4 pKi = 5.4 Binding
NoneNone
PDSP KiDatabase 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
2875 10925 61 125I-ICYP -501 53 Human 5.4 pKi = 5.4 Binding
NoneNone
PDSP KiDatabase 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
5736 10925 61 125I-ICYP -501 53 Human 5.4 pKi = 5.4 Binding
NoneNone
PDSP KiDatabase 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
CHEMBL285802 10925 61 125I-ICYP -501 53 Human 5.4 pKi = 5.4 Binding
NoneNone
PDSP KiDatabase 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
DB09225 10925 61 125I-ICYP -501 53 Human 5.4 pKi = 5.4 Binding
NoneNone
PDSP KiDatabase 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
1155 8410 53 125I-ICYP -17 5 Guinea pig 5.4 pKi = 5.4 Binding
NoneNone
PDSP KiDatabase 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O None
3343 8410 53 125I-ICYP -17 5 Guinea pig 5.4 pKi = 5.4 Binding
NoneNone
PDSP KiDatabase 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O None
557 8410 53 125I-ICYP -17 5 Guinea pig 5.4 pKi = 5.4 Binding
NoneNone
PDSP KiDatabase 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O None
CHEMBL32800 8410 53 125I-ICYP -17 5 Guinea pig 5.4 pKi = 5.4 Binding
NoneNone
PDSP KiDatabase 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O None
DB01288 8410 53 125I-ICYP -17 5 Guinea pig 5.4 pKi = 5.4 Binding
NoneNone
PDSP KiDatabase 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O None
3663 106743 83 125I-Pindolol -125 28 Rat 5.4 pKi = 5.4 Binding
NoneNone
PDSP KiDatabase 504 0 6 8 5.1 Cc1cc(O)c2c(=O)c3c(O)cc(O)c4c5c(O)cc(O)c6c(=O)c7c(O)cc(C)c8c1c2c(c34)c(c78)c65 None
CHEMBL286494 106743 83 125I-Pindolol -125 28 Rat 5.4 pKi = 5.4 Binding
NoneNone
PDSP KiDatabase 504 0 6 8 5.1 Cc1cc(O)c2c(=O)c3c(O)cc(O)c4c5c(O)cc(O)c6c(=O)c7c(O)cc(C)c8c1c2c(c34)c(c78)c65 None
1499 8872 47 125I-ICYP -67 17 Guinea pig 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C None
3779 8872 47 125I-ICYP -67 17 Guinea pig 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C None
536 8872 47 125I-ICYP -67 17 Guinea pig 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C None
CHEMBL434 8872 47 125I-ICYP -67 17 Guinea pig 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C None
DB01064 8872 47 125I-ICYP -67 17 Guinea pig 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C None
1786 9298 85 125I-CYP -1 11 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O None
4171 9298 85 125I-CYP -1 11 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O None
553 9298 85 125I-CYP -1 11 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O None
CHEMBL13 9298 85 125I-CYP -1 11 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O None
DB00264 9298 85 125I-CYP -1 11 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O None
3682 196216 12 125I-CYP -229 8 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 277 6 2 3 2.6 Cc1ccc(OCC(O)C(C)NC(C)C)c2c1CCC2 None
CHEMBL1256784 196216 12 125I-CYP -229 8 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 277 6 2 3 2.6 Cc1ccc(OCC(O)C(C)NC(C)C)c2c1CCC2 None
CHEMBL513389 196216 12 125I-CYP -229 8 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 277 6 2 3 2.6 Cc1ccc(OCC(O)C(C)NC(C)C)c2c1CCC2 None
681 8247 72 None -44 38 Rat 8.3 pKi = 8.3 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
Drug Central 153 2 3 3 0.6 NCCc1ccc(c(c1)O)O None
940 8247 72 None -44 38 Rat 8.3 pKi = 8.3 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
Drug Central 153 2 3 3 0.6 NCCc1ccc(c(c1)O)O None
947 8247 72 None -44 38 Rat 8.3 pKi = 8.3 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
Drug Central 153 2 3 3 0.6 NCCc1ccc(c(c1)O)O None
CHEMBL59 8247 72 None -44 38 Rat 8.3 pKi = 8.3 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
Drug Central 153 2 3 3 0.6 NCCc1ccc(c(c1)O)O None
DB00988 8247 72 None -44 38 Rat 8.3 pKi = 8.3 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
Drug Central 153 2 3 3 0.6 NCCc1ccc(c(c1)O)O None
2247 7293 81 None -128 42 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 None
249 7293 81 None -128 42 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 None
2603 7293 81 None -128 42 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 None
CHEMBL296419 7293 81 None -128 42 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 None
DB00637 7293 81 None -128 42 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 None
1016 10519 78 None -43 35 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 None
2561 10519 78 None -43 35 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 None
2733526 10519 78 None -43 35 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 None
5384 10519 78 None -43 35 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 None
CHEMBL83 10519 78 None -43 35 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 None
DB00675 10519 78 None -43 35 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 None
681 8247 72 None 1 38 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 153 2 3 3 0.6 NCCc1ccc(c(c1)O)O None
940 8247 72 None 1 38 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 153 2 3 3 0.6 NCCc1ccc(c(c1)O)O None
947 8247 72 None 1 38 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 153 2 3 3 0.6 NCCc1ccc(c(c1)O)O None
CHEMBL59 8247 72 None 1 38 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 153 2 3 3 0.6 NCCc1ccc(c(c1)O)O None
DB00988 8247 72 None 1 38 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 153 2 3 3 0.6 NCCc1ccc(c(c1)O)O None
43815 193699 64 None 1 25 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 329 4 1 4 3.3 Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1 None
CHEMBL1708 193699 64 None 1 25 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 329 4 1 4 3.3 Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1 None
CHEMBL490 193699 64 None 1 25 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 329 4 1 4 3.3 Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1 None
3198 212292 76 None -38 34 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 None
CHEMBL1201049 212292 76 None -38 34 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 None
CHEMBL808 212292 76 None -38 34 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 None
4189 213701 96 None -38 34 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 414 6 0 3 6.5 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 None
CHEMBL1559 213701 96 None -38 34 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 414 6 0 3 6.5 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 None
CHEMBL91 213701 96 None -38 34 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 414 6 0 3 6.5 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 None
2812 11551 101 None -38 34 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 344 4 0 2 5.4 Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1 None
CHEMBL104 11551 101 None -38 34 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 344 4 0 2 5.4 Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1 None
165193 222724 0 125I-ICYP -22 30 Guinea pig 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 259 6 2 3 2.6 CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O None
62882 222724 0 125I-ICYP -22 30 Guinea pig 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 259 6 2 3 2.6 CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O None
66366 222724 0 125I-ICYP -22 30 Guinea pig 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 259 6 2 3 2.6 CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O None
1209 8439 75 None 1 32 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F None
203 8439 75 None 1 32 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F None
3386 8439 75 None 1 32 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F None
CHEMBL41 8439 75 None 1 32 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F None
DB00472 8439 75 None 1 32 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F None
5581 108435 11 125I-ICYP 3 4 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 345 5 3 6 2.6 COc1cc(CC2NCCc3cc(O)c(O)cc32)cc(OC)c1OC None
CHEMBL299175 108435 11 125I-ICYP 3 4 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 345 5 3 6 2.6 COc1cc(CC2NCCc3cc(O)c(O)cc32)cc(OC)c1OC None
103 10925 61 None -501 53 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
2875 10925 61 None -501 53 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
5736 10925 61 None -501 53 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
CHEMBL285802 10925 61 None -501 53 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
DB09225 10925 61 None -501 53 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
105 10234 91 125I-ICYP 1 6 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 239 4 4 4 1.3 OCc1cc(ccc1O)C(CNC(C)(C)C)O None
2083 10234 91 125I-ICYP 1 6 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 239 4 4 4 1.3 OCc1cc(ccc1O)C(CNC(C)(C)C)O None
558 10234 91 125I-ICYP 1 6 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 239 4 4 4 1.3 OCc1cc(ccc1O)C(CNC(C)(C)C)O None
CHEMBL714 10234 91 125I-ICYP 1 6 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 239 4 4 4 1.3 OCc1cc(ccc1O)C(CNC(C)(C)C)O None
DB01001 10234 91 125I-ICYP 1 6 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 239 4 4 4 1.3 OCc1cc(ccc1O)C(CNC(C)(C)C)O None
1028 7079 71 None -23 30 Guinea pig 8.3 pKi = 8.3 Binding
Binding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenololBinding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenolol
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
139148732 7079 71 None -23 30 Guinea pig 8.3 pKi = 8.3 Binding
Binding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenololBinding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenolol
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
479 7079 71 None -23 30 Guinea pig 8.3 pKi = 8.3 Binding
Binding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenololBinding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenolol
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
5816 7079 71 None -23 30 Guinea pig 8.3 pKi = 8.3 Binding
Binding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenololBinding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenolol
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
CHEMBL679 7079 71 None -23 30 Guinea pig 8.3 pKi = 8.3 Binding
Binding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenololBinding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenolol
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
DB00668 7079 71 None -23 30 Guinea pig 8.3 pKi = 8.3 Binding
Binding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenololBinding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenolol
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
2865 10915 73 None -1071 53 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
59 10915 73 None -1071 53 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
60854 10915 73 None -1071 53 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
CHEMBL708 10915 73 None -1071 53 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
DB00246 10915 73 None -1071 53 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
105 10234 91 None 1 6 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 239 4 4 4 1.3 OCc1cc(ccc1O)C(CNC(C)(C)C)O None
2083 10234 91 None 1 6 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 239 4 4 4 1.3 OCc1cc(ccc1O)C(CNC(C)(C)C)O None
558 10234 91 None 1 6 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 239 4 4 4 1.3 OCc1cc(ccc1O)C(CNC(C)(C)C)O None
CHEMBL714 10234 91 None 1 6 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 239 4 4 4 1.3 OCc1cc(ccc1O)C(CNC(C)(C)C)O None
DB01001 10234 91 None 1 6 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 239 4 4 4 1.3 OCc1cc(ccc1O)C(CNC(C)(C)C)O None
11954224 222732 0 None -3388 59 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 581 4 3 6 2.0 CC1(C(=O)N2C(C(=O)N3CCCC3C2(O1)O)CC4=CC=CC=C4)NC(=O)C5CN(C6CC7=CNC8=CC=CC(=C78)C6=C5)C None
5311064 8148 46 None - 1 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 317 8 3 5 2.3 COc1cc(CCNC[C@@H](c2ccc(cc2)O)O)ccc1OC None
534 8148 46 None - 1 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 317 8 3 5 2.3 COc1cc(CCNC[C@@H](c2ccc(cc2)O)O)ccc1OC None
806 8148 46 None - 1 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 317 8 3 5 2.3 COc1cc(CCNC[C@@H](c2ccc(cc2)O)O)ccc1OC None
CHEMBL493682 8148 46 None - 1 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 317 8 3 5 2.3 COc1cc(CCNC[C@@H](c2ccc(cc2)O)O)ccc1OC None
137 7158 52 125I-CYP -19 12 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O None
2119 7158 52 125I-CYP -19 12 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O None
563 7158 52 125I-CYP -19 12 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O None
66368 7158 52 125I-CYP -19 12 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O None
CHEMBL266195 7158 52 125I-CYP -19 12 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O None
DB00866 7158 52 125I-CYP -19 12 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O None
2810 74376 55 None -1 2 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 213 4 2 2 2.4 CC(C)NCC(O)c1ccccc1Cl None
CHEMBL1902627 74376 55 None -1 2 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 213 4 2 2 2.4 CC(C)NCC(O)c1ccccc1Cl None
31101 7516 40 None -245 35 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
35 7516 40 None -245 35 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
403 7516 40 None -245 35 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
CHEMBL493 7516 40 None -245 35 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
DB01200 7516 40 None -245 35 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
1028 7079 71 None -66 30 Rat 8.2 pKi = 8.2 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
139148732 7079 71 None -66 30 Rat 8.2 pKi = 8.2 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
479 7079 71 None -66 30 Rat 8.2 pKi = 8.2 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
5816 7079 71 None -66 30 Rat 8.2 pKi = 8.2 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
CHEMBL679 7079 71 None -66 30 Rat 8.2 pKi = 8.2 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
DB00668 7079 71 None -66 30 Rat 8.2 pKi = 8.2 Binding
Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranesBinding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
135398737 7745 93 125I-ICYP -269 90 Human 5.3 pKi = 5.3 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
38 7745 93 125I-ICYP -269 90 Human 5.3 pKi = 5.3 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
722 7745 93 125I-ICYP -269 90 Human 5.3 pKi = 5.3 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
CHEMBL42 7745 93 125I-ICYP -269 90 Human 5.3 pKi = 5.3 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
DB00363 7745 93 125I-ICYP -269 90 Human 5.3 pKi = 5.3 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
135398745 9688 112 125I-ICYP -331 65 Human 5.3 pKi = 5.3 Binding
NoneNone
PDSP KiDatabase 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
47 9688 112 125I-ICYP -331 65 Human 5.3 pKi = 5.3 Binding
NoneNone
PDSP KiDatabase 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
CHEMBL715 9688 112 125I-ICYP -331 65 Human 5.3 pKi = 5.3 Binding
NoneNone
PDSP KiDatabase 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
DB00334 9688 112 125I-ICYP -331 65 Human 5.3 pKi = 5.3 Binding
NoneNone
PDSP KiDatabase 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
2181 9902 46 125I-ICYP -134 34 Human 5.3 pKi = 5.3 Binding
NoneNone
PDSP KiDatabase 375 7 1 4 2.6 O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N None
4830 9902 46 125I-ICYP -134 34 Human 5.3 pKi = 5.3 Binding
NoneNone
PDSP KiDatabase 375 7 1 4 2.6 O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N None
92 9902 46 125I-ICYP -134 34 Human 5.3 pKi = 5.3 Binding
NoneNone
PDSP KiDatabase 375 7 1 4 2.6 O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N None
CHEMBL440294 9902 46 125I-ICYP -134 34 Human 5.3 pKi = 5.3 Binding
NoneNone
PDSP KiDatabase 375 7 1 4 2.6 O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N None
DB09286 9902 46 125I-ICYP -134 34 Human 5.3 pKi = 5.3 Binding
NoneNone
PDSP KiDatabase 375 7 1 4 2.6 O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N None
2337 10030 77 125I-ICYP -72 62 Human 5.3 pKi = 5.3 Binding
NoneNone
PDSP KiDatabase 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
50 10030 77 125I-ICYP -72 62 Human 5.3 pKi = 5.3 Binding
NoneNone
PDSP KiDatabase 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
5002 10030 77 125I-ICYP -72 62 Human 5.3 pKi = 5.3 Binding
NoneNone
PDSP KiDatabase 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
CHEMBL716 10030 77 125I-ICYP -72 62 Human 5.3 pKi = 5.3 Binding
NoneNone
PDSP KiDatabase 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
DB01224 10030 77 125I-ICYP -72 62 Human 5.3 pKi = 5.3 Binding
NoneNone
PDSP KiDatabase 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
2389 10104 118 125I-ICYP -1737 66 Human 5.3 pKi = 5.3 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
5073 10104 118 125I-ICYP -1737 66 Human 5.3 pKi = 5.3 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
96 10104 118 125I-ICYP -1737 66 Human 5.3 pKi = 5.3 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
CHEMBL85 10104 118 125I-ICYP -1737 66 Human 5.3 pKi = 5.3 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
DB00734 10104 118 125I-ICYP -1737 66 Human 5.3 pKi = 5.3 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
2435 10362 83 125I-ICYP -316 48 Human 5.3 pKi = 5.3 Binding
NoneNone
PDSP KiDatabase 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
60149 10362 83 125I-ICYP -316 48 Human 5.3 pKi = 5.3 Binding
NoneNone
PDSP KiDatabase 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
98 10362 83 125I-ICYP -316 48 Human 5.3 pKi = 5.3 Binding
NoneNone
PDSP KiDatabase 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
CHEMBL12713 10362 83 125I-ICYP -316 48 Human 5.3 pKi = 5.3 Binding
NoneNone
PDSP KiDatabase 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
DB06144 10362 83 125I-ICYP -316 48 Human 5.3 pKi = 5.3 Binding
NoneNone
PDSP KiDatabase 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
115237 62359 119 125I-ICYP -2754 54 Human 5.3 pKi = 5.3 Binding
NoneNone
PDSP KiDatabase 426 4 1 7 3.1 Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2O None
CHEMBL1621 62359 119 125I-ICYP -2754 54 Human 5.3 pKi = 5.3 Binding
NoneNone
PDSP KiDatabase 426 4 1 7 3.1 Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2O None
46780481 114308 20 125I-ICYP -954 53 Human 5.3 pKi = 5.3 Binding
NoneNone
PDSP KiDatabase 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
9903970 114308 20 125I-ICYP -954 53 Human 5.3 pKi = 5.3 Binding
NoneNone
PDSP KiDatabase 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
CHEMBL3187365 114308 20 125I-ICYP -954 53 Human 5.3 pKi = 5.3 Binding
NoneNone
PDSP KiDatabase 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
CHEMBL3544974 114308 20 125I-ICYP -954 53 Human 5.3 pKi = 5.3 Binding
NoneNone
PDSP KiDatabase 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
31101 7516 40 3H-CGP-12177 -245 35 Human 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
35 7516 40 3H-CGP-12177 -245 35 Human 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
403 7516 40 3H-CGP-12177 -245 35 Human 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
CHEMBL493 7516 40 3H-CGP-12177 -245 35 Human 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
DB01200 7516 40 3H-CGP-12177 -245 35 Human 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
1222 8445 49 125I-ICYP -100 32 Human 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
3396 8445 49 125I-ICYP -100 32 Human 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
85 8445 49 125I-ICYP -100 32 Human 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
CHEMBL46516 8445 49 125I-ICYP -100 32 Human 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
DB04842 8445 49 125I-ICYP -100 32 Human 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
1960 9632 67 None -20 26 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
439260 9632 67 None -20 26 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
505 9632 67 None -20 26 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
CHEMBL1437 9632 67 None -20 26 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
DB00368 9632 67 None -20 26 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
66265 100788 15 None -1 19 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 231 4 1 1 3.2 CCN[C@@H](C)Cc1cccc(C(F)(F)F)c1 None
CHEMBL248702 100788 15 None -1 19 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 231 4 1 1 3.2 CCN[C@@H](C)Cc1cccc(C(F)(F)F)c1 None
2419 10236 84 None -154 6 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
Drug Central 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O None
5152 10236 84 None -154 6 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
Drug Central 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O None
559 10236 84 None -154 6 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
Drug Central 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O None
CHEMBL1263 10236 84 None -154 6 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
Drug Central 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O None
DB00938 10236 84 None -154 6 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
Drug Central 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O None
2464 10412 58 None -2 6 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C None
5253 10412 58 None -2 6 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C None
7297 10412 58 None -2 6 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C None
CHEMBL471 10412 58 None -2 6 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C None
DB00489 10412 58 None -2 6 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C None
2419 10236 84 125I-ICYP -154 6 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O None
5152 10236 84 125I-ICYP -154 6 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O None
559 10236 84 125I-ICYP -154 6 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O None
CHEMBL1263 10236 84 125I-ICYP -154 6 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O None
DB00938 10236 84 125I-ICYP -154 6 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O None
3083544 33582 51 125I-ICYP -5 5 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 None
CHEMBL1200811 33582 51 125I-ICYP -5 5 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 None
CHEMBL1363 33582 51 125I-ICYP -5 5 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 None
CHEMBL1951071 33582 51 125I-ICYP -5 5 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 None
CHEMBL605993 33582 51 125I-ICYP -5 5 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 None
1222 8445 49 None -100 32 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
3396 8445 49 None -100 32 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
85 8445 49 None -100 32 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
CHEMBL46516 8445 49 None -100 32 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
DB04842 8445 49 None -100 32 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
2419 10236 84 None -15 6 Mouse 8.2 pKi = 8.2 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
Drug Central 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O None
5152 10236 84 None -15 6 Mouse 8.2 pKi = 8.2 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
Drug Central 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O None
559 10236 84 None -15 6 Mouse 8.2 pKi = 8.2 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
Drug Central 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O None
CHEMBL1263 10236 84 None -15 6 Mouse 8.2 pKi = 8.2 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
Drug Central 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O None
DB00938 10236 84 None -15 6 Mouse 8.2 pKi = 8.2 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
Drug Central 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O None
1960 9632 67 None -10 26 Guinea pig 8.2 pKi = 8.2 Binding
Binding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenololBinding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenolol
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
439260 9632 67 None -10 26 Guinea pig 8.2 pKi = 8.2 Binding
Binding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenololBinding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenolol
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
505 9632 67 None -10 26 Guinea pig 8.2 pKi = 8.2 Binding
Binding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenololBinding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenolol
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
CHEMBL1437 9632 67 None -10 26 Guinea pig 8.2 pKi = 8.2 Binding
Binding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenololBinding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenolol
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
DB00368 9632 67 None -10 26 Guinea pig 8.2 pKi = 8.2 Binding
Binding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenololBinding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenolol
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
1588 9105 27 None -151 44 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
28864 9105 27 None -151 44 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
43 9105 27 None -151 44 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
CHEMBL157138 9105 27 None -151 44 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
DB00589 9105 27 None -151 44 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
3083544 33582 51 None -5 5 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
Drug Central 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 None
CHEMBL1200811 33582 51 None -5 5 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
Drug Central 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 None
CHEMBL1363 33582 51 None -5 5 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
Drug Central 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 None
CHEMBL1951071 33582 51 None -5 5 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
Drug Central 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 None
CHEMBL605993 33582 51 None -5 5 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
Drug Central 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 None
2258 9939 40 None 1 2 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 225 6 3 4 1.1 O[C@H](COc1ccc(cc1)O)CNC(C)C None
42396 9939 40 None 1 2 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 225 6 3 4 1.1 O[C@H](COc1ccc(cc1)O)CNC(C)C None
537 9939 40 None 1 2 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 225 6 3 4 1.1 O[C@H](COc1ccc(cc1)O)CNC(C)C None
CHEMBL1160714 9939 40 None 1 2 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 225 6 3 4 1.1 O[C@H](COc1ccc(cc1)O)CNC(C)C None
DB13777 9939 40 None 1 2 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 225 6 3 4 1.1 O[C@H](COc1ccc(cc1)O)CNC(C)C None
68770 51425 54 None 1 2 Human 8.2 pKi = 8.2 Binding
Binding affinity to beta1 adrenergic receptor (unknown origin) by radioligand binding assayBinding affinity to beta1 adrenergic receptor (unknown origin) by radioligand binding assay
Drug Central 363 7 4 4 3.3 CC(C)(C)NCC(O)COc1ccc(NC(=O)NC2CCCCC2)cc1 None
CHEMBL152067 51425 54 None 1 2 Human 8.2 pKi = 8.2 Binding
Binding affinity to beta1 adrenergic receptor (unknown origin) by radioligand binding assayBinding affinity to beta1 adrenergic receptor (unknown origin) by radioligand binding assay
Drug Central 363 7 4 4 3.3 CC(C)(C)NCC(O)COc1ccc(NC(=O)NC2CCCCC2)cc1 None
443372 17006 26 None -1 3 Mouse 8.2 pKi = 8.2 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
Drug Central 211 4 4 4 1.1 CC(C)NC[C@H](O)c1ccc(O)c(O)c1 None
CHEMBL1160723 17006 26 None -1 3 Mouse 8.2 pKi = 8.2 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
Drug Central 211 4 4 4 1.1 CC(C)NC[C@H](O)c1ccc(O)c(O)c1 None
CHEMBL2062275 17006 26 None -1 3 Mouse 8.2 pKi = 8.2 Binding
Displacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assayDisplacement of [3H]-CGP-12177 from murine beta1-adrenergic receptor expressed in HEK293T cells after 60 mins by radioligand competition binding assay
Drug Central 211 4 4 4 1.1 CC(C)NC[C@H](O)c1ccc(O)c(O)c1 None
1499 8872 47 None -5 17 Mouse 8.2 pKi = 8.2 Binding
Displacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cellsDisplacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cells
Drug Central 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C None
3779 8872 47 None -5 17 Mouse 8.2 pKi = 8.2 Binding
Displacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cellsDisplacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cells
Drug Central 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C None
536 8872 47 None -5 17 Mouse 8.2 pKi = 8.2 Binding
Displacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cellsDisplacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cells
Drug Central 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C None
CHEMBL434 8872 47 None -5 17 Mouse 8.2 pKi = 8.2 Binding
Displacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cellsDisplacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cells
Drug Central 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C None
DB01064 8872 47 None -5 17 Mouse 8.2 pKi = 8.2 Binding
Displacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cellsDisplacement of [3H]CGP12177 from mouse beta1 receptor expressed in HEK293 cells
Drug Central 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C None
2291 9958 58 None -11 12 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O None
2561 9958 58 None -11 12 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O None
4932 9958 58 None -11 12 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O None
CHEMBL631 9958 58 None -11 12 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O None
DB01182 9958 58 None -11 12 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O None
3486 9931 56 None 1 11 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C None
4883 9931 56 None 1 11 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C None
555 9931 56 None 1 11 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C None
CHEMBL6995 9931 56 None 1 11 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C None
DB01297 9931 56 None 1 11 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C None
175540 126033 49 None -1 5 Human 8.2 pKi = 8.2 Binding
Binding affinity to human adrenergic beta1 receptor by radioligand displacement assayBinding affinity to human adrenergic beta1 receptor by radioligand displacement assay
Drug Central 266 8 3 4 0.5 CC(C)NC[C@H](O)COc1ccc(CC(N)=O)cc1 None
CHEMBL343633 126033 49 None -1 5 Human 8.2 pKi = 8.2 Binding
Binding affinity to human adrenergic beta1 receptor by radioligand displacement assayBinding affinity to human adrenergic beta1 receptor by radioligand displacement assay
Drug Central 266 8 3 4 0.5 CC(C)NC[C@H](O)COc1ccc(CC(N)=O)cc1 None
1621 9207 17 None -102 44 Human 8.2 pKi = 8.2 Binding
Binding affinity towards Beta-1 adrenergic receptorBinding affinity towards Beta-1 adrenergic receptor
Drug Central 323 3 1 2 2.9 CCN(C(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
17 9207 17 None -102 44 Human 8.2 pKi = 8.2 Binding
Binding affinity towards Beta-1 adrenergic receptorBinding affinity towards Beta-1 adrenergic receptor
Drug Central 323 3 1 2 2.9 CCN(C(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
5761 9207 17 None -102 44 Human 8.2 pKi = 8.2 Binding
Binding affinity towards Beta-1 adrenergic receptorBinding affinity towards Beta-1 adrenergic receptor
Drug Central 323 3 1 2 2.9 CCN(C(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
CHEMBL263881 9207 17 None -102 44 Human 8.2 pKi = 8.2 Binding
Binding affinity towards Beta-1 adrenergic receptorBinding affinity towards Beta-1 adrenergic receptor
Drug Central 323 3 1 2 2.9 CCN(C(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
DB04829 9207 17 None -102 44 Human 8.2 pKi = 8.2 Binding
Binding affinity towards Beta-1 adrenergic receptorBinding affinity towards Beta-1 adrenergic receptor
Drug Central 323 3 1 2 2.9 CCN(C(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
242 7258 124 None -22 51 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
34 7258 124 None -22 51 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
60795 7258 124 None -22 51 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
CHEMBL1112 7258 124 None -22 51 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
DB01238 7258 124 None -22 51 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
1054 8367 54 None -1 3 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O None
59768 8367 54 None -1 3 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O None
7178 8367 54 None -1 3 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O None
CHEMBL768 8367 54 None -1 3 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O None
DB00187 8367 54 None -1 3 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O None
11823027 199395 37 None -1 3 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 309 5 4 5 0.6 CC(C)(C)NCC(O)COc1cccc2c1CC(O)C(O)C2 None
4411 199395 37 None -1 3 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 309 5 4 5 0.6 CC(C)(C)NCC(O)COc1cccc2c1CC(O)C(O)C2 None
CHEMBL521606 199395 37 None -1 3 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 309 5 4 5 0.6 CC(C)(C)NCC(O)COc1cccc2c1CC(O)C(O)C2 None
1960 9632 67 None -144 26 Rat 8.2 pKi = 8.2 Binding
Tested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligandTested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligand
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
439260 9632 67 None -144 26 Rat 8.2 pKi = 8.2 Binding
Tested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligandTested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligand
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
505 9632 67 None -144 26 Rat 8.2 pKi = 8.2 Binding
Tested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligandTested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligand
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
CHEMBL1437 9632 67 None -144 26 Rat 8.2 pKi = 8.2 Binding
Tested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligandTested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligand
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
DB00368 9632 67 None -144 26 Rat 8.2 pKi = 8.2 Binding
Tested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligandTested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligand
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
135409468 8816 69 125I-Pindolol -2238 39 Human 5.2 pKi = 5.2 Binding
NoneNone
PDSP KiDatabase 312 1 2 4 1.7 Clc1ccc2c(c1)NC(=c1c(=N2)cccc1)N1CCNCC1 None
333 8816 69 125I-Pindolol -2238 39 Human 5.2 pKi = 5.2 Binding
NoneNone
PDSP KiDatabase 312 1 2 4 1.7 Clc1ccc2c(c1)NC(=c1c(=N2)cccc1)N1CCNCC1 None
CHEMBL845 8816 69 125I-Pindolol -2238 39 Human 5.2 pKi = 5.2 Binding
NoneNone
PDSP KiDatabase 312 1 2 4 1.7 Clc1ccc2c(c1)NC(=c1c(=N2)cccc1)N1CCNCC1 None
1786 9298 85 125I-ICYP -21 11 Rat 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O None
4171 9298 85 125I-ICYP -21 11 Rat 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O None
553 9298 85 125I-ICYP -21 11 Rat 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O None
CHEMBL13 9298 85 125I-ICYP -21 11 Rat 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O None
DB00264 9298 85 125I-ICYP -21 11 Rat 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O None
2601 10552 33 3H-CGP-12177 -72 21 Human 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC None
443951 10552 33 3H-CGP-12177 -72 21 Human 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC None
56 10552 33 3H-CGP-12177 -72 21 Human 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC None
CHEMBL73151 10552 33 3H-CGP-12177 -72 21 Human 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC None
DB13399 10552 33 3H-CGP-12177 -72 21 Human 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC None
1588 9105 27 3H-CGP-12177 -151 44 Human 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
28864 9105 27 3H-CGP-12177 -151 44 Human 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
43 9105 27 3H-CGP-12177 -151 44 Human 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
CHEMBL157138 9105 27 3H-CGP-12177 -151 44 Human 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
DB00589 9105 27 3H-CGP-12177 -151 44 Human 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
4183 8806 68 None -2 3 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
Drug Central 392 6 4 4 3.1 CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O None
6918554 8806 68 None -2 3 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
Drug Central 392 6 4 4 3.1 CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O None
7455 8806 68 None -2 3 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
Drug Central 392 6 4 4 3.1 CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O None
CHEMBL1095777 8806 68 None -2 3 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
Drug Central 392 6 4 4 3.1 CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O None
DB05039 8806 68 None -2 3 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]CGP12177 from human beta-1 adrenoceptorDisplacement of [3H]CGP12177 from human beta-1 adrenoceptor
Drug Central 392 6 4 4 3.1 CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O None
12582 7737 45 None -3 5 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O None
2783 7737 45 None -3 5 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O None
CHEMBL49080 7737 45 None -3 5 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O None
DB01407 7737 45 None -3 5 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O None
11978813 7508 79 None -8 24 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 433 7 1 5 4.7 O=c1ccc2c([nH]1)cc(cc2)OCCCCN1CCN(CC1)c1cccc2c1ccs2 None
5014 7508 79 None -8 24 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 433 7 1 5 4.7 O=c1ccc2c([nH]1)cc(cc2)OCCCCN1CCN(CC1)c1cccc2c1ccs2 None
7672 7508 79 None -8 24 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 433 7 1 5 4.7 O=c1ccc2c([nH]1)cc(cc2)OCCCCN1CCN(CC1)c1cccc2c1ccs2 None
CHEMBL2105760 7508 79 None -8 24 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 433 7 1 5 4.7 O=c1ccc2c([nH]1)cc(cc2)OCCCCN1CCN(CC1)c1cccc2c1ccs2 None
DB09128 7508 79 None -8 24 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 433 7 1 5 4.7 O=c1ccc2c([nH]1)cc(cc2)OCCCCN1CCN(CC1)c1cccc2c1ccs2 None
2176 9901 68 125I-ICYP -22 27 Guinea pig 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C None
4828 9901 68 125I-ICYP -22 27 Guinea pig 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C None
91 9901 68 125I-ICYP -22 27 Guinea pig 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C None
CHEMBL500 9901 68 125I-ICYP -22 27 Guinea pig 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C None
DB00960 9901 68 125I-ICYP -22 27 Guinea pig 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C None
1978 7038 60 None -15 6 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 336 10 3 5 3.0 CCCC(=Nc1ccc(c(c1)C(=O)C)OCC(CNC(C)C)O)O None
40 7038 60 None -15 6 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 336 10 3 5 3.0 CCCC(=Nc1ccc(c(c1)C(=O)C)OCC(CNC(C)C)O)O None
7107 7038 60 None -15 6 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 336 10 3 5 3.0 CCCC(=Nc1ccc(c(c1)C(=O)C)OCC(CNC(C)C)O)O None
CHEMBL642 7038 60 None -15 6 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 336 10 3 5 3.0 CCCC(=Nc1ccc(c(c1)C(=O)C)OCC(CNC(C)C)O)O None
DB01193 7038 60 None -15 6 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 336 10 3 5 3.0 CCCC(=Nc1ccc(c(c1)C(=O)C)OCC(CNC(C)C)O)O None
2249 7300 111 None -5 12 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C None
255 7300 111 None -5 12 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C None
548 7300 111 None -5 12 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C None
CHEMBL24 7300 111 None -5 12 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C None
DB00335 7300 111 None -5 12 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C None
1786 9298 85 None 1 11 Mouse 8.1 pKi = 8.1 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
Drug Central 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O None
4171 9298 85 None 1 11 Mouse 8.1 pKi = 8.1 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
Drug Central 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O None
553 9298 85 None 1 11 Mouse 8.1 pKi = 8.1 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
Drug Central 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O None
CHEMBL13 9298 85 None 1 11 Mouse 8.1 pKi = 8.1 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
Drug Central 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O None
DB00264 9298 85 None 1 11 Mouse 8.1 pKi = 8.1 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
Drug Central 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O None
11504295 9697 47 None -1 3 Human 8.1 pKi = 8.1 Binding
competitive binding experiments against [3H]CGP 12177 in the presence of 5'-guanylyl-imidodiphosphatecompetitive binding experiments against [3H]CGP 12177 in the presence of 5'-guanylyl-imidodiphosphate
Drug Central 386 7 4 6 2.4 COc1ccc(cc1)CC(NC[C@@H](c1cc(O)cc2c1OCC(=O)N2)O)(C)C None
4814 9697 47 None -1 3 Human 8.1 pKi = 8.1 Binding
competitive binding experiments against [3H]CGP 12177 in the presence of 5'-guanylyl-imidodiphosphatecompetitive binding experiments against [3H]CGP 12177 in the presence of 5'-guanylyl-imidodiphosphate
Drug Central 386 7 4 6 2.4 COc1ccc(cc1)CC(NC[C@@H](c1cc(O)cc2c1OCC(=O)N2)O)(C)C None
7543 9697 47 None -1 3 Human 8.1 pKi = 8.1 Binding
competitive binding experiments against [3H]CGP 12177 in the presence of 5'-guanylyl-imidodiphosphatecompetitive binding experiments against [3H]CGP 12177 in the presence of 5'-guanylyl-imidodiphosphate
Drug Central 386 7 4 6 2.4 COc1ccc(cc1)CC(NC[C@@H](c1cc(O)cc2c1OCC(=O)N2)O)(C)C None
CHEMBL605846 9697 47 None -1 3 Human 8.1 pKi = 8.1 Binding
competitive binding experiments against [3H]CGP 12177 in the presence of 5'-guanylyl-imidodiphosphatecompetitive binding experiments against [3H]CGP 12177 in the presence of 5'-guanylyl-imidodiphosphate
Drug Central 386 7 4 6 2.4 COc1ccc(cc1)CC(NC[C@@H](c1cc(O)cc2c1OCC(=O)N2)O)(C)C None
DB09080 9697 47 None -1 3 Human 8.1 pKi = 8.1 Binding
competitive binding experiments against [3H]CGP 12177 in the presence of 5'-guanylyl-imidodiphosphatecompetitive binding experiments against [3H]CGP 12177 in the presence of 5'-guanylyl-imidodiphosphate
Drug Central 386 7 4 6 2.4 COc1ccc(cc1)CC(NC[C@@H](c1cc(O)cc2c1OCC(=O)N2)O)(C)C None
4806 10780 88 None -2 13 Human 8.1 pKi = 8.1 Binding
Binding affinity to human beta 1 adrenergic receptorBinding affinity to human beta 1 adrenergic receptor
Drug Central 298 3 1 3 3.9 Cc1ccc(c(c1)C)Sc1ccccc1N1CCNCC1 None
7351 10780 88 None -2 13 Human 8.1 pKi = 8.1 Binding
Binding affinity to human beta 1 adrenergic receptorBinding affinity to human beta 1 adrenergic receptor
Drug Central 298 3 1 3 3.9 Cc1ccc(c(c1)C)Sc1ccccc1N1CCNCC1 None
9966051 10780 88 None -2 13 Human 8.1 pKi = 8.1 Binding
Binding affinity to human beta 1 adrenergic receptorBinding affinity to human beta 1 adrenergic receptor
Drug Central 298 3 1 3 3.9 Cc1ccc(c(c1)C)Sc1ccccc1N1CCNCC1 None
CHEMBL2104993 10780 88 None -2 13 Human 8.1 pKi = 8.1 Binding
Binding affinity to human beta 1 adrenergic receptorBinding affinity to human beta 1 adrenergic receptor
Drug Central 298 3 1 3 3.9 Cc1ccc(c(c1)C)Sc1ccccc1N1CCNCC1 None
DB09068 10780 88 None -2 13 Human 8.1 pKi = 8.1 Binding
Binding affinity to human beta 1 adrenergic receptorBinding affinity to human beta 1 adrenergic receptor
Drug Central 298 3 1 3 3.9 Cc1ccc(c(c1)C)Sc1ccccc1N1CCNCC1 None
1786 9298 85 None -1 11 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O None
4171 9298 85 None -1 11 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O None
553 9298 85 None -1 11 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O None
CHEMBL13 9298 85 None -1 11 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O None
DB00264 9298 85 None -1 11 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O None
2405 7452 76 None -2 4 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 325 12 2 5 2.4 OC(COc1ccc(cc1)COCCOC(C)C)CNC(C)C None
380 7452 76 None -2 4 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 325 12 2 5 2.4 OC(COc1ccc(cc1)COCCOC(C)C)CNC(C)C None
7129 7452 76 None -2 4 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 325 12 2 5 2.4 OC(COc1ccc(cc1)COCCOC(C)C)CNC(C)C None
CHEMBL645 7452 76 None -2 4 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 325 12 2 5 2.4 OC(COc1ccc(cc1)COCCOC(C)C)CNC(C)C None
DB00612 7452 76 None -2 4 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 325 12 2 5 2.4 OC(COc1ccc(cc1)COCCOC(C)C)CNC(C)C None
4631 201751 29 125I-ICYP 1 7 Rat 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 265 9 2 4 2.0 C=CCOc1ccccc1OCC(O)CNC(C)C None
CHEMBL546 201751 29 125I-ICYP 1 7 Rat 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 265 9 2 4 2.0 C=CCOc1ccccc1OCC(O)CNC(C)C None
21268191 96422 0 UNDEFINED -1 3 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 340 6 3 3 3.5 OC(CNC12CC3CC(CC(C3)C1)C2)COc1cccc2[nH]ccc12 None
CHEMBL237572 96422 0 UNDEFINED -1 3 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 340 6 3 3 3.5 OC(CNC12CC3CC(CC(C3)C1)C2)COc1cccc2[nH]ccc12 None
105 10234 91 125I-ICYP -181 6 Guinea pig 5.1 pKi = 5.1 Binding
NoneNone
PDSP KiDatabase 239 4 4 4 1.3 OCc1cc(ccc1O)C(CNC(C)(C)C)O None
2083 10234 91 125I-ICYP -181 6 Guinea pig 5.1 pKi = 5.1 Binding
NoneNone
PDSP KiDatabase 239 4 4 4 1.3 OCc1cc(ccc1O)C(CNC(C)(C)C)O None
558 10234 91 125I-ICYP -181 6 Guinea pig 5.1 pKi = 5.1 Binding
NoneNone
PDSP KiDatabase 239 4 4 4 1.3 OCc1cc(ccc1O)C(CNC(C)(C)C)O None
CHEMBL714 10234 91 125I-ICYP -181 6 Guinea pig 5.1 pKi = 5.1 Binding
NoneNone
PDSP KiDatabase 239 4 4 4 1.3 OCc1cc(ccc1O)C(CNC(C)(C)C)O None
DB01001 10234 91 125I-ICYP -181 6 Guinea pig 5.1 pKi = 5.1 Binding
NoneNone
PDSP KiDatabase 239 4 4 4 1.3 OCc1cc(ccc1O)C(CNC(C)(C)C)O None
119376 8622 48 3H-CGP-26505 -43651 27 Rat 5.1 pKi = 5.1 Binding
NoneNone
PDSP KiDatabase 393 7 1 6 1.6 O=C(c1cn(c2c1cccc2)C)OCC1CCN(CC1)CCNS(=O)(=O)C None
247 8622 48 3H-CGP-26505 -43651 27 Rat 5.1 pKi = 5.1 Binding
NoneNone
PDSP KiDatabase 393 7 1 6 1.6 O=C(c1cn(c2c1cccc2)C)OCC1CCN(CC1)CCNS(=O)(=O)C None
CHEMBL33884 8622 48 3H-CGP-26505 -43651 27 Rat 5.1 pKi = 5.1 Binding
NoneNone
PDSP KiDatabase 393 7 1 6 1.6 O=C(c1cn(c2c1cccc2)C)OCC1CCN(CC1)CCNS(=O)(=O)C None
146294 7715 0 None 6 2 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 323 12 2 5 2.2 OC(COc1ccc(cc1)OCCOCC1CC1)CNC(C)C None
552 7715 0 None 6 2 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 323 12 2 5 2.2 OC(COc1ccc(cc1)OCCOCC1CC1)CNC(C)C None
637 7715 0 None 6 2 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 323 12 2 5 2.2 OC(COc1ccc(cc1)OCCOCC1CC1)CNC(C)C None
CHEMBL2110772 7715 0 None 6 2 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 323 12 2 5 2.2 OC(COc1ccc(cc1)OCCOCC1CC1)CNC(C)C None
2663 105538 34 None -1 3 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 379 9 3 5 2.9 CCN(CC)C(=O)Nc1ccc(OCC(O)CNC(C)(C)C)c(C(C)=O)c1 None
CHEMBL27810 105538 34 None -1 3 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 379 9 3 5 2.9 CCN(CC)C(=O)Nc1ccc(OCC(O)CNC(C)(C)C)c(C(C)=O)c1 None
4631 201751 29 None -1 7 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 265 9 2 4 2.0 C=CCOc1ccccc1OCC(O)CNC(C)C None
CHEMBL546 201751 29 None -1 7 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 265 9 2 4 2.0 C=CCOc1ccccc1OCC(O)CNC(C)C None
71733 224477 0 None 1 2 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 261 4 2 3 3.4 CCC1=CC=CC2=C1OC(=C2)C(O)CNC(C)(C)C None
1531 9046 69 None -1 16 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O None
3869 9046 69 None -1 16 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O None
7207 9046 69 None -1 16 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O None
CHEMBL429 9046 69 None -1 16 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O None
DB00598 9046 69 None -1 16 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O None
2405 7452 76 None 2 4 Mouse 8.1 pKi = 8.1 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
Drug Central 325 12 2 5 2.4 OC(COc1ccc(cc1)COCCOC(C)C)CNC(C)C None
380 7452 76 None 2 4 Mouse 8.1 pKi = 8.1 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
Drug Central 325 12 2 5 2.4 OC(COc1ccc(cc1)COCCOC(C)C)CNC(C)C None
7129 7452 76 None 2 4 Mouse 8.1 pKi = 8.1 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
Drug Central 325 12 2 5 2.4 OC(COc1ccc(cc1)COCCOC(C)C)CNC(C)C None
CHEMBL645 7452 76 None 2 4 Mouse 8.1 pKi = 8.1 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
Drug Central 325 12 2 5 2.4 OC(COc1ccc(cc1)COCCOC(C)C)CNC(C)C None
DB00612 7452 76 None 2 4 Mouse 8.1 pKi = 8.1 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
Drug Central 325 12 2 5 2.4 OC(COc1ccc(cc1)COCCOC(C)C)CNC(C)C None
3914 7527 35 None -3 7 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 291 5 2 4 2.3 CC(C)(C)NCC(COC1=CC=CC2=C1CCCC2=O)O None
39468 7527 35 None -3 7 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 291 5 2 4 2.3 CC(C)(C)NCC(COC1=CC=CC2=C1CCCC2=O)O None
431 7527 35 None -3 7 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 291 5 2 4 2.3 CC(C)(C)NCC(COC1=CC=CC2=C1CCCC2=O)O None
570 7527 35 None -3 7 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 291 5 2 4 2.3 CC(C)(C)NCC(COC1=CC=CC2=C1CCCC2=O)O None
CHEMBL1201237 7527 35 None -3 7 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 291 5 2 4 2.3 CC(C)(C)NCC(COC1=CC=CC2=C1CCCC2=O)O None
CHEMBL293030 7527 35 None -3 7 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 291 5 2 4 2.3 CC(C)(C)NCC(COC1=CC=CC2=C1CCCC2=O)O None
DB01210 7527 35 None -3 7 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)
Drug Central 291 5 2 4 2.3 CC(C)(C)NCC(COC1=CC=CC2=C1CCCC2=O)O None
118422671 9533 65 None 3 4 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 405 6 3 5 2.4 OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O None
1887 9533 65 None 3 4 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 405 6 3 5 2.4 OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O None
71301 9533 65 None 3 4 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 405 6 3 5 2.4 OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O None
7246 9533 65 None 3 4 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 405 6 3 5 2.4 OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O None
CHEMBL434394 9533 65 None 3 4 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 405 6 3 5 2.4 OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O None
DB04861 9533 65 None 3 4 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 405 6 3 5 2.4 OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O None
2303 9961 68 None -46 26 Rat 8.1 pKi = 8.1 Binding
Displacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation counting
Drug Central 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
4946 9961 68 None -46 26 Rat 8.1 pKi = 8.1 Binding
Displacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation counting
Drug Central 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
564 9961 68 None -46 26 Rat 8.1 pKi = 8.1 Binding
Displacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation counting
Drug Central 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
63 9961 68 None -46 26 Rat 8.1 pKi = 8.1 Binding
Displacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation counting
Drug Central 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
91536 9961 68 None -46 26 Rat 8.1 pKi = 8.1 Binding
Displacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation counting
Drug Central 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
CHEMBL27 9961 68 None -46 26 Rat 8.1 pKi = 8.1 Binding
Displacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation counting
Drug Central 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
CHEMBL452861 9961 68 None -46 26 Rat 8.1 pKi = 8.1 Binding
Displacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation counting
Drug Central 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
DB00571 9961 68 None -46 26 Rat 8.1 pKi = 8.1 Binding
Displacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation countingDisplacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation counting
Drug Central 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
2303 9961 68 None -10 26 Mouse 8.1 pKi = 8.1 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
Drug Central 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
4946 9961 68 None -10 26 Mouse 8.1 pKi = 8.1 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
Drug Central 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
564 9961 68 None -10 26 Mouse 8.1 pKi = 8.1 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
Drug Central 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
63 9961 68 None -10 26 Mouse 8.1 pKi = 8.1 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
Drug Central 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
91536 9961 68 None -10 26 Mouse 8.1 pKi = 8.1 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
Drug Central 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
CHEMBL27 9961 68 None -10 26 Mouse 8.1 pKi = 8.1 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
Drug Central 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
CHEMBL452861 9961 68 None -10 26 Mouse 8.1 pKi = 8.1 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
Drug Central 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
DB00571 9961 68 None -10 26 Mouse 8.1 pKi = 8.1 Binding
Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranesDisplacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
Drug Central 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
2303 9961 68 None -9 26 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
4946 9961 68 None -9 26 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
564 9961 68 None -9 26 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
63 9961 68 None -9 26 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
91536 9961 68 None -9 26 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
CHEMBL27 9961 68 None -9 26 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
CHEMBL452861 9961 68 None -9 26 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
DB00571 9961 68 None -9 26 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C None
37464 25993 26 None -1 4 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 291 6 2 3 3.5 CC(C)(C)NC[C@H](O)COc1ccccc1C1CCCC1 None
CHEMBL1290 25993 26 None -1 4 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 291 6 2 3 3.5 CC(C)(C)NC[C@H](O)COc1ccccc1C1CCCC1 None
21138 105227 39 125I-ICYP -1 7 Rat 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 259 6 2 3 2.6 CC(C)NC[C@@H](O)COc1cccc2ccccc12 None
CHEMBL275742 105227 39 125I-ICYP -1 7 Rat 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 259 6 2 3 2.6 CC(C)NC[C@@H](O)COc1cccc2ccccc12 None
2475 7528 0 None -2 3 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 271 5 2 3 2.8 OC(COc1cc(C)ccc1Cl)CNC(C)(C)C None
433 7528 0 None -2 3 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 271 5 2 3 2.8 OC(COc1cc(C)ccc1Cl)CNC(C)(C)C None
550 7528 0 None -2 3 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 271 5 2 3 2.8 OC(COc1cc(C)ccc1Cl)CNC(C)(C)C None
CHEMBL305380 7528 0 None -2 3 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 271 5 2 3 2.8 OC(COc1cc(C)ccc1Cl)CNC(C)(C)C None
DB08808 7528 0 None -2 3 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 271 5 2 3 2.8 OC(COc1cc(C)ccc1Cl)CNC(C)(C)C None
33624 10593 34 None -6 9 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C None
4061 10593 34 None -6 9 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C None
565 10593 34 None -6 9 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C None
CHEMBL499 10593 34 None -6 9 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C None
DB00373 10593 34 None -6 9 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C None
2585 7590 103 None -4 22 Rat 8.0 pKi = 8.0 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation methodDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation method
Drug Central 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O None
522 7590 103 None -4 22 Rat 8.0 pKi = 8.0 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation methodDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation method
Drug Central 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O None
551 7590 103 None -4 22 Rat 8.0 pKi = 8.0 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation methodDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation method
Drug Central 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O None
CHEMBL723 7590 103 None -4 22 Rat 8.0 pKi = 8.0 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation methodDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation method
Drug Central 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O None
DB01136 7590 103 None -4 22 Rat 8.0 pKi = 8.0 Binding
Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation methodDisplacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation method
Drug Central 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O None
60657 21258 34 None -1 3 Human 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 307 11 2 4 2.4 CC(C)NC[C@H](O)COc1ccc(CCOCC2CC2)cc1 None
CHEMBL1201274 21258 34 None -1 3 Human 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 307 11 2 4 2.4 CC(C)NC[C@H](O)COc1ccc(CCOCC2CC2)cc1 None
2583 212673 51 None 2 2 Human 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 292 5 3 4 1.7 CC(C)(C)NCC(O)COc1cccc2c1CCC(=O)N2 None
CHEMBL839 212673 51 None 2 2 Human 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 292 5 3 4 1.7 CC(C)(C)NCC(O)COc1cccc2c1CCC(=O)N2 None
2176 9901 68 None -4 27 Human 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C None
4828 9901 68 None -4 27 Human 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C None
91 9901 68 None -4 27 Human 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C None
CHEMBL500 9901 68 None -4 27 Human 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C None
DB00960 9901 68 None -4 27 Human 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C None
2585 7590 103 None -1 22 Human 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O None
522 7590 103 None -1 22 Human 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O None
551 7590 103 None -1 22 Human 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O None
CHEMBL723 7590 103 None -1 22 Human 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O None
DB01136 7590 103 None -1 22 Human 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O None
44112 128068 48 None -2 7 Human 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 380 7 2 4 4.5 Cc1cc2c(OCC(CNC(C)(C)C)OC(=O)c3ccccc3)cccc2[nH]1 None
CHEMBL357995 128068 48 None -2 7 Human 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 380 7 2 4 4.5 Cc1cc2c(OCC(CNC(C)(C)C)OC(=O)c3ccccc3)cccc2[nH]1 None
2249 7300 111 125I-ICYP -2 12 Rat 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C None
255 7300 111 125I-ICYP -2 12 Rat 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C None
548 7300 111 125I-ICYP -2 12 Rat 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C None
CHEMBL24 7300 111 125I-ICYP -2 12 Rat 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C None
DB00335 7300 111 125I-ICYP -2 12 Rat 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C None
128658 40749 7 125I-ICYP -11 5 Guinea pig 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 363 5 3 6 2.7 COc1cc(CC2NCCc3cc(O)c(O)c(F)c32)cc(OC)c1OC None
CHEMBL142428 40749 7 125I-ICYP -11 5 Guinea pig 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 363 5 3 6 2.7 COc1cc(CC2NCCc3cc(O)c(O)c(F)c32)cc(OC)c1OC None
2249 7300 111 125I-ICYP -2 12 Rat 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C None
255 7300 111 125I-ICYP -2 12 Rat 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C None
548 7300 111 125I-ICYP -2 12 Rat 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C None
CHEMBL24 7300 111 125I-ICYP -2 12 Rat 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C None
DB00335 7300 111 125I-ICYP -2 12 Rat 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C None
3337 213146 27 125I-Pindolol -58 40 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 None
65801 213146 27 125I-Pindolol -58 40 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 None
66264 213146 27 125I-Pindolol -58 40 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 None
91452 213146 27 125I-Pindolol -58 40 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 None
CHEMBL87493 213146 27 125I-Pindolol -58 40 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 None
118422671 9533 65 None 3 4 Human 9.1 pKi = 9.1 Binding
Radioligand bindingRadioligand binding
Guide to Pharmacology 405 6 3 5 2.4 OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O 20590599
1887 9533 65 None 3 4 Human 9.1 pKi = 9.1 Binding
Radioligand bindingRadioligand binding
Guide to Pharmacology 405 6 3 5 2.4 OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O 20590599
71301 9533 65 None 3 4 Human 9.1 pKi = 9.1 Binding
Radioligand bindingRadioligand binding
Guide to Pharmacology 405 6 3 5 2.4 OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O 20590599
7246 9533 65 None 3 4 Human 9.1 pKi = 9.1 Binding
Radioligand bindingRadioligand binding
Guide to Pharmacology 405 6 3 5 2.4 OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O 20590599
CHEMBL434394 9533 65 None 3 4 Human 9.1 pKi = 9.1 Binding
Radioligand bindingRadioligand binding
Guide to Pharmacology 405 6 3 5 2.4 OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O 20590599
DB04861 9533 65 None 3 4 Human 9.1 pKi = 9.1 Binding
Radioligand bindingRadioligand binding
Guide to Pharmacology 405 6 3 5 2.4 OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O 20590599
2598 10550 58 None -239 5 Human 3.9 pKi = 3.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 225 3 4 4 1.5 OC(c1cc(O)cc(c1)O)CNC(C)(C)C 20590599
5403 10550 58 None -239 5 Human 3.9 pKi = 3.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 225 3 4 4 1.5 OC(c1cc(O)cc(c1)O)CNC(C)(C)C 20590599
560 10550 58 None -239 5 Human 3.9 pKi = 3.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 225 3 4 4 1.5 OC(c1cc(O)cc(c1)O)CNC(C)(C)C 20590599
CHEMBL1760 10550 58 None -239 5 Human 3.9 pKi = 3.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 225 3 4 4 1.5 OC(c1cc(O)cc(c1)O)CNC(C)(C)C 20590599
DB00871 10550 58 None -239 5 Human 3.9 pKi = 3.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 225 3 4 4 1.5 OC(c1cc(O)cc(c1)O)CNC(C)(C)C 20590599
123600 9094 0 None -23 2 Human 4.7 pKi = 4.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 239 4 4 4 1.3 OCc1cc(ccc1O)[C@H](CNC(C)(C)C)O 20590599
1575 9094 0 None -23 2 Human 4.7 pKi = 4.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 239 4 4 4 1.3 OCc1cc(ccc1O)[C@H](CNC(C)(C)C)O 20590599
9816 9094 0 None -23 2 Human 4.7 pKi = 4.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 239 4 4 4 1.3 OCc1cc(ccc1O)[C@H](CNC(C)(C)C)O 20590599
CHEMBL1002 9094 0 None -23 2 Human 4.7 pKi = 4.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 239 4 4 4 1.3 OCc1cc(ccc1O)[C@H](CNC(C)(C)C)O 20590599
DB13139 9094 0 None -23 2 Human 4.7 pKi = 4.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 239 4 4 4 1.3 OCc1cc(ccc1O)[C@H](CNC(C)(C)C)O 20590599
1155 8410 53 None -42 5 Human 5.0 pKi = 5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 20590599
3343 8410 53 None -42 5 Human 5.0 pKi = 5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 20590599
557 8410 53 None -42 5 Human 5.0 pKi = 5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 20590599
CHEMBL32800 8410 53 None -42 5 Human 5.0 pKi = 5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 20590599
DB01288 8410 53 None -42 5 Human 5.0 pKi = 5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 20590599
567 7512 16 None -13 5 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 363 9 3 4 3.1 C[C@H](Cc1ccc(cc1)OCC(=O)O)NC[C@@H](c1cccc(c1)Cl)O 20590599
9841972 7512 16 None -13 5 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 363 9 3 4 3.1 C[C@H](Cc1ccc(cc1)OCC(=O)O)NC[C@@H](c1cccc(c1)Cl)O 20590599
CHEMBL284782 7512 16 None -13 5 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 363 9 3 4 3.1 C[C@H](Cc1ccc(cc1)OCC(=O)O)NC[C@@H](c1cccc(c1)Cl)O 20590599
36811 8236 37 None -109 7 Human 5.4 pKi = 5.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 10531390
36811 8236 37 None -109 7 Human 5.4 pKi = 5.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 20590599
535 8236 37 None -109 7 Human 5.4 pKi = 5.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 10531390
535 8236 37 None -109 7 Human 5.4 pKi = 5.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 20590599
937 8236 37 None -109 7 Human 5.4 pKi = 5.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 10531390
937 8236 37 None -109 7 Human 5.4 pKi = 5.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 20590599
CHEMBL926 8236 37 None -109 7 Human 5.4 pKi = 5.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 10531390
CHEMBL926 8236 37 None -109 7 Human 5.4 pKi = 5.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 20590599
DB00841 8236 37 None -109 7 Human 5.4 pKi = 5.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 10531390
DB00841 8236 37 None -109 7 Human 5.4 pKi = 5.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 20590599
1028 7079 71 None -70 30 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 14730417
1028 7079 71 None -70 30 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 20590599
1028 7079 71 None -70 30 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 2849109
139148732 7079 71 None -70 30 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 14730417
139148732 7079 71 None -70 30 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 20590599
139148732 7079 71 None -70 30 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 2849109
479 7079 71 None -70 30 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 14730417
479 7079 71 None -70 30 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 20590599
479 7079 71 None -70 30 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 2849109
5816 7079 71 None -70 30 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 14730417
5816 7079 71 None -70 30 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 20590599
5816 7079 71 None -70 30 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 2849109
CHEMBL679 7079 71 None -70 30 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 14730417
CHEMBL679 7079 71 None -70 30 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 20590599
CHEMBL679 7079 71 None -70 30 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 2849109
DB00668 7079 71 None -70 30 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 14730417
DB00668 7079 71 None -70 30 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 20590599
DB00668 7079 71 None -70 30 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 2849109
1960 9632 67 None -20 26 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 14730417
1960 9632 67 None -20 26 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 20590599
1960 9632 67 None -20 26 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 2849109
439260 9632 67 None -20 26 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 14730417
439260 9632 67 None -20 26 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 20590599
439260 9632 67 None -20 26 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 2849109
505 9632 67 None -20 26 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 14730417
505 9632 67 None -20 26 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 20590599
505 9632 67 None -20 26 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 2849109
CHEMBL1437 9632 67 None -20 26 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 14730417
CHEMBL1437 9632 67 None -20 26 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 20590599
CHEMBL1437 9632 67 None -20 26 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 2849109
DB00368 9632 67 None -20 26 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 14730417
DB00368 9632 67 None -20 26 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 20590599
DB00368 9632 67 None -20 26 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 2849109
5311064 8148 46 None - 1 Human 6.0 pKi = 6.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 317 8 3 5 2.3 COc1cc(CCNC[C@@H](c2ccc(cc2)O)O)ccc1OC 10531390
5311064 8148 46 None - 1 Human 6.0 pKi = 6.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 317 8 3 5 2.3 COc1cc(CCNC[C@@H](c2ccc(cc2)O)O)ccc1OC 20590599
5311064 8148 46 None - 1 Human 6.0 pKi = 6.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 317 8 3 5 2.3 COc1cc(CCNC[C@@H](c2ccc(cc2)O)O)ccc1OC 7902433
534 8148 46 None - 1 Human 6.0 pKi = 6.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 317 8 3 5 2.3 COc1cc(CCNC[C@@H](c2ccc(cc2)O)O)ccc1OC 10531390
534 8148 46 None - 1 Human 6.0 pKi = 6.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 317 8 3 5 2.3 COc1cc(CCNC[C@@H](c2ccc(cc2)O)O)ccc1OC 20590599
534 8148 46 None - 1 Human 6.0 pKi = 6.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 317 8 3 5 2.3 COc1cc(CCNC[C@@H](c2ccc(cc2)O)O)ccc1OC 7902433
806 8148 46 None - 1 Human 6.0 pKi = 6.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 317 8 3 5 2.3 COc1cc(CCNC[C@@H](c2ccc(cc2)O)O)ccc1OC 10531390
806 8148 46 None - 1 Human 6.0 pKi = 6.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 317 8 3 5 2.3 COc1cc(CCNC[C@@H](c2ccc(cc2)O)O)ccc1OC 20590599
806 8148 46 None - 1 Human 6.0 pKi = 6.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 317 8 3 5 2.3 COc1cc(CCNC[C@@H](c2ccc(cc2)O)O)ccc1OC 7902433
CHEMBL493682 8148 46 None - 1 Human 6.0 pKi = 6.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 317 8 3 5 2.3 COc1cc(CCNC[C@@H](c2ccc(cc2)O)O)ccc1OC 10531390
CHEMBL493682 8148 46 None - 1 Human 6.0 pKi = 6.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 317 8 3 5 2.3 COc1cc(CCNC[C@@H](c2ccc(cc2)O)O)ccc1OC 20590599
CHEMBL493682 8148 46 None - 1 Human 6.0 pKi = 6.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 317 8 3 5 2.3 COc1cc(CCNC[C@@H](c2ccc(cc2)O)O)ccc1OC 7902433
2464 10412 58 None -2 6 Human 6.0 pKi = 6.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C 15655528
5253 10412 58 None -2 6 Human 6.0 pKi = 6.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C 15655528
7297 10412 58 None -2 6 Human 6.0 pKi = 6.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C 15655528
CHEMBL471 10412 58 None -2 6 Human 6.0 pKi = 6.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C 15655528
DB00489 10412 58 None -2 6 Human 6.0 pKi = 6.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 272 6 3 4 1.1 CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C 15655528
484 9633 51 None -19 35 Human 6.0 pKi = 6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O 2849109
951 9633 51 None -19 35 Human 6.0 pKi = 6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O 2849109
CHEMBL432 9633 51 None -19 35 Human 6.0 pKi = 6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O 2849109
4508 9913 98 None -199 13 Human 6.0 pKi = 6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNCC(c1ccc(c(c1)O)O)O 2849109
4866774 9913 98 None -199 13 Human 6.0 pKi = 6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNCC(c1ccc(c(c1)O)O)O 2849109
509 9913 98 None -199 13 Human 6.0 pKi = 6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNCC(c1ccc(c(c1)O)O)O 2849109
838 9913 98 None -199 13 Human 6.0 pKi = 6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNCC(c1ccc(c(c1)O)O)O 2849109
CHEMBL1740 9913 98 None -199 13 Human 6.0 pKi = 6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNCC(c1ccc(c(c1)O)O)O 2849109
1239 8458 55 None -53 4 Human 6.3 pKi = 6.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 20590599
1239 8458 55 None -53 4 Human 6.3 pKi = 6.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 20655218
3410 8458 55 None -53 4 Human 6.3 pKi = 6.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 20590599
3410 8458 55 None -53 4 Human 6.3 pKi = 6.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 20655218
3465 8458 55 None -53 4 Human 6.3 pKi = 6.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 20590599
3465 8458 55 None -53 4 Human 6.3 pKi = 6.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 20655218
CHEMBL1256786 8458 55 None -53 4 Human 6.3 pKi = 6.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 20590599
CHEMBL1256786 8458 55 None -53 4 Human 6.3 pKi = 6.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 20655218
DB00983 8458 55 None -53 4 Human 6.3 pKi = 6.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 20590599
DB00983 8458 55 None -53 4 Human 6.3 pKi = 6.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 344 9 4 5 2.2 O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O 20655218
3486 9931 56 None 1 11 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10079020
3486 9931 56 None 1 11 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 15655528
4883 9931 56 None 1 11 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10079020
4883 9931 56 None 1 11 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 15655528
555 9931 56 None 1 11 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10079020
555 9931 56 None 1 11 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 15655528
CHEMBL6995 9931 56 None 1 11 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10079020
CHEMBL6995 9931 56 None 1 11 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 15655528
DB01297 9931 56 None 1 11 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 10079020
DB01297 9931 56 None 1 11 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 266 7 3 4 1.4 OC(COc1ccc(cc1)NC(=O)C)CNC(C)C 15655528
1978 7038 60 None -15 6 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 336 10 3 5 3.0 CCCC(=Nc1ccc(c(c1)C(=O)C)OCC(CNC(C)C)O)O 15655528
40 7038 60 None -15 6 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 336 10 3 5 3.0 CCCC(=Nc1ccc(c(c1)C(=O)C)OCC(CNC(C)C)O)O 15655528
7107 7038 60 None -15 6 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 336 10 3 5 3.0 CCCC(=Nc1ccc(c(c1)C(=O)C)OCC(CNC(C)C)O)O 15655528
CHEMBL642 7038 60 None -15 6 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 336 10 3 5 3.0 CCCC(=Nc1ccc(c(c1)C(=O)C)OCC(CNC(C)C)O)O 15655528
DB01193 7038 60 None -15 6 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 336 10 3 5 3.0 CCCC(=Nc1ccc(c(c1)C(=O)C)OCC(CNC(C)C)O)O 15655528
1499 8872 47 None -53 17 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 20590599
1499 8872 47 None -53 17 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 2849109
1499 8872 47 None -53 17 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 8982677
3779 8872 47 None -53 17 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 20590599
3779 8872 47 None -53 17 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 2849109
3779 8872 47 None -53 17 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 8982677
536 8872 47 None -53 17 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 20590599
536 8872 47 None -53 17 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 2849109
536 8872 47 None -53 17 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 8982677
CHEMBL434 8872 47 None -53 17 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 20590599
CHEMBL434 8872 47 None -53 17 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 2849109
CHEMBL434 8872 47 None -53 17 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 8982677
DB01064 8872 47 None -53 17 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 20590599
DB01064 8872 47 None -53 17 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 2849109
DB01064 8872 47 None -53 17 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 8982677
12578 7723 61 None 19 2 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 219 4 3 4 1.2 CC(C)NCC(C1=CC(=C(C=C1)N)C#N)O 20590599
2755 7723 61 None 19 2 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 219 4 3 4 1.2 CC(C)NCC(C1=CC(=C(C=C1)N)C#N)O 20590599
CHEMBL1374751 7723 61 None 19 2 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 219 4 3 4 1.2 CC(C)NCC(C1=CC(=C(C=C1)N)C#N)O 20590599
2258 9939 40 None 1 2 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 225 6 3 4 1.1 O[C@H](COc1ccc(cc1)O)CNC(C)C 10531390
2258 9939 40 None 1 2 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 225 6 3 4 1.1 O[C@H](COc1ccc(cc1)O)CNC(C)C 2564629
42396 9939 40 None 1 2 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 225 6 3 4 1.1 O[C@H](COc1ccc(cc1)O)CNC(C)C 10531390
42396 9939 40 None 1 2 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 225 6 3 4 1.1 O[C@H](COc1ccc(cc1)O)CNC(C)C 2564629
537 9939 40 None 1 2 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 225 6 3 4 1.1 O[C@H](COc1ccc(cc1)O)CNC(C)C 10531390
537 9939 40 None 1 2 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 225 6 3 4 1.1 O[C@H](COc1ccc(cc1)O)CNC(C)C 2564629
CHEMBL1160714 9939 40 None 1 2 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 225 6 3 4 1.1 O[C@H](COc1ccc(cc1)O)CNC(C)C 10531390
CHEMBL1160714 9939 40 None 1 2 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 225 6 3 4 1.1 O[C@H](COc1ccc(cc1)O)CNC(C)C 2564629
DB13777 9939 40 None 1 2 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 225 6 3 4 1.1 O[C@H](COc1ccc(cc1)O)CNC(C)C 10531390
DB13777 9939 40 None 1 2 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 225 6 3 4 1.1 O[C@H](COc1ccc(cc1)O)CNC(C)C 2564629
4183 8806 68 None -2 3 Human 6.7 pKi = 6.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 392 6 4 4 3.1 CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O 22932315
6918554 8806 68 None -2 3 Human 6.7 pKi = 6.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 392 6 4 4 3.1 CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O 22932315
7455 8806 68 None -2 3 Human 6.7 pKi = 6.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 392 6 4 4 3.1 CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O 22932315
CHEMBL1095777 8806 68 None -2 3 Human 6.7 pKi = 6.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 392 6 4 4 3.1 CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O 22932315
DB05039 8806 68 None -2 3 Human 6.7 pKi = 6.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 392 6 4 4 3.1 CCc1cc2CC(Cc2cc1CC)NC[C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O 22932315
2291 9958 58 None -11 12 Human 6.7 pKi = 6.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O None
2561 9958 58 None -11 12 Human 6.7 pKi = 6.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O None
4932 9958 58 None -11 12 Human 6.7 pKi = 6.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O None
CHEMBL631 9958 58 None -11 12 Human 6.7 pKi = 6.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O None
DB01182 9958 58 None -11 12 Human 6.7 pKi = 6.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O None
1054 8367 54 None -1 3 Human 6.8 pKi = 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O 27451411
59768 8367 54 None -1 3 Human 6.8 pKi = 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O 27451411
7178 8367 54 None -1 3 Human 6.8 pKi = 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O 27451411
CHEMBL768 8367 54 None -1 3 Human 6.8 pKi = 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O 27451411
DB00187 8367 54 None -1 3 Human 6.8 pKi = 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 295 9 2 5 1.5 COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O 27451411
39147 9489 0 None -7 3 Human 6.9 pKi = 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 309 5 4 5 0.6 OC(COc1cccc2c1C[C@H](O)[C@@H](C2)O)CNC(C)(C)C 10411574
554 9489 0 None -7 3 Human 6.9 pKi = 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 309 5 4 5 0.6 OC(COc1cccc2c1C[C@H](O)[C@@H](C2)O)CNC(C)(C)C 10411574
CHEMBL649 9489 0 None -7 3 Human 6.9 pKi = 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 309 5 4 5 0.6 OC(COc1cccc2c1C[C@H](O)[C@@H](C2)O)CNC(C)(C)C 10411574
DB01203 9489 0 None -7 3 Human 6.9 pKi = 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 309 5 4 5 0.6 OC(COc1cccc2c1C[C@H](O)[C@@H](C2)O)CNC(C)(C)C 10411574
114905 9051 0 None - 1 Human 7.0 pKi = 7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 509 13 3 9 0.7 CC1(OC[C@H](O1)COC(=O)CCC2=CC=C(C=C2)OC[C@H](CNCCNC(=O)N3CCOCC3)O)C 27451411
13192 9051 0 None - 1 Human 7.0 pKi = 7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 509 13 3 9 0.7 CC1(OC[C@H](O1)COC(=O)CCC2=CC=C(C=C2)OC[C@H](CNCCNC(=O)N3CCOCC3)O)C 27451411
CHEMBL1742466 9051 0 None - 1 Human 7.0 pKi = 7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 509 13 3 9 0.7 CC1(OC[C@H](O1)COC(=O)CCC2=CC=C(C=C2)OC[C@H](CNCCNC(=O)N3CCOCC3)O)C 27451411
DB12212 9051 0 None - 1 Human 7.0 pKi = 7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 509 13 3 9 0.7 CC1(OC[C@H](O1)COC(=O)CCC2=CC=C(C=C2)OC[C@H](CNCCNC(=O)N3CCOCC3)O)C 27451411
155774 10868 40 None 6 3 Human 7.1 pKi = 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 339 8 4 6 -0.2 OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1 10531390
155774 10868 40 None 6 3 Human 7.1 pKi = 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 339 8 4 6 -0.2 OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1 15655528
2848 10868 40 None 6 3 Human 7.1 pKi = 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 339 8 4 6 -0.2 OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1 10531390
2848 10868 40 None 6 3 Human 7.1 pKi = 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 339 8 4 6 -0.2 OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1 15655528
538 10868 40 None 6 3 Human 7.1 pKi = 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 339 8 4 6 -0.2 OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1 10531390
538 10868 40 None 6 3 Human 7.1 pKi = 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 339 8 4 6 -0.2 OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1 15655528
CHEMBL75753 10868 40 None 6 3 Human 7.1 pKi = 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 339 8 4 6 -0.2 OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1 10531390
CHEMBL75753 10868 40 None 6 3 Human 7.1 pKi = 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 339 8 4 6 -0.2 OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1 15655528
DB13781 10868 40 None 6 3 Human 7.1 pKi = 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 339 8 4 6 -0.2 OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1 10531390
DB13781 10868 40 None 6 3 Human 7.1 pKi = 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 339 8 4 6 -0.2 OC(COc1ccc(cc1)O)CNCCNC(=O)N1CCOCC1 15655528
2249 7300 111 None -5 12 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10079020
2249 7300 111 None -5 12 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 15060759
2249 7300 111 None -5 12 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 15655528
255 7300 111 None -5 12 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10079020
255 7300 111 None -5 12 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 15060759
255 7300 111 None -5 12 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 15655528
548 7300 111 None -5 12 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10079020
548 7300 111 None -5 12 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 15060759
548 7300 111 None -5 12 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 15655528
CHEMBL24 7300 111 None -5 12 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10079020
CHEMBL24 7300 111 None -5 12 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 15060759
CHEMBL24 7300 111 None -5 12 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 15655528
DB00335 7300 111 None -5 12 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 10079020
DB00335 7300 111 None -5 12 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 15060759
DB00335 7300 111 None -5 12 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 266 8 3 4 0.5 OC(COc1ccc(cc1)CC(=O)N)CNC(C)C 15655528
1786 9298 85 None -1 11 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10079020
1786 9298 85 None -1 11 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10411574
1786 9298 85 None -1 11 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 14645666
1786 9298 85 None -1 11 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 14730417
1786 9298 85 None -1 11 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 15655528
4171 9298 85 None -1 11 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10079020
4171 9298 85 None -1 11 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10411574
4171 9298 85 None -1 11 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 14645666
4171 9298 85 None -1 11 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 14730417
4171 9298 85 None -1 11 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 15655528
553 9298 85 None -1 11 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10079020
553 9298 85 None -1 11 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10411574
553 9298 85 None -1 11 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 14645666
553 9298 85 None -1 11 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 14730417
553 9298 85 None -1 11 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 15655528
CHEMBL13 9298 85 None -1 11 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10079020
CHEMBL13 9298 85 None -1 11 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10411574
CHEMBL13 9298 85 None -1 11 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 14645666
CHEMBL13 9298 85 None -1 11 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 14730417
CHEMBL13 9298 85 None -1 11 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 15655528
DB00264 9298 85 None -1 11 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10079020
DB00264 9298 85 None -1 11 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10411574
DB00264 9298 85 None -1 11 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 14645666
DB00264 9298 85 None -1 11 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 14730417
DB00264 9298 85 None -1 11 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 15655528
12582 7737 45 None -3 5 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O 20590599
12582 7737 45 None -3 5 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O 25324048
2783 7737 45 None -3 5 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O 20590599
2783 7737 45 None -3 5 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O 25324048
CHEMBL49080 7737 45 None -3 5 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O 20590599
CHEMBL49080 7737 45 None -3 5 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O 25324048
DB01407 7737 45 None -3 5 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O 20590599
DB01407 7737 45 None -3 5 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O 25324048
2405 7452 76 None -2 4 Human 7.8 pKi = 7.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 325 12 2 5 2.4 OC(COc1ccc(cc1)COCCOC(C)C)CNC(C)C 28400472
380 7452 76 None -2 4 Human 7.8 pKi = 7.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 325 12 2 5 2.4 OC(COc1ccc(cc1)COCCOC(C)C)CNC(C)C 28400472
7129 7452 76 None -2 4 Human 7.8 pKi = 7.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 325 12 2 5 2.4 OC(COc1ccc(cc1)COCCOC(C)C)CNC(C)C 28400472
CHEMBL645 7452 76 None -2 4 Human 7.8 pKi = 7.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 325 12 2 5 2.4 OC(COc1ccc(cc1)COCCOC(C)C)CNC(C)C 28400472
DB00612 7452 76 None -2 4 Human 7.8 pKi = 7.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 325 12 2 5 2.4 OC(COc1ccc(cc1)COCCOC(C)C)CNC(C)C 28400472
1531 9046 69 None -1 16 Human 7.9 pKi = 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O 14645666
1531 9046 69 None -1 16 Human 7.9 pKi = 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O 15655528
3869 9046 69 None -1 16 Human 7.9 pKi = 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O 14645666
3869 9046 69 None -1 16 Human 7.9 pKi = 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O 15655528
7207 9046 69 None -1 16 Human 7.9 pKi = 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O 14645666
7207 9046 69 None -1 16 Human 7.9 pKi = 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O 15655528
CHEMBL429 9046 69 None -1 16 Human 7.9 pKi = 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O 14645666
CHEMBL429 9046 69 None -1 16 Human 7.9 pKi = 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O 15655528
DB00598 9046 69 None -1 16 Human 7.9 pKi = 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O 14645666
DB00598 9046 69 None -1 16 Human 7.9 pKi = 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O 15655528
156297 10123 0 None - 1 Human 8.0 pKi = 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 363 10 4 7 1.7 COc1cc(CCNCC(COc2ccc(c(c2)O)O)O)ccc1OC 9117106
5571 10123 0 None - 1 Human 8.0 pKi = 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 363 10 4 7 1.7 COc1cc(CCNCC(COc2ccc(c(c2)O)O)O)ccc1OC 9117106
5311452 10443 11 None -7 3 Human 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 325 7 2 3 3.7 CCc1ccccc1OC[C@H](CN[C@H]1CCCc2c1cccc2)O 10411574
5311452 10443 11 None -7 3 Human 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 325 7 2 3 3.7 CCc1ccccc1OC[C@H](CN[C@H]1CCCc2c1cccc2)O 15655528
5311452 10443 11 None -7 3 Human 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 325 7 2 3 3.7 CCc1ccccc1OC[C@H](CN[C@H]1CCCc2c1cccc2)O 20590599
547 10443 11 None -7 3 Human 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 325 7 2 3 3.7 CCc1ccccc1OC[C@H](CN[C@H]1CCCc2c1cccc2)O 10411574
547 10443 11 None -7 3 Human 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 325 7 2 3 3.7 CCc1ccccc1OC[C@H](CN[C@H]1CCCc2c1cccc2)O 15655528
547 10443 11 None -7 3 Human 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 325 7 2 3 3.7 CCc1ccccc1OC[C@H](CN[C@H]1CCCc2c1cccc2)O 20590599
CHEMBL1326499 10443 11 None -7 3 Human 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 325 7 2 3 3.7 CCc1ccccc1OC[C@H](CN[C@H]1CCCc2c1cccc2)O 10411574
CHEMBL1326499 10443 11 None -7 3 Human 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 325 7 2 3 3.7 CCc1ccccc1OC[C@H](CN[C@H]1CCCc2c1cccc2)O 15655528
CHEMBL1326499 10443 11 None -7 3 Human 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 325 7 2 3 3.7 CCc1ccccc1OC[C@H](CN[C@H]1CCCc2c1cccc2)O 20590599
2475 7528 0 None -2 3 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 271 5 2 3 2.8 OC(COc1cc(C)ccc1Cl)CNC(C)(C)C 10079020
2475 7528 0 None -2 3 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 271 5 2 3 2.8 OC(COc1cc(C)ccc1Cl)CNC(C)(C)C 10411574
2475 7528 0 None -2 3 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 271 5 2 3 2.8 OC(COc1cc(C)ccc1Cl)CNC(C)(C)C 15655528
433 7528 0 None -2 3 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 271 5 2 3 2.8 OC(COc1cc(C)ccc1Cl)CNC(C)(C)C 10079020
433 7528 0 None -2 3 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 271 5 2 3 2.8 OC(COc1cc(C)ccc1Cl)CNC(C)(C)C 10411574
433 7528 0 None -2 3 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 271 5 2 3 2.8 OC(COc1cc(C)ccc1Cl)CNC(C)(C)C 15655528
550 7528 0 None -2 3 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 271 5 2 3 2.8 OC(COc1cc(C)ccc1Cl)CNC(C)(C)C 10079020
550 7528 0 None -2 3 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 271 5 2 3 2.8 OC(COc1cc(C)ccc1Cl)CNC(C)(C)C 10411574
550 7528 0 None -2 3 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 271 5 2 3 2.8 OC(COc1cc(C)ccc1Cl)CNC(C)(C)C 15655528
CHEMBL305380 7528 0 None -2 3 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 271 5 2 3 2.8 OC(COc1cc(C)ccc1Cl)CNC(C)(C)C 10079020
CHEMBL305380 7528 0 None -2 3 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 271 5 2 3 2.8 OC(COc1cc(C)ccc1Cl)CNC(C)(C)C 10411574
CHEMBL305380 7528 0 None -2 3 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 271 5 2 3 2.8 OC(COc1cc(C)ccc1Cl)CNC(C)(C)C 15655528
DB08808 7528 0 None -2 3 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 271 5 2 3 2.8 OC(COc1cc(C)ccc1Cl)CNC(C)(C)C 10079020
DB08808 7528 0 None -2 3 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 271 5 2 3 2.8 OC(COc1cc(C)ccc1Cl)CNC(C)(C)C 10411574
DB08808 7528 0 None -2 3 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 271 5 2 3 2.8 OC(COc1cc(C)ccc1Cl)CNC(C)(C)C 15655528
12579 9528 0 None 1 2 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 470 14 4 7 3.7 O[C@@H](CNCCOC1=CC=C(C=C1)C(O)=N)COC2=CC3=C(O[C@H](CCCC4CC4)CO3)C=C2 28400472
167993658 9528 0 None 1 2 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 470 14 4 7 3.7 O[C@@H](CNCCOC1=CC=C(C=C1)C(O)=N)COC2=CC3=C(O[C@H](CCCC4CC4)CO3)C=C2 28400472
5311116 9114 9 None 48 3 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 484 15 5 8 2.2 N#Cc1cc(OCCOCC2CC2)ccc1OCC(CNCCNC(=O)Nc1ccc(cc1)O)O 10079020
5311116 9114 9 None 48 3 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 484 15 5 8 2.2 N#Cc1cc(OCCOCC2CC2)ccc1OCC(CNCCNC(=O)Nc1ccc(cc1)O)O 28400472
544 9114 9 None 48 3 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 484 15 5 8 2.2 N#Cc1cc(OCCOCC2CC2)ccc1OCC(CNCCNC(=O)Nc1ccc(cc1)O)O 10079020
544 9114 9 None 48 3 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 484 15 5 8 2.2 N#Cc1cc(OCCOCC2CC2)ccc1OCC(CNCCNC(=O)Nc1ccc(cc1)O)O 28400472
CHEMBL207802 9114 9 None 48 3 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 484 15 5 8 2.2 N#Cc1cc(OCCOCC2CC2)ccc1OCC(CNCCNC(=O)Nc1ccc(cc1)O)O 10079020
CHEMBL207802 9114 9 None 48 3 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 484 15 5 8 2.2 N#Cc1cc(OCCOCC2CC2)ccc1OCC(CNCCNC(=O)Nc1ccc(cc1)O)O 28400472
2303 9961 68 None -9 26 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10079020
2303 9961 68 None -9 26 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 15060759
2303 9961 68 None -9 26 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 15655528
2303 9961 68 None -9 26 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 27588207
4946 9961 68 None -9 26 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10079020
4946 9961 68 None -9 26 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 15060759
4946 9961 68 None -9 26 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 15655528
4946 9961 68 None -9 26 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 27588207
564 9961 68 None -9 26 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10079020
564 9961 68 None -9 26 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 15060759
564 9961 68 None -9 26 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 15655528
564 9961 68 None -9 26 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 27588207
63 9961 68 None -9 26 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10079020
63 9961 68 None -9 26 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 15060759
63 9961 68 None -9 26 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 15655528
63 9961 68 None -9 26 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 27588207
91536 9961 68 None -9 26 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10079020
91536 9961 68 None -9 26 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 15060759
91536 9961 68 None -9 26 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 15655528
91536 9961 68 None -9 26 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 27588207
CHEMBL27 9961 68 None -9 26 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10079020
CHEMBL27 9961 68 None -9 26 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 15060759
CHEMBL27 9961 68 None -9 26 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 15655528
CHEMBL27 9961 68 None -9 26 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 27588207
CHEMBL452861 9961 68 None -9 26 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10079020
CHEMBL452861 9961 68 None -9 26 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 15060759
CHEMBL452861 9961 68 None -9 26 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 15655528
CHEMBL452861 9961 68 None -9 26 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 27588207
DB00571 9961 68 None -9 26 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10079020
DB00571 9961 68 None -9 26 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 15060759
DB00571 9961 68 None -9 26 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 15655528
DB00571 9961 68 None -9 26 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 27588207
3914 7527 35 None -3 7 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 5 2 4 2.3 CC(C)(C)NCC(COC1=CC=CC2=C1CCCC2=O)O None
39468 7527 35 None -3 7 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 5 2 4 2.3 CC(C)(C)NCC(COC1=CC=CC2=C1CCCC2=O)O None
431 7527 35 None -3 7 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 5 2 4 2.3 CC(C)(C)NCC(COC1=CC=CC2=C1CCCC2=O)O None
570 7527 35 None -3 7 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 5 2 4 2.3 CC(C)(C)NCC(COC1=CC=CC2=C1CCCC2=O)O None
CHEMBL1201237 7527 35 None -3 7 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 5 2 4 2.3 CC(C)(C)NCC(COC1=CC=CC2=C1CCCC2=O)O None
CHEMBL293030 7527 35 None -3 7 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 5 2 4 2.3 CC(C)(C)NCC(COC1=CC=CC2=C1CCCC2=O)O None
DB01210 7527 35 None -3 7 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 5 2 4 2.3 CC(C)(C)NCC(COC1=CC=CC2=C1CCCC2=O)O None
2685 7677 21 None -1 7 Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10079020
2685 7677 21 None -1 7 Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10411574
2685 7677 21 None -1 7 Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 15655528
2685 7677 21 None -1 7 Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 26385885
2685 7677 21 None -1 7 Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 27588207
541 7677 21 None -1 7 Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10079020
541 7677 21 None -1 7 Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10411574
541 7677 21 None -1 7 Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 15655528
541 7677 21 None -1 7 Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 26385885
541 7677 21 None -1 7 Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 27588207
CHEMBL280822 7677 21 None -1 7 Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10079020
CHEMBL280822 7677 21 None -1 7 Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 10411574
CHEMBL280822 7677 21 None -1 7 Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 15655528
CHEMBL280822 7677 21 None -1 7 Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 26385885
CHEMBL280822 7677 21 None -1 7 Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 494 11 4 8 2.3 OC(COc1ccc(cc1)c1nc(cn1C)C(F)(F)F)CNCCOc1ccc(c(c1)C(=O)N)O 27588207
12580 9529 0 None 1 2 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 482 13 3 7 3.1 O[C@@H](CNCCOC1=CC=C2C(=O)NCC2=C1)COC3=CC4=C(O[C@H](CCCC5CC5)CO4)C=C3 28400472
167993659 9529 0 None 1 2 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 482 13 3 7 3.1 O[C@@H](CNCCOC1=CC=C2C(=O)NCC2=C1)COC3=CC4=C(O[C@H](CCCC5CC5)CO4)C=C3 28400472
33624 10593 34 None -6 9 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 14645666
33624 10593 34 None -6 9 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 15060759
33624 10593 34 None -6 9 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 15655528
4061 10593 34 None -6 9 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 14645666
4061 10593 34 None -6 9 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 15060759
4061 10593 34 None -6 9 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 15655528
565 10593 34 None -6 9 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 14645666
565 10593 34 None -6 9 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 15060759
565 10593 34 None -6 9 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 15655528
CHEMBL499 10593 34 None -6 9 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 14645666
CHEMBL499 10593 34 None -6 9 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 15060759
CHEMBL499 10593 34 None -6 9 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 15655528
DB00373 10593 34 None -6 9 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 14645666
DB00373 10593 34 None -6 9 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 15060759
DB00373 10593 34 None -6 9 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 316 6 2 8 0.5 O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C 15655528
2369 7409 80 None 3 8 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10079020
2369 7409 80 None 3 8 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 11572462
2369 7409 80 None 3 8 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 15655528
356 7409 80 None 3 8 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10079020
356 7409 80 None 3 8 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 11572462
356 7409 80 None 3 8 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 15655528
549 7409 80 None 3 8 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10079020
549 7409 80 None 3 8 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 11572462
549 7409 80 None 3 8 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 15655528
CHEMBL423 7409 80 None 3 8 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10079020
CHEMBL423 7409 80 None 3 8 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 11572462
CHEMBL423 7409 80 None 3 8 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 15655528
DB00195 7409 80 None 3 8 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 10079020
DB00195 7409 80 None 3 8 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 11572462
DB00195 7409 80 None 3 8 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 307 11 2 4 2.4 OC(COc1ccc(cc1)CCOCC1CC1)CNC(C)C 15655528
123686 8762 51 None -1 9 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 9 4 5 1.7 C1=CC=C(C=C1)NC(=O)NCCNCC(COC2=CC=CC=C2C#N)O 23614528
12581 8762 51 None -1 9 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 9 4 5 1.7 C1=CC=C(C=C1)NC(=O)NCCNCC(COC2=CC=CC=C2C#N)O 23614528
CHEMBL11268 8762 51 None -1 9 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 9 4 5 1.7 C1=CC=C(C=C1)NC(=O)NCCNCC(COC2=CC=CC=C2C#N)O 23614528
2176 9901 68 None -4 27 Human 9.0 pKi = 9.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 17804228
2176 9901 68 None -4 27 Human 9.0 pKi = 9.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 20590599
4828 9901 68 None -4 27 Human 9.0 pKi = 9.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 17804228
4828 9901 68 None -4 27 Human 9.0 pKi = 9.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 20590599
91 9901 68 None -4 27 Human 9.0 pKi = 9.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 17804228
91 9901 68 None -4 27 Human 9.0 pKi = 9.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 20590599
CHEMBL500 9901 68 None -4 27 Human 9.0 pKi = 9.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 17804228
CHEMBL500 9901 68 None -4 27 Human 9.0 pKi = 9.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 20590599
DB00960 9901 68 None -4 27 Human 9.0 pKi = 9.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 17804228
DB00960 9901 68 None -4 27 Human 9.0 pKi = 9.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 20590599
2687 7676 16 None -1 5 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 279 5 4 4 1.0 OC(COc1cccc2c1[nH]c(=O)[nH]2)CNC(C)(C)C 15060759
2687 7676 16 None -1 5 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 279 5 4 4 1.0 OC(COc1cccc2c1[nH]c(=O)[nH]2)CNC(C)(C)C 15655528
2687 7676 16 None -1 5 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 279 5 4 4 1.0 OC(COc1cccc2c1[nH]c(=O)[nH]2)CNC(C)(C)C 27588207
532 7676 16 None -1 5 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 279 5 4 4 1.0 OC(COc1cccc2c1[nH]c(=O)[nH]2)CNC(C)(C)C 15060759
532 7676 16 None -1 5 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 279 5 4 4 1.0 OC(COc1cccc2c1[nH]c(=O)[nH]2)CNC(C)(C)C 15655528
532 7676 16 None -1 5 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 279 5 4 4 1.0 OC(COc1cccc2c1[nH]c(=O)[nH]2)CNC(C)(C)C 27588207
5387 7676 16 None -1 5 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 279 5 4 4 1.0 OC(COc1cccc2c1[nH]c(=O)[nH]2)CNC(C)(C)C 15060759
5387 7676 16 None -1 5 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 279 5 4 4 1.0 OC(COc1cccc2c1[nH]c(=O)[nH]2)CNC(C)(C)C 15655528
5387 7676 16 None -1 5 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 279 5 4 4 1.0 OC(COc1cccc2c1[nH]c(=O)[nH]2)CNC(C)(C)C 27588207
CHEMBL420746 7676 16 None -1 5 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 279 5 4 4 1.0 OC(COc1cccc2c1[nH]c(=O)[nH]2)CNC(C)(C)C 15060759
CHEMBL420746 7676 16 None -1 5 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 279 5 4 4 1.0 OC(COc1cccc2c1[nH]c(=O)[nH]2)CNC(C)(C)C 15655528
CHEMBL420746 7676 16 None -1 5 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 279 5 4 4 1.0 OC(COc1cccc2c1[nH]c(=O)[nH]2)CNC(C)(C)C 27588207
2176 9901 68 None -4 27 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 14645666
2176 9901 68 None -4 27 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 15060759
2176 9901 68 None -4 27 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 20590599
4828 9901 68 None -4 27 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 14645666
4828 9901 68 None -4 27 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 15060759
4828 9901 68 None -4 27 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 20590599
91 9901 68 None -4 27 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 14645666
91 9901 68 None -4 27 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 15060759
91 9901 68 None -4 27 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 20590599
CHEMBL500 9901 68 None -4 27 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 14645666
CHEMBL500 9901 68 None -4 27 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 15060759
CHEMBL500 9901 68 None -4 27 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 20590599
DB00960 9901 68 None -4 27 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 14645666
DB00960 9901 68 None -4 27 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 15060759
DB00960 9901 68 None -4 27 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 20590599
2585 7590 103 None -1 22 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10411574
2585 7590 103 None -1 22 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 15655528
522 7590 103 None -1 22 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10411574
522 7590 103 None -1 22 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 15655528
551 7590 103 None -1 22 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10411574
551 7590 103 None -1 22 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 15655528
CHEMBL723 7590 103 None -1 22 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10411574
CHEMBL723 7590 103 None -1 22 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 15655528
DB01136 7590 103 None -1 22 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10411574
DB01136 7590 103 None -1 22 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 15655528
13193 7523 0 None - 1 Human 9.3 pKi = 9.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 363 8 3 4 3.4 CC(C)(CC1=CNC2=CC=CC=C21)NCC(COC3=CC=CC=C3C#N)O 20590599
51045 7523 0 None - 1 Human 9.3 pKi = 9.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 363 8 3 4 3.4 CC(C)(CC1=CNC2=CC=CC=C21)NCC(COC3=CC=CC=C3C#N)O 20590599
CHEMBL321582 7523 0 None - 1 Human 9.3 pKi = 9.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 363 8 3 4 3.4 CC(C)(CC1=CNC2=CC=CC=C21)NCC(COC3=CC=CC=C3C#N)O 20590599
DB12752 7523 0 None - 1 Human 9.3 pKi = 9.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 363 8 3 4 3.4 CC(C)(CC1=CNC2=CC=CC=C21)NCC(COC3=CC=CC=C3C#N)O 20590599
2687 7676 16 None -1 5 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 279 5 4 4 1.0 OC(COc1cccc2c1[nH]c(=O)[nH]2)CNC(C)(C)C 10079020
2687 7676 16 None -1 5 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 279 5 4 4 1.0 OC(COc1cccc2c1[nH]c(=O)[nH]2)CNC(C)(C)C 15655528
2687 7676 16 None -1 5 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 279 5 4 4 1.0 OC(COc1cccc2c1[nH]c(=O)[nH]2)CNC(C)(C)C 20590599
532 7676 16 None -1 5 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 279 5 4 4 1.0 OC(COc1cccc2c1[nH]c(=O)[nH]2)CNC(C)(C)C 10079020
532 7676 16 None -1 5 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 279 5 4 4 1.0 OC(COc1cccc2c1[nH]c(=O)[nH]2)CNC(C)(C)C 15655528
532 7676 16 None -1 5 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 279 5 4 4 1.0 OC(COc1cccc2c1[nH]c(=O)[nH]2)CNC(C)(C)C 20590599
5387 7676 16 None -1 5 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 279 5 4 4 1.0 OC(COc1cccc2c1[nH]c(=O)[nH]2)CNC(C)(C)C 10079020
5387 7676 16 None -1 5 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 279 5 4 4 1.0 OC(COc1cccc2c1[nH]c(=O)[nH]2)CNC(C)(C)C 15655528
5387 7676 16 None -1 5 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 279 5 4 4 1.0 OC(COc1cccc2c1[nH]c(=O)[nH]2)CNC(C)(C)C 20590599
CHEMBL420746 7676 16 None -1 5 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 279 5 4 4 1.0 OC(COc1cccc2c1[nH]c(=O)[nH]2)CNC(C)(C)C 10079020
CHEMBL420746 7676 16 None -1 5 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 279 5 4 4 1.0 OC(COc1cccc2c1[nH]c(=O)[nH]2)CNC(C)(C)C 15655528
CHEMBL420746 7676 16 None -1 5 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 279 5 4 4 1.0 OC(COc1cccc2c1[nH]c(=O)[nH]2)CNC(C)(C)C 20590599
135398737 7745 93 None -269 90 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
38 7745 93 None -269 90 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
722 7745 93 None -269 90 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
CHEMBL42 7745 93 None -269 90 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
DB00363 7745 93 None -269 90 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
135398745 9688 112 None -331 65 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
47 9688 112 None -331 65 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
CHEMBL715 9688 112 None -331 65 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
DB00334 9688 112 None -331 65 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
2181 9902 46 None -134 34 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 375 7 1 4 2.6 O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N None
4830 9902 46 None -134 34 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 375 7 1 4 2.6 O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N None
92 9902 46 None -134 34 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 375 7 1 4 2.6 O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N None
CHEMBL440294 9902 46 None -134 34 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 375 7 1 4 2.6 O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N None
DB09286 9902 46 None -134 34 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 375 7 1 4 2.6 O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N None
2337 10030 77 None -72 62 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
50 10030 77 None -72 62 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
5002 10030 77 None -72 62 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
CHEMBL716 10030 77 None -72 62 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
DB01224 10030 77 None -72 62 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
2389 10104 118 None -1737 66 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
5073 10104 118 None -1737 66 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
96 10104 118 None -1737 66 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
CHEMBL85 10104 118 None -1737 66 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
DB00734 10104 118 None -1737 66 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
2435 10362 83 None -316 48 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
60149 10362 83 None -316 48 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
98 10362 83 None -316 48 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
CHEMBL12713 10362 83 None -316 48 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
DB06144 10362 83 None -316 48 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
115237 62359 119 None -2754 54 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 426 4 1 7 3.1 Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2O None
CHEMBL1621 62359 119 None -2754 54 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 426 4 1 7 3.1 Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2O None
46780481 114308 20 None -954 53 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
9903970 114308 20 None -954 53 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
CHEMBL3187365 114308 20 None -954 53 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
CHEMBL3544974 114308 20 None -954 53 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
1028 7079 71 None -70 30 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
139148732 7079 71 None -70 30 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
479 7079 71 None -70 30 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
5816 7079 71 None -70 30 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
CHEMBL679 7079 71 None -70 30 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
DB00668 7079 71 None -70 30 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
3337 213146 27 None -58 40 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 None
65801 213146 27 None -58 40 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 None
66264 213146 27 None -58 40 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 None
91452 213146 27 None -58 40 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 None
CHEMBL87493 213146 27 None -58 40 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 None
2601 10552 33 None -72 21 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC None
443951 10552 33 None -72 21 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC None
56 10552 33 None -72 21 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC None
CHEMBL73151 10552 33 None -72 21 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC None
DB13399 10552 33 None -72 21 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC None
65772 67177 8 None -2 6 Human 8.1 pKi None 8.1 Binding
NoneNone
Drug Central 345 5 3 6 2.6 COc1cc(C[C@@H]2NCCc3cc(O)c(O)cc32)cc(OC)c1OC None
CHEMBL174984 67177 8 None -2 6 Human 8.1 pKi None 8.1 Binding
NoneNone
Drug Central 345 5 3 6 2.6 COc1cc(C[C@@H]2NCCc3cc(O)c(O)cc32)cc(OC)c1OC None
173382 10490 0 None - 1 Human 6.6 pKi None 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 333 8 4 6 2.0 COc1cc(CCNCC(c2ccc(c(c2)O)O)O)ccc1OC 8982677
533 10490 0 None - 1 Human 6.6 pKi None 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 333 8 4 6 2.0 COc1cc(CCNCC(c2ccc(c(c2)O)O)O)ccc1OC 8982677
193122 8691 6 None 3 2 Human 7.0 pKi None 7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 283 10 2 5 1.5 COCCOc1ccc(cc1)OCC(CNC(C)C)O 10079020
542 8691 6 None 3 2 Human 7.0 pKi None 7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 283 10 2 5 1.5 COCCOc1ccc(cc1)OCC(CNC(C)C)O 10079020
CHEMBL142773 8691 6 None 3 2 Human 7.0 pKi None 7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 283 10 2 5 1.5 COCCOc1ccc(cc1)OCC(CNC(C)C)O 10079020
10587912 9600 0 None 12 2 Human 7.1 pKi None 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 267 9 3 4 1.3 OCCCc1ccc(cc1)OCC(CNC(C)C)O 10079020
545 9600 0 None 12 2 Human 7.1 pKi None 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 267 9 3 4 1.3 OCCCc1ccc(cc1)OCC(CNC(C)C)O 10079020
146294 7715 0 None 6 2 Human 8.0 pKi None 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 323 12 2 5 2.2 OC(COc1ccc(cc1)OCCOCC1CC1)CNC(C)C 10079020
552 7715 0 None 6 2 Human 8.0 pKi None 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 323 12 2 5 2.2 OC(COc1ccc(cc1)OCCOCC1CC1)CNC(C)C 10079020
637 7715 0 None 6 2 Human 8.0 pKi None 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 323 12 2 5 2.2 OC(COc1ccc(cc1)OCCOCC1CC1)CNC(C)C 10079020
CHEMBL2110772 7715 0 None 6 2 Human 8.0 pKi None 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 323 12 2 5 2.2 OC(COc1ccc(cc1)OCCOCC1CC1)CNC(C)C 10079020
3123920 9602 85 None -2 6 Human 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 209 6 2 3 1.4 OC(COc1ccccc1)CNC(C)C 10079020
546 9602 85 None -2 6 Human 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 209 6 2 3 1.4 OC(COc1ccccc1)CNC(C)C 10079020
CHEMBL7154 9602 85 None -2 6 Human 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 209 6 2 3 1.4 OC(COc1ccccc1)CNC(C)C 10079020